data_2mx1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mx1 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.042 0.449 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.442 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 10.1 mp -62.1 -42.13 98.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.01 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -60.88 -41.73 96.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.018 0.437 . . . . 0.0 110.127 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.66 -38.85 90.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.098 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 162' ' ' PHE . 60.6 t0 -60.52 -47.23 87.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.258 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.95 -45.98 91.28 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.383 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 10' ' ' ILE . 97.0 mt -63.45 -43.76 98.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.207 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.23 -46.42 82.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.177 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.66 -44.09 97.16 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.946 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.69 -53.28 59.32 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.8 pt -69.39 -39.81 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.757 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -58.72 -55.14 38.94 Favored 'General case' 0 C--O 1.217 -0.634 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.695 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.475 ' O ' ' N ' ' A' ' 20' ' ' GLU . 93.5 t -61.96 -39.28 83.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.6 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.444 ' CD2' ' C ' ' A' ' 17' ' ' LEU . 6.3 tt -52.64 -50.49 63.07 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.453 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -80.2 -51.38 9.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.992 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -65.52 -33.54 76.17 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.159 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.6 mt-10 58.14 88.11 0.06 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.816 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.04 -136.78 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.328 -0.397 . . . . 0.0 109.975 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.1 p -141.19 138.42 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pp -130.44 166.59 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-O 121.0 0.429 . . . . 0.0 111.876 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.58 134.71 56.97 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.936 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.473 ' CZ ' ' O ' ' A' ' 26' ' ' PRO . 2.0 t80 -128.73 133.63 25.4 Favored Pre-proline 0 CA--C 1.552 1.035 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.821 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.473 ' O ' ' CZ ' ' A' ' 25' ' ' TYR . 27.8 Cg_exo -60.09 146.04 97.05 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 CA-C-N 121.048 1.41 . . . . 0.0 110.898 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.444 ' C ' ' H ' ' A' ' 29' ' ' ALA . 78.7 m -129.36 142.5 50.8 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.188 0.518 . . . . 0.0 110.378 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -77.66 20.1 0.35 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.641 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.444 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -160.21 -69.26 0.07 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.625 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.9 t -127.24 130.14 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.477 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 77.3 m-85 -42.24 136.6 2.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.178 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.43 -170.81 12.18 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.9 m -132.47 165.43 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.52 -177.05 27.49 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.303 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.439 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -156.22 -168.08 2.63 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.604 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.496 ' OD1' ' CE1' ' A' ' 131' ' ' TYR . 19.1 t70 -96.07 109.69 48.19 Favored Pre-proline 0 CA--C 1.553 1.063 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -178.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 36' ' ' ASP . 23.6 Cg_exo -36.79 170.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.865 2.377 . . . . 0.0 114.126 177.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 40.94 68.3 0.44 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.961 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.3 m -151.02 142.03 23.03 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.839 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -66.39 -32.56 74.02 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.43 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.0 t -59.48 -40.88 88.41 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.528 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.8 -52.19 66.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.256 0.55 . . . . 0.0 111.506 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 p -64.12 -45.87 95.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.876 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 91.3 mtp -66.79 -46.84 73.99 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.414 ' O ' ' CD2' ' A' ' 49' ' ' LEU . 40.8 ptt85 -63.01 -30.64 71.76 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.416 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 64.0 mt -73.55 -60.95 2.01 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 119.591 -0.843 . . . . 0.0 109.493 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.4 mt -53.11 -21.38 4.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.446 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -64.11 -85.23 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.665 -177.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.414 ' CD2' ' O ' ' A' ' 45' ' ' ARG . 2.3 pt? -75.93 -32.8 59.74 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -77.17 -71.49 0.4 Allowed 'General case' 0 C--N 1.346 0.423 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.564 -176.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.408 ' O ' ' CG ' ' A' ' 51' ' ' GLN . 3.6 tt0 53.73 80.56 0.11 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.463 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.2 mtp85 161.19 -63.95 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.073 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -66.81 -12.52 36.34 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 122.568 2.179 . . . . 0.0 112.165 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.435 ' CG1' ' N ' ' A' ' 55' ' ' ASP . 7.3 p -43.9 -46.67 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.026 0.441 . . . . 0.0 110.625 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 110' ' ' ARG . 12.5 t0 -66.69 -44.75 80.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.629 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -59.8 -39.97 86.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.939 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 67.35 109.86 0.02 OUTLIER Glycine 0 CA--C 1.522 0.471 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.573 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -49.24 -170.17 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.935 -0.632 . . . . 0.0 112.222 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.438 ' O ' ' OG ' ' A' ' 137' ' ' SER . 83.0 mt -104.8 139.92 24.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.3 mt -109.02 145.02 36.25 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.433 ' CD1' ' HE ' ' A' ' 117' ' ' ARG . 9.1 tp -110.69 129.88 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-O 121.316 0.579 . . . . 0.0 110.247 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.55 153.82 33.58 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.403 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.36 -27.05 7.72 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.617 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 21.4 m120 -117.05 144.86 44.15 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.193 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -72.91 -14.21 61.42 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.324 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -50.53 -33.95 23.54 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.513 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.617 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 4.8 pm0 -93.59 -9.26 38.71 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.13 -16.63 27.46 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.462 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 43.6 tttm -76.69 -39.1 2.28 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -178.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 93.7 Cg_endo -102.06 -4.97 0.33 Allowed 'Trans proline' 0 C--N 1.318 -1.027 0 C-N-CA 122.65 2.233 . . . . 0.0 111.846 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.436 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 55.6 t80 -92.36 -14.48 28.64 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.892 0.377 . . . . 0.0 110.181 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.423 ' CG2' ' N ' ' A' ' 73' ' ' ASP . 4.6 mp -134.19 158.49 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.423 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 21.9 m-20 -62.97 145.74 54.67 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -79.04 -4.57 50.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.751 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.1 t -73.56 -37.9 65.4 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.033 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 63.2 mmm -64.57 -47.45 78.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.759 0.79 . . . . 0.0 109.672 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.7 mp -79.02 135.07 36.78 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 113.886 -1.506 . . . . 0.0 111.18 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.608 ' HG1' ' N ' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -160.23 158.73 30.5 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.876 -178.697 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.608 ' N ' ' HG1' ' A' ' 78' ' ' THR . 99.3 m-20 -38.57 -47.36 1.3 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.841 -178.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.89 -34.44 68.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.097 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.457 ' N ' ' O ' ' A' ' 78' ' ' THR . 65.9 tp60 -65.51 -40.45 93.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.747 0.308 . . . . 0.0 110.727 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -63.95 -52.53 59.3 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 122.309 1.052 . . . . 0.0 109.235 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' A' ' 87' ' ' SER . 83.1 tt0 -55.24 -50.41 69.53 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.145 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.4 m -61.46 -50.25 73.52 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.216 -1.356 . . . . 0.0 111.966 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.4 tt -67.97 -32.5 56.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.717 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -76.67 -34.67 58.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.543 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 83' ' ' GLU . 11.6 m -87.83 -15.73 36.03 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.642 0.258 . . . . 0.0 111.13 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.436 ' O ' ' O ' ' A' ' 89' ' ' TRP . 68.4 ttt180 -116.3 75.62 0.97 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.813 0.34 . . . . 0.0 110.372 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.436 ' O ' ' O ' ' A' ' 88' ' ' ARG . 75.0 m95 57.7 148.13 0.06 OUTLIER Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.709 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.44 -29.26 37.95 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.922 1.748 . . . . 0.0 112.044 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 149.68 80.05 0.03 OUTLIER Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -85.08 -8.91 8.81 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.992 2.462 . . . . 0.0 112.17 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.7 p -135.99 147.87 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.185 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 82.7 m -85.48 141.25 30.05 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.292 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -123.0 142.74 50.51 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.465 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.2 t -106.03 112.8 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-O 121.261 0.553 . . . . 0.0 110.66 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -97.94 150.68 37.01 Favored Pre-proline 0 N--CA 1.472 0.646 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.72 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.69 86.59 0.86 Allowed 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 122.118 1.879 . . . . 0.0 111.341 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -48.61 150.9 2.23 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.969 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.07 145.36 66.99 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.88 1.72 . . . . 0.0 112.197 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.437 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.951 -179.971 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.473 ' O ' ' N ' ' A' ' 109' ' ' GLY . 2.0 tpt180 . . . . . 0 N--CA 1.471 0.593 0 CA-C-O 120.409 0.147 . . . . 0.0 110.792 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 47.3 p-90 -75.5 -9.55 58.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.763 0.316 . . . . 0.0 110.461 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.653 ' CD1' ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -76.55 -25.11 53.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.19 -179.217 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.55 ' C ' ' H ' ' A' ' 110' ' ' ARG . 24.4 m -144.24 -42.58 0.26 Allowed 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 49.49 0.98 0.01 OUTLIER Glycine 0 CA--C 1.537 1.42 0 C-N-CA 121.368 -0.444 . . . . 0.0 113.125 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.55 ' H ' ' C ' ' A' ' 108' ' ' THR . 0.0 OUTLIER -93.88 -62.31 1.37 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 117.882 0.841 . . . . 0.0 109.853 179.715 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.55 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 87.8 t80 -147.57 169.72 18.99 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.101 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.55 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 4.2 p-10 -84.0 73.74 10.33 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.519 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 54.3 p -169.15 126.02 0.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -117.01 120.21 37.68 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.28 117.21 20.85 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.508 177.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.6 p -141.4 159.47 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.587 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.433 ' HE ' ' CD1' ' A' ' 61' ' ' ILE . 61.6 ttp180 -139.77 150.71 45.09 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.667 0.27 . . . . 0.0 111.13 -179.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.8 t -120.68 131.92 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.9 t -135.84 134.96 39.41 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -139.5 87.1 2.16 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.864 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.562 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 52.1 t-80 -172.58 -36.91 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.562 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 58.5 Cg_endo -95.33 -159.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 122.181 1.921 . . . . 0.0 112.006 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.8 mt -77.53 -5.98 52.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.26 0.552 . . . . 0.0 110.387 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.2 t -57.95 -45.23 87.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.837 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.576 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 27.8 m -53.83 -61.81 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.926 0 C-N-CA 119.413 -0.915 . . . . 0.0 108.92 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.576 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -41.0 -45.52 2.62 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.581 0.229 . . . . 0.0 110.93 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.5 tp -68.99 -47.09 66.41 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.268 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 64.2 m -70.44 -49.54 47.65 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.411 0.624 . . . . 0.0 110.997 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 125' ' ' VAL . 1.2 pp0? -54.73 -41.75 70.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.438 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.445 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -58.6 -56.77 17.92 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.735 -177.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.496 ' CE1' ' OD1' ' A' ' 36' ' ' ASP . 3.9 t80 -63.57 -22.11 66.72 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.705 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 81.27 3.42 90.66 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.3 mttt -151.83 158.19 34.1 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.645 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -43.08 178.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 123.63 2.887 . . . . 0.0 113.536 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.9 tp -135.18 123.2 22.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 113.57 -1.65 . . . . 0.0 106.826 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.88 144.32 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 C-N-CA 118.041 -1.463 . . . . 0.0 108.072 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 59' ' ' ILE . 1.1 p -113.97 123.74 50.47 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.64 0.588 . . . . 0.0 111.693 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 4.0 m -128.85 162.09 28.3 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.595 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.1 m -74.61 149.78 39.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.335 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.54 81.98 5.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.602 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -160.4 164.08 32.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.389 0.614 . . . . 0.0 110.578 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.68 -165.96 1.74 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.127 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.2 t -59.71 -44.11 93.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.414 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -162.55 12.49 0.11 Allowed Glycine 0 C--N 1.327 0.075 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.9 tp -89.1 126.4 59.11 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -39.64 157.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.538 1.492 . . . . 0.0 112.297 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.62 -161.0 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.411 2.074 . . . . 0.0 111.759 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 148' ' ' CYS . 28.1 p -126.4 86.05 2.47 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.477 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 51.6 ptt85 -53.34 -37.47 62.37 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.862 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.36 171.48 20.16 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.6 m -59.28 -22.48 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 CA-C-O 121.484 0.659 . . . . 0.0 109.297 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -65.26 -25.46 67.67 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 155' ' ' ARG . 0.0 OUTLIER -71.78 -78.97 0.08 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.49 179.282 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.4 p -34.75 -29.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.489 0.715 . . . . 0.0 110.072 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -73.68 -51.77 15.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.921 179.646 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 153' ' ' GLU . . . -69.78 -20.33 63.48 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 122.542 1.163 . . . . 0.0 108.064 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -82.78 -45.93 13.75 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 112.753 -2.021 . . . . 0.0 111.563 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -129.26 -22.66 3.08 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 90.01 22.7 34.81 Favored Glycine 0 N--CA 1.467 0.708 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.42 ' O ' ' O ' ' A' ' 159' ' ' GLY . . . -43.27 -98.28 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.742 0.306 . . . . 0.0 110.942 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.46 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 62.62 35.12 14.49 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.539 ' C ' ' H ' ' A' ' 164' ' ' VAL . 1.7 m-85 -174.06 -62.16 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.057 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -73.41 29.05 0.3 Allowed 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.175 1.917 . . . . 0.0 110.476 177.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.539 ' H ' ' C ' ' A' ' 162' ' ' PHE . 15.3 m -131.55 166.86 27.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.747 -178.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.8 t -123.0 65.7 28.04 Favored Pre-proline 0 N--CA 1.473 0.684 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.796 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -36.31 142.42 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 123.561 2.841 . . . . 0.0 115.008 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 165.1 -167.91 38.97 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 114.006 -1.452 . . . . 0.0 110.88 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -152.71 177.84 10.27 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.466 0.36 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.404 179.952 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 . . . . . 0 N--CA 1.445 -0.7 0 CA-C-O 120.639 0.257 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.0 pt -122.7 102.5 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 121.182 0.515 . . . . 0.0 110.331 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -95.53 156.2 16.42 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.339 0.59 . . . . 0.0 111.847 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -76.4 106.36 7.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.822 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -64.68 -12.03 42.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.704 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.493 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.6 mm? -63.03 -42.05 99.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.348 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.71 -42.79 3.07 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.528 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.88 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.815 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 . . . . . 0 N--CA 1.468 0.444 0 CA-C-O 120.713 0.292 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.4 mp -62.74 -41.83 99.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.965 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -63.37 -42.8 98.88 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.417 0.627 . . . . 0.0 109.783 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -62.31 -41.36 98.47 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.476 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -62.11 -45.55 92.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.741 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.89 90.02 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.19 0.519 . . . . 0.0 110.379 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.408 HG23 HD12 ' A' ' 10' ' ' ILE . 94.6 mt -63.48 -43.72 98.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.613 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.52 -45.59 81.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.191 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.72 -39.25 90.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.618 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.4 -53.98 49.52 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.51 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.6 pt -71.59 -31.01 40.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.232 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -59.57 -55.08 38.95 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 20' ' ' GLU . 88.7 t -63.72 -40.35 88.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.896 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.449 ' CD2' ' C ' ' A' ' 17' ' ' LEU . 6.5 tt -52.28 -50.28 62.44 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.555 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -79.82 -50.13 10.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.073 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -66.25 -34.59 78.36 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.952 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.8 mt-10 60.92 82.38 0.17 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 178.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.47 -139.51 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.232 177.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 p -134.67 142.63 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 pp -129.35 163.66 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 120.896 0.379 . . . . 0.0 111.304 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.89 131.22 48.02 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.215 0.531 . . . . 0.0 111.11 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.494 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 0.4 OUTLIER -121.02 140.36 30.8 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.494 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 65.3 Cg_endo -79.33 154.73 24.84 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.553 1.502 . . . . 0.0 111.931 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.49 ' C ' ' H ' ' A' ' 29' ' ' ALA . 23.0 m -142.2 141.38 32.55 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.221 0.534 . . . . 0.0 110.955 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -75.44 23.18 0.12 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.547 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.49 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -154.21 -75.48 0.11 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.965 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.4 t -125.73 128.83 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 120.973 0.416 . . . . 0.0 110.174 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.503 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 93.5 m-85 -46.67 147.48 1.24 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.144 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -152.47 -174.47 23.03 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.6 m -126.55 168.16 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.412 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -157.64 177.65 34.33 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.098 -1.049 . . . . 0.0 112.235 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -154.66 -166.75 2.41 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.508 0.194 . . . . 0.0 110.594 -179.401 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.451 ' O ' ' O ' ' A' ' 37' ' ' PRO . 3.8 m-20 -95.52 108.78 41.84 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -178.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.451 ' O ' ' O ' ' A' ' 36' ' ' ASP . 54.1 Cg_exo -38.69 174.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.76 2.307 . . . . 0.0 114.042 177.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 38.08 69.72 0.23 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.302 -1.317 . . . . 0.0 111.429 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 51.0 m -149.1 144.09 26.44 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.376 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -69.5 -36.46 76.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.426 0.631 . . . . 0.0 110.64 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.39 -43.68 93.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.664 -178.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.46 -50.05 75.11 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.041 -0.263 . . . . 0.0 111.413 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.1 p -62.32 -44.96 99.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.391 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 91.1 mtp -63.66 -40.49 96.98 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 34.0 ttt-85 -61.02 -41.6 96.86 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.923 0.868 . . . . 0.0 108.844 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.94 -54.74 25.85 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.238 -178.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.4 mt -69.1 -11.41 60.77 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.349 -0.842 . . . . 0.0 112.002 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -69.57 -82.48 0.04 OUTLIER 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 120.996 0.426 . . . . 0.0 110.778 -177.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.433 HD22 ' H ' ' A' ' 50' ' ' LYS . 2.2 pt? -76.42 -35.29 58.62 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -178.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.433 ' H ' HD22 ' A' ' 49' ' ' LEU . 24.9 mmmt -76.36 -50.56 13.91 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.797 -177.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 35.29 66.55 0.31 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.724 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 178.12 -53.05 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.898 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.397 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.56 -5.42 13.31 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.866 2.377 . . . . 0.0 112.584 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.401 ' CG1' ' N ' ' A' ' 55' ' ' ASP . 8.0 p -44.71 -45.13 2.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.073 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.401 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 67.5 t0 -65.62 -40.38 92.52 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.588 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -62.21 -39.19 91.96 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 71.25 109.62 0.04 OUTLIER Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.564 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -51.7 -163.34 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.232 0.539 . . . . 0.0 112.209 -179.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.451 ' O ' ' OG ' ' A' ' 137' ' ' SER . 61.1 mt -105.12 137.28 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.897 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.7 mt -115.68 143.01 45.98 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.3 tp -111.82 132.91 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 121.149 0.5 . . . . 0.0 110.741 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.47 150.92 41.85 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.95 -29.79 8.42 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.04 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.663 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 14.3 m120 -113.12 150.05 32.7 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.155 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -79.01 -14.28 59.28 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -54.49 -30.19 52.54 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.913 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.663 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 4.0 pm0 -95.01 -11.06 29.1 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.42 ' CD2' ' N ' ' A' ' 68' ' ' LEU . 3.7 mm? -91.16 -18.8 23.88 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.459 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 43.4 tttm -75.57 -39.43 2.99 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 85.3 Cg_endo -104.18 -2.61 0.23 Allowed 'Trans proline' 0 C--N 1.319 -1.009 0 C-N-CA 122.91 2.407 . . . . 0.0 112.363 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.408 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 63.7 t80 -96.95 -11.12 25.04 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.692 -178.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.1 mp -127.94 155.96 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -64.29 158.52 23.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.965 0.412 . . . . 0.0 110.08 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -94.74 7.74 44.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.028 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.419 ' CG2' ' N ' ' A' ' 76' ' ' MET . 13.2 t -74.32 -42.57 59.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.029 0.442 . . . . 0.0 111.075 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.419 ' N ' ' CG2' ' A' ' 75' ' ' THR . 24.4 ptm -95.34 -15.74 22.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.093 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 tp -93.92 127.57 39.76 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.113 0.482 . . . . 0.0 110.63 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.458 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -157.73 161.94 38.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.858 -177.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -39.61 -47.52 1.96 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.776 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.58 -32.64 57.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.853 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.458 ' N ' ' O ' ' A' ' 78' ' ' THR . 58.6 tp60 -63.48 -40.97 98.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.204 0.526 . . . . 0.0 110.19 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.6 mmt85 -65.41 -52.85 50.49 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 122.484 1.135 . . . . 0.0 109.42 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -54.25 -50.96 65.99 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 113.801 -1.545 . . . . 0.0 110.143 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.6 m -61.1 -50.04 74.88 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.574 -1.193 . . . . 0.0 111.979 -177.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.6 tt -67.81 -32.13 55.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.072 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -76.47 -36.05 58.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.753 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.8 m -87.4 -14.19 41.28 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.633 0.254 . . . . 0.0 111.298 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 89' ' ' TRP . 69.2 ttt180 -115.34 75.43 0.94 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.427 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.452 ' O ' ' O ' ' A' ' 88' ' ' ARG . 13.9 m-90 56.37 153.11 0.07 OUTLIER Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.507 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.6 -21.23 39.87 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.133 1.889 . . . . 0.0 111.649 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.519 ' O ' ' NE ' ' A' ' 117' ' ' ARG . . . 158.52 81.27 0.04 OUTLIER Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.55 -17.8 11.07 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.262 1.974 . . . . 0.0 112.047 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.0 p -136.95 146.32 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.132 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.6 m -91.31 129.33 37.32 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.389 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -117.5 138.05 52.14 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.779 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.2 t -92.46 104.65 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 121.301 0.572 . . . . 0.0 110.761 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 97' ' ' PHE . 30.4 m-85 -86.3 147.1 43.85 Favored Pre-proline 0 N--CA 1.466 0.362 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.529 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.54 83.76 1.85 Allowed 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.993 1.796 . . . . 0.0 111.6 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -46.2 152.46 0.81 Allowed Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -69.46 156.28 64.56 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.036 1.824 . . . . 0.0 111.607 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.464 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.17 179.996 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' A' ' 109' ' ' GLY . 8.0 tpt180 . . . . . 0 CA--C 1.528 0.118 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 8.6 p90 -81.31 -10.08 59.63 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.662 0.744 . . . . 0.0 109.057 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.541 ' H ' ' CD2' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -77.38 -15.28 59.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.638 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 85.3 m -143.28 -40.57 0.31 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.316 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 92.33 -19.28 51.04 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 116.263 -0.426 . . . . 0.0 113.714 178.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.419 ' O ' ' NH2' ' A' ' 105' ' ' ARG . 18.1 tpt180 -144.86 -80.4 0.17 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 117.953 0.877 . . . . 0.0 111.786 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.406 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 29.7 t80 -75.63 -125.47 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.667 -178.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.406 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 48.1 t0 -170.52 54.38 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.834 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.6 p -157.27 155.33 30.58 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.13 137.78 8.58 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.55 135.41 50.02 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 113.212 -1.813 . . . . 0.0 109.777 178.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.6 p -149.73 153.71 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 120.888 0.375 . . . . 0.0 110.7 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.519 ' NE ' ' O ' ' A' ' 91' ' ' GLY . 75.7 ttt180 -142.33 152.55 43.04 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.507 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 49.5 t -119.93 133.05 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.2 t -137.72 138.32 39.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.042 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -145.27 85.2 1.72 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.689 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.597 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 8.2 t60 -173.39 -36.58 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.179 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.597 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 67.7 Cg_endo -95.04 -160.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 122.298 1.999 . . . . 0.0 111.964 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.6 mp -76.84 -7.51 55.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.175 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.0 t -56.74 -45.06 82.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.797 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.571 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 26.8 m -53.84 -61.84 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.875 0 C-N-CA 119.35 -0.94 . . . . 0.0 108.981 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.571 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -41.04 -44.08 2.32 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.894 0.378 . . . . 0.0 110.992 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.6 -48.3 60.58 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.362 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 61.6 m -69.9 -49.28 53.67 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.421 0.629 . . . . 0.0 110.684 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 125' ' ' VAL . 1.0 OUTLIER -54.39 -42.71 70.72 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.42 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.43 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -58.5 -54.96 41.18 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.585 -177.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.443 ' CE1' ' OD2' ' A' ' 36' ' ' ASP . 39.6 t80 -62.46 -21.6 65.57 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.919 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.86 -1.93 82.02 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' A' ' 134' ' ' PRO . 14.2 mtpp -149.5 159.01 37.34 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 133' ' ' LYS . 3.4 Cg_exo -41.68 178.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 123.847 3.031 . . . . 0.0 113.128 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.4 tp -132.34 123.16 26.27 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 176.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.412 ' O ' ' CA ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -63.79 153.12 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 C-N-CA 117.888 -1.525 . . . . 0.0 106.986 -179.702 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 59' ' ' ILE . 1.4 p -130.12 133.78 46.88 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.109 0.48 . . . . 0.0 111.1 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.5 m -134.44 164.67 26.93 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.708 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.6 m -70.45 148.46 48.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.386 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.4 -36.9 81.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.221 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 141' ' ' ASN . 50.3 p30 -67.28 144.41 55.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.043 0.449 . . . . 0.0 110.475 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.563 ' CD1' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -150.94 163.57 38.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.219 -179.607 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 142' ' ' LEU . 29.1 t 28.45 -87.88 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 O-C-N 123.603 0.564 . . . . 0.0 112.192 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 142' ' ' LEU . . . -157.41 16.78 0.35 Allowed Glycine 0 C--N 1.332 0.307 0 N-CA-C 109.976 -1.249 . . . . 0.0 109.976 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.9 tp -94.61 129.25 37.0 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 115.21 -0.495 . . . . 0.0 109.691 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -37.21 156.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.802 1.668 . . . . 0.0 112.384 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -75.71 -164.82 0.26 Allowed 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.42 2.08 . . . . 0.0 112.888 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 29.7 m -111.39 80.12 1.28 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.123 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.503 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 33.9 ptt180 -54.54 -35.16 62.93 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.21 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.95 169.81 19.08 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -57.28 -22.82 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -63.5 -30.83 71.89 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 155' ' ' ARG . 6.0 tm-20 -63.76 -79.61 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.204 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.1 p -36.64 -30.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.922 0.889 . . . . 0.0 111.118 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.472 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -69.69 -52.21 27.71 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.628 -178.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.92 -17.69 62.68 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 122.697 1.236 . . . . 0.0 108.386 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -83.87 -45.62 13.04 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 112.492 -2.14 . . . . 0.0 111.847 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -131.11 -23.46 2.45 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 87.98 26.75 28.08 Favored Glycine 0 N--CA 1.464 0.553 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 159' ' ' GLY . . . -43.01 -97.33 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.65 -0.275 . . . . 0.0 111.018 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.465 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 65.85 33.13 8.23 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-O 121.362 0.601 . . . . 0.0 109.453 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.555 ' C ' ' H ' ' A' ' 164' ' ' VAL . 1.8 m-85 -175.58 -62.09 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.505 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.38 31.94 0.28 Allowed 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.169 1.913 . . . . 0.0 110.363 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.555 ' H ' ' C ' ' A' ' 162' ' ' PHE . 15.4 m -134.64 167.17 26.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.734 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.3 t -123.72 66.14 36.49 Favored Pre-proline 0 N--CA 1.472 0.657 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.549 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -37.73 147.59 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 123.551 2.834 . . . . 0.0 115.072 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 163.84 -173.39 39.9 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 113.739 -1.573 . . . . 0.0 111.105 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -145.68 150.86 37.07 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.718 0.294 . . . . 0.0 110.472 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.466 0.359 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.053 179.865 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.448 -0.564 0 CA-C-O 120.738 0.304 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 18.3 tt -111.91 120.5 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.067 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -125.28 164.2 20.87 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 122.052 0.93 . . . . 0.0 110.768 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 184' ' ' GLY . 43.2 t0 -77.05 106.71 8.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.037 -1.438 . . . . 0.0 108.79 178.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.28 -20.52 64.37 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.692 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.477 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.4 mm? -63.77 -42.27 97.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.854 0.359 . . . . 0.0 110.408 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.86 -47.12 2.31 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.773 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 180' ' ' ASP . . . . . . . . 0 CA--C 1.526 0.776 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 120.659 0.266 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.447 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 10.0 mp -62.49 -42.38 99.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.458 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.6 -42.66 91.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.911 0.386 . . . . 0.0 110.26 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 63.3 ttm-85 -62.88 -42.29 99.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.379 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -62.16 -43.49 98.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.398 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.2 -47.14 87.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.06 0.457 . . . . 0.0 110.02 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.22 -43.24 98.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.817 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.85 -40.88 85.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.44 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.24 -43.08 92.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.029 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.16 -52.45 64.79 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.787 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 16.7 pt -68.5 -39.06 80.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.357 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -58.22 -54.9 41.81 Favored 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.201 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 20' ' ' GLU . 94.0 t -59.75 -39.73 80.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.776 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.435 ' CD2' ' C ' ' A' ' 17' ' ' LEU . 6.5 tt -52.06 -50.0 62.38 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.104 -0.638 . . . . 0.0 109.674 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -81.31 -52.71 7.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.904 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.458 ' O ' ' NH1' ' A' ' 21' ' ' ARG . 69.4 mm-40 -63.25 -35.56 80.76 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.438 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.2 mt-10 59.69 81.89 0.16 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.458 ' NH1' ' O ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -155.28 -136.73 0.06 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 177.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.6 p -142.09 139.8 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -126.92 165.64 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.03 0.443 . . . . 0.0 111.363 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.45 129.48 40.04 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.04 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -109.88 133.35 20.99 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.129 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -84.57 140.96 8.56 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.246 1.297 . . . . 0.0 111.789 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.535 ' C ' ' H ' ' A' ' 29' ' ' ALA . 28.2 m -136.01 135.89 39.85 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.871 0.367 . . . . 0.0 110.839 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -74.77 29.43 0.09 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.998 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.535 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -158.52 -77.18 0.07 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.289 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.1 m -120.37 126.28 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-O 121.118 0.485 . . . . 0.0 110.781 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.524 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 77.9 m-85 -60.67 145.17 50.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.509 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -154.4 -166.62 15.27 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.6 m -131.91 170.85 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.422 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -159.87 -176.35 31.85 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 119.518 -1.325 . . . . 0.0 112.51 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.502 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -163.48 -163.36 0.81 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.137 -179.147 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.502 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 43.0 t0 -90.74 106.43 15.45 Favored Pre-proline 0 CA--C 1.555 1.167 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -38.16 -61.89 0.34 Allowed 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.283 1.989 . . . . 0.0 112.129 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -69.71 62.63 0.18 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.315 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.4 m -155.1 131.89 10.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.083 0.468 . . . . 0.0 110.928 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.08 -17.92 63.93 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.247 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.41 ' CG2' ' N ' ' A' ' 42' ' ' ALA . 15.3 t -61.26 -41.91 97.73 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.511 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.41 ' N ' ' CG2' ' A' ' 41' ' ' THR . . . -58.13 -51.26 70.45 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.63 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 p -63.05 -44.19 99.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.434 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 62.3 mtt -65.22 -39.93 93.44 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -61.92 -32.83 73.26 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.632 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 81.9 mt -76.92 -57.67 3.72 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.4 mt -57.2 -16.09 7.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.387 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.52 -85.77 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.589 -178.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -76.08 -32.47 59.26 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.987 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -79.11 -71.01 0.46 Allowed 'General case' 0 C--N 1.349 0.57 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.428 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.424 ' O ' ' CG ' ' A' ' 51' ' ' GLN . 3.7 tt0 54.4 79.85 0.13 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.381 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 161.45 -62.7 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.856 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.332 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.01 -8.53 23.84 Favored 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.58 2.187 . . . . 0.0 111.641 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -43.74 -46.34 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.926 0.394 . . . . 0.0 110.466 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 110' ' ' ARG . 10.0 t0 -66.28 -42.87 87.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.196 0.522 . . . . 0.0 109.941 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -61.35 -40.87 95.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.422 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 64.52 117.34 0.01 OUTLIER Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.572 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -51.21 -164.53 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.21 0.529 . . . . 0.0 112.131 179.676 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.406 HD12 HG22 ' A' ' 59' ' ' ILE . 92.5 mt -105.62 145.19 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 16.9 mt -117.15 146.33 43.26 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.4 tp -113.8 132.77 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-O 121.39 0.614 . . . . 0.0 111.325 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.39 154.1 35.59 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.103 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.04 -27.58 6.89 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.49 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 98.1 m-20 -114.13 143.74 44.31 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.105 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -73.48 -14.29 61.21 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -50.28 -33.13 18.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.502 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.49 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 3.8 pm0 -94.4 -12.25 28.25 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.43 ' CD2' ' N ' ' A' ' 68' ' ' LEU . 3.6 mm? -91.67 -14.92 29.26 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.424 -0.797 . . . . 0.0 108.885 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.464 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 43.0 tttm -78.64 -39.93 1.64 Allowed Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 66.6 Cg_endo -104.43 -2.07 0.23 Allowed 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 122.853 2.368 . . . . 0.0 112.351 -178.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.463 ' OH ' ' CD2' ' A' ' 114' ' ' LEU . 55.6 t80 -97.73 -9.47 26.59 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.988 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.494 ' CG2' ' N ' ' A' ' 73' ' ' ASP . 4.6 mp -123.34 168.91 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.494 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 96.5 m-20 -60.56 -12.43 9.93 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.051 -0.259 . . . . 0.0 111.141 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 57.8 t0 55.71 30.52 15.73 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.282 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.403 ' CG2' ' N ' ' A' ' 76' ' ' MET . 9.2 t -96.13 -43.5 7.72 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.208 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.403 ' N ' ' CG2' ' A' ' 75' ' ' THR . 18.9 ptp -84.69 -5.97 59.34 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.237 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.3 tp -92.8 127.56 38.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.251 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -160.2 161.63 33.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.683 -177.735 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -38.77 -49.18 1.59 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.727 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.02 -33.54 61.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.048 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' A' ' 78' ' ' THR . 65.4 tp60 -66.31 -39.03 89.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.619 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.5 mmt85 -63.54 -53.45 51.64 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 122.38 1.086 . . . . 0.0 108.619 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -54.31 -50.39 67.46 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.013 -1.449 . . . . 0.0 110.117 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -60.83 -50.56 72.95 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.883 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.0 tt -67.9 -32.6 57.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.102 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -72.41 -41.66 66.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.82 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.7 m -78.03 -33.09 51.27 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.566 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 89' ' ' TRP . 76.7 ttt180 -95.74 157.69 15.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.04 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.413 ' C ' ' O ' ' A' ' 88' ' ' ARG . 3.7 m-90 -31.37 148.52 0.05 OUTLIER Pre-proline 0 N--CA 1.47 0.55 0 O-C-N 123.482 0.488 . . . . 0.0 111.43 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -67.02 -17.64 51.32 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.051 1.834 . . . . 0.0 111.41 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 108.92 73.75 0.79 Allowed Glycine 0 N--CA 1.468 0.831 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.78 -36.15 81.33 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.833 2.355 . . . . 0.0 111.675 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.4 p -90.44 147.61 5.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.038 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 57.7 m -86.15 147.34 26.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.662 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -127.32 143.5 51.22 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.469 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -99.23 105.39 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-O 121.209 0.528 . . . . 0.0 109.985 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -88.84 149.7 44.19 Favored Pre-proline 0 N--CA 1.469 0.52 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.968 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -76.74 110.18 3.0 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.229 1.953 . . . . 0.0 110.977 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.91 147.72 97.85 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.501 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 40.0 Cg_endo -64.19 -26.27 64.83 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.817 1.678 . . . . 0.0 111.848 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.501 ' CB ' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . 0 N--CA 1.471 0.589 0 O-C-N 123.706 0.629 . . . . 0.0 110.869 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.46 ' NH1' ' OD1' ' A' ' 112' ' ' ASP . 2.8 tpp85 . . . . . 0 CA--C 1.533 0.295 0 CA-C-O 120.746 0.307 . . . . 0.0 110.536 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.531 ' CD1' ' N ' ' A' ' 106' ' ' TRP . 4.5 m0 -78.66 -7.36 57.58 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.6 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.652 ' CD1' ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -72.41 -31.8 65.83 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.573 ' C ' ' H ' ' A' ' 110' ' ' ARG . 25.9 m -141.01 -42.02 0.39 Allowed 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.515 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 49.36 -0.22 0.01 OUTLIER Glycine 0 CA--C 1.539 1.562 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.13 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.573 ' H ' ' C ' ' A' ' 108' ' ' THR . 0.5 OUTLIER -86.74 -51.17 6.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.025 0.912 . . . . 0.0 108.862 179.366 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.582 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 83.5 t80 -151.36 173.18 14.82 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.498 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.582 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 93.3 m-20 -78.91 51.08 1.08 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.105 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 82.5 p -161.05 158.85 28.5 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.463 ' CD2' ' OH ' ' A' ' 71' ' ' TYR . 0.3 OUTLIER -158.36 136.62 10.84 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -178.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.02 125.11 25.3 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 113.389 -1.732 . . . . 0.0 110.527 177.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.409 ' CG2' ' N ' ' A' ' 117' ' ' ARG . 4.2 p -151.57 161.48 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.409 ' N ' ' CG2' ' A' ' 116' ' ' VAL . 61.5 ttp180 -147.06 154.38 41.11 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.934 0.397 . . . . 0.0 111.756 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 56.0 t -119.95 133.09 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.604 178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.4 t -132.41 129.65 39.6 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.924 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.539 ' O ' ' CG ' ' A' ' 121' ' ' HIS . 67.4 t0 -136.99 75.47 1.53 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.163 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.603 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 18.7 m-70 -165.52 -36.5 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.301 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.603 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 18.7 Cg_endo -91.97 -162.14 0.1 Allowed 'Trans proline' 0 N--CA 1.485 0.984 0 C-N-CA 121.793 1.662 . . . . 0.0 112.01 -178.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.7 mt -77.3 -6.29 52.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.649 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 83.0 t -57.79 -44.12 85.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.632 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.591 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 34.5 m -52.32 -62.46 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.879 0 C-N-CA 119.354 -0.938 . . . . 0.0 108.828 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.591 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -41.97 -44.03 3.34 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.697 0.284 . . . . 0.0 110.995 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 40.3 tp -68.75 -49.26 60.15 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.447 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.477 ' O ' ' N ' ' A' ' 132' ' ' GLY . 75.7 m -70.6 -47.92 57.74 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.263 0.554 . . . . 0.0 111.123 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.449 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -54.64 -42.52 71.37 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.449 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -58.6 -54.59 45.38 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.167 -177.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.401 ' OH ' ' OD1' ' A' ' 36' ' ' ASP . 43.7 t80 -65.71 -22.39 66.61 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 114.766 -1.107 . . . . 0.0 108.136 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 128' ' ' CYS . . . 78.97 2.28 86.53 Favored Glycine 0 N--CA 1.44 -1.087 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -149.57 159.69 35.78 Favored Pre-proline 0 CA--C 1.55 0.951 0 CA-C-N 117.204 0.502 . . . . 0.0 110.556 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -47.59 163.76 0.17 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 124.045 3.163 . . . . 0.0 113.667 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.3 tp -119.95 123.99 44.88 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.422 ' O ' ' CA ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -63.41 147.87 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 C-N-CA 117.755 -1.578 . . . . 0.0 106.899 179.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.3 t -122.53 127.15 49.14 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.648 0.592 . . . . 0.0 111.515 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.4 m -128.62 165.75 20.22 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.602 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 24.0 m -72.25 148.49 45.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.668 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.92 -36.6 79.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.199 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 57.2 p30 -61.98 152.34 32.56 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.746 0.784 . . . . 0.0 111.293 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.18 -155.36 0.63 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.328 -1.306 . . . . 0.0 109.809 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 79.4 p -62.44 -39.05 92.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.327 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -167.97 7.55 0.05 OUTLIER Glycine 0 CA--C 1.51 -0.257 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.2 tp -86.74 128.15 57.5 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-O 119.223 -0.418 . . . . 0.0 110.037 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -38.22 156.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.666 1.578 . . . . 0.0 112.092 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.435 ' O ' ' OE2' ' A' ' 153' ' ' GLU . 97.6 Cg_endo -74.65 -169.72 0.65 Allowed 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.656 2.237 . . . . 0.0 111.983 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 14.6 m -116.71 75.54 0.97 Allowed 'General case' 0 CA--C 1.522 -0.109 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.661 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.524 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 31.3 ptt-85 -51.12 -38.7 53.44 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.386 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -161.22 170.47 20.21 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.142 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.3 m -57.8 -20.8 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -64.8 -33.96 77.23 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.435 ' OE2' ' O ' ' A' ' 147' ' ' PRO . 0.0 OUTLIER -61.54 -79.69 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.807 179.289 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.2 p -35.14 -33.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.969 0.908 . . . . 0.0 111.104 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.459 ' O ' ' N ' ' A' ' 159' ' ' GLY . 4.9 tmt_? -68.32 -51.76 41.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.679 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.51 -17.55 62.95 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.633 1.206 . . . . 0.0 107.956 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -83.42 -45.63 13.45 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 112.582 -2.099 . . . . 0.0 111.86 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -130.79 -27.35 2.11 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 94.01 24.39 20.01 Favored Glycine 0 N--CA 1.467 0.754 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 -178.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -43.07 -95.99 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.749 0.309 . . . . 0.0 110.968 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.514 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 60.53 35.45 20.17 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.559 ' C ' ' H ' ' A' ' 164' ' ' VAL . 2.0 m-85 -172.61 -63.02 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.005 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -71.84 25.13 0.25 Allowed 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.301 2.001 . . . . 0.0 110.813 177.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.559 ' H ' ' C ' ' A' ' 162' ' ' PHE . 16.0 m -128.38 166.09 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.694 -178.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.19 65.05 28.21 Favored Pre-proline 0 N--CA 1.476 0.832 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.552 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -36.12 142.65 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 123.429 2.753 . . . . 0.0 114.862 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 176.63 -168.49 40.53 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 113.934 -1.485 . . . . 0.0 111.132 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -155.52 148.96 24.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.775 0.322 . . . . 0.0 110.171 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.468 0.46 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.677 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 . . . . . 0 N--CA 1.443 -0.778 0 CA-C-O 121.039 0.447 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 43.6 pt -119.85 143.82 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.988 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -130.97 166.86 20.05 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.714 0.769 . . . . 0.0 111.413 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -79.46 105.72 10.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.156 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -64.67 -19.18 65.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.659 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.475 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.5 mm? -62.4 -41.78 98.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.195 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.17 -42.4 7.07 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.512 0 N-CA-C 110.451 -1.059 . . . . 0.0 110.451 179.816 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.734 0.302 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.7 mp -62.24 -42.86 99.69 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -64.6 -40.55 95.71 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -63.18 -41.73 99.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.72 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -60.57 -44.99 95.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.698 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.65 -44.47 96.91 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.099 0.476 . . . . 0.0 110.044 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.75 -43.13 97.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.69 -42.66 79.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.943 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.79 -41.02 99.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.86 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.37 -54.72 42.3 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.828 0.347 . . . . 0.0 111.333 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.7 pt -68.17 -35.71 72.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.241 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -59.39 -51.4 70.05 Favored 'General case' 0 C--O 1.216 -0.693 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.939 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.503 ' O ' ' N ' ' A' ' 20' ' ' GLU . 87.8 t -63.15 -38.91 83.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.61 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.448 ' CD2' ' C ' ' A' ' 17' ' ' LEU . 6.5 tt -52.63 -51.11 61.51 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.282 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -78.0 -49.06 14.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.176 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -67.78 -29.82 69.11 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.046 0.45 . . . . 0.0 110.813 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 16' ' ' VAL . 96.7 mt-10 56.88 60.39 3.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.42 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.43 ' NH2' ' O ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -154.65 159.49 40.83 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.59 0.709 . . . . 0.0 110.642 179.139 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.43 ' O ' ' NH2' ' A' ' 21' ' ' ARG . 8.7 p -74.67 137.06 23.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.771 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.62 165.56 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 120.631 0.253 . . . . 0.0 110.444 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.91 135.85 57.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.251 0.548 . . . . 0.0 111.046 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.495 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 1.3 t80 -124.6 140.85 36.33 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.495 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 59.3 Cg_endo -81.65 145.32 14.49 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.106 1.204 . . . . 0.0 111.108 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.536 ' C ' ' H ' ' A' ' 29' ' ' ALA . 55.7 m -132.06 134.61 45.71 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.865 0.364 . . . . 0.0 110.939 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -73.91 31.02 0.08 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.519 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.536 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -157.49 -78.73 0.08 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.477 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 73.2 t -127.09 129.35 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.511 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 93.2 m-85 -43.3 146.27 0.48 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.302 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -152.95 -172.12 20.99 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.7 m -131.92 167.32 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.83 176.39 34.91 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.114 -1.041 . . . . 0.0 112.081 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.504 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -154.03 -163.57 1.66 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.636 -178.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.504 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 17.2 p-10 -97.44 108.09 42.87 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -177.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 36' ' ' ASP . 64.6 Cg_exo -38.93 174.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.82 2.347 . . . . 0.0 113.937 177.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 46.2 t0 37.59 77.98 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.433 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.5 m -153.22 142.96 21.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.137 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.556 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -71.5 -35.65 70.83 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.27 0.557 . . . . 0.0 109.745 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.2 -43.59 91.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.566 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.94 -49.42 77.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.743 0.306 . . . . 0.0 111.339 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.3 p -63.93 -47.03 92.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.811 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.3 mtt -65.64 -48.18 73.06 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -61.72 -33.17 73.57 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -70.71 -46.32 63.3 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.419 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.3 mt -76.39 -11.1 59.84 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 120.897 0.379 . . . . 0.0 111.248 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.99 -81.26 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.592 -176.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.424 HD22 ' H ' ' A' ' 50' ' ' LYS . 2.3 pt? -72.94 -35.93 67.1 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.424 ' H ' HD22 ' A' ' 49' ' ' LEU . 26.5 mmmt -75.21 -50.04 17.48 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.928 -177.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 33.95 67.05 0.22 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.759 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.2 mmm-85 178.58 -54.02 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.91 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.692 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.91 -6.57 17.58 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.647 2.232 . . . . 0.0 112.748 -178.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.451 ' CG1' ' N ' ' A' ' 55' ' ' ASP . 14.8 p -43.18 -46.74 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.456 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.451 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 41.0 t0 -64.16 -42.68 96.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.025 0.44 . . . . 0.0 110.305 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -61.28 -39.63 91.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.62 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 64.72 112.03 0.01 OUTLIER Glycine 0 CA--C 1.519 0.314 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.553 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -54.57 -158.35 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.097 0.475 . . . . 0.0 111.857 -179.488 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 67.9 mt -112.75 146.24 17.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.247 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 14.7 mt -122.16 150.15 42.62 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.7 tp -120.28 130.56 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-O 121.178 0.514 . . . . 0.0 110.599 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.54 149.48 41.26 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.7 -29.34 8.75 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.178 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.533 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 10.9 m120 -116.72 150.02 38.9 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.038 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -77.24 -13.95 59.85 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -50.87 -31.32 17.02 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.47 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.533 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 4.7 pm0 -94.52 -13.08 26.44 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -92.94 -12.33 31.11 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.476 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 75.0 tttt -80.16 -39.63 1.23 Allowed Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.589 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 44.0 Cg_endo -105.55 -0.95 0.19 Allowed 'Trans proline' 0 C--N 1.316 -1.163 0 C-N-CA 122.968 2.445 . . . . 0.0 112.474 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.412 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 68.0 t80 -97.85 -5.2 35.12 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -177.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.469 ' CG2' ' N ' ' A' ' 73' ' ' ASP . 5.1 mp -127.1 166.33 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.469 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 93.3 m-20 -64.2 -9.46 17.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.23 -179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 55.65 33.68 21.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.89 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.1 t -96.81 -42.02 8.17 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 10.5 ptp -91.45 -6.84 52.08 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.396 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.3 tp -93.02 126.05 37.92 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.685 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.527 ' HG1' ' N ' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -159.77 160.85 34.4 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.92 -177.003 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.527 ' N ' ' HG1' ' A' ' 78' ' ' THR . 98.5 m-20 -39.22 -47.3 1.62 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.748 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.17 -33.57 63.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.022 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' A' ' 78' ' ' THR . 67.8 tp60 -65.03 -40.77 95.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.974 0.416 . . . . 0.0 110.508 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.9 mmt85 -62.69 -52.33 63.71 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 122.469 1.128 . . . . 0.0 108.95 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 87' ' ' SER . 81.9 tt0 -55.9 -50.68 70.01 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 113.781 -1.554 . . . . 0.0 110.135 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 m -61.12 -50.17 74.31 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.976 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.4 tt -67.49 -31.97 55.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.864 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -77.72 -35.25 52.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.774 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 83' ' ' GLU . 13.1 m -87.27 -16.67 34.51 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.582 0.229 . . . . 0.0 110.994 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 89' ' ' TRP . 74.5 ttt-85 -113.34 75.51 0.92 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.7 0.286 . . . . 0.0 110.237 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.452 ' O ' ' O ' ' A' ' 88' ' ' ARG . 82.5 m95 56.85 147.64 0.05 OUTLIER Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.615 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.35 -24.49 37.08 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.172 1.915 . . . . 0.0 112.488 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 156.91 79.48 0.03 OUTLIER Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -83.82 -9.46 9.86 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.72 2.28 . . . . 0.0 112.162 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.0 p -137.15 147.49 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.296 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.9 m -90.27 125.98 35.68 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.189 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -117.4 140.5 49.5 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.1 t -99.77 109.75 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-O 121.546 0.688 . . . . 0.0 111.156 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -96.92 151.05 37.53 Favored Pre-proline 0 N--CA 1.469 0.482 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.69 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -65.77 104.8 0.71 Allowed 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.822 1.681 . . . . 0.0 111.247 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.14 162.39 71.65 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.55 141.16 90.78 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 CA-C-N 120.098 1.071 . . . . 0.0 111.756 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.21 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.341 179.889 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.477 ' NH2' ' O ' ' A' ' 110' ' ' ARG . 6.4 tpt180 . . . . . 0 CA--C 1.532 0.271 0 CA-C-O 120.612 0.244 . . . . 0.0 110.626 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 2.3 p90 -70.85 -8.99 56.61 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.098 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.65 ' CD1' ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -77.28 -18.38 57.62 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.44 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 54' ' ' VAL . 94.1 m -141.76 -39.33 0.38 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.918 0.389 . . . . 0.0 110.572 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 83.27 13.95 75.48 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.606 -0.597 . . . . 0.0 111.606 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.477 ' O ' ' NH2' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -162.41 -77.77 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.101 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -99.17 -162.12 0.93 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.311 -0.404 . . . . 0.0 109.957 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 53.4 p30 -134.55 61.8 1.66 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.828 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 83.0 p -156.94 128.75 7.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.613 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 53.6 mt -124.13 134.96 53.21 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.95 120.99 18.34 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.439 175.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.4 p -143.74 158.39 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.824 0.345 . . . . 0.0 110.413 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -144.73 161.77 38.39 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.815 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.9 t -123.23 130.38 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.1 t -129.83 128.25 41.92 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.767 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -133.95 82.64 1.99 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.848 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.581 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 70.6 t60 -172.88 -35.73 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.581 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 39.6 Cg_endo -93.06 -161.43 0.09 OUTLIER 'Trans proline' 0 N--CA 1.484 0.949 0 C-N-CA 122.045 1.83 . . . . 0.0 111.847 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 37.6 mt -78.42 -5.74 53.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.891 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.2 t -58.05 -45.07 88.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.808 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.581 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 27.1 m -53.05 -62.31 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.789 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.705 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.581 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -41.38 -42.72 2.32 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.877 0.37 . . . . 0.0 110.898 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.4 tp -69.67 -48.95 57.97 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.303 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 56.0 m -70.65 -48.92 52.43 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.548 0.689 . . . . 0.0 110.757 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.456 ' N ' ' O ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER -54.28 -42.04 69.56 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.216 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.432 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -58.17 -55.44 35.0 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.234 -177.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -61.59 -21.22 64.14 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.515 -1.221 . . . . 0.0 108.932 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.57 -0.23 85.94 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' A' ' 134' ' ' PRO . 31.4 mttp -151.46 159.53 33.25 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 120.605 -0.438 . . . . 0.0 109.944 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 133' ' ' LYS . 5.7 Cg_exo -41.0 176.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 123.855 3.036 . . . . 0.0 113.021 -178.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.8 tp -130.94 123.24 28.44 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.94 152.99 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 10.8 t -129.54 132.86 46.95 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.107 0.479 . . . . 0.0 111.305 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.8 m -135.3 164.49 27.61 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.888 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.1 m -71.4 146.95 48.4 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.47 81.16 1.93 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.712 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 48.1 p-10 -159.43 168.06 27.19 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.303 0.573 . . . . 0.0 110.454 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.2 -162.35 1.43 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.166 -178.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 77.5 p -61.92 -39.74 93.08 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.611 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -163.61 4.85 0.07 OUTLIER Glycine 0 CA--C 1.511 -0.179 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.7 tp -81.43 127.69 72.55 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.164 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -39.24 157.94 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.7 1.6 . . . . 0.0 111.972 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.424 ' O ' ' OE1' ' A' ' 153' ' ' GLU . 76.3 Cg_endo -73.15 -163.89 0.17 Allowed 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.505 2.137 . . . . 0.0 112.242 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 11.3 m -118.52 73.71 0.93 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.524 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.511 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 37.6 ptt180 -54.14 -35.91 62.72 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.169 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.95 167.89 20.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -56.23 -18.6 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 CA-C-O 121.638 0.732 . . . . 0.0 109.128 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -64.41 -36.45 84.19 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.429 ' OE1' ' OE1' ' A' ' 157' ' ' GLN . 0.4 OUTLIER -59.26 -72.06 0.11 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.793 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.3 p -47.97 -30.17 2.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.421 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.457 ' O ' ' N ' ' A' ' 159' ' ' GLY . 4.5 tmt_? -84.01 -44.81 13.77 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 122.293 1.044 . . . . 0.0 110.187 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.41 -41.89 85.95 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.497 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.453 ' CG ' ' N ' ' A' ' 158' ' ' PHE . 8.1 pt20 -80.95 -48.52 12.18 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 113.195 -1.82 . . . . 0.0 111.978 -177.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.453 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 33.7 t80 -107.07 -35.94 6.73 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -177.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 96.86 24.64 12.79 Favored Glycine 0 N--CA 1.475 1.259 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 -178.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -43.23 -93.96 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.66 0.267 . . . . 0.0 110.655 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.47 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.66 36.11 16.73 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.526 ' C ' ' H ' ' A' ' 164' ' ' VAL . 2.0 m-85 -175.18 -62.69 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.172 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -72.91 28.73 0.29 Allowed 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.364 2.043 . . . . 0.0 110.794 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.526 ' H ' ' C ' ' A' ' 162' ' ' PHE . 15.8 m -132.2 167.78 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.899 -178.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.9 t -124.0 65.5 37.56 Favored Pre-proline 0 N--CA 1.473 0.677 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.698 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -37.51 139.99 0.25 Allowed 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 123.586 2.857 . . . . 0.0 114.967 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 160.46 174.25 30.05 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 113.987 -1.461 . . . . 0.0 110.72 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -159.51 133.77 7.63 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 C--N 1.327 -0.404 0 CA-C-O 120.983 0.421 . . . . 0.0 110.148 179.585 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 . . . . . 0 N--CA 1.447 -0.589 0 CA-C-O 120.911 0.386 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 19.9 tt -108.47 127.91 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.212 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -127.86 164.34 22.45 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.753 0.787 . . . . 0.0 112.353 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -81.28 106.68 13.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.075 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -70.77 -12.39 61.52 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.314 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.461 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.7 mm? -64.23 -40.58 96.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.867 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.8 -41.71 6.42 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.111 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.71 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 -179.77 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.688 0.28 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 9.7 mp -62.08 -42.66 99.44 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -63.95 -41.32 97.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.021 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 78.8 ttt-85 -61.96 -42.36 99.04 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.887 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -60.72 -45.2 95.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.562 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.42 -42.54 98.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.998 0.428 . . . . 0.0 110.337 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.38 -43.63 98.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.721 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.12 -47.22 78.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.493 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.06 -39.09 91.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.635 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.34 -53.08 62.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.629 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 38.2 pt -70.01 -33.43 55.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.197 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.423 ' OD1' ' OE2' ' A' ' 19' ' ' GLU . 24.6 t70 -57.74 -55.13 38.79 Favored 'General case' 0 C--O 1.217 -0.637 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.147 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 20' ' ' GLU . 97.9 t -63.6 -40.11 87.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.704 0.288 . . . . 0.0 110.675 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.44 ' CD2' ' C ' ' A' ' 17' ' ' LEU . 6.3 tt -52.16 -48.91 64.69 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.303 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -80.29 -52.59 7.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.289 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.423 ' OE2' ' OD1' ' A' ' 15' ' ' ASP . 92.7 mt-10 -66.91 -34.97 78.94 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.801 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.8 mt-10 60.19 87.48 0.09 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.122 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.08 -135.74 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.668 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.3 p -140.62 140.76 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -129.76 166.18 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 120.982 0.42 . . . . 0.0 111.757 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.96 129.34 39.36 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.411 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.513 ' CE2' ' O ' ' A' ' 26' ' ' PRO . 4.4 t80 -115.48 138.25 23.63 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.513 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 64.0 Cg_endo -81.41 144.08 14.16 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.144 1.229 . . . . 0.0 111.615 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.532 ' C ' ' H ' ' A' ' 29' ' ' ALA . 58.1 m -134.53 132.93 39.76 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.013 0.435 . . . . 0.0 111.153 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -72.84 30.3 0.06 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.71 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.532 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -158.54 -76.1 0.08 Allowed 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 120.784 0.326 . . . . 0.0 110.82 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.3 t -125.77 127.69 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 120.96 0.41 . . . . 0.0 110.26 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -48.88 145.76 3.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.765 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -154.83 -173.9 24.17 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.7 m -131.23 170.58 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.407 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -158.95 -176.96 31.58 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 119.765 -1.207 . . . . 0.0 112.453 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -158.16 -167.2 2.14 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.592 0.234 . . . . 0.0 110.716 -179.104 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.472 ' CG ' ' CZ ' ' A' ' 131' ' ' TYR . 18.3 t70 -95.12 109.4 44.41 Favored Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 36' ' ' ASP . 32.8 Cg_exo -37.28 172.27 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.778 2.319 . . . . 0.0 114.358 177.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.432 ' C ' ' HG ' ' A' ' 39' ' ' SER . 98.0 m-20 40.9 72.22 0.17 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.855 178.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.432 ' HG ' ' C ' ' A' ' 38' ' ' ASP . 3.2 m -153.16 137.55 16.68 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.557 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -67.6 -33.62 75.37 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.075 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.458 ' CG2' ' N ' ' A' ' 42' ' ' ALA . 12.9 t -62.26 -46.11 90.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.026 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.458 ' N ' ' CG2' ' A' ' 41' ' ' THR . . . -58.4 -51.23 70.68 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.408 -178.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.5 p -62.59 -44.14 99.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.412 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 61.9 mtt -64.03 -39.3 93.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.15 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 51.3 ttt-85 -62.39 -34.4 76.64 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 87.9 mt -74.72 -58.78 3.07 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.3 mt -55.96 -16.3 4.63 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.36 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -68.6 -86.43 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -77.13 -33.66 56.75 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -76.18 -50.43 14.58 Favored 'General case' 0 C--N 1.349 0.557 0 C-N-CA 119.798 -0.761 . . . . 0.0 110.723 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 35.47 65.77 0.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.703 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 179.61 -54.28 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.83 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.235 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.09 -6.71 17.59 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.637 2.224 . . . . 0.0 112.088 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.4 p -43.57 -49.29 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.73 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 55' ' ' ASP . 39.8 t0 -66.28 -40.94 90.43 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.687 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -60.88 -39.8 90.61 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.084 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 65.48 107.63 0.01 OUTLIER Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.564 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -52.62 -161.28 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.375 0.607 . . . . 0.0 112.278 -179.477 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 73.2 mt -106.58 142.95 18.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.166 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 16.0 mt -118.05 142.63 47.19 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.4 tp -111.82 126.91 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-O 121.408 0.623 . . . . 0.0 111.622 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.76 148.29 39.99 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.094 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.55 -27.65 9.76 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.075 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.716 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 98.6 m-20 -117.91 151.12 38.04 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.946 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -79.26 -13.51 59.63 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -52.54 -31.99 38.46 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.216 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.716 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 4.8 pm0 -93.79 -10.63 33.49 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.79 -18.73 24.43 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.45 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 47.1 tttm -76.71 -39.0 2.24 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 69.7 Cg_endo -104.38 -2.38 0.23 Allowed 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 122.923 2.416 . . . . 0.0 112.582 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.402 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 68.7 t80 -94.85 -10.55 30.99 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.838 0.351 . . . . 0.0 111.06 -178.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.474 ' CG2' ' N ' ' A' ' 73' ' ' ASP . 5.1 mp -125.52 168.14 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.474 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 93.0 m-20 -62.3 -13.03 24.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.786 0.327 . . . . 0.0 110.829 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 44.7 t0 55.54 21.74 4.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.841 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.481 ' CG2' ' H ' ' A' ' 76' ' ' MET . 8.4 t -89.53 -54.51 4.05 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.481 ' H ' ' CG2' ' A' ' 75' ' ' THR . 13.5 ptp -68.08 -37.52 81.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.225 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 tp -64.22 139.13 58.73 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.208 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.9 173.19 14.06 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.461 -176.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -60.26 -43.06 96.49 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.202 0.314 . . . . 0.0 111.23 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.9 p -60.92 -32.48 52.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.994 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -63.47 -40.89 98.32 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.094 0.473 . . . . 0.0 110.498 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.0 mmt85 -63.34 -51.51 65.65 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 122.648 1.213 . . . . 0.0 108.782 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 87' ' ' SER . 80.7 tt0 -57.17 -50.22 73.5 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 113.667 -1.606 . . . . 0.0 110.096 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.5 m -62.04 -49.03 77.65 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.264 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 89' ' ' TRP . 13.9 tt -68.52 -26.05 32.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.585 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -86.02 -32.22 21.58 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.438 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 83' ' ' GLU . 10.7 m -88.64 -9.12 53.23 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.745 0.307 . . . . 0.0 110.784 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 89' ' ' TRP . 62.4 ttm-85 -128.47 79.53 1.91 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.514 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.448 ' O ' ' O ' ' A' ' 88' ' ' ARG . 2.7 m-90 56.43 152.54 0.07 OUTLIER Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.667 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.88 -23.15 41.53 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.879 1.719 . . . . 0.0 111.753 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 157.95 79.08 0.03 OUTLIER Glycine 0 CA--C 1.53 1.004 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.53 -35.63 86.32 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.714 2.276 . . . . 0.0 112.427 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.2 p -133.84 147.69 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.84 0.352 . . . . 0.0 110.455 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 26.4 m -84.16 141.45 31.05 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.362 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -119.01 139.81 51.09 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.732 0.301 . . . . 0.0 110.964 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.3 t -96.85 103.55 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 121.424 0.63 . . . . 0.0 109.689 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -91.54 152.01 43.08 Favored Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.079 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.04 110.74 3.15 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.883 1.722 . . . . 0.0 111.341 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.7 153.23 70.33 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.852 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.66 151.95 78.58 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.155 1.904 . . . . 0.0 111.664 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.311 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.388 179.903 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.486 ' NH1' ' O ' ' A' ' 110' ' ' ARG . 5.5 tpp85 . . . . . 0 CA--C 1.531 0.238 0 CA-C-O 120.732 0.301 . . . . 0.0 110.935 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 63.5 p-90 -74.03 -8.6 56.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.753 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.674 ' CD1' ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -73.56 -23.42 59.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.081 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 88.6 m -142.71 -39.33 0.34 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.107 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 89.31 9.03 67.65 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.486 ' O ' ' NH1' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -158.24 -79.17 0.07 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 117.038 0.419 . . . . 0.0 109.911 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -93.41 -129.61 0.12 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.268 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -157.89 61.58 0.47 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.507 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.6 p -157.52 153.65 27.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.81 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.78 139.17 9.93 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.354 1.073 . . . . 0.0 113.461 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.56 133.04 48.71 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 112.971 -1.922 . . . . 0.0 109.885 178.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.8 p -149.98 153.82 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.805 0.336 . . . . 0.0 110.341 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 71.7 ttp85 -147.89 158.7 44.17 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.571 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.2 t -122.18 133.55 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 116.288 -0.414 . . . . 0.0 109.928 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.7 t -132.71 130.9 40.64 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -135.85 85.22 2.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.626 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.527 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 36.2 t60 -172.83 -38.36 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.422 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.527 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 29.1 Cg_endo -92.84 -161.83 0.09 OUTLIER 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 122.026 1.818 . . . . 0.0 112.028 -178.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.4 mp -78.35 -4.15 46.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.822 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 87.9 t -58.27 -44.96 89.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.855 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.584 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 29.6 m -53.98 -61.94 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.844 0 C-N-CA 119.434 -0.906 . . . . 0.0 108.633 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.584 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -41.08 -43.34 2.19 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.91 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 45.4 tp -70.16 -47.86 59.8 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 120.589 -0.445 . . . . 0.0 111.275 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 64.2 m -70.22 -49.15 53.0 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.517 0.675 . . . . 0.0 110.791 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.437 ' N ' ' O ' ' A' ' 125' ' ' VAL . 1.0 OUTLIER -55.01 -42.02 72.02 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.455 179.354 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.436 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -58.07 -56.27 24.23 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.93 -177.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.472 ' CZ ' ' CG ' ' A' ' 36' ' ' ASP . 4.2 t80 -63.44 -26.33 68.68 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.263 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.92 3.26 85.69 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 134' ' ' PRO . 69.4 mttt -149.46 157.87 38.57 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-N 116.908 0.354 . . . . 0.0 110.758 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 133' ' ' LYS . 5.7 Cg_exo -42.67 178.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 123.874 3.049 . . . . 0.0 112.705 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.0 tp -134.76 122.36 22.03 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.407 ' O ' ' CA ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -64.23 143.1 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 C-N-CA 117.975 -1.49 . . . . 0.0 107.166 -179.788 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.7 t -116.76 123.88 48.26 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 123.568 0.542 . . . . 0.0 111.333 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.6 m -128.86 165.27 21.34 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.152 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.5 t -70.96 149.42 46.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.643 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.25 -38.85 91.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.178 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 55.2 p30 -55.48 152.08 9.41 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.889 0.852 . . . . 0.0 111.351 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.8 -157.0 0.72 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.575 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.5 t -60.31 -45.27 93.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.492 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -161.13 4.46 0.09 OUTLIER Glycine 0 C--N 1.329 0.17 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.2 tp -84.94 127.27 65.41 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -37.47 157.03 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.8 1.667 . . . . 0.0 112.429 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.93 -163.52 0.2 Allowed 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.38 2.053 . . . . 0.0 112.314 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 15.8 t -114.4 78.88 1.19 Allowed 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.515 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -58.67 -34.71 71.55 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.966 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -163.02 165.29 25.02 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -55.9 -18.84 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -65.38 -34.17 77.68 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.519 ' OE1' ' NE2' ' A' ' 157' ' ' GLN . 6.7 tm-20 -59.21 -70.56 0.15 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.507 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.4 p -50.02 -29.58 5.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.359 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -84.42 -43.76 14.35 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 122.392 1.091 . . . . 0.0 110.143 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.93 -41.23 86.84 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.454 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.519 ' NE2' ' OE1' ' A' ' 153' ' ' GLU . 0.7 OUTLIER -82.46 -48.6 10.89 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 112.981 -1.918 . . . . 0.0 112.143 -177.02 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.474 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 38.3 t80 -106.97 -36.62 6.56 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -177.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 97.44 25.68 10.73 Favored Glycine 0 N--CA 1.473 1.106 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -43.43 -94.9 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.612 0.244 . . . . 0.0 110.734 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.424 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 63.44 36.68 11.19 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 121.292 0.568 . . . . 0.0 109.739 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.534 ' C ' ' H ' ' A' ' 164' ' ' VAL . 1.2 m-85 -177.14 -61.63 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.214 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.85 29.24 0.32 Allowed 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.14 1.893 . . . . 0.0 110.505 178.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.534 ' H ' ' C ' ' A' ' 162' ' ' PHE . 15.9 m -132.34 167.65 25.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.558 -178.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.0 t -124.27 65.11 39.12 Favored Pre-proline 0 N--CA 1.476 0.84 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.71 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -37.41 145.06 0.12 Allowed 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 123.815 3.01 . . . . 0.0 115.158 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 165.77 116.92 0.38 Allowed Glycine 0 CA--C 1.523 0.573 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.493 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -85.06 144.99 27.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.886 0.374 . . . . 0.0 110.068 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.205 179.896 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 . . . . . 0 N--CA 1.445 -0.723 0 CA-C-O 120.818 0.342 . . . . 0.0 110.698 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 14.2 pt -106.02 134.35 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.284 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 19.3 mmm-85 -120.12 157.44 28.98 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.526 0.679 . . . . 0.0 110.189 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 184' ' ' GLY . 97.6 m-20 -72.03 104.53 3.59 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.903 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -68.49 -18.33 64.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.041 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.478 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.7 mm? -64.01 -41.38 97.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.018 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 5.2 t -121.3 -51.46 2.09 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.695 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 180' ' ' ASP . . . . . . . . 0 N--CA 1.464 0.567 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 . . . . . 0 CA--C 1.53 0.192 0 CA-C-O 120.693 0.283 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.433 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 10.2 mp -63.15 -42.08 99.38 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.962 0.41 . . . . 0.0 110.048 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -63.32 -42.04 98.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.421 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -63.2 -39.36 94.42 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.408 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -61.52 -43.78 98.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.681 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.48 -45.23 88.24 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.808 0.337 . . . . 0.0 110.264 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.0 mm -63.69 -43.11 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.26 -47.37 78.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.045 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.01 -41.59 96.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.103 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.64 -54.62 44.34 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.9 0.381 . . . . 0.0 111.187 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.8 pt -69.23 -37.04 75.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.149 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -56.59 -56.2 24.3 Favored 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 20' ' ' GLU . 99.6 t -63.29 -39.93 87.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 121.16 -0.216 . . . . 0.0 110.59 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.441 ' CD2' ' C ' ' A' ' 17' ' ' LEU . 6.4 tt -51.79 -49.9 61.79 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.701 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -80.47 -51.87 8.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.148 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -65.86 -34.98 79.4 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.506 -178.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 16' ' ' VAL . 96.2 mt-10 58.51 88.37 0.06 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.107 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.47 -133.99 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.8 p -141.99 140.92 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 pp -129.01 167.62 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-O 121.122 0.487 . . . . 0.0 111.875 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.77 129.6 40.35 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.735 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.539 ' CE2' ' O ' ' A' ' 26' ' ' PRO . 7.8 t80 -117.14 138.82 25.2 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.297 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.539 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 63.6 Cg_endo -79.51 144.69 18.01 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.28 1.32 . . . . 0.0 111.751 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.51 ' C ' ' H ' ' A' ' 29' ' ' ALA . 63.2 m -132.6 134.79 45.35 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.248 0.547 . . . . 0.0 111.057 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -74.69 26.27 0.09 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.77 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.51 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -160.85 -70.28 0.07 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.993 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.6 p -127.93 123.57 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 121.108 0.48 . . . . 0.0 110.097 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.524 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 94.7 m-85 -42.52 151.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.744 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -155.51 -178.68 29.98 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.2 m -130.67 169.66 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.51 -177.39 33.57 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 119.839 -1.172 . . . . 0.0 112.323 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.429 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -158.76 -171.42 3.41 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.511 ' OD1' ' CE1' ' A' ' 131' ' ' TYR . 27.8 t70 -92.66 111.82 52.77 Favored Pre-proline 0 CA--C 1.553 1.083 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 36' ' ' ASP . 12.6 Cg_exo -35.55 167.72 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.81 2.34 . . . . 0.0 114.126 177.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 40.8 78.06 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.679 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.4 m -152.89 149.81 28.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.967 0.413 . . . . 0.0 110.707 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -71.03 -33.2 70.09 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.408 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.19 -43.19 95.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.808 -178.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.0 -50.24 74.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.227 0.536 . . . . 0.0 111.024 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.9 p -64.74 -45.73 94.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.569 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 59.3 mtt -66.67 -45.04 80.18 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.3 ptt85 -64.58 -30.35 71.37 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.933 0.397 . . . . 0.0 110.102 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.1 mt -73.67 -59.75 2.57 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.273 177.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.4 mt -54.81 -20.53 8.82 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.45 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -64.16 -86.24 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.353 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.409 HD22 ' H ' ' A' ' 50' ' ' LYS . 2.2 pt? -77.01 -34.87 57.43 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.409 ' H ' HD22 ' A' ' 49' ' ' LEU . 24.7 mmmt -75.3 -49.65 18.52 Favored 'General case' 0 C--N 1.352 0.682 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.193 -176.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 36.56 65.56 0.46 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.709 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 178.55 -53.99 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.858 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.351 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -77.5 -4.74 14.95 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 C-N-CA 122.781 2.321 . . . . 0.0 112.345 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.431 ' CG1' ' N ' ' A' ' 55' ' ' ASP . 7.2 p -45.46 -48.66 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.56 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 110' ' ' ARG . 13.2 t0 -66.64 -45.41 79.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.334 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -59.69 -41.55 90.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.559 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 69.48 114.48 0.03 OUTLIER Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.567 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -51.03 -164.86 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.337 0.589 . . . . 0.0 112.304 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.411 HG22 HD12 ' A' ' 59' ' ' ILE . 86.4 mt -104.49 145.1 13.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 16.0 mt -117.45 144.54 44.91 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.2 tp -111.18 127.53 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-O 121.069 0.461 . . . . 0.0 110.702 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.11 153.35 30.9 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.57 -28.71 7.06 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.764 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.56 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 98.6 m-20 -114.39 142.1 46.78 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.973 0.416 . . . . 0.0 110.903 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -72.66 -13.65 61.41 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -50.41 -33.78 22.03 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.209 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.56 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 4.3 pm0 -94.08 -11.29 30.91 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -90.06 -17.7 27.28 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.391 -0.818 . . . . 0.0 109.322 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.457 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 48.4 tttm -78.45 -39.17 1.62 Allowed Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.457 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 63.9 Cg_endo -104.01 -2.39 0.25 Allowed 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 122.634 2.223 . . . . 0.0 112.287 -178.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.415 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 67.7 t80 -95.45 -10.18 30.56 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.812 0.339 . . . . 0.0 110.87 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.485 ' CG2' ' N ' ' A' ' 73' ' ' ASP . 4.6 mp -123.3 167.36 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.485 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 98.6 m-20 -59.65 -14.24 12.97 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.237 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 58.8 t0 57.14 28.72 15.42 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.85 0.357 . . . . 0.0 110.467 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.5 t -95.86 -43.05 8.02 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.715 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 18.4 ptm -85.63 -8.13 58.42 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.144 0.497 . . . . 0.0 109.923 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.3 tp -86.51 128.26 34.95 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.611 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.36 164.42 36.35 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.08 -176.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -45.94 -46.77 16.34 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 112.088 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.6 -32.69 54.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.843 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -64.68 -39.78 94.27 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.251 0.548 . . . . 0.0 110.492 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.8 mmt85 -65.86 -52.13 52.99 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 122.33 1.062 . . . . 0.0 108.8 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -55.09 -50.89 68.04 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 113.825 -1.534 . . . . 0.0 110.03 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.3 m -61.07 -49.55 76.9 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.574 -1.194 . . . . 0.0 112.247 -177.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.424 ' O ' ' O ' ' A' ' 89' ' ' TRP . 10.0 tt -68.11 -31.11 50.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.617 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -76.75 -36.2 57.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.541 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.1 m -86.63 -44.28 11.99 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.055 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.482 ' O ' ' CD1' ' A' ' 89' ' ' TRP . 61.8 ttt85 -70.14 -77.06 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.936 0.398 . . . . 0.0 110.44 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.482 ' CD1' ' O ' ' A' ' 88' ' ' ARG . 5.8 m0 -158.4 149.37 16.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.449 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -66.65 -23.59 49.03 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.684 1.59 . . . . 0.0 111.946 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 152.36 83.17 0.04 OUTLIER Glycine 0 CA--C 1.533 1.189 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -76.05 -19.4 15.75 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.631 1.554 . . . . 0.0 111.472 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.4 p -136.19 148.91 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.517 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.5 m -83.18 134.21 34.99 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.813 0.34 . . . . 0.0 110.383 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -113.93 138.93 49.66 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.843 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.2 t -95.87 103.04 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 121.459 0.647 . . . . 0.0 109.592 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -87.37 148.91 45.67 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.537 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.04 108.88 2.77 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.93 1.753 . . . . 0.0 111.194 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.44 155.62 92.25 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.264 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.445 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 89.2 Cg_exo -45.43 -32.33 7.76 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.661 1.574 . . . . 0.0 111.979 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.445 ' CB ' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . 0 N--CA 1.465 0.292 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.595 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 109' ' ' GLY . 20.1 mmt180 . . . . . 0 N--CA 1.472 0.664 0 CA-C-O 120.377 0.132 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 2.7 p90 -67.9 -10.28 51.91 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.796 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.662 ' CD1' ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -69.81 -39.24 76.64 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.559 ' C ' ' H ' ' A' ' 110' ' ' ARG . 45.6 m -143.81 -41.4 0.28 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.858 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 56.24 -8.57 0.01 OUTLIER Glycine 0 CA--C 1.535 1.301 0 CA-C-N 115.95 -0.568 . . . . 0.0 113.077 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.559 ' H ' ' C ' ' A' ' 108' ' ' THR . 0.5 OUTLIER -85.03 -52.68 5.79 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 117.898 0.849 . . . . 0.0 109.574 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.529 ' CE2' ' OD1' ' A' ' 112' ' ' ASP . 57.7 t80 -152.44 169.36 22.76 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.324 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.529 ' OD1' ' CE2' ' A' ' 111' ' ' PHE . 18.1 p30 -79.27 49.74 1.0 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.184 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.7 p -160.25 158.04 29.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.084 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.01 138.04 11.24 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.98 132.69 46.31 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 113.557 -1.656 . . . . 0.0 110.296 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.425 ' CG2' ' N ' ' A' ' 117' ' ' ARG . 4.9 p -156.61 163.79 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.425 ' N ' ' CG2' ' A' ' 116' ' ' VAL . 22.6 ptt180 -153.5 160.19 42.46 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.246 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.3 t -125.26 139.89 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.023 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.9 t -141.64 130.04 22.44 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.975 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -132.69 90.17 2.74 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.546 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 9.9 t-80 -173.78 -37.91 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.466 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.546 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 38.2 Cg_endo -93.82 -160.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.32 -0.922 0 C-N-CA 121.932 1.755 . . . . 0.0 112.201 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.7 mp -78.97 -6.51 56.45 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.701 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.2 t -57.16 -45.24 84.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.989 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.584 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 31.5 m -52.91 -62.02 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.21 -0.995 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.022 178.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.584 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -41.23 -45.97 3.03 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 122.369 -0.207 . . . . 0.0 110.943 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.4 tp -67.91 -48.64 65.44 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.206 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 72.1 m -69.53 -49.33 55.49 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.21 0.529 . . . . 0.0 111.197 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.454 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.2 pp0? -54.88 -42.03 71.59 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.855 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.454 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -58.76 -56.39 22.8 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.778 -177.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.511 ' CE1' ' OD1' ' A' ' 36' ' ' ASP . 4.8 t80 -63.0 -24.11 67.76 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.895 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.8 2.76 89.7 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 114.187 -1.37 . . . . 0.0 110.311 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.418 ' O ' ' O ' ' A' ' 134' ' ' PRO . 29.9 mttp -150.2 158.32 36.56 Favored Pre-proline 0 CA--C 1.547 0.833 0 CA-C-N 117.157 0.478 . . . . 0.0 110.342 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 133' ' ' LYS . 6.3 Cg_exo -42.36 -179.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 123.84 3.027 . . . . 0.0 113.442 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.0 tp -134.56 122.78 22.85 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 176.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -64.07 144.87 14.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 117.37 -1.732 . . . . 0.0 107.664 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 12.6 t -116.55 126.8 53.83 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.197 0.522 . . . . 0.0 111.481 -179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.08 162.52 31.51 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.683 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.9 t -72.12 149.14 45.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.044 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.68 78.88 7.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.577 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 56.1 p30 -157.68 165.35 35.69 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.182 0.515 . . . . 0.0 110.328 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.32 -165.82 2.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.174 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.1 p -63.47 -41.25 98.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.043 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -157.4 3.84 0.15 Allowed Glycine 0 N--CA 1.462 0.424 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 146' ' ' PRO . 1.3 tm? -84.0 111.35 32.35 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-O 119.078 -0.487 . . . . 0.0 109.767 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 145' ' ' LEU . 19.5 Cg_exo -34.92 156.52 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.095 1.863 . . . . 0.0 112.745 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.43 171.38 16.31 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.646 2.23 . . . . 0.0 112.229 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 34.7 t -96.09 77.46 3.11 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.664 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.524 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 36.2 ptt180 -53.58 -36.67 62.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.892 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.89 167.24 29.93 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.7 m -57.94 -18.62 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.736 0 CA-C-O 121.846 0.831 . . . . 0.0 109.081 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.62 -36.67 84.57 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.531 ' OE1' ' NE2' ' A' ' 157' ' ' GLN . 5.1 tm-20 -59.48 -73.87 0.08 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.244 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.1 p -45.8 -29.47 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.847 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 159' ' ' GLY . 4.8 tmt_? -83.92 -44.48 14.2 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 122.028 0.918 . . . . 0.0 110.08 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.53 -41.64 85.95 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.257 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.531 ' NE2' ' OE1' ' A' ' 153' ' ' GLU . 0.6 OUTLIER -81.63 -48.74 11.35 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 113.018 -1.901 . . . . 0.0 112.487 -177.092 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.469 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 36.0 t80 -107.04 -35.55 6.85 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -177.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 96.8 24.86 12.44 Favored Glycine 0 N--CA 1.475 1.296 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -44.06 -95.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.953 -0.124 . . . . 0.0 110.812 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.473 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 62.8 38.01 11.97 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.306 0.575 . . . . 0.0 109.955 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.547 ' C ' ' H ' ' A' ' 164' ' ' VAL . 1.4 m-85 -177.97 -61.14 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.377 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -72.69 22.78 0.29 Allowed 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.156 1.904 . . . . 0.0 110.998 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.547 ' H ' ' C ' ' A' ' 162' ' ' PHE . 16.8 m -128.04 167.54 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.636 -177.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.0 t -123.84 65.69 36.48 Favored Pre-proline 0 N--CA 1.476 0.825 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.71 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -35.81 141.83 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 123.748 2.965 . . . . 0.0 115.401 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 176.46 -176.26 47.76 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.721 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -150.91 151.49 32.25 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.467 0.378 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 -179.959 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 . . . . . 0 N--CA 1.443 -0.811 0 CA-C-O 121.072 0.463 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 8.5 pt -99.89 130.96 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.733 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -125.32 165.54 18.17 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.327 0.584 . . . . 0.0 111.552 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 184' ' ' GLY . 99.4 m-20 -76.73 105.91 8.08 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.074 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -67.99 -15.01 63.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.364 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.498 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.4 mm? -64.6 -41.1 96.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.469 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 5.5 t -121.4 -26.97 4.9 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.956 0.407 . . . . 0.0 111.042 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 180' ' ' ASP . . . . . . . . 0 CA--C 1.522 0.479 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.691 0.281 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.409 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 10.5 mp -62.98 -42.77 99.93 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.873 0.368 . . . . 0.0 110.255 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.59 -41.6 96.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.338 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -65.69 -40.7 92.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.23 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -61.46 -47.8 84.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.698 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.79 -46.86 86.03 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.298 0.571 . . . . 0.0 110.569 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.4 -43.88 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.466 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.78 -41.64 82.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.259 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.54 -41.73 97.78 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.917 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.59 -55.24 36.99 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.319 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.4 pt -69.37 -27.49 34.66 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.148 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -60.95 -56.16 24.35 Favored 'General case' 0 C--O 1.216 -0.659 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.106 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 20' ' ' GLU . 94.0 t -64.57 -40.6 89.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 C-N-CA 121.264 -0.174 . . . . 0.0 111.374 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.417 ' CD1' ' C ' ' A' ' 17' ' ' LEU . 2.0 tm? -56.3 -48.11 77.33 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.354 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -76.51 -49.14 17.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.201 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -69.06 -34.9 75.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.557 -178.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 16' ' ' VAL . 97.2 mt-10 62.5 80.36 0.23 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.22 -139.21 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.844 0.354 . . . . 0.0 110.483 177.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.2 p -134.58 140.61 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 pp -128.81 162.92 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-O 121.023 0.44 . . . . 0.0 111.064 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.26 129.39 41.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.71 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.514 ' CZ ' ' O ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -122.84 148.65 54.36 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -179.432 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.514 ' O ' ' CZ ' ' A' ' 25' ' ' TYR . 57.6 Cg_endo -78.91 148.66 22.31 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.993 1.795 . . . . 0.0 111.783 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.529 ' C ' ' H ' ' A' ' 29' ' ' ALA . 40.8 m -131.41 133.85 45.65 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.469 ' OE2' ' NH1' ' A' ' 117' ' ' ARG . 22.3 pt-20 -74.7 23.12 0.09 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.826 0.346 . . . . 0.0 110.425 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.529 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -155.19 -73.44 0.11 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.2 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 p -128.28 129.85 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.342 0.592 . . . . 0.0 110.751 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.507 ' CD2' ' O ' ' A' ' 148' ' ' CYS . 46.8 p90 -37.73 144.88 0.08 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.798 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -155.61 -173.41 24.24 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.5 m -132.27 168.06 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.411 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -156.96 -178.94 31.52 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.553 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.454 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.8 OUTLIER -159.24 -165.21 1.54 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.025 0.441 . . . . 0.0 111.328 -178.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.454 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 85.0 m-20 -91.61 108.02 26.34 Favored Pre-proline 0 CA--C 1.555 1.155 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -43.64 -61.18 0.6 Allowed 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.916 1.744 . . . . 0.0 112.262 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -71.94 67.01 0.6 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.058 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.1 m -155.71 133.99 11.57 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.88 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -65.73 -34.32 77.92 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.341 0.591 . . . . 0.0 110.688 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.0 t -60.76 -41.19 94.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.171 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.64 -51.64 67.94 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.608 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.65 -42.14 95.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.285 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 92.2 mtp -63.77 -40.24 96.21 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.9 ttt85 -59.95 -42.54 94.28 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 121.967 0.889 . . . . 0.0 108.611 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.99 -53.13 54.96 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.73 -178.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.8 mt -70.77 -11.62 61.06 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.2 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -70.21 -82.6 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 121.152 0.501 . . . . 0.0 111.342 -177.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.421 HD22 ' H ' ' A' ' 50' ' ' LYS . 2.3 pt? -75.97 -35.26 59.7 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.421 ' H ' HD22 ' A' ' 49' ' ' LEU . 24.9 mmmt -76.95 -50.28 13.57 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.966 -177.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 35.32 65.34 0.39 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.919 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 179.02 -53.48 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.778 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.27 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.91 -3.31 12.7 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.709 2.273 . . . . 0.0 112.388 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.428 ' O ' ' O ' ' A' ' 108' ' ' THR . 7.9 p -44.03 -43.87 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.47 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -66.45 -41.73 88.66 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.041 0.448 . . . . 0.0 110.246 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.416 ' CD ' ' N ' ' A' ' 56' ' ' LYS . 1.1 mptm? -60.29 -39.64 87.64 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 62.29 107.71 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.561 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -53.14 -163.2 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.229 0.538 . . . . 0.0 111.591 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.5 mt -101.01 144.32 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.538 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.4 mt -121.7 143.14 49.52 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.5 tp -113.86 128.67 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-O 121.244 0.545 . . . . 0.0 110.958 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.23 156.55 24.11 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.951 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.15 -26.37 5.94 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -118.42 142.64 47.35 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.086 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -69.81 -12.68 61.81 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.64 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -50.75 -31.58 17.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.927 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -95.76 -13.59 24.01 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.403 ' CD2' ' N ' ' A' ' 68' ' ' LEU . 4.0 mm? -92.16 -13.8 30.08 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.471 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 76.8 tttt -80.56 -38.16 1.05 Allowed Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 86.1 Cg_endo -102.38 -3.85 0.33 Allowed 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 122.696 2.264 . . . . 0.0 111.39 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.54 ' HH ' ' CD2' ' A' ' 114' ' ' LEU . 44.9 t80 -92.84 -14.86 27.17 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.687 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.47 ' CG2' ' N ' ' A' ' 73' ' ' ASP . 4.2 mp -122.62 159.9 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.47 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 27.7 p30 -65.86 144.37 56.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.374 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -87.19 7.2 29.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.548 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.442 ' CG2' ' N ' ' A' ' 76' ' ' MET . 15.0 t -78.11 -45.52 23.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.246 0.546 . . . . 0.0 110.854 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.442 ' N ' ' CG2' ' A' ' 75' ' ' THR . 25.0 ptm -84.92 -19.33 32.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.666 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.4 tp -81.78 130.07 34.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.027 -178.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.84 167.26 30.51 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.681 -177.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -48.51 -44.5 36.09 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.725 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.71 -31.76 51.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.994 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -64.52 -40.67 96.06 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.399 0.619 . . . . 0.0 110.533 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.3 mmt85 -66.58 -51.99 50.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.477 1.132 . . . . 0.0 109.462 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 87' ' ' SER . 83.1 tt0 -55.86 -50.66 69.99 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 113.852 -1.522 . . . . 0.0 110.421 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.7 m -61.16 -49.95 75.17 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.013 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.5 tt -67.53 -29.74 46.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.853 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -79.49 -35.31 40.39 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.621 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 83' ' ' GLU . 10.9 m -89.85 -15.35 32.42 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.425 ' O ' ' O ' ' A' ' 89' ' ' TRP . 69.4 ttt180 -115.98 74.67 0.91 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.863 0.363 . . . . 0.0 110.714 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.425 ' O ' ' O ' ' A' ' 88' ' ' ARG . 1.5 m0 59.25 150.32 0.08 OUTLIER Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.668 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.57 -15.55 45.15 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.739 1.626 . . . . 0.0 110.636 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 104.95 69.35 0.76 Allowed Glycine 0 N--CA 1.471 1.031 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.088 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -55.94 -38.95 93.92 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.556 2.171 . . . . 0.0 112.222 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.3 p -75.64 147.47 8.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.209 0.528 . . . . 0.0 111.104 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.496 ' N ' ' O ' ' A' ' 177' ' ' GLU . 19.3 m -102.45 126.25 49.42 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.981 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -116.12 143.04 46.01 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.271 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 84.2 t -84.08 98.96 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-O 121.123 0.487 . . . . 0.0 111.323 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -83.65 139.36 40.83 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.804 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.36 104.92 1.81 Allowed 'Trans proline' 0 N--CA 1.489 1.21 0 C-N-CA 121.566 1.51 . . . . 0.0 110.901 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 112' ' ' ASP . . . -61.9 149.56 85.3 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.8 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -73.08 165.82 31.7 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.427 2.085 . . . . 0.0 112.098 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.737 179.626 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.536 ' O ' ' N ' ' A' ' 109' ' ' GLY . 5.3 tpp85 . . . . . 0 CA--C 1.531 0.233 0 CA-C-O 120.932 0.396 . . . . 0.0 110.132 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -78.07 -10.86 59.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 122.05 0.929 . . . . 0.0 109.401 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.583 ' H ' ' CD2' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -82.39 -16.27 49.71 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.017 -1.447 . . . . 0.0 111.064 -179.567 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.428 ' O ' ' O ' ' A' ' 54' ' ' VAL . 99.0 m -140.69 -42.06 0.4 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.942 0.401 . . . . 0.0 109.972 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 77.94 19.81 74.46 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.301 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.19 -75.78 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 117.614 0.707 . . . . 0.0 110.478 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -111.18 162.4 14.98 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.29 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' A' ' 99' ' ' ALA . 90.4 m-20 -95.2 60.39 2.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.088 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.6 p -158.13 145.04 17.8 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.54 ' CD2' ' HH ' ' A' ' 71' ' ' TYR . 3.7 pp -166.98 145.71 5.14 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.55 127.38 31.64 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 113.728 -1.578 . . . . 0.0 109.398 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.9 p -145.35 161.23 12.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.469 ' NH1' ' OE2' ' A' ' 28' ' ' GLU . 61.7 ttp180 -148.23 155.32 41.22 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.205 0.526 . . . . 0.0 111.811 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.7 t -119.97 135.69 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.1 t -135.51 150.31 49.73 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.925 0.393 . . . . 0.0 110.1 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 34.4 p30 -154.01 81.9 1.14 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.223 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.602 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 6.8 t60 -171.75 -35.93 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.602 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 73.3 Cg_endo -96.77 -160.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.927 0 C-N-CA 122.077 1.851 . . . . 0.0 112.114 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.4 mt -77.35 -5.14 48.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.669 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 77.8 t -58.12 -45.81 88.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.084 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.585 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 27.7 m -54.26 -62.73 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.21 -0.986 0 C-N-CA 119.402 -0.919 . . . . 0.0 108.696 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.585 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -41.35 -44.66 2.83 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.708 0.29 . . . . 0.0 111.12 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.34 -47.89 63.05 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.27 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 70.9 m -70.46 -48.99 53.23 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.204 0.526 . . . . 0.0 111.08 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.456 ' N ' ' O ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER -53.93 -42.78 69.19 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.437 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.435 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -59.69 -53.38 58.66 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.589 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -63.83 -24.64 67.83 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.166 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.11 1.69 90.4 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 134' ' ' PRO . 34.8 mttm -153.33 157.8 32.82 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 120.574 -0.451 . . . . 0.0 110.122 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.4 ' O ' ' O ' ' A' ' 133' ' ' LYS . 5.2 Cg_exo -41.41 175.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 123.926 3.084 . . . . 0.0 113.581 -178.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.5 tp -129.38 122.73 30.04 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 176.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.411 ' O ' ' CA ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -66.19 143.33 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.955 0 C-N-CA 118.108 -1.437 . . . . 0.0 107.404 -179.52 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.8 t -114.88 122.09 45.22 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 123.792 0.682 . . . . 0.0 110.597 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.9 m -130.01 162.98 27.49 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.881 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.0 m -72.25 145.45 47.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.382 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.81 81.6 1.16 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.019 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 57.7 p30 -160.47 161.42 32.87 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.616 0.722 . . . . 0.0 111.031 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.49 -167.12 1.88 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.318 -178.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.6 t -61.03 -43.24 99.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.44 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -158.32 4.71 0.13 Allowed Glycine 0 C--N 1.33 0.227 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.2 tt -83.44 127.92 66.4 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -39.74 158.21 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.549 1.499 . . . . 0.0 112.207 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -77.04 -163.22 0.2 Allowed 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.733 2.288 . . . . 0.0 111.889 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.507 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 19.5 t -126.38 78.23 1.76 Allowed 'General case' 0 C--N 1.34 0.155 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -49.8 -39.51 38.57 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.676 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.16 169.81 23.69 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.5 m -58.04 -20.87 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 CA-C-O 121.786 0.803 . . . . 0.0 108.984 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -64.53 -33.34 75.67 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 155' ' ' ARG . 0.4 OUTLIER -62.26 -79.37 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.401 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.8 p -34.91 -33.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.983 0.913 . . . . 0.0 111.109 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.493 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -68.61 -53.27 23.66 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.533 -179.265 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -68.76 -18.61 64.24 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 122.571 1.177 . . . . 0.0 108.068 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.61 -45.56 14.41 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 112.517 -2.128 . . . . 0.0 111.559 -178.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -130.17 -29.76 2.02 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 96.48 23.75 15.64 Favored Glycine 0 N--CA 1.469 0.894 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -178.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 159' ' ' GLY . . . -43.12 -97.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.533 -0.333 . . . . 0.0 111.17 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.518 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.95 34.81 16.56 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -178.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.538 ' C ' ' H ' ' A' ' 164' ' ' VAL . 2.2 m-85 -172.67 -62.64 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.136 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -72.99 27.07 0.29 Allowed 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.258 1.972 . . . . 0.0 110.758 177.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.538 ' H ' ' C ' ' A' ' 162' ' ' PHE . 15.4 m -129.64 167.48 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.426 -178.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 16.4 t -124.37 65.86 42.3 Favored Pre-proline 0 N--CA 1.471 0.601 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.637 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -37.15 140.04 0.21 Allowed 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 123.413 2.742 . . . . 0.0 115.189 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 162.45 170.78 27.74 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 113.929 -1.487 . . . . 0.0 110.883 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -157.99 147.19 19.55 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.665 0.269 . . . . 0.0 110.427 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.469 0.494 0 CA-C-O 120.892 0.377 . . . . 0.0 110.529 179.645 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 94' ' ' THR . 98.0 mt-10 . . . . . 0 N--CA 1.45 -0.46 0 CA-C-O 120.717 0.294 . . . . 0.0 111.602 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 18.4 tt -90.33 122.85 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.117 0.484 . . . . 0.0 111.834 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -134.74 170.69 15.45 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.252 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -87.01 107.2 18.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.242 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -69.21 -11.9 61.2 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.907 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.46 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.8 mm? -64.28 -42.62 96.34 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.45 -41.81 4.26 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.619 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.716 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -179.874 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.767 0.318 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.465 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 9.2 mp -63.18 -42.51 99.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.155 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -64.5 -40.52 95.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.024 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.1 tpt180 -63.22 -41.65 99.14 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.35 -43.93 98.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.462 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.56 -46.49 90.01 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.993 0.425 . . . . 0.0 110.024 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.415 HG21 HD13 ' A' ' 10' ' ' ILE . 96.4 mt -63.34 -43.6 98.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.636 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.07 -41.38 78.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.131 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.67 -44.07 94.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.245 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.86 -53.09 62.02 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.915 0.388 . . . . 0.0 111.561 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.8 pt -68.89 -39.36 79.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.232 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -57.92 -53.66 55.75 Favored 'General case' 0 C--O 1.215 -0.719 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.22 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 20' ' ' GLU . 86.5 t -61.07 -40.05 84.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.233 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.453 ' CD2' ' C ' ' A' ' 17' ' ' LEU . 6.2 tt -51.89 -50.59 60.74 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.441 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -81.56 -49.26 10.76 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.253 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -66.0 -31.6 72.59 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.08 -178.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 16' ' ' VAL . 97.0 mt-10 57.14 83.91 0.1 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.075 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.411 ' H ' HG12 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -164.8 -159.14 0.44 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.86 178.586 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.8 p -119.02 137.26 53.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pp -126.14 166.92 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 120.799 0.333 . . . . 0.0 111.327 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.23 137.39 58.19 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.25 0.548 . . . . 0.0 111.342 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.537 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 2.2 t80 -130.77 139.13 34.67 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.537 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 96.5 Cg_endo -76.88 144.47 24.34 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.488 1.459 . . . . 0.0 111.96 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.2 m -140.37 138.13 34.58 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.943 0.401 . . . . 0.0 110.363 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -56.73 -45.77 81.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.736 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.48 -79.28 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.806 0.336 . . . . 0.0 111.349 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 90.6 t -135.56 129.96 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -37.85 140.39 0.26 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.183 0.516 . . . . 0.0 111.546 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -137.74 -168.25 11.28 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.0 m -128.19 171.92 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -162.48 -177.53 35.59 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.221 -0.99 . . . . 0.0 111.719 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.504 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.8 OUTLIER -160.92 -161.42 0.83 Allowed 'General case' 0 C--N 1.342 0.259 0 C-N-CA 120.259 -0.577 . . . . 0.0 112.169 -179.227 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.504 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 69.2 m-20 -92.13 107.3 22.07 Favored Pre-proline 0 CA--C 1.557 1.241 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -45.46 -55.75 3.29 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 122.038 1.825 . . . . 0.0 111.71 177.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -50.81 -33.4 23.4 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.026 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.3 m -76.5 118.89 19.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.326 0.584 . . . . 0.0 110.659 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -65.02 -32.19 73.79 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.87 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.5 t -43.48 -28.04 0.33 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.796 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.3 -51.6 62.67 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.27 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.0 p -64.5 -39.34 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.171 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 92.6 mtp -66.11 -39.24 89.77 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.6 ttt85 -63.01 -33.27 75.07 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.86 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 87.2 mt -74.4 -59.04 2.91 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.3 mt -53.72 -19.54 4.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.334 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -66.66 -84.95 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.572 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -77.48 -34.75 54.2 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -74.94 -50.05 18.09 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.826 -176.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 37.25 62.01 0.88 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.665 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.9 ttm-85 -179.04 -61.91 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.895 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.215 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -63.36 -11.75 27.18 Favored 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 122.872 2.381 . . . . 0.0 112.422 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 55' ' ' ASP . 9.7 p -41.76 -48.61 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.831 -0.347 . . . . 0.0 111.143 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.467 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 65.6 t0 -66.73 -39.74 88.09 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.88 0.371 . . . . 0.0 111.051 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -60.82 -39.91 90.76 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 64.73 108.3 0.01 OUTLIER Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.567 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -53.63 -159.16 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.319 0.581 . . . . 0.0 112.095 -179.603 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 67.6 mt -103.94 144.07 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.896 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 20.4 mt -121.98 142.4 50.35 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.9 tp -112.45 134.59 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-O 121.368 0.604 . . . . 0.0 110.88 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.61 150.92 41.99 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.99 -27.27 8.49 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -116.48 151.0 36.97 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.796 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -79.68 -13.55 59.39 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -51.94 -31.44 28.81 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.482 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.13 -12.64 28.0 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -92.63 -16.62 25.37 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 118.793 0.724 . . . . 0.0 109.276 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.501 ' HZ2' HH22 ' A' ' 82' ' ' ARG . 44.5 tttp -77.5 -38.88 1.9 Allowed Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.774 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 67.6 Cg_endo -103.99 -2.89 0.24 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 122.91 2.407 . . . . 0.0 112.38 -178.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.424 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 58.9 t80 -95.84 -9.34 31.78 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.033 -178.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.464 ' CG2' ' N ' ' A' ' 73' ' ' ASP . 4.2 mp -125.64 161.96 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.464 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 0.5 OUTLIER -58.5 177.24 0.14 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.856 0.36 . . . . 0.0 110.232 -179.326 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -105.38 15.47 27.18 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.484 ' OG1' ' N ' ' A' ' 76' ' ' MET . 32.3 p -80.88 -64.53 1.17 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.095 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.484 ' N ' ' OG1' ' A' ' 75' ' ' THR . 26.4 ptm -70.23 -5.09 25.09 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.184 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.2 tp -83.93 100.92 11.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.32 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -155.15 160.28 40.8 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.78 -177.572 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -39.37 -48.51 1.91 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.813 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.1 p -61.86 -34.0 60.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.661 -0.415 . . . . 0.0 111.279 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 78' ' ' THR . 64.8 tp60 -65.57 -41.56 92.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.916 0.389 . . . . 0.0 110.715 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.501 HH22 ' HZ2' ' A' ' 69' ' ' LYS . 8.8 mmt85 -63.63 -51.98 62.85 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 122.589 1.185 . . . . 0.0 109.136 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -55.08 -50.3 69.5 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.776 -1.556 . . . . 0.0 110.018 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -60.52 -49.95 75.5 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.939 -178.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.0 tt -67.73 -37.19 78.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.097 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -70.37 -43.09 70.87 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.488 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.4 m -75.23 -37.73 60.93 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.195 0.521 . . . . 0.0 110.561 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -76.15 150.58 37.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -36.29 153.96 0.08 OUTLIER Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.888 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 118' ' ' VAL . 41.5 Cg_endo -64.28 -24.25 65.3 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.048 1.832 . . . . 0.0 111.439 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.492 ' O ' ' NH2' ' A' ' 117' ' ' ARG . . . 176.51 79.27 0.05 OUTLIER Glycine 0 CA--C 1.531 1.037 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.09 -44.35 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.058 1.839 . . . . 0.0 111.941 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.0 p -137.26 145.82 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.196 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.9 m -83.8 130.27 34.94 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.214 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -117.85 140.03 50.28 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.512 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.4 t -90.28 101.37 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 121.477 0.656 . . . . 0.0 110.023 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -90.23 152.32 45.7 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.377 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.42 113.04 3.69 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.199 1.933 . . . . 0.0 111.189 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.14 150.95 75.22 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.26 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -72.27 156.04 55.45 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.075 1.85 . . . . 0.0 112.159 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.384 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.016 -179.981 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 109' ' ' GLY . 7.4 tpt180 . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 120.667 0.27 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 66.8 p-90 -75.8 -7.34 54.21 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.957 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.665 ' CD1' ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -70.91 -30.14 66.39 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 89.9 m -140.38 -38.46 0.45 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.705 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 86.04 -11.38 62.8 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.608 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -142.13 -72.3 0.32 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.56 0.68 . . . . 0.0 110.788 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.443 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 21.4 t80 -91.32 -167.38 1.79 Allowed 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.443 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 94.9 m-20 -130.53 57.6 1.72 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.653 0.263 . . . . 0.0 110.693 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.7 p -156.51 156.92 34.53 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.187 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.1 pp -168.96 138.88 2.25 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.32 131.56 44.33 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 113.787 -1.551 . . . . 0.0 109.932 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.8 p -147.06 155.35 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 120.727 0.299 . . . . 0.0 110.364 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.492 ' NH2' ' O ' ' A' ' 91' ' ' GLY . 79.3 ttt180 -146.1 153.27 40.52 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.847 -179.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 90' ' ' PRO . 49.6 t -120.5 136.24 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.9 t -139.74 142.13 36.82 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.025 0.441 . . . . 0.0 110.629 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 51.0 p-10 -145.82 81.82 1.61 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.686 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.576 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 7.3 t60 -171.49 -36.29 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.576 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 43.0 Cg_endo -94.72 -161.14 0.07 OUTLIER 'Trans proline' 0 N--CA 1.483 0.907 0 C-N-CA 122.044 1.829 . . . . 0.0 111.955 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.3 mt -78.01 -6.17 53.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.392 0.615 . . . . 0.0 110.013 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 98.8 t -58.08 -45.29 88.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.072 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.585 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 28.7 m -53.2 -62.15 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.906 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.019 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.585 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -41.68 -44.01 3.02 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 120.938 0.399 . . . . 0.0 110.723 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.3 tp -68.93 -48.26 63.68 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.235 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 60.7 m -70.28 -49.29 51.26 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.387 0.613 . . . . 0.0 110.907 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 125' ' ' VAL . 1.1 pp0? -54.55 -41.95 70.36 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.341 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.438 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -58.64 -55.07 39.83 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.257 -178.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -62.46 -21.9 65.81 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.919 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.73 1.27 89.19 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -152.27 160.56 31.18 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 120.506 -0.477 . . . . 0.0 110.357 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -45.04 164.3 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 123.943 3.095 . . . . 0.0 112.54 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.4 tp -119.36 122.93 42.93 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.417 ' O ' ' CA ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -63.54 144.69 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 C-N-CA 117.913 -1.515 . . . . 0.0 106.945 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.1 t -116.82 125.1 51.06 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 123.583 0.552 . . . . 0.0 111.283 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.3 m -134.54 158.39 44.08 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.781 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.6 m -71.31 142.56 50.45 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.168 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.72 85.39 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.558 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -160.63 165.44 30.65 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.438 0.637 . . . . 0.0 111.079 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.93 -164.65 2.01 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.315 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 42.5 t -61.37 -43.08 99.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.022 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -157.25 3.91 0.16 Allowed Glycine 0 N--CA 1.461 0.355 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 146' ' ' PRO . 1.3 tm? -81.18 112.28 31.57 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 145' ' ' LEU . 20.1 Cg_exo -35.46 156.84 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.104 1.869 . . . . 0.0 112.542 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.7 -174.21 1.23 Allowed 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.4 2.067 . . . . 0.0 112.57 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 17.6 m -114.44 82.89 1.79 Allowed 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.378 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -59.07 -35.58 73.6 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.637 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -161.82 169.41 21.38 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.721 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -57.02 -23.19 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 CA-C-O 121.437 0.637 . . . . 0.0 109.378 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -62.71 -32.41 73.51 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 155' ' ' ARG . 6.4 tm-20 -63.09 -80.45 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.568 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.3 p -36.37 -27.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.167 0.987 . . . . 0.0 111.044 177.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.471 ' N ' ' O ' ' A' ' 153' ' ' GLU . 4.3 tmt_? -74.4 -50.73 17.34 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.855 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.7 -17.75 62.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 122.631 1.205 . . . . 0.0 107.781 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -83.32 -57.04 3.42 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 112.553 -2.112 . . . . 0.0 111.987 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -119.99 -20.6 7.42 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 160' ' ' ALA . . . 84.72 27.63 34.5 Favored Glycine 0 N--CA 1.466 0.642 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' A' ' 159' ' ' GLY . . . -42.21 -98.37 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.58 -0.31 . . . . 0.0 111.36 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.516 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 67.79 34.44 4.35 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.299 0.571 . . . . 0.0 109.578 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.54 ' C ' ' H ' ' A' ' 164' ' ' VAL . 1.6 m-85 -176.36 -61.89 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.235 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -73.44 31.45 0.31 Allowed 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.044 1.829 . . . . 0.0 110.439 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.54 ' H ' ' C ' ' A' ' 162' ' ' PHE . 15.4 m -134.67 168.22 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.834 -178.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 8.3 t -125.15 64.82 46.6 Favored Pre-proline 0 N--CA 1.475 0.79 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.855 178.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -40.13 151.0 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 123.706 2.938 . . . . 0.0 114.97 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 162.68 -174.93 39.1 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.983 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -141.68 145.12 34.53 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.465 0.308 0 CA-C-O 121.036 0.446 . . . . 0.0 110.809 -179.717 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 . . . . . 0 N--CA 1.449 -0.482 0 CA-C-O 120.584 0.23 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 17.2 tt -109.68 129.87 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 120.795 0.331 . . . . 0.0 110.539 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -132.63 166.34 22.35 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.711 0.767 . . . . 0.0 112.018 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -80.36 106.87 12.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.502 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -64.47 -20.05 65.95 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.216 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.449 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.5 mm? -63.02 -42.64 99.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.933 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.85 -45.28 2.88 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.836 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.673 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.735 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 41.5 t30 . . . . . 0 C--O 1.235 0.309 0 CA-C-O 120.92 0.39 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.446 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 10.0 mp -61.95 -43.08 99.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.22 0.533 . . . . 0.0 109.608 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -67.96 -35.35 78.23 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.127 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -60.71 -43.61 97.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.543 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 9' ' ' ALA . 1.5 p30 -70.97 -39.22 72.67 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.166 -0.613 . . . . 0.0 110.469 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.523 ' N ' ' OD1' ' A' ' 8' ' ' ASP . . . -62.12 -48.3 80.77 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.269 0.557 . . . . 0.0 110.122 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.0 -43.59 99.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.912 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.56 -45.31 77.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.635 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.07 -46.68 88.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.924 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.94 -52.1 66.87 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 14.3 pt -69.37 -39.67 79.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.518 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -58.75 -53.47 57.99 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.123 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.465 ' O ' ' N ' ' A' ' 20' ' ' GLU . 89.6 t -60.76 -40.42 84.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.508 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.455 ' CD2' ' C ' ' A' ' 17' ' ' LEU . 6.4 tt -51.67 -50.59 60.12 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.77 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -80.77 -50.99 9.14 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.056 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -63.7 -32.75 74.34 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.049 -178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.465 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.9 mt-10 58.49 85.35 0.09 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.385 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.57 -141.06 0.07 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.319 178.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.8 p -137.55 139.58 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pp -129.85 165.9 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-O 120.945 0.402 . . . . 0.0 111.41 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.63 136.97 58.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.301 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.51 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -134.54 142.23 41.92 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.51 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 62.6 Cg_endo -77.25 151.09 29.64 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.771 1.647 . . . . 0.0 111.82 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.515 ' C ' ' H ' ' A' ' 29' ' ' ALA . 45.7 m -132.13 136.49 47.16 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.844 0.354 . . . . 0.0 110.87 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -74.98 23.83 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.357 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.515 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -157.27 -73.44 0.09 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.313 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.8 p -127.52 126.95 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.316 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.511 ' CD1' ' O ' ' A' ' 148' ' ' CYS . 35.4 p90 -40.24 147.83 0.09 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.323 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -156.34 -169.45 20.46 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.3 m -133.21 170.87 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.406 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -158.58 -175.48 29.56 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.012 -1.089 . . . . 0.0 112.102 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.521 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -158.44 -164.13 1.41 Allowed 'General case' 0 C--O 1.227 -0.103 0 CA-C-O 120.568 0.223 . . . . 0.0 110.81 -179.312 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.521 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 90.5 m-20 -98.72 109.69 54.29 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -178.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 36' ' ' ASP . 22.4 Cg_exo -36.73 170.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.854 2.369 . . . . 0.0 114.325 177.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 41.98 71.94 0.19 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.074 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.5 m -148.81 138.86 22.23 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.373 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -69.87 -34.79 74.06 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.462 0.648 . . . . 0.0 110.54 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.98 -43.0 99.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.667 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.71 -51.34 70.18 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.726 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 p -63.62 -42.6 96.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 90.4 mtp -64.24 -39.71 94.52 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.451 ' O ' ' CD2' ' A' ' 49' ' ' LEU . 45.8 ttt-85 -62.15 -33.8 75.18 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.067 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 89.4 mt -75.09 -59.93 2.52 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.2 mt -54.18 -18.42 3.8 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.361 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -67.35 -85.67 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.741 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.451 ' CD2' ' O ' ' A' ' 45' ' ' ARG . 2.3 pt? -75.72 -32.76 60.17 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.906 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.406 ' H ' HD23 ' A' ' 49' ' ' LEU . 23.8 mmmt -78.18 -70.44 0.49 Allowed 'General case' 0 C--N 1.349 0.571 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.489 -177.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 52.84 81.05 0.09 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.0 mtm180 161.72 -63.14 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.86 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.1 -11.68 32.79 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.819 2.346 . . . . 0.0 112.255 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.9 p -41.83 -49.9 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.815 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 55' ' ' ASP . 65.7 t0 -66.74 -40.13 88.22 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.018 0.437 . . . . 0.0 111.146 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -61.36 -39.97 92.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.692 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 66.39 112.49 0.01 OUTLIER Glycine 0 CA--C 1.519 0.295 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.555 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -52.99 -162.37 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.325 0.583 . . . . 0.0 112.298 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.431 HD13 HG22 ' A' ' 59' ' ' ILE . 70.9 mt -105.02 145.23 13.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.825 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.6 mt -121.15 142.66 49.67 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.4 tp -110.78 127.8 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-O 121.076 0.465 . . . . 0.0 110.708 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -117.64 148.15 42.22 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -106.4 -27.68 10.81 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 116.297 -0.411 . . . . 0.0 109.915 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.616 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 12.4 m120 -115.79 150.32 37.11 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.735 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -79.98 -14.42 58.6 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -52.91 -30.82 36.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.585 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.616 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 4.4 pm0 -94.04 -12.22 29.05 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.413 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 3.8 mm? -91.4 -20.81 21.4 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.513 -0.742 . . . . 0.0 109.591 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.462 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 49.1 tttm -76.03 -37.45 2.17 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 68.7 Cg_endo -103.39 -3.48 0.26 Allowed 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 122.548 2.166 . . . . 0.0 112.007 -178.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.446 ' OH ' ' CD1' ' A' ' 114' ' ' LEU . 53.9 t80 -98.25 -4.1 35.98 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.037 0.446 . . . . 0.0 111.07 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.481 ' CG2' ' N ' ' A' ' 73' ' ' ASP . 4.6 mp -132.91 166.54 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.481 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 98.7 m-20 -58.0 -9.66 1.47 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.475 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 58.2 t0 58.54 30.4 19.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.9 t -95.23 -36.79 11.3 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.091 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -83.07 -18.83 38.25 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.86 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 36.0 tp -86.03 125.35 33.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.148 0.499 . . . . 0.0 110.287 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -161.56 161.74 29.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.156 -177.075 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -39.49 -48.41 2.0 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.849 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.13 -32.96 58.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.976 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.454 ' N ' ' O ' ' A' ' 78' ' ' THR . 63.2 tp60 -65.14 -40.57 94.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.585 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.2 mmt85 -64.79 -53.05 53.07 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 122.164 0.983 . . . . 0.0 109.252 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -53.98 -51.02 65.24 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.011 -1.45 . . . . 0.0 110.39 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.5 m -61.05 -50.34 73.7 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.853 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 89' ' ' TRP . 8.6 tt -68.02 -33.75 62.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.728 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -73.82 -38.89 64.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.168 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.7 m -83.41 -34.55 25.48 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.8 0.333 . . . . 0.0 111.416 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 63.9 ttm-85 -81.14 -75.26 0.29 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.504 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.436 ' O ' ' O ' ' A' ' 85' ' ' ILE . 2.2 m0 -162.02 152.85 14.83 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -65.31 -22.51 60.21 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.296 1.997 . . . . 0.0 112.198 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 161.44 78.02 0.03 OUTLIER Glycine 0 CA--C 1.531 1.077 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.514 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.53 -23.59 11.23 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 121.946 1.764 . . . . 0.0 112.404 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.15 147.22 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.216 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 26.9 m -89.89 138.47 31.46 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.257 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -124.46 139.94 53.42 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.999 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.6 t -97.76 109.72 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 CA-C-O 121.433 0.635 . . . . 0.0 111.084 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -92.08 147.64 35.16 Favored Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.421 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.51 98.1 1.09 Allowed 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.847 1.698 . . . . 0.0 110.985 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -46.87 148.04 2.01 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -63.36 -28.71 71.82 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.261 1.974 . . . . 0.0 112.561 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.236 0 CA-C-O 120.71 0.29 . . . . 0.0 110.617 -179.529 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 109' ' ' GLY . 8.0 tpt180 . . . . . 0 CA--C 1.53 0.18 0 CA-C-O 120.835 0.35 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -73.37 -6.96 49.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.669 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.642 ' CD1' ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -77.71 -21.28 52.2 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.059 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 93.1 m -142.79 -40.34 0.33 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.141 0.495 . . . . 0.0 109.981 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 91.44 -15.44 61.33 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.642 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.422 ' O ' ' NH2' ' A' ' 105' ' ' ARG . 17.3 tpt180 -145.23 -76.95 0.21 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 117.578 0.689 . . . . 0.0 111.488 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.449 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 22.0 t80 -87.1 -167.33 1.85 Allowed 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.449 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 52.8 p-10 -136.03 73.15 1.45 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.103 0.477 . . . . 0.0 111.302 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.7 p -159.68 129.49 5.45 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.446 ' CD1' ' OH ' ' A' ' 71' ' ' TYR . 34.4 mt -127.72 121.62 30.79 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -177.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.84 126.56 29.93 Favored 'General case' 0 C--N 1.345 0.397 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 175.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.8 p -143.88 152.84 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.198 0.523 . . . . 0.0 111.1 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -139.82 154.3 47.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.116 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.7 t -123.86 132.8 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.3 t -132.21 149.91 52.28 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.985 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 33.8 p30 -152.75 80.7 1.22 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.07 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.602 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 49.3 t-80 -171.79 -35.31 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.602 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 56.5 Cg_endo -94.99 -161.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.98 1.787 . . . . 0.0 111.834 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 11.3 mt -78.16 -4.79 49.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.978 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 82.4 t -58.24 -45.76 88.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.968 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.577 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 27.8 m -53.71 -62.31 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.941 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.044 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.577 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -41.67 -43.27 2.77 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.968 0.413 . . . . 0.0 110.842 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.7 tp -69.93 -47.66 61.53 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.414 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 62.7 m -70.48 -49.22 50.74 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.539 0.685 . . . . 0.0 110.531 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 125' ' ' VAL . 1.1 pp0? -54.41 -42.24 70.24 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.433 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -58.88 -54.57 45.64 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.455 -178.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -62.41 -23.25 66.74 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.001 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.51 0.58 90.06 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 134' ' ' PRO . 33.1 mttm -153.67 159.18 32.39 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 133' ' ' LYS . 6.3 Cg_exo -41.35 179.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 123.886 3.057 . . . . 0.0 113.239 -178.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.0 tp -133.44 123.26 24.98 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 176.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.406 ' O ' ' CA ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -65.6 146.48 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 C-N-CA 117.64 -1.624 . . . . 0.0 107.271 -179.45 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.8 t -118.65 126.95 53.06 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 123.573 0.545 . . . . 0.0 111.214 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.7 m -132.74 163.5 28.88 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.04 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.8 m -74.2 146.94 42.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.443 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.45 83.55 1.97 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.917 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -159.12 164.71 35.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.398 0.618 . . . . 0.0 110.977 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.88 -166.18 2.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.073 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 61.1 m -60.09 -42.7 95.21 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.799 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -160.63 5.38 0.1 OUTLIER Glycine 0 C--N 1.331 0.28 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.4 tp -81.19 127.9 72.42 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 119.36 -0.352 . . . . 0.0 110.104 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -39.28 151.28 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 121.637 1.558 . . . . 0.0 111.804 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 149' ' ' ARG . 89.2 Cg_endo -75.17 148.58 34.83 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.234 1.956 . . . . 0.0 112.446 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.511 ' O ' ' CD1' ' A' ' 31' ' ' PHE . 4.2 m -62.74 71.35 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.354 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 147' ' ' PRO . 17.3 ptm180 -57.87 -32.94 68.17 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.415 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.517 ' HG1' ' C ' ' A' ' 149' ' ' ARG . 0.0 OUTLIER -163.11 164.22 25.44 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.862 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -56.33 -18.01 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 CA-C-O 121.721 0.772 . . . . 0.0 108.971 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -64.71 -35.53 81.35 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 177.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 150' ' ' THR . 5.6 tm-20 -58.94 -74.07 0.07 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.869 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.1 p -45.68 -30.06 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.34 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -83.98 -44.28 14.34 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 122.226 1.012 . . . . 0.0 110.285 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.36 -42.14 86.3 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.435 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.471 ' CG ' ' N ' ' A' ' 158' ' ' PHE . 8.1 pt20 -81.47 -48.93 11.22 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 112.858 -1.974 . . . . 0.0 112.134 -177.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.471 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 30.5 t80 -106.85 -36.54 6.63 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -177.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 97.68 24.45 12.09 Favored Glycine 0 N--CA 1.476 1.341 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -42.89 -94.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.564 0.221 . . . . 0.0 111.094 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.45 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.96 37.51 14.98 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.204 0.526 . . . . 0.0 109.714 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.55 ' C ' ' H ' ' A' ' 164' ' ' VAL . 1.5 m-85 -177.07 -61.83 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.764 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -73.73 28.19 0.32 Allowed 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 122.367 2.045 . . . . 0.0 110.443 178.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.55 ' H ' ' C ' ' A' ' 162' ' ' PHE . 15.9 m -131.03 167.4 26.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.85 -178.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.7 t -123.82 65.58 35.97 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.501 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -36.68 141.22 0.15 Allowed 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 123.6 2.867 . . . . 0.0 115.15 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 154.67 145.68 4.22 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.54 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -141.99 132.25 24.92 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.303 0.573 . . . . 0.0 110.973 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.4 t . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.929 179.309 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 N--CA 1.446 -0.638 0 CA-C-O 121.125 0.488 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 19.3 tt -110.93 127.82 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.112 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -129.46 166.95 18.59 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.727 0.775 . . . . 0.0 112.273 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 184' ' ' GLY . 97.7 m-20 -78.93 106.93 11.3 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.427 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -67.15 -16.93 64.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.744 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.487 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.4 mm? -63.6 -42.43 98.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.099 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.409 ' CG2' ' H ' ' A' ' 184' ' ' GLY . 5.0 t -120.31 -52.89 2.15 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.207 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.409 ' H ' ' CG2' ' A' ' 183' ' ' THR . . . . . . . . 0 N--CA 1.468 0.818 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 . . . . . 0 N--CA 1.466 0.342 0 CA-C-O 120.791 0.329 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 10.0 mp -62.57 -42.3 99.47 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.212 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -63.43 -39.93 95.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.163 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -63.76 -40.7 97.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.4 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 162' ' ' PHE . 65.2 t0 -61.94 -48.37 80.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.686 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.25 -45.36 93.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.487 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.96 -43.48 97.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.284 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.78 -45.02 82.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.816 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.22 -43.47 94.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.145 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.72 -52.56 64.59 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.706 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.8 pt -67.7 -39.75 82.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.163 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -57.58 -55.34 36.1 Favored 'General case' 0 C--O 1.215 -0.755 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.338 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 20' ' ' GLU . 95.4 t -60.15 -40.69 84.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.876 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.454 ' CD2' ' C ' ' A' ' 17' ' ' LEU . 6.2 tt -51.61 -50.22 60.66 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.697 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -81.84 -51.51 8.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.993 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -63.63 -35.0 79.08 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.109 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 16' ' ' VAL . 97.1 mt-10 59.02 86.46 0.09 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.664 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.72 -134.81 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.1 p -140.22 140.36 35.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.9 pp -129.87 165.82 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 120.852 0.358 . . . . 0.0 111.133 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.87 138.55 58.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.133 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.511 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 0.6 OUTLIER -131.19 141.59 42.43 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.363 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.511 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 91.2 Cg_endo -77.16 144.8 23.85 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.4 1.4 . . . . 0.0 111.892 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.519 ' C ' ' H ' ' A' ' 29' ' ' ALA . 79.4 m -135.85 135.09 39.5 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.32 0.581 . . . . 0.0 110.868 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -72.96 32.52 0.07 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.802 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.519 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -163.0 -75.73 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.833 0.349 . . . . 0.0 110.975 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.3 m -126.59 128.55 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.128 0.49 . . . . 0.0 110.229 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.519 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 80.3 m-85 -46.99 143.0 3.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.117 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -148.58 -169.15 15.12 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.8 m -133.33 169.37 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.401 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -156.98 -179.05 31.62 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.009 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.3 p -157.98 -165.73 1.8 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.6 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 7.0 p30 -89.65 107.68 20.29 Favored Pre-proline 0 CA--C 1.558 1.256 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -178.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -42.82 -60.78 0.66 Allowed 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.076 1.851 . . . . 0.0 112.633 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -77.63 70.65 4.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.427 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 54.9 m -156.57 144.01 19.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.619 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -71.1 -34.22 70.9 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.178 0.513 . . . . 0.0 111.158 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -42.19 95.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.99 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.88 -52.36 65.81 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 p -62.19 -42.6 95.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.147 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.9 mtt -64.65 -41.44 96.13 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.449 HH22 ' CB ' ' A' ' 138' ' ' THR . 31.9 ttt-85 -60.4 -42.26 95.57 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-O 121.98 0.895 . . . . 0.0 108.916 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.2 -53.47 48.74 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.664 -178.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.7 mt -71.03 -10.57 59.98 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.153 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -69.85 -82.35 0.04 OUTLIER 'General case' 0 N--CA 1.432 -1.354 0 CA-C-O 121.09 0.471 . . . . 0.0 110.924 -177.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.421 HD21 ' H ' ' A' ' 50' ' ' LYS . 2.3 pt? -76.54 -35.57 58.19 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.421 ' H ' HD21 ' A' ' 49' ' ' LEU . 24.9 mmmt -76.51 -50.22 14.53 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.082 -177.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 35.76 65.09 0.44 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.012 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.1 mtm-85 178.82 -52.51 0.0 OUTLIER Pre-proline 0 CA--C 1.551 0.981 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.744 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.11 -2.81 11.92 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 123.008 2.472 . . . . 0.0 112.499 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.7 p -44.61 -45.47 2.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.033 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -64.13 -41.14 97.32 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.726 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -60.86 -35.33 76.31 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 59.19 102.26 0.01 OUTLIER Glycine 0 CA--C 1.52 0.36 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.572 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -48.73 -172.55 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.303 0.573 . . . . 0.0 112.205 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.6 mt -91.14 141.21 14.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.419 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.3 mt -118.88 145.74 45.47 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.3 tp -113.38 127.68 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-O 121.203 0.525 . . . . 0.0 111.184 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.99 151.77 31.9 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.87 -28.16 8.17 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.629 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 99.0 m-20 -115.69 148.55 39.6 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.316 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -77.16 -13.46 59.94 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -51.87 -32.45 32.22 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.262 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.629 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 4.0 pm0 -94.28 -9.83 34.78 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -92.18 -16.23 26.53 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.473 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 17.4 ttpp -78.07 -37.3 1.46 Allowed Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 67.5 Cg_endo -103.44 -3.23 0.27 Allowed 'Trans proline' 0 C--N 1.321 -0.921 0 C-N-CA 122.801 2.334 . . . . 0.0 111.873 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.524 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 42.0 t80 -91.73 -12.05 35.05 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.295 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.475 ' CG2' ' N ' ' A' ' 73' ' ' ASP . 4.7 mp -123.2 163.43 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.475 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 96.8 m-20 -63.43 -3.98 2.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.277 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 3.3 p30 45.01 22.85 0.07 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.883 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.434 ' CG2' ' N ' ' A' ' 76' ' ' MET . 8.9 t -88.72 -44.81 10.29 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.13 0.49 . . . . 0.0 109.827 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.434 ' N ' ' CG2' ' A' ' 75' ' ' THR . 18.2 ptp -80.63 -14.76 57.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.975 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 tp -79.0 134.12 36.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.701 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -158.61 161.04 37.18 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.972 -177.553 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -38.92 -48.93 1.63 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.768 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.5 p -63.26 -33.49 61.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.007 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.427 ' N ' ' O ' ' A' ' 78' ' ' THR . 62.8 tp60 -64.47 -39.47 93.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.944 0.402 . . . . 0.0 110.4 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -63.87 -53.12 55.55 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 122.517 1.151 . . . . 0.0 109.111 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.499 ' O ' ' N ' ' A' ' 87' ' ' SER . 80.8 tt0 -54.18 -50.37 67.19 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.989 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.4 m -61.48 -49.29 77.35 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.988 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 89' ' ' TRP . 8.7 tt -69.79 -31.24 47.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.574 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -80.14 -31.31 39.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.753 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 83' ' ' GLU . 53.2 m -90.1 -12.71 37.55 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.769 0.318 . . . . 0.0 111.201 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.446 ' O ' ' O ' ' A' ' 89' ' ' TRP . 62.0 ttm-85 -121.95 75.84 1.24 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.446 ' O ' ' O ' ' A' ' 88' ' ' ARG . 7.9 m-90 56.75 152.26 0.07 OUTLIER Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.377 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.24 -19.26 38.84 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.881 1.72 . . . . 0.0 111.673 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 159.56 81.05 0.04 OUTLIER Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -81.42 -9.77 12.38 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.492 2.128 . . . . 0.0 112.143 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.1 p -136.12 144.8 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.951 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.4 m -95.99 124.31 39.95 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -113.09 143.03 45.04 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.401 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 98.8 t -89.08 102.71 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 121.152 0.501 . . . . 0.0 111.393 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -90.08 146.82 35.77 Favored Pre-proline 0 N--CA 1.469 0.504 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.786 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -79.39 87.03 1.59 Allowed 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.241 1.961 . . . . 0.0 111.449 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -48.28 151.55 1.81 Allowed Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.91 144.58 88.54 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.091 1.861 . . . . 0.0 111.664 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.48 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.192 -179.673 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 109' ' ' GLY . 5.9 tpt180 . . . . . 0 N--CA 1.461 0.089 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 66.7 p-90 -79.1 -11.59 59.99 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.665 0.745 . . . . 0.0 109.404 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.549 ' H ' ' CD2' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -76.58 -16.45 59.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.811 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 94.8 m -142.93 -40.96 0.32 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.356 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 91.9 -13.4 66.96 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 119.863 -0.41 . . . . 0.0 112.896 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.451 ' O ' ' CZ ' ' A' ' 105' ' ' ARG . 13.5 tpt180 -148.01 -80.43 0.14 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.883 0.842 . . . . 0.0 111.226 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -90.95 -174.83 4.15 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -124.35 61.18 1.13 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.083 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.0 p -168.14 151.78 5.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.193 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 pp -169.34 147.58 3.71 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.27 134.94 55.71 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 113.76 -1.564 . . . . 0.0 109.635 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.6 p -147.98 160.06 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -145.53 154.64 42.42 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.907 0.384 . . . . 0.0 111.425 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.3 t -123.0 136.07 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.9 t -138.38 150.25 46.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.178 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 50.7 p-10 -153.7 84.9 1.17 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.923 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.585 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 8.5 t-80 -171.52 -36.58 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.292 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.585 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 60.9 Cg_endo -95.15 -159.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.949 0 C-N-CA 121.879 1.719 . . . . 0.0 112.032 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.7 mt -78.79 -5.79 54.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.372 0.606 . . . . 0.0 110.459 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 87.8 t -58.1 -44.77 88.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.787 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.594 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 27.1 m -53.35 -62.57 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.922 0 C-N-CA 119.269 -0.972 . . . . 0.0 108.883 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.594 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -41.29 -43.82 2.54 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 120.831 0.348 . . . . 0.0 111.152 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.1 tp -69.04 -48.77 62.01 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.998 0.428 . . . . 0.0 111.224 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 75.4 m -70.26 -48.38 57.1 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.373 0.606 . . . . 0.0 110.991 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.45 ' N ' ' O ' ' A' ' 125' ' ' VAL . 1.1 pp0? -55.03 -42.26 72.38 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.43 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -57.87 -57.22 13.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.665 -178.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -62.47 -26.46 68.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.385 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.92 -2.44 88.25 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' A' ' 134' ' ' PRO . 25.0 mmtm -142.91 155.78 62.5 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 117.137 0.469 . . . . 0.0 110.043 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 133' ' ' LYS . 6.0 Cg_exo -41.34 175.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 123.604 2.869 . . . . 0.0 112.984 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.1 tp -128.59 122.96 32.15 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 177.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.401 ' O ' ' CA ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -66.11 142.67 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.9 0 C-N-CA 117.762 -1.575 . . . . 0.0 107.256 -179.712 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 t -111.69 118.91 36.93 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 123.802 0.688 . . . . 0.0 110.88 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.449 ' CB ' HH22 ' A' ' 45' ' ' ARG . 18.8 m -127.72 150.55 49.73 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.756 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 140' ' ' ALA . 24.7 m -64.59 149.21 49.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.491 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.436 ' O ' ' O ' ' A' ' 139' ' ' SER . . . -53.78 -164.09 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.997 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . 0.431 ' O ' ' O ' ' A' ' 140' ' ' ALA . 6.7 p30 53.37 156.98 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.702 0.763 . . . . 0.0 111.687 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.07 -147.15 0.37 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.185 -178.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.4 p -63.15 -39.32 94.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.058 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -161.78 -2.4 0.05 OUTLIER Glycine 0 N--CA 1.457 0.059 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.421 ' O ' ' O ' ' A' ' 146' ' ' PRO . 11.7 tp -71.71 128.68 89.36 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 119.355 -0.355 . . . . 0.0 110.358 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 145' ' ' LEU . 26.2 Cg_exo -35.25 157.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.295 1.996 . . . . 0.0 112.451 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.98 -163.62 0.13 Allowed 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.291 1.994 . . . . 0.0 112.508 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 27.3 m -132.14 69.48 1.48 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.966 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.519 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 17.3 ptm180 -56.96 -36.47 70.34 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.581 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.85 168.79 23.98 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.7 m -59.4 -17.7 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 CA-C-O 121.612 0.72 . . . . 0.0 109.553 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -65.62 -35.19 80.07 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.432 ' OE1' ' OE1' ' A' ' 157' ' ' GLN . 5.8 tm-20 -60.11 -73.78 0.08 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.895 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.3 p -45.51 -30.03 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.016 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.06 -43.34 15.2 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 122.214 1.007 . . . . 0.0 110.007 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.9 -42.26 89.17 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 122.518 1.151 . . . . 0.0 109.265 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.471 ' CG ' ' N ' ' A' ' 158' ' ' PHE . 8.0 pt20 -80.74 -49.61 10.94 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 112.974 -1.921 . . . . 0.0 112.042 -177.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.471 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 39.6 t80 -106.07 -37.24 6.68 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -177.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 98.88 25.3 9.82 Favored Glycine 0 N--CA 1.473 1.11 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -43.87 -97.27 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.561 0.219 . . . . 0.0 111.091 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.473 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 64.95 36.55 7.52 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.199 0.523 . . . . 0.0 109.899 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.548 ' C ' ' H ' ' A' ' 164' ' ' VAL . 1.5 m-85 -177.74 -61.24 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.182 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.25 29.06 0.3 Allowed 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 122.447 2.098 . . . . 0.0 110.556 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.548 ' H ' ' C ' ' A' ' 162' ' ' PHE . 16.0 m -132.65 167.37 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.215 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 9.0 t -123.49 65.13 31.34 Favored Pre-proline 0 N--CA 1.476 0.844 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.848 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -36.54 141.39 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 123.77 2.98 . . . . 0.0 115.045 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 163.27 -161.59 34.13 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 113.761 -1.563 . . . . 0.0 110.972 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -147.49 175.39 10.87 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.982 0.42 . . . . 0.0 110.193 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.463 0.195 0 CA-C-O 121.035 0.445 . . . . 0.0 110.509 179.957 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 . . . . . 0 N--CA 1.446 -0.631 0 CA-C-O 121.241 0.543 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 13.1 tt -94.89 130.37 43.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.435 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -133.19 168.65 18.16 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.51 0.671 . . . . 0.0 111.574 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -87.25 108.05 18.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.165 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -72.93 -14.3 61.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.239 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.491 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.6 mm? -64.91 -42.02 95.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.989 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.22 -43.66 4.54 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.058 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.758 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 179.888 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 . . . . . 0 N--CA 1.469 0.479 0 CA-C-O 120.783 0.325 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.412 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 10.5 mp -62.46 -42.62 99.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.21 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -61.49 -40.42 94.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.934 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -64.16 -41.5 97.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.14 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -59.24 -45.78 90.23 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.198 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.42 -45.61 92.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.045 0.45 . . . . 0.0 110.424 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.412 HG23 HD12 ' A' ' 10' ' ' ILE . 96.9 mt -63.5 -42.44 96.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.29 -44.69 84.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.382 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.09 -42.76 99.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.086 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.06 -52.33 65.83 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.898 0.38 . . . . 0.0 111.825 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 18.8 pt -68.58 -37.48 77.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.091 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -58.6 -51.19 70.97 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 120.281 -0.567 . . . . 0.0 110.047 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' A' ' 20' ' ' GLU . 88.6 t -63.86 -38.37 82.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.007 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.449 ' CD2' ' C ' ' A' ' 17' ' ' LEU . 6.3 tt -52.77 -50.58 63.25 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.439 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -79.59 -47.94 14.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.21 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -67.19 -31.97 72.73 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.831 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.7 mt-10 58.22 56.6 4.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.271 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.41 ' NH2' ' O ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -149.88 158.51 44.24 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.591 0.71 . . . . 0.0 110.588 178.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.41 ' O ' ' NH2' ' A' ' 21' ' ' ARG . 7.8 p -74.29 137.67 22.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.799 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.9 pp -124.58 168.25 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-O 120.587 0.232 . . . . 0.0 110.534 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.74 134.82 56.0 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.191 0.519 . . . . 0.0 111.023 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.532 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 0.6 OUTLIER -125.48 141.5 39.12 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.706 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.532 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 60.5 Cg_endo -80.23 151.91 20.78 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.709 1.606 . . . . 0.0 111.235 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.477 ' C ' ' H ' ' A' ' 29' ' ' ALA . 47.8 m -133.36 140.72 47.54 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.372 0.606 . . . . 0.0 111.108 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -77.51 23.06 0.23 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.132 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.477 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -160.53 -70.77 0.07 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.194 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.7 p -126.97 125.63 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-O 121.109 0.48 . . . . 0.0 110.34 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.531 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 96.7 m-85 -45.48 150.39 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.668 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -160.99 -169.07 23.74 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.2 m -130.45 170.13 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.25 177.77 35.66 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.686 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -155.45 -164.83 1.84 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 120.433 -0.507 . . . . 0.0 112.122 -178.52 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.467 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 23.6 m-20 -90.86 106.27 15.06 Favored Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -177.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -34.92 -62.35 0.21 Allowed 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 122.461 2.107 . . . . 0.0 112.716 178.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.464 ' C ' ' HG ' ' A' ' 39' ' ' SER . 56.7 p-10 -74.31 67.51 1.41 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.103 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.464 ' HG ' ' C ' ' A' ' 38' ' ' ASP . 23.3 m -157.07 133.05 9.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.159 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -66.14 -20.55 66.18 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.307 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.4 t -60.08 -34.76 73.89 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.932 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.71 -52.2 66.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.874 0.368 . . . . 0.0 111.575 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -64.61 -45.77 94.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.929 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 63.0 mtt -67.51 -46.89 71.58 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.635 HH22 ' HG1' ' A' ' 138' ' ' THR . 40.7 ptt85 -63.02 -30.38 71.55 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.829 0.347 . . . . 0.0 110.221 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.7 mt -73.48 -60.91 2.03 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.269 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.0 mt -54.34 -20.5 7.36 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.449 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -63.47 -86.12 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.543 -178.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.411 HD22 ' H ' ' A' ' 50' ' ' LYS . 2.2 pt? -78.68 -34.35 46.29 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.411 ' H ' HD22 ' A' ' 49' ' ' LEU . 24.6 mmmt -74.92 -50.67 16.03 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.916 -176.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 37.19 64.7 0.58 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.985 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 179.0 -54.0 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.856 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.455 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -75.61 -8.27 19.24 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.323 2.015 . . . . 0.0 111.493 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.488 ' CG1' ' N ' ' A' ' 55' ' ' ASP . 10.8 p -46.71 -43.9 6.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.254 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 110' ' ' ARG . 11.1 t0 -70.59 -44.58 67.04 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.198 -178.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -61.27 -38.3 86.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.6 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 74.77 101.9 0.1 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.572 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -50.92 -167.55 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.092 0.472 . . . . 0.0 112.231 -179.658 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.445 ' O ' ' OG ' ' A' ' 137' ' ' SER . 77.2 mt -100.67 135.29 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.143 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 16.0 mt -112.43 144.51 41.77 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.5 tt -114.53 129.77 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 CA-C-O 121.445 0.64 . . . . 0.0 110.88 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.79 155.09 29.55 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.579 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.97 -30.08 6.15 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.707 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 79.5 m-20 -112.46 150.01 31.81 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.135 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -76.77 -21.97 54.42 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.707 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -50.96 -30.31 14.59 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.875 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.707 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 5.9 pm0 -93.82 -6.13 46.58 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.823 -0.172 . . . . 0.0 111.431 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -89.79 -21.69 22.49 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.452 ' NZ ' ' CB ' ' A' ' 69' ' ' LYS . 8.0 mtpm? -73.76 -38.27 3.87 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -178.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 94.6 Cg_endo -101.75 -5.01 0.35 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.628 2.219 . . . . 0.0 111.986 -179.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.438 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 55.5 t80 -87.81 -18.96 28.18 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.772 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.477 ' CG2' ' N ' ' A' ' 73' ' ' ASP . 5.1 mp -119.27 166.93 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.477 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 97.8 m-20 -61.75 -14.39 31.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.329 . . . . 0.0 111.054 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 41.1 t0 59.54 32.67 21.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.86 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.445 ' CG2' ' N ' ' A' ' 76' ' ' MET . 14.1 t -105.14 -42.38 5.31 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.903 0.382 . . . . 0.0 110.476 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.445 ' N ' ' CG2' ' A' ' 75' ' ' THR . 21.0 ptm -88.78 -23.37 22.9 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.366 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 30.3 tp -67.65 133.08 48.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.124 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.95 170.26 19.25 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.577 -176.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -59.94 -42.11 93.29 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 123.364 0.415 . . . . 0.0 111.389 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.1 p -60.63 -33.27 54.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.42 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -63.23 -41.17 99.06 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.113 0.482 . . . . 0.0 110.358 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.5 mmt85 -63.94 -52.11 61.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.479 1.133 . . . . 0.0 109.117 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -55.69 -50.04 71.36 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.798 -1.547 . . . . 0.0 110.028 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.2 m -61.18 -49.92 75.22 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.47 -1.241 . . . . 0.0 112.091 -178.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.401 ' O ' ' O ' ' A' ' 89' ' ' TRP . 9.1 tt -68.25 -30.12 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.696 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -78.4 -37.3 44.29 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.759 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.2 m -84.72 -10.64 57.07 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.722 0.296 . . . . 0.0 111.166 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.442 ' O ' ' O ' ' A' ' 89' ' ' TRP . 62.0 ttm-85 -122.61 83.64 2.14 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.442 ' O ' ' O ' ' A' ' 88' ' ' ARG . 14.6 m95 57.68 150.33 0.07 OUTLIER Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.231 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.415 ' O ' ' O ' ' A' ' 118' ' ' VAL . 55.8 Cg_endo -68.01 -23.35 40.49 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.203 1.935 . . . . 0.0 111.973 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 159.1 80.65 0.03 OUTLIER Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.74 -24.2 7.49 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 122.163 1.909 . . . . 0.0 112.395 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.5 p -137.04 146.56 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 120.783 0.325 . . . . 0.0 110.474 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 53.8 m -89.71 149.7 22.64 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.845 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -128.0 144.78 51.11 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.202 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.5 t -102.05 108.67 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-O 121.34 0.59 . . . . 0.0 110.46 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -94.98 150.37 37.64 Favored Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.898 -178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.21 89.44 0.39 Allowed 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.265 1.977 . . . . 0.0 111.47 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.93 149.71 80.19 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.138 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -72.14 157.34 54.26 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.207 1.938 . . . . 0.0 111.992 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.47 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.837 179.885 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 109' ' ' GLY . 23.7 mmt180 . . . . . 0 N--CA 1.468 0.436 0 CA-C-O 120.452 0.168 . . . . 0.0 110.68 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 2.0 p90 -66.73 -10.76 50.32 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.949 -0.301 . . . . 0.0 111.593 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.687 ' CD1' ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -67.23 -39.8 86.25 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.568 ' C ' ' H ' ' A' ' 110' ' ' ARG . 16.6 m -145.99 -39.92 0.22 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.65 177.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 58.53 -12.01 0.02 OUTLIER Glycine 0 CA--C 1.532 1.126 0 CA-C-N 115.711 -0.677 . . . . 0.0 113.29 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.568 ' H ' ' C ' ' A' ' 108' ' ' THR . 0.0 OUTLIER -86.54 -51.51 6.13 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 117.714 0.757 . . . . 0.0 109.446 -179.437 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.452 ' CD2' ' N ' ' A' ' 112' ' ' ASP . 85.4 t80 -160.18 -95.34 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.019 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.452 ' N ' ' CD2' ' A' ' 111' ' ' PHE . 35.8 t70 -171.01 67.96 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.541 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.5 p -166.77 129.36 1.81 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.742 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 87.2 mt -126.41 128.01 46.34 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.67 119.69 14.29 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.344 176.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.4 p -145.96 158.49 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -151.57 160.81 43.51 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.745 0.307 . . . . 0.0 110.983 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.415 ' O ' ' O ' ' A' ' 90' ' ' PRO . 55.9 t -123.44 137.75 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.1 t -128.65 157.44 41.3 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.304 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 5.8 p30 -158.74 77.97 0.77 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.134 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.578 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 56.9 t-80 -172.62 -35.81 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.578 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 37.3 Cg_endo -94.44 -163.33 0.09 OUTLIER 'Trans proline' 0 N--CA 1.485 0.981 0 C-N-CA 121.973 1.782 . . . . 0.0 111.991 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 36.5 mt -78.22 -4.39 47.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.511 0.672 . . . . 0.0 109.908 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 93.4 t -58.35 -44.93 89.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.061 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.584 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 30.8 m -54.24 -62.52 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 C-N-CA 119.538 -0.865 . . . . 0.0 108.727 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.584 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -41.6 -43.27 2.7 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.021 0.439 . . . . 0.0 110.657 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.9 tp -69.28 -48.87 60.45 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.828 0.347 . . . . 0.0 111.455 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 80.3 m -70.46 -48.42 55.94 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.365 0.602 . . . . 0.0 110.851 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.445 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -54.72 -43.27 72.45 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.73 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.445 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -59.02 -55.21 38.08 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.235 -1.348 . . . . 0.0 109.459 -178.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.413 ' OH ' ' OD1' ' A' ' 38' ' ' ASP . 39.2 t80 -61.84 -21.84 64.98 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 114.545 -1.207 . . . . 0.0 109.151 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.54 0.69 84.83 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -151.52 158.72 34.16 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -43.8 174.16 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 123.697 2.931 . . . . 0.0 113.722 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.5 tp -128.63 123.13 32.48 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -66.12 144.34 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 C-N-CA 118.353 -1.339 . . . . 0.0 108.049 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -110.01 120.14 41.51 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.305 1.003 . . . . 0.0 110.876 -179.179 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.635 ' HG1' HH22 ' A' ' 45' ' ' ARG . 2.4 m -134.11 160.06 38.94 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.898 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.5 m -72.11 142.44 49.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.882 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.88 -36.32 83.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.813 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' A' ' 141' ' ' ASN . 56.9 p30 -46.97 150.04 0.81 Allowed 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.959 0.885 . . . . 0.0 111.255 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.4 -161.55 0.89 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.211 -1.359 . . . . 0.0 110.569 -178.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.2 p -62.02 -39.81 93.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.297 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -164.9 9.24 0.07 OUTLIER Glycine 0 C--N 1.33 0.224 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.3 tp -91.65 127.89 48.54 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-O 119.355 -0.355 . . . . 0.0 110.186 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -38.61 156.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 121.648 1.565 . . . . 0.0 112.276 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -76.54 -167.01 0.41 Allowed 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.773 2.316 . . . . 0.0 112.524 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 83.3 m -111.48 74.33 0.86 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.461 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.531 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 38.0 ptt180 -51.84 -37.54 52.33 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.432 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -159.87 168.08 26.62 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.763 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.1 m -57.88 -21.65 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.83 -30.58 71.66 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 150' ' ' THR . 6.7 tm-20 -63.73 -79.85 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.534 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.0 p -36.45 -30.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.082 0.953 . . . . 0.0 110.971 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.466 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -70.68 -51.68 26.12 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.518 -179.351 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.09 -17.54 62.58 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 122.451 1.119 . . . . 0.0 108.024 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -83.77 -47.82 10.75 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 112.705 -2.043 . . . . 0.0 111.794 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -130.58 -19.92 2.97 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 85.82 26.15 35.84 Favored Glycine 0 N--CA 1.468 0.823 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.4 ' O ' ' O ' ' A' ' 159' ' ' GLY . . . -43.64 -95.9 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.587 0.232 . . . . 0.0 111.195 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.467 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 63.43 35.43 12.1 Favored 'General case' 0 CA--C 1.527 0.09 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.538 ' C ' ' H ' ' A' ' 164' ' ' VAL . 1.6 m-85 -175.47 -61.9 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.153 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.49 27.35 0.31 Allowed 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.298 1.999 . . . . 0.0 110.751 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.538 ' H ' ' C ' ' A' ' 162' ' ' PHE . 14.9 m -129.45 167.64 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.805 -178.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.0 t -123.16 64.53 26.31 Favored Pre-proline 0 N--CA 1.472 0.668 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.831 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -37.65 144.27 0.15 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 123.291 2.66 . . . . 0.0 114.823 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -175.22 -158.25 18.67 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 114.101 -1.409 . . . . 0.0 111.472 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -141.92 -154.42 0.52 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.735 0.302 . . . . 0.0 110.527 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 CA--C 1.532 0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.511 -179.604 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 . . . . . 0 N--CA 1.448 -0.56 0 CA-C-O 120.85 0.357 . . . . 0.0 110.726 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 39.0 pt -117.61 142.88 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.917 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -131.26 166.19 21.72 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.462 0.649 . . . . 0.0 111.654 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 184' ' ' GLY . 97.6 m-20 -78.55 106.48 10.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.679 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -65.86 -18.01 65.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.739 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.493 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.4 mm? -63.15 -41.72 99.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.221 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.43 -41.12 2.62 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.69 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 180' ' ' ASP . . . . . . . . 0 CA--C 1.526 0.777 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.738 0.304 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.7 mp -63.03 -42.75 99.86 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -64.58 -40.75 96.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.744 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 61.8 ttt85 -63.01 -41.74 99.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.166 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.7 -44.07 96.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.448 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.45 -44.52 94.27 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.166 0.508 . . . . 0.0 109.918 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.9 mt -63.52 -42.58 96.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.357 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.48 -41.09 80.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.329 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.76 -43.9 91.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.935 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.09 -53.08 62.01 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 17.6 pt -68.2 -36.94 77.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.806 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -58.06 -50.03 74.85 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.613 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' A' ' 20' ' ' GLU . 90.8 t -64.59 -38.66 83.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.946 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.451 ' CD2' ' C ' ' A' ' 17' ' ' LEU . 6.5 tt -52.7 -51.02 62.12 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.287 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -78.34 -47.97 16.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.402 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -67.83 -31.36 71.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.951 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.6 mt-10 57.54 57.64 4.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.182 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.42 ' NH2' ' O ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -151.15 159.17 44.61 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.582 0.706 . . . . 0.0 110.336 179.088 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.42 ' O ' ' NH2' ' A' ' 21' ' ' ARG . 8.9 p -74.08 140.17 18.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.452 -178.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pp -126.69 166.43 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-O 120.879 0.371 . . . . 0.0 110.927 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.85 137.9 58.24 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.332 0.587 . . . . 0.0 111.008 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.53 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 0.4 OUTLIER -130.52 141.86 43.44 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.123 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.53 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 58.3 Cg_endo -79.38 146.79 19.79 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 121.451 1.434 . . . . 0.0 111.682 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.528 ' C ' ' H ' ' A' ' 29' ' ' ALA . 33.7 m -130.02 133.42 46.73 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.905 0.383 . . . . 0.0 110.931 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -74.53 25.26 0.08 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.152 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.528 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -157.3 -74.43 0.09 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.001 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.3 t -124.93 125.51 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-O 120.894 0.378 . . . . 0.0 110.313 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -44.37 139.24 2.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.934 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -149.44 -172.28 18.87 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.5 m -130.06 169.98 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.5 178.98 34.49 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.757 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.55 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -154.53 -162.97 1.49 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.819 0.342 . . . . 0.0 111.393 -178.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.55 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 5.7 m-20 -97.82 107.34 39.64 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -177.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 36' ' ' ASP . 38.6 Cg_exo -37.86 173.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 123.074 2.516 . . . . 0.0 114.215 177.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 66.7 t0 35.66 76.39 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.492 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.0 m -152.73 139.03 18.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.336 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -70.12 -34.3 72.92 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.244 0.545 . . . . 0.0 110.74 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.32 -44.39 91.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.86 -178.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.63 -50.61 71.85 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.515 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.6 p -62.58 -44.51 99.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.177 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 90.7 mtp -64.0 -40.02 95.43 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.4 ' O ' ' CD2' ' A' ' 49' ' ' LEU . 56.0 ttt85 -61.68 -33.02 73.25 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.341 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 85.8 mt -75.04 -60.81 2.12 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.6 mt -53.56 -18.35 2.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.56 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -66.83 -86.15 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -178.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.4 ' CD2' ' O ' ' A' ' 45' ' ' ARG . 2.2 pt? -76.82 -34.34 57.91 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -75.03 -49.69 18.96 Favored 'General case' 0 C--N 1.345 0.409 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.56 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 35.62 64.81 0.45 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.855 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 179.29 -53.35 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.902 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.497 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.74 -8.79 20.7 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.399 2.066 . . . . 0.0 112.267 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -41.52 -48.17 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.809 -179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 55' ' ' ASP . 33.9 t0 -69.39 -38.71 78.11 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.547 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.481 ' CD ' ' N ' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -59.78 -39.26 84.31 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.767 -179.092 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 59.62 104.69 0.01 OUTLIER Glycine 0 CA--C 1.518 0.247 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.568 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -52.53 -161.3 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.615 0.721 . . . . 0.0 111.735 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.0 mt -108.41 146.77 13.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.912 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.7 mt -119.55 141.24 49.42 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.408 ' CD1' ' HE ' ' A' ' 117' ' ' ARG . 8.0 tp -108.96 131.68 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-O 121.222 0.534 . . . . 0.0 110.569 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.81 153.25 34.78 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.385 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.29 -26.93 7.79 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -117.46 151.17 37.64 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.823 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -78.99 -13.42 59.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.511 0.672 . . . . 0.0 109.346 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -51.14 -30.26 16.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.843 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.462 HE21 ' N ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -94.82 -13.62 25.4 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.562 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -92.36 -13.67 29.83 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.479 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 79.0 tttt -80.08 -37.79 1.11 Allowed Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 68.6 Cg_endo -102.59 -3.64 0.32 Allowed 'Trans proline' 0 C--N 1.316 -1.169 0 C-N-CA 122.812 2.341 . . . . 0.0 111.564 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.508 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 42.9 t80 -93.07 -13.13 28.97 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.365 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.7 mp -125.75 155.1 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -64.41 153.02 39.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.063 0.459 . . . . 0.0 110.114 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 66.5 t0 -96.22 46.03 1.07 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.308 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.9 t -115.83 -40.08 3.39 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.269 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 13.6 ptm -95.55 -24.41 16.63 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.217 0.532 . . . . 0.0 110.224 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 30.8 tp -80.09 134.98 36.23 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.436 -178.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.654 ' HG1' ' N ' ' A' ' 79' ' ' ASP . 0.9 OUTLIER -148.07 169.74 19.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.708 -177.171 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.654 ' N ' ' HG1' ' A' ' 78' ' ' THR . 99.2 m-20 -60.36 -41.92 94.7 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.367 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.46 -33.39 56.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.115 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -63.24 -40.39 97.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.068 0.461 . . . . 0.0 110.569 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.5 mmt85 -64.17 -52.03 60.96 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 122.655 1.217 . . . . 0.0 109.02 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 87' ' ' SER . 82.6 tt0 -56.68 -50.42 72.18 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.618 -1.628 . . . . 0.0 110.372 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.2 m -62.41 -49.47 75.35 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.349 -1.296 . . . . 0.0 112.232 -177.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.8 tt -67.46 -25.31 33.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.325 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -86.47 -32.6 20.73 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.241 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 83' ' ' GLU . 6.7 m -88.52 -20.24 25.35 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.293 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.442 ' O ' ' O ' ' A' ' 89' ' ' TRP . 70.2 ttt180 -116.19 82.26 1.75 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.668 0.27 . . . . 0.0 110.636 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.442 ' O ' ' O ' ' A' ' 88' ' ' ARG . 3.9 m-90 56.56 151.82 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.828 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.4 -17.82 44.07 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.058 1.839 . . . . 0.0 111.449 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 99.26 69.71 0.93 Allowed Glycine 0 N--CA 1.471 0.972 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.52 -38.55 93.95 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.893 2.396 . . . . 0.0 112.307 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.7 p -73.92 136.15 25.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.322 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 56.1 m -88.92 144.23 26.33 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.821 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -126.94 144.55 50.97 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.227 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.5 t -99.91 103.4 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 121.296 0.569 . . . . 0.0 109.475 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -87.77 148.21 43.13 Favored Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.815 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.9 101.66 1.51 Allowed 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.651 1.567 . . . . 0.0 110.948 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.38 150.53 79.95 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.896 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -71.53 152.11 59.57 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.222 1.948 . . . . 0.0 112.406 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.037 179.955 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.489 HH22 ' C ' ' A' ' 111' ' ' PHE . 7.1 tpt85 . . . . . 0 N--CA 1.466 0.361 0 CA-C-O 120.685 0.279 . . . . 0.0 110.441 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 43.4 m95 -77.26 -2.97 37.45 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 120.839 0.352 . . . . 0.0 110.517 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.659 ' CD1' ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -82.44 -19.6 38.64 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.537 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 51.3 m -142.74 -41.53 0.32 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.435 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 64.81 24.06 69.62 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.453 178.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.93 -75.22 0.11 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 117.54 0.67 . . . . 0.0 110.527 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.489 ' C ' HH22 ' A' ' 105' ' ' ARG . 72.2 m-85 -113.63 159.5 19.58 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.018 0.437 . . . . 0.0 110.312 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -93.06 76.82 4.68 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.284 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 19.5 p -163.57 128.85 3.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.967 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -134.04 128.26 33.94 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.83 124.14 23.25 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 113.815 -1.539 . . . . 0.0 109.333 176.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.3 p -144.21 152.27 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.881 0.372 . . . . 0.0 110.783 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.408 ' HE ' ' CD1' ' A' ' 61' ' ' ILE . 62.2 ttp180 -140.58 153.81 46.25 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.682 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 56.0 t -121.91 134.05 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 7.9 t -134.02 153.28 51.89 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.215 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 51.2 p-10 -153.72 82.99 1.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.075 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.565 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 40.7 t60 -172.47 -37.36 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.565 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 40.7 Cg_endo -94.15 -161.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -0.977 0 C-N-CA 122.122 1.881 . . . . 0.0 112.156 -178.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 27.4 mt -79.04 -4.97 52.8 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.929 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 95.0 t -58.15 -45.03 88.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.915 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.587 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 30.3 m -54.1 -62.54 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.847 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.587 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -41.41 -44.13 2.75 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 120.936 0.398 . . . . 0.0 110.819 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.5 tp -68.83 -48.32 63.8 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.469 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 61.8 m -70.66 -49.04 51.62 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.431 0.634 . . . . 0.0 110.835 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 125' ' ' VAL . 1.1 pp0? -54.62 -41.93 70.57 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.44 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -59.5 -54.37 47.43 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.049 -177.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.499 ' CE1' ' OD2' ' A' ' 36' ' ' ASP . 41.4 t80 -61.78 -20.42 63.57 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.321 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.73 -1.14 84.53 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.412 ' O ' ' O ' ' A' ' 134' ' ' PRO . 33.3 mttm -151.65 159.64 32.94 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.412 ' O ' ' O ' ' A' ' 133' ' ' LYS . 4.1 Cg_exo -42.24 177.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 123.858 3.039 . . . . 0.0 112.933 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.4 tp -131.43 123.58 28.44 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.41 145.87 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 C-N-CA 117.927 -1.509 . . . . 0.0 107.329 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t -118.28 121.93 41.64 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 123.408 0.443 . . . . 0.0 111.191 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.2 m -129.77 162.03 29.36 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.255 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 17.7 m -72.04 145.57 48.19 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.93 81.19 1.67 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.694 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 57.6 p30 -158.7 164.71 35.66 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.335 0.588 . . . . 0.0 110.581 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.15 -163.4 1.47 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.186 -178.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 38.8 t -61.27 -44.25 97.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.676 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -159.71 4.9 0.11 Allowed Glycine 0 N--CA 1.46 0.28 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.5 tp -82.04 127.05 73.3 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -38.95 156.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.621 1.548 . . . . 0.0 112.271 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -75.71 -167.21 0.41 Allowed 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.352 2.035 . . . . 0.0 112.316 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 8.7 t -114.81 77.97 1.12 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.333 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -57.66 -34.97 69.93 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.229 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.45 168.4 20.3 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.4 m -57.66 -17.61 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -65.05 -35.63 81.77 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 177.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.444 ' OE1' ' OE1' ' A' ' 157' ' ' GLN . 5.8 tm-20 -59.83 -72.5 0.1 Allowed 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.765 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.8 p -48.04 -30.63 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.342 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.426 ' O ' ' N ' ' A' ' 159' ' ' GLY . 3.8 tmt_? -83.84 -45.36 13.36 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 122.185 0.993 . . . . 0.0 110.285 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.75 -41.03 81.07 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.416 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.466 ' CG ' ' N ' ' A' ' 158' ' ' PHE . 7.9 pt20 -82.65 -48.7 10.62 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 112.932 -1.94 . . . . 0.0 112.224 -176.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.466 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 32.0 t80 -106.85 -35.92 6.81 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 96.22 25.26 12.82 Favored Glycine 0 N--CA 1.472 1.092 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -178.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -43.36 -94.27 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.514 0.197 . . . . 0.0 110.901 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.474 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 62.13 36.47 15.11 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-O 121.25 0.547 . . . . 0.0 109.857 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.553 ' C ' ' H ' ' A' ' 164' ' ' VAL . 1.8 m-85 -175.77 -62.06 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.277 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.46 28.87 0.31 Allowed 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.32 2.013 . . . . 0.0 110.367 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.553 ' H ' ' C ' ' A' ' 162' ' ' PHE . 16.8 m -133.27 167.01 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.053 -178.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 6.8 t -124.3 65.51 40.6 Favored Pre-proline 0 N--CA 1.473 0.696 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.694 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -37.22 143.88 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 123.611 2.874 . . . . 0.0 115.08 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 165.94 177.65 38.25 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 113.734 -1.576 . . . . 0.0 110.598 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -151.14 151.53 32.07 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.467 0.42 0 CA-C-O 120.991 0.424 . . . . 0.0 110.925 -179.739 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 . . . . . 0 N--CA 1.445 -0.692 0 CA-C-O 120.643 0.258 . . . . 0.0 111.333 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 29.7 pt -90.84 132.49 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 121.13 0.49 . . . . 0.0 110.817 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 22.7 mmm-85 -129.48 158.51 39.02 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.762 0.791 . . . . 0.0 110.817 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 184' ' ' GLY . 99.8 m-20 -77.06 104.88 7.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.151 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -64.78 -22.97 67.1 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.148 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.476 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.6 mm? -63.68 -41.62 98.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.611 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.1 t -121.0 -42.71 2.48 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.583 0.23 . . . . 0.0 111.099 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 180' ' ' ASP . . . . . . . . 0 CA--C 1.524 0.625 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 . . . . . 0 N--CA 1.462 0.136 0 CA-C-O 120.956 0.408 . . . . 0.0 110.764 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.467 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 9.2 mp -62.73 -42.05 99.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.107 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -63.97 -43.29 96.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.756 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -64.07 -41.49 97.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.264 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -61.26 -44.21 97.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.109 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.75 -45.55 92.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.975 0.417 . . . . 0.0 109.959 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.6 mt -63.92 -43.15 97.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.81 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.04 -41.75 88.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.528 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.38 -47.38 79.49 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.858 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.05 -51.79 66.58 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.4 pp -67.71 -39.3 81.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.873 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -58.63 -50.04 75.29 Favored 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.306 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 20' ' ' GLU . 88.3 t -64.07 -38.66 83.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.933 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.449 ' CD2' ' C ' ' A' ' 17' ' ' LEU . 6.3 tt -52.69 -51.0 62.18 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.42 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -78.91 -47.1 17.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.409 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -68.28 -31.17 70.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.136 0.494 . . . . 0.0 111.22 -178.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.4 mt-10 57.13 59.92 3.2 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.123 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.21 158.9 43.51 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.176 0.512 . . . . 0.0 110.13 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.2 p -75.99 140.55 17.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.57 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pp -125.4 167.73 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.615 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.25 132.22 48.51 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.277 0.561 . . . . 0.0 111.718 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -115.87 133.55 22.84 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -83.76 140.68 9.32 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 CA-C-N 120.567 1.238 . . . . 0.0 111.857 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.3 m -138.45 134.63 34.28 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -56.94 -42.91 80.92 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.824 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.66 -79.6 0.07 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.8 t -132.53 129.55 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -41.08 157.05 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.796 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -159.95 -169.53 23.37 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.4 m -131.08 168.52 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.414 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -159.29 178.98 35.21 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.059 -1.067 . . . . 0.0 111.818 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.476 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.8 OUTLIER -158.22 -163.2 1.25 Allowed 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.948 -178.826 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.476 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 35.9 m-20 -91.71 105.78 14.56 Favored Pre-proline 0 CA--C 1.555 1.168 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -177.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -38.11 -62.15 0.32 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.521 2.148 . . . . 0.0 112.929 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -71.91 65.12 0.52 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.516 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 m -151.18 131.18 13.39 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.683 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -66.36 -32.75 74.34 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.214 0.531 . . . . 0.0 111.184 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.422 ' CG2' ' N ' ' A' ' 42' ' ' ALA . 15.1 t -60.19 -42.53 95.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.34 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.422 ' N ' ' CG2' ' A' ' 41' ' ' THR . . . -56.63 -50.43 72.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.968 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 p -64.44 -42.62 95.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.207 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 94.0 mtp -63.92 -39.46 94.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -60.46 -41.77 94.79 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 122.087 0.946 . . . . 0.0 108.448 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.1 tt -64.15 -53.33 51.16 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.369 -178.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.8 mt -70.0 -11.46 60.89 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.062 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -70.32 -83.02 0.03 OUTLIER 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.121 0.486 . . . . 0.0 111.193 -177.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.41 HD21 ' H ' ' A' ' 50' ' ' LYS . 2.2 pt? -76.16 -33.92 59.37 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 -178.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.41 ' H ' HD21 ' A' ' 49' ' ' LEU . 24.5 mmmt -77.58 -51.93 9.87 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.435 -177.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 36.51 66.47 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.861 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.2 mtm-85 177.8 -53.96 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.918 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.149 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -78.12 -5.96 15.45 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.604 2.202 . . . . 0.0 112.341 -178.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.1 p -44.34 -44.82 2.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.888 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -64.34 -42.72 96.13 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.223 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -61.92 -36.6 81.83 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 63.15 113.73 0.01 OUTLIER Glycine 0 C--N 1.332 0.332 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.548 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -53.78 -160.67 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.008 0.433 . . . . 0.0 111.776 -179.314 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.0 mt -106.63 141.4 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.872 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.7 mt -118.89 142.62 47.58 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.8 tp -111.64 132.41 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-O 121.226 0.536 . . . . 0.0 110.853 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.97 153.45 35.94 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.26 -27.67 7.89 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.643 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 12.9 m120 -116.97 147.04 42.63 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.018 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -76.34 -13.5 60.14 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -50.82 -32.68 20.86 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.256 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.643 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 4.1 pm0 -93.71 -12.34 29.46 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -91.13 -15.92 28.63 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.463 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 11.3 ttmm -79.33 -38.49 1.3 Allowed Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 84.9 Cg_endo -103.59 -3.0 0.26 Allowed 'Trans proline' 0 C--N 1.316 -1.146 0 C-N-CA 122.764 2.309 . . . . 0.0 112.116 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.456 ' OH ' ' CD2' ' A' ' 114' ' ' LEU . 64.1 t80 -96.09 -8.34 33.63 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.92 0.39 . . . . 0.0 110.549 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.3 mp -138.16 167.58 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.515 ' C ' ' H ' ' A' ' 75' ' ' THR . 98.7 m-20 -63.34 -17.42 62.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.09 0.471 . . . . 0.0 110.086 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.0 t70 54.29 5.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.954 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.515 ' H ' ' C ' ' A' ' 73' ' ' ASP . 13.4 t -69.26 -37.49 77.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.181 0.515 . . . . 0.0 109.941 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.405 ' O ' ' OE1' ' A' ' 81' ' ' GLN . 76.1 mmm -66.47 -41.96 88.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.942 0.877 . . . . 0.0 109.018 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.432 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 9.4 mp -70.79 144.64 50.78 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 113.875 -1.511 . . . . 0.0 110.845 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.49 160.89 43.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.063 -179.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -42.89 -44.92 4.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.906 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.2 p -60.49 -41.06 86.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.1 -179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.405 ' OE1' ' O ' ' A' ' 76' ' ' MET . 35.4 mt-30 -64.09 -40.16 95.62 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.608 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -65.28 -52.02 56.94 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 122.508 1.147 . . . . 0.0 108.819 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -54.3 -50.53 67.11 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 113.7 -1.591 . . . . 0.0 109.724 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.1 m -60.83 -50.42 73.52 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.31 -1.314 . . . . 0.0 111.666 -178.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 88' ' ' ARG . 7.6 tt -67.11 -34.09 67.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 119.371 -0.932 . . . . 0.0 109.262 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -70.16 -38.94 75.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.941 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.5 m -87.22 -17.45 32.59 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.009 0.433 . . . . 0.0 110.869 -178.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 85' ' ' ILE . 53.0 ttt85 -114.55 171.97 7.31 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 4.4 m0 -33.27 148.29 0.07 OUTLIER Pre-proline 0 CA--C 1.54 0.569 0 O-C-N 123.186 0.304 . . . . 0.0 111.35 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.56 -17.13 48.31 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.19 1.927 . . . . 0.0 111.506 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 103.03 70.53 0.85 Allowed Glycine 0 N--CA 1.469 0.842 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.57 -42.23 67.45 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.495 2.13 . . . . 0.0 112.321 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.523 ' O ' ' CE1' ' A' ' 95' ' ' PHE . 11.7 p -75.37 140.03 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.957 0.408 . . . . 0.0 110.776 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 22.7 m -90.57 150.29 21.8 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.91 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.599 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -130.49 148.44 52.3 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.087 179.69 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.03 112.95 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -99.24 152.14 37.67 Favored Pre-proline 0 N--CA 1.47 0.561 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.699 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.78 112.2 3.46 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.189 1.926 . . . . 0.0 111.475 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.71 152.82 78.05 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.82 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.36 152.37 81.72 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.028 1.819 . . . . 0.0 111.395 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.249 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.126 -179.54 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 109' ' ' GLY . 8.4 tpt180 . . . . . 0 CA--C 1.532 0.286 0 CA-C-O 120.602 0.239 . . . . 0.0 110.724 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 53.6 p-90 -74.47 -7.7 53.86 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.146 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.642 ' CD1' ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -71.13 -35.58 71.77 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.605 179.551 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.8 m -133.98 -39.13 0.87 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.651 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 84.57 -5.92 79.47 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.226 -0.511 . . . . 0.0 112.727 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -148.85 -72.47 0.19 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 117.723 0.762 . . . . 0.0 111.402 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.447 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 18.8 t80 -88.89 -165.5 1.35 Allowed 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.447 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 51.2 p30 -130.9 51.43 2.14 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.836 0.351 . . . . 0.0 110.897 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.2 p -152.31 153.24 33.29 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.456 ' CD2' ' OH ' ' A' ' 71' ' ' TYR . 0.3 OUTLIER -159.81 136.43 9.12 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -179.261 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.39 127.32 32.54 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 113.225 -1.807 . . . . 0.0 109.967 177.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.6 p -148.01 153.61 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -146.52 155.87 42.84 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.831 0.348 . . . . 0.0 111.021 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 53.2 t -122.63 135.37 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.7 t -133.49 153.42 51.64 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.275 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 52.6 p-10 -154.53 81.28 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.378 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.556 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 27.0 t-80 -171.95 -37.42 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.556 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 31.2 Cg_endo -94.0 -163.08 0.1 OUTLIER 'Trans proline' 0 C--N 1.32 -0.922 0 C-N-CA 121.954 1.769 . . . . 0.0 111.959 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 16.2 mt -76.94 -4.84 45.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.939 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 91.8 t -57.86 -45.58 87.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.171 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.6 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 28.2 m -53.17 -62.22 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 C-N-CA 119.467 -0.893 . . . . 0.0 108.67 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.6 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -41.79 -42.54 2.67 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.008 0.432 . . . . 0.0 110.685 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.4 tp -70.05 -48.33 58.3 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.489 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 63.9 m -70.56 -48.3 56.05 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.575 0.702 . . . . 0.0 110.781 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.435 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -55.08 -42.15 72.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.788 -1.096 . . . . 0.0 108.195 179.29 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.435 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -59.32 -55.66 31.98 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.648 -177.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -61.7 -21.94 64.91 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.656 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.6 1.48 86.68 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -151.66 160.1 32.22 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.113 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -45.41 166.17 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 123.833 3.022 . . . . 0.0 112.967 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.4 tp -121.21 122.81 40.77 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 176.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.414 ' O ' ' CA ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -63.6 146.9 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.856 0 C-N-CA 117.712 -1.595 . . . . 0.0 106.722 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.9 t -122.56 126.13 47.12 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.694 0.621 . . . . 0.0 111.572 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 3.7 m -132.37 164.55 26.23 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.53 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 30.4 t -71.07 151.19 44.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.844 0.354 . . . . 0.0 110.728 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.75 -37.3 81.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.975 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 54.7 p30 -55.87 154.77 6.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.657 0.741 . . . . 0.0 111.425 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.45 -159.15 0.94 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.629 -178.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.9 p -61.36 -38.7 87.94 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.061 0.458 . . . . 0.0 110.153 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -165.8 0.78 0.05 OUTLIER Glycine 0 CA--C 1.511 -0.166 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.2 tp -81.68 124.8 79.43 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.237 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -38.73 156.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.939 1.759 . . . . 0.0 111.931 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -74.84 -162.87 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.391 2.061 . . . . 0.0 112.256 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 73.0 m -119.5 76.4 1.13 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.7 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -54.16 -32.97 56.89 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.817 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.0 165.55 15.78 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -55.75 -17.66 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.746 0 CA-C-O 121.751 0.786 . . . . 0.0 109.267 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -66.24 -34.58 78.33 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.33 -70.6 0.16 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.729 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.5 p -48.62 -31.11 3.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.155 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 159' ' ' GLY . 4.6 tmt_? -79.64 -51.65 8.99 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.863 0.84 . . . . 0.0 109.338 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.98 -44.22 63.95 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.886 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.482 HE21 ' C ' ' A' ' 157' ' ' GLN . 0.0 OUTLIER -84.13 -30.59 25.78 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 112.845 -1.979 . . . . 0.0 114.351 -175.279 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -126.3 -32.9 2.66 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 118.012 0.369 . . . . 0.0 111.294 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 93.75 23.41 23.41 Favored Glycine 0 N--CA 1.467 0.744 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -42.77 -95.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.493 0.187 . . . . 0.0 110.957 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.454 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.93 37.04 15.43 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.189 0.519 . . . . 0.0 109.61 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.543 ' C ' ' H ' ' A' ' 164' ' ' VAL . 1.4 m-85 -175.88 -62.1 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.907 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.28 28.05 0.3 Allowed 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.349 2.032 . . . . 0.0 110.536 178.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.543 ' H ' ' C ' ' A' ' 162' ' ' PHE . 16.0 m -131.78 167.47 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.05 -178.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.2 65.96 30.74 Favored Pre-proline 0 N--CA 1.477 0.878 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.645 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -38.27 147.42 0.11 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 123.686 2.924 . . . . 0.0 114.962 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 174.53 -148.72 10.0 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.117 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -143.4 -164.65 1.91 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.9 t . . . . . 0 N--CA 1.464 0.257 0 CA-C-O 121.354 0.597 . . . . 0.0 111.071 -179.722 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.444 -0.731 0 CA-C-O 120.889 0.376 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 18.8 tt -112.28 130.74 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.698 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -133.83 169.4 17.12 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.714 0.768 . . . . 0.0 112.17 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -80.63 106.99 13.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.201 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -68.47 -16.68 63.98 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.214 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.466 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.8 mm? -63.37 -41.8 98.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.047 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.09 -44.31 3.6 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.176 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.563 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 179.854 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 . . . . . 0 N--CA 1.465 0.307 0 CA-C-O 120.616 0.246 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.462 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 9.4 mp -63.27 -42.27 99.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.968 0.413 . . . . 0.0 110.252 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -64.81 -43.43 93.14 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.189 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -65.56 -38.67 90.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.277 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 162' ' ' PHE . 67.9 t0 -62.73 -45.65 91.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.613 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.14 -45.87 91.52 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.912 0.387 . . . . 0.0 110.031 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.406 HD13 HG22 ' A' ' 10' ' ' ILE . 97.1 mt -63.63 -43.06 98.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.839 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.91 -42.62 85.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.541 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.13 -46.62 86.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.174 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.07 -51.4 69.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.811 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 14.7 pt -68.71 -39.84 80.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.409 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -57.15 -53.19 60.9 Favored 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 120.486 -0.485 . . . . 0.0 109.921 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 20' ' ' GLU . 89.0 t -61.61 -40.42 86.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.638 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.442 ' CD2' ' C ' ' A' ' 17' ' ' LEU . 6.3 tt -52.99 -50.47 64.11 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.383 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -79.49 -51.23 9.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.753 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -64.8 -31.04 72.08 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.812 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 16' ' ' VAL . 96.7 mt-10 58.44 85.11 0.1 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.124 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.41 -142.54 0.09 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.706 0.288 . . . . 0.0 110.289 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.2 p -137.74 138.73 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 pp -128.05 163.99 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-O 121.118 0.485 . . . . 0.0 111.78 -178.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.68 128.43 36.2 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.914 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.518 ' CE2' ' O ' ' A' ' 26' ' ' PRO . 2.1 t80 -118.32 138.49 25.72 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.255 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.518 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 64.8 Cg_endo -80.93 149.51 17.83 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.191 1.26 . . . . 0.0 111.352 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.472 ' C ' ' H ' ' A' ' 29' ' ' ALA . 25.9 m -135.15 140.93 45.8 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.271 0.557 . . . . 0.0 110.808 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -77.77 20.07 0.36 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.033 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -154.97 -73.41 0.12 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.206 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 67.5 t -122.74 126.28 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 120.859 0.361 . . . . 0.0 110.737 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.521 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 90.9 m-85 -53.5 144.48 17.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.195 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -154.35 -168.37 17.7 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.2 m -132.08 168.31 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.97 -176.96 27.79 Favored Glycine 0 N--CA 1.464 0.566 0 C-N-CA 120.008 -1.092 . . . . 0.0 111.925 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -153.34 -166.2 2.36 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.734 0.302 . . . . 0.0 110.359 -179.43 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.514 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 7.8 m-20 -99.43 109.79 56.17 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-O 118.729 -0.653 . . . . 0.0 112.441 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 36' ' ' ASP . 15.4 Cg_exo -35.19 168.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.68 2.254 . . . . 0.0 114.302 177.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 44.73 67.39 0.7 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.433 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.7 m -142.94 137.59 29.53 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.07 0.462 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.547 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -71.65 -34.37 69.7 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.296 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.45 -45.28 91.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.644 -178.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.1 -47.68 81.81 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.598 -178.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.3 p -62.59 -44.45 99.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.249 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 62.1 mtt -64.95 -39.79 94.02 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 -61.77 -32.98 73.29 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.026 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 79.9 mt -75.95 -57.23 4.0 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.4 mt -54.46 -18.91 4.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.243 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -67.23 -84.66 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.695 -178.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -75.83 -33.26 60.05 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -77.71 -71.23 0.43 Allowed 'General case' 0 C--N 1.346 0.445 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.738 -176.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.411 ' CG ' ' O ' ' A' ' 51' ' ' GLN . 3.2 tt0 53.65 80.98 0.1 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.399 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.3 mtp85 160.69 -64.04 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.116 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -66.78 -11.25 31.26 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 122.641 2.228 . . . . 0.0 111.775 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' A' ' 55' ' ' ASP . 13.9 p -46.05 -45.97 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 110' ' ' ARG . 10.3 t0 -67.58 -44.44 78.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.676 -178.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -60.35 -40.5 90.96 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.759 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 71.39 111.66 0.04 OUTLIER Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.573 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -49.54 -169.86 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.986 -0.607 . . . . 0.0 111.896 179.632 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.439 ' O ' ' OG ' ' A' ' 137' ' ' SER . 80.9 mt -100.25 139.54 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.5 mt -113.24 143.84 43.73 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -178.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.0 tp -112.26 127.97 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 CA-C-O 121.122 0.487 . . . . 0.0 110.548 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.46 154.59 26.76 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.56 -26.29 7.11 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -118.76 145.05 45.88 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.607 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -71.62 -12.53 61.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.571 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -49.6 -33.91 16.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.565 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -95.04 -15.74 23.23 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.427 ' CD2' ' N ' ' A' ' 68' ' ' LEU . 3.8 mm? -92.94 -13.14 29.23 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.598 ' HZ3' ' NH2' ' A' ' 82' ' ' ARG . 27.9 tptt -80.49 -39.08 1.13 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.803 -178.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 65.8 Cg_endo -103.09 -3.4 0.28 Allowed 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 122.78 2.32 . . . . 0.0 111.784 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.485 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 39.8 t80 -96.56 -11.01 25.98 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.161 -178.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.431 ' CG2' ' N ' ' A' ' 73' ' ' ASP . 5.2 mp -131.46 159.36 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.431 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 91.2 m-20 -71.37 160.45 32.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.06 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 39.2 p30 -95.64 7.79 45.27 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.848 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.1 t -67.08 -45.77 76.3 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.325 0.583 . . . . 0.0 110.547 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 23.1 ptp -84.33 -6.26 59.37 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.232 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.3 tp -94.33 116.3 28.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.619 -177.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -154.95 167.2 31.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.91 -177.817 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -42.49 -44.49 4.1 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.196 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.66 -33.03 59.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.923 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 78' ' ' THR . 1.0 OUTLIER -65.75 -43.26 89.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.203 0.525 . . . . 0.0 110.52 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.598 ' NH2' ' HZ3' ' A' ' 69' ' ' LYS . 9.5 mmt85 -59.92 -49.17 78.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 122.76 1.267 . . . . 0.0 108.657 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -57.29 -49.84 74.82 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 113.446 -1.706 . . . . 0.0 110.005 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.7 m -62.59 -49.19 76.24 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.227 -1.351 . . . . 0.0 112.444 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.8 tt -68.42 -30.75 48.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.139 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -82.37 -40.02 21.93 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.917 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.2 m -78.35 -3.31 42.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.907 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -121.92 166.95 13.64 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 15.9 m-90 -43.49 150.71 0.5 Allowed Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.12 -19.37 45.11 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.911 1.741 . . . . 0.0 111.593 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.474 ' O ' ' NH2' ' A' ' 117' ' ' ARG . . . 177.64 78.78 0.06 OUTLIER Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -79.57 -35.52 0.79 Allowed 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.042 1.828 . . . . 0.0 112.516 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.515 ' CG1' ' CZ ' ' A' ' 95' ' ' PHE . 9.7 p -137.92 149.2 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 120.801 0.334 . . . . 0.0 110.886 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 16.3 m -81.39 129.51 34.66 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.515 ' CZ ' ' CG1' ' A' ' 93' ' ' VAL . 46.2 m-85 -117.02 137.4 52.26 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.733 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.5 t -92.05 102.59 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 121.277 0.561 . . . . 0.0 109.759 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -81.12 143.68 53.17 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.198 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -79.64 108.16 2.24 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 122.032 1.821 . . . . 0.0 111.099 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 112' ' ' ASP . . . -64.93 156.61 79.43 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.491 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 49.0 Cg_endo -66.69 -19.23 53.81 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.231 1.954 . . . . 0.0 112.187 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . 0 N--CA 1.472 0.671 0 O-C-N 123.536 0.523 . . . . 0.0 110.551 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 109' ' ' GLY . 0.6 OUTLIER . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 2.5 p90 -79.56 -9.83 59.69 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.676 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.649 ' CD1' ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -69.28 -34.06 74.17 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.427 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.574 ' C ' ' H ' ' A' ' 110' ' ' ARG . 28.5 m -141.39 -40.73 0.38 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.428 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 60.29 -13.62 0.04 OUTLIER Glycine 0 CA--C 1.536 1.398 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.657 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.574 ' H ' ' C ' ' A' ' 108' ' ' THR . 0.0 OUTLIER -85.52 -52.61 5.72 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 117.659 0.73 . . . . 0.0 109.284 179.758 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.534 ' CE2' ' OD1' ' A' ' 112' ' ' ASP . 17.6 t80 -154.37 -178.26 7.02 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.306 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.534 ' OD1' ' CE2' ' A' ' 111' ' ' PHE . 48.8 p30 -89.01 51.63 2.21 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.299 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.5 p -159.51 156.82 28.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.244 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.75 141.5 7.38 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.7 125.23 26.09 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 113.737 -1.574 . . . . 0.0 109.617 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.3 p -146.66 161.19 9.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.474 ' NH2' ' O ' ' A' ' 91' ' ' GLY . 78.7 ttt-85 -144.03 153.23 41.99 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.91 0.386 . . . . 0.0 111.389 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 52.2 t -122.45 136.64 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.2 t -135.24 149.04 49.77 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.249 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 35.4 p30 -151.68 78.82 1.26 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.763 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.549 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 10.3 t-80 -172.51 -36.85 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.549 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 18.9 Cg_endo -92.73 -161.66 0.09 OUTLIER 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 121.993 1.795 . . . . 0.0 111.686 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.4 mt -78.83 -4.68 50.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.016 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.4 t -58.21 -45.0 89.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.971 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.583 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 27.6 m -52.7 -62.2 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.935 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.583 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -40.96 -45.41 2.57 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.881 0.372 . . . . 0.0 111.027 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.69 -51.37 56.8 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.253 0.549 . . . . 0.0 110.778 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 71.2 m -69.5 -47.79 62.68 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.237 0.541 . . . . 0.0 111.425 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 125' ' ' VAL . 1.2 pp0? -54.87 -42.2 71.75 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.445 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -60.4 -53.12 61.37 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.771 -177.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.45 ' CE1' ' OD2' ' A' ' 36' ' ' ASP . 42.0 t80 -64.48 -22.46 66.97 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.825 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.94 2.07 90.14 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 134' ' ' PRO . 34.3 mttm -152.4 159.56 32.52 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 133' ' ' LYS . 5.9 Cg_exo -41.12 -179.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 124.061 3.174 . . . . 0.0 113.941 -178.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.0 tp -134.47 123.85 24.65 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 176.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -66.14 143.73 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 C-N-CA 117.764 -1.574 . . . . 0.0 108.518 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -108.82 121.88 46.0 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.96 0.788 . . . . 0.0 110.924 -179.346 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.9 m -132.38 157.64 44.02 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.819 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.6 m -73.0 143.2 47.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.011 0.434 . . . . 0.0 110.577 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.7 -36.76 85.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.034 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 51.8 p30 -52.37 150.38 4.82 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.774 0.797 . . . . 0.0 110.997 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.13 -158.39 0.73 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.048 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 45.2 m -59.93 -42.99 95.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.471 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -162.55 11.87 0.11 Allowed Glycine 0 N--CA 1.459 0.172 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.7 tp -93.44 127.51 46.13 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -38.76 157.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 121.758 1.638 . . . . 0.0 112.468 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -76.55 -166.94 0.41 Allowed 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 122.721 2.281 . . . . 0.0 112.487 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 70.9 m -112.03 76.93 1.0 Allowed 'General case' 0 C--O 1.231 0.103 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.521 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 17.5 ptm180 -54.06 -37.81 64.57 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.952 -178.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -158.42 167.64 29.13 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.808 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.6 m -57.37 -20.35 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.6 0 CA-C-O 121.77 0.795 . . . . 0.0 109.248 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -64.21 -34.61 78.49 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 150' ' ' THR . 0.4 OUTLIER -61.03 -79.49 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.872 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.3 p -35.22 -34.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.687 0.795 . . . . 0.0 111.155 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.475 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -67.38 -52.79 35.66 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.347 0.594 . . . . 0.0 111.852 -178.618 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -69.35 -16.93 63.64 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 122.538 1.161 . . . . 0.0 108.035 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -84.23 -45.37 12.96 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 112.672 -2.058 . . . . 0.0 111.891 -178.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -130.34 -27.93 2.16 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.638 0.256 . . . . 0.0 111.642 -178.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 94.56 24.17 19.16 Favored Glycine 0 N--CA 1.468 0.783 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -43.68 -96.69 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.78 0.324 . . . . 0.0 111.126 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.508 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 62.3 34.8 15.61 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -178.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.547 ' C ' ' H ' ' A' ' 164' ' ' VAL . 2.1 m-85 -174.04 -62.16 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.238 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.86 25.88 0.29 Allowed 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.349 2.033 . . . . 0.0 110.932 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.547 ' H ' ' C ' ' A' ' 162' ' ' PHE . 13.7 m -127.43 167.64 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.746 -178.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.1 t -122.35 64.87 21.58 Favored Pre-proline 0 N--CA 1.472 0.647 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.829 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -37.62 144.32 0.15 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 123.652 2.901 . . . . 0.0 115.031 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 164.54 -176.78 40.36 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 113.901 -1.5 . . . . 0.0 110.878 178.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -142.09 152.8 43.63 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.469 0.487 0 CA-C-O 121.088 0.47 . . . . 0.0 111.169 -179.769 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.504 ' OE1' ' NH1' ' A' ' 179' ' ' ARG . 98.1 mt-10 . . . . . 0 N--CA 1.444 -0.747 0 CA-C-O 120.874 0.369 . . . . 0.0 110.834 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 18.7 tt -111.25 125.13 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.653 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.504 ' NH1' ' OE1' ' A' ' 177' ' ' GLU . 7.2 mpt_? -122.5 161.43 23.62 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 122.102 0.953 . . . . 0.0 110.889 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -77.79 105.88 9.26 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.157 -1.383 . . . . 0.0 107.979 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -66.95 -13.61 61.98 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.753 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.467 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.4 mm? -63.54 -42.02 98.42 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.062 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.2 -43.44 2.53 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.818 0.342 . . . . 0.0 110.623 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.781 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.701 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.821 0.343 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.421 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 10.4 mp -63.11 -42.32 99.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.212 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -61.96 -49.6 75.45 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.001 0.429 . . . . 0.0 110.053 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -58.51 -41.36 85.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.947 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.74 -44.76 96.29 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.588 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.43 -45.29 93.75 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.241 0.544 . . . . 0.0 109.94 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.9 -42.94 98.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.9 -42.43 79.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.156 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.2 -47.48 85.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.149 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.02 -53.21 60.53 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.626 -0.43 . . . . 0.0 112.053 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 14.2 pt -66.75 -38.32 81.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.117 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -58.36 -50.77 72.47 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.168 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.493 ' O ' ' N ' ' A' ' 20' ' ' GLU . 92.6 t -62.81 -39.27 84.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.75 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.435 ' CD2' ' C ' ' A' ' 17' ' ' LEU . 6.3 tt -52.48 -52.2 55.57 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.209 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -76.79 -48.72 17.76 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.223 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -67.14 -29.47 69.2 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.058 0.456 . . . . 0.0 110.837 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 16' ' ' VAL . 96.7 mt-10 56.36 60.52 3.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.564 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.65 159.6 42.12 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.302 0.573 . . . . 0.0 110.323 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 p -76.92 137.97 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.436 -178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.86 166.79 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-O 120.692 0.282 . . . . 0.0 110.898 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.05 133.86 53.86 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.379 0.609 . . . . 0.0 111.462 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.524 ' CE2' ' O ' ' A' ' 26' ' ' PRO . 3.5 t80 -126.66 138.68 33.0 Favored Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.524 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 64.3 Cg_endo -80.32 150.21 19.72 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 CA-C-N 120.419 1.185 . . . . 0.0 111.588 -178.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.484 ' C ' ' H ' ' A' ' 29' ' ' ALA . 30.2 m -130.14 140.09 50.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.649 0.262 . . . . 0.0 110.451 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -77.6 21.11 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.484 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -154.76 -74.59 0.11 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.124 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.4 p -123.79 127.41 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 121.24 0.543 . . . . 0.0 110.622 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 149' ' ' ARG . 97.4 m-85 -43.37 147.98 0.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.999 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -157.64 -174.72 27.71 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.4 m -131.23 169.38 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.43 178.92 33.55 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 119.946 -1.121 . . . . 0.0 112.656 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.564 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -152.97 -162.84 1.57 Allowed 'General case' 0 C--N 1.341 0.226 0 CA-C-N 115.521 -0.34 . . . . 0.0 110.309 -179.231 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.564 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 2.1 m-20 -101.52 111.12 63.39 Favored Pre-proline 0 CA--C 1.548 0.869 0 CA-C-O 118.802 -0.618 . . . . 0.0 112.622 -178.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 36' ' ' ASP . 22.8 Cg_exo -35.89 170.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.804 2.336 . . . . 0.0 114.413 177.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.8 t70 41.53 73.45 0.13 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.887 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 36' ' ' ASP . 4.9 m -151.79 141.99 22.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.084 0.469 . . . . 0.0 110.308 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.556 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -70.43 -30.55 67.44 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.555 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.6 t -60.09 -42.52 94.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.988 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.17 -52.53 65.15 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.345 -178.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.07 -45.33 99.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.137 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 60.6 mtt -67.62 -45.29 75.84 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -65.8 -28.7 69.2 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.634 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 52.7 mt -74.72 -60.95 2.05 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.232 177.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.9 mt -51.63 -23.22 4.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.065 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.49 -85.73 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.723 -178.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -76.56 -33.66 58.51 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -75.5 -71.16 0.38 Allowed 'General case' 0 C--N 1.346 0.434 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.959 -176.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.406 ' O ' ' CG ' ' A' ' 51' ' ' GLN . 3.8 tt0 53.46 80.62 0.1 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.388 0.613 . . . . 0.0 109.454 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.1 mtt-85 161.07 -63.44 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.215 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.36 -10.4 28.87 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 122.737 2.291 . . . . 0.0 112.175 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.417 ' CG1' ' N ' ' A' ' 55' ' ' ASP . 7.3 p -44.95 -48.19 2.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.914 -178.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 110' ' ' ARG . 10.9 t0 -68.49 -42.29 78.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.425 -178.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -58.9 -41.96 88.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.398 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 68.97 112.86 0.02 OUTLIER Glycine 0 CA--C 1.518 0.248 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.568 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -49.64 -170.63 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.085 -0.558 . . . . 0.0 112.353 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.3 mt -97.7 148.29 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.1 mt -122.35 142.65 50.28 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.6 tp -114.45 129.93 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-O 121.176 0.512 . . . . 0.0 110.984 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.11 159.9 19.52 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -124.94 -24.72 4.02 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.486 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 99.2 m-20 -116.76 125.31 51.46 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.287 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -58.46 -13.23 5.02 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -50.23 -33.58 20.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.527 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.486 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 4.3 pm0 -94.83 -11.55 28.64 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.409 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 3.8 mm? -91.98 -14.6 29.21 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 118.864 0.757 . . . . 0.0 109.192 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.474 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 42.9 tttm -79.6 -38.56 1.26 Allowed Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.766 -178.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 73.6 Cg_endo -103.07 -3.43 0.28 Allowed 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 122.699 2.266 . . . . 0.0 111.836 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.431 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 51.8 t80 -96.53 -10.46 27.25 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.666 -178.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.413 ' CG2' ' N ' ' A' ' 73' ' ' ASP . 4.7 mp -137.02 164.23 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.413 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 97.6 m-20 -66.71 160.16 26.26 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -94.85 12.01 29.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.695 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.409 ' CG2' ' N ' ' A' ' 76' ' ' MET . 10.7 t -72.48 -41.12 66.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.223 0.535 . . . . 0.0 110.067 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.409 ' N ' ' CG2' ' A' ' 75' ' ' THR . 22.1 ptp -85.15 -18.26 34.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.546 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 tp -95.25 119.36 33.63 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.904 -178.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.473 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -158.03 161.03 38.04 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.303 -177.701 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -38.92 -47.86 1.5 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.837 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.1 p -62.86 -34.13 64.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.757 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 78' ' ' THR . 67.4 tp60 -65.99 -39.54 90.4 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.808 0.337 . . . . 0.0 110.93 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 -64.4 -52.86 56.07 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 122.581 1.181 . . . . 0.0 109.14 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -55.67 -50.39 70.38 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.126 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 88' ' ' ARG . 3.1 m -60.77 -51.05 70.97 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.926 -178.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.0 tt -65.91 -36.49 77.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.596 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -67.14 -41.03 86.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.127 178.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.9 m -84.71 -19.02 33.4 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.8 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 84' ' ' THR . 77.8 ttt-85 -103.56 151.52 22.79 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.741 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -34.38 152.62 0.05 OUTLIER Pre-proline 0 N--CA 1.469 0.484 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.188 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.12 -17.93 55.62 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.132 1.888 . . . . 0.0 110.991 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 99.19 69.32 0.92 Allowed Glycine 0 CA--C 1.529 0.967 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.779 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.54 -39.35 88.65 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.865 2.377 . . . . 0.0 111.493 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.2 p -78.59 147.84 6.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.328 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 85.5 m -88.11 143.62 26.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.731 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -127.01 140.35 52.37 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.661 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.4 t -93.86 101.77 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-O 121.474 0.654 . . . . 0.0 109.633 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -91.81 151.31 42.06 Favored Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.882 -177.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.82 142.19 56.69 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.764 1.643 . . . . 0.0 110.309 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -114.95 116.54 42.64 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.397 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -45.59 167.4 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 121.6 1.533 . . . . 0.0 112.623 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.484 179.495 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.492 ' NH1' ' OD1' ' A' ' 112' ' ' ASP . 11.4 tpp180 . . . . . 0 N--CA 1.463 0.208 0 CA-C-O 120.749 0.309 . . . . 0.0 110.475 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 6.1 p90 -84.5 -9.4 58.38 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.547 ' H ' ' CD2' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -77.57 -17.65 57.67 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.678 -179.639 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.563 ' C ' ' H ' ' A' ' 110' ' ' ARG . 26.6 m -144.75 -43.85 0.24 Allowed 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.827 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 50.42 -1.87 0.01 OUTLIER Glycine 0 CA--C 1.541 1.688 0 CA-C-O 119.726 -0.485 . . . . 0.0 113.339 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.563 ' H ' ' C ' ' A' ' 108' ' ' THR . 0.5 OUTLIER -88.15 -54.87 4.0 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 117.947 0.873 . . . . 0.0 109.552 179.741 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.613 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 85.4 t80 -154.51 173.72 15.9 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.417 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.613 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 89.8 m-20 -79.12 50.92 1.1 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.372 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 82.1 p -158.52 160.04 36.24 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.3 pp -167.13 140.02 3.51 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.87 112.21 4.17 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 113.437 -1.71 . . . . 0.0 110.75 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.1 p -143.97 160.42 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -155.99 162.16 40.38 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.949 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.7 t -121.24 138.82 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.543 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 7.9 t -132.62 150.43 52.16 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.957 0.408 . . . . 0.0 110.103 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.401 ' O ' ' OD1' ' A' ' 120' ' ' ASP . 30.6 p30 -150.4 81.1 1.36 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.324 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.537 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 61.7 t60 -171.81 -37.79 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.537 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 38.7 Cg_endo -95.49 -163.62 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 121.941 1.761 . . . . 0.0 112.3 -178.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.6 mt -78.54 -4.09 46.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.89 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 83.3 t -57.62 -45.96 86.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.648 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.568 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 27.1 m -52.96 -62.18 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.87 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.568 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -41.33 -43.84 2.58 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.243 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.1 tp -69.49 -48.07 61.85 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.954 0.406 . . . . 0.0 110.99 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 82.1 m -70.0 -48.96 55.98 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.408 0.623 . . . . 0.0 110.915 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.437 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.0 OUTLIER -55.24 -41.61 72.36 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.423 179.428 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.437 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -58.94 -54.42 47.36 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.383 -1.281 . . . . 0.0 109.605 -177.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.402 ' CE1' ' OD2' ' A' ' 36' ' ' ASP . 42.8 t80 -62.05 -21.47 64.95 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.983 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 81.43 -0.11 88.3 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 134' ' ' PRO . 24.7 mttp -152.37 159.14 33.12 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.004 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 133' ' ' LYS . 6.1 Cg_exo -41.61 179.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 123.838 3.026 . . . . 0.0 113.75 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.0 tp -134.58 123.73 24.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.443 -1.708 . . . . 0.0 106.578 177.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -66.06 146.42 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 C-N-CA 117.684 -1.606 . . . . 0.0 107.327 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.0 t -118.3 129.25 55.35 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.249 0.547 . . . . 0.0 110.894 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.3 m -129.06 162.31 27.97 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.085 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 17.8 m -72.02 147.99 46.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.246 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.63 -37.44 87.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.913 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . 0.437 ' O ' ' ND2' ' A' ' 141' ' ' ASN . 0.1 OUTLIER -54.31 157.38 2.76 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.594 0.711 . . . . 0.0 111.256 -179.445 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.74 -158.31 0.88 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.103 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.6 t -60.33 -44.08 95.81 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.382 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -165.97 12.43 0.07 OUTLIER Glycine 0 N--CA 1.46 0.264 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.3 tp -90.24 127.64 52.47 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -39.47 153.74 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 121.702 1.602 . . . . 0.0 112.22 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.29 157.43 41.57 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.431 2.088 . . . . 0.0 112.373 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 18.7 m -80.37 76.35 7.18 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.534 ' O ' ' CD1' ' A' ' 31' ' ' PHE . 32.9 ptt-85 -55.19 -35.7 65.11 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.93 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.71 169.49 24.52 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -59.62 -23.82 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.23 -23.73 67.41 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 177.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 155' ' ' ARG . 5.6 tm-20 -69.56 -78.87 0.06 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.85 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.424 ' O ' ' N ' ' A' ' 158' ' ' PHE . 3.2 p -35.08 -30.66 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.473 0.709 . . . . 0.0 110.564 177.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -72.58 -51.43 19.79 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.083 -179.32 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 153' ' ' GLU . . . -67.32 -20.12 65.56 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.666 1.222 . . . . 0.0 107.793 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -83.09 -44.62 14.94 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 112.403 -2.181 . . . . 0.0 111.808 -178.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.424 ' N ' ' O ' ' A' ' 154' ' ' VAL . 49.4 t80 -130.63 -26.62 2.22 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.816 0.341 . . . . 0.0 111.84 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 92.18 25.74 20.81 Favored Glycine 0 N--CA 1.468 0.813 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -43.67 -96.74 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.498 -0.351 . . . . 0.0 111.189 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . 63.42 33.07 14.05 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -178.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.558 ' C ' ' H ' ' A' ' 164' ' ' VAL . 0.4 OUTLIER -174.24 -61.12 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.497 -179.58 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.83 28.93 0.28 Allowed 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.003 1.802 . . . . 0.0 110.652 177.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.558 ' H ' ' C ' ' A' ' 162' ' ' PHE . 15.4 m -130.63 166.91 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.088 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.5 t -121.51 65.68 17.28 Favored Pre-proline 0 N--CA 1.476 0.836 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.869 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -35.41 139.07 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 123.628 2.885 . . . . 0.0 115.225 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 169.28 173.7 37.13 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.905 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -158.14 144.83 17.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.957 0.408 . . . . 0.0 110.51 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.9 t . . . . . 0 N--CA 1.466 0.336 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.656 179.534 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 . . . . . 0 N--CA 1.448 -0.575 0 CA-C-O 120.468 0.175 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 45.4 pt -122.22 143.21 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.933 0.397 . . . . 0.0 111.016 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -137.8 167.52 21.57 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.778 0.799 . . . . 0.0 111.949 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -83.97 106.7 15.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.205 -1.361 . . . . 0.0 110.355 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -65.01 -13.96 59.19 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.071 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.434 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.5 mm? -62.91 -42.0 99.65 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.33 -42.69 3.65 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.265 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.683 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.877 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.935 0.398 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.454 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 9.6 mp -61.68 -42.4 98.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.971 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -63.38 -45.57 90.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.09 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -61.62 -38.11 86.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.994 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.04 -43.6 98.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.686 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.93 -49.23 78.29 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.633 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.9 mm -63.92 -43.19 97.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.537 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.49 -46.7 83.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.705 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.0 -43.61 98.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.41 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.88 -53.24 59.75 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.62 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.9 pt -69.5 -38.85 77.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.482 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -58.76 -55.35 36.29 Favored 'General case' 0 C--O 1.214 -0.807 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.338 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 20' ' ' GLU . 91.1 t -61.72 -40.23 86.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.386 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.447 ' CD2' ' C ' ' A' ' 17' ' ' LEU . 6.3 tt -52.56 -51.26 60.61 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.681 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -79.81 -50.48 10.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.873 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -63.67 -32.71 74.27 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.615 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 16' ' ' VAL . 96.8 mt-10 58.7 82.86 0.13 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.377 0.881 . . . . 0.0 113.377 178.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.28 -141.38 0.05 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.679 0.275 . . . . 0.0 110.488 177.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.0 p -135.13 139.16 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pp -129.02 164.16 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 120.924 0.392 . . . . 0.0 111.98 -178.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.28 141.88 58.61 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.939 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -145.55 160.81 43.53 Favored Pre-proline 0 CA--C 1.546 0.82 0 CA-C-O 119.047 -0.501 . . . . 0.0 110.522 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.52 157.17 32.46 Favored 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 121.579 1.519 . . . . 0.0 111.442 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.2 m -136.97 155.2 50.02 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.276 0.56 . . . . 0.0 110.538 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -83.78 14.54 3.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.729 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -160.43 -64.93 0.07 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.165 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.9 t -125.49 127.45 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.071 0.463 . . . . 0.0 110.685 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -56.72 131.07 48.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.313 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -141.03 -153.62 6.01 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.5 m -131.57 166.68 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -156.99 -179.95 32.32 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.987 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -153.68 -179.58 7.93 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 37' ' ' PRO . 36.7 t70 -91.98 110.08 41.56 Favored Pre-proline 0 CA--C 1.552 1.033 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 36' ' ' ASP . 57.0 Cg_exo -36.79 173.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 123.039 2.493 . . . . 0.0 114.517 177.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 49.01 64.64 1.64 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.861 -1.518 . . . . 0.0 111.216 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 65.2 m -147.2 138.03 23.65 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.043 0.449 . . . . 0.0 110.405 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.46 -35.95 73.62 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.531 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.06 -42.59 96.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.463 -179.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.92 75.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.643 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 p -62.4 -44.91 99.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.277 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 90.0 mtp -64.01 -40.84 97.26 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 27.8 ttt-85 -61.4 -41.52 97.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.41 -54.3 34.92 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.595 -178.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.4 mt -69.74 -12.12 61.38 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.246 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -69.03 -82.54 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.149 0.5 . . . . 0.0 111.133 -177.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.407 HD21 ' H ' ' A' ' 50' ' ' LYS . 2.3 pt? -76.21 -35.1 59.22 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -178.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.407 ' H ' HD21 ' A' ' 49' ' ' LEU . 24.2 mmmt -76.45 -50.41 14.14 Favored 'General case' 0 C--N 1.344 0.358 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.901 -177.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 35.52 65.5 0.4 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.995 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.7 mtm-85 178.49 -52.85 0.0 OUTLIER Pre-proline 0 CA--C 1.551 0.986 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.644 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.25 -4.28 13.65 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.875 2.384 . . . . 0.0 112.537 -178.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.442 ' CG1' ' N ' ' A' ' 55' ' ' ASP . 10.9 p -47.35 -44.76 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.111 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.442 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 41.3 t0 -66.47 -40.44 89.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.445 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -60.69 -38.04 83.66 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 64.89 107.27 0.01 OUTLIER Glycine 0 CA--C 1.518 0.264 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.567 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -52.34 -163.32 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.022 0.439 . . . . 0.0 111.673 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.449 ' O ' ' OG ' ' A' ' 137' ' ' SER . 73.6 mt -109.07 135.16 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.3 mt -109.79 142.12 41.48 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.413 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 9.3 tp -110.21 123.93 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-O 121.033 0.444 . . . . 0.0 111.304 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.99 157.15 22.84 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.499 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.97 -24.51 4.75 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.453 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -115.88 130.66 56.92 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.73 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -63.99 -13.03 43.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.752 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -50.57 -30.36 13.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.622 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -96.06 -15.87 21.94 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -92.11 -15.32 27.88 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.666 -0.646 . . . . 0.0 109.329 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.517 ' HZ3' ' NH2' ' A' ' 82' ' ' ARG . 35.4 tttp -80.53 -38.52 1.08 Allowed Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.693 -178.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 66.0 Cg_endo -103.55 -2.77 0.27 Allowed 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 122.663 2.242 . . . . 0.0 111.896 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.431 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 60.7 t80 -97.89 -9.46 26.29 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.032 -178.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.3 mp -131.86 159.38 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -65.56 158.57 26.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.968 0.413 . . . . 0.0 110.389 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 74' ' ' ASP . 37.1 p-10 -93.72 9.35 37.37 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.882 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.6 t -75.85 -39.16 57.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.131 0.491 . . . . 0.0 110.538 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 20.9 ptp -96.9 -15.28 21.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.257 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.7 tp -100.21 125.68 46.4 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.436 0.636 . . . . 0.0 111.331 -177.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.476 ' OG1' ' N ' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -148.76 178.46 8.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.984 -178.143 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.476 ' N ' ' OG1' ' A' ' 78' ' ' THR . 98.2 m-20 -59.97 -42.49 94.27 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 123.233 0.333 . . . . 0.0 111.082 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.6 p -61.05 -31.23 49.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.533 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -62.74 -41.61 99.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.391 0.615 . . . . 0.0 109.939 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.517 ' NH2' ' HZ3' ' A' ' 69' ' ' LYS . 12.6 mmt85 -65.46 -53.77 38.0 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 122.379 1.085 . . . . 0.0 109.821 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 87' ' ' SER . 82.0 tt0 -53.74 -50.34 66.18 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.317 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.1 m -62.39 -49.8 74.08 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.576 -1.193 . . . . 0.0 112.138 -177.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 89' ' ' TRP . 8.4 tt -68.54 -26.2 32.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.484 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -87.82 -22.52 24.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.932 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 83' ' ' GLU . 68.4 m -107.17 -56.07 2.25 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.573 ' O ' ' CG ' ' A' ' 89' ' ' TRP . 78.7 ttt-85 -61.61 -45.79 92.58 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.474 -178.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.573 ' CG ' ' O ' ' A' ' 88' ' ' ARG . 1.1 m0 174.72 154.37 0.31 Allowed Pre-proline 0 N--CA 1.47 0.532 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -68.71 -16.99 42.62 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.319 2.013 . . . . 0.0 111.452 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 97.14 69.24 0.98 Allowed Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.98 -37.25 93.71 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.478 2.119 . . . . 0.0 111.38 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.1 p -77.98 144.4 11.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.536 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 27.2 m -93.57 143.57 26.18 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.385 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -127.39 145.09 50.93 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.436 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.9 t -96.57 103.51 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 121.545 0.688 . . . . 0.0 110.145 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -89.39 148.0 39.47 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.55 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -77.76 111.59 3.15 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.93 1.753 . . . . 0.0 111.278 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.47 148.26 90.44 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -63.94 146.4 91.33 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.901 1.734 . . . . 0.0 112.272 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.521 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.67 179.744 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.527 ' NH2' ' O ' ' A' ' 110' ' ' ARG . 4.1 tpt180 . . . . . 0 N--CA 1.468 0.451 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -75.0 -1.24 21.78 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.011 0.434 . . . . 0.0 110.895 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.656 ' CD1' ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -86.56 -17.9 32.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.669 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.2 m -142.01 -39.99 0.36 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.374 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 74.83 18.95 80.11 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.361 179.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.527 ' O ' ' NH2' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -158.35 -74.1 0.08 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 117.313 0.557 . . . . 0.0 110.434 179.433 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -102.78 -173.68 2.38 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.26 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 49.1 p30 -115.38 57.88 0.73 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.786 0.327 . . . . 0.0 111.051 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.0 p -159.03 159.52 34.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.32 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.6 pp -166.15 142.54 5.02 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.8 121.48 16.61 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 113.349 -1.751 . . . . 0.0 109.276 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.9 p -142.36 157.15 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -146.48 149.83 34.42 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.157 0.503 . . . . 0.0 111.46 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.5 t -115.05 134.28 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.3 t -129.87 151.09 50.82 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.025 0.441 . . . . 0.0 110.924 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 49.9 p-10 -151.87 85.57 1.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.196 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.542 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 9.2 t60 -171.67 -38.03 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.542 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 74.2 Cg_endo -97.49 -159.45 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.931 0 C-N-CA 122.45 2.1 . . . . 0.0 112.318 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 32.5 mt -79.71 -4.99 54.27 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.343 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 74.2 t -57.08 -46.13 84.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.777 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.577 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 30.2 m -55.24 -61.49 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.302 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.024 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.577 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -40.44 -47.09 2.55 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.844 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.436 ' CD1' ' C ' ' A' ' 127' ' ' LEU . 2.8 tm? -69.82 -47.28 63.36 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.571 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.457 ' O ' ' N ' ' A' ' 132' ' ' GLY . 85.3 m -68.71 -47.3 66.71 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.103 0.477 . . . . 0.0 111.296 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 125' ' ' VAL . 1.3 pp0? -55.63 -43.06 75.81 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.429 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -59.48 -56.09 26.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.311 -177.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -63.16 -35.66 81.03 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.128 -1.397 . . . . 0.0 108.346 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 128' ' ' CYS . . . 89.96 3.32 73.6 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 113.388 -1.733 . . . . 0.0 109.684 -179.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -141.79 153.77 64.98 Favored Pre-proline 0 CA--C 1.552 1.043 0 CA-C-N 117.258 0.529 . . . . 0.0 111.21 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -48.46 -174.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 123.724 2.949 . . . . 0.0 113.969 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.1 tp -140.8 125.36 17.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 113.02 -1.9 . . . . 0.0 106.31 177.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -64.67 142.93 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 C-N-CA 118.179 -1.408 . . . . 0.0 108.931 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 59' ' ' ILE . 0.8 OUTLIER -108.96 121.1 44.42 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 123.762 0.664 . . . . 0.0 110.583 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 18.7 m -132.18 145.47 51.37 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.9 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.1 m -66.7 144.12 56.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.529 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.11 88.57 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -162.23 164.33 27.75 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.275 0.56 . . . . 0.0 110.589 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.8 -163.85 1.82 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.173 -178.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 80.2 p -63.54 -40.41 96.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.752 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -159.35 0.81 0.09 OUTLIER Glycine 0 N--CA 1.461 0.332 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 146' ' ' PRO . 1.2 tm? -79.24 111.83 23.49 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 145' ' ' LEU . 14.3 Cg_exo -33.59 155.23 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.213 1.942 . . . . 0.0 113.095 -179.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.51 -168.79 0.37 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.513 2.142 . . . . 0.0 112.555 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 15.3 m -129.81 82.37 2.07 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.477 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 52.2 ptt85 -52.25 -37.49 55.46 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.362 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.28 173.63 14.74 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.2 m -58.81 -23.92 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 CA-C-O 121.567 0.699 . . . . 0.0 109.386 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -64.73 -27.27 68.79 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 155' ' ' ARG . 0.0 OUTLIER -68.99 -79.52 0.06 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.449 179.194 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.7 p -34.67 -30.23 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.607 0.763 . . . . 0.0 110.418 178.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 159' ' ' GLY . 4.8 tmt_? -71.9 -52.89 15.07 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.082 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 153' ' ' GLU . . . -69.93 -18.37 63.37 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 122.493 1.14 . . . . 0.0 108.186 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -84.16 -44.69 13.73 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 112.87 -1.968 . . . . 0.0 111.578 -178.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -130.37 -24.88 2.49 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 91.03 23.95 28.54 Favored Glycine 0 N--CA 1.47 0.948 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 -178.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -43.9 -93.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.584 -0.308 . . . . 0.0 111.091 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . 60.06 31.11 20.47 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.56 ' C ' ' H ' ' A' ' 164' ' ' VAL . 0.5 OUTLIER -170.19 -61.38 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.903 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -72.85 29.5 0.29 Allowed 'Trans proline' 0 N--CA 1.502 1.99 0 C-N-CA 122.283 1.989 . . . . 0.0 110.515 177.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.56 ' H ' ' C ' ' A' ' 162' ' ' PHE . 15.7 m -132.44 167.0 27.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.64 -178.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.1 t -123.63 66.86 37.69 Favored Pre-proline 0 N--CA 1.476 0.871 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.65 178.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -38.45 147.22 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 123.693 2.929 . . . . 0.0 115.015 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 168.49 134.28 1.7 Allowed Glycine 0 CA--C 1.528 0.849 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.2 178.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -80.92 152.12 28.23 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.466 0.364 0 CA-C-O 121.125 0.488 . . . . 0.0 111.222 -179.587 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.662 ' H ' ' NH1' ' A' ' 179' ' ' ARG . 96.2 mt-10 . . . . . 0 N--CA 1.449 -0.517 0 CA-C-O 120.635 0.255 . . . . 0.0 110.569 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.7 pt -101.04 130.35 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 120.978 0.418 . . . . 0.0 110.337 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.662 ' NH1' ' H ' ' A' ' 177' ' ' GLU . 7.6 mpt_? -123.44 163.3 21.13 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.601 0.715 . . . . 0.0 110.26 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -77.95 104.43 8.51 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.513 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -63.95 -17.66 63.49 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.879 -178.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.467 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.4 mm? -62.5 -42.26 99.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.947 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.53 -41.54 8.12 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.687 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.977 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.747 0.308 . . . . 0.0 110.501 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.421 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 10.3 mp -62.19 -42.59 99.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.164 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -65.03 -41.49 95.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.708 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -64.51 -42.54 95.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.075 0.465 . . . . 0.0 110.758 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.432 ' OD2' ' O ' ' A' ' 164' ' ' VAL . 66.1 t0 -65.78 -45.78 81.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.332 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.54 -48.75 73.92 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 11' ' ' ALA . 19.3 tt -67.35 -41.75 86.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.177 0.513 . . . . 0.0 110.761 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.426 ' N ' ' CG2' ' A' ' 10' ' ' ILE . . . -61.53 -40.9 96.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.754 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.95 -46.41 74.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.956 0.408 . . . . 0.0 110.525 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.78 -50.57 70.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.229 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.3 pp -68.92 -38.85 79.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.346 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.35 -54.52 45.84 Favored 'General case' 0 C--O 1.216 -0.71 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.264 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 20' ' ' GLU . 99.5 t -60.54 -40.1 83.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.606 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.447 ' CD2' ' C ' ' A' ' 17' ' ' LEU . 6.2 tt -52.41 -49.92 63.55 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.846 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -82.17 -51.2 8.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.614 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -63.65 -33.64 76.07 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.282 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.474 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.5 mt-10 58.16 83.26 0.12 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.451 179.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.4 -145.96 0.15 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.405 178.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.2 p -133.33 140.31 47.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -128.19 165.46 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-O 120.859 0.362 . . . . 0.0 111.531 -178.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.47 127.14 30.24 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.633 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.474 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 0.6 OUTLIER -117.09 140.49 27.15 Favored Pre-proline 0 N--CA 1.473 0.721 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.741 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.474 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 93.3 Cg_endo -77.3 144.06 22.81 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.242 1.295 . . . . 0.0 111.651 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.8 m -137.66 134.43 35.43 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.433 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -53.38 -44.85 68.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.167 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.94 -81.33 0.07 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.632 0.253 . . . . 0.0 111.444 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 71.8 t -133.32 128.69 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -36.77 144.67 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.773 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -141.17 -163.93 9.74 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.9 m -130.67 168.72 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -160.18 -179.34 34.9 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 119.963 -1.113 . . . . 0.0 112.297 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -157.97 -168.2 2.44 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.975 -179.242 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 19.9 p-10 -93.24 108.7 35.07 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 36' ' ' ASP . 33.7 Cg_exo -36.86 172.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.972 2.448 . . . . 0.0 114.574 177.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 41.76 73.32 0.13 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.231 -1.349 . . . . 0.0 111.124 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.1 m -153.39 134.34 13.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.608 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -67.69 -34.16 76.34 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.811 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.448 ' CG2' ' N ' ' A' ' 42' ' ' ALA . 15.1 t -63.34 -46.49 86.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.996 -178.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.448 ' N ' ' CG2' ' A' ' 41' ' ' THR . . . -60.12 -50.43 73.74 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.538 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 p -62.04 -45.23 99.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.831 0.348 . . . . 0.0 110.279 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 61.7 mtt -64.36 -39.53 94.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.865 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 -60.91 -34.25 74.39 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 123.537 0.523 . . . . 0.0 109.831 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 82.2 mt -73.56 -60.39 2.27 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.2 mt -54.77 -18.02 4.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.678 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -67.85 -84.67 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.901 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -75.86 -33.06 59.99 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.581 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -76.1 -69.69 0.49 Allowed 'General case' 0 C--N 1.348 0.525 0 C-N-CA 119.421 -0.911 . . . . 0.0 110.382 -177.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 50.89 80.27 0.08 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.706 0.765 . . . . 0.0 109.201 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.7 mtm180 162.87 -62.71 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.271 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.14 -15.51 48.72 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.423 2.082 . . . . 0.0 112.455 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.48 ' CG1' ' N ' ' A' ' 55' ' ' ASP . 10.9 p -41.79 -49.31 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.72 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.48 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 37.0 t0 -65.38 -41.87 93.28 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.029 0.443 . . . . 0.0 110.935 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -59.89 -37.06 78.29 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.392 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 63.32 107.8 0.01 OUTLIER Glycine 0 CA--C 1.519 0.284 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.566 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -52.92 -162.46 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.216 0.531 . . . . 0.0 111.661 -179.449 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.7 mt -108.17 146.95 13.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.7 mt -119.62 139.29 52.42 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.8 tp -110.28 133.08 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-O 121.133 0.492 . . . . 0.0 110.917 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.73 152.43 39.43 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.469 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.65 -29.6 7.95 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -111.29 149.8 30.56 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.233 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -79.26 -14.11 59.24 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -53.01 -30.83 37.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.961 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.02 -12.05 27.32 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.471 ' CD2' ' N ' ' A' ' 68' ' ' LEU . 3.3 mm? -92.57 -16.25 25.93 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.002 0.819 . . . . 0.0 108.97 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.467 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 50.9 tttm -77.71 -38.83 1.82 Allowed Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.671 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 67.1 Cg_endo -104.73 -2.64 0.2 Allowed 'Trans proline' 0 C--N 1.318 -1.03 0 C-N-CA 122.835 2.356 . . . . 0.0 112.648 -178.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.418 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 49.9 t80 -97.78 -8.46 28.45 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.749 0.309 . . . . 0.0 110.791 -178.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 73' ' ' ASP . 5.3 mp -135.75 162.97 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.445 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 92.6 m-20 -64.78 156.65 29.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.628 -0.429 . . . . 0.0 109.857 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -94.29 8.48 41.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.76 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.43 ' CG2' ' N ' ' A' ' 76' ' ' MET . 14.9 t -73.58 -41.73 62.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.181 0.515 . . . . 0.0 110.568 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.43 ' N ' ' CG2' ' A' ' 75' ' ' THR . 21.7 ptp -90.12 -7.37 53.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.095 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 tp -102.0 120.41 40.37 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.097 0.475 . . . . 0.0 110.746 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.578 ' HG1' ' N ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -159.12 160.68 35.91 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.576 -177.828 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.578 ' N ' ' HG1' ' A' ' 78' ' ' THR . 99.2 m-20 -39.13 -48.17 1.67 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.789 -178.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.3 p -62.96 -33.19 59.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.852 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 78' ' ' THR . 63.6 tp60 -65.49 -39.66 92.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.974 0.416 . . . . 0.0 110.764 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.1 mmt85 -65.07 -52.14 57.4 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 122.523 1.154 . . . . 0.0 109.181 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -55.35 -50.5 69.51 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 113.702 -1.59 . . . . 0.0 110.235 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.1 m -61.19 -49.92 75.24 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.167 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.0 tt -67.98 -34.07 64.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.202 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -75.66 -39.36 57.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.865 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.5 m -77.4 -32.46 54.82 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 120.991 0.424 . . . . 0.0 110.955 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 89' ' ' TRP . 76.1 ttt180 -97.14 75.93 2.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.389 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.435 ' O ' ' O ' ' A' ' 88' ' ' ARG . 57.7 m95 56.19 150.19 0.06 OUTLIER Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.244 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.77 -19.84 35.53 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.277 1.985 . . . . 0.0 111.738 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 163.11 82.03 0.04 OUTLIER Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -80.84 -30.91 1.58 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.352 2.035 . . . . 0.0 112.169 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.532 ' O ' ' CE1' ' A' ' 95' ' ' PHE . 9.4 p -136.76 149.14 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.738 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 91.8 m -91.59 143.16 26.86 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.627 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.543 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 0.2 OUTLIER -125.5 147.01 49.4 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.207 179.24 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 t -99.6 107.84 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 121.376 0.607 . . . . 0.0 109.394 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -94.53 151.17 39.08 Favored Pre-proline 0 N--CA 1.47 0.552 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.734 -178.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.11 106.44 2.27 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 121.695 1.597 . . . . 0.0 110.403 178.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.81 150.1 83.34 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.02 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 101' ' ' ALA . 98.9 Cg_endo -73.07 157.49 50.74 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.379 2.053 . . . . 0.0 112.986 -178.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.438 ' O ' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.627 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.523 ' O ' ' N ' ' A' ' 109' ' ' GLY . 11.6 tpp180 . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.778 0.323 . . . . 0.0 110.679 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 61.7 p-90 -73.6 -10.75 60.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.929 0.395 . . . . 0.0 110.434 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.654 ' CD1' ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -85.99 -16.56 37.9 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.115 -179.766 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.418 ' O ' ' O ' ' A' ' 54' ' ' VAL . 98.9 m -141.9 -39.53 0.37 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.724 0.297 . . . . 0.0 110.8 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 82.31 13.86 77.84 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.66 -68.83 0.06 Allowed 'General case' 0 CA--C 1.535 0.366 0 O-C-N 122.444 -0.445 . . . . 0.0 110.166 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -103.58 -162.47 0.91 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.967 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.9 p-10 -127.64 62.29 1.39 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.026 0.441 . . . . 0.0 110.957 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.2 p -158.77 157.47 31.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.015 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.41 140.9 11.66 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.58 126.93 31.01 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 113.094 -1.867 . . . . 0.0 109.702 177.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.4 p -146.02 152.83 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -147.81 156.94 43.25 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.783 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.7 t -119.74 132.32 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.3 t -133.27 128.36 35.66 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.734 179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -135.82 84.1 2.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.925 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.59 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 16.6 t-80 -173.2 -35.63 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.58 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.59 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 67.7 Cg_endo -94.74 -159.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.935 0 C-N-CA 121.995 1.797 . . . . 0.0 111.907 -178.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 36.7 mt -77.69 -7.38 56.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.535 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 95.7 t -57.46 -45.27 85.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.716 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.583 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 27.9 m -51.63 -62.05 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.943 0 C-N-CA 119.555 -0.858 . . . . 0.0 108.797 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.583 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -41.34 -44.81 2.86 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.792 0.329 . . . . 0.0 110.809 178.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -50.96 61.83 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 121.27 0.557 . . . . 0.0 110.723 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 62.3 m -69.64 -48.46 59.82 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.326 0.584 . . . . 0.0 111.558 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 125' ' ' VAL . 0.8 OUTLIER -54.58 -42.38 70.96 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.451 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.432 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -59.28 -55.5 34.02 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.583 -177.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -62.62 -24.71 67.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.191 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.69 2.07 88.85 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 134' ' ' PRO . 59.7 mttt -153.53 159.54 32.0 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 133' ' ' LYS . 3.6 Cg_exo -42.23 177.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 123.876 3.051 . . . . 0.0 113.008 -178.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.3 tp -132.38 122.42 24.99 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.404 ' O ' ' CA ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -64.14 147.47 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 C-N-CA 117.775 -1.57 . . . . 0.0 106.83 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.9 t -122.54 127.26 49.27 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.206 0.527 . . . . 0.0 111.269 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.9 162.18 30.22 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.663 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.6 m -73.59 145.95 45.06 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.95 88.28 2.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.367 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 56.8 p30 -160.74 164.39 31.61 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.342 0.592 . . . . 0.0 110.421 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.57 -167.15 2.13 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.991 -178.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.1 p -61.77 -40.19 94.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.785 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -162.18 9.81 0.1 Allowed Glycine 0 N--CA 1.459 0.216 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.6 tp -89.99 126.88 55.83 Favored Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -37.52 157.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.942 1.761 . . . . 0.0 112.516 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.0 -166.45 0.37 Allowed 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.578 2.186 . . . . 0.0 112.668 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 7.4 t -118.14 76.7 1.09 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.359 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -56.47 -33.89 66.38 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.389 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -162.72 169.56 19.81 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.104 -0.639 . . . . 0.0 109.319 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -58.6 -20.33 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -65.21 -33.05 75.09 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 177.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.447 ' O ' ' N ' ' A' ' 155' ' ' ARG . 6.5 tm-20 -63.72 -79.78 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.804 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.3 p -36.11 -30.42 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.589 0.756 . . . . 0.0 110.643 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.447 ' N ' ' O ' ' A' ' 153' ' ' GLU . 4.1 tmt_? -71.77 -49.17 41.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.243 0.544 . . . . 0.0 111.79 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 153' ' ' GLU . . . -71.45 -18.1 62.33 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 122.628 1.204 . . . . 0.0 108.004 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.17 -55.27 4.45 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 112.349 -2.205 . . . . 0.0 112.149 -177.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -123.99 -18.05 6.07 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -177.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 85.18 25.05 41.62 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -42.3 -94.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.649 0.262 . . . . 0.0 111.437 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.405 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.95 33.83 17.14 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.365 0.602 . . . . 0.0 109.46 -178.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.549 ' C ' ' H ' ' A' ' 164' ' ' VAL . 1.8 m-85 -172.42 -62.56 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.353 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.39 28.51 0.27 Allowed 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 122.438 2.092 . . . . 0.0 110.579 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.549 ' H ' ' C ' ' A' ' 162' ' ' PHE . 15.8 m -131.52 167.93 25.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.79 -178.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.0 t -124.12 64.6 35.99 Favored Pre-proline 0 N--CA 1.473 0.724 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.055 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -39.95 149.23 0.13 Allowed 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 123.453 2.769 . . . . 0.0 114.616 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 172.47 -141.18 6.11 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 114.33 -1.305 . . . . 0.0 111.813 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -147.79 179.88 7.39 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.752 0.311 . . . . 0.0 110.195 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.3 t . . . . . 0 N--CA 1.465 0.299 0 CA-C-O 121.106 0.479 . . . . 0.0 110.631 -179.727 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 . . . . . 0 N--CA 1.442 -0.867 0 CA-C-O 120.537 0.208 . . . . 0.0 111.482 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 31.9 pt -91.72 135.56 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.401 0.619 . . . . 0.0 111.26 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -135.28 171.74 14.0 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.254 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 184' ' ' GLY . 98.6 m-20 -78.76 104.54 9.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.227 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -65.18 -20.23 66.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.573 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.488 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.5 mm? -63.77 -42.67 97.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.486 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.18 -44.3 3.02 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.49 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 180' ' ' ASP . . . . . . . . 0 CA--C 1.527 0.795 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 39.2 p-10 . . . . . 0 N--CA 1.461 0.106 0 CA-C-O 120.7 0.286 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.43 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 10.1 mp -62.4 -42.17 99.22 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -63.67 -42.32 98.08 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -63.08 -41.68 99.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.771 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 162' ' ' PHE . 63.6 t0 -59.09 -46.99 86.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.498 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.34 -44.39 97.27 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.191 0.519 . . . . 0.0 110.082 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.7 mt -63.56 -42.97 97.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.469 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.73 -43.92 81.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.572 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.17 -47.11 85.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.459 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.69 -52.18 66.62 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.7 pt -68.14 -38.97 80.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.112 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -57.95 -52.92 63.5 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.215 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 20' ' ' GLU . 96.8 t -61.17 -40.55 86.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.703 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.448 ' CD2' ' C ' ' A' ' 17' ' ' LEU . 6.3 tt -52.51 -51.1 61.16 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.673 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -79.88 -50.62 10.22 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.774 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -63.45 -31.64 72.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.027 0.442 . . . . 0.0 110.721 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 16' ' ' VAL . 96.5 mt-10 58.55 81.09 0.16 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 178.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.85 -146.71 0.1 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.813 0.34 . . . . 0.0 110.641 177.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.8 p -128.16 139.67 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pp -128.96 167.76 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 120.892 0.377 . . . . 0.0 111.564 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.88 135.87 56.92 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.325 0.583 . . . . 0.0 111.528 -178.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.5 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 1.6 t80 -127.96 139.19 34.67 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.5 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 68.1 Cg_endo -78.99 144.61 18.97 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 121.327 1.351 . . . . 0.0 111.572 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.536 ' C ' ' H ' ' A' ' 29' ' ' ALA . 47.6 m -134.19 132.93 40.35 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.74 0.305 . . . . 0.0 110.416 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -72.97 32.13 0.07 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.635 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.536 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -156.91 -77.75 0.09 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.723 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.1 p -128.36 130.3 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -44.01 142.6 1.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.141 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.29 -175.71 22.64 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.1 m -129.72 171.21 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.413 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -159.54 -179.38 34.31 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.111 -1.042 . . . . 0.0 111.896 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.471 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 1.4 p -159.42 -161.83 0.98 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 120.209 -0.596 . . . . 0.0 112.015 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.471 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 68.0 m-20 -93.02 107.07 22.15 Favored Pre-proline 0 CA--C 1.557 1.218 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -37.88 -61.73 0.34 Allowed 'Trans proline' 0 N--CA 1.5 1.854 0 C-N-CA 122.592 2.195 . . . . 0.0 112.928 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -76.45 69.51 2.92 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.364 -178.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.1 m -153.66 130.93 11.21 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.793 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.568 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -69.58 -33.26 72.46 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.59 -179.934 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.426 ' CG2' ' N ' ' A' ' 42' ' ' ALA . 14.2 t -57.56 -41.85 81.88 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.636 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.426 ' N ' ' CG2' ' A' ' 41' ' ' THR . . . -60.04 -52.55 64.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.498 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -61.58 -42.97 96.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-O 120.974 0.416 . . . . 0.0 110.511 -178.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.418 ' O ' ' CG ' ' A' ' 48' ' ' GLU . 56.8 mtt -65.19 -52.75 52.94 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.547 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -62.75 -37.31 86.09 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.186 0.517 . . . . 0.0 111.36 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -66.57 -53.42 34.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.407 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.8 mt -78.49 -7.59 57.63 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.187 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 44' ' ' MET . 1.3 mm-40 -68.64 -79.93 0.05 Allowed 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.312 0.577 . . . . 0.0 111.707 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.432 HD23 ' H ' ' A' ' 50' ' ' LYS . 2.3 pt? -71.7 -37.56 70.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.775 -177.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.432 ' H ' HD23 ' A' ' 49' ' ' LEU . 22.7 mmmt -67.76 -47.93 67.83 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.787 -178.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 30.24 66.59 0.12 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.032 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -178.31 -54.76 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.604 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -72.99 -1.43 10.48 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.965 1.777 . . . . 0.0 109.448 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -45.17 -48.99 3.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.435 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -71.59 -39.61 70.43 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 110.936 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.409 ' N ' ' CD ' ' A' ' 56' ' ' LYS . 1.1 mptm? -61.2 -38.8 87.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.306 -179.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 62.33 107.8 0.01 OUTLIER Glycine 0 CA--C 1.521 0.437 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.553 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -54.1 -160.24 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.52 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.2 mt -110.04 148.14 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.095 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.4 mt -122.61 142.01 51.1 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.3 tp -109.44 131.02 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-O 120.878 0.37 . . . . 0.0 110.854 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.31 146.84 45.72 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.94 -29.19 10.63 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.114 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.712 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 11.8 m120 -117.95 152.27 35.8 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.146 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -79.85 -14.34 58.73 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.632 0.73 . . . . 0.0 109.438 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -51.58 -32.55 29.01 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.206 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.712 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 5.5 pm0 -93.12 -8.93 41.25 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.893 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -90.76 -18.87 24.22 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.548 ' NZ ' HH12 ' A' ' 82' ' ' ARG . 32.6 mttp -76.22 -37.92 2.21 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 63.2 Cg_endo -104.82 -2.51 0.2 Allowed 'Trans proline' 0 C--N 1.319 -1.019 0 C-N-CA 122.868 2.378 . . . . 0.0 112.755 -178.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.406 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 76.6 t80 -93.87 -10.98 32.11 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.723 0.296 . . . . 0.0 111.158 -178.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.475 ' CG2' ' N ' ' A' ' 73' ' ' ASP . 5.2 mp -125.45 168.76 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.475 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 91.5 m-20 -63.14 -17.9 62.86 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.869 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.6 t70 57.04 22.38 7.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.929 0.395 . . . . 0.0 110.8 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.431 ' CG2' ' N ' ' A' ' 76' ' ' MET . 13.6 t -88.76 -41.56 12.47 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.779 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.431 ' N ' ' CG2' ' A' ' 75' ' ' THR . 14.2 ptp -84.38 -21.89 30.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.142 179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 tp -73.18 136.25 44.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.663 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.27 165.56 35.91 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.682 -177.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -48.45 -45.61 36.7 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.211 0.32 . . . . 0.0 111.799 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.1 p -61.96 -33.27 57.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.175 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 66.7 tp60 -64.4 -40.04 95.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.922 0.391 . . . . 0.0 110.455 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.548 HH12 ' NZ ' ' A' ' 69' ' ' LYS . 5.5 mmt85 -64.2 -53.09 54.76 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 122.256 1.027 . . . . 0.0 109.169 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -54.63 -50.2 68.69 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.884 -1.507 . . . . 0.0 109.984 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 m -61.33 -50.01 74.66 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.412 -1.267 . . . . 0.0 112.003 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.8 tt -68.44 -31.16 50.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.863 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -77.53 -36.29 52.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.528 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.8 m -85.57 -18.91 31.99 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.098 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 89' ' ' TRP . 58.5 ttt85 -112.63 78.56 1.14 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.334 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.438 ' O ' ' O ' ' A' ' 88' ' ' ARG . 41.3 m95 56.94 150.26 0.06 OUTLIER Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.431 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.09 -23.31 46.26 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 122.24 1.96 . . . . 0.0 112.094 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 158.73 79.61 0.03 OUTLIER Glycine 0 CA--C 1.528 0.906 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -81.33 -15.24 10.18 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.391 2.06 . . . . 0.0 111.985 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.9 p -136.06 144.45 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.562 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.498 ' N ' ' O ' ' A' ' 177' ' ' GLU . 25.6 m -95.13 132.85 39.6 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.92 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -118.08 140.79 49.25 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.437 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.5 t -100.12 109.79 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 121.549 0.69 . . . . 0.0 110.811 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -95.62 148.74 35.08 Favored Pre-proline 0 N--CA 1.471 0.577 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.023 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.48 87.98 0.41 Allowed 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 121.952 1.768 . . . . 0.0 110.587 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -50.59 149.94 5.36 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.894 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -73.99 157.36 47.07 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.116 1.877 . . . . 0.0 110.148 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.35 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.667 -179.655 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.513 ' NH2' ' O ' ' A' ' 110' ' ' ARG . 7.7 tpt180 . . . . . 0 C--O 1.225 -0.194 0 CA-C-O 120.6 0.238 . . . . 0.0 110.723 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 66.5 p-90 -87.3 -10.74 51.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.603 0.716 . . . . 0.0 109.927 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.585 ' H ' ' CD2' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -85.02 -18.18 35.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.618 -179.113 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.413 ' H ' HD22 ' A' ' 107' ' ' LEU . 87.2 m -144.63 -39.98 0.26 Allowed 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.573 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.7 -3.32 87.02 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.262 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.513 ' O ' ' NH2' ' A' ' 105' ' ' ARG . 13.6 tpt180 -154.8 -78.68 0.09 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.036 0.918 . . . . 0.0 111.311 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -95.52 -175.27 3.41 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -125.28 81.52 1.98 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.019 0.437 . . . . 0.0 110.842 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 24.9 p -166.33 128.5 1.87 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.409 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 69.1 mt -125.27 127.33 46.54 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.39 130.35 38.84 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.892 176.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.5 p -144.63 153.75 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 120.897 0.379 . . . . 0.0 110.563 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -142.99 156.55 44.88 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.14 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.0 t -124.29 132.31 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-O 121.103 0.478 . . . . 0.0 109.795 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.4 t -135.32 129.01 32.82 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.656 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -135.47 87.08 2.29 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.859 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.582 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 34.9 t60 -172.15 -36.92 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.582 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 63.5 Cg_endo -95.24 -160.48 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.939 0 C-N-CA 122.23 1.953 . . . . 0.0 111.619 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.9 mt -77.78 -5.03 49.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.253 0.549 . . . . 0.0 110.703 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 83.2 t -58.05 -44.81 87.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.725 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.571 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 27.0 m -53.01 -61.73 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 C-N-CA 119.626 -0.83 . . . . 0.0 108.884 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.571 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -41.05 -44.17 2.36 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.886 0.374 . . . . 0.0 110.749 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.6 tp -69.41 -47.37 64.36 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.452 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 57.9 m -70.47 -49.93 43.4 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.574 0.702 . . . . 0.0 110.623 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 125' ' ' VAL . 1.1 pp0? -54.19 -41.75 68.93 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.383 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.435 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -58.78 -55.22 37.88 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.81 -177.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.455 ' CE1' ' OD2' ' A' ' 36' ' ' ASP . 46.7 t80 -61.28 -18.96 61.05 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.565 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.61 0.44 84.29 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -154.18 159.56 31.85 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 120.614 -0.434 . . . . 0.0 109.931 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -40.99 173.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 124.043 3.162 . . . . 0.0 113.22 -178.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.6 tp -127.53 123.23 35.33 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 176.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.413 ' O ' ' CA ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -65.56 146.83 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 C-N-CA 117.998 -1.481 . . . . 0.0 107.487 -179.492 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 t -117.44 122.64 44.33 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 123.638 0.586 . . . . 0.0 110.664 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 3.2 m -131.9 163.82 27.47 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.842 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.4 m -72.26 145.44 47.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.238 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.11 -37.81 88.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.982 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . 0.401 ' OD1' ' O ' ' A' ' 141' ' ' ASN . 53.4 p30 -49.46 150.43 1.89 Allowed 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.674 0.749 . . . . 0.0 111.095 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.32 -158.37 0.79 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.232 -178.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.5 t -62.47 -42.51 99.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.03 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -161.75 2.62 0.07 OUTLIER Glycine 0 N--CA 1.459 0.217 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.5 tp -85.95 125.23 69.22 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-O 119.389 -0.339 . . . . 0.0 110.35 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -40.45 157.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.627 1.551 . . . . 0.0 111.826 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.35 -162.92 0.18 Allowed 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.519 2.146 . . . . 0.0 112.083 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 148' ' ' CYS . 29.0 p -112.29 80.01 1.29 Allowed 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -55.09 -32.75 62.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.664 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -164.77 163.86 21.26 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.342 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.3 m -56.72 -15.75 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.806 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -66.76 -34.04 76.95 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 150' ' ' THR . 5.1 tm-20 -60.48 -71.87 0.12 Allowed 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.933 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.3 p -48.48 -32.91 4.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.275 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 159' ' ' GLY . 4.1 tmt_? -78.96 -51.66 9.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.773 0.796 . . . . 0.0 109.416 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.94 -44.85 64.08 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.676 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.71 -29.33 27.63 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 112.826 -1.988 . . . . 0.0 114.28 -175.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -126.39 -33.95 2.53 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 118.341 0.519 . . . . 0.0 111.331 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 94.59 24.7 17.5 Favored Glycine 0 N--CA 1.466 0.682 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -43.3 -94.4 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.517 0.199 . . . . 0.0 110.685 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.435 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.55 37.18 16.53 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.544 ' C ' ' H ' ' A' ' 164' ' ' VAL . 1.5 m-85 -176.48 -62.06 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.284 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -73.58 28.86 0.31 Allowed 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.544 2.163 . . . . 0.0 110.46 178.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.544 ' H ' ' C ' ' A' ' 162' ' ' PHE . 16.1 m -132.62 166.1 30.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.814 -178.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.6 t -123.06 65.41 27.87 Favored Pre-proline 0 N--CA 1.475 0.797 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.517 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -35.41 142.78 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 123.588 2.858 . . . . 0.0 115.362 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 169.01 178.28 40.33 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 113.688 -1.596 . . . . 0.0 110.89 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -155.84 149.83 25.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.775 0.321 . . . . 0.0 110.386 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.465 0.313 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.457 179.885 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 94' ' ' THR . 1.2 pp20? . . . . . 0 N--CA 1.466 0.36 0 CA-C-O 120.848 0.356 . . . . 0.0 110.052 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.474 ' N ' ' CD ' ' A' ' 177' ' ' GLU . 18.3 tt -96.4 121.03 46.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.307 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -129.22 165.01 22.2 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.491 0.662 . . . . 0.0 111.73 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -78.14 106.13 9.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.008 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -66.33 -18.87 65.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.664 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.467 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.5 mm? -62.61 -41.9 99.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.398 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.53 -45.07 3.03 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.716 0.293 . . . . 0.0 110.61 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.66 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -179.682 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 N--CA 1.461 0.116 0 CA-C-O 120.752 0.311 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.48 ' N ' ' CD2' ' A' ' 5' ' ' LEU . 3.0 mm? -63.07 -41.65 99.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.878 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -61.46 -43.67 98.45 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -59.34 -41.45 89.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.459 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 162' ' ' PHE . 41.3 t0 -61.31 -40.25 93.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.264 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.6 -48.42 81.86 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.813 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.5 mm -63.51 -44.78 98.87 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.698 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.46 -46.56 76.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.053 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.48 -45.71 91.79 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.06 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.12 -51.15 70.32 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 13.3 pt -69.3 -40.09 79.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.506 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -58.47 -54.62 44.94 Favored 'General case' 0 C--O 1.218 -0.557 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.136 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.491 ' O ' ' N ' ' A' ' 20' ' ' GLU . 99.5 t -62.01 -39.81 85.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.638 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.44 ' CD2' ' C ' ' A' ' 17' ' ' LEU . 6.5 tt -52.38 -50.4 62.51 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.587 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -79.95 -51.6 8.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.644 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -64.83 -34.43 78.35 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.41 -178.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.8 mt-10 58.5 87.41 0.07 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.311 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.47 -132.8 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 178.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.6 p -144.29 140.08 24.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pp -130.72 163.95 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 121.163 0.506 . . . . 0.0 111.905 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.76 136.3 57.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.87 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.532 ' CZ ' ' O ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -132.13 145.39 57.16 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.21 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.532 ' O ' ' CZ ' ' A' ' 25' ' ' TYR . 61.9 Cg_endo -78.85 146.83 21.06 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.465 1.443 . . . . 0.0 111.383 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.521 ' C ' ' H ' ' A' ' 29' ' ' ALA . 28.7 m -130.21 135.9 48.64 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.88 0.372 . . . . 0.0 110.123 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -75.35 22.0 0.13 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -156.17 -73.63 0.1 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.327 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.4 p -122.71 126.28 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-O 121.335 0.588 . . . . 0.0 111.392 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.486 ' CD1' ' O ' ' A' ' 148' ' ' CYS . 16.7 t80 -45.34 132.36 7.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.389 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.62 -171.52 13.9 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.309 -0.717 . . . . 0.0 111.309 -179.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 m -131.12 169.51 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.408 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -157.98 -178.21 31.81 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 120.105 -1.045 . . . . 0.0 112.616 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -156.56 -163.04 1.35 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.546 0.213 . . . . 0.0 110.577 -179.757 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.516 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 44.3 m-20 -100.39 109.11 55.95 Favored Pre-proline 0 CA--C 1.554 1.123 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -178.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 36' ' ' ASP . 55.5 Cg_exo -38.36 173.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.765 2.31 . . . . 0.0 114.105 177.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 42.91 65.66 0.91 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.719 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.0 m -152.35 139.22 18.99 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.41 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -65.98 -28.43 68.88 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.104 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.9 t -59.93 -42.8 94.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.666 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.07 -52.02 67.53 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.38 0.61 . . . . 0.0 111.414 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.11 -45.76 95.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.895 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 91.9 mtp -66.41 -47.05 74.48 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.5 ptt85 -62.23 -30.24 70.96 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.173 -178.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 45.2 mt -73.4 -61.89 1.67 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.382 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.2 mt -54.02 -20.43 6.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.655 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -63.81 -85.61 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.666 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.404 HD23 ' H ' ' A' ' 50' ' ' LYS . 2.2 pt? -77.5 -35.42 53.57 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.404 ' H ' HD23 ' A' ' 49' ' ' LEU . 23.7 mmmt -73.67 -48.18 34.22 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 119.709 -0.797 . . . . 0.0 111.049 -176.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 35.25 65.17 0.4 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.957 -1.019 . . . . 0.0 111.78 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.1 mtm-85 179.84 -53.73 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.909 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.675 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.1 -7.16 18.83 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.422 2.081 . . . . 0.0 112.783 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' A' ' 55' ' ' ASP . 12.8 p -41.42 -47.03 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.119 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.476 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 36.6 t0 -67.66 -39.5 84.55 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.076 0.465 . . . . 0.0 110.786 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.479 ' CD ' ' N ' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -61.92 -39.52 92.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.318 -179.299 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 62.9 105.6 0.01 OUTLIER Glycine 0 CA--C 1.52 0.394 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.57 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -49.76 -168.2 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.821 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.422 HD11 HG22 ' A' ' 59' ' ' ILE . 75.0 mt -102.64 147.84 8.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.1 mt -120.73 141.25 50.62 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.6 tp -108.88 132.46 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-O 121.062 0.458 . . . . 0.0 109.96 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -123.35 152.99 40.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.392 0.615 . . . . 0.0 109.86 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -112.32 -30.03 7.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.181 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -114.1 151.78 32.07 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.648 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -79.05 -13.84 59.52 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.567 0.698 . . . . 0.0 109.974 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -53.8 -30.96 47.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.267 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.79 -8.81 39.52 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.53 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -89.13 -20.79 23.83 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.446 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 69.9 tttt -73.81 -39.97 4.78 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 95.2 Cg_endo -102.38 -5.36 0.29 Allowed 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 122.672 2.248 . . . . 0.0 112.478 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.428 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 43.6 t80 -88.57 -17.87 29.28 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.652 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.423 ' CG2' ' N ' ' A' ' 73' ' ' ASP . 5.0 mp -122.34 157.53 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.423 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 4.4 m-20 -64.34 146.59 54.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.846 0.355 . . . . 0.0 110.203 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -91.9 38.8 1.0 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.058 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.422 ' CG2' ' N ' ' A' ' 76' ' ' MET . 11.3 t -108.34 -41.76 4.78 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.995 0.426 . . . . 0.0 110.208 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.422 ' N ' ' CG2' ' A' ' 75' ' ' THR . 8.4 ptp -93.05 -17.5 23.78 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.239 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 31.7 tp -79.83 128.18 33.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.277 -177.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.632 ' HG1' ' N ' ' A' ' 79' ' ' ASP . 0.5 OUTLIER -153.86 163.63 39.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.726 -177.225 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.632 ' N ' ' HG1' ' A' ' 78' ' ' THR . 98.0 m-20 -49.15 -45.74 44.23 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.718 -178.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -61.09 -31.94 51.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.964 -0.295 . . . . 0.0 111.197 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 66.8 tp60 -65.56 -40.6 92.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.216 0.531 . . . . 0.0 110.427 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.7 mmt85 -64.21 -51.65 62.7 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 122.522 1.154 . . . . 0.0 109.287 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -56.44 -50.33 71.98 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 113.668 -1.605 . . . . 0.0 110.325 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -61.74 -49.7 75.37 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.826 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.1 tt -67.59 -31.53 52.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.486 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -77.32 -35.09 55.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.748 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.6 m -88.0 -18.65 28.55 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.475 0.178 . . . . 0.0 111.282 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.414 ' O ' ' O ' ' A' ' 89' ' ' TRP . 77.3 ttt-85 -110.39 77.84 1.08 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.554 ' CD1' ' N ' ' A' ' 89' ' ' TRP . 1.2 m0 59.18 148.71 0.07 OUTLIER Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.21 -31.53 35.67 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 121.741 1.627 . . . . 0.0 112.508 -178.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 150.35 61.12 0.01 OUTLIER Glycine 0 CA--C 1.531 1.061 0 C-N-CA 121.089 -0.577 . . . . 0.0 111.97 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.22 -15.73 35.43 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.718 2.279 . . . . 0.0 111.828 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.0 p -122.6 136.47 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.137 0.494 . . . . 0.0 110.079 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 177' ' ' GLU . 27.3 m -91.37 135.26 33.95 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.936 -179.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -120.69 139.71 52.65 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.914 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.4 t -97.17 109.02 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-O 121.347 0.594 . . . . 0.0 110.902 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -94.37 149.9 37.38 Favored Pre-proline 0 N--CA 1.469 0.506 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.965 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.403 ' O ' ' OD2' ' A' ' 73' ' ' ASP . 58.7 Cg_endo -69.41 86.93 0.52 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.991 1.794 . . . . 0.0 111.12 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.423 ' O ' ' OD1' ' A' ' 112' ' ' ASP . . . -50.95 153.51 3.0 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.452 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.44 157.47 58.97 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.193 1.929 . . . . 0.0 111.629 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.251 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.396 -179.827 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 109' ' ' GLY . 8.2 tpt180 . . . . . 0 CA--C 1.531 0.243 0 CA-C-O 120.878 0.37 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 2.4 p90 -71.67 -7.13 46.06 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.531 -179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.665 ' CD1' ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -73.08 -23.25 60.51 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.769 179.823 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 85.1 m -143.09 -40.1 0.32 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.812 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 80.2 -0.42 83.99 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.638 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -148.21 -80.64 0.13 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.427 0.613 . . . . 0.0 110.822 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -89.91 -173.02 3.74 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 99' ' ' ALA . 66.3 t0 -131.05 70.83 1.46 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.91 0.386 . . . . 0.0 110.832 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 80.5 p -160.6 127.83 4.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.583 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 63.0 mt -124.03 129.04 50.25 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -178.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.32 122.54 25.26 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.276 176.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.9 p -141.29 155.96 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.937 0.398 . . . . 0.0 110.54 -179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.546 HH21 ' HG ' ' A' ' 137' ' ' SER . 19.3 ptt180 -149.19 158.22 44.0 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.665 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 70.8 t -122.52 134.87 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.11 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.2 t -138.4 127.85 24.67 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.664 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -133.24 87.45 2.39 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.129 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.604 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 19.1 t60 -172.01 -35.22 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 112.486 0.551 . . . . 0.0 112.486 -179.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.604 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 73.7 Cg_endo -95.7 -158.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.482 0.795 0 C-N-CA 122.288 1.992 . . . . 0.0 111.761 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 19.4 mt -79.26 -6.18 56.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.661 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 79.9 t -57.22 -45.62 84.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.538 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.574 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 26.9 m -51.01 -61.68 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.864 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.574 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -41.63 -44.52 3.12 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.984 0.421 . . . . 0.0 110.726 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.54 -51.54 55.43 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.08 0.467 . . . . 0.0 110.571 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 79.2 m -69.34 -48.45 61.33 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.252 0.549 . . . . 0.0 111.396 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.441 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.1 pp0? -54.56 -42.05 70.51 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.441 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -60.11 -54.83 41.22 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.139 -1.392 . . . . 0.0 109.399 -177.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -64.13 -21.67 66.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.085 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.41 1.55 86.34 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 55.5 mttt -152.66 159.48 32.43 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 120.718 -0.393 . . . . 0.0 109.971 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -43.16 178.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 124.053 3.169 . . . . 0.0 113.389 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.407 ' CD1' ' O ' ' A' ' 35' ' ' CYS . 8.2 tp -133.35 123.29 25.14 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 177.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.475 ' CG2' ' HG ' ' A' ' 35' ' ' CYS . 0.8 OUTLIER -64.65 146.16 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 C-N-CA 117.796 -1.562 . . . . 0.0 107.678 -179.736 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.546 ' HG ' HH21 ' A' ' 117' ' ' ARG . 5.9 t -119.37 129.53 54.87 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.283 0.563 . . . . 0.0 111.23 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.5 m -131.79 164.23 26.48 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.241 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.2 m -75.18 148.06 39.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.24 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.51 88.91 2.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.615 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 57.6 p30 -164.02 163.28 23.39 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.396 0.617 . . . . 0.0 110.814 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.85 -165.57 1.91 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.096 -178.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 38.8 t -61.95 -43.89 97.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.925 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -160.65 11.08 0.14 Allowed Glycine 0 N--CA 1.459 0.22 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.6 tp -88.71 127.17 57.28 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -39.13 154.12 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.682 1.588 . . . . 0.0 111.83 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.418 ' O ' ' N ' ' A' ' 149' ' ' ARG . 89.9 Cg_endo -74.38 149.99 40.71 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.227 1.951 . . . . 0.0 112.392 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.486 ' O ' ' CD1' ' A' ' 31' ' ' PHE . 72.8 m -67.92 74.22 0.19 Allowed 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 147' ' ' PRO . 32.2 ptt-85 -58.3 -34.38 70.49 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.502 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -160.33 163.75 33.04 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.472 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -56.62 -17.45 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.821 0 CA-C-O 121.577 0.703 . . . . 0.0 109.223 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -64.71 -35.67 81.79 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 177.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.437 ' OE1' ' OE1' ' A' ' 157' ' ' GLN . 5.1 tm-20 -59.49 -74.86 0.06 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.688 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.8 p -44.7 -29.04 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.242 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.421 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -83.95 -45.3 13.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 122.201 1.0 . . . . 0.0 110.047 179.767 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.84 -40.69 80.7 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.769 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.437 ' OE1' ' OE1' ' A' ' 153' ' ' GLU . 8.7 pt20 -81.57 -49.02 11.04 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 113.167 -1.833 . . . . 0.0 112.566 -176.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.429 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 20.8 m-85 -110.05 -33.55 6.66 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 97.61 27.63 8.96 Favored Glycine 0 N--CA 1.475 1.285 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.606 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -44.13 -94.8 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.759 0.314 . . . . 0.0 111.07 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.507 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.83 35.71 16.43 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -178.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.537 ' C ' ' H ' ' A' ' 164' ' ' VAL . 2.1 m-85 -174.77 -62.53 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.471 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -73.03 28.85 0.29 Allowed 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.525 2.15 . . . . 0.0 110.49 178.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.537 ' H ' ' C ' ' A' ' 162' ' ' PHE . 17.1 m -131.98 167.39 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.542 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.0 t -124.24 64.82 37.87 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.549 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -35.18 142.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 123.699 2.933 . . . . 0.0 115.056 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 167.02 -177.71 41.56 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 114.051 -1.431 . . . . 0.0 110.989 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -146.98 152.33 38.44 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.467 0.382 0 CA-C-O 120.993 0.425 . . . . 0.0 110.944 -179.757 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 94' ' ' THR . 5.7 pt-20 . . . . . 0 N--CA 1.471 0.597 0 CA-C-O 120.404 0.145 . . . . 0.0 111.134 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 18.2 tt -87.08 122.63 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-O 120.922 0.391 . . . . 0.0 110.763 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -135.21 168.08 19.82 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.409 0.623 . . . . 0.0 111.648 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -78.73 106.03 10.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.562 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -65.57 -13.57 59.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.649 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.476 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.4 mm? -63.32 -41.08 98.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.193 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 5.2 t -119.75 -23.49 6.48 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.955 0.407 . . . . 0.0 110.458 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.743 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -179.876 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 56.5 p30 . . . . . 0 N--CA 1.47 0.543 0 CA-C-O 120.896 0.379 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.401 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 10.8 mp -62.54 -42.22 99.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.039 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -63.88 -40.85 97.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.321 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -64.72 -40.87 96.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.636 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 162' ' ' PHE . 63.1 t0 -59.34 -46.38 88.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.332 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.19 -43.9 97.79 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.95 0.405 . . . . 0.0 110.17 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.1 mt -63.76 -43.19 97.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.97 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.2 -46.52 82.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.533 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.91 -45.98 92.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.423 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.25 -52.86 63.48 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 14.4 pt -68.57 -39.47 80.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.392 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -56.77 -53.72 54.51 Favored 'General case' 0 C--O 1.215 -0.738 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.197 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 20' ' ' GLU . 97.6 t -61.97 -40.62 87.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.89 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.444 ' CD2' ' C ' ' A' ' 17' ' ' LEU . 6.3 tt -52.48 -51.98 56.64 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.508 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -78.33 -49.92 12.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.368 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -65.47 -32.06 73.47 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.694 -178.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 16' ' ' VAL . 97.1 mt-10 59.91 80.67 0.2 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 178.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.04 -148.23 0.12 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.857 177.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.3 p -125.45 140.63 47.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.9 pp -129.68 165.84 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-O 120.907 0.384 . . . . 0.0 111.62 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.26 135.73 57.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.302 0.572 . . . . 0.0 110.793 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.53 ' CZ ' ' O ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -132.49 145.38 57.0 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.585 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.53 ' O ' ' CZ ' ' A' ' 25' ' ' TYR . 97.6 Cg_endo -75.61 145.84 29.89 Favored 'Trans proline' 0 N--CA 1.498 1.794 0 C-N-CA 121.597 1.531 . . . . 0.0 111.384 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.526 ' C ' ' H ' ' A' ' 29' ' ' ALA . 63.0 m -131.76 131.32 42.87 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.95 0.405 . . . . 0.0 110.644 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -75.01 30.94 0.09 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.411 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.526 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -160.32 -73.47 0.07 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.621 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.9 p -131.77 132.22 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.045 0.45 . . . . 0.0 110.188 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.527 ' CD2' ' O ' ' A' ' 148' ' ' CYS . 36.0 p90 -39.5 144.37 0.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.45 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -156.78 -174.27 26.3 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.8 m -131.07 172.33 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.402 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -158.42 178.51 34.63 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.095 -1.05 . . . . 0.0 111.795 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -157.25 -170.42 3.25 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.737 -178.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.467 ' CG ' ' CZ ' ' A' ' 131' ' ' TYR . 18.3 t70 -86.57 108.08 16.47 Favored Pre-proline 0 CA--C 1.555 1.168 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -177.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -36.52 -61.42 0.31 Allowed 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 122.533 2.155 . . . . 0.0 113.161 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -74.03 72.01 1.63 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.593 -178.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 m -155.73 130.52 9.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.678 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -66.33 -33.93 76.84 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.988 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.434 ' CG2' ' N ' ' A' ' 42' ' ' ALA . 15.1 t -62.08 -43.56 98.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.866 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.434 ' N ' ' CG2' ' A' ' 41' ' ' THR . . . -55.78 -52.52 63.68 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -62.19 -42.6 95.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.312 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 91.2 mtp -63.22 -40.61 97.96 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.496 HH22 ' CD1' ' A' ' 142' ' ' LEU . 7.9 ttt85 -60.52 -40.77 92.68 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-O 121.695 0.76 . . . . 0.0 108.959 178.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.96 -55.61 15.92 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.248 -178.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.6 mt -67.64 -12.1 59.7 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.981 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.71 -82.57 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 120.995 0.426 . . . . 0.0 110.678 -177.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.401 HD22 ' H ' ' A' ' 50' ' ' LYS . 2.3 pt? -76.37 -36.28 58.24 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.401 ' H ' HD22 ' A' ' 49' ' ' LEU . 25.2 mmmt -74.63 -51.38 14.61 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 119.552 -0.859 . . . . 0.0 111.026 -176.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 36.12 64.93 0.48 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.866 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.6 mtp85 178.66 -53.99 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.529 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.17 -6.45 16.55 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.92 2.413 . . . . 0.0 111.93 -178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.4 ' CG1' ' N ' ' A' ' 55' ' ' ASP . 9.7 p -45.59 -43.52 3.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.404 -178.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.4 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 50.7 t0 -65.41 -41.25 93.81 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.573 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.409 ' CD ' ' N ' ' A' ' 56' ' ' LYS . 4.1 mptp? -62.55 -37.68 87.06 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 64.4 108.71 0.01 OUTLIER Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 178.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.562 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -51.19 -166.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.057 0.456 . . . . 0.0 111.937 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.438 ' O ' ' OG ' ' A' ' 137' ' ' SER . 70.3 mt -104.55 135.35 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.044 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.6 mt -111.72 144.66 40.64 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.0 tp -112.75 126.8 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-O 121.156 0.503 . . . . 0.0 111.082 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.83 147.92 39.2 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.182 178.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -106.52 -27.59 10.81 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.431 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.662 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 71.1 m-80 -121.46 151.6 40.06 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 120.789 0.328 . . . . 0.0 111.136 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -76.93 -13.29 59.99 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -50.89 -32.19 19.81 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.554 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.662 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 3.0 pm0 -94.17 -13.38 26.74 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.93 -16.19 26.96 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.658 -0.651 . . . . 0.0 109.648 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.467 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 77.1 tttt -78.91 -37.97 1.33 Allowed Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 84.8 Cg_endo -103.47 -3.64 0.26 Allowed 'Trans proline' 0 C--N 1.319 -1.01 0 C-N-CA 122.593 2.195 . . . . 0.0 112.049 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.436 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 60.8 t80 -94.9 -10.9 29.77 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.948 0.404 . . . . 0.0 110.774 -178.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.477 ' CG2' ' N ' ' A' ' 73' ' ' ASP . 5.1 mp -127.11 167.26 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.477 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 99.9 m-20 -61.12 -12.8 13.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.007 0.432 . . . . 0.0 110.381 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 46.2 t0 56.3 22.29 6.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.709 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.0 t -92.6 -38.94 11.6 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.02 0.438 . . . . 0.0 110.177 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.44 -24.4 46.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.208 0.528 . . . . 0.0 110.398 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.445 ' CG ' ' HE ' ' A' ' 82' ' ' ARG . 51.2 tp -77.94 134.21 37.91 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.557 0.694 . . . . 0.0 111.109 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.39 172.56 13.32 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.389 -177.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.13 -40.76 90.92 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.814 0.34 . . . . 0.0 111.105 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.5 p -61.7 -35.07 65.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.495 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -62.97 -41.34 99.51 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.868 0.366 . . . . 0.0 110.511 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.445 ' HE ' ' CG ' ' A' ' 77' ' ' LEU . 2.4 mmt85 -62.88 -52.81 61.64 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 122.506 1.146 . . . . 0.0 109.025 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -55.64 -50.73 69.41 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.812 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.6 m -61.44 -49.83 75.25 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.936 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' A' ' 89' ' ' TRP . 9.6 tt -67.52 -32.08 55.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 119.746 -0.781 . . . . 0.0 109.595 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -75.3 -36.43 61.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.424 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.5 m -86.82 -16.44 36.17 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.741 -0.209 . . . . 0.0 111.145 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.444 ' O ' ' O ' ' A' ' 89' ' ' TRP . 77.2 ttt-85 -119.58 78.52 1.32 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.587 0.232 . . . . 0.0 110.879 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.444 ' O ' ' O ' ' A' ' 88' ' ' ARG . 27.3 m95 56.2 149.66 0.05 OUTLIER Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.029 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -67.13 -21.32 48.94 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.331 2.021 . . . . 0.0 112.045 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.529 ' O ' ' NE ' ' A' ' 117' ' ' ARG . . . 157.26 82.87 0.04 OUTLIER Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -76.44 -21.49 13.21 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.885 1.723 . . . . 0.0 112.578 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.4 p -136.39 143.62 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-O 121.088 0.471 . . . . 0.0 110.843 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 85.1 m -87.73 144.86 26.41 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.246 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -126.85 142.32 51.58 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.754 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.3 t -98.2 105.59 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 121.299 0.571 . . . . 0.0 109.801 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -90.13 150.83 44.07 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.931 -178.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.96 109.29 2.81 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 121.874 1.716 . . . . 0.0 110.525 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.401 ' O ' ' OD1' ' A' ' 112' ' ' ASP . . . -67.29 147.75 98.86 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.05 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.29 155.22 51.5 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.441 2.094 . . . . 0.0 112.385 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.041 179.768 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' A' ' 109' ' ' GLY . 15.0 mmt180 . . . . . 0 N--CA 1.467 0.417 0 CA-C-O 120.895 0.379 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.55 ' CD1' ' N ' ' A' ' 106' ' ' TRP . 14.2 m0 -73.04 -14.43 61.41 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.562 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.66 ' CD1' ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -68.99 -37.63 78.84 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.736 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.429 ' C ' ' H ' ' A' ' 110' ' ' ARG . 21.8 m -143.94 -39.48 0.29 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.432 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 65.59 -13.64 0.28 Allowed Glycine 0 CA--C 1.53 0.972 0 CA-C-N 115.64 -0.709 . . . . 0.0 113.764 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.429 ' H ' ' C ' ' A' ' 108' ' ' THR . 24.7 tpt85 -112.22 -83.08 0.59 Allowed 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 117.848 0.824 . . . . 0.0 111.027 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -78.88 -121.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.525 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 99' ' ' ALA . 44.0 t0 -171.29 51.26 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.667 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.5 p -158.7 162.75 37.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.294 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.0 pp -165.79 137.59 3.93 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.72 127.97 34.74 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 113.085 -1.87 . . . . 0.0 109.904 177.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.3 p -147.21 151.19 14.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.986 0.422 . . . . 0.0 110.063 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.529 ' NE ' ' O ' ' A' ' 91' ' ' GLY . 80.5 ttt180 -141.21 156.16 45.95 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.701 -178.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.5 t -121.41 130.87 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.9 t -134.03 127.94 33.3 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.764 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -135.43 84.3 2.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.849 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.607 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 47.1 t60 -172.62 -35.56 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.308 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.607 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 72.7 Cg_endo -95.07 -159.41 0.06 OUTLIER 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 121.889 1.726 . . . . 0.0 111.979 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 42.7 mt -78.22 -4.65 48.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.341 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 82.9 t -58.53 -45.9 90.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.964 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.586 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 27.6 m -53.57 -61.89 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.586 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -41.26 -43.95 2.53 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.717 178.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.2 tp -69.32 -48.6 61.04 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.361 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 65.1 m -70.4 -48.88 54.09 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.49 0.662 . . . . 0.0 110.913 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.472 ' N ' ' O ' ' A' ' 125' ' ' VAL . 1.1 pp0? -54.71 -42.24 71.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.572 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.437 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -58.78 -56.1 26.52 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.178 -1.374 . . . . 0.0 110.062 -177.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.467 ' CZ ' ' CG ' ' A' ' 36' ' ' ASP . 7.4 t80 -63.32 -29.21 70.56 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.644 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 90.26 1.0 76.05 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' A' ' 134' ' ' PRO . 61.2 mttt -151.0 158.64 34.68 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.999 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' A' ' 133' ' ' LYS . 5.9 Cg_exo -41.12 175.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 123.976 3.117 . . . . 0.0 113.166 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.6 tp -131.34 123.09 27.53 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 177.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.402 ' O ' ' CA ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -66.0 145.58 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 C-N-CA 118.477 -1.289 . . . . 0.0 108.662 -179.212 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -109.44 120.85 43.77 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.122 0.889 . . . . 0.0 110.756 -179.669 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 5.2 m -136.2 163.39 30.48 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.122 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.7 t -67.27 149.37 50.49 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.916 0.389 . . . . 0.0 110.976 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.54 -38.46 91.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.195 -0.457 . . . . 0.0 112.117 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 56.6 p30 -65.75 155.99 34.44 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.468 0.651 . . . . 0.0 111.599 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.496 ' CD1' HH22 ' A' ' 45' ' ' ARG . 0.8 OUTLIER -144.75 179.08 7.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.385 -178.523 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 38.8 t -61.39 -42.74 99.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.226 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -141.65 57.01 0.58 Allowed Glycine 0 N--CA 1.468 0.803 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.1 tp -157.41 108.04 1.85 Allowed Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 119.399 -0.334 . . . . 0.0 110.213 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -40.92 156.09 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.394 1.396 . . . . 0.0 111.212 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -59.97 -159.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.113 1.876 . . . . 0.0 111.855 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.527 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 79.5 m -149.12 73.32 1.2 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.027 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -54.66 -40.61 69.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.232 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.15 168.49 26.32 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.0 m -59.47 -22.76 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 CA-C-O 121.266 0.555 . . . . 0.0 109.855 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -65.12 -25.06 67.6 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 155' ' ' ARG . 6.2 tm-20 -69.08 -79.42 0.06 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.319 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.419 ' N ' ' OE1' ' A' ' 153' ' ' GLU . 5.4 p -35.83 -30.15 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.577 0.751 . . . . 0.0 110.312 177.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.482 ' N ' ' O ' ' A' ' 153' ' ' GLU . 4.1 tmt_? -71.59 -49.94 35.67 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.063 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 153' ' ' GLU . . . -72.01 -19.41 61.86 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 122.529 1.157 . . . . 0.0 108.212 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -83.04 -44.38 15.26 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 112.623 -2.081 . . . . 0.0 111.763 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -129.78 -34.26 1.75 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.775 0.322 . . . . 0.0 111.631 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 160' ' ' ALA . . . 102.12 23.91 8.82 Favored Glycine 0 N--CA 1.468 0.792 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.412 ' O ' ' O ' ' A' ' 159' ' ' GLY . . . -43.97 -97.9 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.597 0.237 . . . . 0.0 110.893 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . 64.17 33.6 11.68 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.547 ' C ' ' H ' ' A' ' 164' ' ' VAL . 1.6 m-85 -173.54 -62.2 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.013 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -72.67 28.22 0.28 Allowed 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 122.296 1.997 . . . . 0.0 110.718 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.547 ' H ' ' C ' ' A' ' 162' ' ' PHE . 13.6 m -129.89 167.31 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.877 -178.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 11.7 t -121.6 65.2 17.19 Favored Pre-proline 0 N--CA 1.471 0.615 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.859 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -36.35 139.84 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 123.612 2.875 . . . . 0.0 115.041 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 160.61 -172.81 37.05 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 114.077 -1.42 . . . . 0.0 111.112 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -159.29 170.68 21.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.935 0.397 . . . . 0.0 110.524 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.624 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.024 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 120.807 0.337 . . . . 0.0 110.577 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 16.3 pt -113.12 133.59 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.117 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -127.62 166.52 17.9 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.511 0.672 . . . . 0.0 111.452 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 184' ' ' GLY . 46.0 t0 -80.05 106.3 11.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.921 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.61 -18.63 62.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.502 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.477 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.4 mm? -63.5 -41.15 98.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.841 0.353 . . . . 0.0 110.545 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.1 -43.38 2.33 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.395 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 180' ' ' ASP . . . . . . . . 0 CA--C 1.529 0.911 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.2 m120 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -63.17 -40.73 98.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.766 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -63.47 -40.91 98.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.424 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.442 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 10.1 mp -62.1 -42.13 98.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.01 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -60.88 -41.73 96.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.018 0.437 . . . . 0.0 110.127 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.66 -38.85 90.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.098 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 162' ' ' PHE . 60.6 t0 -60.52 -47.23 87.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.258 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.95 -45.98 91.28 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.383 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 10' ' ' ILE . 97.0 mt -63.45 -43.76 98.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.207 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.23 -46.42 82.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.177 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.66 -44.09 97.16 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.946 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.69 -53.28 59.32 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.8 pt -69.39 -39.81 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.757 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -58.72 -55.14 38.94 Favored 'General case' 0 C--O 1.217 -0.634 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.695 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.475 ' O ' ' N ' ' A' ' 20' ' ' GLU . 93.5 t -61.96 -39.28 83.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.6 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.444 ' CD2' ' C ' ' A' ' 17' ' ' LEU . 6.3 tt -52.64 -50.49 63.07 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.453 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -80.2 -51.38 9.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.992 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -65.52 -33.54 76.17 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.159 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.6 mt-10 58.14 88.11 0.06 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.816 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.04 -136.78 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.328 -0.397 . . . . 0.0 109.975 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.1 p -141.19 138.42 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pp -130.44 166.59 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-O 121.0 0.429 . . . . 0.0 111.876 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.58 134.71 56.97 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.936 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.473 ' CZ ' ' O ' ' A' ' 26' ' ' PRO . 2.0 t80 -128.73 133.63 25.4 Favored Pre-proline 0 CA--C 1.552 1.035 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.821 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.473 ' O ' ' CZ ' ' A' ' 25' ' ' TYR . 27.8 Cg_exo -60.09 146.04 97.05 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 CA-C-N 121.048 1.41 . . . . 0.0 110.898 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.444 ' C ' ' H ' ' A' ' 29' ' ' ALA . 78.7 m -129.36 142.5 50.8 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.188 0.518 . . . . 0.0 110.378 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -77.66 20.1 0.35 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.641 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.444 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -160.21 -69.26 0.07 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.625 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.9 t -127.24 130.14 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.477 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 77.3 m-85 -42.24 136.6 2.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.178 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.43 -170.81 12.18 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.9 m -132.47 165.43 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.52 -177.05 27.49 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.303 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.439 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -156.22 -168.08 2.63 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.604 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.496 ' OD1' ' CE1' ' A' ' 131' ' ' TYR . 19.1 t70 -96.07 109.69 48.19 Favored Pre-proline 0 CA--C 1.553 1.063 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -178.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 36' ' ' ASP . 23.6 Cg_exo -36.79 170.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.865 2.377 . . . . 0.0 114.126 177.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 40.94 68.3 0.44 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.961 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.3 m -151.02 142.03 23.03 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.839 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -66.39 -32.56 74.02 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.43 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.0 t -59.48 -40.88 88.41 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.528 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.8 -52.19 66.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.256 0.55 . . . . 0.0 111.506 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 p -64.12 -45.87 95.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.876 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 91.3 mtp -66.79 -46.84 73.99 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.414 ' O ' ' CD2' ' A' ' 49' ' ' LEU . 40.8 ptt85 -63.01 -30.64 71.76 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.416 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 64.0 mt -73.55 -60.95 2.01 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 119.591 -0.843 . . . . 0.0 109.493 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.4 mt -53.11 -21.38 4.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.446 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -64.11 -85.23 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.665 -177.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.414 ' CD2' ' O ' ' A' ' 45' ' ' ARG . 2.3 pt? -75.93 -32.8 59.74 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -77.17 -71.49 0.4 Allowed 'General case' 0 C--N 1.346 0.423 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.564 -176.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.408 ' O ' ' CG ' ' A' ' 51' ' ' GLN . 3.6 tt0 53.73 80.56 0.11 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.463 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.2 mtp85 161.19 -63.95 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.073 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -66.81 -12.52 36.34 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 122.568 2.179 . . . . 0.0 112.165 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.435 ' CG1' ' N ' ' A' ' 55' ' ' ASP . 7.3 p -43.9 -46.67 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.026 0.441 . . . . 0.0 110.625 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 110' ' ' ARG . 12.5 t0 -66.69 -44.75 80.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.629 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -59.8 -39.97 86.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.939 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 67.35 109.86 0.02 OUTLIER Glycine 0 CA--C 1.522 0.471 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.573 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -49.24 -170.17 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.935 -0.632 . . . . 0.0 112.222 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.438 ' O ' ' OG ' ' A' ' 137' ' ' SER . 83.0 mt -104.8 139.92 24.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.3 mt -109.02 145.02 36.25 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.433 ' CD1' ' HE ' ' A' ' 117' ' ' ARG . 9.1 tp -110.69 129.88 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-O 121.316 0.579 . . . . 0.0 110.247 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.55 153.82 33.58 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.403 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.36 -27.05 7.72 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.617 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 21.4 m120 -117.05 144.86 44.15 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.193 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -72.91 -14.21 61.42 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.324 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -50.53 -33.95 23.54 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.513 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.617 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 4.8 pm0 -93.59 -9.26 38.71 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.13 -16.63 27.46 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.462 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 43.6 tttm -76.69 -39.1 2.28 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -178.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 93.7 Cg_endo -102.06 -4.97 0.33 Allowed 'Trans proline' 0 C--N 1.318 -1.027 0 C-N-CA 122.65 2.233 . . . . 0.0 111.846 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.436 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 55.6 t80 -92.36 -14.48 28.64 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.892 0.377 . . . . 0.0 110.181 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.423 ' CG2' ' N ' ' A' ' 73' ' ' ASP . 4.6 mp -134.19 158.49 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.423 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 21.9 m-20 -62.97 145.74 54.67 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -79.04 -4.57 50.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.751 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.1 t -73.56 -37.9 65.4 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.033 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 63.2 mmm -64.57 -47.45 78.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.759 0.79 . . . . 0.0 109.672 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.7 mp -79.02 135.07 36.78 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 113.886 -1.506 . . . . 0.0 111.18 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.608 ' HG1' ' N ' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -160.23 158.73 30.5 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.876 -178.697 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.608 ' N ' ' HG1' ' A' ' 78' ' ' THR . 99.3 m-20 -38.57 -47.36 1.3 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.841 -178.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.89 -34.44 68.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.097 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.457 ' N ' ' O ' ' A' ' 78' ' ' THR . 65.9 tp60 -65.51 -40.45 93.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.747 0.308 . . . . 0.0 110.727 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -63.95 -52.53 59.3 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 122.309 1.052 . . . . 0.0 109.235 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' A' ' 87' ' ' SER . 83.1 tt0 -55.24 -50.41 69.53 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.145 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.4 m -61.46 -50.25 73.52 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.216 -1.356 . . . . 0.0 111.966 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.4 tt -67.97 -32.5 56.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.717 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -76.67 -34.67 58.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.543 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 83' ' ' GLU . 11.6 m -87.83 -15.73 36.03 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.642 0.258 . . . . 0.0 111.13 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.436 ' O ' ' O ' ' A' ' 89' ' ' TRP . 68.4 ttt180 -116.3 75.62 0.97 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.813 0.34 . . . . 0.0 110.372 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.436 ' O ' ' O ' ' A' ' 88' ' ' ARG . 75.0 m95 57.7 148.13 0.06 OUTLIER Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.709 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.44 -29.26 37.95 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.922 1.748 . . . . 0.0 112.044 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 149.68 80.05 0.03 OUTLIER Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -85.08 -8.91 8.81 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.992 2.462 . . . . 0.0 112.17 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.7 p -135.99 147.87 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.185 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 82.7 m -85.48 141.25 30.05 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.292 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -123.0 142.74 50.51 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.465 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.2 t -106.03 112.8 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-O 121.261 0.553 . . . . 0.0 110.66 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -97.94 150.68 37.01 Favored Pre-proline 0 N--CA 1.472 0.646 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.72 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.69 86.59 0.86 Allowed 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 122.118 1.879 . . . . 0.0 111.341 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -48.61 150.9 2.23 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.969 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.427 ' O ' ' OG1' ' A' ' 103' ' ' THR . 60.7 Cg_endo -68.07 145.36 66.99 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.88 1.72 . . . . 0.0 112.197 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.5 -36.49 84.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.951 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 82.1 p -53.22 -43.26 67.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.729 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.49 ' O ' ' O ' ' A' ' 104' ' ' PRO . 5.0 p -59.51 155.62 37.07 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-O 119.226 -0.416 . . . . 0.0 110.094 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.49 ' O ' ' O ' ' A' ' 103' ' ' THR . 52.0 Cg_exo -49.13 -158.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.033 0 C-N-CA 122.342 2.028 . . . . 0.0 113.104 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.473 ' O ' ' N ' ' A' ' 109' ' ' GLY . 2.0 tpt180 -145.72 -0.62 0.82 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.792 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 47.3 p-90 -75.5 -9.55 58.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.763 0.316 . . . . 0.0 110.461 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.653 ' CD1' ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -76.55 -25.11 53.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.19 -179.217 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.55 ' C ' ' H ' ' A' ' 110' ' ' ARG . 24.4 m -144.24 -42.58 0.26 Allowed 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 49.49 0.98 0.01 OUTLIER Glycine 0 CA--C 1.537 1.42 0 C-N-CA 121.368 -0.444 . . . . 0.0 113.125 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.55 ' H ' ' C ' ' A' ' 108' ' ' THR . 0.0 OUTLIER -93.88 -62.31 1.37 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 117.882 0.841 . . . . 0.0 109.853 179.715 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.55 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 87.8 t80 -147.57 169.72 18.99 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.101 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.55 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 4.2 p-10 -84.0 73.74 10.33 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.519 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 54.3 p -169.15 126.02 0.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -117.01 120.21 37.68 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.28 117.21 20.85 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.508 177.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.6 p -141.4 159.47 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.587 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.433 ' HE ' ' CD1' ' A' ' 61' ' ' ILE . 61.6 ttp180 -139.77 150.71 45.09 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.667 0.27 . . . . 0.0 111.13 -179.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.8 t -120.68 131.92 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.9 t -135.84 134.96 39.41 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -139.5 87.1 2.16 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.864 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.562 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 52.1 t-80 -172.58 -36.91 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.562 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 58.5 Cg_endo -95.33 -159.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 122.181 1.921 . . . . 0.0 112.006 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.8 mt -77.53 -5.98 52.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.26 0.552 . . . . 0.0 110.387 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.2 t -57.95 -45.23 87.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.837 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.576 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 27.8 m -53.83 -61.81 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.926 0 C-N-CA 119.413 -0.915 . . . . 0.0 108.92 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.576 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -41.0 -45.52 2.62 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.581 0.229 . . . . 0.0 110.93 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.5 tp -68.99 -47.09 66.41 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.268 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 64.2 m -70.44 -49.54 47.65 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.411 0.624 . . . . 0.0 110.997 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 125' ' ' VAL . 1.2 pp0? -54.73 -41.75 70.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.438 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.445 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -58.6 -56.77 17.92 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.735 -177.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.496 ' CE1' ' OD1' ' A' ' 36' ' ' ASP . 3.9 t80 -63.57 -22.11 66.72 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.705 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 81.27 3.42 90.66 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.3 mttt -151.83 158.19 34.1 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.645 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -43.08 178.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 123.63 2.887 . . . . 0.0 113.536 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.9 tp -135.18 123.2 22.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 113.57 -1.65 . . . . 0.0 106.826 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.88 144.32 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 C-N-CA 118.041 -1.463 . . . . 0.0 108.072 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 59' ' ' ILE . 1.1 p -113.97 123.74 50.47 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.64 0.588 . . . . 0.0 111.693 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 4.0 m -128.85 162.09 28.3 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.595 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.1 m -74.61 149.78 39.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.335 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.54 81.98 5.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.602 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -160.4 164.08 32.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.389 0.614 . . . . 0.0 110.578 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.68 -165.96 1.74 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.127 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.2 t -59.71 -44.11 93.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.414 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -162.55 12.49 0.11 Allowed Glycine 0 C--N 1.327 0.075 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.9 tp -89.1 126.4 59.11 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -39.64 157.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.538 1.492 . . . . 0.0 112.297 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.62 -161.0 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.411 2.074 . . . . 0.0 111.759 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 148' ' ' CYS . 28.1 p -126.4 86.05 2.47 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.477 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 51.6 ptt85 -53.34 -37.47 62.37 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.862 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.36 171.48 20.16 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.6 m -59.28 -22.48 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 CA-C-O 121.484 0.659 . . . . 0.0 109.297 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -65.26 -25.46 67.67 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 155' ' ' ARG . 0.0 OUTLIER -71.78 -78.97 0.08 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.49 179.282 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.4 p -34.75 -29.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.489 0.715 . . . . 0.0 110.072 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -73.68 -51.77 15.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.921 179.646 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 153' ' ' GLU . . . -69.78 -20.33 63.48 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 122.542 1.163 . . . . 0.0 108.064 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -82.78 -45.93 13.75 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 112.753 -2.021 . . . . 0.0 111.563 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -129.26 -22.66 3.08 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 90.01 22.7 34.81 Favored Glycine 0 N--CA 1.467 0.708 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.42 ' O ' ' O ' ' A' ' 159' ' ' GLY . . . -43.27 -98.28 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.742 0.306 . . . . 0.0 110.942 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.46 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 62.62 35.12 14.49 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.539 ' C ' ' H ' ' A' ' 164' ' ' VAL . 1.7 m-85 -174.06 -62.16 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.057 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -73.41 29.05 0.3 Allowed 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.175 1.917 . . . . 0.0 110.476 177.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.539 ' H ' ' C ' ' A' ' 162' ' ' PHE . 15.3 m -131.55 166.86 27.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.747 -178.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.8 t -123.0 65.7 28.04 Favored Pre-proline 0 N--CA 1.473 0.684 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.796 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -36.31 142.42 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 123.561 2.841 . . . . 0.0 115.008 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 165.1 -167.91 38.97 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 114.006 -1.452 . . . . 0.0 110.88 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -152.71 177.84 10.27 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.2 t -145.53 152.66 40.09 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.404 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -51.57 -69.02 1.26 Allowed Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 137.44 105.47 0.72 Allowed Glycine 0 N--CA 1.468 0.784 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -137.08 150.99 48.39 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.756 0.312 . . . . 0.0 110.365 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.421 ' CD1' ' N ' ' A' ' 173' ' ' LEU . 10.3 mp -60.09 -73.7 0.08 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.356 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -174.74 59.37 0.21 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.696 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -68.41 -17.39 44.03 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.502 2.135 . . . . 0.0 111.907 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 43.0 t -92.07 121.98 34.14 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.438 0.637 . . . . 0.0 110.087 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -134.64 -169.96 2.45 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.803 -178.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.0 pt -122.7 102.5 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 121.182 0.515 . . . . 0.0 110.331 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -95.53 156.2 16.42 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.339 0.59 . . . . 0.0 111.847 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -76.4 106.36 7.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.822 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -64.68 -12.03 42.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.704 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.493 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.6 mm? -63.03 -42.05 99.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.348 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.71 -42.79 3.07 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.528 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 73.85 19.35 79.75 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -72.31 151.61 42.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.191 0.519 . . . . 0.0 110.98 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.435 ' N ' ' CD2' ' A' ' 186' ' ' LEU . 0.7 OUTLIER -67.51 179.18 1.37 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.597 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . 0.504 ' C ' HE22 ' A' ' 189' ' ' GLN . 89.9 t80 -91.75 -31.77 15.65 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.92 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -78.18 139.69 38.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.058 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.504 HE22 ' C ' ' A' ' 187' ' ' PHE . 27.9 mp0 -128.52 -15.5 4.51 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.046 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.711 0 CA-C-O 118.157 -1.357 . . . . 0.0 111.067 179.807 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 65.2 t30 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -83.04 142.03 31.61 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.645 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -144.92 -44.75 0.23 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.46 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.4 mp -62.74 -41.83 99.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.965 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -63.37 -42.8 98.88 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.417 0.627 . . . . 0.0 109.783 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -62.31 -41.36 98.47 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.476 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -62.11 -45.55 92.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.741 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.89 90.02 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.19 0.519 . . . . 0.0 110.379 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.408 HG23 HD12 ' A' ' 10' ' ' ILE . 94.6 mt -63.48 -43.72 98.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.613 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.52 -45.59 81.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.191 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.72 -39.25 90.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.618 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.4 -53.98 49.52 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.51 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.6 pt -71.59 -31.01 40.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.232 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -59.57 -55.08 38.95 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 20' ' ' GLU . 88.7 t -63.72 -40.35 88.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.896 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.449 ' CD2' ' C ' ' A' ' 17' ' ' LEU . 6.5 tt -52.28 -50.28 62.44 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.555 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -79.82 -50.13 10.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.073 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -66.25 -34.59 78.36 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.952 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.8 mt-10 60.92 82.38 0.17 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 178.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.47 -139.51 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.232 177.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 p -134.67 142.63 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 pp -129.35 163.66 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 120.896 0.379 . . . . 0.0 111.304 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.89 131.22 48.02 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.215 0.531 . . . . 0.0 111.11 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.494 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 0.4 OUTLIER -121.02 140.36 30.8 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.494 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 65.3 Cg_endo -79.33 154.73 24.84 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.553 1.502 . . . . 0.0 111.931 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.49 ' C ' ' H ' ' A' ' 29' ' ' ALA . 23.0 m -142.2 141.38 32.55 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.221 0.534 . . . . 0.0 110.955 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -75.44 23.18 0.12 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.547 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.49 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -154.21 -75.48 0.11 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.965 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.4 t -125.73 128.83 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 120.973 0.416 . . . . 0.0 110.174 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.503 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 93.5 m-85 -46.67 147.48 1.24 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.144 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -152.47 -174.47 23.03 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.6 m -126.55 168.16 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.412 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -157.64 177.65 34.33 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.098 -1.049 . . . . 0.0 112.235 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -154.66 -166.75 2.41 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.508 0.194 . . . . 0.0 110.594 -179.401 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.451 ' O ' ' O ' ' A' ' 37' ' ' PRO . 3.8 m-20 -95.52 108.78 41.84 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -178.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.451 ' O ' ' O ' ' A' ' 36' ' ' ASP . 54.1 Cg_exo -38.69 174.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.76 2.307 . . . . 0.0 114.042 177.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 38.08 69.72 0.23 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.302 -1.317 . . . . 0.0 111.429 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 51.0 m -149.1 144.09 26.44 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.376 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -69.5 -36.46 76.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.426 0.631 . . . . 0.0 110.64 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.39 -43.68 93.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.664 -178.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.46 -50.05 75.11 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.041 -0.263 . . . . 0.0 111.413 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.1 p -62.32 -44.96 99.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.391 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 91.1 mtp -63.66 -40.49 96.98 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 34.0 ttt-85 -61.02 -41.6 96.86 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.923 0.868 . . . . 0.0 108.844 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.94 -54.74 25.85 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.238 -178.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.4 mt -69.1 -11.41 60.77 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.349 -0.842 . . . . 0.0 112.002 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -69.57 -82.48 0.04 OUTLIER 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 120.996 0.426 . . . . 0.0 110.778 -177.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.433 HD22 ' H ' ' A' ' 50' ' ' LYS . 2.2 pt? -76.42 -35.29 58.62 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -178.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.433 ' H ' HD22 ' A' ' 49' ' ' LEU . 24.9 mmmt -76.36 -50.56 13.91 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.797 -177.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 35.29 66.55 0.31 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.724 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 178.12 -53.05 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.898 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.397 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.56 -5.42 13.31 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.866 2.377 . . . . 0.0 112.584 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.401 ' CG1' ' N ' ' A' ' 55' ' ' ASP . 8.0 p -44.71 -45.13 2.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.073 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.401 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 67.5 t0 -65.62 -40.38 92.52 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.588 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -62.21 -39.19 91.96 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 71.25 109.62 0.04 OUTLIER Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.564 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -51.7 -163.34 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.232 0.539 . . . . 0.0 112.209 -179.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.451 ' O ' ' OG ' ' A' ' 137' ' ' SER . 61.1 mt -105.12 137.28 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.897 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.7 mt -115.68 143.01 45.98 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.3 tp -111.82 132.91 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 121.149 0.5 . . . . 0.0 110.741 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.47 150.92 41.85 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.95 -29.79 8.42 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.04 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.663 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 14.3 m120 -113.12 150.05 32.7 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.155 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -79.01 -14.28 59.28 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -54.49 -30.19 52.54 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.913 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.663 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 4.0 pm0 -95.01 -11.06 29.1 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.42 ' CD2' ' N ' ' A' ' 68' ' ' LEU . 3.7 mm? -91.16 -18.8 23.88 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.459 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 43.4 tttm -75.57 -39.43 2.99 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 85.3 Cg_endo -104.18 -2.61 0.23 Allowed 'Trans proline' 0 C--N 1.319 -1.009 0 C-N-CA 122.91 2.407 . . . . 0.0 112.363 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.408 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 63.7 t80 -96.95 -11.12 25.04 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.692 -178.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.1 mp -127.94 155.96 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -64.29 158.52 23.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.965 0.412 . . . . 0.0 110.08 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -94.74 7.74 44.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.028 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.419 ' CG2' ' N ' ' A' ' 76' ' ' MET . 13.2 t -74.32 -42.57 59.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.029 0.442 . . . . 0.0 111.075 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.419 ' N ' ' CG2' ' A' ' 75' ' ' THR . 24.4 ptm -95.34 -15.74 22.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.093 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 tp -93.92 127.57 39.76 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.113 0.482 . . . . 0.0 110.63 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.458 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -157.73 161.94 38.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.858 -177.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -39.61 -47.52 1.96 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.776 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.58 -32.64 57.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.853 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.458 ' N ' ' O ' ' A' ' 78' ' ' THR . 58.6 tp60 -63.48 -40.97 98.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.204 0.526 . . . . 0.0 110.19 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.6 mmt85 -65.41 -52.85 50.49 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 122.484 1.135 . . . . 0.0 109.42 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -54.25 -50.96 65.99 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 113.801 -1.545 . . . . 0.0 110.143 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.6 m -61.1 -50.04 74.88 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.574 -1.193 . . . . 0.0 111.979 -177.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.6 tt -67.81 -32.13 55.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.072 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -76.47 -36.05 58.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.753 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.8 m -87.4 -14.19 41.28 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.633 0.254 . . . . 0.0 111.298 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 89' ' ' TRP . 69.2 ttt180 -115.34 75.43 0.94 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.427 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.452 ' O ' ' O ' ' A' ' 88' ' ' ARG . 13.9 m-90 56.37 153.11 0.07 OUTLIER Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.507 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.6 -21.23 39.87 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.133 1.889 . . . . 0.0 111.649 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.519 ' O ' ' NE ' ' A' ' 117' ' ' ARG . . . 158.52 81.27 0.04 OUTLIER Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.55 -17.8 11.07 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.262 1.974 . . . . 0.0 112.047 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.0 p -136.95 146.32 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.132 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.6 m -91.31 129.33 37.32 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.389 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -117.5 138.05 52.14 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.779 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.2 t -92.46 104.65 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 121.301 0.572 . . . . 0.0 110.761 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 97' ' ' PHE . 30.4 m-85 -86.3 147.1 43.85 Favored Pre-proline 0 N--CA 1.466 0.362 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.529 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.54 83.76 1.85 Allowed 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.993 1.796 . . . . 0.0 111.6 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -46.2 152.46 0.81 Allowed Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -69.46 156.28 64.56 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.036 1.824 . . . . 0.0 111.607 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -136.6 53.61 1.91 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.17 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.416 ' O ' ' OG1' ' A' ' 103' ' ' THR . 40.8 p -67.93 -32.95 73.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.69 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.641 ' H ' ' CD ' ' A' ' 104' ' ' PRO . 1.2 m -167.16 -37.3 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.641 ' CD ' ' H ' ' A' ' 103' ' ' THR . 16.7 Cg_exo -66.7 -167.95 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.473 2.115 . . . . 0.0 113.021 -178.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' A' ' 109' ' ' GLY . 8.0 tpt180 -178.58 -3.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.407 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 8.6 p90 -81.31 -10.08 59.63 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.662 0.744 . . . . 0.0 109.057 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.541 ' H ' ' CD2' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -77.38 -15.28 59.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.638 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 85.3 m -143.28 -40.57 0.31 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.316 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 92.33 -19.28 51.04 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 116.263 -0.426 . . . . 0.0 113.714 178.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.419 ' O ' ' NH2' ' A' ' 105' ' ' ARG . 18.1 tpt180 -144.86 -80.4 0.17 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 117.953 0.877 . . . . 0.0 111.786 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.406 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 29.7 t80 -75.63 -125.47 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.667 -178.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.406 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 48.1 t0 -170.52 54.38 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.834 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.6 p -157.27 155.33 30.58 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.13 137.78 8.58 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.55 135.41 50.02 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 113.212 -1.813 . . . . 0.0 109.777 178.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.6 p -149.73 153.71 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 120.888 0.375 . . . . 0.0 110.7 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.519 ' NE ' ' O ' ' A' ' 91' ' ' GLY . 75.7 ttt180 -142.33 152.55 43.04 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.507 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 49.5 t -119.93 133.05 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.2 t -137.72 138.32 39.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.042 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -145.27 85.2 1.72 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.689 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.597 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 8.2 t60 -173.39 -36.58 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.179 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.597 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 67.7 Cg_endo -95.04 -160.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 122.298 1.999 . . . . 0.0 111.964 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.6 mp -76.84 -7.51 55.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.175 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.0 t -56.74 -45.06 82.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.797 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.571 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 26.8 m -53.84 -61.84 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.875 0 C-N-CA 119.35 -0.94 . . . . 0.0 108.981 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.571 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -41.04 -44.08 2.32 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.894 0.378 . . . . 0.0 110.992 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.6 -48.3 60.58 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.362 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 61.6 m -69.9 -49.28 53.67 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.421 0.629 . . . . 0.0 110.684 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 125' ' ' VAL . 1.0 OUTLIER -54.39 -42.71 70.72 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.42 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.43 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -58.5 -54.96 41.18 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.585 -177.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.443 ' CE1' ' OD2' ' A' ' 36' ' ' ASP . 39.6 t80 -62.46 -21.6 65.57 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.919 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.86 -1.93 82.02 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' A' ' 134' ' ' PRO . 14.2 mtpp -149.5 159.01 37.34 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 133' ' ' LYS . 3.4 Cg_exo -41.68 178.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 123.847 3.031 . . . . 0.0 113.128 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.4 tp -132.34 123.16 26.27 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 176.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.412 ' O ' ' CA ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -63.79 153.12 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 C-N-CA 117.888 -1.525 . . . . 0.0 106.986 -179.702 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 59' ' ' ILE . 1.4 p -130.12 133.78 46.88 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.109 0.48 . . . . 0.0 111.1 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.5 m -134.44 164.67 26.93 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.708 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.6 m -70.45 148.46 48.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.386 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.4 -36.9 81.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.221 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 141' ' ' ASN . 50.3 p30 -67.28 144.41 55.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.043 0.449 . . . . 0.0 110.475 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.563 ' CD1' ' N ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -150.94 163.57 38.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.219 -179.607 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 142' ' ' LEU . 29.1 t 28.45 -87.88 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 O-C-N 123.603 0.564 . . . . 0.0 112.192 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 142' ' ' LEU . . . -157.41 16.78 0.35 Allowed Glycine 0 C--N 1.332 0.307 0 N-CA-C 109.976 -1.249 . . . . 0.0 109.976 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.9 tp -94.61 129.25 37.0 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 115.21 -0.495 . . . . 0.0 109.691 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -37.21 156.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.802 1.668 . . . . 0.0 112.384 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -75.71 -164.82 0.26 Allowed 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.42 2.08 . . . . 0.0 112.888 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 29.7 m -111.39 80.12 1.28 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.123 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.503 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 33.9 ptt180 -54.54 -35.16 62.93 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.21 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.95 169.81 19.08 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -57.28 -22.82 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -63.5 -30.83 71.89 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 155' ' ' ARG . 6.0 tm-20 -63.76 -79.61 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.204 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.1 p -36.64 -30.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.922 0.889 . . . . 0.0 111.118 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.472 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -69.69 -52.21 27.71 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.628 -178.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.92 -17.69 62.68 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 122.697 1.236 . . . . 0.0 108.386 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -83.87 -45.62 13.04 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 112.492 -2.14 . . . . 0.0 111.847 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -131.11 -23.46 2.45 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 87.98 26.75 28.08 Favored Glycine 0 N--CA 1.464 0.553 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 159' ' ' GLY . . . -43.01 -97.33 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.65 -0.275 . . . . 0.0 111.018 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.465 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 65.85 33.13 8.23 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-O 121.362 0.601 . . . . 0.0 109.453 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.555 ' C ' ' H ' ' A' ' 164' ' ' VAL . 1.8 m-85 -175.58 -62.09 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.505 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.38 31.94 0.28 Allowed 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.169 1.913 . . . . 0.0 110.363 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.555 ' H ' ' C ' ' A' ' 162' ' ' PHE . 15.4 m -134.64 167.17 26.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.734 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.3 t -123.72 66.14 36.49 Favored Pre-proline 0 N--CA 1.472 0.657 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.549 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -37.73 147.59 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 123.551 2.834 . . . . 0.0 115.072 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 163.84 -173.39 39.9 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 113.739 -1.573 . . . . 0.0 111.105 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -145.68 150.86 37.07 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.718 0.294 . . . . 0.0 110.472 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.5 t -147.06 153.2 39.7 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.053 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -60.76 -69.81 1.19 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 102.48 5.29 48.93 Favored Glycine 0 N--CA 1.469 0.841 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.31 -38.62 90.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.873 0.368 . . . . 0.0 110.906 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.421 ' CD1' ' N ' ' A' ' 173' ' ' LEU . 10.2 mp -61.6 -169.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.122 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -84.53 150.17 56.25 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.426 ' O ' ' OG ' ' A' ' 176' ' ' SER . 29.6 Cg_endo -60.01 -43.89 33.48 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 122.114 1.876 . . . . 0.0 111.618 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 175' ' ' PRO . 45.5 m -171.51 128.15 0.66 Allowed 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.607 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -106.51 103.65 13.15 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.901 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 18.3 tt -111.91 120.5 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.067 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -125.28 164.2 20.87 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 122.052 0.93 . . . . 0.0 110.768 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 184' ' ' GLY . 43.2 t0 -77.05 106.71 8.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.037 -1.438 . . . . 0.0 108.79 178.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.28 -20.52 64.37 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.692 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.477 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.4 mm? -63.77 -42.27 97.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.854 0.359 . . . . 0.0 110.408 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.86 -47.12 2.31 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.773 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 180' ' ' ASP . . . 76.24 20.14 77.59 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -83.5 178.48 7.99 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-O 121.025 0.441 . . . . 0.0 111.032 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.44 ' H ' ' CD2' ' A' ' 186' ' ' LEU . 0.7 OUTLIER -83.65 179.22 7.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.583 179.742 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -84.97 -39.79 17.69 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.761 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.85 136.19 48.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.898 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -133.64 -19.59 2.09 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.335 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.73 0 CA-C-O 118.028 -1.429 . . . . 0.0 111.065 -179.95 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 54.1 p30 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 57.55 34.73 24.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.339 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -63.97 -40.76 97.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.656 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.447 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 10.0 mp -62.49 -42.38 99.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.458 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.6 -42.66 91.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.911 0.386 . . . . 0.0 110.26 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 63.3 ttm-85 -62.88 -42.29 99.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.379 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -62.16 -43.49 98.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.398 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.2 -47.14 87.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.06 0.457 . . . . 0.0 110.02 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.22 -43.24 98.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.817 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.85 -40.88 85.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.44 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.24 -43.08 92.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.029 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.16 -52.45 64.79 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.787 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 16.7 pt -68.5 -39.06 80.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.357 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -58.22 -54.9 41.81 Favored 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.201 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 20' ' ' GLU . 94.0 t -59.75 -39.73 80.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.776 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.435 ' CD2' ' C ' ' A' ' 17' ' ' LEU . 6.5 tt -52.06 -50.0 62.38 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.104 -0.638 . . . . 0.0 109.674 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -81.31 -52.71 7.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.904 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.458 ' O ' ' NH1' ' A' ' 21' ' ' ARG . 69.4 mm-40 -63.25 -35.56 80.76 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.438 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.2 mt-10 59.69 81.89 0.16 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.458 ' NH1' ' O ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -155.28 -136.73 0.06 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 177.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.6 p -142.09 139.8 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -126.92 165.64 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.03 0.443 . . . . 0.0 111.363 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.45 129.48 40.04 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.04 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -109.88 133.35 20.99 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.129 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -84.57 140.96 8.56 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.246 1.297 . . . . 0.0 111.789 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.535 ' C ' ' H ' ' A' ' 29' ' ' ALA . 28.2 m -136.01 135.89 39.85 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.871 0.367 . . . . 0.0 110.839 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -74.77 29.43 0.09 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.998 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.535 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -158.52 -77.18 0.07 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.289 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.1 m -120.37 126.28 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-O 121.118 0.485 . . . . 0.0 110.781 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.524 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 77.9 m-85 -60.67 145.17 50.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.509 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -154.4 -166.62 15.27 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.6 m -131.91 170.85 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.422 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -159.87 -176.35 31.85 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 119.518 -1.325 . . . . 0.0 112.51 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.502 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -163.48 -163.36 0.81 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.137 -179.147 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.502 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 43.0 t0 -90.74 106.43 15.45 Favored Pre-proline 0 CA--C 1.555 1.167 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -38.16 -61.89 0.34 Allowed 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.283 1.989 . . . . 0.0 112.129 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -69.71 62.63 0.18 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.315 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.4 m -155.1 131.89 10.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.083 0.468 . . . . 0.0 110.928 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.08 -17.92 63.93 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.247 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.41 ' CG2' ' N ' ' A' ' 42' ' ' ALA . 15.3 t -61.26 -41.91 97.73 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.511 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.41 ' N ' ' CG2' ' A' ' 41' ' ' THR . . . -58.13 -51.26 70.45 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.63 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 p -63.05 -44.19 99.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.434 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 62.3 mtt -65.22 -39.93 93.44 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -61.92 -32.83 73.26 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.632 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 81.9 mt -76.92 -57.67 3.72 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.4 mt -57.2 -16.09 7.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.387 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.52 -85.77 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.589 -178.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -76.08 -32.47 59.26 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.987 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -79.11 -71.01 0.46 Allowed 'General case' 0 C--N 1.349 0.57 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.428 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.424 ' O ' ' CG ' ' A' ' 51' ' ' GLN . 3.7 tt0 54.4 79.85 0.13 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.381 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 161.45 -62.7 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.856 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.332 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.01 -8.53 23.84 Favored 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.58 2.187 . . . . 0.0 111.641 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -43.74 -46.34 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.926 0.394 . . . . 0.0 110.466 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 110' ' ' ARG . 10.0 t0 -66.28 -42.87 87.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.196 0.522 . . . . 0.0 109.941 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -61.35 -40.87 95.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.422 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 64.52 117.34 0.01 OUTLIER Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.572 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -51.21 -164.53 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.21 0.529 . . . . 0.0 112.131 179.676 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.406 HD12 HG22 ' A' ' 59' ' ' ILE . 92.5 mt -105.62 145.19 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 16.9 mt -117.15 146.33 43.26 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.4 tp -113.8 132.77 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-O 121.39 0.614 . . . . 0.0 111.325 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.39 154.1 35.59 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.103 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.04 -27.58 6.89 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.49 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 98.1 m-20 -114.13 143.74 44.31 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.105 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -73.48 -14.29 61.21 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -50.28 -33.13 18.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.502 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.49 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 3.8 pm0 -94.4 -12.25 28.25 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.43 ' CD2' ' N ' ' A' ' 68' ' ' LEU . 3.6 mm? -91.67 -14.92 29.26 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.424 -0.797 . . . . 0.0 108.885 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.464 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 43.0 tttm -78.64 -39.93 1.64 Allowed Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 66.6 Cg_endo -104.43 -2.07 0.23 Allowed 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 122.853 2.368 . . . . 0.0 112.351 -178.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.463 ' OH ' ' CD2' ' A' ' 114' ' ' LEU . 55.6 t80 -97.73 -9.47 26.59 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.988 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.494 ' CG2' ' N ' ' A' ' 73' ' ' ASP . 4.6 mp -123.34 168.91 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.494 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 96.5 m-20 -60.56 -12.43 9.93 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.051 -0.259 . . . . 0.0 111.141 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 57.8 t0 55.71 30.52 15.73 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.282 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.403 ' CG2' ' N ' ' A' ' 76' ' ' MET . 9.2 t -96.13 -43.5 7.72 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.208 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.403 ' N ' ' CG2' ' A' ' 75' ' ' THR . 18.9 ptp -84.69 -5.97 59.34 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.237 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.3 tp -92.8 127.56 38.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.251 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -160.2 161.63 33.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.683 -177.735 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -38.77 -49.18 1.59 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.727 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.02 -33.54 61.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.048 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' A' ' 78' ' ' THR . 65.4 tp60 -66.31 -39.03 89.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.619 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.5 mmt85 -63.54 -53.45 51.64 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 122.38 1.086 . . . . 0.0 108.619 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -54.31 -50.39 67.46 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.013 -1.449 . . . . 0.0 110.117 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -60.83 -50.56 72.95 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.883 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.0 tt -67.9 -32.6 57.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.102 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -72.41 -41.66 66.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.82 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.7 m -78.03 -33.09 51.27 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.566 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 89' ' ' TRP . 76.7 ttt180 -95.74 157.69 15.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.04 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.413 ' C ' ' O ' ' A' ' 88' ' ' ARG . 3.7 m-90 -31.37 148.52 0.05 OUTLIER Pre-proline 0 N--CA 1.47 0.55 0 O-C-N 123.482 0.488 . . . . 0.0 111.43 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -67.02 -17.64 51.32 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.051 1.834 . . . . 0.0 111.41 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 108.92 73.75 0.79 Allowed Glycine 0 N--CA 1.468 0.831 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.78 -36.15 81.33 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.833 2.355 . . . . 0.0 111.675 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.4 p -90.44 147.61 5.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.038 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 57.7 m -86.15 147.34 26.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.662 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -127.32 143.5 51.22 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.469 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -99.23 105.39 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-O 121.209 0.528 . . . . 0.0 109.985 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -88.84 149.7 44.19 Favored Pre-proline 0 N--CA 1.469 0.52 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.968 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -76.74 110.18 3.0 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.229 1.953 . . . . 0.0 110.977 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.91 147.72 97.85 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.501 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 40.0 Cg_endo -64.19 -26.27 64.83 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.817 1.678 . . . . 0.0 111.848 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.501 ' CB ' ' O ' ' A' ' 100' ' ' PRO . . . 93.33 -26.19 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 O-C-N 123.706 0.629 . . . . 0.0 110.869 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.5 p -55.38 -44.45 76.11 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.612 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.431 ' CB ' ' CD ' ' A' ' 104' ' ' PRO . 0.1 OUTLIER -64.87 -177.41 0.23 Allowed Pre-proline 0 CA--C 1.531 0.249 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.25 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' A' ' 103' ' ' THR . 52.8 Cg_exo -56.68 -155.35 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.901 1.734 . . . . 0.0 111.485 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.46 ' NH1' ' OD1' ' A' ' 112' ' ' ASP . 2.8 tpp85 -158.76 5.29 0.11 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.536 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.531 ' CD1' ' N ' ' A' ' 106' ' ' TRP . 4.5 m0 -78.66 -7.36 57.58 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.6 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.652 ' CD1' ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -72.41 -31.8 65.83 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.573 ' C ' ' H ' ' A' ' 110' ' ' ARG . 25.9 m -141.01 -42.02 0.39 Allowed 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.515 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 49.36 -0.22 0.01 OUTLIER Glycine 0 CA--C 1.539 1.562 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.13 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.573 ' H ' ' C ' ' A' ' 108' ' ' THR . 0.5 OUTLIER -86.74 -51.17 6.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.025 0.912 . . . . 0.0 108.862 179.366 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.582 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 83.5 t80 -151.36 173.18 14.82 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.498 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.582 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 93.3 m-20 -78.91 51.08 1.08 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.105 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 82.5 p -161.05 158.85 28.5 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.463 ' CD2' ' OH ' ' A' ' 71' ' ' TYR . 0.3 OUTLIER -158.36 136.62 10.84 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -178.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.02 125.11 25.3 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 113.389 -1.732 . . . . 0.0 110.527 177.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.409 ' CG2' ' N ' ' A' ' 117' ' ' ARG . 4.2 p -151.57 161.48 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.409 ' N ' ' CG2' ' A' ' 116' ' ' VAL . 61.5 ttp180 -147.06 154.38 41.11 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.934 0.397 . . . . 0.0 111.756 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 56.0 t -119.95 133.09 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.604 178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.4 t -132.41 129.65 39.6 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.924 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.539 ' O ' ' CG ' ' A' ' 121' ' ' HIS . 67.4 t0 -136.99 75.47 1.53 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.163 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.603 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 18.7 m-70 -165.52 -36.5 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.301 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.603 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 18.7 Cg_endo -91.97 -162.14 0.1 Allowed 'Trans proline' 0 N--CA 1.485 0.984 0 C-N-CA 121.793 1.662 . . . . 0.0 112.01 -178.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.7 mt -77.3 -6.29 52.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.649 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 83.0 t -57.79 -44.12 85.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.632 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.591 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 34.5 m -52.32 -62.46 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.879 0 C-N-CA 119.354 -0.938 . . . . 0.0 108.828 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.591 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -41.97 -44.03 3.34 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.697 0.284 . . . . 0.0 110.995 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 40.3 tp -68.75 -49.26 60.15 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.447 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.477 ' O ' ' N ' ' A' ' 132' ' ' GLY . 75.7 m -70.6 -47.92 57.74 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.263 0.554 . . . . 0.0 111.123 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.449 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -54.64 -42.52 71.37 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.449 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -58.6 -54.59 45.38 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.167 -177.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.401 ' OH ' ' OD1' ' A' ' 36' ' ' ASP . 43.7 t80 -65.71 -22.39 66.61 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 114.766 -1.107 . . . . 0.0 108.136 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 128' ' ' CYS . . . 78.97 2.28 86.53 Favored Glycine 0 N--CA 1.44 -1.087 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -149.57 159.69 35.78 Favored Pre-proline 0 CA--C 1.55 0.951 0 CA-C-N 117.204 0.502 . . . . 0.0 110.556 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -47.59 163.76 0.17 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 124.045 3.163 . . . . 0.0 113.667 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.3 tp -119.95 123.99 44.88 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.422 ' O ' ' CA ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -63.41 147.87 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 C-N-CA 117.755 -1.578 . . . . 0.0 106.899 179.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.3 t -122.53 127.15 49.14 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.648 0.592 . . . . 0.0 111.515 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.4 m -128.62 165.75 20.22 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.602 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 24.0 m -72.25 148.49 45.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.668 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.92 -36.6 79.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.199 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 57.2 p30 -61.98 152.34 32.56 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.746 0.784 . . . . 0.0 111.293 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.18 -155.36 0.63 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.328 -1.306 . . . . 0.0 109.809 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 79.4 p -62.44 -39.05 92.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.327 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -167.97 7.55 0.05 OUTLIER Glycine 0 CA--C 1.51 -0.257 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.2 tp -86.74 128.15 57.5 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-O 119.223 -0.418 . . . . 0.0 110.037 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -38.22 156.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.666 1.578 . . . . 0.0 112.092 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.435 ' O ' ' OE2' ' A' ' 153' ' ' GLU . 97.6 Cg_endo -74.65 -169.72 0.65 Allowed 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.656 2.237 . . . . 0.0 111.983 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 14.6 m -116.71 75.54 0.97 Allowed 'General case' 0 CA--C 1.522 -0.109 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.661 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.524 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 31.3 ptt-85 -51.12 -38.7 53.44 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.386 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -161.22 170.47 20.21 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.142 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.3 m -57.8 -20.8 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -64.8 -33.96 77.23 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.435 ' OE2' ' O ' ' A' ' 147' ' ' PRO . 0.0 OUTLIER -61.54 -79.69 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.807 179.289 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.2 p -35.14 -33.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.969 0.908 . . . . 0.0 111.104 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.459 ' O ' ' N ' ' A' ' 159' ' ' GLY . 4.9 tmt_? -68.32 -51.76 41.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.679 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.51 -17.55 62.95 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.633 1.206 . . . . 0.0 107.956 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -83.42 -45.63 13.45 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 112.582 -2.099 . . . . 0.0 111.86 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -130.79 -27.35 2.11 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 94.01 24.39 20.01 Favored Glycine 0 N--CA 1.467 0.754 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 -178.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -43.07 -95.99 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.749 0.309 . . . . 0.0 110.968 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.514 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 60.53 35.45 20.17 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.559 ' C ' ' H ' ' A' ' 164' ' ' VAL . 2.0 m-85 -172.61 -63.02 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.005 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -71.84 25.13 0.25 Allowed 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.301 2.001 . . . . 0.0 110.813 177.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.559 ' H ' ' C ' ' A' ' 162' ' ' PHE . 16.0 m -128.38 166.09 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.694 -178.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.19 65.05 28.21 Favored Pre-proline 0 N--CA 1.476 0.832 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.552 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -36.12 142.65 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 123.429 2.753 . . . . 0.0 114.862 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 176.63 -168.49 40.53 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 113.934 -1.485 . . . . 0.0 111.132 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -155.52 148.96 24.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.775 0.322 . . . . 0.0 110.171 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.7 t -108.1 136.04 48.45 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -54.07 -69.62 1.18 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 144.36 77.2 0.03 OUTLIER Glycine 0 N--CA 1.466 0.673 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.527 ' O ' ' N ' ' A' ' 174' ' ' ASN . 86.4 mtm-85 -122.82 14.67 10.05 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.332 0.253 . . . . 0.0 110.741 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.418 ' CD1' ' N ' ' A' ' 173' ' ' LEU . 10.0 mp 58.03 -74.4 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.696 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.527 ' N ' ' O ' ' A' ' 172' ' ' ARG . 75.2 m-20 37.54 71.99 0.92 Allowed Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.413 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.34 144.39 99.51 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.535 2.157 . . . . 0.0 111.188 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 14.2 p -78.47 114.48 17.41 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.312 0.577 . . . . 0.0 110.034 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -135.18 158.36 44.57 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.145 -177.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 43.6 pt -119.85 143.82 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.988 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -130.97 166.86 20.05 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.714 0.769 . . . . 0.0 111.413 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -79.46 105.72 10.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.156 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -64.67 -19.18 65.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.659 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.475 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.5 mm? -62.4 -41.78 98.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.195 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.17 -42.4 7.07 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 63.23 25.99 68.88 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.451 -1.059 . . . . 0.0 110.451 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -63.41 136.1 57.4 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.18 0.514 . . . . 0.0 110.862 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.552 ' H ' ' CD2' ' A' ' 186' ' ' LEU . 0.7 OUTLIER -105.57 179.73 4.18 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.488 -179.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -125.24 68.01 1.13 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.594 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.521 ' CD ' ' H ' ' A' ' 188' ' ' ARG . 0.0 OUTLIER -72.46 -20.36 61.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.54 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.67 -30.21 70.87 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.883 0 CA-C-O 118.201 -1.333 . . . . 0.0 110.695 -179.674 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -93.27 7.86 42.67 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.469 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -62.57 -40.74 97.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.619 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.7 mp -62.24 -42.86 99.69 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -64.6 -40.55 95.71 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -63.18 -41.73 99.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.72 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -60.57 -44.99 95.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.698 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.65 -44.47 96.91 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.099 0.476 . . . . 0.0 110.044 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.75 -43.13 97.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.69 -42.66 79.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.943 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.79 -41.02 99.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.86 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.37 -54.72 42.3 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.828 0.347 . . . . 0.0 111.333 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.7 pt -68.17 -35.71 72.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.241 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -59.39 -51.4 70.05 Favored 'General case' 0 C--O 1.216 -0.693 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.939 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.503 ' O ' ' N ' ' A' ' 20' ' ' GLU . 87.8 t -63.15 -38.91 83.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.61 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.448 ' CD2' ' C ' ' A' ' 17' ' ' LEU . 6.5 tt -52.63 -51.11 61.51 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.282 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -78.0 -49.06 14.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.176 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -67.78 -29.82 69.11 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.046 0.45 . . . . 0.0 110.813 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 16' ' ' VAL . 96.7 mt-10 56.88 60.39 3.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.42 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.43 ' NH2' ' O ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -154.65 159.49 40.83 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.59 0.709 . . . . 0.0 110.642 179.139 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.43 ' O ' ' NH2' ' A' ' 21' ' ' ARG . 8.7 p -74.67 137.06 23.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.771 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.62 165.56 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 120.631 0.253 . . . . 0.0 110.444 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.91 135.85 57.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.251 0.548 . . . . 0.0 111.046 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.495 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 1.3 t80 -124.6 140.85 36.33 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.495 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 59.3 Cg_endo -81.65 145.32 14.49 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.106 1.204 . . . . 0.0 111.108 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.536 ' C ' ' H ' ' A' ' 29' ' ' ALA . 55.7 m -132.06 134.61 45.71 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.865 0.364 . . . . 0.0 110.939 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -73.91 31.02 0.08 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.519 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.536 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -157.49 -78.73 0.08 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.477 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 73.2 t -127.09 129.35 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.511 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 93.2 m-85 -43.3 146.27 0.48 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.302 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -152.95 -172.12 20.99 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.7 m -131.92 167.32 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.83 176.39 34.91 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.114 -1.041 . . . . 0.0 112.081 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.504 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -154.03 -163.57 1.66 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.636 -178.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.504 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 17.2 p-10 -97.44 108.09 42.87 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -177.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 36' ' ' ASP . 64.6 Cg_exo -38.93 174.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.82 2.347 . . . . 0.0 113.937 177.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 46.2 t0 37.59 77.98 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.433 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.5 m -153.22 142.96 21.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.137 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.556 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -71.5 -35.65 70.83 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.27 0.557 . . . . 0.0 109.745 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.2 -43.59 91.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.566 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.94 -49.42 77.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.743 0.306 . . . . 0.0 111.339 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.3 p -63.93 -47.03 92.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.811 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.3 mtt -65.64 -48.18 73.06 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -61.72 -33.17 73.57 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -70.71 -46.32 63.3 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.419 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.3 mt -76.39 -11.1 59.84 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 120.897 0.379 . . . . 0.0 111.248 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.99 -81.26 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.592 -176.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.424 HD22 ' H ' ' A' ' 50' ' ' LYS . 2.3 pt? -72.94 -35.93 67.1 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.424 ' H ' HD22 ' A' ' 49' ' ' LEU . 26.5 mmmt -75.21 -50.04 17.48 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.928 -177.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 33.95 67.05 0.22 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.759 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.2 mmm-85 178.58 -54.02 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.91 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.692 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.91 -6.57 17.58 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.647 2.232 . . . . 0.0 112.748 -178.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.451 ' CG1' ' N ' ' A' ' 55' ' ' ASP . 14.8 p -43.18 -46.74 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.456 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.451 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 41.0 t0 -64.16 -42.68 96.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.025 0.44 . . . . 0.0 110.305 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -61.28 -39.63 91.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.62 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 64.72 112.03 0.01 OUTLIER Glycine 0 CA--C 1.519 0.314 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.553 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -54.57 -158.35 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.097 0.475 . . . . 0.0 111.857 -179.488 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 67.9 mt -112.75 146.24 17.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.247 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 14.7 mt -122.16 150.15 42.62 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.7 tp -120.28 130.56 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-O 121.178 0.514 . . . . 0.0 110.599 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.54 149.48 41.26 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.7 -29.34 8.75 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.178 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.533 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 10.9 m120 -116.72 150.02 38.9 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.038 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -77.24 -13.95 59.85 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -50.87 -31.32 17.02 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.47 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.533 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 4.7 pm0 -94.52 -13.08 26.44 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -92.94 -12.33 31.11 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.476 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 75.0 tttt -80.16 -39.63 1.23 Allowed Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.589 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 44.0 Cg_endo -105.55 -0.95 0.19 Allowed 'Trans proline' 0 C--N 1.316 -1.163 0 C-N-CA 122.968 2.445 . . . . 0.0 112.474 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.412 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 68.0 t80 -97.85 -5.2 35.12 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -177.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.469 ' CG2' ' N ' ' A' ' 73' ' ' ASP . 5.1 mp -127.1 166.33 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.469 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 93.3 m-20 -64.2 -9.46 17.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.23 -179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 55.65 33.68 21.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.89 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.1 t -96.81 -42.02 8.17 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 10.5 ptp -91.45 -6.84 52.08 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.396 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.3 tp -93.02 126.05 37.92 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.685 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.527 ' HG1' ' N ' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -159.77 160.85 34.4 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.92 -177.003 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.527 ' N ' ' HG1' ' A' ' 78' ' ' THR . 98.5 m-20 -39.22 -47.3 1.62 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.748 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.17 -33.57 63.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.022 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' A' ' 78' ' ' THR . 67.8 tp60 -65.03 -40.77 95.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.974 0.416 . . . . 0.0 110.508 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.9 mmt85 -62.69 -52.33 63.71 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 122.469 1.128 . . . . 0.0 108.95 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 87' ' ' SER . 81.9 tt0 -55.9 -50.68 70.01 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 113.781 -1.554 . . . . 0.0 110.135 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 m -61.12 -50.17 74.31 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.976 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.4 tt -67.49 -31.97 55.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.864 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -77.72 -35.25 52.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.774 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 83' ' ' GLU . 13.1 m -87.27 -16.67 34.51 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.582 0.229 . . . . 0.0 110.994 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 89' ' ' TRP . 74.5 ttt-85 -113.34 75.51 0.92 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.7 0.286 . . . . 0.0 110.237 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.452 ' O ' ' O ' ' A' ' 88' ' ' ARG . 82.5 m95 56.85 147.64 0.05 OUTLIER Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.615 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.35 -24.49 37.08 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.172 1.915 . . . . 0.0 112.488 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 156.91 79.48 0.03 OUTLIER Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -83.82 -9.46 9.86 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.72 2.28 . . . . 0.0 112.162 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.0 p -137.15 147.49 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.296 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.9 m -90.27 125.98 35.68 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.189 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -117.4 140.5 49.5 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.1 t -99.77 109.75 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-O 121.546 0.688 . . . . 0.0 111.156 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -96.92 151.05 37.53 Favored Pre-proline 0 N--CA 1.469 0.482 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.69 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -65.77 104.8 0.71 Allowed 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.822 1.681 . . . . 0.0 111.247 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.14 162.39 71.65 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.55 141.16 90.78 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 CA-C-N 120.098 1.071 . . . . 0.0 111.756 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -156.61 54.97 0.55 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.341 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 75.5 p -73.02 -23.07 60.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.277 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.612 ' H ' ' CD ' ' A' ' 104' ' ' PRO . 0.5 OUTLIER -166.92 -39.32 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.612 ' CD ' ' H ' ' A' ' 103' ' ' THR . 9.9 Cg_exo -70.11 -166.41 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.324 2.016 . . . . 0.0 112.445 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.477 ' NH2' ' O ' ' A' ' 110' ' ' ARG . 6.4 tpt180 -169.58 0.08 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.626 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 2.3 p90 -70.85 -8.99 56.61 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.098 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.65 ' CD1' ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -77.28 -18.38 57.62 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.44 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 54' ' ' VAL . 94.1 m -141.76 -39.33 0.38 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.918 0.389 . . . . 0.0 110.572 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 83.27 13.95 75.48 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.606 -0.597 . . . . 0.0 111.606 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.477 ' O ' ' NH2' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -162.41 -77.77 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.101 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -99.17 -162.12 0.93 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.311 -0.404 . . . . 0.0 109.957 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 53.4 p30 -134.55 61.8 1.66 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.828 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 83.0 p -156.94 128.75 7.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.613 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 53.6 mt -124.13 134.96 53.21 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.95 120.99 18.34 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.439 175.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.4 p -143.74 158.39 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.824 0.345 . . . . 0.0 110.413 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -144.73 161.77 38.39 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.815 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.9 t -123.23 130.38 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.1 t -129.83 128.25 41.92 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.767 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -133.95 82.64 1.99 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.848 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.581 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 70.6 t60 -172.88 -35.73 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.581 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 39.6 Cg_endo -93.06 -161.43 0.09 OUTLIER 'Trans proline' 0 N--CA 1.484 0.949 0 C-N-CA 122.045 1.83 . . . . 0.0 111.847 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 37.6 mt -78.42 -5.74 53.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.891 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.2 t -58.05 -45.07 88.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.808 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.581 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 27.1 m -53.05 -62.31 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.789 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.705 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.581 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -41.38 -42.72 2.32 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.877 0.37 . . . . 0.0 110.898 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.4 tp -69.67 -48.95 57.97 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.303 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 56.0 m -70.65 -48.92 52.43 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.548 0.689 . . . . 0.0 110.757 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.456 ' N ' ' O ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER -54.28 -42.04 69.56 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.216 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.432 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -58.17 -55.44 35.0 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.234 -177.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -61.59 -21.22 64.14 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.515 -1.221 . . . . 0.0 108.932 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.57 -0.23 85.94 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' A' ' 134' ' ' PRO . 31.4 mttp -151.46 159.53 33.25 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 120.605 -0.438 . . . . 0.0 109.944 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 133' ' ' LYS . 5.7 Cg_exo -41.0 176.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 123.855 3.036 . . . . 0.0 113.021 -178.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.8 tp -130.94 123.24 28.44 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.94 152.99 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 10.8 t -129.54 132.86 46.95 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.107 0.479 . . . . 0.0 111.305 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.8 m -135.3 164.49 27.61 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.888 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.1 m -71.4 146.95 48.4 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.47 81.16 1.93 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.712 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 48.1 p-10 -159.43 168.06 27.19 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.303 0.573 . . . . 0.0 110.454 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.2 -162.35 1.43 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.166 -178.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 77.5 p -61.92 -39.74 93.08 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.611 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -163.61 4.85 0.07 OUTLIER Glycine 0 CA--C 1.511 -0.179 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.7 tp -81.43 127.69 72.55 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.164 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -39.24 157.94 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.7 1.6 . . . . 0.0 111.972 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.424 ' O ' ' OE1' ' A' ' 153' ' ' GLU . 76.3 Cg_endo -73.15 -163.89 0.17 Allowed 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.505 2.137 . . . . 0.0 112.242 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 11.3 m -118.52 73.71 0.93 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.524 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.511 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 37.6 ptt180 -54.14 -35.91 62.72 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.169 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.95 167.89 20.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -56.23 -18.6 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 CA-C-O 121.638 0.732 . . . . 0.0 109.128 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -64.41 -36.45 84.19 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.429 ' OE1' ' OE1' ' A' ' 157' ' ' GLN . 0.4 OUTLIER -59.26 -72.06 0.11 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.793 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.3 p -47.97 -30.17 2.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.421 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.457 ' O ' ' N ' ' A' ' 159' ' ' GLY . 4.5 tmt_? -84.01 -44.81 13.77 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 122.293 1.044 . . . . 0.0 110.187 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.41 -41.89 85.95 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.497 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.453 ' CG ' ' N ' ' A' ' 158' ' ' PHE . 8.1 pt20 -80.95 -48.52 12.18 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 113.195 -1.82 . . . . 0.0 111.978 -177.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.453 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 33.7 t80 -107.07 -35.94 6.73 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -177.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 96.86 24.64 12.79 Favored Glycine 0 N--CA 1.475 1.259 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 -178.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -43.23 -93.96 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.66 0.267 . . . . 0.0 110.655 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.47 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.66 36.11 16.73 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.526 ' C ' ' H ' ' A' ' 164' ' ' VAL . 2.0 m-85 -175.18 -62.69 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.172 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -72.91 28.73 0.29 Allowed 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.364 2.043 . . . . 0.0 110.794 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.526 ' H ' ' C ' ' A' ' 162' ' ' PHE . 15.8 m -132.2 167.78 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.899 -178.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.9 t -124.0 65.5 37.56 Favored Pre-proline 0 N--CA 1.473 0.677 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.698 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -37.51 139.99 0.25 Allowed 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 123.586 2.857 . . . . 0.0 114.967 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 160.46 174.25 30.05 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 113.987 -1.461 . . . . 0.0 110.72 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -159.51 133.77 7.63 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 10.3 t -88.3 -32.54 18.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.983 0.421 . . . . 0.0 110.148 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 150.4 -40.14 0.84 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 105.83 6.25 37.77 Favored Glycine 0 N--CA 1.466 0.639 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -83.32 139.63 32.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.464 -0.368 . . . . 0.0 110.236 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 60.3 tp -76.25 151.65 36.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.191 0.519 . . . . 0.0 110.663 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -126.39 149.41 67.37 Favored Pre-proline 0 N--CA 1.472 0.656 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.826 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -74.98 87.6 1.31 Allowed 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.046 1.831 . . . . 0.0 111.886 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 71.1 m -128.66 123.19 32.56 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.31 0.576 . . . . 0.0 110.062 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -133.85 174.3 10.61 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.81 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 19.9 tt -108.47 127.91 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.212 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -127.86 164.34 22.45 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.753 0.787 . . . . 0.0 112.353 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -81.28 106.68 13.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.075 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -70.77 -12.39 61.52 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.314 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.461 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.7 mm? -64.23 -40.58 96.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.867 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.8 -41.71 6.42 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.111 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 60.29 26.95 64.66 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -58.79 134.44 56.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.097 0.475 . . . . 0.0 110.701 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.575 ' H ' ' CD2' ' A' ' 186' ' ' LEU . 0.6 OUTLIER -108.78 -176.14 2.96 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.423 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -98.58 58.4 1.22 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.436 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.61 138.65 52.92 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.885 0.374 . . . . 0.0 110.476 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -138.01 137.06 37.49 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.285 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.833 0 CA-C-O 118.026 -1.43 . . . . 0.0 110.813 -179.935 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -95.68 6.34 49.17 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.304 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -63.37 -40.83 98.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.578 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 9.7 mp -62.08 -42.66 99.44 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -63.95 -41.32 97.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.021 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 78.8 ttt-85 -61.96 -42.36 99.04 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.887 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -60.72 -45.2 95.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.562 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.42 -42.54 98.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.998 0.428 . . . . 0.0 110.337 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.38 -43.63 98.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.721 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.12 -47.22 78.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.493 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.06 -39.09 91.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.635 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.34 -53.08 62.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.629 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 38.2 pt -70.01 -33.43 55.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.197 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.423 ' OD1' ' OE2' ' A' ' 19' ' ' GLU . 24.6 t70 -57.74 -55.13 38.79 Favored 'General case' 0 C--O 1.217 -0.637 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.147 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 20' ' ' GLU . 97.9 t -63.6 -40.11 87.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.704 0.288 . . . . 0.0 110.675 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.44 ' CD2' ' C ' ' A' ' 17' ' ' LEU . 6.3 tt -52.16 -48.91 64.69 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.303 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -80.29 -52.59 7.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.289 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.423 ' OE2' ' OD1' ' A' ' 15' ' ' ASP . 92.7 mt-10 -66.91 -34.97 78.94 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.801 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.8 mt-10 60.19 87.48 0.09 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.122 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.08 -135.74 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.668 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.3 p -140.62 140.76 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -129.76 166.18 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 120.982 0.42 . . . . 0.0 111.757 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.96 129.34 39.36 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.411 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.513 ' CE2' ' O ' ' A' ' 26' ' ' PRO . 4.4 t80 -115.48 138.25 23.63 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.513 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 64.0 Cg_endo -81.41 144.08 14.16 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.144 1.229 . . . . 0.0 111.615 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.532 ' C ' ' H ' ' A' ' 29' ' ' ALA . 58.1 m -134.53 132.93 39.76 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.013 0.435 . . . . 0.0 111.153 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -72.84 30.3 0.06 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.71 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.532 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -158.54 -76.1 0.08 Allowed 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 120.784 0.326 . . . . 0.0 110.82 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.3 t -125.77 127.69 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 120.96 0.41 . . . . 0.0 110.26 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -48.88 145.76 3.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.765 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -154.83 -173.9 24.17 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.7 m -131.23 170.58 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.407 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -158.95 -176.96 31.58 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 119.765 -1.207 . . . . 0.0 112.453 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -158.16 -167.2 2.14 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.592 0.234 . . . . 0.0 110.716 -179.104 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.472 ' CG ' ' CZ ' ' A' ' 131' ' ' TYR . 18.3 t70 -95.12 109.4 44.41 Favored Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 36' ' ' ASP . 32.8 Cg_exo -37.28 172.27 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.778 2.319 . . . . 0.0 114.358 177.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.432 ' C ' ' HG ' ' A' ' 39' ' ' SER . 98.0 m-20 40.9 72.22 0.17 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.855 178.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.432 ' HG ' ' C ' ' A' ' 38' ' ' ASP . 3.2 m -153.16 137.55 16.68 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.557 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -67.6 -33.62 75.37 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.075 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.458 ' CG2' ' N ' ' A' ' 42' ' ' ALA . 12.9 t -62.26 -46.11 90.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.026 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.458 ' N ' ' CG2' ' A' ' 41' ' ' THR . . . -58.4 -51.23 70.68 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.408 -178.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.5 p -62.59 -44.14 99.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.412 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 61.9 mtt -64.03 -39.3 93.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.15 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 51.3 ttt-85 -62.39 -34.4 76.64 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 87.9 mt -74.72 -58.78 3.07 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.3 mt -55.96 -16.3 4.63 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.36 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -68.6 -86.43 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -77.13 -33.66 56.75 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -76.18 -50.43 14.58 Favored 'General case' 0 C--N 1.349 0.557 0 C-N-CA 119.798 -0.761 . . . . 0.0 110.723 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 35.47 65.77 0.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.703 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 179.61 -54.28 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.83 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.235 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.09 -6.71 17.59 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.637 2.224 . . . . 0.0 112.088 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.4 p -43.57 -49.29 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.73 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 55' ' ' ASP . 39.8 t0 -66.28 -40.94 90.43 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.687 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -60.88 -39.8 90.61 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.084 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 65.48 107.63 0.01 OUTLIER Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.564 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -52.62 -161.28 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.375 0.607 . . . . 0.0 112.278 -179.477 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 73.2 mt -106.58 142.95 18.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.166 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 16.0 mt -118.05 142.63 47.19 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.4 tp -111.82 126.91 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-O 121.408 0.623 . . . . 0.0 111.622 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.76 148.29 39.99 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.094 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.55 -27.65 9.76 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.075 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.716 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 98.6 m-20 -117.91 151.12 38.04 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.946 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -79.26 -13.51 59.63 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -52.54 -31.99 38.46 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.216 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.716 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 4.8 pm0 -93.79 -10.63 33.49 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.79 -18.73 24.43 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.45 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 47.1 tttm -76.71 -39.0 2.24 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 69.7 Cg_endo -104.38 -2.38 0.23 Allowed 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 122.923 2.416 . . . . 0.0 112.582 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.402 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 68.7 t80 -94.85 -10.55 30.99 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.838 0.351 . . . . 0.0 111.06 -178.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.474 ' CG2' ' N ' ' A' ' 73' ' ' ASP . 5.1 mp -125.52 168.14 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.474 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 93.0 m-20 -62.3 -13.03 24.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.786 0.327 . . . . 0.0 110.829 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 44.7 t0 55.54 21.74 4.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.841 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.481 ' CG2' ' H ' ' A' ' 76' ' ' MET . 8.4 t -89.53 -54.51 4.05 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.481 ' H ' ' CG2' ' A' ' 75' ' ' THR . 13.5 ptp -68.08 -37.52 81.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.225 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 tp -64.22 139.13 58.73 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.208 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.9 173.19 14.06 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.461 -176.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -60.26 -43.06 96.49 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.202 0.314 . . . . 0.0 111.23 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.9 p -60.92 -32.48 52.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.994 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -63.47 -40.89 98.32 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.094 0.473 . . . . 0.0 110.498 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.0 mmt85 -63.34 -51.51 65.65 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 122.648 1.213 . . . . 0.0 108.782 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 87' ' ' SER . 80.7 tt0 -57.17 -50.22 73.5 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 113.667 -1.606 . . . . 0.0 110.096 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.5 m -62.04 -49.03 77.65 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.264 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 89' ' ' TRP . 13.9 tt -68.52 -26.05 32.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.585 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -86.02 -32.22 21.58 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.438 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 83' ' ' GLU . 10.7 m -88.64 -9.12 53.23 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.745 0.307 . . . . 0.0 110.784 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 89' ' ' TRP . 62.4 ttm-85 -128.47 79.53 1.91 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.514 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.448 ' O ' ' O ' ' A' ' 88' ' ' ARG . 2.7 m-90 56.43 152.54 0.07 OUTLIER Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.667 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.88 -23.15 41.53 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.879 1.719 . . . . 0.0 111.753 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 157.95 79.08 0.03 OUTLIER Glycine 0 CA--C 1.53 1.004 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.53 -35.63 86.32 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.714 2.276 . . . . 0.0 112.427 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.2 p -133.84 147.69 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.84 0.352 . . . . 0.0 110.455 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 26.4 m -84.16 141.45 31.05 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.362 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -119.01 139.81 51.09 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.732 0.301 . . . . 0.0 110.964 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.3 t -96.85 103.55 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 121.424 0.63 . . . . 0.0 109.689 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -91.54 152.01 43.08 Favored Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.079 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.04 110.74 3.15 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.883 1.722 . . . . 0.0 111.341 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.7 153.23 70.33 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.852 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.66 151.95 78.58 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.155 1.904 . . . . 0.0 111.664 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -151.65 70.74 0.96 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.388 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.417 ' O ' ' OG1' ' A' ' 103' ' ' THR . 69.5 p -66.65 -30.92 71.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.707 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.635 ' H ' ' CD ' ' A' ' 104' ' ' PRO . 1.2 m -167.1 -38.01 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.635 ' CD ' ' H ' ' A' ' 103' ' ' THR . 15.4 Cg_exo -67.57 -163.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.448 2.099 . . . . 0.0 112.266 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.486 ' NH1' ' O ' ' A' ' 110' ' ' ARG . 5.5 tpp85 -167.77 3.35 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.935 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 63.5 p-90 -74.03 -8.6 56.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.753 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.674 ' CD1' ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -73.56 -23.42 59.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.081 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 88.6 m -142.71 -39.33 0.34 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.107 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 89.31 9.03 67.65 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.486 ' O ' ' NH1' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -158.24 -79.17 0.07 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 117.038 0.419 . . . . 0.0 109.911 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -93.41 -129.61 0.12 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.268 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -157.89 61.58 0.47 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.507 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.6 p -157.52 153.65 27.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.81 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.78 139.17 9.93 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.354 1.073 . . . . 0.0 113.461 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.56 133.04 48.71 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 112.971 -1.922 . . . . 0.0 109.885 178.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.8 p -149.98 153.82 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.805 0.336 . . . . 0.0 110.341 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 71.7 ttp85 -147.89 158.7 44.17 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.571 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.2 t -122.18 133.55 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 116.288 -0.414 . . . . 0.0 109.928 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.7 t -132.71 130.9 40.64 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -135.85 85.22 2.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.626 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.527 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 36.2 t60 -172.83 -38.36 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.422 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.527 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 29.1 Cg_endo -92.84 -161.83 0.09 OUTLIER 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 122.026 1.818 . . . . 0.0 112.028 -178.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.4 mp -78.35 -4.15 46.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.822 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 87.9 t -58.27 -44.96 89.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.855 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.584 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 29.6 m -53.98 -61.94 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.844 0 C-N-CA 119.434 -0.906 . . . . 0.0 108.633 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.584 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -41.08 -43.34 2.19 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.91 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 45.4 tp -70.16 -47.86 59.8 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 120.589 -0.445 . . . . 0.0 111.275 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 64.2 m -70.22 -49.15 53.0 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.517 0.675 . . . . 0.0 110.791 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.437 ' N ' ' O ' ' A' ' 125' ' ' VAL . 1.0 OUTLIER -55.01 -42.02 72.02 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.455 179.354 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.436 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -58.07 -56.27 24.23 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.93 -177.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.472 ' CZ ' ' CG ' ' A' ' 36' ' ' ASP . 4.2 t80 -63.44 -26.33 68.68 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.263 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.92 3.26 85.69 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 134' ' ' PRO . 69.4 mttt -149.46 157.87 38.57 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-N 116.908 0.354 . . . . 0.0 110.758 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 133' ' ' LYS . 5.7 Cg_exo -42.67 178.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 123.874 3.049 . . . . 0.0 112.705 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.0 tp -134.76 122.36 22.03 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.407 ' O ' ' CA ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -64.23 143.1 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 C-N-CA 117.975 -1.49 . . . . 0.0 107.166 -179.788 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.7 t -116.76 123.88 48.26 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 123.568 0.542 . . . . 0.0 111.333 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.6 m -128.86 165.27 21.34 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.152 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.5 t -70.96 149.42 46.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.643 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.25 -38.85 91.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.178 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 55.2 p30 -55.48 152.08 9.41 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.889 0.852 . . . . 0.0 111.351 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.8 -157.0 0.72 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.575 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.5 t -60.31 -45.27 93.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.492 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -161.13 4.46 0.09 OUTLIER Glycine 0 C--N 1.329 0.17 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.2 tp -84.94 127.27 65.41 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -37.47 157.03 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.8 1.667 . . . . 0.0 112.429 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.93 -163.52 0.2 Allowed 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.38 2.053 . . . . 0.0 112.314 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 15.8 t -114.4 78.88 1.19 Allowed 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.515 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -58.67 -34.71 71.55 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.966 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -163.02 165.29 25.02 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -55.9 -18.84 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -65.38 -34.17 77.68 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.519 ' OE1' ' NE2' ' A' ' 157' ' ' GLN . 6.7 tm-20 -59.21 -70.56 0.15 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.507 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.4 p -50.02 -29.58 5.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.359 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -84.42 -43.76 14.35 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 122.392 1.091 . . . . 0.0 110.143 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.93 -41.23 86.84 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.454 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.519 ' NE2' ' OE1' ' A' ' 153' ' ' GLU . 0.7 OUTLIER -82.46 -48.6 10.89 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 112.981 -1.918 . . . . 0.0 112.143 -177.02 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.474 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 38.3 t80 -106.97 -36.62 6.56 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -177.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 97.44 25.68 10.73 Favored Glycine 0 N--CA 1.473 1.106 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -43.43 -94.9 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.612 0.244 . . . . 0.0 110.734 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.424 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 63.44 36.68 11.19 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 121.292 0.568 . . . . 0.0 109.739 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.534 ' C ' ' H ' ' A' ' 164' ' ' VAL . 1.2 m-85 -177.14 -61.63 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.214 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.85 29.24 0.32 Allowed 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.14 1.893 . . . . 0.0 110.505 178.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.534 ' H ' ' C ' ' A' ' 162' ' ' PHE . 15.9 m -132.34 167.65 25.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.558 -178.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.0 t -124.27 65.11 39.12 Favored Pre-proline 0 N--CA 1.476 0.84 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.71 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -37.41 145.06 0.12 Allowed 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 123.815 3.01 . . . . 0.0 115.158 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 165.77 116.92 0.38 Allowed Glycine 0 CA--C 1.523 0.573 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.493 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -85.06 144.99 27.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.886 0.374 . . . . 0.0 110.068 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.8 t -147.14 151.23 36.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.205 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -61.26 -70.12 1.11 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 172' ' ' ARG . . . 167.06 -75.06 0.14 Allowed Glycine 0 CA--C 1.521 0.424 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' A' ' 171' ' ' GLY . 69.5 ttt180 58.71 136.02 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.063 0.459 . . . . 0.0 110.737 179.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.426 ' CD1' ' N ' ' A' ' 173' ' ' LEU . 10.2 mp -56.8 -97.84 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.777 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 41.54 63.54 6.2 Favored Pre-proline 0 N--CA 1.462 0.173 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.28 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -74.61 159.44 42.62 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.618 2.212 . . . . 0.0 111.823 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 61.3 m -94.54 115.23 27.34 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.54 0.686 . . . . 0.0 109.902 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -126.11 144.46 50.73 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.698 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 14.2 pt -106.02 134.35 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.284 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 19.3 mmm-85 -120.12 157.44 28.98 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.526 0.679 . . . . 0.0 110.189 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 184' ' ' GLY . 97.6 m-20 -72.03 104.53 3.59 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.903 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -68.49 -18.33 64.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.041 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.478 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.7 mm? -64.01 -41.38 97.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.018 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 5.2 t -121.3 -51.46 2.09 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.695 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 180' ' ' ASP . . . 93.54 41.96 4.34 Favored Glycine 0 N--CA 1.464 0.567 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -89.87 141.61 28.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.265 0.555 . . . . 0.0 111.334 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.445 ' N ' ' CD2' ' A' ' 186' ' ' LEU . 0.7 OUTLIER -73.63 -179.35 3.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.781 179.79 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -104.27 -13.67 16.08 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.608 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.94 141.34 30.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.23 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -149.86 -29.59 0.23 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.886 0.374 . . . . 0.0 110.337 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.76 0 CA-C-O 118.075 -1.403 . . . . 0.0 111.01 179.961 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.2 p30 -78.96 -6.98 57.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.455 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -62.16 -41.03 97.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.555 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.433 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 10.2 mp -63.15 -42.08 99.38 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.962 0.41 . . . . 0.0 110.048 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -63.32 -42.04 98.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.421 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -63.2 -39.36 94.42 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.408 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -61.52 -43.78 98.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.681 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.48 -45.23 88.24 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.808 0.337 . . . . 0.0 110.264 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.0 mm -63.69 -43.11 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.26 -47.37 78.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.045 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.01 -41.59 96.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.103 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.64 -54.62 44.34 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.9 0.381 . . . . 0.0 111.187 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.8 pt -69.23 -37.04 75.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.149 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -56.59 -56.2 24.3 Favored 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 20' ' ' GLU . 99.6 t -63.29 -39.93 87.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 121.16 -0.216 . . . . 0.0 110.59 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.441 ' CD2' ' C ' ' A' ' 17' ' ' LEU . 6.4 tt -51.79 -49.9 61.79 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.701 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -80.47 -51.87 8.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.148 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -65.86 -34.98 79.4 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.506 -178.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 16' ' ' VAL . 96.2 mt-10 58.51 88.37 0.06 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.107 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.47 -133.99 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.8 p -141.99 140.92 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 pp -129.01 167.62 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-O 121.122 0.487 . . . . 0.0 111.875 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.77 129.6 40.35 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.735 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.539 ' CE2' ' O ' ' A' ' 26' ' ' PRO . 7.8 t80 -117.14 138.82 25.2 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.297 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.539 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 63.6 Cg_endo -79.51 144.69 18.01 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.28 1.32 . . . . 0.0 111.751 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.51 ' C ' ' H ' ' A' ' 29' ' ' ALA . 63.2 m -132.6 134.79 45.35 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.248 0.547 . . . . 0.0 111.057 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -74.69 26.27 0.09 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.77 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.51 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -160.85 -70.28 0.07 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.993 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.6 p -127.93 123.57 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 121.108 0.48 . . . . 0.0 110.097 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.524 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 94.7 m-85 -42.52 151.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.744 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -155.51 -178.68 29.98 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.2 m -130.67 169.66 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.51 -177.39 33.57 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 119.839 -1.172 . . . . 0.0 112.323 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.429 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -158.76 -171.42 3.41 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.511 ' OD1' ' CE1' ' A' ' 131' ' ' TYR . 27.8 t70 -92.66 111.82 52.77 Favored Pre-proline 0 CA--C 1.553 1.083 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 36' ' ' ASP . 12.6 Cg_exo -35.55 167.72 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.81 2.34 . . . . 0.0 114.126 177.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 40.8 78.06 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.679 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.4 m -152.89 149.81 28.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.967 0.413 . . . . 0.0 110.707 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -71.03 -33.2 70.09 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.408 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.19 -43.19 95.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.808 -178.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.0 -50.24 74.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.227 0.536 . . . . 0.0 111.024 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.9 p -64.74 -45.73 94.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.569 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 59.3 mtt -66.67 -45.04 80.18 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.3 ptt85 -64.58 -30.35 71.37 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.933 0.397 . . . . 0.0 110.102 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.1 mt -73.67 -59.75 2.57 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.273 177.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.4 mt -54.81 -20.53 8.82 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.45 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -64.16 -86.24 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.353 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.409 HD22 ' H ' ' A' ' 50' ' ' LYS . 2.2 pt? -77.01 -34.87 57.43 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.409 ' H ' HD22 ' A' ' 49' ' ' LEU . 24.7 mmmt -75.3 -49.65 18.52 Favored 'General case' 0 C--N 1.352 0.682 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.193 -176.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 36.56 65.56 0.46 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.709 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 178.55 -53.99 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.858 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.351 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -77.5 -4.74 14.95 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 C-N-CA 122.781 2.321 . . . . 0.0 112.345 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.431 ' CG1' ' N ' ' A' ' 55' ' ' ASP . 7.2 p -45.46 -48.66 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.56 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 110' ' ' ARG . 13.2 t0 -66.64 -45.41 79.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.334 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -59.69 -41.55 90.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.559 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 69.48 114.48 0.03 OUTLIER Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.567 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -51.03 -164.86 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.337 0.589 . . . . 0.0 112.304 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.411 HG22 HD12 ' A' ' 59' ' ' ILE . 86.4 mt -104.49 145.1 13.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 16.0 mt -117.45 144.54 44.91 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.2 tp -111.18 127.53 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-O 121.069 0.461 . . . . 0.0 110.702 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.11 153.35 30.9 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.57 -28.71 7.06 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.764 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.56 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 98.6 m-20 -114.39 142.1 46.78 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.973 0.416 . . . . 0.0 110.903 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -72.66 -13.65 61.41 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -50.41 -33.78 22.03 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.209 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.56 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 4.3 pm0 -94.08 -11.29 30.91 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -90.06 -17.7 27.28 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.391 -0.818 . . . . 0.0 109.322 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.457 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 48.4 tttm -78.45 -39.17 1.62 Allowed Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.457 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 63.9 Cg_endo -104.01 -2.39 0.25 Allowed 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 122.634 2.223 . . . . 0.0 112.287 -178.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.415 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 67.7 t80 -95.45 -10.18 30.56 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.812 0.339 . . . . 0.0 110.87 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.485 ' CG2' ' N ' ' A' ' 73' ' ' ASP . 4.6 mp -123.3 167.36 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.485 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 98.6 m-20 -59.65 -14.24 12.97 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.237 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 58.8 t0 57.14 28.72 15.42 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.85 0.357 . . . . 0.0 110.467 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.5 t -95.86 -43.05 8.02 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.715 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 18.4 ptm -85.63 -8.13 58.42 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.144 0.497 . . . . 0.0 109.923 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.3 tp -86.51 128.26 34.95 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.611 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.36 164.42 36.35 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.08 -176.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -45.94 -46.77 16.34 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 112.088 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.6 -32.69 54.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.843 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -64.68 -39.78 94.27 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.251 0.548 . . . . 0.0 110.492 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.8 mmt85 -65.86 -52.13 52.99 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 122.33 1.062 . . . . 0.0 108.8 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -55.09 -50.89 68.04 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 113.825 -1.534 . . . . 0.0 110.03 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.3 m -61.07 -49.55 76.9 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.574 -1.194 . . . . 0.0 112.247 -177.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.424 ' O ' ' O ' ' A' ' 89' ' ' TRP . 10.0 tt -68.11 -31.11 50.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.617 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -76.75 -36.2 57.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.541 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.1 m -86.63 -44.28 11.99 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.055 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.482 ' O ' ' CD1' ' A' ' 89' ' ' TRP . 61.8 ttt85 -70.14 -77.06 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.936 0.398 . . . . 0.0 110.44 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.482 ' CD1' ' O ' ' A' ' 88' ' ' ARG . 5.8 m0 -158.4 149.37 16.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.449 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -66.65 -23.59 49.03 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.684 1.59 . . . . 0.0 111.946 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 152.36 83.17 0.04 OUTLIER Glycine 0 CA--C 1.533 1.189 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -76.05 -19.4 15.75 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.631 1.554 . . . . 0.0 111.472 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.4 p -136.19 148.91 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.517 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.5 m -83.18 134.21 34.99 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.813 0.34 . . . . 0.0 110.383 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -113.93 138.93 49.66 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.843 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.2 t -95.87 103.04 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 121.459 0.647 . . . . 0.0 109.592 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -87.37 148.91 45.67 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.537 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.04 108.88 2.77 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.93 1.753 . . . . 0.0 111.194 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.44 155.62 92.25 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.264 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.445 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 89.2 Cg_exo -45.43 -32.33 7.76 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.661 1.574 . . . . 0.0 111.979 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.445 ' CB ' ' O ' ' A' ' 100' ' ' PRO . . . 84.64 -39.85 0.06 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.595 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 52.1 p -61.07 -31.76 71.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.353 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.446 ' CB ' ' CD ' ' A' ' 104' ' ' PRO . 0.1 OUTLIER -55.73 -178.18 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.431 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.446 ' CD ' ' CB ' ' A' ' 103' ' ' THR . 43.0 Cg_exo -57.07 -153.4 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.21 1.94 . . . . 0.0 111.998 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 109' ' ' GLY . 20.1 mmt180 -139.82 -14.7 1.06 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.869 -0.15 . . . . 0.0 111.095 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 2.7 p90 -67.9 -10.28 51.91 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.796 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.662 ' CD1' ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -69.81 -39.24 76.64 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.559 ' C ' ' H ' ' A' ' 110' ' ' ARG . 45.6 m -143.81 -41.4 0.28 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.858 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 56.24 -8.57 0.01 OUTLIER Glycine 0 CA--C 1.535 1.301 0 CA-C-N 115.95 -0.568 . . . . 0.0 113.077 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.559 ' H ' ' C ' ' A' ' 108' ' ' THR . 0.5 OUTLIER -85.03 -52.68 5.79 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 117.898 0.849 . . . . 0.0 109.574 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.529 ' CE2' ' OD1' ' A' ' 112' ' ' ASP . 57.7 t80 -152.44 169.36 22.76 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.324 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.529 ' OD1' ' CE2' ' A' ' 111' ' ' PHE . 18.1 p30 -79.27 49.74 1.0 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.184 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.7 p -160.25 158.04 29.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.084 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.01 138.04 11.24 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.98 132.69 46.31 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 113.557 -1.656 . . . . 0.0 110.296 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.425 ' CG2' ' N ' ' A' ' 117' ' ' ARG . 4.9 p -156.61 163.79 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.425 ' N ' ' CG2' ' A' ' 116' ' ' VAL . 22.6 ptt180 -153.5 160.19 42.46 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.246 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.3 t -125.26 139.89 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.023 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.9 t -141.64 130.04 22.44 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.975 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -132.69 90.17 2.74 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.546 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 9.9 t-80 -173.78 -37.91 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.466 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.546 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 38.2 Cg_endo -93.82 -160.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.32 -0.922 0 C-N-CA 121.932 1.755 . . . . 0.0 112.201 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.7 mp -78.97 -6.51 56.45 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.701 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.2 t -57.16 -45.24 84.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.989 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.584 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 31.5 m -52.91 -62.02 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.21 -0.995 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.022 178.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.584 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -41.23 -45.97 3.03 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 122.369 -0.207 . . . . 0.0 110.943 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.4 tp -67.91 -48.64 65.44 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.206 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 72.1 m -69.53 -49.33 55.49 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.21 0.529 . . . . 0.0 111.197 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.454 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.2 pp0? -54.88 -42.03 71.59 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.855 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.454 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -58.76 -56.39 22.8 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.778 -177.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.511 ' CE1' ' OD1' ' A' ' 36' ' ' ASP . 4.8 t80 -63.0 -24.11 67.76 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.895 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.8 2.76 89.7 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 114.187 -1.37 . . . . 0.0 110.311 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.418 ' O ' ' O ' ' A' ' 134' ' ' PRO . 29.9 mttp -150.2 158.32 36.56 Favored Pre-proline 0 CA--C 1.547 0.833 0 CA-C-N 117.157 0.478 . . . . 0.0 110.342 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 133' ' ' LYS . 6.3 Cg_exo -42.36 -179.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 123.84 3.027 . . . . 0.0 113.442 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.0 tp -134.56 122.78 22.85 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 176.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -64.07 144.87 14.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 117.37 -1.732 . . . . 0.0 107.664 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 12.6 t -116.55 126.8 53.83 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.197 0.522 . . . . 0.0 111.481 -179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.08 162.52 31.51 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.683 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.9 t -72.12 149.14 45.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.044 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.68 78.88 7.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.577 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 56.1 p30 -157.68 165.35 35.69 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.182 0.515 . . . . 0.0 110.328 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.32 -165.82 2.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.174 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.1 p -63.47 -41.25 98.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.043 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -157.4 3.84 0.15 Allowed Glycine 0 N--CA 1.462 0.424 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 146' ' ' PRO . 1.3 tm? -84.0 111.35 32.35 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-O 119.078 -0.487 . . . . 0.0 109.767 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 145' ' ' LEU . 19.5 Cg_exo -34.92 156.52 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.095 1.863 . . . . 0.0 112.745 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.43 171.38 16.31 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.646 2.23 . . . . 0.0 112.229 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 34.7 t -96.09 77.46 3.11 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.664 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.524 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 36.2 ptt180 -53.58 -36.67 62.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.892 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.89 167.24 29.93 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.7 m -57.94 -18.62 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.736 0 CA-C-O 121.846 0.831 . . . . 0.0 109.081 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.62 -36.67 84.57 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.531 ' OE1' ' NE2' ' A' ' 157' ' ' GLN . 5.1 tm-20 -59.48 -73.87 0.08 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.244 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.1 p -45.8 -29.47 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.847 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 159' ' ' GLY . 4.8 tmt_? -83.92 -44.48 14.2 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 122.028 0.918 . . . . 0.0 110.08 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.53 -41.64 85.95 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.257 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.531 ' NE2' ' OE1' ' A' ' 153' ' ' GLU . 0.6 OUTLIER -81.63 -48.74 11.35 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 113.018 -1.901 . . . . 0.0 112.487 -177.092 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.469 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 36.0 t80 -107.04 -35.55 6.85 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -177.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 96.8 24.86 12.44 Favored Glycine 0 N--CA 1.475 1.296 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -44.06 -95.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.953 -0.124 . . . . 0.0 110.812 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.473 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 62.8 38.01 11.97 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.306 0.575 . . . . 0.0 109.955 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.547 ' C ' ' H ' ' A' ' 164' ' ' VAL . 1.4 m-85 -177.97 -61.14 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.377 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -72.69 22.78 0.29 Allowed 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.156 1.904 . . . . 0.0 110.998 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.547 ' H ' ' C ' ' A' ' 162' ' ' PHE . 16.8 m -128.04 167.54 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.636 -177.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.0 t -123.84 65.69 36.48 Favored Pre-proline 0 N--CA 1.476 0.825 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.71 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -35.81 141.83 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 123.748 2.965 . . . . 0.0 115.401 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 176.46 -176.26 47.76 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.721 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -150.91 151.49 32.25 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.2 t -122.91 137.39 54.96 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -53.21 -61.6 6.79 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 152.12 12.67 0.08 OUTLIER Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -62.94 132.98 53.89 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 55.0 tp -62.43 -45.47 92.96 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.776 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 39.23 71.68 1.1 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.988 0.423 . . . . 0.0 111.082 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -59.81 141.78 97.41 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.428 2.085 . . . . 0.0 112.02 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 58.7 m -149.7 119.29 6.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.972 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -135.68 178.77 6.79 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.539 -178.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 8.5 pt -99.89 130.96 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.733 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -125.32 165.54 18.17 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.327 0.584 . . . . 0.0 111.552 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 184' ' ' GLY . 99.4 m-20 -76.73 105.91 8.08 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.074 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -67.99 -15.01 63.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.364 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.498 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.4 mm? -64.6 -41.1 96.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.469 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 5.5 t -121.4 -26.97 4.9 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.956 0.407 . . . . 0.0 111.042 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 180' ' ' ASP . . . 84.39 33.24 20.41 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -167.19 146.92 5.32 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.66 0.267 . . . . 0.0 110.533 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.564 ' H ' ' CD2' ' A' ' 186' ' ' LEU . 0.8 OUTLIER -104.49 176.46 5.15 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.567 179.731 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -107.97 -13.21 15.01 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.252 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.72 144.4 30.24 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.529 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -140.76 142.65 34.73 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.389 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.803 0 CA-C-O 117.878 -1.512 . . . . 0.0 110.933 -179.478 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -63.58 -40.18 96.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.798 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -63.47 -40.36 96.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.629 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.409 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 10.5 mp -62.98 -42.77 99.93 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.873 0.368 . . . . 0.0 110.255 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.59 -41.6 96.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.338 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -65.69 -40.7 92.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.23 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -61.46 -47.8 84.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.698 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.79 -46.86 86.03 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.298 0.571 . . . . 0.0 110.569 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.4 -43.88 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.466 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.78 -41.64 82.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.259 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.54 -41.73 97.78 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.917 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.59 -55.24 36.99 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.319 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.4 pt -69.37 -27.49 34.66 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.148 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -60.95 -56.16 24.35 Favored 'General case' 0 C--O 1.216 -0.659 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.106 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 20' ' ' GLU . 94.0 t -64.57 -40.6 89.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 C-N-CA 121.264 -0.174 . . . . 0.0 111.374 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.417 ' CD1' ' C ' ' A' ' 17' ' ' LEU . 2.0 tm? -56.3 -48.11 77.33 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.354 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -76.51 -49.14 17.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.201 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -69.06 -34.9 75.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.557 -178.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 16' ' ' VAL . 97.2 mt-10 62.5 80.36 0.23 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.22 -139.21 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.844 0.354 . . . . 0.0 110.483 177.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.2 p -134.58 140.61 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 pp -128.81 162.92 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-O 121.023 0.44 . . . . 0.0 111.064 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.26 129.39 41.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.71 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.514 ' CZ ' ' O ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -122.84 148.65 54.36 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -179.432 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.514 ' O ' ' CZ ' ' A' ' 25' ' ' TYR . 57.6 Cg_endo -78.91 148.66 22.31 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.993 1.795 . . . . 0.0 111.783 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.529 ' C ' ' H ' ' A' ' 29' ' ' ALA . 40.8 m -131.41 133.85 45.65 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.469 ' OE2' ' NH1' ' A' ' 117' ' ' ARG . 22.3 pt-20 -74.7 23.12 0.09 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.826 0.346 . . . . 0.0 110.425 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.529 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -155.19 -73.44 0.11 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.2 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 p -128.28 129.85 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.342 0.592 . . . . 0.0 110.751 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.507 ' CD2' ' O ' ' A' ' 148' ' ' CYS . 46.8 p90 -37.73 144.88 0.08 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.798 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -155.61 -173.41 24.24 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.5 m -132.27 168.06 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.411 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -156.96 -178.94 31.52 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.553 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.454 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.8 OUTLIER -159.24 -165.21 1.54 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.025 0.441 . . . . 0.0 111.328 -178.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.454 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 85.0 m-20 -91.61 108.02 26.34 Favored Pre-proline 0 CA--C 1.555 1.155 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -43.64 -61.18 0.6 Allowed 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.916 1.744 . . . . 0.0 112.262 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -71.94 67.01 0.6 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.058 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.1 m -155.71 133.99 11.57 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.88 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -65.73 -34.32 77.92 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.341 0.591 . . . . 0.0 110.688 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.0 t -60.76 -41.19 94.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.171 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.64 -51.64 67.94 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.608 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.65 -42.14 95.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.285 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 92.2 mtp -63.77 -40.24 96.21 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.9 ttt85 -59.95 -42.54 94.28 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 121.967 0.889 . . . . 0.0 108.611 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.99 -53.13 54.96 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.73 -178.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.8 mt -70.77 -11.62 61.06 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.2 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -70.21 -82.6 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 121.152 0.501 . . . . 0.0 111.342 -177.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.421 HD22 ' H ' ' A' ' 50' ' ' LYS . 2.3 pt? -75.97 -35.26 59.7 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.421 ' H ' HD22 ' A' ' 49' ' ' LEU . 24.9 mmmt -76.95 -50.28 13.57 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.966 -177.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 35.32 65.34 0.39 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.919 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 179.02 -53.48 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.778 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.27 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.91 -3.31 12.7 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.709 2.273 . . . . 0.0 112.388 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.428 ' O ' ' O ' ' A' ' 108' ' ' THR . 7.9 p -44.03 -43.87 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.47 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -66.45 -41.73 88.66 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.041 0.448 . . . . 0.0 110.246 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.416 ' CD ' ' N ' ' A' ' 56' ' ' LYS . 1.1 mptm? -60.29 -39.64 87.64 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 62.29 107.71 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.561 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -53.14 -163.2 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.229 0.538 . . . . 0.0 111.591 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.5 mt -101.01 144.32 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.538 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.4 mt -121.7 143.14 49.52 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.5 tp -113.86 128.67 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-O 121.244 0.545 . . . . 0.0 110.958 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.23 156.55 24.11 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.951 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.15 -26.37 5.94 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -118.42 142.64 47.35 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.086 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -69.81 -12.68 61.81 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.64 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -50.75 -31.58 17.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.927 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -95.76 -13.59 24.01 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.403 ' CD2' ' N ' ' A' ' 68' ' ' LEU . 4.0 mm? -92.16 -13.8 30.08 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.471 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 76.8 tttt -80.56 -38.16 1.05 Allowed Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 86.1 Cg_endo -102.38 -3.85 0.33 Allowed 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 122.696 2.264 . . . . 0.0 111.39 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.54 ' HH ' ' CD2' ' A' ' 114' ' ' LEU . 44.9 t80 -92.84 -14.86 27.17 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.687 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.47 ' CG2' ' N ' ' A' ' 73' ' ' ASP . 4.2 mp -122.62 159.9 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.47 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 27.7 p30 -65.86 144.37 56.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.374 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -87.19 7.2 29.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.548 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.442 ' CG2' ' N ' ' A' ' 76' ' ' MET . 15.0 t -78.11 -45.52 23.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.246 0.546 . . . . 0.0 110.854 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.442 ' N ' ' CG2' ' A' ' 75' ' ' THR . 25.0 ptm -84.92 -19.33 32.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.666 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.4 tp -81.78 130.07 34.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.027 -178.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.84 167.26 30.51 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.681 -177.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -48.51 -44.5 36.09 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.725 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.71 -31.76 51.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.994 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -64.52 -40.67 96.06 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.399 0.619 . . . . 0.0 110.533 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.3 mmt85 -66.58 -51.99 50.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.477 1.132 . . . . 0.0 109.462 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 87' ' ' SER . 83.1 tt0 -55.86 -50.66 69.99 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 113.852 -1.522 . . . . 0.0 110.421 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.7 m -61.16 -49.95 75.17 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.013 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.5 tt -67.53 -29.74 46.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.853 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -79.49 -35.31 40.39 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.621 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 83' ' ' GLU . 10.9 m -89.85 -15.35 32.42 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.425 ' O ' ' O ' ' A' ' 89' ' ' TRP . 69.4 ttt180 -115.98 74.67 0.91 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.863 0.363 . . . . 0.0 110.714 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.425 ' O ' ' O ' ' A' ' 88' ' ' ARG . 1.5 m0 59.25 150.32 0.08 OUTLIER Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.668 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.57 -15.55 45.15 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.739 1.626 . . . . 0.0 110.636 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 104.95 69.35 0.76 Allowed Glycine 0 N--CA 1.471 1.031 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.088 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -55.94 -38.95 93.92 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.556 2.171 . . . . 0.0 112.222 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.3 p -75.64 147.47 8.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.209 0.528 . . . . 0.0 111.104 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.496 ' N ' ' O ' ' A' ' 177' ' ' GLU . 19.3 m -102.45 126.25 49.42 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.981 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -116.12 143.04 46.01 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.271 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 84.2 t -84.08 98.96 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-O 121.123 0.487 . . . . 0.0 111.323 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -83.65 139.36 40.83 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.804 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.36 104.92 1.81 Allowed 'Trans proline' 0 N--CA 1.489 1.21 0 C-N-CA 121.566 1.51 . . . . 0.0 110.901 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 112' ' ' ASP . . . -61.9 149.56 85.3 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.8 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.448 ' O ' ' OG1' ' A' ' 103' ' ' THR . 93.9 Cg_endo -73.08 165.82 31.7 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.427 2.085 . . . . 0.0 112.098 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.22 -29.81 71.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.737 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 75.7 p -55.22 -44.24 75.24 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.445 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 100' ' ' PRO . 6.4 p -50.94 151.66 4.29 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.96 -103.85 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.749 1.632 . . . . 0.0 112.387 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.536 ' O ' ' N ' ' A' ' 109' ' ' GLY . 5.3 tpp85 -176.14 -5.02 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.932 0.396 . . . . 0.0 110.132 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -78.07 -10.86 59.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 122.05 0.929 . . . . 0.0 109.401 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.583 ' H ' ' CD2' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -82.39 -16.27 49.71 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.017 -1.447 . . . . 0.0 111.064 -179.567 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.428 ' O ' ' O ' ' A' ' 54' ' ' VAL . 99.0 m -140.69 -42.06 0.4 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.942 0.401 . . . . 0.0 109.972 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 77.94 19.81 74.46 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.301 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.19 -75.78 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 117.614 0.707 . . . . 0.0 110.478 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -111.18 162.4 14.98 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.29 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' A' ' 99' ' ' ALA . 90.4 m-20 -95.2 60.39 2.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.088 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.6 p -158.13 145.04 17.8 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.54 ' CD2' ' HH ' ' A' ' 71' ' ' TYR . 3.7 pp -166.98 145.71 5.14 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.55 127.38 31.64 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 113.728 -1.578 . . . . 0.0 109.398 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.9 p -145.35 161.23 12.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.469 ' NH1' ' OE2' ' A' ' 28' ' ' GLU . 61.7 ttp180 -148.23 155.32 41.22 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.205 0.526 . . . . 0.0 111.811 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.7 t -119.97 135.69 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.1 t -135.51 150.31 49.73 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.925 0.393 . . . . 0.0 110.1 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 34.4 p30 -154.01 81.9 1.14 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.223 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.602 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 6.8 t60 -171.75 -35.93 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.602 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 73.3 Cg_endo -96.77 -160.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.927 0 C-N-CA 122.077 1.851 . . . . 0.0 112.114 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.4 mt -77.35 -5.14 48.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.669 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 77.8 t -58.12 -45.81 88.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.084 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.585 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 27.7 m -54.26 -62.73 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.21 -0.986 0 C-N-CA 119.402 -0.919 . . . . 0.0 108.696 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.585 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -41.35 -44.66 2.83 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.708 0.29 . . . . 0.0 111.12 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.34 -47.89 63.05 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.27 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 70.9 m -70.46 -48.99 53.23 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.204 0.526 . . . . 0.0 111.08 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.456 ' N ' ' O ' ' A' ' 125' ' ' VAL . 0.1 OUTLIER -53.93 -42.78 69.19 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.437 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.435 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -59.69 -53.38 58.66 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.589 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -63.83 -24.64 67.83 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.166 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.11 1.69 90.4 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 134' ' ' PRO . 34.8 mttm -153.33 157.8 32.82 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 120.574 -0.451 . . . . 0.0 110.122 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.4 ' O ' ' O ' ' A' ' 133' ' ' LYS . 5.2 Cg_exo -41.41 175.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 123.926 3.084 . . . . 0.0 113.581 -178.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.5 tp -129.38 122.73 30.04 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 176.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.411 ' O ' ' CA ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -66.19 143.33 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.955 0 C-N-CA 118.108 -1.437 . . . . 0.0 107.404 -179.52 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.8 t -114.88 122.09 45.22 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 123.792 0.682 . . . . 0.0 110.597 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.9 m -130.01 162.98 27.49 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.881 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.0 m -72.25 145.45 47.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.382 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.81 81.6 1.16 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.019 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 57.7 p30 -160.47 161.42 32.87 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.616 0.722 . . . . 0.0 111.031 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.49 -167.12 1.88 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.318 -178.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.6 t -61.03 -43.24 99.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.44 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -158.32 4.71 0.13 Allowed Glycine 0 C--N 1.33 0.227 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.2 tt -83.44 127.92 66.4 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -39.74 158.21 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.549 1.499 . . . . 0.0 112.207 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -77.04 -163.22 0.2 Allowed 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.733 2.288 . . . . 0.0 111.889 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.507 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 19.5 t -126.38 78.23 1.76 Allowed 'General case' 0 C--N 1.34 0.155 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -49.8 -39.51 38.57 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.676 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.16 169.81 23.69 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.5 m -58.04 -20.87 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 CA-C-O 121.786 0.803 . . . . 0.0 108.984 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -64.53 -33.34 75.67 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 155' ' ' ARG . 0.4 OUTLIER -62.26 -79.37 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.401 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.8 p -34.91 -33.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.983 0.913 . . . . 0.0 111.109 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.493 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -68.61 -53.27 23.66 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.533 -179.265 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -68.76 -18.61 64.24 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 122.571 1.177 . . . . 0.0 108.068 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.61 -45.56 14.41 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 112.517 -2.128 . . . . 0.0 111.559 -178.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -130.17 -29.76 2.02 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 96.48 23.75 15.64 Favored Glycine 0 N--CA 1.469 0.894 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -178.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 159' ' ' GLY . . . -43.12 -97.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.533 -0.333 . . . . 0.0 111.17 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.518 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.95 34.81 16.56 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -178.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.538 ' C ' ' H ' ' A' ' 164' ' ' VAL . 2.2 m-85 -172.67 -62.64 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.136 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -72.99 27.07 0.29 Allowed 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.258 1.972 . . . . 0.0 110.758 177.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.538 ' H ' ' C ' ' A' ' 162' ' ' PHE . 15.4 m -129.64 167.48 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.426 -178.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 16.4 t -124.37 65.86 42.3 Favored Pre-proline 0 N--CA 1.471 0.601 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.637 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -37.15 140.04 0.21 Allowed 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 123.413 2.742 . . . . 0.0 115.189 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 162.45 170.78 27.74 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 113.929 -1.487 . . . . 0.0 110.883 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -157.99 147.19 19.55 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.665 0.269 . . . . 0.0 110.427 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.6 t -148.87 157.21 43.26 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.892 0.377 . . . . 0.0 110.529 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -64.28 -75.05 0.4 Allowed Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 89.31 32.7 10.15 Favored Glycine 0 N--CA 1.466 0.693 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -65.12 -41.6 94.73 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.206 -0.997 . . . . 0.0 111.681 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.435 ' CD1' ' N ' ' A' ' 173' ' ' LEU . 9.9 mp -82.48 -109.14 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.624 0.25 . . . . 0.0 110.512 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.444 ' N ' ' CD ' ' A' ' 175' ' ' PRO . 60.9 m-80 45.06 52.54 10.56 Favored Pre-proline 0 N--CA 1.466 0.326 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.141 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 174' ' ' ASN . 45.4 Cg_endo -65.08 -31.33 55.15 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.727 2.285 . . . . 0.0 112.134 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.516 ' HG ' HH21 ' A' ' 179' ' ' ARG . 49.8 p -162.72 128.68 3.37 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.247 0.546 . . . . 0.0 110.293 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 94' ' ' THR . 98.0 mt-10 -108.18 -50.98 2.96 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.602 -178.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 18.4 tt -90.33 122.85 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.117 0.484 . . . . 0.0 111.834 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.516 HH21 ' HG ' ' A' ' 176' ' ' SER . 91.1 mtt180 -134.74 170.69 15.45 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.252 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -87.01 107.2 18.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.242 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -69.21 -11.9 61.2 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.907 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.46 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.8 mm? -64.28 -42.62 96.34 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.45 -41.81 4.26 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.619 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 65.1 24.36 70.29 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -62.91 136.21 57.72 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.422 0.629 . . . . 0.0 111.269 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.485 ' H ' ' CD2' ' A' ' 186' ' ' LEU . 0.7 OUTLIER -82.0 178.68 8.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.254 179.433 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . 0.514 ' O ' ' CD2' ' A' ' 187' ' ' PHE . 88.5 t80 -96.14 67.05 2.57 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.374 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.68 140.98 51.48 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.071 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -147.79 -17.12 0.36 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.224 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.71 0 CA-C-O 118.172 -1.349 . . . . 0.0 110.71 179.836 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -75.42 -12.54 60.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.871 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -63.78 -41.13 98.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.373 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.465 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 9.2 mp -63.18 -42.51 99.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.155 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -64.5 -40.52 95.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.024 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.1 tpt180 -63.22 -41.65 99.14 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.35 -43.93 98.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.462 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.56 -46.49 90.01 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.993 0.425 . . . . 0.0 110.024 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.415 HG21 HD13 ' A' ' 10' ' ' ILE . 96.4 mt -63.34 -43.6 98.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.636 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.07 -41.38 78.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.131 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.67 -44.07 94.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.245 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.86 -53.09 62.02 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.915 0.388 . . . . 0.0 111.561 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.8 pt -68.89 -39.36 79.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.232 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -57.92 -53.66 55.75 Favored 'General case' 0 C--O 1.215 -0.719 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.22 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 20' ' ' GLU . 86.5 t -61.07 -40.05 84.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.233 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.453 ' CD2' ' C ' ' A' ' 17' ' ' LEU . 6.2 tt -51.89 -50.59 60.74 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.441 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -81.56 -49.26 10.76 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.253 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -66.0 -31.6 72.59 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.08 -178.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 16' ' ' VAL . 97.0 mt-10 57.14 83.91 0.1 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.075 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.411 ' H ' HG12 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -164.8 -159.14 0.44 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.86 178.586 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.8 p -119.02 137.26 53.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pp -126.14 166.92 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 120.799 0.333 . . . . 0.0 111.327 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.23 137.39 58.19 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.25 0.548 . . . . 0.0 111.342 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.537 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 2.2 t80 -130.77 139.13 34.67 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.537 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 96.5 Cg_endo -76.88 144.47 24.34 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.488 1.459 . . . . 0.0 111.96 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.2 m -140.37 138.13 34.58 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.943 0.401 . . . . 0.0 110.363 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -56.73 -45.77 81.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.736 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.48 -79.28 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.806 0.336 . . . . 0.0 111.349 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 90.6 t -135.56 129.96 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -37.85 140.39 0.26 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.183 0.516 . . . . 0.0 111.546 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -137.74 -168.25 11.28 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.0 m -128.19 171.92 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -162.48 -177.53 35.59 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.221 -0.99 . . . . 0.0 111.719 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.504 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.8 OUTLIER -160.92 -161.42 0.83 Allowed 'General case' 0 C--N 1.342 0.259 0 C-N-CA 120.259 -0.577 . . . . 0.0 112.169 -179.227 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.504 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 69.2 m-20 -92.13 107.3 22.07 Favored Pre-proline 0 CA--C 1.557 1.241 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -45.46 -55.75 3.29 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 122.038 1.825 . . . . 0.0 111.71 177.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -50.81 -33.4 23.4 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.026 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.3 m -76.5 118.89 19.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.326 0.584 . . . . 0.0 110.659 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -65.02 -32.19 73.79 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.87 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.5 t -43.48 -28.04 0.33 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.796 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.3 -51.6 62.67 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.27 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.0 p -64.5 -39.34 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.171 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 92.6 mtp -66.11 -39.24 89.77 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.6 ttt85 -63.01 -33.27 75.07 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.86 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 87.2 mt -74.4 -59.04 2.91 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.3 mt -53.72 -19.54 4.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.334 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -66.66 -84.95 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.572 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -77.48 -34.75 54.2 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -74.94 -50.05 18.09 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.826 -176.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 37.25 62.01 0.88 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.665 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.9 ttm-85 -179.04 -61.91 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.895 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.215 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -63.36 -11.75 27.18 Favored 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 122.872 2.381 . . . . 0.0 112.422 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 55' ' ' ASP . 9.7 p -41.76 -48.61 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.831 -0.347 . . . . 0.0 111.143 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.467 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 65.6 t0 -66.73 -39.74 88.09 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.88 0.371 . . . . 0.0 111.051 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -60.82 -39.91 90.76 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 64.73 108.3 0.01 OUTLIER Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.567 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -53.63 -159.16 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.319 0.581 . . . . 0.0 112.095 -179.603 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 67.6 mt -103.94 144.07 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.896 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 20.4 mt -121.98 142.4 50.35 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.9 tp -112.45 134.59 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-O 121.368 0.604 . . . . 0.0 110.88 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.61 150.92 41.99 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.99 -27.27 8.49 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -116.48 151.0 36.97 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.796 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -79.68 -13.55 59.39 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -51.94 -31.44 28.81 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.482 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.13 -12.64 28.0 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -92.63 -16.62 25.37 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 118.793 0.724 . . . . 0.0 109.276 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.501 ' HZ2' HH22 ' A' ' 82' ' ' ARG . 44.5 tttp -77.5 -38.88 1.9 Allowed Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.774 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 67.6 Cg_endo -103.99 -2.89 0.24 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 122.91 2.407 . . . . 0.0 112.38 -178.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.424 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 58.9 t80 -95.84 -9.34 31.78 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.033 -178.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.464 ' CG2' ' N ' ' A' ' 73' ' ' ASP . 4.2 mp -125.64 161.96 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.464 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 0.5 OUTLIER -58.5 177.24 0.14 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.856 0.36 . . . . 0.0 110.232 -179.326 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -105.38 15.47 27.18 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.484 ' OG1' ' N ' ' A' ' 76' ' ' MET . 32.3 p -80.88 -64.53 1.17 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.095 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.484 ' N ' ' OG1' ' A' ' 75' ' ' THR . 26.4 ptm -70.23 -5.09 25.09 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.184 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.2 tp -83.93 100.92 11.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.32 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -155.15 160.28 40.8 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.78 -177.572 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -39.37 -48.51 1.91 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.813 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.1 p -61.86 -34.0 60.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.661 -0.415 . . . . 0.0 111.279 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 78' ' ' THR . 64.8 tp60 -65.57 -41.56 92.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.916 0.389 . . . . 0.0 110.715 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.501 HH22 ' HZ2' ' A' ' 69' ' ' LYS . 8.8 mmt85 -63.63 -51.98 62.85 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 122.589 1.185 . . . . 0.0 109.136 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -55.08 -50.3 69.5 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.776 -1.556 . . . . 0.0 110.018 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -60.52 -49.95 75.5 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.939 -178.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.0 tt -67.73 -37.19 78.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.097 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -70.37 -43.09 70.87 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.488 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.4 m -75.23 -37.73 60.93 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.195 0.521 . . . . 0.0 110.561 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -76.15 150.58 37.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -36.29 153.96 0.08 OUTLIER Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.888 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 118' ' ' VAL . 41.5 Cg_endo -64.28 -24.25 65.3 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.048 1.832 . . . . 0.0 111.439 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.492 ' O ' ' NH2' ' A' ' 117' ' ' ARG . . . 176.51 79.27 0.05 OUTLIER Glycine 0 CA--C 1.531 1.037 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.09 -44.35 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.058 1.839 . . . . 0.0 111.941 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.0 p -137.26 145.82 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.196 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.9 m -83.8 130.27 34.94 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.214 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -117.85 140.03 50.28 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.512 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.4 t -90.28 101.37 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 121.477 0.656 . . . . 0.0 110.023 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -90.23 152.32 45.7 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.377 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.42 113.04 3.69 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.199 1.933 . . . . 0.0 111.189 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.14 150.95 75.22 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.26 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -72.27 156.04 55.45 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.075 1.85 . . . . 0.0 112.159 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -139.74 58.69 1.6 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.016 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 37.1 p -67.1 -35.5 79.92 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.586 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.63 ' H ' ' CD ' ' A' ' 104' ' ' PRO . 0.4 OUTLIER -165.82 -40.1 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.221 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.63 ' CD ' ' H ' ' A' ' 103' ' ' THR . 6.3 Cg_exo -71.53 -166.07 0.23 Allowed 'Trans proline' 0 C--N 1.313 -1.342 0 C-N-CA 122.379 2.052 . . . . 0.0 111.849 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 109' ' ' GLY . 7.4 tpt180 -173.93 6.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.921 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 66.8 p-90 -75.8 -7.34 54.21 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.957 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.665 ' CD1' ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -70.91 -30.14 66.39 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 89.9 m -140.38 -38.46 0.45 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.705 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 86.04 -11.38 62.8 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.608 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -142.13 -72.3 0.32 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.56 0.68 . . . . 0.0 110.788 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.443 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 21.4 t80 -91.32 -167.38 1.79 Allowed 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.443 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 94.9 m-20 -130.53 57.6 1.72 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.653 0.263 . . . . 0.0 110.693 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.7 p -156.51 156.92 34.53 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.187 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.1 pp -168.96 138.88 2.25 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.32 131.56 44.33 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 113.787 -1.551 . . . . 0.0 109.932 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.8 p -147.06 155.35 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 120.727 0.299 . . . . 0.0 110.364 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.492 ' NH2' ' O ' ' A' ' 91' ' ' GLY . 79.3 ttt180 -146.1 153.27 40.52 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.847 -179.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 90' ' ' PRO . 49.6 t -120.5 136.24 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.9 t -139.74 142.13 36.82 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.025 0.441 . . . . 0.0 110.629 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 51.0 p-10 -145.82 81.82 1.61 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.686 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.576 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 7.3 t60 -171.49 -36.29 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.576 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 43.0 Cg_endo -94.72 -161.14 0.07 OUTLIER 'Trans proline' 0 N--CA 1.483 0.907 0 C-N-CA 122.044 1.829 . . . . 0.0 111.955 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.3 mt -78.01 -6.17 53.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.392 0.615 . . . . 0.0 110.013 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 98.8 t -58.08 -45.29 88.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.072 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.585 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 28.7 m -53.2 -62.15 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.906 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.019 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.585 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -41.68 -44.01 3.02 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 120.938 0.399 . . . . 0.0 110.723 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.3 tp -68.93 -48.26 63.68 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.235 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 60.7 m -70.28 -49.29 51.26 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.387 0.613 . . . . 0.0 110.907 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 125' ' ' VAL . 1.1 pp0? -54.55 -41.95 70.36 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.341 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.438 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -58.64 -55.07 39.83 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.257 -178.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -62.46 -21.9 65.81 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.919 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.73 1.27 89.19 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -152.27 160.56 31.18 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 120.506 -0.477 . . . . 0.0 110.357 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -45.04 164.3 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 123.943 3.095 . . . . 0.0 112.54 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.4 tp -119.36 122.93 42.93 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.417 ' O ' ' CA ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -63.54 144.69 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 C-N-CA 117.913 -1.515 . . . . 0.0 106.945 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.1 t -116.82 125.1 51.06 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 123.583 0.552 . . . . 0.0 111.283 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.3 m -134.54 158.39 44.08 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.781 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.6 m -71.31 142.56 50.45 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.168 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.72 85.39 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.558 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -160.63 165.44 30.65 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.438 0.637 . . . . 0.0 111.079 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.93 -164.65 2.01 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.315 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 42.5 t -61.37 -43.08 99.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.022 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -157.25 3.91 0.16 Allowed Glycine 0 N--CA 1.461 0.355 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 146' ' ' PRO . 1.3 tm? -81.18 112.28 31.57 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 145' ' ' LEU . 20.1 Cg_exo -35.46 156.84 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.104 1.869 . . . . 0.0 112.542 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.7 -174.21 1.23 Allowed 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.4 2.067 . . . . 0.0 112.57 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 17.6 m -114.44 82.89 1.79 Allowed 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.378 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -59.07 -35.58 73.6 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.637 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -161.82 169.41 21.38 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.721 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -57.02 -23.19 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 CA-C-O 121.437 0.637 . . . . 0.0 109.378 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -62.71 -32.41 73.51 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 155' ' ' ARG . 6.4 tm-20 -63.09 -80.45 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.568 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.3 p -36.37 -27.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.167 0.987 . . . . 0.0 111.044 177.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.471 ' N ' ' O ' ' A' ' 153' ' ' GLU . 4.3 tmt_? -74.4 -50.73 17.34 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.855 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.7 -17.75 62.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 122.631 1.205 . . . . 0.0 107.781 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -83.32 -57.04 3.42 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 112.553 -2.112 . . . . 0.0 111.987 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -119.99 -20.6 7.42 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 160' ' ' ALA . . . 84.72 27.63 34.5 Favored Glycine 0 N--CA 1.466 0.642 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' A' ' 159' ' ' GLY . . . -42.21 -98.37 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.58 -0.31 . . . . 0.0 111.36 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.516 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 67.79 34.44 4.35 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.299 0.571 . . . . 0.0 109.578 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.54 ' C ' ' H ' ' A' ' 164' ' ' VAL . 1.6 m-85 -176.36 -61.89 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.235 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -73.44 31.45 0.31 Allowed 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.044 1.829 . . . . 0.0 110.439 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.54 ' H ' ' C ' ' A' ' 162' ' ' PHE . 15.4 m -134.67 168.22 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.834 -178.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 8.3 t -125.15 64.82 46.6 Favored Pre-proline 0 N--CA 1.475 0.79 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.855 178.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -40.13 151.0 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 123.706 2.938 . . . . 0.0 114.97 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 162.68 -174.93 39.1 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.983 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -141.68 145.12 34.53 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.1 t -148.24 161.24 41.89 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.036 0.446 . . . . 0.0 110.809 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -152.5 79.23 0.2 Allowed Glycine 0 N--CA 1.459 0.218 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -118.31 -57.8 0.28 Allowed Glycine 0 N--CA 1.468 0.772 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 41.93 37.07 0.73 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.801 0.334 . . . . 0.0 110.966 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 8.4 tp -66.29 -128.97 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.097 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -70.35 148.03 95.39 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.545 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -67.31 -21.97 46.82 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.016 1.81 . . . . 0.0 111.668 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 52.5 p -160.38 127.25 4.3 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.362 0.601 . . . . 0.0 110.683 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -105.68 49.07 0.82 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.912 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 17.2 tt -109.68 129.87 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 120.795 0.331 . . . . 0.0 110.539 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -132.63 166.34 22.35 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.711 0.767 . . . . 0.0 112.018 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -80.36 106.87 12.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.502 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -64.47 -20.05 65.95 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.216 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.449 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.5 mm? -63.02 -42.64 99.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.933 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.85 -45.28 2.88 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.836 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 67.29 22.8 73.06 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -66.96 146.51 54.3 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.202 0.525 . . . . 0.0 111.187 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.44 ' N ' ' CD2' ' A' ' 186' ' ' LEU . 0.8 OUTLIER -69.14 177.7 2.61 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.725 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -125.33 85.77 2.45 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.281 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -70.54 138.89 51.36 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.313 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -174.09 -23.98 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.369 177.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.727 0 CA-C-O 118.037 -1.424 . . . . 0.0 110.939 179.894 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.8 m120 . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -63.06 -40.35 97.43 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.564 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -60.86 -40.53 93.27 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.92 0.39 . . . . 0.0 110.519 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.446 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 10.0 mp -61.95 -43.08 99.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.22 0.533 . . . . 0.0 109.608 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -67.96 -35.35 78.23 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.127 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -60.71 -43.61 97.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.543 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 9' ' ' ALA . 1.5 p30 -70.97 -39.22 72.67 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.166 -0.613 . . . . 0.0 110.469 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.523 ' N ' ' OD1' ' A' ' 8' ' ' ASP . . . -62.12 -48.3 80.77 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.269 0.557 . . . . 0.0 110.122 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.0 -43.59 99.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.912 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.56 -45.31 77.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.635 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.07 -46.68 88.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.924 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.94 -52.1 66.87 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 14.3 pt -69.37 -39.67 79.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.518 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -58.75 -53.47 57.99 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.123 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.465 ' O ' ' N ' ' A' ' 20' ' ' GLU . 89.6 t -60.76 -40.42 84.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.508 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.455 ' CD2' ' C ' ' A' ' 17' ' ' LEU . 6.4 tt -51.67 -50.59 60.12 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.77 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -80.77 -50.99 9.14 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.056 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -63.7 -32.75 74.34 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.049 -178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.465 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.9 mt-10 58.49 85.35 0.09 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.385 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.57 -141.06 0.07 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.319 178.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.8 p -137.55 139.58 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pp -129.85 165.9 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-O 120.945 0.402 . . . . 0.0 111.41 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.63 136.97 58.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.301 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.51 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -134.54 142.23 41.92 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.51 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 62.6 Cg_endo -77.25 151.09 29.64 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.771 1.647 . . . . 0.0 111.82 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.515 ' C ' ' H ' ' A' ' 29' ' ' ALA . 45.7 m -132.13 136.49 47.16 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.844 0.354 . . . . 0.0 110.87 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -74.98 23.83 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.357 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.515 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -157.27 -73.44 0.09 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.313 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.8 p -127.52 126.95 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.316 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.511 ' CD1' ' O ' ' A' ' 148' ' ' CYS . 35.4 p90 -40.24 147.83 0.09 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.323 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -156.34 -169.45 20.46 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.3 m -133.21 170.87 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.406 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -158.58 -175.48 29.56 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.012 -1.089 . . . . 0.0 112.102 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.521 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -158.44 -164.13 1.41 Allowed 'General case' 0 C--O 1.227 -0.103 0 CA-C-O 120.568 0.223 . . . . 0.0 110.81 -179.312 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.521 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 90.5 m-20 -98.72 109.69 54.29 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -178.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 36' ' ' ASP . 22.4 Cg_exo -36.73 170.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.854 2.369 . . . . 0.0 114.325 177.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 41.98 71.94 0.19 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.074 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.5 m -148.81 138.86 22.23 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.373 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -69.87 -34.79 74.06 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.462 0.648 . . . . 0.0 110.54 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.98 -43.0 99.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.667 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.71 -51.34 70.18 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.726 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 p -63.62 -42.6 96.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 90.4 mtp -64.24 -39.71 94.52 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.451 ' O ' ' CD2' ' A' ' 49' ' ' LEU . 45.8 ttt-85 -62.15 -33.8 75.18 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.067 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 89.4 mt -75.09 -59.93 2.52 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.2 mt -54.18 -18.42 3.8 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.361 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -67.35 -85.67 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.741 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.451 ' CD2' ' O ' ' A' ' 45' ' ' ARG . 2.3 pt? -75.72 -32.76 60.17 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.906 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.406 ' H ' HD23 ' A' ' 49' ' ' LEU . 23.8 mmmt -78.18 -70.44 0.49 Allowed 'General case' 0 C--N 1.349 0.571 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.489 -177.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 52.84 81.05 0.09 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.0 mtm180 161.72 -63.14 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.86 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.1 -11.68 32.79 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.819 2.346 . . . . 0.0 112.255 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.9 p -41.83 -49.9 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.815 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 55' ' ' ASP . 65.7 t0 -66.74 -40.13 88.22 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.018 0.437 . . . . 0.0 111.146 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -61.36 -39.97 92.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.692 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 66.39 112.49 0.01 OUTLIER Glycine 0 CA--C 1.519 0.295 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.555 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -52.99 -162.37 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.325 0.583 . . . . 0.0 112.298 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.431 HD13 HG22 ' A' ' 59' ' ' ILE . 70.9 mt -105.02 145.23 13.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.825 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.6 mt -121.15 142.66 49.67 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.4 tp -110.78 127.8 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-O 121.076 0.465 . . . . 0.0 110.708 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -117.64 148.15 42.22 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -106.4 -27.68 10.81 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 116.297 -0.411 . . . . 0.0 109.915 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.616 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 12.4 m120 -115.79 150.32 37.11 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.735 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -79.98 -14.42 58.6 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -52.91 -30.82 36.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.585 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.616 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 4.4 pm0 -94.04 -12.22 29.05 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.413 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 3.8 mm? -91.4 -20.81 21.4 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.513 -0.742 . . . . 0.0 109.591 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.462 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 49.1 tttm -76.03 -37.45 2.17 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 68.7 Cg_endo -103.39 -3.48 0.26 Allowed 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 122.548 2.166 . . . . 0.0 112.007 -178.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.446 ' OH ' ' CD1' ' A' ' 114' ' ' LEU . 53.9 t80 -98.25 -4.1 35.98 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.037 0.446 . . . . 0.0 111.07 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.481 ' CG2' ' N ' ' A' ' 73' ' ' ASP . 4.6 mp -132.91 166.54 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.481 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 98.7 m-20 -58.0 -9.66 1.47 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.475 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 58.2 t0 58.54 30.4 19.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.9 t -95.23 -36.79 11.3 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.091 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -83.07 -18.83 38.25 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.86 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 36.0 tp -86.03 125.35 33.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.148 0.499 . . . . 0.0 110.287 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -161.56 161.74 29.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.156 -177.075 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -39.49 -48.41 2.0 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.849 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.13 -32.96 58.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.976 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.454 ' N ' ' O ' ' A' ' 78' ' ' THR . 63.2 tp60 -65.14 -40.57 94.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.585 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.2 mmt85 -64.79 -53.05 53.07 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 122.164 0.983 . . . . 0.0 109.252 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -53.98 -51.02 65.24 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.011 -1.45 . . . . 0.0 110.39 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.5 m -61.05 -50.34 73.7 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.853 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 89' ' ' TRP . 8.6 tt -68.02 -33.75 62.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.728 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -73.82 -38.89 64.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.168 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.7 m -83.41 -34.55 25.48 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.8 0.333 . . . . 0.0 111.416 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 63.9 ttm-85 -81.14 -75.26 0.29 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.504 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.436 ' O ' ' O ' ' A' ' 85' ' ' ILE . 2.2 m0 -162.02 152.85 14.83 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -65.31 -22.51 60.21 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.296 1.997 . . . . 0.0 112.198 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 161.44 78.02 0.03 OUTLIER Glycine 0 CA--C 1.531 1.077 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.514 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.53 -23.59 11.23 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 121.946 1.764 . . . . 0.0 112.404 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.15 147.22 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.216 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 26.9 m -89.89 138.47 31.46 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.257 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -124.46 139.94 53.42 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.999 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.6 t -97.76 109.72 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 CA-C-O 121.433 0.635 . . . . 0.0 111.084 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -92.08 147.64 35.16 Favored Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.421 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.51 98.1 1.09 Allowed 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.847 1.698 . . . . 0.0 110.985 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -46.87 148.04 2.01 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -63.36 -28.71 71.82 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.261 1.974 . . . . 0.0 112.561 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 41.1 68.23 0.45 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.71 0.29 . . . . 0.0 110.617 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.422 ' O ' ' OG1' ' A' ' 103' ' ' THR . 40.4 p -64.58 -35.07 79.8 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.75 -178.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.597 ' H ' ' CD ' ' A' ' 104' ' ' PRO . 0.2 OUTLIER -169.28 -40.85 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.597 ' CD ' ' H ' ' A' ' 103' ' ' THR . 15.9 Cg_exo -67.21 -162.88 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.734 2.289 . . . . 0.0 112.12 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 109' ' ' GLY . 8.0 tpt180 -163.08 1.97 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.181 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -73.37 -6.96 49.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.669 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.642 ' CD1' ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -77.71 -21.28 52.2 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.059 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 93.1 m -142.79 -40.34 0.33 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.141 0.495 . . . . 0.0 109.981 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 91.44 -15.44 61.33 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.642 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.422 ' O ' ' NH2' ' A' ' 105' ' ' ARG . 17.3 tpt180 -145.23 -76.95 0.21 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 117.578 0.689 . . . . 0.0 111.488 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.449 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 22.0 t80 -87.1 -167.33 1.85 Allowed 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.449 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 52.8 p-10 -136.03 73.15 1.45 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.103 0.477 . . . . 0.0 111.302 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.7 p -159.68 129.49 5.45 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.446 ' CD1' ' OH ' ' A' ' 71' ' ' TYR . 34.4 mt -127.72 121.62 30.79 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -177.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.84 126.56 29.93 Favored 'General case' 0 C--N 1.345 0.397 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 175.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.8 p -143.88 152.84 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.198 0.523 . . . . 0.0 111.1 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -139.82 154.3 47.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.116 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.7 t -123.86 132.8 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.3 t -132.21 149.91 52.28 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.985 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 33.8 p30 -152.75 80.7 1.22 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.07 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.602 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 49.3 t-80 -171.79 -35.31 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.602 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 56.5 Cg_endo -94.99 -161.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.98 1.787 . . . . 0.0 111.834 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 11.3 mt -78.16 -4.79 49.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.978 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 82.4 t -58.24 -45.76 88.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.968 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.577 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 27.8 m -53.71 -62.31 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.941 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.044 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.577 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -41.67 -43.27 2.77 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.968 0.413 . . . . 0.0 110.842 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.7 tp -69.93 -47.66 61.53 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.414 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 62.7 m -70.48 -49.22 50.74 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.539 0.685 . . . . 0.0 110.531 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 125' ' ' VAL . 1.1 pp0? -54.41 -42.24 70.24 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.433 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -58.88 -54.57 45.64 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.455 -178.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -62.41 -23.25 66.74 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.001 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.51 0.58 90.06 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 134' ' ' PRO . 33.1 mttm -153.67 159.18 32.39 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 133' ' ' LYS . 6.3 Cg_exo -41.35 179.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 123.886 3.057 . . . . 0.0 113.239 -178.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.0 tp -133.44 123.26 24.98 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 176.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.406 ' O ' ' CA ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -65.6 146.48 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 C-N-CA 117.64 -1.624 . . . . 0.0 107.271 -179.45 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.8 t -118.65 126.95 53.06 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 123.573 0.545 . . . . 0.0 111.214 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.7 m -132.74 163.5 28.88 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.04 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.8 m -74.2 146.94 42.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.443 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.45 83.55 1.97 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.917 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -159.12 164.71 35.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.398 0.618 . . . . 0.0 110.977 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.88 -166.18 2.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.073 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 61.1 m -60.09 -42.7 95.21 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.799 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -160.63 5.38 0.1 OUTLIER Glycine 0 C--N 1.331 0.28 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.4 tp -81.19 127.9 72.42 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 119.36 -0.352 . . . . 0.0 110.104 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -39.28 151.28 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 121.637 1.558 . . . . 0.0 111.804 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 149' ' ' ARG . 89.2 Cg_endo -75.17 148.58 34.83 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.234 1.956 . . . . 0.0 112.446 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.511 ' O ' ' CD1' ' A' ' 31' ' ' PHE . 4.2 m -62.74 71.35 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.354 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 147' ' ' PRO . 17.3 ptm180 -57.87 -32.94 68.17 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.415 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.517 ' HG1' ' C ' ' A' ' 149' ' ' ARG . 0.0 OUTLIER -163.11 164.22 25.44 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.862 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -56.33 -18.01 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 CA-C-O 121.721 0.772 . . . . 0.0 108.971 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -64.71 -35.53 81.35 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 177.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 150' ' ' THR . 5.6 tm-20 -58.94 -74.07 0.07 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.869 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.1 p -45.68 -30.06 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.34 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -83.98 -44.28 14.34 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 122.226 1.012 . . . . 0.0 110.285 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.36 -42.14 86.3 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.435 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.471 ' CG ' ' N ' ' A' ' 158' ' ' PHE . 8.1 pt20 -81.47 -48.93 11.22 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 112.858 -1.974 . . . . 0.0 112.134 -177.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.471 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 30.5 t80 -106.85 -36.54 6.63 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -177.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 97.68 24.45 12.09 Favored Glycine 0 N--CA 1.476 1.341 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -42.89 -94.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.564 0.221 . . . . 0.0 111.094 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.45 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.96 37.51 14.98 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.204 0.526 . . . . 0.0 109.714 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.55 ' C ' ' H ' ' A' ' 164' ' ' VAL . 1.5 m-85 -177.07 -61.83 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.764 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -73.73 28.19 0.32 Allowed 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 122.367 2.045 . . . . 0.0 110.443 178.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.55 ' H ' ' C ' ' A' ' 162' ' ' PHE . 15.9 m -131.03 167.4 26.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.85 -178.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.7 t -123.82 65.58 35.97 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.501 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -36.68 141.22 0.15 Allowed 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 123.6 2.867 . . . . 0.0 115.15 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 154.67 145.68 4.22 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.54 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -141.99 132.25 24.92 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.303 0.573 . . . . 0.0 110.973 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.4 t -158.05 148.53 20.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.929 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -67.78 -40.76 89.7 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.576 ' C ' ' H ' ' A' ' 173' ' ' LEU . . . 138.8 -71.18 0.45 Allowed Glycine 0 N--CA 1.468 0.81 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 64.83 -30.9 0.12 Allowed 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.353 0.661 . . . . 0.0 111.788 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.576 ' H ' ' C ' ' A' ' 171' ' ' GLY . 8.4 mp -80.8 156.38 26.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.094 0.473 . . . . 0.0 110.096 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -46.61 150.26 1.26 Allowed Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.321 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.41 158.66 50.93 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 122.209 1.939 . . . . 0.0 111.578 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 8.4 t -97.33 123.25 41.08 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -126.67 158.68 35.75 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.231 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 19.3 tt -110.93 127.82 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.112 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -129.46 166.95 18.59 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.727 0.775 . . . . 0.0 112.273 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 184' ' ' GLY . 97.7 m-20 -78.93 106.93 11.3 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.427 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -67.15 -16.93 64.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.744 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.487 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.4 mm? -63.6 -42.43 98.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.099 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.409 ' CG2' ' H ' ' A' ' 184' ' ' GLY . 5.0 t -120.31 -52.89 2.15 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.207 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.409 ' H ' ' CG2' ' A' ' 183' ' ' THR . . . 95.11 41.29 4.06 Favored Glycine 0 N--CA 1.468 0.818 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -114.49 149.38 36.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.053 -0.574 . . . . 0.0 111.398 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.467 ' N ' ' CD2' ' A' ' 186' ' ' LEU . 0.7 OUTLIER -65.12 -172.59 0.1 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.018 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -123.82 50.6 1.61 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.035 0.445 . . . . 0.0 110.109 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.402 ' H ' ' HG ' ' A' ' 186' ' ' LEU . 3.7 tmt_? -89.94 -64.27 1.16 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.203 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -67.45 -25.58 65.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.964 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.83 0 CA-C-O 118.192 -1.338 . . . . 0.0 110.923 179.887 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.8 m120 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 56.23 35.35 25.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.649 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.86 5.68 47.51 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.528 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 10.0 mp -62.57 -42.3 99.47 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.212 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -63.43 -39.93 95.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.163 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -63.76 -40.7 97.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.4 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 162' ' ' PHE . 65.2 t0 -61.94 -48.37 80.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.686 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.25 -45.36 93.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.487 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.96 -43.48 97.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.284 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.78 -45.02 82.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.816 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.22 -43.47 94.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.145 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.72 -52.56 64.59 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.706 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.8 pt -67.7 -39.75 82.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.163 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -57.58 -55.34 36.1 Favored 'General case' 0 C--O 1.215 -0.755 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.338 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 20' ' ' GLU . 95.4 t -60.15 -40.69 84.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.876 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.454 ' CD2' ' C ' ' A' ' 17' ' ' LEU . 6.2 tt -51.61 -50.22 60.66 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.697 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -81.84 -51.51 8.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.993 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -63.63 -35.0 79.08 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.109 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 16' ' ' VAL . 97.1 mt-10 59.02 86.46 0.09 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.664 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.72 -134.81 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.1 p -140.22 140.36 35.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.9 pp -129.87 165.82 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 120.852 0.358 . . . . 0.0 111.133 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.87 138.55 58.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.133 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.511 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 0.6 OUTLIER -131.19 141.59 42.43 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.363 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.511 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 91.2 Cg_endo -77.16 144.8 23.85 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.4 1.4 . . . . 0.0 111.892 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.519 ' C ' ' H ' ' A' ' 29' ' ' ALA . 79.4 m -135.85 135.09 39.5 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.32 0.581 . . . . 0.0 110.868 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -72.96 32.52 0.07 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.802 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.519 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -163.0 -75.73 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.833 0.349 . . . . 0.0 110.975 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.3 m -126.59 128.55 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.128 0.49 . . . . 0.0 110.229 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.519 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 80.3 m-85 -46.99 143.0 3.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.117 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -148.58 -169.15 15.12 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.8 m -133.33 169.37 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.401 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -156.98 -179.05 31.62 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.009 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.3 p -157.98 -165.73 1.8 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.6 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 7.0 p30 -89.65 107.68 20.29 Favored Pre-proline 0 CA--C 1.558 1.256 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -178.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -42.82 -60.78 0.66 Allowed 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.076 1.851 . . . . 0.0 112.633 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -77.63 70.65 4.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.427 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 54.9 m -156.57 144.01 19.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.619 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -71.1 -34.22 70.9 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.178 0.513 . . . . 0.0 111.158 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -42.19 95.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.99 -178.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.88 -52.36 65.81 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 p -62.19 -42.6 95.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.147 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.9 mtt -64.65 -41.44 96.13 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.449 HH22 ' CB ' ' A' ' 138' ' ' THR . 31.9 ttt-85 -60.4 -42.26 95.57 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-O 121.98 0.895 . . . . 0.0 108.916 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.2 -53.47 48.74 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.664 -178.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.7 mt -71.03 -10.57 59.98 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.153 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -69.85 -82.35 0.04 OUTLIER 'General case' 0 N--CA 1.432 -1.354 0 CA-C-O 121.09 0.471 . . . . 0.0 110.924 -177.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.421 HD21 ' H ' ' A' ' 50' ' ' LYS . 2.3 pt? -76.54 -35.57 58.19 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.421 ' H ' HD21 ' A' ' 49' ' ' LEU . 24.9 mmmt -76.51 -50.22 14.53 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.082 -177.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 35.76 65.09 0.44 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.012 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.1 mtm-85 178.82 -52.51 0.0 OUTLIER Pre-proline 0 CA--C 1.551 0.981 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.744 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.11 -2.81 11.92 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 123.008 2.472 . . . . 0.0 112.499 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.7 p -44.61 -45.47 2.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.033 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -64.13 -41.14 97.32 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.726 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -60.86 -35.33 76.31 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 59.19 102.26 0.01 OUTLIER Glycine 0 CA--C 1.52 0.36 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.572 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -48.73 -172.55 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.303 0.573 . . . . 0.0 112.205 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.6 mt -91.14 141.21 14.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.419 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.3 mt -118.88 145.74 45.47 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.3 tp -113.38 127.68 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-O 121.203 0.525 . . . . 0.0 111.184 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.99 151.77 31.9 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.87 -28.16 8.17 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.629 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 99.0 m-20 -115.69 148.55 39.6 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.316 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -77.16 -13.46 59.94 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -51.87 -32.45 32.22 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.262 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.629 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 4.0 pm0 -94.28 -9.83 34.78 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -92.18 -16.23 26.53 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.473 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 17.4 ttpp -78.07 -37.3 1.46 Allowed Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 67.5 Cg_endo -103.44 -3.23 0.27 Allowed 'Trans proline' 0 C--N 1.321 -0.921 0 C-N-CA 122.801 2.334 . . . . 0.0 111.873 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.524 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 42.0 t80 -91.73 -12.05 35.05 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.295 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.475 ' CG2' ' N ' ' A' ' 73' ' ' ASP . 4.7 mp -123.2 163.43 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.475 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 96.8 m-20 -63.43 -3.98 2.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.277 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 3.3 p30 45.01 22.85 0.07 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.883 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.434 ' CG2' ' N ' ' A' ' 76' ' ' MET . 8.9 t -88.72 -44.81 10.29 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.13 0.49 . . . . 0.0 109.827 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.434 ' N ' ' CG2' ' A' ' 75' ' ' THR . 18.2 ptp -80.63 -14.76 57.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.975 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 tp -79.0 134.12 36.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.701 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -158.61 161.04 37.18 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.972 -177.553 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -38.92 -48.93 1.63 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.768 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.5 p -63.26 -33.49 61.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.007 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.427 ' N ' ' O ' ' A' ' 78' ' ' THR . 62.8 tp60 -64.47 -39.47 93.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.944 0.402 . . . . 0.0 110.4 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -63.87 -53.12 55.55 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 122.517 1.151 . . . . 0.0 109.111 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.499 ' O ' ' N ' ' A' ' 87' ' ' SER . 80.8 tt0 -54.18 -50.37 67.19 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.989 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.4 m -61.48 -49.29 77.35 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.988 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 89' ' ' TRP . 8.7 tt -69.79 -31.24 47.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.574 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -80.14 -31.31 39.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.753 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 83' ' ' GLU . 53.2 m -90.1 -12.71 37.55 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.769 0.318 . . . . 0.0 111.201 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.446 ' O ' ' O ' ' A' ' 89' ' ' TRP . 62.0 ttm-85 -121.95 75.84 1.24 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.446 ' O ' ' O ' ' A' ' 88' ' ' ARG . 7.9 m-90 56.75 152.26 0.07 OUTLIER Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.377 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.24 -19.26 38.84 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.881 1.72 . . . . 0.0 111.673 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 159.56 81.05 0.04 OUTLIER Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -81.42 -9.77 12.38 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.492 2.128 . . . . 0.0 112.143 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.1 p -136.12 144.8 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.951 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.4 m -95.99 124.31 39.95 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -113.09 143.03 45.04 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.401 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 98.8 t -89.08 102.71 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 121.152 0.501 . . . . 0.0 111.393 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -90.08 146.82 35.77 Favored Pre-proline 0 N--CA 1.469 0.504 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.786 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -79.39 87.03 1.59 Allowed 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.241 1.961 . . . . 0.0 111.449 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -48.28 151.55 1.81 Allowed Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.91 144.58 88.54 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.091 1.861 . . . . 0.0 111.664 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -128.51 50.32 2.11 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.192 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.435 ' O ' ' OG1' ' A' ' 103' ' ' THR . 53.3 p -65.52 -35.49 81.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.338 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.616 ' H ' ' CD ' ' A' ' 104' ' ' PRO . 1.5 m -167.42 -37.77 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.616 ' CD ' ' H ' ' A' ' 103' ' ' THR . 24.8 Cg_exo -63.12 -168.58 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.515 2.143 . . . . 0.0 113.308 -177.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 109' ' ' GLY . 5.9 tpt180 -176.49 -7.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.489 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 66.7 p-90 -79.1 -11.59 59.99 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.665 0.745 . . . . 0.0 109.404 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.549 ' H ' ' CD2' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -76.58 -16.45 59.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.811 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 94.8 m -142.93 -40.96 0.32 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.356 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 91.9 -13.4 66.96 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 119.863 -0.41 . . . . 0.0 112.896 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.451 ' O ' ' CZ ' ' A' ' 105' ' ' ARG . 13.5 tpt180 -148.01 -80.43 0.14 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.883 0.842 . . . . 0.0 111.226 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -90.95 -174.83 4.15 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -124.35 61.18 1.13 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.083 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.0 p -168.14 151.78 5.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.193 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 pp -169.34 147.58 3.71 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.27 134.94 55.71 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 113.76 -1.564 . . . . 0.0 109.635 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.6 p -147.98 160.06 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -145.53 154.64 42.42 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.907 0.384 . . . . 0.0 111.425 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.3 t -123.0 136.07 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.9 t -138.38 150.25 46.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.178 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 50.7 p-10 -153.7 84.9 1.17 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.923 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.585 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 8.5 t-80 -171.52 -36.58 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.292 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.585 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 60.9 Cg_endo -95.15 -159.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.949 0 C-N-CA 121.879 1.719 . . . . 0.0 112.032 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.7 mt -78.79 -5.79 54.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.372 0.606 . . . . 0.0 110.459 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 87.8 t -58.1 -44.77 88.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.787 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.594 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 27.1 m -53.35 -62.57 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.922 0 C-N-CA 119.269 -0.972 . . . . 0.0 108.883 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.594 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -41.29 -43.82 2.54 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 120.831 0.348 . . . . 0.0 111.152 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.1 tp -69.04 -48.77 62.01 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.998 0.428 . . . . 0.0 111.224 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 75.4 m -70.26 -48.38 57.1 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.373 0.606 . . . . 0.0 110.991 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.45 ' N ' ' O ' ' A' ' 125' ' ' VAL . 1.1 pp0? -55.03 -42.26 72.38 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.43 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -57.87 -57.22 13.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.665 -178.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -62.47 -26.46 68.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.385 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.92 -2.44 88.25 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' A' ' 134' ' ' PRO . 25.0 mmtm -142.91 155.78 62.5 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 117.137 0.469 . . . . 0.0 110.043 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 133' ' ' LYS . 6.0 Cg_exo -41.34 175.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 123.604 2.869 . . . . 0.0 112.984 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.1 tp -128.59 122.96 32.15 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 177.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.401 ' O ' ' CA ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -66.11 142.67 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.9 0 C-N-CA 117.762 -1.575 . . . . 0.0 107.256 -179.712 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 t -111.69 118.91 36.93 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 123.802 0.688 . . . . 0.0 110.88 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.449 ' CB ' HH22 ' A' ' 45' ' ' ARG . 18.8 m -127.72 150.55 49.73 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.756 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 140' ' ' ALA . 24.7 m -64.59 149.21 49.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.491 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.436 ' O ' ' O ' ' A' ' 139' ' ' SER . . . -53.78 -164.09 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.997 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.431 ' O ' ' O ' ' A' ' 140' ' ' ALA . 6.7 p30 53.37 156.98 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.702 0.763 . . . . 0.0 111.687 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.07 -147.15 0.37 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.185 -178.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.4 p -63.15 -39.32 94.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.058 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -161.78 -2.4 0.05 OUTLIER Glycine 0 N--CA 1.457 0.059 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.421 ' O ' ' O ' ' A' ' 146' ' ' PRO . 11.7 tp -71.71 128.68 89.36 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 119.355 -0.355 . . . . 0.0 110.358 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 145' ' ' LEU . 26.2 Cg_exo -35.25 157.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.295 1.996 . . . . 0.0 112.451 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.98 -163.62 0.13 Allowed 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.291 1.994 . . . . 0.0 112.508 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 27.3 m -132.14 69.48 1.48 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.966 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.519 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 17.3 ptm180 -56.96 -36.47 70.34 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.581 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.85 168.79 23.98 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.7 m -59.4 -17.7 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 CA-C-O 121.612 0.72 . . . . 0.0 109.553 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -65.62 -35.19 80.07 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.432 ' OE1' ' OE1' ' A' ' 157' ' ' GLN . 5.8 tm-20 -60.11 -73.78 0.08 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.895 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.3 p -45.51 -30.03 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.016 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.06 -43.34 15.2 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 122.214 1.007 . . . . 0.0 110.007 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.9 -42.26 89.17 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 122.518 1.151 . . . . 0.0 109.265 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.471 ' CG ' ' N ' ' A' ' 158' ' ' PHE . 8.0 pt20 -80.74 -49.61 10.94 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 112.974 -1.921 . . . . 0.0 112.042 -177.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.471 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 39.6 t80 -106.07 -37.24 6.68 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -177.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 98.88 25.3 9.82 Favored Glycine 0 N--CA 1.473 1.11 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -43.87 -97.27 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.561 0.219 . . . . 0.0 111.091 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.473 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 64.95 36.55 7.52 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.199 0.523 . . . . 0.0 109.899 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.548 ' C ' ' H ' ' A' ' 164' ' ' VAL . 1.5 m-85 -177.74 -61.24 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.182 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.25 29.06 0.3 Allowed 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 122.447 2.098 . . . . 0.0 110.556 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.548 ' H ' ' C ' ' A' ' 162' ' ' PHE . 16.0 m -132.65 167.37 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.215 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 9.0 t -123.49 65.13 31.34 Favored Pre-proline 0 N--CA 1.476 0.844 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.848 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -36.54 141.39 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 123.77 2.98 . . . . 0.0 115.045 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 163.27 -161.59 34.13 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 113.761 -1.563 . . . . 0.0 110.972 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -147.49 175.39 10.87 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.982 0.42 . . . . 0.0 110.193 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.571 ' HG1' ' N ' ' A' ' 170' ' ' GLY . 3.4 t -145.96 156.37 43.47 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.035 0.445 . . . . 0.0 110.509 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.571 ' N ' ' HG1' ' A' ' 169' ' ' THR . . . -52.36 -66.73 2.45 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.626 -0.989 . . . . 0.0 110.626 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 129.22 4.61 4.95 Favored Glycine 0 N--CA 1.469 0.87 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -83.95 133.64 34.69 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.89 0.376 . . . . 0.0 110.251 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.453 ' CD1' ' N ' ' A' ' 173' ' ' LEU . 9.2 mp -85.95 167.23 15.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.452 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.56 ' N ' ' CD ' ' A' ' 175' ' ' PRO . 3.6 m120 71.22 44.36 0.22 Allowed Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.444 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 174' ' ' ASN . 56.5 Cg_endo -66.56 -22.45 51.2 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 122.751 2.301 . . . . 0.0 111.364 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 41.2 t -166.11 129.14 2.02 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.687 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -99.11 150.37 22.09 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.277 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 13.1 tt -94.89 130.37 43.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.435 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -133.19 168.65 18.16 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.51 0.671 . . . . 0.0 111.574 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -87.25 108.05 18.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.165 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -72.93 -14.3 61.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.239 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.491 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.6 mm? -64.91 -42.02 95.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.989 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.22 -43.66 4.54 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.058 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 67.08 24.25 73.18 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -66.33 138.69 57.79 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.385 0.612 . . . . 0.0 111.034 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.427 ' N ' ' CD2' ' A' ' 186' ' ' LEU . 0.7 OUTLIER -74.18 177.28 5.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.496 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . 0.425 ' O ' ' CD2' ' A' ' 187' ' ' PHE . 88.6 t80 -103.64 73.35 1.18 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.625 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.94 143.57 50.21 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.503 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -147.92 144.65 28.21 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.09 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.73 0 CA-C-O 117.973 -1.459 . . . . 0.0 111.043 -179.98 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 61.1 t30 56.78 40.0 29.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.754 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -98.48 9.43 43.19 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.547 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.412 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 10.5 mp -62.46 -42.62 99.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.21 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -61.49 -40.42 94.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.934 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -64.16 -41.5 97.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.14 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -59.24 -45.78 90.23 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.198 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.42 -45.61 92.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.045 0.45 . . . . 0.0 110.424 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.412 HG23 HD12 ' A' ' 10' ' ' ILE . 96.9 mt -63.5 -42.44 96.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.29 -44.69 84.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.382 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.09 -42.76 99.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.086 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.06 -52.33 65.83 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.898 0.38 . . . . 0.0 111.825 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 18.8 pt -68.58 -37.48 77.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.091 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -58.6 -51.19 70.97 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 120.281 -0.567 . . . . 0.0 110.047 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' A' ' 20' ' ' GLU . 88.6 t -63.86 -38.37 82.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.007 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.449 ' CD2' ' C ' ' A' ' 17' ' ' LEU . 6.3 tt -52.77 -50.58 63.25 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.439 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -79.59 -47.94 14.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.21 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -67.19 -31.97 72.73 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.831 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.7 mt-10 58.22 56.6 4.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.271 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.41 ' NH2' ' O ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -149.88 158.51 44.24 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.591 0.71 . . . . 0.0 110.588 178.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.41 ' O ' ' NH2' ' A' ' 21' ' ' ARG . 7.8 p -74.29 137.67 22.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.799 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.9 pp -124.58 168.25 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-O 120.587 0.232 . . . . 0.0 110.534 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.74 134.82 56.0 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.191 0.519 . . . . 0.0 111.023 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.532 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 0.6 OUTLIER -125.48 141.5 39.12 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.706 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.532 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 60.5 Cg_endo -80.23 151.91 20.78 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.709 1.606 . . . . 0.0 111.235 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.477 ' C ' ' H ' ' A' ' 29' ' ' ALA . 47.8 m -133.36 140.72 47.54 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.372 0.606 . . . . 0.0 111.108 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -77.51 23.06 0.23 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.132 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.477 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -160.53 -70.77 0.07 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.194 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.7 p -126.97 125.63 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-O 121.109 0.48 . . . . 0.0 110.34 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.531 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 96.7 m-85 -45.48 150.39 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.668 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -160.99 -169.07 23.74 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.2 m -130.45 170.13 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.25 177.77 35.66 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.686 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -155.45 -164.83 1.84 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 120.433 -0.507 . . . . 0.0 112.122 -178.52 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.467 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 23.6 m-20 -90.86 106.27 15.06 Favored Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -177.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -34.92 -62.35 0.21 Allowed 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 122.461 2.107 . . . . 0.0 112.716 178.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.464 ' C ' ' HG ' ' A' ' 39' ' ' SER . 56.7 p-10 -74.31 67.51 1.41 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.103 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.464 ' HG ' ' C ' ' A' ' 38' ' ' ASP . 23.3 m -157.07 133.05 9.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.159 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -66.14 -20.55 66.18 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.307 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.4 t -60.08 -34.76 73.89 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.932 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.71 -52.2 66.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.874 0.368 . . . . 0.0 111.575 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -64.61 -45.77 94.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.929 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 63.0 mtt -67.51 -46.89 71.58 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.635 HH22 ' HG1' ' A' ' 138' ' ' THR . 40.7 ptt85 -63.02 -30.38 71.55 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.829 0.347 . . . . 0.0 110.221 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.7 mt -73.48 -60.91 2.03 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.269 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.0 mt -54.34 -20.5 7.36 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.449 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -63.47 -86.12 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.543 -178.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.411 HD22 ' H ' ' A' ' 50' ' ' LYS . 2.2 pt? -78.68 -34.35 46.29 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.411 ' H ' HD22 ' A' ' 49' ' ' LEU . 24.6 mmmt -74.92 -50.67 16.03 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.916 -176.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 37.19 64.7 0.58 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.985 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 179.0 -54.0 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.856 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.455 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -75.61 -8.27 19.24 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.323 2.015 . . . . 0.0 111.493 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.488 ' CG1' ' N ' ' A' ' 55' ' ' ASP . 10.8 p -46.71 -43.9 6.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.254 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 110' ' ' ARG . 11.1 t0 -70.59 -44.58 67.04 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.198 -178.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -61.27 -38.3 86.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.6 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 74.77 101.9 0.1 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.572 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -50.92 -167.55 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.092 0.472 . . . . 0.0 112.231 -179.658 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.445 ' O ' ' OG ' ' A' ' 137' ' ' SER . 77.2 mt -100.67 135.29 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.143 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 16.0 mt -112.43 144.51 41.77 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.5 tt -114.53 129.77 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 CA-C-O 121.445 0.64 . . . . 0.0 110.88 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.79 155.09 29.55 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.579 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.97 -30.08 6.15 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.707 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 79.5 m-20 -112.46 150.01 31.81 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.135 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -76.77 -21.97 54.42 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.707 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -50.96 -30.31 14.59 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.875 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.707 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 5.9 pm0 -93.82 -6.13 46.58 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.823 -0.172 . . . . 0.0 111.431 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -89.79 -21.69 22.49 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.452 ' NZ ' ' CB ' ' A' ' 69' ' ' LYS . 8.0 mtpm? -73.76 -38.27 3.87 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -178.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 94.6 Cg_endo -101.75 -5.01 0.35 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.628 2.219 . . . . 0.0 111.986 -179.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.438 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 55.5 t80 -87.81 -18.96 28.18 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.772 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.477 ' CG2' ' N ' ' A' ' 73' ' ' ASP . 5.1 mp -119.27 166.93 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.477 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 97.8 m-20 -61.75 -14.39 31.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.329 . . . . 0.0 111.054 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 41.1 t0 59.54 32.67 21.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.86 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.445 ' CG2' ' N ' ' A' ' 76' ' ' MET . 14.1 t -105.14 -42.38 5.31 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.903 0.382 . . . . 0.0 110.476 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.445 ' N ' ' CG2' ' A' ' 75' ' ' THR . 21.0 ptm -88.78 -23.37 22.9 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.366 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 30.3 tp -67.65 133.08 48.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.124 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.95 170.26 19.25 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.577 -176.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -59.94 -42.11 93.29 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 123.364 0.415 . . . . 0.0 111.389 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.1 p -60.63 -33.27 54.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.42 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -63.23 -41.17 99.06 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.113 0.482 . . . . 0.0 110.358 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.5 mmt85 -63.94 -52.11 61.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.479 1.133 . . . . 0.0 109.117 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -55.69 -50.04 71.36 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.798 -1.547 . . . . 0.0 110.028 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.2 m -61.18 -49.92 75.22 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.47 -1.241 . . . . 0.0 112.091 -178.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.401 ' O ' ' O ' ' A' ' 89' ' ' TRP . 9.1 tt -68.25 -30.12 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.696 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -78.4 -37.3 44.29 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.759 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.2 m -84.72 -10.64 57.07 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.722 0.296 . . . . 0.0 111.166 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.442 ' O ' ' O ' ' A' ' 89' ' ' TRP . 62.0 ttm-85 -122.61 83.64 2.14 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.442 ' O ' ' O ' ' A' ' 88' ' ' ARG . 14.6 m95 57.68 150.33 0.07 OUTLIER Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.231 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.415 ' O ' ' O ' ' A' ' 118' ' ' VAL . 55.8 Cg_endo -68.01 -23.35 40.49 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.203 1.935 . . . . 0.0 111.973 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 159.1 80.65 0.03 OUTLIER Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.74 -24.2 7.49 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 122.163 1.909 . . . . 0.0 112.395 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.5 p -137.04 146.56 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 120.783 0.325 . . . . 0.0 110.474 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 53.8 m -89.71 149.7 22.64 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.845 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -128.0 144.78 51.11 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.202 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.5 t -102.05 108.67 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-O 121.34 0.59 . . . . 0.0 110.46 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -94.98 150.37 37.64 Favored Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.898 -178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.21 89.44 0.39 Allowed 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.265 1.977 . . . . 0.0 111.47 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.93 149.71 80.19 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.138 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -72.14 157.34 54.26 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.207 1.938 . . . . 0.0 111.992 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -139.73 87.69 2.19 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.837 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.415 ' O ' ' OG1' ' A' ' 103' ' ' THR . 21.2 p -62.68 -43.53 98.57 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.099 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.603 ' H ' ' CD ' ' A' ' 104' ' ' PRO . 0.6 OUTLIER -168.43 -39.57 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.603 ' CD ' ' H ' ' A' ' 103' ' ' THR . 12.5 Cg_exo -67.8 -167.2 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.386 2.057 . . . . 0.0 112.996 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 109' ' ' GLY . 23.7 mmt180 -144.53 -11.62 0.61 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.68 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 2.0 p90 -66.73 -10.76 50.32 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.949 -0.301 . . . . 0.0 111.593 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.687 ' CD1' ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -67.23 -39.8 86.25 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.568 ' C ' ' H ' ' A' ' 110' ' ' ARG . 16.6 m -145.99 -39.92 0.22 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.65 177.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 58.53 -12.01 0.02 OUTLIER Glycine 0 CA--C 1.532 1.126 0 CA-C-N 115.711 -0.677 . . . . 0.0 113.29 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.568 ' H ' ' C ' ' A' ' 108' ' ' THR . 0.0 OUTLIER -86.54 -51.51 6.13 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 117.714 0.757 . . . . 0.0 109.446 -179.437 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.452 ' CD2' ' N ' ' A' ' 112' ' ' ASP . 85.4 t80 -160.18 -95.34 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.019 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.452 ' N ' ' CD2' ' A' ' 111' ' ' PHE . 35.8 t70 -171.01 67.96 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.541 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.5 p -166.77 129.36 1.81 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.742 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 87.2 mt -126.41 128.01 46.34 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.67 119.69 14.29 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.344 176.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.4 p -145.96 158.49 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -151.57 160.81 43.51 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.745 0.307 . . . . 0.0 110.983 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.415 ' O ' ' O ' ' A' ' 90' ' ' PRO . 55.9 t -123.44 137.75 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.1 t -128.65 157.44 41.3 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.304 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 5.8 p30 -158.74 77.97 0.77 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.134 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.578 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 56.9 t-80 -172.62 -35.81 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.578 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 37.3 Cg_endo -94.44 -163.33 0.09 OUTLIER 'Trans proline' 0 N--CA 1.485 0.981 0 C-N-CA 121.973 1.782 . . . . 0.0 111.991 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 36.5 mt -78.22 -4.39 47.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.511 0.672 . . . . 0.0 109.908 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 93.4 t -58.35 -44.93 89.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.061 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.584 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 30.8 m -54.24 -62.52 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 C-N-CA 119.538 -0.865 . . . . 0.0 108.727 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.584 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -41.6 -43.27 2.7 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.021 0.439 . . . . 0.0 110.657 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.9 tp -69.28 -48.87 60.45 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.828 0.347 . . . . 0.0 111.455 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 80.3 m -70.46 -48.42 55.94 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.365 0.602 . . . . 0.0 110.851 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.445 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -54.72 -43.27 72.45 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.73 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.445 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -59.02 -55.21 38.08 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.235 -1.348 . . . . 0.0 109.459 -178.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.413 ' OH ' ' OD1' ' A' ' 38' ' ' ASP . 39.2 t80 -61.84 -21.84 64.98 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 114.545 -1.207 . . . . 0.0 109.151 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.54 0.69 84.83 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -151.52 158.72 34.16 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -43.8 174.16 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 123.697 2.931 . . . . 0.0 113.722 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.5 tp -128.63 123.13 32.48 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -66.12 144.34 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 C-N-CA 118.353 -1.339 . . . . 0.0 108.049 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -110.01 120.14 41.51 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.305 1.003 . . . . 0.0 110.876 -179.179 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.635 ' HG1' HH22 ' A' ' 45' ' ' ARG . 2.4 m -134.11 160.06 38.94 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.898 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.5 m -72.11 142.44 49.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.882 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.88 -36.32 83.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.813 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' A' ' 141' ' ' ASN . 56.9 p30 -46.97 150.04 0.81 Allowed 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.959 0.885 . . . . 0.0 111.255 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.4 -161.55 0.89 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.211 -1.359 . . . . 0.0 110.569 -178.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.2 p -62.02 -39.81 93.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.297 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -164.9 9.24 0.07 OUTLIER Glycine 0 C--N 1.33 0.224 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.3 tp -91.65 127.89 48.54 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-O 119.355 -0.355 . . . . 0.0 110.186 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -38.61 156.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 121.648 1.565 . . . . 0.0 112.276 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -76.54 -167.01 0.41 Allowed 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.773 2.316 . . . . 0.0 112.524 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 83.3 m -111.48 74.33 0.86 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.461 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.531 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 38.0 ptt180 -51.84 -37.54 52.33 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.432 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -159.87 168.08 26.62 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.763 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.1 m -57.88 -21.65 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.83 -30.58 71.66 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 150' ' ' THR . 6.7 tm-20 -63.73 -79.85 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.534 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.0 p -36.45 -30.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.082 0.953 . . . . 0.0 110.971 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.466 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -70.68 -51.68 26.12 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.518 -179.351 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.09 -17.54 62.58 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 122.451 1.119 . . . . 0.0 108.024 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -83.77 -47.82 10.75 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 112.705 -2.043 . . . . 0.0 111.794 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -130.58 -19.92 2.97 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 85.82 26.15 35.84 Favored Glycine 0 N--CA 1.468 0.823 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.4 ' O ' ' O ' ' A' ' 159' ' ' GLY . . . -43.64 -95.9 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.587 0.232 . . . . 0.0 111.195 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.467 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 63.43 35.43 12.1 Favored 'General case' 0 CA--C 1.527 0.09 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.538 ' C ' ' H ' ' A' ' 164' ' ' VAL . 1.6 m-85 -175.47 -61.9 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.153 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.49 27.35 0.31 Allowed 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.298 1.999 . . . . 0.0 110.751 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.538 ' H ' ' C ' ' A' ' 162' ' ' PHE . 14.9 m -129.45 167.64 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.805 -178.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.0 t -123.16 64.53 26.31 Favored Pre-proline 0 N--CA 1.472 0.668 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.831 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -37.65 144.27 0.15 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 123.291 2.66 . . . . 0.0 114.823 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -175.22 -158.25 18.67 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 114.101 -1.409 . . . . 0.0 111.472 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -141.92 -154.42 0.52 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.735 0.302 . . . . 0.0 110.527 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.539 ' OG1' ' N ' ' A' ' 170' ' ' GLY . 1.6 t -150.05 -122.21 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.511 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.539 ' N ' ' OG1' ' A' ' 169' ' ' THR . . . 84.44 15.81 67.88 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -149.54 51.12 0.54 Allowed Glycine 0 N--CA 1.467 0.706 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 76.8 mtm-85 -97.29 9.93 40.92 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.803 0.335 . . . . 0.0 110.336 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.499 ' CD1' ' N ' ' A' ' 173' ' ' LEU . 8.5 mp -61.36 -46.17 91.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.872 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.584 HD21 ' H ' ' A' ' 174' ' ' ASN . 1.2 p30 -74.41 112.51 17.53 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.008 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.99 156.47 26.67 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.796 1.664 . . . . 0.0 111.629 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 48.3 m -107.54 121.2 44.17 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.35 0.595 . . . . 0.0 110.608 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -132.71 172.94 11.9 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.726 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 39.0 pt -117.61 142.88 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.917 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -131.26 166.19 21.72 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.462 0.649 . . . . 0.0 111.654 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 184' ' ' GLY . 97.6 m-20 -78.55 106.48 10.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.679 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -65.86 -18.01 65.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.739 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.493 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.4 mm? -63.15 -41.72 99.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.221 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.43 -41.12 2.62 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.69 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 180' ' ' ASP . . . 61.55 28.92 70.49 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -80.38 158.34 26.04 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.205 0.526 . . . . 0.0 111.368 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.446 ' N ' ' CD2' ' A' ' 186' ' ' LEU . 0.8 OUTLIER -70.81 178.06 3.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.412 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -108.7 75.45 0.97 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.143 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 13.8 tpp85 -70.07 139.31 52.58 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 120.912 0.387 . . . . 0.0 109.997 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -174.0 -20.72 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.294 177.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.81 0 CA-C-O 118.265 -1.297 . . . . 0.0 111.114 179.818 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 57.9 p30 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -63.77 -40.68 97.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.526 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -156.51 18.91 0.34 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.78 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.7 mp -63.03 -42.75 99.86 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -64.58 -40.75 96.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.744 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 61.8 ttt85 -63.01 -41.74 99.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.166 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.7 -44.07 96.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.448 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.45 -44.52 94.27 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.166 0.508 . . . . 0.0 109.918 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.9 mt -63.52 -42.58 96.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.357 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.48 -41.09 80.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.329 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.76 -43.9 91.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.935 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.09 -53.08 62.01 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 17.6 pt -68.2 -36.94 77.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.806 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -58.06 -50.03 74.85 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.613 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' A' ' 20' ' ' GLU . 90.8 t -64.59 -38.66 83.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.946 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.451 ' CD2' ' C ' ' A' ' 17' ' ' LEU . 6.5 tt -52.7 -51.02 62.12 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.287 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -78.34 -47.97 16.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.402 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -67.83 -31.36 71.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.951 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.6 mt-10 57.54 57.64 4.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.182 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.42 ' NH2' ' O ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -151.15 159.17 44.61 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.582 0.706 . . . . 0.0 110.336 179.088 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.42 ' O ' ' NH2' ' A' ' 21' ' ' ARG . 8.9 p -74.08 140.17 18.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.452 -178.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pp -126.69 166.43 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-O 120.879 0.371 . . . . 0.0 110.927 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.85 137.9 58.24 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.332 0.587 . . . . 0.0 111.008 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.53 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 0.4 OUTLIER -130.52 141.86 43.44 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.123 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.53 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 58.3 Cg_endo -79.38 146.79 19.79 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 121.451 1.434 . . . . 0.0 111.682 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.528 ' C ' ' H ' ' A' ' 29' ' ' ALA . 33.7 m -130.02 133.42 46.73 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.905 0.383 . . . . 0.0 110.931 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -74.53 25.26 0.08 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.152 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.528 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -157.3 -74.43 0.09 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.001 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.3 t -124.93 125.51 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-O 120.894 0.378 . . . . 0.0 110.313 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -44.37 139.24 2.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.934 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -149.44 -172.28 18.87 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.5 m -130.06 169.98 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.5 178.98 34.49 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.757 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.55 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -154.53 -162.97 1.49 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.819 0.342 . . . . 0.0 111.393 -178.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.55 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 5.7 m-20 -97.82 107.34 39.64 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -177.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 36' ' ' ASP . 38.6 Cg_exo -37.86 173.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 123.074 2.516 . . . . 0.0 114.215 177.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 66.7 t0 35.66 76.39 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.492 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.0 m -152.73 139.03 18.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.336 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -70.12 -34.3 72.92 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.244 0.545 . . . . 0.0 110.74 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.32 -44.39 91.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.86 -178.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.63 -50.61 71.85 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.515 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.6 p -62.58 -44.51 99.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.177 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 90.7 mtp -64.0 -40.02 95.43 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.4 ' O ' ' CD2' ' A' ' 49' ' ' LEU . 56.0 ttt85 -61.68 -33.02 73.25 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.341 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 85.8 mt -75.04 -60.81 2.12 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.6 mt -53.56 -18.35 2.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.56 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -66.83 -86.15 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -178.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.4 ' CD2' ' O ' ' A' ' 45' ' ' ARG . 2.2 pt? -76.82 -34.34 57.91 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -75.03 -49.69 18.96 Favored 'General case' 0 C--N 1.345 0.409 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.56 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 35.62 64.81 0.45 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.855 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 179.29 -53.35 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.902 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.497 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.74 -8.79 20.7 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.399 2.066 . . . . 0.0 112.267 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -41.52 -48.17 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.809 -179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 55' ' ' ASP . 33.9 t0 -69.39 -38.71 78.11 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.547 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.481 ' CD ' ' N ' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -59.78 -39.26 84.31 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.767 -179.092 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 59.62 104.69 0.01 OUTLIER Glycine 0 CA--C 1.518 0.247 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.568 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -52.53 -161.3 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.615 0.721 . . . . 0.0 111.735 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.0 mt -108.41 146.77 13.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.912 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.7 mt -119.55 141.24 49.42 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.408 ' CD1' ' HE ' ' A' ' 117' ' ' ARG . 8.0 tp -108.96 131.68 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-O 121.222 0.534 . . . . 0.0 110.569 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.81 153.25 34.78 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.385 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.29 -26.93 7.79 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -117.46 151.17 37.64 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.823 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -78.99 -13.42 59.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.511 0.672 . . . . 0.0 109.346 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -51.14 -30.26 16.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.843 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.462 HE21 ' N ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -94.82 -13.62 25.4 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.562 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -92.36 -13.67 29.83 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.479 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 79.0 tttt -80.08 -37.79 1.11 Allowed Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 68.6 Cg_endo -102.59 -3.64 0.32 Allowed 'Trans proline' 0 C--N 1.316 -1.169 0 C-N-CA 122.812 2.341 . . . . 0.0 111.564 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.508 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 42.9 t80 -93.07 -13.13 28.97 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.365 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.7 mp -125.75 155.1 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -64.41 153.02 39.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.063 0.459 . . . . 0.0 110.114 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 66.5 t0 -96.22 46.03 1.07 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.308 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.9 t -115.83 -40.08 3.39 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.269 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 13.6 ptm -95.55 -24.41 16.63 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.217 0.532 . . . . 0.0 110.224 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 30.8 tp -80.09 134.98 36.23 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.436 -178.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.654 ' HG1' ' N ' ' A' ' 79' ' ' ASP . 0.9 OUTLIER -148.07 169.74 19.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.708 -177.171 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.654 ' N ' ' HG1' ' A' ' 78' ' ' THR . 99.2 m-20 -60.36 -41.92 94.7 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.367 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.46 -33.39 56.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.115 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -63.24 -40.39 97.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.068 0.461 . . . . 0.0 110.569 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.5 mmt85 -64.17 -52.03 60.96 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 122.655 1.217 . . . . 0.0 109.02 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 87' ' ' SER . 82.6 tt0 -56.68 -50.42 72.18 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.618 -1.628 . . . . 0.0 110.372 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.2 m -62.41 -49.47 75.35 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.349 -1.296 . . . . 0.0 112.232 -177.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.8 tt -67.46 -25.31 33.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.325 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -86.47 -32.6 20.73 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.241 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 83' ' ' GLU . 6.7 m -88.52 -20.24 25.35 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.293 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.442 ' O ' ' O ' ' A' ' 89' ' ' TRP . 70.2 ttt180 -116.19 82.26 1.75 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.668 0.27 . . . . 0.0 110.636 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.442 ' O ' ' O ' ' A' ' 88' ' ' ARG . 3.9 m-90 56.56 151.82 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.828 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.4 -17.82 44.07 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.058 1.839 . . . . 0.0 111.449 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 99.26 69.71 0.93 Allowed Glycine 0 N--CA 1.471 0.972 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.52 -38.55 93.95 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.893 2.396 . . . . 0.0 112.307 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.7 p -73.92 136.15 25.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.322 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 56.1 m -88.92 144.23 26.33 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.821 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -126.94 144.55 50.97 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.227 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.5 t -99.91 103.4 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 121.296 0.569 . . . . 0.0 109.475 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -87.77 148.21 43.13 Favored Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.815 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.9 101.66 1.51 Allowed 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.651 1.567 . . . . 0.0 110.948 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.38 150.53 79.95 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.896 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.436 ' O ' ' OG1' ' A' ' 103' ' ' THR . 79.2 Cg_endo -71.53 152.11 59.57 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.222 1.948 . . . . 0.0 112.406 -179.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.61 -35.52 81.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.037 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 81.9 p -55.66 -42.52 75.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.485 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.478 ' O ' ' O ' ' A' ' 104' ' ' PRO . 4.7 p -61.94 155.69 61.55 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 103' ' ' THR . 78.1 Cg_exo -47.89 -160.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.944 0 C-N-CA 122.577 2.185 . . . . 0.0 113.707 178.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.489 HH22 ' C ' ' A' ' 111' ' ' PHE . 7.1 tpt85 -140.37 0.1 1.65 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.441 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 43.4 m95 -77.26 -2.97 37.45 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 120.839 0.352 . . . . 0.0 110.517 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.659 ' CD1' ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -82.44 -19.6 38.64 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.537 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 51.3 m -142.74 -41.53 0.32 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.435 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 64.81 24.06 69.62 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.453 178.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.93 -75.22 0.11 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 117.54 0.67 . . . . 0.0 110.527 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.489 ' C ' HH22 ' A' ' 105' ' ' ARG . 72.2 m-85 -113.63 159.5 19.58 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.018 0.437 . . . . 0.0 110.312 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -93.06 76.82 4.68 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.284 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 19.5 p -163.57 128.85 3.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.967 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -134.04 128.26 33.94 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.83 124.14 23.25 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 113.815 -1.539 . . . . 0.0 109.333 176.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.3 p -144.21 152.27 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.881 0.372 . . . . 0.0 110.783 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.408 ' HE ' ' CD1' ' A' ' 61' ' ' ILE . 62.2 ttp180 -140.58 153.81 46.25 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.682 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 56.0 t -121.91 134.05 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 7.9 t -134.02 153.28 51.89 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.215 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 51.2 p-10 -153.72 82.99 1.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.075 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.565 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 40.7 t60 -172.47 -37.36 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.565 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 40.7 Cg_endo -94.15 -161.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -0.977 0 C-N-CA 122.122 1.881 . . . . 0.0 112.156 -178.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 27.4 mt -79.04 -4.97 52.8 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.929 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 95.0 t -58.15 -45.03 88.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.915 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.587 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 30.3 m -54.1 -62.54 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.847 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.587 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -41.41 -44.13 2.75 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 120.936 0.398 . . . . 0.0 110.819 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.5 tp -68.83 -48.32 63.8 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.469 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 61.8 m -70.66 -49.04 51.62 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.431 0.634 . . . . 0.0 110.835 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 125' ' ' VAL . 1.1 pp0? -54.62 -41.93 70.57 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.44 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -59.5 -54.37 47.43 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.049 -177.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.499 ' CE1' ' OD2' ' A' ' 36' ' ' ASP . 41.4 t80 -61.78 -20.42 63.57 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.321 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.73 -1.14 84.53 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.412 ' O ' ' O ' ' A' ' 134' ' ' PRO . 33.3 mttm -151.65 159.64 32.94 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.412 ' O ' ' O ' ' A' ' 133' ' ' LYS . 4.1 Cg_exo -42.24 177.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 123.858 3.039 . . . . 0.0 112.933 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.4 tp -131.43 123.58 28.44 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.41 145.87 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 C-N-CA 117.927 -1.509 . . . . 0.0 107.329 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t -118.28 121.93 41.64 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 123.408 0.443 . . . . 0.0 111.191 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.2 m -129.77 162.03 29.36 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.255 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 17.7 m -72.04 145.57 48.19 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.93 81.19 1.67 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.694 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 57.6 p30 -158.7 164.71 35.66 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.335 0.588 . . . . 0.0 110.581 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.15 -163.4 1.47 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.186 -178.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 38.8 t -61.27 -44.25 97.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.676 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -159.71 4.9 0.11 Allowed Glycine 0 N--CA 1.46 0.28 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.5 tp -82.04 127.05 73.3 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -38.95 156.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.621 1.548 . . . . 0.0 112.271 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -75.71 -167.21 0.41 Allowed 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.352 2.035 . . . . 0.0 112.316 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 8.7 t -114.81 77.97 1.12 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.333 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -57.66 -34.97 69.93 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.229 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.45 168.4 20.3 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.4 m -57.66 -17.61 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -65.05 -35.63 81.77 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 177.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.444 ' OE1' ' OE1' ' A' ' 157' ' ' GLN . 5.8 tm-20 -59.83 -72.5 0.1 Allowed 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.765 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.8 p -48.04 -30.63 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.342 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.426 ' O ' ' N ' ' A' ' 159' ' ' GLY . 3.8 tmt_? -83.84 -45.36 13.36 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 122.185 0.993 . . . . 0.0 110.285 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.75 -41.03 81.07 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.416 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.466 ' CG ' ' N ' ' A' ' 158' ' ' PHE . 7.9 pt20 -82.65 -48.7 10.62 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 112.932 -1.94 . . . . 0.0 112.224 -176.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.466 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 32.0 t80 -106.85 -35.92 6.81 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 96.22 25.26 12.82 Favored Glycine 0 N--CA 1.472 1.092 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -178.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -43.36 -94.27 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.514 0.197 . . . . 0.0 110.901 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.474 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 62.13 36.47 15.11 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-O 121.25 0.547 . . . . 0.0 109.857 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.553 ' C ' ' H ' ' A' ' 164' ' ' VAL . 1.8 m-85 -175.77 -62.06 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.277 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.46 28.87 0.31 Allowed 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.32 2.013 . . . . 0.0 110.367 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.553 ' H ' ' C ' ' A' ' 162' ' ' PHE . 16.8 m -133.27 167.01 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.053 -178.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 6.8 t -124.3 65.51 40.6 Favored Pre-proline 0 N--CA 1.473 0.696 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.694 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -37.22 143.88 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 123.611 2.874 . . . . 0.0 115.08 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 165.94 177.65 38.25 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 113.734 -1.576 . . . . 0.0 110.598 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -151.14 151.53 32.07 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.3 t -145.75 154.13 41.72 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.991 0.424 . . . . 0.0 110.925 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -49.14 -67.56 1.68 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 129.17 36.97 0.4 Allowed Glycine 0 N--CA 1.468 0.822 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 -83.35 131.65 35.05 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.408 ' CD1' ' N ' ' A' ' 173' ' ' LEU . 9.0 mp -83.57 159.09 21.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.935 0.397 . . . . 0.0 110.287 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -88.8 147.67 39.68 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.921 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.22 -19.98 38.0 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.879 1.719 . . . . 0.0 111.565 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 63.1 m -157.97 123.61 4.57 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.405 0.621 . . . . 0.0 110.032 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -94.91 -91.99 0.2 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.333 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 29.7 pt -90.84 132.49 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 121.13 0.49 . . . . 0.0 110.817 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 22.7 mmm-85 -129.48 158.51 39.02 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.762 0.791 . . . . 0.0 110.817 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 184' ' ' GLY . 99.8 m-20 -77.06 104.88 7.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.151 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -64.78 -22.97 67.1 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.148 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.476 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.6 mm? -63.68 -41.62 98.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.611 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.1 t -121.0 -42.71 2.48 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.583 0.23 . . . . 0.0 111.099 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 180' ' ' ASP . . . 69.93 32.06 69.88 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -112.68 158.73 19.67 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.945 0.402 . . . . 0.0 111.025 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.453 ' N ' ' CD2' ' A' ' 186' ' ' LEU . 0.7 OUTLIER -64.95 -175.19 0.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.423 179.694 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -128.64 84.03 2.2 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.228 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -74.66 139.18 43.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.026 0.441 . . . . 0.0 110.548 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -173.62 -21.86 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.588 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.736 0 CA-C-O 118.008 -1.44 . . . . 0.0 110.928 -179.844 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 57.7 t30 . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -86.47 136.78 32.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.494 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -63.29 -40.1 96.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.764 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.467 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 9.2 mp -62.73 -42.05 99.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.107 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -63.97 -43.29 96.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.756 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -64.07 -41.49 97.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.264 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -61.26 -44.21 97.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.109 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.75 -45.55 92.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.975 0.417 . . . . 0.0 109.959 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.6 mt -63.92 -43.15 97.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.81 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.04 -41.75 88.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.528 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.38 -47.38 79.49 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.858 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.05 -51.79 66.58 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.4 pp -67.71 -39.3 81.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.873 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -58.63 -50.04 75.29 Favored 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.306 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 20' ' ' GLU . 88.3 t -64.07 -38.66 83.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.933 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.449 ' CD2' ' C ' ' A' ' 17' ' ' LEU . 6.3 tt -52.69 -51.0 62.18 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.42 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -78.91 -47.1 17.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.409 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -68.28 -31.17 70.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.136 0.494 . . . . 0.0 111.22 -178.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.4 mt-10 57.13 59.92 3.2 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.123 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.21 158.9 43.51 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.176 0.512 . . . . 0.0 110.13 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.2 p -75.99 140.55 17.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.57 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pp -125.4 167.73 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.615 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.25 132.22 48.51 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.277 0.561 . . . . 0.0 111.718 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -115.87 133.55 22.84 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -83.76 140.68 9.32 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 CA-C-N 120.567 1.238 . . . . 0.0 111.857 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.3 m -138.45 134.63 34.28 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -56.94 -42.91 80.92 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.824 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.66 -79.6 0.07 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.8 t -132.53 129.55 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -41.08 157.05 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.796 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -159.95 -169.53 23.37 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.4 m -131.08 168.52 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.414 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -159.29 178.98 35.21 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.059 -1.067 . . . . 0.0 111.818 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.476 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.8 OUTLIER -158.22 -163.2 1.25 Allowed 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.948 -178.826 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.476 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 35.9 m-20 -91.71 105.78 14.56 Favored Pre-proline 0 CA--C 1.555 1.168 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -177.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -38.11 -62.15 0.32 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.521 2.148 . . . . 0.0 112.929 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -71.91 65.12 0.52 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.516 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 m -151.18 131.18 13.39 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.683 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -66.36 -32.75 74.34 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.214 0.531 . . . . 0.0 111.184 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.422 ' CG2' ' N ' ' A' ' 42' ' ' ALA . 15.1 t -60.19 -42.53 95.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.34 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.422 ' N ' ' CG2' ' A' ' 41' ' ' THR . . . -56.63 -50.43 72.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.968 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 p -64.44 -42.62 95.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.207 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 94.0 mtp -63.92 -39.46 94.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -60.46 -41.77 94.79 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 122.087 0.946 . . . . 0.0 108.448 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.1 tt -64.15 -53.33 51.16 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.369 -178.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.8 mt -70.0 -11.46 60.89 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.062 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -70.32 -83.02 0.03 OUTLIER 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.121 0.486 . . . . 0.0 111.193 -177.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.41 HD21 ' H ' ' A' ' 50' ' ' LYS . 2.2 pt? -76.16 -33.92 59.37 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 -178.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.41 ' H ' HD21 ' A' ' 49' ' ' LEU . 24.5 mmmt -77.58 -51.93 9.87 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.435 -177.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 36.51 66.47 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.861 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.2 mtm-85 177.8 -53.96 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.918 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.149 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -78.12 -5.96 15.45 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.604 2.202 . . . . 0.0 112.341 -178.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.1 p -44.34 -44.82 2.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.888 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -64.34 -42.72 96.13 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.223 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -61.92 -36.6 81.83 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 63.15 113.73 0.01 OUTLIER Glycine 0 C--N 1.332 0.332 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.548 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -53.78 -160.67 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.008 0.433 . . . . 0.0 111.776 -179.314 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.0 mt -106.63 141.4 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.872 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.7 mt -118.89 142.62 47.58 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.8 tp -111.64 132.41 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-O 121.226 0.536 . . . . 0.0 110.853 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.97 153.45 35.94 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.26 -27.67 7.89 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.643 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 12.9 m120 -116.97 147.04 42.63 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.018 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -76.34 -13.5 60.14 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -50.82 -32.68 20.86 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.256 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.643 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 4.1 pm0 -93.71 -12.34 29.46 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -91.13 -15.92 28.63 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.463 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 11.3 ttmm -79.33 -38.49 1.3 Allowed Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 84.9 Cg_endo -103.59 -3.0 0.26 Allowed 'Trans proline' 0 C--N 1.316 -1.146 0 C-N-CA 122.764 2.309 . . . . 0.0 112.116 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.456 ' OH ' ' CD2' ' A' ' 114' ' ' LEU . 64.1 t80 -96.09 -8.34 33.63 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.92 0.39 . . . . 0.0 110.549 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.3 mp -138.16 167.58 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.515 ' C ' ' H ' ' A' ' 75' ' ' THR . 98.7 m-20 -63.34 -17.42 62.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.09 0.471 . . . . 0.0 110.086 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.0 t70 54.29 5.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.954 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.515 ' H ' ' C ' ' A' ' 73' ' ' ASP . 13.4 t -69.26 -37.49 77.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.181 0.515 . . . . 0.0 109.941 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.405 ' O ' ' OE1' ' A' ' 81' ' ' GLN . 76.1 mmm -66.47 -41.96 88.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.942 0.877 . . . . 0.0 109.018 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.432 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 9.4 mp -70.79 144.64 50.78 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 113.875 -1.511 . . . . 0.0 110.845 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.49 160.89 43.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.063 -179.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -42.89 -44.92 4.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.906 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.2 p -60.49 -41.06 86.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.1 -179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.405 ' OE1' ' O ' ' A' ' 76' ' ' MET . 35.4 mt-30 -64.09 -40.16 95.62 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.608 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -65.28 -52.02 56.94 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 122.508 1.147 . . . . 0.0 108.819 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -54.3 -50.53 67.11 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 113.7 -1.591 . . . . 0.0 109.724 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.1 m -60.83 -50.42 73.52 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.31 -1.314 . . . . 0.0 111.666 -178.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 88' ' ' ARG . 7.6 tt -67.11 -34.09 67.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 119.371 -0.932 . . . . 0.0 109.262 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -70.16 -38.94 75.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.941 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.5 m -87.22 -17.45 32.59 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.009 0.433 . . . . 0.0 110.869 -178.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 85' ' ' ILE . 53.0 ttt85 -114.55 171.97 7.31 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 4.4 m0 -33.27 148.29 0.07 OUTLIER Pre-proline 0 CA--C 1.54 0.569 0 O-C-N 123.186 0.304 . . . . 0.0 111.35 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.56 -17.13 48.31 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.19 1.927 . . . . 0.0 111.506 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 103.03 70.53 0.85 Allowed Glycine 0 N--CA 1.469 0.842 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.57 -42.23 67.45 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.495 2.13 . . . . 0.0 112.321 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.523 ' O ' ' CE1' ' A' ' 95' ' ' PHE . 11.7 p -75.37 140.03 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.957 0.408 . . . . 0.0 110.776 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 22.7 m -90.57 150.29 21.8 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.91 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.599 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -130.49 148.44 52.3 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.087 179.69 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.03 112.95 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -99.24 152.14 37.67 Favored Pre-proline 0 N--CA 1.47 0.561 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.699 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.78 112.2 3.46 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.189 1.926 . . . . 0.0 111.475 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.71 152.82 78.05 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.82 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.36 152.37 81.72 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.028 1.819 . . . . 0.0 111.395 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.04 -28.28 19.16 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.126 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.8 m -57.96 -45.68 86.3 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.301 -178.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 104' ' ' PRO . 5.0 t -54.99 145.2 44.8 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.476 ' O ' ' O ' ' A' ' 103' ' ' THR . 0.8 OUTLIER -28.38 -109.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 123.435 2.756 . . . . 0.0 114.464 -179.803 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 109' ' ' GLY . 8.4 tpt180 -172.29 2.87 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.955 -0.466 . . . . 0.0 110.724 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 53.6 p-90 -74.47 -7.7 53.86 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.146 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.642 ' CD1' ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -71.13 -35.58 71.77 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.605 179.551 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.8 m -133.98 -39.13 0.87 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.651 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 84.57 -5.92 79.47 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.226 -0.511 . . . . 0.0 112.727 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -148.85 -72.47 0.19 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 117.723 0.762 . . . . 0.0 111.402 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.447 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 18.8 t80 -88.89 -165.5 1.35 Allowed 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.447 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 51.2 p30 -130.9 51.43 2.14 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.836 0.351 . . . . 0.0 110.897 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.2 p -152.31 153.24 33.29 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.456 ' CD2' ' OH ' ' A' ' 71' ' ' TYR . 0.3 OUTLIER -159.81 136.43 9.12 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -179.261 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.39 127.32 32.54 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 113.225 -1.807 . . . . 0.0 109.967 177.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.6 p -148.01 153.61 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -146.52 155.87 42.84 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.831 0.348 . . . . 0.0 111.021 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 53.2 t -122.63 135.37 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.7 t -133.49 153.42 51.64 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.275 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 52.6 p-10 -154.53 81.28 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.378 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.556 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 27.0 t-80 -171.95 -37.42 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.556 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 31.2 Cg_endo -94.0 -163.08 0.1 OUTLIER 'Trans proline' 0 C--N 1.32 -0.922 0 C-N-CA 121.954 1.769 . . . . 0.0 111.959 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 16.2 mt -76.94 -4.84 45.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.939 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 91.8 t -57.86 -45.58 87.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.171 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.6 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 28.2 m -53.17 -62.22 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 C-N-CA 119.467 -0.893 . . . . 0.0 108.67 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.6 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -41.79 -42.54 2.67 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.008 0.432 . . . . 0.0 110.685 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.4 tp -70.05 -48.33 58.3 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.489 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 63.9 m -70.56 -48.3 56.05 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.575 0.702 . . . . 0.0 110.781 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.435 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -55.08 -42.15 72.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.788 -1.096 . . . . 0.0 108.195 179.29 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.435 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -59.32 -55.66 31.98 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.648 -177.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -61.7 -21.94 64.91 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.656 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.6 1.48 86.68 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -151.66 160.1 32.22 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.113 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -45.41 166.17 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 123.833 3.022 . . . . 0.0 112.967 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.4 tp -121.21 122.81 40.77 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 176.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.414 ' O ' ' CA ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -63.6 146.9 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.856 0 C-N-CA 117.712 -1.595 . . . . 0.0 106.722 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.9 t -122.56 126.13 47.12 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.694 0.621 . . . . 0.0 111.572 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 3.7 m -132.37 164.55 26.23 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.53 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 30.4 t -71.07 151.19 44.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.844 0.354 . . . . 0.0 110.728 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.75 -37.3 81.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.975 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 54.7 p30 -55.87 154.77 6.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.657 0.741 . . . . 0.0 111.425 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.45 -159.15 0.94 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.629 -178.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.9 p -61.36 -38.7 87.94 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.061 0.458 . . . . 0.0 110.153 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -165.8 0.78 0.05 OUTLIER Glycine 0 CA--C 1.511 -0.166 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.2 tp -81.68 124.8 79.43 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.237 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -38.73 156.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.939 1.759 . . . . 0.0 111.931 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -74.84 -162.87 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.391 2.061 . . . . 0.0 112.256 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 73.0 m -119.5 76.4 1.13 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.7 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -54.16 -32.97 56.89 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.817 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.0 165.55 15.78 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -55.75 -17.66 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.746 0 CA-C-O 121.751 0.786 . . . . 0.0 109.267 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -66.24 -34.58 78.33 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.33 -70.6 0.16 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.729 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.5 p -48.62 -31.11 3.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.155 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 159' ' ' GLY . 4.6 tmt_? -79.64 -51.65 8.99 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.863 0.84 . . . . 0.0 109.338 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.98 -44.22 63.95 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.886 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.482 HE21 ' C ' ' A' ' 157' ' ' GLN . 0.0 OUTLIER -84.13 -30.59 25.78 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 112.845 -1.979 . . . . 0.0 114.351 -175.279 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -126.3 -32.9 2.66 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 118.012 0.369 . . . . 0.0 111.294 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 93.75 23.41 23.41 Favored Glycine 0 N--CA 1.467 0.744 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -42.77 -95.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.493 0.187 . . . . 0.0 110.957 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.454 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.93 37.04 15.43 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.189 0.519 . . . . 0.0 109.61 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.543 ' C ' ' H ' ' A' ' 164' ' ' VAL . 1.4 m-85 -175.88 -62.1 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.907 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.28 28.05 0.3 Allowed 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.349 2.032 . . . . 0.0 110.536 178.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.543 ' H ' ' C ' ' A' ' 162' ' ' PHE . 16.0 m -131.78 167.47 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.05 -178.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.2 65.96 30.74 Favored Pre-proline 0 N--CA 1.477 0.878 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.645 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -38.27 147.42 0.11 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 123.686 2.924 . . . . 0.0 114.962 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 174.53 -148.72 10.0 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.117 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -143.4 -164.65 1.91 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.9 t -144.41 153.25 41.74 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.354 0.597 . . . . 0.0 111.071 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -167.53 78.43 0.11 Allowed Glycine 0 N--CA 1.454 -0.148 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.25 62.41 0.02 OUTLIER Glycine 0 C--N 1.317 -0.502 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -79.52 -9.03 59.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.557 -0.322 . . . . 0.0 111.083 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.484 ' CD2' ' N ' ' A' ' 173' ' ' LEU . 3.6 mm? -61.36 -40.47 94.41 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.429 ' N ' ' CD ' ' A' ' 175' ' ' PRO . 0.1 OUTLIER 72.61 52.34 0.29 Allowed Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.388 179.243 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 174' ' ' ASN . 58.9 Cg_endo -69.49 -17.42 38.83 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.508 2.139 . . . . 0.0 111.014 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 6.2 p -96.93 122.91 40.43 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.715 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -133.92 -163.57 1.38 Allowed 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.614 -178.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 18.8 tt -112.28 130.74 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.698 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -133.83 169.4 17.12 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.714 0.768 . . . . 0.0 112.17 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -80.63 106.99 13.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.201 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -68.47 -16.68 63.98 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.214 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.466 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.8 mm? -63.37 -41.8 98.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.047 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.09 -44.31 3.6 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.176 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 72.92 20.05 79.75 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -68.7 145.39 53.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.051 0.453 . . . . 0.0 110.886 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.443 ' N ' ' CD2' ' A' ' 186' ' ' LEU . 0.9 OUTLIER -69.04 174.96 4.04 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.823 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . 0.458 ' O ' ' CD2' ' A' ' 187' ' ' PHE . 65.7 t80 -122.27 12.67 10.25 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.131 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 52.3 ttt-85 -71.5 -131.43 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.352 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -67.41 -39.0 85.51 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.124 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.762 0 CA-C-O 118.111 -1.383 . . . . 0.0 111.021 -179.972 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -82.45 140.67 33.27 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -88.04 -9.33 53.72 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.642 -0.253 . . . . 0.0 110.579 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.462 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 9.4 mp -63.27 -42.27 99.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.968 0.413 . . . . 0.0 110.252 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -64.81 -43.43 93.14 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.189 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -65.56 -38.67 90.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.277 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 162' ' ' PHE . 67.9 t0 -62.73 -45.65 91.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.613 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.14 -45.87 91.52 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.912 0.387 . . . . 0.0 110.031 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.406 HD13 HG22 ' A' ' 10' ' ' ILE . 97.1 mt -63.63 -43.06 98.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.839 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.91 -42.62 85.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.541 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.13 -46.62 86.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.174 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.07 -51.4 69.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.811 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 14.7 pt -68.71 -39.84 80.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.409 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -57.15 -53.19 60.9 Favored 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 120.486 -0.485 . . . . 0.0 109.921 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 20' ' ' GLU . 89.0 t -61.61 -40.42 86.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.638 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.442 ' CD2' ' C ' ' A' ' 17' ' ' LEU . 6.3 tt -52.99 -50.47 64.11 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.383 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -79.49 -51.23 9.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.753 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -64.8 -31.04 72.08 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.812 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 16' ' ' VAL . 96.7 mt-10 58.44 85.11 0.1 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.124 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.41 -142.54 0.09 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.706 0.288 . . . . 0.0 110.289 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.2 p -137.74 138.73 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 pp -128.05 163.99 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-O 121.118 0.485 . . . . 0.0 111.78 -178.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.68 128.43 36.2 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.914 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.518 ' CE2' ' O ' ' A' ' 26' ' ' PRO . 2.1 t80 -118.32 138.49 25.72 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.255 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.518 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 64.8 Cg_endo -80.93 149.51 17.83 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.191 1.26 . . . . 0.0 111.352 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.472 ' C ' ' H ' ' A' ' 29' ' ' ALA . 25.9 m -135.15 140.93 45.8 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.271 0.557 . . . . 0.0 110.808 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -77.77 20.07 0.36 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.033 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -154.97 -73.41 0.12 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.206 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 67.5 t -122.74 126.28 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 120.859 0.361 . . . . 0.0 110.737 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.521 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 90.9 m-85 -53.5 144.48 17.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.195 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -154.35 -168.37 17.7 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.2 m -132.08 168.31 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.97 -176.96 27.79 Favored Glycine 0 N--CA 1.464 0.566 0 C-N-CA 120.008 -1.092 . . . . 0.0 111.925 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -153.34 -166.2 2.36 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.734 0.302 . . . . 0.0 110.359 -179.43 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.514 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 7.8 m-20 -99.43 109.79 56.17 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-O 118.729 -0.653 . . . . 0.0 112.441 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 36' ' ' ASP . 15.4 Cg_exo -35.19 168.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.68 2.254 . . . . 0.0 114.302 177.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 44.73 67.39 0.7 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.433 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.7 m -142.94 137.59 29.53 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.07 0.462 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.547 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -71.65 -34.37 69.7 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.296 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.45 -45.28 91.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.644 -178.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.1 -47.68 81.81 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.598 -178.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.3 p -62.59 -44.45 99.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.249 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 62.1 mtt -64.95 -39.79 94.02 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 -61.77 -32.98 73.29 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.026 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 79.9 mt -75.95 -57.23 4.0 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.4 mt -54.46 -18.91 4.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.243 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -67.23 -84.66 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.695 -178.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -75.83 -33.26 60.05 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -77.71 -71.23 0.43 Allowed 'General case' 0 C--N 1.346 0.445 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.738 -176.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.411 ' CG ' ' O ' ' A' ' 51' ' ' GLN . 3.2 tt0 53.65 80.98 0.1 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.399 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.3 mtp85 160.69 -64.04 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.116 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -66.78 -11.25 31.26 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 122.641 2.228 . . . . 0.0 111.775 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' A' ' 55' ' ' ASP . 13.9 p -46.05 -45.97 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 110' ' ' ARG . 10.3 t0 -67.58 -44.44 78.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.676 -178.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -60.35 -40.5 90.96 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.759 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 71.39 111.66 0.04 OUTLIER Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.573 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -49.54 -169.86 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.986 -0.607 . . . . 0.0 111.896 179.632 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.439 ' O ' ' OG ' ' A' ' 137' ' ' SER . 80.9 mt -100.25 139.54 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.5 mt -113.24 143.84 43.73 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -178.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.0 tp -112.26 127.97 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 CA-C-O 121.122 0.487 . . . . 0.0 110.548 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.46 154.59 26.76 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.56 -26.29 7.11 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -118.76 145.05 45.88 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.607 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -71.62 -12.53 61.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.571 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -49.6 -33.91 16.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.565 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -95.04 -15.74 23.23 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.427 ' CD2' ' N ' ' A' ' 68' ' ' LEU . 3.8 mm? -92.94 -13.14 29.23 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.598 ' HZ3' ' NH2' ' A' ' 82' ' ' ARG . 27.9 tptt -80.49 -39.08 1.13 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.803 -178.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 65.8 Cg_endo -103.09 -3.4 0.28 Allowed 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 122.78 2.32 . . . . 0.0 111.784 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.485 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 39.8 t80 -96.56 -11.01 25.98 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.161 -178.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.431 ' CG2' ' N ' ' A' ' 73' ' ' ASP . 5.2 mp -131.46 159.36 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.431 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 91.2 m-20 -71.37 160.45 32.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.06 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 39.2 p30 -95.64 7.79 45.27 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.848 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.1 t -67.08 -45.77 76.3 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.325 0.583 . . . . 0.0 110.547 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 23.1 ptp -84.33 -6.26 59.37 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.232 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.3 tp -94.33 116.3 28.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.619 -177.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -154.95 167.2 31.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.91 -177.817 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -42.49 -44.49 4.1 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.196 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.66 -33.03 59.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.923 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 78' ' ' THR . 1.0 OUTLIER -65.75 -43.26 89.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.203 0.525 . . . . 0.0 110.52 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.598 ' NH2' ' HZ3' ' A' ' 69' ' ' LYS . 9.5 mmt85 -59.92 -49.17 78.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 122.76 1.267 . . . . 0.0 108.657 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -57.29 -49.84 74.82 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 113.446 -1.706 . . . . 0.0 110.005 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.7 m -62.59 -49.19 76.24 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.227 -1.351 . . . . 0.0 112.444 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.8 tt -68.42 -30.75 48.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.139 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -82.37 -40.02 21.93 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.917 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.2 m -78.35 -3.31 42.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.907 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -121.92 166.95 13.64 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 15.9 m-90 -43.49 150.71 0.5 Allowed Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.12 -19.37 45.11 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.911 1.741 . . . . 0.0 111.593 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.474 ' O ' ' NH2' ' A' ' 117' ' ' ARG . . . 177.64 78.78 0.06 OUTLIER Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -79.57 -35.52 0.79 Allowed 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.042 1.828 . . . . 0.0 112.516 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.515 ' CG1' ' CZ ' ' A' ' 95' ' ' PHE . 9.7 p -137.92 149.2 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 120.801 0.334 . . . . 0.0 110.886 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 16.3 m -81.39 129.51 34.66 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.515 ' CZ ' ' CG1' ' A' ' 93' ' ' VAL . 46.2 m-85 -117.02 137.4 52.26 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.733 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.5 t -92.05 102.59 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 121.277 0.561 . . . . 0.0 109.759 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -81.12 143.68 53.17 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.198 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -79.64 108.16 2.24 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 122.032 1.821 . . . . 0.0 111.099 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 112' ' ' ASP . . . -64.93 156.61 79.43 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.491 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 49.0 Cg_endo -66.69 -19.23 53.81 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.231 1.954 . . . . 0.0 112.187 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' A' ' 100' ' ' PRO . . . 91.63 -27.57 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.536 0.523 . . . . 0.0 110.551 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.4 m -58.19 -45.17 88.02 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.54 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.511 ' O ' ' O ' ' A' ' 104' ' ' PRO . 0.1 OUTLIER -52.32 151.66 7.02 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.217 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.511 ' O ' ' O ' ' A' ' 103' ' ' THR . 9.2 Cg_exo -31.64 -115.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.504 2.139 0 C-N-CA 124.088 3.192 . . . . 0.0 114.64 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 109' ' ' GLY . 0.6 OUTLIER -179.45 -4.25 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.957 -0.464 . . . . 0.0 110.409 -179.642 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 2.5 p90 -79.56 -9.83 59.69 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.676 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.649 ' CD1' ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -69.28 -34.06 74.17 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.427 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.574 ' C ' ' H ' ' A' ' 110' ' ' ARG . 28.5 m -141.39 -40.73 0.38 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.428 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 60.29 -13.62 0.04 OUTLIER Glycine 0 CA--C 1.536 1.398 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.657 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.574 ' H ' ' C ' ' A' ' 108' ' ' THR . 0.0 OUTLIER -85.52 -52.61 5.72 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 117.659 0.73 . . . . 0.0 109.284 179.758 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.534 ' CE2' ' OD1' ' A' ' 112' ' ' ASP . 17.6 t80 -154.37 -178.26 7.02 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.306 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.534 ' OD1' ' CE2' ' A' ' 111' ' ' PHE . 48.8 p30 -89.01 51.63 2.21 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.299 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.5 p -159.51 156.82 28.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.244 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.75 141.5 7.38 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.7 125.23 26.09 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 113.737 -1.574 . . . . 0.0 109.617 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.3 p -146.66 161.19 9.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.474 ' NH2' ' O ' ' A' ' 91' ' ' GLY . 78.7 ttt-85 -144.03 153.23 41.99 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.91 0.386 . . . . 0.0 111.389 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 52.2 t -122.45 136.64 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.2 t -135.24 149.04 49.77 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.249 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 35.4 p30 -151.68 78.82 1.26 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.763 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.549 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 10.3 t-80 -172.51 -36.85 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.549 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 18.9 Cg_endo -92.73 -161.66 0.09 OUTLIER 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 121.993 1.795 . . . . 0.0 111.686 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.4 mt -78.83 -4.68 50.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.016 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.4 t -58.21 -45.0 89.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.971 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.583 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 27.6 m -52.7 -62.2 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.935 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.583 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -40.96 -45.41 2.57 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.881 0.372 . . . . 0.0 111.027 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.69 -51.37 56.8 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.253 0.549 . . . . 0.0 110.778 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 71.2 m -69.5 -47.79 62.68 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.237 0.541 . . . . 0.0 111.425 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 125' ' ' VAL . 1.2 pp0? -54.87 -42.2 71.75 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.445 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -60.4 -53.12 61.37 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.771 -177.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.45 ' CE1' ' OD2' ' A' ' 36' ' ' ASP . 42.0 t80 -64.48 -22.46 66.97 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.825 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.94 2.07 90.14 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 134' ' ' PRO . 34.3 mttm -152.4 159.56 32.52 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 133' ' ' LYS . 5.9 Cg_exo -41.12 -179.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 124.061 3.174 . . . . 0.0 113.941 -178.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.0 tp -134.47 123.85 24.65 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 176.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -66.14 143.73 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 C-N-CA 117.764 -1.574 . . . . 0.0 108.518 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -108.82 121.88 46.0 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.96 0.788 . . . . 0.0 110.924 -179.346 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.9 m -132.38 157.64 44.02 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.819 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.6 m -73.0 143.2 47.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.011 0.434 . . . . 0.0 110.577 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.7 -36.76 85.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.034 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 51.8 p30 -52.37 150.38 4.82 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.774 0.797 . . . . 0.0 110.997 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.13 -158.39 0.73 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.048 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 45.2 m -59.93 -42.99 95.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.471 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -162.55 11.87 0.11 Allowed Glycine 0 N--CA 1.459 0.172 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.7 tp -93.44 127.51 46.13 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -38.76 157.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 121.758 1.638 . . . . 0.0 112.468 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -76.55 -166.94 0.41 Allowed 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 122.721 2.281 . . . . 0.0 112.487 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 70.9 m -112.03 76.93 1.0 Allowed 'General case' 0 C--O 1.231 0.103 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.521 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 17.5 ptm180 -54.06 -37.81 64.57 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.952 -178.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -158.42 167.64 29.13 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.808 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.6 m -57.37 -20.35 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.6 0 CA-C-O 121.77 0.795 . . . . 0.0 109.248 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -64.21 -34.61 78.49 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 150' ' ' THR . 0.4 OUTLIER -61.03 -79.49 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.872 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.3 p -35.22 -34.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.687 0.795 . . . . 0.0 111.155 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.475 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -67.38 -52.79 35.66 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.347 0.594 . . . . 0.0 111.852 -178.618 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -69.35 -16.93 63.64 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 122.538 1.161 . . . . 0.0 108.035 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -84.23 -45.37 12.96 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 112.672 -2.058 . . . . 0.0 111.891 -178.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -130.34 -27.93 2.16 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.638 0.256 . . . . 0.0 111.642 -178.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 94.56 24.17 19.16 Favored Glycine 0 N--CA 1.468 0.783 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -43.68 -96.69 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.78 0.324 . . . . 0.0 111.126 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.508 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 62.3 34.8 15.61 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -178.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.547 ' C ' ' H ' ' A' ' 164' ' ' VAL . 2.1 m-85 -174.04 -62.16 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.238 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.86 25.88 0.29 Allowed 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.349 2.033 . . . . 0.0 110.932 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.547 ' H ' ' C ' ' A' ' 162' ' ' PHE . 13.7 m -127.43 167.64 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.746 -178.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.1 t -122.35 64.87 21.58 Favored Pre-proline 0 N--CA 1.472 0.647 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.829 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -37.62 144.32 0.15 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 123.652 2.901 . . . . 0.0 115.031 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 164.54 -176.78 40.36 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 113.901 -1.5 . . . . 0.0 110.878 178.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -142.09 152.8 43.63 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.4 t -144.99 155.55 43.45 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.088 0.47 . . . . 0.0 111.169 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -152.13 80.33 0.19 Allowed Glycine 0 CA--C 1.519 0.295 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -166.45 67.27 0.2 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -91.73 3.17 55.71 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.687 0.279 . . . . 0.0 111.062 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 56.9 tp -61.73 -46.8 88.07 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.694 HD21 ' H ' ' A' ' 174' ' ' ASN . 0.0 OUTLIER -117.95 89.13 33.33 Favored Pre-proline 0 N--CA 1.47 0.574 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.845 179.478 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.438 ' O ' ' CB ' ' A' ' 176' ' ' SER . 73.6 Cg_endo -76.28 -8.19 18.43 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.844 1.696 . . . . 0.0 111.985 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 175' ' ' PRO . 0.7 OUTLIER 81.34 104.0 0.06 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.514 0.674 . . . . 0.0 111.146 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.504 ' OE1' ' NH1' ' A' ' 179' ' ' ARG . 98.1 mt-10 -90.14 -178.93 5.54 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.834 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 18.7 tt -111.25 125.13 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.653 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.504 ' NH1' ' OE1' ' A' ' 177' ' ' GLU . 7.2 mpt_? -122.5 161.43 23.62 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 122.102 0.953 . . . . 0.0 110.889 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -77.79 105.88 9.26 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.157 -1.383 . . . . 0.0 107.979 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -66.95 -13.61 61.98 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.753 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.467 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.4 mm? -63.54 -42.02 98.42 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.062 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.2 -43.44 2.53 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.818 0.342 . . . . 0.0 110.623 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 63.57 24.72 68.12 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.15 156.28 36.1 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.299 0.571 . . . . 0.0 111.179 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.441 ' N ' ' CD2' ' A' ' 186' ' ' LEU . 0.8 OUTLIER -72.03 176.4 5.11 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.304 179.695 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -104.97 -7.81 19.01 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.915 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -74.34 135.97 42.51 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.912 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -131.87 122.68 26.09 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.011 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.892 0 CA-C-O 117.747 -1.585 . . . . 0.0 110.895 -179.923 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -80.25 147.93 31.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.176 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -63.21 -41.94 99.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.517 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.421 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 10.4 mp -63.11 -42.32 99.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.212 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -61.96 -49.6 75.45 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.001 0.429 . . . . 0.0 110.053 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -58.51 -41.36 85.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.947 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.74 -44.76 96.29 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.588 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.43 -45.29 93.75 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.241 0.544 . . . . 0.0 109.94 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.9 -42.94 98.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.9 -42.43 79.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.156 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.2 -47.48 85.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.149 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.02 -53.21 60.53 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.626 -0.43 . . . . 0.0 112.053 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 14.2 pt -66.75 -38.32 81.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.117 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -58.36 -50.77 72.47 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.168 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.493 ' O ' ' N ' ' A' ' 20' ' ' GLU . 92.6 t -62.81 -39.27 84.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.75 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.435 ' CD2' ' C ' ' A' ' 17' ' ' LEU . 6.3 tt -52.48 -52.2 55.57 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.209 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -76.79 -48.72 17.76 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.223 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -67.14 -29.47 69.2 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.058 0.456 . . . . 0.0 110.837 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 16' ' ' VAL . 96.7 mt-10 56.36 60.52 3.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.564 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.65 159.6 42.12 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.302 0.573 . . . . 0.0 110.323 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 p -76.92 137.97 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.436 -178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.86 166.79 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-O 120.692 0.282 . . . . 0.0 110.898 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.05 133.86 53.86 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.379 0.609 . . . . 0.0 111.462 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.524 ' CE2' ' O ' ' A' ' 26' ' ' PRO . 3.5 t80 -126.66 138.68 33.0 Favored Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.524 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 64.3 Cg_endo -80.32 150.21 19.72 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 CA-C-N 120.419 1.185 . . . . 0.0 111.588 -178.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.484 ' C ' ' H ' ' A' ' 29' ' ' ALA . 30.2 m -130.14 140.09 50.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.649 0.262 . . . . 0.0 110.451 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -77.6 21.11 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.484 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -154.76 -74.59 0.11 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.124 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.4 p -123.79 127.41 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 121.24 0.543 . . . . 0.0 110.622 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 149' ' ' ARG . 97.4 m-85 -43.37 147.98 0.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.999 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -157.64 -174.72 27.71 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.4 m -131.23 169.38 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.43 178.92 33.55 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 119.946 -1.121 . . . . 0.0 112.656 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.564 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -152.97 -162.84 1.57 Allowed 'General case' 0 C--N 1.341 0.226 0 CA-C-N 115.521 -0.34 . . . . 0.0 110.309 -179.231 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.564 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 2.1 m-20 -101.52 111.12 63.39 Favored Pre-proline 0 CA--C 1.548 0.869 0 CA-C-O 118.802 -0.618 . . . . 0.0 112.622 -178.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 36' ' ' ASP . 22.8 Cg_exo -35.89 170.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.804 2.336 . . . . 0.0 114.413 177.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.8 t70 41.53 73.45 0.13 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.887 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 36' ' ' ASP . 4.9 m -151.79 141.99 22.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.084 0.469 . . . . 0.0 110.308 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.556 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -70.43 -30.55 67.44 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.555 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.6 t -60.09 -42.52 94.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.988 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.17 -52.53 65.15 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.345 -178.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.07 -45.33 99.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.137 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 60.6 mtt -67.62 -45.29 75.84 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -65.8 -28.7 69.2 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.634 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 52.7 mt -74.72 -60.95 2.05 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.232 177.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.9 mt -51.63 -23.22 4.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.065 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.49 -85.73 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.723 -178.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -76.56 -33.66 58.51 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -75.5 -71.16 0.38 Allowed 'General case' 0 C--N 1.346 0.434 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.959 -176.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.406 ' O ' ' CG ' ' A' ' 51' ' ' GLN . 3.8 tt0 53.46 80.62 0.1 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.388 0.613 . . . . 0.0 109.454 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.1 mtt-85 161.07 -63.44 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.215 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.36 -10.4 28.87 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 122.737 2.291 . . . . 0.0 112.175 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.417 ' CG1' ' N ' ' A' ' 55' ' ' ASP . 7.3 p -44.95 -48.19 2.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.914 -178.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 110' ' ' ARG . 10.9 t0 -68.49 -42.29 78.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.425 -178.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -58.9 -41.96 88.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.398 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 68.97 112.86 0.02 OUTLIER Glycine 0 CA--C 1.518 0.248 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.568 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -49.64 -170.63 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.085 -0.558 . . . . 0.0 112.353 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.3 mt -97.7 148.29 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.1 mt -122.35 142.65 50.28 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.6 tp -114.45 129.93 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-O 121.176 0.512 . . . . 0.0 110.984 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.11 159.9 19.52 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -124.94 -24.72 4.02 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.486 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 99.2 m-20 -116.76 125.31 51.46 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.287 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -58.46 -13.23 5.02 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -50.23 -33.58 20.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.527 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.486 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 4.3 pm0 -94.83 -11.55 28.64 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.409 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 3.8 mm? -91.98 -14.6 29.21 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 118.864 0.757 . . . . 0.0 109.192 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.474 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 42.9 tttm -79.6 -38.56 1.26 Allowed Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.766 -178.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 73.6 Cg_endo -103.07 -3.43 0.28 Allowed 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 122.699 2.266 . . . . 0.0 111.836 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.431 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 51.8 t80 -96.53 -10.46 27.25 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.666 -178.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.413 ' CG2' ' N ' ' A' ' 73' ' ' ASP . 4.7 mp -137.02 164.23 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.413 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 97.6 m-20 -66.71 160.16 26.26 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -94.85 12.01 29.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.695 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.409 ' CG2' ' N ' ' A' ' 76' ' ' MET . 10.7 t -72.48 -41.12 66.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.223 0.535 . . . . 0.0 110.067 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.409 ' N ' ' CG2' ' A' ' 75' ' ' THR . 22.1 ptp -85.15 -18.26 34.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.546 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 tp -95.25 119.36 33.63 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.904 -178.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.473 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -158.03 161.03 38.04 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.303 -177.701 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -38.92 -47.86 1.5 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.837 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.1 p -62.86 -34.13 64.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.757 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 78' ' ' THR . 67.4 tp60 -65.99 -39.54 90.4 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.808 0.337 . . . . 0.0 110.93 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 -64.4 -52.86 56.07 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 122.581 1.181 . . . . 0.0 109.14 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -55.67 -50.39 70.38 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.126 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 88' ' ' ARG . 3.1 m -60.77 -51.05 70.97 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.926 -178.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.0 tt -65.91 -36.49 77.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.596 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -67.14 -41.03 86.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.127 178.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.9 m -84.71 -19.02 33.4 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.8 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 84' ' ' THR . 77.8 ttt-85 -103.56 151.52 22.79 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.741 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -34.38 152.62 0.05 OUTLIER Pre-proline 0 N--CA 1.469 0.484 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.188 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.12 -17.93 55.62 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.132 1.888 . . . . 0.0 110.991 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 99.19 69.32 0.92 Allowed Glycine 0 CA--C 1.529 0.967 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.779 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.54 -39.35 88.65 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.865 2.377 . . . . 0.0 111.493 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.2 p -78.59 147.84 6.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.328 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 85.5 m -88.11 143.62 26.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.731 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -127.01 140.35 52.37 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.661 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.4 t -93.86 101.77 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-O 121.474 0.654 . . . . 0.0 109.633 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -91.81 151.31 42.06 Favored Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.882 -177.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.82 142.19 56.69 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.764 1.643 . . . . 0.0 110.309 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -114.95 116.54 42.64 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.397 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -45.59 167.4 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 121.6 1.533 . . . . 0.0 112.623 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.49 -25.04 45.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.484 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.1 p -66.1 -33.16 75.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.473 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.536 ' H ' ' HG1' ' A' ' 103' ' ' THR . 0.9 OUTLIER -69.85 160.15 81.24 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.468 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.495 ' O ' ' O ' ' A' ' 103' ' ' THR . 84.4 Cg_exo -47.55 -158.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.251 0 C-N-CA 122.724 2.283 . . . . 0.0 113.851 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.492 ' NH1' ' OD1' ' A' ' 112' ' ' ASP . 11.4 tpp180 -168.51 -4.97 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.475 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 6.1 p90 -84.5 -9.4 58.38 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.547 ' H ' ' CD2' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -77.57 -17.65 57.67 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.678 -179.639 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.563 ' C ' ' H ' ' A' ' 110' ' ' ARG . 26.6 m -144.75 -43.85 0.24 Allowed 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.827 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 50.42 -1.87 0.01 OUTLIER Glycine 0 CA--C 1.541 1.688 0 CA-C-O 119.726 -0.485 . . . . 0.0 113.339 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.563 ' H ' ' C ' ' A' ' 108' ' ' THR . 0.5 OUTLIER -88.15 -54.87 4.0 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 117.947 0.873 . . . . 0.0 109.552 179.741 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.613 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 85.4 t80 -154.51 173.72 15.9 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.417 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.613 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 89.8 m-20 -79.12 50.92 1.1 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.372 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 82.1 p -158.52 160.04 36.24 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.3 pp -167.13 140.02 3.51 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.87 112.21 4.17 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 113.437 -1.71 . . . . 0.0 110.75 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.1 p -143.97 160.42 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -155.99 162.16 40.38 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.949 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.7 t -121.24 138.82 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.543 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 7.9 t -132.62 150.43 52.16 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.957 0.408 . . . . 0.0 110.103 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.401 ' O ' ' OD1' ' A' ' 120' ' ' ASP . 30.6 p30 -150.4 81.1 1.36 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.324 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.537 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 61.7 t60 -171.81 -37.79 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.537 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 38.7 Cg_endo -95.49 -163.62 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 121.941 1.761 . . . . 0.0 112.3 -178.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.6 mt -78.54 -4.09 46.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.89 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 83.3 t -57.62 -45.96 86.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.648 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.568 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 27.1 m -52.96 -62.18 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.87 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.568 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -41.33 -43.84 2.58 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.243 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.1 tp -69.49 -48.07 61.85 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.954 0.406 . . . . 0.0 110.99 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 82.1 m -70.0 -48.96 55.98 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.408 0.623 . . . . 0.0 110.915 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.437 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.0 OUTLIER -55.24 -41.61 72.36 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.423 179.428 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.437 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -58.94 -54.42 47.36 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.383 -1.281 . . . . 0.0 109.605 -177.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.402 ' CE1' ' OD2' ' A' ' 36' ' ' ASP . 42.8 t80 -62.05 -21.47 64.95 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.983 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 81.43 -0.11 88.3 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 134' ' ' PRO . 24.7 mttp -152.37 159.14 33.12 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.004 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 133' ' ' LYS . 6.1 Cg_exo -41.61 179.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 123.838 3.026 . . . . 0.0 113.75 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.0 tp -134.58 123.73 24.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.443 -1.708 . . . . 0.0 106.578 177.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -66.06 146.42 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 C-N-CA 117.684 -1.606 . . . . 0.0 107.327 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.0 t -118.3 129.25 55.35 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.249 0.547 . . . . 0.0 110.894 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.3 m -129.06 162.31 27.97 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.085 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 17.8 m -72.02 147.99 46.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.246 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.63 -37.44 87.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.913 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.437 ' O ' ' ND2' ' A' ' 141' ' ' ASN . 0.1 OUTLIER -54.31 157.38 2.76 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.594 0.711 . . . . 0.0 111.256 -179.445 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.74 -158.31 0.88 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.103 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.6 t -60.33 -44.08 95.81 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.382 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -165.97 12.43 0.07 OUTLIER Glycine 0 N--CA 1.46 0.264 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.3 tp -90.24 127.64 52.47 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -39.47 153.74 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 121.702 1.602 . . . . 0.0 112.22 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.29 157.43 41.57 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.431 2.088 . . . . 0.0 112.373 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 18.7 m -80.37 76.35 7.18 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.534 ' O ' ' CD1' ' A' ' 31' ' ' PHE . 32.9 ptt-85 -55.19 -35.7 65.11 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.93 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.71 169.49 24.52 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -59.62 -23.82 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.23 -23.73 67.41 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 177.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 155' ' ' ARG . 5.6 tm-20 -69.56 -78.87 0.06 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.85 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.424 ' O ' ' N ' ' A' ' 158' ' ' PHE . 3.2 p -35.08 -30.66 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.473 0.709 . . . . 0.0 110.564 177.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -72.58 -51.43 19.79 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.083 -179.32 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 153' ' ' GLU . . . -67.32 -20.12 65.56 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.666 1.222 . . . . 0.0 107.793 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -83.09 -44.62 14.94 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 112.403 -2.181 . . . . 0.0 111.808 -178.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.424 ' N ' ' O ' ' A' ' 154' ' ' VAL . 49.4 t80 -130.63 -26.62 2.22 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.816 0.341 . . . . 0.0 111.84 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 92.18 25.74 20.81 Favored Glycine 0 N--CA 1.468 0.813 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -43.67 -96.74 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.498 -0.351 . . . . 0.0 111.189 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . 63.42 33.07 14.05 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -178.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.558 ' C ' ' H ' ' A' ' 164' ' ' VAL . 0.4 OUTLIER -174.24 -61.12 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.497 -179.58 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.83 28.93 0.28 Allowed 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.003 1.802 . . . . 0.0 110.652 177.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.558 ' H ' ' C ' ' A' ' 162' ' ' PHE . 15.4 m -130.63 166.91 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.088 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.5 t -121.51 65.68 17.28 Favored Pre-proline 0 N--CA 1.476 0.836 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.869 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -35.41 139.07 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 123.628 2.885 . . . . 0.0 115.225 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 169.28 173.7 37.13 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.905 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -158.14 144.83 17.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.957 0.408 . . . . 0.0 110.51 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.9 t -148.09 152.58 37.59 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.656 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -61.64 -74.9 0.34 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 79.99 18.82 71.43 Favored Glycine 0 CA--C 1.517 0.172 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -68.31 -38.65 81.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 113.981 -1.11 . . . . 0.0 111.346 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 44.6 tp -61.66 -46.68 88.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.461 -178.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 42.21 62.92 7.35 Favored Pre-proline 0 N--CA 1.468 0.43 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.531 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' A' ' 176' ' ' SER . 64.0 Cg_endo -71.02 -22.28 26.54 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.388 2.059 . . . . 0.0 113.496 -178.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 175' ' ' PRO . 1.6 m 162.86 147.57 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.386 0.613 . . . . 0.0 110.033 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -102.07 -71.25 0.72 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.982 -178.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 45.4 pt -122.22 143.21 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.933 0.397 . . . . 0.0 111.016 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -137.8 167.52 21.57 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.778 0.799 . . . . 0.0 111.949 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -83.97 106.7 15.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.205 -1.361 . . . . 0.0 110.355 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -65.01 -13.96 59.19 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.071 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.434 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.5 mm? -62.91 -42.0 99.65 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.33 -42.69 3.65 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.265 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 72.44 19.88 79.12 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -71.02 -172.93 0.74 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.13 0.49 . . . . 0.0 110.887 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.46 ' H ' ' CD2' ' A' ' 186' ' ' LEU . 0.8 OUTLIER -80.68 175.71 10.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.722 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -122.77 82.34 1.97 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.205 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -77.94 138.14 38.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.492 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.417 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 0.7 OUTLIER -173.45 -27.98 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.134 177.624 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.73 0 CA-C-O 117.932 -1.482 . . . . 0.0 110.647 179.834 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 56.6 p30 . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -62.42 -41.23 98.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.616 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -63.91 -40.39 96.37 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.289 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.454 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 9.6 mp -61.68 -42.4 98.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.971 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -63.38 -45.57 90.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.09 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -61.62 -38.11 86.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.994 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.04 -43.6 98.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.686 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.93 -49.23 78.29 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.633 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.9 mm -63.92 -43.19 97.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.537 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.49 -46.7 83.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.705 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.0 -43.61 98.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.41 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.88 -53.24 59.75 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.62 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.9 pt -69.5 -38.85 77.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.482 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -58.76 -55.35 36.29 Favored 'General case' 0 C--O 1.214 -0.807 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.338 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 20' ' ' GLU . 91.1 t -61.72 -40.23 86.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.386 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.447 ' CD2' ' C ' ' A' ' 17' ' ' LEU . 6.3 tt -52.56 -51.26 60.61 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.681 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -79.81 -50.48 10.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.873 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -63.67 -32.71 74.27 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.615 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 16' ' ' VAL . 96.8 mt-10 58.7 82.86 0.13 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.377 0.881 . . . . 0.0 113.377 178.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.28 -141.38 0.05 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.679 0.275 . . . . 0.0 110.488 177.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.0 p -135.13 139.16 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pp -129.02 164.16 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 120.924 0.392 . . . . 0.0 111.98 -178.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.28 141.88 58.61 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.939 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -145.55 160.81 43.53 Favored Pre-proline 0 CA--C 1.546 0.82 0 CA-C-O 119.047 -0.501 . . . . 0.0 110.522 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.52 157.17 32.46 Favored 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 121.579 1.519 . . . . 0.0 111.442 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.2 m -136.97 155.2 50.02 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.276 0.56 . . . . 0.0 110.538 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -83.78 14.54 3.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.729 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -160.43 -64.93 0.07 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.165 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.9 t -125.49 127.45 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.071 0.463 . . . . 0.0 110.685 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -56.72 131.07 48.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.313 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -141.03 -153.62 6.01 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.5 m -131.57 166.68 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -156.99 -179.95 32.32 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.987 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -153.68 -179.58 7.93 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 37' ' ' PRO . 36.7 t70 -91.98 110.08 41.56 Favored Pre-proline 0 CA--C 1.552 1.033 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 36' ' ' ASP . 57.0 Cg_exo -36.79 173.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 123.039 2.493 . . . . 0.0 114.517 177.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 49.01 64.64 1.64 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.861 -1.518 . . . . 0.0 111.216 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 65.2 m -147.2 138.03 23.65 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.043 0.449 . . . . 0.0 110.405 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.46 -35.95 73.62 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.531 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.06 -42.59 96.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.463 -179.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.92 75.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.643 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 p -62.4 -44.91 99.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.277 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 90.0 mtp -64.01 -40.84 97.26 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 27.8 ttt-85 -61.4 -41.52 97.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.41 -54.3 34.92 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.595 -178.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.4 mt -69.74 -12.12 61.38 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.246 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -69.03 -82.54 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.149 0.5 . . . . 0.0 111.133 -177.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.407 HD21 ' H ' ' A' ' 50' ' ' LYS . 2.3 pt? -76.21 -35.1 59.22 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -178.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.407 ' H ' HD21 ' A' ' 49' ' ' LEU . 24.2 mmmt -76.45 -50.41 14.14 Favored 'General case' 0 C--N 1.344 0.358 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.901 -177.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 35.52 65.5 0.4 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.995 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.7 mtm-85 178.49 -52.85 0.0 OUTLIER Pre-proline 0 CA--C 1.551 0.986 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.644 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.25 -4.28 13.65 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.875 2.384 . . . . 0.0 112.537 -178.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.442 ' CG1' ' N ' ' A' ' 55' ' ' ASP . 10.9 p -47.35 -44.76 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.111 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.442 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 41.3 t0 -66.47 -40.44 89.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.445 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -60.69 -38.04 83.66 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 64.89 107.27 0.01 OUTLIER Glycine 0 CA--C 1.518 0.264 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.567 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -52.34 -163.32 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.022 0.439 . . . . 0.0 111.673 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.449 ' O ' ' OG ' ' A' ' 137' ' ' SER . 73.6 mt -109.07 135.16 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.3 mt -109.79 142.12 41.48 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.413 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 9.3 tp -110.21 123.93 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-O 121.033 0.444 . . . . 0.0 111.304 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.99 157.15 22.84 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.499 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.97 -24.51 4.75 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.453 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -115.88 130.66 56.92 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.73 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -63.99 -13.03 43.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.752 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -50.57 -30.36 13.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.622 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -96.06 -15.87 21.94 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -92.11 -15.32 27.88 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.666 -0.646 . . . . 0.0 109.329 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.517 ' HZ3' ' NH2' ' A' ' 82' ' ' ARG . 35.4 tttp -80.53 -38.52 1.08 Allowed Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.693 -178.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 66.0 Cg_endo -103.55 -2.77 0.27 Allowed 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 122.663 2.242 . . . . 0.0 111.896 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.431 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 60.7 t80 -97.89 -9.46 26.29 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.032 -178.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.3 mp -131.86 159.38 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -65.56 158.57 26.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.968 0.413 . . . . 0.0 110.389 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 74' ' ' ASP . 37.1 p-10 -93.72 9.35 37.37 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.882 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.6 t -75.85 -39.16 57.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.131 0.491 . . . . 0.0 110.538 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 20.9 ptp -96.9 -15.28 21.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.257 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.7 tp -100.21 125.68 46.4 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.436 0.636 . . . . 0.0 111.331 -177.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.476 ' OG1' ' N ' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -148.76 178.46 8.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.984 -178.143 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.476 ' N ' ' OG1' ' A' ' 78' ' ' THR . 98.2 m-20 -59.97 -42.49 94.27 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 123.233 0.333 . . . . 0.0 111.082 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.6 p -61.05 -31.23 49.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.533 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -62.74 -41.61 99.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.391 0.615 . . . . 0.0 109.939 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.517 ' NH2' ' HZ3' ' A' ' 69' ' ' LYS . 12.6 mmt85 -65.46 -53.77 38.0 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 122.379 1.085 . . . . 0.0 109.821 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 87' ' ' SER . 82.0 tt0 -53.74 -50.34 66.18 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.317 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.1 m -62.39 -49.8 74.08 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.576 -1.193 . . . . 0.0 112.138 -177.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 89' ' ' TRP . 8.4 tt -68.54 -26.2 32.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.484 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -87.82 -22.52 24.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.932 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 83' ' ' GLU . 68.4 m -107.17 -56.07 2.25 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.573 ' O ' ' CG ' ' A' ' 89' ' ' TRP . 78.7 ttt-85 -61.61 -45.79 92.58 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.474 -178.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.573 ' CG ' ' O ' ' A' ' 88' ' ' ARG . 1.1 m0 174.72 154.37 0.31 Allowed Pre-proline 0 N--CA 1.47 0.532 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -68.71 -16.99 42.62 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.319 2.013 . . . . 0.0 111.452 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 97.14 69.24 0.98 Allowed Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.98 -37.25 93.71 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.478 2.119 . . . . 0.0 111.38 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.1 p -77.98 144.4 11.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.536 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 27.2 m -93.57 143.57 26.18 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.385 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -127.39 145.09 50.93 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.436 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.9 t -96.57 103.51 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 121.545 0.688 . . . . 0.0 110.145 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -89.39 148.0 39.47 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.55 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -77.76 111.59 3.15 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.93 1.753 . . . . 0.0 111.278 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.47 148.26 90.44 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.424 ' O ' ' OG1' ' A' ' 103' ' ' THR . 38.6 Cg_endo -63.94 146.4 91.33 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.901 1.734 . . . . 0.0 112.272 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.47 -35.7 81.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.67 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 76.3 p -56.04 -41.37 74.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.52 -179.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.487 ' O ' ' O ' ' A' ' 104' ' ' PRO . 3.4 p -63.74 156.11 73.79 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 120.399 -0.521 . . . . 0.0 109.938 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' A' ' 103' ' ' THR . 73.9 Cg_exo -47.32 -156.41 0.0 OUTLIER 'Trans proline' 0 N--CA 1.505 2.161 0 C-N-CA 122.812 2.341 . . . . 0.0 114.245 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.527 ' NH2' ' O ' ' A' ' 110' ' ' ARG . 4.1 tpt180 -136.16 -1.11 2.42 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.198 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -75.0 -1.24 21.78 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.011 0.434 . . . . 0.0 110.895 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.656 ' CD1' ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -86.56 -17.9 32.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.669 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.2 m -142.01 -39.99 0.36 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.374 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 74.83 18.95 80.11 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.361 179.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.527 ' O ' ' NH2' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -158.35 -74.1 0.08 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 117.313 0.557 . . . . 0.0 110.434 179.433 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -102.78 -173.68 2.38 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.26 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 49.1 p30 -115.38 57.88 0.73 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.786 0.327 . . . . 0.0 111.051 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.0 p -159.03 159.52 34.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.32 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.6 pp -166.15 142.54 5.02 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.8 121.48 16.61 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 113.349 -1.751 . . . . 0.0 109.276 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.9 p -142.36 157.15 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -146.48 149.83 34.42 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.157 0.503 . . . . 0.0 111.46 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.5 t -115.05 134.28 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.3 t -129.87 151.09 50.82 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.025 0.441 . . . . 0.0 110.924 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 49.9 p-10 -151.87 85.57 1.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.196 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.542 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 9.2 t60 -171.67 -38.03 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.542 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 74.2 Cg_endo -97.49 -159.45 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.931 0 C-N-CA 122.45 2.1 . . . . 0.0 112.318 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 32.5 mt -79.71 -4.99 54.27 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.343 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 74.2 t -57.08 -46.13 84.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.777 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.577 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 30.2 m -55.24 -61.49 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.302 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.024 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.577 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -40.44 -47.09 2.55 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.844 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.436 ' CD1' ' C ' ' A' ' 127' ' ' LEU . 2.8 tm? -69.82 -47.28 63.36 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.571 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.457 ' O ' ' N ' ' A' ' 132' ' ' GLY . 85.3 m -68.71 -47.3 66.71 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.103 0.477 . . . . 0.0 111.296 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 125' ' ' VAL . 1.3 pp0? -55.63 -43.06 75.81 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.429 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -59.48 -56.09 26.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.311 -177.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -63.16 -35.66 81.03 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.128 -1.397 . . . . 0.0 108.346 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 128' ' ' CYS . . . 89.96 3.32 73.6 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 113.388 -1.733 . . . . 0.0 109.684 -179.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -141.79 153.77 64.98 Favored Pre-proline 0 CA--C 1.552 1.043 0 CA-C-N 117.258 0.529 . . . . 0.0 111.21 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -48.46 -174.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 123.724 2.949 . . . . 0.0 113.969 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.1 tp -140.8 125.36 17.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 113.02 -1.9 . . . . 0.0 106.31 177.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -64.67 142.93 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 C-N-CA 118.179 -1.408 . . . . 0.0 108.931 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 59' ' ' ILE . 0.8 OUTLIER -108.96 121.1 44.42 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 123.762 0.664 . . . . 0.0 110.583 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 18.7 m -132.18 145.47 51.37 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.9 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.1 m -66.7 144.12 56.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.529 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.11 88.57 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -162.23 164.33 27.75 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.275 0.56 . . . . 0.0 110.589 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.8 -163.85 1.82 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.173 -178.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 80.2 p -63.54 -40.41 96.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.752 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -159.35 0.81 0.09 OUTLIER Glycine 0 N--CA 1.461 0.332 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 146' ' ' PRO . 1.2 tm? -79.24 111.83 23.49 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 145' ' ' LEU . 14.3 Cg_exo -33.59 155.23 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.213 1.942 . . . . 0.0 113.095 -179.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.51 -168.79 0.37 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.513 2.142 . . . . 0.0 112.555 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 15.3 m -129.81 82.37 2.07 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.477 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 52.2 ptt85 -52.25 -37.49 55.46 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.362 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.28 173.63 14.74 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.2 m -58.81 -23.92 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 CA-C-O 121.567 0.699 . . . . 0.0 109.386 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -64.73 -27.27 68.79 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 155' ' ' ARG . 0.0 OUTLIER -68.99 -79.52 0.06 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.449 179.194 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.7 p -34.67 -30.23 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.607 0.763 . . . . 0.0 110.418 178.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 159' ' ' GLY . 4.8 tmt_? -71.9 -52.89 15.07 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.082 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 153' ' ' GLU . . . -69.93 -18.37 63.37 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 122.493 1.14 . . . . 0.0 108.186 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -84.16 -44.69 13.73 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 112.87 -1.968 . . . . 0.0 111.578 -178.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -130.37 -24.88 2.49 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 91.03 23.95 28.54 Favored Glycine 0 N--CA 1.47 0.948 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 -178.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -43.9 -93.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.584 -0.308 . . . . 0.0 111.091 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . 60.06 31.11 20.47 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.56 ' C ' ' H ' ' A' ' 164' ' ' VAL . 0.5 OUTLIER -170.19 -61.38 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.903 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -72.85 29.5 0.29 Allowed 'Trans proline' 0 N--CA 1.502 1.99 0 C-N-CA 122.283 1.989 . . . . 0.0 110.515 177.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.56 ' H ' ' C ' ' A' ' 162' ' ' PHE . 15.7 m -132.44 167.0 27.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.64 -178.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.1 t -123.63 66.86 37.69 Favored Pre-proline 0 N--CA 1.476 0.871 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.65 178.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -38.45 147.22 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 123.693 2.929 . . . . 0.0 115.015 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 168.49 134.28 1.7 Allowed Glycine 0 CA--C 1.528 0.849 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.2 178.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -80.92 152.12 28.23 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.5 t -145.55 148.35 33.09 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.125 0.488 . . . . 0.0 111.222 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -54.81 -66.87 2.52 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.463 ' C ' ' H ' ' A' ' 173' ' ' LEU . . . 93.54 6.88 62.2 Favored Glycine 0 N--CA 1.466 0.661 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -76.97 26.19 0.14 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.818 -0.691 . . . . 0.0 110.903 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.469 ' CD1' ' N ' ' A' ' 173' ' ' LEU . 9.2 mp 53.32 -166.98 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -138.16 150.21 66.23 Favored Pre-proline 0 N--CA 1.469 0.503 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.57 -15.8 41.87 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.085 1.856 . . . . 0.0 111.82 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 27.6 p -155.04 155.94 35.02 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.087 0.47 . . . . 0.0 110.09 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.662 ' H ' ' NH1' ' A' ' 179' ' ' ARG . 96.2 mt-10 -128.72 -95.57 0.41 Allowed 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.569 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.7 pt -101.04 130.35 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 120.978 0.418 . . . . 0.0 110.337 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.662 ' NH1' ' H ' ' A' ' 177' ' ' GLU . 7.6 mpt_? -123.44 163.3 21.13 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.601 0.715 . . . . 0.0 110.26 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -77.95 104.43 8.51 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.513 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -63.95 -17.66 63.49 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.879 -178.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.467 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.4 mm? -62.5 -42.26 99.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.947 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.53 -41.54 8.12 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 60.74 25.44 63.62 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -54.3 128.64 32.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.054 0.454 . . . . 0.0 110.572 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.539 ' H ' ' CD2' ' A' ' 186' ' ' LEU . 0.7 OUTLIER -97.5 178.49 5.17 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.609 -179.792 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -87.95 -33.64 18.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.657 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -70.73 141.44 51.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.701 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -138.04 -24.5 1.0 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.825 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.739 0 CA-C-O 118.073 -1.404 . . . . 0.0 110.873 179.756 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 55.0 p30 -99.57 11.05 40.22 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.921 0.391 . . . . 0.0 110.565 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -63.9 -40.94 97.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.501 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.421 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 10.3 mp -62.19 -42.59 99.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.164 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -65.03 -41.49 95.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.708 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -64.51 -42.54 95.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.075 0.465 . . . . 0.0 110.758 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.432 ' OD2' ' O ' ' A' ' 164' ' ' VAL . 66.1 t0 -65.78 -45.78 81.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.332 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.54 -48.75 73.92 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 11' ' ' ALA . 19.3 tt -67.35 -41.75 86.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.177 0.513 . . . . 0.0 110.761 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.426 ' N ' ' CG2' ' A' ' 10' ' ' ILE . . . -61.53 -40.9 96.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.754 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.95 -46.41 74.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.956 0.408 . . . . 0.0 110.525 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.78 -50.57 70.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.229 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.3 pp -68.92 -38.85 79.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.346 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.35 -54.52 45.84 Favored 'General case' 0 C--O 1.216 -0.71 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.264 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 20' ' ' GLU . 99.5 t -60.54 -40.1 83.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.606 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.447 ' CD2' ' C ' ' A' ' 17' ' ' LEU . 6.2 tt -52.41 -49.92 63.55 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.846 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -82.17 -51.2 8.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.614 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -63.65 -33.64 76.07 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.282 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.474 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.5 mt-10 58.16 83.26 0.12 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.451 179.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.4 -145.96 0.15 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.405 178.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.2 p -133.33 140.31 47.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -128.19 165.46 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-O 120.859 0.362 . . . . 0.0 111.531 -178.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.47 127.14 30.24 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.633 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.474 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 0.6 OUTLIER -117.09 140.49 27.15 Favored Pre-proline 0 N--CA 1.473 0.721 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.741 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.474 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 93.3 Cg_endo -77.3 144.06 22.81 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.242 1.295 . . . . 0.0 111.651 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.8 m -137.66 134.43 35.43 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.433 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -53.38 -44.85 68.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.167 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.94 -81.33 0.07 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.632 0.253 . . . . 0.0 111.444 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 71.8 t -133.32 128.69 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -36.77 144.67 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.773 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -141.17 -163.93 9.74 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.9 m -130.67 168.72 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -160.18 -179.34 34.9 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 119.963 -1.113 . . . . 0.0 112.297 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -157.97 -168.2 2.44 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.975 -179.242 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 19.9 p-10 -93.24 108.7 35.07 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 36' ' ' ASP . 33.7 Cg_exo -36.86 172.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.972 2.448 . . . . 0.0 114.574 177.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 41.76 73.32 0.13 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.231 -1.349 . . . . 0.0 111.124 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.1 m -153.39 134.34 13.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.608 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -67.69 -34.16 76.34 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.811 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.448 ' CG2' ' N ' ' A' ' 42' ' ' ALA . 15.1 t -63.34 -46.49 86.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.996 -178.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.448 ' N ' ' CG2' ' A' ' 41' ' ' THR . . . -60.12 -50.43 73.74 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.538 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 p -62.04 -45.23 99.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.831 0.348 . . . . 0.0 110.279 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 61.7 mtt -64.36 -39.53 94.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.865 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 -60.91 -34.25 74.39 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 123.537 0.523 . . . . 0.0 109.831 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 82.2 mt -73.56 -60.39 2.27 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.2 mt -54.77 -18.02 4.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.678 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -67.85 -84.67 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.901 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -75.86 -33.06 59.99 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.581 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -76.1 -69.69 0.49 Allowed 'General case' 0 C--N 1.348 0.525 0 C-N-CA 119.421 -0.911 . . . . 0.0 110.382 -177.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 50.89 80.27 0.08 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.706 0.765 . . . . 0.0 109.201 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.7 mtm180 162.87 -62.71 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.271 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.14 -15.51 48.72 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.423 2.082 . . . . 0.0 112.455 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.48 ' CG1' ' N ' ' A' ' 55' ' ' ASP . 10.9 p -41.79 -49.31 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.72 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.48 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 37.0 t0 -65.38 -41.87 93.28 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.029 0.443 . . . . 0.0 110.935 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -59.89 -37.06 78.29 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.392 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 63.32 107.8 0.01 OUTLIER Glycine 0 CA--C 1.519 0.284 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.566 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -52.92 -162.46 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.216 0.531 . . . . 0.0 111.661 -179.449 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.7 mt -108.17 146.95 13.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.7 mt -119.62 139.29 52.42 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.8 tp -110.28 133.08 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-O 121.133 0.492 . . . . 0.0 110.917 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.73 152.43 39.43 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.469 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.65 -29.6 7.95 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -111.29 149.8 30.56 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.233 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -79.26 -14.11 59.24 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -53.01 -30.83 37.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.961 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.02 -12.05 27.32 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.471 ' CD2' ' N ' ' A' ' 68' ' ' LEU . 3.3 mm? -92.57 -16.25 25.93 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.002 0.819 . . . . 0.0 108.97 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.467 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 50.9 tttm -77.71 -38.83 1.82 Allowed Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.671 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 67.1 Cg_endo -104.73 -2.64 0.2 Allowed 'Trans proline' 0 C--N 1.318 -1.03 0 C-N-CA 122.835 2.356 . . . . 0.0 112.648 -178.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.418 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 49.9 t80 -97.78 -8.46 28.45 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.749 0.309 . . . . 0.0 110.791 -178.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 73' ' ' ASP . 5.3 mp -135.75 162.97 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.445 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 92.6 m-20 -64.78 156.65 29.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.628 -0.429 . . . . 0.0 109.857 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -94.29 8.48 41.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.76 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.43 ' CG2' ' N ' ' A' ' 76' ' ' MET . 14.9 t -73.58 -41.73 62.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.181 0.515 . . . . 0.0 110.568 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.43 ' N ' ' CG2' ' A' ' 75' ' ' THR . 21.7 ptp -90.12 -7.37 53.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.095 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 tp -102.0 120.41 40.37 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.097 0.475 . . . . 0.0 110.746 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.578 ' HG1' ' N ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -159.12 160.68 35.91 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.576 -177.828 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.578 ' N ' ' HG1' ' A' ' 78' ' ' THR . 99.2 m-20 -39.13 -48.17 1.67 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.789 -178.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.3 p -62.96 -33.19 59.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.852 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 78' ' ' THR . 63.6 tp60 -65.49 -39.66 92.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.974 0.416 . . . . 0.0 110.764 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.1 mmt85 -65.07 -52.14 57.4 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 122.523 1.154 . . . . 0.0 109.181 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -55.35 -50.5 69.51 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 113.702 -1.59 . . . . 0.0 110.235 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.1 m -61.19 -49.92 75.24 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.167 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.0 tt -67.98 -34.07 64.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.202 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -75.66 -39.36 57.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.865 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.5 m -77.4 -32.46 54.82 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 120.991 0.424 . . . . 0.0 110.955 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 89' ' ' TRP . 76.1 ttt180 -97.14 75.93 2.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.389 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.435 ' O ' ' O ' ' A' ' 88' ' ' ARG . 57.7 m95 56.19 150.19 0.06 OUTLIER Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.244 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.77 -19.84 35.53 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.277 1.985 . . . . 0.0 111.738 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 163.11 82.03 0.04 OUTLIER Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -80.84 -30.91 1.58 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.352 2.035 . . . . 0.0 112.169 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.532 ' O ' ' CE1' ' A' ' 95' ' ' PHE . 9.4 p -136.76 149.14 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.738 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 91.8 m -91.59 143.16 26.86 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.627 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.543 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 0.2 OUTLIER -125.5 147.01 49.4 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.207 179.24 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 t -99.6 107.84 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 121.376 0.607 . . . . 0.0 109.394 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -94.53 151.17 39.08 Favored Pre-proline 0 N--CA 1.47 0.552 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.734 -178.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.11 106.44 2.27 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 121.695 1.597 . . . . 0.0 110.403 178.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.81 150.1 83.34 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.02 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 101' ' ' ALA . 98.9 Cg_endo -73.07 157.49 50.74 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.379 2.053 . . . . 0.0 112.986 -178.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.438 ' O ' ' O ' ' A' ' 100' ' ' PRO . . . 57.27 126.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.627 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.6 p -99.46 -5.26 29.7 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.569 ' N ' ' CD ' ' A' ' 104' ' ' PRO . 0.2 OUTLIER -55.79 -42.56 96.73 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.145 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 103' ' ' THR . 37.5 Cg_endo -90.01 177.63 2.45 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.742 2.295 . . . . 0.0 111.154 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.523 ' O ' ' N ' ' A' ' 109' ' ' GLY . 11.6 tpp180 -159.92 5.03 0.08 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.679 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 61.7 p-90 -73.6 -10.75 60.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.929 0.395 . . . . 0.0 110.434 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.654 ' CD1' ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -85.99 -16.56 37.9 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.115 -179.766 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.418 ' O ' ' O ' ' A' ' 54' ' ' VAL . 98.9 m -141.9 -39.53 0.37 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.724 0.297 . . . . 0.0 110.8 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 82.31 13.86 77.84 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.66 -68.83 0.06 Allowed 'General case' 0 CA--C 1.535 0.366 0 O-C-N 122.444 -0.445 . . . . 0.0 110.166 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -103.58 -162.47 0.91 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.967 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.9 p-10 -127.64 62.29 1.39 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.026 0.441 . . . . 0.0 110.957 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.2 p -158.77 157.47 31.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.015 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.41 140.9 11.66 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.58 126.93 31.01 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 113.094 -1.867 . . . . 0.0 109.702 177.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.4 p -146.02 152.83 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -147.81 156.94 43.25 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.783 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.7 t -119.74 132.32 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.3 t -133.27 128.36 35.66 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.734 179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -135.82 84.1 2.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.925 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.59 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 16.6 t-80 -173.2 -35.63 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.58 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.59 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 67.7 Cg_endo -94.74 -159.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.935 0 C-N-CA 121.995 1.797 . . . . 0.0 111.907 -178.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 36.7 mt -77.69 -7.38 56.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.535 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 95.7 t -57.46 -45.27 85.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.716 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.583 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 27.9 m -51.63 -62.05 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.943 0 C-N-CA 119.555 -0.858 . . . . 0.0 108.797 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.583 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -41.34 -44.81 2.86 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.792 0.329 . . . . 0.0 110.809 178.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -50.96 61.83 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 121.27 0.557 . . . . 0.0 110.723 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 62.3 m -69.64 -48.46 59.82 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.326 0.584 . . . . 0.0 111.558 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 125' ' ' VAL . 0.8 OUTLIER -54.58 -42.38 70.96 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.451 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.432 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -59.28 -55.5 34.02 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.583 -177.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -62.62 -24.71 67.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.191 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.69 2.07 88.85 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 134' ' ' PRO . 59.7 mttt -153.53 159.54 32.0 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 133' ' ' LYS . 3.6 Cg_exo -42.23 177.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 123.876 3.051 . . . . 0.0 113.008 -178.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.3 tp -132.38 122.42 24.99 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.404 ' O ' ' CA ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -64.14 147.47 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 C-N-CA 117.775 -1.57 . . . . 0.0 106.83 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.9 t -122.54 127.26 49.27 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.206 0.527 . . . . 0.0 111.269 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.9 162.18 30.22 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.663 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.6 m -73.59 145.95 45.06 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.95 88.28 2.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.367 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 56.8 p30 -160.74 164.39 31.61 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.342 0.592 . . . . 0.0 110.421 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.57 -167.15 2.13 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.991 -178.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.1 p -61.77 -40.19 94.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.785 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -162.18 9.81 0.1 Allowed Glycine 0 N--CA 1.459 0.216 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.6 tp -89.99 126.88 55.83 Favored Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -37.52 157.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.942 1.761 . . . . 0.0 112.516 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.0 -166.45 0.37 Allowed 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.578 2.186 . . . . 0.0 112.668 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 7.4 t -118.14 76.7 1.09 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.359 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -56.47 -33.89 66.38 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.389 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -162.72 169.56 19.81 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.104 -0.639 . . . . 0.0 109.319 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -58.6 -20.33 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -65.21 -33.05 75.09 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 177.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.447 ' O ' ' N ' ' A' ' 155' ' ' ARG . 6.5 tm-20 -63.72 -79.78 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.804 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.3 p -36.11 -30.42 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.589 0.756 . . . . 0.0 110.643 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.447 ' N ' ' O ' ' A' ' 153' ' ' GLU . 4.1 tmt_? -71.77 -49.17 41.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.243 0.544 . . . . 0.0 111.79 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 153' ' ' GLU . . . -71.45 -18.1 62.33 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 122.628 1.204 . . . . 0.0 108.004 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.17 -55.27 4.45 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 112.349 -2.205 . . . . 0.0 112.149 -177.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -123.99 -18.05 6.07 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -177.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 85.18 25.05 41.62 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -42.3 -94.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.649 0.262 . . . . 0.0 111.437 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.405 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.95 33.83 17.14 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.365 0.602 . . . . 0.0 109.46 -178.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.549 ' C ' ' H ' ' A' ' 164' ' ' VAL . 1.8 m-85 -172.42 -62.56 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.353 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.39 28.51 0.27 Allowed 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 122.438 2.092 . . . . 0.0 110.579 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.549 ' H ' ' C ' ' A' ' 162' ' ' PHE . 15.8 m -131.52 167.93 25.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.79 -178.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.0 t -124.12 64.6 35.99 Favored Pre-proline 0 N--CA 1.473 0.724 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.055 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -39.95 149.23 0.13 Allowed 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 123.453 2.769 . . . . 0.0 114.616 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 172.47 -141.18 6.11 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 114.33 -1.305 . . . . 0.0 111.813 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -147.79 179.88 7.39 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.752 0.311 . . . . 0.0 110.195 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.3 t -144.83 158.21 43.88 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.106 0.479 . . . . 0.0 110.631 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 167.37 62.74 0.03 OUTLIER Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -161.7 89.78 0.11 Allowed Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -136.5 88.48 2.38 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.755 0.312 . . . . 0.0 111.013 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.535 ' CD2' ' N ' ' A' ' 173' ' ' LEU . 2.9 mm? -82.94 -112.35 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.257 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -85.36 149.82 53.01 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.398 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.92 157.68 54.31 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.089 1.86 . . . . 0.0 112.049 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.4 m 68.69 97.31 0.06 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.643 0.735 . . . . 0.0 110.693 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -84.81 -15.52 44.55 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.482 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 31.9 pt -91.72 135.56 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.401 0.619 . . . . 0.0 111.26 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -135.28 171.74 14.0 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.254 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 184' ' ' GLY . 98.6 m-20 -78.76 104.54 9.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.227 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -65.18 -20.23 66.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.573 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.488 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.5 mm? -63.77 -42.67 97.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.486 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.18 -44.3 3.02 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.49 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 180' ' ' ASP . . . 66.28 25.14 72.34 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -69.52 -178.71 1.49 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.088 0.471 . . . . 0.0 110.763 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.33 177.23 9.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.53 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -87.57 -39.29 15.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.564 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.5 138.78 51.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.716 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -149.05 -26.19 0.3 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.122 0.487 . . . . 0.0 110.359 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.71 0 CA-C-O 117.95 -1.472 . . . . 0.0 110.883 -179.652 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -63.54 -40.62 97.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.274 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 39.2 p-10 -155.1 7.66 0.27 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.576 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.43 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 10.1 mp -62.4 -42.17 99.22 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -63.67 -42.32 98.08 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -63.08 -41.68 99.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.771 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 162' ' ' PHE . 63.6 t0 -59.09 -46.99 86.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.498 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.34 -44.39 97.27 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.191 0.519 . . . . 0.0 110.082 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.7 mt -63.56 -42.97 97.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.469 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.73 -43.92 81.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.572 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.17 -47.11 85.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.459 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.69 -52.18 66.62 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.7 pt -68.14 -38.97 80.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.112 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -57.95 -52.92 63.5 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.215 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 20' ' ' GLU . 96.8 t -61.17 -40.55 86.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.703 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.448 ' CD2' ' C ' ' A' ' 17' ' ' LEU . 6.3 tt -52.51 -51.1 61.16 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.673 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -79.88 -50.62 10.22 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.774 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -63.45 -31.64 72.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.027 0.442 . . . . 0.0 110.721 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 16' ' ' VAL . 96.5 mt-10 58.55 81.09 0.16 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 178.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.85 -146.71 0.1 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.813 0.34 . . . . 0.0 110.641 177.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.8 p -128.16 139.67 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pp -128.96 167.76 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 120.892 0.377 . . . . 0.0 111.564 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.88 135.87 56.92 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.325 0.583 . . . . 0.0 111.528 -178.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.5 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 1.6 t80 -127.96 139.19 34.67 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.5 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 68.1 Cg_endo -78.99 144.61 18.97 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 121.327 1.351 . . . . 0.0 111.572 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.536 ' C ' ' H ' ' A' ' 29' ' ' ALA . 47.6 m -134.19 132.93 40.35 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.74 0.305 . . . . 0.0 110.416 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -72.97 32.13 0.07 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.635 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.536 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -156.91 -77.75 0.09 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.723 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.1 p -128.36 130.3 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -44.01 142.6 1.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.141 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.29 -175.71 22.64 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.1 m -129.72 171.21 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.413 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -159.54 -179.38 34.31 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.111 -1.042 . . . . 0.0 111.896 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.471 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 1.4 p -159.42 -161.83 0.98 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 120.209 -0.596 . . . . 0.0 112.015 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.471 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 68.0 m-20 -93.02 107.07 22.15 Favored Pre-proline 0 CA--C 1.557 1.218 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -37.88 -61.73 0.34 Allowed 'Trans proline' 0 N--CA 1.5 1.854 0 C-N-CA 122.592 2.195 . . . . 0.0 112.928 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -76.45 69.51 2.92 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.364 -178.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.1 m -153.66 130.93 11.21 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.793 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.568 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -69.58 -33.26 72.46 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.59 -179.934 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.426 ' CG2' ' N ' ' A' ' 42' ' ' ALA . 14.2 t -57.56 -41.85 81.88 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.636 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.426 ' N ' ' CG2' ' A' ' 41' ' ' THR . . . -60.04 -52.55 64.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.498 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -61.58 -42.97 96.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-O 120.974 0.416 . . . . 0.0 110.511 -178.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.418 ' O ' ' CG ' ' A' ' 48' ' ' GLU . 56.8 mtt -65.19 -52.75 52.94 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.547 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -62.75 -37.31 86.09 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.186 0.517 . . . . 0.0 111.36 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -66.57 -53.42 34.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.407 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.8 mt -78.49 -7.59 57.63 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.187 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 44' ' ' MET . 1.3 mm-40 -68.64 -79.93 0.05 Allowed 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.312 0.577 . . . . 0.0 111.707 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.432 HD23 ' H ' ' A' ' 50' ' ' LYS . 2.3 pt? -71.7 -37.56 70.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.775 -177.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.432 ' H ' HD23 ' A' ' 49' ' ' LEU . 22.7 mmmt -67.76 -47.93 67.83 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.787 -178.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 30.24 66.59 0.12 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.032 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -178.31 -54.76 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.604 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -72.99 -1.43 10.48 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.965 1.777 . . . . 0.0 109.448 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -45.17 -48.99 3.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.435 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -71.59 -39.61 70.43 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 110.936 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.409 ' N ' ' CD ' ' A' ' 56' ' ' LYS . 1.1 mptm? -61.2 -38.8 87.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.306 -179.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 62.33 107.8 0.01 OUTLIER Glycine 0 CA--C 1.521 0.437 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.553 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -54.1 -160.24 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.52 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.2 mt -110.04 148.14 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.095 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.4 mt -122.61 142.01 51.1 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.3 tp -109.44 131.02 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-O 120.878 0.37 . . . . 0.0 110.854 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.31 146.84 45.72 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.94 -29.19 10.63 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.114 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.712 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 11.8 m120 -117.95 152.27 35.8 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.146 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -79.85 -14.34 58.73 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.632 0.73 . . . . 0.0 109.438 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -51.58 -32.55 29.01 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.206 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.712 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 5.5 pm0 -93.12 -8.93 41.25 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.893 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -90.76 -18.87 24.22 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.548 ' NZ ' HH12 ' A' ' 82' ' ' ARG . 32.6 mttp -76.22 -37.92 2.21 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 63.2 Cg_endo -104.82 -2.51 0.2 Allowed 'Trans proline' 0 C--N 1.319 -1.019 0 C-N-CA 122.868 2.378 . . . . 0.0 112.755 -178.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.406 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 76.6 t80 -93.87 -10.98 32.11 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.723 0.296 . . . . 0.0 111.158 -178.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.475 ' CG2' ' N ' ' A' ' 73' ' ' ASP . 5.2 mp -125.45 168.76 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.475 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 91.5 m-20 -63.14 -17.9 62.86 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.869 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.6 t70 57.04 22.38 7.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.929 0.395 . . . . 0.0 110.8 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.431 ' CG2' ' N ' ' A' ' 76' ' ' MET . 13.6 t -88.76 -41.56 12.47 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.779 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.431 ' N ' ' CG2' ' A' ' 75' ' ' THR . 14.2 ptp -84.38 -21.89 30.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.142 179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 tp -73.18 136.25 44.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.663 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.27 165.56 35.91 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.682 -177.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -48.45 -45.61 36.7 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.211 0.32 . . . . 0.0 111.799 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.1 p -61.96 -33.27 57.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.175 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 66.7 tp60 -64.4 -40.04 95.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.922 0.391 . . . . 0.0 110.455 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.548 HH12 ' NZ ' ' A' ' 69' ' ' LYS . 5.5 mmt85 -64.2 -53.09 54.76 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 122.256 1.027 . . . . 0.0 109.169 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -54.63 -50.2 68.69 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.884 -1.507 . . . . 0.0 109.984 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 m -61.33 -50.01 74.66 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.412 -1.267 . . . . 0.0 112.003 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.8 tt -68.44 -31.16 50.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.863 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -77.53 -36.29 52.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.528 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.8 m -85.57 -18.91 31.99 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.098 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 89' ' ' TRP . 58.5 ttt85 -112.63 78.56 1.14 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.334 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.438 ' O ' ' O ' ' A' ' 88' ' ' ARG . 41.3 m95 56.94 150.26 0.06 OUTLIER Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.431 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.09 -23.31 46.26 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 122.24 1.96 . . . . 0.0 112.094 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 158.73 79.61 0.03 OUTLIER Glycine 0 CA--C 1.528 0.906 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -81.33 -15.24 10.18 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.391 2.06 . . . . 0.0 111.985 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.9 p -136.06 144.45 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.562 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.498 ' N ' ' O ' ' A' ' 177' ' ' GLU . 25.6 m -95.13 132.85 39.6 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.92 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -118.08 140.79 49.25 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.437 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.5 t -100.12 109.79 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 121.549 0.69 . . . . 0.0 110.811 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -95.62 148.74 35.08 Favored Pre-proline 0 N--CA 1.471 0.577 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.023 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.48 87.98 0.41 Allowed 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 121.952 1.768 . . . . 0.0 110.587 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -50.59 149.94 5.36 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.894 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -73.99 157.36 47.07 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.116 1.877 . . . . 0.0 110.148 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 179.37 120.06 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.667 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 33.7 p -86.69 -57.49 2.97 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.6 p -157.38 61.79 2.42 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.223 178.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.469 ' CG ' ' H ' ' A' ' 105' ' ' ARG . 93.4 Cg_endo -104.15 -79.55 0.0 OUTLIER 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 123.467 2.778 . . . . 0.0 112.135 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.513 ' NH2' ' O ' ' A' ' 110' ' ' ARG . 7.7 tpt180 79.9 -4.64 1.92 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.723 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 66.5 p-90 -87.3 -10.74 51.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.603 0.716 . . . . 0.0 109.927 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.585 ' H ' ' CD2' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -85.02 -18.18 35.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.618 -179.113 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.413 ' H ' HD22 ' A' ' 107' ' ' LEU . 87.2 m -144.63 -39.98 0.26 Allowed 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.573 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.7 -3.32 87.02 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.262 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.513 ' O ' ' NH2' ' A' ' 105' ' ' ARG . 13.6 tpt180 -154.8 -78.68 0.09 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.036 0.918 . . . . 0.0 111.311 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -95.52 -175.27 3.41 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -125.28 81.52 1.98 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.019 0.437 . . . . 0.0 110.842 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 24.9 p -166.33 128.5 1.87 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.409 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 69.1 mt -125.27 127.33 46.54 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.39 130.35 38.84 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.892 176.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.5 p -144.63 153.75 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 120.897 0.379 . . . . 0.0 110.563 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -142.99 156.55 44.88 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.14 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.0 t -124.29 132.31 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-O 121.103 0.478 . . . . 0.0 109.795 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.4 t -135.32 129.01 32.82 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.656 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -135.47 87.08 2.29 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.859 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.582 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 34.9 t60 -172.15 -36.92 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.582 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 63.5 Cg_endo -95.24 -160.48 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.939 0 C-N-CA 122.23 1.953 . . . . 0.0 111.619 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.9 mt -77.78 -5.03 49.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.253 0.549 . . . . 0.0 110.703 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 83.2 t -58.05 -44.81 87.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.725 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.571 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 27.0 m -53.01 -61.73 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 C-N-CA 119.626 -0.83 . . . . 0.0 108.884 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.571 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -41.05 -44.17 2.36 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.886 0.374 . . . . 0.0 110.749 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.6 tp -69.41 -47.37 64.36 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.452 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 57.9 m -70.47 -49.93 43.4 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.574 0.702 . . . . 0.0 110.623 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 125' ' ' VAL . 1.1 pp0? -54.19 -41.75 68.93 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.383 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.435 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -58.78 -55.22 37.88 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.81 -177.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.455 ' CE1' ' OD2' ' A' ' 36' ' ' ASP . 46.7 t80 -61.28 -18.96 61.05 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.565 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.61 0.44 84.29 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -154.18 159.56 31.85 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 120.614 -0.434 . . . . 0.0 109.931 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -40.99 173.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 124.043 3.162 . . . . 0.0 113.22 -178.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.6 tp -127.53 123.23 35.33 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 176.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.413 ' O ' ' CA ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -65.56 146.83 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 C-N-CA 117.998 -1.481 . . . . 0.0 107.487 -179.492 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 t -117.44 122.64 44.33 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 123.638 0.586 . . . . 0.0 110.664 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 3.2 m -131.9 163.82 27.47 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.842 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.4 m -72.26 145.44 47.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.238 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.11 -37.81 88.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.982 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.401 ' OD1' ' O ' ' A' ' 141' ' ' ASN . 53.4 p30 -49.46 150.43 1.89 Allowed 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.674 0.749 . . . . 0.0 111.095 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.32 -158.37 0.79 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.232 -178.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.5 t -62.47 -42.51 99.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.03 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -161.75 2.62 0.07 OUTLIER Glycine 0 N--CA 1.459 0.217 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.5 tp -85.95 125.23 69.22 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-O 119.389 -0.339 . . . . 0.0 110.35 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -40.45 157.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.627 1.551 . . . . 0.0 111.826 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.35 -162.92 0.18 Allowed 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.519 2.146 . . . . 0.0 112.083 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 148' ' ' CYS . 29.0 p -112.29 80.01 1.29 Allowed 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -55.09 -32.75 62.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.664 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -164.77 163.86 21.26 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.342 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.3 m -56.72 -15.75 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.806 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -66.76 -34.04 76.95 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 150' ' ' THR . 5.1 tm-20 -60.48 -71.87 0.12 Allowed 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.933 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.3 p -48.48 -32.91 4.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.275 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 159' ' ' GLY . 4.1 tmt_? -78.96 -51.66 9.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.773 0.796 . . . . 0.0 109.416 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.94 -44.85 64.08 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.676 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.71 -29.33 27.63 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 112.826 -1.988 . . . . 0.0 114.28 -175.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -126.39 -33.95 2.53 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 118.341 0.519 . . . . 0.0 111.331 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 94.59 24.7 17.5 Favored Glycine 0 N--CA 1.466 0.682 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -43.3 -94.4 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.517 0.199 . . . . 0.0 110.685 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.435 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.55 37.18 16.53 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.544 ' C ' ' H ' ' A' ' 164' ' ' VAL . 1.5 m-85 -176.48 -62.06 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.284 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -73.58 28.86 0.31 Allowed 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.544 2.163 . . . . 0.0 110.46 178.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.544 ' H ' ' C ' ' A' ' 162' ' ' PHE . 16.1 m -132.62 166.1 30.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.814 -178.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.6 t -123.06 65.41 27.87 Favored Pre-proline 0 N--CA 1.475 0.797 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.517 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -35.41 142.78 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 123.588 2.858 . . . . 0.0 115.362 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 169.01 178.28 40.33 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 113.688 -1.596 . . . . 0.0 110.89 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -155.84 149.83 25.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.775 0.321 . . . . 0.0 110.386 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.2 t -145.82 151.74 38.4 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.457 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -55.54 -67.98 1.93 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 155.29 60.46 0.01 OUTLIER Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -79.4 106.62 11.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.781 0.324 . . . . 0.0 110.616 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.423 ' CD1' ' N ' ' A' ' 173' ' ' LEU . 10.2 mp -78.99 164.53 24.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.231 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -153.49 72.7 6.78 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.054 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -60.98 143.06 99.25 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.743 2.296 . . . . 0.0 112.092 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 4.3 m 59.37 72.79 0.51 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.202 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 94' ' ' THR . 1.2 pp20? -101.15 -30.75 11.39 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.052 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.474 ' N ' ' CD ' ' A' ' 177' ' ' GLU . 18.3 tt -96.4 121.03 46.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.307 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -129.22 165.01 22.2 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.491 0.662 . . . . 0.0 111.73 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -78.14 106.13 9.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.008 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -66.33 -18.87 65.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.664 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.467 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.5 mm? -62.61 -41.9 99.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.398 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.53 -45.07 3.03 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.716 0.293 . . . . 0.0 110.61 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 66.24 24.85 72.2 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -61.63 131.97 51.74 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.476 0.655 . . . . 0.0 110.94 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.443 ' H ' ' CD2' ' A' ' 186' ' ' LEU . 0.7 OUTLIER -76.55 -177.64 4.29 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.656 -179.874 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -104.26 68.08 0.87 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.788 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.03 144.42 51.45 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.336 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -137.41 -18.31 1.28 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.255 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.761 0 CA-C-O 118.041 -1.422 . . . . 0.0 110.794 179.825 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -91.79 5.13 51.07 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.904 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -63.23 -41.03 99.05 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.752 0.311 . . . . 0.0 110.629 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.48 ' N ' ' CD2' ' A' ' 5' ' ' LEU . 3.0 mm? -63.07 -41.65 99.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.878 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -61.46 -43.67 98.45 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -59.34 -41.45 89.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.459 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 162' ' ' PHE . 41.3 t0 -61.31 -40.25 93.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.264 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.6 -48.42 81.86 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.813 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.5 mm -63.51 -44.78 98.87 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.698 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.46 -46.56 76.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.053 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.48 -45.71 91.79 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.06 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.12 -51.15 70.32 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 13.3 pt -69.3 -40.09 79.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.506 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -58.47 -54.62 44.94 Favored 'General case' 0 C--O 1.218 -0.557 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.136 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.491 ' O ' ' N ' ' A' ' 20' ' ' GLU . 99.5 t -62.01 -39.81 85.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.638 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.44 ' CD2' ' C ' ' A' ' 17' ' ' LEU . 6.5 tt -52.38 -50.4 62.51 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.587 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -79.95 -51.6 8.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.644 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -64.83 -34.43 78.35 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.41 -178.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.8 mt-10 58.5 87.41 0.07 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.311 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.47 -132.8 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 178.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.6 p -144.29 140.08 24.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pp -130.72 163.95 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 121.163 0.506 . . . . 0.0 111.905 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.76 136.3 57.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.87 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.532 ' CZ ' ' O ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -132.13 145.39 57.16 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.21 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.532 ' O ' ' CZ ' ' A' ' 25' ' ' TYR . 61.9 Cg_endo -78.85 146.83 21.06 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.465 1.443 . . . . 0.0 111.383 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.521 ' C ' ' H ' ' A' ' 29' ' ' ALA . 28.7 m -130.21 135.9 48.64 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.88 0.372 . . . . 0.0 110.123 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -75.35 22.0 0.13 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -156.17 -73.63 0.1 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.327 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.4 p -122.71 126.28 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-O 121.335 0.588 . . . . 0.0 111.392 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.486 ' CD1' ' O ' ' A' ' 148' ' ' CYS . 16.7 t80 -45.34 132.36 7.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.389 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.62 -171.52 13.9 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.309 -0.717 . . . . 0.0 111.309 -179.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 m -131.12 169.51 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.408 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -157.98 -178.21 31.81 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 120.105 -1.045 . . . . 0.0 112.616 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.516 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -156.56 -163.04 1.35 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.546 0.213 . . . . 0.0 110.577 -179.757 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.516 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 44.3 m-20 -100.39 109.11 55.95 Favored Pre-proline 0 CA--C 1.554 1.123 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -178.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 36' ' ' ASP . 55.5 Cg_exo -38.36 173.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.765 2.31 . . . . 0.0 114.105 177.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 42.91 65.66 0.91 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.719 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.0 m -152.35 139.22 18.99 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.41 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -65.98 -28.43 68.88 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.104 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.9 t -59.93 -42.8 94.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.666 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.07 -52.02 67.53 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.38 0.61 . . . . 0.0 111.414 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.11 -45.76 95.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.895 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 91.9 mtp -66.41 -47.05 74.48 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.5 ptt85 -62.23 -30.24 70.96 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.173 -178.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 45.2 mt -73.4 -61.89 1.67 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.382 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.2 mt -54.02 -20.43 6.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.655 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -63.81 -85.61 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.666 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.404 HD23 ' H ' ' A' ' 50' ' ' LYS . 2.2 pt? -77.5 -35.42 53.57 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.404 ' H ' HD23 ' A' ' 49' ' ' LEU . 23.7 mmmt -73.67 -48.18 34.22 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 119.709 -0.797 . . . . 0.0 111.049 -176.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 35.25 65.17 0.4 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.957 -1.019 . . . . 0.0 111.78 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.1 mtm-85 179.84 -53.73 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.909 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.675 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.1 -7.16 18.83 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.422 2.081 . . . . 0.0 112.783 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' A' ' 55' ' ' ASP . 12.8 p -41.42 -47.03 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.119 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.476 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 36.6 t0 -67.66 -39.5 84.55 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.076 0.465 . . . . 0.0 110.786 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.479 ' CD ' ' N ' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -61.92 -39.52 92.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.318 -179.299 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 62.9 105.6 0.01 OUTLIER Glycine 0 CA--C 1.52 0.394 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.57 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -49.76 -168.2 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.821 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.422 HD11 HG22 ' A' ' 59' ' ' ILE . 75.0 mt -102.64 147.84 8.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.1 mt -120.73 141.25 50.62 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.6 tp -108.88 132.46 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-O 121.062 0.458 . . . . 0.0 109.96 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -123.35 152.99 40.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.392 0.615 . . . . 0.0 109.86 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -112.32 -30.03 7.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.181 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -114.1 151.78 32.07 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.648 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -79.05 -13.84 59.52 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.567 0.698 . . . . 0.0 109.974 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -53.8 -30.96 47.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.267 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.79 -8.81 39.52 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.53 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -89.13 -20.79 23.83 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.446 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 69.9 tttt -73.81 -39.97 4.78 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 95.2 Cg_endo -102.38 -5.36 0.29 Allowed 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 122.672 2.248 . . . . 0.0 112.478 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.428 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 43.6 t80 -88.57 -17.87 29.28 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.652 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.423 ' CG2' ' N ' ' A' ' 73' ' ' ASP . 5.0 mp -122.34 157.53 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.423 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 4.4 m-20 -64.34 146.59 54.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.846 0.355 . . . . 0.0 110.203 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -91.9 38.8 1.0 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.058 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.422 ' CG2' ' N ' ' A' ' 76' ' ' MET . 11.3 t -108.34 -41.76 4.78 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.995 0.426 . . . . 0.0 110.208 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.422 ' N ' ' CG2' ' A' ' 75' ' ' THR . 8.4 ptp -93.05 -17.5 23.78 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.239 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 31.7 tp -79.83 128.18 33.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.277 -177.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.632 ' HG1' ' N ' ' A' ' 79' ' ' ASP . 0.5 OUTLIER -153.86 163.63 39.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.726 -177.225 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.632 ' N ' ' HG1' ' A' ' 78' ' ' THR . 98.0 m-20 -49.15 -45.74 44.23 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.718 -178.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -61.09 -31.94 51.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.964 -0.295 . . . . 0.0 111.197 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 66.8 tp60 -65.56 -40.6 92.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.216 0.531 . . . . 0.0 110.427 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 9.7 mmt85 -64.21 -51.65 62.7 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 122.522 1.154 . . . . 0.0 109.287 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -56.44 -50.33 71.98 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 113.668 -1.605 . . . . 0.0 110.325 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -61.74 -49.7 75.37 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.826 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.1 tt -67.59 -31.53 52.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.486 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -77.32 -35.09 55.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.748 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.6 m -88.0 -18.65 28.55 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.475 0.178 . . . . 0.0 111.282 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.414 ' O ' ' O ' ' A' ' 89' ' ' TRP . 77.3 ttt-85 -110.39 77.84 1.08 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.554 ' CD1' ' N ' ' A' ' 89' ' ' TRP . 1.2 m0 59.18 148.71 0.07 OUTLIER Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.21 -31.53 35.67 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 121.741 1.627 . . . . 0.0 112.508 -178.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 150.35 61.12 0.01 OUTLIER Glycine 0 CA--C 1.531 1.061 0 C-N-CA 121.089 -0.577 . . . . 0.0 111.97 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.22 -15.73 35.43 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.718 2.279 . . . . 0.0 111.828 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.0 p -122.6 136.47 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.137 0.494 . . . . 0.0 110.079 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 177' ' ' GLU . 27.3 m -91.37 135.26 33.95 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.936 -179.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -120.69 139.71 52.65 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.914 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.4 t -97.17 109.02 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-O 121.347 0.594 . . . . 0.0 110.902 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -94.37 149.9 37.38 Favored Pre-proline 0 N--CA 1.469 0.506 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.965 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.403 ' O ' ' OD2' ' A' ' 73' ' ' ASP . 58.7 Cg_endo -69.41 86.93 0.52 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.991 1.794 . . . . 0.0 111.12 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.423 ' O ' ' OD1' ' A' ' 112' ' ' ASP . . . -50.95 153.51 3.0 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.452 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.44 157.47 58.97 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.193 1.929 . . . . 0.0 111.629 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -149.05 74.04 1.24 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.396 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.421 ' O ' ' OG1' ' A' ' 103' ' ' THR . 57.8 p -66.6 -33.75 76.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.915 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.618 ' H ' ' CD ' ' A' ' 104' ' ' PRO . 0.6 OUTLIER -168.18 -39.3 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -179.748 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.618 ' CD ' ' H ' ' A' ' 103' ' ' THR . 18.5 Cg_exo -66.31 -164.61 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.583 2.189 . . . . 0.0 113.129 -178.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 109' ' ' GLY . 8.2 tpt180 -172.28 0.36 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.149 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 2.4 p90 -71.67 -7.13 46.06 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.531 -179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.665 ' CD1' ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -73.08 -23.25 60.51 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.769 179.823 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 85.1 m -143.09 -40.1 0.32 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.812 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 80.2 -0.42 83.99 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.638 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -148.21 -80.64 0.13 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.427 0.613 . . . . 0.0 110.822 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -89.91 -173.02 3.74 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 99' ' ' ALA . 66.3 t0 -131.05 70.83 1.46 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.91 0.386 . . . . 0.0 110.832 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 80.5 p -160.6 127.83 4.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.583 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 63.0 mt -124.03 129.04 50.25 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -178.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.32 122.54 25.26 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.276 176.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.9 p -141.29 155.96 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.937 0.398 . . . . 0.0 110.54 -179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.546 HH21 ' HG ' ' A' ' 137' ' ' SER . 19.3 ptt180 -149.19 158.22 44.0 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.665 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 70.8 t -122.52 134.87 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.11 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.2 t -138.4 127.85 24.67 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.664 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -133.24 87.45 2.39 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.129 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.604 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 19.1 t60 -172.01 -35.22 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 112.486 0.551 . . . . 0.0 112.486 -179.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.604 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 73.7 Cg_endo -95.7 -158.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.482 0.795 0 C-N-CA 122.288 1.992 . . . . 0.0 111.761 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 19.4 mt -79.26 -6.18 56.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.661 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 79.9 t -57.22 -45.62 84.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.538 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.574 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 26.9 m -51.01 -61.68 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.864 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.574 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -41.63 -44.52 3.12 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.984 0.421 . . . . 0.0 110.726 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.54 -51.54 55.43 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.08 0.467 . . . . 0.0 110.571 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 79.2 m -69.34 -48.45 61.33 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.252 0.549 . . . . 0.0 111.396 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.441 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.1 pp0? -54.56 -42.05 70.51 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.441 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -60.11 -54.83 41.22 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.139 -1.392 . . . . 0.0 109.399 -177.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -64.13 -21.67 66.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.085 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.41 1.55 86.34 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 55.5 mttt -152.66 159.48 32.43 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 120.718 -0.393 . . . . 0.0 109.971 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -43.16 178.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 124.053 3.169 . . . . 0.0 113.389 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.407 ' CD1' ' O ' ' A' ' 35' ' ' CYS . 8.2 tp -133.35 123.29 25.14 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 177.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.475 ' CG2' ' HG ' ' A' ' 35' ' ' CYS . 0.8 OUTLIER -64.65 146.16 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 C-N-CA 117.796 -1.562 . . . . 0.0 107.678 -179.736 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.546 ' HG ' HH21 ' A' ' 117' ' ' ARG . 5.9 t -119.37 129.53 54.87 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.283 0.563 . . . . 0.0 111.23 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.5 m -131.79 164.23 26.48 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.241 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.2 m -75.18 148.06 39.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.24 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.51 88.91 2.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.615 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 57.6 p30 -164.02 163.28 23.39 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.396 0.617 . . . . 0.0 110.814 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.85 -165.57 1.91 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.096 -178.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 38.8 t -61.95 -43.89 97.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.925 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -160.65 11.08 0.14 Allowed Glycine 0 N--CA 1.459 0.22 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.6 tp -88.71 127.17 57.28 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -39.13 154.12 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.682 1.588 . . . . 0.0 111.83 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.418 ' O ' ' N ' ' A' ' 149' ' ' ARG . 89.9 Cg_endo -74.38 149.99 40.71 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.227 1.951 . . . . 0.0 112.392 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.486 ' O ' ' CD1' ' A' ' 31' ' ' PHE . 72.8 m -67.92 74.22 0.19 Allowed 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 147' ' ' PRO . 32.2 ptt-85 -58.3 -34.38 70.49 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.502 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -160.33 163.75 33.04 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.472 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -56.62 -17.45 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.821 0 CA-C-O 121.577 0.703 . . . . 0.0 109.223 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -64.71 -35.67 81.79 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 177.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.437 ' OE1' ' OE1' ' A' ' 157' ' ' GLN . 5.1 tm-20 -59.49 -74.86 0.06 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.688 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.8 p -44.7 -29.04 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.242 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.421 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -83.95 -45.3 13.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 122.201 1.0 . . . . 0.0 110.047 179.767 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.84 -40.69 80.7 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.769 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.437 ' OE1' ' OE1' ' A' ' 153' ' ' GLU . 8.7 pt20 -81.57 -49.02 11.04 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 113.167 -1.833 . . . . 0.0 112.566 -176.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.429 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 20.8 m-85 -110.05 -33.55 6.66 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 97.61 27.63 8.96 Favored Glycine 0 N--CA 1.475 1.285 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.606 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -44.13 -94.8 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.759 0.314 . . . . 0.0 111.07 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.507 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.83 35.71 16.43 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -178.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.537 ' C ' ' H ' ' A' ' 164' ' ' VAL . 2.1 m-85 -174.77 -62.53 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.471 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -73.03 28.85 0.29 Allowed 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.525 2.15 . . . . 0.0 110.49 178.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.537 ' H ' ' C ' ' A' ' 162' ' ' PHE . 17.1 m -131.98 167.39 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.542 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.0 t -124.24 64.82 37.87 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.549 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -35.18 142.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 123.699 2.933 . . . . 0.0 115.056 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 167.02 -177.71 41.56 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 114.051 -1.431 . . . . 0.0 110.989 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -146.98 152.33 38.44 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.414 ' HG1' ' N ' ' A' ' 170' ' ' GLY . 3.5 t -143.93 148.49 35.45 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.993 0.425 . . . . 0.0 110.944 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.414 ' N ' ' HG1' ' A' ' 169' ' ' THR . . . -107.51 58.21 0.42 Allowed Glycine 0 N--CA 1.47 0.917 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 29' ' ' ALA . . . -163.21 50.7 0.31 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 22.5 mmt85 -64.74 -43.22 94.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.749 0.309 . . . . 0.0 110.492 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.433 ' O ' ' CB ' ' A' ' 174' ' ' ASN . 9.1 mp -100.07 178.94 4.64 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.588 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 173' ' ' LEU . 9.8 t-20 82.8 55.19 0.07 OUTLIER Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.307 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.478 ' O ' ' CB ' ' A' ' 176' ' ' SER . 72.2 Cg_endo -72.48 144.61 40.86 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.709 2.272 . . . . 0.0 111.164 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 175' ' ' PRO . 2.0 m 160.41 77.29 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 94' ' ' THR . 5.7 pt-20 -132.66 -26.57 1.79 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.134 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 18.2 tt -87.08 122.63 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-O 120.922 0.391 . . . . 0.0 110.763 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -135.21 168.08 19.82 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.409 0.623 . . . . 0.0 111.648 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -78.73 106.03 10.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.562 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -65.57 -13.57 59.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.649 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.476 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.4 mm? -63.32 -41.08 98.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.193 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 5.2 t -119.75 -23.49 6.48 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.955 0.407 . . . . 0.0 110.458 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 85.79 31.07 22.02 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -167.8 145.16 4.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.677 0.275 . . . . 0.0 110.77 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.513 ' H ' ' CD2' ' A' ' 186' ' ' LEU . 0.9 OUTLIER -88.88 175.8 7.3 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.86 0.362 . . . . 0.0 110.638 179.669 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -110.53 -12.06 14.41 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.419 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -74.19 137.6 43.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.575 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -152.94 -18.45 0.15 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.244 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.733 0 CA-C-O 117.717 -1.601 . . . . 0.0 111.183 179.771 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 53.9 p30 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -143.37 83.57 1.78 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.329 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 56.5 p30 -104.62 13.78 31.0 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.687 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.401 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 10.8 mp -62.54 -42.22 99.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.039 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -63.88 -40.85 97.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.321 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -64.72 -40.87 96.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.636 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 162' ' ' PHE . 63.1 t0 -59.34 -46.38 88.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.332 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.19 -43.9 97.79 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.95 0.405 . . . . 0.0 110.17 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.1 mt -63.76 -43.19 97.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.97 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.2 -46.52 82.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.533 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.91 -45.98 92.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.423 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.25 -52.86 63.48 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 14.4 pt -68.57 -39.47 80.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.392 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -56.77 -53.72 54.51 Favored 'General case' 0 C--O 1.215 -0.738 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.197 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 20' ' ' GLU . 97.6 t -61.97 -40.62 87.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.89 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.444 ' CD2' ' C ' ' A' ' 17' ' ' LEU . 6.3 tt -52.48 -51.98 56.64 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.508 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -78.33 -49.92 12.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.368 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -65.47 -32.06 73.47 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.694 -178.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 16' ' ' VAL . 97.1 mt-10 59.91 80.67 0.2 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 178.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.04 -148.23 0.12 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.857 177.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.3 p -125.45 140.63 47.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.9 pp -129.68 165.84 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-O 120.907 0.384 . . . . 0.0 111.62 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.26 135.73 57.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.302 0.572 . . . . 0.0 110.793 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.53 ' CZ ' ' O ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -132.49 145.38 57.0 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.585 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.53 ' O ' ' CZ ' ' A' ' 25' ' ' TYR . 97.6 Cg_endo -75.61 145.84 29.89 Favored 'Trans proline' 0 N--CA 1.498 1.794 0 C-N-CA 121.597 1.531 . . . . 0.0 111.384 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.526 ' C ' ' H ' ' A' ' 29' ' ' ALA . 63.0 m -131.76 131.32 42.87 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.95 0.405 . . . . 0.0 110.644 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -75.01 30.94 0.09 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.411 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.526 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -160.32 -73.47 0.07 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.621 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.9 p -131.77 132.22 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.045 0.45 . . . . 0.0 110.188 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.527 ' CD2' ' O ' ' A' ' 148' ' ' CYS . 36.0 p90 -39.5 144.37 0.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.45 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -156.78 -174.27 26.3 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.8 m -131.07 172.33 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.402 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -158.42 178.51 34.63 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.095 -1.05 . . . . 0.0 111.795 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -157.25 -170.42 3.25 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.737 -178.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.467 ' CG ' ' CZ ' ' A' ' 131' ' ' TYR . 18.3 t70 -86.57 108.08 16.47 Favored Pre-proline 0 CA--C 1.555 1.168 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -177.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -36.52 -61.42 0.31 Allowed 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 122.533 2.155 . . . . 0.0 113.161 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -74.03 72.01 1.63 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.593 -178.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 m -155.73 130.52 9.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.678 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -66.33 -33.93 76.84 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.988 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.434 ' CG2' ' N ' ' A' ' 42' ' ' ALA . 15.1 t -62.08 -43.56 98.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.866 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.434 ' N ' ' CG2' ' A' ' 41' ' ' THR . . . -55.78 -52.52 63.68 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -62.19 -42.6 95.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.312 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 91.2 mtp -63.22 -40.61 97.96 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.496 HH22 ' CD1' ' A' ' 142' ' ' LEU . 7.9 ttt85 -60.52 -40.77 92.68 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-O 121.695 0.76 . . . . 0.0 108.959 178.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.96 -55.61 15.92 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.248 -178.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.6 mt -67.64 -12.1 59.7 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.981 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.71 -82.57 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 120.995 0.426 . . . . 0.0 110.678 -177.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.401 HD22 ' H ' ' A' ' 50' ' ' LYS . 2.3 pt? -76.37 -36.28 58.24 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.401 ' H ' HD22 ' A' ' 49' ' ' LEU . 25.2 mmmt -74.63 -51.38 14.61 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 119.552 -0.859 . . . . 0.0 111.026 -176.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 36.12 64.93 0.48 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.866 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.6 mtp85 178.66 -53.99 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.529 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.17 -6.45 16.55 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.92 2.413 . . . . 0.0 111.93 -178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.4 ' CG1' ' N ' ' A' ' 55' ' ' ASP . 9.7 p -45.59 -43.52 3.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.404 -178.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.4 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 50.7 t0 -65.41 -41.25 93.81 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.573 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.409 ' CD ' ' N ' ' A' ' 56' ' ' LYS . 4.1 mptp? -62.55 -37.68 87.06 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 64.4 108.71 0.01 OUTLIER Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 178.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.562 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -51.19 -166.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.057 0.456 . . . . 0.0 111.937 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.438 ' O ' ' OG ' ' A' ' 137' ' ' SER . 70.3 mt -104.55 135.35 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.044 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.6 mt -111.72 144.66 40.64 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.0 tp -112.75 126.8 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-O 121.156 0.503 . . . . 0.0 111.082 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.83 147.92 39.2 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.182 178.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -106.52 -27.59 10.81 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.431 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.662 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 71.1 m-80 -121.46 151.6 40.06 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 120.789 0.328 . . . . 0.0 111.136 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -76.93 -13.29 59.99 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -50.89 -32.19 19.81 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.554 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.662 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 3.0 pm0 -94.17 -13.38 26.74 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.93 -16.19 26.96 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.658 -0.651 . . . . 0.0 109.648 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.467 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 77.1 tttt -78.91 -37.97 1.33 Allowed Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 84.8 Cg_endo -103.47 -3.64 0.26 Allowed 'Trans proline' 0 C--N 1.319 -1.01 0 C-N-CA 122.593 2.195 . . . . 0.0 112.049 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.436 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 60.8 t80 -94.9 -10.9 29.77 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.948 0.404 . . . . 0.0 110.774 -178.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.477 ' CG2' ' N ' ' A' ' 73' ' ' ASP . 5.1 mp -127.11 167.26 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.477 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 99.9 m-20 -61.12 -12.8 13.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.007 0.432 . . . . 0.0 110.381 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 46.2 t0 56.3 22.29 6.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.709 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.0 t -92.6 -38.94 11.6 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.02 0.438 . . . . 0.0 110.177 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.44 -24.4 46.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.208 0.528 . . . . 0.0 110.398 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.445 ' CG ' ' HE ' ' A' ' 82' ' ' ARG . 51.2 tp -77.94 134.21 37.91 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.557 0.694 . . . . 0.0 111.109 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.39 172.56 13.32 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.389 -177.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.13 -40.76 90.92 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.814 0.34 . . . . 0.0 111.105 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.5 p -61.7 -35.07 65.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.495 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -62.97 -41.34 99.51 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.868 0.366 . . . . 0.0 110.511 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.445 ' HE ' ' CG ' ' A' ' 77' ' ' LEU . 2.4 mmt85 -62.88 -52.81 61.64 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 122.506 1.146 . . . . 0.0 109.025 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -55.64 -50.73 69.41 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.812 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.6 m -61.44 -49.83 75.25 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.936 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' A' ' 89' ' ' TRP . 9.6 tt -67.52 -32.08 55.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 119.746 -0.781 . . . . 0.0 109.595 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -75.3 -36.43 61.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.424 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.5 m -86.82 -16.44 36.17 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.741 -0.209 . . . . 0.0 111.145 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.444 ' O ' ' O ' ' A' ' 89' ' ' TRP . 77.2 ttt-85 -119.58 78.52 1.32 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.587 0.232 . . . . 0.0 110.879 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.444 ' O ' ' O ' ' A' ' 88' ' ' ARG . 27.3 m95 56.2 149.66 0.05 OUTLIER Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.029 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -67.13 -21.32 48.94 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.331 2.021 . . . . 0.0 112.045 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.529 ' O ' ' NE ' ' A' ' 117' ' ' ARG . . . 157.26 82.87 0.04 OUTLIER Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -76.44 -21.49 13.21 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.885 1.723 . . . . 0.0 112.578 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.4 p -136.39 143.62 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-O 121.088 0.471 . . . . 0.0 110.843 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 85.1 m -87.73 144.86 26.41 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.246 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -126.85 142.32 51.58 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.754 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.3 t -98.2 105.59 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 121.299 0.571 . . . . 0.0 109.801 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -90.13 150.83 44.07 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.931 -178.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.96 109.29 2.81 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 121.874 1.716 . . . . 0.0 110.525 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.401 ' O ' ' OD1' ' A' ' 112' ' ' ASP . . . -67.29 147.75 98.86 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.05 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.441 ' O ' ' OG1' ' A' ' 103' ' ' THR . 93.0 Cg_endo -73.29 155.22 51.5 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.441 2.094 . . . . 0.0 112.385 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.47 -35.94 78.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.041 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.419 ' HG1' ' N ' ' A' ' 103' ' ' THR . 45.7 p -56.06 -42.06 76.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.775 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.51 ' O ' ' O ' ' A' ' 104' ' ' PRO . 1.7 p -56.43 156.86 10.57 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.51 ' O ' ' O ' ' A' ' 103' ' ' THR . 78.3 Cg_exo -47.65 -139.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.507 2.305 0 C-N-CA 122.984 2.456 . . . . 0.0 114.158 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' A' ' 109' ' ' GLY . 15.0 mmt180 -142.96 -7.08 0.83 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.217 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.55 ' CD1' ' N ' ' A' ' 106' ' ' TRP . 14.2 m0 -73.04 -14.43 61.41 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.562 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.66 ' CD1' ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -68.99 -37.63 78.84 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.736 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.429 ' C ' ' H ' ' A' ' 110' ' ' ARG . 21.8 m -143.94 -39.48 0.29 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.432 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 65.59 -13.64 0.28 Allowed Glycine 0 CA--C 1.53 0.972 0 CA-C-N 115.64 -0.709 . . . . 0.0 113.764 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.429 ' H ' ' C ' ' A' ' 108' ' ' THR . 24.7 tpt85 -112.22 -83.08 0.59 Allowed 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 117.848 0.824 . . . . 0.0 111.027 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -78.88 -121.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.525 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 99' ' ' ALA . 44.0 t0 -171.29 51.26 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.667 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.5 p -158.7 162.75 37.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.294 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.0 pp -165.79 137.59 3.93 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.72 127.97 34.74 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 113.085 -1.87 . . . . 0.0 109.904 177.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.3 p -147.21 151.19 14.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.986 0.422 . . . . 0.0 110.063 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.529 ' NE ' ' O ' ' A' ' 91' ' ' GLY . 80.5 ttt180 -141.21 156.16 45.95 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.701 -178.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.5 t -121.41 130.87 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.9 t -134.03 127.94 33.3 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.764 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -135.43 84.3 2.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.849 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.607 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 47.1 t60 -172.62 -35.56 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.308 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.607 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 72.7 Cg_endo -95.07 -159.41 0.06 OUTLIER 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 121.889 1.726 . . . . 0.0 111.979 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 42.7 mt -78.22 -4.65 48.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.341 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 82.9 t -58.53 -45.9 90.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.964 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.586 ' CG2' ' H ' ' A' ' 126' ' ' ALA . 27.6 m -53.57 -61.89 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.586 ' H ' ' CG2' ' A' ' 125' ' ' VAL . . . -41.26 -43.95 2.53 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.717 178.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.2 tp -69.32 -48.6 61.04 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.361 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 65.1 m -70.4 -48.88 54.09 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.49 0.662 . . . . 0.0 110.913 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.472 ' N ' ' O ' ' A' ' 125' ' ' VAL . 1.1 pp0? -54.71 -42.24 71.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.572 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.437 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -58.78 -56.1 26.52 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.178 -1.374 . . . . 0.0 110.062 -177.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.467 ' CZ ' ' CG ' ' A' ' 36' ' ' ASP . 7.4 t80 -63.32 -29.21 70.56 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.644 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 90.26 1.0 76.05 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' A' ' 134' ' ' PRO . 61.2 mttt -151.0 158.64 34.68 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.999 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' A' ' 133' ' ' LYS . 5.9 Cg_exo -41.12 175.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 123.976 3.117 . . . . 0.0 113.166 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.6 tp -131.34 123.09 27.53 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 177.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.402 ' O ' ' CA ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -66.0 145.58 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 C-N-CA 118.477 -1.289 . . . . 0.0 108.662 -179.212 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -109.44 120.85 43.77 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.122 0.889 . . . . 0.0 110.756 -179.669 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 5.2 m -136.2 163.39 30.48 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.122 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.7 t -67.27 149.37 50.49 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.916 0.389 . . . . 0.0 110.976 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.54 -38.46 91.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.195 -0.457 . . . . 0.0 112.117 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 56.6 p30 -65.75 155.99 34.44 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.468 0.651 . . . . 0.0 111.599 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.496 ' CD1' HH22 ' A' ' 45' ' ' ARG . 0.8 OUTLIER -144.75 179.08 7.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.385 -178.523 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 38.8 t -61.39 -42.74 99.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.226 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -141.65 57.01 0.58 Allowed Glycine 0 N--CA 1.468 0.803 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.1 tp -157.41 108.04 1.85 Allowed Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 119.399 -0.334 . . . . 0.0 110.213 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -40.92 156.09 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.394 1.396 . . . . 0.0 111.212 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -59.97 -159.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.113 1.876 . . . . 0.0 111.855 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.527 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 79.5 m -149.12 73.32 1.2 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.027 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -54.66 -40.61 69.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.232 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.15 168.49 26.32 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.0 m -59.47 -22.76 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 CA-C-O 121.266 0.555 . . . . 0.0 109.855 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -65.12 -25.06 67.6 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 155' ' ' ARG . 6.2 tm-20 -69.08 -79.42 0.06 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.319 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.419 ' N ' ' OE1' ' A' ' 153' ' ' GLU . 5.4 p -35.83 -30.15 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.577 0.751 . . . . 0.0 110.312 177.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.482 ' N ' ' O ' ' A' ' 153' ' ' GLU . 4.1 tmt_? -71.59 -49.94 35.67 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.063 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 153' ' ' GLU . . . -72.01 -19.41 61.86 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 122.529 1.157 . . . . 0.0 108.212 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -83.04 -44.38 15.26 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 112.623 -2.081 . . . . 0.0 111.763 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -129.78 -34.26 1.75 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.775 0.322 . . . . 0.0 111.631 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 160' ' ' ALA . . . 102.12 23.91 8.82 Favored Glycine 0 N--CA 1.468 0.792 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.412 ' O ' ' O ' ' A' ' 159' ' ' GLY . . . -43.97 -97.9 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.597 0.237 . . . . 0.0 110.893 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . 64.17 33.6 11.68 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.547 ' C ' ' H ' ' A' ' 164' ' ' VAL . 1.6 m-85 -173.54 -62.2 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.013 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -72.67 28.22 0.28 Allowed 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 122.296 1.997 . . . . 0.0 110.718 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.547 ' H ' ' C ' ' A' ' 162' ' ' PHE . 13.6 m -129.89 167.31 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.877 -178.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 11.7 t -121.6 65.2 17.19 Favored Pre-proline 0 N--CA 1.471 0.615 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.859 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -36.35 139.84 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 123.612 2.875 . . . . 0.0 115.041 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 160.61 -172.81 37.05 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 114.077 -1.42 . . . . 0.0 111.112 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -159.29 170.68 21.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.935 0.397 . . . . 0.0 110.524 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.49 -40.02 0.89 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.024 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 127.69 -72.5 0.47 Allowed Glycine 0 N--CA 1.47 0.911 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 154.56 115.72 0.56 Allowed Glycine 0 CA--C 1.517 0.213 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -135.91 140.37 44.02 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.738 0.304 . . . . 0.0 110.794 -179.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 50.8 tp -62.06 -47.45 84.64 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.586 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.589 HD21 ' N ' ' A' ' 174' ' ' ASN . 0.0 OUTLIER -176.37 82.51 0.27 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.389 -179.622 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -75.04 -14.72 20.96 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.727 1.618 . . . . 0.0 111.847 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 41.3 p -149.4 127.59 12.06 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.518 0.675 . . . . 0.0 110.906 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -116.96 -175.71 2.83 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.577 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 16.3 pt -113.12 133.59 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.117 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -127.62 166.52 17.9 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.511 0.672 . . . . 0.0 111.452 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 184' ' ' GLY . 46.0 t0 -80.05 106.3 11.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.921 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.61 -18.63 62.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.502 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.477 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.4 mm? -63.5 -41.15 98.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.841 0.353 . . . . 0.0 110.545 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.1 -43.38 2.33 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.395 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 180' ' ' ASP . . . 74.03 19.74 79.75 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -75.04 -167.99 0.69 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.004 0.43 . . . . 0.0 111.149 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.563 ' H ' ' CD2' ' A' ' 186' ' ' LEU . 0.8 OUTLIER -98.66 -179.93 4.47 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.233 179.875 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -101.02 45.23 0.98 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.679 0.276 . . . . 0.0 110.847 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -93.81 134.71 35.88 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.469 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -142.72 -16.25 0.71 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.5 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.73 0 CA-C-O 118.056 -1.414 . . . . 0.0 111.075 -179.836 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.042 0.449 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.521 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.1 mp -62.1 -42.13 98.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.01 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -60.88 -41.73 96.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.018 0.437 . . . . 0.0 110.127 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.66 -38.85 90.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.098 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 162' ' ' PHE . 60.6 t0 -60.52 -47.23 87.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.258 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.95 -45.98 91.28 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.383 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.45 -43.76 98.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.207 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.23 -46.42 82.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.177 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.66 -44.09 97.16 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.946 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.69 -53.28 59.32 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.8 pt -69.39 -39.81 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.757 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -58.72 -55.14 38.94 Favored 'General case' 0 C--O 1.217 -0.634 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.695 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 20' ' ' GLU . 93.5 t -61.96 -39.28 83.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.6 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.672 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.3 tt -52.64 -50.49 63.07 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.453 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -80.2 -51.38 9.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.992 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -65.52 -33.54 76.17 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.159 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.6 mt-10 58.14 88.11 0.06 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.816 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.04 -136.78 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.328 -0.397 . . . . 0.0 109.975 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.1 p -141.19 138.42 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.469 HD12 ' O ' ' A' ' 24' ' ' ALA . 2.8 pp -130.44 166.59 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-O 121.0 0.429 . . . . 0.0 111.876 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.469 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -58.58 134.71 56.97 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.936 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.473 ' CZ ' ' O ' ' A' ' 26' ' ' PRO . 2.0 t80 -128.73 133.63 25.4 Favored Pre-proline 0 CA--C 1.552 1.035 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.821 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.473 ' O ' ' CZ ' ' A' ' 25' ' ' TYR . 27.8 Cg_exo -60.09 146.04 97.05 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 CA-C-N 121.048 1.41 . . . . 0.0 110.898 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.432 HG22 ' H ' ' A' ' 29' ' ' ALA . 78.7 m -129.36 142.5 50.8 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.188 0.518 . . . . 0.0 110.378 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -77.66 20.1 0.35 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.641 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.432 ' H ' HG22 ' A' ' 27' ' ' THR . . . -160.21 -69.26 0.07 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.625 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.9 t -127.24 130.14 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.477 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 77.3 m-85 -42.24 136.6 2.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.178 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.43 -170.81 12.18 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.9 m -132.47 165.43 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.52 -177.05 27.49 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.303 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.439 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -156.22 -168.08 2.63 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.604 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.496 ' OD1' ' CE1' ' A' ' 131' ' ' TYR . 19.1 t70 -96.07 109.69 48.19 Favored Pre-proline 0 CA--C 1.553 1.063 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -178.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 36' ' ' ASP . 23.6 Cg_exo -36.79 170.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.865 2.377 . . . . 0.0 114.126 177.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 40.94 68.3 0.44 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.961 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.3 m -151.02 142.03 23.03 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.839 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -66.39 -32.56 74.02 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.43 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.448 HG23 ' N ' ' A' ' 42' ' ' ALA . 10.0 t -59.48 -40.88 88.41 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.528 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.448 ' N ' HG23 ' A' ' 41' ' ' THR . . . -58.8 -52.19 66.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.256 0.55 . . . . 0.0 111.506 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.409 HG12 ' H ' ' A' ' 43' ' ' VAL . 2.6 p -64.12 -45.87 95.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.876 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 91.3 mtp -66.79 -46.84 73.99 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.414 ' O ' ' CD2' ' A' ' 49' ' ' LEU . 40.8 ptt85 -63.01 -30.64 71.76 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.416 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 64.0 mt -73.55 -60.95 2.01 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 119.591 -0.843 . . . . 0.0 109.493 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.4 mt -53.11 -21.38 4.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.446 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -64.11 -85.23 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.665 -177.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.517 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -75.93 -32.8 59.74 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -77.17 -71.49 0.4 Allowed 'General case' 0 C--N 1.346 0.423 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.564 -176.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.408 ' O ' ' CG ' ' A' ' 51' ' ' GLN . 3.6 tt0 53.73 80.56 0.11 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.463 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.2 mtp85 161.19 -63.95 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.073 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -66.81 -12.52 36.34 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 122.568 2.179 . . . . 0.0 112.165 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.609 HG13 ' N ' ' A' ' 55' ' ' ASP . 7.3 p -43.9 -46.67 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.026 0.441 . . . . 0.0 110.625 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.609 ' N ' HG13 ' A' ' 54' ' ' VAL . 12.5 t0 -66.69 -44.75 80.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.629 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -59.8 -39.97 86.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.939 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 67.35 109.86 0.02 OUTLIER Glycine 0 CA--C 1.522 0.471 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.573 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -49.24 -170.17 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.935 -0.632 . . . . 0.0 112.222 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.438 ' O ' ' OG ' ' A' ' 137' ' ' SER . 83.0 mt -104.8 139.92 24.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.3 mt -109.02 145.02 36.25 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.471 ' CD1' ' HE ' ' A' ' 117' ' ' ARG . 9.1 tp -110.69 129.88 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-O 121.316 0.579 . . . . 0.0 110.247 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.458 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -118.55 153.82 33.58 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.403 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.36 -27.05 7.72 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -117.05 144.86 44.15 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.193 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -72.91 -14.21 61.42 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.324 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -50.53 -33.95 23.54 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.513 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.59 -9.26 38.71 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.13 -16.63 27.46 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.462 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 43.6 tttm -76.69 -39.1 2.28 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -178.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 93.7 Cg_endo -102.06 -4.97 0.33 Allowed 'Trans proline' 0 C--N 1.318 -1.027 0 C-N-CA 122.65 2.233 . . . . 0.0 111.846 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -92.36 -14.48 28.64 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.892 0.377 . . . . 0.0 110.181 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.575 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.6 mp -134.19 158.49 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.575 ' N ' HG22 ' A' ' 72' ' ' ILE . 21.9 m-20 -62.97 145.74 54.67 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -79.04 -4.57 50.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.751 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.407 HG23 ' SD ' ' A' ' 76' ' ' MET . 8.1 t -73.56 -37.9 65.4 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.033 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.407 ' SD ' HG23 ' A' ' 75' ' ' THR . 63.2 mmm -64.57 -47.45 78.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.759 0.79 . . . . 0.0 109.672 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.7 mp -79.02 135.07 36.78 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 113.886 -1.506 . . . . 0.0 111.18 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.457 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -160.23 158.73 30.5 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.876 -178.697 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -38.57 -47.36 1.3 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.841 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.89 -34.44 68.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.097 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.457 ' N ' ' O ' ' A' ' 78' ' ' THR . 65.9 tp60 -65.51 -40.45 93.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.747 0.308 . . . . 0.0 110.727 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -63.95 -52.53 59.3 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 122.309 1.052 . . . . 0.0 109.235 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' A' ' 87' ' ' SER . 83.1 tt0 -55.24 -50.41 69.53 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.145 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.4 m -61.46 -50.25 73.52 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.216 -1.356 . . . . 0.0 111.966 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.4 tt -67.97 -32.5 56.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.717 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -76.67 -34.67 58.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.543 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 83' ' ' GLU . 11.6 m -87.83 -15.73 36.03 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.642 0.258 . . . . 0.0 111.13 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.436 ' O ' ' O ' ' A' ' 89' ' ' TRP . 68.4 ttt180 -116.3 75.62 0.97 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.813 0.34 . . . . 0.0 110.372 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.436 ' O ' ' O ' ' A' ' 88' ' ' ARG . 75.0 m95 57.7 148.13 0.06 OUTLIER Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.709 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.44 -29.26 37.95 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.922 1.748 . . . . 0.0 112.044 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 149.68 80.05 0.03 OUTLIER Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -85.08 -8.91 8.81 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.992 2.462 . . . . 0.0 112.17 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.455 HG13 ' CZ ' ' A' ' 95' ' ' PHE . 2.7 p -135.99 147.87 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.185 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 82.7 m -85.48 141.25 30.05 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.292 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.485 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 97.8 m-85 -123.0 142.74 50.51 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.465 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.732 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.2 t -106.03 112.8 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-O 121.261 0.553 . . . . 0.0 110.66 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -97.94 150.68 37.01 Favored Pre-proline 0 N--CA 1.472 0.646 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.72 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.69 86.59 0.86 Allowed 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 122.118 1.879 . . . . 0.0 111.341 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -48.61 150.9 2.23 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.969 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.07 145.36 66.99 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.88 1.72 . . . . 0.0 112.197 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.437 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.951 -179.971 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.473 ' O ' ' N ' ' A' ' 109' ' ' GLY . 2.0 tpt180 . . . . . 0 N--CA 1.471 0.593 0 CA-C-O 120.409 0.147 . . . . 0.0 110.792 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 47.3 p-90 -75.5 -9.55 58.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.763 0.316 . . . . 0.0 110.461 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.981 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -76.55 -25.11 53.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.19 -179.217 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.701 ' H ' HD22 ' A' ' 107' ' ' LEU . 24.4 m -144.24 -42.58 0.26 Allowed 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 49.49 0.98 0.01 OUTLIER Glycine 0 CA--C 1.537 1.42 0 C-N-CA 121.368 -0.444 . . . . 0.0 113.125 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.53 ' H ' ' C ' ' A' ' 108' ' ' THR . 0.0 OUTLIER -93.88 -62.31 1.37 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 117.882 0.841 . . . . 0.0 109.853 179.715 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.55 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 87.8 t80 -147.57 169.72 18.99 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.101 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.55 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 4.2 p-10 -84.0 73.74 10.33 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.519 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.491 ' C ' HD22 ' A' ' 114' ' ' LEU . 54.3 p -169.15 126.02 0.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.491 HD22 ' C ' ' A' ' 113' ' ' SER . 2.9 mm? -117.01 120.21 37.68 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -177.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.548 ' N ' HG13 ' A' ' 96' ' ' VAL . . . -80.28 117.21 20.85 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.508 177.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.471 HG22 ' N ' ' A' ' 117' ' ' ARG . 4.6 p -141.4 159.47 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.587 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.471 ' HE ' ' CD1' ' A' ' 61' ' ' ILE . 61.6 ttp180 -139.77 150.71 45.09 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.667 0.27 . . . . 0.0 111.13 -179.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.458 HG22 ' HB3' ' A' ' 62' ' ' ALA . 54.8 t -120.68 131.92 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.9 t -135.84 134.96 39.41 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -139.5 87.1 2.16 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.864 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.638 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 52.1 t-80 -172.58 -36.91 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.638 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 58.5 Cg_endo -95.33 -159.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 122.181 1.921 . . . . 0.0 112.006 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.8 mt -77.53 -5.98 52.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.26 0.552 . . . . 0.0 110.387 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.2 t -57.95 -45.23 87.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.837 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.746 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.8 m -53.83 -61.81 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.926 0 C-N-CA 119.413 -0.915 . . . . 0.0 108.92 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.746 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.0 -45.52 2.62 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.581 0.229 . . . . 0.0 110.93 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.5 tp -68.99 -47.09 66.41 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.268 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 64.2 m -70.44 -49.54 47.65 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.411 0.624 . . . . 0.0 110.997 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.474 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.2 pp0? -54.73 -41.75 70.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.438 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.523 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.6 -56.77 17.92 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.735 -177.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.496 ' CE1' ' OD1' ' A' ' 36' ' ' ASP . 3.9 t80 -63.57 -22.11 66.72 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.705 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 81.27 3.42 90.66 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.3 mttt -151.83 158.19 34.1 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.645 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -43.08 178.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 123.63 2.887 . . . . 0.0 113.536 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.9 tp -135.18 123.2 22.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 113.57 -1.65 . . . . 0.0 106.826 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.409 HG13 ' H ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -63.88 144.32 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 C-N-CA 118.041 -1.463 . . . . 0.0 108.072 -179.454 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 59' ' ' ILE . 1.1 p -113.97 123.74 50.47 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.64 0.588 . . . . 0.0 111.693 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 4.0 m -128.85 162.09 28.3 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.595 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.1 m -74.61 149.78 39.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.335 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.572 ' HB1' ' SG ' ' A' ' 148' ' ' CYS . . . -79.54 81.98 5.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.602 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -160.4 164.08 32.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.389 0.614 . . . . 0.0 110.578 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.68 -165.96 1.74 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.127 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.2 t -59.71 -44.11 93.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.414 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -162.55 12.49 0.11 Allowed Glycine 0 C--N 1.327 0.075 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.9 tp -89.1 126.4 59.11 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -39.64 157.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.538 1.492 . . . . 0.0 112.297 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.62 -161.0 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.411 2.074 . . . . 0.0 111.759 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.572 ' SG ' ' HB1' ' A' ' 140' ' ' ALA . 28.1 p -126.4 86.05 2.47 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.477 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 51.6 ptt85 -53.34 -37.47 62.37 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.862 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.36 171.48 20.16 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.43 ' H ' HG22 ' A' ' 151' ' ' VAL . 1.6 m -59.28 -22.48 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 CA-C-O 121.484 0.659 . . . . 0.0 109.297 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -65.26 -25.46 67.67 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 155' ' ' ARG . 0.0 OUTLIER -71.78 -78.97 0.08 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.49 179.282 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.4 p -34.75 -29.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.489 0.715 . . . . 0.0 110.072 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -73.68 -51.77 15.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.921 179.646 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 153' ' ' GLU . . . -69.78 -20.33 63.48 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 122.542 1.163 . . . . 0.0 108.064 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -82.78 -45.93 13.75 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 112.753 -2.021 . . . . 0.0 111.563 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -129.26 -22.66 3.08 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 90.01 22.7 34.81 Favored Glycine 0 N--CA 1.467 0.708 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.42 ' O ' ' O ' ' A' ' 159' ' ' GLY . . . -43.27 -98.28 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.742 0.306 . . . . 0.0 110.942 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.46 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 62.62 35.12 14.49 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.526 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.7 m-85 -174.06 -62.16 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.057 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -73.41 29.05 0.3 Allowed 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.175 1.917 . . . . 0.0 110.476 177.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.559 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.3 m -131.55 166.86 27.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.747 -178.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.8 t -123.0 65.7 28.04 Favored Pre-proline 0 N--CA 1.473 0.684 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.796 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.559 ' HD3' HG23 ' A' ' 164' ' ' VAL . 21.2 Cg_exo -36.31 142.42 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 123.561 2.841 . . . . 0.0 115.008 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 165.1 -167.91 38.97 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 114.006 -1.452 . . . . 0.0 110.88 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -152.71 177.84 10.27 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.466 0.36 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.404 179.952 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 . . . . . 0 N--CA 1.445 -0.7 0 CA-C-O 120.639 0.257 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.0 pt -122.7 102.5 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 121.182 0.515 . . . . 0.0 110.331 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -95.53 156.2 16.42 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.339 0.59 . . . . 0.0 111.847 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -76.4 106.36 7.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.822 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -64.68 -12.03 42.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.704 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.515 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.6 mm? -63.03 -42.05 99.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.348 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.71 -42.79 3.07 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.528 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.88 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.815 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 . . . . . 0 N--CA 1.468 0.444 0 CA-C-O 120.713 0.292 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.513 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.4 mp -62.74 -41.83 99.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.965 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -63.37 -42.8 98.88 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.417 0.627 . . . . 0.0 109.783 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -62.31 -41.36 98.47 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.476 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -62.11 -45.55 92.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.741 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.89 90.02 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.19 0.519 . . . . 0.0 110.379 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.48 -43.72 98.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.613 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.52 -45.59 81.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.191 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.72 -39.25 90.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.618 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.4 -53.98 49.52 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.51 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.6 pt -71.59 -31.01 40.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.232 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -59.57 -55.08 38.95 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' A' ' 20' ' ' GLU . 88.7 t -63.72 -40.35 88.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.896 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.675 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.5 tt -52.28 -50.28 62.44 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.555 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -79.82 -50.13 10.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.073 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -66.25 -34.59 78.36 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.952 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.8 mt-10 60.92 82.38 0.17 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 178.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.4 ' H ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -163.47 -139.51 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.232 177.507 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 34' ' ' GLY . 9.2 p -134.67 142.63 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 pp -129.35 163.66 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 120.896 0.379 . . . . 0.0 111.304 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.89 131.22 48.02 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.215 0.531 . . . . 0.0 111.11 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.494 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 0.4 OUTLIER -121.02 140.36 30.8 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.494 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 65.3 Cg_endo -79.33 154.73 24.84 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.553 1.502 . . . . 0.0 111.931 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.472 ' C ' ' H ' ' A' ' 29' ' ' ALA . 23.0 m -142.2 141.38 32.55 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.221 0.534 . . . . 0.0 110.955 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -75.44 23.18 0.12 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.547 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -154.21 -75.48 0.11 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.965 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.4 t -125.73 128.83 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 120.973 0.416 . . . . 0.0 110.174 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.503 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 93.5 m-85 -46.67 147.48 1.24 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.144 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -152.47 -174.47 23.03 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.6 m -126.55 168.16 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -157.64 177.65 34.33 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.098 -1.049 . . . . 0.0 112.235 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -154.66 -166.75 2.41 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.508 0.194 . . . . 0.0 110.594 -179.401 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.451 ' O ' ' O ' ' A' ' 37' ' ' PRO . 3.8 m-20 -95.52 108.78 41.84 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -178.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.451 ' O ' ' O ' ' A' ' 36' ' ' ASP . 54.1 Cg_exo -38.69 174.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.76 2.307 . . . . 0.0 114.042 177.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 38.08 69.72 0.23 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.302 -1.317 . . . . 0.0 111.429 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 51.0 m -149.1 144.09 26.44 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.376 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -69.5 -36.46 76.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.426 0.631 . . . . 0.0 110.64 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 41' ' ' THR . 0.1 OUTLIER -64.39 -43.68 93.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.664 -178.873 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.46 -50.05 75.11 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.041 -0.263 . . . . 0.0 111.413 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.1 p -62.32 -44.96 99.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.391 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 91.1 mtp -63.66 -40.49 96.98 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.475 ' NH2' HG21 ' A' ' 22' ' ' VAL . 34.0 ttt-85 -61.02 -41.6 96.86 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.923 0.868 . . . . 0.0 108.844 178.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.431 ' O ' HD23 ' A' ' 46' ' ' LEU . 1.0 OUTLIER -64.94 -54.74 25.85 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.238 -178.417 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.4 mt -69.1 -11.41 60.77 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.349 -0.842 . . . . 0.0 112.002 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -69.57 -82.48 0.04 OUTLIER 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 120.996 0.426 . . . . 0.0 110.778 -177.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.585 HD12 ' H ' ' A' ' 143' ' ' SER . 2.2 pt? -76.42 -35.29 58.62 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -178.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -76.36 -50.56 13.91 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.797 -177.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 35.29 66.55 0.31 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.724 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.408 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 4.7 mtt180 178.12 -53.05 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.898 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.397 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.408 ' HD2' ' H ' ' A' ' 52' ' ' ARG . 83.0 Cg_endo -80.56 -5.42 13.31 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.866 2.377 . . . . 0.0 112.584 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.59 HG13 ' N ' ' A' ' 55' ' ' ASP . 8.0 p -44.71 -45.13 2.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.073 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.59 ' N ' HG13 ' A' ' 54' ' ' VAL . 67.5 t0 -65.62 -40.38 92.52 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.588 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -62.21 -39.19 91.96 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 71.25 109.62 0.04 OUTLIER Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.564 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -51.7 -163.34 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.232 0.539 . . . . 0.0 112.209 -179.805 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.434 ' O ' ' OG ' ' A' ' 137' ' ' SER . 61.1 mt -105.12 137.28 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.897 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.7 mt -115.68 143.01 45.98 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.3 tp -111.82 132.91 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 121.149 0.5 . . . . 0.0 110.741 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.47 150.92 41.85 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.95 -29.79 8.42 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.04 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -113.12 150.05 32.7 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.155 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -79.01 -14.28 59.28 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -54.49 -30.19 52.54 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.913 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.01 -11.06 29.1 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.525 HD22 ' N ' ' A' ' 68' ' ' LEU . 3.7 mm? -91.16 -18.8 23.88 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.459 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 43.4 tttm -75.57 -39.43 2.99 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 85.3 Cg_endo -104.18 -2.61 0.23 Allowed 'Trans proline' 0 C--N 1.319 -1.009 0 C-N-CA 122.91 2.407 . . . . 0.0 112.363 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -96.95 -11.12 25.04 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.692 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.516 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.1 mp -127.94 155.96 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.516 ' N ' HG22 ' A' ' 72' ' ' ILE . 93.9 m-20 -64.29 158.52 23.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.965 0.412 . . . . 0.0 110.08 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -94.74 7.74 44.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.028 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.517 HG23 ' N ' ' A' ' 76' ' ' MET . 13.2 t -74.32 -42.57 59.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.029 0.442 . . . . 0.0 111.075 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.517 ' N ' HG23 ' A' ' 75' ' ' THR . 24.4 ptm -95.34 -15.74 22.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.093 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 tp -93.92 127.57 39.76 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.113 0.482 . . . . 0.0 110.63 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.458 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -157.73 161.94 38.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.858 -177.976 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -39.61 -47.52 1.96 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.776 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.58 -32.64 57.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.853 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.458 ' N ' ' O ' ' A' ' 78' ' ' THR . 58.6 tp60 -63.48 -40.97 98.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.204 0.526 . . . . 0.0 110.19 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.422 ' HG2' ' H ' ' A' ' 82' ' ' ARG . 10.6 mmt85 -65.41 -52.85 50.49 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 122.484 1.135 . . . . 0.0 109.42 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -54.25 -50.96 65.99 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 113.801 -1.545 . . . . 0.0 110.143 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.6 m -61.1 -50.04 74.88 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.574 -1.193 . . . . 0.0 111.979 -177.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.6 tt -67.81 -32.13 55.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.072 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -76.47 -36.05 58.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.753 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.8 m -87.4 -14.19 41.28 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.633 0.254 . . . . 0.0 111.298 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 89' ' ' TRP . 69.2 ttt180 -115.34 75.43 0.94 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.427 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.452 ' O ' ' O ' ' A' ' 88' ' ' ARG . 13.9 m-90 56.37 153.11 0.07 OUTLIER Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.507 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.6 -21.23 39.87 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.133 1.889 . . . . 0.0 111.649 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.519 ' O ' ' NE ' ' A' ' 117' ' ' ARG . . . 158.52 81.27 0.04 OUTLIER Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.55 -17.8 11.07 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.262 1.974 . . . . 0.0 112.047 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.451 HG13 ' CE2' ' A' ' 95' ' ' PHE . 3.0 p -136.95 146.32 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.132 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.6 m -91.31 129.33 37.32 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.389 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.46 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 38.8 m-85 -117.5 138.05 52.14 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.779 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.623 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 5.2 t -92.46 104.65 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 121.301 0.572 . . . . 0.0 110.761 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 97' ' ' PHE . 30.4 m-85 -86.3 147.1 43.85 Favored Pre-proline 0 N--CA 1.466 0.362 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.529 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.54 83.76 1.85 Allowed 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.993 1.796 . . . . 0.0 111.6 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -46.2 152.46 0.81 Allowed Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -69.46 156.28 64.56 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.036 1.824 . . . . 0.0 111.607 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.464 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.17 179.996 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' A' ' 109' ' ' GLY . 8.0 tpt180 . . . . . 0 CA--C 1.528 0.118 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 8.6 p90 -81.31 -10.08 59.63 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.662 0.744 . . . . 0.0 109.057 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.622 ' H ' ' CD2' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -77.38 -15.28 59.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.638 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 85.3 m -143.28 -40.57 0.31 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.316 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 92.33 -19.28 51.04 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 116.263 -0.426 . . . . 0.0 113.714 178.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.419 ' O ' ' NH2' ' A' ' 105' ' ' ARG . 18.1 tpt180 -144.86 -80.4 0.17 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 117.953 0.877 . . . . 0.0 111.786 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.406 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 29.7 t80 -75.63 -125.47 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.667 -178.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.406 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 48.1 t0 -170.52 54.38 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.834 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.6 p -157.27 155.33 30.58 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.492 ' O ' HD12 ' A' ' 114' ' ' LEU . 0.3 OUTLIER -161.13 137.78 8.58 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.227 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.445 ' HB2' HG22 ' A' ' 96' ' ' VAL . . . -69.55 135.41 50.02 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 113.212 -1.813 . . . . 0.0 109.777 178.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.6 p -149.73 153.71 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 120.888 0.375 . . . . 0.0 110.7 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.519 ' NE ' ' O ' ' A' ' 91' ' ' GLY . 75.7 ttt180 -142.33 152.55 43.04 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.507 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 49.5 t -119.93 133.05 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.2 t -137.72 138.32 39.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.042 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -145.27 85.2 1.72 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.689 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.664 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 8.2 t60 -173.39 -36.58 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.179 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.664 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 67.7 Cg_endo -95.04 -160.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 122.298 1.999 . . . . 0.0 111.964 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.526 HD12 ' N ' ' A' ' 123' ' ' LEU . 9.6 mp -76.84 -7.51 55.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.175 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.0 t -56.74 -45.06 82.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.797 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.738 HG23 ' H ' ' A' ' 126' ' ' ALA . 26.8 m -53.84 -61.84 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.875 0 C-N-CA 119.35 -0.94 . . . . 0.0 108.981 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.738 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.04 -44.08 2.32 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.894 0.378 . . . . 0.0 110.992 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.6 -48.3 60.58 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.362 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 61.6 m -69.9 -49.28 53.67 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.421 0.629 . . . . 0.0 110.684 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.457 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.0 OUTLIER -54.39 -42.71 70.72 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.42 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.536 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.5 -54.96 41.18 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.585 -177.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.443 ' CE1' ' OD2' ' A' ' 36' ' ' ASP . 39.6 t80 -62.46 -21.6 65.57 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.919 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.86 -1.93 82.02 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' A' ' 134' ' ' PRO . 14.2 mtpp -149.5 159.01 37.34 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 133' ' ' LYS . 3.4 Cg_exo -41.68 178.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 123.847 3.031 . . . . 0.0 113.128 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.4 tp -132.34 123.16 26.27 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 176.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.429 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -63.79 153.12 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 C-N-CA 117.888 -1.525 . . . . 0.0 106.986 -179.702 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 59' ' ' ILE . 1.4 p -130.12 133.78 46.88 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.109 0.48 . . . . 0.0 111.1 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.5 m -134.44 164.67 26.93 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.708 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.6 m -70.45 148.46 48.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.386 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.527 ' HB1' ' H ' ' A' ' 148' ' ' CYS . . . -61.4 -36.9 81.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.221 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 141' ' ' ASN . 50.3 p30 -67.28 144.41 55.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.043 0.449 . . . . 0.0 110.475 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.698 HD22 ' C ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -150.94 163.57 38.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.219 -179.607 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.585 ' H ' HD12 ' A' ' 49' ' ' LEU . 29.1 t 28.45 -87.88 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 O-C-N 123.603 0.564 . . . . 0.0 112.192 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 142' ' ' LEU . . . -157.41 16.78 0.35 Allowed Glycine 0 C--N 1.332 0.307 0 N-CA-C 109.976 -1.249 . . . . 0.0 109.976 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.9 tp -94.61 129.25 37.0 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 115.21 -0.495 . . . . 0.0 109.691 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -37.21 156.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.802 1.668 . . . . 0.0 112.384 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -75.71 -164.82 0.26 Allowed 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.42 2.08 . . . . 0.0 112.888 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.527 ' H ' ' HB1' ' A' ' 140' ' ' ALA . 29.7 m -111.39 80.12 1.28 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.123 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.503 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 33.9 ptt180 -54.54 -35.16 62.93 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.21 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.95 169.81 19.08 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.439 HG22 ' H ' ' A' ' 151' ' ' VAL . 0.7 OUTLIER -57.28 -22.82 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.412 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -63.5 -30.83 71.89 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 155' ' ' ARG . 6.0 tm-20 -63.76 -79.61 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.204 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.1 p -36.64 -30.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.922 0.889 . . . . 0.0 111.118 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.472 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -69.69 -52.21 27.71 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.628 -178.896 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.92 -17.69 62.68 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 122.697 1.236 . . . . 0.0 108.386 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -83.87 -45.62 13.04 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 112.492 -2.14 . . . . 0.0 111.847 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -131.11 -23.46 2.45 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 87.98 26.75 28.08 Favored Glycine 0 N--CA 1.464 0.553 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 159' ' ' GLY . . . -43.01 -97.33 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.65 -0.275 . . . . 0.0 111.018 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.465 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 65.85 33.13 8.23 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-O 121.362 0.601 . . . . 0.0 109.453 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.527 ' C ' ' H ' ' A' ' 164' ' ' VAL . 1.8 m-85 -175.58 -62.09 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.505 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.38 31.94 0.28 Allowed 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.169 1.913 . . . . 0.0 110.363 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.577 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.4 m -134.64 167.17 26.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.734 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.3 t -123.72 66.14 36.49 Favored Pre-proline 0 N--CA 1.472 0.657 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.549 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.577 ' HD3' HG23 ' A' ' 164' ' ' VAL . 38.7 Cg_exo -37.73 147.59 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 123.551 2.834 . . . . 0.0 115.072 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 163.84 -173.39 39.9 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 113.739 -1.573 . . . . 0.0 111.105 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -145.68 150.86 37.07 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.718 0.294 . . . . 0.0 110.472 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.466 0.359 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.053 179.865 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.448 -0.564 0 CA-C-O 120.738 0.304 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.502 ' O ' HG23 ' A' ' 178' ' ' ILE . 18.3 tt -111.91 120.5 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.067 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -125.28 164.2 20.87 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 122.052 0.93 . . . . 0.0 110.768 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 184' ' ' GLY . 43.2 t0 -77.05 106.71 8.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.037 -1.438 . . . . 0.0 108.79 178.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -62.28 -20.52 64.37 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.692 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.477 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.4 mm? -63.77 -42.27 97.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.854 0.359 . . . . 0.0 110.408 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.86 -47.12 2.31 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.773 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 180' ' ' ASP . . . . . . . . 0 CA--C 1.526 0.776 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 120.659 0.266 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.54 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.0 mp -62.49 -42.38 99.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.458 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.6 -42.66 91.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.911 0.386 . . . . 0.0 110.26 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 63.3 ttm-85 -62.88 -42.29 99.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.379 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -62.16 -43.49 98.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.398 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.2 -47.14 87.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.06 0.457 . . . . 0.0 110.02 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.22 -43.24 98.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.817 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.85 -40.88 85.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.44 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.24 -43.08 92.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.029 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.16 -52.45 64.79 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.787 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 14' ' ' ILE . 16.7 pt -68.5 -39.06 80.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.357 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -58.22 -54.9 41.81 Favored 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.201 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 20' ' ' GLU . 94.0 t -59.75 -39.73 80.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.776 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.651 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.5 tt -52.06 -50.0 62.38 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.104 -0.638 . . . . 0.0 109.674 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -81.31 -52.71 7.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.904 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.458 ' O ' ' NH1' ' A' ' 21' ' ' ARG . 69.4 mm-40 -63.25 -35.56 80.76 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.438 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.2 mt-10 59.69 81.89 0.16 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.458 ' NH1' ' O ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -155.28 -136.73 0.06 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 177.998 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 34' ' ' GLY . 6.6 p -142.09 139.8 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -126.92 165.64 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.03 0.443 . . . . 0.0 111.363 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.45 129.48 40.04 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.04 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -109.88 133.35 20.99 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.129 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -84.57 140.96 8.56 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.246 1.297 . . . . 0.0 111.789 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.5 ' C ' ' H ' ' A' ' 29' ' ' ALA . 28.2 m -136.01 135.89 39.85 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.871 0.367 . . . . 0.0 110.839 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -74.77 29.43 0.09 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.998 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.5 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -158.52 -77.18 0.07 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.289 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.1 m -120.37 126.28 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-O 121.118 0.485 . . . . 0.0 110.781 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.524 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 77.9 m-85 -60.67 145.17 50.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.509 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -154.4 -166.62 15.27 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.6 m -131.91 170.85 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.441 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -159.87 -176.35 31.85 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 119.518 -1.325 . . . . 0.0 112.51 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.502 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -163.48 -163.36 0.81 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.137 -179.147 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.502 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 43.0 t0 -90.74 106.43 15.45 Favored Pre-proline 0 CA--C 1.555 1.167 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -38.16 -61.89 0.34 Allowed 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.283 1.989 . . . . 0.0 112.129 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -69.71 62.63 0.18 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.315 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.4 m -155.1 131.89 10.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.083 0.468 . . . . 0.0 110.928 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.08 -17.92 63.93 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.247 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.514 HG23 ' N ' ' A' ' 42' ' ' ALA . 15.3 t -61.26 -41.91 97.73 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.511 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.514 ' N ' HG23 ' A' ' 41' ' ' THR . . . -58.13 -51.26 70.45 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.63 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 p -63.05 -44.19 99.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.434 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 62.3 mtt -65.22 -39.93 93.44 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -61.92 -32.83 73.26 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.632 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 81.9 mt -76.92 -57.67 3.72 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.4 mt -57.2 -16.09 7.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.387 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.52 -85.77 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.589 -178.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.505 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -76.08 -32.47 59.26 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.987 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -79.11 -71.01 0.46 Allowed 'General case' 0 C--N 1.349 0.57 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.428 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.424 ' O ' ' CG ' ' A' ' 51' ' ' GLN . 3.7 tt0 54.4 79.85 0.13 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.381 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 161.45 -62.7 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.856 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.332 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.01 -8.53 23.84 Favored 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.58 2.187 . . . . 0.0 111.641 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.557 HG13 ' N ' ' A' ' 55' ' ' ASP . 7.7 p -43.74 -46.34 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.926 0.394 . . . . 0.0 110.466 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.557 ' N ' HG13 ' A' ' 54' ' ' VAL . 10.0 t0 -66.28 -42.87 87.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.196 0.522 . . . . 0.0 109.941 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -61.35 -40.87 95.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.422 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 64.52 117.34 0.01 OUTLIER Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.572 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -51.21 -164.53 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.21 0.529 . . . . 0.0 112.131 179.676 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.5 mt -105.62 145.19 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 16.9 mt -117.15 146.33 43.26 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.4 tp -113.8 132.77 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-O 121.39 0.614 . . . . 0.0 111.325 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.51 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -120.39 154.1 35.59 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.103 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.04 -27.58 6.89 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -114.13 143.74 44.31 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.105 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -73.48 -14.29 61.21 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -50.28 -33.13 18.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.502 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.4 -12.25 28.25 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.548 ' O ' HD13 ' A' ' 72' ' ' ILE . 3.6 mm? -91.67 -14.92 29.26 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.424 -0.797 . . . . 0.0 108.885 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.464 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 43.0 tttm -78.64 -39.93 1.64 Allowed Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 66.6 Cg_endo -104.43 -2.07 0.23 Allowed 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 122.853 2.368 . . . . 0.0 112.351 -178.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.463 ' OH ' ' CD2' ' A' ' 114' ' ' LEU . 55.6 t80 -97.73 -9.47 26.59 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.988 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.619 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.6 mp -123.34 168.91 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.619 ' N ' HG22 ' A' ' 72' ' ' ILE . 96.5 m-20 -60.56 -12.43 9.93 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.051 -0.259 . . . . 0.0 111.141 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 57.8 t0 55.71 30.52 15.73 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.282 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.546 HG23 ' N ' ' A' ' 76' ' ' MET . 9.2 t -96.13 -43.5 7.72 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.208 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.546 ' N ' HG23 ' A' ' 75' ' ' THR . 18.9 ptp -84.69 -5.97 59.34 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.237 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.3 tp -92.8 127.56 38.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.251 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.438 ' H ' ' HB3' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -160.2 161.63 33.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.683 -177.735 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -38.77 -49.18 1.59 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.727 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.02 -33.54 61.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.048 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.438 ' HB3' ' H ' ' A' ' 78' ' ' THR . 65.4 tp60 -66.31 -39.03 89.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.619 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.5 mmt85 -63.54 -53.45 51.64 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 122.38 1.086 . . . . 0.0 108.619 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -54.31 -50.39 67.46 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.013 -1.449 . . . . 0.0 110.117 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -60.83 -50.56 72.95 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.883 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.0 tt -67.9 -32.6 57.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.102 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -72.41 -41.66 66.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.82 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.7 m -78.03 -33.09 51.27 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.566 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 89' ' ' TRP . 76.7 ttt180 -95.74 157.69 15.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.04 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.413 ' C ' ' O ' ' A' ' 88' ' ' ARG . 3.7 m-90 -31.37 148.52 0.05 OUTLIER Pre-proline 0 N--CA 1.47 0.55 0 O-C-N 123.482 0.488 . . . . 0.0 111.43 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -67.02 -17.64 51.32 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.051 1.834 . . . . 0.0 111.41 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.425 ' H ' ' HD3' ' A' ' 92' ' ' PRO . . . 108.92 73.75 0.79 Allowed Glycine 0 N--CA 1.468 0.831 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.425 ' HD3' ' H ' ' A' ' 91' ' ' GLY . 50.3 Cg_exo -53.78 -36.15 81.33 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.833 2.355 . . . . 0.0 111.675 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.422 HG13 ' CZ ' ' A' ' 95' ' ' PHE . 3.4 p -90.44 147.61 5.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.038 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 57.7 m -86.15 147.34 26.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.662 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.424 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 81.7 m-85 -127.32 143.5 51.22 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.469 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.626 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.8 t -99.23 105.39 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-O 121.209 0.528 . . . . 0.0 109.985 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -88.84 149.7 44.19 Favored Pre-proline 0 N--CA 1.469 0.52 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.968 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -76.74 110.18 3.0 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.229 1.953 . . . . 0.0 110.977 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.91 147.72 97.85 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.607 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 40.0 Cg_endo -64.19 -26.27 64.83 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.817 1.678 . . . . 0.0 111.848 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . 0 N--CA 1.471 0.589 0 O-C-N 123.706 0.629 . . . . 0.0 110.869 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.46 ' NH1' ' OD1' ' A' ' 112' ' ' ASP . 2.8 tpp85 . . . . . 0 CA--C 1.533 0.295 0 CA-C-O 120.746 0.307 . . . . 0.0 110.536 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.531 ' CD1' ' N ' ' A' ' 106' ' ' TRP . 4.5 m0 -78.66 -7.36 57.58 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.6 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.942 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -72.41 -31.8 65.83 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.772 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.691 ' H ' HD22 ' A' ' 107' ' ' LEU . 25.9 m -141.01 -42.02 0.39 Allowed 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.515 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 49.36 -0.22 0.01 OUTLIER Glycine 0 CA--C 1.539 1.562 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.13 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.555 ' N ' ' O ' ' A' ' 108' ' ' THR . 0.5 OUTLIER -86.74 -51.17 6.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.025 0.912 . . . . 0.0 108.862 179.366 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.582 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 83.5 t80 -151.36 173.18 14.82 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.498 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.582 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 93.3 m-20 -78.91 51.08 1.08 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.105 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 82.5 p -161.05 158.85 28.5 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.498 ' O ' HD12 ' A' ' 114' ' ' LEU . 0.3 OUTLIER -158.36 136.62 10.84 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -178.834 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.433 ' N ' HG13 ' A' ' 96' ' ' VAL . . . -68.02 125.11 25.3 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 113.389 -1.732 . . . . 0.0 110.527 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.507 HG22 ' N ' ' A' ' 117' ' ' ARG . 4.2 p -151.57 161.48 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.507 ' N ' HG22 ' A' ' 116' ' ' VAL . 61.5 ttp180 -147.06 154.38 41.11 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.934 0.397 . . . . 0.0 111.756 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.51 HG22 ' HB3' ' A' ' 62' ' ' ALA . 56.0 t -119.95 133.09 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.604 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.424 ' O ' HG23 ' A' ' 119' ' ' THR . 11.4 t -132.41 129.65 39.6 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.924 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.539 ' O ' ' CG ' ' A' ' 121' ' ' HIS . 67.4 t0 -136.99 75.47 1.53 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.163 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.682 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 18.7 m-70 -165.52 -36.5 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.301 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.682 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 18.7 Cg_endo -91.97 -162.14 0.1 Allowed 'Trans proline' 0 N--CA 1.485 0.984 0 C-N-CA 121.793 1.662 . . . . 0.0 112.01 -178.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.7 mt -77.3 -6.29 52.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.649 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 83.0 t -57.79 -44.12 85.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.632 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.747 HG23 ' H ' ' A' ' 126' ' ' ALA . 34.5 m -52.32 -62.46 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.879 0 C-N-CA 119.354 -0.938 . . . . 0.0 108.828 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.747 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.97 -44.03 3.34 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.697 0.284 . . . . 0.0 110.995 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 40.3 tp -68.75 -49.26 60.15 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.447 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.477 ' O ' ' N ' ' A' ' 132' ' ' GLY . 75.7 m -70.6 -47.92 57.74 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.263 0.554 . . . . 0.0 111.123 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.479 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -54.64 -42.52 71.37 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.493 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.6 -54.59 45.38 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.167 -177.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -65.71 -22.39 66.61 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 114.766 -1.107 . . . . 0.0 108.136 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 128' ' ' CYS . . . 78.97 2.28 86.53 Favored Glycine 0 N--CA 1.44 -1.087 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -149.57 159.69 35.78 Favored Pre-proline 0 CA--C 1.55 0.951 0 CA-C-N 117.204 0.502 . . . . 0.0 110.556 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -47.59 163.76 0.17 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 124.045 3.163 . . . . 0.0 113.667 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.3 tp -119.95 123.99 44.88 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.422 ' O ' ' CA ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -63.41 147.87 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 C-N-CA 117.755 -1.578 . . . . 0.0 106.899 179.846 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.3 t -122.53 127.15 49.14 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.648 0.592 . . . . 0.0 111.515 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.4 m -128.62 165.75 20.22 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.602 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 24.0 m -72.25 148.49 45.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.668 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.576 ' HB1' ' H ' ' A' ' 148' ' ' CYS . . . -60.92 -36.6 79.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.199 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 57.2 p30 -61.98 152.34 32.56 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.746 0.784 . . . . 0.0 111.293 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.18 -155.36 0.63 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.328 -1.306 . . . . 0.0 109.809 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 79.4 p -62.44 -39.05 92.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.327 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -167.97 7.55 0.05 OUTLIER Glycine 0 CA--C 1.51 -0.257 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.2 tp -86.74 128.15 57.5 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-O 119.223 -0.418 . . . . 0.0 110.037 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -38.22 156.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.666 1.578 . . . . 0.0 112.092 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.435 ' O ' ' OE2' ' A' ' 153' ' ' GLU . 97.6 Cg_endo -74.65 -169.72 0.65 Allowed 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.656 2.237 . . . . 0.0 111.983 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.576 ' H ' ' HB1' ' A' ' 140' ' ' ALA . 14.6 m -116.71 75.54 0.97 Allowed 'General case' 0 CA--C 1.522 -0.109 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.661 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.524 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 31.3 ptt-85 -51.12 -38.7 53.44 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.386 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -161.22 170.47 20.21 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.142 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.404 HG11 ' HA ' ' A' ' 166' ' ' PRO . 1.3 m -57.8 -20.8 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -64.8 -33.96 77.23 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.435 ' OE2' ' O ' ' A' ' 147' ' ' PRO . 0.0 OUTLIER -61.54 -79.69 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.807 179.289 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.441 HG13 ' N ' ' A' ' 155' ' ' ARG . 7.2 p -35.14 -33.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.969 0.908 . . . . 0.0 111.104 178.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.459 ' O ' ' N ' ' A' ' 159' ' ' GLY . 4.9 tmt_? -68.32 -51.76 41.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.679 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.51 -17.55 62.95 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.633 1.206 . . . . 0.0 107.956 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -83.42 -45.63 13.45 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 112.582 -2.099 . . . . 0.0 111.86 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -130.79 -27.35 2.11 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 94.01 24.39 20.01 Favored Glycine 0 N--CA 1.467 0.754 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 -178.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -43.07 -95.99 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.749 0.309 . . . . 0.0 110.968 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.514 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 60.53 35.45 20.17 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.537 ' H ' HG22 ' A' ' 164' ' ' VAL . 2.0 m-85 -172.61 -63.02 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.005 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -71.84 25.13 0.25 Allowed 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.301 2.001 . . . . 0.0 110.813 177.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.568 HG23 ' HD3' ' A' ' 166' ' ' PRO . 16.0 m -128.38 166.09 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.694 -178.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.19 65.05 28.21 Favored Pre-proline 0 N--CA 1.476 0.832 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.552 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.568 ' HD3' HG23 ' A' ' 164' ' ' VAL . 17.1 Cg_exo -36.12 142.65 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 123.429 2.753 . . . . 0.0 114.862 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 176.63 -168.49 40.53 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 113.934 -1.485 . . . . 0.0 111.132 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -155.52 148.96 24.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.775 0.322 . . . . 0.0 110.171 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.468 0.46 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.677 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 . . . . . 0 N--CA 1.443 -0.778 0 CA-C-O 121.039 0.447 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 43.6 pt -119.85 143.82 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.988 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -130.97 166.86 20.05 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.714 0.769 . . . . 0.0 111.413 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -79.46 105.72 10.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.156 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -64.67 -19.18 65.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.659 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.481 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.5 mm? -62.4 -41.78 98.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.195 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.17 -42.4 7.07 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.512 0 N-CA-C 110.451 -1.059 . . . . 0.0 110.451 179.816 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.734 0.302 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.53 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.7 mp -62.24 -42.86 99.69 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -64.6 -40.55 95.71 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -63.18 -41.73 99.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.72 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -60.57 -44.99 95.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.698 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.65 -44.47 96.91 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.099 0.476 . . . . 0.0 110.044 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.75 -43.13 97.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.69 -42.66 79.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.943 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.79 -41.02 99.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.86 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.37 -54.72 42.3 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.828 0.347 . . . . 0.0 111.333 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.7 pt -68.17 -35.71 72.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.241 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -59.39 -51.4 70.05 Favored 'General case' 0 C--O 1.216 -0.693 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.939 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.531 HG13 ' O ' ' A' ' 21' ' ' ARG . 87.8 t -63.15 -38.91 83.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.61 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.675 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.5 tt -52.63 -51.11 61.51 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.282 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -78.0 -49.06 14.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.176 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -67.78 -29.82 69.11 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.046 0.45 . . . . 0.0 110.813 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 16' ' ' VAL . 96.7 mt-10 56.88 60.39 3.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.42 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.531 ' O ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -154.65 159.49 40.83 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.59 0.709 . . . . 0.0 110.642 179.139 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 34' ' ' GLY . 8.7 p -74.67 137.06 23.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.771 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.497 HG22 ' NH2' ' A' ' 21' ' ' ARG . 2.8 pp -124.62 165.56 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 120.631 0.253 . . . . 0.0 110.444 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.427 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -62.91 135.85 57.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.251 0.548 . . . . 0.0 111.046 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.495 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 1.3 t80 -124.6 140.85 36.33 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.495 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 59.3 Cg_endo -81.65 145.32 14.49 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.106 1.204 . . . . 0.0 111.108 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.502 ' C ' ' H ' ' A' ' 29' ' ' ALA . 55.7 m -132.06 134.61 45.71 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.865 0.364 . . . . 0.0 110.939 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -73.91 31.02 0.08 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.519 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.502 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -157.49 -78.73 0.08 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.477 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 73.2 t -127.09 129.35 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.511 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 93.2 m-85 -43.3 146.27 0.48 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.302 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -152.95 -172.12 20.99 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.7 m -131.92 167.32 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.505 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -157.83 176.39 34.91 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.114 -1.041 . . . . 0.0 112.081 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.504 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -154.03 -163.57 1.66 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.636 -178.873 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.504 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 17.2 p-10 -97.44 108.09 42.87 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -177.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 36' ' ' ASP . 64.6 Cg_exo -38.93 174.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.82 2.347 . . . . 0.0 113.937 177.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 46.2 t0 37.59 77.98 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.433 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.5 m -153.22 142.96 21.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.137 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.642 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -71.5 -35.65 70.83 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.27 0.557 . . . . 0.0 109.745 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.439 HG22 ' H ' ' A' ' 41' ' ' THR . 0.1 OUTLIER -65.2 -43.59 91.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.566 -179.129 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.94 -49.42 77.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.743 0.306 . . . . 0.0 111.339 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.3 p -63.93 -47.03 92.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.811 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.3 mtt -65.64 -48.18 73.06 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.425 ' NH2' HG12 ' A' ' 22' ' ' VAL . 7.2 ptm180 -61.72 -33.17 73.57 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.587 HD13 ' C ' ' A' ' 46' ' ' LEU . 2.6 tm? -70.71 -46.32 63.3 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.419 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.482 HD21 HG21 ' A' ' 54' ' ' VAL . 6.3 mt -76.39 -11.1 59.84 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 120.897 0.379 . . . . 0.0 111.248 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.99 -81.26 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.592 -176.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.443 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -72.94 -35.93 67.1 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -75.21 -50.04 17.48 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.928 -177.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 33.95 67.05 0.22 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.759 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.2 mmm-85 178.58 -54.02 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.91 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.692 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.91 -6.57 17.58 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.647 2.232 . . . . 0.0 112.748 -178.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.595 HG13 ' N ' ' A' ' 55' ' ' ASP . 14.8 p -43.18 -46.74 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.456 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.595 ' N ' HG13 ' A' ' 54' ' ' VAL . 41.0 t0 -64.16 -42.68 96.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.025 0.44 . . . . 0.0 110.305 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -61.28 -39.63 91.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.62 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 64.72 112.03 0.01 OUTLIER Glycine 0 CA--C 1.519 0.314 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.553 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -54.57 -158.35 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.097 0.475 . . . . 0.0 111.857 -179.488 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 67.9 mt -112.75 146.24 17.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.247 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 14.7 mt -122.16 150.15 42.62 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.7 tp -120.28 130.56 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-O 121.178 0.514 . . . . 0.0 110.599 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.417 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -118.54 149.48 41.26 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.7 -29.34 8.75 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.178 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -116.72 150.02 38.9 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.038 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -77.24 -13.95 59.85 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -50.87 -31.32 17.02 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.47 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.52 -13.08 26.44 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.504 HD22 ' N ' ' A' ' 68' ' ' LEU . 4.0 mm? -92.94 -12.33 31.11 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.476 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 75.0 tttt -80.16 -39.63 1.23 Allowed Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.589 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 44.0 Cg_endo -105.55 -0.95 0.19 Allowed 'Trans proline' 0 C--N 1.316 -1.163 0 C-N-CA 122.968 2.445 . . . . 0.0 112.474 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -97.85 -5.2 35.12 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.612 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.1 mp -127.1 166.33 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.612 ' N ' HG22 ' A' ' 72' ' ' ILE . 93.3 m-20 -64.2 -9.46 17.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.23 -179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 55.65 33.68 21.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.89 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.517 HG23 ' N ' ' A' ' 76' ' ' MET . 10.1 t -96.81 -42.02 8.17 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.517 ' N ' HG23 ' A' ' 75' ' ' THR . 10.5 ptp -91.45 -6.84 52.08 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.396 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.3 tp -93.02 126.05 37.92 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.685 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.453 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -159.77 160.85 34.4 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.92 -177.003 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -39.22 -47.3 1.62 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.748 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.17 -33.57 63.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.022 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' A' ' 78' ' ' THR . 67.8 tp60 -65.03 -40.77 95.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.974 0.416 . . . . 0.0 110.508 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.407 ' HG2' ' H ' ' A' ' 82' ' ' ARG . 6.9 mmt85 -62.69 -52.33 63.71 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 122.469 1.128 . . . . 0.0 108.95 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 87' ' ' SER . 81.9 tt0 -55.9 -50.68 70.01 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 113.781 -1.554 . . . . 0.0 110.135 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 m -61.12 -50.17 74.31 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.976 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.4 tt -67.49 -31.97 55.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.864 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -77.72 -35.25 52.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.774 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 83' ' ' GLU . 13.1 m -87.27 -16.67 34.51 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.582 0.229 . . . . 0.0 110.994 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 89' ' ' TRP . 74.5 ttt-85 -113.34 75.51 0.92 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.7 0.286 . . . . 0.0 110.237 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.452 ' O ' ' O ' ' A' ' 88' ' ' ARG . 82.5 m95 56.85 147.64 0.05 OUTLIER Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.615 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.35 -24.49 37.08 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.172 1.915 . . . . 0.0 112.488 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 156.91 79.48 0.03 OUTLIER Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -83.82 -9.46 9.86 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.72 2.28 . . . . 0.0 112.162 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.482 HG13 ' CE2' ' A' ' 95' ' ' PHE . 3.0 p -137.15 147.49 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.296 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.538 HG22 ' HB1' ' A' ' 115' ' ' ALA . 10.9 m -90.27 125.98 35.68 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.189 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.523 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 34.4 m-85 -117.4 140.5 49.5 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.755 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 3.1 t -99.77 109.75 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-O 121.546 0.688 . . . . 0.0 111.156 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -96.92 151.05 37.53 Favored Pre-proline 0 N--CA 1.469 0.482 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.69 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -65.77 104.8 0.71 Allowed 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.822 1.681 . . . . 0.0 111.247 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.14 162.39 71.65 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.55 141.16 90.78 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 CA-C-N 120.098 1.071 . . . . 0.0 111.756 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.21 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.341 179.889 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.477 ' NH2' ' O ' ' A' ' 110' ' ' ARG . 6.4 tpt180 . . . . . 0 CA--C 1.532 0.271 0 CA-C-O 120.612 0.244 . . . . 0.0 110.626 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 2.3 p90 -70.85 -8.99 56.61 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.098 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.986 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -77.28 -18.38 57.62 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.44 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.614 ' N ' HD22 ' A' ' 107' ' ' LEU . 94.1 m -141.76 -39.33 0.38 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.918 0.389 . . . . 0.0 110.572 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 83.27 13.95 75.48 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.606 -0.597 . . . . 0.0 111.606 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.477 ' O ' ' NH2' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -162.41 -77.77 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.101 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -99.17 -162.12 0.93 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.311 -0.404 . . . . 0.0 109.957 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 53.4 p30 -134.55 61.8 1.66 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.828 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 83.0 p -156.94 128.75 7.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.613 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.567 ' C ' HG13 ' A' ' 96' ' ' VAL . 53.6 mt -124.13 134.96 53.21 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -178.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.538 ' HB1' HG22 ' A' ' 94' ' ' THR . . . -71.95 120.99 18.34 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.439 175.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.441 HG22 ' N ' ' A' ' 117' ' ' ARG . 3.4 p -143.74 158.39 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.824 0.345 . . . . 0.0 110.413 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.441 ' N ' HG22 ' A' ' 116' ' ' VAL . 88.1 mtm180 -144.73 161.77 38.39 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.815 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.417 HG22 ' HB3' ' A' ' 62' ' ' ALA . 55.9 t -123.23 130.38 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.451 ' O ' HG23 ' A' ' 119' ' ' THR . 14.1 t -129.83 128.25 41.92 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.767 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -133.95 82.64 1.99 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.848 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.65 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 70.6 t60 -172.88 -35.73 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.65 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 39.6 Cg_endo -93.06 -161.43 0.09 OUTLIER 'Trans proline' 0 N--CA 1.484 0.949 0 C-N-CA 122.045 1.83 . . . . 0.0 111.847 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 37.6 mt -78.42 -5.74 53.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.891 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.2 t -58.05 -45.07 88.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.808 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.763 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.1 m -53.05 -62.31 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.789 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.705 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.763 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.38 -42.72 2.32 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.877 0.37 . . . . 0.0 110.898 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.4 tp -69.67 -48.95 57.97 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.303 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 56.0 m -70.65 -48.92 52.43 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.548 0.689 . . . . 0.0 110.757 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.462 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -54.28 -42.04 69.56 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.216 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.17 -55.44 35.0 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.234 -177.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -61.59 -21.22 64.14 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.515 -1.221 . . . . 0.0 108.932 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.57 -0.23 85.94 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' A' ' 134' ' ' PRO . 31.4 mttp -151.46 159.53 33.25 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 120.605 -0.438 . . . . 0.0 109.944 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 133' ' ' LYS . 5.7 Cg_exo -41.0 176.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 123.855 3.036 . . . . 0.0 113.021 -178.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.43 HD12 ' O ' ' A' ' 35' ' ' CYS . 7.8 tp -130.94 123.24 28.44 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 176.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.433 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -64.94 152.99 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 10.8 t -129.54 132.86 46.95 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.107 0.479 . . . . 0.0 111.305 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.8 m -135.3 164.49 27.61 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.888 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.1 m -71.4 146.95 48.4 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.465 ' HB1' ' SG ' ' A' ' 148' ' ' CYS . . . -74.47 81.16 1.93 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.712 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 48.1 p-10 -159.43 168.06 27.19 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.303 0.573 . . . . 0.0 110.454 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.2 -162.35 1.43 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.166 -178.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 77.5 p -61.92 -39.74 93.08 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.611 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -163.61 4.85 0.07 OUTLIER Glycine 0 CA--C 1.511 -0.179 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.7 tp -81.43 127.69 72.55 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.164 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -39.24 157.94 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.7 1.6 . . . . 0.0 111.972 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.424 ' O ' ' OE1' ' A' ' 153' ' ' GLU . 76.3 Cg_endo -73.15 -163.89 0.17 Allowed 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.505 2.137 . . . . 0.0 112.242 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.465 ' SG ' ' HB1' ' A' ' 140' ' ' ALA . 11.3 m -118.52 73.71 0.93 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.524 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.511 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 37.6 ptt180 -54.14 -35.91 62.72 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.169 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.95 167.89 20.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.436 HG22 ' H ' ' A' ' 151' ' ' VAL . 0.9 OUTLIER -56.23 -18.6 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 CA-C-O 121.638 0.732 . . . . 0.0 109.128 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -64.41 -36.45 84.19 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.429 ' OE1' ' OE1' ' A' ' 157' ' ' GLN . 0.4 OUTLIER -59.26 -72.06 0.11 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.793 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.3 p -47.97 -30.17 2.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.421 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.457 ' O ' ' N ' ' A' ' 159' ' ' GLY . 4.5 tmt_? -84.01 -44.81 13.77 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 122.293 1.044 . . . . 0.0 110.187 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.41 -41.89 85.95 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.497 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.453 ' CG ' ' N ' ' A' ' 158' ' ' PHE . 8.1 pt20 -80.95 -48.52 12.18 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 113.195 -1.82 . . . . 0.0 111.978 -177.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.453 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 33.7 t80 -107.07 -35.94 6.73 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -177.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 96.86 24.64 12.79 Favored Glycine 0 N--CA 1.475 1.259 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 -178.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -43.23 -93.96 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.66 0.267 . . . . 0.0 110.655 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.47 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.66 36.11 16.73 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.518 ' H ' HG22 ' A' ' 164' ' ' VAL . 2.0 m-85 -175.18 -62.69 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.172 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -72.91 28.73 0.29 Allowed 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.364 2.043 . . . . 0.0 110.794 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.58 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.8 m -132.2 167.78 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.899 -178.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.9 t -124.0 65.5 37.56 Favored Pre-proline 0 N--CA 1.473 0.677 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.698 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.58 ' HD3' HG23 ' A' ' 164' ' ' VAL . 33.4 Cg_exo -37.51 139.99 0.25 Allowed 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 123.586 2.857 . . . . 0.0 114.967 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 160.46 174.25 30.05 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 113.987 -1.461 . . . . 0.0 110.72 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -159.51 133.77 7.63 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 C--N 1.327 -0.404 0 CA-C-O 120.983 0.421 . . . . 0.0 110.148 179.585 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 . . . . . 0 N--CA 1.447 -0.589 0 CA-C-O 120.911 0.386 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 178' ' ' ILE . 19.9 tt -108.47 127.91 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.212 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -127.86 164.34 22.45 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.753 0.787 . . . . 0.0 112.353 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -81.28 106.68 13.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.075 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.755 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -70.77 -12.39 61.52 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.314 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.482 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.7 mm? -64.23 -40.58 96.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.867 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.8 -41.71 6.42 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.111 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.71 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 -179.77 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.688 0.28 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.547 HD12 ' N ' ' A' ' 5' ' ' LEU . 9.7 mp -62.08 -42.66 99.44 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -63.95 -41.32 97.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.021 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 78.8 ttt-85 -61.96 -42.36 99.04 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.887 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -60.72 -45.2 95.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.562 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.42 -42.54 98.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.998 0.428 . . . . 0.0 110.337 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.38 -43.63 98.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.721 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.12 -47.22 78.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.493 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.06 -39.09 91.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.635 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.34 -53.08 62.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.629 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 38.2 pt -70.01 -33.43 55.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.197 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.423 ' OD1' ' OE2' ' A' ' 19' ' ' GLU . 24.6 t70 -57.74 -55.13 38.79 Favored 'General case' 0 C--O 1.217 -0.637 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.147 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 20' ' ' GLU . 97.9 t -63.6 -40.11 87.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.704 0.288 . . . . 0.0 110.675 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.681 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.3 tt -52.16 -48.91 64.69 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.303 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -80.29 -52.59 7.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.289 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.423 ' OE2' ' OD1' ' A' ' 15' ' ' ASP . 92.7 mt-10 -66.91 -34.97 78.94 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.801 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.8 mt-10 60.19 87.48 0.09 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.122 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.439 ' H ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -161.08 -135.74 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.668 178.865 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.3 p -140.62 140.76 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -129.76 166.18 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 120.982 0.42 . . . . 0.0 111.757 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.96 129.34 39.36 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.411 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.513 ' CE2' ' O ' ' A' ' 26' ' ' PRO . 4.4 t80 -115.48 138.25 23.63 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.513 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 64.0 Cg_endo -81.41 144.08 14.16 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.144 1.229 . . . . 0.0 111.615 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.5 ' C ' ' H ' ' A' ' 29' ' ' ALA . 58.1 m -134.53 132.93 39.76 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.013 0.435 . . . . 0.0 111.153 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -72.84 30.3 0.06 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.71 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.5 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -158.54 -76.1 0.08 Allowed 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 120.784 0.326 . . . . 0.0 110.82 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.3 t -125.77 127.69 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 120.96 0.41 . . . . 0.0 110.26 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -48.88 145.76 3.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.765 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -154.83 -173.9 24.17 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.7 m -131.23 170.58 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.407 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -158.95 -176.96 31.58 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 119.765 -1.207 . . . . 0.0 112.453 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -158.16 -167.2 2.14 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.592 0.234 . . . . 0.0 110.716 -179.104 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.472 ' CG ' ' CZ ' ' A' ' 131' ' ' TYR . 18.3 t70 -95.12 109.4 44.41 Favored Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 36' ' ' ASP . 32.8 Cg_exo -37.28 172.27 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.778 2.319 . . . . 0.0 114.358 177.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 40.9 72.22 0.17 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.855 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 m -153.16 137.55 16.68 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.557 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -67.6 -33.62 75.37 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.075 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.588 HG23 ' N ' ' A' ' 42' ' ' ALA . 12.9 t -62.26 -46.11 90.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.026 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.588 ' N ' HG23 ' A' ' 41' ' ' THR . . . -58.4 -51.23 70.68 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.408 -178.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.5 p -62.59 -44.14 99.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.412 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 61.9 mtt -64.03 -39.3 93.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.15 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 51.3 ttt-85 -62.39 -34.4 76.64 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 87.9 mt -74.72 -58.78 3.07 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.3 mt -55.96 -16.3 4.63 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.36 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -68.6 -86.43 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.493 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.2 pt? -77.13 -33.66 56.75 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -76.18 -50.43 14.58 Favored 'General case' 0 C--N 1.349 0.557 0 C-N-CA 119.798 -0.761 . . . . 0.0 110.723 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 35.47 65.77 0.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.703 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 179.61 -54.28 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.83 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.235 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.09 -6.71 17.59 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.637 2.224 . . . . 0.0 112.088 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.565 HG13 ' N ' ' A' ' 55' ' ' ASP . 7.4 p -43.57 -49.29 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.73 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.565 ' N ' HG13 ' A' ' 54' ' ' VAL . 39.8 t0 -66.28 -40.94 90.43 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.687 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -60.88 -39.8 90.61 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.084 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 65.48 107.63 0.01 OUTLIER Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.564 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -52.62 -161.28 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.375 0.607 . . . . 0.0 112.278 -179.477 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 73.2 mt -106.58 142.95 18.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.166 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 16.0 mt -118.05 142.63 47.19 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.4 tp -111.82 126.91 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-O 121.408 0.623 . . . . 0.0 111.622 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.76 148.29 39.99 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.094 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.55 -27.65 9.76 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.075 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -117.91 151.12 38.04 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.946 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -79.26 -13.51 59.63 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -52.54 -31.99 38.46 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.216 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.79 -10.63 33.49 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.414 ' O ' HD13 ' A' ' 72' ' ' ILE . 4.3 mm? -90.79 -18.73 24.43 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.45 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 47.1 tttm -76.71 -39.0 2.24 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 69.7 Cg_endo -104.38 -2.38 0.23 Allowed 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 122.923 2.416 . . . . 0.0 112.582 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -94.85 -10.55 30.99 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.838 0.351 . . . . 0.0 111.06 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.633 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.1 mp -125.52 168.14 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.633 ' N ' HG22 ' A' ' 72' ' ' ILE . 93.0 m-20 -62.3 -13.03 24.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.786 0.327 . . . . 0.0 110.829 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 44.7 t0 55.54 21.74 4.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.841 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.657 HG23 ' N ' ' A' ' 76' ' ' MET . 8.4 t -89.53 -54.51 4.05 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.657 ' N ' HG23 ' A' ' 75' ' ' THR . 13.5 ptp -68.08 -37.52 81.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.225 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 tp -64.22 139.13 58.73 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.208 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.9 173.19 14.06 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.461 -176.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -60.26 -43.06 96.49 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.202 0.314 . . . . 0.0 111.23 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.9 p -60.92 -32.48 52.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.994 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -63.47 -40.89 98.32 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.094 0.473 . . . . 0.0 110.498 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.428 ' HG2' ' H ' ' A' ' 82' ' ' ARG . 7.0 mmt85 -63.34 -51.51 65.65 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 122.648 1.213 . . . . 0.0 108.782 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 87' ' ' SER . 80.7 tt0 -57.17 -50.22 73.5 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 113.667 -1.606 . . . . 0.0 110.096 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.5 m -62.04 -49.03 77.65 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.264 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 89' ' ' TRP . 13.9 tt -68.52 -26.05 32.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.585 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -86.02 -32.22 21.58 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.438 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 83' ' ' GLU . 10.7 m -88.64 -9.12 53.23 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.745 0.307 . . . . 0.0 110.784 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 89' ' ' TRP . 62.4 ttm-85 -128.47 79.53 1.91 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.514 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.448 ' O ' ' O ' ' A' ' 88' ' ' ARG . 2.7 m-90 56.43 152.54 0.07 OUTLIER Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.667 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.88 -23.15 41.53 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.879 1.719 . . . . 0.0 111.753 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 157.95 79.08 0.03 OUTLIER Glycine 0 CA--C 1.53 1.004 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.53 -35.63 86.32 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.714 2.276 . . . . 0.0 112.427 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.2 p -133.84 147.69 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.84 0.352 . . . . 0.0 110.455 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 26.4 m -84.16 141.45 31.05 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.362 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.459 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 70.8 m-85 -119.01 139.81 51.09 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.732 0.301 . . . . 0.0 110.964 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.667 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 3.3 t -96.85 103.55 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 121.424 0.63 . . . . 0.0 109.689 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -91.54 152.01 43.08 Favored Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.079 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.04 110.74 3.15 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.883 1.722 . . . . 0.0 111.341 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.7 153.23 70.33 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.852 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.66 151.95 78.58 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.155 1.904 . . . . 0.0 111.664 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.311 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.388 179.903 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.486 ' NH1' ' O ' ' A' ' 110' ' ' ARG . 5.5 tpp85 . . . . . 0 CA--C 1.531 0.238 0 CA-C-O 120.732 0.301 . . . . 0.0 110.935 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 63.5 p-90 -74.03 -8.6 56.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.753 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.971 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -73.56 -23.42 59.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.081 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.66 ' H ' HD22 ' A' ' 107' ' ' LEU . 88.6 m -142.71 -39.33 0.34 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.107 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 89.31 9.03 67.65 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.486 ' O ' ' NH1' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -158.24 -79.17 0.07 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 117.038 0.419 . . . . 0.0 109.911 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -93.41 -129.61 0.12 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.268 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -157.89 61.58 0.47 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.507 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.6 p -157.52 153.65 27.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.81 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.481 ' O ' HD12 ' A' ' 114' ' ' LEU . 0.3 OUTLIER -160.78 139.17 9.93 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.354 1.073 . . . . 0.0 113.461 -179.508 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.56 133.04 48.71 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 112.971 -1.922 . . . . 0.0 109.885 178.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.8 p -149.98 153.82 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.805 0.336 . . . . 0.0 110.341 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 71.7 ttp85 -147.89 158.7 44.17 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.571 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.2 t -122.18 133.55 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 116.288 -0.414 . . . . 0.0 109.928 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.7 t -132.71 130.9 40.64 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -135.85 85.22 2.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.626 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.597 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 36.2 t60 -172.83 -38.36 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.422 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.597 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 29.1 Cg_endo -92.84 -161.83 0.09 OUTLIER 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 122.026 1.818 . . . . 0.0 112.028 -178.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 123' ' ' LEU . 9.4 mp -78.35 -4.15 46.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.822 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 87.9 t -58.27 -44.96 89.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.855 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.756 HG23 ' H ' ' A' ' 126' ' ' ALA . 29.6 m -53.98 -61.94 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.844 0 C-N-CA 119.434 -0.906 . . . . 0.0 108.633 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.756 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.08 -43.34 2.19 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.91 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 45.4 tp -70.16 -47.86 59.8 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 120.589 -0.445 . . . . 0.0 111.275 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 64.2 m -70.22 -49.15 53.0 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.517 0.675 . . . . 0.0 110.791 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.465 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.0 OUTLIER -55.01 -42.02 72.02 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.455 179.354 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.07 -56.27 24.23 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.93 -177.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.472 ' CZ ' ' CG ' ' A' ' 36' ' ' ASP . 4.2 t80 -63.44 -26.33 68.68 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.263 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.92 3.26 85.69 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 134' ' ' PRO . 69.4 mttt -149.46 157.87 38.57 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-N 116.908 0.354 . . . . 0.0 110.758 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 133' ' ' LYS . 5.7 Cg_exo -42.67 178.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 123.874 3.049 . . . . 0.0 112.705 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.0 tp -134.76 122.36 22.03 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.441 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -64.23 143.1 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 C-N-CA 117.975 -1.49 . . . . 0.0 107.166 -179.788 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.7 t -116.76 123.88 48.26 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 123.568 0.542 . . . . 0.0 111.333 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.6 m -128.86 165.27 21.34 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.152 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.5 t -70.96 149.42 46.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.643 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.25 -38.85 91.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.178 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 55.2 p30 -55.48 152.08 9.41 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.889 0.852 . . . . 0.0 111.351 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.8 -157.0 0.72 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.575 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.5 t -60.31 -45.27 93.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.492 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -161.13 4.46 0.09 OUTLIER Glycine 0 C--N 1.329 0.17 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.2 tp -84.94 127.27 65.41 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -37.47 157.03 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.8 1.667 . . . . 0.0 112.429 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.93 -163.52 0.2 Allowed 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.38 2.053 . . . . 0.0 112.314 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 15.8 t -114.4 78.88 1.19 Allowed 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.515 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -58.67 -34.71 71.55 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.966 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -163.02 165.29 25.02 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.945 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 151' ' ' VAL . 0.7 OUTLIER -55.9 -18.84 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.59 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 156' ' ' ALA . 99.6 m-20 -65.38 -34.17 77.68 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 150' ' ' THR . 6.7 tm-20 -59.21 -70.56 0.15 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.507 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.4 p -50.02 -29.58 5.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.359 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -84.42 -43.76 14.35 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 122.392 1.091 . . . . 0.0 110.143 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 152' ' ' ASP . . . -58.93 -41.23 86.84 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.454 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.474 ' CG ' ' N ' ' A' ' 158' ' ' PHE . 8.2 pt20 -82.46 -48.6 10.89 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 112.981 -1.918 . . . . 0.0 112.143 -177.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.474 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 38.3 t80 -106.97 -36.62 6.56 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -177.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 97.44 25.68 10.73 Favored Glycine 0 N--CA 1.473 1.106 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.409 ' HB1' ' HG2' ' A' ' 163' ' ' PRO . . . -43.43 -94.9 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.612 0.244 . . . . 0.0 110.734 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.424 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 63.44 36.68 11.19 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 121.292 0.568 . . . . 0.0 109.739 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.534 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.2 m-85 -177.14 -61.63 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.214 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.409 ' HG2' ' HB1' ' A' ' 160' ' ' ALA . 91.5 Cg_endo -73.85 29.24 0.32 Allowed 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.14 1.893 . . . . 0.0 110.505 178.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.581 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.9 m -132.34 167.65 25.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.558 -178.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.0 t -124.27 65.11 39.12 Favored Pre-proline 0 N--CA 1.476 0.84 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.71 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.581 ' HD3' HG23 ' A' ' 164' ' ' VAL . 31.3 Cg_exo -37.41 145.06 0.12 Allowed 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 123.815 3.01 . . . . 0.0 115.158 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 165.77 116.92 0.38 Allowed Glycine 0 CA--C 1.523 0.573 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.493 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -85.06 144.99 27.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.886 0.374 . . . . 0.0 110.068 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.205 179.896 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 . . . . . 0 N--CA 1.445 -0.723 0 CA-C-O 120.818 0.342 . . . . 0.0 110.698 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.416 HD13 HG21 ' A' ' 178' ' ' ILE . 14.2 pt -106.02 134.35 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.284 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 19.3 mmm-85 -120.12 157.44 28.98 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.526 0.679 . . . . 0.0 110.189 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 184' ' ' GLY . 97.6 m-20 -72.03 104.53 3.59 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.903 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -68.49 -18.33 64.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.041 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.506 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.7 mm? -64.01 -41.38 97.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.018 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.56 HG23 ' N ' ' A' ' 184' ' ' GLY . 5.2 t -121.3 -51.46 2.09 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.695 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.56 ' N ' HG23 ' A' ' 183' ' ' THR . . . . . . . . 0 N--CA 1.464 0.567 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 . . . . . 0 CA--C 1.53 0.192 0 CA-C-O 120.693 0.283 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.55 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.2 mp -63.15 -42.08 99.38 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.962 0.41 . . . . 0.0 110.048 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -63.32 -42.04 98.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.421 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -63.2 -39.36 94.42 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.408 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -61.52 -43.78 98.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.681 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.48 -45.23 88.24 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.808 0.337 . . . . 0.0 110.264 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.0 mm -63.69 -43.11 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.26 -47.37 78.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.045 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.01 -41.59 96.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.103 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.64 -54.62 44.34 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.9 0.381 . . . . 0.0 111.187 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 14' ' ' ILE . 19.8 pt -69.23 -37.04 75.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.149 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -56.59 -56.2 24.3 Favored 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.469 ' O ' ' N ' ' A' ' 20' ' ' GLU . 99.6 t -63.29 -39.93 87.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 121.16 -0.216 . . . . 0.0 110.59 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.671 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.4 tt -51.79 -49.9 61.79 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.701 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -80.47 -51.87 8.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.148 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -65.86 -34.98 79.4 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.506 -178.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 16' ' ' VAL . 96.2 mt-10 58.51 88.37 0.06 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.107 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.414 ' H ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -162.47 -133.99 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.605 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.8 p -141.99 140.92 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 pp -129.01 167.62 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-O 121.122 0.487 . . . . 0.0 111.875 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.77 129.6 40.35 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.735 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.539 ' CE2' ' O ' ' A' ' 26' ' ' PRO . 7.8 t80 -117.14 138.82 25.2 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.297 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.539 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 63.6 Cg_endo -79.51 144.69 18.01 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.28 1.32 . . . . 0.0 111.751 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.476 ' C ' ' H ' ' A' ' 29' ' ' ALA . 63.2 m -132.6 134.79 45.35 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.248 0.547 . . . . 0.0 111.057 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -74.69 26.27 0.09 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.77 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.476 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -160.85 -70.28 0.07 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.993 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.6 p -127.93 123.57 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 121.108 0.48 . . . . 0.0 110.097 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.524 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 94.7 m-85 -42.52 151.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.744 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -155.51 -178.68 29.98 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.2 m -130.67 169.66 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.51 -177.39 33.57 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 119.839 -1.172 . . . . 0.0 112.323 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.429 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -158.76 -171.42 3.41 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.511 ' OD1' ' CE1' ' A' ' 131' ' ' TYR . 27.8 t70 -92.66 111.82 52.77 Favored Pre-proline 0 CA--C 1.553 1.083 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 36' ' ' ASP . 12.6 Cg_exo -35.55 167.72 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.81 2.34 . . . . 0.0 114.126 177.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 40.8 78.06 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.679 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.4 m -152.89 149.81 28.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.967 0.413 . . . . 0.0 110.707 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -71.03 -33.2 70.09 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.408 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.432 ' H ' HG22 ' A' ' 41' ' ' THR . 0.0 OUTLIER -64.19 -43.19 95.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.808 -178.402 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.0 -50.24 74.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.227 0.536 . . . . 0.0 111.024 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.402 HG12 ' H ' ' A' ' 43' ' ' VAL . 2.9 p -64.74 -45.73 94.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.569 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 59.3 mtt -66.67 -45.04 80.18 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.3 ptt85 -64.58 -30.35 71.37 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.933 0.397 . . . . 0.0 110.102 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.1 mt -73.67 -59.75 2.57 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.273 177.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.4 mt -54.81 -20.53 8.82 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.45 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -64.16 -86.24 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.353 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.518 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.2 pt? -77.01 -34.87 57.43 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -75.3 -49.65 18.52 Favored 'General case' 0 C--N 1.352 0.682 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.193 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 36.56 65.56 0.46 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.709 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 178.55 -53.99 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.858 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.351 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -77.5 -4.74 14.95 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 C-N-CA 122.781 2.321 . . . . 0.0 112.345 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.606 HG13 ' N ' ' A' ' 55' ' ' ASP . 7.2 p -45.46 -48.66 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.56 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.606 ' N ' HG13 ' A' ' 54' ' ' VAL . 13.2 t0 -66.64 -45.41 79.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.334 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -59.69 -41.55 90.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.559 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 69.48 114.48 0.03 OUTLIER Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.567 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -51.03 -164.86 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.337 0.589 . . . . 0.0 112.304 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.4 mt -104.49 145.1 13.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 16.0 mt -117.45 144.54 44.91 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.2 tp -111.18 127.53 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-O 121.069 0.461 . . . . 0.0 110.702 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.631 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -115.11 153.35 30.9 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.57 -28.71 7.06 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.764 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -114.39 142.1 46.78 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.973 0.416 . . . . 0.0 110.903 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -72.66 -13.65 61.41 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -50.41 -33.78 22.03 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.209 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.08 -11.29 30.91 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.481 ' O ' HD13 ' A' ' 72' ' ' ILE . 4.1 mm? -90.06 -17.7 27.28 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.391 -0.818 . . . . 0.0 109.322 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.457 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 48.4 tttm -78.45 -39.17 1.62 Allowed Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.457 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 63.9 Cg_endo -104.01 -2.39 0.25 Allowed 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 122.634 2.223 . . . . 0.0 112.287 -178.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -95.45 -10.18 30.56 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.812 0.339 . . . . 0.0 110.87 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.607 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.6 mp -123.3 167.36 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.607 ' N ' HG22 ' A' ' 72' ' ' ILE . 98.6 m-20 -59.65 -14.24 12.97 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.237 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 58.8 t0 57.14 28.72 15.42 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.85 0.357 . . . . 0.0 110.467 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.524 HG23 ' N ' ' A' ' 76' ' ' MET . 9.5 t -95.86 -43.05 8.02 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.715 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.524 ' N ' HG23 ' A' ' 75' ' ' THR . 18.4 ptm -85.63 -8.13 58.42 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.144 0.497 . . . . 0.0 109.923 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.3 tp -86.51 128.26 34.95 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.611 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.36 164.42 36.35 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.08 -176.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -45.94 -46.77 16.34 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 112.088 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.6 -32.69 54.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.843 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -64.68 -39.78 94.27 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.251 0.548 . . . . 0.0 110.492 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.8 mmt85 -65.86 -52.13 52.99 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 122.33 1.062 . . . . 0.0 108.8 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -55.09 -50.89 68.04 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 113.825 -1.534 . . . . 0.0 110.03 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.3 m -61.07 -49.55 76.9 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.574 -1.194 . . . . 0.0 112.247 -177.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.424 ' O ' ' O ' ' A' ' 89' ' ' TRP . 10.0 tt -68.11 -31.11 50.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.617 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -76.75 -36.2 57.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.541 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.1 m -86.63 -44.28 11.99 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.055 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.482 ' O ' ' CD1' ' A' ' 89' ' ' TRP . 61.8 ttt85 -70.14 -77.06 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.936 0.398 . . . . 0.0 110.44 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.482 ' CD1' ' O ' ' A' ' 88' ' ' ARG . 5.8 m0 -158.4 149.37 16.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.449 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -66.65 -23.59 49.03 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.684 1.59 . . . . 0.0 111.946 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 152.36 83.17 0.04 OUTLIER Glycine 0 CA--C 1.533 1.189 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -76.05 -19.4 15.75 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.631 1.554 . . . . 0.0 111.472 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.405 HG13 ' CE2' ' A' ' 95' ' ' PHE . 12.4 p -136.19 148.91 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.517 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.5 m -83.18 134.21 34.99 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.813 0.34 . . . . 0.0 110.383 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.488 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 67.7 m-85 -113.93 138.93 49.66 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.843 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.667 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 5.2 t -95.87 103.04 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 121.459 0.647 . . . . 0.0 109.592 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -87.37 148.91 45.67 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.537 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.04 108.88 2.77 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.93 1.753 . . . . 0.0 111.194 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.44 155.62 92.25 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.264 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.611 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 89.2 Cg_exo -45.43 -32.33 7.76 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.661 1.574 . . . . 0.0 111.979 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.611 ' HB3' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . 0 N--CA 1.465 0.292 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.595 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 109' ' ' GLY . 20.1 mmt180 . . . . . 0 N--CA 1.472 0.664 0 CA-C-O 120.377 0.132 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 2.7 p90 -67.9 -10.28 51.91 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.796 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 1.03 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -69.81 -39.24 76.64 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.795 ' H ' HD22 ' A' ' 107' ' ' LEU . 45.6 m -143.81 -41.4 0.28 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.858 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 56.24 -8.57 0.01 OUTLIER Glycine 0 CA--C 1.535 1.301 0 CA-C-N 115.95 -0.568 . . . . 0.0 113.077 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.548 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 0.5 OUTLIER -85.03 -52.68 5.79 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 117.898 0.849 . . . . 0.0 109.574 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.529 ' CE2' ' OD1' ' A' ' 112' ' ' ASP . 57.7 t80 -152.44 169.36 22.76 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.324 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.529 ' OD1' ' CE2' ' A' ' 111' ' ' PHE . 18.1 p30 -79.27 49.74 1.0 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.184 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.7 p -160.25 158.04 29.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.084 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.515 ' O ' HD12 ' A' ' 114' ' ' LEU . 0.3 OUTLIER -159.01 138.04 11.24 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -179.292 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.44 ' HB2' HG22 ' A' ' 96' ' ' VAL . . . -69.98 132.69 46.31 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 113.557 -1.656 . . . . 0.0 110.296 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.545 HG22 ' N ' ' A' ' 117' ' ' ARG . 4.9 p -156.61 163.79 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.545 ' N ' HG22 ' A' ' 116' ' ' VAL . 22.6 ptt180 -153.5 160.19 42.46 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.246 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.631 HG22 ' HB3' ' A' ' 62' ' ' ALA . 54.3 t -125.26 139.89 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.023 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 119' ' ' THR . 14.9 t -141.64 130.04 22.44 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.975 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -132.69 90.17 2.74 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.612 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 9.9 t-80 -173.78 -37.91 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.466 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.612 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 38.2 Cg_endo -93.82 -160.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.32 -0.922 0 C-N-CA 121.932 1.755 . . . . 0.0 112.201 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 123' ' ' LEU . 9.7 mp -78.97 -6.51 56.45 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.701 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.2 t -57.16 -45.24 84.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.989 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.738 HG23 ' H ' ' A' ' 126' ' ' ALA . 31.5 m -52.91 -62.02 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.21 -0.995 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.022 178.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.738 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.23 -45.97 3.03 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 122.369 -0.207 . . . . 0.0 110.943 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.4 tp -67.91 -48.64 65.44 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.206 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 72.1 m -69.53 -49.33 55.49 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.21 0.529 . . . . 0.0 111.197 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.485 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.2 pp0? -54.88 -42.03 71.59 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.855 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.76 -56.39 22.8 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.778 -177.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.511 ' CE1' ' OD1' ' A' ' 36' ' ' ASP . 4.8 t80 -63.0 -24.11 67.76 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.895 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.8 2.76 89.7 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 114.187 -1.37 . . . . 0.0 110.311 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.418 ' O ' ' O ' ' A' ' 134' ' ' PRO . 29.9 mttp -150.2 158.32 36.56 Favored Pre-proline 0 CA--C 1.547 0.833 0 CA-C-N 117.157 0.478 . . . . 0.0 110.342 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 133' ' ' LYS . 6.3 Cg_exo -42.36 -179.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 123.84 3.027 . . . . 0.0 113.442 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.0 tp -134.56 122.78 22.85 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 176.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.437 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.9 OUTLIER -64.07 144.87 14.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 117.37 -1.732 . . . . 0.0 107.664 -179.304 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 12.6 t -116.55 126.8 53.83 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.197 0.522 . . . . 0.0 111.481 -179.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.08 162.52 31.51 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.683 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.9 t -72.12 149.14 45.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.044 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.68 78.88 7.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.577 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 56.1 p30 -157.68 165.35 35.69 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.182 0.515 . . . . 0.0 110.328 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.32 -165.82 2.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.174 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.1 p -63.47 -41.25 98.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.043 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -157.4 3.84 0.15 Allowed Glycine 0 N--CA 1.462 0.424 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.476 HD13 ' C ' ' A' ' 145' ' ' LEU . 1.3 tm? -84.0 111.35 32.35 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-O 119.078 -0.487 . . . . 0.0 109.767 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 145' ' ' LEU . 19.5 Cg_exo -34.92 156.52 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.095 1.863 . . . . 0.0 112.745 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.43 171.38 16.31 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.646 2.23 . . . . 0.0 112.229 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 34.7 t -96.09 77.46 3.11 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.664 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.524 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 36.2 ptt180 -53.58 -36.67 62.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.892 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.89 167.24 29.93 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.421 HG11 ' HA ' ' A' ' 166' ' ' PRO . 1.7 m -57.94 -18.62 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.736 0 CA-C-O 121.846 0.831 . . . . 0.0 109.081 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.62 -36.67 84.57 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -59.48 -73.87 0.08 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.244 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.436 HG11 HG11 ' A' ' 164' ' ' VAL . 7.1 p -45.8 -29.47 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.847 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 159' ' ' GLY . 4.8 tmt_? -83.92 -44.48 14.2 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 122.028 0.918 . . . . 0.0 110.08 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.53 -41.64 85.95 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.257 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.469 ' CG ' ' N ' ' A' ' 158' ' ' PHE . 8.3 pt20 -81.63 -48.74 11.35 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 113.018 -1.901 . . . . 0.0 112.487 -177.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.469 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 36.0 t80 -107.04 -35.55 6.85 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -177.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 96.8 24.86 12.44 Favored Glycine 0 N--CA 1.475 1.296 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.426 ' HB1' ' HG2' ' A' ' 163' ' ' PRO . . . -44.06 -95.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.953 -0.124 . . . . 0.0 110.812 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.473 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 62.8 38.01 11.97 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.306 0.575 . . . . 0.0 109.955 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.57 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.4 m-85 -177.97 -61.14 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.377 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.426 ' HG2' ' HB1' ' A' ' 160' ' ' ALA . 93.6 Cg_endo -72.69 22.78 0.29 Allowed 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.156 1.904 . . . . 0.0 110.998 178.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.59 HG23 ' HD3' ' A' ' 166' ' ' PRO . 16.8 m -128.04 167.54 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.636 -177.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.0 t -123.84 65.69 36.48 Favored Pre-proline 0 N--CA 1.476 0.825 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.71 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.59 ' HD3' HG23 ' A' ' 164' ' ' VAL . 22.8 Cg_exo -35.81 141.83 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 123.748 2.965 . . . . 0.0 115.401 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 176.46 -176.26 47.76 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.721 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -150.91 151.49 32.25 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.467 0.378 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 -179.959 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 . . . . . 0 N--CA 1.443 -0.811 0 CA-C-O 121.072 0.463 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 8.5 pt -99.89 130.96 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.733 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -125.32 165.54 18.17 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.327 0.584 . . . . 0.0 111.552 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 184' ' ' GLY . 99.4 m-20 -76.73 105.91 8.08 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.074 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -67.99 -15.01 63.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.364 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.51 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.4 mm? -64.6 -41.1 96.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.469 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 5.5 t -121.4 -26.97 4.9 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.956 0.407 . . . . 0.0 111.042 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 180' ' ' ASP . . . . . . . . 0 CA--C 1.522 0.479 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.691 0.281 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.541 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.5 mp -62.98 -42.77 99.93 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.873 0.368 . . . . 0.0 110.255 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.59 -41.6 96.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.338 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -65.69 -40.7 92.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.23 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -61.46 -47.8 84.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.698 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.79 -46.86 86.03 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.298 0.571 . . . . 0.0 110.569 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.4 -43.88 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.466 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.78 -41.64 82.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.259 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.54 -41.73 97.78 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.917 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.59 -55.24 36.99 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.319 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.4 pt -69.37 -27.49 34.66 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.148 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -60.95 -56.16 24.35 Favored 'General case' 0 C--O 1.216 -0.659 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.106 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 20' ' ' GLU . 94.0 t -64.57 -40.6 89.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 C-N-CA 121.264 -0.174 . . . . 0.0 111.374 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.668 HD13 ' C ' ' A' ' 17' ' ' LEU . 2.0 tm? -56.3 -48.11 77.33 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.354 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -76.51 -49.14 17.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.201 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -69.06 -34.9 75.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.557 -178.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 16' ' ' VAL . 97.2 mt-10 62.5 80.36 0.23 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.22 -139.21 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.844 0.354 . . . . 0.0 110.483 177.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 34' ' ' GLY . 8.2 p -134.58 140.61 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 pp -128.81 162.92 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-O 121.023 0.44 . . . . 0.0 111.064 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.26 129.39 41.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.71 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.514 ' CZ ' ' O ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -122.84 148.65 54.36 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -179.432 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.514 ' O ' ' CZ ' ' A' ' 25' ' ' TYR . 57.6 Cg_endo -78.91 148.66 22.31 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.993 1.795 . . . . 0.0 111.783 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.498 ' C ' ' H ' ' A' ' 29' ' ' ALA . 40.8 m -131.41 133.85 45.65 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.469 ' OE2' ' NH1' ' A' ' 117' ' ' ARG . 22.3 pt-20 -74.7 23.12 0.09 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.826 0.346 . . . . 0.0 110.425 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.498 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -155.19 -73.44 0.11 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.2 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 p -128.28 129.85 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.342 0.592 . . . . 0.0 110.751 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.507 ' CD2' ' O ' ' A' ' 148' ' ' CYS . 46.8 p90 -37.73 144.88 0.08 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.798 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -155.61 -173.41 24.24 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.5 m -132.27 168.06 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.486 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -156.96 -178.94 31.52 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.553 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.454 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.8 OUTLIER -159.24 -165.21 1.54 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.025 0.441 . . . . 0.0 111.328 -178.914 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.454 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 85.0 m-20 -91.61 108.02 26.34 Favored Pre-proline 0 CA--C 1.555 1.155 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -43.64 -61.18 0.6 Allowed 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.916 1.744 . . . . 0.0 112.262 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -71.94 67.01 0.6 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.058 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.1 m -155.71 133.99 11.57 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.88 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -65.73 -34.32 77.92 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.341 0.591 . . . . 0.0 110.688 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.496 HG23 ' N ' ' A' ' 42' ' ' ALA . 15.0 t -60.76 -41.19 94.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.171 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.496 ' N ' HG23 ' A' ' 41' ' ' THR . . . -56.64 -51.64 67.94 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.608 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.65 -42.14 95.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.285 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 92.2 mtp -63.77 -40.24 96.21 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.9 ttt85 -59.95 -42.54 94.28 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 121.967 0.889 . . . . 0.0 108.611 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.459 ' O ' HD23 ' A' ' 46' ' ' LEU . 1.0 OUTLIER -63.99 -53.13 54.96 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.73 -178.588 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.8 mt -70.77 -11.62 61.06 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.2 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -70.21 -82.6 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 121.152 0.501 . . . . 0.0 111.342 -177.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.504 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -75.97 -35.26 59.7 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -76.95 -50.28 13.57 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.966 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 35.32 65.34 0.39 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.919 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.416 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 1.6 mtt85 179.02 -53.48 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.778 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.27 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.416 ' HD2' ' H ' ' A' ' 52' ' ' ARG . 84.6 Cg_endo -79.91 -3.31 12.7 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.709 2.273 . . . . 0.0 112.388 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.54 HG13 ' N ' ' A' ' 55' ' ' ASP . 7.9 p -44.03 -43.87 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.47 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.54 ' N ' HG13 ' A' ' 54' ' ' VAL . 37.4 t0 -66.45 -41.73 88.66 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.041 0.448 . . . . 0.0 110.246 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.416 ' CD ' ' N ' ' A' ' 56' ' ' LYS . 1.1 mptm? -60.29 -39.64 87.64 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 62.29 107.71 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.561 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -53.14 -163.2 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.229 0.538 . . . . 0.0 111.591 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.533 HG23 HG21 ' A' ' 94' ' ' THR . 78.5 mt -101.01 144.32 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.538 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.4 mt -121.7 143.14 49.52 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.407 ' CD1' ' HE ' ' A' ' 117' ' ' ARG . 8.5 tp -113.86 128.67 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-O 121.244 0.545 . . . . 0.0 110.958 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.438 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -114.23 156.55 24.11 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.951 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.15 -26.37 5.94 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -118.42 142.64 47.35 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.086 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -69.81 -12.68 61.81 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.64 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -50.75 -31.58 17.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.927 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.76 -13.59 24.01 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.518 HD22 ' N ' ' A' ' 68' ' ' LEU . 4.0 mm? -92.16 -13.8 30.08 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.471 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 76.8 tttt -80.56 -38.16 1.05 Allowed Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 86.1 Cg_endo -102.38 -3.85 0.33 Allowed 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 122.696 2.264 . . . . 0.0 111.39 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.546 ' OH ' HD21 ' A' ' 114' ' ' LEU . 44.9 t80 -92.84 -14.86 27.17 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.687 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.543 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.2 mp -122.62 159.9 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.543 ' N ' HG22 ' A' ' 72' ' ' ILE . 27.7 p30 -65.86 144.37 56.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.374 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -87.19 7.2 29.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.548 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.553 HG23 ' N ' ' A' ' 76' ' ' MET . 15.0 t -78.11 -45.52 23.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.246 0.546 . . . . 0.0 110.854 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.553 ' N ' HG23 ' A' ' 75' ' ' THR . 25.0 ptm -84.92 -19.33 32.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.666 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.402 ' HG ' ' HE ' ' A' ' 82' ' ' ARG . 6.4 tp -81.78 130.07 34.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.027 -178.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.84 167.26 30.51 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.681 -177.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -48.51 -44.5 36.09 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.725 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.71 -31.76 51.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.994 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -64.52 -40.67 96.06 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.399 0.619 . . . . 0.0 110.533 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.421 ' HG2' ' H ' ' A' ' 82' ' ' ARG . 12.3 mmt85 -66.58 -51.99 50.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.477 1.132 . . . . 0.0 109.462 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 87' ' ' SER . 83.1 tt0 -55.86 -50.66 69.99 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 113.852 -1.522 . . . . 0.0 110.421 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.7 m -61.16 -49.95 75.17 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.013 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.5 tt -67.53 -29.74 46.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.853 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -79.49 -35.31 40.39 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.621 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 83' ' ' GLU . 10.9 m -89.85 -15.35 32.42 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.425 ' O ' ' O ' ' A' ' 89' ' ' TRP . 69.4 ttt180 -115.98 74.67 0.91 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.863 0.363 . . . . 0.0 110.714 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.425 ' O ' ' O ' ' A' ' 88' ' ' ARG . 1.5 m0 59.25 150.32 0.08 OUTLIER Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.668 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.57 -15.55 45.15 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.739 1.626 . . . . 0.0 110.636 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.493 ' H ' ' HD3' ' A' ' 92' ' ' PRO . . . 104.95 69.35 0.76 Allowed Glycine 0 N--CA 1.471 1.031 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.088 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.493 ' HD3' ' H ' ' A' ' 91' ' ' GLY . 48.7 Cg_exo -55.94 -38.95 93.92 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.556 2.171 . . . . 0.0 112.222 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.3 p -75.64 147.47 8.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.209 0.528 . . . . 0.0 111.104 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.533 HG21 HG23 ' A' ' 59' ' ' ILE . 19.3 m -102.45 126.25 49.42 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.981 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.573 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 43.8 m-85 -116.12 143.04 46.01 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.271 -178.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.733 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 84.2 t -84.08 98.96 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-O 121.123 0.487 . . . . 0.0 111.323 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -83.65 139.36 40.83 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.804 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.36 104.92 1.81 Allowed 'Trans proline' 0 N--CA 1.489 1.21 0 C-N-CA 121.566 1.51 . . . . 0.0 110.901 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 112' ' ' ASP . . . -61.9 149.56 85.3 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.8 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -73.08 165.82 31.7 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.427 2.085 . . . . 0.0 112.098 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.737 179.626 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.536 ' O ' ' N ' ' A' ' 109' ' ' GLY . 5.3 tpp85 . . . . . 0 CA--C 1.531 0.233 0 CA-C-O 120.932 0.396 . . . . 0.0 110.132 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -78.07 -10.86 59.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 122.05 0.929 . . . . 0.0 109.401 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.672 ' H ' ' CD2' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -82.39 -16.27 49.71 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.017 -1.447 . . . . 0.0 111.064 -179.567 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.428 ' O ' ' O ' ' A' ' 54' ' ' VAL . 99.0 m -140.69 -42.06 0.4 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.942 0.401 . . . . 0.0 109.972 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 77.94 19.81 74.46 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.301 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.19 -75.78 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 117.614 0.707 . . . . 0.0 110.478 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -111.18 162.4 14.98 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.29 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' A' ' 99' ' ' ALA . 90.4 m-20 -95.2 60.39 2.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.088 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.6 p -158.13 145.04 17.8 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.546 HD21 ' OH ' ' A' ' 71' ' ' TYR . 3.7 pp -166.98 145.71 5.14 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.441 ' HB1' HG22 ' A' ' 94' ' ' THR . . . -65.55 127.38 31.64 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 113.728 -1.578 . . . . 0.0 109.398 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.464 HG22 ' N ' ' A' ' 117' ' ' ARG . 3.9 p -145.35 161.23 12.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.469 ' NH1' ' OE2' ' A' ' 28' ' ' GLU . 61.7 ttp180 -148.23 155.32 41.22 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.205 0.526 . . . . 0.0 111.811 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.438 HG22 ' HB3' ' A' ' 62' ' ' ALA . 55.7 t -119.97 135.69 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.1 t -135.51 150.31 49.73 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.925 0.393 . . . . 0.0 110.1 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 34.4 p30 -154.01 81.9 1.14 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.223 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.674 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 6.8 t60 -171.75 -35.93 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.674 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 73.3 Cg_endo -96.77 -160.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.927 0 C-N-CA 122.077 1.851 . . . . 0.0 112.114 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.4 mt -77.35 -5.14 48.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.669 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 77.8 t -58.12 -45.81 88.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.084 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.766 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.7 m -54.26 -62.73 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.21 -0.986 0 C-N-CA 119.402 -0.919 . . . . 0.0 108.696 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.766 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.35 -44.66 2.83 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.708 0.29 . . . . 0.0 111.12 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.34 -47.89 63.05 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.27 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 70.9 m -70.46 -48.99 53.23 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.204 0.526 . . . . 0.0 111.08 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.469 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -53.93 -42.78 69.19 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.437 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -59.69 -53.38 58.66 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.589 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -63.83 -24.64 67.83 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.166 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.11 1.69 90.4 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 134' ' ' PRO . 34.8 mttm -153.33 157.8 32.82 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 120.574 -0.451 . . . . 0.0 110.122 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.4 ' O ' ' O ' ' A' ' 133' ' ' LYS . 5.2 Cg_exo -41.41 175.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 123.926 3.084 . . . . 0.0 113.581 -178.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.5 tp -129.38 122.73 30.04 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 176.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.428 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -66.19 143.33 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.955 0 C-N-CA 118.108 -1.437 . . . . 0.0 107.404 -179.52 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.8 t -114.88 122.09 45.22 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 123.792 0.682 . . . . 0.0 110.597 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.9 m -130.01 162.98 27.49 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.881 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.0 m -72.25 145.45 47.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.382 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.81 81.6 1.16 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.019 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 57.7 p30 -160.47 161.42 32.87 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.616 0.722 . . . . 0.0 111.031 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.49 -167.12 1.88 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.318 -178.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.6 t -61.03 -43.24 99.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.44 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -158.32 4.71 0.13 Allowed Glycine 0 C--N 1.33 0.227 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.2 tt -83.44 127.92 66.4 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -39.74 158.21 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.549 1.499 . . . . 0.0 112.207 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -77.04 -163.22 0.2 Allowed 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.733 2.288 . . . . 0.0 111.889 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.507 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 19.5 t -126.38 78.23 1.76 Allowed 'General case' 0 C--N 1.34 0.155 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -49.8 -39.51 38.57 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.676 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.16 169.81 23.69 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.445 ' H ' HG22 ' A' ' 151' ' ' VAL . 1.5 m -58.04 -20.87 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 CA-C-O 121.786 0.803 . . . . 0.0 108.984 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -64.53 -33.34 75.67 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 155' ' ' ARG . 0.4 OUTLIER -62.26 -79.37 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.401 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.425 HG13 ' N ' ' A' ' 155' ' ' ARG . 6.8 p -34.91 -33.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.983 0.913 . . . . 0.0 111.109 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.493 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -68.61 -53.27 23.66 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.533 -179.265 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -68.76 -18.61 64.24 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 122.571 1.177 . . . . 0.0 108.068 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -82.61 -45.56 14.41 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 112.517 -2.128 . . . . 0.0 111.559 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -130.17 -29.76 2.02 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 96.48 23.75 15.64 Favored Glycine 0 N--CA 1.469 0.894 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -178.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 159' ' ' GLY . . . -43.12 -97.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.533 -0.333 . . . . 0.0 111.17 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.518 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.95 34.81 16.56 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -178.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.524 ' C ' ' H ' ' A' ' 164' ' ' VAL . 2.2 m-85 -172.67 -62.64 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.136 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -72.99 27.07 0.29 Allowed 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.258 1.972 . . . . 0.0 110.758 177.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.557 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.4 m -129.64 167.48 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.426 -178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 16.4 t -124.37 65.86 42.3 Favored Pre-proline 0 N--CA 1.471 0.601 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.637 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.557 ' HD3' HG23 ' A' ' 164' ' ' VAL . 29.4 Cg_exo -37.15 140.04 0.21 Allowed 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 123.413 2.742 . . . . 0.0 115.189 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 162.45 170.78 27.74 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 113.929 -1.487 . . . . 0.0 110.883 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -157.99 147.19 19.55 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.665 0.269 . . . . 0.0 110.427 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.469 0.494 0 CA-C-O 120.892 0.377 . . . . 0.0 110.529 179.645 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 94' ' ' THR . 98.0 mt-10 . . . . . 0 N--CA 1.45 -0.46 0 CA-C-O 120.717 0.294 . . . . 0.0 111.602 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.474 ' O ' HG23 ' A' ' 178' ' ' ILE . 18.4 tt -90.33 122.85 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.117 0.484 . . . . 0.0 111.834 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -134.74 170.69 15.45 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.252 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -87.01 107.2 18.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.242 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.733 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -69.21 -11.9 61.2 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.907 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.492 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.8 mm? -64.28 -42.62 96.34 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.45 -41.81 4.26 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.619 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.716 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -179.874 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.767 0.318 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.555 HD12 ' N ' ' A' ' 5' ' ' LEU . 9.2 mp -63.18 -42.51 99.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.155 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -64.5 -40.52 95.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.024 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.1 tpt180 -63.22 -41.65 99.14 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.35 -43.93 98.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.462 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.56 -46.49 90.01 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.993 0.425 . . . . 0.0 110.024 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.34 -43.6 98.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.636 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.07 -41.38 78.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.131 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.67 -44.07 94.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.245 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.86 -53.09 62.02 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.915 0.388 . . . . 0.0 111.561 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.8 pt -68.89 -39.36 79.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.232 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -57.92 -53.66 55.75 Favored 'General case' 0 C--O 1.215 -0.719 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.22 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.428 HG13 ' H ' ' A' ' 21' ' ' ARG . 86.5 t -61.07 -40.05 84.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.233 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.685 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.2 tt -51.89 -50.59 60.74 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.441 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -81.56 -49.26 10.76 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.253 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -66.0 -31.6 72.59 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.08 -178.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 16' ' ' VAL . 97.0 mt-10 57.14 83.91 0.1 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.075 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.428 ' H ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -164.8 -159.14 0.44 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.86 178.586 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.8 p -119.02 137.26 53.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.442 HD12 ' O ' ' A' ' 24' ' ' ALA . 2.8 pp -126.14 166.92 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 120.799 0.333 . . . . 0.0 111.327 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.442 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -63.23 137.39 58.19 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.25 0.548 . . . . 0.0 111.342 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.537 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 2.2 t80 -130.77 139.13 34.67 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.537 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 96.5 Cg_endo -76.88 144.47 24.34 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.488 1.459 . . . . 0.0 111.96 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.2 m -140.37 138.13 34.58 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.943 0.401 . . . . 0.0 110.363 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -56.73 -45.77 81.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.736 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.48 -79.28 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.806 0.336 . . . . 0.0 111.349 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 90.6 t -135.56 129.96 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -37.85 140.39 0.26 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.183 0.516 . . . . 0.0 111.546 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -137.74 -168.25 11.28 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.0 m -128.19 171.92 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -162.48 -177.53 35.59 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.221 -0.99 . . . . 0.0 111.719 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.539 ' SG ' ' HB2' ' A' ' 42' ' ' ALA . 0.8 OUTLIER -160.92 -161.42 0.83 Allowed 'General case' 0 C--N 1.342 0.259 0 C-N-CA 120.259 -0.577 . . . . 0.0 112.169 -179.227 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.504 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 69.2 m-20 -92.13 107.3 22.07 Favored Pre-proline 0 CA--C 1.557 1.241 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -45.46 -55.75 3.29 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 122.038 1.825 . . . . 0.0 111.71 177.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -50.81 -33.4 23.4 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.026 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.3 m -76.5 118.89 19.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.326 0.584 . . . . 0.0 110.659 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.535 ' O ' HG12 ' A' ' 43' ' ' VAL . 16.3 pt-20 -65.02 -32.19 73.79 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.87 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.5 t -43.48 -28.04 0.33 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.796 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.539 ' HB2' ' SG ' ' A' ' 35' ' ' CYS . . . -64.3 -51.6 62.67 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.27 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 40' ' ' GLU . 3.0 p -64.5 -39.34 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.171 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 92.6 mtp -66.11 -39.24 89.77 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.6 ttt85 -63.01 -33.27 75.07 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.86 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 87.2 mt -74.4 -59.04 2.91 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.3 mt -53.72 -19.54 4.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.334 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -66.66 -84.95 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.572 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.504 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.2 pt? -77.48 -34.75 54.2 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -74.94 -50.05 18.09 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.826 -176.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 37.25 62.01 0.88 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.665 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.9 ttm-85 -179.04 -61.91 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.895 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.215 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -63.36 -11.75 27.18 Favored 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 122.872 2.381 . . . . 0.0 112.422 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.589 HG13 ' N ' ' A' ' 55' ' ' ASP . 9.7 p -41.76 -48.61 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.831 -0.347 . . . . 0.0 111.143 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.589 ' N ' HG13 ' A' ' 54' ' ' VAL . 65.6 t0 -66.73 -39.74 88.09 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.88 0.371 . . . . 0.0 111.051 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -60.82 -39.91 90.76 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 64.73 108.3 0.01 OUTLIER Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.567 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -53.63 -159.16 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.319 0.581 . . . . 0.0 112.095 -179.603 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.446 HG23 HG21 ' A' ' 94' ' ' THR . 67.6 mt -103.94 144.07 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.896 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 20.4 mt -121.98 142.4 50.35 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.9 tp -112.45 134.59 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-O 121.368 0.604 . . . . 0.0 110.88 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.467 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -122.61 150.92 41.99 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.99 -27.27 8.49 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -116.48 151.0 36.97 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.796 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -79.68 -13.55 59.39 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -51.94 -31.44 28.81 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.482 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.13 -12.64 28.0 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.499 HD22 ' N ' ' A' ' 68' ' ' LEU . 4.1 mm? -92.63 -16.62 25.37 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 118.793 0.724 . . . . 0.0 109.276 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.474 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 44.5 tttp -77.5 -38.88 1.9 Allowed Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.774 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 67.6 Cg_endo -103.99 -2.89 0.24 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 122.91 2.407 . . . . 0.0 112.38 -178.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -95.84 -9.34 31.78 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.033 -178.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.553 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.2 mp -125.64 161.96 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.553 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -58.5 177.24 0.14 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.856 0.36 . . . . 0.0 110.232 -179.326 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -105.38 15.47 27.18 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.484 ' OG1' ' N ' ' A' ' 76' ' ' MET . 32.3 p -80.88 -64.53 1.17 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.095 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.484 ' N ' ' OG1' ' A' ' 75' ' ' THR . 26.4 ptm -70.23 -5.09 25.09 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.184 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.2 tp -83.93 100.92 11.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.32 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -155.15 160.28 40.8 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.78 -177.572 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -39.37 -48.51 1.91 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.813 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.1 p -61.86 -34.0 60.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.661 -0.415 . . . . 0.0 111.279 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 78' ' ' THR . 64.8 tp60 -65.57 -41.56 92.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.916 0.389 . . . . 0.0 110.715 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.417 ' HG2' ' H ' ' A' ' 82' ' ' ARG . 8.8 mmt85 -63.63 -51.98 62.85 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 122.589 1.185 . . . . 0.0 109.136 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -55.08 -50.3 69.5 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.776 -1.556 . . . . 0.0 110.018 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -60.52 -49.95 75.5 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.939 -178.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.0 tt -67.73 -37.19 78.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.097 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -70.37 -43.09 70.87 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.488 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.4 m -75.23 -37.73 60.93 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.195 0.521 . . . . 0.0 110.561 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -76.15 150.58 37.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -36.29 153.96 0.08 OUTLIER Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.888 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 118' ' ' VAL . 41.5 Cg_endo -64.28 -24.25 65.3 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.048 1.832 . . . . 0.0 111.439 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.492 ' O ' ' NH2' ' A' ' 117' ' ' ARG . . . 176.51 79.27 0.05 OUTLIER Glycine 0 CA--C 1.531 1.037 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.09 -44.35 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.058 1.839 . . . . 0.0 111.941 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.505 HG13 ' CE2' ' A' ' 95' ' ' PHE . 3.0 p -137.26 145.82 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.196 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.446 HG21 HG23 ' A' ' 59' ' ' ILE . 17.9 m -83.8 130.27 34.94 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.214 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.505 ' CE2' HG13 ' A' ' 93' ' ' VAL . 34.0 m-85 -117.85 140.03 50.28 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.512 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.628 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 4.4 t -90.28 101.37 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 121.477 0.656 . . . . 0.0 110.023 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -90.23 152.32 45.7 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.377 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.42 113.04 3.69 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.199 1.933 . . . . 0.0 111.189 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.14 150.95 75.22 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.26 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -72.27 156.04 55.45 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.075 1.85 . . . . 0.0 112.159 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.384 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.016 -179.981 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 109' ' ' GLY . 7.4 tpt180 . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 120.667 0.27 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 66.8 p-90 -75.8 -7.34 54.21 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.957 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.977 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -70.91 -30.14 66.39 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.702 ' H ' HD22 ' A' ' 107' ' ' LEU . 89.9 m -140.38 -38.46 0.45 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.705 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 86.04 -11.38 62.8 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.608 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -142.13 -72.3 0.32 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.56 0.68 . . . . 0.0 110.788 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.443 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 21.4 t80 -91.32 -167.38 1.79 Allowed 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.443 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 94.9 m-20 -130.53 57.6 1.72 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.653 0.263 . . . . 0.0 110.693 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.7 p -156.51 156.92 34.53 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.187 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.446 ' O ' HD12 ' A' ' 114' ' ' LEU . 3.1 pp -168.96 138.88 2.25 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.446 ' HB2' HG22 ' A' ' 96' ' ' VAL . . . -70.32 131.56 44.33 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 113.787 -1.551 . . . . 0.0 109.932 177.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.8 p -147.06 155.35 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 120.727 0.299 . . . . 0.0 110.364 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.492 ' NH2' ' O ' ' A' ' 91' ' ' GLY . 79.3 ttt180 -146.1 153.27 40.52 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.847 -179.081 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.467 HG22 ' HB3' ' A' ' 62' ' ' ALA . 49.6 t -120.5 136.24 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.9 t -139.74 142.13 36.82 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.025 0.441 . . . . 0.0 110.629 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 51.0 p-10 -145.82 81.82 1.61 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.686 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.639 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 7.3 t60 -171.49 -36.29 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.639 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 43.0 Cg_endo -94.72 -161.14 0.07 OUTLIER 'Trans proline' 0 N--CA 1.483 0.907 0 C-N-CA 122.044 1.829 . . . . 0.0 111.955 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.3 mt -78.01 -6.17 53.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.392 0.615 . . . . 0.0 110.013 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 98.8 t -58.08 -45.29 88.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.072 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.772 HG23 ' H ' ' A' ' 126' ' ' ALA . 28.7 m -53.2 -62.15 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.906 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.019 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.772 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.68 -44.01 3.02 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 120.938 0.399 . . . . 0.0 110.723 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.3 tp -68.93 -48.26 63.68 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.235 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 60.7 m -70.28 -49.29 51.26 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.387 0.613 . . . . 0.0 110.907 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.466 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.1 pp0? -54.55 -41.95 70.36 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.341 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.64 -55.07 39.83 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.257 -178.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -62.46 -21.9 65.81 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.919 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.73 1.27 89.19 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -152.27 160.56 31.18 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 120.506 -0.477 . . . . 0.0 110.357 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -45.04 164.3 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 123.943 3.095 . . . . 0.0 112.54 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.4 tp -119.36 122.93 42.93 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.43 HG13 ' H ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -63.54 144.69 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 C-N-CA 117.913 -1.515 . . . . 0.0 106.945 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.1 t -116.82 125.1 51.06 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 123.583 0.552 . . . . 0.0 111.283 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.3 m -134.54 158.39 44.08 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.781 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.6 m -71.31 142.56 50.45 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.168 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.72 85.39 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.558 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -160.63 165.44 30.65 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.438 0.637 . . . . 0.0 111.079 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.93 -164.65 2.01 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.315 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 42.5 t -61.37 -43.08 99.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.022 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -157.25 3.91 0.16 Allowed Glycine 0 N--CA 1.461 0.355 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.457 HD13 ' C ' ' A' ' 145' ' ' LEU . 1.3 tm? -81.18 112.28 31.57 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 145' ' ' LEU . 20.1 Cg_exo -35.46 156.84 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.104 1.869 . . . . 0.0 112.542 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.7 -174.21 1.23 Allowed 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.4 2.067 . . . . 0.0 112.57 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 17.6 m -114.44 82.89 1.79 Allowed 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.378 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -59.07 -35.58 73.6 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.637 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.82 169.41 21.38 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.434 ' H ' HG22 ' A' ' 151' ' ' VAL . 0.9 OUTLIER -57.02 -23.19 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 CA-C-O 121.437 0.637 . . . . 0.0 109.378 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -62.71 -32.41 73.51 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 155' ' ' ARG . 6.4 tm-20 -63.09 -80.45 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.568 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.3 p -36.37 -27.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.167 0.987 . . . . 0.0 111.044 177.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.471 ' N ' ' O ' ' A' ' 153' ' ' GLU . 4.3 tmt_? -74.4 -50.73 17.34 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.855 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.7 -17.75 62.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 122.631 1.205 . . . . 0.0 107.781 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -83.32 -57.04 3.42 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 112.553 -2.112 . . . . 0.0 111.987 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -119.99 -20.6 7.42 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 160' ' ' ALA . . . 84.72 27.63 34.5 Favored Glycine 0 N--CA 1.466 0.642 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.474 ' O ' ' HB3' ' A' ' 161' ' ' ALA . . . -42.21 -98.37 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.58 -0.31 . . . . 0.0 111.36 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.516 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 67.79 34.44 4.35 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.299 0.571 . . . . 0.0 109.578 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.519 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.6 m-85 -176.36 -61.89 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.235 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -73.44 31.45 0.31 Allowed 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.044 1.829 . . . . 0.0 110.439 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.563 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.4 m -134.67 168.22 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.834 -178.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 8.3 t -125.15 64.82 46.6 Favored Pre-proline 0 N--CA 1.475 0.79 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.855 178.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.563 ' HD3' HG23 ' A' ' 164' ' ' VAL . 55.4 Cg_exo -40.13 151.0 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 123.706 2.938 . . . . 0.0 114.97 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 162.68 -174.93 39.1 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.983 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -141.68 145.12 34.53 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.465 0.308 0 CA-C-O 121.036 0.446 . . . . 0.0 110.809 -179.717 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 . . . . . 0 N--CA 1.449 -0.482 0 CA-C-O 120.584 0.23 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.424 ' O ' HG23 ' A' ' 178' ' ' ILE . 17.2 tt -109.68 129.87 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 120.795 0.331 . . . . 0.0 110.539 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -132.63 166.34 22.35 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.711 0.767 . . . . 0.0 112.018 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -80.36 106.87 12.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.502 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -64.47 -20.05 65.95 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.216 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.449 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.5 mm? -63.02 -42.64 99.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.933 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.85 -45.28 2.88 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.836 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.673 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.735 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 41.5 t30 . . . . . 0 C--O 1.235 0.309 0 CA-C-O 120.92 0.39 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.55 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.0 mp -61.95 -43.08 99.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.22 0.533 . . . . 0.0 109.608 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -67.96 -35.35 78.23 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.127 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -60.71 -43.61 97.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.543 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 9' ' ' ALA . 1.5 p30 -70.97 -39.22 72.67 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.166 -0.613 . . . . 0.0 110.469 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.523 ' N ' ' OD1' ' A' ' 8' ' ' ASP . . . -62.12 -48.3 80.77 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.269 0.557 . . . . 0.0 110.122 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.0 -43.59 99.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.912 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.56 -45.31 77.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.635 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.07 -46.68 88.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.924 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.94 -52.1 66.87 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 14.3 pt -69.37 -39.67 79.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.518 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -58.75 -53.47 57.99 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.123 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' A' ' 20' ' ' GLU . 89.6 t -60.76 -40.42 84.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.508 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.684 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.4 tt -51.67 -50.59 60.12 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.77 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -80.77 -50.99 9.14 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.056 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -63.7 -32.75 74.34 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.049 -178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.9 mt-10 58.49 85.35 0.09 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.385 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.57 -141.06 0.07 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.319 178.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.405 HG11 HH21 ' A' ' 45' ' ' ARG . 4.8 p -137.55 139.58 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.448 HD12 ' O ' ' A' ' 24' ' ' ALA . 2.8 pp -129.85 165.9 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-O 120.945 0.402 . . . . 0.0 111.41 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.448 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -61.63 136.97 58.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.301 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.51 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -134.54 142.23 41.92 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.51 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 62.6 Cg_endo -77.25 151.09 29.64 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.771 1.647 . . . . 0.0 111.82 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.492 ' C ' ' H ' ' A' ' 29' ' ' ALA . 45.7 m -132.13 136.49 47.16 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.844 0.354 . . . . 0.0 110.87 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -74.98 23.83 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.357 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.492 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -157.27 -73.44 0.09 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.313 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.8 p -127.52 126.95 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.316 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.511 ' CD1' ' O ' ' A' ' 148' ' ' CYS . 35.4 p90 -40.24 147.83 0.09 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.323 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -156.34 -169.45 20.46 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.3 m -133.21 170.87 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.406 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -158.58 -175.48 29.56 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.012 -1.089 . . . . 0.0 112.102 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.521 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -158.44 -164.13 1.41 Allowed 'General case' 0 C--O 1.227 -0.103 0 CA-C-O 120.568 0.223 . . . . 0.0 110.81 -179.312 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.521 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 90.5 m-20 -98.72 109.69 54.29 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -178.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 36' ' ' ASP . 22.4 Cg_exo -36.73 170.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.854 2.369 . . . . 0.0 114.325 177.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 41.98 71.94 0.19 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.074 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.5 m -148.81 138.86 22.23 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.373 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -69.87 -34.79 74.06 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.462 0.648 . . . . 0.0 110.54 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.449 HG22 ' H ' ' A' ' 41' ' ' THR . 0.1 OUTLIER -62.98 -43.0 99.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.667 -179.071 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.71 -51.34 70.18 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.726 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 p -63.62 -42.6 96.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 90.4 mtp -64.24 -39.71 94.52 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.451 ' O ' ' CD2' ' A' ' 49' ' ' LEU . 45.8 ttt-85 -62.15 -33.8 75.18 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.067 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 89.4 mt -75.09 -59.93 2.52 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.2 mt -54.18 -18.42 3.8 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.361 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -67.35 -85.67 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.741 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.503 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -75.72 -32.76 60.17 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.906 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -78.18 -70.44 0.49 Allowed 'General case' 0 C--N 1.349 0.571 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.489 -177.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 52.84 81.05 0.09 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.0 mtm180 161.72 -63.14 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.86 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.1 -11.68 32.79 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.819 2.346 . . . . 0.0 112.255 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.565 HG13 ' N ' ' A' ' 55' ' ' ASP . 6.9 p -41.83 -49.9 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.815 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.565 ' N ' HG13 ' A' ' 54' ' ' VAL . 65.7 t0 -66.74 -40.13 88.22 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.018 0.437 . . . . 0.0 111.146 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -61.36 -39.97 92.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.692 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 66.39 112.49 0.01 OUTLIER Glycine 0 CA--C 1.519 0.295 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.555 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -52.99 -162.37 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.325 0.583 . . . . 0.0 112.298 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 70.9 mt -105.02 145.23 13.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.825 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.6 mt -121.15 142.66 49.67 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.449 HD13 ' HE ' ' A' ' 117' ' ' ARG . 9.4 tp -110.78 127.8 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-O 121.076 0.465 . . . . 0.0 110.708 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -117.64 148.15 42.22 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -106.4 -27.68 10.81 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 116.297 -0.411 . . . . 0.0 109.915 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -115.79 150.32 37.11 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.735 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -79.98 -14.42 58.6 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -52.91 -30.82 36.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.585 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.04 -12.22 29.05 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.531 HD22 ' N ' ' A' ' 68' ' ' LEU . 3.8 mm? -91.4 -20.81 21.4 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.513 -0.742 . . . . 0.0 109.591 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.462 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 49.1 tttm -76.03 -37.45 2.17 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 68.7 Cg_endo -103.39 -3.48 0.26 Allowed 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 122.548 2.166 . . . . 0.0 112.007 -178.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.446 ' OH ' ' CD1' ' A' ' 114' ' ' LEU . 53.9 t80 -98.25 -4.1 35.98 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.037 0.446 . . . . 0.0 111.07 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.618 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.6 mp -132.91 166.54 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.618 ' N ' HG22 ' A' ' 72' ' ' ILE . 98.7 m-20 -58.0 -9.66 1.47 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.475 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 58.2 t0 58.54 30.4 19.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.9 t -95.23 -36.79 11.3 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.091 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -83.07 -18.83 38.25 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.86 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 36.0 tp -86.03 125.35 33.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.148 0.499 . . . . 0.0 110.287 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -161.56 161.74 29.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.156 -177.075 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -39.49 -48.41 2.0 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.849 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.13 -32.96 58.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.976 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.454 ' N ' ' O ' ' A' ' 78' ' ' THR . 63.2 tp60 -65.14 -40.57 94.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.585 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.2 mmt85 -64.79 -53.05 53.07 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 122.164 0.983 . . . . 0.0 109.252 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -53.98 -51.02 65.24 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.011 -1.45 . . . . 0.0 110.39 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.5 m -61.05 -50.34 73.7 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.853 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 89' ' ' TRP . 8.6 tt -68.02 -33.75 62.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.728 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -73.82 -38.89 64.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.168 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.7 m -83.41 -34.55 25.48 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.8 0.333 . . . . 0.0 111.416 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 63.9 ttm-85 -81.14 -75.26 0.29 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.504 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.436 ' O ' ' O ' ' A' ' 85' ' ' ILE . 2.2 m0 -162.02 152.85 14.83 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -65.31 -22.51 60.21 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.296 1.997 . . . . 0.0 112.198 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 161.44 78.02 0.03 OUTLIER Glycine 0 CA--C 1.531 1.077 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.514 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.53 -23.59 11.23 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 121.946 1.764 . . . . 0.0 112.404 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.42 HG13 ' CE2' ' A' ' 95' ' ' PHE . 3.2 p -136.15 147.22 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.216 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 26.9 m -89.89 138.47 31.46 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.257 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.485 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 42.0 m-85 -124.46 139.94 53.42 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.999 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.677 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.6 t -97.76 109.72 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 CA-C-O 121.433 0.635 . . . . 0.0 111.084 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -92.08 147.64 35.16 Favored Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.421 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.51 98.1 1.09 Allowed 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.847 1.698 . . . . 0.0 110.985 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -46.87 148.04 2.01 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -63.36 -28.71 71.82 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.261 1.974 . . . . 0.0 112.561 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.236 0 CA-C-O 120.71 0.29 . . . . 0.0 110.617 -179.529 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 109' ' ' GLY . 8.0 tpt180 . . . . . 0 CA--C 1.53 0.18 0 CA-C-O 120.835 0.35 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -73.37 -6.96 49.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.669 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.968 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -77.71 -21.28 52.2 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.059 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.625 ' H ' HD22 ' A' ' 107' ' ' LEU . 93.1 m -142.79 -40.34 0.33 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.141 0.495 . . . . 0.0 109.981 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 91.44 -15.44 61.33 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.642 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.422 ' O ' ' NH2' ' A' ' 105' ' ' ARG . 17.3 tpt180 -145.23 -76.95 0.21 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 117.578 0.689 . . . . 0.0 111.488 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.449 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 22.0 t80 -87.1 -167.33 1.85 Allowed 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.449 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 52.8 p-10 -136.03 73.15 1.45 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.103 0.477 . . . . 0.0 111.302 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.7 p -159.68 129.49 5.45 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.446 ' CD1' ' OH ' ' A' ' 71' ' ' TYR . 34.4 mt -127.72 121.62 30.79 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -177.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.447 ' N ' HG13 ' A' ' 96' ' ' VAL . . . -70.84 126.56 29.93 Favored 'General case' 0 C--N 1.345 0.397 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 175.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.425 HG22 ' N ' ' A' ' 117' ' ' ARG . 14.8 p -143.88 152.84 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.198 0.523 . . . . 0.0 111.1 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.449 ' HE ' HD13 ' A' ' 61' ' ' ILE . 62.5 ttp180 -139.82 154.3 47.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.116 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.7 t -123.86 132.8 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.3 t -132.21 149.91 52.28 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.985 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 33.8 p30 -152.75 80.7 1.22 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.07 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.681 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 49.3 t-80 -171.79 -35.31 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.681 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 56.5 Cg_endo -94.99 -161.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.98 1.787 . . . . 0.0 111.834 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 11.3 mt -78.16 -4.79 49.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.978 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 82.4 t -58.24 -45.76 88.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.968 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.753 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.8 m -53.71 -62.31 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.941 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.044 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.753 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.67 -43.27 2.77 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.968 0.413 . . . . 0.0 110.842 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.7 tp -69.93 -47.66 61.53 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.414 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 62.7 m -70.48 -49.22 50.74 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.539 0.685 . . . . 0.0 110.531 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 125' ' ' VAL . 1.1 pp0? -54.41 -42.24 70.24 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.88 -54.57 45.64 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.455 -178.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -62.41 -23.25 66.74 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.001 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.51 0.58 90.06 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 134' ' ' PRO . 33.1 mttm -153.67 159.18 32.39 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 133' ' ' LYS . 6.3 Cg_exo -41.35 179.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 123.886 3.057 . . . . 0.0 113.239 -178.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 35' ' ' CYS . 8.0 tp -133.44 123.26 24.98 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 176.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.449 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -65.6 146.48 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 C-N-CA 117.64 -1.624 . . . . 0.0 107.271 -179.45 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.8 t -118.65 126.95 53.06 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 123.573 0.545 . . . . 0.0 111.214 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.7 m -132.74 163.5 28.88 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.04 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.8 m -74.2 146.94 42.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.443 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.45 83.55 1.97 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.917 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -159.12 164.71 35.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.398 0.618 . . . . 0.0 110.977 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.88 -166.18 2.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.073 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 61.1 m -60.09 -42.7 95.21 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.799 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -160.63 5.38 0.1 OUTLIER Glycine 0 C--N 1.331 0.28 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.4 tp -81.19 127.9 72.42 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 119.36 -0.352 . . . . 0.0 110.104 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -39.28 151.28 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 121.637 1.558 . . . . 0.0 111.804 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 149' ' ' ARG . 89.2 Cg_endo -75.17 148.58 34.83 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.234 1.956 . . . . 0.0 112.446 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.511 ' O ' ' CD1' ' A' ' 31' ' ' PHE . 4.2 m -62.74 71.35 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.354 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 147' ' ' PRO . 17.3 ptm180 -57.87 -32.94 68.17 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.415 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -163.11 164.22 25.44 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.862 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.441 ' H ' HG22 ' A' ' 151' ' ' VAL . 0.8 OUTLIER -56.33 -18.01 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 CA-C-O 121.721 0.772 . . . . 0.0 108.971 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -64.71 -35.53 81.35 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 177.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 150' ' ' THR . 5.6 tm-20 -58.94 -74.07 0.07 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.869 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.1 p -45.68 -30.06 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.34 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -83.98 -44.28 14.34 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 122.226 1.012 . . . . 0.0 110.285 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.36 -42.14 86.3 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.435 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.471 ' CG ' ' N ' ' A' ' 158' ' ' PHE . 8.1 pt20 -81.47 -48.93 11.22 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 112.858 -1.974 . . . . 0.0 112.134 -177.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.471 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 30.5 t80 -106.85 -36.54 6.63 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -177.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 97.68 24.45 12.09 Favored Glycine 0 N--CA 1.476 1.341 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -42.89 -94.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.564 0.221 . . . . 0.0 111.094 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.45 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.96 37.51 14.98 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.204 0.526 . . . . 0.0 109.714 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.562 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.5 m-85 -177.07 -61.83 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.764 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -73.73 28.19 0.32 Allowed 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 122.367 2.045 . . . . 0.0 110.443 178.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.586 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.9 m -131.03 167.4 26.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.85 -178.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.7 t -123.82 65.58 35.97 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.501 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.586 ' HD3' HG23 ' A' ' 164' ' ' VAL . 30.6 Cg_exo -36.68 141.22 0.15 Allowed 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 123.6 2.867 . . . . 0.0 115.15 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 154.67 145.68 4.22 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.54 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -141.99 132.25 24.92 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.303 0.573 . . . . 0.0 110.973 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.4 t . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.929 179.309 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 N--CA 1.446 -0.638 0 CA-C-O 121.125 0.488 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.449 ' O ' HG23 ' A' ' 178' ' ' ILE . 19.3 tt -110.93 127.82 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.112 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -129.46 166.95 18.59 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.727 0.775 . . . . 0.0 112.273 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 184' ' ' GLY . 97.7 m-20 -78.93 106.93 11.3 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.427 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -67.15 -16.93 64.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.744 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.491 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.4 mm? -63.6 -42.43 98.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.099 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.581 HG23 ' N ' ' A' ' 184' ' ' GLY . 5.0 t -120.31 -52.89 2.15 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.207 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.581 ' N ' HG23 ' A' ' 183' ' ' THR . . . . . . . . 0 N--CA 1.468 0.818 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 . . . . . 0 N--CA 1.466 0.342 0 CA-C-O 120.791 0.329 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.548 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.0 mp -62.57 -42.3 99.47 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.212 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -63.43 -39.93 95.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.163 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -63.76 -40.7 97.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.4 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 162' ' ' PHE . 65.2 t0 -61.94 -48.37 80.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.686 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.25 -45.36 93.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.487 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.96 -43.48 97.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.284 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.78 -45.02 82.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.816 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.22 -43.47 94.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.145 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.72 -52.56 64.59 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.706 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.8 pt -67.7 -39.75 82.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.163 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -57.58 -55.34 36.1 Favored 'General case' 0 C--O 1.215 -0.755 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.338 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 20' ' ' GLU . 95.4 t -60.15 -40.69 84.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.876 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.689 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.2 tt -51.61 -50.22 60.66 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.697 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -81.84 -51.51 8.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.993 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -63.63 -35.0 79.08 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.109 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 16' ' ' VAL . 97.1 mt-10 59.02 86.46 0.09 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.664 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.403 ' H ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -163.72 -134.81 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.982 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.504 HG21 ' NH2' ' A' ' 45' ' ' ARG . 6.1 p -140.22 140.36 35.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.439 HD12 ' O ' ' A' ' 24' ' ' ALA . 2.9 pp -129.87 165.82 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 120.852 0.358 . . . . 0.0 111.133 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.439 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -62.87 138.55 58.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.133 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.511 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 0.6 OUTLIER -131.19 141.59 42.43 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.363 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.511 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 91.2 Cg_endo -77.16 144.8 23.85 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.4 1.4 . . . . 0.0 111.892 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.471 ' C ' ' H ' ' A' ' 29' ' ' ALA . 79.4 m -135.85 135.09 39.5 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.32 0.581 . . . . 0.0 110.868 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -72.96 32.52 0.07 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.802 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.471 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -163.0 -75.73 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.833 0.349 . . . . 0.0 110.975 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.3 m -126.59 128.55 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.128 0.49 . . . . 0.0 110.229 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.519 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 80.3 m-85 -46.99 143.0 3.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.117 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -148.58 -169.15 15.12 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.8 m -133.33 169.37 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.404 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -156.98 -179.05 31.62 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.009 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.426 ' SG ' ' HB2' ' A' ' 42' ' ' ALA . 1.3 p -157.98 -165.73 1.8 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.6 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 7.0 p30 -89.65 107.68 20.29 Favored Pre-proline 0 CA--C 1.558 1.256 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -178.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -42.82 -60.78 0.66 Allowed 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.076 1.851 . . . . 0.0 112.633 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -77.63 70.65 4.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.427 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 54.9 m -156.57 144.01 19.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.619 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -71.1 -34.22 70.9 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.178 0.513 . . . . 0.0 111.158 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.443 HG22 ' H ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -60.52 -42.19 95.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.99 -178.719 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.426 ' HB2' ' SG ' ' A' ' 35' ' ' CYS . . . -57.88 -52.36 65.81 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 p -62.19 -42.6 95.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.147 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.9 mtt -64.65 -41.44 96.13 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.504 ' NH2' HG21 ' A' ' 22' ' ' VAL . 31.9 ttt-85 -60.4 -42.26 95.57 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-O 121.98 0.895 . . . . 0.0 108.916 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.457 ' O ' HD23 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -64.2 -53.47 48.74 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.664 -178.751 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.7 mt -71.03 -10.57 59.98 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.153 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -69.85 -82.35 0.04 OUTLIER 'General case' 0 N--CA 1.432 -1.354 0 CA-C-O 121.09 0.471 . . . . 0.0 110.924 -177.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.526 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -76.54 -35.57 58.19 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -76.51 -50.22 14.53 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.082 -177.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 35.76 65.09 0.44 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.012 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.428 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 7.1 mtm-85 178.82 -52.51 0.0 OUTLIER Pre-proline 0 CA--C 1.551 0.981 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.744 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.428 ' HD2' ' H ' ' A' ' 52' ' ' ARG . 85.6 Cg_endo -81.11 -2.81 11.92 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 123.008 2.472 . . . . 0.0 112.499 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.574 HG13 ' N ' ' A' ' 55' ' ' ASP . 8.7 p -44.61 -45.47 2.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.033 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.574 ' N ' HG13 ' A' ' 54' ' ' VAL . 41.7 t0 -64.13 -41.14 97.32 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.726 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -60.86 -35.33 76.31 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 59.19 102.26 0.01 OUTLIER Glycine 0 CA--C 1.52 0.36 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.572 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -48.73 -172.55 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.303 0.573 . . . . 0.0 112.205 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.6 mt -91.14 141.21 14.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.419 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.3 mt -118.88 145.74 45.47 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.423 ' O ' HG23 ' A' ' 61' ' ' ILE . 9.3 tp -113.38 127.68 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-O 121.203 0.525 . . . . 0.0 111.184 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.551 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -113.99 151.77 31.9 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.87 -28.16 8.17 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -115.69 148.55 39.6 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.316 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -77.16 -13.46 59.94 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -51.87 -32.45 32.22 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.262 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.28 -9.83 34.78 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.425 HD22 ' N ' ' A' ' 68' ' ' LEU . 4.3 mm? -92.18 -16.23 26.53 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.37 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.473 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 17.4 ttpp -78.07 -37.3 1.46 Allowed Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 67.5 Cg_endo -103.44 -3.23 0.27 Allowed 'Trans proline' 0 C--N 1.321 -0.921 0 C-N-CA 122.801 2.334 . . . . 0.0 111.873 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.524 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 42.0 t80 -91.73 -12.05 35.05 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.295 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.597 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.7 mp -123.2 163.43 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.597 ' N ' HG22 ' A' ' 72' ' ' ILE . 96.8 m-20 -63.43 -3.98 2.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.277 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 3.3 p30 45.01 22.85 0.07 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.883 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.555 HG23 ' N ' ' A' ' 76' ' ' MET . 8.9 t -88.72 -44.81 10.29 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.13 0.49 . . . . 0.0 109.827 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.555 ' N ' HG23 ' A' ' 75' ' ' THR . 18.2 ptp -80.63 -14.76 57.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.975 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 tp -79.0 134.12 36.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.701 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -158.61 161.04 37.18 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.972 -177.553 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -38.92 -48.93 1.63 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.768 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.5 p -63.26 -33.49 61.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.007 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.427 ' N ' ' O ' ' A' ' 78' ' ' THR . 62.8 tp60 -64.47 -39.47 93.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.944 0.402 . . . . 0.0 110.4 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -63.87 -53.12 55.55 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 122.517 1.151 . . . . 0.0 109.111 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.499 ' O ' ' N ' ' A' ' 87' ' ' SER . 80.8 tt0 -54.18 -50.37 67.19 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.989 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.4 m -61.48 -49.29 77.35 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.988 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 89' ' ' TRP . 8.7 tt -69.79 -31.24 47.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.574 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -80.14 -31.31 39.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.753 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 83' ' ' GLU . 53.2 m -90.1 -12.71 37.55 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.769 0.318 . . . . 0.0 111.201 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.446 ' O ' ' O ' ' A' ' 89' ' ' TRP . 62.0 ttm-85 -121.95 75.84 1.24 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.446 ' O ' ' O ' ' A' ' 88' ' ' ARG . 7.9 m-90 56.75 152.26 0.07 OUTLIER Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.377 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.24 -19.26 38.84 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.881 1.72 . . . . 0.0 111.673 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 159.56 81.05 0.04 OUTLIER Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -81.42 -9.77 12.38 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.492 2.128 . . . . 0.0 112.143 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.419 HG13 ' CE2' ' A' ' 95' ' ' PHE . 3.1 p -136.12 144.8 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.951 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.464 HG22 ' HB1' ' A' ' 115' ' ' ALA . 7.4 m -95.99 124.31 39.95 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.588 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 41.7 m-85 -113.09 143.03 45.04 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.401 -178.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.806 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 98.8 t -89.08 102.71 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 121.152 0.501 . . . . 0.0 111.393 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -90.08 146.82 35.77 Favored Pre-proline 0 N--CA 1.469 0.504 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.786 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -79.39 87.03 1.59 Allowed 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.241 1.961 . . . . 0.0 111.449 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -48.28 151.55 1.81 Allowed Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.91 144.58 88.54 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.091 1.861 . . . . 0.0 111.664 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.48 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.192 -179.673 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 109' ' ' GLY . 5.9 tpt180 . . . . . 0 N--CA 1.461 0.089 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 66.7 p-90 -79.1 -11.59 59.99 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.665 0.745 . . . . 0.0 109.404 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.631 ' H ' ' CD2' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -76.58 -16.45 59.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.811 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.409 ' H ' HD23 ' A' ' 107' ' ' LEU . 94.8 m -142.93 -40.96 0.32 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.356 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 91.9 -13.4 66.96 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 119.863 -0.41 . . . . 0.0 112.896 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.451 ' O ' ' CZ ' ' A' ' 105' ' ' ARG . 13.5 tpt180 -148.01 -80.43 0.14 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.883 0.842 . . . . 0.0 111.226 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -90.95 -174.83 4.15 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -124.35 61.18 1.13 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.083 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.0 p -168.14 151.78 5.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.193 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 pp -169.34 147.58 3.71 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.464 ' HB1' HG22 ' A' ' 94' ' ' THR . . . -64.27 134.94 55.71 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 113.76 -1.564 . . . . 0.0 109.635 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.47 HG22 ' N ' ' A' ' 117' ' ' ARG . 6.6 p -147.98 160.06 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.47 ' N ' HG22 ' A' ' 116' ' ' VAL . 62.5 ttp180 -145.53 154.64 42.42 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.907 0.384 . . . . 0.0 111.425 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.551 HG22 ' HB3' ' A' ' 62' ' ' ALA . 48.3 t -123.0 136.07 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.9 t -138.38 150.25 46.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.178 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 50.7 p-10 -153.7 84.9 1.17 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.923 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.657 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 8.5 t-80 -171.52 -36.58 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.292 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.657 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 60.9 Cg_endo -95.15 -159.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.949 0 C-N-CA 121.879 1.719 . . . . 0.0 112.032 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.7 mt -78.79 -5.79 54.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.372 0.606 . . . . 0.0 110.459 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 87.8 t -58.1 -44.77 88.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.787 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.774 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.1 m -53.35 -62.57 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.922 0 C-N-CA 119.269 -0.972 . . . . 0.0 108.883 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.774 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.29 -43.82 2.54 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 120.831 0.348 . . . . 0.0 111.152 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.409 HD23 HD22 ' A' ' 135' ' ' LEU . 41.1 tp -69.04 -48.77 62.01 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.998 0.428 . . . . 0.0 111.224 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 75.4 m -70.26 -48.38 57.1 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.373 0.606 . . . . 0.0 110.991 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.46 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.1 pp0? -55.03 -42.26 72.38 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -57.87 -57.22 13.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.665 -178.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -62.47 -26.46 68.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.385 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.92 -2.44 88.25 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' A' ' 134' ' ' PRO . 25.0 mmtm -142.91 155.78 62.5 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 117.137 0.469 . . . . 0.0 110.043 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 133' ' ' LYS . 6.0 Cg_exo -41.34 175.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 123.604 2.869 . . . . 0.0 112.984 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.409 HD22 HD23 ' A' ' 127' ' ' LEU . 8.1 tp -128.59 122.96 32.15 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 177.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.426 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -66.11 142.67 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.9 0 C-N-CA 117.762 -1.575 . . . . 0.0 107.256 -179.712 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 t -111.69 118.91 36.93 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 123.802 0.688 . . . . 0.0 110.88 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.465 ' CB ' HH22 ' A' ' 45' ' ' ARG . 18.8 m -127.72 150.55 49.73 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.756 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 140' ' ' ALA . 24.7 m -64.59 149.21 49.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.491 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.436 ' O ' ' O ' ' A' ' 139' ' ' SER . . . -53.78 -164.09 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.997 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.431 ' O ' ' O ' ' A' ' 140' ' ' ALA . 6.7 p30 53.37 156.98 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.702 0.763 . . . . 0.0 111.687 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.07 -147.15 0.37 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.185 -178.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.4 p -63.15 -39.32 94.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.058 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.426 ' H ' ' H ' ' A' ' 145' ' ' LEU . . . -161.78 -2.4 0.05 OUTLIER Glycine 0 N--CA 1.457 0.059 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.426 ' H ' ' H ' ' A' ' 144' ' ' GLY . 11.7 tp -71.71 128.68 89.36 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 119.355 -0.355 . . . . 0.0 110.358 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 145' ' ' LEU . 26.2 Cg_exo -35.25 157.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.295 1.996 . . . . 0.0 112.451 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.98 -163.62 0.13 Allowed 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.291 1.994 . . . . 0.0 112.508 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 27.3 m -132.14 69.48 1.48 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.966 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.519 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 17.3 ptm180 -56.96 -36.47 70.34 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.581 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.85 168.79 23.98 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.418 HG11 ' HA ' ' A' ' 166' ' ' PRO . 1.7 m -59.4 -17.7 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 CA-C-O 121.612 0.72 . . . . 0.0 109.553 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -65.62 -35.19 80.07 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.432 ' OE1' ' OE1' ' A' ' 157' ' ' GLN . 5.8 tm-20 -60.11 -73.78 0.08 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.895 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.427 HG11 HG11 ' A' ' 164' ' ' VAL . 7.3 p -45.51 -30.03 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.016 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.06 -43.34 15.2 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 122.214 1.007 . . . . 0.0 110.007 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.9 -42.26 89.17 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 122.518 1.151 . . . . 0.0 109.265 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.471 ' CG ' ' N ' ' A' ' 158' ' ' PHE . 8.0 pt20 -80.74 -49.61 10.94 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 112.974 -1.921 . . . . 0.0 112.042 -177.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.471 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 39.6 t80 -106.07 -37.24 6.68 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -177.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 98.88 25.3 9.82 Favored Glycine 0 N--CA 1.473 1.11 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 161' ' ' ALA . . . -43.87 -97.27 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.561 0.219 . . . . 0.0 111.091 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.473 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 64.95 36.55 7.52 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.199 0.523 . . . . 0.0 109.899 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.547 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.5 m-85 -177.74 -61.24 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.182 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.25 29.06 0.3 Allowed 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 122.447 2.098 . . . . 0.0 110.556 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.57 HG23 ' HD3' ' A' ' 166' ' ' PRO . 16.0 m -132.65 167.37 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.215 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 9.0 t -123.49 65.13 31.34 Favored Pre-proline 0 N--CA 1.476 0.844 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.848 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.57 ' HD3' HG23 ' A' ' 164' ' ' VAL . 31.7 Cg_exo -36.54 141.39 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 123.77 2.98 . . . . 0.0 115.045 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 163.27 -161.59 34.13 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 113.761 -1.563 . . . . 0.0 110.972 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -147.49 175.39 10.87 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.982 0.42 . . . . 0.0 110.193 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.463 0.195 0 CA-C-O 121.035 0.445 . . . . 0.0 110.509 179.957 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 . . . . . 0 N--CA 1.446 -0.631 0 CA-C-O 121.241 0.543 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 13.1 tt -94.89 130.37 43.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.435 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -133.19 168.65 18.16 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.51 0.671 . . . . 0.0 111.574 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -87.25 108.05 18.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.165 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.806 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -72.93 -14.3 61.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.239 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.498 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.6 mm? -64.91 -42.02 95.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.989 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.22 -43.66 4.54 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.058 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.758 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 179.888 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 . . . . . 0 N--CA 1.469 0.479 0 CA-C-O 120.783 0.325 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.533 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.5 mp -62.46 -42.62 99.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.21 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -61.49 -40.42 94.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.934 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -64.16 -41.5 97.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.14 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -59.24 -45.78 90.23 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.198 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.42 -45.61 92.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.045 0.45 . . . . 0.0 110.424 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.5 -42.44 96.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.29 -44.69 84.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.382 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.09 -42.76 99.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.086 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.06 -52.33 65.83 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.898 0.38 . . . . 0.0 111.825 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.41 HG21 HD13 ' A' ' 14' ' ' ILE . 18.8 pt -68.58 -37.48 77.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.091 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -58.6 -51.19 70.97 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 120.281 -0.567 . . . . 0.0 110.047 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 21' ' ' ARG . 88.6 t -63.86 -38.37 82.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.007 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.68 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.3 tt -52.77 -50.58 63.25 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.439 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -79.59 -47.94 14.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.21 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -67.19 -31.97 72.73 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.831 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.46 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.7 mt-10 58.22 56.6 4.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.271 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.557 ' O ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -149.88 158.51 44.24 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.591 0.71 . . . . 0.0 110.588 178.949 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 34' ' ' GLY . 7.8 p -74.29 137.67 22.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.799 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.507 HG22 ' NH2' ' A' ' 21' ' ' ARG . 2.9 pp -124.58 168.25 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-O 120.587 0.232 . . . . 0.0 110.534 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.416 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -63.74 134.82 56.0 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.191 0.519 . . . . 0.0 111.023 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.532 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 0.6 OUTLIER -125.48 141.5 39.12 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.706 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.532 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 60.5 Cg_endo -80.23 151.91 20.78 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.709 1.606 . . . . 0.0 111.235 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.445 ' C ' ' H ' ' A' ' 29' ' ' ALA . 47.8 m -133.36 140.72 47.54 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.372 0.606 . . . . 0.0 111.108 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -77.51 23.06 0.23 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.132 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.445 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -160.53 -70.77 0.07 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.194 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.7 p -126.97 125.63 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-O 121.109 0.48 . . . . 0.0 110.34 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.531 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 96.7 m-85 -45.48 150.39 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.668 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -160.99 -169.07 23.74 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.2 m -130.45 170.13 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.532 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -159.25 177.77 35.66 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.686 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -155.45 -164.83 1.84 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 120.433 -0.507 . . . . 0.0 112.122 -178.52 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.467 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 23.6 m-20 -90.86 106.27 15.06 Favored Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -177.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -34.92 -62.35 0.21 Allowed 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 122.461 2.107 . . . . 0.0 112.716 178.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 56.7 p-10 -74.31 67.51 1.41 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.103 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.3 m -157.07 133.05 9.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.159 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -66.14 -20.55 66.18 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.307 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.4 t -60.08 -34.76 73.89 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.932 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.71 -52.2 66.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.874 0.368 . . . . 0.0 111.575 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 43' ' ' VAL . 2.5 p -64.61 -45.77 94.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.929 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 63.0 mtt -67.51 -46.89 71.58 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.442 ' NH2' ' OG1' ' A' ' 138' ' ' THR . 40.7 ptt85 -63.02 -30.38 71.55 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.829 0.347 . . . . 0.0 110.221 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.7 mt -73.48 -60.91 2.03 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.269 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.0 mt -54.34 -20.5 7.36 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.449 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -63.47 -86.12 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.543 -178.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.526 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.2 pt? -78.68 -34.35 46.29 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -74.92 -50.67 16.03 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.916 -176.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 37.19 64.7 0.58 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.985 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.403 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 6.3 mtt180 179.0 -54.0 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.856 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.455 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.403 ' HD2' ' H ' ' A' ' 52' ' ' ARG . 69.8 Cg_endo -75.61 -8.27 19.24 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.323 2.015 . . . . 0.0 111.493 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.575 HG13 ' N ' ' A' ' 55' ' ' ASP . 10.8 p -46.71 -43.9 6.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.254 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.575 ' N ' HG13 ' A' ' 54' ' ' VAL . 11.1 t0 -70.59 -44.58 67.04 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.198 -178.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -61.27 -38.3 86.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.6 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 74.77 101.9 0.1 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.572 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -50.92 -167.55 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.092 0.472 . . . . 0.0 112.231 -179.658 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.445 ' O ' ' OG ' ' A' ' 137' ' ' SER . 77.2 mt -100.67 135.29 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.143 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 16.0 mt -112.43 144.51 41.77 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.5 tt -114.53 129.77 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 CA-C-O 121.445 0.64 . . . . 0.0 110.88 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.552 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -116.79 155.09 29.55 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.579 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.97 -30.08 6.15 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -112.46 150.01 31.81 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.135 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -76.77 -21.97 54.42 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.707 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.458 ' HG3' HE21 ' A' ' 67' ' ' GLN . 22.3 pt-20 -50.96 -30.31 14.59 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.875 -178.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.458 HE21 ' HG3' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -93.82 -6.13 46.58 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.823 -0.172 . . . . 0.0 111.431 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -89.79 -21.69 22.49 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.452 ' NZ ' ' CB ' ' A' ' 69' ' ' LYS . 8.0 mtpm? -73.76 -38.27 3.87 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -178.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 94.6 Cg_endo -101.75 -5.01 0.35 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.628 2.219 . . . . 0.0 111.986 -179.107 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -87.81 -18.96 28.18 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.772 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.623 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.1 mp -119.27 166.93 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.623 ' N ' HG22 ' A' ' 72' ' ' ILE . 97.8 m-20 -61.75 -14.39 31.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.329 . . . . 0.0 111.054 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 41.1 t0 59.54 32.67 21.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.86 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.538 HG23 ' N ' ' A' ' 76' ' ' MET . 14.1 t -105.14 -42.38 5.31 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.903 0.382 . . . . 0.0 110.476 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.538 ' N ' HG23 ' A' ' 75' ' ' THR . 21.0 ptm -88.78 -23.37 22.9 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.366 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.531 HD21 ' NH2' ' A' ' 82' ' ' ARG . 30.3 tp -67.65 133.08 48.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.124 -177.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.95 170.26 19.25 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.577 -176.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -59.94 -42.11 93.29 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 123.364 0.415 . . . . 0.0 111.389 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.1 p -60.63 -33.27 54.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.42 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -63.23 -41.17 99.06 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.113 0.482 . . . . 0.0 110.358 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.531 ' NH2' HD21 ' A' ' 77' ' ' LEU . 7.5 mmt85 -63.94 -52.11 61.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.479 1.133 . . . . 0.0 109.117 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -55.69 -50.04 71.36 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.798 -1.547 . . . . 0.0 110.028 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.2 m -61.18 -49.92 75.22 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.47 -1.241 . . . . 0.0 112.091 -178.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 85' ' ' ILE . 9.1 tt -68.25 -30.12 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.696 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -78.4 -37.3 44.29 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.759 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.2 m -84.72 -10.64 57.07 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.722 0.296 . . . . 0.0 111.166 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.442 ' O ' ' O ' ' A' ' 89' ' ' TRP . 62.0 ttm-85 -122.61 83.64 2.14 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.442 ' O ' ' O ' ' A' ' 88' ' ' ARG . 14.6 m95 57.68 150.33 0.07 OUTLIER Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.231 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.415 ' O ' ' O ' ' A' ' 118' ' ' VAL . 55.8 Cg_endo -68.01 -23.35 40.49 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.203 1.935 . . . . 0.0 111.973 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 159.1 80.65 0.03 OUTLIER Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.74 -24.2 7.49 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 122.163 1.909 . . . . 0.0 112.395 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.409 HG13 ' CZ ' ' A' ' 95' ' ' PHE . 3.5 p -137.04 146.56 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 120.783 0.325 . . . . 0.0 110.474 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 53.8 m -89.71 149.7 22.64 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.845 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.454 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 83.2 m-85 -128.0 144.78 51.11 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.202 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.657 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.5 t -102.05 108.67 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-O 121.34 0.59 . . . . 0.0 110.46 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -94.98 150.37 37.64 Favored Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.898 -178.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.21 89.44 0.39 Allowed 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.265 1.977 . . . . 0.0 111.47 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.93 149.71 80.19 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.138 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -72.14 157.34 54.26 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.207 1.938 . . . . 0.0 111.992 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.47 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.837 179.885 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 109' ' ' GLY . 23.7 mmt180 . . . . . 0 N--CA 1.468 0.436 0 CA-C-O 120.452 0.168 . . . . 0.0 110.68 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 2.0 p90 -66.73 -10.76 50.32 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.949 -0.301 . . . . 0.0 111.593 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 1.049 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -67.23 -39.8 86.25 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.798 ' H ' HD22 ' A' ' 107' ' ' LEU . 16.6 m -145.99 -39.92 0.22 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.65 177.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 58.53 -12.01 0.02 OUTLIER Glycine 0 CA--C 1.532 1.126 0 CA-C-N 115.711 -0.677 . . . . 0.0 113.29 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.557 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -86.54 -51.51 6.13 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 117.714 0.757 . . . . 0.0 109.446 -179.437 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.452 ' CD2' ' N ' ' A' ' 112' ' ' ASP . 85.4 t80 -160.18 -95.34 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.019 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.452 ' N ' ' CD2' ' A' ' 111' ' ' PHE . 35.8 t70 -171.01 67.96 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.541 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.5 p -166.77 129.36 1.81 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.742 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.647 HD21 ' OG1' ' A' ' 108' ' ' THR . 87.2 mt -126.41 128.01 46.34 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.476 ' N ' HG13 ' A' ' 96' ' ' VAL . . . -69.67 119.69 14.29 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.344 176.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.468 HG22 ' N ' ' A' ' 117' ' ' ARG . 5.4 p -145.96 158.49 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.468 ' N ' HG22 ' A' ' 116' ' ' VAL . 33.5 ptt180 -151.57 160.81 43.51 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.745 0.307 . . . . 0.0 110.983 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.552 HG22 ' HB3' ' A' ' 62' ' ' ALA . 55.9 t -123.44 137.75 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.1 t -128.65 157.44 41.3 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.304 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 5.8 p30 -158.74 77.97 0.77 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.134 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.637 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 56.9 t-80 -172.62 -35.81 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.637 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 37.3 Cg_endo -94.44 -163.33 0.09 OUTLIER 'Trans proline' 0 N--CA 1.485 0.981 0 C-N-CA 121.973 1.782 . . . . 0.0 111.991 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 36.5 mt -78.22 -4.39 47.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.511 0.672 . . . . 0.0 109.908 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 93.4 t -58.35 -44.93 89.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.061 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.77 HG23 ' H ' ' A' ' 126' ' ' ALA . 30.8 m -54.24 -62.52 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 C-N-CA 119.538 -0.865 . . . . 0.0 108.727 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.77 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.6 -43.27 2.7 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.021 0.439 . . . . 0.0 110.657 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.9 tp -69.28 -48.87 60.45 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.828 0.347 . . . . 0.0 111.455 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 80.3 m -70.46 -48.42 55.94 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.365 0.602 . . . . 0.0 110.851 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.477 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -54.72 -43.27 72.45 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.73 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -59.02 -55.21 38.08 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.235 -1.348 . . . . 0.0 109.459 -178.038 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -61.84 -21.84 64.98 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 114.545 -1.207 . . . . 0.0 109.151 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.54 0.69 84.83 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -151.52 158.72 34.16 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -43.8 174.16 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 123.697 2.931 . . . . 0.0 113.722 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.5 tp -128.63 123.13 32.48 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.421 HG13 ' H ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -66.12 144.34 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 C-N-CA 118.353 -1.339 . . . . 0.0 108.049 -179.674 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -110.01 120.14 41.51 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.305 1.003 . . . . 0.0 110.876 -179.179 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.442 ' OG1' ' NH2' ' A' ' 45' ' ' ARG . 2.4 m -134.11 160.06 38.94 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.898 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.5 m -72.11 142.44 49.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.882 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.88 -36.32 83.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.813 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' A' ' 141' ' ' ASN . 56.9 p30 -46.97 150.04 0.81 Allowed 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.959 0.885 . . . . 0.0 111.255 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.4 -161.55 0.89 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.211 -1.359 . . . . 0.0 110.569 -178.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.2 p -62.02 -39.81 93.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.297 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -164.9 9.24 0.07 OUTLIER Glycine 0 C--N 1.33 0.224 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.3 tp -91.65 127.89 48.54 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-O 119.355 -0.355 . . . . 0.0 110.186 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -38.61 156.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 121.648 1.565 . . . . 0.0 112.276 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -76.54 -167.01 0.41 Allowed 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.773 2.316 . . . . 0.0 112.524 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 83.3 m -111.48 74.33 0.86 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.461 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.531 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 38.0 ptt180 -51.84 -37.54 52.33 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.432 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.422 ' O ' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -159.87 168.08 26.62 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.763 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.41 HG11 ' HA ' ' A' ' 166' ' ' PRO . 1.1 m -57.88 -21.65 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.83 -30.58 71.66 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 155' ' ' ARG . 6.7 tm-20 -63.73 -79.85 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.534 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.0 p -36.45 -30.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.082 0.953 . . . . 0.0 110.971 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.466 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -70.68 -51.68 26.12 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.518 -179.351 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.09 -17.54 62.58 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 122.451 1.119 . . . . 0.0 108.024 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -83.77 -47.82 10.75 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 112.705 -2.043 . . . . 0.0 111.794 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -130.58 -19.92 2.97 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 85.82 26.15 35.84 Favored Glycine 0 N--CA 1.468 0.823 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.4 ' O ' ' O ' ' A' ' 159' ' ' GLY . . . -43.64 -95.9 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.587 0.232 . . . . 0.0 111.195 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.467 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 63.43 35.43 12.1 Favored 'General case' 0 CA--C 1.527 0.09 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.546 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.6 m-85 -175.47 -61.9 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.153 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.49 27.35 0.31 Allowed 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.298 1.999 . . . . 0.0 110.751 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.558 HG23 ' HD3' ' A' ' 166' ' ' PRO . 14.9 m -129.45 167.64 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.805 -178.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.0 t -123.16 64.53 26.31 Favored Pre-proline 0 N--CA 1.472 0.668 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.831 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.558 ' HD3' HG23 ' A' ' 164' ' ' VAL . 36.5 Cg_exo -37.65 144.27 0.15 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 123.291 2.66 . . . . 0.0 114.823 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -175.22 -158.25 18.67 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 114.101 -1.409 . . . . 0.0 111.472 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -141.92 -154.42 0.52 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.735 0.302 . . . . 0.0 110.527 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 CA--C 1.532 0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.511 -179.604 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 . . . . . 0 N--CA 1.448 -0.56 0 CA-C-O 120.85 0.357 . . . . 0.0 110.726 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 39.0 pt -117.61 142.88 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.917 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -131.26 166.19 21.72 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.462 0.649 . . . . 0.0 111.654 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 184' ' ' GLY . 97.6 m-20 -78.55 106.48 10.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.679 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -65.86 -18.01 65.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.739 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.508 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.4 mm? -63.15 -41.72 99.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.221 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.43 -41.12 2.62 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.69 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 180' ' ' ASP . . . . . . . . 0 CA--C 1.526 0.777 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.738 0.304 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.525 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.7 mp -63.03 -42.75 99.86 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -64.58 -40.75 96.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.744 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 61.8 ttt85 -63.01 -41.74 99.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.166 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.7 -44.07 96.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.448 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.45 -44.52 94.27 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.166 0.508 . . . . 0.0 109.918 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.9 mt -63.52 -42.58 96.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.357 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.48 -41.09 80.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.329 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.76 -43.9 91.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.935 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.09 -53.08 62.01 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 17.6 pt -68.2 -36.94 77.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.806 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -58.06 -50.03 74.85 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.613 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.529 HG13 ' O ' ' A' ' 21' ' ' ARG . 90.8 t -64.59 -38.66 83.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.946 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.68 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.5 tt -52.7 -51.02 62.12 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.287 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -78.34 -47.97 16.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.402 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -67.83 -31.36 71.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.951 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.6 mt-10 57.54 57.64 4.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.182 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.529 ' O ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -151.15 159.17 44.61 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.582 0.706 . . . . 0.0 110.336 179.088 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 34' ' ' GLY . 8.9 p -74.08 140.17 18.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.452 -178.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.507 HG22 ' NH2' ' A' ' 21' ' ' ARG . 2.8 pp -126.69 166.43 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-O 120.879 0.371 . . . . 0.0 110.927 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.422 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -63.85 137.9 58.24 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.332 0.587 . . . . 0.0 111.008 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.53 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 0.4 OUTLIER -130.52 141.86 43.44 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.123 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.53 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 58.3 Cg_endo -79.38 146.79 19.79 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 121.451 1.434 . . . . 0.0 111.682 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.506 ' C ' ' H ' ' A' ' 29' ' ' ALA . 33.7 m -130.02 133.42 46.73 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.905 0.383 . . . . 0.0 110.931 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -74.53 25.26 0.08 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.152 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.506 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -157.3 -74.43 0.09 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.001 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.3 t -124.93 125.51 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-O 120.894 0.378 . . . . 0.0 110.313 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -44.37 139.24 2.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.934 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -149.44 -172.28 18.87 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.5 m -130.06 169.98 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.439 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -158.5 178.98 34.49 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.757 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.55 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -154.53 -162.97 1.49 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.819 0.342 . . . . 0.0 111.393 -178.8 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.55 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 5.7 m-20 -97.82 107.34 39.64 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -177.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 36' ' ' ASP . 38.6 Cg_exo -37.86 173.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 123.074 2.516 . . . . 0.0 114.215 177.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 66.7 t0 35.66 76.39 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.492 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.0 m -152.73 139.03 18.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.336 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -70.12 -34.3 72.92 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.244 0.545 . . . . 0.0 110.74 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 41' ' ' THR . 0.1 OUTLIER -64.32 -44.39 91.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.86 -178.853 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.63 -50.61 71.85 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.515 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.6 p -62.58 -44.51 99.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.177 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 90.7 mtp -64.0 -40.02 95.43 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.4 ' O ' ' CD2' ' A' ' 49' ' ' LEU . 56.0 ttt85 -61.68 -33.02 73.25 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.341 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 85.8 mt -75.04 -60.81 2.12 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.6 mt -53.56 -18.35 2.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.56 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -66.83 -86.15 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -178.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.505 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.2 pt? -76.82 -34.34 57.91 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -75.03 -49.69 18.96 Favored 'General case' 0 C--N 1.345 0.409 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.56 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 35.62 64.81 0.45 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.855 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.407 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 8.1 mtt180 179.29 -53.35 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.902 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.497 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.407 ' HD2' ' H ' ' A' ' 52' ' ' ARG . 60.1 Cg_endo -74.74 -8.79 20.7 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.399 2.066 . . . . 0.0 112.267 -179.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.546 HG13 ' N ' ' A' ' 55' ' ' ASP . 7.5 p -41.52 -48.17 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.809 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.546 ' N ' HG13 ' A' ' 54' ' ' VAL . 33.9 t0 -69.39 -38.71 78.11 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.547 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.481 ' CD ' ' N ' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -59.78 -39.26 84.31 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.767 -179.092 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 59.62 104.69 0.01 OUTLIER Glycine 0 CA--C 1.518 0.247 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.568 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -52.53 -161.3 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.615 0.721 . . . . 0.0 111.735 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.0 mt -108.41 146.77 13.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.912 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.7 mt -119.55 141.24 49.42 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.448 ' CD1' ' HE ' ' A' ' 117' ' ' ARG . 8.0 tp -108.96 131.68 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-O 121.222 0.534 . . . . 0.0 110.569 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.472 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -118.81 153.25 34.78 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.385 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.29 -26.93 7.79 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -117.46 151.17 37.64 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.823 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -78.99 -13.42 59.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.511 0.672 . . . . 0.0 109.346 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -51.14 -30.26 16.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.843 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.487 HE21 ' N ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -94.82 -13.62 25.4 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.562 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 68' ' ' LEU . 4.2 mm? -92.36 -13.67 29.83 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.479 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 79.0 tttt -80.08 -37.79 1.11 Allowed Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 68.6 Cg_endo -102.59 -3.64 0.32 Allowed 'Trans proline' 0 C--N 1.316 -1.169 0 C-N-CA 122.812 2.341 . . . . 0.0 111.564 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.508 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 42.9 t80 -93.07 -13.13 28.97 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.365 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.472 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.7 mp -125.75 155.1 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.472 ' N ' HG22 ' A' ' 72' ' ' ILE . 84.3 m-20 -64.41 153.02 39.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.063 0.459 . . . . 0.0 110.114 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 66.5 t0 -96.22 46.03 1.07 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.308 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.492 HG23 ' N ' ' A' ' 76' ' ' MET . 10.9 t -115.83 -40.08 3.39 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.269 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.492 ' N ' HG23 ' A' ' 75' ' ' THR . 13.6 ptm -95.55 -24.41 16.63 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.217 0.532 . . . . 0.0 110.224 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.571 HD21 ' NH2' ' A' ' 82' ' ' ARG . 30.8 tp -80.09 134.98 36.23 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.436 -178.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.07 169.74 19.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.708 -177.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.36 -41.92 94.7 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.367 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.46 -33.39 56.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.115 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -63.24 -40.39 97.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.068 0.461 . . . . 0.0 110.569 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.571 ' NH2' HD21 ' A' ' 77' ' ' LEU . 7.5 mmt85 -64.17 -52.03 60.96 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 122.655 1.217 . . . . 0.0 109.02 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 87' ' ' SER . 82.6 tt0 -56.68 -50.42 72.18 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.618 -1.628 . . . . 0.0 110.372 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.2 m -62.41 -49.47 75.35 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.349 -1.296 . . . . 0.0 112.232 -177.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.8 tt -67.46 -25.31 33.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.325 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -86.47 -32.6 20.73 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.241 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 83' ' ' GLU . 6.7 m -88.52 -20.24 25.35 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.293 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.442 ' O ' ' O ' ' A' ' 89' ' ' TRP . 70.2 ttt180 -116.19 82.26 1.75 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.668 0.27 . . . . 0.0 110.636 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.442 ' O ' ' O ' ' A' ' 88' ' ' ARG . 3.9 m-90 56.56 151.82 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.828 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.4 -17.82 44.07 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.058 1.839 . . . . 0.0 111.449 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.459 ' H ' ' HD3' ' A' ' 92' ' ' PRO . . . 99.26 69.71 0.93 Allowed Glycine 0 N--CA 1.471 0.972 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.459 ' HD3' ' H ' ' A' ' 91' ' ' GLY . 51.9 Cg_exo -55.52 -38.55 93.95 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.893 2.396 . . . . 0.0 112.307 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.7 p -73.92 136.15 25.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.322 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 56.1 m -88.92 144.23 26.33 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.821 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.42 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 55.8 m-85 -126.94 144.55 50.97 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.227 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.623 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.5 t -99.91 103.4 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 121.296 0.569 . . . . 0.0 109.475 178.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -87.77 148.21 43.13 Favored Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.815 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.9 101.66 1.51 Allowed 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.651 1.567 . . . . 0.0 110.948 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.38 150.53 79.95 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.896 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -71.53 152.11 59.57 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.222 1.948 . . . . 0.0 112.406 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.037 179.955 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.506 HH22 ' C ' ' A' ' 111' ' ' PHE . 7.1 tpt85 . . . . . 0 N--CA 1.466 0.361 0 CA-C-O 120.685 0.279 . . . . 0.0 110.441 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 43.4 m95 -77.26 -2.97 37.45 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 120.839 0.352 . . . . 0.0 110.517 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.934 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -82.44 -19.6 38.64 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.537 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.64 ' H ' HD22 ' A' ' 107' ' ' LEU . 51.3 m -142.74 -41.53 0.32 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.435 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 64.81 24.06 69.62 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.453 178.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.93 -75.22 0.11 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 117.54 0.67 . . . . 0.0 110.527 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.506 ' C ' HH22 ' A' ' 105' ' ' ARG . 72.2 m-85 -113.63 159.5 19.58 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.018 0.437 . . . . 0.0 110.312 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -93.06 76.82 4.68 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.284 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.828 ' C ' HD22 ' A' ' 114' ' ' LEU . 19.5 p -163.57 128.85 3.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.967 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.828 HD22 ' C ' ' A' ' 113' ' ' SER . 3.7 mm? -134.04 128.26 33.94 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -178.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.462 ' N ' HG13 ' A' ' 96' ' ' VAL . . . -69.83 124.14 23.25 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 113.815 -1.539 . . . . 0.0 109.333 176.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.3 p -144.21 152.27 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.881 0.372 . . . . 0.0 110.783 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.448 ' HE ' ' CD1' ' A' ' 61' ' ' ILE . 62.2 ttp180 -140.58 153.81 46.25 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.682 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.472 HG22 ' HB3' ' A' ' 62' ' ' ALA . 56.0 t -121.91 134.05 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 7.9 t -134.02 153.28 51.89 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.215 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 51.2 p-10 -153.72 82.99 1.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.075 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.635 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 40.7 t60 -172.47 -37.36 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.635 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 40.7 Cg_endo -94.15 -161.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -0.977 0 C-N-CA 122.122 1.881 . . . . 0.0 112.156 -178.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 27.4 mt -79.04 -4.97 52.8 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.929 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 95.0 t -58.15 -45.03 88.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.915 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.777 HG23 ' H ' ' A' ' 126' ' ' ALA . 30.3 m -54.1 -62.54 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.847 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.777 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.41 -44.13 2.75 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 120.936 0.398 . . . . 0.0 110.819 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.5 tp -68.83 -48.32 63.8 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.469 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 61.8 m -70.66 -49.04 51.62 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.431 0.634 . . . . 0.0 110.835 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.472 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.1 pp0? -54.62 -41.93 70.57 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -59.5 -54.37 47.43 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.049 -177.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.499 ' CE1' ' OD2' ' A' ' 36' ' ' ASP . 41.4 t80 -61.78 -20.42 63.57 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.321 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.73 -1.14 84.53 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.412 ' O ' ' O ' ' A' ' 134' ' ' PRO . 33.3 mttm -151.65 159.64 32.94 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.412 ' O ' ' O ' ' A' ' 133' ' ' LYS . 4.1 Cg_exo -42.24 177.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 123.858 3.039 . . . . 0.0 112.933 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.4 tp -131.43 123.58 28.44 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.413 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -65.41 145.87 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 C-N-CA 117.927 -1.509 . . . . 0.0 107.329 -179.562 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t -118.28 121.93 41.64 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 123.408 0.443 . . . . 0.0 111.191 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.2 m -129.77 162.03 29.36 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.255 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 17.7 m -72.04 145.57 48.19 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.93 81.19 1.67 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.694 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 57.6 p30 -158.7 164.71 35.66 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.335 0.588 . . . . 0.0 110.581 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.15 -163.4 1.47 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.186 -178.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 38.8 t -61.27 -44.25 97.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.676 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -159.71 4.9 0.11 Allowed Glycine 0 N--CA 1.46 0.28 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.5 tp -82.04 127.05 73.3 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -38.95 156.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.621 1.548 . . . . 0.0 112.271 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -75.71 -167.21 0.41 Allowed 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.352 2.035 . . . . 0.0 112.316 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 8.7 t -114.81 77.97 1.12 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.333 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -57.66 -34.97 69.93 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.229 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.45 168.4 20.3 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.438 HG11 ' HA ' ' A' ' 166' ' ' PRO . 1.4 m -57.66 -17.61 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.436 ' O ' ' HB2' ' A' ' 156' ' ' ALA . 66.9 t0 -65.05 -35.63 81.77 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 177.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.444 ' OE1' ' OE1' ' A' ' 157' ' ' GLN . 5.8 tm-20 -59.83 -72.5 0.1 Allowed 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.765 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.404 HG11 HG11 ' A' ' 164' ' ' VAL . 7.8 p -48.04 -30.63 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.342 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.426 ' O ' ' N ' ' A' ' 159' ' ' GLY . 3.8 tmt_? -83.84 -45.36 13.36 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 122.185 0.993 . . . . 0.0 110.285 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 152' ' ' ASP . . . -57.75 -41.03 81.07 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.416 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.466 ' CG ' ' N ' ' A' ' 158' ' ' PHE . 7.9 pt20 -82.65 -48.7 10.62 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 112.932 -1.94 . . . . 0.0 112.224 -176.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.466 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 32.0 t80 -106.85 -35.92 6.81 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 96.22 25.26 12.82 Favored Glycine 0 N--CA 1.472 1.092 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -178.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.407 ' HB1' ' HG2' ' A' ' 163' ' ' PRO . . . -43.36 -94.27 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.514 0.197 . . . . 0.0 110.901 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.474 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 62.13 36.47 15.11 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-O 121.25 0.547 . . . . 0.0 109.857 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.559 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.8 m-85 -175.77 -62.06 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.277 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.407 ' HG2' ' HB1' ' A' ' 160' ' ' ALA . 86.4 Cg_endo -73.46 28.87 0.31 Allowed 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.32 2.013 . . . . 0.0 110.367 177.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.581 HG23 ' HD3' ' A' ' 166' ' ' PRO . 16.8 m -133.27 167.01 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.053 -178.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 6.8 t -124.3 65.51 40.6 Favored Pre-proline 0 N--CA 1.473 0.696 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.694 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.581 ' HD3' HG23 ' A' ' 164' ' ' VAL . 31.0 Cg_exo -37.22 143.88 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 123.611 2.874 . . . . 0.0 115.08 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 165.94 177.65 38.25 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 113.734 -1.576 . . . . 0.0 110.598 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -151.14 151.53 32.07 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.467 0.42 0 CA-C-O 120.991 0.424 . . . . 0.0 110.925 -179.739 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 . . . . . 0 N--CA 1.445 -0.692 0 CA-C-O 120.643 0.258 . . . . 0.0 111.333 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 178' ' ' ILE . 29.7 pt -90.84 132.49 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 121.13 0.49 . . . . 0.0 110.817 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 22.7 mmm-85 -129.48 158.51 39.02 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.762 0.791 . . . . 0.0 110.817 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 184' ' ' GLY . 99.8 m-20 -77.06 104.88 7.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.151 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -64.78 -22.97 67.1 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.148 -178.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.496 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.6 mm? -63.68 -41.62 98.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.611 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.1 t -121.0 -42.71 2.48 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.583 0.23 . . . . 0.0 111.099 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 180' ' ' ASP . . . . . . . . 0 CA--C 1.524 0.625 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 . . . . . 0 N--CA 1.462 0.136 0 CA-C-O 120.956 0.408 . . . . 0.0 110.764 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.559 HD12 ' N ' ' A' ' 5' ' ' LEU . 9.2 mp -62.73 -42.05 99.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.107 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -63.97 -43.29 96.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.756 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -64.07 -41.49 97.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.264 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -61.26 -44.21 97.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.109 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.75 -45.55 92.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.975 0.417 . . . . 0.0 109.959 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.6 mt -63.92 -43.15 97.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.81 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.04 -41.75 88.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.528 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.38 -47.38 79.49 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.858 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.05 -51.79 66.58 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.4 pp -67.71 -39.3 81.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.873 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -58.63 -50.04 75.29 Favored 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.306 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 21' ' ' ARG . 88.3 t -64.07 -38.66 83.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.933 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.68 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.3 tt -52.69 -51.0 62.18 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.42 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -78.91 -47.1 17.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.409 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -68.28 -31.17 70.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.136 0.494 . . . . 0.0 111.22 -178.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.4 mt-10 57.13 59.92 3.2 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.123 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.528 ' O ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -152.21 158.9 43.51 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.176 0.512 . . . . 0.0 110.13 179.039 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 34' ' ' GLY . 8.2 p -75.99 140.55 17.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.57 -178.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.421 HG22 ' NH2' ' A' ' 21' ' ' ARG . 2.8 pp -125.4 167.73 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.615 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.25 132.22 48.51 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.277 0.561 . . . . 0.0 111.718 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -115.87 133.55 22.84 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -83.76 140.68 9.32 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 CA-C-N 120.567 1.238 . . . . 0.0 111.857 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.3 m -138.45 134.63 34.28 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -56.94 -42.91 80.92 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.824 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.66 -79.6 0.07 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.8 t -132.53 129.55 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -41.08 157.05 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.796 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -159.95 -169.53 23.37 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.4 m -131.08 168.52 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.543 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -159.29 178.98 35.21 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.059 -1.067 . . . . 0.0 111.818 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.476 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.8 OUTLIER -158.22 -163.2 1.25 Allowed 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.948 -178.826 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.476 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 35.9 m-20 -91.71 105.78 14.56 Favored Pre-proline 0 CA--C 1.555 1.168 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -177.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -38.11 -62.15 0.32 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.521 2.148 . . . . 0.0 112.929 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -71.91 65.12 0.52 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.516 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 m -151.18 131.18 13.39 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.683 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -66.36 -32.75 74.34 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.214 0.531 . . . . 0.0 111.184 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.522 HG23 ' N ' ' A' ' 42' ' ' ALA . 15.1 t -60.19 -42.53 95.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.34 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.522 ' N ' HG23 ' A' ' 41' ' ' THR . . . -56.63 -50.43 72.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.968 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 p -64.44 -42.62 95.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.207 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 94.0 mtp -63.92 -39.46 94.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -60.46 -41.77 94.79 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 122.087 0.946 . . . . 0.0 108.448 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.454 ' O ' HD23 ' A' ' 46' ' ' LEU . 1.1 tt -64.15 -53.33 51.16 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.369 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.8 mt -70.0 -11.46 60.89 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.062 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -70.32 -83.02 0.03 OUTLIER 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.121 0.486 . . . . 0.0 111.193 -177.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.5 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.2 pt? -76.16 -33.92 59.37 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 -178.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -77.58 -51.93 9.87 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.435 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 36.51 66.47 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.861 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.2 mtm-85 177.8 -53.96 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.918 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.149 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -78.12 -5.96 15.45 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.604 2.202 . . . . 0.0 112.341 -178.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.537 HG13 ' N ' ' A' ' 55' ' ' ASP . 7.1 p -44.34 -44.82 2.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.888 -179.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.537 ' N ' HG13 ' A' ' 54' ' ' VAL . 48.4 t0 -64.34 -42.72 96.13 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.223 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -61.92 -36.6 81.83 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 63.15 113.73 0.01 OUTLIER Glycine 0 C--N 1.332 0.332 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.548 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -53.78 -160.67 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.008 0.433 . . . . 0.0 111.776 -179.314 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.0 mt -106.63 141.4 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.872 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.7 mt -118.89 142.62 47.58 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.8 tp -111.64 132.41 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-O 121.226 0.536 . . . . 0.0 110.853 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.481 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -119.97 153.45 35.94 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.26 -27.67 7.89 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -116.97 147.04 42.63 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.018 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -76.34 -13.5 60.14 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -50.82 -32.68 20.86 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.256 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.71 -12.34 29.46 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.449 HD22 ' N ' ' A' ' 68' ' ' LEU . 4.2 mm? -91.13 -15.92 28.63 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.463 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 11.3 ttmm -79.33 -38.49 1.3 Allowed Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 84.9 Cg_endo -103.59 -3.0 0.26 Allowed 'Trans proline' 0 C--N 1.316 -1.146 0 C-N-CA 122.764 2.309 . . . . 0.0 112.116 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.456 ' OH ' ' CD2' ' A' ' 114' ' ' LEU . 64.1 t80 -96.09 -8.34 33.63 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.92 0.39 . . . . 0.0 110.549 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.591 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.3 mp -138.16 167.58 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.591 ' N ' HG22 ' A' ' 72' ' ' ILE . 98.7 m-20 -63.34 -17.42 62.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.09 0.471 . . . . 0.0 110.086 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.0 t70 54.29 5.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.954 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.487 ' H ' ' C ' ' A' ' 73' ' ' ASP . 13.4 t -69.26 -37.49 77.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.181 0.515 . . . . 0.0 109.941 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.428 ' N ' HG23 ' A' ' 75' ' ' THR . 76.1 mmm -66.47 -41.96 88.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.942 0.877 . . . . 0.0 109.018 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 77' ' ' LEU . 9.4 mp -70.79 144.64 50.78 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 113.875 -1.511 . . . . 0.0 110.845 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.49 160.89 43.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.063 -179.016 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -42.89 -44.92 4.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.906 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.502 HG13 ' N ' ' A' ' 81' ' ' GLN . 12.2 p -60.49 -41.06 86.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.1 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.502 ' N ' HG13 ' A' ' 80' ' ' VAL . 35.4 mt-30 -64.09 -40.16 95.62 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.608 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -65.28 -52.02 56.94 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 122.508 1.147 . . . . 0.0 108.819 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.414 ' O ' ' N ' ' A' ' 87' ' ' SER . 81.7 tt0 -54.3 -50.53 67.11 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 113.7 -1.591 . . . . 0.0 109.724 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.1 m -60.83 -50.42 73.52 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.31 -1.314 . . . . 0.0 111.666 -178.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 88' ' ' ARG . 7.6 tt -67.11 -34.09 67.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 119.371 -0.932 . . . . 0.0 109.262 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -70.16 -38.94 75.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.941 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 83' ' ' GLU . 4.5 m -87.22 -17.45 32.59 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.009 0.433 . . . . 0.0 110.869 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 85' ' ' ILE . 53.0 ttt85 -114.55 171.97 7.31 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 4.4 m0 -33.27 148.29 0.07 OUTLIER Pre-proline 0 CA--C 1.54 0.569 0 O-C-N 123.186 0.304 . . . . 0.0 111.35 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.56 -17.13 48.31 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.19 1.927 . . . . 0.0 111.506 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.465 ' H ' ' HD3' ' A' ' 92' ' ' PRO . . . 103.03 70.53 0.85 Allowed Glycine 0 N--CA 1.469 0.842 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.465 ' HD3' ' H ' ' A' ' 91' ' ' GLY . 50.8 Cg_exo -53.57 -42.23 67.45 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.495 2.13 . . . . 0.0 112.321 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.523 ' O ' ' CE1' ' A' ' 95' ' ' PHE . 11.7 p -75.37 140.03 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.957 0.408 . . . . 0.0 110.776 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 22.7 m -90.57 150.29 21.8 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.91 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.599 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -130.49 148.44 52.3 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.087 179.69 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.715 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.9 t -102.03 112.95 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.434 ' CE1' ' HB1' ' A' ' 181' ' ' ALA . 53.1 m-85 -99.24 152.14 37.67 Favored Pre-proline 0 N--CA 1.47 0.561 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.699 -178.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.78 112.2 3.46 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.189 1.926 . . . . 0.0 111.475 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.71 152.82 78.05 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.82 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.36 152.37 81.72 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.028 1.819 . . . . 0.0 111.395 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.249 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.126 -179.54 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.406 ' O ' ' N ' ' A' ' 109' ' ' GLY . 8.4 tpt180 . . . . . 0 CA--C 1.532 0.286 0 CA-C-O 120.602 0.239 . . . . 0.0 110.724 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 53.6 p-90 -74.47 -7.7 53.86 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.146 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.958 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -71.13 -35.58 71.77 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.605 179.551 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.702 ' H ' HD22 ' A' ' 107' ' ' LEU . 86.8 m -133.98 -39.13 0.87 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.651 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 84.57 -5.92 79.47 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.226 -0.511 . . . . 0.0 112.727 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -148.85 -72.47 0.19 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 117.723 0.762 . . . . 0.0 111.402 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.447 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 18.8 t80 -88.89 -165.5 1.35 Allowed 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.447 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 51.2 p30 -130.9 51.43 2.14 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.836 0.351 . . . . 0.0 110.897 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.2 p -152.31 153.24 33.29 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.515 ' C ' HG13 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -159.81 136.43 9.12 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -179.261 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.439 ' N ' HG13 ' A' ' 96' ' ' VAL . . . -68.39 127.32 32.54 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 113.225 -1.807 . . . . 0.0 109.967 177.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.6 p -148.01 153.61 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -146.52 155.87 42.84 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.831 0.348 . . . . 0.0 111.021 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.481 HG22 ' HB3' ' A' ' 62' ' ' ALA . 53.2 t -122.63 135.37 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.7 t -133.49 153.42 51.64 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.275 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 52.6 p-10 -154.53 81.28 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.378 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.628 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 27.0 t-80 -171.95 -37.42 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.628 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 31.2 Cg_endo -94.0 -163.08 0.1 OUTLIER 'Trans proline' 0 C--N 1.32 -0.922 0 C-N-CA 121.954 1.769 . . . . 0.0 111.959 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 16.2 mt -76.94 -4.84 45.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.939 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 91.8 t -57.86 -45.58 87.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.171 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.764 HG23 ' H ' ' A' ' 126' ' ' ALA . 28.2 m -53.17 -62.22 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 C-N-CA 119.467 -0.893 . . . . 0.0 108.67 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.764 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.79 -42.54 2.67 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.008 0.432 . . . . 0.0 110.685 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.4 tp -70.05 -48.33 58.3 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.489 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 63.9 m -70.56 -48.3 56.05 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.575 0.702 . . . . 0.0 110.781 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.465 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -55.08 -42.15 72.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.788 -1.096 . . . . 0.0 108.195 179.29 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -59.32 -55.66 31.98 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.648 -177.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -61.7 -21.94 64.91 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.656 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.6 1.48 86.68 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -151.66 160.1 32.22 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.113 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -45.41 166.17 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 123.833 3.022 . . . . 0.0 112.967 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.4 tp -121.21 122.81 40.77 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 176.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.414 ' O ' ' CA ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -63.6 146.9 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.856 0 C-N-CA 117.712 -1.595 . . . . 0.0 106.722 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.9 t -122.56 126.13 47.12 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.694 0.621 . . . . 0.0 111.572 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 3.7 m -132.37 164.55 26.23 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.53 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 30.4 t -71.07 151.19 44.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.844 0.354 . . . . 0.0 110.728 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.436 ' HB1' ' H ' ' A' ' 148' ' ' CYS . . . -60.75 -37.3 81.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.975 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 54.7 p30 -55.87 154.77 6.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.657 0.741 . . . . 0.0 111.425 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.45 -159.15 0.94 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.629 -178.382 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.9 p -61.36 -38.7 87.94 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.061 0.458 . . . . 0.0 110.153 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -165.8 0.78 0.05 OUTLIER Glycine 0 CA--C 1.511 -0.166 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.2 tp -81.68 124.8 79.43 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.237 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -38.73 156.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.939 1.759 . . . . 0.0 111.931 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -74.84 -162.87 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.391 2.061 . . . . 0.0 112.256 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.436 ' H ' ' HB1' ' A' ' 140' ' ' ALA . 73.0 m -119.5 76.4 1.13 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.7 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -54.16 -32.97 56.89 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.817 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.0 165.55 15.78 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.417 HG11 ' HA ' ' A' ' 166' ' ' PRO . 0.9 OUTLIER -55.75 -17.66 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.746 0 CA-C-O 121.751 0.786 . . . . 0.0 109.267 179.925 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -66.24 -34.58 78.33 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.33 -70.6 0.16 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.729 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.5 p -48.62 -31.11 3.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.155 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 159' ' ' GLY . 4.6 tmt_? -79.64 -51.65 8.99 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.863 0.84 . . . . 0.0 109.338 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.98 -44.22 63.95 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.886 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.13 -30.59 25.78 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 112.845 -1.979 . . . . 0.0 114.351 -175.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -126.3 -32.9 2.66 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 118.012 0.369 . . . . 0.0 111.294 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 93.75 23.41 23.41 Favored Glycine 0 N--CA 1.467 0.744 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -42.77 -95.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.493 0.187 . . . . 0.0 110.957 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.454 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.93 37.04 15.43 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.189 0.519 . . . . 0.0 109.61 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.556 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.4 m-85 -175.88 -62.1 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.907 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.28 28.05 0.3 Allowed 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.349 2.032 . . . . 0.0 110.536 178.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.573 HG23 ' HD3' ' A' ' 166' ' ' PRO . 16.0 m -131.78 167.47 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.05 -178.07 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.2 65.96 30.74 Favored Pre-proline 0 N--CA 1.477 0.878 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.645 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.573 ' HD3' HG23 ' A' ' 164' ' ' VAL . 33.0 Cg_exo -38.27 147.42 0.11 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 123.686 2.924 . . . . 0.0 114.962 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 174.53 -148.72 10.0 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.117 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -143.4 -164.65 1.91 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.9 t . . . . . 0 N--CA 1.464 0.257 0 CA-C-O 121.354 0.597 . . . . 0.0 111.071 -179.722 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.444 -0.731 0 CA-C-O 120.889 0.376 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 178' ' ' ILE . 18.8 tt -112.28 130.74 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.698 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -133.83 169.4 17.12 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.714 0.768 . . . . 0.0 112.17 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -80.63 106.99 13.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.201 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -68.47 -16.68 63.98 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.214 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.8 mm? -63.37 -41.8 98.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.047 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.09 -44.31 3.6 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.176 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.563 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 179.854 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 . . . . . 0 N--CA 1.465 0.307 0 CA-C-O 120.616 0.246 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.552 HD12 ' N ' ' A' ' 5' ' ' LEU . 9.4 mp -63.27 -42.27 99.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.968 0.413 . . . . 0.0 110.252 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -64.81 -43.43 93.14 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.189 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -65.56 -38.67 90.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.277 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 162' ' ' PHE . 67.9 t0 -62.73 -45.65 91.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.613 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.14 -45.87 91.52 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.912 0.387 . . . . 0.0 110.031 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.63 -43.06 98.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.839 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.91 -42.62 85.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.541 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.13 -46.62 86.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.174 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.07 -51.4 69.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.811 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 14.7 pt -68.71 -39.84 80.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.409 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -57.15 -53.19 60.9 Favored 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 120.486 -0.485 . . . . 0.0 109.921 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 20' ' ' GLU . 89.0 t -61.61 -40.42 86.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.638 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.682 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.3 tt -52.99 -50.47 64.11 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.383 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -79.49 -51.23 9.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.753 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -64.8 -31.04 72.08 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.812 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 16' ' ' VAL . 96.7 mt-10 58.44 85.11 0.1 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.124 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.41 -142.54 0.09 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.706 0.288 . . . . 0.0 110.289 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.2 p -137.74 138.73 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 pp -128.05 163.99 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-O 121.118 0.485 . . . . 0.0 111.78 -178.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.68 128.43 36.2 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.914 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.518 ' CE2' ' O ' ' A' ' 26' ' ' PRO . 2.1 t80 -118.32 138.49 25.72 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.255 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.518 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 64.8 Cg_endo -80.93 149.51 17.83 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.191 1.26 . . . . 0.0 111.352 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.436 ' C ' ' H ' ' A' ' 29' ' ' ALA . 25.9 m -135.15 140.93 45.8 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.271 0.557 . . . . 0.0 110.808 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -77.77 20.07 0.36 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.033 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.436 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -154.97 -73.41 0.12 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.206 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 67.5 t -122.74 126.28 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 120.859 0.361 . . . . 0.0 110.737 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.521 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 90.9 m-85 -53.5 144.48 17.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.195 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -154.35 -168.37 17.7 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.2 m -132.08 168.31 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.97 -176.96 27.79 Favored Glycine 0 N--CA 1.464 0.566 0 C-N-CA 120.008 -1.092 . . . . 0.0 111.925 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -153.34 -166.2 2.36 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.734 0.302 . . . . 0.0 110.359 -179.43 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.514 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 7.8 m-20 -99.43 109.79 56.17 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-O 118.729 -0.653 . . . . 0.0 112.441 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 36' ' ' ASP . 15.4 Cg_exo -35.19 168.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.68 2.254 . . . . 0.0 114.302 177.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 44.73 67.39 0.7 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.433 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.7 m -142.94 137.59 29.53 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.07 0.462 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.631 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -71.65 -34.37 69.7 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.296 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.432 ' H ' HG22 ' A' ' 41' ' ' THR . 0.1 OUTLIER -63.45 -45.28 91.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.644 -178.121 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.424 ' HB2' ' SG ' ' A' ' 35' ' ' CYS . . . -63.1 -47.68 81.81 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.598 -178.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.3 p -62.59 -44.45 99.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.249 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 62.1 mtt -64.95 -39.79 94.02 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 -61.77 -32.98 73.29 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.026 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 79.9 mt -75.95 -57.23 4.0 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.4 mt -54.46 -18.91 4.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.243 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -67.23 -84.66 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.695 -178.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.515 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -75.83 -33.26 60.05 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -77.71 -71.23 0.43 Allowed 'General case' 0 C--N 1.346 0.445 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.738 -176.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.411 ' CG ' ' O ' ' A' ' 51' ' ' GLN . 3.2 tt0 53.65 80.98 0.1 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.399 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.3 mtp85 160.69 -64.04 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.116 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -66.78 -11.25 31.26 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 122.641 2.228 . . . . 0.0 111.775 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.596 HG13 ' N ' ' A' ' 55' ' ' ASP . 13.9 p -46.05 -45.97 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.596 ' N ' HG13 ' A' ' 54' ' ' VAL . 10.3 t0 -67.58 -44.44 78.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.676 -178.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -60.35 -40.5 90.96 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.759 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 71.39 111.66 0.04 OUTLIER Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.573 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -49.54 -169.86 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.986 -0.607 . . . . 0.0 111.896 179.632 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.439 ' O ' ' OG ' ' A' ' 137' ' ' SER . 80.9 mt -100.25 139.54 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.5 mt -113.24 143.84 43.73 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -178.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.412 ' O ' HG23 ' A' ' 61' ' ' ILE . 10.0 tp -112.26 127.97 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 CA-C-O 121.122 0.487 . . . . 0.0 110.548 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.497 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -113.46 154.59 26.76 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.56 -26.29 7.11 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -118.76 145.05 45.88 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.607 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -71.62 -12.53 61.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.571 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -49.6 -33.91 16.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.565 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -95.04 -15.74 23.23 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.582 HD22 ' N ' ' A' ' 68' ' ' LEU . 3.8 mm? -92.94 -13.14 29.23 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.476 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 27.9 tptt -80.49 -39.08 1.13 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.803 -178.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 65.8 Cg_endo -103.09 -3.4 0.28 Allowed 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 122.78 2.32 . . . . 0.0 111.784 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.561 ' OH ' HD21 ' A' ' 114' ' ' LEU . 39.8 t80 -96.56 -11.01 25.98 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.161 -178.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.581 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.2 mp -131.46 159.36 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.581 ' N ' HG22 ' A' ' 72' ' ' ILE . 91.2 m-20 -71.37 160.45 32.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.06 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 39.2 p30 -95.64 7.79 45.27 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.848 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.561 HG23 ' N ' ' A' ' 76' ' ' MET . 7.1 t -67.08 -45.77 76.3 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.325 0.583 . . . . 0.0 110.547 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.561 ' N ' HG23 ' A' ' 75' ' ' THR . 23.1 ptp -84.33 -6.26 59.37 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.232 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.3 tp -94.33 116.3 28.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.619 -177.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -154.95 167.2 31.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.91 -177.817 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -42.49 -44.49 4.1 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.196 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.66 -33.03 59.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.923 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 78' ' ' THR . 1.0 OUTLIER -65.75 -43.26 89.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.203 0.525 . . . . 0.0 110.52 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.402 ' NH2' ' HZ1' ' A' ' 69' ' ' LYS . 9.5 mmt85 -59.92 -49.17 78.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 122.76 1.267 . . . . 0.0 108.657 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -57.29 -49.84 74.82 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 113.446 -1.706 . . . . 0.0 110.005 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.7 m -62.59 -49.19 76.24 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.227 -1.351 . . . . 0.0 112.444 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.8 tt -68.42 -30.75 48.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.139 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -82.37 -40.02 21.93 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.917 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.2 m -78.35 -3.31 42.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.907 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -121.92 166.95 13.64 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 15.9 m-90 -43.49 150.71 0.5 Allowed Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.12 -19.37 45.11 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.911 1.741 . . . . 0.0 111.593 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.474 ' O ' ' NH2' ' A' ' 117' ' ' ARG . . . 177.64 78.78 0.06 OUTLIER Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -79.57 -35.52 0.79 Allowed 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.042 1.828 . . . . 0.0 112.516 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.515 ' CG1' ' CZ ' ' A' ' 95' ' ' PHE . 9.7 p -137.92 149.2 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 120.801 0.334 . . . . 0.0 110.886 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 16.3 m -81.39 129.51 34.66 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.515 ' CZ ' ' CG1' ' A' ' 93' ' ' VAL . 46.2 m-85 -117.02 137.4 52.26 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.733 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.697 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 5.5 t -92.05 102.59 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 121.277 0.561 . . . . 0.0 109.759 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -81.12 143.68 53.17 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.198 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -79.64 108.16 2.24 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 122.032 1.821 . . . . 0.0 111.099 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 112' ' ' ASP . . . -64.93 156.61 79.43 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.624 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 49.0 Cg_endo -66.69 -19.23 53.81 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.231 1.954 . . . . 0.0 112.187 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . 0 N--CA 1.472 0.671 0 O-C-N 123.536 0.523 . . . . 0.0 110.551 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 109' ' ' GLY . 0.6 OUTLIER . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 2.5 p90 -79.56 -9.83 59.69 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.676 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.969 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -69.28 -34.06 74.17 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.427 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.746 ' H ' HD22 ' A' ' 107' ' ' LEU . 28.5 m -141.39 -40.73 0.38 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.428 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 60.29 -13.62 0.04 OUTLIER Glycine 0 CA--C 1.536 1.398 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.657 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.558 ' H ' ' C ' ' A' ' 108' ' ' THR . 0.0 OUTLIER -85.52 -52.61 5.72 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 117.659 0.73 . . . . 0.0 109.284 179.758 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.534 ' CE2' ' OD1' ' A' ' 112' ' ' ASP . 17.6 t80 -154.37 -178.26 7.02 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.306 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.534 ' OD1' ' CE2' ' A' ' 111' ' ' PHE . 48.8 p30 -89.01 51.63 2.21 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.299 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.5 p -159.51 156.82 28.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.244 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.561 HD21 ' OH ' ' A' ' 71' ' ' TYR . 0.3 OUTLIER -163.75 141.5 7.38 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.421 ' HB2' HG22 ' A' ' 96' ' ' VAL . . . -69.7 125.23 26.09 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 113.737 -1.574 . . . . 0.0 109.617 177.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.491 HG22 ' N ' ' A' ' 117' ' ' ARG . 4.3 p -146.66 161.19 9.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.491 ' N ' HG22 ' A' ' 116' ' ' VAL . 78.7 ttt-85 -144.03 153.23 41.99 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.91 0.386 . . . . 0.0 111.389 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.497 HG22 ' HB3' ' A' ' 62' ' ' ALA . 52.2 t -122.45 136.64 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.2 t -135.24 149.04 49.77 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.249 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 35.4 p30 -151.68 78.82 1.26 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.763 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.61 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 10.3 t-80 -172.51 -36.85 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.61 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 18.9 Cg_endo -92.73 -161.66 0.09 OUTLIER 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 121.993 1.795 . . . . 0.0 111.686 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.4 mt -78.83 -4.68 50.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.016 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.4 t -58.21 -45.0 89.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.971 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.754 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.6 m -52.7 -62.2 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.935 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.754 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -40.96 -45.41 2.57 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.881 0.372 . . . . 0.0 111.027 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.435 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -66.69 -51.37 56.8 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.253 0.549 . . . . 0.0 110.778 179.535 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 71.2 m -69.5 -47.79 62.68 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.237 0.541 . . . . 0.0 111.425 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.475 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.2 pp0? -54.87 -42.2 71.75 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -60.4 -53.12 61.37 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.771 -177.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.45 ' CE1' ' OD2' ' A' ' 36' ' ' ASP . 42.0 t80 -64.48 -22.46 66.97 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.825 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.94 2.07 90.14 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 134' ' ' PRO . 34.3 mttm -152.4 159.56 32.52 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 133' ' ' LYS . 5.9 Cg_exo -41.12 -179.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 124.061 3.174 . . . . 0.0 113.941 -178.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.447 HD12 ' O ' ' A' ' 35' ' ' CYS . 8.0 tp -134.47 123.85 24.65 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 176.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.423 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.9 OUTLIER -66.14 143.73 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 C-N-CA 117.764 -1.574 . . . . 0.0 108.518 -179.153 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -108.82 121.88 46.0 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.96 0.788 . . . . 0.0 110.924 -179.346 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.9 m -132.38 157.64 44.02 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.819 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.6 m -73.0 143.2 47.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.011 0.434 . . . . 0.0 110.577 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.7 -36.76 85.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.034 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 51.8 p30 -52.37 150.38 4.82 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.774 0.797 . . . . 0.0 110.997 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.13 -158.39 0.73 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.048 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 45.2 m -59.93 -42.99 95.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.471 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -162.55 11.87 0.11 Allowed Glycine 0 N--CA 1.459 0.172 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.7 tp -93.44 127.51 46.13 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -38.76 157.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 121.758 1.638 . . . . 0.0 112.468 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -76.55 -166.94 0.41 Allowed 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 122.721 2.281 . . . . 0.0 112.487 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 70.9 m -112.03 76.93 1.0 Allowed 'General case' 0 C--O 1.231 0.103 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.521 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 17.5 ptm180 -54.06 -37.81 64.57 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.952 -178.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.42 167.64 29.13 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.441 HG22 ' H ' ' A' ' 151' ' ' VAL . 1.6 m -57.37 -20.35 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.6 0 CA-C-O 121.77 0.795 . . . . 0.0 109.248 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -64.21 -34.61 78.49 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.03 -79.49 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.872 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.439 HG13 ' N ' ' A' ' 155' ' ' ARG . 6.3 p -35.22 -34.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.687 0.795 . . . . 0.0 111.155 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.475 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -67.38 -52.79 35.66 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.347 0.594 . . . . 0.0 111.852 -178.618 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -69.35 -16.93 63.64 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 122.538 1.161 . . . . 0.0 108.035 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -84.23 -45.37 12.96 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 112.672 -2.058 . . . . 0.0 111.891 -178.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -130.34 -27.93 2.16 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.638 0.256 . . . . 0.0 111.642 -178.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 94.56 24.17 19.16 Favored Glycine 0 N--CA 1.468 0.783 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -43.68 -96.69 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.78 0.324 . . . . 0.0 111.126 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.508 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 62.3 34.8 15.61 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -178.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.544 ' H ' HG22 ' A' ' 164' ' ' VAL . 2.1 m-85 -174.04 -62.16 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.238 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.86 25.88 0.29 Allowed 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.349 2.033 . . . . 0.0 110.932 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.571 HG23 ' HD3' ' A' ' 166' ' ' PRO . 13.7 m -127.43 167.64 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.746 -178.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.1 t -122.35 64.87 21.58 Favored Pre-proline 0 N--CA 1.472 0.647 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.829 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.571 ' HD3' HG23 ' A' ' 164' ' ' VAL . 38.9 Cg_exo -37.62 144.32 0.15 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 123.652 2.901 . . . . 0.0 115.031 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 164.54 -176.78 40.36 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 113.901 -1.5 . . . . 0.0 110.878 178.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -142.09 152.8 43.63 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.469 0.487 0 CA-C-O 121.088 0.47 . . . . 0.0 111.169 -179.769 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.504 ' OE1' ' NH1' ' A' ' 179' ' ' ARG . 98.1 mt-10 . . . . . 0 N--CA 1.444 -0.747 0 CA-C-O 120.874 0.369 . . . . 0.0 110.834 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.479 ' O ' HG23 ' A' ' 178' ' ' ILE . 18.7 tt -111.25 125.13 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.653 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.504 ' NH1' ' OE1' ' A' ' 177' ' ' GLU . 7.2 mpt_? -122.5 161.43 23.62 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 122.102 0.953 . . . . 0.0 110.889 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -77.79 105.88 9.26 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.157 -1.383 . . . . 0.0 107.979 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -66.95 -13.61 61.98 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.753 -178.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.475 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.4 mm? -63.54 -42.02 98.42 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.062 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.2 -43.44 2.53 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.818 0.342 . . . . 0.0 110.623 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.781 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.701 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.821 0.343 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.4 mp -63.11 -42.32 99.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.212 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -61.96 -49.6 75.45 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.001 0.429 . . . . 0.0 110.053 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -58.51 -41.36 85.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.947 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.74 -44.76 96.29 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.588 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.43 -45.29 93.75 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.241 0.544 . . . . 0.0 109.94 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.9 -42.94 98.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.9 -42.43 79.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.156 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.2 -47.48 85.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.149 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.02 -53.21 60.53 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.626 -0.43 . . . . 0.0 112.053 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 14.2 pt -66.75 -38.32 81.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.117 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -58.36 -50.77 72.47 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.168 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 21' ' ' ARG . 92.6 t -62.81 -39.27 84.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.75 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.671 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.3 tt -52.48 -52.2 55.57 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.209 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -76.79 -48.72 17.76 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.223 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -67.14 -29.47 69.2 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.058 0.456 . . . . 0.0 110.837 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 16' ' ' VAL . 96.7 mt-10 56.36 60.52 3.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.564 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.542 ' O ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -153.65 159.6 42.12 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.302 0.573 . . . . 0.0 110.323 179.164 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 p -76.92 137.97 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.436 -178.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.513 HG22 ' NH2' ' A' ' 21' ' ' ARG . 2.8 pp -124.86 166.79 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-O 120.692 0.282 . . . . 0.0 110.898 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.05 133.86 53.86 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.379 0.609 . . . . 0.0 111.462 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.524 ' CE2' ' O ' ' A' ' 26' ' ' PRO . 3.5 t80 -126.66 138.68 33.0 Favored Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.524 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 64.3 Cg_endo -80.32 150.21 19.72 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 CA-C-N 120.419 1.185 . . . . 0.0 111.588 -178.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.448 ' C ' ' H ' ' A' ' 29' ' ' ALA . 30.2 m -130.14 140.09 50.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.649 0.262 . . . . 0.0 110.451 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -77.6 21.11 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.448 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -154.76 -74.59 0.11 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.124 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.4 p -123.79 127.41 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 121.24 0.543 . . . . 0.0 110.622 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 149' ' ' ARG . 97.4 m-85 -43.37 147.98 0.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.999 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -157.64 -174.72 27.71 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.4 m -131.23 169.38 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.43 178.92 33.55 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 119.946 -1.121 . . . . 0.0 112.656 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.564 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -152.97 -162.84 1.57 Allowed 'General case' 0 C--N 1.341 0.226 0 CA-C-N 115.521 -0.34 . . . . 0.0 110.309 -179.231 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.564 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 2.1 m-20 -101.52 111.12 63.39 Favored Pre-proline 0 CA--C 1.548 0.869 0 CA-C-O 118.802 -0.618 . . . . 0.0 112.622 -178.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 36' ' ' ASP . 22.8 Cg_exo -35.89 170.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.804 2.336 . . . . 0.0 114.413 177.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.8 t70 41.53 73.45 0.13 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.887 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.9 m -151.79 141.99 22.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.084 0.469 . . . . 0.0 110.308 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.644 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -70.43 -30.55 67.44 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.555 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.533 HG23 ' N ' ' A' ' 42' ' ' ALA . 12.6 t -60.09 -42.52 94.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.988 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.533 ' N ' HG23 ' A' ' 41' ' ' THR . . . -58.17 -52.53 65.15 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.345 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.07 -45.33 99.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.137 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 60.6 mtt -67.62 -45.29 75.84 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -65.8 -28.7 69.2 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.634 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 52.7 mt -74.72 -60.95 2.05 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.232 177.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.9 mt -51.63 -23.22 4.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.065 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.49 -85.73 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.723 -178.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.52 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -76.56 -33.66 58.51 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -75.5 -71.16 0.38 Allowed 'General case' 0 C--N 1.346 0.434 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.959 -176.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.406 ' O ' ' CG ' ' A' ' 51' ' ' GLN . 3.8 tt0 53.46 80.62 0.1 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.388 0.613 . . . . 0.0 109.454 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.1 mtt-85 161.07 -63.44 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.215 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.36 -10.4 28.87 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 122.737 2.291 . . . . 0.0 112.175 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.595 HG13 ' N ' ' A' ' 55' ' ' ASP . 7.3 p -44.95 -48.19 2.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.914 -178.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.595 ' N ' HG13 ' A' ' 54' ' ' VAL . 10.9 t0 -68.49 -42.29 78.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.425 -178.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -58.9 -41.96 88.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.398 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 68.97 112.86 0.02 OUTLIER Glycine 0 CA--C 1.518 0.248 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.568 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -49.64 -170.63 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.085 -0.558 . . . . 0.0 112.353 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.3 mt -97.7 148.29 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.1 mt -122.35 142.65 50.28 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 61' ' ' ILE . 8.6 tp -114.45 129.93 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-O 121.176 0.512 . . . . 0.0 110.984 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.601 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -114.11 159.9 19.52 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -124.94 -24.72 4.02 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -116.76 125.31 51.46 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.287 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -58.46 -13.23 5.02 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -50.23 -33.58 20.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.527 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.83 -11.55 28.64 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.512 HD22 ' N ' ' A' ' 68' ' ' LEU . 3.8 mm? -91.98 -14.6 29.21 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 118.864 0.757 . . . . 0.0 109.192 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.474 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 42.9 tttm -79.6 -38.56 1.26 Allowed Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.766 -178.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 73.6 Cg_endo -103.07 -3.43 0.28 Allowed 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 122.699 2.266 . . . . 0.0 111.836 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -96.53 -10.46 27.25 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.666 -178.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.602 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.7 mp -137.02 164.23 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.602 ' N ' HG22 ' A' ' 72' ' ' ILE . 97.6 m-20 -66.71 160.16 26.26 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -94.85 12.01 29.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.695 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.525 HG23 ' N ' ' A' ' 76' ' ' MET . 10.7 t -72.48 -41.12 66.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.223 0.535 . . . . 0.0 110.067 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.525 ' N ' HG23 ' A' ' 75' ' ' THR . 22.1 ptp -85.15 -18.26 34.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.546 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 tp -95.25 119.36 33.63 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.904 -178.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.473 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -158.03 161.03 38.04 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.303 -177.701 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -38.92 -47.86 1.5 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.837 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.1 p -62.86 -34.13 64.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.757 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 78' ' ' THR . 67.4 tp60 -65.99 -39.54 90.4 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.808 0.337 . . . . 0.0 110.93 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.436 ' HG2' ' H ' ' A' ' 82' ' ' ARG . 6.8 mmt85 -64.4 -52.86 56.07 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 122.581 1.181 . . . . 0.0 109.14 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -55.67 -50.39 70.38 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.126 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 88' ' ' ARG . 3.1 m -60.77 -51.05 70.97 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.926 -178.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 85' ' ' ILE . 10.0 tt -65.91 -36.49 77.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.596 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -67.14 -41.03 86.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.127 178.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.9 m -84.71 -19.02 33.4 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.8 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 84' ' ' THR . 77.8 ttt-85 -103.56 151.52 22.79 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.741 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -34.38 152.62 0.05 OUTLIER Pre-proline 0 N--CA 1.469 0.484 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.188 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.12 -17.93 55.62 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.132 1.888 . . . . 0.0 110.991 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.455 ' H ' ' HD3' ' A' ' 92' ' ' PRO . . . 99.19 69.32 0.92 Allowed Glycine 0 CA--C 1.529 0.967 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.779 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.455 ' HD3' ' H ' ' A' ' 91' ' ' GLY . 52.8 Cg_exo -54.54 -39.35 88.65 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.865 2.377 . . . . 0.0 111.493 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.425 HG13 ' CE2' ' A' ' 95' ' ' PHE . 3.2 p -78.59 147.84 6.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.328 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 85.5 m -88.11 143.62 26.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.731 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.449 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 61.6 m-85 -127.01 140.35 52.37 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.661 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.649 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 3.4 t -93.86 101.77 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-O 121.474 0.654 . . . . 0.0 109.633 178.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -91.81 151.31 42.06 Favored Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.882 -177.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.82 142.19 56.69 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.764 1.643 . . . . 0.0 110.309 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -114.95 116.54 42.64 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.397 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -45.59 167.4 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 121.6 1.533 . . . . 0.0 112.623 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.484 179.495 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.492 ' NH1' ' OD1' ' A' ' 112' ' ' ASP . 11.4 tpp180 . . . . . 0 N--CA 1.463 0.208 0 CA-C-O 120.749 0.309 . . . . 0.0 110.475 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 6.1 p90 -84.5 -9.4 58.38 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.632 ' H ' ' CD2' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -77.57 -17.65 57.67 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.678 -179.639 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.543 ' C ' ' H ' ' A' ' 110' ' ' ARG . 26.6 m -144.75 -43.85 0.24 Allowed 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.827 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 50.42 -1.87 0.01 OUTLIER Glycine 0 CA--C 1.541 1.688 0 CA-C-O 119.726 -0.485 . . . . 0.0 113.339 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.543 ' H ' ' C ' ' A' ' 108' ' ' THR . 0.5 OUTLIER -88.15 -54.87 4.0 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 117.947 0.873 . . . . 0.0 109.552 179.741 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.613 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 85.4 t80 -154.51 173.72 15.9 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.417 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.613 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 89.8 m-20 -79.12 50.92 1.1 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.372 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 82.1 p -158.52 160.04 36.24 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.457 ' C ' HG13 ' A' ' 96' ' ' VAL . 2.3 pp -167.13 140.02 3.51 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.87 112.21 4.17 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 113.437 -1.71 . . . . 0.0 110.75 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.499 HG22 ' N ' ' A' ' 117' ' ' ARG . 6.1 p -143.97 160.42 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.499 ' N ' HG22 ' A' ' 116' ' ' VAL . 14.8 ptt180 -155.99 162.16 40.38 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.949 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.601 HG22 ' HB3' ' A' ' 62' ' ' ALA . 54.7 t -121.24 138.82 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.543 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 7.9 t -132.62 150.43 52.16 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.957 0.408 . . . . 0.0 110.103 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.401 ' O ' ' OD1' ' A' ' 120' ' ' ASP . 30.6 p30 -150.4 81.1 1.36 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.324 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.605 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 61.7 t60 -171.81 -37.79 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.605 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 38.7 Cg_endo -95.49 -163.62 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 121.941 1.761 . . . . 0.0 112.3 -178.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.6 mt -78.54 -4.09 46.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.89 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 83.3 t -57.62 -45.96 86.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.648 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.756 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.1 m -52.96 -62.18 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.87 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.756 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.33 -43.84 2.58 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.243 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.1 tp -69.49 -48.07 61.85 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.954 0.406 . . . . 0.0 110.99 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 82.1 m -70.0 -48.96 55.98 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.408 0.623 . . . . 0.0 110.915 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.47 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.0 OUTLIER -55.24 -41.61 72.36 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.423 179.428 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.94 -54.42 47.36 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.383 -1.281 . . . . 0.0 109.605 -177.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.402 ' CE1' ' OD2' ' A' ' 36' ' ' ASP . 42.8 t80 -62.05 -21.47 64.95 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.983 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 81.43 -0.11 88.3 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 134' ' ' PRO . 24.7 mttp -152.37 159.14 33.12 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.004 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 133' ' ' LYS . 6.1 Cg_exo -41.61 179.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 123.838 3.026 . . . . 0.0 113.75 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.0 tp -134.58 123.73 24.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.443 -1.708 . . . . 0.0 106.578 177.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.43 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.9 OUTLIER -66.06 146.42 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 C-N-CA 117.684 -1.606 . . . . 0.0 107.327 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.0 t -118.3 129.25 55.35 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.249 0.547 . . . . 0.0 110.894 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.3 m -129.06 162.31 27.97 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.085 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 17.8 m -72.02 147.99 46.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.246 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.618 ' HB1' ' H ' ' A' ' 148' ' ' CYS . . . -63.63 -37.44 87.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.913 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -54.31 157.38 2.76 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.594 0.711 . . . . 0.0 111.256 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.74 -158.31 0.88 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.103 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.6 t -60.33 -44.08 95.81 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.382 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -165.97 12.43 0.07 OUTLIER Glycine 0 N--CA 1.46 0.264 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.3 tp -90.24 127.64 52.47 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -39.47 153.74 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 121.702 1.602 . . . . 0.0 112.22 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.29 157.43 41.57 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.431 2.088 . . . . 0.0 112.373 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.618 ' H ' ' HB1' ' A' ' 140' ' ' ALA . 18.7 m -80.37 76.35 7.18 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.534 ' O ' ' CD1' ' A' ' 31' ' ' PHE . 32.9 ptt-85 -55.19 -35.7 65.11 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.93 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.71 169.49 24.52 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.409 ' H ' HG22 ' A' ' 151' ' ' VAL . 1.0 OUTLIER -59.62 -23.82 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.547 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.23 -23.73 67.41 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 177.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 155' ' ' ARG . 5.6 tm-20 -69.56 -78.87 0.06 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.85 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.424 ' O ' ' N ' ' A' ' 158' ' ' PHE . 3.2 p -35.08 -30.66 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.473 0.709 . . . . 0.0 110.564 177.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -72.58 -51.43 19.79 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.083 -179.32 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 153' ' ' GLU . . . -67.32 -20.12 65.56 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.666 1.222 . . . . 0.0 107.793 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -83.09 -44.62 14.94 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 112.403 -2.181 . . . . 0.0 111.808 -178.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.424 ' N ' ' O ' ' A' ' 154' ' ' VAL . 49.4 t80 -130.63 -26.62 2.22 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.816 0.341 . . . . 0.0 111.84 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 92.18 25.74 20.81 Favored Glycine 0 N--CA 1.468 0.813 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.049 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -43.67 -96.74 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.498 -0.351 . . . . 0.0 111.189 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . 63.42 33.07 14.05 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -178.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.524 ' C ' ' H ' ' A' ' 164' ' ' VAL . 0.4 OUTLIER -174.24 -61.12 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.497 -179.58 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.83 28.93 0.28 Allowed 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.003 1.802 . . . . 0.0 110.652 177.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.565 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.4 m -130.63 166.91 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.088 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.5 t -121.51 65.68 17.28 Favored Pre-proline 0 N--CA 1.476 0.836 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.869 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.565 ' HD3' HG23 ' A' ' 164' ' ' VAL . 23.1 Cg_exo -35.41 139.07 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 123.628 2.885 . . . . 0.0 115.225 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 169.28 173.7 37.13 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.905 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -158.14 144.83 17.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.957 0.408 . . . . 0.0 110.51 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.9 t . . . . . 0 N--CA 1.466 0.336 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.656 179.534 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 . . . . . 0 N--CA 1.448 -0.575 0 CA-C-O 120.468 0.175 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 45.4 pt -122.22 143.21 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.933 0.397 . . . . 0.0 111.016 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -137.8 167.52 21.57 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.778 0.799 . . . . 0.0 111.949 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -83.97 106.7 15.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.205 -1.361 . . . . 0.0 110.355 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -65.01 -13.96 59.19 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.071 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.434 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.5 mm? -62.91 -42.0 99.65 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.33 -42.69 3.65 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.265 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.683 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.877 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.935 0.398 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.547 HD12 ' N ' ' A' ' 5' ' ' LEU . 9.6 mp -61.68 -42.4 98.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.971 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -63.38 -45.57 90.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.09 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -61.62 -38.11 86.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.994 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.04 -43.6 98.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.686 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.93 -49.23 78.29 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.633 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.9 mm -63.92 -43.19 97.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.537 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.49 -46.7 83.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.705 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.0 -43.61 98.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.41 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.88 -53.24 59.75 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.62 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.9 pt -69.5 -38.85 77.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.482 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -58.76 -55.35 36.29 Favored 'General case' 0 C--O 1.214 -0.807 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.338 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 20' ' ' GLU . 91.1 t -61.72 -40.23 86.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.386 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.677 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.3 tt -52.56 -51.26 60.61 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.681 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -79.81 -50.48 10.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.873 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -63.67 -32.71 74.27 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.615 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 16' ' ' VAL . 96.8 mt-10 58.7 82.86 0.13 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.377 0.881 . . . . 0.0 113.377 178.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.28 -141.38 0.05 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.679 0.275 . . . . 0.0 110.488 177.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.0 p -135.13 139.16 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.475 HD12 ' O ' ' A' ' 24' ' ' ALA . 2.8 pp -129.02 164.16 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 120.924 0.392 . . . . 0.0 111.98 -178.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.475 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -64.28 141.88 58.61 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.939 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -145.55 160.81 43.53 Favored Pre-proline 0 CA--C 1.546 0.82 0 CA-C-O 119.047 -0.501 . . . . 0.0 110.522 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.52 157.17 32.46 Favored 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 121.579 1.519 . . . . 0.0 111.442 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.2 m -136.97 155.2 50.02 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.276 0.56 . . . . 0.0 110.538 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -83.78 14.54 3.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.729 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -160.43 -64.93 0.07 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.165 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.9 t -125.49 127.45 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.071 0.463 . . . . 0.0 110.685 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.561 ' CZ ' HG13 ' A' ' 151' ' ' VAL . 35.8 t80 -56.72 131.07 48.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.313 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -141.03 -153.62 6.01 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.5 m -131.57 166.68 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -156.99 -179.95 32.32 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.987 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.406 ' O ' HD12 ' A' ' 135' ' ' LEU . 0.6 OUTLIER -153.68 -179.58 7.93 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -179.667 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 37' ' ' PRO . 36.7 t70 -91.98 110.08 41.56 Favored Pre-proline 0 CA--C 1.552 1.033 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 36' ' ' ASP . 57.0 Cg_exo -36.79 173.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 123.039 2.493 . . . . 0.0 114.517 177.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 49.01 64.64 1.64 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.861 -1.518 . . . . 0.0 111.216 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 65.2 m -147.2 138.03 23.65 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.043 0.449 . . . . 0.0 110.405 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.46 -35.95 73.62 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.531 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 41' ' ' THR . 0.3 OUTLIER -64.06 -42.59 96.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.463 -179.068 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.92 75.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.643 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 p -62.4 -44.91 99.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.277 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 90.0 mtp -64.01 -40.84 97.26 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 27.8 ttt-85 -61.4 -41.52 97.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.448 ' O ' HD23 ' A' ' 46' ' ' LEU . 1.0 OUTLIER -64.41 -54.3 34.92 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.595 -178.236 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.4 mt -69.74 -12.12 61.38 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.246 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -69.03 -82.54 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.149 0.5 . . . . 0.0 111.133 -177.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -76.21 -35.1 59.22 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -178.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -76.45 -50.41 14.14 Favored 'General case' 0 C--N 1.344 0.358 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.901 -177.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 35.52 65.5 0.4 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.995 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.415 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 6.7 mtm-85 178.49 -52.85 0.0 OUTLIER Pre-proline 0 CA--C 1.551 0.986 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.644 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.415 ' HD2' ' H ' ' A' ' 52' ' ' ARG . 91.1 Cg_endo -79.25 -4.28 13.65 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.875 2.384 . . . . 0.0 112.537 -178.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.602 HG13 ' N ' ' A' ' 55' ' ' ASP . 10.9 p -47.35 -44.76 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.111 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.602 ' N ' HG13 ' A' ' 54' ' ' VAL . 41.3 t0 -66.47 -40.44 89.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.445 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -60.69 -38.04 83.66 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 64.89 107.27 0.01 OUTLIER Glycine 0 CA--C 1.518 0.264 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.567 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -52.34 -163.32 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.022 0.439 . . . . 0.0 111.673 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.449 ' O ' ' OG ' ' A' ' 137' ' ' SER . 73.6 mt -109.07 135.16 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.3 mt -109.79 142.12 41.48 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.478 ' O ' HG23 ' A' ' 61' ' ' ILE . 9.3 tp -110.21 123.93 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-O 121.033 0.444 . . . . 0.0 111.304 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.507 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -113.99 157.15 22.84 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.499 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.97 -24.51 4.75 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.453 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -115.88 130.66 56.92 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.73 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -63.99 -13.03 43.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.752 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -50.57 -30.36 13.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.622 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.06 -15.87 21.94 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.546 HD22 ' N ' ' A' ' 68' ' ' LEU . 3.9 mm? -92.11 -15.32 27.88 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.666 -0.646 . . . . 0.0 109.329 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.474 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 35.4 tttp -80.53 -38.52 1.08 Allowed Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.693 -178.156 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 66.0 Cg_endo -103.55 -2.77 0.27 Allowed 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 122.663 2.242 . . . . 0.0 111.896 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.471 ' OH ' HD21 ' A' ' 114' ' ' LEU . 60.7 t80 -97.89 -9.46 26.29 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.032 -178.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.543 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.3 mp -131.86 159.38 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.543 ' N ' HG22 ' A' ' 72' ' ' ILE . 95.8 m-20 -65.56 158.57 26.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.968 0.413 . . . . 0.0 110.389 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 74' ' ' ASP . 37.1 p-10 -93.72 9.35 37.37 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.882 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.469 HG23 ' N ' ' A' ' 76' ' ' MET . 13.6 t -75.85 -39.16 57.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.131 0.491 . . . . 0.0 110.538 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.469 ' N ' HG23 ' A' ' 75' ' ' THR . 20.9 ptp -96.9 -15.28 21.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.257 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.7 tp -100.21 125.68 46.4 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.436 0.636 . . . . 0.0 111.331 -177.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.476 ' OG1' ' N ' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -148.76 178.46 8.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.984 -178.143 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.476 ' N ' ' OG1' ' A' ' 78' ' ' THR . 98.2 m-20 -59.97 -42.49 94.27 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 123.233 0.333 . . . . 0.0 111.082 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.6 p -61.05 -31.23 49.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.533 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -62.74 -41.61 99.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.391 0.615 . . . . 0.0 109.939 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.407 ' HG2' ' H ' ' A' ' 82' ' ' ARG . 12.6 mmt85 -65.46 -53.77 38.0 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 122.379 1.085 . . . . 0.0 109.821 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 87' ' ' SER . 82.0 tt0 -53.74 -50.34 66.18 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.317 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.1 m -62.39 -49.8 74.08 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.576 -1.193 . . . . 0.0 112.138 -177.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 89' ' ' TRP . 8.4 tt -68.54 -26.2 32.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.484 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -87.82 -22.52 24.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.932 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 83' ' ' GLU . 68.4 m -107.17 -56.07 2.25 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.573 ' O ' ' CG ' ' A' ' 89' ' ' TRP . 78.7 ttt-85 -61.61 -45.79 92.58 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.474 -178.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.573 ' CG ' ' O ' ' A' ' 88' ' ' ARG . 1.1 m0 174.72 154.37 0.31 Allowed Pre-proline 0 N--CA 1.47 0.532 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -68.71 -16.99 42.62 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.319 2.013 . . . . 0.0 111.452 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.452 ' H ' ' HD3' ' A' ' 92' ' ' PRO . . . 97.14 69.24 0.98 Allowed Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.452 ' HD3' ' H ' ' A' ' 91' ' ' GLY . 52.1 Cg_exo -54.98 -37.25 93.71 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.478 2.119 . . . . 0.0 111.38 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.1 p -77.98 144.4 11.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.536 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 27.2 m -93.57 143.57 26.18 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.385 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.42 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 63.5 m-85 -127.39 145.09 50.93 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.436 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.608 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.9 t -96.57 103.51 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 121.545 0.688 . . . . 0.0 110.145 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -89.39 148.0 39.47 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.55 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -77.76 111.59 3.15 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.93 1.753 . . . . 0.0 111.278 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.47 148.26 90.44 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -63.94 146.4 91.33 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.901 1.734 . . . . 0.0 112.272 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.521 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.67 179.744 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.527 ' NH2' ' O ' ' A' ' 110' ' ' ARG . 4.1 tpt180 . . . . . 0 N--CA 1.468 0.451 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -75.0 -1.24 21.78 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.011 0.434 . . . . 0.0 110.895 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.934 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -86.56 -17.9 32.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.669 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.633 ' N ' HD22 ' A' ' 107' ' ' LEU . 95.2 m -142.01 -39.99 0.36 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.374 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 74.83 18.95 80.11 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.361 179.012 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.527 ' O ' ' NH2' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -158.35 -74.1 0.08 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 117.313 0.557 . . . . 0.0 110.434 179.433 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -102.78 -173.68 2.38 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.26 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 49.1 p30 -115.38 57.88 0.73 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.786 0.327 . . . . 0.0 111.051 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.0 p -159.03 159.52 34.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.32 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.769 ' O ' HD12 ' A' ' 114' ' ' LEU . 4.6 pp -166.15 142.54 5.02 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.401 ' N ' HG13 ' A' ' 96' ' ' VAL . . . -68.8 121.48 16.61 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 113.349 -1.751 . . . . 0.0 109.276 177.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.433 HG22 ' N ' ' A' ' 117' ' ' ARG . 4.9 p -142.36 157.15 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.433 ' N ' HG22 ' A' ' 116' ' ' VAL . 62.1 ttp180 -146.48 149.83 34.42 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.157 0.503 . . . . 0.0 111.46 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.507 HG22 ' HB3' ' A' ' 62' ' ' ALA . 61.5 t -115.05 134.28 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.3 t -129.87 151.09 50.82 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.025 0.441 . . . . 0.0 110.924 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 49.9 p-10 -151.87 85.57 1.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.196 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.62 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 9.2 t60 -171.67 -38.03 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.62 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 74.2 Cg_endo -97.49 -159.45 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.931 0 C-N-CA 122.45 2.1 . . . . 0.0 112.318 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 32.5 mt -79.71 -4.99 54.27 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.343 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 74.2 t -57.08 -46.13 84.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.777 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.75 HG23 ' H ' ' A' ' 126' ' ' ALA . 30.2 m -55.24 -61.49 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.302 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.024 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.75 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -40.44 -47.09 2.55 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.844 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.695 HD13 ' C ' ' A' ' 127' ' ' LEU . 2.8 tm? -69.82 -47.28 63.36 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.571 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 85.3 m -68.71 -47.3 66.71 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.103 0.477 . . . . 0.0 111.296 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.462 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.3 pp0? -55.63 -43.06 75.81 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.462 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -59.48 -56.09 26.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.311 -177.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -63.16 -35.66 81.03 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.128 -1.397 . . . . 0.0 108.346 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 89.96 3.32 73.6 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 113.388 -1.733 . . . . 0.0 109.684 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -141.79 153.77 64.98 Favored Pre-proline 0 CA--C 1.552 1.043 0 CA-C-N 117.258 0.529 . . . . 0.0 111.21 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -48.46 -174.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 123.724 2.949 . . . . 0.0 113.969 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.406 HD12 ' O ' ' A' ' 35' ' ' CYS . 8.1 tp -140.8 125.36 17.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 113.02 -1.9 . . . . 0.0 106.31 177.12 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.428 HG13 ' H ' ' A' ' 136' ' ' VAL . 0.9 OUTLIER -64.67 142.93 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 C-N-CA 118.179 -1.408 . . . . 0.0 108.931 -179.494 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 59' ' ' ILE . 0.8 OUTLIER -108.96 121.1 44.42 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 123.762 0.664 . . . . 0.0 110.583 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 18.7 m -132.18 145.47 51.37 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.9 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.1 m -66.7 144.12 56.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.529 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.11 88.57 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -162.23 164.33 27.75 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.275 0.56 . . . . 0.0 110.589 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.8 -163.85 1.82 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.173 -178.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 80.2 p -63.54 -40.41 96.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.752 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -159.35 0.81 0.09 OUTLIER Glycine 0 N--CA 1.461 0.332 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.488 HD13 ' C ' ' A' ' 145' ' ' LEU . 1.2 tm? -79.24 111.83 23.49 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 145' ' ' LEU . 14.3 Cg_exo -33.59 155.23 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.213 1.942 . . . . 0.0 113.095 -179.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.51 -168.79 0.37 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.513 2.142 . . . . 0.0 112.555 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 15.3 m -129.81 82.37 2.07 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.477 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 52.2 ptt85 -52.25 -37.49 55.46 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.362 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.28 173.63 14.74 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.561 HG13 ' CZ ' ' A' ' 31' ' ' PHE . 1.2 m -58.81 -23.92 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 CA-C-O 121.567 0.699 . . . . 0.0 109.386 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -64.73 -27.27 68.79 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 155' ' ' ARG . 0.0 OUTLIER -68.99 -79.52 0.06 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.449 179.194 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.405 HG13 ' N ' ' A' ' 155' ' ' ARG . 7.7 p -34.67 -30.23 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.607 0.763 . . . . 0.0 110.418 178.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 159' ' ' GLY . 4.8 tmt_? -71.9 -52.89 15.07 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.082 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 153' ' ' GLU . . . -69.93 -18.37 63.37 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 122.493 1.14 . . . . 0.0 108.186 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -84.16 -44.69 13.73 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 112.87 -1.968 . . . . 0.0 111.578 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -130.37 -24.88 2.49 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 91.03 23.95 28.54 Favored Glycine 0 N--CA 1.47 0.948 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 -178.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -43.9 -93.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.584 -0.308 . . . . 0.0 111.091 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . 60.06 31.11 20.47 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.531 ' C ' ' H ' ' A' ' 164' ' ' VAL . 0.5 OUTLIER -170.19 -61.38 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.903 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -72.85 29.5 0.29 Allowed 'Trans proline' 0 N--CA 1.502 1.99 0 C-N-CA 122.283 1.989 . . . . 0.0 110.515 177.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.577 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.7 m -132.44 167.0 27.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.64 -178.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.1 t -123.63 66.86 37.69 Favored Pre-proline 0 N--CA 1.476 0.871 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.65 178.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.577 ' HD3' HG23 ' A' ' 164' ' ' VAL . 29.8 Cg_exo -38.45 147.22 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 123.693 2.929 . . . . 0.0 115.015 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 168.49 134.28 1.7 Allowed Glycine 0 CA--C 1.528 0.849 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.2 178.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -80.92 152.12 28.23 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.466 0.364 0 CA-C-O 121.125 0.488 . . . . 0.0 111.222 -179.587 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 N--CA 1.449 -0.517 0 CA-C-O 120.635 0.255 . . . . 0.0 110.569 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.7 pt -101.04 130.35 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 120.978 0.418 . . . . 0.0 110.337 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -123.44 163.3 21.13 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.601 0.715 . . . . 0.0 110.26 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -77.95 104.43 8.51 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.513 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -63.95 -17.66 63.49 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.879 -178.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.467 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.4 mm? -62.5 -42.26 99.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.947 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.53 -41.54 8.12 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.687 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.977 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.747 0.308 . . . . 0.0 110.501 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.538 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.3 mp -62.19 -42.59 99.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.164 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -65.03 -41.49 95.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.708 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -64.51 -42.54 95.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.075 0.465 . . . . 0.0 110.758 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.432 ' OD2' ' O ' ' A' ' 164' ' ' VAL . 66.1 t0 -65.78 -45.78 81.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.332 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.54 -48.75 73.92 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.456 HG23 ' N ' ' A' ' 11' ' ' ALA . 19.3 tt -67.35 -41.75 86.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.177 0.513 . . . . 0.0 110.761 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.456 ' N ' HG23 ' A' ' 10' ' ' ILE . . . -61.53 -40.9 96.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.754 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.95 -46.41 74.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.956 0.408 . . . . 0.0 110.525 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.78 -50.57 70.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.229 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.3 pp -68.92 -38.85 79.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.346 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.35 -54.52 45.84 Favored 'General case' 0 C--O 1.216 -0.71 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.264 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.426 ' O ' ' N ' ' A' ' 20' ' ' GLU . 99.5 t -60.54 -40.1 83.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.606 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.697 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.2 tt -52.41 -49.92 63.55 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.846 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -82.17 -51.2 8.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.614 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -63.65 -33.64 76.07 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.282 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.5 mt-10 58.16 83.26 0.12 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.451 179.098 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.4 -145.96 0.15 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.405 178.054 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.2 p -133.33 140.31 47.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -128.19 165.46 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-O 120.859 0.362 . . . . 0.0 111.531 -178.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.47 127.14 30.24 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.633 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.474 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 0.6 OUTLIER -117.09 140.49 27.15 Favored Pre-proline 0 N--CA 1.473 0.721 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.741 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.474 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 93.3 Cg_endo -77.3 144.06 22.81 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.242 1.295 . . . . 0.0 111.651 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.8 m -137.66 134.43 35.43 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.433 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -53.38 -44.85 68.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.167 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.94 -81.33 0.07 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.632 0.253 . . . . 0.0 111.444 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 71.8 t -133.32 128.69 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -36.77 144.67 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.773 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -141.17 -163.93 9.74 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.9 m -130.67 168.72 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -160.18 -179.34 34.9 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 119.963 -1.113 . . . . 0.0 112.297 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -157.97 -168.2 2.44 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.975 -179.242 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 19.9 p-10 -93.24 108.7 35.07 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 36' ' ' ASP . 33.7 Cg_exo -36.86 172.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.972 2.448 . . . . 0.0 114.574 177.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 41.76 73.32 0.13 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.231 -1.349 . . . . 0.0 111.124 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.1 m -153.39 134.34 13.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.608 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -67.69 -34.16 76.34 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.811 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.574 HG23 ' N ' ' A' ' 42' ' ' ALA . 15.1 t -63.34 -46.49 86.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.996 -178.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.574 ' N ' HG23 ' A' ' 41' ' ' THR . . . -60.12 -50.43 73.74 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.538 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 p -62.04 -45.23 99.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.831 0.348 . . . . 0.0 110.279 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 61.7 mtt -64.36 -39.53 94.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.865 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 -60.91 -34.25 74.39 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 123.537 0.523 . . . . 0.0 109.831 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 82.2 mt -73.56 -60.39 2.27 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.2 mt -54.77 -18.02 4.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.678 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -67.85 -84.67 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.901 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -75.86 -33.06 59.99 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.581 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -76.1 -69.69 0.49 Allowed 'General case' 0 C--N 1.348 0.525 0 C-N-CA 119.421 -0.911 . . . . 0.0 110.382 -177.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 50.89 80.27 0.08 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.706 0.765 . . . . 0.0 109.201 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.7 mtm180 162.87 -62.71 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.271 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.14 -15.51 48.72 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.423 2.082 . . . . 0.0 112.455 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.612 HG13 ' N ' ' A' ' 55' ' ' ASP . 10.9 p -41.79 -49.31 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.72 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.612 ' N ' HG13 ' A' ' 54' ' ' VAL . 37.0 t0 -65.38 -41.87 93.28 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.029 0.443 . . . . 0.0 110.935 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -59.89 -37.06 78.29 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.392 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 63.32 107.8 0.01 OUTLIER Glycine 0 CA--C 1.519 0.284 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.566 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -52.92 -162.46 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.216 0.531 . . . . 0.0 111.661 -179.449 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.7 mt -108.17 146.95 13.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.7 mt -119.62 139.29 52.42 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.8 tp -110.28 133.08 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-O 121.133 0.492 . . . . 0.0 110.917 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.403 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -121.73 152.43 39.43 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.469 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.65 -29.6 7.95 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -111.29 149.8 30.56 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.233 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -79.26 -14.11 59.24 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -53.01 -30.83 37.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.961 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.02 -12.05 27.32 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.59 HD22 ' N ' ' A' ' 68' ' ' LEU . 3.3 mm? -92.57 -16.25 25.93 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.002 0.819 . . . . 0.0 108.97 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.467 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 50.9 tttm -77.71 -38.83 1.82 Allowed Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.671 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 67.1 Cg_endo -104.73 -2.64 0.2 Allowed 'Trans proline' 0 C--N 1.318 -1.03 0 C-N-CA 122.835 2.356 . . . . 0.0 112.648 -178.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -97.78 -8.46 28.45 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.749 0.309 . . . . 0.0 110.791 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.611 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.3 mp -135.75 162.97 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.611 ' N ' HG22 ' A' ' 72' ' ' ILE . 92.6 m-20 -64.78 156.65 29.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.628 -0.429 . . . . 0.0 109.857 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -94.29 8.48 41.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.76 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.528 HG23 ' N ' ' A' ' 76' ' ' MET . 14.9 t -73.58 -41.73 62.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.181 0.515 . . . . 0.0 110.568 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.528 ' N ' HG23 ' A' ' 75' ' ' THR . 21.7 ptp -90.12 -7.37 53.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.095 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 tp -102.0 120.41 40.37 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.097 0.475 . . . . 0.0 110.746 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -159.12 160.68 35.91 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.576 -177.828 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -39.13 -48.17 1.67 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.789 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.3 p -62.96 -33.19 59.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.852 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 78' ' ' THR . 63.6 tp60 -65.49 -39.66 92.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.974 0.416 . . . . 0.0 110.764 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.1 mmt85 -65.07 -52.14 57.4 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 122.523 1.154 . . . . 0.0 109.181 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -55.35 -50.5 69.51 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 113.702 -1.59 . . . . 0.0 110.235 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.1 m -61.19 -49.92 75.24 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.167 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 85' ' ' ILE . 9.0 tt -67.98 -34.07 64.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.202 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -75.66 -39.36 57.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.865 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.5 m -77.4 -32.46 54.82 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 120.991 0.424 . . . . 0.0 110.955 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 89' ' ' TRP . 76.1 ttt180 -97.14 75.93 2.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.389 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.435 ' O ' ' O ' ' A' ' 88' ' ' ARG . 57.7 m95 56.19 150.19 0.06 OUTLIER Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.244 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.77 -19.84 35.53 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.277 1.985 . . . . 0.0 111.738 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 163.11 82.03 0.04 OUTLIER Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -80.84 -30.91 1.58 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.352 2.035 . . . . 0.0 112.169 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.532 ' O ' ' CE1' ' A' ' 95' ' ' PHE . 9.4 p -136.76 149.14 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.738 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 91.8 m -91.59 143.16 26.86 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.627 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.543 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 0.2 OUTLIER -125.5 147.01 49.4 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.207 179.24 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.617 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 3.0 t -99.6 107.84 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 121.376 0.607 . . . . 0.0 109.394 178.391 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.402 ' CE1' ' HB1' ' A' ' 181' ' ' ALA . 58.8 m-85 -94.53 151.17 39.08 Favored Pre-proline 0 N--CA 1.47 0.552 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.734 -178.07 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.11 106.44 2.27 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 121.695 1.597 . . . . 0.0 110.403 178.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.81 150.1 83.34 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.02 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 101' ' ' ALA . 98.9 Cg_endo -73.07 157.49 50.74 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.379 2.053 . . . . 0.0 112.986 -178.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.438 ' O ' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.627 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.523 ' O ' ' N ' ' A' ' 109' ' ' GLY . 11.6 tpp180 . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.778 0.323 . . . . 0.0 110.679 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 61.7 p-90 -73.6 -10.75 60.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.929 0.395 . . . . 0.0 110.434 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.952 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -85.99 -16.56 37.9 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.115 -179.766 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.623 ' N ' HD22 ' A' ' 107' ' ' LEU . 98.9 m -141.9 -39.53 0.37 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.724 0.297 . . . . 0.0 110.8 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 82.31 13.86 77.84 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.66 -68.83 0.06 Allowed 'General case' 0 CA--C 1.535 0.366 0 O-C-N 122.444 -0.445 . . . . 0.0 110.166 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -103.58 -162.47 0.91 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.967 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.9 p-10 -127.64 62.29 1.39 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.026 0.441 . . . . 0.0 110.957 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.2 p -158.77 157.47 31.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.015 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.514 ' O ' HD12 ' A' ' 114' ' ' LEU . 0.3 OUTLIER -160.41 140.9 11.66 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -179.258 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.431 ' N ' HG13 ' A' ' 96' ' ' VAL . . . -70.58 126.93 31.01 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 113.094 -1.867 . . . . 0.0 109.702 177.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.4 p -146.02 152.83 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -147.81 156.94 43.25 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.783 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.403 HG22 ' HB3' ' A' ' 62' ' ' ALA . 54.7 t -119.74 132.32 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.432 ' O ' HG23 ' A' ' 119' ' ' THR . 11.3 t -133.27 128.36 35.66 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.734 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -135.82 84.1 2.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.925 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.66 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 16.6 t-80 -173.2 -35.63 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.58 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.66 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 67.7 Cg_endo -94.74 -159.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.935 0 C-N-CA 121.995 1.797 . . . . 0.0 111.907 -178.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 36.7 mt -77.69 -7.38 56.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.535 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 95.7 t -57.46 -45.27 85.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.716 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.752 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.9 m -51.63 -62.05 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.943 0 C-N-CA 119.555 -0.858 . . . . 0.0 108.797 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.752 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.34 -44.81 2.86 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.792 0.329 . . . . 0.0 110.809 178.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.441 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -66.33 -50.96 61.83 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 121.27 0.557 . . . . 0.0 110.723 179.461 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 62.3 m -69.64 -48.46 59.82 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.326 0.584 . . . . 0.0 111.558 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.457 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 0.8 OUTLIER -54.58 -42.38 70.96 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.451 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -59.28 -55.5 34.02 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.583 -177.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -62.62 -24.71 67.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.191 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.69 2.07 88.85 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 134' ' ' PRO . 59.7 mttt -153.53 159.54 32.0 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 133' ' ' LYS . 3.6 Cg_exo -42.23 177.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 123.876 3.051 . . . . 0.0 113.008 -178.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.3 tp -132.38 122.42 24.99 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.417 HG13 ' H ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -64.14 147.47 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 C-N-CA 117.775 -1.57 . . . . 0.0 106.83 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.9 t -122.54 127.26 49.27 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.206 0.527 . . . . 0.0 111.269 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.9 162.18 30.22 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.663 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.6 m -73.59 145.95 45.06 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.95 88.28 2.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.367 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 56.8 p30 -160.74 164.39 31.61 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.342 0.592 . . . . 0.0 110.421 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.57 -167.15 2.13 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.991 -178.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.1 p -61.77 -40.19 94.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.785 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -162.18 9.81 0.1 Allowed Glycine 0 N--CA 1.459 0.216 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.6 tp -89.99 126.88 55.83 Favored Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -37.52 157.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.942 1.761 . . . . 0.0 112.516 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.0 -166.45 0.37 Allowed 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.578 2.186 . . . . 0.0 112.668 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 7.4 t -118.14 76.7 1.09 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.359 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -56.47 -33.89 66.38 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.389 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -162.72 169.56 19.81 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.104 -0.639 . . . . 0.0 109.319 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.433 ' H ' HG22 ' A' ' 151' ' ' VAL . 0.9 OUTLIER -58.6 -20.33 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.285 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -65.21 -33.05 75.09 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 177.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.447 ' O ' ' N ' ' A' ' 155' ' ' ARG . 6.5 tm-20 -63.72 -79.78 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.804 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.431 HG11 HG11 ' A' ' 164' ' ' VAL . 7.3 p -36.11 -30.42 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.589 0.756 . . . . 0.0 110.643 178.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.447 ' N ' ' O ' ' A' ' 153' ' ' GLU . 4.1 tmt_? -71.77 -49.17 41.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.243 0.544 . . . . 0.0 111.79 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 153' ' ' GLU . . . -71.45 -18.1 62.33 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 122.628 1.204 . . . . 0.0 108.004 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.17 -55.27 4.45 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 112.349 -2.205 . . . . 0.0 112.149 -177.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -123.99 -18.05 6.07 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -177.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 85.18 25.05 41.62 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -42.3 -94.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.649 0.262 . . . . 0.0 111.437 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.405 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.95 33.83 17.14 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.365 0.602 . . . . 0.0 109.46 -178.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.519 ' C ' ' H ' ' A' ' 164' ' ' VAL . 1.8 m-85 -172.42 -62.56 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.353 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.39 28.51 0.27 Allowed 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 122.438 2.092 . . . . 0.0 110.579 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.545 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.8 m -131.52 167.93 25.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.79 -178.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.0 t -124.12 64.6 35.99 Favored Pre-proline 0 N--CA 1.473 0.724 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.055 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.545 ' HD3' HG23 ' A' ' 164' ' ' VAL . 42.6 Cg_exo -39.95 149.23 0.13 Allowed 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 123.453 2.769 . . . . 0.0 114.616 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 172.47 -141.18 6.11 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 114.33 -1.305 . . . . 0.0 111.813 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -147.79 179.88 7.39 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.752 0.311 . . . . 0.0 110.195 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.3 t . . . . . 0 N--CA 1.465 0.299 0 CA-C-O 121.106 0.479 . . . . 0.0 110.631 -179.727 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 . . . . . 0 N--CA 1.442 -0.867 0 CA-C-O 120.537 0.208 . . . . 0.0 111.482 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 31.9 pt -91.72 135.56 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.401 0.619 . . . . 0.0 111.26 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -135.28 171.74 14.0 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.254 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 184' ' ' GLY . 98.6 m-20 -78.76 104.54 9.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.227 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.617 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -65.18 -20.23 66.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.573 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.508 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.5 mm? -63.77 -42.67 97.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.486 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.18 -44.3 3.02 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.49 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 180' ' ' ASP . . . . . . . . 0 CA--C 1.527 0.795 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 39.2 p-10 . . . . . 0 N--CA 1.461 0.106 0 CA-C-O 120.7 0.286 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.529 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.1 mp -62.4 -42.17 99.22 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -63.67 -42.32 98.08 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -63.08 -41.68 99.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.771 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 162' ' ' PHE . 63.6 t0 -59.09 -46.99 86.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.498 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.34 -44.39 97.27 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.191 0.519 . . . . 0.0 110.082 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.7 mt -63.56 -42.97 97.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.469 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.73 -43.92 81.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.572 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.17 -47.11 85.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.459 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.69 -52.18 66.62 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.7 pt -68.14 -38.97 80.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.112 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -57.95 -52.92 63.5 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.215 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 20' ' ' GLU . 96.8 t -61.17 -40.55 86.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.703 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.676 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.3 tt -52.51 -51.1 61.16 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.673 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -79.88 -50.62 10.22 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.774 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -63.45 -31.64 72.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.027 0.442 . . . . 0.0 110.721 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 16' ' ' VAL . 96.5 mt-10 58.55 81.09 0.16 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 178.224 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.85 -146.71 0.1 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.813 0.34 . . . . 0.0 110.641 177.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.421 HG12 ' NH2' ' A' ' 45' ' ' ARG . 5.8 p -128.16 139.67 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.434 HD12 ' O ' ' A' ' 24' ' ' ALA . 2.8 pp -128.96 167.76 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 120.892 0.377 . . . . 0.0 111.564 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.434 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -63.88 135.87 56.92 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.325 0.583 . . . . 0.0 111.528 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.5 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 1.6 t80 -127.96 139.19 34.67 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.5 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 68.1 Cg_endo -78.99 144.61 18.97 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 121.327 1.351 . . . . 0.0 111.572 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.503 ' C ' ' H ' ' A' ' 29' ' ' ALA . 47.6 m -134.19 132.93 40.35 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.74 0.305 . . . . 0.0 110.416 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -72.97 32.13 0.07 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.635 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.503 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -156.91 -77.75 0.09 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.723 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.1 p -128.36 130.3 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -44.01 142.6 1.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.141 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.29 -175.71 22.64 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.1 m -129.72 171.21 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.413 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -159.54 -179.38 34.31 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.111 -1.042 . . . . 0.0 111.896 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.471 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 1.4 p -159.42 -161.83 0.98 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 120.209 -0.596 . . . . 0.0 112.015 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.471 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 68.0 m-20 -93.02 107.07 22.15 Favored Pre-proline 0 CA--C 1.557 1.218 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -37.88 -61.73 0.34 Allowed 'Trans proline' 0 N--CA 1.5 1.854 0 C-N-CA 122.592 2.195 . . . . 0.0 112.928 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -76.45 69.51 2.92 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.364 -178.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.1 m -153.66 130.93 11.21 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.793 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.62 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -69.58 -33.26 72.46 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.59 -179.934 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.504 HG23 ' N ' ' A' ' 42' ' ' ALA . 14.2 t -57.56 -41.85 81.88 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.636 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.504 ' N ' HG23 ' A' ' 41' ' ' THR . . . -60.04 -52.55 64.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.498 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.405 ' H ' HG13 ' A' ' 43' ' ' VAL . 0.8 OUTLIER -61.58 -42.97 96.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-O 120.974 0.416 . . . . 0.0 110.511 -178.719 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.418 ' O ' ' CG ' ' A' ' 48' ' ' GLU . 56.8 mtt -65.19 -52.75 52.94 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.547 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.421 ' NH2' HG12 ' A' ' 22' ' ' VAL . 7.4 ptm180 -62.75 -37.31 86.09 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.186 0.517 . . . . 0.0 111.36 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -66.57 -53.42 34.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.407 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.449 HD22 HG23 ' A' ' 54' ' ' VAL . 7.8 mt -78.49 -7.59 57.63 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.187 -178.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 44' ' ' MET . 1.3 mm-40 -68.64 -79.93 0.05 Allowed 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.312 0.577 . . . . 0.0 111.707 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.423 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -71.7 -37.56 70.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.775 -177.224 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -67.76 -47.93 67.83 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.787 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 30.24 66.59 0.12 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.032 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.418 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 3.5 mtt180 -178.31 -54.76 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.604 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 52' ' ' ARG . 71.4 Cg_endo -72.99 -1.43 10.48 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.965 1.777 . . . . 0.0 109.448 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.449 HG23 HD22 ' A' ' 47' ' ' LEU . 0.7 OUTLIER -45.17 -48.99 3.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.435 -179.618 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -71.59 -39.61 70.43 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 110.936 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.409 ' N ' ' CD ' ' A' ' 56' ' ' LYS . 1.1 mptm? -61.2 -38.8 87.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.306 -179.076 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 62.33 107.8 0.01 OUTLIER Glycine 0 CA--C 1.521 0.437 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.553 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -54.1 -160.24 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.52 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.2 mt -110.04 148.14 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.095 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.4 mt -122.61 142.01 51.1 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.3 tp -109.44 131.02 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-O 120.878 0.37 . . . . 0.0 110.854 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.31 146.84 45.72 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.94 -29.19 10.63 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.114 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -117.95 152.27 35.8 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.146 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -79.85 -14.34 58.73 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.632 0.73 . . . . 0.0 109.438 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -51.58 -32.55 29.01 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.206 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.12 -8.93 41.25 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.893 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -90.76 -18.87 24.22 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.555 ' NZ ' HH12 ' A' ' 82' ' ' ARG . 32.6 mttp -76.22 -37.92 2.21 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 63.2 Cg_endo -104.82 -2.51 0.2 Allowed 'Trans proline' 0 C--N 1.319 -1.019 0 C-N-CA 122.868 2.378 . . . . 0.0 112.755 -178.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -93.87 -10.98 32.11 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.723 0.296 . . . . 0.0 111.158 -178.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.635 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.2 mp -125.45 168.76 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.635 ' N ' HG22 ' A' ' 72' ' ' ILE . 91.5 m-20 -63.14 -17.9 62.86 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.869 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.6 t70 57.04 22.38 7.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.929 0.395 . . . . 0.0 110.8 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.526 HG23 ' N ' ' A' ' 76' ' ' MET . 13.6 t -88.76 -41.56 12.47 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.779 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.526 ' N ' HG23 ' A' ' 75' ' ' THR . 14.2 ptp -84.38 -21.89 30.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.142 179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 tp -73.18 136.25 44.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.663 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.27 165.56 35.91 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.682 -177.035 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -48.45 -45.61 36.7 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.211 0.32 . . . . 0.0 111.799 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.1 p -61.96 -33.27 57.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.175 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 66.7 tp60 -64.4 -40.04 95.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.922 0.391 . . . . 0.0 110.455 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.555 HH12 ' NZ ' ' A' ' 69' ' ' LYS . 5.5 mmt85 -64.2 -53.09 54.76 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 122.256 1.027 . . . . 0.0 109.169 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -54.63 -50.2 68.69 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.884 -1.507 . . . . 0.0 109.984 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 m -61.33 -50.01 74.66 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.412 -1.267 . . . . 0.0 112.003 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.8 tt -68.44 -31.16 50.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.863 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -77.53 -36.29 52.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.528 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.8 m -85.57 -18.91 31.99 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.098 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 89' ' ' TRP . 58.5 ttt85 -112.63 78.56 1.14 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.334 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.438 ' O ' ' O ' ' A' ' 88' ' ' ARG . 41.3 m95 56.94 150.26 0.06 OUTLIER Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.431 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.09 -23.31 46.26 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 122.24 1.96 . . . . 0.0 112.094 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 158.73 79.61 0.03 OUTLIER Glycine 0 CA--C 1.528 0.906 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -81.33 -15.24 10.18 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.391 2.06 . . . . 0.0 111.985 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.9 p -136.06 144.45 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.562 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.498 ' N ' ' O ' ' A' ' 177' ' ' GLU . 25.6 m -95.13 132.85 39.6 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.92 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.49 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 45.9 m-85 -118.08 140.79 49.25 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.437 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.64 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.5 t -100.12 109.79 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 121.549 0.69 . . . . 0.0 110.811 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -95.62 148.74 35.08 Favored Pre-proline 0 N--CA 1.471 0.577 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.023 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.48 87.98 0.41 Allowed 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 121.952 1.768 . . . . 0.0 110.587 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -50.59 149.94 5.36 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.894 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.445 ' O ' ' HB2' ' A' ' 101' ' ' ALA . 98.1 Cg_endo -73.99 157.36 47.07 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.116 1.877 . . . . 0.0 110.148 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.445 ' HB2' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . 0 C--N 1.328 -0.35 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.667 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.513 ' NH2' ' O ' ' A' ' 110' ' ' ARG . 7.7 tpt180 . . . . . 0 C--O 1.225 -0.194 0 CA-C-O 120.6 0.238 . . . . 0.0 110.723 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 66.5 p-90 -87.3 -10.74 51.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.603 0.716 . . . . 0.0 109.927 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.679 ' H ' ' CD2' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -85.02 -18.18 35.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.618 -179.113 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.409 ' H ' HD23 ' A' ' 107' ' ' LEU . 87.2 m -144.63 -39.98 0.26 Allowed 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.573 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.7 -3.32 87.02 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.262 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.513 ' O ' ' NH2' ' A' ' 105' ' ' ARG . 13.6 tpt180 -154.8 -78.68 0.09 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.036 0.918 . . . . 0.0 111.311 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -95.52 -175.27 3.41 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -125.28 81.52 1.98 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.019 0.437 . . . . 0.0 110.842 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 24.9 p -166.33 128.5 1.87 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.409 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.483 ' C ' HG13 ' A' ' 96' ' ' VAL . 69.1 mt -125.27 127.33 46.54 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.524 ' HB2' HG22 ' A' ' 96' ' ' VAL . . . -75.39 130.35 38.84 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.892 176.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.416 HG22 ' N ' ' A' ' 117' ' ' ARG . 13.5 p -144.63 153.75 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 120.897 0.379 . . . . 0.0 110.563 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.416 ' N ' HG22 ' A' ' 116' ' ' VAL . 62.3 ttp180 -142.99 156.55 44.88 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.14 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.0 t -124.29 132.31 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-O 121.103 0.478 . . . . 0.0 109.795 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.443 ' O ' HG23 ' A' ' 119' ' ' THR . 14.4 t -135.32 129.01 32.82 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.656 178.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -135.47 87.08 2.29 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.859 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.653 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 34.9 t60 -172.15 -36.92 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.653 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 63.5 Cg_endo -95.24 -160.48 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.939 0 C-N-CA 122.23 1.953 . . . . 0.0 111.619 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.9 mt -77.78 -5.03 49.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.253 0.549 . . . . 0.0 110.703 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 83.2 t -58.05 -44.81 87.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.725 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.748 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.0 m -53.01 -61.73 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 C-N-CA 119.626 -0.83 . . . . 0.0 108.884 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.748 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.05 -44.17 2.36 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.886 0.374 . . . . 0.0 110.749 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.6 tp -69.41 -47.37 64.36 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.452 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 57.9 m -70.47 -49.93 43.4 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.574 0.702 . . . . 0.0 110.623 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.465 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.1 pp0? -54.19 -41.75 68.93 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.383 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.78 -55.22 37.88 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.81 -177.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.455 ' CE1' ' OD2' ' A' ' 36' ' ' ASP . 46.7 t80 -61.28 -18.96 61.05 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.565 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.61 0.44 84.29 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -154.18 159.56 31.85 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 120.614 -0.434 . . . . 0.0 109.931 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -40.99 173.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 124.043 3.162 . . . . 0.0 113.22 -178.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.405 HD12 ' O ' ' A' ' 35' ' ' CYS . 7.6 tp -127.53 123.23 35.33 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 176.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.462 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -65.56 146.83 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 C-N-CA 117.998 -1.481 . . . . 0.0 107.487 -179.492 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 t -117.44 122.64 44.33 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 123.638 0.586 . . . . 0.0 110.664 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 3.2 m -131.9 163.82 27.47 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.842 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.4 m -72.26 145.44 47.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.238 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.11 -37.81 88.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.982 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.401 ' OD1' ' O ' ' A' ' 141' ' ' ASN . 53.4 p30 -49.46 150.43 1.89 Allowed 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.674 0.749 . . . . 0.0 111.095 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.32 -158.37 0.79 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.232 -178.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.5 t -62.47 -42.51 99.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.03 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -161.75 2.62 0.07 OUTLIER Glycine 0 N--CA 1.459 0.217 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.5 tp -85.95 125.23 69.22 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-O 119.389 -0.339 . . . . 0.0 110.35 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -40.45 157.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.627 1.551 . . . . 0.0 111.826 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.35 -162.92 0.18 Allowed 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.519 2.146 . . . . 0.0 112.083 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 148' ' ' CYS . 29.0 p -112.29 80.01 1.29 Allowed 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -55.09 -32.75 62.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.664 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -164.77 163.86 21.26 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.342 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.427 HG11 ' HA ' ' A' ' 166' ' ' PRO . 1.3 m -56.72 -15.75 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.806 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -66.76 -34.04 76.95 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 150' ' ' THR . 5.1 tm-20 -60.48 -71.87 0.12 Allowed 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.933 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.437 HG11 HG11 ' A' ' 164' ' ' VAL . 7.3 p -48.48 -32.91 4.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.275 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 159' ' ' GLY . 4.1 tmt_? -78.96 -51.66 9.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.773 0.796 . . . . 0.0 109.416 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.94 -44.85 64.08 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.676 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.71 -29.33 27.63 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 112.826 -1.988 . . . . 0.0 114.28 -175.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -126.39 -33.95 2.53 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 118.341 0.519 . . . . 0.0 111.331 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 94.59 24.7 17.5 Favored Glycine 0 N--CA 1.466 0.682 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.411 ' HB1' ' HG2' ' A' ' 163' ' ' PRO . . . -43.3 -94.4 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.517 0.199 . . . . 0.0 110.685 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.435 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.55 37.18 16.53 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.546 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.5 m-85 -176.48 -62.06 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.284 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.411 ' HG2' ' HB1' ' A' ' 160' ' ' ALA . 84.3 Cg_endo -73.58 28.86 0.31 Allowed 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.544 2.163 . . . . 0.0 110.46 178.024 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.569 HG23 ' HD3' ' A' ' 166' ' ' PRO . 16.1 m -132.62 166.1 30.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.814 -178.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.6 t -123.06 65.41 27.87 Favored Pre-proline 0 N--CA 1.475 0.797 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.517 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.569 ' HD3' HG23 ' A' ' 164' ' ' VAL . 23.7 Cg_exo -35.41 142.78 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 123.588 2.858 . . . . 0.0 115.362 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 169.01 178.28 40.33 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 113.688 -1.596 . . . . 0.0 110.89 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -155.84 149.83 25.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.775 0.321 . . . . 0.0 110.386 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.465 0.313 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.457 179.885 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 94' ' ' THR . 1.2 pp20? . . . . . 0 N--CA 1.466 0.36 0 CA-C-O 120.848 0.356 . . . . 0.0 110.052 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.501 ' O ' HG23 ' A' ' 178' ' ' ILE . 18.3 tt -96.4 121.03 46.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.307 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -129.22 165.01 22.2 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.491 0.662 . . . . 0.0 111.73 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -78.14 106.13 9.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.008 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -66.33 -18.87 65.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.664 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.472 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.5 mm? -62.61 -41.9 99.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.398 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.53 -45.07 3.03 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.716 0.293 . . . . 0.0 110.61 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.66 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -179.682 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 N--CA 1.461 0.116 0 CA-C-O 120.752 0.311 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.666 HD22 ' N ' ' A' ' 5' ' ' LEU . 3.0 mm? -63.07 -41.65 99.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.878 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -61.46 -43.67 98.45 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -59.34 -41.45 89.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.459 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 162' ' ' PHE . 41.3 t0 -61.31 -40.25 93.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.264 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.6 -48.42 81.86 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.813 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.5 mm -63.51 -44.78 98.87 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.698 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.46 -46.56 76.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.053 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.48 -45.71 91.79 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.06 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.12 -51.15 70.32 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 13.3 pt -69.3 -40.09 79.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.506 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -58.47 -54.62 44.94 Favored 'General case' 0 C--O 1.218 -0.557 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.136 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.491 ' O ' ' N ' ' A' ' 20' ' ' GLU . 99.5 t -62.01 -39.81 85.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.638 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.661 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.5 tt -52.38 -50.4 62.51 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.587 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -79.95 -51.6 8.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.644 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -64.83 -34.43 78.35 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.41 -178.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.8 mt-10 58.5 87.41 0.07 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.311 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.47 -132.8 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 178.253 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.6 p -144.29 140.08 24.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.457 HD12 ' O ' ' A' ' 24' ' ' ALA . 2.8 pp -130.72 163.95 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 121.163 0.506 . . . . 0.0 111.905 -178.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.457 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -59.76 136.3 57.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.87 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.532 ' CZ ' ' O ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -132.13 145.39 57.16 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.21 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.532 ' O ' ' CZ ' ' A' ' 25' ' ' TYR . 61.9 Cg_endo -78.85 146.83 21.06 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.465 1.443 . . . . 0.0 111.383 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.489 ' C ' ' H ' ' A' ' 29' ' ' ALA . 28.7 m -130.21 135.9 48.64 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.88 0.372 . . . . 0.0 110.123 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -75.35 22.0 0.13 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.489 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -156.17 -73.63 0.1 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.327 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.4 p -122.71 126.28 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-O 121.335 0.588 . . . . 0.0 111.392 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.486 ' CD1' ' O ' ' A' ' 148' ' ' CYS . 16.7 t80 -45.34 132.36 7.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.389 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.62 -171.52 13.9 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.309 -0.717 . . . . 0.0 111.309 -179.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 m -131.12 169.51 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.408 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -157.98 -178.21 31.81 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 120.105 -1.045 . . . . 0.0 112.616 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.554 ' O ' HD12 ' A' ' 135' ' ' LEU . 0.5 OUTLIER -156.56 -163.04 1.35 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.546 0.213 . . . . 0.0 110.577 -179.757 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.516 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 44.3 m-20 -100.39 109.11 55.95 Favored Pre-proline 0 CA--C 1.554 1.123 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -178.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 36' ' ' ASP . 55.5 Cg_exo -38.36 173.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.765 2.31 . . . . 0.0 114.105 177.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 42.91 65.66 0.91 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.719 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.0 m -152.35 139.22 18.99 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.41 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -65.98 -28.43 68.88 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.104 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.524 HG23 ' N ' ' A' ' 42' ' ' ALA . 14.9 t -59.93 -42.8 94.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.666 -178.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.524 ' N ' HG23 ' A' ' 41' ' ' THR . . . -59.07 -52.02 67.53 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.38 0.61 . . . . 0.0 111.414 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.11 -45.76 95.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.895 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 91.9 mtp -66.41 -47.05 74.48 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.5 ptt85 -62.23 -30.24 70.96 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.173 -178.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 45.2 mt -73.4 -61.89 1.67 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.382 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.2 mt -54.02 -20.43 6.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.655 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -63.81 -85.61 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.666 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.497 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.2 pt? -77.5 -35.42 53.57 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -73.67 -48.18 34.22 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 119.709 -0.797 . . . . 0.0 111.049 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 35.25 65.17 0.4 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.957 -1.019 . . . . 0.0 111.78 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.407 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 8.1 mtm-85 179.84 -53.73 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.909 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.675 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.407 ' HD2' ' H ' ' A' ' 52' ' ' ARG . 72.1 Cg_endo -75.1 -7.16 18.83 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.422 2.081 . . . . 0.0 112.783 -178.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.614 HG13 ' N ' ' A' ' 55' ' ' ASP . 12.8 p -41.42 -47.03 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.119 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.614 ' N ' HG13 ' A' ' 54' ' ' VAL . 36.6 t0 -67.66 -39.5 84.55 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.076 0.465 . . . . 0.0 110.786 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.479 ' CD ' ' N ' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -61.92 -39.52 92.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.318 -179.299 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 62.9 105.6 0.01 OUTLIER Glycine 0 CA--C 1.52 0.394 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.57 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -49.76 -168.2 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.821 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.4 HG23 HG21 ' A' ' 94' ' ' THR . 75.0 mt -102.64 147.84 8.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.1 mt -120.73 141.25 50.62 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.414 HD12 ' HG3' ' A' ' 117' ' ' ARG . 8.6 tp -108.88 132.46 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-O 121.062 0.458 . . . . 0.0 109.96 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.519 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -123.35 152.99 40.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.392 0.615 . . . . 0.0 109.86 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -112.32 -30.03 7.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.181 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -114.1 151.78 32.07 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.648 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -79.05 -13.84 59.52 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.567 0.698 . . . . 0.0 109.974 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -53.8 -30.96 47.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.267 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.79 -8.81 39.52 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.53 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -89.13 -20.79 23.83 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.446 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 69.9 tttt -73.81 -39.97 4.78 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 95.2 Cg_endo -102.38 -5.36 0.29 Allowed 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 122.672 2.248 . . . . 0.0 112.478 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -88.57 -17.87 29.28 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.652 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.532 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.0 mp -122.34 157.53 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.532 ' N ' HG22 ' A' ' 72' ' ' ILE . 4.4 m-20 -64.34 146.59 54.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.846 0.355 . . . . 0.0 110.203 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -91.9 38.8 1.0 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.058 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.536 HG23 ' N ' ' A' ' 76' ' ' MET . 11.3 t -108.34 -41.76 4.78 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.995 0.426 . . . . 0.0 110.208 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.536 ' N ' HG23 ' A' ' 75' ' ' THR . 8.4 ptp -93.05 -17.5 23.78 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.239 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.51 HD21 ' NH2' ' A' ' 82' ' ' ARG . 31.7 tp -79.83 128.18 33.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.277 -177.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -153.86 163.63 39.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.726 -177.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -49.15 -45.74 44.23 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.718 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -61.09 -31.94 51.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.964 -0.295 . . . . 0.0 111.197 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 66.8 tp60 -65.56 -40.6 92.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.216 0.531 . . . . 0.0 110.427 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.51 ' NH2' HD21 ' A' ' 77' ' ' LEU . 9.7 mmt85 -64.21 -51.65 62.7 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 122.522 1.154 . . . . 0.0 109.287 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -56.44 -50.33 71.98 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 113.668 -1.605 . . . . 0.0 110.325 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -61.74 -49.7 75.37 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.826 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.1 tt -67.59 -31.53 52.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.486 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -77.32 -35.09 55.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.748 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.6 m -88.0 -18.65 28.55 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.475 0.178 . . . . 0.0 111.282 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.414 ' O ' ' O ' ' A' ' 89' ' ' TRP . 77.3 ttt-85 -110.39 77.84 1.08 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.554 ' CD1' ' N ' ' A' ' 89' ' ' TRP . 1.2 m0 59.18 148.71 0.07 OUTLIER Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.21 -31.53 35.67 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 121.741 1.627 . . . . 0.0 112.508 -178.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.445 ' H ' ' HD3' ' A' ' 92' ' ' PRO . . . 150.35 61.12 0.01 OUTLIER Glycine 0 CA--C 1.531 1.061 0 C-N-CA 121.089 -0.577 . . . . 0.0 111.97 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.445 ' HD3' ' H ' ' A' ' 91' ' ' GLY . 57.4 Cg_endo -70.22 -15.73 35.43 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.718 2.279 . . . . 0.0 111.828 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.0 p -122.6 136.47 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.137 0.494 . . . . 0.0 110.079 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 177' ' ' GLU . 27.3 m -91.37 135.26 33.95 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.936 -179.087 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.481 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 42.1 m-85 -120.69 139.71 52.65 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.914 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.627 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.4 t -97.17 109.02 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-O 121.347 0.594 . . . . 0.0 110.902 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -94.37 149.9 37.38 Favored Pre-proline 0 N--CA 1.469 0.506 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.965 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.403 ' O ' ' OD2' ' A' ' 73' ' ' ASP . 58.7 Cg_endo -69.41 86.93 0.52 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.991 1.794 . . . . 0.0 111.12 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.423 ' O ' ' OD1' ' A' ' 112' ' ' ASP . . . -50.95 153.51 3.0 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.452 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.44 157.47 58.97 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.193 1.929 . . . . 0.0 111.629 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.251 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.396 -179.827 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 109' ' ' GLY . 8.2 tpt180 . . . . . 0 CA--C 1.531 0.243 0 CA-C-O 120.878 0.37 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 2.4 p90 -71.67 -7.13 46.06 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.531 -179.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 1.029 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -73.08 -23.25 60.51 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.769 179.823 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.673 ' H ' HD22 ' A' ' 107' ' ' LEU . 85.1 m -143.09 -40.1 0.32 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.812 179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 80.2 -0.42 83.99 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.638 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -148.21 -80.64 0.13 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.427 0.613 . . . . 0.0 110.822 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -89.91 -173.02 3.74 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 99' ' ' ALA . 66.3 t0 -131.05 70.83 1.46 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.91 0.386 . . . . 0.0 110.832 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 80.5 p -160.6 127.83 4.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.583 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.494 ' C ' HG13 ' A' ' 96' ' ' VAL . 63.0 mt -124.03 129.04 50.25 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -178.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.528 ' HB2' HG22 ' A' ' 96' ' ' VAL . . . -77.32 122.54 25.26 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.276 176.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.447 HG22 ' N ' ' A' ' 117' ' ' ARG . 10.9 p -141.29 155.96 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.937 0.398 . . . . 0.0 110.54 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.447 ' N ' HG22 ' A' ' 116' ' ' VAL . 19.3 ptt180 -149.19 158.22 44.0 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.665 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.519 HG22 ' HB3' ' A' ' 62' ' ' ALA . 70.8 t -122.52 134.87 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.11 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 119' ' ' THR . 12.2 t -138.4 127.85 24.67 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.664 178.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -133.24 87.45 2.39 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.129 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.682 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 19.1 t60 -172.01 -35.22 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 112.486 0.551 . . . . 0.0 112.486 -179.179 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.682 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 73.7 Cg_endo -95.7 -158.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.482 0.795 0 C-N-CA 122.288 1.992 . . . . 0.0 111.761 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 19.4 mt -79.26 -6.18 56.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.661 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 79.9 t -57.22 -45.62 84.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.538 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.738 HG23 ' H ' ' A' ' 126' ' ' ALA . 26.9 m -51.01 -61.68 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.864 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.738 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.63 -44.52 3.12 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.984 0.421 . . . . 0.0 110.726 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.433 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -66.54 -51.54 55.43 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.08 0.467 . . . . 0.0 110.571 179.413 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 79.2 m -69.34 -48.45 61.33 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.252 0.549 . . . . 0.0 111.396 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.468 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.1 pp0? -54.56 -42.05 70.51 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.507 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -60.11 -54.83 41.22 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.139 -1.392 . . . . 0.0 109.399 -177.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -64.13 -21.67 66.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.085 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.41 1.55 86.34 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 55.5 mttt -152.66 159.48 32.43 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 120.718 -0.393 . . . . 0.0 109.971 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -43.16 178.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 124.053 3.169 . . . . 0.0 113.389 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.554 HD12 ' O ' ' A' ' 35' ' ' CYS . 8.2 tp -133.35 123.29 25.14 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 177.023 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.43 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -64.65 146.16 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 C-N-CA 117.796 -1.562 . . . . 0.0 107.678 -179.736 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.9 t -119.37 129.53 54.87 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.283 0.563 . . . . 0.0 111.23 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.5 m -131.79 164.23 26.48 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.241 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.2 m -75.18 148.06 39.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.24 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.51 88.91 2.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.615 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.668 ' C ' HD21 ' A' ' 141' ' ' ASN . 0.1 OUTLIER -164.02 163.28 23.39 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.396 0.617 . . . . 0.0 110.814 179.442 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.85 -165.57 1.91 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.096 -178.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 38.8 t -61.95 -43.89 97.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.925 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -160.65 11.08 0.14 Allowed Glycine 0 N--CA 1.459 0.22 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.6 tp -88.71 127.17 57.28 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -39.13 154.12 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.682 1.588 . . . . 0.0 111.83 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.418 ' O ' ' N ' ' A' ' 149' ' ' ARG . 89.9 Cg_endo -74.38 149.99 40.71 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.227 1.951 . . . . 0.0 112.392 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.486 ' O ' ' CD1' ' A' ' 31' ' ' PHE . 72.8 m -67.92 74.22 0.19 Allowed 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 147' ' ' PRO . 32.2 ptt-85 -58.3 -34.38 70.49 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.502 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -160.33 163.75 33.04 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.472 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.412 HG11 ' HA ' ' A' ' 166' ' ' PRO . 0.9 OUTLIER -56.62 -17.45 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.821 0 CA-C-O 121.577 0.703 . . . . 0.0 109.223 -179.872 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -64.71 -35.67 81.79 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 177.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.437 ' OE1' ' OE1' ' A' ' 157' ' ' GLN . 5.1 tm-20 -59.49 -74.86 0.06 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.688 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.404 HG11 HG11 ' A' ' 164' ' ' VAL . 7.8 p -44.7 -29.04 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.242 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.421 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -83.95 -45.3 13.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 122.201 1.0 . . . . 0.0 110.047 179.767 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.84 -40.69 80.7 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.769 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.437 ' OE1' ' OE1' ' A' ' 153' ' ' GLU . 8.7 pt20 -81.57 -49.02 11.04 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 113.167 -1.833 . . . . 0.0 112.566 -176.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.429 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 20.8 m-85 -110.05 -33.55 6.66 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 97.61 27.63 8.96 Favored Glycine 0 N--CA 1.475 1.285 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.606 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -44.13 -94.8 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.759 0.314 . . . . 0.0 111.07 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.507 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.83 35.71 16.43 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -178.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.507 ' CD2' ' O ' ' A' ' 161' ' ' ALA . 2.1 m-85 -174.77 -62.53 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.471 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -73.03 28.85 0.29 Allowed 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.525 2.15 . . . . 0.0 110.49 178.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.567 HG23 ' HD3' ' A' ' 166' ' ' PRO . 17.1 m -131.98 167.39 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.542 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.0 t -124.24 64.82 37.87 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.549 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.567 ' HD3' HG23 ' A' ' 164' ' ' VAL . 20.4 Cg_exo -35.18 142.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 123.699 2.933 . . . . 0.0 115.056 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 167.02 -177.71 41.56 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 114.051 -1.431 . . . . 0.0 110.989 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -146.98 152.33 38.44 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.467 0.382 0 CA-C-O 120.993 0.425 . . . . 0.0 110.944 -179.757 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 94' ' ' THR . 5.7 pt-20 . . . . . 0 N--CA 1.471 0.597 0 CA-C-O 120.404 0.145 . . . . 0.0 111.134 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 178' ' ' ILE . 18.2 tt -87.08 122.63 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-O 120.922 0.391 . . . . 0.0 110.763 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -135.21 168.08 19.82 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.409 0.623 . . . . 0.0 111.648 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -78.73 106.03 10.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.562 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -65.57 -13.57 59.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.649 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.476 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.4 mm? -63.32 -41.08 98.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.193 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 5.2 t -119.75 -23.49 6.48 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.955 0.407 . . . . 0.0 110.458 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.743 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -179.876 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 56.5 p30 . . . . . 0 N--CA 1.47 0.543 0 CA-C-O 120.896 0.379 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.8 mp -62.54 -42.22 99.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.039 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -63.88 -40.85 97.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.321 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -64.72 -40.87 96.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.636 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 162' ' ' PHE . 63.1 t0 -59.34 -46.38 88.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.332 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.19 -43.9 97.79 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.95 0.405 . . . . 0.0 110.17 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.1 mt -63.76 -43.19 97.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.97 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.2 -46.52 82.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.533 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.91 -45.98 92.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.423 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.25 -52.86 63.48 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 14.4 pt -68.57 -39.47 80.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.392 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -56.77 -53.72 54.51 Favored 'General case' 0 C--O 1.215 -0.738 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.197 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 20' ' ' GLU . 97.6 t -61.97 -40.62 87.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.89 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.678 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.3 tt -52.48 -51.98 56.64 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.508 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -78.33 -49.92 12.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.368 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -65.47 -32.06 73.47 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.694 -178.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 16' ' ' VAL . 97.1 mt-10 59.91 80.67 0.2 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 178.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.04 -148.23 0.12 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.857 177.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.3 p -125.45 140.63 47.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.456 HD12 ' O ' ' A' ' 24' ' ' ALA . 2.9 pp -129.68 165.84 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-O 120.907 0.384 . . . . 0.0 111.62 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.456 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -60.26 135.73 57.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.302 0.572 . . . . 0.0 110.793 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.53 ' CZ ' ' O ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -132.49 145.38 57.0 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.585 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.53 ' O ' ' CZ ' ' A' ' 25' ' ' TYR . 97.6 Cg_endo -75.61 145.84 29.89 Favored 'Trans proline' 0 N--CA 1.498 1.794 0 C-N-CA 121.597 1.531 . . . . 0.0 111.384 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.493 ' C ' ' H ' ' A' ' 29' ' ' ALA . 63.0 m -131.76 131.32 42.87 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.95 0.405 . . . . 0.0 110.644 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -75.01 30.94 0.09 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.411 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.493 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -160.32 -73.47 0.07 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.621 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.9 p -131.77 132.22 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.045 0.45 . . . . 0.0 110.188 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.527 ' CD2' ' O ' ' A' ' 148' ' ' CYS . 36.0 p90 -39.5 144.37 0.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.45 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -156.78 -174.27 26.3 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.8 m -131.07 172.33 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.402 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -158.42 178.51 34.63 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.095 -1.05 . . . . 0.0 111.795 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -157.25 -170.42 3.25 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.737 -178.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.467 ' CG ' ' CZ ' ' A' ' 131' ' ' TYR . 18.3 t70 -86.57 108.08 16.47 Favored Pre-proline 0 CA--C 1.555 1.168 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -177.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -36.52 -61.42 0.31 Allowed 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 122.533 2.155 . . . . 0.0 113.161 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -74.03 72.01 1.63 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.593 -178.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 m -155.73 130.52 9.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.678 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -66.33 -33.93 76.84 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.988 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.529 HG23 ' N ' ' A' ' 42' ' ' ALA . 15.1 t -62.08 -43.56 98.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.866 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.529 ' N ' HG23 ' A' ' 41' ' ' THR . . . -55.78 -52.52 63.68 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -62.19 -42.6 95.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.312 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 91.2 mtp -63.22 -40.61 97.96 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.514 HH22 ' CD1' ' A' ' 142' ' ' LEU . 7.9 ttt85 -60.52 -40.77 92.68 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-O 121.695 0.76 . . . . 0.0 108.959 178.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.44 ' O ' HD23 ' A' ' 46' ' ' LEU . 1.0 OUTLIER -65.96 -55.61 15.92 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.248 -178.8 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.6 mt -67.64 -12.1 59.7 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.981 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.71 -82.57 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 120.995 0.426 . . . . 0.0 110.678 -177.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -76.37 -36.28 58.24 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.2 mmmt -74.63 -51.38 14.61 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 119.552 -0.859 . . . . 0.0 111.026 -176.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 36.12 64.93 0.48 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.866 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.401 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 2.6 mtp85 178.66 -53.99 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.529 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HD2' ' H ' ' A' ' 52' ' ' ARG . 72.0 Cg_endo -77.17 -6.45 16.55 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.92 2.413 . . . . 0.0 111.93 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.561 HG13 ' N ' ' A' ' 55' ' ' ASP . 9.7 p -45.59 -43.52 3.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.404 -178.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.561 ' N ' HG13 ' A' ' 54' ' ' VAL . 50.7 t0 -65.41 -41.25 93.81 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.573 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.409 ' CD ' ' N ' ' A' ' 56' ' ' LYS . 4.1 mptp? -62.55 -37.68 87.06 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 64.4 108.71 0.01 OUTLIER Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 178.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.562 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -51.19 -166.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.057 0.456 . . . . 0.0 111.937 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.43 ' O ' ' OG ' ' A' ' 137' ' ' SER . 70.3 mt -104.55 135.35 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.044 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.6 mt -111.72 144.66 40.64 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.41 ' O ' HG23 ' A' ' 61' ' ' ILE . 8.0 tp -112.75 126.8 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-O 121.156 0.503 . . . . 0.0 111.082 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.83 147.92 39.2 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.182 178.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -106.52 -27.59 10.81 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.431 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -121.46 151.6 40.06 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 120.789 0.328 . . . . 0.0 111.136 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -76.93 -13.29 59.99 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -50.89 -32.19 19.81 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.554 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.17 -13.38 26.74 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 68' ' ' LEU . 4.1 mm? -91.93 -16.19 26.96 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.658 -0.651 . . . . 0.0 109.648 179.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.467 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 77.1 tttt -78.91 -37.97 1.33 Allowed Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.388 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 84.8 Cg_endo -103.47 -3.64 0.26 Allowed 'Trans proline' 0 C--N 1.319 -1.01 0 C-N-CA 122.593 2.195 . . . . 0.0 112.049 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -94.9 -10.9 29.77 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.948 0.404 . . . . 0.0 110.774 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.625 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.1 mp -127.11 167.26 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.218 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.625 ' N ' HG22 ' A' ' 72' ' ' ILE . 99.9 m-20 -61.12 -12.8 13.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.007 0.432 . . . . 0.0 110.381 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 46.2 t0 56.3 22.29 6.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.709 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.458 HG23 ' N ' ' A' ' 76' ' ' MET . 9.0 t -92.6 -38.94 11.6 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.02 0.438 . . . . 0.0 110.177 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.458 ' N ' HG23 ' A' ' 75' ' ' THR . 0.0 OUTLIER -78.44 -24.4 46.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.208 0.528 . . . . 0.0 110.398 179.57 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.538 HD11 ' NE ' ' A' ' 82' ' ' ARG . 51.2 tp -77.94 134.21 37.91 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.557 0.694 . . . . 0.0 111.109 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.39 172.56 13.32 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.389 -177.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.13 -40.76 90.92 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.814 0.34 . . . . 0.0 111.105 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.5 p -61.7 -35.07 65.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.495 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.444 ' OE1' HD12 ' A' ' 77' ' ' LEU . 22.5 mt-30 -62.97 -41.34 99.51 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.868 0.366 . . . . 0.0 110.511 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.538 ' NE ' HD11 ' A' ' 77' ' ' LEU . 2.4 mmt85 -62.88 -52.81 61.64 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 122.506 1.146 . . . . 0.0 109.025 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -55.64 -50.73 69.41 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.812 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.6 m -61.44 -49.83 75.25 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.936 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' A' ' 89' ' ' TRP . 9.6 tt -67.52 -32.08 55.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 119.746 -0.781 . . . . 0.0 109.595 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -75.3 -36.43 61.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.424 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.5 m -86.82 -16.44 36.17 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.741 -0.209 . . . . 0.0 111.145 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.444 ' O ' ' O ' ' A' ' 89' ' ' TRP . 77.2 ttt-85 -119.58 78.52 1.32 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.587 0.232 . . . . 0.0 110.879 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.444 ' O ' ' O ' ' A' ' 88' ' ' ARG . 27.3 m95 56.2 149.66 0.05 OUTLIER Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.029 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -67.13 -21.32 48.94 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.331 2.021 . . . . 0.0 112.045 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.529 ' O ' ' NE ' ' A' ' 117' ' ' ARG . . . 157.26 82.87 0.04 OUTLIER Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -76.44 -21.49 13.21 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.885 1.723 . . . . 0.0 112.578 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.411 HG13 ' CE2' ' A' ' 95' ' ' PHE . 3.4 p -136.39 143.62 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-O 121.088 0.471 . . . . 0.0 110.843 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 85.1 m -87.73 144.86 26.41 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.246 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.464 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 57.8 m-85 -126.85 142.32 51.58 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.754 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.635 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 3.3 t -98.2 105.59 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 121.299 0.571 . . . . 0.0 109.801 178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -90.13 150.83 44.07 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.931 -178.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.96 109.29 2.81 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 121.874 1.716 . . . . 0.0 110.525 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.401 ' O ' ' OD1' ' A' ' 112' ' ' ASP . . . -67.29 147.75 98.86 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.05 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.29 155.22 51.5 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.441 2.094 . . . . 0.0 112.385 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.041 179.768 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' A' ' 109' ' ' GLY . 15.0 mmt180 . . . . . 0 N--CA 1.467 0.417 0 CA-C-O 120.895 0.379 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.55 ' CD1' ' N ' ' A' ' 106' ' ' TRP . 14.2 m0 -73.04 -14.43 61.41 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.562 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.987 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -68.99 -37.63 78.84 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.736 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.748 ' H ' HD22 ' A' ' 107' ' ' LEU . 21.8 m -143.94 -39.48 0.29 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.432 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 65.59 -13.64 0.28 Allowed Glycine 0 CA--C 1.53 0.972 0 CA-C-N 115.64 -0.709 . . . . 0.0 113.764 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 24.7 tpt85 -112.22 -83.08 0.59 Allowed 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 117.848 0.824 . . . . 0.0 111.027 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -78.88 -121.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.525 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 99' ' ' ALA . 44.0 t0 -171.29 51.26 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.667 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.5 p -158.7 162.75 37.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.294 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.487 ' C ' HG13 ' A' ' 96' ' ' VAL . 3.0 pp -165.79 137.59 3.93 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.421 ' N ' HG13 ' A' ' 96' ' ' VAL . . . -67.72 127.97 34.74 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 113.085 -1.87 . . . . 0.0 109.904 177.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.3 p -147.21 151.19 14.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.986 0.422 . . . . 0.0 110.063 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.529 ' NE ' ' O ' ' A' ' 91' ' ' GLY . 80.5 ttt180 -141.21 156.16 45.95 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.701 -178.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.5 t -121.41 130.87 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 119' ' ' THR . 9.9 t -134.03 127.94 33.3 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.764 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -135.43 84.3 2.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.849 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.679 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 47.1 t60 -172.62 -35.56 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.308 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.679 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 72.7 Cg_endo -95.07 -159.41 0.06 OUTLIER 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 121.889 1.726 . . . . 0.0 111.979 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 42.7 mt -78.22 -4.65 48.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.341 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 82.9 t -58.53 -45.9 90.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.964 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.772 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.6 m -53.57 -61.89 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.772 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.26 -43.95 2.53 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.717 178.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.2 tp -69.32 -48.6 61.04 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.361 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 65.1 m -70.4 -48.88 54.09 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.49 0.662 . . . . 0.0 110.913 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.472 ' N ' ' O ' ' A' ' 125' ' ' VAL . 1.1 pp0? -54.71 -42.24 71.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.572 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.78 -56.1 26.52 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.178 -1.374 . . . . 0.0 110.062 -177.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.467 ' CZ ' ' CG ' ' A' ' 36' ' ' ASP . 7.4 t80 -63.32 -29.21 70.56 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.644 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 90.26 1.0 76.05 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' A' ' 134' ' ' PRO . 61.2 mttt -151.0 158.64 34.68 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.999 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' A' ' 133' ' ' LYS . 5.9 Cg_exo -41.12 175.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 123.976 3.117 . . . . 0.0 113.166 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.6 tp -131.34 123.09 27.53 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 177.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.441 HG13 ' H ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -66.0 145.58 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 C-N-CA 118.477 -1.289 . . . . 0.0 108.662 -179.212 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -109.44 120.85 43.77 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.122 0.889 . . . . 0.0 110.756 -179.669 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 5.2 m -136.2 163.39 30.48 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.122 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.7 t -67.27 149.37 50.49 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.916 0.389 . . . . 0.0 110.976 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.54 -38.46 91.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.195 -0.457 . . . . 0.0 112.117 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 56.6 p30 -65.75 155.99 34.44 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.468 0.651 . . . . 0.0 111.599 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.514 ' CD1' HH22 ' A' ' 45' ' ' ARG . 0.8 OUTLIER -144.75 179.08 7.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.385 -178.523 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 38.8 t -61.39 -42.74 99.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.226 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -141.65 57.01 0.58 Allowed Glycine 0 N--CA 1.468 0.803 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.1 tp -157.41 108.04 1.85 Allowed Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 119.399 -0.334 . . . . 0.0 110.213 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -40.92 156.09 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.394 1.396 . . . . 0.0 111.212 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -59.97 -159.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.113 1.876 . . . . 0.0 111.855 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.527 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 79.5 m -149.12 73.32 1.2 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.027 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -54.66 -40.61 69.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.232 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.15 168.49 26.32 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.42 HG11 ' HA ' ' A' ' 166' ' ' PRO . 2.0 m -59.47 -22.76 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 CA-C-O 121.266 0.555 . . . . 0.0 109.855 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -65.12 -25.06 67.6 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 155' ' ' ARG . 6.2 tm-20 -69.08 -79.42 0.06 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.319 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.419 ' N ' ' OE1' ' A' ' 153' ' ' GLU . 5.4 p -35.83 -30.15 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.577 0.751 . . . . 0.0 110.312 177.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.482 ' N ' ' O ' ' A' ' 153' ' ' GLU . 4.1 tmt_? -71.59 -49.94 35.67 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.063 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 153' ' ' GLU . . . -72.01 -19.41 61.86 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 122.529 1.157 . . . . 0.0 108.212 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.04 -44.38 15.26 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 112.623 -2.081 . . . . 0.0 111.763 -178.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -129.78 -34.26 1.75 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.775 0.322 . . . . 0.0 111.631 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 160' ' ' ALA . . . 102.12 23.91 8.82 Favored Glycine 0 N--CA 1.468 0.792 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.412 ' O ' ' O ' ' A' ' 159' ' ' GLY . . . -43.97 -97.9 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.597 0.237 . . . . 0.0 110.893 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . 64.17 33.6 11.68 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.516 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.6 m-85 -173.54 -62.2 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.013 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -72.67 28.22 0.28 Allowed 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 122.296 1.997 . . . . 0.0 110.718 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.548 HG23 ' HD3' ' A' ' 166' ' ' PRO . 13.6 m -129.89 167.31 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.877 -178.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 11.7 t -121.6 65.2 17.19 Favored Pre-proline 0 N--CA 1.471 0.615 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.859 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.548 ' HD3' HG23 ' A' ' 164' ' ' VAL . 29.1 Cg_exo -36.35 139.84 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 123.612 2.875 . . . . 0.0 115.041 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 160.61 -172.81 37.05 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 114.077 -1.42 . . . . 0.0 111.112 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -159.29 170.68 21.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.935 0.397 . . . . 0.0 110.524 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.624 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.024 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 120.807 0.337 . . . . 0.0 110.577 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 16.3 pt -113.12 133.59 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.117 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -127.62 166.52 17.9 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.511 0.672 . . . . 0.0 111.452 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 184' ' ' GLY . 46.0 t0 -80.05 106.3 11.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.921 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -62.61 -18.63 62.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.502 -179.151 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.488 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.4 mm? -63.5 -41.15 98.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.841 0.353 . . . . 0.0 110.545 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.1 -43.38 2.33 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.395 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 180' ' ' ASP . . . . . . . . 0 CA--C 1.529 0.911 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -63.17 -40.73 98.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.766 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -63.47 -40.91 98.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.424 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.521 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.1 mp -62.1 -42.13 98.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.01 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -60.88 -41.73 96.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.018 0.437 . . . . 0.0 110.127 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.66 -38.85 90.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.098 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 162' ' ' PHE . 60.6 t0 -60.52 -47.23 87.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.258 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.95 -45.98 91.28 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.383 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.45 -43.76 98.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.207 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.23 -46.42 82.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.177 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.66 -44.09 97.16 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.946 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.69 -53.28 59.32 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.8 pt -69.39 -39.81 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.757 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -58.72 -55.14 38.94 Favored 'General case' 0 C--O 1.217 -0.634 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.695 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 20' ' ' GLU . 93.5 t -61.96 -39.28 83.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.6 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.672 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.3 tt -52.64 -50.49 63.07 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.453 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -80.2 -51.38 9.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.992 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -65.52 -33.54 76.17 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.159 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.6 mt-10 58.14 88.11 0.06 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.816 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.04 -136.78 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.328 -0.397 . . . . 0.0 109.975 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.1 p -141.19 138.42 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.469 HD12 ' O ' ' A' ' 24' ' ' ALA . 2.8 pp -130.44 166.59 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-O 121.0 0.429 . . . . 0.0 111.876 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.469 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -58.58 134.71 56.97 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.936 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.473 ' CZ ' ' O ' ' A' ' 26' ' ' PRO . 2.0 t80 -128.73 133.63 25.4 Favored Pre-proline 0 CA--C 1.552 1.035 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.821 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.473 ' O ' ' CZ ' ' A' ' 25' ' ' TYR . 27.8 Cg_exo -60.09 146.04 97.05 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 CA-C-N 121.048 1.41 . . . . 0.0 110.898 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.432 HG22 ' H ' ' A' ' 29' ' ' ALA . 78.7 m -129.36 142.5 50.8 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.188 0.518 . . . . 0.0 110.378 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -77.66 20.1 0.35 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.641 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.432 ' H ' HG22 ' A' ' 27' ' ' THR . . . -160.21 -69.26 0.07 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.625 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.9 t -127.24 130.14 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.477 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 77.3 m-85 -42.24 136.6 2.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.178 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.43 -170.81 12.18 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.9 m -132.47 165.43 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.52 -177.05 27.49 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.303 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.439 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -156.22 -168.08 2.63 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.604 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.496 ' OD1' ' CE1' ' A' ' 131' ' ' TYR . 19.1 t70 -96.07 109.69 48.19 Favored Pre-proline 0 CA--C 1.553 1.063 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -178.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 36' ' ' ASP . 23.6 Cg_exo -36.79 170.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.865 2.377 . . . . 0.0 114.126 177.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 40.94 68.3 0.44 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.961 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.3 m -151.02 142.03 23.03 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.839 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -66.39 -32.56 74.02 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.43 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.448 HG23 ' N ' ' A' ' 42' ' ' ALA . 10.0 t -59.48 -40.88 88.41 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.528 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.448 ' N ' HG23 ' A' ' 41' ' ' THR . . . -58.8 -52.19 66.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.256 0.55 . . . . 0.0 111.506 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.409 HG12 ' H ' ' A' ' 43' ' ' VAL . 2.6 p -64.12 -45.87 95.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.876 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 91.3 mtp -66.79 -46.84 73.99 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.414 ' O ' ' CD2' ' A' ' 49' ' ' LEU . 40.8 ptt85 -63.01 -30.64 71.76 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.416 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 64.0 mt -73.55 -60.95 2.01 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 119.591 -0.843 . . . . 0.0 109.493 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.4 mt -53.11 -21.38 4.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.446 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -64.11 -85.23 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.665 -177.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.517 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -75.93 -32.8 59.74 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -77.17 -71.49 0.4 Allowed 'General case' 0 C--N 1.346 0.423 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.564 -176.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.408 ' O ' ' CG ' ' A' ' 51' ' ' GLN . 3.6 tt0 53.73 80.56 0.11 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.463 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.2 mtp85 161.19 -63.95 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.073 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -66.81 -12.52 36.34 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 122.568 2.179 . . . . 0.0 112.165 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.609 HG13 ' N ' ' A' ' 55' ' ' ASP . 7.3 p -43.9 -46.67 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.026 0.441 . . . . 0.0 110.625 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.609 ' N ' HG13 ' A' ' 54' ' ' VAL . 12.5 t0 -66.69 -44.75 80.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.629 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -59.8 -39.97 86.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.939 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 67.35 109.86 0.02 OUTLIER Glycine 0 CA--C 1.522 0.471 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.573 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -49.24 -170.17 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.935 -0.632 . . . . 0.0 112.222 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.438 ' O ' ' OG ' ' A' ' 137' ' ' SER . 83.0 mt -104.8 139.92 24.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.3 mt -109.02 145.02 36.25 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.471 ' CD1' ' HE ' ' A' ' 117' ' ' ARG . 9.1 tp -110.69 129.88 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-O 121.316 0.579 . . . . 0.0 110.247 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.458 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -118.55 153.82 33.58 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.403 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.36 -27.05 7.72 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -117.05 144.86 44.15 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.193 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -72.91 -14.21 61.42 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.324 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -50.53 -33.95 23.54 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.513 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.59 -9.26 38.71 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.13 -16.63 27.46 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.462 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 43.6 tttm -76.69 -39.1 2.28 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -178.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 93.7 Cg_endo -102.06 -4.97 0.33 Allowed 'Trans proline' 0 C--N 1.318 -1.027 0 C-N-CA 122.65 2.233 . . . . 0.0 111.846 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -92.36 -14.48 28.64 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.892 0.377 . . . . 0.0 110.181 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.575 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.6 mp -134.19 158.49 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.575 ' N ' HG22 ' A' ' 72' ' ' ILE . 21.9 m-20 -62.97 145.74 54.67 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -79.04 -4.57 50.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.751 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.407 HG23 ' SD ' ' A' ' 76' ' ' MET . 8.1 t -73.56 -37.9 65.4 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.033 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.407 ' SD ' HG23 ' A' ' 75' ' ' THR . 63.2 mmm -64.57 -47.45 78.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.759 0.79 . . . . 0.0 109.672 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.7 mp -79.02 135.07 36.78 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 113.886 -1.506 . . . . 0.0 111.18 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.457 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -160.23 158.73 30.5 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.876 -178.697 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -38.57 -47.36 1.3 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.841 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.89 -34.44 68.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.097 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.457 ' N ' ' O ' ' A' ' 78' ' ' THR . 65.9 tp60 -65.51 -40.45 93.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.747 0.308 . . . . 0.0 110.727 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -63.95 -52.53 59.3 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 122.309 1.052 . . . . 0.0 109.235 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' A' ' 87' ' ' SER . 83.1 tt0 -55.24 -50.41 69.53 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.145 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.4 m -61.46 -50.25 73.52 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.216 -1.356 . . . . 0.0 111.966 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.4 tt -67.97 -32.5 56.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.717 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -76.67 -34.67 58.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.543 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 83' ' ' GLU . 11.6 m -87.83 -15.73 36.03 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.642 0.258 . . . . 0.0 111.13 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.436 ' O ' ' O ' ' A' ' 89' ' ' TRP . 68.4 ttt180 -116.3 75.62 0.97 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.813 0.34 . . . . 0.0 110.372 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.436 ' O ' ' O ' ' A' ' 88' ' ' ARG . 75.0 m95 57.7 148.13 0.06 OUTLIER Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.709 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.44 -29.26 37.95 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.922 1.748 . . . . 0.0 112.044 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 149.68 80.05 0.03 OUTLIER Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -85.08 -8.91 8.81 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.992 2.462 . . . . 0.0 112.17 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.455 HG13 ' CZ ' ' A' ' 95' ' ' PHE . 2.7 p -135.99 147.87 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.185 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 82.7 m -85.48 141.25 30.05 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.292 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.485 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 97.8 m-85 -123.0 142.74 50.51 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.465 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.732 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.2 t -106.03 112.8 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-O 121.261 0.553 . . . . 0.0 110.66 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -97.94 150.68 37.01 Favored Pre-proline 0 N--CA 1.472 0.646 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.72 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.69 86.59 0.86 Allowed 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 122.118 1.879 . . . . 0.0 111.341 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -48.61 150.9 2.23 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.969 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.427 ' O ' ' OG1' ' A' ' 103' ' ' THR . 60.7 Cg_endo -68.07 145.36 66.99 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.88 1.72 . . . . 0.0 112.197 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.5 -36.49 84.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.951 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 82.1 p -53.22 -43.26 67.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.729 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.49 ' O ' ' O ' ' A' ' 104' ' ' PRO . 5.0 p -59.51 155.62 37.07 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-O 119.226 -0.416 . . . . 0.0 110.094 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.49 ' O ' ' O ' ' A' ' 103' ' ' THR . 52.0 Cg_exo -49.13 -158.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.033 0 C-N-CA 122.342 2.028 . . . . 0.0 113.104 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.473 ' O ' ' N ' ' A' ' 109' ' ' GLY . 2.0 tpt180 -145.72 -0.62 0.82 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.792 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 47.3 p-90 -75.5 -9.55 58.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.763 0.316 . . . . 0.0 110.461 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.981 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -76.55 -25.11 53.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.19 -179.217 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.701 ' H ' HD22 ' A' ' 107' ' ' LEU . 24.4 m -144.24 -42.58 0.26 Allowed 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 49.49 0.98 0.01 OUTLIER Glycine 0 CA--C 1.537 1.42 0 C-N-CA 121.368 -0.444 . . . . 0.0 113.125 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.53 ' H ' ' C ' ' A' ' 108' ' ' THR . 0.0 OUTLIER -93.88 -62.31 1.37 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 117.882 0.841 . . . . 0.0 109.853 179.715 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.55 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 87.8 t80 -147.57 169.72 18.99 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.101 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.55 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 4.2 p-10 -84.0 73.74 10.33 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.519 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.491 ' C ' HD22 ' A' ' 114' ' ' LEU . 54.3 p -169.15 126.02 0.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.491 HD22 ' C ' ' A' ' 113' ' ' SER . 2.9 mm? -117.01 120.21 37.68 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -177.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.548 ' N ' HG13 ' A' ' 96' ' ' VAL . . . -80.28 117.21 20.85 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.508 177.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.471 HG22 ' N ' ' A' ' 117' ' ' ARG . 4.6 p -141.4 159.47 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.587 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.471 ' HE ' ' CD1' ' A' ' 61' ' ' ILE . 61.6 ttp180 -139.77 150.71 45.09 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.667 0.27 . . . . 0.0 111.13 -179.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.458 HG22 ' HB3' ' A' ' 62' ' ' ALA . 54.8 t -120.68 131.92 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.9 t -135.84 134.96 39.41 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -139.5 87.1 2.16 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.864 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.638 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 52.1 t-80 -172.58 -36.91 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.638 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 58.5 Cg_endo -95.33 -159.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 122.181 1.921 . . . . 0.0 112.006 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.8 mt -77.53 -5.98 52.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.26 0.552 . . . . 0.0 110.387 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.2 t -57.95 -45.23 87.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.837 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.746 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.8 m -53.83 -61.81 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.926 0 C-N-CA 119.413 -0.915 . . . . 0.0 108.92 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.746 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.0 -45.52 2.62 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.581 0.229 . . . . 0.0 110.93 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.5 tp -68.99 -47.09 66.41 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.268 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 64.2 m -70.44 -49.54 47.65 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.411 0.624 . . . . 0.0 110.997 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.474 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.2 pp0? -54.73 -41.75 70.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.438 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.523 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.6 -56.77 17.92 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.735 -177.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.496 ' CE1' ' OD1' ' A' ' 36' ' ' ASP . 3.9 t80 -63.57 -22.11 66.72 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.705 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 81.27 3.42 90.66 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.3 mttt -151.83 158.19 34.1 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.645 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -43.08 178.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 123.63 2.887 . . . . 0.0 113.536 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.9 tp -135.18 123.2 22.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 113.57 -1.65 . . . . 0.0 106.826 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.409 HG13 ' H ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -63.88 144.32 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 C-N-CA 118.041 -1.463 . . . . 0.0 108.072 -179.454 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 59' ' ' ILE . 1.1 p -113.97 123.74 50.47 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.64 0.588 . . . . 0.0 111.693 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 4.0 m -128.85 162.09 28.3 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.595 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.1 m -74.61 149.78 39.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.335 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.572 ' HB1' ' SG ' ' A' ' 148' ' ' CYS . . . -79.54 81.98 5.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.602 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -160.4 164.08 32.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.389 0.614 . . . . 0.0 110.578 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.68 -165.96 1.74 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.127 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.2 t -59.71 -44.11 93.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.414 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -162.55 12.49 0.11 Allowed Glycine 0 C--N 1.327 0.075 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.9 tp -89.1 126.4 59.11 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -39.64 157.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.538 1.492 . . . . 0.0 112.297 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.62 -161.0 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.411 2.074 . . . . 0.0 111.759 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.572 ' SG ' ' HB1' ' A' ' 140' ' ' ALA . 28.1 p -126.4 86.05 2.47 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.477 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 51.6 ptt85 -53.34 -37.47 62.37 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.862 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.36 171.48 20.16 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.43 ' H ' HG22 ' A' ' 151' ' ' VAL . 1.6 m -59.28 -22.48 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 CA-C-O 121.484 0.659 . . . . 0.0 109.297 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -65.26 -25.46 67.67 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 155' ' ' ARG . 0.0 OUTLIER -71.78 -78.97 0.08 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.49 179.282 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.4 p -34.75 -29.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.489 0.715 . . . . 0.0 110.072 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -73.68 -51.77 15.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.921 179.646 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 153' ' ' GLU . . . -69.78 -20.33 63.48 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 122.542 1.163 . . . . 0.0 108.064 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -82.78 -45.93 13.75 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 112.753 -2.021 . . . . 0.0 111.563 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -129.26 -22.66 3.08 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 90.01 22.7 34.81 Favored Glycine 0 N--CA 1.467 0.708 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.42 ' O ' ' O ' ' A' ' 159' ' ' GLY . . . -43.27 -98.28 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.742 0.306 . . . . 0.0 110.942 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.46 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 62.62 35.12 14.49 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.526 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.7 m-85 -174.06 -62.16 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.057 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -73.41 29.05 0.3 Allowed 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.175 1.917 . . . . 0.0 110.476 177.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.559 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.3 m -131.55 166.86 27.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.747 -178.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.8 t -123.0 65.7 28.04 Favored Pre-proline 0 N--CA 1.473 0.684 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.796 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.559 ' HD3' HG23 ' A' ' 164' ' ' VAL . 21.2 Cg_exo -36.31 142.42 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 123.561 2.841 . . . . 0.0 115.008 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 165.1 -167.91 38.97 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 114.006 -1.452 . . . . 0.0 110.88 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -152.71 177.84 10.27 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.2 t -145.53 152.66 40.09 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.404 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -51.57 -69.02 1.26 Allowed Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 137.44 105.47 0.72 Allowed Glycine 0 N--CA 1.468 0.784 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -137.08 150.99 48.39 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.756 0.312 . . . . 0.0 110.365 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.541 ' N ' HD12 ' A' ' 173' ' ' LEU . 10.3 mp -60.09 -73.7 0.08 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.356 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -174.74 59.37 0.21 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.696 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -68.41 -17.39 44.03 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.502 2.135 . . . . 0.0 111.907 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 43.0 t -92.07 121.98 34.14 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.438 0.637 . . . . 0.0 110.087 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -134.64 -169.96 2.45 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.803 -178.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.0 pt -122.7 102.5 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 121.182 0.515 . . . . 0.0 110.331 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -95.53 156.2 16.42 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.339 0.59 . . . . 0.0 111.847 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -76.4 106.36 7.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.822 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -64.68 -12.03 42.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.704 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.515 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.6 mm? -63.03 -42.05 99.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.348 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.71 -42.79 3.07 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.528 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 73.85 19.35 79.75 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -72.31 151.61 42.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.191 0.519 . . . . 0.0 110.98 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.498 HD23 ' N ' ' A' ' 186' ' ' LEU . 0.7 OUTLIER -67.51 179.18 1.37 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.597 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 187' ' ' PHE . . . . . 0.574 ' O ' ' NE2' ' A' ' 189' ' ' GLN . 89.9 t80 -91.75 -31.77 15.65 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.92 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -78.18 139.69 38.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.058 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.574 ' NE2' ' O ' ' A' ' 187' ' ' PHE . 3.1 mp0 -128.52 -15.5 4.51 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.046 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.711 0 CA-C-O 118.157 -1.357 . . . . 0.0 111.067 179.807 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 65.2 t30 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -83.04 142.03 31.61 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.645 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -144.92 -44.75 0.23 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.46 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.513 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.4 mp -62.74 -41.83 99.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.965 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -63.37 -42.8 98.88 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.417 0.627 . . . . 0.0 109.783 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -62.31 -41.36 98.47 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.476 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -62.11 -45.55 92.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.741 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.89 90.02 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.19 0.519 . . . . 0.0 110.379 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.48 -43.72 98.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.613 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.52 -45.59 81.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.191 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.72 -39.25 90.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.618 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.4 -53.98 49.52 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.51 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.6 pt -71.59 -31.01 40.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.232 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -59.57 -55.08 38.95 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' A' ' 20' ' ' GLU . 88.7 t -63.72 -40.35 88.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.896 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.675 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.5 tt -52.28 -50.28 62.44 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.555 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -79.82 -50.13 10.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.073 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -66.25 -34.59 78.36 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.952 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.8 mt-10 60.92 82.38 0.17 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 178.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.4 ' H ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -163.47 -139.51 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.232 177.507 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 34' ' ' GLY . 9.2 p -134.67 142.63 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 pp -129.35 163.66 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 120.896 0.379 . . . . 0.0 111.304 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.89 131.22 48.02 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.215 0.531 . . . . 0.0 111.11 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.494 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 0.4 OUTLIER -121.02 140.36 30.8 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.494 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 65.3 Cg_endo -79.33 154.73 24.84 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.553 1.502 . . . . 0.0 111.931 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.472 ' C ' ' H ' ' A' ' 29' ' ' ALA . 23.0 m -142.2 141.38 32.55 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.221 0.534 . . . . 0.0 110.955 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -75.44 23.18 0.12 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.547 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -154.21 -75.48 0.11 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.965 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.4 t -125.73 128.83 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 120.973 0.416 . . . . 0.0 110.174 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.503 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 93.5 m-85 -46.67 147.48 1.24 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.144 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -152.47 -174.47 23.03 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.6 m -126.55 168.16 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -157.64 177.65 34.33 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.098 -1.049 . . . . 0.0 112.235 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -154.66 -166.75 2.41 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.508 0.194 . . . . 0.0 110.594 -179.401 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.451 ' O ' ' O ' ' A' ' 37' ' ' PRO . 3.8 m-20 -95.52 108.78 41.84 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -178.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.451 ' O ' ' O ' ' A' ' 36' ' ' ASP . 54.1 Cg_exo -38.69 174.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.76 2.307 . . . . 0.0 114.042 177.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 38.08 69.72 0.23 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.302 -1.317 . . . . 0.0 111.429 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 51.0 m -149.1 144.09 26.44 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.376 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -69.5 -36.46 76.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.426 0.631 . . . . 0.0 110.64 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 41' ' ' THR . 0.1 OUTLIER -64.39 -43.68 93.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.664 -178.873 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.46 -50.05 75.11 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.041 -0.263 . . . . 0.0 111.413 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.1 p -62.32 -44.96 99.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.391 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 91.1 mtp -63.66 -40.49 96.98 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.475 ' NH2' HG21 ' A' ' 22' ' ' VAL . 34.0 ttt-85 -61.02 -41.6 96.86 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.923 0.868 . . . . 0.0 108.844 178.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.431 ' O ' HD23 ' A' ' 46' ' ' LEU . 1.0 OUTLIER -64.94 -54.74 25.85 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.238 -178.417 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.4 mt -69.1 -11.41 60.77 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.349 -0.842 . . . . 0.0 112.002 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -69.57 -82.48 0.04 OUTLIER 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 120.996 0.426 . . . . 0.0 110.778 -177.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.585 HD12 ' H ' ' A' ' 143' ' ' SER . 2.2 pt? -76.42 -35.29 58.62 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -178.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -76.36 -50.56 13.91 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.797 -177.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 35.29 66.55 0.31 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.724 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.408 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 4.7 mtt180 178.12 -53.05 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.898 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.397 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.408 ' HD2' ' H ' ' A' ' 52' ' ' ARG . 83.0 Cg_endo -80.56 -5.42 13.31 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.866 2.377 . . . . 0.0 112.584 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.59 HG13 ' N ' ' A' ' 55' ' ' ASP . 8.0 p -44.71 -45.13 2.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.073 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.59 ' N ' HG13 ' A' ' 54' ' ' VAL . 67.5 t0 -65.62 -40.38 92.52 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.588 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -62.21 -39.19 91.96 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 71.25 109.62 0.04 OUTLIER Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.564 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -51.7 -163.34 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.232 0.539 . . . . 0.0 112.209 -179.805 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.434 ' O ' ' OG ' ' A' ' 137' ' ' SER . 61.1 mt -105.12 137.28 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.897 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.7 mt -115.68 143.01 45.98 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.3 tp -111.82 132.91 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 121.149 0.5 . . . . 0.0 110.741 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.47 150.92 41.85 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.95 -29.79 8.42 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.04 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -113.12 150.05 32.7 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.155 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -79.01 -14.28 59.28 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -54.49 -30.19 52.54 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.913 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.01 -11.06 29.1 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.525 HD22 ' N ' ' A' ' 68' ' ' LEU . 3.7 mm? -91.16 -18.8 23.88 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.459 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 43.4 tttm -75.57 -39.43 2.99 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 85.3 Cg_endo -104.18 -2.61 0.23 Allowed 'Trans proline' 0 C--N 1.319 -1.009 0 C-N-CA 122.91 2.407 . . . . 0.0 112.363 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -96.95 -11.12 25.04 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.692 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.516 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.1 mp -127.94 155.96 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.516 ' N ' HG22 ' A' ' 72' ' ' ILE . 93.9 m-20 -64.29 158.52 23.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.965 0.412 . . . . 0.0 110.08 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -94.74 7.74 44.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.028 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.517 HG23 ' N ' ' A' ' 76' ' ' MET . 13.2 t -74.32 -42.57 59.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.029 0.442 . . . . 0.0 111.075 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.517 ' N ' HG23 ' A' ' 75' ' ' THR . 24.4 ptm -95.34 -15.74 22.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.093 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 tp -93.92 127.57 39.76 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.113 0.482 . . . . 0.0 110.63 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.458 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -157.73 161.94 38.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.858 -177.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -39.61 -47.52 1.96 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.776 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.58 -32.64 57.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.853 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.458 ' N ' ' O ' ' A' ' 78' ' ' THR . 58.6 tp60 -63.48 -40.97 98.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.204 0.526 . . . . 0.0 110.19 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.422 ' HG2' ' H ' ' A' ' 82' ' ' ARG . 10.6 mmt85 -65.41 -52.85 50.49 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 122.484 1.135 . . . . 0.0 109.42 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -54.25 -50.96 65.99 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 113.801 -1.545 . . . . 0.0 110.143 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.6 m -61.1 -50.04 74.88 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.574 -1.193 . . . . 0.0 111.979 -177.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.6 tt -67.81 -32.13 55.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.072 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -76.47 -36.05 58.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.753 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.8 m -87.4 -14.19 41.28 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.633 0.254 . . . . 0.0 111.298 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 89' ' ' TRP . 69.2 ttt180 -115.34 75.43 0.94 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.427 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.452 ' O ' ' O ' ' A' ' 88' ' ' ARG . 13.9 m-90 56.37 153.11 0.07 OUTLIER Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.507 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.6 -21.23 39.87 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.133 1.889 . . . . 0.0 111.649 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.519 ' O ' ' NE ' ' A' ' 117' ' ' ARG . . . 158.52 81.27 0.04 OUTLIER Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.55 -17.8 11.07 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.262 1.974 . . . . 0.0 112.047 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.451 HG13 ' CE2' ' A' ' 95' ' ' PHE . 3.0 p -136.95 146.32 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.132 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.6 m -91.31 129.33 37.32 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.389 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.46 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 38.8 m-85 -117.5 138.05 52.14 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.779 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.623 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 5.2 t -92.46 104.65 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 121.301 0.572 . . . . 0.0 110.761 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 97' ' ' PHE . 30.4 m-85 -86.3 147.1 43.85 Favored Pre-proline 0 N--CA 1.466 0.362 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.529 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.54 83.76 1.85 Allowed 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.993 1.796 . . . . 0.0 111.6 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -46.2 152.46 0.81 Allowed Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -69.46 156.28 64.56 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.036 1.824 . . . . 0.0 111.607 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -136.6 53.61 1.91 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.17 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.401 ' O ' ' OG1' ' A' ' 103' ' ' THR . 40.8 p -67.93 -32.95 73.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.69 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.719 ' H ' ' CD ' ' A' ' 104' ' ' PRO . 1.2 m -167.16 -37.3 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.719 ' CD ' ' H ' ' A' ' 103' ' ' THR . 16.7 Cg_exo -66.7 -167.95 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.473 2.115 . . . . 0.0 113.021 -178.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' A' ' 109' ' ' GLY . 8.0 tpt180 -178.58 -3.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.407 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.449 ' H ' ' H ' ' A' ' 105' ' ' ARG . 8.6 p90 -81.31 -10.08 59.63 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.662 0.744 . . . . 0.0 109.057 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.622 ' H ' ' CD2' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -77.38 -15.28 59.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.638 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 85.3 m -143.28 -40.57 0.31 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.316 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 92.33 -19.28 51.04 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 116.263 -0.426 . . . . 0.0 113.714 178.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.419 ' O ' ' NH2' ' A' ' 105' ' ' ARG . 18.1 tpt180 -144.86 -80.4 0.17 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 117.953 0.877 . . . . 0.0 111.786 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.406 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 29.7 t80 -75.63 -125.47 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.667 -178.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.406 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 48.1 t0 -170.52 54.38 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.834 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.6 p -157.27 155.33 30.58 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.492 ' O ' HD12 ' A' ' 114' ' ' LEU . 0.3 OUTLIER -161.13 137.78 8.58 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.227 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.445 ' HB2' HG22 ' A' ' 96' ' ' VAL . . . -69.55 135.41 50.02 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 113.212 -1.813 . . . . 0.0 109.777 178.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.6 p -149.73 153.71 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 120.888 0.375 . . . . 0.0 110.7 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.519 ' NE ' ' O ' ' A' ' 91' ' ' GLY . 75.7 ttt180 -142.33 152.55 43.04 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.507 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 49.5 t -119.93 133.05 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.2 t -137.72 138.32 39.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.042 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -145.27 85.2 1.72 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.689 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.664 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 8.2 t60 -173.39 -36.58 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.179 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.664 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 67.7 Cg_endo -95.04 -160.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 122.298 1.999 . . . . 0.0 111.964 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.526 HD12 ' N ' ' A' ' 123' ' ' LEU . 9.6 mp -76.84 -7.51 55.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.175 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.0 t -56.74 -45.06 82.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.797 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.738 HG23 ' H ' ' A' ' 126' ' ' ALA . 26.8 m -53.84 -61.84 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.875 0 C-N-CA 119.35 -0.94 . . . . 0.0 108.981 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.738 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.04 -44.08 2.32 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.894 0.378 . . . . 0.0 110.992 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.6 -48.3 60.58 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.362 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 61.6 m -69.9 -49.28 53.67 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.421 0.629 . . . . 0.0 110.684 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.457 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.0 OUTLIER -54.39 -42.71 70.72 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.42 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.536 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.5 -54.96 41.18 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.585 -177.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.443 ' CE1' ' OD2' ' A' ' 36' ' ' ASP . 39.6 t80 -62.46 -21.6 65.57 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.919 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.86 -1.93 82.02 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' A' ' 134' ' ' PRO . 14.2 mtpp -149.5 159.01 37.34 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 133' ' ' LYS . 3.4 Cg_exo -41.68 178.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 123.847 3.031 . . . . 0.0 113.128 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.4 tp -132.34 123.16 26.27 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 176.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.429 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -63.79 153.12 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 C-N-CA 117.888 -1.525 . . . . 0.0 106.986 -179.702 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 59' ' ' ILE . 1.4 p -130.12 133.78 46.88 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.109 0.48 . . . . 0.0 111.1 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.5 m -134.44 164.67 26.93 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.708 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.6 m -70.45 148.46 48.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.386 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.527 ' HB1' ' H ' ' A' ' 148' ' ' CYS . . . -61.4 -36.9 81.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.221 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 141' ' ' ASN . 50.3 p30 -67.28 144.41 55.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.043 0.449 . . . . 0.0 110.475 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.698 HD22 ' C ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -150.94 163.57 38.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.219 -179.607 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.585 ' H ' HD12 ' A' ' 49' ' ' LEU . 29.1 t 28.45 -87.88 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 O-C-N 123.603 0.564 . . . . 0.0 112.192 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 142' ' ' LEU . . . -157.41 16.78 0.35 Allowed Glycine 0 C--N 1.332 0.307 0 N-CA-C 109.976 -1.249 . . . . 0.0 109.976 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.9 tp -94.61 129.25 37.0 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 115.21 -0.495 . . . . 0.0 109.691 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -37.21 156.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.802 1.668 . . . . 0.0 112.384 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -75.71 -164.82 0.26 Allowed 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.42 2.08 . . . . 0.0 112.888 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.527 ' H ' ' HB1' ' A' ' 140' ' ' ALA . 29.7 m -111.39 80.12 1.28 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.123 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.503 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 33.9 ptt180 -54.54 -35.16 62.93 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.21 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.95 169.81 19.08 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.439 HG22 ' H ' ' A' ' 151' ' ' VAL . 0.7 OUTLIER -57.28 -22.82 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.412 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -63.5 -30.83 71.89 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 155' ' ' ARG . 6.0 tm-20 -63.76 -79.61 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.204 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.1 p -36.64 -30.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.922 0.889 . . . . 0.0 111.118 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.472 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -69.69 -52.21 27.71 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.628 -178.896 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.92 -17.69 62.68 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 122.697 1.236 . . . . 0.0 108.386 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -83.87 -45.62 13.04 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 112.492 -2.14 . . . . 0.0 111.847 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -131.11 -23.46 2.45 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 87.98 26.75 28.08 Favored Glycine 0 N--CA 1.464 0.553 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 159' ' ' GLY . . . -43.01 -97.33 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.65 -0.275 . . . . 0.0 111.018 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.465 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 65.85 33.13 8.23 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-O 121.362 0.601 . . . . 0.0 109.453 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.527 ' C ' ' H ' ' A' ' 164' ' ' VAL . 1.8 m-85 -175.58 -62.09 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.505 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.38 31.94 0.28 Allowed 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.169 1.913 . . . . 0.0 110.363 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.577 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.4 m -134.64 167.17 26.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.734 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.3 t -123.72 66.14 36.49 Favored Pre-proline 0 N--CA 1.472 0.657 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.549 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.577 ' HD3' HG23 ' A' ' 164' ' ' VAL . 38.7 Cg_exo -37.73 147.59 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 123.551 2.834 . . . . 0.0 115.072 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 163.84 -173.39 39.9 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 113.739 -1.573 . . . . 0.0 111.105 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -145.68 150.86 37.07 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.718 0.294 . . . . 0.0 110.472 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.5 t -147.06 153.2 39.7 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.053 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -60.76 -69.81 1.19 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 102.48 5.29 48.93 Favored Glycine 0 N--CA 1.469 0.841 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.31 -38.62 90.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.873 0.368 . . . . 0.0 110.906 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 173' ' ' LEU . 10.2 mp -61.6 -169.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.122 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -84.53 150.17 56.25 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -60.01 -43.89 33.48 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 122.114 1.876 . . . . 0.0 111.618 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 45.5 m -171.51 128.15 0.66 Allowed 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.607 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -106.51 103.65 13.15 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.901 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.502 ' O ' HG23 ' A' ' 178' ' ' ILE . 18.3 tt -111.91 120.5 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.067 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -125.28 164.2 20.87 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 122.052 0.93 . . . . 0.0 110.768 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 184' ' ' GLY . 43.2 t0 -77.05 106.71 8.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.037 -1.438 . . . . 0.0 108.79 178.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -62.28 -20.52 64.37 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.692 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.477 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.4 mm? -63.77 -42.27 97.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.854 0.359 . . . . 0.0 110.408 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.86 -47.12 2.31 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.773 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 180' ' ' ASP . . . 76.24 20.14 77.59 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -83.5 178.48 7.99 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-O 121.025 0.441 . . . . 0.0 111.032 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.526 ' H ' ' CD2' ' A' ' 186' ' ' LEU . 0.7 OUTLIER -83.65 179.22 7.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.583 179.742 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -84.97 -39.79 17.69 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.761 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.85 136.19 48.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.898 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -133.64 -19.59 2.09 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.335 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.73 0 CA-C-O 118.028 -1.429 . . . . 0.0 111.065 -179.95 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 54.1 p30 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 57.55 34.73 24.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.339 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -63.97 -40.76 97.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.656 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.54 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.0 mp -62.49 -42.38 99.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.458 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.6 -42.66 91.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.911 0.386 . . . . 0.0 110.26 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 63.3 ttm-85 -62.88 -42.29 99.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.379 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -62.16 -43.49 98.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.398 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.2 -47.14 87.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.06 0.457 . . . . 0.0 110.02 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.22 -43.24 98.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.817 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.85 -40.88 85.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.44 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.24 -43.08 92.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.029 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.16 -52.45 64.79 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.787 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 14' ' ' ILE . 16.7 pt -68.5 -39.06 80.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.357 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -58.22 -54.9 41.81 Favored 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.201 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 20' ' ' GLU . 94.0 t -59.75 -39.73 80.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.776 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.651 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.5 tt -52.06 -50.0 62.38 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.104 -0.638 . . . . 0.0 109.674 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -81.31 -52.71 7.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.904 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.458 ' O ' ' NH1' ' A' ' 21' ' ' ARG . 69.4 mm-40 -63.25 -35.56 80.76 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.438 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.2 mt-10 59.69 81.89 0.16 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.458 ' NH1' ' O ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -155.28 -136.73 0.06 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 177.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 34' ' ' GLY . 6.6 p -142.09 139.8 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -126.92 165.64 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.03 0.443 . . . . 0.0 111.363 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.45 129.48 40.04 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.04 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -109.88 133.35 20.99 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.129 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -84.57 140.96 8.56 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.246 1.297 . . . . 0.0 111.789 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.5 ' C ' ' H ' ' A' ' 29' ' ' ALA . 28.2 m -136.01 135.89 39.85 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.871 0.367 . . . . 0.0 110.839 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -74.77 29.43 0.09 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.998 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.5 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -158.52 -77.18 0.07 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.289 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.1 m -120.37 126.28 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-O 121.118 0.485 . . . . 0.0 110.781 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.524 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 77.9 m-85 -60.67 145.17 50.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.509 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -154.4 -166.62 15.27 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.6 m -131.91 170.85 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.441 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -159.87 -176.35 31.85 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 119.518 -1.325 . . . . 0.0 112.51 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.502 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -163.48 -163.36 0.81 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.137 -179.147 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.502 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 43.0 t0 -90.74 106.43 15.45 Favored Pre-proline 0 CA--C 1.555 1.167 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -38.16 -61.89 0.34 Allowed 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.283 1.989 . . . . 0.0 112.129 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -69.71 62.63 0.18 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.315 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.4 m -155.1 131.89 10.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.083 0.468 . . . . 0.0 110.928 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.08 -17.92 63.93 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.247 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.514 HG23 ' N ' ' A' ' 42' ' ' ALA . 15.3 t -61.26 -41.91 97.73 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.511 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.514 ' N ' HG23 ' A' ' 41' ' ' THR . . . -58.13 -51.26 70.45 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.63 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 p -63.05 -44.19 99.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.434 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 62.3 mtt -65.22 -39.93 93.44 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -61.92 -32.83 73.26 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.632 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 81.9 mt -76.92 -57.67 3.72 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.4 mt -57.2 -16.09 7.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.387 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.52 -85.77 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.589 -178.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.505 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -76.08 -32.47 59.26 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.987 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -79.11 -71.01 0.46 Allowed 'General case' 0 C--N 1.349 0.57 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.428 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.424 ' O ' ' CG ' ' A' ' 51' ' ' GLN . 3.7 tt0 54.4 79.85 0.13 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.381 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 161.45 -62.7 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.856 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.332 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.01 -8.53 23.84 Favored 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.58 2.187 . . . . 0.0 111.641 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.557 HG13 ' N ' ' A' ' 55' ' ' ASP . 7.7 p -43.74 -46.34 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.926 0.394 . . . . 0.0 110.466 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.557 ' N ' HG13 ' A' ' 54' ' ' VAL . 10.0 t0 -66.28 -42.87 87.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.196 0.522 . . . . 0.0 109.941 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -61.35 -40.87 95.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.422 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 64.52 117.34 0.01 OUTLIER Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.572 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -51.21 -164.53 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.21 0.529 . . . . 0.0 112.131 179.676 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.5 mt -105.62 145.19 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 16.9 mt -117.15 146.33 43.26 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.4 tp -113.8 132.77 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-O 121.39 0.614 . . . . 0.0 111.325 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.51 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -120.39 154.1 35.59 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.103 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.04 -27.58 6.89 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -114.13 143.74 44.31 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.105 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -73.48 -14.29 61.21 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -50.28 -33.13 18.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.502 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.4 -12.25 28.25 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.548 ' O ' HD13 ' A' ' 72' ' ' ILE . 3.6 mm? -91.67 -14.92 29.26 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.424 -0.797 . . . . 0.0 108.885 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.464 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 43.0 tttm -78.64 -39.93 1.64 Allowed Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 66.6 Cg_endo -104.43 -2.07 0.23 Allowed 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 122.853 2.368 . . . . 0.0 112.351 -178.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.463 ' OH ' ' CD2' ' A' ' 114' ' ' LEU . 55.6 t80 -97.73 -9.47 26.59 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.988 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.619 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.6 mp -123.34 168.91 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.619 ' N ' HG22 ' A' ' 72' ' ' ILE . 96.5 m-20 -60.56 -12.43 9.93 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.051 -0.259 . . . . 0.0 111.141 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 57.8 t0 55.71 30.52 15.73 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.282 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.546 HG23 ' N ' ' A' ' 76' ' ' MET . 9.2 t -96.13 -43.5 7.72 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.208 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.546 ' N ' HG23 ' A' ' 75' ' ' THR . 18.9 ptp -84.69 -5.97 59.34 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.237 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.3 tp -92.8 127.56 38.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.251 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.438 ' H ' ' HB3' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -160.2 161.63 33.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.683 -177.735 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -38.77 -49.18 1.59 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.727 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.02 -33.54 61.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.048 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.438 ' HB3' ' H ' ' A' ' 78' ' ' THR . 65.4 tp60 -66.31 -39.03 89.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.619 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.5 mmt85 -63.54 -53.45 51.64 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 122.38 1.086 . . . . 0.0 108.619 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -54.31 -50.39 67.46 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.013 -1.449 . . . . 0.0 110.117 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -60.83 -50.56 72.95 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.883 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.0 tt -67.9 -32.6 57.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.102 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -72.41 -41.66 66.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.82 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.7 m -78.03 -33.09 51.27 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.566 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 89' ' ' TRP . 76.7 ttt180 -95.74 157.69 15.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.04 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.413 ' C ' ' O ' ' A' ' 88' ' ' ARG . 3.7 m-90 -31.37 148.52 0.05 OUTLIER Pre-proline 0 N--CA 1.47 0.55 0 O-C-N 123.482 0.488 . . . . 0.0 111.43 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -67.02 -17.64 51.32 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.051 1.834 . . . . 0.0 111.41 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.425 ' H ' ' HD3' ' A' ' 92' ' ' PRO . . . 108.92 73.75 0.79 Allowed Glycine 0 N--CA 1.468 0.831 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.425 ' HD3' ' H ' ' A' ' 91' ' ' GLY . 50.3 Cg_exo -53.78 -36.15 81.33 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.833 2.355 . . . . 0.0 111.675 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.422 HG13 ' CZ ' ' A' ' 95' ' ' PHE . 3.4 p -90.44 147.61 5.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.038 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 57.7 m -86.15 147.34 26.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.662 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.424 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 81.7 m-85 -127.32 143.5 51.22 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.469 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.626 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.8 t -99.23 105.39 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-O 121.209 0.528 . . . . 0.0 109.985 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -88.84 149.7 44.19 Favored Pre-proline 0 N--CA 1.469 0.52 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.968 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -76.74 110.18 3.0 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.229 1.953 . . . . 0.0 110.977 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.91 147.72 97.85 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.607 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 40.0 Cg_endo -64.19 -26.27 64.83 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.817 1.678 . . . . 0.0 111.848 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 100' ' ' PRO . . . 93.33 -26.19 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 O-C-N 123.706 0.629 . . . . 0.0 110.869 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.5 p -55.38 -44.45 76.11 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.612 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.445 ' H ' HG23 ' A' ' 103' ' ' THR . 0.1 OUTLIER -64.87 -177.41 0.23 Allowed Pre-proline 0 CA--C 1.531 0.249 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.25 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' A' ' 103' ' ' THR . 52.8 Cg_exo -56.68 -155.35 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.901 1.734 . . . . 0.0 111.485 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.46 ' NH1' ' OD1' ' A' ' 112' ' ' ASP . 2.8 tpp85 -158.76 5.29 0.11 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.536 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.531 ' CD1' ' N ' ' A' ' 106' ' ' TRP . 4.5 m0 -78.66 -7.36 57.58 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.6 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.942 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -72.41 -31.8 65.83 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.772 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.691 ' H ' HD22 ' A' ' 107' ' ' LEU . 25.9 m -141.01 -42.02 0.39 Allowed 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.515 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 49.36 -0.22 0.01 OUTLIER Glycine 0 CA--C 1.539 1.562 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.13 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.555 ' N ' ' O ' ' A' ' 108' ' ' THR . 0.5 OUTLIER -86.74 -51.17 6.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.025 0.912 . . . . 0.0 108.862 179.366 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.582 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 83.5 t80 -151.36 173.18 14.82 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.498 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.582 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 93.3 m-20 -78.91 51.08 1.08 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.105 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 82.5 p -161.05 158.85 28.5 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.498 ' O ' HD12 ' A' ' 114' ' ' LEU . 0.3 OUTLIER -158.36 136.62 10.84 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -178.834 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.433 ' N ' HG13 ' A' ' 96' ' ' VAL . . . -68.02 125.11 25.3 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 113.389 -1.732 . . . . 0.0 110.527 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.507 HG22 ' N ' ' A' ' 117' ' ' ARG . 4.2 p -151.57 161.48 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.507 ' N ' HG22 ' A' ' 116' ' ' VAL . 61.5 ttp180 -147.06 154.38 41.11 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.934 0.397 . . . . 0.0 111.756 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.51 HG22 ' HB3' ' A' ' 62' ' ' ALA . 56.0 t -119.95 133.09 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.604 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.424 ' O ' HG23 ' A' ' 119' ' ' THR . 11.4 t -132.41 129.65 39.6 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.924 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.539 ' O ' ' CG ' ' A' ' 121' ' ' HIS . 67.4 t0 -136.99 75.47 1.53 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.163 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.682 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 18.7 m-70 -165.52 -36.5 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.301 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.682 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 18.7 Cg_endo -91.97 -162.14 0.1 Allowed 'Trans proline' 0 N--CA 1.485 0.984 0 C-N-CA 121.793 1.662 . . . . 0.0 112.01 -178.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.7 mt -77.3 -6.29 52.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.649 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 83.0 t -57.79 -44.12 85.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.632 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.747 HG23 ' H ' ' A' ' 126' ' ' ALA . 34.5 m -52.32 -62.46 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.879 0 C-N-CA 119.354 -0.938 . . . . 0.0 108.828 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.747 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.97 -44.03 3.34 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.697 0.284 . . . . 0.0 110.995 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 40.3 tp -68.75 -49.26 60.15 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.447 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.477 ' O ' ' N ' ' A' ' 132' ' ' GLY . 75.7 m -70.6 -47.92 57.74 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.263 0.554 . . . . 0.0 111.123 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.479 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -54.64 -42.52 71.37 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.493 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.6 -54.59 45.38 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.167 -177.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -65.71 -22.39 66.61 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 114.766 -1.107 . . . . 0.0 108.136 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 128' ' ' CYS . . . 78.97 2.28 86.53 Favored Glycine 0 N--CA 1.44 -1.087 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -149.57 159.69 35.78 Favored Pre-proline 0 CA--C 1.55 0.951 0 CA-C-N 117.204 0.502 . . . . 0.0 110.556 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -47.59 163.76 0.17 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 124.045 3.163 . . . . 0.0 113.667 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.3 tp -119.95 123.99 44.88 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.422 ' O ' ' CA ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -63.41 147.87 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 C-N-CA 117.755 -1.578 . . . . 0.0 106.899 179.846 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.3 t -122.53 127.15 49.14 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.648 0.592 . . . . 0.0 111.515 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.4 m -128.62 165.75 20.22 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.602 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 24.0 m -72.25 148.49 45.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.668 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.576 ' HB1' ' H ' ' A' ' 148' ' ' CYS . . . -60.92 -36.6 79.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.199 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 57.2 p30 -61.98 152.34 32.56 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.746 0.784 . . . . 0.0 111.293 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.18 -155.36 0.63 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.328 -1.306 . . . . 0.0 109.809 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 79.4 p -62.44 -39.05 92.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.327 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -167.97 7.55 0.05 OUTLIER Glycine 0 CA--C 1.51 -0.257 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.2 tp -86.74 128.15 57.5 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-O 119.223 -0.418 . . . . 0.0 110.037 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -38.22 156.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.666 1.578 . . . . 0.0 112.092 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.435 ' O ' ' OE2' ' A' ' 153' ' ' GLU . 97.6 Cg_endo -74.65 -169.72 0.65 Allowed 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.656 2.237 . . . . 0.0 111.983 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.576 ' H ' ' HB1' ' A' ' 140' ' ' ALA . 14.6 m -116.71 75.54 0.97 Allowed 'General case' 0 CA--C 1.522 -0.109 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.661 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.524 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 31.3 ptt-85 -51.12 -38.7 53.44 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.386 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -161.22 170.47 20.21 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.142 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.404 HG11 ' HA ' ' A' ' 166' ' ' PRO . 1.3 m -57.8 -20.8 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -64.8 -33.96 77.23 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.435 ' OE2' ' O ' ' A' ' 147' ' ' PRO . 0.0 OUTLIER -61.54 -79.69 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.807 179.289 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.441 HG13 ' N ' ' A' ' 155' ' ' ARG . 7.2 p -35.14 -33.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.969 0.908 . . . . 0.0 111.104 178.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.459 ' O ' ' N ' ' A' ' 159' ' ' GLY . 4.9 tmt_? -68.32 -51.76 41.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.679 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.51 -17.55 62.95 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.633 1.206 . . . . 0.0 107.956 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -83.42 -45.63 13.45 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 112.582 -2.099 . . . . 0.0 111.86 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -130.79 -27.35 2.11 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 94.01 24.39 20.01 Favored Glycine 0 N--CA 1.467 0.754 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 -178.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -43.07 -95.99 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.749 0.309 . . . . 0.0 110.968 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.514 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 60.53 35.45 20.17 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.537 ' H ' HG22 ' A' ' 164' ' ' VAL . 2.0 m-85 -172.61 -63.02 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.005 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -71.84 25.13 0.25 Allowed 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.301 2.001 . . . . 0.0 110.813 177.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.568 HG23 ' HD3' ' A' ' 166' ' ' PRO . 16.0 m -128.38 166.09 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.694 -178.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.19 65.05 28.21 Favored Pre-proline 0 N--CA 1.476 0.832 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.552 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.568 ' HD3' HG23 ' A' ' 164' ' ' VAL . 17.1 Cg_exo -36.12 142.65 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 123.429 2.753 . . . . 0.0 114.862 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 176.63 -168.49 40.53 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 113.934 -1.485 . . . . 0.0 111.132 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -155.52 148.96 24.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.775 0.322 . . . . 0.0 110.171 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.7 t -108.1 136.04 48.45 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -54.07 -69.62 1.18 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 144.36 77.2 0.03 OUTLIER Glycine 0 N--CA 1.466 0.673 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.527 ' O ' ' N ' ' A' ' 174' ' ' ASN . 86.4 mtm-85 -122.82 14.67 10.05 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.332 0.253 . . . . 0.0 110.741 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.571 ' N ' HD12 ' A' ' 173' ' ' LEU . 10.0 mp 58.03 -74.4 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.696 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.527 ' N ' ' O ' ' A' ' 172' ' ' ARG . 75.2 m-20 37.54 71.99 0.92 Allowed Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.413 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.34 144.39 99.51 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.535 2.157 . . . . 0.0 111.188 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 14.2 p -78.47 114.48 17.41 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.312 0.577 . . . . 0.0 110.034 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -135.18 158.36 44.57 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.145 -177.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 43.6 pt -119.85 143.82 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.988 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -130.97 166.86 20.05 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.714 0.769 . . . . 0.0 111.413 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -79.46 105.72 10.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.156 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -64.67 -19.18 65.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.659 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.481 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.5 mm? -62.4 -41.78 98.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.195 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.17 -42.4 7.07 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 63.23 25.99 68.88 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.451 -1.059 . . . . 0.0 110.451 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -63.41 136.1 57.4 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.18 0.514 . . . . 0.0 110.862 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.67 ' H ' HD23 ' A' ' 186' ' ' LEU . 0.7 OUTLIER -105.57 179.73 4.18 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.488 -179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -125.24 68.01 1.13 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.594 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.609 ' CD ' ' H ' ' A' ' 188' ' ' ARG . 0.0 OUTLIER -72.46 -20.36 61.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.54 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.67 -30.21 70.87 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.883 0 CA-C-O 118.201 -1.333 . . . . 0.0 110.695 -179.674 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -93.27 7.86 42.67 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.469 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -62.57 -40.74 97.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.619 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.53 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.7 mp -62.24 -42.86 99.69 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -64.6 -40.55 95.71 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -63.18 -41.73 99.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.72 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -60.57 -44.99 95.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.698 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.65 -44.47 96.91 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.099 0.476 . . . . 0.0 110.044 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.75 -43.13 97.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.69 -42.66 79.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.943 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.79 -41.02 99.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.86 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.37 -54.72 42.3 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.828 0.347 . . . . 0.0 111.333 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.7 pt -68.17 -35.71 72.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.241 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -59.39 -51.4 70.05 Favored 'General case' 0 C--O 1.216 -0.693 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.939 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.531 HG13 ' O ' ' A' ' 21' ' ' ARG . 87.8 t -63.15 -38.91 83.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.61 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.675 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.5 tt -52.63 -51.11 61.51 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.282 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -78.0 -49.06 14.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.176 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -67.78 -29.82 69.11 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.046 0.45 . . . . 0.0 110.813 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 16' ' ' VAL . 96.7 mt-10 56.88 60.39 3.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.42 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.531 ' O ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -154.65 159.49 40.83 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.59 0.709 . . . . 0.0 110.642 179.139 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 34' ' ' GLY . 8.7 p -74.67 137.06 23.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.771 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.497 HG22 ' NH2' ' A' ' 21' ' ' ARG . 2.8 pp -124.62 165.56 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 120.631 0.253 . . . . 0.0 110.444 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.427 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -62.91 135.85 57.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.251 0.548 . . . . 0.0 111.046 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.495 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 1.3 t80 -124.6 140.85 36.33 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.495 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 59.3 Cg_endo -81.65 145.32 14.49 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.106 1.204 . . . . 0.0 111.108 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.502 ' C ' ' H ' ' A' ' 29' ' ' ALA . 55.7 m -132.06 134.61 45.71 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.865 0.364 . . . . 0.0 110.939 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -73.91 31.02 0.08 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.519 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.502 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -157.49 -78.73 0.08 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.477 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 73.2 t -127.09 129.35 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.511 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 93.2 m-85 -43.3 146.27 0.48 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.302 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -152.95 -172.12 20.99 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.7 m -131.92 167.32 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.505 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -157.83 176.39 34.91 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.114 -1.041 . . . . 0.0 112.081 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.504 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -154.03 -163.57 1.66 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.636 -178.873 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.504 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 17.2 p-10 -97.44 108.09 42.87 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -177.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 36' ' ' ASP . 64.6 Cg_exo -38.93 174.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.82 2.347 . . . . 0.0 113.937 177.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 46.2 t0 37.59 77.98 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.433 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.5 m -153.22 142.96 21.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.137 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.642 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -71.5 -35.65 70.83 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.27 0.557 . . . . 0.0 109.745 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.439 HG22 ' H ' ' A' ' 41' ' ' THR . 0.1 OUTLIER -65.2 -43.59 91.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.566 -179.129 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.94 -49.42 77.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.743 0.306 . . . . 0.0 111.339 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.3 p -63.93 -47.03 92.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.811 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.3 mtt -65.64 -48.18 73.06 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.425 ' NH2' HG12 ' A' ' 22' ' ' VAL . 7.2 ptm180 -61.72 -33.17 73.57 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.587 HD13 ' C ' ' A' ' 46' ' ' LEU . 2.6 tm? -70.71 -46.32 63.3 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.419 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.482 HD21 HG21 ' A' ' 54' ' ' VAL . 6.3 mt -76.39 -11.1 59.84 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 120.897 0.379 . . . . 0.0 111.248 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.99 -81.26 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.592 -176.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.443 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -72.94 -35.93 67.1 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -75.21 -50.04 17.48 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.928 -177.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 33.95 67.05 0.22 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.759 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.2 mmm-85 178.58 -54.02 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.91 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.692 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.91 -6.57 17.58 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.647 2.232 . . . . 0.0 112.748 -178.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.595 HG13 ' N ' ' A' ' 55' ' ' ASP . 14.8 p -43.18 -46.74 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.456 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.595 ' N ' HG13 ' A' ' 54' ' ' VAL . 41.0 t0 -64.16 -42.68 96.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.025 0.44 . . . . 0.0 110.305 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -61.28 -39.63 91.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.62 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 64.72 112.03 0.01 OUTLIER Glycine 0 CA--C 1.519 0.314 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.553 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -54.57 -158.35 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.097 0.475 . . . . 0.0 111.857 -179.488 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 67.9 mt -112.75 146.24 17.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.247 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 14.7 mt -122.16 150.15 42.62 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.7 tp -120.28 130.56 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-O 121.178 0.514 . . . . 0.0 110.599 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.417 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -118.54 149.48 41.26 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.7 -29.34 8.75 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.178 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -116.72 150.02 38.9 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.038 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -77.24 -13.95 59.85 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -50.87 -31.32 17.02 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.47 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.52 -13.08 26.44 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.504 HD22 ' N ' ' A' ' 68' ' ' LEU . 4.0 mm? -92.94 -12.33 31.11 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.476 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 75.0 tttt -80.16 -39.63 1.23 Allowed Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.589 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 44.0 Cg_endo -105.55 -0.95 0.19 Allowed 'Trans proline' 0 C--N 1.316 -1.163 0 C-N-CA 122.968 2.445 . . . . 0.0 112.474 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -97.85 -5.2 35.12 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.612 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.1 mp -127.1 166.33 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.612 ' N ' HG22 ' A' ' 72' ' ' ILE . 93.3 m-20 -64.2 -9.46 17.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.23 -179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 55.65 33.68 21.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.89 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.517 HG23 ' N ' ' A' ' 76' ' ' MET . 10.1 t -96.81 -42.02 8.17 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.517 ' N ' HG23 ' A' ' 75' ' ' THR . 10.5 ptp -91.45 -6.84 52.08 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.396 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.3 tp -93.02 126.05 37.92 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.685 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.453 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -159.77 160.85 34.4 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.92 -177.003 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -39.22 -47.3 1.62 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.748 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.17 -33.57 63.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.022 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' A' ' 78' ' ' THR . 67.8 tp60 -65.03 -40.77 95.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.974 0.416 . . . . 0.0 110.508 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.407 ' HG2' ' H ' ' A' ' 82' ' ' ARG . 6.9 mmt85 -62.69 -52.33 63.71 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 122.469 1.128 . . . . 0.0 108.95 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 87' ' ' SER . 81.9 tt0 -55.9 -50.68 70.01 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 113.781 -1.554 . . . . 0.0 110.135 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 m -61.12 -50.17 74.31 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.976 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.4 tt -67.49 -31.97 55.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.864 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -77.72 -35.25 52.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.774 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 83' ' ' GLU . 13.1 m -87.27 -16.67 34.51 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.582 0.229 . . . . 0.0 110.994 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 89' ' ' TRP . 74.5 ttt-85 -113.34 75.51 0.92 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.7 0.286 . . . . 0.0 110.237 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.452 ' O ' ' O ' ' A' ' 88' ' ' ARG . 82.5 m95 56.85 147.64 0.05 OUTLIER Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.615 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.35 -24.49 37.08 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.172 1.915 . . . . 0.0 112.488 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 156.91 79.48 0.03 OUTLIER Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -83.82 -9.46 9.86 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.72 2.28 . . . . 0.0 112.162 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.482 HG13 ' CE2' ' A' ' 95' ' ' PHE . 3.0 p -137.15 147.49 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.296 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.538 HG22 ' HB1' ' A' ' 115' ' ' ALA . 10.9 m -90.27 125.98 35.68 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.189 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.523 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 34.4 m-85 -117.4 140.5 49.5 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.755 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 3.1 t -99.77 109.75 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-O 121.546 0.688 . . . . 0.0 111.156 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -96.92 151.05 37.53 Favored Pre-proline 0 N--CA 1.469 0.482 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.69 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -65.77 104.8 0.71 Allowed 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.822 1.681 . . . . 0.0 111.247 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.14 162.39 71.65 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.55 141.16 90.78 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 CA-C-N 120.098 1.071 . . . . 0.0 111.756 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -156.61 54.97 0.55 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.341 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 75.5 p -73.02 -23.07 60.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.277 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.695 ' H ' ' CD ' ' A' ' 104' ' ' PRO . 0.5 OUTLIER -166.92 -39.32 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.695 ' CD ' ' H ' ' A' ' 103' ' ' THR . 9.9 Cg_exo -70.11 -166.41 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.324 2.016 . . . . 0.0 112.445 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.477 ' NH2' ' O ' ' A' ' 110' ' ' ARG . 6.4 tpt180 -169.58 0.08 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.626 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.428 ' H ' ' H ' ' A' ' 105' ' ' ARG . 2.3 p90 -70.85 -8.99 56.61 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.098 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.986 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -77.28 -18.38 57.62 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.44 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.614 ' N ' HD22 ' A' ' 107' ' ' LEU . 94.1 m -141.76 -39.33 0.38 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.918 0.389 . . . . 0.0 110.572 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 83.27 13.95 75.48 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.606 -0.597 . . . . 0.0 111.606 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.477 ' O ' ' NH2' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -162.41 -77.77 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.101 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -99.17 -162.12 0.93 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.311 -0.404 . . . . 0.0 109.957 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 53.4 p30 -134.55 61.8 1.66 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.828 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 83.0 p -156.94 128.75 7.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.613 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.567 ' C ' HG13 ' A' ' 96' ' ' VAL . 53.6 mt -124.13 134.96 53.21 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -178.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.538 ' HB1' HG22 ' A' ' 94' ' ' THR . . . -71.95 120.99 18.34 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.439 175.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.441 HG22 ' N ' ' A' ' 117' ' ' ARG . 3.4 p -143.74 158.39 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.824 0.345 . . . . 0.0 110.413 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.441 ' N ' HG22 ' A' ' 116' ' ' VAL . 88.1 mtm180 -144.73 161.77 38.39 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.815 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.417 HG22 ' HB3' ' A' ' 62' ' ' ALA . 55.9 t -123.23 130.38 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.451 ' O ' HG23 ' A' ' 119' ' ' THR . 14.1 t -129.83 128.25 41.92 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.767 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -133.95 82.64 1.99 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.848 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.65 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 70.6 t60 -172.88 -35.73 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.65 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 39.6 Cg_endo -93.06 -161.43 0.09 OUTLIER 'Trans proline' 0 N--CA 1.484 0.949 0 C-N-CA 122.045 1.83 . . . . 0.0 111.847 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 37.6 mt -78.42 -5.74 53.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.891 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.2 t -58.05 -45.07 88.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.808 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.763 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.1 m -53.05 -62.31 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.789 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.705 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.763 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.38 -42.72 2.32 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.877 0.37 . . . . 0.0 110.898 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.4 tp -69.67 -48.95 57.97 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.303 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 56.0 m -70.65 -48.92 52.43 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.548 0.689 . . . . 0.0 110.757 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.462 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -54.28 -42.04 69.56 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.216 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.17 -55.44 35.0 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.234 -177.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -61.59 -21.22 64.14 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.515 -1.221 . . . . 0.0 108.932 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.57 -0.23 85.94 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' A' ' 134' ' ' PRO . 31.4 mttp -151.46 159.53 33.25 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 120.605 -0.438 . . . . 0.0 109.944 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 133' ' ' LYS . 5.7 Cg_exo -41.0 176.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 123.855 3.036 . . . . 0.0 113.021 -178.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.43 HD12 ' O ' ' A' ' 35' ' ' CYS . 7.8 tp -130.94 123.24 28.44 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 176.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.433 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -64.94 152.99 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 10.8 t -129.54 132.86 46.95 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.107 0.479 . . . . 0.0 111.305 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.8 m -135.3 164.49 27.61 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.888 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.1 m -71.4 146.95 48.4 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.465 ' HB1' ' SG ' ' A' ' 148' ' ' CYS . . . -74.47 81.16 1.93 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.712 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 48.1 p-10 -159.43 168.06 27.19 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.303 0.573 . . . . 0.0 110.454 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.2 -162.35 1.43 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.166 -178.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 77.5 p -61.92 -39.74 93.08 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.611 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -163.61 4.85 0.07 OUTLIER Glycine 0 CA--C 1.511 -0.179 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.7 tp -81.43 127.69 72.55 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.164 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -39.24 157.94 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.7 1.6 . . . . 0.0 111.972 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.424 ' O ' ' OE1' ' A' ' 153' ' ' GLU . 76.3 Cg_endo -73.15 -163.89 0.17 Allowed 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.505 2.137 . . . . 0.0 112.242 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.465 ' SG ' ' HB1' ' A' ' 140' ' ' ALA . 11.3 m -118.52 73.71 0.93 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.524 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.511 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 37.6 ptt180 -54.14 -35.91 62.72 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.169 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.95 167.89 20.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.436 HG22 ' H ' ' A' ' 151' ' ' VAL . 0.9 OUTLIER -56.23 -18.6 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 CA-C-O 121.638 0.732 . . . . 0.0 109.128 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -64.41 -36.45 84.19 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.429 ' OE1' ' OE1' ' A' ' 157' ' ' GLN . 0.4 OUTLIER -59.26 -72.06 0.11 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.793 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.3 p -47.97 -30.17 2.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.421 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.457 ' O ' ' N ' ' A' ' 159' ' ' GLY . 4.5 tmt_? -84.01 -44.81 13.77 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 122.293 1.044 . . . . 0.0 110.187 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.41 -41.89 85.95 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.497 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.453 ' CG ' ' N ' ' A' ' 158' ' ' PHE . 8.1 pt20 -80.95 -48.52 12.18 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 113.195 -1.82 . . . . 0.0 111.978 -177.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.453 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 33.7 t80 -107.07 -35.94 6.73 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -177.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 96.86 24.64 12.79 Favored Glycine 0 N--CA 1.475 1.259 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 -178.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -43.23 -93.96 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.66 0.267 . . . . 0.0 110.655 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.47 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.66 36.11 16.73 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.518 ' H ' HG22 ' A' ' 164' ' ' VAL . 2.0 m-85 -175.18 -62.69 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.172 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -72.91 28.73 0.29 Allowed 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.364 2.043 . . . . 0.0 110.794 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.58 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.8 m -132.2 167.78 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.899 -178.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.9 t -124.0 65.5 37.56 Favored Pre-proline 0 N--CA 1.473 0.677 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.698 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.58 ' HD3' HG23 ' A' ' 164' ' ' VAL . 33.4 Cg_exo -37.51 139.99 0.25 Allowed 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 123.586 2.857 . . . . 0.0 114.967 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 160.46 174.25 30.05 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 113.987 -1.461 . . . . 0.0 110.72 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -159.51 133.77 7.63 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 10.3 t -88.3 -32.54 18.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.983 0.421 . . . . 0.0 110.148 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 150.4 -40.14 0.84 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 105.83 6.25 37.77 Favored Glycine 0 N--CA 1.466 0.639 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -83.32 139.63 32.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.464 -0.368 . . . . 0.0 110.236 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 60.3 tp -76.25 151.65 36.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.191 0.519 . . . . 0.0 110.663 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -126.39 149.41 67.37 Favored Pre-proline 0 N--CA 1.472 0.656 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.826 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -74.98 87.6 1.31 Allowed 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.046 1.831 . . . . 0.0 111.886 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 71.1 m -128.66 123.19 32.56 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.31 0.576 . . . . 0.0 110.062 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -133.85 174.3 10.61 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.81 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 178' ' ' ILE . 19.9 tt -108.47 127.91 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.212 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -127.86 164.34 22.45 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.753 0.787 . . . . 0.0 112.353 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -81.28 106.68 13.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.075 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.755 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -70.77 -12.39 61.52 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.314 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.482 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.7 mm? -64.23 -40.58 96.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.867 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.8 -41.71 6.42 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.111 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 60.29 26.95 64.66 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.4 ' HG2' ' H ' ' A' ' 185' ' ' GLU . 4.7 pt-20 -58.79 134.44 56.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.097 0.475 . . . . 0.0 110.701 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.676 ' H ' ' CD2' ' A' ' 186' ' ' LEU . 0.6 OUTLIER -108.78 -176.14 2.96 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.423 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -98.58 58.4 1.22 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.436 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.61 138.65 52.92 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.885 0.374 . . . . 0.0 110.476 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -138.01 137.06 37.49 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.285 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.833 0 CA-C-O 118.026 -1.43 . . . . 0.0 110.813 -179.935 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -95.68 6.34 49.17 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.304 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -63.37 -40.83 98.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.578 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.547 HD12 ' N ' ' A' ' 5' ' ' LEU . 9.7 mp -62.08 -42.66 99.44 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -63.95 -41.32 97.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.021 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 78.8 ttt-85 -61.96 -42.36 99.04 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.887 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -60.72 -45.2 95.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.562 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.42 -42.54 98.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.998 0.428 . . . . 0.0 110.337 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.38 -43.63 98.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.721 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.12 -47.22 78.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.493 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.06 -39.09 91.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.635 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.34 -53.08 62.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.629 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 38.2 pt -70.01 -33.43 55.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.197 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.423 ' OD1' ' OE2' ' A' ' 19' ' ' GLU . 24.6 t70 -57.74 -55.13 38.79 Favored 'General case' 0 C--O 1.217 -0.637 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.147 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 20' ' ' GLU . 97.9 t -63.6 -40.11 87.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.704 0.288 . . . . 0.0 110.675 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.681 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.3 tt -52.16 -48.91 64.69 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.303 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -80.29 -52.59 7.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.289 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.423 ' OE2' ' OD1' ' A' ' 15' ' ' ASP . 92.7 mt-10 -66.91 -34.97 78.94 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.801 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.8 mt-10 60.19 87.48 0.09 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.122 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.439 ' H ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -161.08 -135.74 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.668 178.865 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.3 p -140.62 140.76 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -129.76 166.18 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 120.982 0.42 . . . . 0.0 111.757 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.96 129.34 39.36 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.411 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.513 ' CE2' ' O ' ' A' ' 26' ' ' PRO . 4.4 t80 -115.48 138.25 23.63 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.513 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 64.0 Cg_endo -81.41 144.08 14.16 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.144 1.229 . . . . 0.0 111.615 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.5 ' C ' ' H ' ' A' ' 29' ' ' ALA . 58.1 m -134.53 132.93 39.76 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.013 0.435 . . . . 0.0 111.153 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -72.84 30.3 0.06 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.71 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.5 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -158.54 -76.1 0.08 Allowed 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 120.784 0.326 . . . . 0.0 110.82 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.3 t -125.77 127.69 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 120.96 0.41 . . . . 0.0 110.26 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -48.88 145.76 3.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.765 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -154.83 -173.9 24.17 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.7 m -131.23 170.58 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.407 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -158.95 -176.96 31.58 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 119.765 -1.207 . . . . 0.0 112.453 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -158.16 -167.2 2.14 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.592 0.234 . . . . 0.0 110.716 -179.104 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.472 ' CG ' ' CZ ' ' A' ' 131' ' ' TYR . 18.3 t70 -95.12 109.4 44.41 Favored Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 36' ' ' ASP . 32.8 Cg_exo -37.28 172.27 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.778 2.319 . . . . 0.0 114.358 177.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 40.9 72.22 0.17 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.855 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 m -153.16 137.55 16.68 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.557 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -67.6 -33.62 75.37 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.075 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.588 HG23 ' N ' ' A' ' 42' ' ' ALA . 12.9 t -62.26 -46.11 90.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.026 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.588 ' N ' HG23 ' A' ' 41' ' ' THR . . . -58.4 -51.23 70.68 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.408 -178.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.5 p -62.59 -44.14 99.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.412 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 61.9 mtt -64.03 -39.3 93.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.15 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 51.3 ttt-85 -62.39 -34.4 76.64 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 87.9 mt -74.72 -58.78 3.07 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.3 mt -55.96 -16.3 4.63 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.36 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -68.6 -86.43 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.493 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.2 pt? -77.13 -33.66 56.75 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -76.18 -50.43 14.58 Favored 'General case' 0 C--N 1.349 0.557 0 C-N-CA 119.798 -0.761 . . . . 0.0 110.723 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 35.47 65.77 0.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.703 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 179.61 -54.28 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.83 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.235 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.09 -6.71 17.59 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.637 2.224 . . . . 0.0 112.088 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.565 HG13 ' N ' ' A' ' 55' ' ' ASP . 7.4 p -43.57 -49.29 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.73 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.565 ' N ' HG13 ' A' ' 54' ' ' VAL . 39.8 t0 -66.28 -40.94 90.43 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.687 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -60.88 -39.8 90.61 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.084 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 65.48 107.63 0.01 OUTLIER Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.564 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -52.62 -161.28 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.375 0.607 . . . . 0.0 112.278 -179.477 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 73.2 mt -106.58 142.95 18.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.166 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 16.0 mt -118.05 142.63 47.19 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.4 tp -111.82 126.91 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-O 121.408 0.623 . . . . 0.0 111.622 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.76 148.29 39.99 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.094 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.55 -27.65 9.76 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.075 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -117.91 151.12 38.04 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.946 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -79.26 -13.51 59.63 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -52.54 -31.99 38.46 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.216 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.79 -10.63 33.49 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.414 ' O ' HD13 ' A' ' 72' ' ' ILE . 4.3 mm? -90.79 -18.73 24.43 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.45 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 47.1 tttm -76.71 -39.0 2.24 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 69.7 Cg_endo -104.38 -2.38 0.23 Allowed 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 122.923 2.416 . . . . 0.0 112.582 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -94.85 -10.55 30.99 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.838 0.351 . . . . 0.0 111.06 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.633 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.1 mp -125.52 168.14 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.633 ' N ' HG22 ' A' ' 72' ' ' ILE . 93.0 m-20 -62.3 -13.03 24.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.786 0.327 . . . . 0.0 110.829 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 44.7 t0 55.54 21.74 4.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.841 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.657 HG23 ' N ' ' A' ' 76' ' ' MET . 8.4 t -89.53 -54.51 4.05 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.657 ' N ' HG23 ' A' ' 75' ' ' THR . 13.5 ptp -68.08 -37.52 81.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.225 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 tp -64.22 139.13 58.73 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.208 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.9 173.19 14.06 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.461 -176.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -60.26 -43.06 96.49 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.202 0.314 . . . . 0.0 111.23 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.9 p -60.92 -32.48 52.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.994 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -63.47 -40.89 98.32 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.094 0.473 . . . . 0.0 110.498 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.428 ' HG2' ' H ' ' A' ' 82' ' ' ARG . 7.0 mmt85 -63.34 -51.51 65.65 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 122.648 1.213 . . . . 0.0 108.782 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 87' ' ' SER . 80.7 tt0 -57.17 -50.22 73.5 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 113.667 -1.606 . . . . 0.0 110.096 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.5 m -62.04 -49.03 77.65 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.264 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 89' ' ' TRP . 13.9 tt -68.52 -26.05 32.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.585 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -86.02 -32.22 21.58 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.438 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 83' ' ' GLU . 10.7 m -88.64 -9.12 53.23 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.745 0.307 . . . . 0.0 110.784 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 89' ' ' TRP . 62.4 ttm-85 -128.47 79.53 1.91 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.514 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.448 ' O ' ' O ' ' A' ' 88' ' ' ARG . 2.7 m-90 56.43 152.54 0.07 OUTLIER Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.667 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.88 -23.15 41.53 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.879 1.719 . . . . 0.0 111.753 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 157.95 79.08 0.03 OUTLIER Glycine 0 CA--C 1.53 1.004 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.53 -35.63 86.32 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.714 2.276 . . . . 0.0 112.427 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.2 p -133.84 147.69 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.84 0.352 . . . . 0.0 110.455 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 26.4 m -84.16 141.45 31.05 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.362 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.459 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 70.8 m-85 -119.01 139.81 51.09 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.732 0.301 . . . . 0.0 110.964 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.667 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 3.3 t -96.85 103.55 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 121.424 0.63 . . . . 0.0 109.689 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -91.54 152.01 43.08 Favored Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.079 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.04 110.74 3.15 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.883 1.722 . . . . 0.0 111.341 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.7 153.23 70.33 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.852 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.66 151.95 78.58 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.155 1.904 . . . . 0.0 111.664 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -151.65 70.74 0.96 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.388 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 69.5 p -66.65 -30.92 71.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.707 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.715 ' H ' ' CD ' ' A' ' 104' ' ' PRO . 1.2 m -167.1 -38.01 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.715 ' CD ' ' H ' ' A' ' 103' ' ' THR . 15.4 Cg_exo -67.57 -163.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.448 2.099 . . . . 0.0 112.266 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.486 ' NH1' ' O ' ' A' ' 110' ' ' ARG . 5.5 tpp85 -167.77 3.35 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.935 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 63.5 p-90 -74.03 -8.6 56.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.753 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.971 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -73.56 -23.42 59.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.081 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.66 ' H ' HD22 ' A' ' 107' ' ' LEU . 88.6 m -142.71 -39.33 0.34 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.107 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 89.31 9.03 67.65 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.486 ' O ' ' NH1' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -158.24 -79.17 0.07 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 117.038 0.419 . . . . 0.0 109.911 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -93.41 -129.61 0.12 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.268 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -157.89 61.58 0.47 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.507 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.6 p -157.52 153.65 27.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.81 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.481 ' O ' HD12 ' A' ' 114' ' ' LEU . 0.3 OUTLIER -160.78 139.17 9.93 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.354 1.073 . . . . 0.0 113.461 -179.508 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.56 133.04 48.71 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 112.971 -1.922 . . . . 0.0 109.885 178.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.8 p -149.98 153.82 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.805 0.336 . . . . 0.0 110.341 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 71.7 ttp85 -147.89 158.7 44.17 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.571 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.2 t -122.18 133.55 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 116.288 -0.414 . . . . 0.0 109.928 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.7 t -132.71 130.9 40.64 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -135.85 85.22 2.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.626 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.597 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 36.2 t60 -172.83 -38.36 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.422 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.597 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 29.1 Cg_endo -92.84 -161.83 0.09 OUTLIER 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 122.026 1.818 . . . . 0.0 112.028 -178.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 123' ' ' LEU . 9.4 mp -78.35 -4.15 46.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.822 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 87.9 t -58.27 -44.96 89.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.855 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.756 HG23 ' H ' ' A' ' 126' ' ' ALA . 29.6 m -53.98 -61.94 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.844 0 C-N-CA 119.434 -0.906 . . . . 0.0 108.633 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.756 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.08 -43.34 2.19 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.91 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 45.4 tp -70.16 -47.86 59.8 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 120.589 -0.445 . . . . 0.0 111.275 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 64.2 m -70.22 -49.15 53.0 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.517 0.675 . . . . 0.0 110.791 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.465 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.0 OUTLIER -55.01 -42.02 72.02 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.455 179.354 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.07 -56.27 24.23 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.93 -177.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.472 ' CZ ' ' CG ' ' A' ' 36' ' ' ASP . 4.2 t80 -63.44 -26.33 68.68 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.263 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.92 3.26 85.69 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 134' ' ' PRO . 69.4 mttt -149.46 157.87 38.57 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-N 116.908 0.354 . . . . 0.0 110.758 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 133' ' ' LYS . 5.7 Cg_exo -42.67 178.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 123.874 3.049 . . . . 0.0 112.705 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.0 tp -134.76 122.36 22.03 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.441 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -64.23 143.1 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 C-N-CA 117.975 -1.49 . . . . 0.0 107.166 -179.788 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.7 t -116.76 123.88 48.26 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 123.568 0.542 . . . . 0.0 111.333 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.6 m -128.86 165.27 21.34 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.152 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.5 t -70.96 149.42 46.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.643 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.25 -38.85 91.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.178 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 55.2 p30 -55.48 152.08 9.41 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.889 0.852 . . . . 0.0 111.351 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.8 -157.0 0.72 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.575 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.5 t -60.31 -45.27 93.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.492 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -161.13 4.46 0.09 OUTLIER Glycine 0 C--N 1.329 0.17 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.2 tp -84.94 127.27 65.41 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -37.47 157.03 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.8 1.667 . . . . 0.0 112.429 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.93 -163.52 0.2 Allowed 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.38 2.053 . . . . 0.0 112.314 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 15.8 t -114.4 78.88 1.19 Allowed 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.515 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -58.67 -34.71 71.55 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.966 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -163.02 165.29 25.02 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.945 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 151' ' ' VAL . 0.7 OUTLIER -55.9 -18.84 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.59 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 156' ' ' ALA . 99.6 m-20 -65.38 -34.17 77.68 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 150' ' ' THR . 6.7 tm-20 -59.21 -70.56 0.15 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.507 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.4 p -50.02 -29.58 5.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.359 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -84.42 -43.76 14.35 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 122.392 1.091 . . . . 0.0 110.143 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 152' ' ' ASP . . . -58.93 -41.23 86.84 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.454 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.474 ' CG ' ' N ' ' A' ' 158' ' ' PHE . 8.2 pt20 -82.46 -48.6 10.89 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 112.981 -1.918 . . . . 0.0 112.143 -177.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.474 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 38.3 t80 -106.97 -36.62 6.56 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -177.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 97.44 25.68 10.73 Favored Glycine 0 N--CA 1.473 1.106 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.409 ' HB1' ' HG2' ' A' ' 163' ' ' PRO . . . -43.43 -94.9 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.612 0.244 . . . . 0.0 110.734 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.424 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 63.44 36.68 11.19 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 121.292 0.568 . . . . 0.0 109.739 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.534 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.2 m-85 -177.14 -61.63 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.214 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.409 ' HG2' ' HB1' ' A' ' 160' ' ' ALA . 91.5 Cg_endo -73.85 29.24 0.32 Allowed 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.14 1.893 . . . . 0.0 110.505 178.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.581 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.9 m -132.34 167.65 25.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.558 -178.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.0 t -124.27 65.11 39.12 Favored Pre-proline 0 N--CA 1.476 0.84 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.71 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.581 ' HD3' HG23 ' A' ' 164' ' ' VAL . 31.3 Cg_exo -37.41 145.06 0.12 Allowed 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 123.815 3.01 . . . . 0.0 115.158 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 165.77 116.92 0.38 Allowed Glycine 0 CA--C 1.523 0.573 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.493 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -85.06 144.99 27.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.886 0.374 . . . . 0.0 110.068 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.8 t -147.14 151.23 36.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.205 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -61.26 -70.12 1.11 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 172' ' ' ARG . . . 167.06 -75.06 0.14 Allowed Glycine 0 CA--C 1.521 0.424 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' A' ' 171' ' ' GLY . 69.5 ttt180 58.71 136.02 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.063 0.459 . . . . 0.0 110.737 179.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.547 ' N ' HD12 ' A' ' 173' ' ' LEU . 10.2 mp -56.8 -97.84 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.777 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 41.54 63.54 6.2 Favored Pre-proline 0 N--CA 1.462 0.173 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.28 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -74.61 159.44 42.62 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.618 2.212 . . . . 0.0 111.823 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 61.3 m -94.54 115.23 27.34 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.54 0.686 . . . . 0.0 109.902 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -126.11 144.46 50.73 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.698 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.416 HD13 HG21 ' A' ' 178' ' ' ILE . 14.2 pt -106.02 134.35 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.284 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 19.3 mmm-85 -120.12 157.44 28.98 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.526 0.679 . . . . 0.0 110.189 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 184' ' ' GLY . 97.6 m-20 -72.03 104.53 3.59 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.903 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -68.49 -18.33 64.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.041 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.506 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.7 mm? -64.01 -41.38 97.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.018 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.56 HG23 ' N ' ' A' ' 184' ' ' GLY . 5.2 t -121.3 -51.46 2.09 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.695 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.56 ' N ' HG23 ' A' ' 183' ' ' THR . . . 93.54 41.96 4.34 Favored Glycine 0 N--CA 1.464 0.567 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -89.87 141.61 28.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.265 0.555 . . . . 0.0 111.334 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.498 ' H ' ' CD2' ' A' ' 186' ' ' LEU . 0.7 OUTLIER -73.63 -179.35 3.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.781 179.79 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -104.27 -13.67 16.08 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.608 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.94 141.34 30.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.23 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -149.86 -29.59 0.23 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.886 0.374 . . . . 0.0 110.337 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.76 0 CA-C-O 118.075 -1.403 . . . . 0.0 111.01 179.961 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.2 p30 -78.96 -6.98 57.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.455 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -62.16 -41.03 97.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.555 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.55 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.2 mp -63.15 -42.08 99.38 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.962 0.41 . . . . 0.0 110.048 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -63.32 -42.04 98.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.421 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -63.2 -39.36 94.42 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.408 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -61.52 -43.78 98.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.681 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.48 -45.23 88.24 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.808 0.337 . . . . 0.0 110.264 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.0 mm -63.69 -43.11 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.26 -47.37 78.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.045 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.01 -41.59 96.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.103 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.64 -54.62 44.34 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.9 0.381 . . . . 0.0 111.187 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 14' ' ' ILE . 19.8 pt -69.23 -37.04 75.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.149 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -56.59 -56.2 24.3 Favored 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.469 ' O ' ' N ' ' A' ' 20' ' ' GLU . 99.6 t -63.29 -39.93 87.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 121.16 -0.216 . . . . 0.0 110.59 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.671 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.4 tt -51.79 -49.9 61.79 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.701 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -80.47 -51.87 8.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.148 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -65.86 -34.98 79.4 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.506 -178.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 16' ' ' VAL . 96.2 mt-10 58.51 88.37 0.06 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.107 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.414 ' H ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -162.47 -133.99 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.605 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.8 p -141.99 140.92 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 pp -129.01 167.62 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-O 121.122 0.487 . . . . 0.0 111.875 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.77 129.6 40.35 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.735 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.539 ' CE2' ' O ' ' A' ' 26' ' ' PRO . 7.8 t80 -117.14 138.82 25.2 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.297 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.539 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 63.6 Cg_endo -79.51 144.69 18.01 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.28 1.32 . . . . 0.0 111.751 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.476 ' C ' ' H ' ' A' ' 29' ' ' ALA . 63.2 m -132.6 134.79 45.35 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.248 0.547 . . . . 0.0 111.057 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -74.69 26.27 0.09 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.77 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.476 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -160.85 -70.28 0.07 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.993 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.6 p -127.93 123.57 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 121.108 0.48 . . . . 0.0 110.097 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.524 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 94.7 m-85 -42.52 151.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.744 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -155.51 -178.68 29.98 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.2 m -130.67 169.66 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.51 -177.39 33.57 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 119.839 -1.172 . . . . 0.0 112.323 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.429 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -158.76 -171.42 3.41 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.511 ' OD1' ' CE1' ' A' ' 131' ' ' TYR . 27.8 t70 -92.66 111.82 52.77 Favored Pre-proline 0 CA--C 1.553 1.083 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 36' ' ' ASP . 12.6 Cg_exo -35.55 167.72 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.81 2.34 . . . . 0.0 114.126 177.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 40.8 78.06 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.679 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.4 m -152.89 149.81 28.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.967 0.413 . . . . 0.0 110.707 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -71.03 -33.2 70.09 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.408 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.432 ' H ' HG22 ' A' ' 41' ' ' THR . 0.0 OUTLIER -64.19 -43.19 95.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.808 -178.402 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.0 -50.24 74.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.227 0.536 . . . . 0.0 111.024 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.402 HG12 ' H ' ' A' ' 43' ' ' VAL . 2.9 p -64.74 -45.73 94.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.569 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 59.3 mtt -66.67 -45.04 80.18 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.3 ptt85 -64.58 -30.35 71.37 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.933 0.397 . . . . 0.0 110.102 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.1 mt -73.67 -59.75 2.57 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.273 177.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.4 mt -54.81 -20.53 8.82 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.45 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -64.16 -86.24 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.353 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.518 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.2 pt? -77.01 -34.87 57.43 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -75.3 -49.65 18.52 Favored 'General case' 0 C--N 1.352 0.682 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.193 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 36.56 65.56 0.46 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.709 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 178.55 -53.99 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.858 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.351 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -77.5 -4.74 14.95 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 C-N-CA 122.781 2.321 . . . . 0.0 112.345 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.606 HG13 ' N ' ' A' ' 55' ' ' ASP . 7.2 p -45.46 -48.66 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.56 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.606 ' N ' HG13 ' A' ' 54' ' ' VAL . 13.2 t0 -66.64 -45.41 79.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.334 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -59.69 -41.55 90.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.559 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 69.48 114.48 0.03 OUTLIER Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.567 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -51.03 -164.86 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.337 0.589 . . . . 0.0 112.304 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.4 mt -104.49 145.1 13.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 16.0 mt -117.45 144.54 44.91 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.2 tp -111.18 127.53 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-O 121.069 0.461 . . . . 0.0 110.702 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.631 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -115.11 153.35 30.9 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.57 -28.71 7.06 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.764 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -114.39 142.1 46.78 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.973 0.416 . . . . 0.0 110.903 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -72.66 -13.65 61.41 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -50.41 -33.78 22.03 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.209 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.08 -11.29 30.91 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.481 ' O ' HD13 ' A' ' 72' ' ' ILE . 4.1 mm? -90.06 -17.7 27.28 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.391 -0.818 . . . . 0.0 109.322 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.457 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 48.4 tttm -78.45 -39.17 1.62 Allowed Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.457 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 63.9 Cg_endo -104.01 -2.39 0.25 Allowed 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 122.634 2.223 . . . . 0.0 112.287 -178.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -95.45 -10.18 30.56 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.812 0.339 . . . . 0.0 110.87 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.607 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.6 mp -123.3 167.36 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.607 ' N ' HG22 ' A' ' 72' ' ' ILE . 98.6 m-20 -59.65 -14.24 12.97 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.237 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 58.8 t0 57.14 28.72 15.42 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.85 0.357 . . . . 0.0 110.467 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.524 HG23 ' N ' ' A' ' 76' ' ' MET . 9.5 t -95.86 -43.05 8.02 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.715 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.524 ' N ' HG23 ' A' ' 75' ' ' THR . 18.4 ptm -85.63 -8.13 58.42 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.144 0.497 . . . . 0.0 109.923 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.3 tp -86.51 128.26 34.95 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.611 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.36 164.42 36.35 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.08 -176.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -45.94 -46.77 16.34 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 112.088 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.6 -32.69 54.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.843 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -64.68 -39.78 94.27 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.251 0.548 . . . . 0.0 110.492 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.8 mmt85 -65.86 -52.13 52.99 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 122.33 1.062 . . . . 0.0 108.8 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -55.09 -50.89 68.04 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 113.825 -1.534 . . . . 0.0 110.03 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.3 m -61.07 -49.55 76.9 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.574 -1.194 . . . . 0.0 112.247 -177.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.424 ' O ' ' O ' ' A' ' 89' ' ' TRP . 10.0 tt -68.11 -31.11 50.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.617 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -76.75 -36.2 57.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.541 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.1 m -86.63 -44.28 11.99 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.055 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.482 ' O ' ' CD1' ' A' ' 89' ' ' TRP . 61.8 ttt85 -70.14 -77.06 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.936 0.398 . . . . 0.0 110.44 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.482 ' CD1' ' O ' ' A' ' 88' ' ' ARG . 5.8 m0 -158.4 149.37 16.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.449 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -66.65 -23.59 49.03 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.684 1.59 . . . . 0.0 111.946 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 152.36 83.17 0.04 OUTLIER Glycine 0 CA--C 1.533 1.189 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -76.05 -19.4 15.75 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.631 1.554 . . . . 0.0 111.472 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.405 HG13 ' CE2' ' A' ' 95' ' ' PHE . 12.4 p -136.19 148.91 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.517 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.5 m -83.18 134.21 34.99 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.813 0.34 . . . . 0.0 110.383 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.488 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 67.7 m-85 -113.93 138.93 49.66 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.843 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.667 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 5.2 t -95.87 103.04 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 121.459 0.647 . . . . 0.0 109.592 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -87.37 148.91 45.67 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.537 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.04 108.88 2.77 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.93 1.753 . . . . 0.0 111.194 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.44 155.62 92.25 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.264 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.611 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 89.2 Cg_exo -45.43 -32.33 7.76 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.661 1.574 . . . . 0.0 111.979 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.611 ' HB3' ' O ' ' A' ' 100' ' ' PRO . . . 84.64 -39.85 0.06 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.595 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 52.1 p -61.07 -31.76 71.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.353 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.446 ' CB ' ' CD ' ' A' ' 104' ' ' PRO . 0.1 OUTLIER -55.73 -178.18 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.431 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.446 ' CD ' ' CB ' ' A' ' 103' ' ' THR . 43.0 Cg_exo -57.07 -153.4 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.21 1.94 . . . . 0.0 111.998 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 109' ' ' GLY . 20.1 mmt180 -139.82 -14.7 1.06 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.869 -0.15 . . . . 0.0 111.095 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 2.7 p90 -67.9 -10.28 51.91 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.796 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 1.03 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -69.81 -39.24 76.64 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.795 ' H ' HD22 ' A' ' 107' ' ' LEU . 45.6 m -143.81 -41.4 0.28 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.858 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 56.24 -8.57 0.01 OUTLIER Glycine 0 CA--C 1.535 1.301 0 CA-C-N 115.95 -0.568 . . . . 0.0 113.077 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.548 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 0.5 OUTLIER -85.03 -52.68 5.79 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 117.898 0.849 . . . . 0.0 109.574 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.529 ' CE2' ' OD1' ' A' ' 112' ' ' ASP . 57.7 t80 -152.44 169.36 22.76 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.324 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.529 ' OD1' ' CE2' ' A' ' 111' ' ' PHE . 18.1 p30 -79.27 49.74 1.0 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.184 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.7 p -160.25 158.04 29.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.084 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.515 ' O ' HD12 ' A' ' 114' ' ' LEU . 0.3 OUTLIER -159.01 138.04 11.24 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -179.292 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.44 ' HB2' HG22 ' A' ' 96' ' ' VAL . . . -69.98 132.69 46.31 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 113.557 -1.656 . . . . 0.0 110.296 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.545 HG22 ' N ' ' A' ' 117' ' ' ARG . 4.9 p -156.61 163.79 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.545 ' N ' HG22 ' A' ' 116' ' ' VAL . 22.6 ptt180 -153.5 160.19 42.46 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.246 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.631 HG22 ' HB3' ' A' ' 62' ' ' ALA . 54.3 t -125.26 139.89 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.023 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 119' ' ' THR . 14.9 t -141.64 130.04 22.44 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.975 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -132.69 90.17 2.74 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.612 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 9.9 t-80 -173.78 -37.91 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.466 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.612 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 38.2 Cg_endo -93.82 -160.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.32 -0.922 0 C-N-CA 121.932 1.755 . . . . 0.0 112.201 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 123' ' ' LEU . 9.7 mp -78.97 -6.51 56.45 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.701 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.2 t -57.16 -45.24 84.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.989 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.738 HG23 ' H ' ' A' ' 126' ' ' ALA . 31.5 m -52.91 -62.02 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.21 -0.995 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.022 178.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.738 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.23 -45.97 3.03 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 122.369 -0.207 . . . . 0.0 110.943 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.4 tp -67.91 -48.64 65.44 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.206 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 72.1 m -69.53 -49.33 55.49 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.21 0.529 . . . . 0.0 111.197 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.485 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.2 pp0? -54.88 -42.03 71.59 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.855 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.76 -56.39 22.8 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.778 -177.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.511 ' CE1' ' OD1' ' A' ' 36' ' ' ASP . 4.8 t80 -63.0 -24.11 67.76 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.895 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.8 2.76 89.7 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 114.187 -1.37 . . . . 0.0 110.311 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.418 ' O ' ' O ' ' A' ' 134' ' ' PRO . 29.9 mttp -150.2 158.32 36.56 Favored Pre-proline 0 CA--C 1.547 0.833 0 CA-C-N 117.157 0.478 . . . . 0.0 110.342 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 133' ' ' LYS . 6.3 Cg_exo -42.36 -179.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 123.84 3.027 . . . . 0.0 113.442 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.0 tp -134.56 122.78 22.85 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 176.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.437 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.9 OUTLIER -64.07 144.87 14.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 117.37 -1.732 . . . . 0.0 107.664 -179.304 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 12.6 t -116.55 126.8 53.83 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.197 0.522 . . . . 0.0 111.481 -179.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.08 162.52 31.51 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.683 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.9 t -72.12 149.14 45.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.044 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.68 78.88 7.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.577 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 56.1 p30 -157.68 165.35 35.69 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.182 0.515 . . . . 0.0 110.328 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.32 -165.82 2.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.174 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.1 p -63.47 -41.25 98.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.043 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -157.4 3.84 0.15 Allowed Glycine 0 N--CA 1.462 0.424 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.476 HD13 ' C ' ' A' ' 145' ' ' LEU . 1.3 tm? -84.0 111.35 32.35 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-O 119.078 -0.487 . . . . 0.0 109.767 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 145' ' ' LEU . 19.5 Cg_exo -34.92 156.52 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.095 1.863 . . . . 0.0 112.745 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.43 171.38 16.31 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.646 2.23 . . . . 0.0 112.229 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 34.7 t -96.09 77.46 3.11 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.664 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.524 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 36.2 ptt180 -53.58 -36.67 62.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.892 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.89 167.24 29.93 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.421 HG11 ' HA ' ' A' ' 166' ' ' PRO . 1.7 m -57.94 -18.62 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.736 0 CA-C-O 121.846 0.831 . . . . 0.0 109.081 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.62 -36.67 84.57 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -59.48 -73.87 0.08 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.244 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.436 HG11 HG11 ' A' ' 164' ' ' VAL . 7.1 p -45.8 -29.47 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.847 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 159' ' ' GLY . 4.8 tmt_? -83.92 -44.48 14.2 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 122.028 0.918 . . . . 0.0 110.08 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.53 -41.64 85.95 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.257 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.469 ' CG ' ' N ' ' A' ' 158' ' ' PHE . 8.3 pt20 -81.63 -48.74 11.35 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 113.018 -1.901 . . . . 0.0 112.487 -177.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.469 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 36.0 t80 -107.04 -35.55 6.85 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -177.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 96.8 24.86 12.44 Favored Glycine 0 N--CA 1.475 1.296 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.426 ' HB1' ' HG2' ' A' ' 163' ' ' PRO . . . -44.06 -95.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.953 -0.124 . . . . 0.0 110.812 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.473 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 62.8 38.01 11.97 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.306 0.575 . . . . 0.0 109.955 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.57 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.4 m-85 -177.97 -61.14 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.377 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.426 ' HG2' ' HB1' ' A' ' 160' ' ' ALA . 93.6 Cg_endo -72.69 22.78 0.29 Allowed 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.156 1.904 . . . . 0.0 110.998 178.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.59 HG23 ' HD3' ' A' ' 166' ' ' PRO . 16.8 m -128.04 167.54 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.636 -177.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.0 t -123.84 65.69 36.48 Favored Pre-proline 0 N--CA 1.476 0.825 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.71 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.59 ' HD3' HG23 ' A' ' 164' ' ' VAL . 22.8 Cg_exo -35.81 141.83 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 123.748 2.965 . . . . 0.0 115.401 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 176.46 -176.26 47.76 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.721 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -150.91 151.49 32.25 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.2 t -122.91 137.39 54.96 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -53.21 -61.6 6.79 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.401 ' H ' ' H ' ' A' ' 172' ' ' ARG . . . 152.12 12.67 0.08 OUTLIER Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.401 ' H ' ' H ' ' A' ' 171' ' ' GLY . 96.1 mtt-85 -62.94 132.98 53.89 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 55.0 tp -62.43 -45.47 92.96 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.776 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 39.23 71.68 1.1 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.988 0.423 . . . . 0.0 111.082 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -59.81 141.78 97.41 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.428 2.085 . . . . 0.0 112.02 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 58.7 m -149.7 119.29 6.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.972 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -135.68 178.77 6.79 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.539 -178.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 8.5 pt -99.89 130.96 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.733 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -125.32 165.54 18.17 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.327 0.584 . . . . 0.0 111.552 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 184' ' ' GLY . 99.4 m-20 -76.73 105.91 8.08 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.074 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -67.99 -15.01 63.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.364 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.51 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.4 mm? -64.6 -41.1 96.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.469 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.463 HG23 ' H ' ' A' ' 185' ' ' GLU . 5.5 t -121.4 -26.97 4.9 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.956 0.407 . . . . 0.0 111.042 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 180' ' ' ASP . . . 84.39 33.24 20.41 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.463 ' H ' HG23 ' A' ' 183' ' ' THR . 7.7 pt-20 -167.19 146.92 5.32 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.66 0.267 . . . . 0.0 110.533 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.66 ' H ' HD23 ' A' ' 186' ' ' LEU . 0.8 OUTLIER -104.49 176.46 5.15 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.567 179.731 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -107.97 -13.21 15.01 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.252 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.72 144.4 30.24 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.529 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -140.76 142.65 34.73 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.389 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.803 0 CA-C-O 117.878 -1.512 . . . . 0.0 110.933 -179.478 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -63.58 -40.18 96.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.798 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -63.47 -40.36 96.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.629 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.541 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.5 mp -62.98 -42.77 99.93 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.873 0.368 . . . . 0.0 110.255 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.59 -41.6 96.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.338 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -65.69 -40.7 92.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.23 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -61.46 -47.8 84.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.698 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.79 -46.86 86.03 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.298 0.571 . . . . 0.0 110.569 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.4 -43.88 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.466 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.78 -41.64 82.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.259 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.54 -41.73 97.78 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.917 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.59 -55.24 36.99 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.319 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.4 pt -69.37 -27.49 34.66 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.148 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -60.95 -56.16 24.35 Favored 'General case' 0 C--O 1.216 -0.659 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.106 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 20' ' ' GLU . 94.0 t -64.57 -40.6 89.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 C-N-CA 121.264 -0.174 . . . . 0.0 111.374 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.668 HD13 ' C ' ' A' ' 17' ' ' LEU . 2.0 tm? -56.3 -48.11 77.33 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.354 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -76.51 -49.14 17.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.201 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -69.06 -34.9 75.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.557 -178.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 16' ' ' VAL . 97.2 mt-10 62.5 80.36 0.23 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.22 -139.21 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.844 0.354 . . . . 0.0 110.483 177.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 34' ' ' GLY . 8.2 p -134.58 140.61 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 pp -128.81 162.92 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-O 121.023 0.44 . . . . 0.0 111.064 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.26 129.39 41.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.71 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.514 ' CZ ' ' O ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -122.84 148.65 54.36 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -179.432 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.514 ' O ' ' CZ ' ' A' ' 25' ' ' TYR . 57.6 Cg_endo -78.91 148.66 22.31 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.993 1.795 . . . . 0.0 111.783 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.498 ' C ' ' H ' ' A' ' 29' ' ' ALA . 40.8 m -131.41 133.85 45.65 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.469 ' OE2' ' NH1' ' A' ' 117' ' ' ARG . 22.3 pt-20 -74.7 23.12 0.09 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.826 0.346 . . . . 0.0 110.425 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.498 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -155.19 -73.44 0.11 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.2 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 p -128.28 129.85 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.342 0.592 . . . . 0.0 110.751 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.507 ' CD2' ' O ' ' A' ' 148' ' ' CYS . 46.8 p90 -37.73 144.88 0.08 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.798 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -155.61 -173.41 24.24 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.5 m -132.27 168.06 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.486 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -156.96 -178.94 31.52 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.553 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.454 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.8 OUTLIER -159.24 -165.21 1.54 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.025 0.441 . . . . 0.0 111.328 -178.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.454 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 85.0 m-20 -91.61 108.02 26.34 Favored Pre-proline 0 CA--C 1.555 1.155 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -43.64 -61.18 0.6 Allowed 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.916 1.744 . . . . 0.0 112.262 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -71.94 67.01 0.6 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.058 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.1 m -155.71 133.99 11.57 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.88 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -65.73 -34.32 77.92 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.341 0.591 . . . . 0.0 110.688 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.496 HG23 ' N ' ' A' ' 42' ' ' ALA . 15.0 t -60.76 -41.19 94.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.171 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.496 ' N ' HG23 ' A' ' 41' ' ' THR . . . -56.64 -51.64 67.94 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.608 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.65 -42.14 95.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.285 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 92.2 mtp -63.77 -40.24 96.21 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.9 ttt85 -59.95 -42.54 94.28 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 121.967 0.889 . . . . 0.0 108.611 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.459 ' O ' HD23 ' A' ' 46' ' ' LEU . 1.0 OUTLIER -63.99 -53.13 54.96 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.73 -178.588 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.8 mt -70.77 -11.62 61.06 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.2 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -70.21 -82.6 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 121.152 0.501 . . . . 0.0 111.342 -177.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.504 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -75.97 -35.26 59.7 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -76.95 -50.28 13.57 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.966 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 35.32 65.34 0.39 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.919 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.416 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 1.6 mtt85 179.02 -53.48 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.778 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.27 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.416 ' HD2' ' H ' ' A' ' 52' ' ' ARG . 84.6 Cg_endo -79.91 -3.31 12.7 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.709 2.273 . . . . 0.0 112.388 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.54 HG13 ' N ' ' A' ' 55' ' ' ASP . 7.9 p -44.03 -43.87 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.47 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.54 ' N ' HG13 ' A' ' 54' ' ' VAL . 37.4 t0 -66.45 -41.73 88.66 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.041 0.448 . . . . 0.0 110.246 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.416 ' CD ' ' N ' ' A' ' 56' ' ' LYS . 1.1 mptm? -60.29 -39.64 87.64 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 62.29 107.71 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.561 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -53.14 -163.2 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.229 0.538 . . . . 0.0 111.591 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.533 HG23 HG21 ' A' ' 94' ' ' THR . 78.5 mt -101.01 144.32 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.538 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.4 mt -121.7 143.14 49.52 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.407 ' CD1' ' HE ' ' A' ' 117' ' ' ARG . 8.5 tp -113.86 128.67 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-O 121.244 0.545 . . . . 0.0 110.958 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.438 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -114.23 156.55 24.11 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.951 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.15 -26.37 5.94 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -118.42 142.64 47.35 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.086 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -69.81 -12.68 61.81 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.64 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -50.75 -31.58 17.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.927 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.76 -13.59 24.01 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.518 HD22 ' N ' ' A' ' 68' ' ' LEU . 4.0 mm? -92.16 -13.8 30.08 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.471 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 76.8 tttt -80.56 -38.16 1.05 Allowed Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 86.1 Cg_endo -102.38 -3.85 0.33 Allowed 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 122.696 2.264 . . . . 0.0 111.39 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.546 ' OH ' HD21 ' A' ' 114' ' ' LEU . 44.9 t80 -92.84 -14.86 27.17 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.687 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.543 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.2 mp -122.62 159.9 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.543 ' N ' HG22 ' A' ' 72' ' ' ILE . 27.7 p30 -65.86 144.37 56.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.374 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -87.19 7.2 29.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.548 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.553 HG23 ' N ' ' A' ' 76' ' ' MET . 15.0 t -78.11 -45.52 23.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.246 0.546 . . . . 0.0 110.854 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.553 ' N ' HG23 ' A' ' 75' ' ' THR . 25.0 ptm -84.92 -19.33 32.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.666 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.402 ' HG ' ' HE ' ' A' ' 82' ' ' ARG . 6.4 tp -81.78 130.07 34.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.027 -178.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.84 167.26 30.51 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.681 -177.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -48.51 -44.5 36.09 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.725 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.71 -31.76 51.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.994 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -64.52 -40.67 96.06 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.399 0.619 . . . . 0.0 110.533 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.421 ' HG2' ' H ' ' A' ' 82' ' ' ARG . 12.3 mmt85 -66.58 -51.99 50.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.477 1.132 . . . . 0.0 109.462 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 87' ' ' SER . 83.1 tt0 -55.86 -50.66 69.99 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 113.852 -1.522 . . . . 0.0 110.421 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.7 m -61.16 -49.95 75.17 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.013 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.5 tt -67.53 -29.74 46.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.853 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -79.49 -35.31 40.39 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.621 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 83' ' ' GLU . 10.9 m -89.85 -15.35 32.42 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.425 ' O ' ' O ' ' A' ' 89' ' ' TRP . 69.4 ttt180 -115.98 74.67 0.91 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.863 0.363 . . . . 0.0 110.714 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.425 ' O ' ' O ' ' A' ' 88' ' ' ARG . 1.5 m0 59.25 150.32 0.08 OUTLIER Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.668 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.57 -15.55 45.15 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.739 1.626 . . . . 0.0 110.636 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.493 ' H ' ' HD3' ' A' ' 92' ' ' PRO . . . 104.95 69.35 0.76 Allowed Glycine 0 N--CA 1.471 1.031 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.088 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.493 ' HD3' ' H ' ' A' ' 91' ' ' GLY . 48.7 Cg_exo -55.94 -38.95 93.92 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.556 2.171 . . . . 0.0 112.222 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.3 p -75.64 147.47 8.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.209 0.528 . . . . 0.0 111.104 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.533 HG21 HG23 ' A' ' 59' ' ' ILE . 19.3 m -102.45 126.25 49.42 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.981 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.573 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 43.8 m-85 -116.12 143.04 46.01 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.271 -178.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.733 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 84.2 t -84.08 98.96 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-O 121.123 0.487 . . . . 0.0 111.323 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -83.65 139.36 40.83 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.804 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.36 104.92 1.81 Allowed 'Trans proline' 0 N--CA 1.489 1.21 0 C-N-CA 121.566 1.51 . . . . 0.0 110.901 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 112' ' ' ASP . . . -61.9 149.56 85.3 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.8 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.448 ' O ' ' OG1' ' A' ' 103' ' ' THR . 93.9 Cg_endo -73.08 165.82 31.7 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.427 2.085 . . . . 0.0 112.098 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.22 -29.81 71.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.737 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 75.7 p -55.22 -44.24 75.24 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.445 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 100' ' ' PRO . 6.4 p -50.94 151.66 4.29 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.96 -103.85 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.749 1.632 . . . . 0.0 112.387 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.536 ' O ' ' N ' ' A' ' 109' ' ' GLY . 5.3 tpp85 -176.14 -5.02 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.932 0.396 . . . . 0.0 110.132 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.434 ' H ' ' H ' ' A' ' 105' ' ' ARG . 2.8 m0 -78.07 -10.86 59.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 122.05 0.929 . . . . 0.0 109.401 -179.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.672 ' H ' ' CD2' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -82.39 -16.27 49.71 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.017 -1.447 . . . . 0.0 111.064 -179.567 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.428 ' O ' ' O ' ' A' ' 54' ' ' VAL . 99.0 m -140.69 -42.06 0.4 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.942 0.401 . . . . 0.0 109.972 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 77.94 19.81 74.46 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.301 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.19 -75.78 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 117.614 0.707 . . . . 0.0 110.478 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -111.18 162.4 14.98 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.29 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' A' ' 99' ' ' ALA . 90.4 m-20 -95.2 60.39 2.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.088 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.6 p -158.13 145.04 17.8 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.546 HD21 ' OH ' ' A' ' 71' ' ' TYR . 3.7 pp -166.98 145.71 5.14 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.441 ' HB1' HG22 ' A' ' 94' ' ' THR . . . -65.55 127.38 31.64 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 113.728 -1.578 . . . . 0.0 109.398 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.464 HG22 ' N ' ' A' ' 117' ' ' ARG . 3.9 p -145.35 161.23 12.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.469 ' NH1' ' OE2' ' A' ' 28' ' ' GLU . 61.7 ttp180 -148.23 155.32 41.22 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.205 0.526 . . . . 0.0 111.811 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.438 HG22 ' HB3' ' A' ' 62' ' ' ALA . 55.7 t -119.97 135.69 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.1 t -135.51 150.31 49.73 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.925 0.393 . . . . 0.0 110.1 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 34.4 p30 -154.01 81.9 1.14 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.223 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.674 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 6.8 t60 -171.75 -35.93 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.674 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 73.3 Cg_endo -96.77 -160.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.927 0 C-N-CA 122.077 1.851 . . . . 0.0 112.114 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.4 mt -77.35 -5.14 48.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.669 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 77.8 t -58.12 -45.81 88.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.084 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.766 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.7 m -54.26 -62.73 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.21 -0.986 0 C-N-CA 119.402 -0.919 . . . . 0.0 108.696 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.766 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.35 -44.66 2.83 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.708 0.29 . . . . 0.0 111.12 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.34 -47.89 63.05 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.27 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 70.9 m -70.46 -48.99 53.23 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.204 0.526 . . . . 0.0 111.08 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.469 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -53.93 -42.78 69.19 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.437 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -59.69 -53.38 58.66 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.589 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -63.83 -24.64 67.83 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.166 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.11 1.69 90.4 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 134' ' ' PRO . 34.8 mttm -153.33 157.8 32.82 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 120.574 -0.451 . . . . 0.0 110.122 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.4 ' O ' ' O ' ' A' ' 133' ' ' LYS . 5.2 Cg_exo -41.41 175.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 123.926 3.084 . . . . 0.0 113.581 -178.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.5 tp -129.38 122.73 30.04 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 176.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.428 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -66.19 143.33 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.955 0 C-N-CA 118.108 -1.437 . . . . 0.0 107.404 -179.52 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.8 t -114.88 122.09 45.22 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 123.792 0.682 . . . . 0.0 110.597 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.9 m -130.01 162.98 27.49 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.881 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.0 m -72.25 145.45 47.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.382 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.81 81.6 1.16 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.019 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 57.7 p30 -160.47 161.42 32.87 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.616 0.722 . . . . 0.0 111.031 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.49 -167.12 1.88 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.318 -178.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.6 t -61.03 -43.24 99.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.44 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -158.32 4.71 0.13 Allowed Glycine 0 C--N 1.33 0.227 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.2 tt -83.44 127.92 66.4 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -39.74 158.21 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.549 1.499 . . . . 0.0 112.207 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -77.04 -163.22 0.2 Allowed 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.733 2.288 . . . . 0.0 111.889 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.507 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 19.5 t -126.38 78.23 1.76 Allowed 'General case' 0 C--N 1.34 0.155 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -49.8 -39.51 38.57 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.676 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.16 169.81 23.69 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.445 ' H ' HG22 ' A' ' 151' ' ' VAL . 1.5 m -58.04 -20.87 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 CA-C-O 121.786 0.803 . . . . 0.0 108.984 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -64.53 -33.34 75.67 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 155' ' ' ARG . 0.4 OUTLIER -62.26 -79.37 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.401 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.425 HG13 ' N ' ' A' ' 155' ' ' ARG . 6.8 p -34.91 -33.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.983 0.913 . . . . 0.0 111.109 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.493 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -68.61 -53.27 23.66 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.533 -179.265 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -68.76 -18.61 64.24 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 122.571 1.177 . . . . 0.0 108.068 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -82.61 -45.56 14.41 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 112.517 -2.128 . . . . 0.0 111.559 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -130.17 -29.76 2.02 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 96.48 23.75 15.64 Favored Glycine 0 N--CA 1.469 0.894 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -178.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 159' ' ' GLY . . . -43.12 -97.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.533 -0.333 . . . . 0.0 111.17 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.518 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.95 34.81 16.56 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -178.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.524 ' C ' ' H ' ' A' ' 164' ' ' VAL . 2.2 m-85 -172.67 -62.64 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.136 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -72.99 27.07 0.29 Allowed 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.258 1.972 . . . . 0.0 110.758 177.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.557 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.4 m -129.64 167.48 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.426 -178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 16.4 t -124.37 65.86 42.3 Favored Pre-proline 0 N--CA 1.471 0.601 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.637 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.557 ' HD3' HG23 ' A' ' 164' ' ' VAL . 29.4 Cg_exo -37.15 140.04 0.21 Allowed 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 123.413 2.742 . . . . 0.0 115.189 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 162.45 170.78 27.74 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 113.929 -1.487 . . . . 0.0 110.883 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -157.99 147.19 19.55 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.665 0.269 . . . . 0.0 110.427 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.6 t -148.87 157.21 43.26 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.892 0.377 . . . . 0.0 110.529 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -64.28 -75.05 0.4 Allowed Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 89.31 32.7 10.15 Favored Glycine 0 N--CA 1.466 0.693 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -65.12 -41.6 94.73 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.206 -0.997 . . . . 0.0 111.681 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.575 ' N ' HD12 ' A' ' 173' ' ' LEU . 9.9 mp -82.48 -109.14 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.624 0.25 . . . . 0.0 110.512 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.444 ' N ' ' CD ' ' A' ' 175' ' ' PRO . 60.9 m-80 45.06 52.54 10.56 Favored Pre-proline 0 N--CA 1.466 0.326 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.141 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 174' ' ' ASN . 45.4 Cg_endo -65.08 -31.33 55.15 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.727 2.285 . . . . 0.0 112.134 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 49.8 p -162.72 128.68 3.37 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.247 0.546 . . . . 0.0 110.293 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 94' ' ' THR . 98.0 mt-10 -108.18 -50.98 2.96 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.602 -178.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.474 ' O ' HG23 ' A' ' 178' ' ' ILE . 18.4 tt -90.33 122.85 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.117 0.484 . . . . 0.0 111.834 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -134.74 170.69 15.45 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.252 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -87.01 107.2 18.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.242 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.733 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -69.21 -11.9 61.2 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.907 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.492 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.8 mm? -64.28 -42.62 96.34 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.45 -41.81 4.26 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.619 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 65.1 24.36 70.29 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -62.91 136.21 57.72 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.422 0.629 . . . . 0.0 111.269 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.574 ' H ' ' CD2' ' A' ' 186' ' ' LEU . 0.7 OUTLIER -82.0 178.68 8.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.254 179.433 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 187' ' ' PHE . . . . . 0.514 ' O ' ' CD2' ' A' ' 187' ' ' PHE . 88.5 t80 -96.14 67.05 2.57 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.374 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.68 140.98 51.48 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.071 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.406 ' H ' ' H ' ' A' ' 190' ' ' GLY . 57.2 tt0 -147.79 -17.12 0.36 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.224 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.406 ' H ' ' H ' ' A' ' 189' ' ' GLN . . . . . . . . 0 CA--C 1.525 0.71 0 CA-C-O 118.172 -1.349 . . . . 0.0 110.71 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -75.42 -12.54 60.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.871 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -63.78 -41.13 98.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.373 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.555 HD12 ' N ' ' A' ' 5' ' ' LEU . 9.2 mp -63.18 -42.51 99.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.155 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -64.5 -40.52 95.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.024 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.1 tpt180 -63.22 -41.65 99.14 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.35 -43.93 98.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.462 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.56 -46.49 90.01 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.993 0.425 . . . . 0.0 110.024 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.34 -43.6 98.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.636 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.07 -41.38 78.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.131 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.67 -44.07 94.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.245 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.86 -53.09 62.02 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.915 0.388 . . . . 0.0 111.561 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.8 pt -68.89 -39.36 79.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.232 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -57.92 -53.66 55.75 Favored 'General case' 0 C--O 1.215 -0.719 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.22 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.428 HG13 ' H ' ' A' ' 21' ' ' ARG . 86.5 t -61.07 -40.05 84.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.233 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.685 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.2 tt -51.89 -50.59 60.74 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.441 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -81.56 -49.26 10.76 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.253 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -66.0 -31.6 72.59 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.08 -178.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 16' ' ' VAL . 97.0 mt-10 57.14 83.91 0.1 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.075 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.428 ' H ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -164.8 -159.14 0.44 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.86 178.586 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.8 p -119.02 137.26 53.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.442 HD12 ' O ' ' A' ' 24' ' ' ALA . 2.8 pp -126.14 166.92 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 120.799 0.333 . . . . 0.0 111.327 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.442 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -63.23 137.39 58.19 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.25 0.548 . . . . 0.0 111.342 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.537 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 2.2 t80 -130.77 139.13 34.67 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.537 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 96.5 Cg_endo -76.88 144.47 24.34 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.488 1.459 . . . . 0.0 111.96 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.2 m -140.37 138.13 34.58 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.943 0.401 . . . . 0.0 110.363 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -56.73 -45.77 81.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.736 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.48 -79.28 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.806 0.336 . . . . 0.0 111.349 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 90.6 t -135.56 129.96 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -37.85 140.39 0.26 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.183 0.516 . . . . 0.0 111.546 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -137.74 -168.25 11.28 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.0 m -128.19 171.92 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -162.48 -177.53 35.59 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.221 -0.99 . . . . 0.0 111.719 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.539 ' SG ' ' HB2' ' A' ' 42' ' ' ALA . 0.8 OUTLIER -160.92 -161.42 0.83 Allowed 'General case' 0 C--N 1.342 0.259 0 C-N-CA 120.259 -0.577 . . . . 0.0 112.169 -179.227 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.504 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 69.2 m-20 -92.13 107.3 22.07 Favored Pre-proline 0 CA--C 1.557 1.241 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -45.46 -55.75 3.29 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 122.038 1.825 . . . . 0.0 111.71 177.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -50.81 -33.4 23.4 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.026 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.3 m -76.5 118.89 19.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.326 0.584 . . . . 0.0 110.659 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.535 ' O ' HG12 ' A' ' 43' ' ' VAL . 16.3 pt-20 -65.02 -32.19 73.79 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.87 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.5 t -43.48 -28.04 0.33 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.796 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.539 ' HB2' ' SG ' ' A' ' 35' ' ' CYS . . . -64.3 -51.6 62.67 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.27 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 40' ' ' GLU . 3.0 p -64.5 -39.34 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.171 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 92.6 mtp -66.11 -39.24 89.77 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.6 ttt85 -63.01 -33.27 75.07 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.86 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 87.2 mt -74.4 -59.04 2.91 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.3 mt -53.72 -19.54 4.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.334 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -66.66 -84.95 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.572 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.504 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.2 pt? -77.48 -34.75 54.2 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -74.94 -50.05 18.09 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.826 -176.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 37.25 62.01 0.88 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.665 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.9 ttm-85 -179.04 -61.91 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.895 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.215 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -63.36 -11.75 27.18 Favored 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 122.872 2.381 . . . . 0.0 112.422 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.589 HG13 ' N ' ' A' ' 55' ' ' ASP . 9.7 p -41.76 -48.61 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.831 -0.347 . . . . 0.0 111.143 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.589 ' N ' HG13 ' A' ' 54' ' ' VAL . 65.6 t0 -66.73 -39.74 88.09 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.88 0.371 . . . . 0.0 111.051 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -60.82 -39.91 90.76 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 64.73 108.3 0.01 OUTLIER Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.567 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -53.63 -159.16 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.319 0.581 . . . . 0.0 112.095 -179.603 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.446 HG23 HG21 ' A' ' 94' ' ' THR . 67.6 mt -103.94 144.07 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.896 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 20.4 mt -121.98 142.4 50.35 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.9 tp -112.45 134.59 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-O 121.368 0.604 . . . . 0.0 110.88 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.467 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -122.61 150.92 41.99 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.99 -27.27 8.49 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -116.48 151.0 36.97 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.796 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -79.68 -13.55 59.39 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -51.94 -31.44 28.81 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.482 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.13 -12.64 28.0 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.499 HD22 ' N ' ' A' ' 68' ' ' LEU . 4.1 mm? -92.63 -16.62 25.37 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 118.793 0.724 . . . . 0.0 109.276 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.474 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 44.5 tttp -77.5 -38.88 1.9 Allowed Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.774 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 67.6 Cg_endo -103.99 -2.89 0.24 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 122.91 2.407 . . . . 0.0 112.38 -178.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -95.84 -9.34 31.78 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.033 -178.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.553 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.2 mp -125.64 161.96 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.553 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -58.5 177.24 0.14 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.856 0.36 . . . . 0.0 110.232 -179.326 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -105.38 15.47 27.18 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.484 ' OG1' ' N ' ' A' ' 76' ' ' MET . 32.3 p -80.88 -64.53 1.17 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.095 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.484 ' N ' ' OG1' ' A' ' 75' ' ' THR . 26.4 ptm -70.23 -5.09 25.09 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.184 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.2 tp -83.93 100.92 11.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.32 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -155.15 160.28 40.8 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.78 -177.572 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -39.37 -48.51 1.91 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.813 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.1 p -61.86 -34.0 60.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.661 -0.415 . . . . 0.0 111.279 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 78' ' ' THR . 64.8 tp60 -65.57 -41.56 92.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.916 0.389 . . . . 0.0 110.715 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.417 ' HG2' ' H ' ' A' ' 82' ' ' ARG . 8.8 mmt85 -63.63 -51.98 62.85 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 122.589 1.185 . . . . 0.0 109.136 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -55.08 -50.3 69.5 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.776 -1.556 . . . . 0.0 110.018 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -60.52 -49.95 75.5 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.939 -178.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.0 tt -67.73 -37.19 78.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.097 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -70.37 -43.09 70.87 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.488 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.4 m -75.23 -37.73 60.93 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.195 0.521 . . . . 0.0 110.561 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -76.15 150.58 37.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -36.29 153.96 0.08 OUTLIER Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.888 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 118' ' ' VAL . 41.5 Cg_endo -64.28 -24.25 65.3 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.048 1.832 . . . . 0.0 111.439 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.492 ' O ' ' NH2' ' A' ' 117' ' ' ARG . . . 176.51 79.27 0.05 OUTLIER Glycine 0 CA--C 1.531 1.037 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.09 -44.35 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.058 1.839 . . . . 0.0 111.941 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.505 HG13 ' CE2' ' A' ' 95' ' ' PHE . 3.0 p -137.26 145.82 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.196 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.446 HG21 HG23 ' A' ' 59' ' ' ILE . 17.9 m -83.8 130.27 34.94 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.214 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.505 ' CE2' HG13 ' A' ' 93' ' ' VAL . 34.0 m-85 -117.85 140.03 50.28 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.512 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.628 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 4.4 t -90.28 101.37 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 121.477 0.656 . . . . 0.0 110.023 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -90.23 152.32 45.7 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.377 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.42 113.04 3.69 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.199 1.933 . . . . 0.0 111.189 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.14 150.95 75.22 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.26 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -72.27 156.04 55.45 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.075 1.85 . . . . 0.0 112.159 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -139.74 58.69 1.6 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.016 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 37.1 p -67.1 -35.5 79.92 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.586 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.701 ' H ' ' CD ' ' A' ' 104' ' ' PRO . 0.4 OUTLIER -165.82 -40.1 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.221 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.701 ' CD ' ' H ' ' A' ' 103' ' ' THR . 6.3 Cg_exo -71.53 -166.07 0.23 Allowed 'Trans proline' 0 C--N 1.313 -1.342 0 C-N-CA 122.379 2.052 . . . . 0.0 111.849 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 109' ' ' GLY . 7.4 tpt180 -173.93 6.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.921 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 66.8 p-90 -75.8 -7.34 54.21 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.957 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.977 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -70.91 -30.14 66.39 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.702 ' H ' HD22 ' A' ' 107' ' ' LEU . 89.9 m -140.38 -38.46 0.45 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.705 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 86.04 -11.38 62.8 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.608 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -142.13 -72.3 0.32 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.56 0.68 . . . . 0.0 110.788 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.443 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 21.4 t80 -91.32 -167.38 1.79 Allowed 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.443 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 94.9 m-20 -130.53 57.6 1.72 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.653 0.263 . . . . 0.0 110.693 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.7 p -156.51 156.92 34.53 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.187 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.446 ' O ' HD12 ' A' ' 114' ' ' LEU . 3.1 pp -168.96 138.88 2.25 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.446 ' HB2' HG22 ' A' ' 96' ' ' VAL . . . -70.32 131.56 44.33 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 113.787 -1.551 . . . . 0.0 109.932 177.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.8 p -147.06 155.35 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 120.727 0.299 . . . . 0.0 110.364 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.492 ' NH2' ' O ' ' A' ' 91' ' ' GLY . 79.3 ttt180 -146.1 153.27 40.52 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.847 -179.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.467 HG22 ' HB3' ' A' ' 62' ' ' ALA . 49.6 t -120.5 136.24 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.9 t -139.74 142.13 36.82 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.025 0.441 . . . . 0.0 110.629 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 51.0 p-10 -145.82 81.82 1.61 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.686 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.639 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 7.3 t60 -171.49 -36.29 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.639 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 43.0 Cg_endo -94.72 -161.14 0.07 OUTLIER 'Trans proline' 0 N--CA 1.483 0.907 0 C-N-CA 122.044 1.829 . . . . 0.0 111.955 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.3 mt -78.01 -6.17 53.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.392 0.615 . . . . 0.0 110.013 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 98.8 t -58.08 -45.29 88.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.072 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.772 HG23 ' H ' ' A' ' 126' ' ' ALA . 28.7 m -53.2 -62.15 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.906 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.019 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.772 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.68 -44.01 3.02 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 120.938 0.399 . . . . 0.0 110.723 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.3 tp -68.93 -48.26 63.68 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.235 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 60.7 m -70.28 -49.29 51.26 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.387 0.613 . . . . 0.0 110.907 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.466 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.1 pp0? -54.55 -41.95 70.36 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.341 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.64 -55.07 39.83 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.257 -178.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -62.46 -21.9 65.81 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.919 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.73 1.27 89.19 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -152.27 160.56 31.18 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 120.506 -0.477 . . . . 0.0 110.357 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -45.04 164.3 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 123.943 3.095 . . . . 0.0 112.54 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.4 tp -119.36 122.93 42.93 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.43 HG13 ' H ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -63.54 144.69 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 C-N-CA 117.913 -1.515 . . . . 0.0 106.945 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.1 t -116.82 125.1 51.06 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 123.583 0.552 . . . . 0.0 111.283 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.3 m -134.54 158.39 44.08 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.781 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.6 m -71.31 142.56 50.45 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.168 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.72 85.39 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.558 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -160.63 165.44 30.65 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.438 0.637 . . . . 0.0 111.079 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.93 -164.65 2.01 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.315 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 42.5 t -61.37 -43.08 99.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.022 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -157.25 3.91 0.16 Allowed Glycine 0 N--CA 1.461 0.355 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.457 HD13 ' C ' ' A' ' 145' ' ' LEU . 1.3 tm? -81.18 112.28 31.57 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 145' ' ' LEU . 20.1 Cg_exo -35.46 156.84 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.104 1.869 . . . . 0.0 112.542 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.7 -174.21 1.23 Allowed 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.4 2.067 . . . . 0.0 112.57 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 17.6 m -114.44 82.89 1.79 Allowed 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.378 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -59.07 -35.58 73.6 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.637 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.82 169.41 21.38 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.434 ' H ' HG22 ' A' ' 151' ' ' VAL . 0.9 OUTLIER -57.02 -23.19 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 CA-C-O 121.437 0.637 . . . . 0.0 109.378 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -62.71 -32.41 73.51 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 155' ' ' ARG . 6.4 tm-20 -63.09 -80.45 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.568 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.3 p -36.37 -27.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.167 0.987 . . . . 0.0 111.044 177.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.471 ' N ' ' O ' ' A' ' 153' ' ' GLU . 4.3 tmt_? -74.4 -50.73 17.34 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.855 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.7 -17.75 62.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 122.631 1.205 . . . . 0.0 107.781 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -83.32 -57.04 3.42 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 112.553 -2.112 . . . . 0.0 111.987 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -119.99 -20.6 7.42 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 160' ' ' ALA . . . 84.72 27.63 34.5 Favored Glycine 0 N--CA 1.466 0.642 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.474 ' O ' ' HB3' ' A' ' 161' ' ' ALA . . . -42.21 -98.37 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.58 -0.31 . . . . 0.0 111.36 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.516 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 67.79 34.44 4.35 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.299 0.571 . . . . 0.0 109.578 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.519 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.6 m-85 -176.36 -61.89 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.235 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -73.44 31.45 0.31 Allowed 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.044 1.829 . . . . 0.0 110.439 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.563 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.4 m -134.67 168.22 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.834 -178.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 8.3 t -125.15 64.82 46.6 Favored Pre-proline 0 N--CA 1.475 0.79 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.855 178.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.563 ' HD3' HG23 ' A' ' 164' ' ' VAL . 55.4 Cg_exo -40.13 151.0 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 123.706 2.938 . . . . 0.0 114.97 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 162.68 -174.93 39.1 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.983 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -141.68 145.12 34.53 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.1 t -148.24 161.24 41.89 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.036 0.446 . . . . 0.0 110.809 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -152.5 79.23 0.2 Allowed Glycine 0 N--CA 1.459 0.218 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -118.31 -57.8 0.28 Allowed Glycine 0 N--CA 1.468 0.772 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 41.93 37.07 0.73 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.801 0.334 . . . . 0.0 110.966 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 8.4 tp -66.29 -128.97 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.097 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -70.35 148.03 95.39 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.545 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -67.31 -21.97 46.82 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.016 1.81 . . . . 0.0 111.668 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 52.5 p -160.38 127.25 4.3 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.362 0.601 . . . . 0.0 110.683 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -105.68 49.07 0.82 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.912 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.424 ' O ' HG23 ' A' ' 178' ' ' ILE . 17.2 tt -109.68 129.87 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 120.795 0.331 . . . . 0.0 110.539 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -132.63 166.34 22.35 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.711 0.767 . . . . 0.0 112.018 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -80.36 106.87 12.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.502 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -64.47 -20.05 65.95 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.216 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.449 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.5 mm? -63.02 -42.64 99.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.933 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.85 -45.28 2.88 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.836 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 67.29 22.8 73.06 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -66.96 146.51 54.3 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.202 0.525 . . . . 0.0 111.187 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.501 HD23 ' N ' ' A' ' 186' ' ' LEU . 0.8 OUTLIER -69.14 177.7 2.61 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.725 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -125.33 85.77 2.45 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.281 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -70.54 138.89 51.36 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.313 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -174.09 -23.98 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.369 177.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.727 0 CA-C-O 118.037 -1.424 . . . . 0.0 110.939 179.894 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -63.06 -40.35 97.43 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.564 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -60.86 -40.53 93.27 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.92 0.39 . . . . 0.0 110.519 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.55 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.0 mp -61.95 -43.08 99.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.22 0.533 . . . . 0.0 109.608 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -67.96 -35.35 78.23 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.127 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -60.71 -43.61 97.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.543 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 9' ' ' ALA . 1.5 p30 -70.97 -39.22 72.67 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.166 -0.613 . . . . 0.0 110.469 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.523 ' N ' ' OD1' ' A' ' 8' ' ' ASP . . . -62.12 -48.3 80.77 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.269 0.557 . . . . 0.0 110.122 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.0 -43.59 99.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.912 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.56 -45.31 77.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.635 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.07 -46.68 88.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.924 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.94 -52.1 66.87 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 14.3 pt -69.37 -39.67 79.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.518 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -58.75 -53.47 57.99 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.123 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' A' ' 20' ' ' GLU . 89.6 t -60.76 -40.42 84.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.508 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.684 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.4 tt -51.67 -50.59 60.12 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.77 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -80.77 -50.99 9.14 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.056 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -63.7 -32.75 74.34 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.049 -178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.9 mt-10 58.49 85.35 0.09 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.385 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.57 -141.06 0.07 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.319 178.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.405 HG11 HH21 ' A' ' 45' ' ' ARG . 4.8 p -137.55 139.58 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.448 HD12 ' O ' ' A' ' 24' ' ' ALA . 2.8 pp -129.85 165.9 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-O 120.945 0.402 . . . . 0.0 111.41 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.448 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -61.63 136.97 58.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.301 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.51 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -134.54 142.23 41.92 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.51 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 62.6 Cg_endo -77.25 151.09 29.64 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.771 1.647 . . . . 0.0 111.82 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.492 ' C ' ' H ' ' A' ' 29' ' ' ALA . 45.7 m -132.13 136.49 47.16 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.844 0.354 . . . . 0.0 110.87 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -74.98 23.83 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.357 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.492 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -157.27 -73.44 0.09 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.313 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.8 p -127.52 126.95 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.316 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.511 ' CD1' ' O ' ' A' ' 148' ' ' CYS . 35.4 p90 -40.24 147.83 0.09 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.323 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -156.34 -169.45 20.46 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.3 m -133.21 170.87 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.406 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -158.58 -175.48 29.56 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.012 -1.089 . . . . 0.0 112.102 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.521 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -158.44 -164.13 1.41 Allowed 'General case' 0 C--O 1.227 -0.103 0 CA-C-O 120.568 0.223 . . . . 0.0 110.81 -179.312 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.521 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 90.5 m-20 -98.72 109.69 54.29 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -178.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 36' ' ' ASP . 22.4 Cg_exo -36.73 170.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.854 2.369 . . . . 0.0 114.325 177.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 41.98 71.94 0.19 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.074 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.5 m -148.81 138.86 22.23 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.373 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -69.87 -34.79 74.06 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.462 0.648 . . . . 0.0 110.54 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.449 HG22 ' H ' ' A' ' 41' ' ' THR . 0.1 OUTLIER -62.98 -43.0 99.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.667 -179.071 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.71 -51.34 70.18 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.726 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 p -63.62 -42.6 96.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 90.4 mtp -64.24 -39.71 94.52 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.451 ' O ' ' CD2' ' A' ' 49' ' ' LEU . 45.8 ttt-85 -62.15 -33.8 75.18 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.067 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 89.4 mt -75.09 -59.93 2.52 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.2 mt -54.18 -18.42 3.8 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.361 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -67.35 -85.67 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.741 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.503 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -75.72 -32.76 60.17 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.906 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -78.18 -70.44 0.49 Allowed 'General case' 0 C--N 1.349 0.571 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.489 -177.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 52.84 81.05 0.09 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.0 mtm180 161.72 -63.14 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.86 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.1 -11.68 32.79 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.819 2.346 . . . . 0.0 112.255 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.565 HG13 ' N ' ' A' ' 55' ' ' ASP . 6.9 p -41.83 -49.9 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.815 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.565 ' N ' HG13 ' A' ' 54' ' ' VAL . 65.7 t0 -66.74 -40.13 88.22 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.018 0.437 . . . . 0.0 111.146 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -61.36 -39.97 92.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.692 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 66.39 112.49 0.01 OUTLIER Glycine 0 CA--C 1.519 0.295 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.555 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -52.99 -162.37 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.325 0.583 . . . . 0.0 112.298 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 70.9 mt -105.02 145.23 13.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.825 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.6 mt -121.15 142.66 49.67 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.449 HD13 ' HE ' ' A' ' 117' ' ' ARG . 9.4 tp -110.78 127.8 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-O 121.076 0.465 . . . . 0.0 110.708 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -117.64 148.15 42.22 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -106.4 -27.68 10.81 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 116.297 -0.411 . . . . 0.0 109.915 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -115.79 150.32 37.11 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.735 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -79.98 -14.42 58.6 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -52.91 -30.82 36.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.585 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.04 -12.22 29.05 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.531 HD22 ' N ' ' A' ' 68' ' ' LEU . 3.8 mm? -91.4 -20.81 21.4 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.513 -0.742 . . . . 0.0 109.591 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.462 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 49.1 tttm -76.03 -37.45 2.17 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 68.7 Cg_endo -103.39 -3.48 0.26 Allowed 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 122.548 2.166 . . . . 0.0 112.007 -178.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.446 ' OH ' ' CD1' ' A' ' 114' ' ' LEU . 53.9 t80 -98.25 -4.1 35.98 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.037 0.446 . . . . 0.0 111.07 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.618 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.6 mp -132.91 166.54 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.618 ' N ' HG22 ' A' ' 72' ' ' ILE . 98.7 m-20 -58.0 -9.66 1.47 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.475 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 58.2 t0 58.54 30.4 19.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.9 t -95.23 -36.79 11.3 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.091 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -83.07 -18.83 38.25 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.86 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 36.0 tp -86.03 125.35 33.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.148 0.499 . . . . 0.0 110.287 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -161.56 161.74 29.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.156 -177.075 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -39.49 -48.41 2.0 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.849 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.13 -32.96 58.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.976 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.454 ' N ' ' O ' ' A' ' 78' ' ' THR . 63.2 tp60 -65.14 -40.57 94.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.585 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.2 mmt85 -64.79 -53.05 53.07 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 122.164 0.983 . . . . 0.0 109.252 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -53.98 -51.02 65.24 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.011 -1.45 . . . . 0.0 110.39 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.5 m -61.05 -50.34 73.7 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.853 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 89' ' ' TRP . 8.6 tt -68.02 -33.75 62.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.728 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -73.82 -38.89 64.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.168 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.7 m -83.41 -34.55 25.48 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.8 0.333 . . . . 0.0 111.416 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 63.9 ttm-85 -81.14 -75.26 0.29 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.504 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.436 ' O ' ' O ' ' A' ' 85' ' ' ILE . 2.2 m0 -162.02 152.85 14.83 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -65.31 -22.51 60.21 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.296 1.997 . . . . 0.0 112.198 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 161.44 78.02 0.03 OUTLIER Glycine 0 CA--C 1.531 1.077 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.514 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.53 -23.59 11.23 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 121.946 1.764 . . . . 0.0 112.404 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.42 HG13 ' CE2' ' A' ' 95' ' ' PHE . 3.2 p -136.15 147.22 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.216 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 26.9 m -89.89 138.47 31.46 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.257 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.485 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 42.0 m-85 -124.46 139.94 53.42 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.999 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.677 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.6 t -97.76 109.72 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 CA-C-O 121.433 0.635 . . . . 0.0 111.084 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -92.08 147.64 35.16 Favored Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.421 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.51 98.1 1.09 Allowed 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.847 1.698 . . . . 0.0 110.985 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -46.87 148.04 2.01 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -63.36 -28.71 71.82 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.261 1.974 . . . . 0.0 112.561 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 41.1 68.23 0.45 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.71 0.29 . . . . 0.0 110.617 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.421 ' O ' ' OG1' ' A' ' 103' ' ' THR . 40.4 p -64.58 -35.07 79.8 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.75 -178.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.67 ' H ' ' CD ' ' A' ' 104' ' ' PRO . 0.2 OUTLIER -169.28 -40.85 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.67 ' CD ' ' H ' ' A' ' 103' ' ' THR . 15.9 Cg_exo -67.21 -162.88 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.734 2.289 . . . . 0.0 112.12 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 109' ' ' GLY . 8.0 tpt180 -163.08 1.97 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.181 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -73.37 -6.96 49.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.669 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.968 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -77.71 -21.28 52.2 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.059 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.625 ' H ' HD22 ' A' ' 107' ' ' LEU . 93.1 m -142.79 -40.34 0.33 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.141 0.495 . . . . 0.0 109.981 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 91.44 -15.44 61.33 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.642 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.422 ' O ' ' NH2' ' A' ' 105' ' ' ARG . 17.3 tpt180 -145.23 -76.95 0.21 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 117.578 0.689 . . . . 0.0 111.488 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.449 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 22.0 t80 -87.1 -167.33 1.85 Allowed 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.449 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 52.8 p-10 -136.03 73.15 1.45 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.103 0.477 . . . . 0.0 111.302 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.7 p -159.68 129.49 5.45 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.446 ' CD1' ' OH ' ' A' ' 71' ' ' TYR . 34.4 mt -127.72 121.62 30.79 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -177.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.447 ' N ' HG13 ' A' ' 96' ' ' VAL . . . -70.84 126.56 29.93 Favored 'General case' 0 C--N 1.345 0.397 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 175.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.425 HG22 ' N ' ' A' ' 117' ' ' ARG . 14.8 p -143.88 152.84 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.198 0.523 . . . . 0.0 111.1 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.449 ' HE ' HD13 ' A' ' 61' ' ' ILE . 62.5 ttp180 -139.82 154.3 47.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.116 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.7 t -123.86 132.8 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.3 t -132.21 149.91 52.28 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.985 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 33.8 p30 -152.75 80.7 1.22 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.07 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.681 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 49.3 t-80 -171.79 -35.31 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.681 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 56.5 Cg_endo -94.99 -161.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.98 1.787 . . . . 0.0 111.834 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 11.3 mt -78.16 -4.79 49.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.978 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 82.4 t -58.24 -45.76 88.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.968 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.753 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.8 m -53.71 -62.31 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.941 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.044 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.753 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.67 -43.27 2.77 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.968 0.413 . . . . 0.0 110.842 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.7 tp -69.93 -47.66 61.53 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.414 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 62.7 m -70.48 -49.22 50.74 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.539 0.685 . . . . 0.0 110.531 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 125' ' ' VAL . 1.1 pp0? -54.41 -42.24 70.24 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.88 -54.57 45.64 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.455 -178.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -62.41 -23.25 66.74 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.001 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.51 0.58 90.06 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 134' ' ' PRO . 33.1 mttm -153.67 159.18 32.39 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 133' ' ' LYS . 6.3 Cg_exo -41.35 179.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 123.886 3.057 . . . . 0.0 113.239 -178.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 35' ' ' CYS . 8.0 tp -133.44 123.26 24.98 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 176.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.449 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -65.6 146.48 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 C-N-CA 117.64 -1.624 . . . . 0.0 107.271 -179.45 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.8 t -118.65 126.95 53.06 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 123.573 0.545 . . . . 0.0 111.214 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.7 m -132.74 163.5 28.88 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.04 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.8 m -74.2 146.94 42.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.443 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.45 83.55 1.97 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.917 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -159.12 164.71 35.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.398 0.618 . . . . 0.0 110.977 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.88 -166.18 2.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.073 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 61.1 m -60.09 -42.7 95.21 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.799 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -160.63 5.38 0.1 OUTLIER Glycine 0 C--N 1.331 0.28 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.4 tp -81.19 127.9 72.42 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 119.36 -0.352 . . . . 0.0 110.104 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -39.28 151.28 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 121.637 1.558 . . . . 0.0 111.804 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 149' ' ' ARG . 89.2 Cg_endo -75.17 148.58 34.83 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.234 1.956 . . . . 0.0 112.446 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.511 ' O ' ' CD1' ' A' ' 31' ' ' PHE . 4.2 m -62.74 71.35 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.354 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 147' ' ' PRO . 17.3 ptm180 -57.87 -32.94 68.17 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.415 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -163.11 164.22 25.44 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.862 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.441 ' H ' HG22 ' A' ' 151' ' ' VAL . 0.8 OUTLIER -56.33 -18.01 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 CA-C-O 121.721 0.772 . . . . 0.0 108.971 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -64.71 -35.53 81.35 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 177.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 150' ' ' THR . 5.6 tm-20 -58.94 -74.07 0.07 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.869 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.1 p -45.68 -30.06 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.34 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -83.98 -44.28 14.34 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 122.226 1.012 . . . . 0.0 110.285 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.36 -42.14 86.3 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.435 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.471 ' CG ' ' N ' ' A' ' 158' ' ' PHE . 8.1 pt20 -81.47 -48.93 11.22 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 112.858 -1.974 . . . . 0.0 112.134 -177.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.471 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 30.5 t80 -106.85 -36.54 6.63 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -177.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 97.68 24.45 12.09 Favored Glycine 0 N--CA 1.476 1.341 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -42.89 -94.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.564 0.221 . . . . 0.0 111.094 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.45 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.96 37.51 14.98 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.204 0.526 . . . . 0.0 109.714 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.562 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.5 m-85 -177.07 -61.83 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.764 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -73.73 28.19 0.32 Allowed 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 122.367 2.045 . . . . 0.0 110.443 178.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.586 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.9 m -131.03 167.4 26.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.85 -178.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.7 t -123.82 65.58 35.97 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.501 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.586 ' HD3' HG23 ' A' ' 164' ' ' VAL . 30.6 Cg_exo -36.68 141.22 0.15 Allowed 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 123.6 2.867 . . . . 0.0 115.15 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 154.67 145.68 4.22 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.54 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -141.99 132.25 24.92 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.303 0.573 . . . . 0.0 110.973 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.4 t -158.05 148.53 20.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.929 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -67.78 -40.76 89.7 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.545 ' C ' ' H ' ' A' ' 173' ' ' LEU . . . 138.8 -71.18 0.45 Allowed Glycine 0 N--CA 1.468 0.81 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 64.83 -30.9 0.12 Allowed 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.353 0.661 . . . . 0.0 111.788 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.545 ' H ' ' C ' ' A' ' 171' ' ' GLY . 8.4 mp -80.8 156.38 26.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.094 0.473 . . . . 0.0 110.096 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -46.61 150.26 1.26 Allowed Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.321 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.41 158.66 50.93 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 122.209 1.939 . . . . 0.0 111.578 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 8.4 t -97.33 123.25 41.08 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -126.67 158.68 35.75 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.231 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.449 ' O ' HG23 ' A' ' 178' ' ' ILE . 19.3 tt -110.93 127.82 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.112 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -129.46 166.95 18.59 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.727 0.775 . . . . 0.0 112.273 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 184' ' ' GLY . 97.7 m-20 -78.93 106.93 11.3 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.427 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -67.15 -16.93 64.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.744 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.491 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.4 mm? -63.6 -42.43 98.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.099 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.581 HG23 ' N ' ' A' ' 184' ' ' GLY . 5.0 t -120.31 -52.89 2.15 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.207 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.581 ' N ' HG23 ' A' ' 183' ' ' THR . . . 95.11 41.29 4.06 Favored Glycine 0 N--CA 1.468 0.818 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -114.49 149.38 36.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.053 -0.574 . . . . 0.0 111.398 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.515 HD23 ' N ' ' A' ' 186' ' ' LEU . 0.7 OUTLIER -65.12 -172.59 0.1 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.018 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -123.82 50.6 1.61 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.035 0.445 . . . . 0.0 110.109 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.442 ' H ' ' HG ' ' A' ' 186' ' ' LEU . 3.7 tmt_? -89.94 -64.27 1.16 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.203 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -67.45 -25.58 65.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.964 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.83 0 CA-C-O 118.192 -1.338 . . . . 0.0 110.923 179.887 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 56.23 35.35 25.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.649 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.86 5.68 47.51 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.528 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.548 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.0 mp -62.57 -42.3 99.47 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.212 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -63.43 -39.93 95.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.163 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -63.76 -40.7 97.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.4 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 162' ' ' PHE . 65.2 t0 -61.94 -48.37 80.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.686 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.25 -45.36 93.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.487 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.96 -43.48 97.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.284 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.78 -45.02 82.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.816 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.22 -43.47 94.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.145 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.72 -52.56 64.59 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.706 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.8 pt -67.7 -39.75 82.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.163 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -57.58 -55.34 36.1 Favored 'General case' 0 C--O 1.215 -0.755 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.338 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 20' ' ' GLU . 95.4 t -60.15 -40.69 84.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.876 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.689 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.2 tt -51.61 -50.22 60.66 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.697 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -81.84 -51.51 8.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.993 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -63.63 -35.0 79.08 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.109 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 16' ' ' VAL . 97.1 mt-10 59.02 86.46 0.09 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.664 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.403 ' H ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -163.72 -134.81 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.982 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.504 HG21 ' NH2' ' A' ' 45' ' ' ARG . 6.1 p -140.22 140.36 35.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.439 HD12 ' O ' ' A' ' 24' ' ' ALA . 2.9 pp -129.87 165.82 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 120.852 0.358 . . . . 0.0 111.133 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.439 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -62.87 138.55 58.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.133 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.511 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 0.6 OUTLIER -131.19 141.59 42.43 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.363 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.511 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 91.2 Cg_endo -77.16 144.8 23.85 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.4 1.4 . . . . 0.0 111.892 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.471 ' C ' ' H ' ' A' ' 29' ' ' ALA . 79.4 m -135.85 135.09 39.5 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.32 0.581 . . . . 0.0 110.868 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -72.96 32.52 0.07 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.802 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.471 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -163.0 -75.73 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.833 0.349 . . . . 0.0 110.975 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.3 m -126.59 128.55 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.128 0.49 . . . . 0.0 110.229 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.519 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 80.3 m-85 -46.99 143.0 3.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.117 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -148.58 -169.15 15.12 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.8 m -133.33 169.37 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.404 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -156.98 -179.05 31.62 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.009 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.426 ' SG ' ' HB2' ' A' ' 42' ' ' ALA . 1.3 p -157.98 -165.73 1.8 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.6 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 7.0 p30 -89.65 107.68 20.29 Favored Pre-proline 0 CA--C 1.558 1.256 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -178.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -42.82 -60.78 0.66 Allowed 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.076 1.851 . . . . 0.0 112.633 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -77.63 70.65 4.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.427 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 54.9 m -156.57 144.01 19.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.619 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -71.1 -34.22 70.9 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.178 0.513 . . . . 0.0 111.158 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.443 HG22 ' H ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -60.52 -42.19 95.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.99 -178.719 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.426 ' HB2' ' SG ' ' A' ' 35' ' ' CYS . . . -57.88 -52.36 65.81 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 p -62.19 -42.6 95.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.147 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.9 mtt -64.65 -41.44 96.13 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.504 ' NH2' HG21 ' A' ' 22' ' ' VAL . 31.9 ttt-85 -60.4 -42.26 95.57 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-O 121.98 0.895 . . . . 0.0 108.916 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.457 ' O ' HD23 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -64.2 -53.47 48.74 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.664 -178.751 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.7 mt -71.03 -10.57 59.98 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.153 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -69.85 -82.35 0.04 OUTLIER 'General case' 0 N--CA 1.432 -1.354 0 CA-C-O 121.09 0.471 . . . . 0.0 110.924 -177.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.526 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -76.54 -35.57 58.19 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -76.51 -50.22 14.53 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.082 -177.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 35.76 65.09 0.44 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.012 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.428 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 7.1 mtm-85 178.82 -52.51 0.0 OUTLIER Pre-proline 0 CA--C 1.551 0.981 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.744 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.428 ' HD2' ' H ' ' A' ' 52' ' ' ARG . 85.6 Cg_endo -81.11 -2.81 11.92 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 123.008 2.472 . . . . 0.0 112.499 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.574 HG13 ' N ' ' A' ' 55' ' ' ASP . 8.7 p -44.61 -45.47 2.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.033 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.574 ' N ' HG13 ' A' ' 54' ' ' VAL . 41.7 t0 -64.13 -41.14 97.32 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.726 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -60.86 -35.33 76.31 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 59.19 102.26 0.01 OUTLIER Glycine 0 CA--C 1.52 0.36 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.572 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -48.73 -172.55 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.303 0.573 . . . . 0.0 112.205 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.6 mt -91.14 141.21 14.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.419 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.3 mt -118.88 145.74 45.47 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.423 ' O ' HG23 ' A' ' 61' ' ' ILE . 9.3 tp -113.38 127.68 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-O 121.203 0.525 . . . . 0.0 111.184 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.551 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -113.99 151.77 31.9 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.87 -28.16 8.17 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -115.69 148.55 39.6 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.316 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -77.16 -13.46 59.94 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -51.87 -32.45 32.22 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.262 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.28 -9.83 34.78 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.425 HD22 ' N ' ' A' ' 68' ' ' LEU . 4.3 mm? -92.18 -16.23 26.53 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.473 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 17.4 ttpp -78.07 -37.3 1.46 Allowed Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 67.5 Cg_endo -103.44 -3.23 0.27 Allowed 'Trans proline' 0 C--N 1.321 -0.921 0 C-N-CA 122.801 2.334 . . . . 0.0 111.873 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.524 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 42.0 t80 -91.73 -12.05 35.05 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.295 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.597 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.7 mp -123.2 163.43 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.597 ' N ' HG22 ' A' ' 72' ' ' ILE . 96.8 m-20 -63.43 -3.98 2.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.277 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 3.3 p30 45.01 22.85 0.07 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.883 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.555 HG23 ' N ' ' A' ' 76' ' ' MET . 8.9 t -88.72 -44.81 10.29 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.13 0.49 . . . . 0.0 109.827 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.555 ' N ' HG23 ' A' ' 75' ' ' THR . 18.2 ptp -80.63 -14.76 57.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.975 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 tp -79.0 134.12 36.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.701 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -158.61 161.04 37.18 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.972 -177.553 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -38.92 -48.93 1.63 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.768 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.5 p -63.26 -33.49 61.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.007 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.427 ' N ' ' O ' ' A' ' 78' ' ' THR . 62.8 tp60 -64.47 -39.47 93.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.944 0.402 . . . . 0.0 110.4 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -63.87 -53.12 55.55 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 122.517 1.151 . . . . 0.0 109.111 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.499 ' O ' ' N ' ' A' ' 87' ' ' SER . 80.8 tt0 -54.18 -50.37 67.19 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.989 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.4 m -61.48 -49.29 77.35 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.988 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 89' ' ' TRP . 8.7 tt -69.79 -31.24 47.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.574 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -80.14 -31.31 39.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.753 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 83' ' ' GLU . 53.2 m -90.1 -12.71 37.55 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.769 0.318 . . . . 0.0 111.201 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.446 ' O ' ' O ' ' A' ' 89' ' ' TRP . 62.0 ttm-85 -121.95 75.84 1.24 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.446 ' O ' ' O ' ' A' ' 88' ' ' ARG . 7.9 m-90 56.75 152.26 0.07 OUTLIER Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.377 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.24 -19.26 38.84 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.881 1.72 . . . . 0.0 111.673 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 159.56 81.05 0.04 OUTLIER Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -81.42 -9.77 12.38 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.492 2.128 . . . . 0.0 112.143 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.419 HG13 ' CE2' ' A' ' 95' ' ' PHE . 3.1 p -136.12 144.8 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.951 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.464 HG22 ' HB1' ' A' ' 115' ' ' ALA . 7.4 m -95.99 124.31 39.95 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.588 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 41.7 m-85 -113.09 143.03 45.04 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.401 -178.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.806 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 98.8 t -89.08 102.71 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 121.152 0.501 . . . . 0.0 111.393 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -90.08 146.82 35.77 Favored Pre-proline 0 N--CA 1.469 0.504 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.786 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -79.39 87.03 1.59 Allowed 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.241 1.961 . . . . 0.0 111.449 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -48.28 151.55 1.81 Allowed Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.91 144.58 88.54 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.091 1.861 . . . . 0.0 111.664 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -128.51 50.32 2.11 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.192 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.434 ' O ' ' OG1' ' A' ' 103' ' ' THR . 53.3 p -65.52 -35.49 81.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.338 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.703 ' H ' ' CD ' ' A' ' 104' ' ' PRO . 1.5 m -167.42 -37.77 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.703 ' CD ' ' H ' ' A' ' 103' ' ' THR . 24.8 Cg_exo -63.12 -168.58 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.515 2.143 . . . . 0.0 113.308 -177.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 109' ' ' GLY . 5.9 tpt180 -176.49 -7.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.489 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 66.7 p-90 -79.1 -11.59 59.99 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.665 0.745 . . . . 0.0 109.404 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.631 ' H ' ' CD2' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -76.58 -16.45 59.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.811 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.409 ' H ' HD23 ' A' ' 107' ' ' LEU . 94.8 m -142.93 -40.96 0.32 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.356 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 91.9 -13.4 66.96 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 119.863 -0.41 . . . . 0.0 112.896 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.451 ' O ' ' CZ ' ' A' ' 105' ' ' ARG . 13.5 tpt180 -148.01 -80.43 0.14 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.883 0.842 . . . . 0.0 111.226 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -90.95 -174.83 4.15 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -124.35 61.18 1.13 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.083 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.0 p -168.14 151.78 5.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.193 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 pp -169.34 147.58 3.71 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.464 ' HB1' HG22 ' A' ' 94' ' ' THR . . . -64.27 134.94 55.71 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 113.76 -1.564 . . . . 0.0 109.635 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.47 HG22 ' N ' ' A' ' 117' ' ' ARG . 6.6 p -147.98 160.06 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.47 ' N ' HG22 ' A' ' 116' ' ' VAL . 62.5 ttp180 -145.53 154.64 42.42 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.907 0.384 . . . . 0.0 111.425 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.551 HG22 ' HB3' ' A' ' 62' ' ' ALA . 48.3 t -123.0 136.07 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.9 t -138.38 150.25 46.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.178 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 50.7 p-10 -153.7 84.9 1.17 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.923 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.657 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 8.5 t-80 -171.52 -36.58 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.292 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.657 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 60.9 Cg_endo -95.15 -159.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.949 0 C-N-CA 121.879 1.719 . . . . 0.0 112.032 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.7 mt -78.79 -5.79 54.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.372 0.606 . . . . 0.0 110.459 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 87.8 t -58.1 -44.77 88.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.787 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.774 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.1 m -53.35 -62.57 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.922 0 C-N-CA 119.269 -0.972 . . . . 0.0 108.883 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.774 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.29 -43.82 2.54 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 120.831 0.348 . . . . 0.0 111.152 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.409 HD23 HD22 ' A' ' 135' ' ' LEU . 41.1 tp -69.04 -48.77 62.01 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.998 0.428 . . . . 0.0 111.224 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 75.4 m -70.26 -48.38 57.1 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.373 0.606 . . . . 0.0 110.991 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.46 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.1 pp0? -55.03 -42.26 72.38 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -57.87 -57.22 13.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.665 -178.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -62.47 -26.46 68.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.385 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.92 -2.44 88.25 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' A' ' 134' ' ' PRO . 25.0 mmtm -142.91 155.78 62.5 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 117.137 0.469 . . . . 0.0 110.043 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 133' ' ' LYS . 6.0 Cg_exo -41.34 175.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 123.604 2.869 . . . . 0.0 112.984 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.409 HD22 HD23 ' A' ' 127' ' ' LEU . 8.1 tp -128.59 122.96 32.15 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 177.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.426 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -66.11 142.67 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.9 0 C-N-CA 117.762 -1.575 . . . . 0.0 107.256 -179.712 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 t -111.69 118.91 36.93 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 123.802 0.688 . . . . 0.0 110.88 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.465 ' CB ' HH22 ' A' ' 45' ' ' ARG . 18.8 m -127.72 150.55 49.73 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.756 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 140' ' ' ALA . 24.7 m -64.59 149.21 49.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.491 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.436 ' O ' ' O ' ' A' ' 139' ' ' SER . . . -53.78 -164.09 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.997 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.431 ' O ' ' O ' ' A' ' 140' ' ' ALA . 6.7 p30 53.37 156.98 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.702 0.763 . . . . 0.0 111.687 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.07 -147.15 0.37 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.185 -178.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.4 p -63.15 -39.32 94.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.058 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.426 ' H ' ' H ' ' A' ' 145' ' ' LEU . . . -161.78 -2.4 0.05 OUTLIER Glycine 0 N--CA 1.457 0.059 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.426 ' H ' ' H ' ' A' ' 144' ' ' GLY . 11.7 tp -71.71 128.68 89.36 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 119.355 -0.355 . . . . 0.0 110.358 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 145' ' ' LEU . 26.2 Cg_exo -35.25 157.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.295 1.996 . . . . 0.0 112.451 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.98 -163.62 0.13 Allowed 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.291 1.994 . . . . 0.0 112.508 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 27.3 m -132.14 69.48 1.48 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.966 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.519 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 17.3 ptm180 -56.96 -36.47 70.34 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.581 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.85 168.79 23.98 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.418 HG11 ' HA ' ' A' ' 166' ' ' PRO . 1.7 m -59.4 -17.7 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 CA-C-O 121.612 0.72 . . . . 0.0 109.553 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -65.62 -35.19 80.07 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.432 ' OE1' ' OE1' ' A' ' 157' ' ' GLN . 5.8 tm-20 -60.11 -73.78 0.08 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.895 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.427 HG11 HG11 ' A' ' 164' ' ' VAL . 7.3 p -45.51 -30.03 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.016 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.06 -43.34 15.2 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 122.214 1.007 . . . . 0.0 110.007 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.9 -42.26 89.17 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 122.518 1.151 . . . . 0.0 109.265 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.471 ' CG ' ' N ' ' A' ' 158' ' ' PHE . 8.0 pt20 -80.74 -49.61 10.94 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 112.974 -1.921 . . . . 0.0 112.042 -177.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.471 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 39.6 t80 -106.07 -37.24 6.68 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -177.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 98.88 25.3 9.82 Favored Glycine 0 N--CA 1.473 1.11 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 161' ' ' ALA . . . -43.87 -97.27 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.561 0.219 . . . . 0.0 111.091 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.473 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 64.95 36.55 7.52 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.199 0.523 . . . . 0.0 109.899 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.547 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.5 m-85 -177.74 -61.24 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.182 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.25 29.06 0.3 Allowed 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 122.447 2.098 . . . . 0.0 110.556 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.57 HG23 ' HD3' ' A' ' 166' ' ' PRO . 16.0 m -132.65 167.37 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.215 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 9.0 t -123.49 65.13 31.34 Favored Pre-proline 0 N--CA 1.476 0.844 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.848 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.57 ' HD3' HG23 ' A' ' 164' ' ' VAL . 31.7 Cg_exo -36.54 141.39 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 123.77 2.98 . . . . 0.0 115.045 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 163.27 -161.59 34.13 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 113.761 -1.563 . . . . 0.0 110.972 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -147.49 175.39 10.87 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.982 0.42 . . . . 0.0 110.193 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.4 t -145.96 156.37 43.47 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.035 0.445 . . . . 0.0 110.509 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -52.36 -66.73 2.45 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.626 -0.989 . . . . 0.0 110.626 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 129.22 4.61 4.95 Favored Glycine 0 N--CA 1.469 0.87 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -83.95 133.64 34.69 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.89 0.376 . . . . 0.0 110.251 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.589 ' N ' HD12 ' A' ' 173' ' ' LEU . 9.2 mp -85.95 167.23 15.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.452 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.56 ' N ' ' CD ' ' A' ' 175' ' ' PRO . 3.6 m120 71.22 44.36 0.22 Allowed Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.444 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 174' ' ' ASN . 56.5 Cg_endo -66.56 -22.45 51.2 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 122.751 2.301 . . . . 0.0 111.364 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 41.2 t -166.11 129.14 2.02 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.687 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -99.11 150.37 22.09 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.277 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 13.1 tt -94.89 130.37 43.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.435 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -133.19 168.65 18.16 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.51 0.671 . . . . 0.0 111.574 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -87.25 108.05 18.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.165 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.806 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -72.93 -14.3 61.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.239 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.498 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.6 mm? -64.91 -42.02 95.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.989 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.22 -43.66 4.54 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.058 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 67.08 24.25 73.18 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -66.33 138.69 57.79 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.385 0.612 . . . . 0.0 111.034 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.5 ' H ' ' CD2' ' A' ' 186' ' ' LEU . 0.7 OUTLIER -74.18 177.28 5.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.496 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 187' ' ' PHE . . . . . 0.425 ' O ' ' CD2' ' A' ' 187' ' ' PHE . 88.6 t80 -103.64 73.35 1.18 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.625 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.94 143.57 50.21 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.503 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -147.92 144.65 28.21 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.09 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.73 0 CA-C-O 117.973 -1.459 . . . . 0.0 111.043 -179.98 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 61.1 t30 56.78 40.0 29.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.754 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -98.48 9.43 43.19 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.547 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.533 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.5 mp -62.46 -42.62 99.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.21 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -61.49 -40.42 94.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.934 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -64.16 -41.5 97.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.14 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -59.24 -45.78 90.23 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.198 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.42 -45.61 92.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.045 0.45 . . . . 0.0 110.424 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.5 -42.44 96.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.29 -44.69 84.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.382 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.09 -42.76 99.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.086 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.06 -52.33 65.83 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.898 0.38 . . . . 0.0 111.825 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.41 HG21 HD13 ' A' ' 14' ' ' ILE . 18.8 pt -68.58 -37.48 77.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.091 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -58.6 -51.19 70.97 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 120.281 -0.567 . . . . 0.0 110.047 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 21' ' ' ARG . 88.6 t -63.86 -38.37 82.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.007 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.68 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.3 tt -52.77 -50.58 63.25 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.439 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -79.59 -47.94 14.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.21 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -67.19 -31.97 72.73 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.831 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.46 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.7 mt-10 58.22 56.6 4.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.271 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.557 ' O ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -149.88 158.51 44.24 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.591 0.71 . . . . 0.0 110.588 178.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 34' ' ' GLY . 7.8 p -74.29 137.67 22.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.799 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.507 HG22 ' NH2' ' A' ' 21' ' ' ARG . 2.9 pp -124.58 168.25 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-O 120.587 0.232 . . . . 0.0 110.534 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.416 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -63.74 134.82 56.0 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.191 0.519 . . . . 0.0 111.023 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.532 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 0.6 OUTLIER -125.48 141.5 39.12 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.706 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.532 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 60.5 Cg_endo -80.23 151.91 20.78 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.709 1.606 . . . . 0.0 111.235 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.445 ' C ' ' H ' ' A' ' 29' ' ' ALA . 47.8 m -133.36 140.72 47.54 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.372 0.606 . . . . 0.0 111.108 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -77.51 23.06 0.23 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.132 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.445 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -160.53 -70.77 0.07 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.194 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.7 p -126.97 125.63 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-O 121.109 0.48 . . . . 0.0 110.34 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.531 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 96.7 m-85 -45.48 150.39 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.668 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -160.99 -169.07 23.74 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.2 m -130.45 170.13 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.532 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -159.25 177.77 35.66 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.686 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -155.45 -164.83 1.84 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 120.433 -0.507 . . . . 0.0 112.122 -178.52 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.467 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 23.6 m-20 -90.86 106.27 15.06 Favored Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -177.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -34.92 -62.35 0.21 Allowed 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 122.461 2.107 . . . . 0.0 112.716 178.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 56.7 p-10 -74.31 67.51 1.41 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.103 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.3 m -157.07 133.05 9.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.159 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -66.14 -20.55 66.18 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.307 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.4 t -60.08 -34.76 73.89 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.932 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.71 -52.2 66.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.874 0.368 . . . . 0.0 111.575 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 43' ' ' VAL . 2.5 p -64.61 -45.77 94.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.929 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 63.0 mtt -67.51 -46.89 71.58 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.442 ' NH2' ' OG1' ' A' ' 138' ' ' THR . 40.7 ptt85 -63.02 -30.38 71.55 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.829 0.347 . . . . 0.0 110.221 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.7 mt -73.48 -60.91 2.03 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.269 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.0 mt -54.34 -20.5 7.36 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.449 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -63.47 -86.12 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.543 -178.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.526 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.2 pt? -78.68 -34.35 46.29 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -74.92 -50.67 16.03 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.916 -176.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 37.19 64.7 0.58 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.985 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.403 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 6.3 mtt180 179.0 -54.0 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.856 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.455 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.403 ' HD2' ' H ' ' A' ' 52' ' ' ARG . 69.8 Cg_endo -75.61 -8.27 19.24 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.323 2.015 . . . . 0.0 111.493 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.575 HG13 ' N ' ' A' ' 55' ' ' ASP . 10.8 p -46.71 -43.9 6.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.254 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.575 ' N ' HG13 ' A' ' 54' ' ' VAL . 11.1 t0 -70.59 -44.58 67.04 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.198 -178.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -61.27 -38.3 86.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.6 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 74.77 101.9 0.1 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.572 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -50.92 -167.55 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.092 0.472 . . . . 0.0 112.231 -179.658 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.445 ' O ' ' OG ' ' A' ' 137' ' ' SER . 77.2 mt -100.67 135.29 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.143 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 16.0 mt -112.43 144.51 41.77 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.5 tt -114.53 129.77 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 CA-C-O 121.445 0.64 . . . . 0.0 110.88 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.552 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -116.79 155.09 29.55 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.579 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.97 -30.08 6.15 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -112.46 150.01 31.81 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.135 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -76.77 -21.97 54.42 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.707 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.458 ' HG3' HE21 ' A' ' 67' ' ' GLN . 22.3 pt-20 -50.96 -30.31 14.59 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.875 -178.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.458 HE21 ' HG3' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -93.82 -6.13 46.58 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.823 -0.172 . . . . 0.0 111.431 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -89.79 -21.69 22.49 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.452 ' NZ ' ' CB ' ' A' ' 69' ' ' LYS . 8.0 mtpm? -73.76 -38.27 3.87 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -178.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 94.6 Cg_endo -101.75 -5.01 0.35 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.628 2.219 . . . . 0.0 111.986 -179.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -87.81 -18.96 28.18 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.772 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.623 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.1 mp -119.27 166.93 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.623 ' N ' HG22 ' A' ' 72' ' ' ILE . 97.8 m-20 -61.75 -14.39 31.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.329 . . . . 0.0 111.054 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 41.1 t0 59.54 32.67 21.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.86 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.538 HG23 ' N ' ' A' ' 76' ' ' MET . 14.1 t -105.14 -42.38 5.31 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.903 0.382 . . . . 0.0 110.476 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.538 ' N ' HG23 ' A' ' 75' ' ' THR . 21.0 ptm -88.78 -23.37 22.9 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.366 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.531 HD21 ' NH2' ' A' ' 82' ' ' ARG . 30.3 tp -67.65 133.08 48.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.124 -177.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.95 170.26 19.25 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.577 -176.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -59.94 -42.11 93.29 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 123.364 0.415 . . . . 0.0 111.389 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.1 p -60.63 -33.27 54.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.42 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -63.23 -41.17 99.06 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.113 0.482 . . . . 0.0 110.358 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.531 ' NH2' HD21 ' A' ' 77' ' ' LEU . 7.5 mmt85 -63.94 -52.11 61.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.479 1.133 . . . . 0.0 109.117 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -55.69 -50.04 71.36 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.798 -1.547 . . . . 0.0 110.028 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.2 m -61.18 -49.92 75.22 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.47 -1.241 . . . . 0.0 112.091 -178.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 85' ' ' ILE . 9.1 tt -68.25 -30.12 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.696 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -78.4 -37.3 44.29 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.759 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.2 m -84.72 -10.64 57.07 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.722 0.296 . . . . 0.0 111.166 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.442 ' O ' ' O ' ' A' ' 89' ' ' TRP . 62.0 ttm-85 -122.61 83.64 2.14 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.442 ' O ' ' O ' ' A' ' 88' ' ' ARG . 14.6 m95 57.68 150.33 0.07 OUTLIER Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.231 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.415 ' O ' ' O ' ' A' ' 118' ' ' VAL . 55.8 Cg_endo -68.01 -23.35 40.49 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.203 1.935 . . . . 0.0 111.973 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 159.1 80.65 0.03 OUTLIER Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.74 -24.2 7.49 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 122.163 1.909 . . . . 0.0 112.395 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.409 HG13 ' CZ ' ' A' ' 95' ' ' PHE . 3.5 p -137.04 146.56 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 120.783 0.325 . . . . 0.0 110.474 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 53.8 m -89.71 149.7 22.64 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.845 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.454 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 83.2 m-85 -128.0 144.78 51.11 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.202 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.657 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.5 t -102.05 108.67 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-O 121.34 0.59 . . . . 0.0 110.46 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -94.98 150.37 37.64 Favored Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.898 -178.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.21 89.44 0.39 Allowed 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.265 1.977 . . . . 0.0 111.47 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.93 149.71 80.19 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.138 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -72.14 157.34 54.26 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.207 1.938 . . . . 0.0 111.992 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -139.73 87.69 2.19 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.837 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.405 ' O ' ' OG1' ' A' ' 103' ' ' THR . 21.2 p -62.68 -43.53 98.57 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.099 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.682 ' H ' ' CD ' ' A' ' 104' ' ' PRO . 0.6 OUTLIER -168.43 -39.57 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.682 ' CD ' ' H ' ' A' ' 103' ' ' THR . 12.5 Cg_exo -67.8 -167.2 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.386 2.057 . . . . 0.0 112.996 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 109' ' ' GLY . 23.7 mmt180 -144.53 -11.62 0.61 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.68 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 2.0 p90 -66.73 -10.76 50.32 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.949 -0.301 . . . . 0.0 111.593 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 1.049 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -67.23 -39.8 86.25 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.798 ' H ' HD22 ' A' ' 107' ' ' LEU . 16.6 m -145.99 -39.92 0.22 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.65 177.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 58.53 -12.01 0.02 OUTLIER Glycine 0 CA--C 1.532 1.126 0 CA-C-N 115.711 -0.677 . . . . 0.0 113.29 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.557 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -86.54 -51.51 6.13 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 117.714 0.757 . . . . 0.0 109.446 -179.437 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.452 ' CD2' ' N ' ' A' ' 112' ' ' ASP . 85.4 t80 -160.18 -95.34 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.019 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.452 ' N ' ' CD2' ' A' ' 111' ' ' PHE . 35.8 t70 -171.01 67.96 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.541 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.5 p -166.77 129.36 1.81 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.742 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.647 HD21 ' OG1' ' A' ' 108' ' ' THR . 87.2 mt -126.41 128.01 46.34 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.476 ' N ' HG13 ' A' ' 96' ' ' VAL . . . -69.67 119.69 14.29 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.344 176.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.468 HG22 ' N ' ' A' ' 117' ' ' ARG . 5.4 p -145.96 158.49 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.468 ' N ' HG22 ' A' ' 116' ' ' VAL . 33.5 ptt180 -151.57 160.81 43.51 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.745 0.307 . . . . 0.0 110.983 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.552 HG22 ' HB3' ' A' ' 62' ' ' ALA . 55.9 t -123.44 137.75 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.1 t -128.65 157.44 41.3 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.304 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 5.8 p30 -158.74 77.97 0.77 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.134 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.637 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 56.9 t-80 -172.62 -35.81 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.637 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 37.3 Cg_endo -94.44 -163.33 0.09 OUTLIER 'Trans proline' 0 N--CA 1.485 0.981 0 C-N-CA 121.973 1.782 . . . . 0.0 111.991 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 36.5 mt -78.22 -4.39 47.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.511 0.672 . . . . 0.0 109.908 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 93.4 t -58.35 -44.93 89.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.061 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.77 HG23 ' H ' ' A' ' 126' ' ' ALA . 30.8 m -54.24 -62.52 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 C-N-CA 119.538 -0.865 . . . . 0.0 108.727 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.77 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.6 -43.27 2.7 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.021 0.439 . . . . 0.0 110.657 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.9 tp -69.28 -48.87 60.45 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.828 0.347 . . . . 0.0 111.455 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 80.3 m -70.46 -48.42 55.94 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.365 0.602 . . . . 0.0 110.851 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.477 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -54.72 -43.27 72.45 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.73 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -59.02 -55.21 38.08 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.235 -1.348 . . . . 0.0 109.459 -178.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -61.84 -21.84 64.98 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 114.545 -1.207 . . . . 0.0 109.151 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.54 0.69 84.83 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -151.52 158.72 34.16 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -43.8 174.16 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 123.697 2.931 . . . . 0.0 113.722 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.5 tp -128.63 123.13 32.48 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.421 HG13 ' H ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -66.12 144.34 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 C-N-CA 118.353 -1.339 . . . . 0.0 108.049 -179.674 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -110.01 120.14 41.51 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.305 1.003 . . . . 0.0 110.876 -179.179 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.442 ' OG1' ' NH2' ' A' ' 45' ' ' ARG . 2.4 m -134.11 160.06 38.94 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.898 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.5 m -72.11 142.44 49.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.882 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.88 -36.32 83.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.813 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' A' ' 141' ' ' ASN . 56.9 p30 -46.97 150.04 0.81 Allowed 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.959 0.885 . . . . 0.0 111.255 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.4 -161.55 0.89 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.211 -1.359 . . . . 0.0 110.569 -178.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.2 p -62.02 -39.81 93.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.297 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -164.9 9.24 0.07 OUTLIER Glycine 0 C--N 1.33 0.224 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.3 tp -91.65 127.89 48.54 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-O 119.355 -0.355 . . . . 0.0 110.186 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -38.61 156.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 121.648 1.565 . . . . 0.0 112.276 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -76.54 -167.01 0.41 Allowed 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.773 2.316 . . . . 0.0 112.524 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 83.3 m -111.48 74.33 0.86 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.461 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.531 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 38.0 ptt180 -51.84 -37.54 52.33 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.432 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.422 ' O ' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -159.87 168.08 26.62 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.763 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.41 HG11 ' HA ' ' A' ' 166' ' ' PRO . 1.1 m -57.88 -21.65 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.83 -30.58 71.66 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 155' ' ' ARG . 6.7 tm-20 -63.73 -79.85 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.534 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.0 p -36.45 -30.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.082 0.953 . . . . 0.0 110.971 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.466 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -70.68 -51.68 26.12 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.518 -179.351 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.09 -17.54 62.58 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 122.451 1.119 . . . . 0.0 108.024 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -83.77 -47.82 10.75 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 112.705 -2.043 . . . . 0.0 111.794 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -130.58 -19.92 2.97 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 85.82 26.15 35.84 Favored Glycine 0 N--CA 1.468 0.823 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.4 ' O ' ' O ' ' A' ' 159' ' ' GLY . . . -43.64 -95.9 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.587 0.232 . . . . 0.0 111.195 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.467 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 63.43 35.43 12.1 Favored 'General case' 0 CA--C 1.527 0.09 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.546 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.6 m-85 -175.47 -61.9 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.153 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.49 27.35 0.31 Allowed 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.298 1.999 . . . . 0.0 110.751 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.558 HG23 ' HD3' ' A' ' 166' ' ' PRO . 14.9 m -129.45 167.64 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.805 -178.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.0 t -123.16 64.53 26.31 Favored Pre-proline 0 N--CA 1.472 0.668 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.831 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.558 ' HD3' HG23 ' A' ' 164' ' ' VAL . 36.5 Cg_exo -37.65 144.27 0.15 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 123.291 2.66 . . . . 0.0 114.823 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -175.22 -158.25 18.67 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 114.101 -1.409 . . . . 0.0 111.472 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -141.92 -154.42 0.52 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.735 0.302 . . . . 0.0 110.527 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.539 ' OG1' ' N ' ' A' ' 170' ' ' GLY . 1.6 t -150.05 -122.21 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.511 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.539 ' N ' ' OG1' ' A' ' 169' ' ' THR . . . 84.44 15.81 67.88 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -149.54 51.12 0.54 Allowed Glycine 0 N--CA 1.467 0.706 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 76.8 mtm-85 -97.29 9.93 40.92 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.803 0.335 . . . . 0.0 110.336 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.552 ' N ' HD12 ' A' ' 173' ' ' LEU . 8.5 mp -61.36 -46.17 91.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.872 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -74.41 112.51 17.53 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.008 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.99 156.47 26.67 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.796 1.664 . . . . 0.0 111.629 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 48.3 m -107.54 121.2 44.17 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.35 0.595 . . . . 0.0 110.608 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -132.71 172.94 11.9 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.726 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 39.0 pt -117.61 142.88 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.917 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -131.26 166.19 21.72 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.462 0.649 . . . . 0.0 111.654 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 184' ' ' GLY . 97.6 m-20 -78.55 106.48 10.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.679 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -65.86 -18.01 65.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.739 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.508 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.4 mm? -63.15 -41.72 99.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.221 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.43 -41.12 2.62 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.69 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 180' ' ' ASP . . . 61.55 28.92 70.49 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -80.38 158.34 26.04 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.205 0.526 . . . . 0.0 111.368 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.504 HD23 ' N ' ' A' ' 186' ' ' LEU . 0.8 OUTLIER -70.81 178.06 3.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.412 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -108.7 75.45 0.97 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.143 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 13.8 tpp85 -70.07 139.31 52.58 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 120.912 0.387 . . . . 0.0 109.997 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -174.0 -20.72 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.294 177.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.81 0 CA-C-O 118.265 -1.297 . . . . 0.0 111.114 179.818 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 57.9 p30 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -63.77 -40.68 97.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.526 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -156.51 18.91 0.34 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.78 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.525 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.7 mp -63.03 -42.75 99.86 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -64.58 -40.75 96.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.744 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 61.8 ttt85 -63.01 -41.74 99.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.166 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.7 -44.07 96.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.448 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.45 -44.52 94.27 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.166 0.508 . . . . 0.0 109.918 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.9 mt -63.52 -42.58 96.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.357 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.48 -41.09 80.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.329 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.76 -43.9 91.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.935 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.09 -53.08 62.01 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 17.6 pt -68.2 -36.94 77.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.806 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -58.06 -50.03 74.85 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.613 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.529 HG13 ' O ' ' A' ' 21' ' ' ARG . 90.8 t -64.59 -38.66 83.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.946 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.68 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.5 tt -52.7 -51.02 62.12 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.287 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -78.34 -47.97 16.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.402 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -67.83 -31.36 71.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.951 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.6 mt-10 57.54 57.64 4.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.182 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.529 ' O ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -151.15 159.17 44.61 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.582 0.706 . . . . 0.0 110.336 179.088 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 34' ' ' GLY . 8.9 p -74.08 140.17 18.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.452 -178.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.507 HG22 ' NH2' ' A' ' 21' ' ' ARG . 2.8 pp -126.69 166.43 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-O 120.879 0.371 . . . . 0.0 110.927 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.422 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -63.85 137.9 58.24 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.332 0.587 . . . . 0.0 111.008 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.53 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 0.4 OUTLIER -130.52 141.86 43.44 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.123 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.53 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 58.3 Cg_endo -79.38 146.79 19.79 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 121.451 1.434 . . . . 0.0 111.682 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.506 ' C ' ' H ' ' A' ' 29' ' ' ALA . 33.7 m -130.02 133.42 46.73 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.905 0.383 . . . . 0.0 110.931 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -74.53 25.26 0.08 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.152 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.506 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -157.3 -74.43 0.09 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.001 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.3 t -124.93 125.51 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-O 120.894 0.378 . . . . 0.0 110.313 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -44.37 139.24 2.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.934 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -149.44 -172.28 18.87 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.5 m -130.06 169.98 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.439 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -158.5 178.98 34.49 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.757 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.55 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -154.53 -162.97 1.49 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.819 0.342 . . . . 0.0 111.393 -178.8 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.55 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 5.7 m-20 -97.82 107.34 39.64 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -177.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 36' ' ' ASP . 38.6 Cg_exo -37.86 173.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 123.074 2.516 . . . . 0.0 114.215 177.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 66.7 t0 35.66 76.39 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.492 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.0 m -152.73 139.03 18.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.336 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -70.12 -34.3 72.92 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.244 0.545 . . . . 0.0 110.74 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 41' ' ' THR . 0.1 OUTLIER -64.32 -44.39 91.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.86 -178.853 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.63 -50.61 71.85 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.515 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.6 p -62.58 -44.51 99.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.177 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 90.7 mtp -64.0 -40.02 95.43 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.4 ' O ' ' CD2' ' A' ' 49' ' ' LEU . 56.0 ttt85 -61.68 -33.02 73.25 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.341 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 85.8 mt -75.04 -60.81 2.12 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.6 mt -53.56 -18.35 2.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.56 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -66.83 -86.15 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -178.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.505 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.2 pt? -76.82 -34.34 57.91 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -75.03 -49.69 18.96 Favored 'General case' 0 C--N 1.345 0.409 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.56 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 35.62 64.81 0.45 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.855 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.407 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 8.1 mtt180 179.29 -53.35 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.902 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.497 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.407 ' HD2' ' H ' ' A' ' 52' ' ' ARG . 60.1 Cg_endo -74.74 -8.79 20.7 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.399 2.066 . . . . 0.0 112.267 -179.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.546 HG13 ' N ' ' A' ' 55' ' ' ASP . 7.5 p -41.52 -48.17 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.809 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.546 ' N ' HG13 ' A' ' 54' ' ' VAL . 33.9 t0 -69.39 -38.71 78.11 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.547 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.481 ' CD ' ' N ' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -59.78 -39.26 84.31 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.767 -179.092 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 59.62 104.69 0.01 OUTLIER Glycine 0 CA--C 1.518 0.247 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.568 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -52.53 -161.3 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.615 0.721 . . . . 0.0 111.735 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.0 mt -108.41 146.77 13.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.912 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.7 mt -119.55 141.24 49.42 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.448 ' CD1' ' HE ' ' A' ' 117' ' ' ARG . 8.0 tp -108.96 131.68 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-O 121.222 0.534 . . . . 0.0 110.569 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.472 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -118.81 153.25 34.78 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.385 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.29 -26.93 7.79 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -117.46 151.17 37.64 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.823 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -78.99 -13.42 59.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.511 0.672 . . . . 0.0 109.346 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -51.14 -30.26 16.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.843 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.487 HE21 ' N ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -94.82 -13.62 25.4 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.562 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 68' ' ' LEU . 4.2 mm? -92.36 -13.67 29.83 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.479 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 79.0 tttt -80.08 -37.79 1.11 Allowed Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 68.6 Cg_endo -102.59 -3.64 0.32 Allowed 'Trans proline' 0 C--N 1.316 -1.169 0 C-N-CA 122.812 2.341 . . . . 0.0 111.564 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.508 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 42.9 t80 -93.07 -13.13 28.97 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.365 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.472 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.7 mp -125.75 155.1 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.472 ' N ' HG22 ' A' ' 72' ' ' ILE . 84.3 m-20 -64.41 153.02 39.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.063 0.459 . . . . 0.0 110.114 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 66.5 t0 -96.22 46.03 1.07 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.308 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.492 HG23 ' N ' ' A' ' 76' ' ' MET . 10.9 t -115.83 -40.08 3.39 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.269 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.492 ' N ' HG23 ' A' ' 75' ' ' THR . 13.6 ptm -95.55 -24.41 16.63 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.217 0.532 . . . . 0.0 110.224 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.571 HD21 ' NH2' ' A' ' 82' ' ' ARG . 30.8 tp -80.09 134.98 36.23 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.436 -178.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.07 169.74 19.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.708 -177.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.36 -41.92 94.7 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.367 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.46 -33.39 56.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.115 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -63.24 -40.39 97.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.068 0.461 . . . . 0.0 110.569 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.571 ' NH2' HD21 ' A' ' 77' ' ' LEU . 7.5 mmt85 -64.17 -52.03 60.96 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 122.655 1.217 . . . . 0.0 109.02 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 87' ' ' SER . 82.6 tt0 -56.68 -50.42 72.18 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.618 -1.628 . . . . 0.0 110.372 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.2 m -62.41 -49.47 75.35 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.349 -1.296 . . . . 0.0 112.232 -177.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.8 tt -67.46 -25.31 33.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.325 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -86.47 -32.6 20.73 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.241 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 83' ' ' GLU . 6.7 m -88.52 -20.24 25.35 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.293 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.442 ' O ' ' O ' ' A' ' 89' ' ' TRP . 70.2 ttt180 -116.19 82.26 1.75 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.668 0.27 . . . . 0.0 110.636 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.442 ' O ' ' O ' ' A' ' 88' ' ' ARG . 3.9 m-90 56.56 151.82 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.828 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.4 -17.82 44.07 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.058 1.839 . . . . 0.0 111.449 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.459 ' H ' ' HD3' ' A' ' 92' ' ' PRO . . . 99.26 69.71 0.93 Allowed Glycine 0 N--CA 1.471 0.972 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.459 ' HD3' ' H ' ' A' ' 91' ' ' GLY . 51.9 Cg_exo -55.52 -38.55 93.95 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.893 2.396 . . . . 0.0 112.307 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.7 p -73.92 136.15 25.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.322 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 56.1 m -88.92 144.23 26.33 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.821 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.42 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 55.8 m-85 -126.94 144.55 50.97 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.227 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.623 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.5 t -99.91 103.4 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 121.296 0.569 . . . . 0.0 109.475 178.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -87.77 148.21 43.13 Favored Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.815 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.9 101.66 1.51 Allowed 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.651 1.567 . . . . 0.0 110.948 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.38 150.53 79.95 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.896 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.436 ' O ' ' OG1' ' A' ' 103' ' ' THR . 79.2 Cg_endo -71.53 152.11 59.57 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.222 1.948 . . . . 0.0 112.406 -179.334 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.61 -35.52 81.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.037 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 81.9 p -55.66 -42.52 75.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.485 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.478 ' O ' ' O ' ' A' ' 104' ' ' PRO . 4.7 p -61.94 155.69 61.55 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 103' ' ' THR . 78.1 Cg_exo -47.89 -160.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.944 0 C-N-CA 122.577 2.185 . . . . 0.0 113.707 178.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.506 HH22 ' C ' ' A' ' 111' ' ' PHE . 7.1 tpt85 -140.37 0.1 1.65 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.441 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 43.4 m95 -77.26 -2.97 37.45 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 120.839 0.352 . . . . 0.0 110.517 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.934 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -82.44 -19.6 38.64 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.537 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.64 ' H ' HD22 ' A' ' 107' ' ' LEU . 51.3 m -142.74 -41.53 0.32 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.435 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 64.81 24.06 69.62 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.453 178.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.93 -75.22 0.11 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 117.54 0.67 . . . . 0.0 110.527 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.506 ' C ' HH22 ' A' ' 105' ' ' ARG . 72.2 m-85 -113.63 159.5 19.58 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.018 0.437 . . . . 0.0 110.312 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -93.06 76.82 4.68 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.284 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.828 ' C ' HD22 ' A' ' 114' ' ' LEU . 19.5 p -163.57 128.85 3.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.967 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.828 HD22 ' C ' ' A' ' 113' ' ' SER . 3.7 mm? -134.04 128.26 33.94 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -178.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.462 ' N ' HG13 ' A' ' 96' ' ' VAL . . . -69.83 124.14 23.25 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 113.815 -1.539 . . . . 0.0 109.333 176.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.3 p -144.21 152.27 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.881 0.372 . . . . 0.0 110.783 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.448 ' HE ' ' CD1' ' A' ' 61' ' ' ILE . 62.2 ttp180 -140.58 153.81 46.25 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.682 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.472 HG22 ' HB3' ' A' ' 62' ' ' ALA . 56.0 t -121.91 134.05 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 7.9 t -134.02 153.28 51.89 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.215 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 51.2 p-10 -153.72 82.99 1.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.075 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.635 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 40.7 t60 -172.47 -37.36 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.635 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 40.7 Cg_endo -94.15 -161.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -0.977 0 C-N-CA 122.122 1.881 . . . . 0.0 112.156 -178.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 27.4 mt -79.04 -4.97 52.8 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.929 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 95.0 t -58.15 -45.03 88.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.915 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.777 HG23 ' H ' ' A' ' 126' ' ' ALA . 30.3 m -54.1 -62.54 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.847 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.777 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.41 -44.13 2.75 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 120.936 0.398 . . . . 0.0 110.819 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.5 tp -68.83 -48.32 63.8 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.469 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 61.8 m -70.66 -49.04 51.62 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.431 0.634 . . . . 0.0 110.835 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.472 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.1 pp0? -54.62 -41.93 70.57 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -59.5 -54.37 47.43 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.049 -177.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.499 ' CE1' ' OD2' ' A' ' 36' ' ' ASP . 41.4 t80 -61.78 -20.42 63.57 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.321 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.73 -1.14 84.53 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.412 ' O ' ' O ' ' A' ' 134' ' ' PRO . 33.3 mttm -151.65 159.64 32.94 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.412 ' O ' ' O ' ' A' ' 133' ' ' LYS . 4.1 Cg_exo -42.24 177.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 123.858 3.039 . . . . 0.0 112.933 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.4 tp -131.43 123.58 28.44 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.413 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -65.41 145.87 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 C-N-CA 117.927 -1.509 . . . . 0.0 107.329 -179.562 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t -118.28 121.93 41.64 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 123.408 0.443 . . . . 0.0 111.191 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.2 m -129.77 162.03 29.36 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.255 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 17.7 m -72.04 145.57 48.19 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.93 81.19 1.67 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.694 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 57.6 p30 -158.7 164.71 35.66 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.335 0.588 . . . . 0.0 110.581 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.15 -163.4 1.47 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.186 -178.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 38.8 t -61.27 -44.25 97.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.676 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -159.71 4.9 0.11 Allowed Glycine 0 N--CA 1.46 0.28 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.5 tp -82.04 127.05 73.3 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -38.95 156.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.621 1.548 . . . . 0.0 112.271 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -75.71 -167.21 0.41 Allowed 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.352 2.035 . . . . 0.0 112.316 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 8.7 t -114.81 77.97 1.12 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.333 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -57.66 -34.97 69.93 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.229 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.45 168.4 20.3 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.438 HG11 ' HA ' ' A' ' 166' ' ' PRO . 1.4 m -57.66 -17.61 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.436 ' O ' ' HB2' ' A' ' 156' ' ' ALA . 66.9 t0 -65.05 -35.63 81.77 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 177.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.444 ' OE1' ' OE1' ' A' ' 157' ' ' GLN . 5.8 tm-20 -59.83 -72.5 0.1 Allowed 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.765 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.404 HG11 HG11 ' A' ' 164' ' ' VAL . 7.8 p -48.04 -30.63 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.342 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.426 ' O ' ' N ' ' A' ' 159' ' ' GLY . 3.8 tmt_? -83.84 -45.36 13.36 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 122.185 0.993 . . . . 0.0 110.285 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 152' ' ' ASP . . . -57.75 -41.03 81.07 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.416 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.466 ' CG ' ' N ' ' A' ' 158' ' ' PHE . 7.9 pt20 -82.65 -48.7 10.62 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 112.932 -1.94 . . . . 0.0 112.224 -176.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.466 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 32.0 t80 -106.85 -35.92 6.81 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 96.22 25.26 12.82 Favored Glycine 0 N--CA 1.472 1.092 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -178.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.407 ' HB1' ' HG2' ' A' ' 163' ' ' PRO . . . -43.36 -94.27 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.514 0.197 . . . . 0.0 110.901 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.474 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 62.13 36.47 15.11 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-O 121.25 0.547 . . . . 0.0 109.857 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.559 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.8 m-85 -175.77 -62.06 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.277 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.407 ' HG2' ' HB1' ' A' ' 160' ' ' ALA . 86.4 Cg_endo -73.46 28.87 0.31 Allowed 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.32 2.013 . . . . 0.0 110.367 177.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.581 HG23 ' HD3' ' A' ' 166' ' ' PRO . 16.8 m -133.27 167.01 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.053 -178.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 6.8 t -124.3 65.51 40.6 Favored Pre-proline 0 N--CA 1.473 0.696 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.694 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.581 ' HD3' HG23 ' A' ' 164' ' ' VAL . 31.0 Cg_exo -37.22 143.88 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 123.611 2.874 . . . . 0.0 115.08 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 165.94 177.65 38.25 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 113.734 -1.576 . . . . 0.0 110.598 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -151.14 151.53 32.07 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.3 t -145.75 154.13 41.72 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.991 0.424 . . . . 0.0 110.925 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -49.14 -67.56 1.68 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 129.17 36.97 0.4 Allowed Glycine 0 N--CA 1.468 0.822 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 -83.35 131.65 35.05 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.584 ' N ' HD12 ' A' ' 173' ' ' LEU . 9.0 mp -83.57 159.09 21.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.935 0.397 . . . . 0.0 110.287 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -88.8 147.67 39.68 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.921 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.22 -19.98 38.0 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.879 1.719 . . . . 0.0 111.565 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 63.1 m -157.97 123.61 4.57 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.405 0.621 . . . . 0.0 110.032 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -94.91 -91.99 0.2 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.333 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 178' ' ' ILE . 29.7 pt -90.84 132.49 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 121.13 0.49 . . . . 0.0 110.817 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 22.7 mmm-85 -129.48 158.51 39.02 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.762 0.791 . . . . 0.0 110.817 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 184' ' ' GLY . 99.8 m-20 -77.06 104.88 7.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.151 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -64.78 -22.97 67.1 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.148 -178.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.496 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.6 mm? -63.68 -41.62 98.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.611 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.1 t -121.0 -42.71 2.48 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.583 0.23 . . . . 0.0 111.099 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 180' ' ' ASP . . . 69.93 32.06 69.88 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -112.68 158.73 19.67 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.945 0.402 . . . . 0.0 111.025 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.498 HD23 ' N ' ' A' ' 186' ' ' LEU . 0.7 OUTLIER -64.95 -175.19 0.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.423 179.694 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -128.64 84.03 2.2 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.228 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -74.66 139.18 43.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.026 0.441 . . . . 0.0 110.548 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -173.62 -21.86 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.588 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.736 0 CA-C-O 118.008 -1.44 . . . . 0.0 110.928 -179.844 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 57.7 t30 . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -86.47 136.78 32.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.494 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -63.29 -40.1 96.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.764 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.559 HD12 ' N ' ' A' ' 5' ' ' LEU . 9.2 mp -62.73 -42.05 99.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.107 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -63.97 -43.29 96.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.756 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -64.07 -41.49 97.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.264 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -61.26 -44.21 97.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.109 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.75 -45.55 92.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.975 0.417 . . . . 0.0 109.959 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.6 mt -63.92 -43.15 97.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.81 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.04 -41.75 88.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.528 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.38 -47.38 79.49 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.858 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.05 -51.79 66.58 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.4 pp -67.71 -39.3 81.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.873 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -58.63 -50.04 75.29 Favored 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.306 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 21' ' ' ARG . 88.3 t -64.07 -38.66 83.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.933 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.68 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.3 tt -52.69 -51.0 62.18 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.42 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -78.91 -47.1 17.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.409 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -68.28 -31.17 70.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.136 0.494 . . . . 0.0 111.22 -178.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.4 mt-10 57.13 59.92 3.2 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.123 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.528 ' O ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -152.21 158.9 43.51 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.176 0.512 . . . . 0.0 110.13 179.039 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 34' ' ' GLY . 8.2 p -75.99 140.55 17.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.57 -178.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.421 HG22 ' NH2' ' A' ' 21' ' ' ARG . 2.8 pp -125.4 167.73 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.615 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.25 132.22 48.51 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.277 0.561 . . . . 0.0 111.718 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -115.87 133.55 22.84 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -83.76 140.68 9.32 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 CA-C-N 120.567 1.238 . . . . 0.0 111.857 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.3 m -138.45 134.63 34.28 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -56.94 -42.91 80.92 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.824 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.66 -79.6 0.07 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.8 t -132.53 129.55 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -41.08 157.05 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.796 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -159.95 -169.53 23.37 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.4 m -131.08 168.52 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.543 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -159.29 178.98 35.21 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.059 -1.067 . . . . 0.0 111.818 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.476 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.8 OUTLIER -158.22 -163.2 1.25 Allowed 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.948 -178.826 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.476 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 35.9 m-20 -91.71 105.78 14.56 Favored Pre-proline 0 CA--C 1.555 1.168 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -177.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -38.11 -62.15 0.32 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.521 2.148 . . . . 0.0 112.929 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -71.91 65.12 0.52 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.516 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 m -151.18 131.18 13.39 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.683 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -66.36 -32.75 74.34 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.214 0.531 . . . . 0.0 111.184 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.522 HG23 ' N ' ' A' ' 42' ' ' ALA . 15.1 t -60.19 -42.53 95.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.34 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.522 ' N ' HG23 ' A' ' 41' ' ' THR . . . -56.63 -50.43 72.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.968 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 p -64.44 -42.62 95.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.207 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 94.0 mtp -63.92 -39.46 94.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -60.46 -41.77 94.79 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 122.087 0.946 . . . . 0.0 108.448 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.454 ' O ' HD23 ' A' ' 46' ' ' LEU . 1.1 tt -64.15 -53.33 51.16 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.369 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.8 mt -70.0 -11.46 60.89 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.062 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -70.32 -83.02 0.03 OUTLIER 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.121 0.486 . . . . 0.0 111.193 -177.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.5 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.2 pt? -76.16 -33.92 59.37 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 -178.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -77.58 -51.93 9.87 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.435 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 36.51 66.47 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.861 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.2 mtm-85 177.8 -53.96 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.918 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.149 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -78.12 -5.96 15.45 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.604 2.202 . . . . 0.0 112.341 -178.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.537 HG13 ' N ' ' A' ' 55' ' ' ASP . 7.1 p -44.34 -44.82 2.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.888 -179.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.537 ' N ' HG13 ' A' ' 54' ' ' VAL . 48.4 t0 -64.34 -42.72 96.13 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.223 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -61.92 -36.6 81.83 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 63.15 113.73 0.01 OUTLIER Glycine 0 C--N 1.332 0.332 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.548 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -53.78 -160.67 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.008 0.433 . . . . 0.0 111.776 -179.314 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.0 mt -106.63 141.4 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.872 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.7 mt -118.89 142.62 47.58 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.8 tp -111.64 132.41 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-O 121.226 0.536 . . . . 0.0 110.853 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.481 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -119.97 153.45 35.94 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.26 -27.67 7.89 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -116.97 147.04 42.63 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.018 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -76.34 -13.5 60.14 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -50.82 -32.68 20.86 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.256 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.71 -12.34 29.46 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.449 HD22 ' N ' ' A' ' 68' ' ' LEU . 4.2 mm? -91.13 -15.92 28.63 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.463 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 11.3 ttmm -79.33 -38.49 1.3 Allowed Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 84.9 Cg_endo -103.59 -3.0 0.26 Allowed 'Trans proline' 0 C--N 1.316 -1.146 0 C-N-CA 122.764 2.309 . . . . 0.0 112.116 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.456 ' OH ' ' CD2' ' A' ' 114' ' ' LEU . 64.1 t80 -96.09 -8.34 33.63 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.92 0.39 . . . . 0.0 110.549 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.591 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.3 mp -138.16 167.58 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.591 ' N ' HG22 ' A' ' 72' ' ' ILE . 98.7 m-20 -63.34 -17.42 62.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.09 0.471 . . . . 0.0 110.086 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.0 t70 54.29 5.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.954 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.487 ' H ' ' C ' ' A' ' 73' ' ' ASP . 13.4 t -69.26 -37.49 77.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.181 0.515 . . . . 0.0 109.941 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.428 ' N ' HG23 ' A' ' 75' ' ' THR . 76.1 mmm -66.47 -41.96 88.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.942 0.877 . . . . 0.0 109.018 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 77' ' ' LEU . 9.4 mp -70.79 144.64 50.78 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 113.875 -1.511 . . . . 0.0 110.845 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.49 160.89 43.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.063 -179.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -42.89 -44.92 4.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.906 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.502 HG13 ' N ' ' A' ' 81' ' ' GLN . 12.2 p -60.49 -41.06 86.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.1 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.502 ' N ' HG13 ' A' ' 80' ' ' VAL . 35.4 mt-30 -64.09 -40.16 95.62 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.608 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -65.28 -52.02 56.94 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 122.508 1.147 . . . . 0.0 108.819 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.414 ' O ' ' N ' ' A' ' 87' ' ' SER . 81.7 tt0 -54.3 -50.53 67.11 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 113.7 -1.591 . . . . 0.0 109.724 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.1 m -60.83 -50.42 73.52 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.31 -1.314 . . . . 0.0 111.666 -178.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 88' ' ' ARG . 7.6 tt -67.11 -34.09 67.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 119.371 -0.932 . . . . 0.0 109.262 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -70.16 -38.94 75.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.941 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 83' ' ' GLU . 4.5 m -87.22 -17.45 32.59 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.009 0.433 . . . . 0.0 110.869 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 85' ' ' ILE . 53.0 ttt85 -114.55 171.97 7.31 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 4.4 m0 -33.27 148.29 0.07 OUTLIER Pre-proline 0 CA--C 1.54 0.569 0 O-C-N 123.186 0.304 . . . . 0.0 111.35 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.56 -17.13 48.31 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.19 1.927 . . . . 0.0 111.506 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.465 ' H ' ' HD3' ' A' ' 92' ' ' PRO . . . 103.03 70.53 0.85 Allowed Glycine 0 N--CA 1.469 0.842 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.465 ' HD3' ' H ' ' A' ' 91' ' ' GLY . 50.8 Cg_exo -53.57 -42.23 67.45 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.495 2.13 . . . . 0.0 112.321 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.523 ' O ' ' CE1' ' A' ' 95' ' ' PHE . 11.7 p -75.37 140.03 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.957 0.408 . . . . 0.0 110.776 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 22.7 m -90.57 150.29 21.8 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.91 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.599 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -130.49 148.44 52.3 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.087 179.69 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.715 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.9 t -102.03 112.95 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.434 ' CE1' ' HB1' ' A' ' 181' ' ' ALA . 53.1 m-85 -99.24 152.14 37.67 Favored Pre-proline 0 N--CA 1.47 0.561 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.699 -178.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.78 112.2 3.46 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.189 1.926 . . . . 0.0 111.475 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.71 152.82 78.05 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.82 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.36 152.37 81.72 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.028 1.819 . . . . 0.0 111.395 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.04 -28.28 19.16 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.126 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.8 m -57.96 -45.68 86.3 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.301 -178.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 104' ' ' PRO . 5.0 t -54.99 145.2 44.8 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.476 ' O ' ' O ' ' A' ' 103' ' ' THR . 0.8 OUTLIER -28.38 -109.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 123.435 2.756 . . . . 0.0 114.464 -179.803 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.406 ' O ' ' N ' ' A' ' 109' ' ' GLY . 8.4 tpt180 -172.29 2.87 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.955 -0.466 . . . . 0.0 110.724 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 53.6 p-90 -74.47 -7.7 53.86 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.146 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.958 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -71.13 -35.58 71.77 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.605 179.551 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.702 ' H ' HD22 ' A' ' 107' ' ' LEU . 86.8 m -133.98 -39.13 0.87 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.651 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 84.57 -5.92 79.47 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.226 -0.511 . . . . 0.0 112.727 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -148.85 -72.47 0.19 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 117.723 0.762 . . . . 0.0 111.402 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.447 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 18.8 t80 -88.89 -165.5 1.35 Allowed 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.447 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 51.2 p30 -130.9 51.43 2.14 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.836 0.351 . . . . 0.0 110.897 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.2 p -152.31 153.24 33.29 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.515 ' C ' HG13 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -159.81 136.43 9.12 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -179.261 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.439 ' N ' HG13 ' A' ' 96' ' ' VAL . . . -68.39 127.32 32.54 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 113.225 -1.807 . . . . 0.0 109.967 177.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.6 p -148.01 153.61 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -146.52 155.87 42.84 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.831 0.348 . . . . 0.0 111.021 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.481 HG22 ' HB3' ' A' ' 62' ' ' ALA . 53.2 t -122.63 135.37 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.7 t -133.49 153.42 51.64 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.275 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 52.6 p-10 -154.53 81.28 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.378 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.628 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 27.0 t-80 -171.95 -37.42 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.628 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 31.2 Cg_endo -94.0 -163.08 0.1 OUTLIER 'Trans proline' 0 C--N 1.32 -0.922 0 C-N-CA 121.954 1.769 . . . . 0.0 111.959 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 16.2 mt -76.94 -4.84 45.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.939 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 91.8 t -57.86 -45.58 87.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.171 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.764 HG23 ' H ' ' A' ' 126' ' ' ALA . 28.2 m -53.17 -62.22 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 C-N-CA 119.467 -0.893 . . . . 0.0 108.67 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.764 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.79 -42.54 2.67 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.008 0.432 . . . . 0.0 110.685 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.4 tp -70.05 -48.33 58.3 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.489 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 63.9 m -70.56 -48.3 56.05 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.575 0.702 . . . . 0.0 110.781 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.465 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -55.08 -42.15 72.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.788 -1.096 . . . . 0.0 108.195 179.29 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -59.32 -55.66 31.98 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.648 -177.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -61.7 -21.94 64.91 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.656 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.6 1.48 86.68 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -151.66 160.1 32.22 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.113 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -45.41 166.17 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 123.833 3.022 . . . . 0.0 112.967 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.4 tp -121.21 122.81 40.77 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 176.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.414 ' O ' ' CA ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -63.6 146.9 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.856 0 C-N-CA 117.712 -1.595 . . . . 0.0 106.722 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.9 t -122.56 126.13 47.12 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.694 0.621 . . . . 0.0 111.572 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 3.7 m -132.37 164.55 26.23 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.53 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 30.4 t -71.07 151.19 44.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.844 0.354 . . . . 0.0 110.728 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.436 ' HB1' ' H ' ' A' ' 148' ' ' CYS . . . -60.75 -37.3 81.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.975 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 54.7 p30 -55.87 154.77 6.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.657 0.741 . . . . 0.0 111.425 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.45 -159.15 0.94 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.629 -178.382 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.9 p -61.36 -38.7 87.94 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.061 0.458 . . . . 0.0 110.153 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -165.8 0.78 0.05 OUTLIER Glycine 0 CA--C 1.511 -0.166 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.2 tp -81.68 124.8 79.43 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.237 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -38.73 156.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.939 1.759 . . . . 0.0 111.931 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -74.84 -162.87 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.391 2.061 . . . . 0.0 112.256 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.436 ' H ' ' HB1' ' A' ' 140' ' ' ALA . 73.0 m -119.5 76.4 1.13 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.7 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -54.16 -32.97 56.89 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.817 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.0 165.55 15.78 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.417 HG11 ' HA ' ' A' ' 166' ' ' PRO . 0.9 OUTLIER -55.75 -17.66 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.746 0 CA-C-O 121.751 0.786 . . . . 0.0 109.267 179.925 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -66.24 -34.58 78.33 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.33 -70.6 0.16 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.729 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.5 p -48.62 -31.11 3.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.155 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 159' ' ' GLY . 4.6 tmt_? -79.64 -51.65 8.99 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.863 0.84 . . . . 0.0 109.338 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.98 -44.22 63.95 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.886 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.13 -30.59 25.78 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 112.845 -1.979 . . . . 0.0 114.351 -175.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -126.3 -32.9 2.66 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 118.012 0.369 . . . . 0.0 111.294 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 93.75 23.41 23.41 Favored Glycine 0 N--CA 1.467 0.744 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -42.77 -95.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.493 0.187 . . . . 0.0 110.957 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.454 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.93 37.04 15.43 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.189 0.519 . . . . 0.0 109.61 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.556 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.4 m-85 -175.88 -62.1 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.907 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.28 28.05 0.3 Allowed 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.349 2.032 . . . . 0.0 110.536 178.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.573 HG23 ' HD3' ' A' ' 166' ' ' PRO . 16.0 m -131.78 167.47 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.05 -178.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.2 65.96 30.74 Favored Pre-proline 0 N--CA 1.477 0.878 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.645 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.573 ' HD3' HG23 ' A' ' 164' ' ' VAL . 33.0 Cg_exo -38.27 147.42 0.11 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 123.686 2.924 . . . . 0.0 114.962 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 174.53 -148.72 10.0 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.117 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -143.4 -164.65 1.91 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.9 t -144.41 153.25 41.74 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.354 0.597 . . . . 0.0 111.071 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -167.53 78.43 0.11 Allowed Glycine 0 N--CA 1.454 -0.148 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.25 62.41 0.02 OUTLIER Glycine 0 C--N 1.317 -0.502 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -79.52 -9.03 59.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.557 -0.322 . . . . 0.0 111.083 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.504 HD22 ' N ' ' A' ' 173' ' ' LEU . 3.6 mm? -61.36 -40.47 94.41 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.429 ' N ' ' CD ' ' A' ' 175' ' ' PRO . 10.0 t-20 72.61 52.34 0.29 Allowed Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.388 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 174' ' ' ASN . 58.9 Cg_endo -69.49 -17.42 38.83 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.508 2.139 . . . . 0.0 111.014 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 6.2 p -96.93 122.91 40.43 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.715 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.442 ' H ' HG23 ' A' ' 93' ' ' VAL . 95.8 mt-10 -133.92 -163.57 1.38 Allowed 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.614 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 178' ' ' ILE . 18.8 tt -112.28 130.74 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.698 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -133.83 169.4 17.12 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.714 0.768 . . . . 0.0 112.17 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -80.63 106.99 13.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.201 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -68.47 -16.68 63.98 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.214 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.8 mm? -63.37 -41.8 98.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.047 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.09 -44.31 3.6 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.176 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 72.92 20.05 79.75 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -68.7 145.39 53.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.051 0.453 . . . . 0.0 110.886 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.515 HD23 ' N ' ' A' ' 186' ' ' LEU . 0.9 OUTLIER -69.04 174.96 4.04 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.823 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 187' ' ' PHE . . . . . 0.458 ' O ' ' CD2' ' A' ' 187' ' ' PHE . 65.7 t80 -122.27 12.67 10.25 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.131 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 52.3 ttt-85 -71.5 -131.43 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.352 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -67.41 -39.0 85.51 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.124 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.762 0 CA-C-O 118.111 -1.383 . . . . 0.0 111.021 -179.972 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -82.45 140.67 33.27 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -88.04 -9.33 53.72 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.642 -0.253 . . . . 0.0 110.579 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.552 HD12 ' N ' ' A' ' 5' ' ' LEU . 9.4 mp -63.27 -42.27 99.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.968 0.413 . . . . 0.0 110.252 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -64.81 -43.43 93.14 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.189 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -65.56 -38.67 90.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.277 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 162' ' ' PHE . 67.9 t0 -62.73 -45.65 91.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.613 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.14 -45.87 91.52 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.912 0.387 . . . . 0.0 110.031 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.63 -43.06 98.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.839 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.91 -42.62 85.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.541 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.13 -46.62 86.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.174 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.07 -51.4 69.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.811 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 14.7 pt -68.71 -39.84 80.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.409 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -57.15 -53.19 60.9 Favored 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 120.486 -0.485 . . . . 0.0 109.921 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 20' ' ' GLU . 89.0 t -61.61 -40.42 86.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.638 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.682 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.3 tt -52.99 -50.47 64.11 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.383 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -79.49 -51.23 9.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.753 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -64.8 -31.04 72.08 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.812 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 16' ' ' VAL . 96.7 mt-10 58.44 85.11 0.1 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.124 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.41 -142.54 0.09 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.706 0.288 . . . . 0.0 110.289 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.2 p -137.74 138.73 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 pp -128.05 163.99 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-O 121.118 0.485 . . . . 0.0 111.78 -178.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.68 128.43 36.2 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.914 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.518 ' CE2' ' O ' ' A' ' 26' ' ' PRO . 2.1 t80 -118.32 138.49 25.72 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.255 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.518 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 64.8 Cg_endo -80.93 149.51 17.83 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.191 1.26 . . . . 0.0 111.352 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.436 ' C ' ' H ' ' A' ' 29' ' ' ALA . 25.9 m -135.15 140.93 45.8 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.271 0.557 . . . . 0.0 110.808 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -77.77 20.07 0.36 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.033 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.436 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -154.97 -73.41 0.12 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.206 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 67.5 t -122.74 126.28 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 120.859 0.361 . . . . 0.0 110.737 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.521 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 90.9 m-85 -53.5 144.48 17.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.195 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -154.35 -168.37 17.7 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.2 m -132.08 168.31 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.97 -176.96 27.79 Favored Glycine 0 N--CA 1.464 0.566 0 C-N-CA 120.008 -1.092 . . . . 0.0 111.925 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -153.34 -166.2 2.36 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.734 0.302 . . . . 0.0 110.359 -179.43 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.514 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 7.8 m-20 -99.43 109.79 56.17 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-O 118.729 -0.653 . . . . 0.0 112.441 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 36' ' ' ASP . 15.4 Cg_exo -35.19 168.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.68 2.254 . . . . 0.0 114.302 177.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 44.73 67.39 0.7 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.433 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.7 m -142.94 137.59 29.53 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.07 0.462 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.631 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -71.65 -34.37 69.7 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.296 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.432 ' H ' HG22 ' A' ' 41' ' ' THR . 0.1 OUTLIER -63.45 -45.28 91.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.644 -178.121 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.424 ' HB2' ' SG ' ' A' ' 35' ' ' CYS . . . -63.1 -47.68 81.81 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.598 -178.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.3 p -62.59 -44.45 99.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.249 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 62.1 mtt -64.95 -39.79 94.02 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 -61.77 -32.98 73.29 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.026 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 79.9 mt -75.95 -57.23 4.0 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.4 mt -54.46 -18.91 4.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.243 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -67.23 -84.66 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.695 -178.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.515 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -75.83 -33.26 60.05 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -77.71 -71.23 0.43 Allowed 'General case' 0 C--N 1.346 0.445 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.738 -176.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.411 ' CG ' ' O ' ' A' ' 51' ' ' GLN . 3.2 tt0 53.65 80.98 0.1 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.399 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.3 mtp85 160.69 -64.04 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.116 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -66.78 -11.25 31.26 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 122.641 2.228 . . . . 0.0 111.775 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.596 HG13 ' N ' ' A' ' 55' ' ' ASP . 13.9 p -46.05 -45.97 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.596 ' N ' HG13 ' A' ' 54' ' ' VAL . 10.3 t0 -67.58 -44.44 78.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.676 -178.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -60.35 -40.5 90.96 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.759 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 71.39 111.66 0.04 OUTLIER Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.573 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -49.54 -169.86 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.986 -0.607 . . . . 0.0 111.896 179.632 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.439 ' O ' ' OG ' ' A' ' 137' ' ' SER . 80.9 mt -100.25 139.54 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.5 mt -113.24 143.84 43.73 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -178.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.412 ' O ' HG23 ' A' ' 61' ' ' ILE . 10.0 tp -112.26 127.97 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 CA-C-O 121.122 0.487 . . . . 0.0 110.548 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.497 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -113.46 154.59 26.76 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.56 -26.29 7.11 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -118.76 145.05 45.88 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.607 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -71.62 -12.53 61.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.571 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -49.6 -33.91 16.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.565 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -95.04 -15.74 23.23 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.582 HD22 ' N ' ' A' ' 68' ' ' LEU . 3.8 mm? -92.94 -13.14 29.23 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.476 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 27.9 tptt -80.49 -39.08 1.13 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.803 -178.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 65.8 Cg_endo -103.09 -3.4 0.28 Allowed 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 122.78 2.32 . . . . 0.0 111.784 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.561 ' OH ' HD21 ' A' ' 114' ' ' LEU . 39.8 t80 -96.56 -11.01 25.98 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.161 -178.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.581 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.2 mp -131.46 159.36 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.581 ' N ' HG22 ' A' ' 72' ' ' ILE . 91.2 m-20 -71.37 160.45 32.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.06 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 39.2 p30 -95.64 7.79 45.27 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.848 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.561 HG23 ' N ' ' A' ' 76' ' ' MET . 7.1 t -67.08 -45.77 76.3 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.325 0.583 . . . . 0.0 110.547 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.561 ' N ' HG23 ' A' ' 75' ' ' THR . 23.1 ptp -84.33 -6.26 59.37 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.232 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.3 tp -94.33 116.3 28.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.619 -177.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -154.95 167.2 31.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.91 -177.817 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -42.49 -44.49 4.1 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.196 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.66 -33.03 59.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.923 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 78' ' ' THR . 1.0 OUTLIER -65.75 -43.26 89.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.203 0.525 . . . . 0.0 110.52 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.402 ' NH2' ' HZ1' ' A' ' 69' ' ' LYS . 9.5 mmt85 -59.92 -49.17 78.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 122.76 1.267 . . . . 0.0 108.657 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -57.29 -49.84 74.82 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 113.446 -1.706 . . . . 0.0 110.005 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.7 m -62.59 -49.19 76.24 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.227 -1.351 . . . . 0.0 112.444 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.8 tt -68.42 -30.75 48.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.139 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -82.37 -40.02 21.93 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.917 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.2 m -78.35 -3.31 42.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.907 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -121.92 166.95 13.64 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 15.9 m-90 -43.49 150.71 0.5 Allowed Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.12 -19.37 45.11 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.911 1.741 . . . . 0.0 111.593 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.474 ' O ' ' NH2' ' A' ' 117' ' ' ARG . . . 177.64 78.78 0.06 OUTLIER Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -79.57 -35.52 0.79 Allowed 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.042 1.828 . . . . 0.0 112.516 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.515 ' CG1' ' CZ ' ' A' ' 95' ' ' PHE . 9.7 p -137.92 149.2 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 120.801 0.334 . . . . 0.0 110.886 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 16.3 m -81.39 129.51 34.66 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.515 ' CZ ' ' CG1' ' A' ' 93' ' ' VAL . 46.2 m-85 -117.02 137.4 52.26 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.733 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.697 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 5.5 t -92.05 102.59 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 121.277 0.561 . . . . 0.0 109.759 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -81.12 143.68 53.17 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.198 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -79.64 108.16 2.24 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 122.032 1.821 . . . . 0.0 111.099 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 112' ' ' ASP . . . -64.93 156.61 79.43 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.624 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 49.0 Cg_endo -66.69 -19.23 53.81 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.231 1.954 . . . . 0.0 112.187 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 100' ' ' PRO . . . 91.63 -27.57 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.536 0.523 . . . . 0.0 110.551 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.4 m -58.19 -45.17 88.02 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.54 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.511 ' O ' ' O ' ' A' ' 104' ' ' PRO . 0.1 OUTLIER -52.32 151.66 7.02 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.217 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.511 ' O ' ' O ' ' A' ' 103' ' ' THR . 9.2 Cg_exo -31.64 -115.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.504 2.139 0 C-N-CA 124.088 3.192 . . . . 0.0 114.64 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 109' ' ' GLY . 0.6 OUTLIER -179.45 -4.25 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.957 -0.464 . . . . 0.0 110.409 -179.642 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 2.5 p90 -79.56 -9.83 59.69 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.676 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.969 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -69.28 -34.06 74.17 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.427 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.746 ' H ' HD22 ' A' ' 107' ' ' LEU . 28.5 m -141.39 -40.73 0.38 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.428 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 60.29 -13.62 0.04 OUTLIER Glycine 0 CA--C 1.536 1.398 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.657 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.558 ' H ' ' C ' ' A' ' 108' ' ' THR . 0.0 OUTLIER -85.52 -52.61 5.72 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 117.659 0.73 . . . . 0.0 109.284 179.758 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.534 ' CE2' ' OD1' ' A' ' 112' ' ' ASP . 17.6 t80 -154.37 -178.26 7.02 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.306 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.534 ' OD1' ' CE2' ' A' ' 111' ' ' PHE . 48.8 p30 -89.01 51.63 2.21 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.299 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.5 p -159.51 156.82 28.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.244 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.561 HD21 ' OH ' ' A' ' 71' ' ' TYR . 0.3 OUTLIER -163.75 141.5 7.38 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.421 ' HB2' HG22 ' A' ' 96' ' ' VAL . . . -69.7 125.23 26.09 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 113.737 -1.574 . . . . 0.0 109.617 177.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.491 HG22 ' N ' ' A' ' 117' ' ' ARG . 4.3 p -146.66 161.19 9.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.491 ' N ' HG22 ' A' ' 116' ' ' VAL . 78.7 ttt-85 -144.03 153.23 41.99 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.91 0.386 . . . . 0.0 111.389 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.497 HG22 ' HB3' ' A' ' 62' ' ' ALA . 52.2 t -122.45 136.64 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.2 t -135.24 149.04 49.77 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.249 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 35.4 p30 -151.68 78.82 1.26 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.763 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.61 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 10.3 t-80 -172.51 -36.85 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.61 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 18.9 Cg_endo -92.73 -161.66 0.09 OUTLIER 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 121.993 1.795 . . . . 0.0 111.686 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.4 mt -78.83 -4.68 50.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.016 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.4 t -58.21 -45.0 89.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.971 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.754 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.6 m -52.7 -62.2 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.935 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.754 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -40.96 -45.41 2.57 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.881 0.372 . . . . 0.0 111.027 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.435 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -66.69 -51.37 56.8 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.253 0.549 . . . . 0.0 110.778 179.535 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 71.2 m -69.5 -47.79 62.68 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.237 0.541 . . . . 0.0 111.425 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.475 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.2 pp0? -54.87 -42.2 71.75 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -60.4 -53.12 61.37 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.771 -177.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.45 ' CE1' ' OD2' ' A' ' 36' ' ' ASP . 42.0 t80 -64.48 -22.46 66.97 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.825 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.94 2.07 90.14 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 134' ' ' PRO . 34.3 mttm -152.4 159.56 32.52 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 133' ' ' LYS . 5.9 Cg_exo -41.12 -179.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 124.061 3.174 . . . . 0.0 113.941 -178.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.447 HD12 ' O ' ' A' ' 35' ' ' CYS . 8.0 tp -134.47 123.85 24.65 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 176.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.423 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.9 OUTLIER -66.14 143.73 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 C-N-CA 117.764 -1.574 . . . . 0.0 108.518 -179.153 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -108.82 121.88 46.0 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.96 0.788 . . . . 0.0 110.924 -179.346 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.9 m -132.38 157.64 44.02 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.819 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.6 m -73.0 143.2 47.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.011 0.434 . . . . 0.0 110.577 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.7 -36.76 85.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.034 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 51.8 p30 -52.37 150.38 4.82 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.774 0.797 . . . . 0.0 110.997 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.13 -158.39 0.73 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.048 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 45.2 m -59.93 -42.99 95.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.471 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -162.55 11.87 0.11 Allowed Glycine 0 N--CA 1.459 0.172 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.7 tp -93.44 127.51 46.13 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -38.76 157.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 121.758 1.638 . . . . 0.0 112.468 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -76.55 -166.94 0.41 Allowed 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 122.721 2.281 . . . . 0.0 112.487 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 70.9 m -112.03 76.93 1.0 Allowed 'General case' 0 C--O 1.231 0.103 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.521 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 17.5 ptm180 -54.06 -37.81 64.57 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.952 -178.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.42 167.64 29.13 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.441 HG22 ' H ' ' A' ' 151' ' ' VAL . 1.6 m -57.37 -20.35 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.6 0 CA-C-O 121.77 0.795 . . . . 0.0 109.248 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -64.21 -34.61 78.49 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.03 -79.49 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.872 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.439 HG13 ' N ' ' A' ' 155' ' ' ARG . 6.3 p -35.22 -34.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.687 0.795 . . . . 0.0 111.155 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.475 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -67.38 -52.79 35.66 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.347 0.594 . . . . 0.0 111.852 -178.618 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -69.35 -16.93 63.64 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 122.538 1.161 . . . . 0.0 108.035 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -84.23 -45.37 12.96 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 112.672 -2.058 . . . . 0.0 111.891 -178.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -130.34 -27.93 2.16 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.638 0.256 . . . . 0.0 111.642 -178.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 94.56 24.17 19.16 Favored Glycine 0 N--CA 1.468 0.783 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -43.68 -96.69 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.78 0.324 . . . . 0.0 111.126 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.508 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 62.3 34.8 15.61 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -178.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.544 ' H ' HG22 ' A' ' 164' ' ' VAL . 2.1 m-85 -174.04 -62.16 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.238 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.86 25.88 0.29 Allowed 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.349 2.033 . . . . 0.0 110.932 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.571 HG23 ' HD3' ' A' ' 166' ' ' PRO . 13.7 m -127.43 167.64 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.746 -178.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.1 t -122.35 64.87 21.58 Favored Pre-proline 0 N--CA 1.472 0.647 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.829 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.571 ' HD3' HG23 ' A' ' 164' ' ' VAL . 38.9 Cg_exo -37.62 144.32 0.15 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 123.652 2.901 . . . . 0.0 115.031 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 164.54 -176.78 40.36 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 113.901 -1.5 . . . . 0.0 110.878 178.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -142.09 152.8 43.63 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.4 t -144.99 155.55 43.45 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.088 0.47 . . . . 0.0 111.169 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -152.13 80.33 0.19 Allowed Glycine 0 CA--C 1.519 0.295 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -166.45 67.27 0.2 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -91.73 3.17 55.71 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.687 0.279 . . . . 0.0 111.062 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 56.9 tp -61.73 -46.8 88.07 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -117.95 89.13 33.33 Favored Pre-proline 0 N--CA 1.47 0.574 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.845 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.438 ' O ' ' CB ' ' A' ' 176' ' ' SER . 73.6 Cg_endo -76.28 -8.19 18.43 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.844 1.696 . . . . 0.0 111.985 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 175' ' ' PRO . 0.7 OUTLIER 81.34 104.0 0.06 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.514 0.674 . . . . 0.0 111.146 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.504 ' OE1' ' NH1' ' A' ' 179' ' ' ARG . 98.1 mt-10 -90.14 -178.93 5.54 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.834 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.479 ' O ' HG23 ' A' ' 178' ' ' ILE . 18.7 tt -111.25 125.13 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.653 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.504 ' NH1' ' OE1' ' A' ' 177' ' ' GLU . 7.2 mpt_? -122.5 161.43 23.62 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 122.102 0.953 . . . . 0.0 110.889 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -77.79 105.88 9.26 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.157 -1.383 . . . . 0.0 107.979 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -66.95 -13.61 61.98 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.753 -178.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.475 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.4 mm? -63.54 -42.02 98.42 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.062 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.2 -43.44 2.53 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.818 0.342 . . . . 0.0 110.623 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 63.57 24.72 68.12 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.15 156.28 36.1 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.299 0.571 . . . . 0.0 111.179 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.484 HD23 ' N ' ' A' ' 186' ' ' LEU . 0.8 OUTLIER -72.03 176.4 5.11 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.304 179.695 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -104.97 -7.81 19.01 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.915 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -74.34 135.97 42.51 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.912 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -131.87 122.68 26.09 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.011 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.892 0 CA-C-O 117.747 -1.585 . . . . 0.0 110.895 -179.923 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -80.25 147.93 31.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.176 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -63.21 -41.94 99.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.517 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.4 mp -63.11 -42.32 99.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.212 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -61.96 -49.6 75.45 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.001 0.429 . . . . 0.0 110.053 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -58.51 -41.36 85.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.947 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.74 -44.76 96.29 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.588 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.43 -45.29 93.75 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.241 0.544 . . . . 0.0 109.94 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.9 -42.94 98.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.9 -42.43 79.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.156 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.2 -47.48 85.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.149 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.02 -53.21 60.53 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.626 -0.43 . . . . 0.0 112.053 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 14.2 pt -66.75 -38.32 81.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.117 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -58.36 -50.77 72.47 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.168 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 21' ' ' ARG . 92.6 t -62.81 -39.27 84.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.75 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.671 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.3 tt -52.48 -52.2 55.57 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.209 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -76.79 -48.72 17.76 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.223 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -67.14 -29.47 69.2 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.058 0.456 . . . . 0.0 110.837 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 16' ' ' VAL . 96.7 mt-10 56.36 60.52 3.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.564 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.542 ' O ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -153.65 159.6 42.12 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.302 0.573 . . . . 0.0 110.323 179.164 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 p -76.92 137.97 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.436 -178.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.513 HG22 ' NH2' ' A' ' 21' ' ' ARG . 2.8 pp -124.86 166.79 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-O 120.692 0.282 . . . . 0.0 110.898 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.05 133.86 53.86 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.379 0.609 . . . . 0.0 111.462 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.524 ' CE2' ' O ' ' A' ' 26' ' ' PRO . 3.5 t80 -126.66 138.68 33.0 Favored Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.524 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 64.3 Cg_endo -80.32 150.21 19.72 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 CA-C-N 120.419 1.185 . . . . 0.0 111.588 -178.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.448 ' C ' ' H ' ' A' ' 29' ' ' ALA . 30.2 m -130.14 140.09 50.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.649 0.262 . . . . 0.0 110.451 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -77.6 21.11 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.448 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -154.76 -74.59 0.11 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.124 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.4 p -123.79 127.41 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 121.24 0.543 . . . . 0.0 110.622 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 149' ' ' ARG . 97.4 m-85 -43.37 147.98 0.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.999 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -157.64 -174.72 27.71 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.4 m -131.23 169.38 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.43 178.92 33.55 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 119.946 -1.121 . . . . 0.0 112.656 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.564 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -152.97 -162.84 1.57 Allowed 'General case' 0 C--N 1.341 0.226 0 CA-C-N 115.521 -0.34 . . . . 0.0 110.309 -179.231 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.564 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 2.1 m-20 -101.52 111.12 63.39 Favored Pre-proline 0 CA--C 1.548 0.869 0 CA-C-O 118.802 -0.618 . . . . 0.0 112.622 -178.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 36' ' ' ASP . 22.8 Cg_exo -35.89 170.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.804 2.336 . . . . 0.0 114.413 177.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.8 t70 41.53 73.45 0.13 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.887 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.9 m -151.79 141.99 22.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.084 0.469 . . . . 0.0 110.308 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.644 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -70.43 -30.55 67.44 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.555 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.533 HG23 ' N ' ' A' ' 42' ' ' ALA . 12.6 t -60.09 -42.52 94.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.988 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.533 ' N ' HG23 ' A' ' 41' ' ' THR . . . -58.17 -52.53 65.15 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.345 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.07 -45.33 99.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.137 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 60.6 mtt -67.62 -45.29 75.84 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -65.8 -28.7 69.2 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.634 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 52.7 mt -74.72 -60.95 2.05 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.232 177.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.9 mt -51.63 -23.22 4.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.065 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.49 -85.73 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.723 -178.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.52 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -76.56 -33.66 58.51 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -75.5 -71.16 0.38 Allowed 'General case' 0 C--N 1.346 0.434 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.959 -176.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.406 ' O ' ' CG ' ' A' ' 51' ' ' GLN . 3.8 tt0 53.46 80.62 0.1 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.388 0.613 . . . . 0.0 109.454 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.1 mtt-85 161.07 -63.44 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.215 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.36 -10.4 28.87 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 122.737 2.291 . . . . 0.0 112.175 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.595 HG13 ' N ' ' A' ' 55' ' ' ASP . 7.3 p -44.95 -48.19 2.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.914 -178.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.595 ' N ' HG13 ' A' ' 54' ' ' VAL . 10.9 t0 -68.49 -42.29 78.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.425 -178.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -58.9 -41.96 88.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.398 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 68.97 112.86 0.02 OUTLIER Glycine 0 CA--C 1.518 0.248 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.568 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -49.64 -170.63 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.085 -0.558 . . . . 0.0 112.353 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.3 mt -97.7 148.29 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.1 mt -122.35 142.65 50.28 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 61' ' ' ILE . 8.6 tp -114.45 129.93 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-O 121.176 0.512 . . . . 0.0 110.984 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.601 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -114.11 159.9 19.52 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -124.94 -24.72 4.02 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -116.76 125.31 51.46 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.287 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -58.46 -13.23 5.02 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -50.23 -33.58 20.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.527 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.83 -11.55 28.64 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.512 HD22 ' N ' ' A' ' 68' ' ' LEU . 3.8 mm? -91.98 -14.6 29.21 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 118.864 0.757 . . . . 0.0 109.192 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.474 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 42.9 tttm -79.6 -38.56 1.26 Allowed Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.766 -178.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 73.6 Cg_endo -103.07 -3.43 0.28 Allowed 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 122.699 2.266 . . . . 0.0 111.836 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -96.53 -10.46 27.25 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.666 -178.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.602 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.7 mp -137.02 164.23 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.602 ' N ' HG22 ' A' ' 72' ' ' ILE . 97.6 m-20 -66.71 160.16 26.26 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -94.85 12.01 29.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.695 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.525 HG23 ' N ' ' A' ' 76' ' ' MET . 10.7 t -72.48 -41.12 66.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.223 0.535 . . . . 0.0 110.067 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.525 ' N ' HG23 ' A' ' 75' ' ' THR . 22.1 ptp -85.15 -18.26 34.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.546 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 tp -95.25 119.36 33.63 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.904 -178.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.473 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -158.03 161.03 38.04 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.303 -177.701 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -38.92 -47.86 1.5 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.837 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.1 p -62.86 -34.13 64.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.757 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 78' ' ' THR . 67.4 tp60 -65.99 -39.54 90.4 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.808 0.337 . . . . 0.0 110.93 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.436 ' HG2' ' H ' ' A' ' 82' ' ' ARG . 6.8 mmt85 -64.4 -52.86 56.07 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 122.581 1.181 . . . . 0.0 109.14 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -55.67 -50.39 70.38 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.126 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 88' ' ' ARG . 3.1 m -60.77 -51.05 70.97 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.926 -178.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 85' ' ' ILE . 10.0 tt -65.91 -36.49 77.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.596 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -67.14 -41.03 86.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.127 178.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.9 m -84.71 -19.02 33.4 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.8 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 84' ' ' THR . 77.8 ttt-85 -103.56 151.52 22.79 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.741 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -34.38 152.62 0.05 OUTLIER Pre-proline 0 N--CA 1.469 0.484 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.188 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.12 -17.93 55.62 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.132 1.888 . . . . 0.0 110.991 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.455 ' H ' ' HD3' ' A' ' 92' ' ' PRO . . . 99.19 69.32 0.92 Allowed Glycine 0 CA--C 1.529 0.967 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.779 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.455 ' HD3' ' H ' ' A' ' 91' ' ' GLY . 52.8 Cg_exo -54.54 -39.35 88.65 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.865 2.377 . . . . 0.0 111.493 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.425 HG13 ' CE2' ' A' ' 95' ' ' PHE . 3.2 p -78.59 147.84 6.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.328 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 85.5 m -88.11 143.62 26.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.731 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.449 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 61.6 m-85 -127.01 140.35 52.37 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.661 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.649 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 3.4 t -93.86 101.77 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-O 121.474 0.654 . . . . 0.0 109.633 178.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -91.81 151.31 42.06 Favored Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.882 -177.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.82 142.19 56.69 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.764 1.643 . . . . 0.0 110.309 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -114.95 116.54 42.64 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.397 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -45.59 167.4 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 121.6 1.533 . . . . 0.0 112.623 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.49 -25.04 45.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.484 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.1 p -66.1 -33.16 75.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.473 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.495 ' O ' ' O ' ' A' ' 104' ' ' PRO . 0.9 OUTLIER -69.85 160.15 81.24 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.468 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.495 ' O ' ' O ' ' A' ' 103' ' ' THR . 84.4 Cg_exo -47.55 -158.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.251 0 C-N-CA 122.724 2.283 . . . . 0.0 113.851 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.492 ' NH1' ' OD1' ' A' ' 112' ' ' ASP . 11.4 tpp180 -168.51 -4.97 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.475 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 6.1 p90 -84.5 -9.4 58.38 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.632 ' H ' ' CD2' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -77.57 -17.65 57.67 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.678 -179.639 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.543 ' C ' ' H ' ' A' ' 110' ' ' ARG . 26.6 m -144.75 -43.85 0.24 Allowed 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.827 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 50.42 -1.87 0.01 OUTLIER Glycine 0 CA--C 1.541 1.688 0 CA-C-O 119.726 -0.485 . . . . 0.0 113.339 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.543 ' H ' ' C ' ' A' ' 108' ' ' THR . 0.5 OUTLIER -88.15 -54.87 4.0 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 117.947 0.873 . . . . 0.0 109.552 179.741 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.613 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 85.4 t80 -154.51 173.72 15.9 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.417 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.613 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 89.8 m-20 -79.12 50.92 1.1 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.372 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 82.1 p -158.52 160.04 36.24 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.457 ' C ' HG13 ' A' ' 96' ' ' VAL . 2.3 pp -167.13 140.02 3.51 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.87 112.21 4.17 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 113.437 -1.71 . . . . 0.0 110.75 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.499 HG22 ' N ' ' A' ' 117' ' ' ARG . 6.1 p -143.97 160.42 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.499 ' N ' HG22 ' A' ' 116' ' ' VAL . 14.8 ptt180 -155.99 162.16 40.38 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.949 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.601 HG22 ' HB3' ' A' ' 62' ' ' ALA . 54.7 t -121.24 138.82 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.543 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 7.9 t -132.62 150.43 52.16 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.957 0.408 . . . . 0.0 110.103 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.401 ' O ' ' OD1' ' A' ' 120' ' ' ASP . 30.6 p30 -150.4 81.1 1.36 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.324 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.605 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 61.7 t60 -171.81 -37.79 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.605 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 38.7 Cg_endo -95.49 -163.62 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 121.941 1.761 . . . . 0.0 112.3 -178.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.6 mt -78.54 -4.09 46.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.89 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 83.3 t -57.62 -45.96 86.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.648 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.756 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.1 m -52.96 -62.18 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.87 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.756 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.33 -43.84 2.58 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.243 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.1 tp -69.49 -48.07 61.85 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.954 0.406 . . . . 0.0 110.99 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 82.1 m -70.0 -48.96 55.98 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.408 0.623 . . . . 0.0 110.915 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.47 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.0 OUTLIER -55.24 -41.61 72.36 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.423 179.428 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.94 -54.42 47.36 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.383 -1.281 . . . . 0.0 109.605 -177.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.402 ' CE1' ' OD2' ' A' ' 36' ' ' ASP . 42.8 t80 -62.05 -21.47 64.95 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.983 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 81.43 -0.11 88.3 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 134' ' ' PRO . 24.7 mttp -152.37 159.14 33.12 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.004 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 133' ' ' LYS . 6.1 Cg_exo -41.61 179.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 123.838 3.026 . . . . 0.0 113.75 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.0 tp -134.58 123.73 24.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.443 -1.708 . . . . 0.0 106.578 177.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.43 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.9 OUTLIER -66.06 146.42 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 C-N-CA 117.684 -1.606 . . . . 0.0 107.327 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.0 t -118.3 129.25 55.35 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.249 0.547 . . . . 0.0 110.894 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.3 m -129.06 162.31 27.97 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.085 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 17.8 m -72.02 147.99 46.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.246 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.618 ' HB1' ' H ' ' A' ' 148' ' ' CYS . . . -63.63 -37.44 87.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.913 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -54.31 157.38 2.76 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.594 0.711 . . . . 0.0 111.256 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.74 -158.31 0.88 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.103 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.6 t -60.33 -44.08 95.81 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.382 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -165.97 12.43 0.07 OUTLIER Glycine 0 N--CA 1.46 0.264 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.3 tp -90.24 127.64 52.47 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -39.47 153.74 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 121.702 1.602 . . . . 0.0 112.22 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.29 157.43 41.57 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.431 2.088 . . . . 0.0 112.373 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.618 ' H ' ' HB1' ' A' ' 140' ' ' ALA . 18.7 m -80.37 76.35 7.18 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.534 ' O ' ' CD1' ' A' ' 31' ' ' PHE . 32.9 ptt-85 -55.19 -35.7 65.11 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.93 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.71 169.49 24.52 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.409 ' H ' HG22 ' A' ' 151' ' ' VAL . 1.0 OUTLIER -59.62 -23.82 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.547 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.23 -23.73 67.41 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 177.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 155' ' ' ARG . 5.6 tm-20 -69.56 -78.87 0.06 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.85 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.424 ' O ' ' N ' ' A' ' 158' ' ' PHE . 3.2 p -35.08 -30.66 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.473 0.709 . . . . 0.0 110.564 177.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -72.58 -51.43 19.79 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.083 -179.32 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 153' ' ' GLU . . . -67.32 -20.12 65.56 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.666 1.222 . . . . 0.0 107.793 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -83.09 -44.62 14.94 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 112.403 -2.181 . . . . 0.0 111.808 -178.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.424 ' N ' ' O ' ' A' ' 154' ' ' VAL . 49.4 t80 -130.63 -26.62 2.22 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.816 0.341 . . . . 0.0 111.84 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 92.18 25.74 20.81 Favored Glycine 0 N--CA 1.468 0.813 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -43.67 -96.74 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.498 -0.351 . . . . 0.0 111.189 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . 63.42 33.07 14.05 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -178.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.524 ' C ' ' H ' ' A' ' 164' ' ' VAL . 0.4 OUTLIER -174.24 -61.12 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.497 -179.58 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.83 28.93 0.28 Allowed 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.003 1.802 . . . . 0.0 110.652 177.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.565 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.4 m -130.63 166.91 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.088 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.5 t -121.51 65.68 17.28 Favored Pre-proline 0 N--CA 1.476 0.836 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.869 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.565 ' HD3' HG23 ' A' ' 164' ' ' VAL . 23.1 Cg_exo -35.41 139.07 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 123.628 2.885 . . . . 0.0 115.225 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 169.28 173.7 37.13 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.905 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -158.14 144.83 17.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.957 0.408 . . . . 0.0 110.51 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.9 t -148.09 152.58 37.59 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.656 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -61.64 -74.9 0.34 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 79.99 18.82 71.43 Favored Glycine 0 CA--C 1.517 0.172 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -68.31 -38.65 81.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 113.981 -1.11 . . . . 0.0 111.346 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 44.6 tp -61.66 -46.68 88.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.461 -178.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 42.21 62.92 7.35 Favored Pre-proline 0 N--CA 1.468 0.43 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.531 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' A' ' 176' ' ' SER . 64.0 Cg_endo -71.02 -22.28 26.54 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.388 2.059 . . . . 0.0 113.496 -178.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 175' ' ' PRO . 1.6 m 162.86 147.57 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.386 0.613 . . . . 0.0 110.033 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -102.07 -71.25 0.72 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.982 -178.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 45.4 pt -122.22 143.21 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.933 0.397 . . . . 0.0 111.016 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.407 HH21 ' CB ' ' A' ' 176' ' ' SER . 89.8 mtt180 -137.8 167.52 21.57 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.778 0.799 . . . . 0.0 111.949 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -83.97 106.7 15.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.205 -1.361 . . . . 0.0 110.355 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -65.01 -13.96 59.19 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.071 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.434 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.5 mm? -62.91 -42.0 99.65 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.33 -42.69 3.65 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.265 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 72.44 19.88 79.12 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -71.02 -172.93 0.74 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.13 0.49 . . . . 0.0 110.887 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.544 ' H ' ' CD2' ' A' ' 186' ' ' LEU . 0.8 OUTLIER -80.68 175.71 10.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.722 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -122.77 82.34 1.97 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.205 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -77.94 138.14 38.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.492 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.417 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 0.7 OUTLIER -173.45 -27.98 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.134 177.624 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.73 0 CA-C-O 117.932 -1.482 . . . . 0.0 110.647 179.834 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 56.6 p30 . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -62.42 -41.23 98.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.616 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -63.91 -40.39 96.37 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.289 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.547 HD12 ' N ' ' A' ' 5' ' ' LEU . 9.6 mp -61.68 -42.4 98.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.971 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -63.38 -45.57 90.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.09 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -61.62 -38.11 86.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.994 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.04 -43.6 98.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.686 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.93 -49.23 78.29 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.633 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.9 mm -63.92 -43.19 97.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.537 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.49 -46.7 83.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.705 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.0 -43.61 98.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.41 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.88 -53.24 59.75 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.62 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.9 pt -69.5 -38.85 77.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.482 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -58.76 -55.35 36.29 Favored 'General case' 0 C--O 1.214 -0.807 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.338 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 20' ' ' GLU . 91.1 t -61.72 -40.23 86.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.386 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.677 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.3 tt -52.56 -51.26 60.61 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.681 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -79.81 -50.48 10.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.873 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -63.67 -32.71 74.27 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.615 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 16' ' ' VAL . 96.8 mt-10 58.7 82.86 0.13 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.377 0.881 . . . . 0.0 113.377 178.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.28 -141.38 0.05 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.679 0.275 . . . . 0.0 110.488 177.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.0 p -135.13 139.16 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.475 HD12 ' O ' ' A' ' 24' ' ' ALA . 2.8 pp -129.02 164.16 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 120.924 0.392 . . . . 0.0 111.98 -178.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.475 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -64.28 141.88 58.61 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.939 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -145.55 160.81 43.53 Favored Pre-proline 0 CA--C 1.546 0.82 0 CA-C-O 119.047 -0.501 . . . . 0.0 110.522 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.52 157.17 32.46 Favored 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 121.579 1.519 . . . . 0.0 111.442 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.2 m -136.97 155.2 50.02 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.276 0.56 . . . . 0.0 110.538 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -83.78 14.54 3.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.729 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -160.43 -64.93 0.07 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.165 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.9 t -125.49 127.45 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.071 0.463 . . . . 0.0 110.685 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.561 ' CZ ' HG13 ' A' ' 151' ' ' VAL . 35.8 t80 -56.72 131.07 48.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.313 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -141.03 -153.62 6.01 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.5 m -131.57 166.68 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -156.99 -179.95 32.32 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.987 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.406 ' O ' HD12 ' A' ' 135' ' ' LEU . 0.6 OUTLIER -153.68 -179.58 7.93 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -179.667 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 37' ' ' PRO . 36.7 t70 -91.98 110.08 41.56 Favored Pre-proline 0 CA--C 1.552 1.033 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 36' ' ' ASP . 57.0 Cg_exo -36.79 173.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 123.039 2.493 . . . . 0.0 114.517 177.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 49.01 64.64 1.64 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.861 -1.518 . . . . 0.0 111.216 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 65.2 m -147.2 138.03 23.65 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.043 0.449 . . . . 0.0 110.405 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.46 -35.95 73.62 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.531 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 41' ' ' THR . 0.3 OUTLIER -64.06 -42.59 96.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.463 -179.068 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.92 75.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.643 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 p -62.4 -44.91 99.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.277 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 90.0 mtp -64.01 -40.84 97.26 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 27.8 ttt-85 -61.4 -41.52 97.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.448 ' O ' HD23 ' A' ' 46' ' ' LEU . 1.0 OUTLIER -64.41 -54.3 34.92 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.595 -178.236 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.4 mt -69.74 -12.12 61.38 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.246 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -69.03 -82.54 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.149 0.5 . . . . 0.0 111.133 -177.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -76.21 -35.1 59.22 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -178.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -76.45 -50.41 14.14 Favored 'General case' 0 C--N 1.344 0.358 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.901 -177.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 35.52 65.5 0.4 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.995 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.415 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 6.7 mtm-85 178.49 -52.85 0.0 OUTLIER Pre-proline 0 CA--C 1.551 0.986 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.644 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.415 ' HD2' ' H ' ' A' ' 52' ' ' ARG . 91.1 Cg_endo -79.25 -4.28 13.65 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.875 2.384 . . . . 0.0 112.537 -178.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.602 HG13 ' N ' ' A' ' 55' ' ' ASP . 10.9 p -47.35 -44.76 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.111 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.602 ' N ' HG13 ' A' ' 54' ' ' VAL . 41.3 t0 -66.47 -40.44 89.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.445 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -60.69 -38.04 83.66 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 64.89 107.27 0.01 OUTLIER Glycine 0 CA--C 1.518 0.264 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.567 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -52.34 -163.32 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.022 0.439 . . . . 0.0 111.673 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.449 ' O ' ' OG ' ' A' ' 137' ' ' SER . 73.6 mt -109.07 135.16 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.3 mt -109.79 142.12 41.48 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.478 ' O ' HG23 ' A' ' 61' ' ' ILE . 9.3 tp -110.21 123.93 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-O 121.033 0.444 . . . . 0.0 111.304 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.507 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -113.99 157.15 22.84 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.499 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.97 -24.51 4.75 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.453 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -115.88 130.66 56.92 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.73 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -63.99 -13.03 43.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.752 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -50.57 -30.36 13.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.622 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.06 -15.87 21.94 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.546 HD22 ' N ' ' A' ' 68' ' ' LEU . 3.9 mm? -92.11 -15.32 27.88 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.666 -0.646 . . . . 0.0 109.329 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.474 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 35.4 tttp -80.53 -38.52 1.08 Allowed Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.693 -178.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 66.0 Cg_endo -103.55 -2.77 0.27 Allowed 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 122.663 2.242 . . . . 0.0 111.896 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.471 ' OH ' HD21 ' A' ' 114' ' ' LEU . 60.7 t80 -97.89 -9.46 26.29 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.032 -178.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.543 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.3 mp -131.86 159.38 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.543 ' N ' HG22 ' A' ' 72' ' ' ILE . 95.8 m-20 -65.56 158.57 26.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.968 0.413 . . . . 0.0 110.389 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 74' ' ' ASP . 37.1 p-10 -93.72 9.35 37.37 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.882 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.469 HG23 ' N ' ' A' ' 76' ' ' MET . 13.6 t -75.85 -39.16 57.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.131 0.491 . . . . 0.0 110.538 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.469 ' N ' HG23 ' A' ' 75' ' ' THR . 20.9 ptp -96.9 -15.28 21.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.257 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.7 tp -100.21 125.68 46.4 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.436 0.636 . . . . 0.0 111.331 -177.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.476 ' OG1' ' N ' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -148.76 178.46 8.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.984 -178.143 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.476 ' N ' ' OG1' ' A' ' 78' ' ' THR . 98.2 m-20 -59.97 -42.49 94.27 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 123.233 0.333 . . . . 0.0 111.082 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.6 p -61.05 -31.23 49.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.533 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -62.74 -41.61 99.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.391 0.615 . . . . 0.0 109.939 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.407 ' HG2' ' H ' ' A' ' 82' ' ' ARG . 12.6 mmt85 -65.46 -53.77 38.0 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 122.379 1.085 . . . . 0.0 109.821 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 87' ' ' SER . 82.0 tt0 -53.74 -50.34 66.18 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.317 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.1 m -62.39 -49.8 74.08 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.576 -1.193 . . . . 0.0 112.138 -177.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 89' ' ' TRP . 8.4 tt -68.54 -26.2 32.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.484 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -87.82 -22.52 24.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.932 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 83' ' ' GLU . 68.4 m -107.17 -56.07 2.25 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.573 ' O ' ' CG ' ' A' ' 89' ' ' TRP . 78.7 ttt-85 -61.61 -45.79 92.58 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.474 -178.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.573 ' CG ' ' O ' ' A' ' 88' ' ' ARG . 1.1 m0 174.72 154.37 0.31 Allowed Pre-proline 0 N--CA 1.47 0.532 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -68.71 -16.99 42.62 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.319 2.013 . . . . 0.0 111.452 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.452 ' H ' ' HD3' ' A' ' 92' ' ' PRO . . . 97.14 69.24 0.98 Allowed Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.452 ' HD3' ' H ' ' A' ' 91' ' ' GLY . 52.1 Cg_exo -54.98 -37.25 93.71 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.478 2.119 . . . . 0.0 111.38 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.1 p -77.98 144.4 11.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.536 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 27.2 m -93.57 143.57 26.18 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.385 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.42 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 63.5 m-85 -127.39 145.09 50.93 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.436 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.608 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.9 t -96.57 103.51 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 121.545 0.688 . . . . 0.0 110.145 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -89.39 148.0 39.47 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.55 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -77.76 111.59 3.15 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.93 1.753 . . . . 0.0 111.278 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.47 148.26 90.44 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.421 ' O ' ' OG1' ' A' ' 103' ' ' THR . 38.6 Cg_endo -63.94 146.4 91.33 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.901 1.734 . . . . 0.0 112.272 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.47 -35.7 81.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.67 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 76.3 p -56.04 -41.37 74.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.52 -179.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.487 ' O ' ' O ' ' A' ' 104' ' ' PRO . 3.4 p -63.74 156.11 73.79 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 120.399 -0.521 . . . . 0.0 109.938 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' A' ' 103' ' ' THR . 73.9 Cg_exo -47.32 -156.41 0.0 OUTLIER 'Trans proline' 0 N--CA 1.505 2.161 0 C-N-CA 122.812 2.341 . . . . 0.0 114.245 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.527 ' NH2' ' O ' ' A' ' 110' ' ' ARG . 4.1 tpt180 -136.16 -1.11 2.42 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.198 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -75.0 -1.24 21.78 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.011 0.434 . . . . 0.0 110.895 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.934 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -86.56 -17.9 32.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.669 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.633 ' N ' HD22 ' A' ' 107' ' ' LEU . 95.2 m -142.01 -39.99 0.36 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.374 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 74.83 18.95 80.11 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.361 179.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.527 ' O ' ' NH2' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -158.35 -74.1 0.08 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 117.313 0.557 . . . . 0.0 110.434 179.433 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -102.78 -173.68 2.38 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.26 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 49.1 p30 -115.38 57.88 0.73 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.786 0.327 . . . . 0.0 111.051 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.0 p -159.03 159.52 34.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.32 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.769 ' O ' HD12 ' A' ' 114' ' ' LEU . 4.6 pp -166.15 142.54 5.02 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.401 ' N ' HG13 ' A' ' 96' ' ' VAL . . . -68.8 121.48 16.61 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 113.349 -1.751 . . . . 0.0 109.276 177.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.433 HG22 ' N ' ' A' ' 117' ' ' ARG . 4.9 p -142.36 157.15 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.433 ' N ' HG22 ' A' ' 116' ' ' VAL . 62.1 ttp180 -146.48 149.83 34.42 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.157 0.503 . . . . 0.0 111.46 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.507 HG22 ' HB3' ' A' ' 62' ' ' ALA . 61.5 t -115.05 134.28 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.3 t -129.87 151.09 50.82 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.025 0.441 . . . . 0.0 110.924 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 49.9 p-10 -151.87 85.57 1.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.196 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.62 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 9.2 t60 -171.67 -38.03 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.62 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 74.2 Cg_endo -97.49 -159.45 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.931 0 C-N-CA 122.45 2.1 . . . . 0.0 112.318 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 32.5 mt -79.71 -4.99 54.27 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.343 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 74.2 t -57.08 -46.13 84.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.777 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.75 HG23 ' H ' ' A' ' 126' ' ' ALA . 30.2 m -55.24 -61.49 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.302 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.024 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.75 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -40.44 -47.09 2.55 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.844 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.695 HD13 ' C ' ' A' ' 127' ' ' LEU . 2.8 tm? -69.82 -47.28 63.36 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.571 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 85.3 m -68.71 -47.3 66.71 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.103 0.477 . . . . 0.0 111.296 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.462 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.3 pp0? -55.63 -43.06 75.81 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.462 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -59.48 -56.09 26.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.311 -177.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -63.16 -35.66 81.03 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.128 -1.397 . . . . 0.0 108.346 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 89.96 3.32 73.6 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 113.388 -1.733 . . . . 0.0 109.684 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -141.79 153.77 64.98 Favored Pre-proline 0 CA--C 1.552 1.043 0 CA-C-N 117.258 0.529 . . . . 0.0 111.21 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -48.46 -174.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 123.724 2.949 . . . . 0.0 113.969 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.406 HD12 ' O ' ' A' ' 35' ' ' CYS . 8.1 tp -140.8 125.36 17.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 113.02 -1.9 . . . . 0.0 106.31 177.12 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.428 HG13 ' H ' ' A' ' 136' ' ' VAL . 0.9 OUTLIER -64.67 142.93 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 C-N-CA 118.179 -1.408 . . . . 0.0 108.931 -179.494 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 59' ' ' ILE . 0.8 OUTLIER -108.96 121.1 44.42 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 123.762 0.664 . . . . 0.0 110.583 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 18.7 m -132.18 145.47 51.37 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.9 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.1 m -66.7 144.12 56.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.529 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.11 88.57 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -162.23 164.33 27.75 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.275 0.56 . . . . 0.0 110.589 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.8 -163.85 1.82 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.173 -178.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 80.2 p -63.54 -40.41 96.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.752 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -159.35 0.81 0.09 OUTLIER Glycine 0 N--CA 1.461 0.332 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.488 HD13 ' C ' ' A' ' 145' ' ' LEU . 1.2 tm? -79.24 111.83 23.49 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 145' ' ' LEU . 14.3 Cg_exo -33.59 155.23 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.213 1.942 . . . . 0.0 113.095 -179.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.51 -168.79 0.37 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.513 2.142 . . . . 0.0 112.555 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 15.3 m -129.81 82.37 2.07 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.477 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 52.2 ptt85 -52.25 -37.49 55.46 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.362 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.28 173.63 14.74 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.561 HG13 ' CZ ' ' A' ' 31' ' ' PHE . 1.2 m -58.81 -23.92 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 CA-C-O 121.567 0.699 . . . . 0.0 109.386 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -64.73 -27.27 68.79 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 155' ' ' ARG . 0.0 OUTLIER -68.99 -79.52 0.06 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.449 179.194 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.405 HG13 ' N ' ' A' ' 155' ' ' ARG . 7.7 p -34.67 -30.23 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.607 0.763 . . . . 0.0 110.418 178.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 159' ' ' GLY . 4.8 tmt_? -71.9 -52.89 15.07 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.082 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 153' ' ' GLU . . . -69.93 -18.37 63.37 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 122.493 1.14 . . . . 0.0 108.186 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -84.16 -44.69 13.73 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 112.87 -1.968 . . . . 0.0 111.578 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -130.37 -24.88 2.49 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 91.03 23.95 28.54 Favored Glycine 0 N--CA 1.47 0.948 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 -178.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -43.9 -93.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.584 -0.308 . . . . 0.0 111.091 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . 60.06 31.11 20.47 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.531 ' C ' ' H ' ' A' ' 164' ' ' VAL . 0.5 OUTLIER -170.19 -61.38 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.903 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -72.85 29.5 0.29 Allowed 'Trans proline' 0 N--CA 1.502 1.99 0 C-N-CA 122.283 1.989 . . . . 0.0 110.515 177.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.577 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.7 m -132.44 167.0 27.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.64 -178.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.1 t -123.63 66.86 37.69 Favored Pre-proline 0 N--CA 1.476 0.871 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.65 178.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.577 ' HD3' HG23 ' A' ' 164' ' ' VAL . 29.8 Cg_exo -38.45 147.22 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 123.693 2.929 . . . . 0.0 115.015 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 168.49 134.28 1.7 Allowed Glycine 0 CA--C 1.528 0.849 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.2 178.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -80.92 152.12 28.23 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.5 t -145.55 148.35 33.09 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.125 0.488 . . . . 0.0 111.222 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -54.81 -66.87 2.52 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 173' ' ' LEU . . . 93.54 6.88 62.2 Favored Glycine 0 N--CA 1.466 0.661 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -76.97 26.19 0.14 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.818 -0.691 . . . . 0.0 110.903 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.583 ' N ' HD12 ' A' ' 173' ' ' LEU . 9.2 mp 53.32 -166.98 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -138.16 150.21 66.23 Favored Pre-proline 0 N--CA 1.469 0.503 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.57 -15.8 41.87 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.085 1.856 . . . . 0.0 111.82 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 27.6 p -155.04 155.94 35.02 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.087 0.47 . . . . 0.0 110.09 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.7 ' H ' ' NH1' ' A' ' 179' ' ' ARG . 96.2 mt-10 -128.72 -95.57 0.41 Allowed 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.569 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.7 pt -101.04 130.35 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 120.978 0.418 . . . . 0.0 110.337 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.7 ' NH1' ' H ' ' A' ' 177' ' ' GLU . 7.6 mpt_? -123.44 163.3 21.13 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.601 0.715 . . . . 0.0 110.26 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -77.95 104.43 8.51 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.513 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -63.95 -17.66 63.49 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.879 -178.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.467 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.4 mm? -62.5 -42.26 99.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.947 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.53 -41.54 8.12 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 60.74 25.44 63.62 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -54.3 128.64 32.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.054 0.454 . . . . 0.0 110.572 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.635 ' H ' ' CD2' ' A' ' 186' ' ' LEU . 0.7 OUTLIER -97.5 178.49 5.17 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.609 -179.792 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -87.95 -33.64 18.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.657 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -70.73 141.44 51.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.701 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -138.04 -24.5 1.0 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.825 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.739 0 CA-C-O 118.073 -1.404 . . . . 0.0 110.873 179.756 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 55.0 p30 -99.57 11.05 40.22 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.921 0.391 . . . . 0.0 110.565 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -63.9 -40.94 97.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.501 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.538 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.3 mp -62.19 -42.59 99.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.164 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -65.03 -41.49 95.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.708 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -64.51 -42.54 95.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.075 0.465 . . . . 0.0 110.758 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.432 ' OD2' ' O ' ' A' ' 164' ' ' VAL . 66.1 t0 -65.78 -45.78 81.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.332 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.54 -48.75 73.92 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.456 HG23 ' N ' ' A' ' 11' ' ' ALA . 19.3 tt -67.35 -41.75 86.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.177 0.513 . . . . 0.0 110.761 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.456 ' N ' HG23 ' A' ' 10' ' ' ILE . . . -61.53 -40.9 96.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.754 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.95 -46.41 74.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.956 0.408 . . . . 0.0 110.525 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.78 -50.57 70.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.229 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.3 pp -68.92 -38.85 79.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.346 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.35 -54.52 45.84 Favored 'General case' 0 C--O 1.216 -0.71 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.264 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.426 ' O ' ' N ' ' A' ' 20' ' ' GLU . 99.5 t -60.54 -40.1 83.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.606 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.697 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.2 tt -52.41 -49.92 63.55 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.846 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -82.17 -51.2 8.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.614 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -63.65 -33.64 76.07 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.282 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.5 mt-10 58.16 83.26 0.12 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.451 179.098 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.4 -145.96 0.15 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.405 178.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.2 p -133.33 140.31 47.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -128.19 165.46 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-O 120.859 0.362 . . . . 0.0 111.531 -178.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.47 127.14 30.24 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.633 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.474 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 0.6 OUTLIER -117.09 140.49 27.15 Favored Pre-proline 0 N--CA 1.473 0.721 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.741 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.474 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 93.3 Cg_endo -77.3 144.06 22.81 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.242 1.295 . . . . 0.0 111.651 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.8 m -137.66 134.43 35.43 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.433 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -53.38 -44.85 68.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.167 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.94 -81.33 0.07 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.632 0.253 . . . . 0.0 111.444 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 71.8 t -133.32 128.69 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -36.77 144.67 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.773 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -141.17 -163.93 9.74 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.9 m -130.67 168.72 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -160.18 -179.34 34.9 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 119.963 -1.113 . . . . 0.0 112.297 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -157.97 -168.2 2.44 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.975 -179.242 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 19.9 p-10 -93.24 108.7 35.07 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 36' ' ' ASP . 33.7 Cg_exo -36.86 172.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.972 2.448 . . . . 0.0 114.574 177.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 41.76 73.32 0.13 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.231 -1.349 . . . . 0.0 111.124 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.1 m -153.39 134.34 13.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.608 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -67.69 -34.16 76.34 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.811 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.574 HG23 ' N ' ' A' ' 42' ' ' ALA . 15.1 t -63.34 -46.49 86.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.996 -178.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.574 ' N ' HG23 ' A' ' 41' ' ' THR . . . -60.12 -50.43 73.74 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.538 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 p -62.04 -45.23 99.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.831 0.348 . . . . 0.0 110.279 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 61.7 mtt -64.36 -39.53 94.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.865 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 -60.91 -34.25 74.39 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 123.537 0.523 . . . . 0.0 109.831 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 82.2 mt -73.56 -60.39 2.27 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.2 mt -54.77 -18.02 4.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.678 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -67.85 -84.67 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.901 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -75.86 -33.06 59.99 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.581 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -76.1 -69.69 0.49 Allowed 'General case' 0 C--N 1.348 0.525 0 C-N-CA 119.421 -0.911 . . . . 0.0 110.382 -177.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 50.89 80.27 0.08 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.706 0.765 . . . . 0.0 109.201 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.7 mtm180 162.87 -62.71 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.271 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.14 -15.51 48.72 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.423 2.082 . . . . 0.0 112.455 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.612 HG13 ' N ' ' A' ' 55' ' ' ASP . 10.9 p -41.79 -49.31 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.72 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.612 ' N ' HG13 ' A' ' 54' ' ' VAL . 37.0 t0 -65.38 -41.87 93.28 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.029 0.443 . . . . 0.0 110.935 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -59.89 -37.06 78.29 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.392 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 63.32 107.8 0.01 OUTLIER Glycine 0 CA--C 1.519 0.284 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.566 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -52.92 -162.46 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.216 0.531 . . . . 0.0 111.661 -179.449 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.7 mt -108.17 146.95 13.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.7 mt -119.62 139.29 52.42 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.8 tp -110.28 133.08 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-O 121.133 0.492 . . . . 0.0 110.917 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.403 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -121.73 152.43 39.43 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.469 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.65 -29.6 7.95 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -111.29 149.8 30.56 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.233 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -79.26 -14.11 59.24 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -53.01 -30.83 37.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.961 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.02 -12.05 27.32 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.59 HD22 ' N ' ' A' ' 68' ' ' LEU . 3.3 mm? -92.57 -16.25 25.93 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.002 0.819 . . . . 0.0 108.97 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.467 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 50.9 tttm -77.71 -38.83 1.82 Allowed Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.671 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 67.1 Cg_endo -104.73 -2.64 0.2 Allowed 'Trans proline' 0 C--N 1.318 -1.03 0 C-N-CA 122.835 2.356 . . . . 0.0 112.648 -178.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -97.78 -8.46 28.45 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.749 0.309 . . . . 0.0 110.791 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.611 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.3 mp -135.75 162.97 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.611 ' N ' HG22 ' A' ' 72' ' ' ILE . 92.6 m-20 -64.78 156.65 29.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.628 -0.429 . . . . 0.0 109.857 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -94.29 8.48 41.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.76 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.528 HG23 ' N ' ' A' ' 76' ' ' MET . 14.9 t -73.58 -41.73 62.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.181 0.515 . . . . 0.0 110.568 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.528 ' N ' HG23 ' A' ' 75' ' ' THR . 21.7 ptp -90.12 -7.37 53.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.095 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 tp -102.0 120.41 40.37 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.097 0.475 . . . . 0.0 110.746 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -159.12 160.68 35.91 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.576 -177.828 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -39.13 -48.17 1.67 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.789 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.3 p -62.96 -33.19 59.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.852 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 78' ' ' THR . 63.6 tp60 -65.49 -39.66 92.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.974 0.416 . . . . 0.0 110.764 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.1 mmt85 -65.07 -52.14 57.4 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 122.523 1.154 . . . . 0.0 109.181 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -55.35 -50.5 69.51 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 113.702 -1.59 . . . . 0.0 110.235 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.1 m -61.19 -49.92 75.24 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.167 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 85' ' ' ILE . 9.0 tt -67.98 -34.07 64.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.202 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -75.66 -39.36 57.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.865 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.5 m -77.4 -32.46 54.82 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 120.991 0.424 . . . . 0.0 110.955 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 89' ' ' TRP . 76.1 ttt180 -97.14 75.93 2.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.389 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.435 ' O ' ' O ' ' A' ' 88' ' ' ARG . 57.7 m95 56.19 150.19 0.06 OUTLIER Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.244 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.77 -19.84 35.53 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.277 1.985 . . . . 0.0 111.738 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 163.11 82.03 0.04 OUTLIER Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -80.84 -30.91 1.58 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.352 2.035 . . . . 0.0 112.169 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.532 ' O ' ' CE1' ' A' ' 95' ' ' PHE . 9.4 p -136.76 149.14 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.738 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 91.8 m -91.59 143.16 26.86 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.627 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.543 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 0.2 OUTLIER -125.5 147.01 49.4 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.207 179.24 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.617 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 3.0 t -99.6 107.84 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 121.376 0.607 . . . . 0.0 109.394 178.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.402 ' CE1' ' HB1' ' A' ' 181' ' ' ALA . 58.8 m-85 -94.53 151.17 39.08 Favored Pre-proline 0 N--CA 1.47 0.552 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.734 -178.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.11 106.44 2.27 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 121.695 1.597 . . . . 0.0 110.403 178.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.81 150.1 83.34 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.02 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 101' ' ' ALA . 98.9 Cg_endo -73.07 157.49 50.74 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.379 2.053 . . . . 0.0 112.986 -178.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.438 ' O ' ' O ' ' A' ' 100' ' ' PRO . . . 57.27 126.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.627 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.6 p -99.46 -5.26 29.7 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.569 ' N ' ' CD ' ' A' ' 104' ' ' PRO . 0.2 OUTLIER -55.79 -42.56 96.73 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.145 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 103' ' ' THR . 37.5 Cg_endo -90.01 177.63 2.45 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.742 2.295 . . . . 0.0 111.154 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.523 ' O ' ' N ' ' A' ' 109' ' ' GLY . 11.6 tpp180 -159.92 5.03 0.08 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.679 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 61.7 p-90 -73.6 -10.75 60.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.929 0.395 . . . . 0.0 110.434 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.952 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -85.99 -16.56 37.9 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.115 -179.766 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.623 ' N ' HD22 ' A' ' 107' ' ' LEU . 98.9 m -141.9 -39.53 0.37 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.724 0.297 . . . . 0.0 110.8 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 82.31 13.86 77.84 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.66 -68.83 0.06 Allowed 'General case' 0 CA--C 1.535 0.366 0 O-C-N 122.444 -0.445 . . . . 0.0 110.166 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -103.58 -162.47 0.91 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.967 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.9 p-10 -127.64 62.29 1.39 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.026 0.441 . . . . 0.0 110.957 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.2 p -158.77 157.47 31.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.015 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.514 ' O ' HD12 ' A' ' 114' ' ' LEU . 0.3 OUTLIER -160.41 140.9 11.66 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -179.258 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.431 ' N ' HG13 ' A' ' 96' ' ' VAL . . . -70.58 126.93 31.01 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 113.094 -1.867 . . . . 0.0 109.702 177.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.4 p -146.02 152.83 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -147.81 156.94 43.25 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.783 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.403 HG22 ' HB3' ' A' ' 62' ' ' ALA . 54.7 t -119.74 132.32 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.432 ' O ' HG23 ' A' ' 119' ' ' THR . 11.3 t -133.27 128.36 35.66 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.734 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -135.82 84.1 2.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.925 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.66 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 16.6 t-80 -173.2 -35.63 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.58 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.66 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 67.7 Cg_endo -94.74 -159.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.935 0 C-N-CA 121.995 1.797 . . . . 0.0 111.907 -178.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 36.7 mt -77.69 -7.38 56.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.535 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 95.7 t -57.46 -45.27 85.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.716 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.752 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.9 m -51.63 -62.05 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.943 0 C-N-CA 119.555 -0.858 . . . . 0.0 108.797 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.752 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.34 -44.81 2.86 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.792 0.329 . . . . 0.0 110.809 178.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.441 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -66.33 -50.96 61.83 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 121.27 0.557 . . . . 0.0 110.723 179.461 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 62.3 m -69.64 -48.46 59.82 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.326 0.584 . . . . 0.0 111.558 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.457 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 0.8 OUTLIER -54.58 -42.38 70.96 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.451 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -59.28 -55.5 34.02 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.583 -177.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -62.62 -24.71 67.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.191 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.69 2.07 88.85 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 134' ' ' PRO . 59.7 mttt -153.53 159.54 32.0 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 133' ' ' LYS . 3.6 Cg_exo -42.23 177.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 123.876 3.051 . . . . 0.0 113.008 -178.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.3 tp -132.38 122.42 24.99 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.417 HG13 ' H ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -64.14 147.47 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 C-N-CA 117.775 -1.57 . . . . 0.0 106.83 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.9 t -122.54 127.26 49.27 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.206 0.527 . . . . 0.0 111.269 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.9 162.18 30.22 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.663 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.6 m -73.59 145.95 45.06 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.95 88.28 2.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.367 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 56.8 p30 -160.74 164.39 31.61 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.342 0.592 . . . . 0.0 110.421 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.57 -167.15 2.13 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.991 -178.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.1 p -61.77 -40.19 94.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.785 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -162.18 9.81 0.1 Allowed Glycine 0 N--CA 1.459 0.216 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.6 tp -89.99 126.88 55.83 Favored Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -37.52 157.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.942 1.761 . . . . 0.0 112.516 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.0 -166.45 0.37 Allowed 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.578 2.186 . . . . 0.0 112.668 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 7.4 t -118.14 76.7 1.09 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.359 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -56.47 -33.89 66.38 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.389 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -162.72 169.56 19.81 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.104 -0.639 . . . . 0.0 109.319 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.433 ' H ' HG22 ' A' ' 151' ' ' VAL . 0.9 OUTLIER -58.6 -20.33 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.285 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -65.21 -33.05 75.09 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 177.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.447 ' O ' ' N ' ' A' ' 155' ' ' ARG . 6.5 tm-20 -63.72 -79.78 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.804 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.431 HG11 HG11 ' A' ' 164' ' ' VAL . 7.3 p -36.11 -30.42 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.589 0.756 . . . . 0.0 110.643 178.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.447 ' N ' ' O ' ' A' ' 153' ' ' GLU . 4.1 tmt_? -71.77 -49.17 41.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.243 0.544 . . . . 0.0 111.79 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 153' ' ' GLU . . . -71.45 -18.1 62.33 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 122.628 1.204 . . . . 0.0 108.004 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.17 -55.27 4.45 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 112.349 -2.205 . . . . 0.0 112.149 -177.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -123.99 -18.05 6.07 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -177.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 85.18 25.05 41.62 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -42.3 -94.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.649 0.262 . . . . 0.0 111.437 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.405 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.95 33.83 17.14 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.365 0.602 . . . . 0.0 109.46 -178.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.519 ' C ' ' H ' ' A' ' 164' ' ' VAL . 1.8 m-85 -172.42 -62.56 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.353 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.39 28.51 0.27 Allowed 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 122.438 2.092 . . . . 0.0 110.579 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.545 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.8 m -131.52 167.93 25.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.79 -178.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.0 t -124.12 64.6 35.99 Favored Pre-proline 0 N--CA 1.473 0.724 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.055 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.545 ' HD3' HG23 ' A' ' 164' ' ' VAL . 42.6 Cg_exo -39.95 149.23 0.13 Allowed 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 123.453 2.769 . . . . 0.0 114.616 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 172.47 -141.18 6.11 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 114.33 -1.305 . . . . 0.0 111.813 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -147.79 179.88 7.39 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.752 0.311 . . . . 0.0 110.195 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.3 t -144.83 158.21 43.88 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.106 0.479 . . . . 0.0 110.631 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 167.37 62.74 0.03 OUTLIER Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -161.7 89.78 0.11 Allowed Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -136.5 88.48 2.38 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.755 0.312 . . . . 0.0 111.013 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.542 HD22 ' N ' ' A' ' 173' ' ' LEU . 2.9 mm? -82.94 -112.35 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.257 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -85.36 149.82 53.01 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.398 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.92 157.68 54.31 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.089 1.86 . . . . 0.0 112.049 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.4 m 68.69 97.31 0.06 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.643 0.735 . . . . 0.0 110.693 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -84.81 -15.52 44.55 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.482 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 31.9 pt -91.72 135.56 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.401 0.619 . . . . 0.0 111.26 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -135.28 171.74 14.0 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.254 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 184' ' ' GLY . 98.6 m-20 -78.76 104.54 9.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.227 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.617 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -65.18 -20.23 66.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.573 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.508 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.5 mm? -63.77 -42.67 97.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.486 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.18 -44.3 3.02 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.49 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 180' ' ' ASP . . . 66.28 25.14 72.34 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -69.52 -178.71 1.49 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.088 0.471 . . . . 0.0 110.763 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.468 ' H ' ' CD2' ' A' ' 186' ' ' LEU . 0.8 OUTLIER -81.33 177.23 9.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.53 -179.952 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -87.57 -39.29 15.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.564 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.5 138.78 51.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.716 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -149.05 -26.19 0.3 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.122 0.487 . . . . 0.0 110.359 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.71 0 CA-C-O 117.95 -1.472 . . . . 0.0 110.883 -179.652 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -63.54 -40.62 97.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.274 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 39.2 p-10 -155.1 7.66 0.27 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.576 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.529 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.1 mp -62.4 -42.17 99.22 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -63.67 -42.32 98.08 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -63.08 -41.68 99.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.771 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 162' ' ' PHE . 63.6 t0 -59.09 -46.99 86.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.498 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.34 -44.39 97.27 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.191 0.519 . . . . 0.0 110.082 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.7 mt -63.56 -42.97 97.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.469 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.73 -43.92 81.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.572 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.17 -47.11 85.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.459 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.69 -52.18 66.62 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.7 pt -68.14 -38.97 80.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.112 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -57.95 -52.92 63.5 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.215 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 20' ' ' GLU . 96.8 t -61.17 -40.55 86.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.703 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.676 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.3 tt -52.51 -51.1 61.16 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.673 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -79.88 -50.62 10.22 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.774 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -63.45 -31.64 72.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.027 0.442 . . . . 0.0 110.721 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 16' ' ' VAL . 96.5 mt-10 58.55 81.09 0.16 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 178.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.85 -146.71 0.1 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.813 0.34 . . . . 0.0 110.641 177.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.421 HG12 ' NH2' ' A' ' 45' ' ' ARG . 5.8 p -128.16 139.67 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.434 HD12 ' O ' ' A' ' 24' ' ' ALA . 2.8 pp -128.96 167.76 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 120.892 0.377 . . . . 0.0 111.564 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.434 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -63.88 135.87 56.92 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.325 0.583 . . . . 0.0 111.528 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.5 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 1.6 t80 -127.96 139.19 34.67 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.5 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 68.1 Cg_endo -78.99 144.61 18.97 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 121.327 1.351 . . . . 0.0 111.572 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.503 ' C ' ' H ' ' A' ' 29' ' ' ALA . 47.6 m -134.19 132.93 40.35 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.74 0.305 . . . . 0.0 110.416 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -72.97 32.13 0.07 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.635 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.503 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -156.91 -77.75 0.09 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.723 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.1 p -128.36 130.3 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -44.01 142.6 1.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.141 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.29 -175.71 22.64 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.1 m -129.72 171.21 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.413 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -159.54 -179.38 34.31 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.111 -1.042 . . . . 0.0 111.896 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.471 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 1.4 p -159.42 -161.83 0.98 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 120.209 -0.596 . . . . 0.0 112.015 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.471 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 68.0 m-20 -93.02 107.07 22.15 Favored Pre-proline 0 CA--C 1.557 1.218 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -37.88 -61.73 0.34 Allowed 'Trans proline' 0 N--CA 1.5 1.854 0 C-N-CA 122.592 2.195 . . . . 0.0 112.928 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -76.45 69.51 2.92 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.364 -178.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.1 m -153.66 130.93 11.21 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.793 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.62 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -69.58 -33.26 72.46 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.59 -179.934 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.504 HG23 ' N ' ' A' ' 42' ' ' ALA . 14.2 t -57.56 -41.85 81.88 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.636 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.504 ' N ' HG23 ' A' ' 41' ' ' THR . . . -60.04 -52.55 64.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.498 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.405 ' H ' HG13 ' A' ' 43' ' ' VAL . 0.8 OUTLIER -61.58 -42.97 96.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-O 120.974 0.416 . . . . 0.0 110.511 -178.719 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.418 ' O ' ' CG ' ' A' ' 48' ' ' GLU . 56.8 mtt -65.19 -52.75 52.94 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.547 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.421 ' NH2' HG12 ' A' ' 22' ' ' VAL . 7.4 ptm180 -62.75 -37.31 86.09 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.186 0.517 . . . . 0.0 111.36 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -66.57 -53.42 34.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.407 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.449 HD22 HG23 ' A' ' 54' ' ' VAL . 7.8 mt -78.49 -7.59 57.63 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.187 -178.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 44' ' ' MET . 1.3 mm-40 -68.64 -79.93 0.05 Allowed 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.312 0.577 . . . . 0.0 111.707 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.423 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -71.7 -37.56 70.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.775 -177.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -67.76 -47.93 67.83 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.787 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 30.24 66.59 0.12 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.032 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.418 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 3.5 mtt180 -178.31 -54.76 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.604 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 52' ' ' ARG . 71.4 Cg_endo -72.99 -1.43 10.48 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.965 1.777 . . . . 0.0 109.448 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.449 HG23 HD22 ' A' ' 47' ' ' LEU . 0.7 OUTLIER -45.17 -48.99 3.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.435 -179.618 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -71.59 -39.61 70.43 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 110.936 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.409 ' N ' ' CD ' ' A' ' 56' ' ' LYS . 1.1 mptm? -61.2 -38.8 87.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.306 -179.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 62.33 107.8 0.01 OUTLIER Glycine 0 CA--C 1.521 0.437 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.553 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -54.1 -160.24 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.52 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.2 mt -110.04 148.14 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.095 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.4 mt -122.61 142.01 51.1 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.3 tp -109.44 131.02 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-O 120.878 0.37 . . . . 0.0 110.854 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.31 146.84 45.72 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.94 -29.19 10.63 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.114 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -117.95 152.27 35.8 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.146 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -79.85 -14.34 58.73 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.632 0.73 . . . . 0.0 109.438 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -51.58 -32.55 29.01 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.206 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.12 -8.93 41.25 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.893 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -90.76 -18.87 24.22 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.555 ' NZ ' HH12 ' A' ' 82' ' ' ARG . 32.6 mttp -76.22 -37.92 2.21 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 63.2 Cg_endo -104.82 -2.51 0.2 Allowed 'Trans proline' 0 C--N 1.319 -1.019 0 C-N-CA 122.868 2.378 . . . . 0.0 112.755 -178.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -93.87 -10.98 32.11 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.723 0.296 . . . . 0.0 111.158 -178.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.635 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.2 mp -125.45 168.76 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.635 ' N ' HG22 ' A' ' 72' ' ' ILE . 91.5 m-20 -63.14 -17.9 62.86 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.869 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.6 t70 57.04 22.38 7.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.929 0.395 . . . . 0.0 110.8 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.526 HG23 ' N ' ' A' ' 76' ' ' MET . 13.6 t -88.76 -41.56 12.47 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.779 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.526 ' N ' HG23 ' A' ' 75' ' ' THR . 14.2 ptp -84.38 -21.89 30.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.142 179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 tp -73.18 136.25 44.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.663 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.27 165.56 35.91 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.682 -177.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -48.45 -45.61 36.7 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.211 0.32 . . . . 0.0 111.799 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.1 p -61.96 -33.27 57.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.175 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 66.7 tp60 -64.4 -40.04 95.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.922 0.391 . . . . 0.0 110.455 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.555 HH12 ' NZ ' ' A' ' 69' ' ' LYS . 5.5 mmt85 -64.2 -53.09 54.76 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 122.256 1.027 . . . . 0.0 109.169 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -54.63 -50.2 68.69 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.884 -1.507 . . . . 0.0 109.984 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 m -61.33 -50.01 74.66 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.412 -1.267 . . . . 0.0 112.003 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.8 tt -68.44 -31.16 50.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.863 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -77.53 -36.29 52.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.528 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.8 m -85.57 -18.91 31.99 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.098 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 89' ' ' TRP . 58.5 ttt85 -112.63 78.56 1.14 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.334 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.438 ' O ' ' O ' ' A' ' 88' ' ' ARG . 41.3 m95 56.94 150.26 0.06 OUTLIER Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.431 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.09 -23.31 46.26 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 122.24 1.96 . . . . 0.0 112.094 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 158.73 79.61 0.03 OUTLIER Glycine 0 CA--C 1.528 0.906 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -81.33 -15.24 10.18 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.391 2.06 . . . . 0.0 111.985 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.9 p -136.06 144.45 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.562 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.498 ' N ' ' O ' ' A' ' 177' ' ' GLU . 25.6 m -95.13 132.85 39.6 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.92 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.49 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 45.9 m-85 -118.08 140.79 49.25 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.437 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.64 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.5 t -100.12 109.79 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 121.549 0.69 . . . . 0.0 110.811 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -95.62 148.74 35.08 Favored Pre-proline 0 N--CA 1.471 0.577 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.023 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.48 87.98 0.41 Allowed 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 121.952 1.768 . . . . 0.0 110.587 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -50.59 149.94 5.36 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.894 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.445 ' O ' ' HB2' ' A' ' 101' ' ' ALA . 98.1 Cg_endo -73.99 157.36 47.07 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.116 1.877 . . . . 0.0 110.148 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.624 ' HB1' ' CG ' ' A' ' 104' ' ' PRO . . . 179.37 120.06 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.667 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.42 ' O ' HG23 ' A' ' 103' ' ' THR . 33.7 p -86.69 -57.49 2.97 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 102' ' ' THR . 35.6 p -157.38 61.79 2.42 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.223 178.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.624 ' CG ' ' HB1' ' A' ' 101' ' ' ALA . 93.4 Cg_endo -104.15 -79.55 0.0 OUTLIER 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 123.467 2.778 . . . . 0.0 112.135 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.513 ' NH2' ' O ' ' A' ' 110' ' ' ARG . 7.7 tpt180 79.9 -4.64 1.92 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.723 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 66.5 p-90 -87.3 -10.74 51.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.603 0.716 . . . . 0.0 109.927 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.679 ' H ' ' CD2' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -85.02 -18.18 35.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.618 -179.113 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.409 ' H ' HD23 ' A' ' 107' ' ' LEU . 87.2 m -144.63 -39.98 0.26 Allowed 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.573 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.7 -3.32 87.02 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.262 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.513 ' O ' ' NH2' ' A' ' 105' ' ' ARG . 13.6 tpt180 -154.8 -78.68 0.09 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.036 0.918 . . . . 0.0 111.311 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -95.52 -175.27 3.41 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -125.28 81.52 1.98 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.019 0.437 . . . . 0.0 110.842 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 24.9 p -166.33 128.5 1.87 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.409 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.483 ' C ' HG13 ' A' ' 96' ' ' VAL . 69.1 mt -125.27 127.33 46.54 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.524 ' HB2' HG22 ' A' ' 96' ' ' VAL . . . -75.39 130.35 38.84 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.892 176.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.416 HG22 ' N ' ' A' ' 117' ' ' ARG . 13.5 p -144.63 153.75 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 120.897 0.379 . . . . 0.0 110.563 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.416 ' N ' HG22 ' A' ' 116' ' ' VAL . 62.3 ttp180 -142.99 156.55 44.88 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.14 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.0 t -124.29 132.31 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-O 121.103 0.478 . . . . 0.0 109.795 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.443 ' O ' HG23 ' A' ' 119' ' ' THR . 14.4 t -135.32 129.01 32.82 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.656 178.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -135.47 87.08 2.29 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.859 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.653 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 34.9 t60 -172.15 -36.92 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.653 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 63.5 Cg_endo -95.24 -160.48 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.939 0 C-N-CA 122.23 1.953 . . . . 0.0 111.619 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.9 mt -77.78 -5.03 49.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.253 0.549 . . . . 0.0 110.703 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 83.2 t -58.05 -44.81 87.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.725 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.748 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.0 m -53.01 -61.73 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 C-N-CA 119.626 -0.83 . . . . 0.0 108.884 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.748 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.05 -44.17 2.36 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.886 0.374 . . . . 0.0 110.749 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.6 tp -69.41 -47.37 64.36 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.452 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 57.9 m -70.47 -49.93 43.4 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.574 0.702 . . . . 0.0 110.623 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.465 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.1 pp0? -54.19 -41.75 68.93 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.383 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.78 -55.22 37.88 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.81 -177.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.455 ' CE1' ' OD2' ' A' ' 36' ' ' ASP . 46.7 t80 -61.28 -18.96 61.05 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.565 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.61 0.44 84.29 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -154.18 159.56 31.85 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 120.614 -0.434 . . . . 0.0 109.931 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -40.99 173.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 124.043 3.162 . . . . 0.0 113.22 -178.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.405 HD12 ' O ' ' A' ' 35' ' ' CYS . 7.6 tp -127.53 123.23 35.33 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 176.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.462 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -65.56 146.83 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 C-N-CA 117.998 -1.481 . . . . 0.0 107.487 -179.492 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 t -117.44 122.64 44.33 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 123.638 0.586 . . . . 0.0 110.664 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 3.2 m -131.9 163.82 27.47 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.842 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.4 m -72.26 145.44 47.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.238 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.11 -37.81 88.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.982 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.401 ' OD1' ' O ' ' A' ' 141' ' ' ASN . 53.4 p30 -49.46 150.43 1.89 Allowed 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.674 0.749 . . . . 0.0 111.095 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.32 -158.37 0.79 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.232 -178.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.5 t -62.47 -42.51 99.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.03 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -161.75 2.62 0.07 OUTLIER Glycine 0 N--CA 1.459 0.217 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.5 tp -85.95 125.23 69.22 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-O 119.389 -0.339 . . . . 0.0 110.35 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -40.45 157.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.627 1.551 . . . . 0.0 111.826 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.35 -162.92 0.18 Allowed 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.519 2.146 . . . . 0.0 112.083 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 148' ' ' CYS . 29.0 p -112.29 80.01 1.29 Allowed 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -55.09 -32.75 62.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.664 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -164.77 163.86 21.26 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.342 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.427 HG11 ' HA ' ' A' ' 166' ' ' PRO . 1.3 m -56.72 -15.75 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.806 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -66.76 -34.04 76.95 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 150' ' ' THR . 5.1 tm-20 -60.48 -71.87 0.12 Allowed 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.933 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.437 HG11 HG11 ' A' ' 164' ' ' VAL . 7.3 p -48.48 -32.91 4.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.275 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 159' ' ' GLY . 4.1 tmt_? -78.96 -51.66 9.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.773 0.796 . . . . 0.0 109.416 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.94 -44.85 64.08 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.676 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.71 -29.33 27.63 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 112.826 -1.988 . . . . 0.0 114.28 -175.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -126.39 -33.95 2.53 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 118.341 0.519 . . . . 0.0 111.331 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 94.59 24.7 17.5 Favored Glycine 0 N--CA 1.466 0.682 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.411 ' HB1' ' HG2' ' A' ' 163' ' ' PRO . . . -43.3 -94.4 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.517 0.199 . . . . 0.0 110.685 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.435 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.55 37.18 16.53 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.546 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.5 m-85 -176.48 -62.06 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.284 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.411 ' HG2' ' HB1' ' A' ' 160' ' ' ALA . 84.3 Cg_endo -73.58 28.86 0.31 Allowed 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.544 2.163 . . . . 0.0 110.46 178.024 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.569 HG23 ' HD3' ' A' ' 166' ' ' PRO . 16.1 m -132.62 166.1 30.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.814 -178.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.6 t -123.06 65.41 27.87 Favored Pre-proline 0 N--CA 1.475 0.797 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.517 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.569 ' HD3' HG23 ' A' ' 164' ' ' VAL . 23.7 Cg_exo -35.41 142.78 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 123.588 2.858 . . . . 0.0 115.362 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 169.01 178.28 40.33 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 113.688 -1.596 . . . . 0.0 110.89 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -155.84 149.83 25.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.775 0.321 . . . . 0.0 110.386 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.2 t -145.82 151.74 38.4 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.457 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -55.54 -67.98 1.93 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 155.29 60.46 0.01 OUTLIER Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -79.4 106.62 11.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.781 0.324 . . . . 0.0 110.616 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 173' ' ' LEU . 10.2 mp -78.99 164.53 24.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.231 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -153.49 72.7 6.78 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.054 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -60.98 143.06 99.25 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.743 2.296 . . . . 0.0 112.092 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 4.3 m 59.37 72.79 0.51 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.202 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 94' ' ' THR . 1.2 pp20? -101.15 -30.75 11.39 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.052 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.501 ' O ' HG23 ' A' ' 178' ' ' ILE . 18.3 tt -96.4 121.03 46.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.307 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -129.22 165.01 22.2 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.491 0.662 . . . . 0.0 111.73 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -78.14 106.13 9.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.008 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -66.33 -18.87 65.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.664 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.472 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.5 mm? -62.61 -41.9 99.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.398 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.53 -45.07 3.03 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.716 0.293 . . . . 0.0 110.61 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 66.24 24.85 72.2 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -61.63 131.97 51.74 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.476 0.655 . . . . 0.0 110.94 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.528 ' H ' ' CD2' ' A' ' 186' ' ' LEU . 0.7 OUTLIER -76.55 -177.64 4.29 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.656 -179.874 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -104.26 68.08 0.87 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.788 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.03 144.42 51.45 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.336 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -137.41 -18.31 1.28 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.255 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.761 0 CA-C-O 118.041 -1.422 . . . . 0.0 110.794 179.825 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -91.79 5.13 51.07 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.904 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -63.23 -41.03 99.05 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.752 0.311 . . . . 0.0 110.629 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.666 HD22 ' N ' ' A' ' 5' ' ' LEU . 3.0 mm? -63.07 -41.65 99.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.878 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -61.46 -43.67 98.45 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -59.34 -41.45 89.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.459 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 162' ' ' PHE . 41.3 t0 -61.31 -40.25 93.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.264 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.6 -48.42 81.86 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.813 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.5 mm -63.51 -44.78 98.87 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.698 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.46 -46.56 76.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.053 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.48 -45.71 91.79 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.06 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.12 -51.15 70.32 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 13.3 pt -69.3 -40.09 79.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.506 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -58.47 -54.62 44.94 Favored 'General case' 0 C--O 1.218 -0.557 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.136 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.491 ' O ' ' N ' ' A' ' 20' ' ' GLU . 99.5 t -62.01 -39.81 85.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.638 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.661 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.5 tt -52.38 -50.4 62.51 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.587 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -79.95 -51.6 8.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.644 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -64.83 -34.43 78.35 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.41 -178.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.8 mt-10 58.5 87.41 0.07 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.311 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.47 -132.8 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 178.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.6 p -144.29 140.08 24.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.457 HD12 ' O ' ' A' ' 24' ' ' ALA . 2.8 pp -130.72 163.95 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 121.163 0.506 . . . . 0.0 111.905 -178.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.457 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -59.76 136.3 57.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.87 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.532 ' CZ ' ' O ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -132.13 145.39 57.16 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.21 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.532 ' O ' ' CZ ' ' A' ' 25' ' ' TYR . 61.9 Cg_endo -78.85 146.83 21.06 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.465 1.443 . . . . 0.0 111.383 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.489 ' C ' ' H ' ' A' ' 29' ' ' ALA . 28.7 m -130.21 135.9 48.64 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.88 0.372 . . . . 0.0 110.123 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -75.35 22.0 0.13 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.489 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -156.17 -73.63 0.1 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.327 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.4 p -122.71 126.28 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-O 121.335 0.588 . . . . 0.0 111.392 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.486 ' CD1' ' O ' ' A' ' 148' ' ' CYS . 16.7 t80 -45.34 132.36 7.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.389 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.62 -171.52 13.9 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.309 -0.717 . . . . 0.0 111.309 -179.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 m -131.12 169.51 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.408 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -157.98 -178.21 31.81 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 120.105 -1.045 . . . . 0.0 112.616 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.554 ' O ' HD12 ' A' ' 135' ' ' LEU . 0.5 OUTLIER -156.56 -163.04 1.35 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.546 0.213 . . . . 0.0 110.577 -179.757 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.516 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 44.3 m-20 -100.39 109.11 55.95 Favored Pre-proline 0 CA--C 1.554 1.123 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -178.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 36' ' ' ASP . 55.5 Cg_exo -38.36 173.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.765 2.31 . . . . 0.0 114.105 177.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 42.91 65.66 0.91 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.719 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.0 m -152.35 139.22 18.99 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.41 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -65.98 -28.43 68.88 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.104 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.524 HG23 ' N ' ' A' ' 42' ' ' ALA . 14.9 t -59.93 -42.8 94.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.666 -178.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.524 ' N ' HG23 ' A' ' 41' ' ' THR . . . -59.07 -52.02 67.53 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.38 0.61 . . . . 0.0 111.414 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.11 -45.76 95.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.895 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 91.9 mtp -66.41 -47.05 74.48 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.5 ptt85 -62.23 -30.24 70.96 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.173 -178.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 45.2 mt -73.4 -61.89 1.67 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.382 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.2 mt -54.02 -20.43 6.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.655 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -63.81 -85.61 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.666 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.497 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.2 pt? -77.5 -35.42 53.57 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -73.67 -48.18 34.22 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 119.709 -0.797 . . . . 0.0 111.049 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 35.25 65.17 0.4 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.957 -1.019 . . . . 0.0 111.78 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.407 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 8.1 mtm-85 179.84 -53.73 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.909 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.675 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.407 ' HD2' ' H ' ' A' ' 52' ' ' ARG . 72.1 Cg_endo -75.1 -7.16 18.83 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.422 2.081 . . . . 0.0 112.783 -178.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.614 HG13 ' N ' ' A' ' 55' ' ' ASP . 12.8 p -41.42 -47.03 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.119 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.614 ' N ' HG13 ' A' ' 54' ' ' VAL . 36.6 t0 -67.66 -39.5 84.55 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.076 0.465 . . . . 0.0 110.786 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.479 ' CD ' ' N ' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -61.92 -39.52 92.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.318 -179.299 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 62.9 105.6 0.01 OUTLIER Glycine 0 CA--C 1.52 0.394 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.57 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -49.76 -168.2 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.821 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.4 HG23 HG21 ' A' ' 94' ' ' THR . 75.0 mt -102.64 147.84 8.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.1 mt -120.73 141.25 50.62 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.414 HD12 ' HG3' ' A' ' 117' ' ' ARG . 8.6 tp -108.88 132.46 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-O 121.062 0.458 . . . . 0.0 109.96 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.519 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -123.35 152.99 40.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.392 0.615 . . . . 0.0 109.86 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -112.32 -30.03 7.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.181 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -114.1 151.78 32.07 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.648 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -79.05 -13.84 59.52 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.567 0.698 . . . . 0.0 109.974 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -53.8 -30.96 47.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.267 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.79 -8.81 39.52 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.53 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -89.13 -20.79 23.83 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.446 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 69.9 tttt -73.81 -39.97 4.78 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 95.2 Cg_endo -102.38 -5.36 0.29 Allowed 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 122.672 2.248 . . . . 0.0 112.478 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -88.57 -17.87 29.28 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.652 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.532 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.0 mp -122.34 157.53 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.532 ' N ' HG22 ' A' ' 72' ' ' ILE . 4.4 m-20 -64.34 146.59 54.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.846 0.355 . . . . 0.0 110.203 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -91.9 38.8 1.0 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.058 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.536 HG23 ' N ' ' A' ' 76' ' ' MET . 11.3 t -108.34 -41.76 4.78 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.995 0.426 . . . . 0.0 110.208 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.536 ' N ' HG23 ' A' ' 75' ' ' THR . 8.4 ptp -93.05 -17.5 23.78 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.239 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.51 HD21 ' NH2' ' A' ' 82' ' ' ARG . 31.7 tp -79.83 128.18 33.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.277 -177.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -153.86 163.63 39.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.726 -177.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -49.15 -45.74 44.23 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.718 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -61.09 -31.94 51.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.964 -0.295 . . . . 0.0 111.197 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 66.8 tp60 -65.56 -40.6 92.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.216 0.531 . . . . 0.0 110.427 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.51 ' NH2' HD21 ' A' ' 77' ' ' LEU . 9.7 mmt85 -64.21 -51.65 62.7 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 122.522 1.154 . . . . 0.0 109.287 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -56.44 -50.33 71.98 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 113.668 -1.605 . . . . 0.0 110.325 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -61.74 -49.7 75.37 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.826 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.1 tt -67.59 -31.53 52.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.486 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -77.32 -35.09 55.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.748 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.6 m -88.0 -18.65 28.55 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.475 0.178 . . . . 0.0 111.282 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.414 ' O ' ' O ' ' A' ' 89' ' ' TRP . 77.3 ttt-85 -110.39 77.84 1.08 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.554 ' CD1' ' N ' ' A' ' 89' ' ' TRP . 1.2 m0 59.18 148.71 0.07 OUTLIER Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.21 -31.53 35.67 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 121.741 1.627 . . . . 0.0 112.508 -178.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.445 ' H ' ' HD3' ' A' ' 92' ' ' PRO . . . 150.35 61.12 0.01 OUTLIER Glycine 0 CA--C 1.531 1.061 0 C-N-CA 121.089 -0.577 . . . . 0.0 111.97 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.445 ' HD3' ' H ' ' A' ' 91' ' ' GLY . 57.4 Cg_endo -70.22 -15.73 35.43 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.718 2.279 . . . . 0.0 111.828 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.0 p -122.6 136.47 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.137 0.494 . . . . 0.0 110.079 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 177' ' ' GLU . 27.3 m -91.37 135.26 33.95 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.936 -179.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.481 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 42.1 m-85 -120.69 139.71 52.65 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.914 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.627 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.4 t -97.17 109.02 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-O 121.347 0.594 . . . . 0.0 110.902 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -94.37 149.9 37.38 Favored Pre-proline 0 N--CA 1.469 0.506 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.965 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.403 ' O ' ' OD2' ' A' ' 73' ' ' ASP . 58.7 Cg_endo -69.41 86.93 0.52 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.991 1.794 . . . . 0.0 111.12 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.423 ' O ' ' OD1' ' A' ' 112' ' ' ASP . . . -50.95 153.51 3.0 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.452 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.44 157.47 58.97 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.193 1.929 . . . . 0.0 111.629 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -149.05 74.04 1.24 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.396 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.42 ' O ' ' OG1' ' A' ' 103' ' ' THR . 57.8 p -66.6 -33.75 76.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.915 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.698 ' H ' ' CD ' ' A' ' 104' ' ' PRO . 0.6 OUTLIER -168.18 -39.3 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -179.748 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.698 ' CD ' ' H ' ' A' ' 103' ' ' THR . 18.5 Cg_exo -66.31 -164.61 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.583 2.189 . . . . 0.0 113.129 -178.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 109' ' ' GLY . 8.2 tpt180 -172.28 0.36 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.149 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 2.4 p90 -71.67 -7.13 46.06 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.531 -179.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 1.029 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -73.08 -23.25 60.51 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.769 179.823 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.673 ' H ' HD22 ' A' ' 107' ' ' LEU . 85.1 m -143.09 -40.1 0.32 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.812 179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 80.2 -0.42 83.99 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.638 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -148.21 -80.64 0.13 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.427 0.613 . . . . 0.0 110.822 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -89.91 -173.02 3.74 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 99' ' ' ALA . 66.3 t0 -131.05 70.83 1.46 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.91 0.386 . . . . 0.0 110.832 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 80.5 p -160.6 127.83 4.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.583 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.494 ' C ' HG13 ' A' ' 96' ' ' VAL . 63.0 mt -124.03 129.04 50.25 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -178.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.528 ' HB2' HG22 ' A' ' 96' ' ' VAL . . . -77.32 122.54 25.26 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.276 176.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.447 HG22 ' N ' ' A' ' 117' ' ' ARG . 10.9 p -141.29 155.96 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.937 0.398 . . . . 0.0 110.54 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.447 ' N ' HG22 ' A' ' 116' ' ' VAL . 19.3 ptt180 -149.19 158.22 44.0 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.665 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.519 HG22 ' HB3' ' A' ' 62' ' ' ALA . 70.8 t -122.52 134.87 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.11 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 119' ' ' THR . 12.2 t -138.4 127.85 24.67 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.664 178.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -133.24 87.45 2.39 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.129 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.682 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 19.1 t60 -172.01 -35.22 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 112.486 0.551 . . . . 0.0 112.486 -179.179 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.682 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 73.7 Cg_endo -95.7 -158.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.482 0.795 0 C-N-CA 122.288 1.992 . . . . 0.0 111.761 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 19.4 mt -79.26 -6.18 56.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.661 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 79.9 t -57.22 -45.62 84.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.538 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.738 HG23 ' H ' ' A' ' 126' ' ' ALA . 26.9 m -51.01 -61.68 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.864 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.738 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.63 -44.52 3.12 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.984 0.421 . . . . 0.0 110.726 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.433 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -66.54 -51.54 55.43 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.08 0.467 . . . . 0.0 110.571 179.413 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 79.2 m -69.34 -48.45 61.33 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.252 0.549 . . . . 0.0 111.396 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.468 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.1 pp0? -54.56 -42.05 70.51 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.507 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -60.11 -54.83 41.22 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.139 -1.392 . . . . 0.0 109.399 -177.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -64.13 -21.67 66.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.085 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.41 1.55 86.34 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 55.5 mttt -152.66 159.48 32.43 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 120.718 -0.393 . . . . 0.0 109.971 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -43.16 178.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 124.053 3.169 . . . . 0.0 113.389 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.554 HD12 ' O ' ' A' ' 35' ' ' CYS . 8.2 tp -133.35 123.29 25.14 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 177.023 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.43 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -64.65 146.16 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 C-N-CA 117.796 -1.562 . . . . 0.0 107.678 -179.736 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.9 t -119.37 129.53 54.87 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.283 0.563 . . . . 0.0 111.23 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.5 m -131.79 164.23 26.48 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.241 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.2 m -75.18 148.06 39.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.24 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.51 88.91 2.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.615 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.668 ' C ' HD21 ' A' ' 141' ' ' ASN . 0.1 OUTLIER -164.02 163.28 23.39 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.396 0.617 . . . . 0.0 110.814 179.442 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.85 -165.57 1.91 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.096 -178.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 38.8 t -61.95 -43.89 97.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.925 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -160.65 11.08 0.14 Allowed Glycine 0 N--CA 1.459 0.22 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.6 tp -88.71 127.17 57.28 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -39.13 154.12 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.682 1.588 . . . . 0.0 111.83 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.418 ' O ' ' N ' ' A' ' 149' ' ' ARG . 89.9 Cg_endo -74.38 149.99 40.71 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.227 1.951 . . . . 0.0 112.392 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.486 ' O ' ' CD1' ' A' ' 31' ' ' PHE . 72.8 m -67.92 74.22 0.19 Allowed 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 147' ' ' PRO . 32.2 ptt-85 -58.3 -34.38 70.49 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.502 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -160.33 163.75 33.04 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.472 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.412 HG11 ' HA ' ' A' ' 166' ' ' PRO . 0.9 OUTLIER -56.62 -17.45 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.821 0 CA-C-O 121.577 0.703 . . . . 0.0 109.223 -179.872 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -64.71 -35.67 81.79 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 177.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.437 ' OE1' ' OE1' ' A' ' 157' ' ' GLN . 5.1 tm-20 -59.49 -74.86 0.06 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.688 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.404 HG11 HG11 ' A' ' 164' ' ' VAL . 7.8 p -44.7 -29.04 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.242 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.421 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -83.95 -45.3 13.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 122.201 1.0 . . . . 0.0 110.047 179.767 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.84 -40.69 80.7 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.769 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.437 ' OE1' ' OE1' ' A' ' 153' ' ' GLU . 8.7 pt20 -81.57 -49.02 11.04 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 113.167 -1.833 . . . . 0.0 112.566 -176.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.429 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 20.8 m-85 -110.05 -33.55 6.66 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 97.61 27.63 8.96 Favored Glycine 0 N--CA 1.475 1.285 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.606 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -44.13 -94.8 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.759 0.314 . . . . 0.0 111.07 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.507 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.83 35.71 16.43 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -178.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.507 ' CD2' ' O ' ' A' ' 161' ' ' ALA . 2.1 m-85 -174.77 -62.53 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.471 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -73.03 28.85 0.29 Allowed 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.525 2.15 . . . . 0.0 110.49 178.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.567 HG23 ' HD3' ' A' ' 166' ' ' PRO . 17.1 m -131.98 167.39 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.542 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.0 t -124.24 64.82 37.87 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.549 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.567 ' HD3' HG23 ' A' ' 164' ' ' VAL . 20.4 Cg_exo -35.18 142.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 123.699 2.933 . . . . 0.0 115.056 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 167.02 -177.71 41.56 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 114.051 -1.431 . . . . 0.0 110.989 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -146.98 152.33 38.44 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.5 t -143.93 148.49 35.45 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.993 0.425 . . . . 0.0 110.944 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -107.51 58.21 0.42 Allowed Glycine 0 N--CA 1.47 0.917 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 29' ' ' ALA . . . -163.21 50.7 0.31 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 22.5 mmt85 -64.74 -43.22 94.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.749 0.309 . . . . 0.0 110.492 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 173' ' ' LEU . 9.1 mp -100.07 178.94 4.64 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.588 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 173' ' ' LEU . 9.8 t-20 82.8 55.19 0.07 OUTLIER Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.307 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.478 ' O ' ' CB ' ' A' ' 176' ' ' SER . 72.2 Cg_endo -72.48 144.61 40.86 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.709 2.272 . . . . 0.0 111.164 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 175' ' ' PRO . 2.0 m 160.41 77.29 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 94' ' ' THR . 5.7 pt-20 -132.66 -26.57 1.79 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.134 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 178' ' ' ILE . 18.2 tt -87.08 122.63 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-O 120.922 0.391 . . . . 0.0 110.763 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -135.21 168.08 19.82 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.409 0.623 . . . . 0.0 111.648 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -78.73 106.03 10.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.562 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -65.57 -13.57 59.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.649 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.476 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.4 mm? -63.32 -41.08 98.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.193 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.442 HG23 ' H ' ' A' ' 185' ' ' GLU . 5.2 t -119.75 -23.49 6.48 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.955 0.407 . . . . 0.0 110.458 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 85.79 31.07 22.02 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.442 ' H ' HG23 ' A' ' 183' ' ' THR . 7.7 pt-20 -167.8 145.16 4.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.677 0.275 . . . . 0.0 110.77 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.602 ' H ' ' CD2' ' A' ' 186' ' ' LEU . 0.9 OUTLIER -88.88 175.8 7.3 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.86 0.362 . . . . 0.0 110.638 179.669 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -110.53 -12.06 14.41 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.419 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -74.19 137.6 43.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.575 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -152.94 -18.45 0.15 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.244 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.733 0 CA-C-O 117.717 -1.601 . . . . 0.0 111.183 179.771 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 53.9 p30 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -143.37 83.57 1.78 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.329 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 56.5 p30 -104.62 13.78 31.0 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.687 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.8 mp -62.54 -42.22 99.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.039 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -63.88 -40.85 97.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.321 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -64.72 -40.87 96.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.636 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 162' ' ' PHE . 63.1 t0 -59.34 -46.38 88.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.332 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.19 -43.9 97.79 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.95 0.405 . . . . 0.0 110.17 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.1 mt -63.76 -43.19 97.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.97 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.2 -46.52 82.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.533 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.91 -45.98 92.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.423 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.25 -52.86 63.48 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 14.4 pt -68.57 -39.47 80.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.392 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -56.77 -53.72 54.51 Favored 'General case' 0 C--O 1.215 -0.738 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.197 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 20' ' ' GLU . 97.6 t -61.97 -40.62 87.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.89 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.678 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.3 tt -52.48 -51.98 56.64 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.508 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -78.33 -49.92 12.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.368 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -65.47 -32.06 73.47 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.694 -178.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 16' ' ' VAL . 97.1 mt-10 59.91 80.67 0.2 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 178.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.04 -148.23 0.12 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.857 177.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.3 p -125.45 140.63 47.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.456 HD12 ' O ' ' A' ' 24' ' ' ALA . 2.9 pp -129.68 165.84 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-O 120.907 0.384 . . . . 0.0 111.62 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.456 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -60.26 135.73 57.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.302 0.572 . . . . 0.0 110.793 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.53 ' CZ ' ' O ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -132.49 145.38 57.0 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.585 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.53 ' O ' ' CZ ' ' A' ' 25' ' ' TYR . 97.6 Cg_endo -75.61 145.84 29.89 Favored 'Trans proline' 0 N--CA 1.498 1.794 0 C-N-CA 121.597 1.531 . . . . 0.0 111.384 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.493 ' C ' ' H ' ' A' ' 29' ' ' ALA . 63.0 m -131.76 131.32 42.87 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.95 0.405 . . . . 0.0 110.644 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -75.01 30.94 0.09 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.411 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.493 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -160.32 -73.47 0.07 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.621 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.9 p -131.77 132.22 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.045 0.45 . . . . 0.0 110.188 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.527 ' CD2' ' O ' ' A' ' 148' ' ' CYS . 36.0 p90 -39.5 144.37 0.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.45 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -156.78 -174.27 26.3 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.8 m -131.07 172.33 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.402 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -158.42 178.51 34.63 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.095 -1.05 . . . . 0.0 111.795 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -157.25 -170.42 3.25 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.737 -178.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.467 ' CG ' ' CZ ' ' A' ' 131' ' ' TYR . 18.3 t70 -86.57 108.08 16.47 Favored Pre-proline 0 CA--C 1.555 1.168 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -177.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -36.52 -61.42 0.31 Allowed 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 122.533 2.155 . . . . 0.0 113.161 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -74.03 72.01 1.63 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.593 -178.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 m -155.73 130.52 9.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.678 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -66.33 -33.93 76.84 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.988 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.529 HG23 ' N ' ' A' ' 42' ' ' ALA . 15.1 t -62.08 -43.56 98.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.866 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.529 ' N ' HG23 ' A' ' 41' ' ' THR . . . -55.78 -52.52 63.68 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -62.19 -42.6 95.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.312 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 91.2 mtp -63.22 -40.61 97.96 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.514 HH22 ' CD1' ' A' ' 142' ' ' LEU . 7.9 ttt85 -60.52 -40.77 92.68 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-O 121.695 0.76 . . . . 0.0 108.959 178.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.44 ' O ' HD23 ' A' ' 46' ' ' LEU . 1.0 OUTLIER -65.96 -55.61 15.92 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.248 -178.8 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.6 mt -67.64 -12.1 59.7 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.981 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.71 -82.57 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 120.995 0.426 . . . . 0.0 110.678 -177.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -76.37 -36.28 58.24 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.2 mmmt -74.63 -51.38 14.61 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 119.552 -0.859 . . . . 0.0 111.026 -176.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 36.12 64.93 0.48 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.866 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.401 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 2.6 mtp85 178.66 -53.99 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.529 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HD2' ' H ' ' A' ' 52' ' ' ARG . 72.0 Cg_endo -77.17 -6.45 16.55 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.92 2.413 . . . . 0.0 111.93 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.561 HG13 ' N ' ' A' ' 55' ' ' ASP . 9.7 p -45.59 -43.52 3.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.404 -178.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.561 ' N ' HG13 ' A' ' 54' ' ' VAL . 50.7 t0 -65.41 -41.25 93.81 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.573 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.409 ' CD ' ' N ' ' A' ' 56' ' ' LYS . 4.1 mptp? -62.55 -37.68 87.06 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 64.4 108.71 0.01 OUTLIER Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 178.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.562 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -51.19 -166.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.057 0.456 . . . . 0.0 111.937 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.43 ' O ' ' OG ' ' A' ' 137' ' ' SER . 70.3 mt -104.55 135.35 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.044 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.6 mt -111.72 144.66 40.64 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.41 ' O ' HG23 ' A' ' 61' ' ' ILE . 8.0 tp -112.75 126.8 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-O 121.156 0.503 . . . . 0.0 111.082 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.83 147.92 39.2 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.182 178.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -106.52 -27.59 10.81 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.431 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -121.46 151.6 40.06 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 120.789 0.328 . . . . 0.0 111.136 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -76.93 -13.29 59.99 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -50.89 -32.19 19.81 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.554 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.17 -13.38 26.74 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 68' ' ' LEU . 4.1 mm? -91.93 -16.19 26.96 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.658 -0.651 . . . . 0.0 109.648 179.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.467 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 77.1 tttt -78.91 -37.97 1.33 Allowed Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 84.8 Cg_endo -103.47 -3.64 0.26 Allowed 'Trans proline' 0 C--N 1.319 -1.01 0 C-N-CA 122.593 2.195 . . . . 0.0 112.049 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -94.9 -10.9 29.77 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.948 0.404 . . . . 0.0 110.774 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.625 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.1 mp -127.11 167.26 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.625 ' N ' HG22 ' A' ' 72' ' ' ILE . 99.9 m-20 -61.12 -12.8 13.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.007 0.432 . . . . 0.0 110.381 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 46.2 t0 56.3 22.29 6.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.709 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.458 HG23 ' N ' ' A' ' 76' ' ' MET . 9.0 t -92.6 -38.94 11.6 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.02 0.438 . . . . 0.0 110.177 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.458 ' N ' HG23 ' A' ' 75' ' ' THR . 0.0 OUTLIER -78.44 -24.4 46.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.208 0.528 . . . . 0.0 110.398 179.57 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.538 HD11 ' NE ' ' A' ' 82' ' ' ARG . 51.2 tp -77.94 134.21 37.91 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.557 0.694 . . . . 0.0 111.109 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.39 172.56 13.32 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.389 -177.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.13 -40.76 90.92 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.814 0.34 . . . . 0.0 111.105 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.5 p -61.7 -35.07 65.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.495 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.444 ' OE1' HD12 ' A' ' 77' ' ' LEU . 22.5 mt-30 -62.97 -41.34 99.51 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.868 0.366 . . . . 0.0 110.511 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.538 ' NE ' HD11 ' A' ' 77' ' ' LEU . 2.4 mmt85 -62.88 -52.81 61.64 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 122.506 1.146 . . . . 0.0 109.025 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -55.64 -50.73 69.41 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.812 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.6 m -61.44 -49.83 75.25 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.936 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' A' ' 89' ' ' TRP . 9.6 tt -67.52 -32.08 55.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 119.746 -0.781 . . . . 0.0 109.595 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -75.3 -36.43 61.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.424 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.5 m -86.82 -16.44 36.17 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.741 -0.209 . . . . 0.0 111.145 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.444 ' O ' ' O ' ' A' ' 89' ' ' TRP . 77.2 ttt-85 -119.58 78.52 1.32 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.587 0.232 . . . . 0.0 110.879 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.444 ' O ' ' O ' ' A' ' 88' ' ' ARG . 27.3 m95 56.2 149.66 0.05 OUTLIER Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.029 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -67.13 -21.32 48.94 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.331 2.021 . . . . 0.0 112.045 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.529 ' O ' ' NE ' ' A' ' 117' ' ' ARG . . . 157.26 82.87 0.04 OUTLIER Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -76.44 -21.49 13.21 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.885 1.723 . . . . 0.0 112.578 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.411 HG13 ' CE2' ' A' ' 95' ' ' PHE . 3.4 p -136.39 143.62 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-O 121.088 0.471 . . . . 0.0 110.843 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 85.1 m -87.73 144.86 26.41 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.246 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.464 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 57.8 m-85 -126.85 142.32 51.58 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.754 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.635 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 3.3 t -98.2 105.59 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 121.299 0.571 . . . . 0.0 109.801 178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -90.13 150.83 44.07 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.931 -178.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.96 109.29 2.81 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 121.874 1.716 . . . . 0.0 110.525 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.401 ' O ' ' OD1' ' A' ' 112' ' ' ASP . . . -67.29 147.75 98.86 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.05 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.441 ' O ' ' OG1' ' A' ' 103' ' ' THR . 93.0 Cg_endo -73.29 155.22 51.5 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.441 2.094 . . . . 0.0 112.385 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.47 -35.94 78.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.041 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 45.7 p -56.06 -42.06 76.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.775 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.51 ' O ' ' O ' ' A' ' 104' ' ' PRO . 1.7 p -56.43 156.86 10.57 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.51 ' O ' ' O ' ' A' ' 103' ' ' THR . 78.3 Cg_exo -47.65 -139.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.507 2.305 0 C-N-CA 122.984 2.456 . . . . 0.0 114.158 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' A' ' 109' ' ' GLY . 15.0 mmt180 -142.96 -7.08 0.83 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.217 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.55 ' CD1' ' N ' ' A' ' 106' ' ' TRP . 14.2 m0 -73.04 -14.43 61.41 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.562 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.987 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -68.99 -37.63 78.84 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.736 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.748 ' H ' HD22 ' A' ' 107' ' ' LEU . 21.8 m -143.94 -39.48 0.29 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.432 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 65.59 -13.64 0.28 Allowed Glycine 0 CA--C 1.53 0.972 0 CA-C-N 115.64 -0.709 . . . . 0.0 113.764 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 24.7 tpt85 -112.22 -83.08 0.59 Allowed 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 117.848 0.824 . . . . 0.0 111.027 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -78.88 -121.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.525 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 99' ' ' ALA . 44.0 t0 -171.29 51.26 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.667 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.5 p -158.7 162.75 37.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.294 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.487 ' C ' HG13 ' A' ' 96' ' ' VAL . 3.0 pp -165.79 137.59 3.93 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.421 ' N ' HG13 ' A' ' 96' ' ' VAL . . . -67.72 127.97 34.74 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 113.085 -1.87 . . . . 0.0 109.904 177.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.3 p -147.21 151.19 14.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.986 0.422 . . . . 0.0 110.063 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.529 ' NE ' ' O ' ' A' ' 91' ' ' GLY . 80.5 ttt180 -141.21 156.16 45.95 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.701 -178.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.5 t -121.41 130.87 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 119' ' ' THR . 9.9 t -134.03 127.94 33.3 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.764 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -135.43 84.3 2.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.849 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.679 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 47.1 t60 -172.62 -35.56 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.308 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.679 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 72.7 Cg_endo -95.07 -159.41 0.06 OUTLIER 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 121.889 1.726 . . . . 0.0 111.979 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 42.7 mt -78.22 -4.65 48.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.341 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 82.9 t -58.53 -45.9 90.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.964 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.772 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.6 m -53.57 -61.89 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.772 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.26 -43.95 2.53 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.717 178.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.2 tp -69.32 -48.6 61.04 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.361 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 65.1 m -70.4 -48.88 54.09 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.49 0.662 . . . . 0.0 110.913 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.472 ' N ' ' O ' ' A' ' 125' ' ' VAL . 1.1 pp0? -54.71 -42.24 71.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.572 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.78 -56.1 26.52 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.178 -1.374 . . . . 0.0 110.062 -177.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.467 ' CZ ' ' CG ' ' A' ' 36' ' ' ASP . 7.4 t80 -63.32 -29.21 70.56 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.644 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 90.26 1.0 76.05 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' A' ' 134' ' ' PRO . 61.2 mttt -151.0 158.64 34.68 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.999 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' A' ' 133' ' ' LYS . 5.9 Cg_exo -41.12 175.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 123.976 3.117 . . . . 0.0 113.166 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.6 tp -131.34 123.09 27.53 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 177.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.441 HG13 ' H ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -66.0 145.58 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 C-N-CA 118.477 -1.289 . . . . 0.0 108.662 -179.212 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -109.44 120.85 43.77 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.122 0.889 . . . . 0.0 110.756 -179.669 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 5.2 m -136.2 163.39 30.48 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.122 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.7 t -67.27 149.37 50.49 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.916 0.389 . . . . 0.0 110.976 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.54 -38.46 91.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.195 -0.457 . . . . 0.0 112.117 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 56.6 p30 -65.75 155.99 34.44 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.468 0.651 . . . . 0.0 111.599 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.514 ' CD1' HH22 ' A' ' 45' ' ' ARG . 0.8 OUTLIER -144.75 179.08 7.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.385 -178.523 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 38.8 t -61.39 -42.74 99.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.226 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -141.65 57.01 0.58 Allowed Glycine 0 N--CA 1.468 0.803 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.1 tp -157.41 108.04 1.85 Allowed Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 119.399 -0.334 . . . . 0.0 110.213 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -40.92 156.09 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.394 1.396 . . . . 0.0 111.212 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -59.97 -159.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.113 1.876 . . . . 0.0 111.855 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.527 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 79.5 m -149.12 73.32 1.2 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.027 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -54.66 -40.61 69.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.232 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.15 168.49 26.32 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.42 HG11 ' HA ' ' A' ' 166' ' ' PRO . 2.0 m -59.47 -22.76 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 CA-C-O 121.266 0.555 . . . . 0.0 109.855 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -65.12 -25.06 67.6 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 155' ' ' ARG . 6.2 tm-20 -69.08 -79.42 0.06 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.319 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.419 ' N ' ' OE1' ' A' ' 153' ' ' GLU . 5.4 p -35.83 -30.15 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.577 0.751 . . . . 0.0 110.312 177.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.482 ' N ' ' O ' ' A' ' 153' ' ' GLU . 4.1 tmt_? -71.59 -49.94 35.67 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.063 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 153' ' ' GLU . . . -72.01 -19.41 61.86 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 122.529 1.157 . . . . 0.0 108.212 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.04 -44.38 15.26 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 112.623 -2.081 . . . . 0.0 111.763 -178.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -129.78 -34.26 1.75 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.775 0.322 . . . . 0.0 111.631 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 160' ' ' ALA . . . 102.12 23.91 8.82 Favored Glycine 0 N--CA 1.468 0.792 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.412 ' O ' ' O ' ' A' ' 159' ' ' GLY . . . -43.97 -97.9 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.597 0.237 . . . . 0.0 110.893 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . 64.17 33.6 11.68 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.516 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.6 m-85 -173.54 -62.2 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.013 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -72.67 28.22 0.28 Allowed 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 122.296 1.997 . . . . 0.0 110.718 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.548 HG23 ' HD3' ' A' ' 166' ' ' PRO . 13.6 m -129.89 167.31 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.877 -178.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 11.7 t -121.6 65.2 17.19 Favored Pre-proline 0 N--CA 1.471 0.615 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.859 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.548 ' HD3' HG23 ' A' ' 164' ' ' VAL . 29.1 Cg_exo -36.35 139.84 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 123.612 2.875 . . . . 0.0 115.041 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 160.61 -172.81 37.05 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 114.077 -1.42 . . . . 0.0 111.112 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -159.29 170.68 21.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.935 0.397 . . . . 0.0 110.524 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.49 -40.02 0.89 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.024 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 127.69 -72.5 0.47 Allowed Glycine 0 N--CA 1.47 0.911 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 154.56 115.72 0.56 Allowed Glycine 0 CA--C 1.517 0.213 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -135.91 140.37 44.02 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.738 0.304 . . . . 0.0 110.794 -179.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 50.8 tp -62.06 -47.45 84.64 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.586 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.451 ' N ' ' OD1' ' A' ' 174' ' ' ASN . 8.9 p30 -176.37 82.51 0.27 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.389 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -75.04 -14.72 20.96 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.727 1.618 . . . . 0.0 111.847 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 41.3 p -149.4 127.59 12.06 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.518 0.675 . . . . 0.0 110.906 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -116.96 -175.71 2.83 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.577 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 16.3 pt -113.12 133.59 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.117 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -127.62 166.52 17.9 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.511 0.672 . . . . 0.0 111.452 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 184' ' ' GLY . 46.0 t0 -80.05 106.3 11.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.921 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -62.61 -18.63 62.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.502 -179.151 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.488 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.4 mm? -63.5 -41.15 98.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.841 0.353 . . . . 0.0 110.545 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.1 -43.38 2.33 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.395 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 180' ' ' ASP . . . 74.03 19.74 79.75 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -75.04 -167.99 0.69 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.004 0.43 . . . . 0.0 111.149 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.653 ' H ' ' CD2' ' A' ' 186' ' ' LEU . 0.8 OUTLIER -98.66 -179.93 4.47 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.233 179.875 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -101.02 45.23 0.98 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.679 0.276 . . . . 0.0 110.847 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -93.81 134.71 35.88 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.469 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -142.72 -16.25 0.71 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.5 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.73 0 CA-C-O 118.056 -1.414 . . . . 0.0 111.075 -179.836 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.042 0.449 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.521 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.1 mp -62.1 -42.13 98.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.01 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -60.88 -41.73 96.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.018 0.437 . . . . 0.0 110.127 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.66 -38.85 90.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.098 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 162' ' ' PHE . 60.6 t0 -60.52 -47.23 87.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.258 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.95 -45.98 91.28 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.383 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.45 -43.76 98.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.207 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.23 -46.42 82.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.177 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.66 -44.09 97.16 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.946 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.69 -53.28 59.32 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.8 pt -69.39 -39.81 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.757 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -58.72 -55.14 38.94 Favored 'General case' 0 C--O 1.217 -0.634 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.695 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 20' ' ' GLU . 93.5 t -61.96 -39.28 83.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.6 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.672 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.3 tt -52.64 -50.49 63.07 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.453 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -80.2 -51.38 9.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.992 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -65.52 -33.54 76.17 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.159 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.6 mt-10 58.14 88.11 0.06 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.816 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.04 -136.78 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.328 -0.397 . . . . 0.0 109.975 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.1 p -141.19 138.42 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.469 HD12 ' O ' ' A' ' 24' ' ' ALA . 2.8 pp -130.44 166.59 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-O 121.0 0.429 . . . . 0.0 111.876 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.469 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -58.58 134.71 56.97 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.936 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.473 ' CZ ' ' O ' ' A' ' 26' ' ' PRO . 2.0 t80 -128.73 133.63 25.4 Favored Pre-proline 0 CA--C 1.552 1.035 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.821 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.473 ' O ' ' CZ ' ' A' ' 25' ' ' TYR . 27.8 Cg_exo -60.09 146.04 97.05 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 CA-C-N 121.048 1.41 . . . . 0.0 110.898 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.432 HG22 ' H ' ' A' ' 29' ' ' ALA . 78.7 m -129.36 142.5 50.8 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.188 0.518 . . . . 0.0 110.378 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -77.66 20.1 0.35 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.641 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.432 ' H ' HG22 ' A' ' 27' ' ' THR . . . -160.21 -69.26 0.07 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.625 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.9 t -127.24 130.14 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.477 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 77.3 m-85 -42.24 136.6 2.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.178 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.43 -170.81 12.18 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.9 m -132.47 165.43 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.52 -177.05 27.49 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.303 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.439 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -156.22 -168.08 2.63 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.604 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.496 ' OD1' ' CE1' ' A' ' 131' ' ' TYR . 19.1 t70 -96.07 109.69 48.19 Favored Pre-proline 0 CA--C 1.553 1.063 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -178.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 36' ' ' ASP . 23.6 Cg_exo -36.79 170.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.865 2.377 . . . . 0.0 114.126 177.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 40.94 68.3 0.44 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.961 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.3 m -151.02 142.03 23.03 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.839 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -66.39 -32.56 74.02 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.43 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.448 HG23 ' N ' ' A' ' 42' ' ' ALA . 10.0 t -59.48 -40.88 88.41 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.528 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.448 ' N ' HG23 ' A' ' 41' ' ' THR . . . -58.8 -52.19 66.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.256 0.55 . . . . 0.0 111.506 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.409 HG12 ' H ' ' A' ' 43' ' ' VAL . 2.6 p -64.12 -45.87 95.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.876 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 91.3 mtp -66.79 -46.84 73.99 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.414 ' O ' ' CD2' ' A' ' 49' ' ' LEU . 40.8 ptt85 -63.01 -30.64 71.76 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.416 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 64.0 mt -73.55 -60.95 2.01 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 119.591 -0.843 . . . . 0.0 109.493 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.4 mt -53.11 -21.38 4.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.446 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -64.11 -85.23 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.665 -177.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.517 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -75.93 -32.8 59.74 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -77.17 -71.49 0.4 Allowed 'General case' 0 C--N 1.346 0.423 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.564 -176.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.408 ' O ' ' CG ' ' A' ' 51' ' ' GLN . 3.6 tt0 53.73 80.56 0.11 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.463 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.2 mtp85 161.19 -63.95 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.073 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -66.81 -12.52 36.34 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 122.568 2.179 . . . . 0.0 112.165 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.609 HG13 ' N ' ' A' ' 55' ' ' ASP . 7.3 p -43.9 -46.67 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.026 0.441 . . . . 0.0 110.625 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.609 ' N ' HG13 ' A' ' 54' ' ' VAL . 12.5 t0 -66.69 -44.75 80.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.629 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -59.8 -39.97 86.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.939 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 67.35 109.86 0.02 OUTLIER Glycine 0 CA--C 1.522 0.471 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.573 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -49.24 -170.17 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.935 -0.632 . . . . 0.0 112.222 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.438 ' O ' ' OG ' ' A' ' 137' ' ' SER . 83.0 mt -104.8 139.92 24.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.3 mt -109.02 145.02 36.25 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.471 ' CD1' ' HE ' ' A' ' 117' ' ' ARG . 9.1 tp -110.69 129.88 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-O 121.316 0.579 . . . . 0.0 110.247 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.458 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -118.55 153.82 33.58 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.403 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.36 -27.05 7.72 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.68 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 21.4 m120 -117.05 144.86 44.15 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.193 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -72.91 -14.21 61.42 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.324 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -50.53 -33.95 23.54 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.513 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.68 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 4.8 pm0 -93.59 -9.26 38.71 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.13 -16.63 27.46 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.462 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 43.6 tttm -76.69 -39.1 2.28 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -178.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 93.7 Cg_endo -102.06 -4.97 0.33 Allowed 'Trans proline' 0 C--N 1.318 -1.027 0 C-N-CA 122.65 2.233 . . . . 0.0 111.846 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -92.36 -14.48 28.64 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.892 0.377 . . . . 0.0 110.181 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.575 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.6 mp -134.19 158.49 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.575 ' N ' HG22 ' A' ' 72' ' ' ILE . 21.9 m-20 -62.97 145.74 54.67 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -79.04 -4.57 50.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.751 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.407 HG23 ' SD ' ' A' ' 76' ' ' MET . 8.1 t -73.56 -37.9 65.4 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.033 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.407 ' SD ' HG23 ' A' ' 75' ' ' THR . 63.2 mmm -64.57 -47.45 78.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.759 0.79 . . . . 0.0 109.672 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.7 mp -79.02 135.07 36.78 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 113.886 -1.506 . . . . 0.0 111.18 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.457 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -160.23 158.73 30.5 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.876 -178.697 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -38.57 -47.36 1.3 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.841 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.89 -34.44 68.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.097 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.457 ' N ' ' O ' ' A' ' 78' ' ' THR . 65.9 tp60 -65.51 -40.45 93.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.747 0.308 . . . . 0.0 110.727 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -63.95 -52.53 59.3 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 122.309 1.052 . . . . 0.0 109.235 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' A' ' 87' ' ' SER . 83.1 tt0 -55.24 -50.41 69.53 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.145 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.4 m -61.46 -50.25 73.52 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.216 -1.356 . . . . 0.0 111.966 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.4 tt -67.97 -32.5 56.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.717 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -76.67 -34.67 58.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.543 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 83' ' ' GLU . 11.6 m -87.83 -15.73 36.03 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.642 0.258 . . . . 0.0 111.13 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.436 ' O ' ' O ' ' A' ' 89' ' ' TRP . 68.4 ttt180 -116.3 75.62 0.97 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.813 0.34 . . . . 0.0 110.372 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.436 ' O ' ' O ' ' A' ' 88' ' ' ARG . 75.0 m95 57.7 148.13 0.06 OUTLIER Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.709 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.44 -29.26 37.95 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.922 1.748 . . . . 0.0 112.044 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 149.68 80.05 0.03 OUTLIER Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -85.08 -8.91 8.81 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.992 2.462 . . . . 0.0 112.17 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.455 HG13 ' CZ ' ' A' ' 95' ' ' PHE . 2.7 p -135.99 147.87 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.185 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 82.7 m -85.48 141.25 30.05 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.292 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.485 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 97.8 m-85 -123.0 142.74 50.51 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.465 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.732 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.2 t -106.03 112.8 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-O 121.261 0.553 . . . . 0.0 110.66 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -97.94 150.68 37.01 Favored Pre-proline 0 N--CA 1.472 0.646 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.72 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.69 86.59 0.86 Allowed 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 122.118 1.879 . . . . 0.0 111.341 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -48.61 150.9 2.23 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.969 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.07 145.36 66.99 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.88 1.72 . . . . 0.0 112.197 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.437 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.951 -179.971 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.473 ' O ' ' N ' ' A' ' 109' ' ' GLY . 2.0 tpt180 . . . . . 0 N--CA 1.471 0.593 0 CA-C-O 120.409 0.147 . . . . 0.0 110.792 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 47.3 p-90 -75.5 -9.55 58.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.763 0.316 . . . . 0.0 110.461 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.981 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -76.55 -25.11 53.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.19 -179.217 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.701 ' H ' HD22 ' A' ' 107' ' ' LEU . 24.4 m -144.24 -42.58 0.26 Allowed 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 49.49 0.98 0.01 OUTLIER Glycine 0 CA--C 1.537 1.42 0 C-N-CA 121.368 -0.444 . . . . 0.0 113.125 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.53 ' H ' ' C ' ' A' ' 108' ' ' THR . 0.0 OUTLIER -93.88 -62.31 1.37 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 117.882 0.841 . . . . 0.0 109.853 179.715 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.55 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 87.8 t80 -147.57 169.72 18.99 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.101 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.55 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 4.2 p-10 -84.0 73.74 10.33 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.519 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.491 ' C ' HD22 ' A' ' 114' ' ' LEU . 54.3 p -169.15 126.02 0.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.491 HD22 ' C ' ' A' ' 113' ' ' SER . 2.9 mm? -117.01 120.21 37.68 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -177.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.548 ' N ' HG13 ' A' ' 96' ' ' VAL . . . -80.28 117.21 20.85 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.508 177.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.471 HG22 ' N ' ' A' ' 117' ' ' ARG . 4.6 p -141.4 159.47 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.587 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.471 ' HE ' ' CD1' ' A' ' 61' ' ' ILE . 61.6 ttp180 -139.77 150.71 45.09 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.667 0.27 . . . . 0.0 111.13 -179.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.458 HG22 ' HB3' ' A' ' 62' ' ' ALA . 54.8 t -120.68 131.92 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.9 t -135.84 134.96 39.41 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -139.5 87.1 2.16 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.864 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.638 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 52.1 t-80 -172.58 -36.91 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.638 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 58.5 Cg_endo -95.33 -159.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 122.181 1.921 . . . . 0.0 112.006 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.8 mt -77.53 -5.98 52.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.26 0.552 . . . . 0.0 110.387 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.2 t -57.95 -45.23 87.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.837 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.746 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.8 m -53.83 -61.81 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.926 0 C-N-CA 119.413 -0.915 . . . . 0.0 108.92 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.746 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.0 -45.52 2.62 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.581 0.229 . . . . 0.0 110.93 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.5 tp -68.99 -47.09 66.41 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.268 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 64.2 m -70.44 -49.54 47.65 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.411 0.624 . . . . 0.0 110.997 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.474 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.2 pp0? -54.73 -41.75 70.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.438 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.523 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.6 -56.77 17.92 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.735 -177.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.496 ' CE1' ' OD1' ' A' ' 36' ' ' ASP . 3.9 t80 -63.57 -22.11 66.72 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.705 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 81.27 3.42 90.66 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.3 mttt -151.83 158.19 34.1 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.645 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -43.08 178.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 123.63 2.887 . . . . 0.0 113.536 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.9 tp -135.18 123.2 22.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 113.57 -1.65 . . . . 0.0 106.826 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.409 HG13 ' H ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -63.88 144.32 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 C-N-CA 118.041 -1.463 . . . . 0.0 108.072 -179.454 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 59' ' ' ILE . 1.1 p -113.97 123.74 50.47 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.64 0.588 . . . . 0.0 111.693 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 4.0 m -128.85 162.09 28.3 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.595 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.1 m -74.61 149.78 39.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.335 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.572 ' HB1' ' SG ' ' A' ' 148' ' ' CYS . . . -79.54 81.98 5.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.602 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -160.4 164.08 32.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.389 0.614 . . . . 0.0 110.578 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.68 -165.96 1.74 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.127 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.2 t -59.71 -44.11 93.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.414 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -162.55 12.49 0.11 Allowed Glycine 0 C--N 1.327 0.075 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.9 tp -89.1 126.4 59.11 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -39.64 157.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.538 1.492 . . . . 0.0 112.297 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.62 -161.0 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.411 2.074 . . . . 0.0 111.759 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.572 ' SG ' ' HB1' ' A' ' 140' ' ' ALA . 28.1 p -126.4 86.05 2.47 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.477 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 51.6 ptt85 -53.34 -37.47 62.37 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.862 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.36 171.48 20.16 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.43 ' H ' HG22 ' A' ' 151' ' ' VAL . 1.6 m -59.28 -22.48 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 CA-C-O 121.484 0.659 . . . . 0.0 109.297 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -65.26 -25.46 67.67 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 155' ' ' ARG . 0.0 OUTLIER -71.78 -78.97 0.08 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.49 179.282 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.4 p -34.75 -29.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.489 0.715 . . . . 0.0 110.072 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -73.68 -51.77 15.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.921 179.646 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 153' ' ' GLU . . . -69.78 -20.33 63.48 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 122.542 1.163 . . . . 0.0 108.064 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -82.78 -45.93 13.75 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 112.753 -2.021 . . . . 0.0 111.563 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -129.26 -22.66 3.08 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 90.01 22.7 34.81 Favored Glycine 0 N--CA 1.467 0.708 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.42 ' O ' ' O ' ' A' ' 159' ' ' GLY . . . -43.27 -98.28 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.742 0.306 . . . . 0.0 110.942 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.46 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 62.62 35.12 14.49 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.526 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.7 m-85 -174.06 -62.16 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.057 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -73.41 29.05 0.3 Allowed 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.175 1.917 . . . . 0.0 110.476 177.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.559 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.3 m -131.55 166.86 27.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.747 -178.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.8 t -123.0 65.7 28.04 Favored Pre-proline 0 N--CA 1.473 0.684 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.796 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.559 ' HD3' HG23 ' A' ' 164' ' ' VAL . 21.2 Cg_exo -36.31 142.42 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 123.561 2.841 . . . . 0.0 115.008 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 165.1 -167.91 38.97 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 114.006 -1.452 . . . . 0.0 110.88 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -152.71 177.84 10.27 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.466 0.36 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.404 179.952 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 . . . . . 0 N--CA 1.445 -0.7 0 CA-C-O 120.639 0.257 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.0 pt -122.7 102.5 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 121.182 0.515 . . . . 0.0 110.331 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -95.53 156.2 16.42 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.339 0.59 . . . . 0.0 111.847 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -76.4 106.36 7.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.822 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -64.68 -12.03 42.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.704 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.515 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.6 mm? -63.03 -42.05 99.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.348 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.71 -42.79 3.07 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.528 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.88 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.815 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 . . . . . 0 N--CA 1.468 0.444 0 CA-C-O 120.713 0.292 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.513 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.4 mp -62.74 -41.83 99.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.965 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -63.37 -42.8 98.88 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.417 0.627 . . . . 0.0 109.783 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -62.31 -41.36 98.47 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.476 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -62.11 -45.55 92.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.741 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.89 90.02 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.19 0.519 . . . . 0.0 110.379 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.48 -43.72 98.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.613 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.52 -45.59 81.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.191 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.72 -39.25 90.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.618 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.4 -53.98 49.52 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.51 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.6 pt -71.59 -31.01 40.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.232 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -59.57 -55.08 38.95 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' A' ' 20' ' ' GLU . 88.7 t -63.72 -40.35 88.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.896 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.675 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.5 tt -52.28 -50.28 62.44 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.555 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -79.82 -50.13 10.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.073 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -66.25 -34.59 78.36 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.952 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.8 mt-10 60.92 82.38 0.17 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 178.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.4 ' H ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -163.47 -139.51 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.232 177.507 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 34' ' ' GLY . 9.2 p -134.67 142.63 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 pp -129.35 163.66 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 120.896 0.379 . . . . 0.0 111.304 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.89 131.22 48.02 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.215 0.531 . . . . 0.0 111.11 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.494 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 0.4 OUTLIER -121.02 140.36 30.8 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.494 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 65.3 Cg_endo -79.33 154.73 24.84 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.553 1.502 . . . . 0.0 111.931 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.472 ' C ' ' H ' ' A' ' 29' ' ' ALA . 23.0 m -142.2 141.38 32.55 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.221 0.534 . . . . 0.0 110.955 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -75.44 23.18 0.12 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.547 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -154.21 -75.48 0.11 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.965 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.4 t -125.73 128.83 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 120.973 0.416 . . . . 0.0 110.174 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.503 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 93.5 m-85 -46.67 147.48 1.24 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.144 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -152.47 -174.47 23.03 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.6 m -126.55 168.16 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -157.64 177.65 34.33 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.098 -1.049 . . . . 0.0 112.235 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -154.66 -166.75 2.41 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.508 0.194 . . . . 0.0 110.594 -179.401 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.451 ' O ' ' O ' ' A' ' 37' ' ' PRO . 3.8 m-20 -95.52 108.78 41.84 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -178.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.451 ' O ' ' O ' ' A' ' 36' ' ' ASP . 54.1 Cg_exo -38.69 174.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.76 2.307 . . . . 0.0 114.042 177.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 38.08 69.72 0.23 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.302 -1.317 . . . . 0.0 111.429 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 51.0 m -149.1 144.09 26.44 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.376 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -69.5 -36.46 76.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.426 0.631 . . . . 0.0 110.64 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 41' ' ' THR . 0.1 OUTLIER -64.39 -43.68 93.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.664 -178.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.46 -50.05 75.11 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.041 -0.263 . . . . 0.0 111.413 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.1 p -62.32 -44.96 99.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.391 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 91.1 mtp -63.66 -40.49 96.98 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.475 ' NH2' HG21 ' A' ' 22' ' ' VAL . 34.0 ttt-85 -61.02 -41.6 96.86 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.923 0.868 . . . . 0.0 108.844 178.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.431 ' O ' HD23 ' A' ' 46' ' ' LEU . 1.0 OUTLIER -64.94 -54.74 25.85 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.238 -178.417 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.4 mt -69.1 -11.41 60.77 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.349 -0.842 . . . . 0.0 112.002 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -69.57 -82.48 0.04 OUTLIER 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 120.996 0.426 . . . . 0.0 110.778 -177.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.585 HD12 ' H ' ' A' ' 143' ' ' SER . 2.2 pt? -76.42 -35.29 58.62 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -178.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -76.36 -50.56 13.91 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.797 -177.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 35.29 66.55 0.31 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.724 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.408 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 4.7 mtt180 178.12 -53.05 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.898 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.397 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.408 ' HD2' ' H ' ' A' ' 52' ' ' ARG . 83.0 Cg_endo -80.56 -5.42 13.31 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.866 2.377 . . . . 0.0 112.584 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.59 HG13 ' N ' ' A' ' 55' ' ' ASP . 8.0 p -44.71 -45.13 2.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.073 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.59 ' N ' HG13 ' A' ' 54' ' ' VAL . 67.5 t0 -65.62 -40.38 92.52 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.588 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -62.21 -39.19 91.96 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 71.25 109.62 0.04 OUTLIER Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.564 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -51.7 -163.34 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.232 0.539 . . . . 0.0 112.209 -179.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.434 ' O ' ' OG ' ' A' ' 137' ' ' SER . 61.1 mt -105.12 137.28 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.897 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.7 mt -115.68 143.01 45.98 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.3 tp -111.82 132.91 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 121.149 0.5 . . . . 0.0 110.741 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.47 150.92 41.85 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.95 -29.79 8.42 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.04 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.714 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 14.3 m120 -113.12 150.05 32.7 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.155 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -79.01 -14.28 59.28 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -54.49 -30.19 52.54 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.913 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.714 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 4.0 pm0 -95.01 -11.06 29.1 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.525 HD22 ' N ' ' A' ' 68' ' ' LEU . 3.7 mm? -91.16 -18.8 23.88 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.459 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 43.4 tttm -75.57 -39.43 2.99 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 85.3 Cg_endo -104.18 -2.61 0.23 Allowed 'Trans proline' 0 C--N 1.319 -1.009 0 C-N-CA 122.91 2.407 . . . . 0.0 112.363 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -96.95 -11.12 25.04 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.692 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.516 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.1 mp -127.94 155.96 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.516 ' N ' HG22 ' A' ' 72' ' ' ILE . 93.9 m-20 -64.29 158.52 23.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.965 0.412 . . . . 0.0 110.08 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -94.74 7.74 44.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.028 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.517 HG23 ' N ' ' A' ' 76' ' ' MET . 13.2 t -74.32 -42.57 59.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.029 0.442 . . . . 0.0 111.075 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.517 ' N ' HG23 ' A' ' 75' ' ' THR . 24.4 ptm -95.34 -15.74 22.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.093 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 tp -93.92 127.57 39.76 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.113 0.482 . . . . 0.0 110.63 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.458 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -157.73 161.94 38.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.858 -177.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -39.61 -47.52 1.96 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.776 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.58 -32.64 57.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.853 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.458 ' N ' ' O ' ' A' ' 78' ' ' THR . 58.6 tp60 -63.48 -40.97 98.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.204 0.526 . . . . 0.0 110.19 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.422 ' HG2' ' H ' ' A' ' 82' ' ' ARG . 10.6 mmt85 -65.41 -52.85 50.49 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 122.484 1.135 . . . . 0.0 109.42 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -54.25 -50.96 65.99 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 113.801 -1.545 . . . . 0.0 110.143 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.6 m -61.1 -50.04 74.88 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.574 -1.193 . . . . 0.0 111.979 -177.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.6 tt -67.81 -32.13 55.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.072 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -76.47 -36.05 58.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.753 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.8 m -87.4 -14.19 41.28 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.633 0.254 . . . . 0.0 111.298 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 89' ' ' TRP . 69.2 ttt180 -115.34 75.43 0.94 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.427 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.452 ' O ' ' O ' ' A' ' 88' ' ' ARG . 13.9 m-90 56.37 153.11 0.07 OUTLIER Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.507 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.6 -21.23 39.87 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.133 1.889 . . . . 0.0 111.649 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.519 ' O ' ' NE ' ' A' ' 117' ' ' ARG . . . 158.52 81.27 0.04 OUTLIER Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.55 -17.8 11.07 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.262 1.974 . . . . 0.0 112.047 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.451 HG13 ' CE2' ' A' ' 95' ' ' PHE . 3.0 p -136.95 146.32 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.132 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.6 m -91.31 129.33 37.32 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.389 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.46 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 38.8 m-85 -117.5 138.05 52.14 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.779 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.623 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 5.2 t -92.46 104.65 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 121.301 0.572 . . . . 0.0 110.761 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 97' ' ' PHE . 30.4 m-85 -86.3 147.1 43.85 Favored Pre-proline 0 N--CA 1.466 0.362 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.529 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.54 83.76 1.85 Allowed 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.993 1.796 . . . . 0.0 111.6 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -46.2 152.46 0.81 Allowed Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -69.46 156.28 64.56 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.036 1.824 . . . . 0.0 111.607 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.464 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.17 179.996 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' A' ' 109' ' ' GLY . 8.0 tpt180 . . . . . 0 CA--C 1.528 0.118 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 8.6 p90 -81.31 -10.08 59.63 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.662 0.744 . . . . 0.0 109.057 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.622 ' H ' ' CD2' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -77.38 -15.28 59.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.638 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 85.3 m -143.28 -40.57 0.31 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.316 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 92.33 -19.28 51.04 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 116.263 -0.426 . . . . 0.0 113.714 178.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.419 ' O ' ' NH2' ' A' ' 105' ' ' ARG . 18.1 tpt180 -144.86 -80.4 0.17 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 117.953 0.877 . . . . 0.0 111.786 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.406 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 29.7 t80 -75.63 -125.47 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.667 -178.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.406 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 48.1 t0 -170.52 54.38 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.834 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.6 p -157.27 155.33 30.58 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.492 ' O ' HD12 ' A' ' 114' ' ' LEU . 0.3 OUTLIER -161.13 137.78 8.58 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.227 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.445 ' HB2' HG22 ' A' ' 96' ' ' VAL . . . -69.55 135.41 50.02 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 113.212 -1.813 . . . . 0.0 109.777 178.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.6 p -149.73 153.71 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 120.888 0.375 . . . . 0.0 110.7 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.519 ' NE ' ' O ' ' A' ' 91' ' ' GLY . 75.7 ttt180 -142.33 152.55 43.04 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.507 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 49.5 t -119.93 133.05 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.2 t -137.72 138.32 39.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.042 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -145.27 85.2 1.72 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.689 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.664 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 8.2 t60 -173.39 -36.58 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.179 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.664 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 67.7 Cg_endo -95.04 -160.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 122.298 1.999 . . . . 0.0 111.964 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.526 HD12 ' N ' ' A' ' 123' ' ' LEU . 9.6 mp -76.84 -7.51 55.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.175 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.0 t -56.74 -45.06 82.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.797 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.738 HG23 ' H ' ' A' ' 126' ' ' ALA . 26.8 m -53.84 -61.84 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.875 0 C-N-CA 119.35 -0.94 . . . . 0.0 108.981 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.738 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.04 -44.08 2.32 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.894 0.378 . . . . 0.0 110.992 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.6 -48.3 60.58 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.362 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 61.6 m -69.9 -49.28 53.67 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.421 0.629 . . . . 0.0 110.684 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.457 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.0 OUTLIER -54.39 -42.71 70.72 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.42 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.536 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.5 -54.96 41.18 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.585 -177.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.443 ' CE1' ' OD2' ' A' ' 36' ' ' ASP . 39.6 t80 -62.46 -21.6 65.57 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.919 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.86 -1.93 82.02 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' A' ' 134' ' ' PRO . 14.2 mtpp -149.5 159.01 37.34 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 133' ' ' LYS . 3.4 Cg_exo -41.68 178.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 123.847 3.031 . . . . 0.0 113.128 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.4 tp -132.34 123.16 26.27 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 176.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.429 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -63.79 153.12 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 C-N-CA 117.888 -1.525 . . . . 0.0 106.986 -179.702 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 59' ' ' ILE . 1.4 p -130.12 133.78 46.88 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.109 0.48 . . . . 0.0 111.1 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.5 m -134.44 164.67 26.93 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.708 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.6 m -70.45 148.46 48.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.386 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.527 ' HB1' ' H ' ' A' ' 148' ' ' CYS . . . -61.4 -36.9 81.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.221 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 141' ' ' ASN . 50.3 p30 -67.28 144.41 55.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.043 0.449 . . . . 0.0 110.475 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.698 HD22 ' C ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -150.94 163.57 38.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.219 -179.607 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.585 ' H ' HD12 ' A' ' 49' ' ' LEU . 29.1 t 28.45 -87.88 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 O-C-N 123.603 0.564 . . . . 0.0 112.192 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 142' ' ' LEU . . . -157.41 16.78 0.35 Allowed Glycine 0 C--N 1.332 0.307 0 N-CA-C 109.976 -1.249 . . . . 0.0 109.976 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.9 tp -94.61 129.25 37.0 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 115.21 -0.495 . . . . 0.0 109.691 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -37.21 156.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.802 1.668 . . . . 0.0 112.384 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -75.71 -164.82 0.26 Allowed 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.42 2.08 . . . . 0.0 112.888 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.527 ' H ' ' HB1' ' A' ' 140' ' ' ALA . 29.7 m -111.39 80.12 1.28 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.123 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.503 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 33.9 ptt180 -54.54 -35.16 62.93 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.21 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.95 169.81 19.08 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.439 HG22 ' H ' ' A' ' 151' ' ' VAL . 0.7 OUTLIER -57.28 -22.82 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.412 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -63.5 -30.83 71.89 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 155' ' ' ARG . 6.0 tm-20 -63.76 -79.61 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.204 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.1 p -36.64 -30.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.922 0.889 . . . . 0.0 111.118 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.472 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -69.69 -52.21 27.71 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.628 -178.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.92 -17.69 62.68 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 122.697 1.236 . . . . 0.0 108.386 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -83.87 -45.62 13.04 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 112.492 -2.14 . . . . 0.0 111.847 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -131.11 -23.46 2.45 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 87.98 26.75 28.08 Favored Glycine 0 N--CA 1.464 0.553 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 159' ' ' GLY . . . -43.01 -97.33 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.65 -0.275 . . . . 0.0 111.018 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.465 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 65.85 33.13 8.23 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-O 121.362 0.601 . . . . 0.0 109.453 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.527 ' C ' ' H ' ' A' ' 164' ' ' VAL . 1.8 m-85 -175.58 -62.09 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.505 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.38 31.94 0.28 Allowed 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.169 1.913 . . . . 0.0 110.363 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.577 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.4 m -134.64 167.17 26.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.734 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.3 t -123.72 66.14 36.49 Favored Pre-proline 0 N--CA 1.472 0.657 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.549 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.577 ' HD3' HG23 ' A' ' 164' ' ' VAL . 38.7 Cg_exo -37.73 147.59 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 123.551 2.834 . . . . 0.0 115.072 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 163.84 -173.39 39.9 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 113.739 -1.573 . . . . 0.0 111.105 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -145.68 150.86 37.07 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.718 0.294 . . . . 0.0 110.472 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.466 0.359 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.053 179.865 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.448 -0.564 0 CA-C-O 120.738 0.304 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.502 ' O ' HG23 ' A' ' 178' ' ' ILE . 18.3 tt -111.91 120.5 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.067 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -125.28 164.2 20.87 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 122.052 0.93 . . . . 0.0 110.768 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 184' ' ' GLY . 43.2 t0 -77.05 106.71 8.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.037 -1.438 . . . . 0.0 108.79 178.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -62.28 -20.52 64.37 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.692 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.477 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.4 mm? -63.77 -42.27 97.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.854 0.359 . . . . 0.0 110.408 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.86 -47.12 2.31 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.773 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 180' ' ' ASP . . . . . . . . 0 CA--C 1.526 0.776 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 120.659 0.266 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.54 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.0 mp -62.49 -42.38 99.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.458 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.6 -42.66 91.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.911 0.386 . . . . 0.0 110.26 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 63.3 ttm-85 -62.88 -42.29 99.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.379 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -62.16 -43.49 98.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.398 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.2 -47.14 87.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.06 0.457 . . . . 0.0 110.02 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.22 -43.24 98.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.817 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.85 -40.88 85.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.44 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.24 -43.08 92.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.029 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.16 -52.45 64.79 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.787 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 14' ' ' ILE . 16.7 pt -68.5 -39.06 80.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.357 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -58.22 -54.9 41.81 Favored 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.201 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 20' ' ' GLU . 94.0 t -59.75 -39.73 80.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.776 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.651 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.5 tt -52.06 -50.0 62.38 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.104 -0.638 . . . . 0.0 109.674 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -81.31 -52.71 7.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.904 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.458 ' O ' ' NH1' ' A' ' 21' ' ' ARG . 69.4 mm-40 -63.25 -35.56 80.76 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.438 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.2 mt-10 59.69 81.89 0.16 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.458 ' NH1' ' O ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -155.28 -136.73 0.06 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 177.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 34' ' ' GLY . 6.6 p -142.09 139.8 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -126.92 165.64 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.03 0.443 . . . . 0.0 111.363 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.45 129.48 40.04 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.04 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -109.88 133.35 20.99 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.129 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -84.57 140.96 8.56 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.246 1.297 . . . . 0.0 111.789 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.5 ' C ' ' H ' ' A' ' 29' ' ' ALA . 28.2 m -136.01 135.89 39.85 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.871 0.367 . . . . 0.0 110.839 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -74.77 29.43 0.09 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.998 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.5 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -158.52 -77.18 0.07 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.289 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.1 m -120.37 126.28 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-O 121.118 0.485 . . . . 0.0 110.781 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.524 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 77.9 m-85 -60.67 145.17 50.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.509 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -154.4 -166.62 15.27 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.6 m -131.91 170.85 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.441 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -159.87 -176.35 31.85 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 119.518 -1.325 . . . . 0.0 112.51 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.502 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -163.48 -163.36 0.81 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.137 -179.147 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.502 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 43.0 t0 -90.74 106.43 15.45 Favored Pre-proline 0 CA--C 1.555 1.167 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -38.16 -61.89 0.34 Allowed 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.283 1.989 . . . . 0.0 112.129 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -69.71 62.63 0.18 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.315 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.4 m -155.1 131.89 10.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.083 0.468 . . . . 0.0 110.928 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.08 -17.92 63.93 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.247 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.514 HG23 ' N ' ' A' ' 42' ' ' ALA . 15.3 t -61.26 -41.91 97.73 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.511 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.514 ' N ' HG23 ' A' ' 41' ' ' THR . . . -58.13 -51.26 70.45 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.63 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 p -63.05 -44.19 99.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.434 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 62.3 mtt -65.22 -39.93 93.44 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -61.92 -32.83 73.26 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.632 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 81.9 mt -76.92 -57.67 3.72 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.4 mt -57.2 -16.09 7.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.387 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.52 -85.77 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.589 -178.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.505 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -76.08 -32.47 59.26 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.987 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -79.11 -71.01 0.46 Allowed 'General case' 0 C--N 1.349 0.57 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.428 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.424 ' O ' ' CG ' ' A' ' 51' ' ' GLN . 3.7 tt0 54.4 79.85 0.13 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.381 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 161.45 -62.7 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.856 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.332 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.01 -8.53 23.84 Favored 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.58 2.187 . . . . 0.0 111.641 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.557 HG13 ' N ' ' A' ' 55' ' ' ASP . 7.7 p -43.74 -46.34 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.926 0.394 . . . . 0.0 110.466 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.557 ' N ' HG13 ' A' ' 54' ' ' VAL . 10.0 t0 -66.28 -42.87 87.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.196 0.522 . . . . 0.0 109.941 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -61.35 -40.87 95.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.422 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 64.52 117.34 0.01 OUTLIER Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.572 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -51.21 -164.53 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.21 0.529 . . . . 0.0 112.131 179.676 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.5 mt -105.62 145.19 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 16.9 mt -117.15 146.33 43.26 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.4 tp -113.8 132.77 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-O 121.39 0.614 . . . . 0.0 111.325 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.51 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -120.39 154.1 35.59 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.103 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.04 -27.58 6.89 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.552 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 98.1 m-20 -114.13 143.74 44.31 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.105 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -73.48 -14.29 61.21 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -50.28 -33.13 18.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.502 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.552 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 3.8 pm0 -94.4 -12.25 28.25 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.548 ' O ' HD13 ' A' ' 72' ' ' ILE . 3.6 mm? -91.67 -14.92 29.26 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.424 -0.797 . . . . 0.0 108.885 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.464 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 43.0 tttm -78.64 -39.93 1.64 Allowed Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 66.6 Cg_endo -104.43 -2.07 0.23 Allowed 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 122.853 2.368 . . . . 0.0 112.351 -178.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.463 ' OH ' ' CD2' ' A' ' 114' ' ' LEU . 55.6 t80 -97.73 -9.47 26.59 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.988 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.619 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.6 mp -123.34 168.91 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.619 ' N ' HG22 ' A' ' 72' ' ' ILE . 96.5 m-20 -60.56 -12.43 9.93 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.051 -0.259 . . . . 0.0 111.141 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 57.8 t0 55.71 30.52 15.73 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.282 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.546 HG23 ' N ' ' A' ' 76' ' ' MET . 9.2 t -96.13 -43.5 7.72 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.208 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.546 ' N ' HG23 ' A' ' 75' ' ' THR . 18.9 ptp -84.69 -5.97 59.34 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.237 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.3 tp -92.8 127.56 38.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.251 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.438 ' H ' ' HB3' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -160.2 161.63 33.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.683 -177.735 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -38.77 -49.18 1.59 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.727 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.02 -33.54 61.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.048 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.438 ' HB3' ' H ' ' A' ' 78' ' ' THR . 65.4 tp60 -66.31 -39.03 89.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.619 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.5 mmt85 -63.54 -53.45 51.64 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 122.38 1.086 . . . . 0.0 108.619 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -54.31 -50.39 67.46 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.013 -1.449 . . . . 0.0 110.117 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -60.83 -50.56 72.95 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.883 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.0 tt -67.9 -32.6 57.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.102 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -72.41 -41.66 66.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.82 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.7 m -78.03 -33.09 51.27 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.566 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 89' ' ' TRP . 76.7 ttt180 -95.74 157.69 15.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.04 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.413 ' C ' ' O ' ' A' ' 88' ' ' ARG . 3.7 m-90 -31.37 148.52 0.05 OUTLIER Pre-proline 0 N--CA 1.47 0.55 0 O-C-N 123.482 0.488 . . . . 0.0 111.43 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -67.02 -17.64 51.32 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.051 1.834 . . . . 0.0 111.41 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.425 ' H ' ' HD3' ' A' ' 92' ' ' PRO . . . 108.92 73.75 0.79 Allowed Glycine 0 N--CA 1.468 0.831 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.425 ' HD3' ' H ' ' A' ' 91' ' ' GLY . 50.3 Cg_exo -53.78 -36.15 81.33 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.833 2.355 . . . . 0.0 111.675 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.422 HG13 ' CZ ' ' A' ' 95' ' ' PHE . 3.4 p -90.44 147.61 5.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.038 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 57.7 m -86.15 147.34 26.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.662 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.424 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 81.7 m-85 -127.32 143.5 51.22 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.469 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.626 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.8 t -99.23 105.39 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-O 121.209 0.528 . . . . 0.0 109.985 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -88.84 149.7 44.19 Favored Pre-proline 0 N--CA 1.469 0.52 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.968 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -76.74 110.18 3.0 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.229 1.953 . . . . 0.0 110.977 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.91 147.72 97.85 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.607 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 40.0 Cg_endo -64.19 -26.27 64.83 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.817 1.678 . . . . 0.0 111.848 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . 0 N--CA 1.471 0.589 0 O-C-N 123.706 0.629 . . . . 0.0 110.869 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.46 ' NH1' ' OD1' ' A' ' 112' ' ' ASP . 2.8 tpp85 . . . . . 0 CA--C 1.533 0.295 0 CA-C-O 120.746 0.307 . . . . 0.0 110.536 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.531 ' CD1' ' N ' ' A' ' 106' ' ' TRP . 4.5 m0 -78.66 -7.36 57.58 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.6 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.942 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -72.41 -31.8 65.83 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.691 ' H ' HD22 ' A' ' 107' ' ' LEU . 25.9 m -141.01 -42.02 0.39 Allowed 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.515 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 49.36 -0.22 0.01 OUTLIER Glycine 0 CA--C 1.539 1.562 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.13 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.555 ' N ' ' O ' ' A' ' 108' ' ' THR . 0.5 OUTLIER -86.74 -51.17 6.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.025 0.912 . . . . 0.0 108.862 179.366 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.582 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 83.5 t80 -151.36 173.18 14.82 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.498 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.582 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 93.3 m-20 -78.91 51.08 1.08 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.105 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 82.5 p -161.05 158.85 28.5 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.498 ' O ' HD12 ' A' ' 114' ' ' LEU . 0.3 OUTLIER -158.36 136.62 10.84 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -178.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.433 ' N ' HG13 ' A' ' 96' ' ' VAL . . . -68.02 125.11 25.3 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 113.389 -1.732 . . . . 0.0 110.527 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.507 HG22 ' N ' ' A' ' 117' ' ' ARG . 4.2 p -151.57 161.48 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.507 ' N ' HG22 ' A' ' 116' ' ' VAL . 61.5 ttp180 -147.06 154.38 41.11 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.934 0.397 . . . . 0.0 111.756 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.51 HG22 ' HB3' ' A' ' 62' ' ' ALA . 56.0 t -119.95 133.09 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.604 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.424 ' O ' HG23 ' A' ' 119' ' ' THR . 11.4 t -132.41 129.65 39.6 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.924 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.539 ' O ' ' CG ' ' A' ' 121' ' ' HIS . 67.4 t0 -136.99 75.47 1.53 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.163 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.682 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 18.7 m-70 -165.52 -36.5 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.301 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.682 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 18.7 Cg_endo -91.97 -162.14 0.1 Allowed 'Trans proline' 0 N--CA 1.485 0.984 0 C-N-CA 121.793 1.662 . . . . 0.0 112.01 -178.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.7 mt -77.3 -6.29 52.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.649 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 83.0 t -57.79 -44.12 85.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.632 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.747 HG23 ' H ' ' A' ' 126' ' ' ALA . 34.5 m -52.32 -62.46 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.879 0 C-N-CA 119.354 -0.938 . . . . 0.0 108.828 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.747 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.97 -44.03 3.34 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.697 0.284 . . . . 0.0 110.995 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 40.3 tp -68.75 -49.26 60.15 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.447 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.477 ' O ' ' N ' ' A' ' 132' ' ' GLY . 75.7 m -70.6 -47.92 57.74 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.263 0.554 . . . . 0.0 111.123 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.479 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -54.64 -42.52 71.37 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.493 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.6 -54.59 45.38 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.167 -177.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -65.71 -22.39 66.61 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 114.766 -1.107 . . . . 0.0 108.136 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 128' ' ' CYS . . . 78.97 2.28 86.53 Favored Glycine 0 N--CA 1.44 -1.087 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -149.57 159.69 35.78 Favored Pre-proline 0 CA--C 1.55 0.951 0 CA-C-N 117.204 0.502 . . . . 0.0 110.556 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -47.59 163.76 0.17 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 124.045 3.163 . . . . 0.0 113.667 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.3 tp -119.95 123.99 44.88 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.422 ' O ' ' CA ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -63.41 147.87 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 C-N-CA 117.755 -1.578 . . . . 0.0 106.899 179.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.3 t -122.53 127.15 49.14 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.648 0.592 . . . . 0.0 111.515 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.4 m -128.62 165.75 20.22 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.602 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 24.0 m -72.25 148.49 45.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.668 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.576 ' HB1' ' H ' ' A' ' 148' ' ' CYS . . . -60.92 -36.6 79.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.199 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 57.2 p30 -61.98 152.34 32.56 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.746 0.784 . . . . 0.0 111.293 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.18 -155.36 0.63 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.328 -1.306 . . . . 0.0 109.809 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 79.4 p -62.44 -39.05 92.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.327 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -167.97 7.55 0.05 OUTLIER Glycine 0 CA--C 1.51 -0.257 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.2 tp -86.74 128.15 57.5 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-O 119.223 -0.418 . . . . 0.0 110.037 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -38.22 156.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.666 1.578 . . . . 0.0 112.092 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.435 ' O ' ' OE2' ' A' ' 153' ' ' GLU . 97.6 Cg_endo -74.65 -169.72 0.65 Allowed 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.656 2.237 . . . . 0.0 111.983 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.576 ' H ' ' HB1' ' A' ' 140' ' ' ALA . 14.6 m -116.71 75.54 0.97 Allowed 'General case' 0 CA--C 1.522 -0.109 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.661 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.524 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 31.3 ptt-85 -51.12 -38.7 53.44 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.386 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -161.22 170.47 20.21 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.142 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.404 HG11 ' HA ' ' A' ' 166' ' ' PRO . 1.3 m -57.8 -20.8 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -64.8 -33.96 77.23 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.435 ' OE2' ' O ' ' A' ' 147' ' ' PRO . 0.0 OUTLIER -61.54 -79.69 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.807 179.289 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.441 HG13 ' N ' ' A' ' 155' ' ' ARG . 7.2 p -35.14 -33.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.969 0.908 . . . . 0.0 111.104 178.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.459 ' O ' ' N ' ' A' ' 159' ' ' GLY . 4.9 tmt_? -68.32 -51.76 41.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.679 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.51 -17.55 62.95 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.633 1.206 . . . . 0.0 107.956 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -83.42 -45.63 13.45 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 112.582 -2.099 . . . . 0.0 111.86 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -130.79 -27.35 2.11 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 94.01 24.39 20.01 Favored Glycine 0 N--CA 1.467 0.754 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 -178.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -43.07 -95.99 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.749 0.309 . . . . 0.0 110.968 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.514 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 60.53 35.45 20.17 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.537 ' H ' HG22 ' A' ' 164' ' ' VAL . 2.0 m-85 -172.61 -63.02 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.005 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -71.84 25.13 0.25 Allowed 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.301 2.001 . . . . 0.0 110.813 177.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.568 HG23 ' HD3' ' A' ' 166' ' ' PRO . 16.0 m -128.38 166.09 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.694 -178.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.19 65.05 28.21 Favored Pre-proline 0 N--CA 1.476 0.832 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.552 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.568 ' HD3' HG23 ' A' ' 164' ' ' VAL . 17.1 Cg_exo -36.12 142.65 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 123.429 2.753 . . . . 0.0 114.862 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 176.63 -168.49 40.53 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 113.934 -1.485 . . . . 0.0 111.132 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -155.52 148.96 24.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.775 0.322 . . . . 0.0 110.171 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.468 0.46 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.677 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 . . . . . 0 N--CA 1.443 -0.778 0 CA-C-O 121.039 0.447 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 43.6 pt -119.85 143.82 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.988 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -130.97 166.86 20.05 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.714 0.769 . . . . 0.0 111.413 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -79.46 105.72 10.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.156 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -64.67 -19.18 65.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.659 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.481 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.5 mm? -62.4 -41.78 98.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.195 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.17 -42.4 7.07 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.512 0 N-CA-C 110.451 -1.059 . . . . 0.0 110.451 179.816 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.734 0.302 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.53 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.7 mp -62.24 -42.86 99.69 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -64.6 -40.55 95.71 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -63.18 -41.73 99.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.72 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -60.57 -44.99 95.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.698 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.65 -44.47 96.91 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.099 0.476 . . . . 0.0 110.044 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.75 -43.13 97.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.69 -42.66 79.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.943 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.79 -41.02 99.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.86 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.37 -54.72 42.3 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.828 0.347 . . . . 0.0 111.333 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.7 pt -68.17 -35.71 72.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.241 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -59.39 -51.4 70.05 Favored 'General case' 0 C--O 1.216 -0.693 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.939 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.531 HG13 ' O ' ' A' ' 21' ' ' ARG . 87.8 t -63.15 -38.91 83.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.61 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.675 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.5 tt -52.63 -51.11 61.51 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.282 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -78.0 -49.06 14.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.176 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -67.78 -29.82 69.11 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.046 0.45 . . . . 0.0 110.813 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 16' ' ' VAL . 96.7 mt-10 56.88 60.39 3.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.42 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.531 ' O ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -154.65 159.49 40.83 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.59 0.709 . . . . 0.0 110.642 179.139 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 34' ' ' GLY . 8.7 p -74.67 137.06 23.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.771 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.497 HG22 ' NH2' ' A' ' 21' ' ' ARG . 2.8 pp -124.62 165.56 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 120.631 0.253 . . . . 0.0 110.444 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.427 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -62.91 135.85 57.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.251 0.548 . . . . 0.0 111.046 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.495 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 1.3 t80 -124.6 140.85 36.33 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.495 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 59.3 Cg_endo -81.65 145.32 14.49 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.106 1.204 . . . . 0.0 111.108 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.502 ' C ' ' H ' ' A' ' 29' ' ' ALA . 55.7 m -132.06 134.61 45.71 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.865 0.364 . . . . 0.0 110.939 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -73.91 31.02 0.08 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.519 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.502 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -157.49 -78.73 0.08 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.477 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 73.2 t -127.09 129.35 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.511 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 93.2 m-85 -43.3 146.27 0.48 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.302 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -152.95 -172.12 20.99 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.7 m -131.92 167.32 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.505 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -157.83 176.39 34.91 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.114 -1.041 . . . . 0.0 112.081 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.504 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -154.03 -163.57 1.66 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.636 -178.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.504 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 17.2 p-10 -97.44 108.09 42.87 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -177.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 36' ' ' ASP . 64.6 Cg_exo -38.93 174.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.82 2.347 . . . . 0.0 113.937 177.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 46.2 t0 37.59 77.98 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.433 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.5 m -153.22 142.96 21.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.137 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.642 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -71.5 -35.65 70.83 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.27 0.557 . . . . 0.0 109.745 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.439 HG22 ' H ' ' A' ' 41' ' ' THR . 0.1 OUTLIER -65.2 -43.59 91.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.566 -179.129 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.94 -49.42 77.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.743 0.306 . . . . 0.0 111.339 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.3 p -63.93 -47.03 92.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.811 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.3 mtt -65.64 -48.18 73.06 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.425 ' NH2' HG12 ' A' ' 22' ' ' VAL . 7.2 ptm180 -61.72 -33.17 73.57 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.587 HD13 ' C ' ' A' ' 46' ' ' LEU . 2.6 tm? -70.71 -46.32 63.3 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.419 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.482 HD21 HG21 ' A' ' 54' ' ' VAL . 6.3 mt -76.39 -11.1 59.84 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 120.897 0.379 . . . . 0.0 111.248 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.99 -81.26 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.592 -176.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.443 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -72.94 -35.93 67.1 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -75.21 -50.04 17.48 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.928 -177.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 33.95 67.05 0.22 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.759 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.2 mmm-85 178.58 -54.02 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.91 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.692 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.91 -6.57 17.58 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.647 2.232 . . . . 0.0 112.748 -178.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.595 HG13 ' N ' ' A' ' 55' ' ' ASP . 14.8 p -43.18 -46.74 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.456 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.595 ' N ' HG13 ' A' ' 54' ' ' VAL . 41.0 t0 -64.16 -42.68 96.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.025 0.44 . . . . 0.0 110.305 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -61.28 -39.63 91.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.62 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 64.72 112.03 0.01 OUTLIER Glycine 0 CA--C 1.519 0.314 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.553 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -54.57 -158.35 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.097 0.475 . . . . 0.0 111.857 -179.488 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 67.9 mt -112.75 146.24 17.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.247 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 14.7 mt -122.16 150.15 42.62 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.7 tp -120.28 130.56 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-O 121.178 0.514 . . . . 0.0 110.599 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.417 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -118.54 149.48 41.26 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.7 -29.34 8.75 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.178 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.595 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 10.9 m120 -116.72 150.02 38.9 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.038 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -77.24 -13.95 59.85 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -50.87 -31.32 17.02 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.47 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.595 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 4.7 pm0 -94.52 -13.08 26.44 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.504 HD22 ' N ' ' A' ' 68' ' ' LEU . 4.0 mm? -92.94 -12.33 31.11 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.476 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 75.0 tttt -80.16 -39.63 1.23 Allowed Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.589 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 44.0 Cg_endo -105.55 -0.95 0.19 Allowed 'Trans proline' 0 C--N 1.316 -1.163 0 C-N-CA 122.968 2.445 . . . . 0.0 112.474 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -97.85 -5.2 35.12 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.612 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.1 mp -127.1 166.33 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.612 ' N ' HG22 ' A' ' 72' ' ' ILE . 93.3 m-20 -64.2 -9.46 17.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.23 -179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 55.65 33.68 21.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.89 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.517 HG23 ' N ' ' A' ' 76' ' ' MET . 10.1 t -96.81 -42.02 8.17 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.517 ' N ' HG23 ' A' ' 75' ' ' THR . 10.5 ptp -91.45 -6.84 52.08 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.396 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.3 tp -93.02 126.05 37.92 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.685 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.453 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -159.77 160.85 34.4 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.92 -177.003 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -39.22 -47.3 1.62 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.748 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.17 -33.57 63.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.022 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' A' ' 78' ' ' THR . 67.8 tp60 -65.03 -40.77 95.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.974 0.416 . . . . 0.0 110.508 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.407 ' HG2' ' H ' ' A' ' 82' ' ' ARG . 6.9 mmt85 -62.69 -52.33 63.71 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 122.469 1.128 . . . . 0.0 108.95 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 87' ' ' SER . 81.9 tt0 -55.9 -50.68 70.01 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 113.781 -1.554 . . . . 0.0 110.135 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 m -61.12 -50.17 74.31 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.976 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.4 tt -67.49 -31.97 55.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.864 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -77.72 -35.25 52.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.774 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 83' ' ' GLU . 13.1 m -87.27 -16.67 34.51 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.582 0.229 . . . . 0.0 110.994 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 89' ' ' TRP . 74.5 ttt-85 -113.34 75.51 0.92 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.7 0.286 . . . . 0.0 110.237 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.452 ' O ' ' O ' ' A' ' 88' ' ' ARG . 82.5 m95 56.85 147.64 0.05 OUTLIER Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.615 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.35 -24.49 37.08 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.172 1.915 . . . . 0.0 112.488 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 156.91 79.48 0.03 OUTLIER Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -83.82 -9.46 9.86 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.72 2.28 . . . . 0.0 112.162 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.482 HG13 ' CE2' ' A' ' 95' ' ' PHE . 3.0 p -137.15 147.49 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.296 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.538 HG22 ' HB1' ' A' ' 115' ' ' ALA . 10.9 m -90.27 125.98 35.68 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.189 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.523 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 34.4 m-85 -117.4 140.5 49.5 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.755 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 3.1 t -99.77 109.75 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-O 121.546 0.688 . . . . 0.0 111.156 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -96.92 151.05 37.53 Favored Pre-proline 0 N--CA 1.469 0.482 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.69 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -65.77 104.8 0.71 Allowed 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.822 1.681 . . . . 0.0 111.247 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.14 162.39 71.65 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.55 141.16 90.78 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 CA-C-N 120.098 1.071 . . . . 0.0 111.756 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.21 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.341 179.889 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.477 ' NH2' ' O ' ' A' ' 110' ' ' ARG . 6.4 tpt180 . . . . . 0 CA--C 1.532 0.271 0 CA-C-O 120.612 0.244 . . . . 0.0 110.626 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 2.3 p90 -70.85 -8.99 56.61 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.098 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.986 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -77.28 -18.38 57.62 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.44 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.614 ' N ' HD22 ' A' ' 107' ' ' LEU . 94.1 m -141.76 -39.33 0.38 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.918 0.389 . . . . 0.0 110.572 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 83.27 13.95 75.48 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.606 -0.597 . . . . 0.0 111.606 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.477 ' O ' ' NH2' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -162.41 -77.77 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.101 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -99.17 -162.12 0.93 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.311 -0.404 . . . . 0.0 109.957 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 53.4 p30 -134.55 61.8 1.66 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.828 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 83.0 p -156.94 128.75 7.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.613 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.567 ' C ' HG13 ' A' ' 96' ' ' VAL . 53.6 mt -124.13 134.96 53.21 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -178.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.538 ' HB1' HG22 ' A' ' 94' ' ' THR . . . -71.95 120.99 18.34 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.439 175.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.441 HG22 ' N ' ' A' ' 117' ' ' ARG . 3.4 p -143.74 158.39 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.824 0.345 . . . . 0.0 110.413 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.441 ' N ' HG22 ' A' ' 116' ' ' VAL . 88.1 mtm180 -144.73 161.77 38.39 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.815 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.417 HG22 ' HB3' ' A' ' 62' ' ' ALA . 55.9 t -123.23 130.38 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.451 ' O ' HG23 ' A' ' 119' ' ' THR . 14.1 t -129.83 128.25 41.92 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.767 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -133.95 82.64 1.99 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.848 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.65 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 70.6 t60 -172.88 -35.73 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.65 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 39.6 Cg_endo -93.06 -161.43 0.09 OUTLIER 'Trans proline' 0 N--CA 1.484 0.949 0 C-N-CA 122.045 1.83 . . . . 0.0 111.847 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 37.6 mt -78.42 -5.74 53.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.891 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.2 t -58.05 -45.07 88.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.808 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.763 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.1 m -53.05 -62.31 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.789 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.705 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.763 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.38 -42.72 2.32 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.877 0.37 . . . . 0.0 110.898 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.4 tp -69.67 -48.95 57.97 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.303 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 56.0 m -70.65 -48.92 52.43 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.548 0.689 . . . . 0.0 110.757 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.462 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -54.28 -42.04 69.56 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.216 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.17 -55.44 35.0 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.234 -177.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -61.59 -21.22 64.14 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.515 -1.221 . . . . 0.0 108.932 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.57 -0.23 85.94 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' A' ' 134' ' ' PRO . 31.4 mttp -151.46 159.53 33.25 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 120.605 -0.438 . . . . 0.0 109.944 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 133' ' ' LYS . 5.7 Cg_exo -41.0 176.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 123.855 3.036 . . . . 0.0 113.021 -178.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.43 HD12 ' O ' ' A' ' 35' ' ' CYS . 7.8 tp -130.94 123.24 28.44 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 176.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.433 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -64.94 152.99 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 10.8 t -129.54 132.86 46.95 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.107 0.479 . . . . 0.0 111.305 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.8 m -135.3 164.49 27.61 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.888 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.1 m -71.4 146.95 48.4 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.465 ' HB1' ' SG ' ' A' ' 148' ' ' CYS . . . -74.47 81.16 1.93 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.712 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 48.1 p-10 -159.43 168.06 27.19 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.303 0.573 . . . . 0.0 110.454 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.2 -162.35 1.43 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.166 -178.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 77.5 p -61.92 -39.74 93.08 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.611 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -163.61 4.85 0.07 OUTLIER Glycine 0 CA--C 1.511 -0.179 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.7 tp -81.43 127.69 72.55 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.164 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -39.24 157.94 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.7 1.6 . . . . 0.0 111.972 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.424 ' O ' ' OE1' ' A' ' 153' ' ' GLU . 76.3 Cg_endo -73.15 -163.89 0.17 Allowed 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.505 2.137 . . . . 0.0 112.242 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.465 ' SG ' ' HB1' ' A' ' 140' ' ' ALA . 11.3 m -118.52 73.71 0.93 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.524 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.511 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 37.6 ptt180 -54.14 -35.91 62.72 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.169 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.95 167.89 20.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.436 HG22 ' H ' ' A' ' 151' ' ' VAL . 0.9 OUTLIER -56.23 -18.6 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 CA-C-O 121.638 0.732 . . . . 0.0 109.128 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -64.41 -36.45 84.19 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.429 ' OE1' ' OE1' ' A' ' 157' ' ' GLN . 0.4 OUTLIER -59.26 -72.06 0.11 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.793 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.3 p -47.97 -30.17 2.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.421 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.457 ' O ' ' N ' ' A' ' 159' ' ' GLY . 4.5 tmt_? -84.01 -44.81 13.77 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 122.293 1.044 . . . . 0.0 110.187 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.41 -41.89 85.95 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.497 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.453 ' CG ' ' N ' ' A' ' 158' ' ' PHE . 8.1 pt20 -80.95 -48.52 12.18 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 113.195 -1.82 . . . . 0.0 111.978 -177.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.453 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 33.7 t80 -107.07 -35.94 6.73 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -177.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 96.86 24.64 12.79 Favored Glycine 0 N--CA 1.475 1.259 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 -178.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -43.23 -93.96 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.66 0.267 . . . . 0.0 110.655 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.47 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.66 36.11 16.73 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.518 ' H ' HG22 ' A' ' 164' ' ' VAL . 2.0 m-85 -175.18 -62.69 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.172 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -72.91 28.73 0.29 Allowed 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.364 2.043 . . . . 0.0 110.794 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.58 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.8 m -132.2 167.78 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.899 -178.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.9 t -124.0 65.5 37.56 Favored Pre-proline 0 N--CA 1.473 0.677 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.698 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.58 ' HD3' HG23 ' A' ' 164' ' ' VAL . 33.4 Cg_exo -37.51 139.99 0.25 Allowed 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 123.586 2.857 . . . . 0.0 114.967 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 160.46 174.25 30.05 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 113.987 -1.461 . . . . 0.0 110.72 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -159.51 133.77 7.63 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 C--N 1.327 -0.404 0 CA-C-O 120.983 0.421 . . . . 0.0 110.148 179.585 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 . . . . . 0 N--CA 1.447 -0.589 0 CA-C-O 120.911 0.386 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 178' ' ' ILE . 19.9 tt -108.47 127.91 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.212 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -127.86 164.34 22.45 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.753 0.787 . . . . 0.0 112.353 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -81.28 106.68 13.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.075 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.755 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -70.77 -12.39 61.52 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.314 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.482 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.7 mm? -64.23 -40.58 96.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.867 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.8 -41.71 6.42 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.111 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.71 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 -179.77 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.688 0.28 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.547 HD12 ' N ' ' A' ' 5' ' ' LEU . 9.7 mp -62.08 -42.66 99.44 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -63.95 -41.32 97.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.021 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 78.8 ttt-85 -61.96 -42.36 99.04 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.887 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -60.72 -45.2 95.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.562 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.42 -42.54 98.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.998 0.428 . . . . 0.0 110.337 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.38 -43.63 98.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.721 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.12 -47.22 78.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.493 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.06 -39.09 91.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.635 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.34 -53.08 62.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.629 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 38.2 pt -70.01 -33.43 55.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.197 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.423 ' OD1' ' OE2' ' A' ' 19' ' ' GLU . 24.6 t70 -57.74 -55.13 38.79 Favored 'General case' 0 C--O 1.217 -0.637 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.147 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 20' ' ' GLU . 97.9 t -63.6 -40.11 87.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.704 0.288 . . . . 0.0 110.675 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.681 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.3 tt -52.16 -48.91 64.69 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.303 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -80.29 -52.59 7.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.289 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.423 ' OE2' ' OD1' ' A' ' 15' ' ' ASP . 92.7 mt-10 -66.91 -34.97 78.94 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.801 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.8 mt-10 60.19 87.48 0.09 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.122 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.439 ' H ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -161.08 -135.74 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.668 178.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.3 p -140.62 140.76 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -129.76 166.18 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 120.982 0.42 . . . . 0.0 111.757 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.96 129.34 39.36 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.411 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.513 ' CE2' ' O ' ' A' ' 26' ' ' PRO . 4.4 t80 -115.48 138.25 23.63 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.513 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 64.0 Cg_endo -81.41 144.08 14.16 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.144 1.229 . . . . 0.0 111.615 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.5 ' C ' ' H ' ' A' ' 29' ' ' ALA . 58.1 m -134.53 132.93 39.76 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.013 0.435 . . . . 0.0 111.153 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -72.84 30.3 0.06 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.71 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.5 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -158.54 -76.1 0.08 Allowed 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 120.784 0.326 . . . . 0.0 110.82 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.3 t -125.77 127.69 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 120.96 0.41 . . . . 0.0 110.26 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -48.88 145.76 3.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.765 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -154.83 -173.9 24.17 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.7 m -131.23 170.58 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.407 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -158.95 -176.96 31.58 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 119.765 -1.207 . . . . 0.0 112.453 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -158.16 -167.2 2.14 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.592 0.234 . . . . 0.0 110.716 -179.104 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.472 ' CG ' ' CZ ' ' A' ' 131' ' ' TYR . 18.3 t70 -95.12 109.4 44.41 Favored Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 36' ' ' ASP . 32.8 Cg_exo -37.28 172.27 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.778 2.319 . . . . 0.0 114.358 177.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 40.9 72.22 0.17 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.855 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 m -153.16 137.55 16.68 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.557 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -67.6 -33.62 75.37 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.075 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.588 HG23 ' N ' ' A' ' 42' ' ' ALA . 12.9 t -62.26 -46.11 90.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.026 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.588 ' N ' HG23 ' A' ' 41' ' ' THR . . . -58.4 -51.23 70.68 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.408 -178.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.5 p -62.59 -44.14 99.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.412 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 61.9 mtt -64.03 -39.3 93.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.15 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 51.3 ttt-85 -62.39 -34.4 76.64 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 87.9 mt -74.72 -58.78 3.07 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.3 mt -55.96 -16.3 4.63 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.36 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -68.6 -86.43 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.493 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.2 pt? -77.13 -33.66 56.75 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -76.18 -50.43 14.58 Favored 'General case' 0 C--N 1.349 0.557 0 C-N-CA 119.798 -0.761 . . . . 0.0 110.723 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 35.47 65.77 0.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.703 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 179.61 -54.28 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.83 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.235 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.09 -6.71 17.59 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.637 2.224 . . . . 0.0 112.088 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.565 HG13 ' N ' ' A' ' 55' ' ' ASP . 7.4 p -43.57 -49.29 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.73 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.565 ' N ' HG13 ' A' ' 54' ' ' VAL . 39.8 t0 -66.28 -40.94 90.43 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.687 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -60.88 -39.8 90.61 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.084 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 65.48 107.63 0.01 OUTLIER Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.564 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -52.62 -161.28 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.375 0.607 . . . . 0.0 112.278 -179.477 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 73.2 mt -106.58 142.95 18.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.166 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 16.0 mt -118.05 142.63 47.19 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.4 tp -111.82 126.91 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-O 121.408 0.623 . . . . 0.0 111.622 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.76 148.29 39.99 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.094 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.55 -27.65 9.76 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.075 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.778 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 98.6 m-20 -117.91 151.12 38.04 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.946 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -79.26 -13.51 59.63 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -52.54 -31.99 38.46 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.216 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.778 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 4.8 pm0 -93.79 -10.63 33.49 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.414 ' O ' HD13 ' A' ' 72' ' ' ILE . 4.3 mm? -90.79 -18.73 24.43 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.45 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 47.1 tttm -76.71 -39.0 2.24 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 69.7 Cg_endo -104.38 -2.38 0.23 Allowed 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 122.923 2.416 . . . . 0.0 112.582 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -94.85 -10.55 30.99 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.838 0.351 . . . . 0.0 111.06 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.633 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.1 mp -125.52 168.14 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.633 ' N ' HG22 ' A' ' 72' ' ' ILE . 93.0 m-20 -62.3 -13.03 24.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.786 0.327 . . . . 0.0 110.829 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 44.7 t0 55.54 21.74 4.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.841 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.657 HG23 ' N ' ' A' ' 76' ' ' MET . 8.4 t -89.53 -54.51 4.05 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.657 ' N ' HG23 ' A' ' 75' ' ' THR . 13.5 ptp -68.08 -37.52 81.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.225 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 tp -64.22 139.13 58.73 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.208 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.9 173.19 14.06 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.461 -176.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -60.26 -43.06 96.49 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.202 0.314 . . . . 0.0 111.23 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.9 p -60.92 -32.48 52.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.994 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -63.47 -40.89 98.32 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.094 0.473 . . . . 0.0 110.498 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.428 ' HG2' ' H ' ' A' ' 82' ' ' ARG . 7.0 mmt85 -63.34 -51.51 65.65 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 122.648 1.213 . . . . 0.0 108.782 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 87' ' ' SER . 80.7 tt0 -57.17 -50.22 73.5 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 113.667 -1.606 . . . . 0.0 110.096 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.5 m -62.04 -49.03 77.65 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.264 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 89' ' ' TRP . 13.9 tt -68.52 -26.05 32.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.585 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -86.02 -32.22 21.58 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.438 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 83' ' ' GLU . 10.7 m -88.64 -9.12 53.23 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.745 0.307 . . . . 0.0 110.784 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 89' ' ' TRP . 62.4 ttm-85 -128.47 79.53 1.91 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.514 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.448 ' O ' ' O ' ' A' ' 88' ' ' ARG . 2.7 m-90 56.43 152.54 0.07 OUTLIER Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.667 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.88 -23.15 41.53 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.879 1.719 . . . . 0.0 111.753 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 157.95 79.08 0.03 OUTLIER Glycine 0 CA--C 1.53 1.004 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.53 -35.63 86.32 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.714 2.276 . . . . 0.0 112.427 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.2 p -133.84 147.69 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.84 0.352 . . . . 0.0 110.455 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 26.4 m -84.16 141.45 31.05 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.362 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.459 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 70.8 m-85 -119.01 139.81 51.09 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.732 0.301 . . . . 0.0 110.964 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.667 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 3.3 t -96.85 103.55 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 121.424 0.63 . . . . 0.0 109.689 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -91.54 152.01 43.08 Favored Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.079 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.04 110.74 3.15 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.883 1.722 . . . . 0.0 111.341 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.7 153.23 70.33 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.852 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.66 151.95 78.58 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.155 1.904 . . . . 0.0 111.664 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.311 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.388 179.903 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.486 ' NH1' ' O ' ' A' ' 110' ' ' ARG . 5.5 tpp85 . . . . . 0 CA--C 1.531 0.238 0 CA-C-O 120.732 0.301 . . . . 0.0 110.935 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 63.5 p-90 -74.03 -8.6 56.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.753 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.971 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -73.56 -23.42 59.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.081 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.66 ' H ' HD22 ' A' ' 107' ' ' LEU . 88.6 m -142.71 -39.33 0.34 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.107 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 89.31 9.03 67.65 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.486 ' O ' ' NH1' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -158.24 -79.17 0.07 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 117.038 0.419 . . . . 0.0 109.911 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -93.41 -129.61 0.12 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.268 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -157.89 61.58 0.47 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.507 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.6 p -157.52 153.65 27.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.81 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.481 ' O ' HD12 ' A' ' 114' ' ' LEU . 0.3 OUTLIER -160.78 139.17 9.93 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.354 1.073 . . . . 0.0 113.461 -179.508 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.56 133.04 48.71 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 112.971 -1.922 . . . . 0.0 109.885 178.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.8 p -149.98 153.82 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.805 0.336 . . . . 0.0 110.341 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 71.7 ttp85 -147.89 158.7 44.17 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.571 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.2 t -122.18 133.55 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 116.288 -0.414 . . . . 0.0 109.928 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.7 t -132.71 130.9 40.64 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -135.85 85.22 2.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.626 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.597 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 36.2 t60 -172.83 -38.36 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.422 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.597 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 29.1 Cg_endo -92.84 -161.83 0.09 OUTLIER 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 122.026 1.818 . . . . 0.0 112.028 -178.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 123' ' ' LEU . 9.4 mp -78.35 -4.15 46.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.822 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 87.9 t -58.27 -44.96 89.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.855 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.756 HG23 ' H ' ' A' ' 126' ' ' ALA . 29.6 m -53.98 -61.94 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.844 0 C-N-CA 119.434 -0.906 . . . . 0.0 108.633 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.756 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.08 -43.34 2.19 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.91 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 45.4 tp -70.16 -47.86 59.8 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 120.589 -0.445 . . . . 0.0 111.275 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 64.2 m -70.22 -49.15 53.0 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.517 0.675 . . . . 0.0 110.791 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.465 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.0 OUTLIER -55.01 -42.02 72.02 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.455 179.354 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.07 -56.27 24.23 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.93 -177.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.472 ' CZ ' ' CG ' ' A' ' 36' ' ' ASP . 4.2 t80 -63.44 -26.33 68.68 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.263 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.92 3.26 85.69 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 134' ' ' PRO . 69.4 mttt -149.46 157.87 38.57 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-N 116.908 0.354 . . . . 0.0 110.758 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 133' ' ' LYS . 5.7 Cg_exo -42.67 178.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 123.874 3.049 . . . . 0.0 112.705 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.0 tp -134.76 122.36 22.03 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.441 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -64.23 143.1 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 C-N-CA 117.975 -1.49 . . . . 0.0 107.166 -179.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.7 t -116.76 123.88 48.26 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 123.568 0.542 . . . . 0.0 111.333 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.6 m -128.86 165.27 21.34 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.152 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.5 t -70.96 149.42 46.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.643 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.25 -38.85 91.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.178 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 55.2 p30 -55.48 152.08 9.41 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.889 0.852 . . . . 0.0 111.351 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.8 -157.0 0.72 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.575 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.5 t -60.31 -45.27 93.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.492 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -161.13 4.46 0.09 OUTLIER Glycine 0 C--N 1.329 0.17 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.2 tp -84.94 127.27 65.41 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -37.47 157.03 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.8 1.667 . . . . 0.0 112.429 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.93 -163.52 0.2 Allowed 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.38 2.053 . . . . 0.0 112.314 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 15.8 t -114.4 78.88 1.19 Allowed 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.515 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -58.67 -34.71 71.55 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.966 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -163.02 165.29 25.02 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 151' ' ' VAL . 0.7 OUTLIER -55.9 -18.84 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.59 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 156' ' ' ALA . 99.6 m-20 -65.38 -34.17 77.68 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.519 ' OE1' ' NE2' ' A' ' 157' ' ' GLN . 6.7 tm-20 -59.21 -70.56 0.15 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.507 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.4 p -50.02 -29.58 5.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.359 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -84.42 -43.76 14.35 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 122.392 1.091 . . . . 0.0 110.143 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 152' ' ' ASP . . . -58.93 -41.23 86.84 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.454 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.519 ' NE2' ' OE1' ' A' ' 153' ' ' GLU . 0.7 OUTLIER -82.46 -48.6 10.89 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 112.981 -1.918 . . . . 0.0 112.143 -177.02 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.474 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 38.3 t80 -106.97 -36.62 6.56 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -177.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 97.44 25.68 10.73 Favored Glycine 0 N--CA 1.473 1.106 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.409 ' HB1' ' HG2' ' A' ' 163' ' ' PRO . . . -43.43 -94.9 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.612 0.244 . . . . 0.0 110.734 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.424 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 63.44 36.68 11.19 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 121.292 0.568 . . . . 0.0 109.739 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.534 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.2 m-85 -177.14 -61.63 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.214 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.409 ' HG2' ' HB1' ' A' ' 160' ' ' ALA . 91.5 Cg_endo -73.85 29.24 0.32 Allowed 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.14 1.893 . . . . 0.0 110.505 178.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.581 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.9 m -132.34 167.65 25.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.558 -178.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.0 t -124.27 65.11 39.12 Favored Pre-proline 0 N--CA 1.476 0.84 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.71 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.581 ' HD3' HG23 ' A' ' 164' ' ' VAL . 31.3 Cg_exo -37.41 145.06 0.12 Allowed 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 123.815 3.01 . . . . 0.0 115.158 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 165.77 116.92 0.38 Allowed Glycine 0 CA--C 1.523 0.573 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.493 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -85.06 144.99 27.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.886 0.374 . . . . 0.0 110.068 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.205 179.896 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 . . . . . 0 N--CA 1.445 -0.723 0 CA-C-O 120.818 0.342 . . . . 0.0 110.698 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.416 HD13 HG21 ' A' ' 178' ' ' ILE . 14.2 pt -106.02 134.35 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.284 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 19.3 mmm-85 -120.12 157.44 28.98 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.526 0.679 . . . . 0.0 110.189 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 184' ' ' GLY . 97.6 m-20 -72.03 104.53 3.59 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.903 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -68.49 -18.33 64.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.041 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.506 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.7 mm? -64.01 -41.38 97.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.018 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.56 HG23 ' N ' ' A' ' 184' ' ' GLY . 5.2 t -121.3 -51.46 2.09 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.695 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.56 ' N ' HG23 ' A' ' 183' ' ' THR . . . . . . . . 0 N--CA 1.464 0.567 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 . . . . . 0 CA--C 1.53 0.192 0 CA-C-O 120.693 0.283 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.55 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.2 mp -63.15 -42.08 99.38 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.962 0.41 . . . . 0.0 110.048 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -63.32 -42.04 98.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.421 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -63.2 -39.36 94.42 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.408 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -61.52 -43.78 98.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.681 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.48 -45.23 88.24 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.808 0.337 . . . . 0.0 110.264 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.0 mm -63.69 -43.11 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.26 -47.37 78.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.045 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.01 -41.59 96.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.103 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.64 -54.62 44.34 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.9 0.381 . . . . 0.0 111.187 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 14' ' ' ILE . 19.8 pt -69.23 -37.04 75.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.149 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -56.59 -56.2 24.3 Favored 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.469 ' O ' ' N ' ' A' ' 20' ' ' GLU . 99.6 t -63.29 -39.93 87.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 121.16 -0.216 . . . . 0.0 110.59 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.671 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.4 tt -51.79 -49.9 61.79 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.701 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -80.47 -51.87 8.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.148 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -65.86 -34.98 79.4 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.506 -178.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 16' ' ' VAL . 96.2 mt-10 58.51 88.37 0.06 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.107 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.414 ' H ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -162.47 -133.99 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.8 p -141.99 140.92 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 pp -129.01 167.62 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-O 121.122 0.487 . . . . 0.0 111.875 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.77 129.6 40.35 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.735 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.539 ' CE2' ' O ' ' A' ' 26' ' ' PRO . 7.8 t80 -117.14 138.82 25.2 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.297 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.539 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 63.6 Cg_endo -79.51 144.69 18.01 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.28 1.32 . . . . 0.0 111.751 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.476 ' C ' ' H ' ' A' ' 29' ' ' ALA . 63.2 m -132.6 134.79 45.35 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.248 0.547 . . . . 0.0 111.057 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -74.69 26.27 0.09 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.77 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.476 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -160.85 -70.28 0.07 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.993 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.6 p -127.93 123.57 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 121.108 0.48 . . . . 0.0 110.097 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.524 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 94.7 m-85 -42.52 151.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.744 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -155.51 -178.68 29.98 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.2 m -130.67 169.66 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.51 -177.39 33.57 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 119.839 -1.172 . . . . 0.0 112.323 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.429 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -158.76 -171.42 3.41 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.511 ' OD1' ' CE1' ' A' ' 131' ' ' TYR . 27.8 t70 -92.66 111.82 52.77 Favored Pre-proline 0 CA--C 1.553 1.083 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 36' ' ' ASP . 12.6 Cg_exo -35.55 167.72 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.81 2.34 . . . . 0.0 114.126 177.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 40.8 78.06 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.679 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.4 m -152.89 149.81 28.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.967 0.413 . . . . 0.0 110.707 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -71.03 -33.2 70.09 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.408 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.432 ' H ' HG22 ' A' ' 41' ' ' THR . 0.0 OUTLIER -64.19 -43.19 95.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.808 -178.402 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.0 -50.24 74.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.227 0.536 . . . . 0.0 111.024 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.402 HG12 ' H ' ' A' ' 43' ' ' VAL . 2.9 p -64.74 -45.73 94.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.569 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 59.3 mtt -66.67 -45.04 80.18 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.3 ptt85 -64.58 -30.35 71.37 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.933 0.397 . . . . 0.0 110.102 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.1 mt -73.67 -59.75 2.57 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.273 177.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.4 mt -54.81 -20.53 8.82 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.45 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -64.16 -86.24 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.353 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.518 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.2 pt? -77.01 -34.87 57.43 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -75.3 -49.65 18.52 Favored 'General case' 0 C--N 1.352 0.682 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.193 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 36.56 65.56 0.46 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.709 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 178.55 -53.99 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.858 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.351 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -77.5 -4.74 14.95 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 C-N-CA 122.781 2.321 . . . . 0.0 112.345 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.606 HG13 ' N ' ' A' ' 55' ' ' ASP . 7.2 p -45.46 -48.66 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.56 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.606 ' N ' HG13 ' A' ' 54' ' ' VAL . 13.2 t0 -66.64 -45.41 79.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.334 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -59.69 -41.55 90.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.559 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 69.48 114.48 0.03 OUTLIER Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.567 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -51.03 -164.86 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.337 0.589 . . . . 0.0 112.304 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.4 mt -104.49 145.1 13.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 16.0 mt -117.45 144.54 44.91 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.2 tp -111.18 127.53 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-O 121.069 0.461 . . . . 0.0 110.702 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.631 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -115.11 153.35 30.9 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.57 -28.71 7.06 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.764 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.619 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 98.6 m-20 -114.39 142.1 46.78 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.973 0.416 . . . . 0.0 110.903 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -72.66 -13.65 61.41 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -50.41 -33.78 22.03 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.209 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.619 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 4.3 pm0 -94.08 -11.29 30.91 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.481 ' O ' HD13 ' A' ' 72' ' ' ILE . 4.1 mm? -90.06 -17.7 27.28 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.391 -0.818 . . . . 0.0 109.322 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.457 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 48.4 tttm -78.45 -39.17 1.62 Allowed Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.457 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 63.9 Cg_endo -104.01 -2.39 0.25 Allowed 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 122.634 2.223 . . . . 0.0 112.287 -178.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -95.45 -10.18 30.56 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.812 0.339 . . . . 0.0 110.87 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.607 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.6 mp -123.3 167.36 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.607 ' N ' HG22 ' A' ' 72' ' ' ILE . 98.6 m-20 -59.65 -14.24 12.97 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.237 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 58.8 t0 57.14 28.72 15.42 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.85 0.357 . . . . 0.0 110.467 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.524 HG23 ' N ' ' A' ' 76' ' ' MET . 9.5 t -95.86 -43.05 8.02 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.715 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.524 ' N ' HG23 ' A' ' 75' ' ' THR . 18.4 ptm -85.63 -8.13 58.42 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.144 0.497 . . . . 0.0 109.923 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.3 tp -86.51 128.26 34.95 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.611 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.36 164.42 36.35 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.08 -176.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -45.94 -46.77 16.34 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 112.088 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.6 -32.69 54.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.843 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -64.68 -39.78 94.27 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.251 0.548 . . . . 0.0 110.492 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.8 mmt85 -65.86 -52.13 52.99 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 122.33 1.062 . . . . 0.0 108.8 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -55.09 -50.89 68.04 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 113.825 -1.534 . . . . 0.0 110.03 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.3 m -61.07 -49.55 76.9 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.574 -1.194 . . . . 0.0 112.247 -177.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.424 ' O ' ' O ' ' A' ' 89' ' ' TRP . 10.0 tt -68.11 -31.11 50.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.617 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -76.75 -36.2 57.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.541 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.1 m -86.63 -44.28 11.99 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.055 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.482 ' O ' ' CD1' ' A' ' 89' ' ' TRP . 61.8 ttt85 -70.14 -77.06 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.936 0.398 . . . . 0.0 110.44 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.482 ' CD1' ' O ' ' A' ' 88' ' ' ARG . 5.8 m0 -158.4 149.37 16.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.449 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -66.65 -23.59 49.03 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.684 1.59 . . . . 0.0 111.946 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 152.36 83.17 0.04 OUTLIER Glycine 0 CA--C 1.533 1.189 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -76.05 -19.4 15.75 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.631 1.554 . . . . 0.0 111.472 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.405 HG13 ' CE2' ' A' ' 95' ' ' PHE . 12.4 p -136.19 148.91 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.517 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.5 m -83.18 134.21 34.99 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.813 0.34 . . . . 0.0 110.383 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.488 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 67.7 m-85 -113.93 138.93 49.66 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.843 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.667 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 5.2 t -95.87 103.04 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 121.459 0.647 . . . . 0.0 109.592 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -87.37 148.91 45.67 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.537 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.04 108.88 2.77 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.93 1.753 . . . . 0.0 111.194 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.44 155.62 92.25 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.264 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.611 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 89.2 Cg_exo -45.43 -32.33 7.76 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.661 1.574 . . . . 0.0 111.979 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.611 ' HB3' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . 0 N--CA 1.465 0.292 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.595 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 109' ' ' GLY . 20.1 mmt180 . . . . . 0 N--CA 1.472 0.664 0 CA-C-O 120.377 0.132 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 2.7 p90 -67.9 -10.28 51.91 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.796 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 1.03 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -69.81 -39.24 76.64 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.795 ' H ' HD22 ' A' ' 107' ' ' LEU . 45.6 m -143.81 -41.4 0.28 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.858 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 56.24 -8.57 0.01 OUTLIER Glycine 0 CA--C 1.535 1.301 0 CA-C-N 115.95 -0.568 . . . . 0.0 113.077 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.548 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 0.5 OUTLIER -85.03 -52.68 5.79 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 117.898 0.849 . . . . 0.0 109.574 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.529 ' CE2' ' OD1' ' A' ' 112' ' ' ASP . 57.7 t80 -152.44 169.36 22.76 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.324 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.529 ' OD1' ' CE2' ' A' ' 111' ' ' PHE . 18.1 p30 -79.27 49.74 1.0 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.184 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.7 p -160.25 158.04 29.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.084 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.515 ' O ' HD12 ' A' ' 114' ' ' LEU . 0.3 OUTLIER -159.01 138.04 11.24 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -179.292 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.44 ' HB2' HG22 ' A' ' 96' ' ' VAL . . . -69.98 132.69 46.31 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 113.557 -1.656 . . . . 0.0 110.296 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.545 HG22 ' N ' ' A' ' 117' ' ' ARG . 4.9 p -156.61 163.79 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.545 ' N ' HG22 ' A' ' 116' ' ' VAL . 22.6 ptt180 -153.5 160.19 42.46 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.246 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.631 HG22 ' HB3' ' A' ' 62' ' ' ALA . 54.3 t -125.26 139.89 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.023 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 119' ' ' THR . 14.9 t -141.64 130.04 22.44 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.975 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -132.69 90.17 2.74 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.612 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 9.9 t-80 -173.78 -37.91 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.466 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.612 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 38.2 Cg_endo -93.82 -160.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.32 -0.922 0 C-N-CA 121.932 1.755 . . . . 0.0 112.201 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 123' ' ' LEU . 9.7 mp -78.97 -6.51 56.45 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.701 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.2 t -57.16 -45.24 84.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.989 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.738 HG23 ' H ' ' A' ' 126' ' ' ALA . 31.5 m -52.91 -62.02 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.21 -0.995 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.022 178.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.738 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.23 -45.97 3.03 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 122.369 -0.207 . . . . 0.0 110.943 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.4 tp -67.91 -48.64 65.44 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.206 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 72.1 m -69.53 -49.33 55.49 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.21 0.529 . . . . 0.0 111.197 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.485 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.2 pp0? -54.88 -42.03 71.59 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.855 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.76 -56.39 22.8 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.778 -177.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.511 ' CE1' ' OD1' ' A' ' 36' ' ' ASP . 4.8 t80 -63.0 -24.11 67.76 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.895 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.8 2.76 89.7 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 114.187 -1.37 . . . . 0.0 110.311 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.418 ' O ' ' O ' ' A' ' 134' ' ' PRO . 29.9 mttp -150.2 158.32 36.56 Favored Pre-proline 0 CA--C 1.547 0.833 0 CA-C-N 117.157 0.478 . . . . 0.0 110.342 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 133' ' ' LYS . 6.3 Cg_exo -42.36 -179.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 123.84 3.027 . . . . 0.0 113.442 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.0 tp -134.56 122.78 22.85 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 176.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.437 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.9 OUTLIER -64.07 144.87 14.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 117.37 -1.732 . . . . 0.0 107.664 -179.304 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 12.6 t -116.55 126.8 53.83 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.197 0.522 . . . . 0.0 111.481 -179.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.08 162.52 31.51 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.683 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.9 t -72.12 149.14 45.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.044 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.68 78.88 7.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.577 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 56.1 p30 -157.68 165.35 35.69 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.182 0.515 . . . . 0.0 110.328 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.32 -165.82 2.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.174 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.1 p -63.47 -41.25 98.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.043 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -157.4 3.84 0.15 Allowed Glycine 0 N--CA 1.462 0.424 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.476 HD13 ' C ' ' A' ' 145' ' ' LEU . 1.3 tm? -84.0 111.35 32.35 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-O 119.078 -0.487 . . . . 0.0 109.767 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 145' ' ' LEU . 19.5 Cg_exo -34.92 156.52 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.095 1.863 . . . . 0.0 112.745 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.43 171.38 16.31 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.646 2.23 . . . . 0.0 112.229 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 34.7 t -96.09 77.46 3.11 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.664 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.524 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 36.2 ptt180 -53.58 -36.67 62.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.892 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.89 167.24 29.93 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.421 HG11 ' HA ' ' A' ' 166' ' ' PRO . 1.7 m -57.94 -18.62 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.736 0 CA-C-O 121.846 0.831 . . . . 0.0 109.081 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.62 -36.67 84.57 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.531 ' OE1' ' NE2' ' A' ' 157' ' ' GLN . 5.1 tm-20 -59.48 -73.87 0.08 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.244 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.436 HG11 HG11 ' A' ' 164' ' ' VAL . 7.1 p -45.8 -29.47 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.847 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 159' ' ' GLY . 4.8 tmt_? -83.92 -44.48 14.2 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 122.028 0.918 . . . . 0.0 110.08 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.53 -41.64 85.95 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.257 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.531 ' NE2' ' OE1' ' A' ' 153' ' ' GLU . 0.6 OUTLIER -81.63 -48.74 11.35 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 113.018 -1.901 . . . . 0.0 112.487 -177.092 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.469 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 36.0 t80 -107.04 -35.55 6.85 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -177.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 96.8 24.86 12.44 Favored Glycine 0 N--CA 1.475 1.296 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.426 ' HB1' ' HG2' ' A' ' 163' ' ' PRO . . . -44.06 -95.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.953 -0.124 . . . . 0.0 110.812 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.473 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 62.8 38.01 11.97 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.306 0.575 . . . . 0.0 109.955 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.57 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.4 m-85 -177.97 -61.14 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.377 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.426 ' HG2' ' HB1' ' A' ' 160' ' ' ALA . 93.6 Cg_endo -72.69 22.78 0.29 Allowed 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.156 1.904 . . . . 0.0 110.998 178.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.59 HG23 ' HD3' ' A' ' 166' ' ' PRO . 16.8 m -128.04 167.54 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.636 -177.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.0 t -123.84 65.69 36.48 Favored Pre-proline 0 N--CA 1.476 0.825 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.71 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.59 ' HD3' HG23 ' A' ' 164' ' ' VAL . 22.8 Cg_exo -35.81 141.83 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 123.748 2.965 . . . . 0.0 115.401 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 176.46 -176.26 47.76 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.721 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -150.91 151.49 32.25 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.467 0.378 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 -179.959 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 . . . . . 0 N--CA 1.443 -0.811 0 CA-C-O 121.072 0.463 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 8.5 pt -99.89 130.96 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.733 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -125.32 165.54 18.17 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.327 0.584 . . . . 0.0 111.552 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 184' ' ' GLY . 99.4 m-20 -76.73 105.91 8.08 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.074 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -67.99 -15.01 63.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.364 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.51 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.4 mm? -64.6 -41.1 96.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.469 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 5.5 t -121.4 -26.97 4.9 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.956 0.407 . . . . 0.0 111.042 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 180' ' ' ASP . . . . . . . . 0 CA--C 1.522 0.479 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.691 0.281 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.541 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.5 mp -62.98 -42.77 99.93 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.873 0.368 . . . . 0.0 110.255 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.59 -41.6 96.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.338 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -65.69 -40.7 92.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.23 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -61.46 -47.8 84.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.698 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.79 -46.86 86.03 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.298 0.571 . . . . 0.0 110.569 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.4 -43.88 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.466 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.78 -41.64 82.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.259 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.54 -41.73 97.78 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.917 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.59 -55.24 36.99 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.319 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.4 pt -69.37 -27.49 34.66 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.148 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -60.95 -56.16 24.35 Favored 'General case' 0 C--O 1.216 -0.659 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.106 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 20' ' ' GLU . 94.0 t -64.57 -40.6 89.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 C-N-CA 121.264 -0.174 . . . . 0.0 111.374 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.668 HD13 ' C ' ' A' ' 17' ' ' LEU . 2.0 tm? -56.3 -48.11 77.33 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.354 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -76.51 -49.14 17.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.201 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -69.06 -34.9 75.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.557 -178.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 16' ' ' VAL . 97.2 mt-10 62.5 80.36 0.23 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.22 -139.21 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.844 0.354 . . . . 0.0 110.483 177.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 34' ' ' GLY . 8.2 p -134.58 140.61 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 pp -128.81 162.92 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-O 121.023 0.44 . . . . 0.0 111.064 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.26 129.39 41.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.71 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.514 ' CZ ' ' O ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -122.84 148.65 54.36 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -179.432 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.514 ' O ' ' CZ ' ' A' ' 25' ' ' TYR . 57.6 Cg_endo -78.91 148.66 22.31 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.993 1.795 . . . . 0.0 111.783 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.498 ' C ' ' H ' ' A' ' 29' ' ' ALA . 40.8 m -131.41 133.85 45.65 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.469 ' OE2' ' NH1' ' A' ' 117' ' ' ARG . 22.3 pt-20 -74.7 23.12 0.09 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.826 0.346 . . . . 0.0 110.425 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.498 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -155.19 -73.44 0.11 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.2 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 p -128.28 129.85 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.342 0.592 . . . . 0.0 110.751 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.507 ' CD2' ' O ' ' A' ' 148' ' ' CYS . 46.8 p90 -37.73 144.88 0.08 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.798 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -155.61 -173.41 24.24 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.5 m -132.27 168.06 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.486 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -156.96 -178.94 31.52 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.553 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.454 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.8 OUTLIER -159.24 -165.21 1.54 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.025 0.441 . . . . 0.0 111.328 -178.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.454 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 85.0 m-20 -91.61 108.02 26.34 Favored Pre-proline 0 CA--C 1.555 1.155 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -43.64 -61.18 0.6 Allowed 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.916 1.744 . . . . 0.0 112.262 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -71.94 67.01 0.6 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.058 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.1 m -155.71 133.99 11.57 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.88 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -65.73 -34.32 77.92 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.341 0.591 . . . . 0.0 110.688 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.496 HG23 ' N ' ' A' ' 42' ' ' ALA . 15.0 t -60.76 -41.19 94.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.171 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.496 ' N ' HG23 ' A' ' 41' ' ' THR . . . -56.64 -51.64 67.94 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.608 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.65 -42.14 95.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.285 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 92.2 mtp -63.77 -40.24 96.21 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.9 ttt85 -59.95 -42.54 94.28 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 121.967 0.889 . . . . 0.0 108.611 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.459 ' O ' HD23 ' A' ' 46' ' ' LEU . 1.0 OUTLIER -63.99 -53.13 54.96 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.73 -178.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.8 mt -70.77 -11.62 61.06 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.2 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -70.21 -82.6 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 121.152 0.501 . . . . 0.0 111.342 -177.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.504 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -75.97 -35.26 59.7 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -76.95 -50.28 13.57 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.966 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 35.32 65.34 0.39 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.919 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.416 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 1.6 mtt85 179.02 -53.48 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.778 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.27 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.416 ' HD2' ' H ' ' A' ' 52' ' ' ARG . 84.6 Cg_endo -79.91 -3.31 12.7 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.709 2.273 . . . . 0.0 112.388 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.54 HG13 ' N ' ' A' ' 55' ' ' ASP . 7.9 p -44.03 -43.87 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.47 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.54 ' N ' HG13 ' A' ' 54' ' ' VAL . 37.4 t0 -66.45 -41.73 88.66 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.041 0.448 . . . . 0.0 110.246 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.416 ' CD ' ' N ' ' A' ' 56' ' ' LYS . 1.1 mptm? -60.29 -39.64 87.64 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 62.29 107.71 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.561 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -53.14 -163.2 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.229 0.538 . . . . 0.0 111.591 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.533 HG23 HG21 ' A' ' 94' ' ' THR . 78.5 mt -101.01 144.32 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.538 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.4 mt -121.7 143.14 49.52 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.407 ' CD1' ' HE ' ' A' ' 117' ' ' ARG . 8.5 tp -113.86 128.67 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-O 121.244 0.545 . . . . 0.0 110.958 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.438 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -114.23 156.55 24.11 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.951 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.15 -26.37 5.94 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.422 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 98.5 m-20 -118.42 142.64 47.35 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.086 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -69.81 -12.68 61.81 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.64 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -50.75 -31.58 17.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.927 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.422 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 2.5 pm0 -95.76 -13.59 24.01 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.518 HD22 ' N ' ' A' ' 68' ' ' LEU . 4.0 mm? -92.16 -13.8 30.08 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.471 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 76.8 tttt -80.56 -38.16 1.05 Allowed Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 86.1 Cg_endo -102.38 -3.85 0.33 Allowed 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 122.696 2.264 . . . . 0.0 111.39 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.546 ' OH ' HD21 ' A' ' 114' ' ' LEU . 44.9 t80 -92.84 -14.86 27.17 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.687 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.543 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.2 mp -122.62 159.9 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.543 ' N ' HG22 ' A' ' 72' ' ' ILE . 27.7 p30 -65.86 144.37 56.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.374 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -87.19 7.2 29.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.548 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.553 HG23 ' N ' ' A' ' 76' ' ' MET . 15.0 t -78.11 -45.52 23.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.246 0.546 . . . . 0.0 110.854 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.553 ' N ' HG23 ' A' ' 75' ' ' THR . 25.0 ptm -84.92 -19.33 32.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.666 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.402 ' HG ' ' HE ' ' A' ' 82' ' ' ARG . 6.4 tp -81.78 130.07 34.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.027 -178.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.84 167.26 30.51 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.681 -177.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -48.51 -44.5 36.09 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.725 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.71 -31.76 51.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.994 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -64.52 -40.67 96.06 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.399 0.619 . . . . 0.0 110.533 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.421 ' HG2' ' H ' ' A' ' 82' ' ' ARG . 12.3 mmt85 -66.58 -51.99 50.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.477 1.132 . . . . 0.0 109.462 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 87' ' ' SER . 83.1 tt0 -55.86 -50.66 69.99 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 113.852 -1.522 . . . . 0.0 110.421 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.7 m -61.16 -49.95 75.17 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.013 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.5 tt -67.53 -29.74 46.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.853 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -79.49 -35.31 40.39 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.621 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 83' ' ' GLU . 10.9 m -89.85 -15.35 32.42 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.425 ' O ' ' O ' ' A' ' 89' ' ' TRP . 69.4 ttt180 -115.98 74.67 0.91 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.863 0.363 . . . . 0.0 110.714 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.425 ' O ' ' O ' ' A' ' 88' ' ' ARG . 1.5 m0 59.25 150.32 0.08 OUTLIER Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.668 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.57 -15.55 45.15 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.739 1.626 . . . . 0.0 110.636 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.493 ' H ' ' HD3' ' A' ' 92' ' ' PRO . . . 104.95 69.35 0.76 Allowed Glycine 0 N--CA 1.471 1.031 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.088 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.493 ' HD3' ' H ' ' A' ' 91' ' ' GLY . 48.7 Cg_exo -55.94 -38.95 93.92 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.556 2.171 . . . . 0.0 112.222 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.3 p -75.64 147.47 8.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.209 0.528 . . . . 0.0 111.104 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.533 HG21 HG23 ' A' ' 59' ' ' ILE . 19.3 m -102.45 126.25 49.42 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.981 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.573 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 43.8 m-85 -116.12 143.04 46.01 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.271 -178.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.733 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 84.2 t -84.08 98.96 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-O 121.123 0.487 . . . . 0.0 111.323 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -83.65 139.36 40.83 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.804 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.36 104.92 1.81 Allowed 'Trans proline' 0 N--CA 1.489 1.21 0 C-N-CA 121.566 1.51 . . . . 0.0 110.901 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 112' ' ' ASP . . . -61.9 149.56 85.3 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.8 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -73.08 165.82 31.7 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.427 2.085 . . . . 0.0 112.098 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.737 179.626 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.536 ' O ' ' N ' ' A' ' 109' ' ' GLY . 5.3 tpp85 . . . . . 0 CA--C 1.531 0.233 0 CA-C-O 120.932 0.396 . . . . 0.0 110.132 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -78.07 -10.86 59.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 122.05 0.929 . . . . 0.0 109.401 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.672 ' H ' ' CD2' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -82.39 -16.27 49.71 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.017 -1.447 . . . . 0.0 111.064 -179.567 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.428 ' O ' ' O ' ' A' ' 54' ' ' VAL . 99.0 m -140.69 -42.06 0.4 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.942 0.401 . . . . 0.0 109.972 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 77.94 19.81 74.46 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.301 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.19 -75.78 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 117.614 0.707 . . . . 0.0 110.478 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -111.18 162.4 14.98 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.29 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' A' ' 99' ' ' ALA . 90.4 m-20 -95.2 60.39 2.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.088 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.6 p -158.13 145.04 17.8 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.546 HD21 ' OH ' ' A' ' 71' ' ' TYR . 3.7 pp -166.98 145.71 5.14 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.441 ' HB1' HG22 ' A' ' 94' ' ' THR . . . -65.55 127.38 31.64 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 113.728 -1.578 . . . . 0.0 109.398 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.464 HG22 ' N ' ' A' ' 117' ' ' ARG . 3.9 p -145.35 161.23 12.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.469 ' NH1' ' OE2' ' A' ' 28' ' ' GLU . 61.7 ttp180 -148.23 155.32 41.22 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.205 0.526 . . . . 0.0 111.811 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.438 HG22 ' HB3' ' A' ' 62' ' ' ALA . 55.7 t -119.97 135.69 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.1 t -135.51 150.31 49.73 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.925 0.393 . . . . 0.0 110.1 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 34.4 p30 -154.01 81.9 1.14 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.223 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.674 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 6.8 t60 -171.75 -35.93 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.674 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 73.3 Cg_endo -96.77 -160.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.927 0 C-N-CA 122.077 1.851 . . . . 0.0 112.114 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.4 mt -77.35 -5.14 48.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.669 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 77.8 t -58.12 -45.81 88.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.084 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.766 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.7 m -54.26 -62.73 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.21 -0.986 0 C-N-CA 119.402 -0.919 . . . . 0.0 108.696 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.766 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.35 -44.66 2.83 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.708 0.29 . . . . 0.0 111.12 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.34 -47.89 63.05 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.27 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 70.9 m -70.46 -48.99 53.23 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.204 0.526 . . . . 0.0 111.08 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.469 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -53.93 -42.78 69.19 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.437 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -59.69 -53.38 58.66 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.589 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -63.83 -24.64 67.83 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.166 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.11 1.69 90.4 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 134' ' ' PRO . 34.8 mttm -153.33 157.8 32.82 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 120.574 -0.451 . . . . 0.0 110.122 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.4 ' O ' ' O ' ' A' ' 133' ' ' LYS . 5.2 Cg_exo -41.41 175.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 123.926 3.084 . . . . 0.0 113.581 -178.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.5 tp -129.38 122.73 30.04 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 176.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.428 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -66.19 143.33 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.955 0 C-N-CA 118.108 -1.437 . . . . 0.0 107.404 -179.52 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.8 t -114.88 122.09 45.22 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 123.792 0.682 . . . . 0.0 110.597 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.9 m -130.01 162.98 27.49 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.881 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.0 m -72.25 145.45 47.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.382 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.81 81.6 1.16 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.019 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 57.7 p30 -160.47 161.42 32.87 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.616 0.722 . . . . 0.0 111.031 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.49 -167.12 1.88 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.318 -178.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.6 t -61.03 -43.24 99.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.44 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -158.32 4.71 0.13 Allowed Glycine 0 C--N 1.33 0.227 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.2 tt -83.44 127.92 66.4 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -39.74 158.21 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.549 1.499 . . . . 0.0 112.207 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -77.04 -163.22 0.2 Allowed 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.733 2.288 . . . . 0.0 111.889 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.507 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 19.5 t -126.38 78.23 1.76 Allowed 'General case' 0 C--N 1.34 0.155 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -49.8 -39.51 38.57 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.676 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.16 169.81 23.69 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.445 ' H ' HG22 ' A' ' 151' ' ' VAL . 1.5 m -58.04 -20.87 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 CA-C-O 121.786 0.803 . . . . 0.0 108.984 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -64.53 -33.34 75.67 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 155' ' ' ARG . 0.4 OUTLIER -62.26 -79.37 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.401 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.425 HG13 ' N ' ' A' ' 155' ' ' ARG . 6.8 p -34.91 -33.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.983 0.913 . . . . 0.0 111.109 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.493 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -68.61 -53.27 23.66 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.533 -179.265 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -68.76 -18.61 64.24 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 122.571 1.177 . . . . 0.0 108.068 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.61 -45.56 14.41 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 112.517 -2.128 . . . . 0.0 111.559 -178.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -130.17 -29.76 2.02 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 96.48 23.75 15.64 Favored Glycine 0 N--CA 1.469 0.894 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -178.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 159' ' ' GLY . . . -43.12 -97.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.533 -0.333 . . . . 0.0 111.17 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.518 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.95 34.81 16.56 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -178.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.524 ' C ' ' H ' ' A' ' 164' ' ' VAL . 2.2 m-85 -172.67 -62.64 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.136 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -72.99 27.07 0.29 Allowed 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.258 1.972 . . . . 0.0 110.758 177.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.557 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.4 m -129.64 167.48 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.426 -178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 16.4 t -124.37 65.86 42.3 Favored Pre-proline 0 N--CA 1.471 0.601 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.637 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.557 ' HD3' HG23 ' A' ' 164' ' ' VAL . 29.4 Cg_exo -37.15 140.04 0.21 Allowed 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 123.413 2.742 . . . . 0.0 115.189 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 162.45 170.78 27.74 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 113.929 -1.487 . . . . 0.0 110.883 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -157.99 147.19 19.55 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.665 0.269 . . . . 0.0 110.427 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.469 0.494 0 CA-C-O 120.892 0.377 . . . . 0.0 110.529 179.645 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 94' ' ' THR . 98.0 mt-10 . . . . . 0 N--CA 1.45 -0.46 0 CA-C-O 120.717 0.294 . . . . 0.0 111.602 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.474 ' O ' HG23 ' A' ' 178' ' ' ILE . 18.4 tt -90.33 122.85 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.117 0.484 . . . . 0.0 111.834 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -134.74 170.69 15.45 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.252 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -87.01 107.2 18.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.242 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.733 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -69.21 -11.9 61.2 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.907 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.492 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.8 mm? -64.28 -42.62 96.34 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.45 -41.81 4.26 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.619 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.716 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -179.874 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.767 0.318 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.555 HD12 ' N ' ' A' ' 5' ' ' LEU . 9.2 mp -63.18 -42.51 99.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.155 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -64.5 -40.52 95.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.024 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.1 tpt180 -63.22 -41.65 99.14 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.35 -43.93 98.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.462 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.56 -46.49 90.01 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.993 0.425 . . . . 0.0 110.024 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.34 -43.6 98.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.636 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.07 -41.38 78.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.131 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.67 -44.07 94.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.245 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.86 -53.09 62.02 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.915 0.388 . . . . 0.0 111.561 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.8 pt -68.89 -39.36 79.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.232 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -57.92 -53.66 55.75 Favored 'General case' 0 C--O 1.215 -0.719 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.22 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.428 HG13 ' H ' ' A' ' 21' ' ' ARG . 86.5 t -61.07 -40.05 84.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.233 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.685 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.2 tt -51.89 -50.59 60.74 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.441 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -81.56 -49.26 10.76 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.253 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -66.0 -31.6 72.59 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.08 -178.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 16' ' ' VAL . 97.0 mt-10 57.14 83.91 0.1 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.075 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.428 ' H ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -164.8 -159.14 0.44 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.86 178.586 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.8 p -119.02 137.26 53.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.442 HD12 ' O ' ' A' ' 24' ' ' ALA . 2.8 pp -126.14 166.92 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 120.799 0.333 . . . . 0.0 111.327 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.442 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -63.23 137.39 58.19 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.25 0.548 . . . . 0.0 111.342 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.537 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 2.2 t80 -130.77 139.13 34.67 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.537 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 96.5 Cg_endo -76.88 144.47 24.34 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.488 1.459 . . . . 0.0 111.96 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.2 m -140.37 138.13 34.58 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.943 0.401 . . . . 0.0 110.363 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -56.73 -45.77 81.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.736 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.48 -79.28 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.806 0.336 . . . . 0.0 111.349 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 90.6 t -135.56 129.96 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -37.85 140.39 0.26 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.183 0.516 . . . . 0.0 111.546 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -137.74 -168.25 11.28 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.0 m -128.19 171.92 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -162.48 -177.53 35.59 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.221 -0.99 . . . . 0.0 111.719 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.539 ' SG ' ' HB2' ' A' ' 42' ' ' ALA . 0.8 OUTLIER -160.92 -161.42 0.83 Allowed 'General case' 0 C--N 1.342 0.259 0 C-N-CA 120.259 -0.577 . . . . 0.0 112.169 -179.227 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.504 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 69.2 m-20 -92.13 107.3 22.07 Favored Pre-proline 0 CA--C 1.557 1.241 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -45.46 -55.75 3.29 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 122.038 1.825 . . . . 0.0 111.71 177.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -50.81 -33.4 23.4 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.026 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.3 m -76.5 118.89 19.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.326 0.584 . . . . 0.0 110.659 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.535 ' O ' HG12 ' A' ' 43' ' ' VAL . 16.3 pt-20 -65.02 -32.19 73.79 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.87 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.5 t -43.48 -28.04 0.33 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.796 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.539 ' HB2' ' SG ' ' A' ' 35' ' ' CYS . . . -64.3 -51.6 62.67 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.27 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 40' ' ' GLU . 3.0 p -64.5 -39.34 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.171 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 92.6 mtp -66.11 -39.24 89.77 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.6 ttt85 -63.01 -33.27 75.07 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.86 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 87.2 mt -74.4 -59.04 2.91 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.3 mt -53.72 -19.54 4.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.334 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -66.66 -84.95 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.572 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.504 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.2 pt? -77.48 -34.75 54.2 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -74.94 -50.05 18.09 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.826 -176.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 37.25 62.01 0.88 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.665 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.9 ttm-85 -179.04 -61.91 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.895 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.215 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -63.36 -11.75 27.18 Favored 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 122.872 2.381 . . . . 0.0 112.422 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.589 HG13 ' N ' ' A' ' 55' ' ' ASP . 9.7 p -41.76 -48.61 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.831 -0.347 . . . . 0.0 111.143 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.589 ' N ' HG13 ' A' ' 54' ' ' VAL . 65.6 t0 -66.73 -39.74 88.09 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.88 0.371 . . . . 0.0 111.051 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -60.82 -39.91 90.76 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 64.73 108.3 0.01 OUTLIER Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.567 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -53.63 -159.16 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.319 0.581 . . . . 0.0 112.095 -179.603 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.446 HG23 HG21 ' A' ' 94' ' ' THR . 67.6 mt -103.94 144.07 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.896 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 20.4 mt -121.98 142.4 50.35 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.9 tp -112.45 134.59 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-O 121.368 0.604 . . . . 0.0 110.88 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.467 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -122.61 150.92 41.99 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.99 -27.27 8.49 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -116.48 151.0 36.97 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.796 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -79.68 -13.55 59.39 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -51.94 -31.44 28.81 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.482 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.13 -12.64 28.0 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.499 HD22 ' N ' ' A' ' 68' ' ' LEU . 4.1 mm? -92.63 -16.62 25.37 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 118.793 0.724 . . . . 0.0 109.276 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.474 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 44.5 tttp -77.5 -38.88 1.9 Allowed Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.774 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 67.6 Cg_endo -103.99 -2.89 0.24 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 122.91 2.407 . . . . 0.0 112.38 -178.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -95.84 -9.34 31.78 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.033 -178.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.553 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.2 mp -125.64 161.96 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.553 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -58.5 177.24 0.14 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.856 0.36 . . . . 0.0 110.232 -179.326 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -105.38 15.47 27.18 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.484 ' OG1' ' N ' ' A' ' 76' ' ' MET . 32.3 p -80.88 -64.53 1.17 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.095 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.484 ' N ' ' OG1' ' A' ' 75' ' ' THR . 26.4 ptm -70.23 -5.09 25.09 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.184 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.2 tp -83.93 100.92 11.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.32 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -155.15 160.28 40.8 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.78 -177.572 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -39.37 -48.51 1.91 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.813 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.1 p -61.86 -34.0 60.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.661 -0.415 . . . . 0.0 111.279 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 78' ' ' THR . 64.8 tp60 -65.57 -41.56 92.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.916 0.389 . . . . 0.0 110.715 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.417 ' HG2' ' H ' ' A' ' 82' ' ' ARG . 8.8 mmt85 -63.63 -51.98 62.85 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 122.589 1.185 . . . . 0.0 109.136 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -55.08 -50.3 69.5 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.776 -1.556 . . . . 0.0 110.018 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -60.52 -49.95 75.5 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.939 -178.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.0 tt -67.73 -37.19 78.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.097 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -70.37 -43.09 70.87 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.488 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.4 m -75.23 -37.73 60.93 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.195 0.521 . . . . 0.0 110.561 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -76.15 150.58 37.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -36.29 153.96 0.08 OUTLIER Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.888 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 118' ' ' VAL . 41.5 Cg_endo -64.28 -24.25 65.3 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.048 1.832 . . . . 0.0 111.439 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.492 ' O ' ' NH2' ' A' ' 117' ' ' ARG . . . 176.51 79.27 0.05 OUTLIER Glycine 0 CA--C 1.531 1.037 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.09 -44.35 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.058 1.839 . . . . 0.0 111.941 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.505 HG13 ' CE2' ' A' ' 95' ' ' PHE . 3.0 p -137.26 145.82 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.196 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.446 HG21 HG23 ' A' ' 59' ' ' ILE . 17.9 m -83.8 130.27 34.94 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.214 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.505 ' CE2' HG13 ' A' ' 93' ' ' VAL . 34.0 m-85 -117.85 140.03 50.28 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.512 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.628 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 4.4 t -90.28 101.37 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 121.477 0.656 . . . . 0.0 110.023 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -90.23 152.32 45.7 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.377 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.42 113.04 3.69 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.199 1.933 . . . . 0.0 111.189 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.14 150.95 75.22 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.26 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -72.27 156.04 55.45 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.075 1.85 . . . . 0.0 112.159 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.384 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.016 -179.981 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 109' ' ' GLY . 7.4 tpt180 . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 120.667 0.27 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 66.8 p-90 -75.8 -7.34 54.21 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.957 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.977 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -70.91 -30.14 66.39 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.702 ' H ' HD22 ' A' ' 107' ' ' LEU . 89.9 m -140.38 -38.46 0.45 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.705 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 86.04 -11.38 62.8 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.608 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -142.13 -72.3 0.32 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.56 0.68 . . . . 0.0 110.788 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.443 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 21.4 t80 -91.32 -167.38 1.79 Allowed 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.443 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 94.9 m-20 -130.53 57.6 1.72 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.653 0.263 . . . . 0.0 110.693 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.7 p -156.51 156.92 34.53 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.187 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.446 ' O ' HD12 ' A' ' 114' ' ' LEU . 3.1 pp -168.96 138.88 2.25 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.446 ' HB2' HG22 ' A' ' 96' ' ' VAL . . . -70.32 131.56 44.33 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 113.787 -1.551 . . . . 0.0 109.932 177.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.8 p -147.06 155.35 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 120.727 0.299 . . . . 0.0 110.364 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.492 ' NH2' ' O ' ' A' ' 91' ' ' GLY . 79.3 ttt180 -146.1 153.27 40.52 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.847 -179.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.467 HG22 ' HB3' ' A' ' 62' ' ' ALA . 49.6 t -120.5 136.24 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.9 t -139.74 142.13 36.82 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.025 0.441 . . . . 0.0 110.629 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 51.0 p-10 -145.82 81.82 1.61 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.686 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.639 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 7.3 t60 -171.49 -36.29 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.639 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 43.0 Cg_endo -94.72 -161.14 0.07 OUTLIER 'Trans proline' 0 N--CA 1.483 0.907 0 C-N-CA 122.044 1.829 . . . . 0.0 111.955 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.3 mt -78.01 -6.17 53.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.392 0.615 . . . . 0.0 110.013 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 98.8 t -58.08 -45.29 88.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.072 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.772 HG23 ' H ' ' A' ' 126' ' ' ALA . 28.7 m -53.2 -62.15 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.906 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.019 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.772 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.68 -44.01 3.02 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 120.938 0.399 . . . . 0.0 110.723 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.3 tp -68.93 -48.26 63.68 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.235 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 60.7 m -70.28 -49.29 51.26 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.387 0.613 . . . . 0.0 110.907 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.466 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.1 pp0? -54.55 -41.95 70.36 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.341 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.64 -55.07 39.83 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.257 -178.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -62.46 -21.9 65.81 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.919 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.73 1.27 89.19 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -152.27 160.56 31.18 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 120.506 -0.477 . . . . 0.0 110.357 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -45.04 164.3 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 123.943 3.095 . . . . 0.0 112.54 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.4 tp -119.36 122.93 42.93 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.43 HG13 ' H ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -63.54 144.69 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 C-N-CA 117.913 -1.515 . . . . 0.0 106.945 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.1 t -116.82 125.1 51.06 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 123.583 0.552 . . . . 0.0 111.283 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.3 m -134.54 158.39 44.08 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.781 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.6 m -71.31 142.56 50.45 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.168 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.72 85.39 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.558 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -160.63 165.44 30.65 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.438 0.637 . . . . 0.0 111.079 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.93 -164.65 2.01 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.315 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 42.5 t -61.37 -43.08 99.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.022 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -157.25 3.91 0.16 Allowed Glycine 0 N--CA 1.461 0.355 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.457 HD13 ' C ' ' A' ' 145' ' ' LEU . 1.3 tm? -81.18 112.28 31.57 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 145' ' ' LEU . 20.1 Cg_exo -35.46 156.84 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.104 1.869 . . . . 0.0 112.542 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.7 -174.21 1.23 Allowed 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.4 2.067 . . . . 0.0 112.57 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 17.6 m -114.44 82.89 1.79 Allowed 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.378 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -59.07 -35.58 73.6 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.637 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.82 169.41 21.38 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.434 ' H ' HG22 ' A' ' 151' ' ' VAL . 0.9 OUTLIER -57.02 -23.19 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 CA-C-O 121.437 0.637 . . . . 0.0 109.378 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -62.71 -32.41 73.51 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 155' ' ' ARG . 6.4 tm-20 -63.09 -80.45 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.568 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.3 p -36.37 -27.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.167 0.987 . . . . 0.0 111.044 177.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.471 ' N ' ' O ' ' A' ' 153' ' ' GLU . 4.3 tmt_? -74.4 -50.73 17.34 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.855 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.7 -17.75 62.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 122.631 1.205 . . . . 0.0 107.781 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -83.32 -57.04 3.42 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 112.553 -2.112 . . . . 0.0 111.987 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -119.99 -20.6 7.42 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 160' ' ' ALA . . . 84.72 27.63 34.5 Favored Glycine 0 N--CA 1.466 0.642 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.474 ' O ' ' HB3' ' A' ' 161' ' ' ALA . . . -42.21 -98.37 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.58 -0.31 . . . . 0.0 111.36 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.516 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 67.79 34.44 4.35 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.299 0.571 . . . . 0.0 109.578 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.519 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.6 m-85 -176.36 -61.89 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.235 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -73.44 31.45 0.31 Allowed 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.044 1.829 . . . . 0.0 110.439 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.563 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.4 m -134.67 168.22 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.834 -178.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 8.3 t -125.15 64.82 46.6 Favored Pre-proline 0 N--CA 1.475 0.79 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.855 178.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.563 ' HD3' HG23 ' A' ' 164' ' ' VAL . 55.4 Cg_exo -40.13 151.0 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 123.706 2.938 . . . . 0.0 114.97 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 162.68 -174.93 39.1 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.983 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -141.68 145.12 34.53 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.465 0.308 0 CA-C-O 121.036 0.446 . . . . 0.0 110.809 -179.717 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 . . . . . 0 N--CA 1.449 -0.482 0 CA-C-O 120.584 0.23 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.424 ' O ' HG23 ' A' ' 178' ' ' ILE . 17.2 tt -109.68 129.87 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 120.795 0.331 . . . . 0.0 110.539 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -132.63 166.34 22.35 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.711 0.767 . . . . 0.0 112.018 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -80.36 106.87 12.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.502 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -64.47 -20.05 65.95 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.216 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.449 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.5 mm? -63.02 -42.64 99.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.933 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.85 -45.28 2.88 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.836 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.673 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.735 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 41.5 t30 . . . . . 0 C--O 1.235 0.309 0 CA-C-O 120.92 0.39 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.55 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.0 mp -61.95 -43.08 99.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.22 0.533 . . . . 0.0 109.608 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -67.96 -35.35 78.23 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.127 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -60.71 -43.61 97.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.543 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 9' ' ' ALA . 1.5 p30 -70.97 -39.22 72.67 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.166 -0.613 . . . . 0.0 110.469 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.523 ' N ' ' OD1' ' A' ' 8' ' ' ASP . . . -62.12 -48.3 80.77 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.269 0.557 . . . . 0.0 110.122 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.0 -43.59 99.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.912 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.56 -45.31 77.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.635 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.07 -46.68 88.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.924 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.94 -52.1 66.87 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 14.3 pt -69.37 -39.67 79.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.518 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -58.75 -53.47 57.99 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.123 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' A' ' 20' ' ' GLU . 89.6 t -60.76 -40.42 84.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.508 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.684 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.4 tt -51.67 -50.59 60.12 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.77 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -80.77 -50.99 9.14 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.056 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -63.7 -32.75 74.34 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.049 -178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.9 mt-10 58.49 85.35 0.09 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.385 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.57 -141.06 0.07 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.319 178.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.405 HG11 HH21 ' A' ' 45' ' ' ARG . 4.8 p -137.55 139.58 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.448 HD12 ' O ' ' A' ' 24' ' ' ALA . 2.8 pp -129.85 165.9 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-O 120.945 0.402 . . . . 0.0 111.41 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.448 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -61.63 136.97 58.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.301 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.51 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -134.54 142.23 41.92 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.51 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 62.6 Cg_endo -77.25 151.09 29.64 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.771 1.647 . . . . 0.0 111.82 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.492 ' C ' ' H ' ' A' ' 29' ' ' ALA . 45.7 m -132.13 136.49 47.16 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.844 0.354 . . . . 0.0 110.87 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -74.98 23.83 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.357 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.492 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -157.27 -73.44 0.09 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.313 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.8 p -127.52 126.95 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.316 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.511 ' CD1' ' O ' ' A' ' 148' ' ' CYS . 35.4 p90 -40.24 147.83 0.09 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.323 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -156.34 -169.45 20.46 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.3 m -133.21 170.87 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.406 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -158.58 -175.48 29.56 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.012 -1.089 . . . . 0.0 112.102 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.521 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -158.44 -164.13 1.41 Allowed 'General case' 0 C--O 1.227 -0.103 0 CA-C-O 120.568 0.223 . . . . 0.0 110.81 -179.312 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.521 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 90.5 m-20 -98.72 109.69 54.29 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -178.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 36' ' ' ASP . 22.4 Cg_exo -36.73 170.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.854 2.369 . . . . 0.0 114.325 177.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 41.98 71.94 0.19 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.074 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.5 m -148.81 138.86 22.23 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.373 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -69.87 -34.79 74.06 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.462 0.648 . . . . 0.0 110.54 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.449 HG22 ' H ' ' A' ' 41' ' ' THR . 0.1 OUTLIER -62.98 -43.0 99.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.667 -179.071 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.71 -51.34 70.18 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.726 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 p -63.62 -42.6 96.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 90.4 mtp -64.24 -39.71 94.52 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.451 ' O ' ' CD2' ' A' ' 49' ' ' LEU . 45.8 ttt-85 -62.15 -33.8 75.18 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.067 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 89.4 mt -75.09 -59.93 2.52 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.2 mt -54.18 -18.42 3.8 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.361 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -67.35 -85.67 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.741 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.503 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -75.72 -32.76 60.17 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.906 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -78.18 -70.44 0.49 Allowed 'General case' 0 C--N 1.349 0.571 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.489 -177.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 52.84 81.05 0.09 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.0 mtm180 161.72 -63.14 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.86 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.1 -11.68 32.79 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.819 2.346 . . . . 0.0 112.255 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.565 HG13 ' N ' ' A' ' 55' ' ' ASP . 6.9 p -41.83 -49.9 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.815 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.565 ' N ' HG13 ' A' ' 54' ' ' VAL . 65.7 t0 -66.74 -40.13 88.22 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.018 0.437 . . . . 0.0 111.146 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -61.36 -39.97 92.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.692 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 66.39 112.49 0.01 OUTLIER Glycine 0 CA--C 1.519 0.295 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.555 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -52.99 -162.37 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.325 0.583 . . . . 0.0 112.298 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 70.9 mt -105.02 145.23 13.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.825 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.6 mt -121.15 142.66 49.67 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.449 HD13 ' HE ' ' A' ' 117' ' ' ARG . 9.4 tp -110.78 127.8 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-O 121.076 0.465 . . . . 0.0 110.708 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -117.64 148.15 42.22 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -106.4 -27.68 10.81 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 116.297 -0.411 . . . . 0.0 109.915 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.674 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 12.4 m120 -115.79 150.32 37.11 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.735 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -79.98 -14.42 58.6 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -52.91 -30.82 36.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.585 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.674 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 4.4 pm0 -94.04 -12.22 29.05 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.531 HD22 ' N ' ' A' ' 68' ' ' LEU . 3.8 mm? -91.4 -20.81 21.4 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.513 -0.742 . . . . 0.0 109.591 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.462 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 49.1 tttm -76.03 -37.45 2.17 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 68.7 Cg_endo -103.39 -3.48 0.26 Allowed 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 122.548 2.166 . . . . 0.0 112.007 -178.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.446 ' OH ' ' CD1' ' A' ' 114' ' ' LEU . 53.9 t80 -98.25 -4.1 35.98 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.037 0.446 . . . . 0.0 111.07 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.618 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.6 mp -132.91 166.54 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.618 ' N ' HG22 ' A' ' 72' ' ' ILE . 98.7 m-20 -58.0 -9.66 1.47 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.475 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 58.2 t0 58.54 30.4 19.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.9 t -95.23 -36.79 11.3 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.091 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -83.07 -18.83 38.25 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.86 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 36.0 tp -86.03 125.35 33.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.148 0.499 . . . . 0.0 110.287 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -161.56 161.74 29.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.156 -177.075 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -39.49 -48.41 2.0 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.849 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.13 -32.96 58.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.976 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.454 ' N ' ' O ' ' A' ' 78' ' ' THR . 63.2 tp60 -65.14 -40.57 94.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.585 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.2 mmt85 -64.79 -53.05 53.07 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 122.164 0.983 . . . . 0.0 109.252 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -53.98 -51.02 65.24 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.011 -1.45 . . . . 0.0 110.39 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.5 m -61.05 -50.34 73.7 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.853 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 89' ' ' TRP . 8.6 tt -68.02 -33.75 62.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.728 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -73.82 -38.89 64.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.168 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.7 m -83.41 -34.55 25.48 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.8 0.333 . . . . 0.0 111.416 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 63.9 ttm-85 -81.14 -75.26 0.29 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.504 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.436 ' O ' ' O ' ' A' ' 85' ' ' ILE . 2.2 m0 -162.02 152.85 14.83 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -65.31 -22.51 60.21 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.296 1.997 . . . . 0.0 112.198 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 161.44 78.02 0.03 OUTLIER Glycine 0 CA--C 1.531 1.077 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.514 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.53 -23.59 11.23 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 121.946 1.764 . . . . 0.0 112.404 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.42 HG13 ' CE2' ' A' ' 95' ' ' PHE . 3.2 p -136.15 147.22 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.216 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 26.9 m -89.89 138.47 31.46 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.257 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.485 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 42.0 m-85 -124.46 139.94 53.42 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.999 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.677 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.6 t -97.76 109.72 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 CA-C-O 121.433 0.635 . . . . 0.0 111.084 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -92.08 147.64 35.16 Favored Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.421 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.51 98.1 1.09 Allowed 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.847 1.698 . . . . 0.0 110.985 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -46.87 148.04 2.01 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -63.36 -28.71 71.82 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.261 1.974 . . . . 0.0 112.561 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.236 0 CA-C-O 120.71 0.29 . . . . 0.0 110.617 -179.529 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 109' ' ' GLY . 8.0 tpt180 . . . . . 0 CA--C 1.53 0.18 0 CA-C-O 120.835 0.35 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -73.37 -6.96 49.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.669 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.968 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -77.71 -21.28 52.2 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.059 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.625 ' H ' HD22 ' A' ' 107' ' ' LEU . 93.1 m -142.79 -40.34 0.33 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.141 0.495 . . . . 0.0 109.981 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 91.44 -15.44 61.33 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.642 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.422 ' O ' ' NH2' ' A' ' 105' ' ' ARG . 17.3 tpt180 -145.23 -76.95 0.21 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 117.578 0.689 . . . . 0.0 111.488 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.449 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 22.0 t80 -87.1 -167.33 1.85 Allowed 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.449 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 52.8 p-10 -136.03 73.15 1.45 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.103 0.477 . . . . 0.0 111.302 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.7 p -159.68 129.49 5.45 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.446 ' CD1' ' OH ' ' A' ' 71' ' ' TYR . 34.4 mt -127.72 121.62 30.79 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -177.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.447 ' N ' HG13 ' A' ' 96' ' ' VAL . . . -70.84 126.56 29.93 Favored 'General case' 0 C--N 1.345 0.397 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 175.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.425 HG22 ' N ' ' A' ' 117' ' ' ARG . 14.8 p -143.88 152.84 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.198 0.523 . . . . 0.0 111.1 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.449 ' HE ' HD13 ' A' ' 61' ' ' ILE . 62.5 ttp180 -139.82 154.3 47.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.116 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.7 t -123.86 132.8 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.3 t -132.21 149.91 52.28 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.985 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 33.8 p30 -152.75 80.7 1.22 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.07 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.681 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 49.3 t-80 -171.79 -35.31 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.681 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 56.5 Cg_endo -94.99 -161.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.98 1.787 . . . . 0.0 111.834 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 11.3 mt -78.16 -4.79 49.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.978 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 82.4 t -58.24 -45.76 88.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.968 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.753 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.8 m -53.71 -62.31 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.941 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.044 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.753 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.67 -43.27 2.77 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.968 0.413 . . . . 0.0 110.842 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.7 tp -69.93 -47.66 61.53 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.414 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 62.7 m -70.48 -49.22 50.74 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.539 0.685 . . . . 0.0 110.531 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 125' ' ' VAL . 1.1 pp0? -54.41 -42.24 70.24 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.88 -54.57 45.64 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.455 -178.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -62.41 -23.25 66.74 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.001 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.51 0.58 90.06 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 134' ' ' PRO . 33.1 mttm -153.67 159.18 32.39 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 133' ' ' LYS . 6.3 Cg_exo -41.35 179.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 123.886 3.057 . . . . 0.0 113.239 -178.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 35' ' ' CYS . 8.0 tp -133.44 123.26 24.98 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 176.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.449 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -65.6 146.48 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 C-N-CA 117.64 -1.624 . . . . 0.0 107.271 -179.45 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.8 t -118.65 126.95 53.06 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 123.573 0.545 . . . . 0.0 111.214 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.7 m -132.74 163.5 28.88 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.04 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.8 m -74.2 146.94 42.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.443 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.45 83.55 1.97 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.917 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -159.12 164.71 35.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.398 0.618 . . . . 0.0 110.977 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.88 -166.18 2.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.073 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 61.1 m -60.09 -42.7 95.21 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.799 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -160.63 5.38 0.1 OUTLIER Glycine 0 C--N 1.331 0.28 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.4 tp -81.19 127.9 72.42 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 119.36 -0.352 . . . . 0.0 110.104 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -39.28 151.28 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 121.637 1.558 . . . . 0.0 111.804 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 149' ' ' ARG . 89.2 Cg_endo -75.17 148.58 34.83 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.234 1.956 . . . . 0.0 112.446 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.511 ' O ' ' CD1' ' A' ' 31' ' ' PHE . 4.2 m -62.74 71.35 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.354 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 147' ' ' PRO . 17.3 ptm180 -57.87 -32.94 68.17 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.415 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -163.11 164.22 25.44 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.441 ' H ' HG22 ' A' ' 151' ' ' VAL . 0.8 OUTLIER -56.33 -18.01 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 CA-C-O 121.721 0.772 . . . . 0.0 108.971 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -64.71 -35.53 81.35 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 177.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 150' ' ' THR . 5.6 tm-20 -58.94 -74.07 0.07 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.869 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.1 p -45.68 -30.06 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.34 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -83.98 -44.28 14.34 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 122.226 1.012 . . . . 0.0 110.285 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.36 -42.14 86.3 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.435 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.471 ' CG ' ' N ' ' A' ' 158' ' ' PHE . 8.1 pt20 -81.47 -48.93 11.22 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 112.858 -1.974 . . . . 0.0 112.134 -177.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.471 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 30.5 t80 -106.85 -36.54 6.63 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -177.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 97.68 24.45 12.09 Favored Glycine 0 N--CA 1.476 1.341 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -42.89 -94.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.564 0.221 . . . . 0.0 111.094 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.45 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.96 37.51 14.98 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.204 0.526 . . . . 0.0 109.714 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.562 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.5 m-85 -177.07 -61.83 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.764 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -73.73 28.19 0.32 Allowed 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 122.367 2.045 . . . . 0.0 110.443 178.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.586 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.9 m -131.03 167.4 26.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.85 -178.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.7 t -123.82 65.58 35.97 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.501 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.586 ' HD3' HG23 ' A' ' 164' ' ' VAL . 30.6 Cg_exo -36.68 141.22 0.15 Allowed 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 123.6 2.867 . . . . 0.0 115.15 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 154.67 145.68 4.22 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.54 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -141.99 132.25 24.92 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.303 0.573 . . . . 0.0 110.973 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.4 t . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.929 179.309 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 N--CA 1.446 -0.638 0 CA-C-O 121.125 0.488 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.449 ' O ' HG23 ' A' ' 178' ' ' ILE . 19.3 tt -110.93 127.82 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.112 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -129.46 166.95 18.59 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.727 0.775 . . . . 0.0 112.273 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 184' ' ' GLY . 97.7 m-20 -78.93 106.93 11.3 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.427 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -67.15 -16.93 64.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.744 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.491 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.4 mm? -63.6 -42.43 98.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.099 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.581 HG23 ' N ' ' A' ' 184' ' ' GLY . 5.0 t -120.31 -52.89 2.15 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.207 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.581 ' N ' HG23 ' A' ' 183' ' ' THR . . . . . . . . 0 N--CA 1.468 0.818 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 . . . . . 0 N--CA 1.466 0.342 0 CA-C-O 120.791 0.329 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.548 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.0 mp -62.57 -42.3 99.47 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.212 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -63.43 -39.93 95.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.163 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -63.76 -40.7 97.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.4 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 162' ' ' PHE . 65.2 t0 -61.94 -48.37 80.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.686 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.25 -45.36 93.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.487 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.96 -43.48 97.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.284 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.78 -45.02 82.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.816 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.22 -43.47 94.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.145 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.72 -52.56 64.59 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.706 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.8 pt -67.7 -39.75 82.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.163 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -57.58 -55.34 36.1 Favored 'General case' 0 C--O 1.215 -0.755 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.338 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 20' ' ' GLU . 95.4 t -60.15 -40.69 84.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.876 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.689 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.2 tt -51.61 -50.22 60.66 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.697 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -81.84 -51.51 8.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.993 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -63.63 -35.0 79.08 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.109 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 16' ' ' VAL . 97.1 mt-10 59.02 86.46 0.09 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.664 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.403 ' H ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -163.72 -134.81 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.504 HG21 ' NH2' ' A' ' 45' ' ' ARG . 6.1 p -140.22 140.36 35.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.439 HD12 ' O ' ' A' ' 24' ' ' ALA . 2.9 pp -129.87 165.82 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 120.852 0.358 . . . . 0.0 111.133 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.439 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -62.87 138.55 58.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.133 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.511 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 0.6 OUTLIER -131.19 141.59 42.43 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.363 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.511 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 91.2 Cg_endo -77.16 144.8 23.85 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.4 1.4 . . . . 0.0 111.892 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.471 ' C ' ' H ' ' A' ' 29' ' ' ALA . 79.4 m -135.85 135.09 39.5 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.32 0.581 . . . . 0.0 110.868 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -72.96 32.52 0.07 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.802 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.471 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -163.0 -75.73 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.833 0.349 . . . . 0.0 110.975 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.3 m -126.59 128.55 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.128 0.49 . . . . 0.0 110.229 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.519 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 80.3 m-85 -46.99 143.0 3.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.117 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -148.58 -169.15 15.12 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.8 m -133.33 169.37 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.404 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -156.98 -179.05 31.62 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.009 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.426 ' SG ' ' HB2' ' A' ' 42' ' ' ALA . 1.3 p -157.98 -165.73 1.8 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.6 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 7.0 p30 -89.65 107.68 20.29 Favored Pre-proline 0 CA--C 1.558 1.256 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -178.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -42.82 -60.78 0.66 Allowed 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.076 1.851 . . . . 0.0 112.633 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -77.63 70.65 4.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.427 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 54.9 m -156.57 144.01 19.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.619 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -71.1 -34.22 70.9 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.178 0.513 . . . . 0.0 111.158 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.443 HG22 ' H ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -60.52 -42.19 95.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.99 -178.719 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.426 ' HB2' ' SG ' ' A' ' 35' ' ' CYS . . . -57.88 -52.36 65.81 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 p -62.19 -42.6 95.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.147 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.9 mtt -64.65 -41.44 96.13 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.504 ' NH2' HG21 ' A' ' 22' ' ' VAL . 31.9 ttt-85 -60.4 -42.26 95.57 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-O 121.98 0.895 . . . . 0.0 108.916 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.457 ' O ' HD23 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -64.2 -53.47 48.74 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.664 -178.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.7 mt -71.03 -10.57 59.98 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.153 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -69.85 -82.35 0.04 OUTLIER 'General case' 0 N--CA 1.432 -1.354 0 CA-C-O 121.09 0.471 . . . . 0.0 110.924 -177.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.526 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -76.54 -35.57 58.19 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -76.51 -50.22 14.53 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.082 -177.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 35.76 65.09 0.44 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.012 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.428 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 7.1 mtm-85 178.82 -52.51 0.0 OUTLIER Pre-proline 0 CA--C 1.551 0.981 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.744 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.428 ' HD2' ' H ' ' A' ' 52' ' ' ARG . 85.6 Cg_endo -81.11 -2.81 11.92 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 123.008 2.472 . . . . 0.0 112.499 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.574 HG13 ' N ' ' A' ' 55' ' ' ASP . 8.7 p -44.61 -45.47 2.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.033 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.574 ' N ' HG13 ' A' ' 54' ' ' VAL . 41.7 t0 -64.13 -41.14 97.32 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.726 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -60.86 -35.33 76.31 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 59.19 102.26 0.01 OUTLIER Glycine 0 CA--C 1.52 0.36 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.572 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -48.73 -172.55 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.303 0.573 . . . . 0.0 112.205 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.6 mt -91.14 141.21 14.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.419 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.3 mt -118.88 145.74 45.47 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.423 ' O ' HG23 ' A' ' 61' ' ' ILE . 9.3 tp -113.38 127.68 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-O 121.203 0.525 . . . . 0.0 111.184 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.551 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -113.99 151.77 31.9 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.87 -28.16 8.17 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.686 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 99.0 m-20 -115.69 148.55 39.6 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.316 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -77.16 -13.46 59.94 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -51.87 -32.45 32.22 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.262 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.686 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 4.0 pm0 -94.28 -9.83 34.78 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.425 HD22 ' N ' ' A' ' 68' ' ' LEU . 4.3 mm? -92.18 -16.23 26.53 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.473 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 17.4 ttpp -78.07 -37.3 1.46 Allowed Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 67.5 Cg_endo -103.44 -3.23 0.27 Allowed 'Trans proline' 0 C--N 1.321 -0.921 0 C-N-CA 122.801 2.334 . . . . 0.0 111.873 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.524 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 42.0 t80 -91.73 -12.05 35.05 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.295 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.597 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.7 mp -123.2 163.43 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.597 ' N ' HG22 ' A' ' 72' ' ' ILE . 96.8 m-20 -63.43 -3.98 2.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.277 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 3.3 p30 45.01 22.85 0.07 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.883 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.555 HG23 ' N ' ' A' ' 76' ' ' MET . 8.9 t -88.72 -44.81 10.29 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.13 0.49 . . . . 0.0 109.827 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.555 ' N ' HG23 ' A' ' 75' ' ' THR . 18.2 ptp -80.63 -14.76 57.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.975 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 tp -79.0 134.12 36.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.701 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -158.61 161.04 37.18 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.972 -177.553 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -38.92 -48.93 1.63 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.768 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.5 p -63.26 -33.49 61.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.007 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.427 ' N ' ' O ' ' A' ' 78' ' ' THR . 62.8 tp60 -64.47 -39.47 93.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.944 0.402 . . . . 0.0 110.4 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -63.87 -53.12 55.55 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 122.517 1.151 . . . . 0.0 109.111 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.499 ' O ' ' N ' ' A' ' 87' ' ' SER . 80.8 tt0 -54.18 -50.37 67.19 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.989 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.4 m -61.48 -49.29 77.35 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.988 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 89' ' ' TRP . 8.7 tt -69.79 -31.24 47.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.574 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -80.14 -31.31 39.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.753 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 83' ' ' GLU . 53.2 m -90.1 -12.71 37.55 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.769 0.318 . . . . 0.0 111.201 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.446 ' O ' ' O ' ' A' ' 89' ' ' TRP . 62.0 ttm-85 -121.95 75.84 1.24 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.446 ' O ' ' O ' ' A' ' 88' ' ' ARG . 7.9 m-90 56.75 152.26 0.07 OUTLIER Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.377 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.24 -19.26 38.84 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.881 1.72 . . . . 0.0 111.673 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 159.56 81.05 0.04 OUTLIER Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -81.42 -9.77 12.38 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.492 2.128 . . . . 0.0 112.143 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.419 HG13 ' CE2' ' A' ' 95' ' ' PHE . 3.1 p -136.12 144.8 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.951 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.464 HG22 ' HB1' ' A' ' 115' ' ' ALA . 7.4 m -95.99 124.31 39.95 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.588 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 41.7 m-85 -113.09 143.03 45.04 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.401 -178.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.806 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 98.8 t -89.08 102.71 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 121.152 0.501 . . . . 0.0 111.393 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -90.08 146.82 35.77 Favored Pre-proline 0 N--CA 1.469 0.504 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.786 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -79.39 87.03 1.59 Allowed 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.241 1.961 . . . . 0.0 111.449 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -48.28 151.55 1.81 Allowed Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.91 144.58 88.54 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.091 1.861 . . . . 0.0 111.664 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.48 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.192 -179.673 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 109' ' ' GLY . 5.9 tpt180 . . . . . 0 N--CA 1.461 0.089 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 66.7 p-90 -79.1 -11.59 59.99 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.665 0.745 . . . . 0.0 109.404 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.631 ' H ' ' CD2' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -76.58 -16.45 59.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.811 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.409 ' H ' HD23 ' A' ' 107' ' ' LEU . 94.8 m -142.93 -40.96 0.32 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.356 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 91.9 -13.4 66.96 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 119.863 -0.41 . . . . 0.0 112.896 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.451 ' O ' ' CZ ' ' A' ' 105' ' ' ARG . 13.5 tpt180 -148.01 -80.43 0.14 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.883 0.842 . . . . 0.0 111.226 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -90.95 -174.83 4.15 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -124.35 61.18 1.13 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.083 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.0 p -168.14 151.78 5.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.193 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 pp -169.34 147.58 3.71 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.464 ' HB1' HG22 ' A' ' 94' ' ' THR . . . -64.27 134.94 55.71 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 113.76 -1.564 . . . . 0.0 109.635 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.47 HG22 ' N ' ' A' ' 117' ' ' ARG . 6.6 p -147.98 160.06 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.47 ' N ' HG22 ' A' ' 116' ' ' VAL . 62.5 ttp180 -145.53 154.64 42.42 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.907 0.384 . . . . 0.0 111.425 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.551 HG22 ' HB3' ' A' ' 62' ' ' ALA . 48.3 t -123.0 136.07 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.9 t -138.38 150.25 46.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.178 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 50.7 p-10 -153.7 84.9 1.17 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.923 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.657 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 8.5 t-80 -171.52 -36.58 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.292 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.657 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 60.9 Cg_endo -95.15 -159.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.949 0 C-N-CA 121.879 1.719 . . . . 0.0 112.032 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.7 mt -78.79 -5.79 54.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.372 0.606 . . . . 0.0 110.459 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 87.8 t -58.1 -44.77 88.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.787 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.774 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.1 m -53.35 -62.57 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.922 0 C-N-CA 119.269 -0.972 . . . . 0.0 108.883 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.774 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.29 -43.82 2.54 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 120.831 0.348 . . . . 0.0 111.152 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.409 HD23 HD22 ' A' ' 135' ' ' LEU . 41.1 tp -69.04 -48.77 62.01 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.998 0.428 . . . . 0.0 111.224 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 75.4 m -70.26 -48.38 57.1 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.373 0.606 . . . . 0.0 110.991 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.46 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.1 pp0? -55.03 -42.26 72.38 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -57.87 -57.22 13.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.665 -178.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -62.47 -26.46 68.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.385 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.92 -2.44 88.25 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' A' ' 134' ' ' PRO . 25.0 mmtm -142.91 155.78 62.5 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 117.137 0.469 . . . . 0.0 110.043 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 133' ' ' LYS . 6.0 Cg_exo -41.34 175.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 123.604 2.869 . . . . 0.0 112.984 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.409 HD22 HD23 ' A' ' 127' ' ' LEU . 8.1 tp -128.59 122.96 32.15 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 177.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.426 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -66.11 142.67 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.9 0 C-N-CA 117.762 -1.575 . . . . 0.0 107.256 -179.712 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 t -111.69 118.91 36.93 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 123.802 0.688 . . . . 0.0 110.88 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.465 ' CB ' HH22 ' A' ' 45' ' ' ARG . 18.8 m -127.72 150.55 49.73 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.756 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 140' ' ' ALA . 24.7 m -64.59 149.21 49.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.491 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.436 ' O ' ' O ' ' A' ' 139' ' ' SER . . . -53.78 -164.09 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.997 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.431 ' O ' ' O ' ' A' ' 140' ' ' ALA . 6.7 p30 53.37 156.98 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.702 0.763 . . . . 0.0 111.687 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.07 -147.15 0.37 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.185 -178.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.4 p -63.15 -39.32 94.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.058 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.426 ' H ' ' H ' ' A' ' 145' ' ' LEU . . . -161.78 -2.4 0.05 OUTLIER Glycine 0 N--CA 1.457 0.059 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.426 ' H ' ' H ' ' A' ' 144' ' ' GLY . 11.7 tp -71.71 128.68 89.36 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 119.355 -0.355 . . . . 0.0 110.358 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 145' ' ' LEU . 26.2 Cg_exo -35.25 157.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.295 1.996 . . . . 0.0 112.451 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.98 -163.62 0.13 Allowed 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.291 1.994 . . . . 0.0 112.508 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 27.3 m -132.14 69.48 1.48 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.966 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.519 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 17.3 ptm180 -56.96 -36.47 70.34 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.581 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.85 168.79 23.98 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.418 HG11 ' HA ' ' A' ' 166' ' ' PRO . 1.7 m -59.4 -17.7 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 CA-C-O 121.612 0.72 . . . . 0.0 109.553 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -65.62 -35.19 80.07 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.432 ' OE1' ' OE1' ' A' ' 157' ' ' GLN . 5.8 tm-20 -60.11 -73.78 0.08 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.895 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.427 HG11 HG11 ' A' ' 164' ' ' VAL . 7.3 p -45.51 -30.03 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.016 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.06 -43.34 15.2 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 122.214 1.007 . . . . 0.0 110.007 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.9 -42.26 89.17 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 122.518 1.151 . . . . 0.0 109.265 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.471 ' CG ' ' N ' ' A' ' 158' ' ' PHE . 8.0 pt20 -80.74 -49.61 10.94 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 112.974 -1.921 . . . . 0.0 112.042 -177.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.471 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 39.6 t80 -106.07 -37.24 6.68 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -177.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 98.88 25.3 9.82 Favored Glycine 0 N--CA 1.473 1.11 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 161' ' ' ALA . . . -43.87 -97.27 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.561 0.219 . . . . 0.0 111.091 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.473 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 64.95 36.55 7.52 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.199 0.523 . . . . 0.0 109.899 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.547 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.5 m-85 -177.74 -61.24 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.182 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.25 29.06 0.3 Allowed 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 122.447 2.098 . . . . 0.0 110.556 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.57 HG23 ' HD3' ' A' ' 166' ' ' PRO . 16.0 m -132.65 167.37 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.215 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 9.0 t -123.49 65.13 31.34 Favored Pre-proline 0 N--CA 1.476 0.844 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.848 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.57 ' HD3' HG23 ' A' ' 164' ' ' VAL . 31.7 Cg_exo -36.54 141.39 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 123.77 2.98 . . . . 0.0 115.045 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 163.27 -161.59 34.13 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 113.761 -1.563 . . . . 0.0 110.972 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -147.49 175.39 10.87 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.982 0.42 . . . . 0.0 110.193 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.463 0.195 0 CA-C-O 121.035 0.445 . . . . 0.0 110.509 179.957 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 . . . . . 0 N--CA 1.446 -0.631 0 CA-C-O 121.241 0.543 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 13.1 tt -94.89 130.37 43.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.435 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -133.19 168.65 18.16 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.51 0.671 . . . . 0.0 111.574 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -87.25 108.05 18.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.165 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.806 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -72.93 -14.3 61.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.239 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.498 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.6 mm? -64.91 -42.02 95.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.989 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.22 -43.66 4.54 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.058 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.758 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 179.888 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 . . . . . 0 N--CA 1.469 0.479 0 CA-C-O 120.783 0.325 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.533 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.5 mp -62.46 -42.62 99.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.21 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -61.49 -40.42 94.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.934 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -64.16 -41.5 97.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.14 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -59.24 -45.78 90.23 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.198 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.42 -45.61 92.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.045 0.45 . . . . 0.0 110.424 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.5 -42.44 96.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.29 -44.69 84.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.382 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.09 -42.76 99.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.086 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.06 -52.33 65.83 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.898 0.38 . . . . 0.0 111.825 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.41 HG21 HD13 ' A' ' 14' ' ' ILE . 18.8 pt -68.58 -37.48 77.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.091 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -58.6 -51.19 70.97 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 120.281 -0.567 . . . . 0.0 110.047 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 21' ' ' ARG . 88.6 t -63.86 -38.37 82.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.007 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.68 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.3 tt -52.77 -50.58 63.25 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.439 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -79.59 -47.94 14.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.21 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -67.19 -31.97 72.73 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.831 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.46 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.7 mt-10 58.22 56.6 4.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.271 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.557 ' O ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -149.88 158.51 44.24 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.591 0.71 . . . . 0.0 110.588 178.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 34' ' ' GLY . 7.8 p -74.29 137.67 22.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.799 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.507 HG22 ' NH2' ' A' ' 21' ' ' ARG . 2.9 pp -124.58 168.25 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-O 120.587 0.232 . . . . 0.0 110.534 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.416 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -63.74 134.82 56.0 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.191 0.519 . . . . 0.0 111.023 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.532 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 0.6 OUTLIER -125.48 141.5 39.12 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.706 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.532 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 60.5 Cg_endo -80.23 151.91 20.78 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.709 1.606 . . . . 0.0 111.235 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.445 ' C ' ' H ' ' A' ' 29' ' ' ALA . 47.8 m -133.36 140.72 47.54 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.372 0.606 . . . . 0.0 111.108 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -77.51 23.06 0.23 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.132 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.445 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -160.53 -70.77 0.07 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.194 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.7 p -126.97 125.63 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-O 121.109 0.48 . . . . 0.0 110.34 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.531 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 96.7 m-85 -45.48 150.39 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.668 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -160.99 -169.07 23.74 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.2 m -130.45 170.13 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.532 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -159.25 177.77 35.66 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.686 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -155.45 -164.83 1.84 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 120.433 -0.507 . . . . 0.0 112.122 -178.52 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.467 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 23.6 m-20 -90.86 106.27 15.06 Favored Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -177.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -34.92 -62.35 0.21 Allowed 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 122.461 2.107 . . . . 0.0 112.716 178.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 56.7 p-10 -74.31 67.51 1.41 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.103 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.3 m -157.07 133.05 9.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.159 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -66.14 -20.55 66.18 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.307 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.4 t -60.08 -34.76 73.89 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.932 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.71 -52.2 66.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.874 0.368 . . . . 0.0 111.575 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 43' ' ' VAL . 2.5 p -64.61 -45.77 94.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.929 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 63.0 mtt -67.51 -46.89 71.58 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.442 ' NH2' ' OG1' ' A' ' 138' ' ' THR . 40.7 ptt85 -63.02 -30.38 71.55 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.829 0.347 . . . . 0.0 110.221 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.7 mt -73.48 -60.91 2.03 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.269 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.0 mt -54.34 -20.5 7.36 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.449 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -63.47 -86.12 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.543 -178.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.526 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.2 pt? -78.68 -34.35 46.29 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -74.92 -50.67 16.03 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.916 -176.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 37.19 64.7 0.58 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.985 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.403 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 6.3 mtt180 179.0 -54.0 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.856 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.455 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.403 ' HD2' ' H ' ' A' ' 52' ' ' ARG . 69.8 Cg_endo -75.61 -8.27 19.24 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.323 2.015 . . . . 0.0 111.493 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.575 HG13 ' N ' ' A' ' 55' ' ' ASP . 10.8 p -46.71 -43.9 6.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.254 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.575 ' N ' HG13 ' A' ' 54' ' ' VAL . 11.1 t0 -70.59 -44.58 67.04 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.198 -178.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -61.27 -38.3 86.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.6 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 74.77 101.9 0.1 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.572 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -50.92 -167.55 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.092 0.472 . . . . 0.0 112.231 -179.658 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.445 ' O ' ' OG ' ' A' ' 137' ' ' SER . 77.2 mt -100.67 135.29 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.143 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 16.0 mt -112.43 144.51 41.77 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.5 tt -114.53 129.77 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 CA-C-O 121.445 0.64 . . . . 0.0 110.88 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.552 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -116.79 155.09 29.55 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.579 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.97 -30.08 6.15 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.781 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 79.5 m-20 -112.46 150.01 31.81 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.135 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -76.77 -21.97 54.42 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.707 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -50.96 -30.31 14.59 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.875 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.781 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 5.9 pm0 -93.82 -6.13 46.58 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.823 -0.172 . . . . 0.0 111.431 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -89.79 -21.69 22.49 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.452 ' NZ ' ' CB ' ' A' ' 69' ' ' LYS . 8.0 mtpm? -73.76 -38.27 3.87 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -178.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 94.6 Cg_endo -101.75 -5.01 0.35 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.628 2.219 . . . . 0.0 111.986 -179.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -87.81 -18.96 28.18 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.772 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.623 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.1 mp -119.27 166.93 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.623 ' N ' HG22 ' A' ' 72' ' ' ILE . 97.8 m-20 -61.75 -14.39 31.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.329 . . . . 0.0 111.054 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 41.1 t0 59.54 32.67 21.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.86 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.538 HG23 ' N ' ' A' ' 76' ' ' MET . 14.1 t -105.14 -42.38 5.31 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.903 0.382 . . . . 0.0 110.476 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.538 ' N ' HG23 ' A' ' 75' ' ' THR . 21.0 ptm -88.78 -23.37 22.9 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.366 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.531 HD21 ' NH2' ' A' ' 82' ' ' ARG . 30.3 tp -67.65 133.08 48.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.124 -177.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.95 170.26 19.25 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.577 -176.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -59.94 -42.11 93.29 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 123.364 0.415 . . . . 0.0 111.389 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.1 p -60.63 -33.27 54.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.42 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -63.23 -41.17 99.06 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.113 0.482 . . . . 0.0 110.358 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.531 ' NH2' HD21 ' A' ' 77' ' ' LEU . 7.5 mmt85 -63.94 -52.11 61.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.479 1.133 . . . . 0.0 109.117 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -55.69 -50.04 71.36 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.798 -1.547 . . . . 0.0 110.028 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.2 m -61.18 -49.92 75.22 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.47 -1.241 . . . . 0.0 112.091 -178.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 85' ' ' ILE . 9.1 tt -68.25 -30.12 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.696 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -78.4 -37.3 44.29 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.759 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.2 m -84.72 -10.64 57.07 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.722 0.296 . . . . 0.0 111.166 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.442 ' O ' ' O ' ' A' ' 89' ' ' TRP . 62.0 ttm-85 -122.61 83.64 2.14 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.442 ' O ' ' O ' ' A' ' 88' ' ' ARG . 14.6 m95 57.68 150.33 0.07 OUTLIER Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.231 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.415 ' O ' ' O ' ' A' ' 118' ' ' VAL . 55.8 Cg_endo -68.01 -23.35 40.49 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.203 1.935 . . . . 0.0 111.973 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 159.1 80.65 0.03 OUTLIER Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.74 -24.2 7.49 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 122.163 1.909 . . . . 0.0 112.395 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.409 HG13 ' CZ ' ' A' ' 95' ' ' PHE . 3.5 p -137.04 146.56 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 120.783 0.325 . . . . 0.0 110.474 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 53.8 m -89.71 149.7 22.64 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.845 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.454 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 83.2 m-85 -128.0 144.78 51.11 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.202 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.657 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.5 t -102.05 108.67 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-O 121.34 0.59 . . . . 0.0 110.46 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -94.98 150.37 37.64 Favored Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.898 -178.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.21 89.44 0.39 Allowed 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.265 1.977 . . . . 0.0 111.47 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.93 149.71 80.19 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.138 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -72.14 157.34 54.26 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.207 1.938 . . . . 0.0 111.992 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.47 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.837 179.885 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 109' ' ' GLY . 23.7 mmt180 . . . . . 0 N--CA 1.468 0.436 0 CA-C-O 120.452 0.168 . . . . 0.0 110.68 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 2.0 p90 -66.73 -10.76 50.32 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.949 -0.301 . . . . 0.0 111.593 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 1.049 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -67.23 -39.8 86.25 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.798 ' H ' HD22 ' A' ' 107' ' ' LEU . 16.6 m -145.99 -39.92 0.22 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.65 177.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 58.53 -12.01 0.02 OUTLIER Glycine 0 CA--C 1.532 1.126 0 CA-C-N 115.711 -0.677 . . . . 0.0 113.29 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.557 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -86.54 -51.51 6.13 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 117.714 0.757 . . . . 0.0 109.446 -179.437 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.452 ' CD2' ' N ' ' A' ' 112' ' ' ASP . 85.4 t80 -160.18 -95.34 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.019 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.452 ' N ' ' CD2' ' A' ' 111' ' ' PHE . 35.8 t70 -171.01 67.96 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.541 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.5 p -166.77 129.36 1.81 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.742 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.647 HD21 ' OG1' ' A' ' 108' ' ' THR . 87.2 mt -126.41 128.01 46.34 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.476 ' N ' HG13 ' A' ' 96' ' ' VAL . . . -69.67 119.69 14.29 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.344 176.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.468 HG22 ' N ' ' A' ' 117' ' ' ARG . 5.4 p -145.96 158.49 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.468 ' N ' HG22 ' A' ' 116' ' ' VAL . 33.5 ptt180 -151.57 160.81 43.51 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.745 0.307 . . . . 0.0 110.983 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.552 HG22 ' HB3' ' A' ' 62' ' ' ALA . 55.9 t -123.44 137.75 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.1 t -128.65 157.44 41.3 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.304 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 5.8 p30 -158.74 77.97 0.77 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.134 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.637 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 56.9 t-80 -172.62 -35.81 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.637 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 37.3 Cg_endo -94.44 -163.33 0.09 OUTLIER 'Trans proline' 0 N--CA 1.485 0.981 0 C-N-CA 121.973 1.782 . . . . 0.0 111.991 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 36.5 mt -78.22 -4.39 47.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.511 0.672 . . . . 0.0 109.908 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 93.4 t -58.35 -44.93 89.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.061 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.77 HG23 ' H ' ' A' ' 126' ' ' ALA . 30.8 m -54.24 -62.52 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 C-N-CA 119.538 -0.865 . . . . 0.0 108.727 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.77 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.6 -43.27 2.7 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.021 0.439 . . . . 0.0 110.657 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.9 tp -69.28 -48.87 60.45 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.828 0.347 . . . . 0.0 111.455 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 80.3 m -70.46 -48.42 55.94 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.365 0.602 . . . . 0.0 110.851 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.477 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -54.72 -43.27 72.45 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.73 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -59.02 -55.21 38.08 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.235 -1.348 . . . . 0.0 109.459 -178.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -61.84 -21.84 64.98 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 114.545 -1.207 . . . . 0.0 109.151 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.54 0.69 84.83 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -151.52 158.72 34.16 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -43.8 174.16 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 123.697 2.931 . . . . 0.0 113.722 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.5 tp -128.63 123.13 32.48 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.421 HG13 ' H ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -66.12 144.34 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 C-N-CA 118.353 -1.339 . . . . 0.0 108.049 -179.674 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -110.01 120.14 41.51 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.305 1.003 . . . . 0.0 110.876 -179.179 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.442 ' OG1' ' NH2' ' A' ' 45' ' ' ARG . 2.4 m -134.11 160.06 38.94 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.898 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.5 m -72.11 142.44 49.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.882 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.88 -36.32 83.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.813 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' A' ' 141' ' ' ASN . 56.9 p30 -46.97 150.04 0.81 Allowed 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.959 0.885 . . . . 0.0 111.255 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.4 -161.55 0.89 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.211 -1.359 . . . . 0.0 110.569 -178.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.2 p -62.02 -39.81 93.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.297 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -164.9 9.24 0.07 OUTLIER Glycine 0 C--N 1.33 0.224 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.3 tp -91.65 127.89 48.54 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-O 119.355 -0.355 . . . . 0.0 110.186 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -38.61 156.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 121.648 1.565 . . . . 0.0 112.276 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -76.54 -167.01 0.41 Allowed 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.773 2.316 . . . . 0.0 112.524 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 83.3 m -111.48 74.33 0.86 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.461 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.531 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 38.0 ptt180 -51.84 -37.54 52.33 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.432 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.422 ' O ' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -159.87 168.08 26.62 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.763 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.41 HG11 ' HA ' ' A' ' 166' ' ' PRO . 1.1 m -57.88 -21.65 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.83 -30.58 71.66 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 155' ' ' ARG . 6.7 tm-20 -63.73 -79.85 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.534 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.0 p -36.45 -30.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.082 0.953 . . . . 0.0 110.971 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.466 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -70.68 -51.68 26.12 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.518 -179.351 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.09 -17.54 62.58 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 122.451 1.119 . . . . 0.0 108.024 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -83.77 -47.82 10.75 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 112.705 -2.043 . . . . 0.0 111.794 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -130.58 -19.92 2.97 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 85.82 26.15 35.84 Favored Glycine 0 N--CA 1.468 0.823 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.4 ' O ' ' O ' ' A' ' 159' ' ' GLY . . . -43.64 -95.9 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.587 0.232 . . . . 0.0 111.195 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.467 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 63.43 35.43 12.1 Favored 'General case' 0 CA--C 1.527 0.09 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.546 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.6 m-85 -175.47 -61.9 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.153 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.49 27.35 0.31 Allowed 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.298 1.999 . . . . 0.0 110.751 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.558 HG23 ' HD3' ' A' ' 166' ' ' PRO . 14.9 m -129.45 167.64 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.805 -178.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.0 t -123.16 64.53 26.31 Favored Pre-proline 0 N--CA 1.472 0.668 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.831 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.558 ' HD3' HG23 ' A' ' 164' ' ' VAL . 36.5 Cg_exo -37.65 144.27 0.15 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 123.291 2.66 . . . . 0.0 114.823 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -175.22 -158.25 18.67 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 114.101 -1.409 . . . . 0.0 111.472 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -141.92 -154.42 0.52 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.735 0.302 . . . . 0.0 110.527 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 CA--C 1.532 0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.511 -179.604 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 . . . . . 0 N--CA 1.448 -0.56 0 CA-C-O 120.85 0.357 . . . . 0.0 110.726 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 39.0 pt -117.61 142.88 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.917 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -131.26 166.19 21.72 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.462 0.649 . . . . 0.0 111.654 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 184' ' ' GLY . 97.6 m-20 -78.55 106.48 10.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.679 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -65.86 -18.01 65.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.739 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.508 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.4 mm? -63.15 -41.72 99.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.221 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.43 -41.12 2.62 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.69 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 180' ' ' ASP . . . . . . . . 0 CA--C 1.526 0.777 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.738 0.304 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.525 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.7 mp -63.03 -42.75 99.86 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -64.58 -40.75 96.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.744 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 61.8 ttt85 -63.01 -41.74 99.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.166 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.7 -44.07 96.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.448 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.45 -44.52 94.27 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.166 0.508 . . . . 0.0 109.918 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.9 mt -63.52 -42.58 96.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.357 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.48 -41.09 80.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.329 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.76 -43.9 91.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.935 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.09 -53.08 62.01 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 17.6 pt -68.2 -36.94 77.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.806 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -58.06 -50.03 74.85 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.613 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.529 HG13 ' O ' ' A' ' 21' ' ' ARG . 90.8 t -64.59 -38.66 83.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.946 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.68 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.5 tt -52.7 -51.02 62.12 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.287 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -78.34 -47.97 16.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.402 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -67.83 -31.36 71.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.951 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.6 mt-10 57.54 57.64 4.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.182 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.529 ' O ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -151.15 159.17 44.61 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.582 0.706 . . . . 0.0 110.336 179.088 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 34' ' ' GLY . 8.9 p -74.08 140.17 18.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.452 -178.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.507 HG22 ' NH2' ' A' ' 21' ' ' ARG . 2.8 pp -126.69 166.43 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-O 120.879 0.371 . . . . 0.0 110.927 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.422 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -63.85 137.9 58.24 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.332 0.587 . . . . 0.0 111.008 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.53 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 0.4 OUTLIER -130.52 141.86 43.44 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.123 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.53 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 58.3 Cg_endo -79.38 146.79 19.79 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 121.451 1.434 . . . . 0.0 111.682 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.506 ' C ' ' H ' ' A' ' 29' ' ' ALA . 33.7 m -130.02 133.42 46.73 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.905 0.383 . . . . 0.0 110.931 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -74.53 25.26 0.08 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.152 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.506 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -157.3 -74.43 0.09 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.001 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.3 t -124.93 125.51 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-O 120.894 0.378 . . . . 0.0 110.313 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -44.37 139.24 2.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.934 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -149.44 -172.28 18.87 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.5 m -130.06 169.98 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.439 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -158.5 178.98 34.49 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.757 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.55 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -154.53 -162.97 1.49 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.819 0.342 . . . . 0.0 111.393 -178.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.55 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 5.7 m-20 -97.82 107.34 39.64 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -177.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 36' ' ' ASP . 38.6 Cg_exo -37.86 173.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 123.074 2.516 . . . . 0.0 114.215 177.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 66.7 t0 35.66 76.39 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.492 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.0 m -152.73 139.03 18.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.336 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -70.12 -34.3 72.92 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.244 0.545 . . . . 0.0 110.74 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 41' ' ' THR . 0.1 OUTLIER -64.32 -44.39 91.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.86 -178.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.63 -50.61 71.85 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.515 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.6 p -62.58 -44.51 99.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.177 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 90.7 mtp -64.0 -40.02 95.43 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.4 ' O ' ' CD2' ' A' ' 49' ' ' LEU . 56.0 ttt85 -61.68 -33.02 73.25 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.341 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 85.8 mt -75.04 -60.81 2.12 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.6 mt -53.56 -18.35 2.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.56 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -66.83 -86.15 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -178.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.505 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.2 pt? -76.82 -34.34 57.91 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -75.03 -49.69 18.96 Favored 'General case' 0 C--N 1.345 0.409 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.56 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 35.62 64.81 0.45 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.855 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.407 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 8.1 mtt180 179.29 -53.35 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.902 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.497 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.407 ' HD2' ' H ' ' A' ' 52' ' ' ARG . 60.1 Cg_endo -74.74 -8.79 20.7 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.399 2.066 . . . . 0.0 112.267 -179.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.546 HG13 ' N ' ' A' ' 55' ' ' ASP . 7.5 p -41.52 -48.17 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.809 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.546 ' N ' HG13 ' A' ' 54' ' ' VAL . 33.9 t0 -69.39 -38.71 78.11 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.547 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.481 ' CD ' ' N ' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -59.78 -39.26 84.31 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.767 -179.092 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 59.62 104.69 0.01 OUTLIER Glycine 0 CA--C 1.518 0.247 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.568 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -52.53 -161.3 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.615 0.721 . . . . 0.0 111.735 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.0 mt -108.41 146.77 13.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.912 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.7 mt -119.55 141.24 49.42 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.448 ' CD1' ' HE ' ' A' ' 117' ' ' ARG . 8.0 tp -108.96 131.68 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-O 121.222 0.534 . . . . 0.0 110.569 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.472 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -118.81 153.25 34.78 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.385 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.29 -26.93 7.79 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -117.46 151.17 37.64 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.823 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -78.99 -13.42 59.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.511 0.672 . . . . 0.0 109.346 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -51.14 -30.26 16.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.843 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.487 HE21 ' N ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -94.82 -13.62 25.4 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.562 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 68' ' ' LEU . 4.2 mm? -92.36 -13.67 29.83 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.479 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 79.0 tttt -80.08 -37.79 1.11 Allowed Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 68.6 Cg_endo -102.59 -3.64 0.32 Allowed 'Trans proline' 0 C--N 1.316 -1.169 0 C-N-CA 122.812 2.341 . . . . 0.0 111.564 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.508 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 42.9 t80 -93.07 -13.13 28.97 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.365 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.472 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.7 mp -125.75 155.1 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.472 ' N ' HG22 ' A' ' 72' ' ' ILE . 84.3 m-20 -64.41 153.02 39.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.063 0.459 . . . . 0.0 110.114 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 66.5 t0 -96.22 46.03 1.07 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.308 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.492 HG23 ' N ' ' A' ' 76' ' ' MET . 10.9 t -115.83 -40.08 3.39 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.269 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.492 ' N ' HG23 ' A' ' 75' ' ' THR . 13.6 ptm -95.55 -24.41 16.63 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.217 0.532 . . . . 0.0 110.224 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.571 HD21 ' NH2' ' A' ' 82' ' ' ARG . 30.8 tp -80.09 134.98 36.23 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.436 -178.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.07 169.74 19.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.708 -177.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.36 -41.92 94.7 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.367 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.46 -33.39 56.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.115 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -63.24 -40.39 97.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.068 0.461 . . . . 0.0 110.569 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.571 ' NH2' HD21 ' A' ' 77' ' ' LEU . 7.5 mmt85 -64.17 -52.03 60.96 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 122.655 1.217 . . . . 0.0 109.02 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 87' ' ' SER . 82.6 tt0 -56.68 -50.42 72.18 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.618 -1.628 . . . . 0.0 110.372 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.2 m -62.41 -49.47 75.35 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.349 -1.296 . . . . 0.0 112.232 -177.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.8 tt -67.46 -25.31 33.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.325 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -86.47 -32.6 20.73 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.241 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 83' ' ' GLU . 6.7 m -88.52 -20.24 25.35 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.293 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.442 ' O ' ' O ' ' A' ' 89' ' ' TRP . 70.2 ttt180 -116.19 82.26 1.75 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.668 0.27 . . . . 0.0 110.636 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.442 ' O ' ' O ' ' A' ' 88' ' ' ARG . 3.9 m-90 56.56 151.82 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.828 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.4 -17.82 44.07 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.058 1.839 . . . . 0.0 111.449 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.459 ' H ' ' HD3' ' A' ' 92' ' ' PRO . . . 99.26 69.71 0.93 Allowed Glycine 0 N--CA 1.471 0.972 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.459 ' HD3' ' H ' ' A' ' 91' ' ' GLY . 51.9 Cg_exo -55.52 -38.55 93.95 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.893 2.396 . . . . 0.0 112.307 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.7 p -73.92 136.15 25.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.322 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 56.1 m -88.92 144.23 26.33 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.821 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.42 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 55.8 m-85 -126.94 144.55 50.97 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.227 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.623 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.5 t -99.91 103.4 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 121.296 0.569 . . . . 0.0 109.475 178.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -87.77 148.21 43.13 Favored Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.815 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.9 101.66 1.51 Allowed 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.651 1.567 . . . . 0.0 110.948 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.38 150.53 79.95 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.896 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -71.53 152.11 59.57 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.222 1.948 . . . . 0.0 112.406 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.037 179.955 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.506 HH22 ' C ' ' A' ' 111' ' ' PHE . 7.1 tpt85 . . . . . 0 N--CA 1.466 0.361 0 CA-C-O 120.685 0.279 . . . . 0.0 110.441 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 43.4 m95 -77.26 -2.97 37.45 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 120.839 0.352 . . . . 0.0 110.517 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.934 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -82.44 -19.6 38.64 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.537 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.64 ' H ' HD22 ' A' ' 107' ' ' LEU . 51.3 m -142.74 -41.53 0.32 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.435 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 64.81 24.06 69.62 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.453 178.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.93 -75.22 0.11 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 117.54 0.67 . . . . 0.0 110.527 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.506 ' C ' HH22 ' A' ' 105' ' ' ARG . 72.2 m-85 -113.63 159.5 19.58 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.018 0.437 . . . . 0.0 110.312 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -93.06 76.82 4.68 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.284 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.828 ' C ' HD22 ' A' ' 114' ' ' LEU . 19.5 p -163.57 128.85 3.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.967 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.828 HD22 ' C ' ' A' ' 113' ' ' SER . 3.7 mm? -134.04 128.26 33.94 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -178.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.462 ' N ' HG13 ' A' ' 96' ' ' VAL . . . -69.83 124.14 23.25 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 113.815 -1.539 . . . . 0.0 109.333 176.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.3 p -144.21 152.27 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.881 0.372 . . . . 0.0 110.783 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.448 ' HE ' ' CD1' ' A' ' 61' ' ' ILE . 62.2 ttp180 -140.58 153.81 46.25 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.682 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.472 HG22 ' HB3' ' A' ' 62' ' ' ALA . 56.0 t -121.91 134.05 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 7.9 t -134.02 153.28 51.89 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.215 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 51.2 p-10 -153.72 82.99 1.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.075 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.635 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 40.7 t60 -172.47 -37.36 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.635 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 40.7 Cg_endo -94.15 -161.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -0.977 0 C-N-CA 122.122 1.881 . . . . 0.0 112.156 -178.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 27.4 mt -79.04 -4.97 52.8 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.929 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 95.0 t -58.15 -45.03 88.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.915 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.777 HG23 ' H ' ' A' ' 126' ' ' ALA . 30.3 m -54.1 -62.54 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.847 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.777 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.41 -44.13 2.75 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 120.936 0.398 . . . . 0.0 110.819 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.5 tp -68.83 -48.32 63.8 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.469 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 61.8 m -70.66 -49.04 51.62 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.431 0.634 . . . . 0.0 110.835 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.472 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.1 pp0? -54.62 -41.93 70.57 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -59.5 -54.37 47.43 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.049 -177.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.499 ' CE1' ' OD2' ' A' ' 36' ' ' ASP . 41.4 t80 -61.78 -20.42 63.57 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.321 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.73 -1.14 84.53 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.412 ' O ' ' O ' ' A' ' 134' ' ' PRO . 33.3 mttm -151.65 159.64 32.94 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.412 ' O ' ' O ' ' A' ' 133' ' ' LYS . 4.1 Cg_exo -42.24 177.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 123.858 3.039 . . . . 0.0 112.933 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.4 tp -131.43 123.58 28.44 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.413 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -65.41 145.87 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 C-N-CA 117.927 -1.509 . . . . 0.0 107.329 -179.562 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t -118.28 121.93 41.64 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 123.408 0.443 . . . . 0.0 111.191 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.2 m -129.77 162.03 29.36 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.255 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 17.7 m -72.04 145.57 48.19 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.93 81.19 1.67 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.694 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 57.6 p30 -158.7 164.71 35.66 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.335 0.588 . . . . 0.0 110.581 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.15 -163.4 1.47 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.186 -178.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 38.8 t -61.27 -44.25 97.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.676 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -159.71 4.9 0.11 Allowed Glycine 0 N--CA 1.46 0.28 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.5 tp -82.04 127.05 73.3 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -38.95 156.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.621 1.548 . . . . 0.0 112.271 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -75.71 -167.21 0.41 Allowed 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.352 2.035 . . . . 0.0 112.316 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 8.7 t -114.81 77.97 1.12 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.333 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -57.66 -34.97 69.93 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.229 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.45 168.4 20.3 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.438 HG11 ' HA ' ' A' ' 166' ' ' PRO . 1.4 m -57.66 -17.61 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.436 ' O ' ' HB2' ' A' ' 156' ' ' ALA . 66.9 t0 -65.05 -35.63 81.77 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 177.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.444 ' OE1' ' OE1' ' A' ' 157' ' ' GLN . 5.8 tm-20 -59.83 -72.5 0.1 Allowed 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.765 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.404 HG11 HG11 ' A' ' 164' ' ' VAL . 7.8 p -48.04 -30.63 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.342 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.426 ' O ' ' N ' ' A' ' 159' ' ' GLY . 3.8 tmt_? -83.84 -45.36 13.36 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 122.185 0.993 . . . . 0.0 110.285 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 152' ' ' ASP . . . -57.75 -41.03 81.07 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.416 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.466 ' CG ' ' N ' ' A' ' 158' ' ' PHE . 7.9 pt20 -82.65 -48.7 10.62 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 112.932 -1.94 . . . . 0.0 112.224 -176.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.466 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 32.0 t80 -106.85 -35.92 6.81 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 96.22 25.26 12.82 Favored Glycine 0 N--CA 1.472 1.092 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -178.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.407 ' HB1' ' HG2' ' A' ' 163' ' ' PRO . . . -43.36 -94.27 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.514 0.197 . . . . 0.0 110.901 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.474 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 62.13 36.47 15.11 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-O 121.25 0.547 . . . . 0.0 109.857 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.559 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.8 m-85 -175.77 -62.06 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.277 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.407 ' HG2' ' HB1' ' A' ' 160' ' ' ALA . 86.4 Cg_endo -73.46 28.87 0.31 Allowed 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.32 2.013 . . . . 0.0 110.367 177.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.581 HG23 ' HD3' ' A' ' 166' ' ' PRO . 16.8 m -133.27 167.01 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.053 -178.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 6.8 t -124.3 65.51 40.6 Favored Pre-proline 0 N--CA 1.473 0.696 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.694 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.581 ' HD3' HG23 ' A' ' 164' ' ' VAL . 31.0 Cg_exo -37.22 143.88 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 123.611 2.874 . . . . 0.0 115.08 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 165.94 177.65 38.25 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 113.734 -1.576 . . . . 0.0 110.598 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -151.14 151.53 32.07 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.467 0.42 0 CA-C-O 120.991 0.424 . . . . 0.0 110.925 -179.739 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 . . . . . 0 N--CA 1.445 -0.692 0 CA-C-O 120.643 0.258 . . . . 0.0 111.333 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 178' ' ' ILE . 29.7 pt -90.84 132.49 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 121.13 0.49 . . . . 0.0 110.817 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 22.7 mmm-85 -129.48 158.51 39.02 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.762 0.791 . . . . 0.0 110.817 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 184' ' ' GLY . 99.8 m-20 -77.06 104.88 7.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.151 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -64.78 -22.97 67.1 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.148 -178.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.496 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.6 mm? -63.68 -41.62 98.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.611 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.1 t -121.0 -42.71 2.48 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.583 0.23 . . . . 0.0 111.099 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 180' ' ' ASP . . . . . . . . 0 CA--C 1.524 0.625 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 . . . . . 0 N--CA 1.462 0.136 0 CA-C-O 120.956 0.408 . . . . 0.0 110.764 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.559 HD12 ' N ' ' A' ' 5' ' ' LEU . 9.2 mp -62.73 -42.05 99.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.107 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -63.97 -43.29 96.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.756 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -64.07 -41.49 97.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.264 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -61.26 -44.21 97.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.109 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.75 -45.55 92.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.975 0.417 . . . . 0.0 109.959 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.6 mt -63.92 -43.15 97.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.81 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.04 -41.75 88.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.528 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.38 -47.38 79.49 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.858 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.05 -51.79 66.58 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.4 pp -67.71 -39.3 81.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.873 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -58.63 -50.04 75.29 Favored 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.306 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 21' ' ' ARG . 88.3 t -64.07 -38.66 83.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.933 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.68 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.3 tt -52.69 -51.0 62.18 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.42 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -78.91 -47.1 17.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.409 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -68.28 -31.17 70.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.136 0.494 . . . . 0.0 111.22 -178.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.4 mt-10 57.13 59.92 3.2 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.123 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.528 ' O ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -152.21 158.9 43.51 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.176 0.512 . . . . 0.0 110.13 179.039 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 34' ' ' GLY . 8.2 p -75.99 140.55 17.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.57 -178.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.421 HG22 ' NH2' ' A' ' 21' ' ' ARG . 2.8 pp -125.4 167.73 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.615 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.25 132.22 48.51 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.277 0.561 . . . . 0.0 111.718 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -115.87 133.55 22.84 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -83.76 140.68 9.32 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 CA-C-N 120.567 1.238 . . . . 0.0 111.857 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.3 m -138.45 134.63 34.28 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -56.94 -42.91 80.92 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.824 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.66 -79.6 0.07 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.8 t -132.53 129.55 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -41.08 157.05 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.796 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -159.95 -169.53 23.37 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.4 m -131.08 168.52 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.543 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -159.29 178.98 35.21 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.059 -1.067 . . . . 0.0 111.818 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.476 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.8 OUTLIER -158.22 -163.2 1.25 Allowed 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.948 -178.826 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.476 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 35.9 m-20 -91.71 105.78 14.56 Favored Pre-proline 0 CA--C 1.555 1.168 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -177.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -38.11 -62.15 0.32 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.521 2.148 . . . . 0.0 112.929 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -71.91 65.12 0.52 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.516 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 m -151.18 131.18 13.39 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.683 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -66.36 -32.75 74.34 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.214 0.531 . . . . 0.0 111.184 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.522 HG23 ' N ' ' A' ' 42' ' ' ALA . 15.1 t -60.19 -42.53 95.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.34 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.522 ' N ' HG23 ' A' ' 41' ' ' THR . . . -56.63 -50.43 72.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.968 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 p -64.44 -42.62 95.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.207 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 94.0 mtp -63.92 -39.46 94.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -60.46 -41.77 94.79 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 122.087 0.946 . . . . 0.0 108.448 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.454 ' O ' HD23 ' A' ' 46' ' ' LEU . 1.1 tt -64.15 -53.33 51.16 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.369 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.8 mt -70.0 -11.46 60.89 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.062 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -70.32 -83.02 0.03 OUTLIER 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.121 0.486 . . . . 0.0 111.193 -177.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.5 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.2 pt? -76.16 -33.92 59.37 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 -178.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -77.58 -51.93 9.87 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.435 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 36.51 66.47 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.861 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.2 mtm-85 177.8 -53.96 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.918 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.149 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -78.12 -5.96 15.45 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.604 2.202 . . . . 0.0 112.341 -178.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.537 HG13 ' N ' ' A' ' 55' ' ' ASP . 7.1 p -44.34 -44.82 2.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.888 -179.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.537 ' N ' HG13 ' A' ' 54' ' ' VAL . 48.4 t0 -64.34 -42.72 96.13 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.223 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -61.92 -36.6 81.83 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 63.15 113.73 0.01 OUTLIER Glycine 0 C--N 1.332 0.332 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.548 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -53.78 -160.67 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.008 0.433 . . . . 0.0 111.776 -179.314 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.0 mt -106.63 141.4 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.872 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.7 mt -118.89 142.62 47.58 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.8 tp -111.64 132.41 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-O 121.226 0.536 . . . . 0.0 110.853 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.481 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -119.97 153.45 35.94 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.26 -27.67 7.89 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.699 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 12.9 m120 -116.97 147.04 42.63 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.018 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -76.34 -13.5 60.14 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -50.82 -32.68 20.86 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.256 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.699 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 4.1 pm0 -93.71 -12.34 29.46 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.449 HD22 ' N ' ' A' ' 68' ' ' LEU . 4.2 mm? -91.13 -15.92 28.63 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.463 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 11.3 ttmm -79.33 -38.49 1.3 Allowed Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 84.9 Cg_endo -103.59 -3.0 0.26 Allowed 'Trans proline' 0 C--N 1.316 -1.146 0 C-N-CA 122.764 2.309 . . . . 0.0 112.116 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.456 ' OH ' ' CD2' ' A' ' 114' ' ' LEU . 64.1 t80 -96.09 -8.34 33.63 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.92 0.39 . . . . 0.0 110.549 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.591 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.3 mp -138.16 167.58 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.591 ' N ' HG22 ' A' ' 72' ' ' ILE . 98.7 m-20 -63.34 -17.42 62.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.09 0.471 . . . . 0.0 110.086 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.0 t70 54.29 5.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.954 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.487 ' H ' ' C ' ' A' ' 73' ' ' ASP . 13.4 t -69.26 -37.49 77.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.181 0.515 . . . . 0.0 109.941 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.428 ' N ' HG23 ' A' ' 75' ' ' THR . 76.1 mmm -66.47 -41.96 88.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.942 0.877 . . . . 0.0 109.018 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 77' ' ' LEU . 9.4 mp -70.79 144.64 50.78 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 113.875 -1.511 . . . . 0.0 110.845 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.49 160.89 43.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.063 -179.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -42.89 -44.92 4.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.906 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.502 HG13 ' N ' ' A' ' 81' ' ' GLN . 12.2 p -60.49 -41.06 86.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.1 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.502 ' N ' HG13 ' A' ' 80' ' ' VAL . 35.4 mt-30 -64.09 -40.16 95.62 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.608 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -65.28 -52.02 56.94 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 122.508 1.147 . . . . 0.0 108.819 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.414 ' O ' ' N ' ' A' ' 87' ' ' SER . 81.7 tt0 -54.3 -50.53 67.11 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 113.7 -1.591 . . . . 0.0 109.724 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.1 m -60.83 -50.42 73.52 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.31 -1.314 . . . . 0.0 111.666 -178.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 88' ' ' ARG . 7.6 tt -67.11 -34.09 67.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 119.371 -0.932 . . . . 0.0 109.262 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -70.16 -38.94 75.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.941 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 83' ' ' GLU . 4.5 m -87.22 -17.45 32.59 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.009 0.433 . . . . 0.0 110.869 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 85' ' ' ILE . 53.0 ttt85 -114.55 171.97 7.31 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 4.4 m0 -33.27 148.29 0.07 OUTLIER Pre-proline 0 CA--C 1.54 0.569 0 O-C-N 123.186 0.304 . . . . 0.0 111.35 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.56 -17.13 48.31 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.19 1.927 . . . . 0.0 111.506 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.465 ' H ' ' HD3' ' A' ' 92' ' ' PRO . . . 103.03 70.53 0.85 Allowed Glycine 0 N--CA 1.469 0.842 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.465 ' HD3' ' H ' ' A' ' 91' ' ' GLY . 50.8 Cg_exo -53.57 -42.23 67.45 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.495 2.13 . . . . 0.0 112.321 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.523 ' O ' ' CE1' ' A' ' 95' ' ' PHE . 11.7 p -75.37 140.03 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.957 0.408 . . . . 0.0 110.776 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 22.7 m -90.57 150.29 21.8 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.91 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.599 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -130.49 148.44 52.3 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.087 179.69 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.715 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.9 t -102.03 112.95 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.434 ' CE1' ' HB1' ' A' ' 181' ' ' ALA . 53.1 m-85 -99.24 152.14 37.67 Favored Pre-proline 0 N--CA 1.47 0.561 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.699 -178.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.78 112.2 3.46 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.189 1.926 . . . . 0.0 111.475 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.71 152.82 78.05 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.82 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.36 152.37 81.72 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.028 1.819 . . . . 0.0 111.395 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.249 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.126 -179.54 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.406 ' O ' ' N ' ' A' ' 109' ' ' GLY . 8.4 tpt180 . . . . . 0 CA--C 1.532 0.286 0 CA-C-O 120.602 0.239 . . . . 0.0 110.724 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 53.6 p-90 -74.47 -7.7 53.86 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.146 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.958 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -71.13 -35.58 71.77 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.605 179.551 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.702 ' H ' HD22 ' A' ' 107' ' ' LEU . 86.8 m -133.98 -39.13 0.87 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.651 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 84.57 -5.92 79.47 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.226 -0.511 . . . . 0.0 112.727 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -148.85 -72.47 0.19 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 117.723 0.762 . . . . 0.0 111.402 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.447 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 18.8 t80 -88.89 -165.5 1.35 Allowed 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.447 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 51.2 p30 -130.9 51.43 2.14 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.836 0.351 . . . . 0.0 110.897 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.2 p -152.31 153.24 33.29 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.515 ' C ' HG13 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -159.81 136.43 9.12 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -179.261 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.439 ' N ' HG13 ' A' ' 96' ' ' VAL . . . -68.39 127.32 32.54 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 113.225 -1.807 . . . . 0.0 109.967 177.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.6 p -148.01 153.61 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -146.52 155.87 42.84 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.831 0.348 . . . . 0.0 111.021 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.481 HG22 ' HB3' ' A' ' 62' ' ' ALA . 53.2 t -122.63 135.37 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.7 t -133.49 153.42 51.64 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.275 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 52.6 p-10 -154.53 81.28 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.378 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.628 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 27.0 t-80 -171.95 -37.42 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.628 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 31.2 Cg_endo -94.0 -163.08 0.1 OUTLIER 'Trans proline' 0 C--N 1.32 -0.922 0 C-N-CA 121.954 1.769 . . . . 0.0 111.959 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 16.2 mt -76.94 -4.84 45.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.939 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 91.8 t -57.86 -45.58 87.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.171 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.764 HG23 ' H ' ' A' ' 126' ' ' ALA . 28.2 m -53.17 -62.22 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 C-N-CA 119.467 -0.893 . . . . 0.0 108.67 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.764 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.79 -42.54 2.67 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.008 0.432 . . . . 0.0 110.685 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.4 tp -70.05 -48.33 58.3 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.489 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 63.9 m -70.56 -48.3 56.05 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.575 0.702 . . . . 0.0 110.781 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.465 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -55.08 -42.15 72.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.788 -1.096 . . . . 0.0 108.195 179.29 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -59.32 -55.66 31.98 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.648 -177.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -61.7 -21.94 64.91 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.656 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.6 1.48 86.68 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -151.66 160.1 32.22 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.113 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -45.41 166.17 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 123.833 3.022 . . . . 0.0 112.967 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.4 tp -121.21 122.81 40.77 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 176.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.414 ' O ' ' CA ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -63.6 146.9 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.856 0 C-N-CA 117.712 -1.595 . . . . 0.0 106.722 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.9 t -122.56 126.13 47.12 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.694 0.621 . . . . 0.0 111.572 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 3.7 m -132.37 164.55 26.23 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.53 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 30.4 t -71.07 151.19 44.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.844 0.354 . . . . 0.0 110.728 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.436 ' HB1' ' H ' ' A' ' 148' ' ' CYS . . . -60.75 -37.3 81.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.975 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 54.7 p30 -55.87 154.77 6.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.657 0.741 . . . . 0.0 111.425 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.45 -159.15 0.94 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.629 -178.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.9 p -61.36 -38.7 87.94 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.061 0.458 . . . . 0.0 110.153 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -165.8 0.78 0.05 OUTLIER Glycine 0 CA--C 1.511 -0.166 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.2 tp -81.68 124.8 79.43 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.237 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -38.73 156.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.939 1.759 . . . . 0.0 111.931 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -74.84 -162.87 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.391 2.061 . . . . 0.0 112.256 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.436 ' H ' ' HB1' ' A' ' 140' ' ' ALA . 73.0 m -119.5 76.4 1.13 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.7 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -54.16 -32.97 56.89 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.817 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.0 165.55 15.78 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.417 HG11 ' HA ' ' A' ' 166' ' ' PRO . 0.9 OUTLIER -55.75 -17.66 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.746 0 CA-C-O 121.751 0.786 . . . . 0.0 109.267 179.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -66.24 -34.58 78.33 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.33 -70.6 0.16 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.729 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.5 p -48.62 -31.11 3.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.155 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 159' ' ' GLY . 4.6 tmt_? -79.64 -51.65 8.99 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.863 0.84 . . . . 0.0 109.338 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.98 -44.22 63.95 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.886 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.504 HE21 ' C ' ' A' ' 157' ' ' GLN . 0.0 OUTLIER -84.13 -30.59 25.78 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 112.845 -1.979 . . . . 0.0 114.351 -175.279 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -126.3 -32.9 2.66 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 118.012 0.369 . . . . 0.0 111.294 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 93.75 23.41 23.41 Favored Glycine 0 N--CA 1.467 0.744 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -42.77 -95.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.493 0.187 . . . . 0.0 110.957 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.454 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.93 37.04 15.43 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.189 0.519 . . . . 0.0 109.61 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.556 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.4 m-85 -175.88 -62.1 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.907 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.28 28.05 0.3 Allowed 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.349 2.032 . . . . 0.0 110.536 178.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.573 HG23 ' HD3' ' A' ' 166' ' ' PRO . 16.0 m -131.78 167.47 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.05 -178.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.2 65.96 30.74 Favored Pre-proline 0 N--CA 1.477 0.878 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.645 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.573 ' HD3' HG23 ' A' ' 164' ' ' VAL . 33.0 Cg_exo -38.27 147.42 0.11 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 123.686 2.924 . . . . 0.0 114.962 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 174.53 -148.72 10.0 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.117 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -143.4 -164.65 1.91 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.9 t . . . . . 0 N--CA 1.464 0.257 0 CA-C-O 121.354 0.597 . . . . 0.0 111.071 -179.722 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.444 -0.731 0 CA-C-O 120.889 0.376 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 178' ' ' ILE . 18.8 tt -112.28 130.74 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.698 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -133.83 169.4 17.12 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.714 0.768 . . . . 0.0 112.17 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -80.63 106.99 13.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.201 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -68.47 -16.68 63.98 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.214 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.8 mm? -63.37 -41.8 98.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.047 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.09 -44.31 3.6 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.176 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.563 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 179.854 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 . . . . . 0 N--CA 1.465 0.307 0 CA-C-O 120.616 0.246 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.552 HD12 ' N ' ' A' ' 5' ' ' LEU . 9.4 mp -63.27 -42.27 99.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.968 0.413 . . . . 0.0 110.252 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -64.81 -43.43 93.14 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.189 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -65.56 -38.67 90.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.277 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 162' ' ' PHE . 67.9 t0 -62.73 -45.65 91.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.613 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.14 -45.87 91.52 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.912 0.387 . . . . 0.0 110.031 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.63 -43.06 98.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.839 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.91 -42.62 85.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.541 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.13 -46.62 86.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.174 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.07 -51.4 69.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.811 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 14.7 pt -68.71 -39.84 80.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.409 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -57.15 -53.19 60.9 Favored 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 120.486 -0.485 . . . . 0.0 109.921 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 20' ' ' GLU . 89.0 t -61.61 -40.42 86.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.638 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.682 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.3 tt -52.99 -50.47 64.11 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.383 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -79.49 -51.23 9.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.753 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -64.8 -31.04 72.08 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.812 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 16' ' ' VAL . 96.7 mt-10 58.44 85.11 0.1 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.124 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.41 -142.54 0.09 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.706 0.288 . . . . 0.0 110.289 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.2 p -137.74 138.73 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 pp -128.05 163.99 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-O 121.118 0.485 . . . . 0.0 111.78 -178.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.68 128.43 36.2 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.914 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.518 ' CE2' ' O ' ' A' ' 26' ' ' PRO . 2.1 t80 -118.32 138.49 25.72 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.255 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.518 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 64.8 Cg_endo -80.93 149.51 17.83 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.191 1.26 . . . . 0.0 111.352 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.436 ' C ' ' H ' ' A' ' 29' ' ' ALA . 25.9 m -135.15 140.93 45.8 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.271 0.557 . . . . 0.0 110.808 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -77.77 20.07 0.36 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.033 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.436 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -154.97 -73.41 0.12 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.206 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 67.5 t -122.74 126.28 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 120.859 0.361 . . . . 0.0 110.737 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.521 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 90.9 m-85 -53.5 144.48 17.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.195 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -154.35 -168.37 17.7 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.2 m -132.08 168.31 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.97 -176.96 27.79 Favored Glycine 0 N--CA 1.464 0.566 0 C-N-CA 120.008 -1.092 . . . . 0.0 111.925 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -153.34 -166.2 2.36 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.734 0.302 . . . . 0.0 110.359 -179.43 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.514 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 7.8 m-20 -99.43 109.79 56.17 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-O 118.729 -0.653 . . . . 0.0 112.441 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 36' ' ' ASP . 15.4 Cg_exo -35.19 168.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.68 2.254 . . . . 0.0 114.302 177.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 44.73 67.39 0.7 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.433 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.7 m -142.94 137.59 29.53 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.07 0.462 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.631 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -71.65 -34.37 69.7 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.296 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.432 ' H ' HG22 ' A' ' 41' ' ' THR . 0.1 OUTLIER -63.45 -45.28 91.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.644 -178.121 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.424 ' HB2' ' SG ' ' A' ' 35' ' ' CYS . . . -63.1 -47.68 81.81 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.598 -178.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.3 p -62.59 -44.45 99.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.249 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 62.1 mtt -64.95 -39.79 94.02 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 -61.77 -32.98 73.29 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.026 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 79.9 mt -75.95 -57.23 4.0 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.4 mt -54.46 -18.91 4.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.243 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -67.23 -84.66 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.695 -178.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.515 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -75.83 -33.26 60.05 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -77.71 -71.23 0.43 Allowed 'General case' 0 C--N 1.346 0.445 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.738 -176.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.411 ' CG ' ' O ' ' A' ' 51' ' ' GLN . 3.2 tt0 53.65 80.98 0.1 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.399 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.3 mtp85 160.69 -64.04 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.116 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -66.78 -11.25 31.26 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 122.641 2.228 . . . . 0.0 111.775 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.596 HG13 ' N ' ' A' ' 55' ' ' ASP . 13.9 p -46.05 -45.97 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.596 ' N ' HG13 ' A' ' 54' ' ' VAL . 10.3 t0 -67.58 -44.44 78.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.676 -178.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -60.35 -40.5 90.96 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.759 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 71.39 111.66 0.04 OUTLIER Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.573 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -49.54 -169.86 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.986 -0.607 . . . . 0.0 111.896 179.632 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.439 ' O ' ' OG ' ' A' ' 137' ' ' SER . 80.9 mt -100.25 139.54 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.5 mt -113.24 143.84 43.73 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -178.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.412 ' O ' HG23 ' A' ' 61' ' ' ILE . 10.0 tp -112.26 127.97 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 CA-C-O 121.122 0.487 . . . . 0.0 110.548 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.497 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -113.46 154.59 26.76 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.56 -26.29 7.11 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -118.76 145.05 45.88 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.607 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -71.62 -12.53 61.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.571 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -49.6 -33.91 16.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.565 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -95.04 -15.74 23.23 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.582 HD22 ' N ' ' A' ' 68' ' ' LEU . 3.8 mm? -92.94 -13.14 29.23 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.476 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 27.9 tptt -80.49 -39.08 1.13 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.803 -178.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 65.8 Cg_endo -103.09 -3.4 0.28 Allowed 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 122.78 2.32 . . . . 0.0 111.784 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.561 ' OH ' HD21 ' A' ' 114' ' ' LEU . 39.8 t80 -96.56 -11.01 25.98 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.161 -178.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.581 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.2 mp -131.46 159.36 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.581 ' N ' HG22 ' A' ' 72' ' ' ILE . 91.2 m-20 -71.37 160.45 32.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.06 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 39.2 p30 -95.64 7.79 45.27 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.848 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.561 HG23 ' N ' ' A' ' 76' ' ' MET . 7.1 t -67.08 -45.77 76.3 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.325 0.583 . . . . 0.0 110.547 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.561 ' N ' HG23 ' A' ' 75' ' ' THR . 23.1 ptp -84.33 -6.26 59.37 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.232 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.3 tp -94.33 116.3 28.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.619 -177.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -154.95 167.2 31.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.91 -177.817 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -42.49 -44.49 4.1 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.196 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.66 -33.03 59.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.923 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 78' ' ' THR . 1.0 OUTLIER -65.75 -43.26 89.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.203 0.525 . . . . 0.0 110.52 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.402 ' NH2' ' HZ1' ' A' ' 69' ' ' LYS . 9.5 mmt85 -59.92 -49.17 78.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 122.76 1.267 . . . . 0.0 108.657 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -57.29 -49.84 74.82 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 113.446 -1.706 . . . . 0.0 110.005 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.7 m -62.59 -49.19 76.24 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.227 -1.351 . . . . 0.0 112.444 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.8 tt -68.42 -30.75 48.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.139 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -82.37 -40.02 21.93 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.917 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.2 m -78.35 -3.31 42.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.907 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -121.92 166.95 13.64 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 15.9 m-90 -43.49 150.71 0.5 Allowed Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.12 -19.37 45.11 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.911 1.741 . . . . 0.0 111.593 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.474 ' O ' ' NH2' ' A' ' 117' ' ' ARG . . . 177.64 78.78 0.06 OUTLIER Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -79.57 -35.52 0.79 Allowed 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.042 1.828 . . . . 0.0 112.516 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.515 ' CG1' ' CZ ' ' A' ' 95' ' ' PHE . 9.7 p -137.92 149.2 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 120.801 0.334 . . . . 0.0 110.886 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 16.3 m -81.39 129.51 34.66 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.515 ' CZ ' ' CG1' ' A' ' 93' ' ' VAL . 46.2 m-85 -117.02 137.4 52.26 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.733 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.697 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 5.5 t -92.05 102.59 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 121.277 0.561 . . . . 0.0 109.759 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -81.12 143.68 53.17 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.198 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -79.64 108.16 2.24 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 122.032 1.821 . . . . 0.0 111.099 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 112' ' ' ASP . . . -64.93 156.61 79.43 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.624 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 49.0 Cg_endo -66.69 -19.23 53.81 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.231 1.954 . . . . 0.0 112.187 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . 0 N--CA 1.472 0.671 0 O-C-N 123.536 0.523 . . . . 0.0 110.551 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 109' ' ' GLY . 0.6 OUTLIER . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 2.5 p90 -79.56 -9.83 59.69 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.676 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.969 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -69.28 -34.06 74.17 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.427 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.746 ' H ' HD22 ' A' ' 107' ' ' LEU . 28.5 m -141.39 -40.73 0.38 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.428 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 60.29 -13.62 0.04 OUTLIER Glycine 0 CA--C 1.536 1.398 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.657 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.558 ' H ' ' C ' ' A' ' 108' ' ' THR . 0.0 OUTLIER -85.52 -52.61 5.72 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 117.659 0.73 . . . . 0.0 109.284 179.758 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.534 ' CE2' ' OD1' ' A' ' 112' ' ' ASP . 17.6 t80 -154.37 -178.26 7.02 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.306 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.534 ' OD1' ' CE2' ' A' ' 111' ' ' PHE . 48.8 p30 -89.01 51.63 2.21 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.299 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.5 p -159.51 156.82 28.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.244 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.561 HD21 ' OH ' ' A' ' 71' ' ' TYR . 0.3 OUTLIER -163.75 141.5 7.38 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.421 ' HB2' HG22 ' A' ' 96' ' ' VAL . . . -69.7 125.23 26.09 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 113.737 -1.574 . . . . 0.0 109.617 177.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.491 HG22 ' N ' ' A' ' 117' ' ' ARG . 4.3 p -146.66 161.19 9.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.491 ' N ' HG22 ' A' ' 116' ' ' VAL . 78.7 ttt-85 -144.03 153.23 41.99 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.91 0.386 . . . . 0.0 111.389 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.497 HG22 ' HB3' ' A' ' 62' ' ' ALA . 52.2 t -122.45 136.64 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.2 t -135.24 149.04 49.77 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.249 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 35.4 p30 -151.68 78.82 1.26 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.763 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.61 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 10.3 t-80 -172.51 -36.85 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.61 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 18.9 Cg_endo -92.73 -161.66 0.09 OUTLIER 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 121.993 1.795 . . . . 0.0 111.686 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.4 mt -78.83 -4.68 50.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.016 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.4 t -58.21 -45.0 89.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.971 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.754 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.6 m -52.7 -62.2 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.935 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.754 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -40.96 -45.41 2.57 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.881 0.372 . . . . 0.0 111.027 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.435 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -66.69 -51.37 56.8 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.253 0.549 . . . . 0.0 110.778 179.535 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 71.2 m -69.5 -47.79 62.68 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.237 0.541 . . . . 0.0 111.425 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.475 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.2 pp0? -54.87 -42.2 71.75 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -60.4 -53.12 61.37 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.771 -177.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.45 ' CE1' ' OD2' ' A' ' 36' ' ' ASP . 42.0 t80 -64.48 -22.46 66.97 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.825 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.94 2.07 90.14 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 134' ' ' PRO . 34.3 mttm -152.4 159.56 32.52 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 133' ' ' LYS . 5.9 Cg_exo -41.12 -179.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 124.061 3.174 . . . . 0.0 113.941 -178.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.447 HD12 ' O ' ' A' ' 35' ' ' CYS . 8.0 tp -134.47 123.85 24.65 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 176.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.423 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.9 OUTLIER -66.14 143.73 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 C-N-CA 117.764 -1.574 . . . . 0.0 108.518 -179.153 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -108.82 121.88 46.0 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.96 0.788 . . . . 0.0 110.924 -179.346 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.9 m -132.38 157.64 44.02 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.819 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.6 m -73.0 143.2 47.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.011 0.434 . . . . 0.0 110.577 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.7 -36.76 85.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.034 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 51.8 p30 -52.37 150.38 4.82 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.774 0.797 . . . . 0.0 110.997 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.13 -158.39 0.73 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.048 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 45.2 m -59.93 -42.99 95.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.471 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -162.55 11.87 0.11 Allowed Glycine 0 N--CA 1.459 0.172 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.7 tp -93.44 127.51 46.13 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -38.76 157.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 121.758 1.638 . . . . 0.0 112.468 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -76.55 -166.94 0.41 Allowed 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 122.721 2.281 . . . . 0.0 112.487 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 70.9 m -112.03 76.93 1.0 Allowed 'General case' 0 C--O 1.231 0.103 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.521 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 17.5 ptm180 -54.06 -37.81 64.57 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.952 -178.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.42 167.64 29.13 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.441 HG22 ' H ' ' A' ' 151' ' ' VAL . 1.6 m -57.37 -20.35 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.6 0 CA-C-O 121.77 0.795 . . . . 0.0 109.248 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -64.21 -34.61 78.49 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.03 -79.49 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.872 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.439 HG13 ' N ' ' A' ' 155' ' ' ARG . 6.3 p -35.22 -34.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.687 0.795 . . . . 0.0 111.155 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.475 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -67.38 -52.79 35.66 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.347 0.594 . . . . 0.0 111.852 -178.618 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -69.35 -16.93 63.64 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 122.538 1.161 . . . . 0.0 108.035 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -84.23 -45.37 12.96 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 112.672 -2.058 . . . . 0.0 111.891 -178.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -130.34 -27.93 2.16 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.638 0.256 . . . . 0.0 111.642 -178.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 94.56 24.17 19.16 Favored Glycine 0 N--CA 1.468 0.783 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -43.68 -96.69 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.78 0.324 . . . . 0.0 111.126 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.508 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 62.3 34.8 15.61 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -178.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.544 ' H ' HG22 ' A' ' 164' ' ' VAL . 2.1 m-85 -174.04 -62.16 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.238 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.86 25.88 0.29 Allowed 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.349 2.033 . . . . 0.0 110.932 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.571 HG23 ' HD3' ' A' ' 166' ' ' PRO . 13.7 m -127.43 167.64 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.746 -178.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.1 t -122.35 64.87 21.58 Favored Pre-proline 0 N--CA 1.472 0.647 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.829 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.571 ' HD3' HG23 ' A' ' 164' ' ' VAL . 38.9 Cg_exo -37.62 144.32 0.15 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 123.652 2.901 . . . . 0.0 115.031 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 164.54 -176.78 40.36 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 113.901 -1.5 . . . . 0.0 110.878 178.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -142.09 152.8 43.63 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.469 0.487 0 CA-C-O 121.088 0.47 . . . . 0.0 111.169 -179.769 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.504 ' OE1' ' NH1' ' A' ' 179' ' ' ARG . 98.1 mt-10 . . . . . 0 N--CA 1.444 -0.747 0 CA-C-O 120.874 0.369 . . . . 0.0 110.834 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.479 ' O ' HG23 ' A' ' 178' ' ' ILE . 18.7 tt -111.25 125.13 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.653 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.504 ' NH1' ' OE1' ' A' ' 177' ' ' GLU . 7.2 mpt_? -122.5 161.43 23.62 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 122.102 0.953 . . . . 0.0 110.889 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -77.79 105.88 9.26 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.157 -1.383 . . . . 0.0 107.979 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -66.95 -13.61 61.98 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.753 -178.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.475 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.4 mm? -63.54 -42.02 98.42 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.062 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.2 -43.44 2.53 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.818 0.342 . . . . 0.0 110.623 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.781 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.701 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.821 0.343 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.4 mp -63.11 -42.32 99.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.212 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -61.96 -49.6 75.45 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.001 0.429 . . . . 0.0 110.053 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -58.51 -41.36 85.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.947 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.74 -44.76 96.29 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.588 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.43 -45.29 93.75 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.241 0.544 . . . . 0.0 109.94 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.9 -42.94 98.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.9 -42.43 79.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.156 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.2 -47.48 85.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.149 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.02 -53.21 60.53 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.626 -0.43 . . . . 0.0 112.053 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 14.2 pt -66.75 -38.32 81.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.117 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -58.36 -50.77 72.47 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.168 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 21' ' ' ARG . 92.6 t -62.81 -39.27 84.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.75 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.671 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.3 tt -52.48 -52.2 55.57 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.209 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -76.79 -48.72 17.76 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.223 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -67.14 -29.47 69.2 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.058 0.456 . . . . 0.0 110.837 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 16' ' ' VAL . 96.7 mt-10 56.36 60.52 3.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.564 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.542 ' O ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -153.65 159.6 42.12 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.302 0.573 . . . . 0.0 110.323 179.164 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 p -76.92 137.97 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.436 -178.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.513 HG22 ' NH2' ' A' ' 21' ' ' ARG . 2.8 pp -124.86 166.79 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-O 120.692 0.282 . . . . 0.0 110.898 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.05 133.86 53.86 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.379 0.609 . . . . 0.0 111.462 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.524 ' CE2' ' O ' ' A' ' 26' ' ' PRO . 3.5 t80 -126.66 138.68 33.0 Favored Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.524 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 64.3 Cg_endo -80.32 150.21 19.72 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 CA-C-N 120.419 1.185 . . . . 0.0 111.588 -178.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.448 ' C ' ' H ' ' A' ' 29' ' ' ALA . 30.2 m -130.14 140.09 50.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.649 0.262 . . . . 0.0 110.451 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -77.6 21.11 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.448 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -154.76 -74.59 0.11 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.124 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.4 p -123.79 127.41 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 121.24 0.543 . . . . 0.0 110.622 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 149' ' ' ARG . 97.4 m-85 -43.37 147.98 0.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.999 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -157.64 -174.72 27.71 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.4 m -131.23 169.38 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.43 178.92 33.55 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 119.946 -1.121 . . . . 0.0 112.656 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.564 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -152.97 -162.84 1.57 Allowed 'General case' 0 C--N 1.341 0.226 0 CA-C-N 115.521 -0.34 . . . . 0.0 110.309 -179.231 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.564 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 2.1 m-20 -101.52 111.12 63.39 Favored Pre-proline 0 CA--C 1.548 0.869 0 CA-C-O 118.802 -0.618 . . . . 0.0 112.622 -178.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 36' ' ' ASP . 22.8 Cg_exo -35.89 170.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.804 2.336 . . . . 0.0 114.413 177.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.8 t70 41.53 73.45 0.13 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.887 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.9 m -151.79 141.99 22.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.084 0.469 . . . . 0.0 110.308 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.644 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -70.43 -30.55 67.44 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.555 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.533 HG23 ' N ' ' A' ' 42' ' ' ALA . 12.6 t -60.09 -42.52 94.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.988 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.533 ' N ' HG23 ' A' ' 41' ' ' THR . . . -58.17 -52.53 65.15 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.345 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.07 -45.33 99.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.137 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 60.6 mtt -67.62 -45.29 75.84 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -65.8 -28.7 69.2 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.634 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 52.7 mt -74.72 -60.95 2.05 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.232 177.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.9 mt -51.63 -23.22 4.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.065 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.49 -85.73 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.723 -178.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.52 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -76.56 -33.66 58.51 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -75.5 -71.16 0.38 Allowed 'General case' 0 C--N 1.346 0.434 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.959 -176.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.406 ' O ' ' CG ' ' A' ' 51' ' ' GLN . 3.8 tt0 53.46 80.62 0.1 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.388 0.613 . . . . 0.0 109.454 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.1 mtt-85 161.07 -63.44 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.215 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.36 -10.4 28.87 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 122.737 2.291 . . . . 0.0 112.175 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.595 HG13 ' N ' ' A' ' 55' ' ' ASP . 7.3 p -44.95 -48.19 2.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.914 -178.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.595 ' N ' HG13 ' A' ' 54' ' ' VAL . 10.9 t0 -68.49 -42.29 78.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.425 -178.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -58.9 -41.96 88.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.398 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 68.97 112.86 0.02 OUTLIER Glycine 0 CA--C 1.518 0.248 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.568 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -49.64 -170.63 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.085 -0.558 . . . . 0.0 112.353 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.3 mt -97.7 148.29 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.1 mt -122.35 142.65 50.28 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 61' ' ' ILE . 8.6 tp -114.45 129.93 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-O 121.176 0.512 . . . . 0.0 110.984 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.601 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -114.11 159.9 19.52 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -124.94 -24.72 4.02 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.553 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 99.2 m-20 -116.76 125.31 51.46 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.287 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -58.46 -13.23 5.02 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -50.23 -33.58 20.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.527 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.553 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 4.3 pm0 -94.83 -11.55 28.64 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.512 HD22 ' N ' ' A' ' 68' ' ' LEU . 3.8 mm? -91.98 -14.6 29.21 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 118.864 0.757 . . . . 0.0 109.192 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.474 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 42.9 tttm -79.6 -38.56 1.26 Allowed Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.766 -178.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 73.6 Cg_endo -103.07 -3.43 0.28 Allowed 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 122.699 2.266 . . . . 0.0 111.836 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -96.53 -10.46 27.25 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.666 -178.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.602 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.7 mp -137.02 164.23 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.602 ' N ' HG22 ' A' ' 72' ' ' ILE . 97.6 m-20 -66.71 160.16 26.26 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -94.85 12.01 29.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.695 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.525 HG23 ' N ' ' A' ' 76' ' ' MET . 10.7 t -72.48 -41.12 66.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.223 0.535 . . . . 0.0 110.067 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.525 ' N ' HG23 ' A' ' 75' ' ' THR . 22.1 ptp -85.15 -18.26 34.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.546 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 tp -95.25 119.36 33.63 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.904 -178.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.473 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -158.03 161.03 38.04 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.303 -177.701 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -38.92 -47.86 1.5 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.837 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.1 p -62.86 -34.13 64.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.757 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 78' ' ' THR . 67.4 tp60 -65.99 -39.54 90.4 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.808 0.337 . . . . 0.0 110.93 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.436 ' HG2' ' H ' ' A' ' 82' ' ' ARG . 6.8 mmt85 -64.4 -52.86 56.07 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 122.581 1.181 . . . . 0.0 109.14 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -55.67 -50.39 70.38 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.126 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 88' ' ' ARG . 3.1 m -60.77 -51.05 70.97 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.926 -178.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 85' ' ' ILE . 10.0 tt -65.91 -36.49 77.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.596 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -67.14 -41.03 86.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.127 178.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.9 m -84.71 -19.02 33.4 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.8 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 84' ' ' THR . 77.8 ttt-85 -103.56 151.52 22.79 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.741 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -34.38 152.62 0.05 OUTLIER Pre-proline 0 N--CA 1.469 0.484 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.188 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.12 -17.93 55.62 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.132 1.888 . . . . 0.0 110.991 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.455 ' H ' ' HD3' ' A' ' 92' ' ' PRO . . . 99.19 69.32 0.92 Allowed Glycine 0 CA--C 1.529 0.967 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.779 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.455 ' HD3' ' H ' ' A' ' 91' ' ' GLY . 52.8 Cg_exo -54.54 -39.35 88.65 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.865 2.377 . . . . 0.0 111.493 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.425 HG13 ' CE2' ' A' ' 95' ' ' PHE . 3.2 p -78.59 147.84 6.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.328 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 85.5 m -88.11 143.62 26.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.731 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.449 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 61.6 m-85 -127.01 140.35 52.37 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.661 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.649 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 3.4 t -93.86 101.77 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-O 121.474 0.654 . . . . 0.0 109.633 178.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -91.81 151.31 42.06 Favored Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.882 -177.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.82 142.19 56.69 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.764 1.643 . . . . 0.0 110.309 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -114.95 116.54 42.64 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.397 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -45.59 167.4 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 121.6 1.533 . . . . 0.0 112.623 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.484 179.495 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.492 ' NH1' ' OD1' ' A' ' 112' ' ' ASP . 11.4 tpp180 . . . . . 0 N--CA 1.463 0.208 0 CA-C-O 120.749 0.309 . . . . 0.0 110.475 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 6.1 p90 -84.5 -9.4 58.38 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.632 ' H ' ' CD2' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -77.57 -17.65 57.67 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.678 -179.639 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.543 ' C ' ' H ' ' A' ' 110' ' ' ARG . 26.6 m -144.75 -43.85 0.24 Allowed 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.827 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 50.42 -1.87 0.01 OUTLIER Glycine 0 CA--C 1.541 1.688 0 CA-C-O 119.726 -0.485 . . . . 0.0 113.339 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.543 ' H ' ' C ' ' A' ' 108' ' ' THR . 0.5 OUTLIER -88.15 -54.87 4.0 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 117.947 0.873 . . . . 0.0 109.552 179.741 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.613 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 85.4 t80 -154.51 173.72 15.9 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.417 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.613 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 89.8 m-20 -79.12 50.92 1.1 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.372 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 82.1 p -158.52 160.04 36.24 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.457 ' C ' HG13 ' A' ' 96' ' ' VAL . 2.3 pp -167.13 140.02 3.51 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.87 112.21 4.17 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 113.437 -1.71 . . . . 0.0 110.75 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.499 HG22 ' N ' ' A' ' 117' ' ' ARG . 6.1 p -143.97 160.42 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.499 ' N ' HG22 ' A' ' 116' ' ' VAL . 14.8 ptt180 -155.99 162.16 40.38 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.949 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.601 HG22 ' HB3' ' A' ' 62' ' ' ALA . 54.7 t -121.24 138.82 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.543 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 7.9 t -132.62 150.43 52.16 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.957 0.408 . . . . 0.0 110.103 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.401 ' O ' ' OD1' ' A' ' 120' ' ' ASP . 30.6 p30 -150.4 81.1 1.36 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.324 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.605 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 61.7 t60 -171.81 -37.79 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.605 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 38.7 Cg_endo -95.49 -163.62 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 121.941 1.761 . . . . 0.0 112.3 -178.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.6 mt -78.54 -4.09 46.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.89 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 83.3 t -57.62 -45.96 86.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.648 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.756 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.1 m -52.96 -62.18 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.87 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.756 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.33 -43.84 2.58 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.243 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.1 tp -69.49 -48.07 61.85 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.954 0.406 . . . . 0.0 110.99 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 82.1 m -70.0 -48.96 55.98 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.408 0.623 . . . . 0.0 110.915 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.47 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.0 OUTLIER -55.24 -41.61 72.36 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.423 179.428 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.94 -54.42 47.36 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.383 -1.281 . . . . 0.0 109.605 -177.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.402 ' CE1' ' OD2' ' A' ' 36' ' ' ASP . 42.8 t80 -62.05 -21.47 64.95 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.983 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 81.43 -0.11 88.3 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 134' ' ' PRO . 24.7 mttp -152.37 159.14 33.12 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.004 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 133' ' ' LYS . 6.1 Cg_exo -41.61 179.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 123.838 3.026 . . . . 0.0 113.75 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.0 tp -134.58 123.73 24.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.443 -1.708 . . . . 0.0 106.578 177.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.43 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.9 OUTLIER -66.06 146.42 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 C-N-CA 117.684 -1.606 . . . . 0.0 107.327 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.0 t -118.3 129.25 55.35 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.249 0.547 . . . . 0.0 110.894 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.3 m -129.06 162.31 27.97 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.085 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 17.8 m -72.02 147.99 46.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.246 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.618 ' HB1' ' H ' ' A' ' 148' ' ' CYS . . . -63.63 -37.44 87.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.913 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.45 ' C ' HD22 ' A' ' 141' ' ' ASN . 0.1 OUTLIER -54.31 157.38 2.76 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.594 0.711 . . . . 0.0 111.256 -179.445 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.74 -158.31 0.88 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.103 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.6 t -60.33 -44.08 95.81 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.382 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -165.97 12.43 0.07 OUTLIER Glycine 0 N--CA 1.46 0.264 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.3 tp -90.24 127.64 52.47 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -39.47 153.74 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 121.702 1.602 . . . . 0.0 112.22 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.29 157.43 41.57 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.431 2.088 . . . . 0.0 112.373 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.618 ' H ' ' HB1' ' A' ' 140' ' ' ALA . 18.7 m -80.37 76.35 7.18 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.534 ' O ' ' CD1' ' A' ' 31' ' ' PHE . 32.9 ptt-85 -55.19 -35.7 65.11 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.93 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.71 169.49 24.52 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.409 ' H ' HG22 ' A' ' 151' ' ' VAL . 1.0 OUTLIER -59.62 -23.82 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.547 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.23 -23.73 67.41 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 177.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 155' ' ' ARG . 5.6 tm-20 -69.56 -78.87 0.06 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.85 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.424 ' O ' ' N ' ' A' ' 158' ' ' PHE . 3.2 p -35.08 -30.66 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.473 0.709 . . . . 0.0 110.564 177.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -72.58 -51.43 19.79 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.083 -179.32 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 153' ' ' GLU . . . -67.32 -20.12 65.56 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.666 1.222 . . . . 0.0 107.793 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -83.09 -44.62 14.94 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 112.403 -2.181 . . . . 0.0 111.808 -178.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.424 ' N ' ' O ' ' A' ' 154' ' ' VAL . 49.4 t80 -130.63 -26.62 2.22 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.816 0.341 . . . . 0.0 111.84 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 92.18 25.74 20.81 Favored Glycine 0 N--CA 1.468 0.813 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -43.67 -96.74 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.498 -0.351 . . . . 0.0 111.189 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . 63.42 33.07 14.05 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -178.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.524 ' C ' ' H ' ' A' ' 164' ' ' VAL . 0.4 OUTLIER -174.24 -61.12 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.497 -179.58 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.83 28.93 0.28 Allowed 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.003 1.802 . . . . 0.0 110.652 177.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.565 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.4 m -130.63 166.91 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.088 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.5 t -121.51 65.68 17.28 Favored Pre-proline 0 N--CA 1.476 0.836 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.869 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.565 ' HD3' HG23 ' A' ' 164' ' ' VAL . 23.1 Cg_exo -35.41 139.07 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 123.628 2.885 . . . . 0.0 115.225 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 169.28 173.7 37.13 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.905 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -158.14 144.83 17.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.957 0.408 . . . . 0.0 110.51 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.9 t . . . . . 0 N--CA 1.466 0.336 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.656 179.534 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 . . . . . 0 N--CA 1.448 -0.575 0 CA-C-O 120.468 0.175 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 45.4 pt -122.22 143.21 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.933 0.397 . . . . 0.0 111.016 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -137.8 167.52 21.57 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.778 0.799 . . . . 0.0 111.949 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -83.97 106.7 15.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.205 -1.361 . . . . 0.0 110.355 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -65.01 -13.96 59.19 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.071 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.434 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.5 mm? -62.91 -42.0 99.65 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.33 -42.69 3.65 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.265 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.683 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.877 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.935 0.398 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.547 HD12 ' N ' ' A' ' 5' ' ' LEU . 9.6 mp -61.68 -42.4 98.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.971 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -63.38 -45.57 90.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.09 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -61.62 -38.11 86.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.994 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.04 -43.6 98.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.686 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.93 -49.23 78.29 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.633 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.9 mm -63.92 -43.19 97.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.537 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.49 -46.7 83.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.705 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.0 -43.61 98.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.41 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.88 -53.24 59.75 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.62 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.9 pt -69.5 -38.85 77.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.482 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -58.76 -55.35 36.29 Favored 'General case' 0 C--O 1.214 -0.807 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.338 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 20' ' ' GLU . 91.1 t -61.72 -40.23 86.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.386 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.677 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.3 tt -52.56 -51.26 60.61 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.681 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -79.81 -50.48 10.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.873 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -63.67 -32.71 74.27 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.615 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 16' ' ' VAL . 96.8 mt-10 58.7 82.86 0.13 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.377 0.881 . . . . 0.0 113.377 178.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.28 -141.38 0.05 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.679 0.275 . . . . 0.0 110.488 177.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.0 p -135.13 139.16 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.475 HD12 ' O ' ' A' ' 24' ' ' ALA . 2.8 pp -129.02 164.16 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 120.924 0.392 . . . . 0.0 111.98 -178.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.475 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -64.28 141.88 58.61 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.939 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -145.55 160.81 43.53 Favored Pre-proline 0 CA--C 1.546 0.82 0 CA-C-O 119.047 -0.501 . . . . 0.0 110.522 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.52 157.17 32.46 Favored 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 121.579 1.519 . . . . 0.0 111.442 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.2 m -136.97 155.2 50.02 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.276 0.56 . . . . 0.0 110.538 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -83.78 14.54 3.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.729 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -160.43 -64.93 0.07 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.165 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.9 t -125.49 127.45 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.071 0.463 . . . . 0.0 110.685 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.561 ' CZ ' HG13 ' A' ' 151' ' ' VAL . 35.8 t80 -56.72 131.07 48.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.313 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -141.03 -153.62 6.01 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.5 m -131.57 166.68 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -156.99 -179.95 32.32 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.987 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.406 ' O ' HD12 ' A' ' 135' ' ' LEU . 0.6 OUTLIER -153.68 -179.58 7.93 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -179.667 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 37' ' ' PRO . 36.7 t70 -91.98 110.08 41.56 Favored Pre-proline 0 CA--C 1.552 1.033 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 36' ' ' ASP . 57.0 Cg_exo -36.79 173.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 123.039 2.493 . . . . 0.0 114.517 177.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 49.01 64.64 1.64 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.861 -1.518 . . . . 0.0 111.216 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 65.2 m -147.2 138.03 23.65 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.043 0.449 . . . . 0.0 110.405 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.46 -35.95 73.62 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.531 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 41' ' ' THR . 0.3 OUTLIER -64.06 -42.59 96.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.463 -179.068 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.92 75.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.643 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 p -62.4 -44.91 99.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.277 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 90.0 mtp -64.01 -40.84 97.26 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 27.8 ttt-85 -61.4 -41.52 97.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.448 ' O ' HD23 ' A' ' 46' ' ' LEU . 1.0 OUTLIER -64.41 -54.3 34.92 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.595 -178.236 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.4 mt -69.74 -12.12 61.38 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.246 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -69.03 -82.54 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.149 0.5 . . . . 0.0 111.133 -177.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -76.21 -35.1 59.22 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -178.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -76.45 -50.41 14.14 Favored 'General case' 0 C--N 1.344 0.358 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.901 -177.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 35.52 65.5 0.4 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.995 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.415 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 6.7 mtm-85 178.49 -52.85 0.0 OUTLIER Pre-proline 0 CA--C 1.551 0.986 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.644 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.415 ' HD2' ' H ' ' A' ' 52' ' ' ARG . 91.1 Cg_endo -79.25 -4.28 13.65 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.875 2.384 . . . . 0.0 112.537 -178.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.602 HG13 ' N ' ' A' ' 55' ' ' ASP . 10.9 p -47.35 -44.76 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.111 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.602 ' N ' HG13 ' A' ' 54' ' ' VAL . 41.3 t0 -66.47 -40.44 89.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.445 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -60.69 -38.04 83.66 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 64.89 107.27 0.01 OUTLIER Glycine 0 CA--C 1.518 0.264 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.567 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -52.34 -163.32 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.022 0.439 . . . . 0.0 111.673 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.449 ' O ' ' OG ' ' A' ' 137' ' ' SER . 73.6 mt -109.07 135.16 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.3 mt -109.79 142.12 41.48 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.478 ' O ' HG23 ' A' ' 61' ' ' ILE . 9.3 tp -110.21 123.93 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-O 121.033 0.444 . . . . 0.0 111.304 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.507 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -113.99 157.15 22.84 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.499 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.97 -24.51 4.75 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.453 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -115.88 130.66 56.92 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.73 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -63.99 -13.03 43.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.752 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -50.57 -30.36 13.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.622 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -96.06 -15.87 21.94 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.546 HD22 ' N ' ' A' ' 68' ' ' LEU . 3.9 mm? -92.11 -15.32 27.88 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.666 -0.646 . . . . 0.0 109.329 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.474 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 35.4 tttp -80.53 -38.52 1.08 Allowed Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.693 -178.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 66.0 Cg_endo -103.55 -2.77 0.27 Allowed 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 122.663 2.242 . . . . 0.0 111.896 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.471 ' OH ' HD21 ' A' ' 114' ' ' LEU . 60.7 t80 -97.89 -9.46 26.29 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.032 -178.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.543 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.3 mp -131.86 159.38 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.543 ' N ' HG22 ' A' ' 72' ' ' ILE . 95.8 m-20 -65.56 158.57 26.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.968 0.413 . . . . 0.0 110.389 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 74' ' ' ASP . 37.1 p-10 -93.72 9.35 37.37 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.882 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.469 HG23 ' N ' ' A' ' 76' ' ' MET . 13.6 t -75.85 -39.16 57.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.131 0.491 . . . . 0.0 110.538 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.469 ' N ' HG23 ' A' ' 75' ' ' THR . 20.9 ptp -96.9 -15.28 21.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.257 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.7 tp -100.21 125.68 46.4 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.436 0.636 . . . . 0.0 111.331 -177.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.476 ' OG1' ' N ' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -148.76 178.46 8.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.984 -178.143 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.476 ' N ' ' OG1' ' A' ' 78' ' ' THR . 98.2 m-20 -59.97 -42.49 94.27 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 123.233 0.333 . . . . 0.0 111.082 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.6 p -61.05 -31.23 49.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.533 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -62.74 -41.61 99.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.391 0.615 . . . . 0.0 109.939 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.407 ' HG2' ' H ' ' A' ' 82' ' ' ARG . 12.6 mmt85 -65.46 -53.77 38.0 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 122.379 1.085 . . . . 0.0 109.821 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 87' ' ' SER . 82.0 tt0 -53.74 -50.34 66.18 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.317 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.1 m -62.39 -49.8 74.08 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.576 -1.193 . . . . 0.0 112.138 -177.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 89' ' ' TRP . 8.4 tt -68.54 -26.2 32.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.484 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -87.82 -22.52 24.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.932 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 83' ' ' GLU . 68.4 m -107.17 -56.07 2.25 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.573 ' O ' ' CG ' ' A' ' 89' ' ' TRP . 78.7 ttt-85 -61.61 -45.79 92.58 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.474 -178.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.573 ' CG ' ' O ' ' A' ' 88' ' ' ARG . 1.1 m0 174.72 154.37 0.31 Allowed Pre-proline 0 N--CA 1.47 0.532 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -68.71 -16.99 42.62 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.319 2.013 . . . . 0.0 111.452 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.452 ' H ' ' HD3' ' A' ' 92' ' ' PRO . . . 97.14 69.24 0.98 Allowed Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.452 ' HD3' ' H ' ' A' ' 91' ' ' GLY . 52.1 Cg_exo -54.98 -37.25 93.71 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.478 2.119 . . . . 0.0 111.38 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.1 p -77.98 144.4 11.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.536 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 27.2 m -93.57 143.57 26.18 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.385 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.42 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 63.5 m-85 -127.39 145.09 50.93 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.436 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.608 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.9 t -96.57 103.51 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 121.545 0.688 . . . . 0.0 110.145 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -89.39 148.0 39.47 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.55 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -77.76 111.59 3.15 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.93 1.753 . . . . 0.0 111.278 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.47 148.26 90.44 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -63.94 146.4 91.33 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.901 1.734 . . . . 0.0 112.272 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.521 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.67 179.744 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.527 ' NH2' ' O ' ' A' ' 110' ' ' ARG . 4.1 tpt180 . . . . . 0 N--CA 1.468 0.451 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -75.0 -1.24 21.78 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.011 0.434 . . . . 0.0 110.895 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.934 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -86.56 -17.9 32.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.669 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.633 ' N ' HD22 ' A' ' 107' ' ' LEU . 95.2 m -142.01 -39.99 0.36 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.374 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 74.83 18.95 80.11 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.361 179.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.527 ' O ' ' NH2' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -158.35 -74.1 0.08 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 117.313 0.557 . . . . 0.0 110.434 179.433 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -102.78 -173.68 2.38 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.26 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 49.1 p30 -115.38 57.88 0.73 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.786 0.327 . . . . 0.0 111.051 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.0 p -159.03 159.52 34.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.32 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.769 ' O ' HD12 ' A' ' 114' ' ' LEU . 4.6 pp -166.15 142.54 5.02 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.401 ' N ' HG13 ' A' ' 96' ' ' VAL . . . -68.8 121.48 16.61 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 113.349 -1.751 . . . . 0.0 109.276 177.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.433 HG22 ' N ' ' A' ' 117' ' ' ARG . 4.9 p -142.36 157.15 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.433 ' N ' HG22 ' A' ' 116' ' ' VAL . 62.1 ttp180 -146.48 149.83 34.42 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.157 0.503 . . . . 0.0 111.46 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.507 HG22 ' HB3' ' A' ' 62' ' ' ALA . 61.5 t -115.05 134.28 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.3 t -129.87 151.09 50.82 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.025 0.441 . . . . 0.0 110.924 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 49.9 p-10 -151.87 85.57 1.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.196 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.62 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 9.2 t60 -171.67 -38.03 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.62 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 74.2 Cg_endo -97.49 -159.45 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.931 0 C-N-CA 122.45 2.1 . . . . 0.0 112.318 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 32.5 mt -79.71 -4.99 54.27 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.343 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 74.2 t -57.08 -46.13 84.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.777 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.75 HG23 ' H ' ' A' ' 126' ' ' ALA . 30.2 m -55.24 -61.49 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.302 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.024 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.75 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -40.44 -47.09 2.55 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.844 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.695 HD13 ' C ' ' A' ' 127' ' ' LEU . 2.8 tm? -69.82 -47.28 63.36 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.571 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 85.3 m -68.71 -47.3 66.71 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.103 0.477 . . . . 0.0 111.296 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.462 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.3 pp0? -55.63 -43.06 75.81 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.462 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -59.48 -56.09 26.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.311 -177.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -63.16 -35.66 81.03 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.128 -1.397 . . . . 0.0 108.346 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 89.96 3.32 73.6 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 113.388 -1.733 . . . . 0.0 109.684 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -141.79 153.77 64.98 Favored Pre-proline 0 CA--C 1.552 1.043 0 CA-C-N 117.258 0.529 . . . . 0.0 111.21 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -48.46 -174.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 123.724 2.949 . . . . 0.0 113.969 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.406 HD12 ' O ' ' A' ' 35' ' ' CYS . 8.1 tp -140.8 125.36 17.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 113.02 -1.9 . . . . 0.0 106.31 177.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.428 HG13 ' H ' ' A' ' 136' ' ' VAL . 0.9 OUTLIER -64.67 142.93 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 C-N-CA 118.179 -1.408 . . . . 0.0 108.931 -179.494 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 59' ' ' ILE . 0.8 OUTLIER -108.96 121.1 44.42 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 123.762 0.664 . . . . 0.0 110.583 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 18.7 m -132.18 145.47 51.37 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.9 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.1 m -66.7 144.12 56.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.529 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.11 88.57 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -162.23 164.33 27.75 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.275 0.56 . . . . 0.0 110.589 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.8 -163.85 1.82 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.173 -178.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 80.2 p -63.54 -40.41 96.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.752 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -159.35 0.81 0.09 OUTLIER Glycine 0 N--CA 1.461 0.332 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.488 HD13 ' C ' ' A' ' 145' ' ' LEU . 1.2 tm? -79.24 111.83 23.49 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 145' ' ' LEU . 14.3 Cg_exo -33.59 155.23 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.213 1.942 . . . . 0.0 113.095 -179.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.51 -168.79 0.37 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.513 2.142 . . . . 0.0 112.555 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 15.3 m -129.81 82.37 2.07 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.477 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 52.2 ptt85 -52.25 -37.49 55.46 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.362 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.28 173.63 14.74 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.561 HG13 ' CZ ' ' A' ' 31' ' ' PHE . 1.2 m -58.81 -23.92 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 CA-C-O 121.567 0.699 . . . . 0.0 109.386 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -64.73 -27.27 68.79 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 155' ' ' ARG . 0.0 OUTLIER -68.99 -79.52 0.06 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.449 179.194 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.405 HG13 ' N ' ' A' ' 155' ' ' ARG . 7.7 p -34.67 -30.23 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.607 0.763 . . . . 0.0 110.418 178.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 159' ' ' GLY . 4.8 tmt_? -71.9 -52.89 15.07 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.082 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 153' ' ' GLU . . . -69.93 -18.37 63.37 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 122.493 1.14 . . . . 0.0 108.186 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -84.16 -44.69 13.73 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 112.87 -1.968 . . . . 0.0 111.578 -178.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -130.37 -24.88 2.49 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 91.03 23.95 28.54 Favored Glycine 0 N--CA 1.47 0.948 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 -178.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -43.9 -93.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.584 -0.308 . . . . 0.0 111.091 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . 60.06 31.11 20.47 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.531 ' C ' ' H ' ' A' ' 164' ' ' VAL . 0.5 OUTLIER -170.19 -61.38 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.903 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -72.85 29.5 0.29 Allowed 'Trans proline' 0 N--CA 1.502 1.99 0 C-N-CA 122.283 1.989 . . . . 0.0 110.515 177.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.577 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.7 m -132.44 167.0 27.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.64 -178.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.1 t -123.63 66.86 37.69 Favored Pre-proline 0 N--CA 1.476 0.871 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.65 178.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.577 ' HD3' HG23 ' A' ' 164' ' ' VAL . 29.8 Cg_exo -38.45 147.22 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 123.693 2.929 . . . . 0.0 115.015 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 168.49 134.28 1.7 Allowed Glycine 0 CA--C 1.528 0.849 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.2 178.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -80.92 152.12 28.23 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.466 0.364 0 CA-C-O 121.125 0.488 . . . . 0.0 111.222 -179.587 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 N--CA 1.449 -0.517 0 CA-C-O 120.635 0.255 . . . . 0.0 110.569 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.7 pt -101.04 130.35 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 120.978 0.418 . . . . 0.0 110.337 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -123.44 163.3 21.13 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.601 0.715 . . . . 0.0 110.26 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -77.95 104.43 8.51 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.513 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -63.95 -17.66 63.49 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.879 -178.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.467 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.4 mm? -62.5 -42.26 99.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.947 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.53 -41.54 8.12 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.687 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.977 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.747 0.308 . . . . 0.0 110.501 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.538 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.3 mp -62.19 -42.59 99.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.164 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -65.03 -41.49 95.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.708 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -64.51 -42.54 95.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.075 0.465 . . . . 0.0 110.758 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.432 ' OD2' ' O ' ' A' ' 164' ' ' VAL . 66.1 t0 -65.78 -45.78 81.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.332 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.54 -48.75 73.92 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.456 HG23 ' N ' ' A' ' 11' ' ' ALA . 19.3 tt -67.35 -41.75 86.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.177 0.513 . . . . 0.0 110.761 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.456 ' N ' HG23 ' A' ' 10' ' ' ILE . . . -61.53 -40.9 96.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.754 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.95 -46.41 74.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.956 0.408 . . . . 0.0 110.525 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.78 -50.57 70.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.229 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.3 pp -68.92 -38.85 79.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.346 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.35 -54.52 45.84 Favored 'General case' 0 C--O 1.216 -0.71 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.264 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.426 ' O ' ' N ' ' A' ' 20' ' ' GLU . 99.5 t -60.54 -40.1 83.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.606 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.697 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.2 tt -52.41 -49.92 63.55 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.846 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -82.17 -51.2 8.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.614 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -63.65 -33.64 76.07 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.282 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.5 mt-10 58.16 83.26 0.12 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.451 179.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.4 -145.96 0.15 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.405 178.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.2 p -133.33 140.31 47.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -128.19 165.46 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-O 120.859 0.362 . . . . 0.0 111.531 -178.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.47 127.14 30.24 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.633 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.474 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 0.6 OUTLIER -117.09 140.49 27.15 Favored Pre-proline 0 N--CA 1.473 0.721 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.741 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.474 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 93.3 Cg_endo -77.3 144.06 22.81 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.242 1.295 . . . . 0.0 111.651 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.8 m -137.66 134.43 35.43 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.433 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -53.38 -44.85 68.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.167 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.94 -81.33 0.07 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.632 0.253 . . . . 0.0 111.444 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 71.8 t -133.32 128.69 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -36.77 144.67 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.773 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -141.17 -163.93 9.74 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.9 m -130.67 168.72 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -160.18 -179.34 34.9 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 119.963 -1.113 . . . . 0.0 112.297 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -157.97 -168.2 2.44 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.975 -179.242 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 19.9 p-10 -93.24 108.7 35.07 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 36' ' ' ASP . 33.7 Cg_exo -36.86 172.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.972 2.448 . . . . 0.0 114.574 177.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 41.76 73.32 0.13 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.231 -1.349 . . . . 0.0 111.124 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.1 m -153.39 134.34 13.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.608 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -67.69 -34.16 76.34 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.811 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.574 HG23 ' N ' ' A' ' 42' ' ' ALA . 15.1 t -63.34 -46.49 86.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.996 -178.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.574 ' N ' HG23 ' A' ' 41' ' ' THR . . . -60.12 -50.43 73.74 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.538 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 p -62.04 -45.23 99.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.831 0.348 . . . . 0.0 110.279 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 61.7 mtt -64.36 -39.53 94.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.865 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 -60.91 -34.25 74.39 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 123.537 0.523 . . . . 0.0 109.831 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 82.2 mt -73.56 -60.39 2.27 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.2 mt -54.77 -18.02 4.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.678 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -67.85 -84.67 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.901 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -75.86 -33.06 59.99 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.581 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -76.1 -69.69 0.49 Allowed 'General case' 0 C--N 1.348 0.525 0 C-N-CA 119.421 -0.911 . . . . 0.0 110.382 -177.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 50.89 80.27 0.08 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.706 0.765 . . . . 0.0 109.201 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.7 mtm180 162.87 -62.71 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.271 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.14 -15.51 48.72 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.423 2.082 . . . . 0.0 112.455 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.612 HG13 ' N ' ' A' ' 55' ' ' ASP . 10.9 p -41.79 -49.31 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.72 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.612 ' N ' HG13 ' A' ' 54' ' ' VAL . 37.0 t0 -65.38 -41.87 93.28 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.029 0.443 . . . . 0.0 110.935 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -59.89 -37.06 78.29 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.392 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 63.32 107.8 0.01 OUTLIER Glycine 0 CA--C 1.519 0.284 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.566 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -52.92 -162.46 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.216 0.531 . . . . 0.0 111.661 -179.449 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.7 mt -108.17 146.95 13.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.7 mt -119.62 139.29 52.42 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.8 tp -110.28 133.08 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-O 121.133 0.492 . . . . 0.0 110.917 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.403 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -121.73 152.43 39.43 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.469 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.65 -29.6 7.95 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -111.29 149.8 30.56 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.233 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -79.26 -14.11 59.24 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -53.01 -30.83 37.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.961 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.02 -12.05 27.32 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.59 HD22 ' N ' ' A' ' 68' ' ' LEU . 3.3 mm? -92.57 -16.25 25.93 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.002 0.819 . . . . 0.0 108.97 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.467 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 50.9 tttm -77.71 -38.83 1.82 Allowed Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.671 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 67.1 Cg_endo -104.73 -2.64 0.2 Allowed 'Trans proline' 0 C--N 1.318 -1.03 0 C-N-CA 122.835 2.356 . . . . 0.0 112.648 -178.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -97.78 -8.46 28.45 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.749 0.309 . . . . 0.0 110.791 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.611 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.3 mp -135.75 162.97 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.611 ' N ' HG22 ' A' ' 72' ' ' ILE . 92.6 m-20 -64.78 156.65 29.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.628 -0.429 . . . . 0.0 109.857 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -94.29 8.48 41.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.76 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.528 HG23 ' N ' ' A' ' 76' ' ' MET . 14.9 t -73.58 -41.73 62.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.181 0.515 . . . . 0.0 110.568 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.528 ' N ' HG23 ' A' ' 75' ' ' THR . 21.7 ptp -90.12 -7.37 53.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.095 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 tp -102.0 120.41 40.37 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.097 0.475 . . . . 0.0 110.746 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -159.12 160.68 35.91 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.576 -177.828 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -39.13 -48.17 1.67 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.789 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.3 p -62.96 -33.19 59.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.852 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 78' ' ' THR . 63.6 tp60 -65.49 -39.66 92.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.974 0.416 . . . . 0.0 110.764 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.1 mmt85 -65.07 -52.14 57.4 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 122.523 1.154 . . . . 0.0 109.181 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -55.35 -50.5 69.51 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 113.702 -1.59 . . . . 0.0 110.235 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.1 m -61.19 -49.92 75.24 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.167 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 85' ' ' ILE . 9.0 tt -67.98 -34.07 64.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.202 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -75.66 -39.36 57.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.865 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.5 m -77.4 -32.46 54.82 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 120.991 0.424 . . . . 0.0 110.955 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 89' ' ' TRP . 76.1 ttt180 -97.14 75.93 2.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.389 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.435 ' O ' ' O ' ' A' ' 88' ' ' ARG . 57.7 m95 56.19 150.19 0.06 OUTLIER Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.244 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.77 -19.84 35.53 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.277 1.985 . . . . 0.0 111.738 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 163.11 82.03 0.04 OUTLIER Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -80.84 -30.91 1.58 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.352 2.035 . . . . 0.0 112.169 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.532 ' O ' ' CE1' ' A' ' 95' ' ' PHE . 9.4 p -136.76 149.14 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.738 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 91.8 m -91.59 143.16 26.86 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.627 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.543 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 0.2 OUTLIER -125.5 147.01 49.4 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.207 179.24 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.617 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 3.0 t -99.6 107.84 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 121.376 0.607 . . . . 0.0 109.394 178.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.402 ' CE1' ' HB1' ' A' ' 181' ' ' ALA . 58.8 m-85 -94.53 151.17 39.08 Favored Pre-proline 0 N--CA 1.47 0.552 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.734 -178.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.11 106.44 2.27 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 121.695 1.597 . . . . 0.0 110.403 178.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.81 150.1 83.34 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.02 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 101' ' ' ALA . 98.9 Cg_endo -73.07 157.49 50.74 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.379 2.053 . . . . 0.0 112.986 -178.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.438 ' O ' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.627 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.523 ' O ' ' N ' ' A' ' 109' ' ' GLY . 11.6 tpp180 . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 120.778 0.323 . . . . 0.0 110.679 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 61.7 p-90 -73.6 -10.75 60.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.929 0.395 . . . . 0.0 110.434 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.952 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -85.99 -16.56 37.9 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.115 -179.766 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.623 ' N ' HD22 ' A' ' 107' ' ' LEU . 98.9 m -141.9 -39.53 0.37 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.724 0.297 . . . . 0.0 110.8 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 82.31 13.86 77.84 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.66 -68.83 0.06 Allowed 'General case' 0 CA--C 1.535 0.366 0 O-C-N 122.444 -0.445 . . . . 0.0 110.166 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -103.58 -162.47 0.91 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.967 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.9 p-10 -127.64 62.29 1.39 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.026 0.441 . . . . 0.0 110.957 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.2 p -158.77 157.47 31.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.015 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.514 ' O ' HD12 ' A' ' 114' ' ' LEU . 0.3 OUTLIER -160.41 140.9 11.66 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -179.258 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.431 ' N ' HG13 ' A' ' 96' ' ' VAL . . . -70.58 126.93 31.01 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 113.094 -1.867 . . . . 0.0 109.702 177.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.4 p -146.02 152.83 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -147.81 156.94 43.25 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.783 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.403 HG22 ' HB3' ' A' ' 62' ' ' ALA . 54.7 t -119.74 132.32 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.432 ' O ' HG23 ' A' ' 119' ' ' THR . 11.3 t -133.27 128.36 35.66 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.734 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -135.82 84.1 2.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.925 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.66 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 16.6 t-80 -173.2 -35.63 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.58 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.66 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 67.7 Cg_endo -94.74 -159.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.935 0 C-N-CA 121.995 1.797 . . . . 0.0 111.907 -178.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 36.7 mt -77.69 -7.38 56.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.535 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 95.7 t -57.46 -45.27 85.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.716 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.752 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.9 m -51.63 -62.05 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.943 0 C-N-CA 119.555 -0.858 . . . . 0.0 108.797 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.752 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.34 -44.81 2.86 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.792 0.329 . . . . 0.0 110.809 178.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.441 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -66.33 -50.96 61.83 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 121.27 0.557 . . . . 0.0 110.723 179.461 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 62.3 m -69.64 -48.46 59.82 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.326 0.584 . . . . 0.0 111.558 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.457 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 0.8 OUTLIER -54.58 -42.38 70.96 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.451 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -59.28 -55.5 34.02 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.583 -177.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -62.62 -24.71 67.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.191 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.69 2.07 88.85 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 134' ' ' PRO . 59.7 mttt -153.53 159.54 32.0 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 133' ' ' LYS . 3.6 Cg_exo -42.23 177.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 123.876 3.051 . . . . 0.0 113.008 -178.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.3 tp -132.38 122.42 24.99 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.417 HG13 ' H ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -64.14 147.47 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 C-N-CA 117.775 -1.57 . . . . 0.0 106.83 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.9 t -122.54 127.26 49.27 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.206 0.527 . . . . 0.0 111.269 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.9 162.18 30.22 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.663 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.6 m -73.59 145.95 45.06 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.95 88.28 2.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.367 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 56.8 p30 -160.74 164.39 31.61 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.342 0.592 . . . . 0.0 110.421 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.57 -167.15 2.13 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.991 -178.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.1 p -61.77 -40.19 94.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.785 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -162.18 9.81 0.1 Allowed Glycine 0 N--CA 1.459 0.216 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.6 tp -89.99 126.88 55.83 Favored Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -37.52 157.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.942 1.761 . . . . 0.0 112.516 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.0 -166.45 0.37 Allowed 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.578 2.186 . . . . 0.0 112.668 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 7.4 t -118.14 76.7 1.09 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.359 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -56.47 -33.89 66.38 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.389 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -162.72 169.56 19.81 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.104 -0.639 . . . . 0.0 109.319 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.433 ' H ' HG22 ' A' ' 151' ' ' VAL . 0.9 OUTLIER -58.6 -20.33 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.285 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -65.21 -33.05 75.09 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 177.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.447 ' O ' ' N ' ' A' ' 155' ' ' ARG . 6.5 tm-20 -63.72 -79.78 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.804 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.431 HG11 HG11 ' A' ' 164' ' ' VAL . 7.3 p -36.11 -30.42 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.589 0.756 . . . . 0.0 110.643 178.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.447 ' N ' ' O ' ' A' ' 153' ' ' GLU . 4.1 tmt_? -71.77 -49.17 41.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.243 0.544 . . . . 0.0 111.79 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 153' ' ' GLU . . . -71.45 -18.1 62.33 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 122.628 1.204 . . . . 0.0 108.004 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.17 -55.27 4.45 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 112.349 -2.205 . . . . 0.0 112.149 -177.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -123.99 -18.05 6.07 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -177.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 85.18 25.05 41.62 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -42.3 -94.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.649 0.262 . . . . 0.0 111.437 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.405 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.95 33.83 17.14 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.365 0.602 . . . . 0.0 109.46 -178.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.519 ' C ' ' H ' ' A' ' 164' ' ' VAL . 1.8 m-85 -172.42 -62.56 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.353 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.39 28.51 0.27 Allowed 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 122.438 2.092 . . . . 0.0 110.579 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.545 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.8 m -131.52 167.93 25.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.79 -178.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.0 t -124.12 64.6 35.99 Favored Pre-proline 0 N--CA 1.473 0.724 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.055 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.545 ' HD3' HG23 ' A' ' 164' ' ' VAL . 42.6 Cg_exo -39.95 149.23 0.13 Allowed 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 123.453 2.769 . . . . 0.0 114.616 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 172.47 -141.18 6.11 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 114.33 -1.305 . . . . 0.0 111.813 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -147.79 179.88 7.39 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.752 0.311 . . . . 0.0 110.195 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.3 t . . . . . 0 N--CA 1.465 0.299 0 CA-C-O 121.106 0.479 . . . . 0.0 110.631 -179.727 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 . . . . . 0 N--CA 1.442 -0.867 0 CA-C-O 120.537 0.208 . . . . 0.0 111.482 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 31.9 pt -91.72 135.56 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.401 0.619 . . . . 0.0 111.26 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -135.28 171.74 14.0 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.254 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 184' ' ' GLY . 98.6 m-20 -78.76 104.54 9.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.227 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.617 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -65.18 -20.23 66.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.573 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.508 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.5 mm? -63.77 -42.67 97.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.486 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.18 -44.3 3.02 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.49 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 180' ' ' ASP . . . . . . . . 0 CA--C 1.527 0.795 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 39.2 p-10 . . . . . 0 N--CA 1.461 0.106 0 CA-C-O 120.7 0.286 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.529 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.1 mp -62.4 -42.17 99.22 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -63.67 -42.32 98.08 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -63.08 -41.68 99.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.771 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 162' ' ' PHE . 63.6 t0 -59.09 -46.99 86.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.498 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.34 -44.39 97.27 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.191 0.519 . . . . 0.0 110.082 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.7 mt -63.56 -42.97 97.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.469 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.73 -43.92 81.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.572 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.17 -47.11 85.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.459 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.69 -52.18 66.62 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.7 pt -68.14 -38.97 80.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.112 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -57.95 -52.92 63.5 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.215 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 20' ' ' GLU . 96.8 t -61.17 -40.55 86.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.703 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.676 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.3 tt -52.51 -51.1 61.16 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.673 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -79.88 -50.62 10.22 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.774 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -63.45 -31.64 72.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.027 0.442 . . . . 0.0 110.721 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 16' ' ' VAL . 96.5 mt-10 58.55 81.09 0.16 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 178.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.85 -146.71 0.1 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.813 0.34 . . . . 0.0 110.641 177.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.421 HG12 ' NH2' ' A' ' 45' ' ' ARG . 5.8 p -128.16 139.67 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.434 HD12 ' O ' ' A' ' 24' ' ' ALA . 2.8 pp -128.96 167.76 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 120.892 0.377 . . . . 0.0 111.564 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.434 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -63.88 135.87 56.92 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.325 0.583 . . . . 0.0 111.528 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.5 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 1.6 t80 -127.96 139.19 34.67 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.5 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 68.1 Cg_endo -78.99 144.61 18.97 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 121.327 1.351 . . . . 0.0 111.572 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.503 ' C ' ' H ' ' A' ' 29' ' ' ALA . 47.6 m -134.19 132.93 40.35 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.74 0.305 . . . . 0.0 110.416 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -72.97 32.13 0.07 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.635 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.503 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -156.91 -77.75 0.09 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.723 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.1 p -128.36 130.3 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -44.01 142.6 1.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.141 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.29 -175.71 22.64 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.1 m -129.72 171.21 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.413 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -159.54 -179.38 34.31 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.111 -1.042 . . . . 0.0 111.896 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.471 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 1.4 p -159.42 -161.83 0.98 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 120.209 -0.596 . . . . 0.0 112.015 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.471 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 68.0 m-20 -93.02 107.07 22.15 Favored Pre-proline 0 CA--C 1.557 1.218 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -37.88 -61.73 0.34 Allowed 'Trans proline' 0 N--CA 1.5 1.854 0 C-N-CA 122.592 2.195 . . . . 0.0 112.928 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -76.45 69.51 2.92 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.364 -178.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.1 m -153.66 130.93 11.21 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.793 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.62 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -69.58 -33.26 72.46 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.59 -179.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.504 HG23 ' N ' ' A' ' 42' ' ' ALA . 14.2 t -57.56 -41.85 81.88 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.636 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.504 ' N ' HG23 ' A' ' 41' ' ' THR . . . -60.04 -52.55 64.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.498 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.405 ' H ' HG13 ' A' ' 43' ' ' VAL . 0.8 OUTLIER -61.58 -42.97 96.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-O 120.974 0.416 . . . . 0.0 110.511 -178.719 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.418 ' O ' ' CG ' ' A' ' 48' ' ' GLU . 56.8 mtt -65.19 -52.75 52.94 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.547 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.421 ' NH2' HG12 ' A' ' 22' ' ' VAL . 7.4 ptm180 -62.75 -37.31 86.09 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.186 0.517 . . . . 0.0 111.36 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -66.57 -53.42 34.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.407 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.449 HD22 HG23 ' A' ' 54' ' ' VAL . 7.8 mt -78.49 -7.59 57.63 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.187 -178.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 44' ' ' MET . 1.3 mm-40 -68.64 -79.93 0.05 Allowed 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.312 0.577 . . . . 0.0 111.707 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.423 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -71.7 -37.56 70.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.775 -177.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -67.76 -47.93 67.83 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.787 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 30.24 66.59 0.12 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.032 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.418 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 3.5 mtt180 -178.31 -54.76 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.604 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 52' ' ' ARG . 71.4 Cg_endo -72.99 -1.43 10.48 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.965 1.777 . . . . 0.0 109.448 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.449 HG23 HD22 ' A' ' 47' ' ' LEU . 0.7 OUTLIER -45.17 -48.99 3.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.435 -179.618 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -71.59 -39.61 70.43 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 110.936 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.409 ' N ' ' CD ' ' A' ' 56' ' ' LYS . 1.1 mptm? -61.2 -38.8 87.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.306 -179.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 62.33 107.8 0.01 OUTLIER Glycine 0 CA--C 1.521 0.437 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.553 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -54.1 -160.24 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.52 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.2 mt -110.04 148.14 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.095 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.4 mt -122.61 142.01 51.1 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.3 tp -109.44 131.02 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-O 120.878 0.37 . . . . 0.0 110.854 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.31 146.84 45.72 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.94 -29.19 10.63 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.114 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.779 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 11.8 m120 -117.95 152.27 35.8 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.146 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -79.85 -14.34 58.73 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.632 0.73 . . . . 0.0 109.438 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -51.58 -32.55 29.01 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.206 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.779 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 5.5 pm0 -93.12 -8.93 41.25 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.893 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -90.76 -18.87 24.22 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.555 ' NZ ' HH12 ' A' ' 82' ' ' ARG . 32.6 mttp -76.22 -37.92 2.21 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 63.2 Cg_endo -104.82 -2.51 0.2 Allowed 'Trans proline' 0 C--N 1.319 -1.019 0 C-N-CA 122.868 2.378 . . . . 0.0 112.755 -178.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -93.87 -10.98 32.11 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.723 0.296 . . . . 0.0 111.158 -178.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.635 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.2 mp -125.45 168.76 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.635 ' N ' HG22 ' A' ' 72' ' ' ILE . 91.5 m-20 -63.14 -17.9 62.86 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.869 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.6 t70 57.04 22.38 7.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.929 0.395 . . . . 0.0 110.8 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.526 HG23 ' N ' ' A' ' 76' ' ' MET . 13.6 t -88.76 -41.56 12.47 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.779 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.526 ' N ' HG23 ' A' ' 75' ' ' THR . 14.2 ptp -84.38 -21.89 30.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.142 179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 tp -73.18 136.25 44.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.663 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.27 165.56 35.91 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.682 -177.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -48.45 -45.61 36.7 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.211 0.32 . . . . 0.0 111.799 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.1 p -61.96 -33.27 57.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.175 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 66.7 tp60 -64.4 -40.04 95.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.922 0.391 . . . . 0.0 110.455 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.555 HH12 ' NZ ' ' A' ' 69' ' ' LYS . 5.5 mmt85 -64.2 -53.09 54.76 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 122.256 1.027 . . . . 0.0 109.169 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -54.63 -50.2 68.69 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.884 -1.507 . . . . 0.0 109.984 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 m -61.33 -50.01 74.66 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.412 -1.267 . . . . 0.0 112.003 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.8 tt -68.44 -31.16 50.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.863 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -77.53 -36.29 52.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.528 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.8 m -85.57 -18.91 31.99 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.098 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 89' ' ' TRP . 58.5 ttt85 -112.63 78.56 1.14 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.334 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.438 ' O ' ' O ' ' A' ' 88' ' ' ARG . 41.3 m95 56.94 150.26 0.06 OUTLIER Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.431 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.09 -23.31 46.26 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 122.24 1.96 . . . . 0.0 112.094 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 158.73 79.61 0.03 OUTLIER Glycine 0 CA--C 1.528 0.906 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -81.33 -15.24 10.18 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.391 2.06 . . . . 0.0 111.985 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.9 p -136.06 144.45 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.562 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.498 ' N ' ' O ' ' A' ' 177' ' ' GLU . 25.6 m -95.13 132.85 39.6 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.92 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.49 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 45.9 m-85 -118.08 140.79 49.25 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.437 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.64 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.5 t -100.12 109.79 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 121.549 0.69 . . . . 0.0 110.811 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -95.62 148.74 35.08 Favored Pre-proline 0 N--CA 1.471 0.577 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.023 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.48 87.98 0.41 Allowed 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 121.952 1.768 . . . . 0.0 110.587 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -50.59 149.94 5.36 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.894 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.445 ' O ' ' HB2' ' A' ' 101' ' ' ALA . 98.1 Cg_endo -73.99 157.36 47.07 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.116 1.877 . . . . 0.0 110.148 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.445 ' HB2' ' O ' ' A' ' 100' ' ' PRO . . . . . . . . 0 C--N 1.328 -0.35 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.667 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.513 ' NH2' ' O ' ' A' ' 110' ' ' ARG . 7.7 tpt180 . . . . . 0 C--O 1.225 -0.194 0 CA-C-O 120.6 0.238 . . . . 0.0 110.723 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 66.5 p-90 -87.3 -10.74 51.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.603 0.716 . . . . 0.0 109.927 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.679 ' H ' ' CD2' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -85.02 -18.18 35.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.618 -179.113 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.409 ' H ' HD23 ' A' ' 107' ' ' LEU . 87.2 m -144.63 -39.98 0.26 Allowed 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.573 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.7 -3.32 87.02 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.262 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.513 ' O ' ' NH2' ' A' ' 105' ' ' ARG . 13.6 tpt180 -154.8 -78.68 0.09 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.036 0.918 . . . . 0.0 111.311 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -95.52 -175.27 3.41 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -125.28 81.52 1.98 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.019 0.437 . . . . 0.0 110.842 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 24.9 p -166.33 128.5 1.87 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.409 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.483 ' C ' HG13 ' A' ' 96' ' ' VAL . 69.1 mt -125.27 127.33 46.54 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.524 ' HB2' HG22 ' A' ' 96' ' ' VAL . . . -75.39 130.35 38.84 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.892 176.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.416 HG22 ' N ' ' A' ' 117' ' ' ARG . 13.5 p -144.63 153.75 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 120.897 0.379 . . . . 0.0 110.563 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.416 ' N ' HG22 ' A' ' 116' ' ' VAL . 62.3 ttp180 -142.99 156.55 44.88 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.14 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.0 t -124.29 132.31 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-O 121.103 0.478 . . . . 0.0 109.795 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.443 ' O ' HG23 ' A' ' 119' ' ' THR . 14.4 t -135.32 129.01 32.82 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.656 178.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -135.47 87.08 2.29 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.859 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.653 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 34.9 t60 -172.15 -36.92 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.653 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 63.5 Cg_endo -95.24 -160.48 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.939 0 C-N-CA 122.23 1.953 . . . . 0.0 111.619 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.9 mt -77.78 -5.03 49.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.253 0.549 . . . . 0.0 110.703 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 83.2 t -58.05 -44.81 87.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.725 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.748 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.0 m -53.01 -61.73 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 C-N-CA 119.626 -0.83 . . . . 0.0 108.884 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.748 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.05 -44.17 2.36 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.886 0.374 . . . . 0.0 110.749 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.6 tp -69.41 -47.37 64.36 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.452 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 57.9 m -70.47 -49.93 43.4 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.574 0.702 . . . . 0.0 110.623 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.465 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.1 pp0? -54.19 -41.75 68.93 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.383 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.78 -55.22 37.88 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.81 -177.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.455 ' CE1' ' OD2' ' A' ' 36' ' ' ASP . 46.7 t80 -61.28 -18.96 61.05 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.565 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.61 0.44 84.29 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -154.18 159.56 31.85 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 120.614 -0.434 . . . . 0.0 109.931 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -40.99 173.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 124.043 3.162 . . . . 0.0 113.22 -178.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.405 HD12 ' O ' ' A' ' 35' ' ' CYS . 7.6 tp -127.53 123.23 35.33 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 176.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.462 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -65.56 146.83 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 C-N-CA 117.998 -1.481 . . . . 0.0 107.487 -179.492 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 t -117.44 122.64 44.33 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 123.638 0.586 . . . . 0.0 110.664 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 3.2 m -131.9 163.82 27.47 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.842 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.4 m -72.26 145.44 47.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.238 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.11 -37.81 88.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.982 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.401 ' OD1' ' O ' ' A' ' 141' ' ' ASN . 53.4 p30 -49.46 150.43 1.89 Allowed 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.674 0.749 . . . . 0.0 111.095 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.32 -158.37 0.79 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.232 -178.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.5 t -62.47 -42.51 99.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.03 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -161.75 2.62 0.07 OUTLIER Glycine 0 N--CA 1.459 0.217 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.5 tp -85.95 125.23 69.22 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-O 119.389 -0.339 . . . . 0.0 110.35 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -40.45 157.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.627 1.551 . . . . 0.0 111.826 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.35 -162.92 0.18 Allowed 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.519 2.146 . . . . 0.0 112.083 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 148' ' ' CYS . 29.0 p -112.29 80.01 1.29 Allowed 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -55.09 -32.75 62.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.664 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -164.77 163.86 21.26 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.342 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.427 HG11 ' HA ' ' A' ' 166' ' ' PRO . 1.3 m -56.72 -15.75 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.806 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -66.76 -34.04 76.95 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 150' ' ' THR . 5.1 tm-20 -60.48 -71.87 0.12 Allowed 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.933 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.437 HG11 HG11 ' A' ' 164' ' ' VAL . 7.3 p -48.48 -32.91 4.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.275 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 159' ' ' GLY . 4.1 tmt_? -78.96 -51.66 9.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.773 0.796 . . . . 0.0 109.416 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.94 -44.85 64.08 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.676 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.71 -29.33 27.63 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 112.826 -1.988 . . . . 0.0 114.28 -175.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -126.39 -33.95 2.53 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 118.341 0.519 . . . . 0.0 111.331 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 94.59 24.7 17.5 Favored Glycine 0 N--CA 1.466 0.682 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.411 ' HB1' ' HG2' ' A' ' 163' ' ' PRO . . . -43.3 -94.4 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.517 0.199 . . . . 0.0 110.685 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.435 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.55 37.18 16.53 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.546 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.5 m-85 -176.48 -62.06 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.284 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.411 ' HG2' ' HB1' ' A' ' 160' ' ' ALA . 84.3 Cg_endo -73.58 28.86 0.31 Allowed 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.544 2.163 . . . . 0.0 110.46 178.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.569 HG23 ' HD3' ' A' ' 166' ' ' PRO . 16.1 m -132.62 166.1 30.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.814 -178.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.6 t -123.06 65.41 27.87 Favored Pre-proline 0 N--CA 1.475 0.797 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.517 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.569 ' HD3' HG23 ' A' ' 164' ' ' VAL . 23.7 Cg_exo -35.41 142.78 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 123.588 2.858 . . . . 0.0 115.362 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 169.01 178.28 40.33 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 113.688 -1.596 . . . . 0.0 110.89 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -155.84 149.83 25.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.775 0.321 . . . . 0.0 110.386 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.465 0.313 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.457 179.885 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 94' ' ' THR . 1.2 pp20? . . . . . 0 N--CA 1.466 0.36 0 CA-C-O 120.848 0.356 . . . . 0.0 110.052 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.501 ' O ' HG23 ' A' ' 178' ' ' ILE . 18.3 tt -96.4 121.03 46.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.307 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -129.22 165.01 22.2 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.491 0.662 . . . . 0.0 111.73 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -78.14 106.13 9.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.008 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -66.33 -18.87 65.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.664 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.472 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.5 mm? -62.61 -41.9 99.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.398 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.53 -45.07 3.03 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.716 0.293 . . . . 0.0 110.61 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.66 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -179.682 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 N--CA 1.461 0.116 0 CA-C-O 120.752 0.311 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.666 HD22 ' N ' ' A' ' 5' ' ' LEU . 3.0 mm? -63.07 -41.65 99.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.878 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -61.46 -43.67 98.45 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -59.34 -41.45 89.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.459 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 162' ' ' PHE . 41.3 t0 -61.31 -40.25 93.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.264 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.6 -48.42 81.86 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.813 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.5 mm -63.51 -44.78 98.87 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.698 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.46 -46.56 76.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.053 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.48 -45.71 91.79 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.06 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.12 -51.15 70.32 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 13.3 pt -69.3 -40.09 79.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.506 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -58.47 -54.62 44.94 Favored 'General case' 0 C--O 1.218 -0.557 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.136 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.491 ' O ' ' N ' ' A' ' 20' ' ' GLU . 99.5 t -62.01 -39.81 85.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.638 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.661 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.5 tt -52.38 -50.4 62.51 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.587 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -79.95 -51.6 8.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.644 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -64.83 -34.43 78.35 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.41 -178.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.8 mt-10 58.5 87.41 0.07 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.311 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.47 -132.8 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 178.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.6 p -144.29 140.08 24.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.457 HD12 ' O ' ' A' ' 24' ' ' ALA . 2.8 pp -130.72 163.95 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 121.163 0.506 . . . . 0.0 111.905 -178.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.457 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -59.76 136.3 57.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.87 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.532 ' CZ ' ' O ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -132.13 145.39 57.16 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.21 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.532 ' O ' ' CZ ' ' A' ' 25' ' ' TYR . 61.9 Cg_endo -78.85 146.83 21.06 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.465 1.443 . . . . 0.0 111.383 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.489 ' C ' ' H ' ' A' ' 29' ' ' ALA . 28.7 m -130.21 135.9 48.64 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.88 0.372 . . . . 0.0 110.123 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -75.35 22.0 0.13 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.489 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -156.17 -73.63 0.1 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.327 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.4 p -122.71 126.28 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-O 121.335 0.588 . . . . 0.0 111.392 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.486 ' CD1' ' O ' ' A' ' 148' ' ' CYS . 16.7 t80 -45.34 132.36 7.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.389 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.62 -171.52 13.9 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.309 -0.717 . . . . 0.0 111.309 -179.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 m -131.12 169.51 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.408 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -157.98 -178.21 31.81 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 120.105 -1.045 . . . . 0.0 112.616 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.554 ' O ' HD12 ' A' ' 135' ' ' LEU . 0.5 OUTLIER -156.56 -163.04 1.35 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.546 0.213 . . . . 0.0 110.577 -179.757 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.516 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 44.3 m-20 -100.39 109.11 55.95 Favored Pre-proline 0 CA--C 1.554 1.123 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -178.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 36' ' ' ASP . 55.5 Cg_exo -38.36 173.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.765 2.31 . . . . 0.0 114.105 177.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 42.91 65.66 0.91 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.719 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.0 m -152.35 139.22 18.99 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.41 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -65.98 -28.43 68.88 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.104 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.524 HG23 ' N ' ' A' ' 42' ' ' ALA . 14.9 t -59.93 -42.8 94.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.666 -178.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.524 ' N ' HG23 ' A' ' 41' ' ' THR . . . -59.07 -52.02 67.53 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.38 0.61 . . . . 0.0 111.414 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.11 -45.76 95.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.895 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 91.9 mtp -66.41 -47.05 74.48 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.5 ptt85 -62.23 -30.24 70.96 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.173 -178.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 45.2 mt -73.4 -61.89 1.67 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.382 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.2 mt -54.02 -20.43 6.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.655 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -63.81 -85.61 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.666 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.497 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.2 pt? -77.5 -35.42 53.57 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -73.67 -48.18 34.22 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 119.709 -0.797 . . . . 0.0 111.049 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 35.25 65.17 0.4 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.957 -1.019 . . . . 0.0 111.78 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.407 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 8.1 mtm-85 179.84 -53.73 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.909 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.675 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.407 ' HD2' ' H ' ' A' ' 52' ' ' ARG . 72.1 Cg_endo -75.1 -7.16 18.83 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.422 2.081 . . . . 0.0 112.783 -178.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.614 HG13 ' N ' ' A' ' 55' ' ' ASP . 12.8 p -41.42 -47.03 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.119 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.614 ' N ' HG13 ' A' ' 54' ' ' VAL . 36.6 t0 -67.66 -39.5 84.55 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.076 0.465 . . . . 0.0 110.786 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.479 ' CD ' ' N ' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -61.92 -39.52 92.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.318 -179.299 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 62.9 105.6 0.01 OUTLIER Glycine 0 CA--C 1.52 0.394 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.57 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -49.76 -168.2 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.821 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.4 HG23 HG21 ' A' ' 94' ' ' THR . 75.0 mt -102.64 147.84 8.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.1 mt -120.73 141.25 50.62 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.414 HD12 ' HG3' ' A' ' 117' ' ' ARG . 8.6 tp -108.88 132.46 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-O 121.062 0.458 . . . . 0.0 109.96 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.519 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -123.35 152.99 40.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.392 0.615 . . . . 0.0 109.86 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -112.32 -30.03 7.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.181 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -114.1 151.78 32.07 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.648 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -79.05 -13.84 59.52 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.567 0.698 . . . . 0.0 109.974 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -53.8 -30.96 47.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.267 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.79 -8.81 39.52 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.53 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -89.13 -20.79 23.83 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.446 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 69.9 tttt -73.81 -39.97 4.78 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 95.2 Cg_endo -102.38 -5.36 0.29 Allowed 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 122.672 2.248 . . . . 0.0 112.478 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -88.57 -17.87 29.28 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.652 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.532 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.0 mp -122.34 157.53 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.532 ' N ' HG22 ' A' ' 72' ' ' ILE . 4.4 m-20 -64.34 146.59 54.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.846 0.355 . . . . 0.0 110.203 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -91.9 38.8 1.0 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.058 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.536 HG23 ' N ' ' A' ' 76' ' ' MET . 11.3 t -108.34 -41.76 4.78 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.995 0.426 . . . . 0.0 110.208 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.536 ' N ' HG23 ' A' ' 75' ' ' THR . 8.4 ptp -93.05 -17.5 23.78 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.239 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.51 HD21 ' NH2' ' A' ' 82' ' ' ARG . 31.7 tp -79.83 128.18 33.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.277 -177.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -153.86 163.63 39.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.726 -177.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -49.15 -45.74 44.23 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.718 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -61.09 -31.94 51.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.964 -0.295 . . . . 0.0 111.197 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 66.8 tp60 -65.56 -40.6 92.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.216 0.531 . . . . 0.0 110.427 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.51 ' NH2' HD21 ' A' ' 77' ' ' LEU . 9.7 mmt85 -64.21 -51.65 62.7 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 122.522 1.154 . . . . 0.0 109.287 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -56.44 -50.33 71.98 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 113.668 -1.605 . . . . 0.0 110.325 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -61.74 -49.7 75.37 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.826 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.1 tt -67.59 -31.53 52.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.486 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -77.32 -35.09 55.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.748 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.6 m -88.0 -18.65 28.55 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.475 0.178 . . . . 0.0 111.282 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.414 ' O ' ' O ' ' A' ' 89' ' ' TRP . 77.3 ttt-85 -110.39 77.84 1.08 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.554 ' CD1' ' N ' ' A' ' 89' ' ' TRP . 1.2 m0 59.18 148.71 0.07 OUTLIER Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.21 -31.53 35.67 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 121.741 1.627 . . . . 0.0 112.508 -178.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.445 ' H ' ' HD3' ' A' ' 92' ' ' PRO . . . 150.35 61.12 0.01 OUTLIER Glycine 0 CA--C 1.531 1.061 0 C-N-CA 121.089 -0.577 . . . . 0.0 111.97 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.445 ' HD3' ' H ' ' A' ' 91' ' ' GLY . 57.4 Cg_endo -70.22 -15.73 35.43 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.718 2.279 . . . . 0.0 111.828 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.0 p -122.6 136.47 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.137 0.494 . . . . 0.0 110.079 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 177' ' ' GLU . 27.3 m -91.37 135.26 33.95 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.936 -179.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.481 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 42.1 m-85 -120.69 139.71 52.65 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.914 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.627 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.4 t -97.17 109.02 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-O 121.347 0.594 . . . . 0.0 110.902 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -94.37 149.9 37.38 Favored Pre-proline 0 N--CA 1.469 0.506 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.965 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.403 ' O ' ' OD2' ' A' ' 73' ' ' ASP . 58.7 Cg_endo -69.41 86.93 0.52 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.991 1.794 . . . . 0.0 111.12 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.423 ' O ' ' OD1' ' A' ' 112' ' ' ASP . . . -50.95 153.51 3.0 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.452 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.44 157.47 58.97 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.193 1.929 . . . . 0.0 111.629 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.251 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.396 -179.827 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 109' ' ' GLY . 8.2 tpt180 . . . . . 0 CA--C 1.531 0.243 0 CA-C-O 120.878 0.37 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 2.4 p90 -71.67 -7.13 46.06 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.531 -179.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 1.029 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -73.08 -23.25 60.51 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.769 179.823 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.673 ' H ' HD22 ' A' ' 107' ' ' LEU . 85.1 m -143.09 -40.1 0.32 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.812 179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 80.2 -0.42 83.99 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.638 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -148.21 -80.64 0.13 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.427 0.613 . . . . 0.0 110.822 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -89.91 -173.02 3.74 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 99' ' ' ALA . 66.3 t0 -131.05 70.83 1.46 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.91 0.386 . . . . 0.0 110.832 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 80.5 p -160.6 127.83 4.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.583 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.494 ' C ' HG13 ' A' ' 96' ' ' VAL . 63.0 mt -124.03 129.04 50.25 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -178.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.528 ' HB2' HG22 ' A' ' 96' ' ' VAL . . . -77.32 122.54 25.26 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.276 176.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.447 HG22 ' N ' ' A' ' 117' ' ' ARG . 10.9 p -141.29 155.96 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.937 0.398 . . . . 0.0 110.54 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.447 ' N ' HG22 ' A' ' 116' ' ' VAL . 19.3 ptt180 -149.19 158.22 44.0 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.665 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.519 HG22 ' HB3' ' A' ' 62' ' ' ALA . 70.8 t -122.52 134.87 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.11 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 119' ' ' THR . 12.2 t -138.4 127.85 24.67 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.664 178.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -133.24 87.45 2.39 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.129 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.682 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 19.1 t60 -172.01 -35.22 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 112.486 0.551 . . . . 0.0 112.486 -179.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.682 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 73.7 Cg_endo -95.7 -158.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.482 0.795 0 C-N-CA 122.288 1.992 . . . . 0.0 111.761 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 19.4 mt -79.26 -6.18 56.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.661 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 79.9 t -57.22 -45.62 84.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.538 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.738 HG23 ' H ' ' A' ' 126' ' ' ALA . 26.9 m -51.01 -61.68 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.864 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.738 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.63 -44.52 3.12 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.984 0.421 . . . . 0.0 110.726 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.433 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -66.54 -51.54 55.43 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.08 0.467 . . . . 0.0 110.571 179.413 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 79.2 m -69.34 -48.45 61.33 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.252 0.549 . . . . 0.0 111.396 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.468 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.1 pp0? -54.56 -42.05 70.51 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.507 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -60.11 -54.83 41.22 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.139 -1.392 . . . . 0.0 109.399 -177.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -64.13 -21.67 66.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.085 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.41 1.55 86.34 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 55.5 mttt -152.66 159.48 32.43 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 120.718 -0.393 . . . . 0.0 109.971 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -43.16 178.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 124.053 3.169 . . . . 0.0 113.389 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.554 HD12 ' O ' ' A' ' 35' ' ' CYS . 8.2 tp -133.35 123.29 25.14 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 177.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.43 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -64.65 146.16 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 C-N-CA 117.796 -1.562 . . . . 0.0 107.678 -179.736 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.9 t -119.37 129.53 54.87 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.283 0.563 . . . . 0.0 111.23 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.5 m -131.79 164.23 26.48 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.241 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.2 m -75.18 148.06 39.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.24 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.51 88.91 2.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.615 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 57.6 p30 -164.02 163.28 23.39 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.396 0.617 . . . . 0.0 110.814 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.85 -165.57 1.91 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.096 -178.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 38.8 t -61.95 -43.89 97.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.925 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -160.65 11.08 0.14 Allowed Glycine 0 N--CA 1.459 0.22 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.6 tp -88.71 127.17 57.28 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -39.13 154.12 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.682 1.588 . . . . 0.0 111.83 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.418 ' O ' ' N ' ' A' ' 149' ' ' ARG . 89.9 Cg_endo -74.38 149.99 40.71 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.227 1.951 . . . . 0.0 112.392 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.486 ' O ' ' CD1' ' A' ' 31' ' ' PHE . 72.8 m -67.92 74.22 0.19 Allowed 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 147' ' ' PRO . 32.2 ptt-85 -58.3 -34.38 70.49 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.502 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -160.33 163.75 33.04 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.472 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.412 HG11 ' HA ' ' A' ' 166' ' ' PRO . 0.9 OUTLIER -56.62 -17.45 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.821 0 CA-C-O 121.577 0.703 . . . . 0.0 109.223 -179.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -64.71 -35.67 81.79 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 177.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.437 ' OE1' ' OE1' ' A' ' 157' ' ' GLN . 5.1 tm-20 -59.49 -74.86 0.06 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.688 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.404 HG11 HG11 ' A' ' 164' ' ' VAL . 7.8 p -44.7 -29.04 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.242 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.421 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -83.95 -45.3 13.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 122.201 1.0 . . . . 0.0 110.047 179.767 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.84 -40.69 80.7 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.769 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.437 ' OE1' ' OE1' ' A' ' 153' ' ' GLU . 8.7 pt20 -81.57 -49.02 11.04 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 113.167 -1.833 . . . . 0.0 112.566 -176.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.429 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 20.8 m-85 -110.05 -33.55 6.66 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 97.61 27.63 8.96 Favored Glycine 0 N--CA 1.475 1.285 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.606 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -44.13 -94.8 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.759 0.314 . . . . 0.0 111.07 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.507 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.83 35.71 16.43 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -178.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.507 ' CD2' ' O ' ' A' ' 161' ' ' ALA . 2.1 m-85 -174.77 -62.53 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.471 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -73.03 28.85 0.29 Allowed 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.525 2.15 . . . . 0.0 110.49 178.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.567 HG23 ' HD3' ' A' ' 166' ' ' PRO . 17.1 m -131.98 167.39 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.542 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.0 t -124.24 64.82 37.87 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.549 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.567 ' HD3' HG23 ' A' ' 164' ' ' VAL . 20.4 Cg_exo -35.18 142.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 123.699 2.933 . . . . 0.0 115.056 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 167.02 -177.71 41.56 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 114.051 -1.431 . . . . 0.0 110.989 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -146.98 152.33 38.44 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.467 0.382 0 CA-C-O 120.993 0.425 . . . . 0.0 110.944 -179.757 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 94' ' ' THR . 5.7 pt-20 . . . . . 0 N--CA 1.471 0.597 0 CA-C-O 120.404 0.145 . . . . 0.0 111.134 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 178' ' ' ILE . 18.2 tt -87.08 122.63 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-O 120.922 0.391 . . . . 0.0 110.763 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -135.21 168.08 19.82 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.409 0.623 . . . . 0.0 111.648 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -78.73 106.03 10.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.562 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -65.57 -13.57 59.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.649 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.476 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.4 mm? -63.32 -41.08 98.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.193 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 5.2 t -119.75 -23.49 6.48 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.955 0.407 . . . . 0.0 110.458 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.743 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -179.876 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 56.5 p30 . . . . . 0 N--CA 1.47 0.543 0 CA-C-O 120.896 0.379 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.8 mp -62.54 -42.22 99.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.039 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -63.88 -40.85 97.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.321 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -64.72 -40.87 96.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.636 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 162' ' ' PHE . 63.1 t0 -59.34 -46.38 88.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.332 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.19 -43.9 97.79 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.95 0.405 . . . . 0.0 110.17 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.1 mt -63.76 -43.19 97.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.97 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.2 -46.52 82.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.533 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.91 -45.98 92.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.423 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.25 -52.86 63.48 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 14.4 pt -68.57 -39.47 80.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.392 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -56.77 -53.72 54.51 Favored 'General case' 0 C--O 1.215 -0.738 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.197 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 20' ' ' GLU . 97.6 t -61.97 -40.62 87.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.89 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.678 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.3 tt -52.48 -51.98 56.64 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.508 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -78.33 -49.92 12.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.368 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -65.47 -32.06 73.47 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.694 -178.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 16' ' ' VAL . 97.1 mt-10 59.91 80.67 0.2 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 178.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.04 -148.23 0.12 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.857 177.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.3 p -125.45 140.63 47.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.456 HD12 ' O ' ' A' ' 24' ' ' ALA . 2.9 pp -129.68 165.84 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-O 120.907 0.384 . . . . 0.0 111.62 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.456 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -60.26 135.73 57.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.302 0.572 . . . . 0.0 110.793 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.53 ' CZ ' ' O ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -132.49 145.38 57.0 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.585 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.53 ' O ' ' CZ ' ' A' ' 25' ' ' TYR . 97.6 Cg_endo -75.61 145.84 29.89 Favored 'Trans proline' 0 N--CA 1.498 1.794 0 C-N-CA 121.597 1.531 . . . . 0.0 111.384 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.493 ' C ' ' H ' ' A' ' 29' ' ' ALA . 63.0 m -131.76 131.32 42.87 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.95 0.405 . . . . 0.0 110.644 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -75.01 30.94 0.09 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.411 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.493 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -160.32 -73.47 0.07 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.621 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.9 p -131.77 132.22 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.045 0.45 . . . . 0.0 110.188 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.527 ' CD2' ' O ' ' A' ' 148' ' ' CYS . 36.0 p90 -39.5 144.37 0.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.45 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -156.78 -174.27 26.3 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.8 m -131.07 172.33 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.402 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -158.42 178.51 34.63 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.095 -1.05 . . . . 0.0 111.795 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -157.25 -170.42 3.25 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.737 -178.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.467 ' CG ' ' CZ ' ' A' ' 131' ' ' TYR . 18.3 t70 -86.57 108.08 16.47 Favored Pre-proline 0 CA--C 1.555 1.168 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -177.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -36.52 -61.42 0.31 Allowed 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 122.533 2.155 . . . . 0.0 113.161 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -74.03 72.01 1.63 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.593 -178.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 m -155.73 130.52 9.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.678 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -66.33 -33.93 76.84 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.988 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.529 HG23 ' N ' ' A' ' 42' ' ' ALA . 15.1 t -62.08 -43.56 98.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.866 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.529 ' N ' HG23 ' A' ' 41' ' ' THR . . . -55.78 -52.52 63.68 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -62.19 -42.6 95.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.312 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 91.2 mtp -63.22 -40.61 97.96 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.514 HH22 ' CD1' ' A' ' 142' ' ' LEU . 7.9 ttt85 -60.52 -40.77 92.68 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-O 121.695 0.76 . . . . 0.0 108.959 178.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.44 ' O ' HD23 ' A' ' 46' ' ' LEU . 1.0 OUTLIER -65.96 -55.61 15.92 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.248 -178.8 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.6 mt -67.64 -12.1 59.7 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.981 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.71 -82.57 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 120.995 0.426 . . . . 0.0 110.678 -177.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -76.37 -36.28 58.24 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.2 mmmt -74.63 -51.38 14.61 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 119.552 -0.859 . . . . 0.0 111.026 -176.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 36.12 64.93 0.48 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.866 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.401 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 2.6 mtp85 178.66 -53.99 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.529 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HD2' ' H ' ' A' ' 52' ' ' ARG . 72.0 Cg_endo -77.17 -6.45 16.55 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.92 2.413 . . . . 0.0 111.93 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.561 HG13 ' N ' ' A' ' 55' ' ' ASP . 9.7 p -45.59 -43.52 3.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.404 -178.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.561 ' N ' HG13 ' A' ' 54' ' ' VAL . 50.7 t0 -65.41 -41.25 93.81 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.573 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.409 ' CD ' ' N ' ' A' ' 56' ' ' LYS . 4.1 mptp? -62.55 -37.68 87.06 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 64.4 108.71 0.01 OUTLIER Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 178.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.562 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -51.19 -166.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.057 0.456 . . . . 0.0 111.937 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.43 ' O ' ' OG ' ' A' ' 137' ' ' SER . 70.3 mt -104.55 135.35 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.044 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.6 mt -111.72 144.66 40.64 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.41 ' O ' HG23 ' A' ' 61' ' ' ILE . 8.0 tp -112.75 126.8 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-O 121.156 0.503 . . . . 0.0 111.082 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.83 147.92 39.2 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.182 178.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -106.52 -27.59 10.81 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.431 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.72 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 71.1 m-80 -121.46 151.6 40.06 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 120.789 0.328 . . . . 0.0 111.136 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -76.93 -13.29 59.99 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -50.89 -32.19 19.81 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.554 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.72 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 3.0 pm0 -94.17 -13.38 26.74 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 68' ' ' LEU . 4.1 mm? -91.93 -16.19 26.96 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.658 -0.651 . . . . 0.0 109.648 179.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.467 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 77.1 tttt -78.91 -37.97 1.33 Allowed Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 84.8 Cg_endo -103.47 -3.64 0.26 Allowed 'Trans proline' 0 C--N 1.319 -1.01 0 C-N-CA 122.593 2.195 . . . . 0.0 112.049 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -94.9 -10.9 29.77 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.948 0.404 . . . . 0.0 110.774 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.625 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.1 mp -127.11 167.26 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.625 ' N ' HG22 ' A' ' 72' ' ' ILE . 99.9 m-20 -61.12 -12.8 13.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.007 0.432 . . . . 0.0 110.381 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 46.2 t0 56.3 22.29 6.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.709 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.458 HG23 ' N ' ' A' ' 76' ' ' MET . 9.0 t -92.6 -38.94 11.6 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.02 0.438 . . . . 0.0 110.177 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.458 ' N ' HG23 ' A' ' 75' ' ' THR . 0.0 OUTLIER -78.44 -24.4 46.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.208 0.528 . . . . 0.0 110.398 179.57 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.538 HD11 ' NE ' ' A' ' 82' ' ' ARG . 51.2 tp -77.94 134.21 37.91 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.557 0.694 . . . . 0.0 111.109 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.39 172.56 13.32 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.389 -177.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.13 -40.76 90.92 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.814 0.34 . . . . 0.0 111.105 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.5 p -61.7 -35.07 65.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.495 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.444 ' OE1' HD12 ' A' ' 77' ' ' LEU . 22.5 mt-30 -62.97 -41.34 99.51 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.868 0.366 . . . . 0.0 110.511 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.538 ' NE ' HD11 ' A' ' 77' ' ' LEU . 2.4 mmt85 -62.88 -52.81 61.64 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 122.506 1.146 . . . . 0.0 109.025 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -55.64 -50.73 69.41 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.812 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.6 m -61.44 -49.83 75.25 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.936 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' A' ' 89' ' ' TRP . 9.6 tt -67.52 -32.08 55.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 119.746 -0.781 . . . . 0.0 109.595 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -75.3 -36.43 61.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.424 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.5 m -86.82 -16.44 36.17 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.741 -0.209 . . . . 0.0 111.145 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.444 ' O ' ' O ' ' A' ' 89' ' ' TRP . 77.2 ttt-85 -119.58 78.52 1.32 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.587 0.232 . . . . 0.0 110.879 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.444 ' O ' ' O ' ' A' ' 88' ' ' ARG . 27.3 m95 56.2 149.66 0.05 OUTLIER Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.029 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -67.13 -21.32 48.94 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.331 2.021 . . . . 0.0 112.045 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.529 ' O ' ' NE ' ' A' ' 117' ' ' ARG . . . 157.26 82.87 0.04 OUTLIER Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -76.44 -21.49 13.21 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.885 1.723 . . . . 0.0 112.578 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.411 HG13 ' CE2' ' A' ' 95' ' ' PHE . 3.4 p -136.39 143.62 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-O 121.088 0.471 . . . . 0.0 110.843 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 85.1 m -87.73 144.86 26.41 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.246 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.464 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 57.8 m-85 -126.85 142.32 51.58 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.754 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.635 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 3.3 t -98.2 105.59 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 121.299 0.571 . . . . 0.0 109.801 178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -90.13 150.83 44.07 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.931 -178.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.96 109.29 2.81 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 121.874 1.716 . . . . 0.0 110.525 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.401 ' O ' ' OD1' ' A' ' 112' ' ' ASP . . . -67.29 147.75 98.86 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.05 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.29 155.22 51.5 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.441 2.094 . . . . 0.0 112.385 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.041 179.768 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' A' ' 109' ' ' GLY . 15.0 mmt180 . . . . . 0 N--CA 1.467 0.417 0 CA-C-O 120.895 0.379 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.55 ' CD1' ' N ' ' A' ' 106' ' ' TRP . 14.2 m0 -73.04 -14.43 61.41 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.562 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.987 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -68.99 -37.63 78.84 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.736 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.748 ' H ' HD22 ' A' ' 107' ' ' LEU . 21.8 m -143.94 -39.48 0.29 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.432 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 65.59 -13.64 0.28 Allowed Glycine 0 CA--C 1.53 0.972 0 CA-C-N 115.64 -0.709 . . . . 0.0 113.764 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 24.7 tpt85 -112.22 -83.08 0.59 Allowed 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 117.848 0.824 . . . . 0.0 111.027 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -78.88 -121.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.525 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 99' ' ' ALA . 44.0 t0 -171.29 51.26 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.667 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.5 p -158.7 162.75 37.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.294 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.487 ' C ' HG13 ' A' ' 96' ' ' VAL . 3.0 pp -165.79 137.59 3.93 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.421 ' N ' HG13 ' A' ' 96' ' ' VAL . . . -67.72 127.97 34.74 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 113.085 -1.87 . . . . 0.0 109.904 177.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.3 p -147.21 151.19 14.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.986 0.422 . . . . 0.0 110.063 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.529 ' NE ' ' O ' ' A' ' 91' ' ' GLY . 80.5 ttt180 -141.21 156.16 45.95 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.701 -178.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.5 t -121.41 130.87 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 119' ' ' THR . 9.9 t -134.03 127.94 33.3 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.764 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -135.43 84.3 2.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.849 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.679 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 47.1 t60 -172.62 -35.56 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.308 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.679 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 72.7 Cg_endo -95.07 -159.41 0.06 OUTLIER 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 121.889 1.726 . . . . 0.0 111.979 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 42.7 mt -78.22 -4.65 48.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.341 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 82.9 t -58.53 -45.9 90.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.964 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.772 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.6 m -53.57 -61.89 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.772 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.26 -43.95 2.53 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.717 178.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.2 tp -69.32 -48.6 61.04 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.361 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 65.1 m -70.4 -48.88 54.09 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.49 0.662 . . . . 0.0 110.913 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.472 ' N ' ' O ' ' A' ' 125' ' ' VAL . 1.1 pp0? -54.71 -42.24 71.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.572 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.78 -56.1 26.52 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.178 -1.374 . . . . 0.0 110.062 -177.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.467 ' CZ ' ' CG ' ' A' ' 36' ' ' ASP . 7.4 t80 -63.32 -29.21 70.56 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.644 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 90.26 1.0 76.05 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' A' ' 134' ' ' PRO . 61.2 mttt -151.0 158.64 34.68 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.999 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' A' ' 133' ' ' LYS . 5.9 Cg_exo -41.12 175.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 123.976 3.117 . . . . 0.0 113.166 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.6 tp -131.34 123.09 27.53 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 177.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.441 HG13 ' H ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -66.0 145.58 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 C-N-CA 118.477 -1.289 . . . . 0.0 108.662 -179.212 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -109.44 120.85 43.77 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.122 0.889 . . . . 0.0 110.756 -179.669 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 5.2 m -136.2 163.39 30.48 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.122 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.7 t -67.27 149.37 50.49 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.916 0.389 . . . . 0.0 110.976 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.54 -38.46 91.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.195 -0.457 . . . . 0.0 112.117 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 56.6 p30 -65.75 155.99 34.44 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.468 0.651 . . . . 0.0 111.599 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.514 ' CD1' HH22 ' A' ' 45' ' ' ARG . 0.8 OUTLIER -144.75 179.08 7.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.385 -178.523 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 38.8 t -61.39 -42.74 99.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.226 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -141.65 57.01 0.58 Allowed Glycine 0 N--CA 1.468 0.803 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.1 tp -157.41 108.04 1.85 Allowed Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 119.399 -0.334 . . . . 0.0 110.213 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -40.92 156.09 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.394 1.396 . . . . 0.0 111.212 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -59.97 -159.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.113 1.876 . . . . 0.0 111.855 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.527 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 79.5 m -149.12 73.32 1.2 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.027 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -54.66 -40.61 69.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.232 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.15 168.49 26.32 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.42 HG11 ' HA ' ' A' ' 166' ' ' PRO . 2.0 m -59.47 -22.76 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 CA-C-O 121.266 0.555 . . . . 0.0 109.855 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -65.12 -25.06 67.6 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 155' ' ' ARG . 6.2 tm-20 -69.08 -79.42 0.06 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.319 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.419 ' N ' ' OE1' ' A' ' 153' ' ' GLU . 5.4 p -35.83 -30.15 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.577 0.751 . . . . 0.0 110.312 177.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.482 ' N ' ' O ' ' A' ' 153' ' ' GLU . 4.1 tmt_? -71.59 -49.94 35.67 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.063 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 153' ' ' GLU . . . -72.01 -19.41 61.86 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 122.529 1.157 . . . . 0.0 108.212 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -83.04 -44.38 15.26 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 112.623 -2.081 . . . . 0.0 111.763 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -129.78 -34.26 1.75 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.775 0.322 . . . . 0.0 111.631 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 160' ' ' ALA . . . 102.12 23.91 8.82 Favored Glycine 0 N--CA 1.468 0.792 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.412 ' O ' ' O ' ' A' ' 159' ' ' GLY . . . -43.97 -97.9 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.597 0.237 . . . . 0.0 110.893 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . 64.17 33.6 11.68 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.516 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.6 m-85 -173.54 -62.2 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.013 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -72.67 28.22 0.28 Allowed 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 122.296 1.997 . . . . 0.0 110.718 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.548 HG23 ' HD3' ' A' ' 166' ' ' PRO . 13.6 m -129.89 167.31 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.877 -178.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 11.7 t -121.6 65.2 17.19 Favored Pre-proline 0 N--CA 1.471 0.615 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.859 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.548 ' HD3' HG23 ' A' ' 164' ' ' VAL . 29.1 Cg_exo -36.35 139.84 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 123.612 2.875 . . . . 0.0 115.041 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 160.61 -172.81 37.05 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 114.077 -1.42 . . . . 0.0 111.112 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -159.29 170.68 21.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.935 0.397 . . . . 0.0 110.524 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.624 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.024 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 120.807 0.337 . . . . 0.0 110.577 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 16.3 pt -113.12 133.59 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.117 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -127.62 166.52 17.9 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.511 0.672 . . . . 0.0 111.452 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 184' ' ' GLY . 46.0 t0 -80.05 106.3 11.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.921 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -62.61 -18.63 62.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.502 -179.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.488 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.4 mm? -63.5 -41.15 98.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.841 0.353 . . . . 0.0 110.545 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.1 -43.38 2.33 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.395 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 180' ' ' ASP . . . . . . . . 0 CA--C 1.529 0.911 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.2 m120 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -63.17 -40.73 98.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.766 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -63.47 -40.91 98.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.424 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.521 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.1 mp -62.1 -42.13 98.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.01 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -60.88 -41.73 96.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.018 0.437 . . . . 0.0 110.127 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.66 -38.85 90.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.098 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 162' ' ' PHE . 60.6 t0 -60.52 -47.23 87.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.258 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.95 -45.98 91.28 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.383 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.45 -43.76 98.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.207 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.23 -46.42 82.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.177 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.66 -44.09 97.16 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.946 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.69 -53.28 59.32 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.8 pt -69.39 -39.81 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.757 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -58.72 -55.14 38.94 Favored 'General case' 0 C--O 1.217 -0.634 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.695 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 20' ' ' GLU . 93.5 t -61.96 -39.28 83.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.6 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.672 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.3 tt -52.64 -50.49 63.07 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.453 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -80.2 -51.38 9.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.992 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -65.52 -33.54 76.17 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.159 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.6 mt-10 58.14 88.11 0.06 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.816 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.04 -136.78 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.328 -0.397 . . . . 0.0 109.975 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.1 p -141.19 138.42 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.469 HD12 ' O ' ' A' ' 24' ' ' ALA . 2.8 pp -130.44 166.59 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-O 121.0 0.429 . . . . 0.0 111.876 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.469 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -58.58 134.71 56.97 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.936 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.473 ' CZ ' ' O ' ' A' ' 26' ' ' PRO . 2.0 t80 -128.73 133.63 25.4 Favored Pre-proline 0 CA--C 1.552 1.035 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.821 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.473 ' O ' ' CZ ' ' A' ' 25' ' ' TYR . 27.8 Cg_exo -60.09 146.04 97.05 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 CA-C-N 121.048 1.41 . . . . 0.0 110.898 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.432 HG22 ' H ' ' A' ' 29' ' ' ALA . 78.7 m -129.36 142.5 50.8 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.188 0.518 . . . . 0.0 110.378 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -77.66 20.1 0.35 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.641 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.432 ' H ' HG22 ' A' ' 27' ' ' THR . . . -160.21 -69.26 0.07 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.625 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.9 t -127.24 130.14 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.477 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 77.3 m-85 -42.24 136.6 2.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.178 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.43 -170.81 12.18 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.9 m -132.47 165.43 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.52 -177.05 27.49 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.303 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.439 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -156.22 -168.08 2.63 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.604 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.496 ' OD1' ' CE1' ' A' ' 131' ' ' TYR . 19.1 t70 -96.07 109.69 48.19 Favored Pre-proline 0 CA--C 1.553 1.063 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -178.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 36' ' ' ASP . 23.6 Cg_exo -36.79 170.1 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.865 2.377 . . . . 0.0 114.126 177.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 40.94 68.3 0.44 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.961 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.3 m -151.02 142.03 23.03 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.839 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -66.39 -32.56 74.02 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.43 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.448 HG23 ' N ' ' A' ' 42' ' ' ALA . 10.0 t -59.48 -40.88 88.41 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.528 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.448 ' N ' HG23 ' A' ' 41' ' ' THR . . . -58.8 -52.19 66.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.256 0.55 . . . . 0.0 111.506 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.409 HG12 ' H ' ' A' ' 43' ' ' VAL . 2.6 p -64.12 -45.87 95.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.876 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 91.3 mtp -66.79 -46.84 73.99 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.414 ' O ' ' CD2' ' A' ' 49' ' ' LEU . 40.8 ptt85 -63.01 -30.64 71.76 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.416 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 64.0 mt -73.55 -60.95 2.01 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 119.591 -0.843 . . . . 0.0 109.493 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.4 mt -53.11 -21.38 4.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.446 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -64.11 -85.23 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.665 -177.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.517 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -75.93 -32.8 59.74 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -77.17 -71.49 0.4 Allowed 'General case' 0 C--N 1.346 0.423 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.564 -176.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.408 ' O ' ' CG ' ' A' ' 51' ' ' GLN . 3.6 tt0 53.73 80.56 0.11 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.463 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.2 mtp85 161.19 -63.95 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.073 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -66.81 -12.52 36.34 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 122.568 2.179 . . . . 0.0 112.165 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.609 HG13 ' N ' ' A' ' 55' ' ' ASP . 7.3 p -43.9 -46.67 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.026 0.441 . . . . 0.0 110.625 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.609 ' N ' HG13 ' A' ' 54' ' ' VAL . 12.5 t0 -66.69 -44.75 80.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.629 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -59.8 -39.97 86.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.939 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 67.35 109.86 0.02 OUTLIER Glycine 0 CA--C 1.522 0.471 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.573 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -49.24 -170.17 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.935 -0.632 . . . . 0.0 112.222 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.438 ' O ' ' OG ' ' A' ' 137' ' ' SER . 83.0 mt -104.8 139.92 24.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.3 mt -109.02 145.02 36.25 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.471 ' CD1' ' HE ' ' A' ' 117' ' ' ARG . 9.1 tp -110.69 129.88 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-O 121.316 0.579 . . . . 0.0 110.247 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.458 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -118.55 153.82 33.58 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.403 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.36 -27.05 7.72 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.68 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 21.4 m120 -117.05 144.86 44.15 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.193 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -72.91 -14.21 61.42 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.324 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -50.53 -33.95 23.54 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.513 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.68 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 4.8 pm0 -93.59 -9.26 38.71 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.13 -16.63 27.46 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.462 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 43.6 tttm -76.69 -39.1 2.28 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -178.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 93.7 Cg_endo -102.06 -4.97 0.33 Allowed 'Trans proline' 0 C--N 1.318 -1.027 0 C-N-CA 122.65 2.233 . . . . 0.0 111.846 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -92.36 -14.48 28.64 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.892 0.377 . . . . 0.0 110.181 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.575 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.6 mp -134.19 158.49 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.575 ' N ' HG22 ' A' ' 72' ' ' ILE . 21.9 m-20 -62.97 145.74 54.67 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -79.04 -4.57 50.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.751 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.407 HG23 ' SD ' ' A' ' 76' ' ' MET . 8.1 t -73.56 -37.9 65.4 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.033 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.407 ' SD ' HG23 ' A' ' 75' ' ' THR . 63.2 mmm -64.57 -47.45 78.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.759 0.79 . . . . 0.0 109.672 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.7 mp -79.02 135.07 36.78 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 113.886 -1.506 . . . . 0.0 111.18 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.457 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -160.23 158.73 30.5 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.876 -178.697 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -38.57 -47.36 1.3 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.841 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.89 -34.44 68.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.097 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.457 ' N ' ' O ' ' A' ' 78' ' ' THR . 65.9 tp60 -65.51 -40.45 93.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.747 0.308 . . . . 0.0 110.727 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -63.95 -52.53 59.3 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 122.309 1.052 . . . . 0.0 109.235 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' A' ' 87' ' ' SER . 83.1 tt0 -55.24 -50.41 69.53 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.145 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.4 m -61.46 -50.25 73.52 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.216 -1.356 . . . . 0.0 111.966 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.4 tt -67.97 -32.5 56.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.717 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -76.67 -34.67 58.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.543 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 83' ' ' GLU . 11.6 m -87.83 -15.73 36.03 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.642 0.258 . . . . 0.0 111.13 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.436 ' O ' ' O ' ' A' ' 89' ' ' TRP . 68.4 ttt180 -116.3 75.62 0.97 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.813 0.34 . . . . 0.0 110.372 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.436 ' O ' ' O ' ' A' ' 88' ' ' ARG . 75.0 m95 57.7 148.13 0.06 OUTLIER Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.709 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.44 -29.26 37.95 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.922 1.748 . . . . 0.0 112.044 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 149.68 80.05 0.03 OUTLIER Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -85.08 -8.91 8.81 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.992 2.462 . . . . 0.0 112.17 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.455 HG13 ' CZ ' ' A' ' 95' ' ' PHE . 2.7 p -135.99 147.87 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.185 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 82.7 m -85.48 141.25 30.05 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.292 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.485 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 97.8 m-85 -123.0 142.74 50.51 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.465 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.732 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.2 t -106.03 112.8 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-O 121.261 0.553 . . . . 0.0 110.66 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -97.94 150.68 37.01 Favored Pre-proline 0 N--CA 1.472 0.646 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.72 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.69 86.59 0.86 Allowed 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 122.118 1.879 . . . . 0.0 111.341 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -48.61 150.9 2.23 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.969 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.427 ' O ' ' OG1' ' A' ' 103' ' ' THR . 60.7 Cg_endo -68.07 145.36 66.99 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.88 1.72 . . . . 0.0 112.197 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.5 -36.49 84.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.951 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 82.1 p -53.22 -43.26 67.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.729 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.49 ' O ' ' O ' ' A' ' 104' ' ' PRO . 5.0 p -59.51 155.62 37.07 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-O 119.226 -0.416 . . . . 0.0 110.094 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.49 ' O ' ' O ' ' A' ' 103' ' ' THR . 52.0 Cg_exo -49.13 -158.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.033 0 C-N-CA 122.342 2.028 . . . . 0.0 113.104 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.473 ' O ' ' N ' ' A' ' 109' ' ' GLY . 2.0 tpt180 -145.72 -0.62 0.82 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.792 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 47.3 p-90 -75.5 -9.55 58.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.763 0.316 . . . . 0.0 110.461 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.981 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -76.55 -25.11 53.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.19 -179.217 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.701 ' H ' HD22 ' A' ' 107' ' ' LEU . 24.4 m -144.24 -42.58 0.26 Allowed 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 49.49 0.98 0.01 OUTLIER Glycine 0 CA--C 1.537 1.42 0 C-N-CA 121.368 -0.444 . . . . 0.0 113.125 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.53 ' H ' ' C ' ' A' ' 108' ' ' THR . 0.0 OUTLIER -93.88 -62.31 1.37 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 117.882 0.841 . . . . 0.0 109.853 179.715 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.55 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 87.8 t80 -147.57 169.72 18.99 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.101 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.55 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 4.2 p-10 -84.0 73.74 10.33 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.519 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.491 ' C ' HD22 ' A' ' 114' ' ' LEU . 54.3 p -169.15 126.02 0.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.491 HD22 ' C ' ' A' ' 113' ' ' SER . 2.9 mm? -117.01 120.21 37.68 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -177.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.548 ' N ' HG13 ' A' ' 96' ' ' VAL . . . -80.28 117.21 20.85 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.508 177.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.471 HG22 ' N ' ' A' ' 117' ' ' ARG . 4.6 p -141.4 159.47 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.587 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.471 ' HE ' ' CD1' ' A' ' 61' ' ' ILE . 61.6 ttp180 -139.77 150.71 45.09 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.667 0.27 . . . . 0.0 111.13 -179.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.458 HG22 ' HB3' ' A' ' 62' ' ' ALA . 54.8 t -120.68 131.92 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.9 t -135.84 134.96 39.41 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -139.5 87.1 2.16 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.864 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.638 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 52.1 t-80 -172.58 -36.91 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.638 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 58.5 Cg_endo -95.33 -159.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 122.181 1.921 . . . . 0.0 112.006 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.8 mt -77.53 -5.98 52.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.26 0.552 . . . . 0.0 110.387 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.2 t -57.95 -45.23 87.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.837 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.746 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.8 m -53.83 -61.81 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.926 0 C-N-CA 119.413 -0.915 . . . . 0.0 108.92 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.746 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.0 -45.52 2.62 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.581 0.229 . . . . 0.0 110.93 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.5 tp -68.99 -47.09 66.41 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.268 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 64.2 m -70.44 -49.54 47.65 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.411 0.624 . . . . 0.0 110.997 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.474 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.2 pp0? -54.73 -41.75 70.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.438 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.523 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.6 -56.77 17.92 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.735 -177.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.496 ' CE1' ' OD1' ' A' ' 36' ' ' ASP . 3.9 t80 -63.57 -22.11 66.72 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.705 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 81.27 3.42 90.66 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.3 mttt -151.83 158.19 34.1 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.645 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -43.08 178.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 123.63 2.887 . . . . 0.0 113.536 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.9 tp -135.18 123.2 22.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 113.57 -1.65 . . . . 0.0 106.826 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.409 HG13 ' H ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -63.88 144.32 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 C-N-CA 118.041 -1.463 . . . . 0.0 108.072 -179.454 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 59' ' ' ILE . 1.1 p -113.97 123.74 50.47 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.64 0.588 . . . . 0.0 111.693 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 4.0 m -128.85 162.09 28.3 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.595 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.1 m -74.61 149.78 39.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.335 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.572 ' HB1' ' SG ' ' A' ' 148' ' ' CYS . . . -79.54 81.98 5.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.602 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -160.4 164.08 32.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.389 0.614 . . . . 0.0 110.578 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.68 -165.96 1.74 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.127 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.2 t -59.71 -44.11 93.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.414 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -162.55 12.49 0.11 Allowed Glycine 0 C--N 1.327 0.075 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.9 tp -89.1 126.4 59.11 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -39.64 157.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.538 1.492 . . . . 0.0 112.297 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.62 -161.0 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.411 2.074 . . . . 0.0 111.759 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.572 ' SG ' ' HB1' ' A' ' 140' ' ' ALA . 28.1 p -126.4 86.05 2.47 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.477 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 51.6 ptt85 -53.34 -37.47 62.37 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.862 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.36 171.48 20.16 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.43 ' H ' HG22 ' A' ' 151' ' ' VAL . 1.6 m -59.28 -22.48 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 CA-C-O 121.484 0.659 . . . . 0.0 109.297 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -65.26 -25.46 67.67 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 155' ' ' ARG . 0.0 OUTLIER -71.78 -78.97 0.08 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.49 179.282 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.4 p -34.75 -29.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.489 0.715 . . . . 0.0 110.072 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -73.68 -51.77 15.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.921 179.646 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 153' ' ' GLU . . . -69.78 -20.33 63.48 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 122.542 1.163 . . . . 0.0 108.064 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -82.78 -45.93 13.75 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 112.753 -2.021 . . . . 0.0 111.563 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -129.26 -22.66 3.08 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 90.01 22.7 34.81 Favored Glycine 0 N--CA 1.467 0.708 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.42 ' O ' ' O ' ' A' ' 159' ' ' GLY . . . -43.27 -98.28 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.742 0.306 . . . . 0.0 110.942 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.46 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 62.62 35.12 14.49 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.526 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.7 m-85 -174.06 -62.16 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.057 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -73.41 29.05 0.3 Allowed 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.175 1.917 . . . . 0.0 110.476 177.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.559 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.3 m -131.55 166.86 27.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.747 -178.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.8 t -123.0 65.7 28.04 Favored Pre-proline 0 N--CA 1.473 0.684 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.796 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.559 ' HD3' HG23 ' A' ' 164' ' ' VAL . 21.2 Cg_exo -36.31 142.42 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 123.561 2.841 . . . . 0.0 115.008 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 165.1 -167.91 38.97 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 114.006 -1.452 . . . . 0.0 110.88 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -152.71 177.84 10.27 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.2 t -145.53 152.66 40.09 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.404 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -51.57 -69.02 1.26 Allowed Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 137.44 105.47 0.72 Allowed Glycine 0 N--CA 1.468 0.784 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -137.08 150.99 48.39 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.756 0.312 . . . . 0.0 110.365 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.541 ' N ' HD12 ' A' ' 173' ' ' LEU . 10.3 mp -60.09 -73.7 0.08 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.356 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -174.74 59.37 0.21 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.696 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -68.41 -17.39 44.03 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.502 2.135 . . . . 0.0 111.907 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 43.0 t -92.07 121.98 34.14 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.438 0.637 . . . . 0.0 110.087 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -134.64 -169.96 2.45 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.803 -178.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.0 pt -122.7 102.5 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 121.182 0.515 . . . . 0.0 110.331 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -95.53 156.2 16.42 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.339 0.59 . . . . 0.0 111.847 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -76.4 106.36 7.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.822 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -64.68 -12.03 42.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.704 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.515 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.6 mm? -63.03 -42.05 99.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.348 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.71 -42.79 3.07 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.528 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 73.85 19.35 79.75 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -72.31 151.61 42.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.191 0.519 . . . . 0.0 110.98 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.498 HD23 ' N ' ' A' ' 186' ' ' LEU . 0.7 OUTLIER -67.51 179.18 1.37 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.597 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . 0.521 ' C ' HE22 ' A' ' 189' ' ' GLN . 89.9 t80 -91.75 -31.77 15.65 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.92 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -78.18 139.69 38.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.058 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.521 HE22 ' C ' ' A' ' 187' ' ' PHE . 27.9 mp0 -128.52 -15.5 4.51 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.046 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.711 0 CA-C-O 118.157 -1.357 . . . . 0.0 111.067 179.807 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 65.2 t30 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -83.04 142.03 31.61 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.645 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -144.92 -44.75 0.23 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.46 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.513 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.4 mp -62.74 -41.83 99.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.965 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -63.37 -42.8 98.88 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.417 0.627 . . . . 0.0 109.783 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -62.31 -41.36 98.47 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.476 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -62.11 -45.55 92.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.741 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.36 -44.89 90.02 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.19 0.519 . . . . 0.0 110.379 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.48 -43.72 98.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.613 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.52 -45.59 81.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.191 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.72 -39.25 90.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.618 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.4 -53.98 49.52 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.51 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.6 pt -71.59 -31.01 40.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.232 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -59.57 -55.08 38.95 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' A' ' 20' ' ' GLU . 88.7 t -63.72 -40.35 88.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.896 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.675 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.5 tt -52.28 -50.28 62.44 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.555 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -79.82 -50.13 10.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.073 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -66.25 -34.59 78.36 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.952 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.8 mt-10 60.92 82.38 0.17 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 178.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.4 ' H ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -163.47 -139.51 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.232 177.507 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 34' ' ' GLY . 9.2 p -134.67 142.63 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 pp -129.35 163.66 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 120.896 0.379 . . . . 0.0 111.304 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.89 131.22 48.02 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.215 0.531 . . . . 0.0 111.11 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.494 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 0.4 OUTLIER -121.02 140.36 30.8 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.494 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 65.3 Cg_endo -79.33 154.73 24.84 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.553 1.502 . . . . 0.0 111.931 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.472 ' C ' ' H ' ' A' ' 29' ' ' ALA . 23.0 m -142.2 141.38 32.55 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.221 0.534 . . . . 0.0 110.955 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -75.44 23.18 0.12 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.547 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -154.21 -75.48 0.11 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.965 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.4 t -125.73 128.83 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 120.973 0.416 . . . . 0.0 110.174 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.503 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 93.5 m-85 -46.67 147.48 1.24 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.144 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -152.47 -174.47 23.03 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.6 m -126.55 168.16 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -157.64 177.65 34.33 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.098 -1.049 . . . . 0.0 112.235 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -154.66 -166.75 2.41 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.508 0.194 . . . . 0.0 110.594 -179.401 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.451 ' O ' ' O ' ' A' ' 37' ' ' PRO . 3.8 m-20 -95.52 108.78 41.84 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -178.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.451 ' O ' ' O ' ' A' ' 36' ' ' ASP . 54.1 Cg_exo -38.69 174.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.76 2.307 . . . . 0.0 114.042 177.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 38.08 69.72 0.23 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.302 -1.317 . . . . 0.0 111.429 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 51.0 m -149.1 144.09 26.44 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.376 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -69.5 -36.46 76.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.426 0.631 . . . . 0.0 110.64 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 41' ' ' THR . 0.1 OUTLIER -64.39 -43.68 93.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.664 -178.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.46 -50.05 75.11 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.041 -0.263 . . . . 0.0 111.413 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.1 p -62.32 -44.96 99.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.391 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 91.1 mtp -63.66 -40.49 96.98 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.475 ' NH2' HG21 ' A' ' 22' ' ' VAL . 34.0 ttt-85 -61.02 -41.6 96.86 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.923 0.868 . . . . 0.0 108.844 178.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.431 ' O ' HD23 ' A' ' 46' ' ' LEU . 1.0 OUTLIER -64.94 -54.74 25.85 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.238 -178.417 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.4 mt -69.1 -11.41 60.77 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.349 -0.842 . . . . 0.0 112.002 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -69.57 -82.48 0.04 OUTLIER 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 120.996 0.426 . . . . 0.0 110.778 -177.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.585 HD12 ' H ' ' A' ' 143' ' ' SER . 2.2 pt? -76.42 -35.29 58.62 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -178.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -76.36 -50.56 13.91 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.797 -177.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 35.29 66.55 0.31 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.724 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.408 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 4.7 mtt180 178.12 -53.05 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.898 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.397 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.408 ' HD2' ' H ' ' A' ' 52' ' ' ARG . 83.0 Cg_endo -80.56 -5.42 13.31 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.866 2.377 . . . . 0.0 112.584 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.59 HG13 ' N ' ' A' ' 55' ' ' ASP . 8.0 p -44.71 -45.13 2.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.073 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.59 ' N ' HG13 ' A' ' 54' ' ' VAL . 67.5 t0 -65.62 -40.38 92.52 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.588 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -62.21 -39.19 91.96 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 71.25 109.62 0.04 OUTLIER Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.564 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -51.7 -163.34 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.232 0.539 . . . . 0.0 112.209 -179.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.434 ' O ' ' OG ' ' A' ' 137' ' ' SER . 61.1 mt -105.12 137.28 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.897 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.7 mt -115.68 143.01 45.98 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.3 tp -111.82 132.91 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 121.149 0.5 . . . . 0.0 110.741 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.47 150.92 41.85 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.95 -29.79 8.42 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.04 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.714 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 14.3 m120 -113.12 150.05 32.7 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.155 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -79.01 -14.28 59.28 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -54.49 -30.19 52.54 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.913 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.714 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 4.0 pm0 -95.01 -11.06 29.1 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.525 HD22 ' N ' ' A' ' 68' ' ' LEU . 3.7 mm? -91.16 -18.8 23.88 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.459 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 43.4 tttm -75.57 -39.43 2.99 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 85.3 Cg_endo -104.18 -2.61 0.23 Allowed 'Trans proline' 0 C--N 1.319 -1.009 0 C-N-CA 122.91 2.407 . . . . 0.0 112.363 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -96.95 -11.12 25.04 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.692 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.516 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.1 mp -127.94 155.96 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.516 ' N ' HG22 ' A' ' 72' ' ' ILE . 93.9 m-20 -64.29 158.52 23.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.965 0.412 . . . . 0.0 110.08 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -94.74 7.74 44.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.028 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.517 HG23 ' N ' ' A' ' 76' ' ' MET . 13.2 t -74.32 -42.57 59.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.029 0.442 . . . . 0.0 111.075 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.517 ' N ' HG23 ' A' ' 75' ' ' THR . 24.4 ptm -95.34 -15.74 22.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.093 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 tp -93.92 127.57 39.76 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.113 0.482 . . . . 0.0 110.63 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.458 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -157.73 161.94 38.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.858 -177.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -39.61 -47.52 1.96 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.776 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.58 -32.64 57.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.853 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.458 ' N ' ' O ' ' A' ' 78' ' ' THR . 58.6 tp60 -63.48 -40.97 98.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.204 0.526 . . . . 0.0 110.19 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.422 ' HG2' ' H ' ' A' ' 82' ' ' ARG . 10.6 mmt85 -65.41 -52.85 50.49 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 122.484 1.135 . . . . 0.0 109.42 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -54.25 -50.96 65.99 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 113.801 -1.545 . . . . 0.0 110.143 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.6 m -61.1 -50.04 74.88 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.574 -1.193 . . . . 0.0 111.979 -177.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.6 tt -67.81 -32.13 55.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.072 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -76.47 -36.05 58.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.753 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.8 m -87.4 -14.19 41.28 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.633 0.254 . . . . 0.0 111.298 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 89' ' ' TRP . 69.2 ttt180 -115.34 75.43 0.94 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.427 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.452 ' O ' ' O ' ' A' ' 88' ' ' ARG . 13.9 m-90 56.37 153.11 0.07 OUTLIER Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.507 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.6 -21.23 39.87 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.133 1.889 . . . . 0.0 111.649 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.519 ' O ' ' NE ' ' A' ' 117' ' ' ARG . . . 158.52 81.27 0.04 OUTLIER Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.55 -17.8 11.07 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.262 1.974 . . . . 0.0 112.047 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.451 HG13 ' CE2' ' A' ' 95' ' ' PHE . 3.0 p -136.95 146.32 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.132 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.6 m -91.31 129.33 37.32 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.389 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.46 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 38.8 m-85 -117.5 138.05 52.14 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.779 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.623 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 5.2 t -92.46 104.65 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 121.301 0.572 . . . . 0.0 110.761 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 97' ' ' PHE . 30.4 m-85 -86.3 147.1 43.85 Favored Pre-proline 0 N--CA 1.466 0.362 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.529 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.54 83.76 1.85 Allowed 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.993 1.796 . . . . 0.0 111.6 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -46.2 152.46 0.81 Allowed Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -69.46 156.28 64.56 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.036 1.824 . . . . 0.0 111.607 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -136.6 53.61 1.91 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.17 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.401 ' O ' ' OG1' ' A' ' 103' ' ' THR . 40.8 p -67.93 -32.95 73.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.69 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.719 ' H ' ' CD ' ' A' ' 104' ' ' PRO . 1.2 m -167.16 -37.3 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.719 ' CD ' ' H ' ' A' ' 103' ' ' THR . 16.7 Cg_exo -66.7 -167.95 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.473 2.115 . . . . 0.0 113.021 -178.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' A' ' 109' ' ' GLY . 8.0 tpt180 -178.58 -3.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.407 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.449 ' H ' ' H ' ' A' ' 105' ' ' ARG . 8.6 p90 -81.31 -10.08 59.63 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.662 0.744 . . . . 0.0 109.057 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.622 ' H ' ' CD2' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -77.38 -15.28 59.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.638 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 85.3 m -143.28 -40.57 0.31 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.316 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 92.33 -19.28 51.04 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 116.263 -0.426 . . . . 0.0 113.714 178.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.419 ' O ' ' NH2' ' A' ' 105' ' ' ARG . 18.1 tpt180 -144.86 -80.4 0.17 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 117.953 0.877 . . . . 0.0 111.786 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.406 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 29.7 t80 -75.63 -125.47 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.667 -178.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.406 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 48.1 t0 -170.52 54.38 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.834 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.6 p -157.27 155.33 30.58 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.492 ' O ' HD12 ' A' ' 114' ' ' LEU . 0.3 OUTLIER -161.13 137.78 8.58 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.227 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.445 ' HB2' HG22 ' A' ' 96' ' ' VAL . . . -69.55 135.41 50.02 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 113.212 -1.813 . . . . 0.0 109.777 178.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.6 p -149.73 153.71 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 120.888 0.375 . . . . 0.0 110.7 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.519 ' NE ' ' O ' ' A' ' 91' ' ' GLY . 75.7 ttt180 -142.33 152.55 43.04 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.507 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 49.5 t -119.93 133.05 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.2 t -137.72 138.32 39.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.042 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -145.27 85.2 1.72 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.689 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.664 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 8.2 t60 -173.39 -36.58 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.179 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.664 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 67.7 Cg_endo -95.04 -160.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 122.298 1.999 . . . . 0.0 111.964 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.526 HD12 ' N ' ' A' ' 123' ' ' LEU . 9.6 mp -76.84 -7.51 55.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.175 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.0 t -56.74 -45.06 82.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.797 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.738 HG23 ' H ' ' A' ' 126' ' ' ALA . 26.8 m -53.84 -61.84 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.875 0 C-N-CA 119.35 -0.94 . . . . 0.0 108.981 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.738 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.04 -44.08 2.32 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.894 0.378 . . . . 0.0 110.992 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.6 -48.3 60.58 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.362 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 61.6 m -69.9 -49.28 53.67 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.421 0.629 . . . . 0.0 110.684 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.457 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.0 OUTLIER -54.39 -42.71 70.72 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.42 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.536 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.5 -54.96 41.18 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.585 -177.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.443 ' CE1' ' OD2' ' A' ' 36' ' ' ASP . 39.6 t80 -62.46 -21.6 65.57 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.919 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.86 -1.93 82.02 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' A' ' 134' ' ' PRO . 14.2 mtpp -149.5 159.01 37.34 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 133' ' ' LYS . 3.4 Cg_exo -41.68 178.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 123.847 3.031 . . . . 0.0 113.128 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.4 tp -132.34 123.16 26.27 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 176.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.429 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -63.79 153.12 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 C-N-CA 117.888 -1.525 . . . . 0.0 106.986 -179.702 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 59' ' ' ILE . 1.4 p -130.12 133.78 46.88 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.109 0.48 . . . . 0.0 111.1 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.5 m -134.44 164.67 26.93 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.708 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.6 m -70.45 148.46 48.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.386 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.527 ' HB1' ' H ' ' A' ' 148' ' ' CYS . . . -61.4 -36.9 81.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.221 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 141' ' ' ASN . 50.3 p30 -67.28 144.41 55.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.043 0.449 . . . . 0.0 110.475 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.698 HD22 ' C ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -150.94 163.57 38.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.219 -179.607 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.585 ' H ' HD12 ' A' ' 49' ' ' LEU . 29.1 t 28.45 -87.88 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 O-C-N 123.603 0.564 . . . . 0.0 112.192 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 142' ' ' LEU . . . -157.41 16.78 0.35 Allowed Glycine 0 C--N 1.332 0.307 0 N-CA-C 109.976 -1.249 . . . . 0.0 109.976 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.9 tp -94.61 129.25 37.0 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 115.21 -0.495 . . . . 0.0 109.691 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -37.21 156.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.802 1.668 . . . . 0.0 112.384 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -75.71 -164.82 0.26 Allowed 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.42 2.08 . . . . 0.0 112.888 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.527 ' H ' ' HB1' ' A' ' 140' ' ' ALA . 29.7 m -111.39 80.12 1.28 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.123 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.503 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 33.9 ptt180 -54.54 -35.16 62.93 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.21 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.95 169.81 19.08 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.439 HG22 ' H ' ' A' ' 151' ' ' VAL . 0.7 OUTLIER -57.28 -22.82 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.412 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -63.5 -30.83 71.89 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 155' ' ' ARG . 6.0 tm-20 -63.76 -79.61 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.204 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.1 p -36.64 -30.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.922 0.889 . . . . 0.0 111.118 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.472 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -69.69 -52.21 27.71 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.628 -178.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.92 -17.69 62.68 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 122.697 1.236 . . . . 0.0 108.386 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -83.87 -45.62 13.04 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 112.492 -2.14 . . . . 0.0 111.847 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -131.11 -23.46 2.45 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 87.98 26.75 28.08 Favored Glycine 0 N--CA 1.464 0.553 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 159' ' ' GLY . . . -43.01 -97.33 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.65 -0.275 . . . . 0.0 111.018 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.465 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 65.85 33.13 8.23 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-O 121.362 0.601 . . . . 0.0 109.453 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.527 ' C ' ' H ' ' A' ' 164' ' ' VAL . 1.8 m-85 -175.58 -62.09 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.505 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.38 31.94 0.28 Allowed 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.169 1.913 . . . . 0.0 110.363 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.577 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.4 m -134.64 167.17 26.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.734 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.3 t -123.72 66.14 36.49 Favored Pre-proline 0 N--CA 1.472 0.657 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.549 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.577 ' HD3' HG23 ' A' ' 164' ' ' VAL . 38.7 Cg_exo -37.73 147.59 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 123.551 2.834 . . . . 0.0 115.072 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 163.84 -173.39 39.9 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 113.739 -1.573 . . . . 0.0 111.105 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -145.68 150.86 37.07 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.718 0.294 . . . . 0.0 110.472 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.5 t -147.06 153.2 39.7 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.053 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -60.76 -69.81 1.19 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 102.48 5.29 48.93 Favored Glycine 0 N--CA 1.469 0.841 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.31 -38.62 90.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.873 0.368 . . . . 0.0 110.906 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 173' ' ' LEU . 10.2 mp -61.6 -169.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.122 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -84.53 150.17 56.25 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -60.01 -43.89 33.48 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 122.114 1.876 . . . . 0.0 111.618 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 45.5 m -171.51 128.15 0.66 Allowed 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.607 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -106.51 103.65 13.15 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.901 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.502 ' O ' HG23 ' A' ' 178' ' ' ILE . 18.3 tt -111.91 120.5 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.067 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -125.28 164.2 20.87 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 122.052 0.93 . . . . 0.0 110.768 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 184' ' ' GLY . 43.2 t0 -77.05 106.71 8.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.037 -1.438 . . . . 0.0 108.79 178.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -62.28 -20.52 64.37 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.692 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.477 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.4 mm? -63.77 -42.27 97.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.854 0.359 . . . . 0.0 110.408 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.86 -47.12 2.31 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.773 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 180' ' ' ASP . . . 76.24 20.14 77.59 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -83.5 178.48 7.99 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-O 121.025 0.441 . . . . 0.0 111.032 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.526 ' H ' ' CD2' ' A' ' 186' ' ' LEU . 0.7 OUTLIER -83.65 179.22 7.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.583 179.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -84.97 -39.79 17.69 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.761 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.85 136.19 48.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.898 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -133.64 -19.59 2.09 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.335 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.73 0 CA-C-O 118.028 -1.429 . . . . 0.0 111.065 -179.95 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 54.1 p30 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 57.55 34.73 24.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.339 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -63.97 -40.76 97.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.656 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.54 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.0 mp -62.49 -42.38 99.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.458 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -65.6 -42.66 91.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.911 0.386 . . . . 0.0 110.26 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 63.3 ttm-85 -62.88 -42.29 99.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.379 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -62.16 -43.49 98.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.398 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.2 -47.14 87.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.06 0.457 . . . . 0.0 110.02 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.22 -43.24 98.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.817 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.85 -40.88 85.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.44 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.24 -43.08 92.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.029 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.16 -52.45 64.79 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.787 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 14' ' ' ILE . 16.7 pt -68.5 -39.06 80.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.357 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -58.22 -54.9 41.81 Favored 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.201 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 20' ' ' GLU . 94.0 t -59.75 -39.73 80.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.776 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.651 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.5 tt -52.06 -50.0 62.38 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.104 -0.638 . . . . 0.0 109.674 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -81.31 -52.71 7.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.904 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.458 ' O ' ' NH1' ' A' ' 21' ' ' ARG . 69.4 mm-40 -63.25 -35.56 80.76 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.438 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.2 mt-10 59.69 81.89 0.16 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.458 ' NH1' ' O ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -155.28 -136.73 0.06 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 177.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 34' ' ' GLY . 6.6 p -142.09 139.8 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -126.92 165.64 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.03 0.443 . . . . 0.0 111.363 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.45 129.48 40.04 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.04 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -109.88 133.35 20.99 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.129 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -84.57 140.96 8.56 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.246 1.297 . . . . 0.0 111.789 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.5 ' C ' ' H ' ' A' ' 29' ' ' ALA . 28.2 m -136.01 135.89 39.85 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.871 0.367 . . . . 0.0 110.839 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -74.77 29.43 0.09 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.998 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.5 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -158.52 -77.18 0.07 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.289 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.1 m -120.37 126.28 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-O 121.118 0.485 . . . . 0.0 110.781 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.524 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 77.9 m-85 -60.67 145.17 50.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.509 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -154.4 -166.62 15.27 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.6 m -131.91 170.85 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.441 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -159.87 -176.35 31.85 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 119.518 -1.325 . . . . 0.0 112.51 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.502 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -163.48 -163.36 0.81 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.137 -179.147 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.502 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 43.0 t0 -90.74 106.43 15.45 Favored Pre-proline 0 CA--C 1.555 1.167 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -38.16 -61.89 0.34 Allowed 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.283 1.989 . . . . 0.0 112.129 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -69.71 62.63 0.18 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.315 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.4 m -155.1 131.89 10.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.083 0.468 . . . . 0.0 110.928 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.08 -17.92 63.93 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.247 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.514 HG23 ' N ' ' A' ' 42' ' ' ALA . 15.3 t -61.26 -41.91 97.73 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.511 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.514 ' N ' HG23 ' A' ' 41' ' ' THR . . . -58.13 -51.26 70.45 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.63 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 p -63.05 -44.19 99.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.434 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 62.3 mtt -65.22 -39.93 93.44 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -61.92 -32.83 73.26 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.632 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 81.9 mt -76.92 -57.67 3.72 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.4 mt -57.2 -16.09 7.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.387 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.52 -85.77 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.589 -178.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.505 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -76.08 -32.47 59.26 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.987 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -79.11 -71.01 0.46 Allowed 'General case' 0 C--N 1.349 0.57 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.428 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.424 ' O ' ' CG ' ' A' ' 51' ' ' GLN . 3.7 tt0 54.4 79.85 0.13 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.381 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 161.45 -62.7 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.856 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.332 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.01 -8.53 23.84 Favored 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.58 2.187 . . . . 0.0 111.641 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.557 HG13 ' N ' ' A' ' 55' ' ' ASP . 7.7 p -43.74 -46.34 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.926 0.394 . . . . 0.0 110.466 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.557 ' N ' HG13 ' A' ' 54' ' ' VAL . 10.0 t0 -66.28 -42.87 87.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.196 0.522 . . . . 0.0 109.941 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -61.35 -40.87 95.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.422 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 64.52 117.34 0.01 OUTLIER Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.572 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -51.21 -164.53 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.21 0.529 . . . . 0.0 112.131 179.676 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.5 mt -105.62 145.19 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 16.9 mt -117.15 146.33 43.26 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.4 tp -113.8 132.77 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-O 121.39 0.614 . . . . 0.0 111.325 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.51 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -120.39 154.1 35.59 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.103 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.04 -27.58 6.89 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.552 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 98.1 m-20 -114.13 143.74 44.31 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.105 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -73.48 -14.29 61.21 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -50.28 -33.13 18.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.502 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.552 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 3.8 pm0 -94.4 -12.25 28.25 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.548 ' O ' HD13 ' A' ' 72' ' ' ILE . 3.6 mm? -91.67 -14.92 29.26 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.424 -0.797 . . . . 0.0 108.885 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.464 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 43.0 tttm -78.64 -39.93 1.64 Allowed Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 66.6 Cg_endo -104.43 -2.07 0.23 Allowed 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 122.853 2.368 . . . . 0.0 112.351 -178.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.463 ' OH ' ' CD2' ' A' ' 114' ' ' LEU . 55.6 t80 -97.73 -9.47 26.59 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.988 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.619 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.6 mp -123.34 168.91 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.619 ' N ' HG22 ' A' ' 72' ' ' ILE . 96.5 m-20 -60.56 -12.43 9.93 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.051 -0.259 . . . . 0.0 111.141 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 57.8 t0 55.71 30.52 15.73 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.282 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.546 HG23 ' N ' ' A' ' 76' ' ' MET . 9.2 t -96.13 -43.5 7.72 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.208 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.546 ' N ' HG23 ' A' ' 75' ' ' THR . 18.9 ptp -84.69 -5.97 59.34 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.237 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.3 tp -92.8 127.56 38.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.251 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.438 ' H ' ' HB3' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -160.2 161.63 33.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.683 -177.735 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -38.77 -49.18 1.59 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.727 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.02 -33.54 61.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.048 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.438 ' HB3' ' H ' ' A' ' 78' ' ' THR . 65.4 tp60 -66.31 -39.03 89.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.619 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.5 mmt85 -63.54 -53.45 51.64 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 122.38 1.086 . . . . 0.0 108.619 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -54.31 -50.39 67.46 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.013 -1.449 . . . . 0.0 110.117 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -60.83 -50.56 72.95 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.883 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.0 tt -67.9 -32.6 57.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.102 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -72.41 -41.66 66.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.82 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.7 m -78.03 -33.09 51.27 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.566 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 89' ' ' TRP . 76.7 ttt180 -95.74 157.69 15.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.04 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.413 ' C ' ' O ' ' A' ' 88' ' ' ARG . 3.7 m-90 -31.37 148.52 0.05 OUTLIER Pre-proline 0 N--CA 1.47 0.55 0 O-C-N 123.482 0.488 . . . . 0.0 111.43 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -67.02 -17.64 51.32 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.051 1.834 . . . . 0.0 111.41 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.425 ' H ' ' HD3' ' A' ' 92' ' ' PRO . . . 108.92 73.75 0.79 Allowed Glycine 0 N--CA 1.468 0.831 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.425 ' HD3' ' H ' ' A' ' 91' ' ' GLY . 50.3 Cg_exo -53.78 -36.15 81.33 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 122.833 2.355 . . . . 0.0 111.675 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.422 HG13 ' CZ ' ' A' ' 95' ' ' PHE . 3.4 p -90.44 147.61 5.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.038 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 57.7 m -86.15 147.34 26.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.662 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.424 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 81.7 m-85 -127.32 143.5 51.22 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.469 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.626 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.8 t -99.23 105.39 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-O 121.209 0.528 . . . . 0.0 109.985 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -88.84 149.7 44.19 Favored Pre-proline 0 N--CA 1.469 0.52 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.968 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -76.74 110.18 3.0 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.229 1.953 . . . . 0.0 110.977 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.91 147.72 97.85 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.607 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 40.0 Cg_endo -64.19 -26.27 64.83 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 121.817 1.678 . . . . 0.0 111.848 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 100' ' ' PRO . . . 93.33 -26.19 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 O-C-N 123.706 0.629 . . . . 0.0 110.869 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.5 p -55.38 -44.45 76.11 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.612 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.445 ' H ' HG23 ' A' ' 103' ' ' THR . 0.1 OUTLIER -64.87 -177.41 0.23 Allowed Pre-proline 0 CA--C 1.531 0.249 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.25 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' A' ' 103' ' ' THR . 52.8 Cg_exo -56.68 -155.35 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.901 1.734 . . . . 0.0 111.485 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.46 ' NH1' ' OD1' ' A' ' 112' ' ' ASP . 2.8 tpp85 -158.76 5.29 0.11 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.536 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.531 ' CD1' ' N ' ' A' ' 106' ' ' TRP . 4.5 m0 -78.66 -7.36 57.58 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.6 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.942 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -72.41 -31.8 65.83 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.691 ' H ' HD22 ' A' ' 107' ' ' LEU . 25.9 m -141.01 -42.02 0.39 Allowed 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.515 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 49.36 -0.22 0.01 OUTLIER Glycine 0 CA--C 1.539 1.562 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.13 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.555 ' N ' ' O ' ' A' ' 108' ' ' THR . 0.5 OUTLIER -86.74 -51.17 6.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.025 0.912 . . . . 0.0 108.862 179.366 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.582 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 83.5 t80 -151.36 173.18 14.82 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.498 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.582 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 93.3 m-20 -78.91 51.08 1.08 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.105 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 82.5 p -161.05 158.85 28.5 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.498 ' O ' HD12 ' A' ' 114' ' ' LEU . 0.3 OUTLIER -158.36 136.62 10.84 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -178.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.433 ' N ' HG13 ' A' ' 96' ' ' VAL . . . -68.02 125.11 25.3 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 113.389 -1.732 . . . . 0.0 110.527 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.507 HG22 ' N ' ' A' ' 117' ' ' ARG . 4.2 p -151.57 161.48 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.507 ' N ' HG22 ' A' ' 116' ' ' VAL . 61.5 ttp180 -147.06 154.38 41.11 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.934 0.397 . . . . 0.0 111.756 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.51 HG22 ' HB3' ' A' ' 62' ' ' ALA . 56.0 t -119.95 133.09 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.604 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.424 ' O ' HG23 ' A' ' 119' ' ' THR . 11.4 t -132.41 129.65 39.6 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.924 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.539 ' O ' ' CG ' ' A' ' 121' ' ' HIS . 67.4 t0 -136.99 75.47 1.53 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.163 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.682 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 18.7 m-70 -165.52 -36.5 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.301 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.682 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 18.7 Cg_endo -91.97 -162.14 0.1 Allowed 'Trans proline' 0 N--CA 1.485 0.984 0 C-N-CA 121.793 1.662 . . . . 0.0 112.01 -178.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.7 mt -77.3 -6.29 52.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.649 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 83.0 t -57.79 -44.12 85.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.632 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.747 HG23 ' H ' ' A' ' 126' ' ' ALA . 34.5 m -52.32 -62.46 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.879 0 C-N-CA 119.354 -0.938 . . . . 0.0 108.828 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.747 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.97 -44.03 3.34 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.697 0.284 . . . . 0.0 110.995 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 40.3 tp -68.75 -49.26 60.15 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.447 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.477 ' O ' ' N ' ' A' ' 132' ' ' GLY . 75.7 m -70.6 -47.92 57.74 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.263 0.554 . . . . 0.0 111.123 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.479 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -54.64 -42.52 71.37 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.493 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.6 -54.59 45.38 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.167 -177.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -65.71 -22.39 66.61 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 114.766 -1.107 . . . . 0.0 108.136 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 128' ' ' CYS . . . 78.97 2.28 86.53 Favored Glycine 0 N--CA 1.44 -1.087 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -149.57 159.69 35.78 Favored Pre-proline 0 CA--C 1.55 0.951 0 CA-C-N 117.204 0.502 . . . . 0.0 110.556 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -47.59 163.76 0.17 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 124.045 3.163 . . . . 0.0 113.667 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.3 tp -119.95 123.99 44.88 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.422 ' O ' ' CA ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -63.41 147.87 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 C-N-CA 117.755 -1.578 . . . . 0.0 106.899 179.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.3 t -122.53 127.15 49.14 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.648 0.592 . . . . 0.0 111.515 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.4 m -128.62 165.75 20.22 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.602 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 24.0 m -72.25 148.49 45.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.668 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.576 ' HB1' ' H ' ' A' ' 148' ' ' CYS . . . -60.92 -36.6 79.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.199 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 57.2 p30 -61.98 152.34 32.56 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.746 0.784 . . . . 0.0 111.293 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.18 -155.36 0.63 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.328 -1.306 . . . . 0.0 109.809 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 79.4 p -62.44 -39.05 92.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.327 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -167.97 7.55 0.05 OUTLIER Glycine 0 CA--C 1.51 -0.257 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.2 tp -86.74 128.15 57.5 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-O 119.223 -0.418 . . . . 0.0 110.037 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -38.22 156.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.666 1.578 . . . . 0.0 112.092 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.435 ' O ' ' OE2' ' A' ' 153' ' ' GLU . 97.6 Cg_endo -74.65 -169.72 0.65 Allowed 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.656 2.237 . . . . 0.0 111.983 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.576 ' H ' ' HB1' ' A' ' 140' ' ' ALA . 14.6 m -116.71 75.54 0.97 Allowed 'General case' 0 CA--C 1.522 -0.109 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.661 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.524 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 31.3 ptt-85 -51.12 -38.7 53.44 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.386 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -161.22 170.47 20.21 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.142 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.404 HG11 ' HA ' ' A' ' 166' ' ' PRO . 1.3 m -57.8 -20.8 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -64.8 -33.96 77.23 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.435 ' OE2' ' O ' ' A' ' 147' ' ' PRO . 0.0 OUTLIER -61.54 -79.69 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.807 179.289 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.441 HG13 ' N ' ' A' ' 155' ' ' ARG . 7.2 p -35.14 -33.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.969 0.908 . . . . 0.0 111.104 178.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.459 ' O ' ' N ' ' A' ' 159' ' ' GLY . 4.9 tmt_? -68.32 -51.76 41.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.679 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.51 -17.55 62.95 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.633 1.206 . . . . 0.0 107.956 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -83.42 -45.63 13.45 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 112.582 -2.099 . . . . 0.0 111.86 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -130.79 -27.35 2.11 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 94.01 24.39 20.01 Favored Glycine 0 N--CA 1.467 0.754 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 -178.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -43.07 -95.99 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.749 0.309 . . . . 0.0 110.968 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.514 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 60.53 35.45 20.17 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.537 ' H ' HG22 ' A' ' 164' ' ' VAL . 2.0 m-85 -172.61 -63.02 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.005 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -71.84 25.13 0.25 Allowed 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.301 2.001 . . . . 0.0 110.813 177.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.568 HG23 ' HD3' ' A' ' 166' ' ' PRO . 16.0 m -128.38 166.09 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.694 -178.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.19 65.05 28.21 Favored Pre-proline 0 N--CA 1.476 0.832 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.552 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.568 ' HD3' HG23 ' A' ' 164' ' ' VAL . 17.1 Cg_exo -36.12 142.65 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 123.429 2.753 . . . . 0.0 114.862 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 176.63 -168.49 40.53 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 113.934 -1.485 . . . . 0.0 111.132 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -155.52 148.96 24.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.775 0.322 . . . . 0.0 110.171 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.7 t -108.1 136.04 48.45 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -54.07 -69.62 1.18 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 144.36 77.2 0.03 OUTLIER Glycine 0 N--CA 1.466 0.673 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.527 ' O ' ' N ' ' A' ' 174' ' ' ASN . 86.4 mtm-85 -122.82 14.67 10.05 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.332 0.253 . . . . 0.0 110.741 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.571 ' N ' HD12 ' A' ' 173' ' ' LEU . 10.0 mp 58.03 -74.4 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.696 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.527 ' N ' ' O ' ' A' ' 172' ' ' ARG . 75.2 m-20 37.54 71.99 0.92 Allowed Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.413 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.34 144.39 99.51 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.535 2.157 . . . . 0.0 111.188 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 14.2 p -78.47 114.48 17.41 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.312 0.577 . . . . 0.0 110.034 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -135.18 158.36 44.57 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.145 -177.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 43.6 pt -119.85 143.82 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.988 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -130.97 166.86 20.05 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.714 0.769 . . . . 0.0 111.413 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -79.46 105.72 10.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.156 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -64.67 -19.18 65.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.659 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.481 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.5 mm? -62.4 -41.78 98.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.195 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.17 -42.4 7.07 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 63.23 25.99 68.88 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.451 -1.059 . . . . 0.0 110.451 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -63.41 136.1 57.4 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.18 0.514 . . . . 0.0 110.862 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.67 ' H ' HD23 ' A' ' 186' ' ' LEU . 0.7 OUTLIER -105.57 179.73 4.18 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.488 -179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -125.24 68.01 1.13 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.594 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.609 ' CD ' ' H ' ' A' ' 188' ' ' ARG . 0.0 OUTLIER -72.46 -20.36 61.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.54 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -65.67 -30.21 70.87 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.883 0 CA-C-O 118.201 -1.333 . . . . 0.0 110.695 -179.674 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -93.27 7.86 42.67 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.469 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -62.57 -40.74 97.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.619 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.53 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.7 mp -62.24 -42.86 99.69 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -64.6 -40.55 95.71 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -63.18 -41.73 99.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.72 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -60.57 -44.99 95.58 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.698 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.65 -44.47 96.91 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.099 0.476 . . . . 0.0 110.044 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.75 -43.13 97.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.69 -42.66 79.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.943 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.79 -41.02 99.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.86 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.37 -54.72 42.3 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.828 0.347 . . . . 0.0 111.333 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.7 pt -68.17 -35.71 72.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.241 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -59.39 -51.4 70.05 Favored 'General case' 0 C--O 1.216 -0.693 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.939 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.531 HG13 ' O ' ' A' ' 21' ' ' ARG . 87.8 t -63.15 -38.91 83.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.61 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.675 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.5 tt -52.63 -51.11 61.51 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.282 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -78.0 -49.06 14.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.176 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -67.78 -29.82 69.11 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.046 0.45 . . . . 0.0 110.813 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 16' ' ' VAL . 96.7 mt-10 56.88 60.39 3.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.42 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.531 ' O ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -154.65 159.49 40.83 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.59 0.709 . . . . 0.0 110.642 179.139 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 34' ' ' GLY . 8.7 p -74.67 137.06 23.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.771 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.497 HG22 ' NH2' ' A' ' 21' ' ' ARG . 2.8 pp -124.62 165.56 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 120.631 0.253 . . . . 0.0 110.444 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.427 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -62.91 135.85 57.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.251 0.548 . . . . 0.0 111.046 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.495 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 1.3 t80 -124.6 140.85 36.33 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.495 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 59.3 Cg_endo -81.65 145.32 14.49 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.106 1.204 . . . . 0.0 111.108 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.502 ' C ' ' H ' ' A' ' 29' ' ' ALA . 55.7 m -132.06 134.61 45.71 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.865 0.364 . . . . 0.0 110.939 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -73.91 31.02 0.08 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.519 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.502 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -157.49 -78.73 0.08 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.477 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 73.2 t -127.09 129.35 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.511 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 93.2 m-85 -43.3 146.27 0.48 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.302 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -152.95 -172.12 20.99 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.7 m -131.92 167.32 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.505 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -157.83 176.39 34.91 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.114 -1.041 . . . . 0.0 112.081 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.504 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -154.03 -163.57 1.66 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.636 -178.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.504 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 17.2 p-10 -97.44 108.09 42.87 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -177.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 36' ' ' ASP . 64.6 Cg_exo -38.93 174.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.82 2.347 . . . . 0.0 113.937 177.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 46.2 t0 37.59 77.98 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.433 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.5 m -153.22 142.96 21.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.137 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.642 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -71.5 -35.65 70.83 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.27 0.557 . . . . 0.0 109.745 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.439 HG22 ' H ' ' A' ' 41' ' ' THR . 0.1 OUTLIER -65.2 -43.59 91.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.566 -179.129 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.94 -49.42 77.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.743 0.306 . . . . 0.0 111.339 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.3 p -63.93 -47.03 92.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.811 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.3 mtt -65.64 -48.18 73.06 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.425 ' NH2' HG12 ' A' ' 22' ' ' VAL . 7.2 ptm180 -61.72 -33.17 73.57 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.587 HD13 ' C ' ' A' ' 46' ' ' LEU . 2.6 tm? -70.71 -46.32 63.3 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.419 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.482 HD21 HG21 ' A' ' 54' ' ' VAL . 6.3 mt -76.39 -11.1 59.84 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 120.897 0.379 . . . . 0.0 111.248 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.99 -81.26 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.592 -176.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.443 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -72.94 -35.93 67.1 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -75.21 -50.04 17.48 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.928 -177.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 33.95 67.05 0.22 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.759 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.2 mmm-85 178.58 -54.02 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.91 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.692 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.91 -6.57 17.58 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.647 2.232 . . . . 0.0 112.748 -178.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.595 HG13 ' N ' ' A' ' 55' ' ' ASP . 14.8 p -43.18 -46.74 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.456 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.595 ' N ' HG13 ' A' ' 54' ' ' VAL . 41.0 t0 -64.16 -42.68 96.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.025 0.44 . . . . 0.0 110.305 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -61.28 -39.63 91.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.62 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 64.72 112.03 0.01 OUTLIER Glycine 0 CA--C 1.519 0.314 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.553 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -54.57 -158.35 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.097 0.475 . . . . 0.0 111.857 -179.488 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 67.9 mt -112.75 146.24 17.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.247 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 14.7 mt -122.16 150.15 42.62 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.7 tp -120.28 130.56 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-O 121.178 0.514 . . . . 0.0 110.599 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.417 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -118.54 149.48 41.26 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.7 -29.34 8.75 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.178 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.595 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 10.9 m120 -116.72 150.02 38.9 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.038 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -77.24 -13.95 59.85 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -50.87 -31.32 17.02 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.47 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.595 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 4.7 pm0 -94.52 -13.08 26.44 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.504 HD22 ' N ' ' A' ' 68' ' ' LEU . 4.0 mm? -92.94 -12.33 31.11 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.476 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 75.0 tttt -80.16 -39.63 1.23 Allowed Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.589 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 44.0 Cg_endo -105.55 -0.95 0.19 Allowed 'Trans proline' 0 C--N 1.316 -1.163 0 C-N-CA 122.968 2.445 . . . . 0.0 112.474 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -97.85 -5.2 35.12 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.612 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.1 mp -127.1 166.33 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.612 ' N ' HG22 ' A' ' 72' ' ' ILE . 93.3 m-20 -64.2 -9.46 17.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.23 -179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 55.65 33.68 21.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.89 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.517 HG23 ' N ' ' A' ' 76' ' ' MET . 10.1 t -96.81 -42.02 8.17 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.517 ' N ' HG23 ' A' ' 75' ' ' THR . 10.5 ptp -91.45 -6.84 52.08 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.396 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.3 tp -93.02 126.05 37.92 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.685 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.453 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -159.77 160.85 34.4 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.92 -177.003 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -39.22 -47.3 1.62 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.748 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.7 p -64.17 -33.57 63.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.022 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' A' ' 78' ' ' THR . 67.8 tp60 -65.03 -40.77 95.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.974 0.416 . . . . 0.0 110.508 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.407 ' HG2' ' H ' ' A' ' 82' ' ' ARG . 6.9 mmt85 -62.69 -52.33 63.71 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 122.469 1.128 . . . . 0.0 108.95 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 87' ' ' SER . 81.9 tt0 -55.9 -50.68 70.01 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 113.781 -1.554 . . . . 0.0 110.135 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 m -61.12 -50.17 74.31 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.976 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.4 tt -67.49 -31.97 55.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.864 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -77.72 -35.25 52.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.774 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 83' ' ' GLU . 13.1 m -87.27 -16.67 34.51 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.582 0.229 . . . . 0.0 110.994 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 89' ' ' TRP . 74.5 ttt-85 -113.34 75.51 0.92 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.7 0.286 . . . . 0.0 110.237 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.452 ' O ' ' O ' ' A' ' 88' ' ' ARG . 82.5 m95 56.85 147.64 0.05 OUTLIER Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.615 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.35 -24.49 37.08 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.172 1.915 . . . . 0.0 112.488 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 156.91 79.48 0.03 OUTLIER Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -83.82 -9.46 9.86 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.72 2.28 . . . . 0.0 112.162 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.482 HG13 ' CE2' ' A' ' 95' ' ' PHE . 3.0 p -137.15 147.49 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.296 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.538 HG22 ' HB1' ' A' ' 115' ' ' ALA . 10.9 m -90.27 125.98 35.68 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.189 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.523 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 34.4 m-85 -117.4 140.5 49.5 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.755 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 3.1 t -99.77 109.75 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-O 121.546 0.688 . . . . 0.0 111.156 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -96.92 151.05 37.53 Favored Pre-proline 0 N--CA 1.469 0.482 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.69 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -65.77 104.8 0.71 Allowed 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 121.822 1.681 . . . . 0.0 111.247 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.14 162.39 71.65 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.55 141.16 90.78 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 CA-C-N 120.098 1.071 . . . . 0.0 111.756 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -156.61 54.97 0.55 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.341 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 75.5 p -73.02 -23.07 60.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.277 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.695 ' H ' ' CD ' ' A' ' 104' ' ' PRO . 0.5 OUTLIER -166.92 -39.32 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.695 ' CD ' ' H ' ' A' ' 103' ' ' THR . 9.9 Cg_exo -70.11 -166.41 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.324 2.016 . . . . 0.0 112.445 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.477 ' NH2' ' O ' ' A' ' 110' ' ' ARG . 6.4 tpt180 -169.58 0.08 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.626 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.428 ' H ' ' H ' ' A' ' 105' ' ' ARG . 2.3 p90 -70.85 -8.99 56.61 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.098 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.986 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -77.28 -18.38 57.62 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.44 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.614 ' N ' HD22 ' A' ' 107' ' ' LEU . 94.1 m -141.76 -39.33 0.38 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.918 0.389 . . . . 0.0 110.572 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 83.27 13.95 75.48 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.606 -0.597 . . . . 0.0 111.606 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.477 ' O ' ' NH2' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -162.41 -77.77 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.101 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -99.17 -162.12 0.93 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.311 -0.404 . . . . 0.0 109.957 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 53.4 p30 -134.55 61.8 1.66 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.828 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 83.0 p -156.94 128.75 7.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.613 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.567 ' C ' HG13 ' A' ' 96' ' ' VAL . 53.6 mt -124.13 134.96 53.21 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -178.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.538 ' HB1' HG22 ' A' ' 94' ' ' THR . . . -71.95 120.99 18.34 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.439 175.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.441 HG22 ' N ' ' A' ' 117' ' ' ARG . 3.4 p -143.74 158.39 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.824 0.345 . . . . 0.0 110.413 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.441 ' N ' HG22 ' A' ' 116' ' ' VAL . 88.1 mtm180 -144.73 161.77 38.39 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.815 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.417 HG22 ' HB3' ' A' ' 62' ' ' ALA . 55.9 t -123.23 130.38 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.451 ' O ' HG23 ' A' ' 119' ' ' THR . 14.1 t -129.83 128.25 41.92 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.767 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -133.95 82.64 1.99 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.848 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.65 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 70.6 t60 -172.88 -35.73 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.65 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 39.6 Cg_endo -93.06 -161.43 0.09 OUTLIER 'Trans proline' 0 N--CA 1.484 0.949 0 C-N-CA 122.045 1.83 . . . . 0.0 111.847 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 37.6 mt -78.42 -5.74 53.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.891 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.2 t -58.05 -45.07 88.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.808 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.763 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.1 m -53.05 -62.31 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.789 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.705 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.763 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.38 -42.72 2.32 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.877 0.37 . . . . 0.0 110.898 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.4 tp -69.67 -48.95 57.97 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.303 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 56.0 m -70.65 -48.92 52.43 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.548 0.689 . . . . 0.0 110.757 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.462 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -54.28 -42.04 69.56 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.216 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.17 -55.44 35.0 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.234 -177.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -61.59 -21.22 64.14 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.515 -1.221 . . . . 0.0 108.932 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.57 -0.23 85.94 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' A' ' 134' ' ' PRO . 31.4 mttp -151.46 159.53 33.25 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 120.605 -0.438 . . . . 0.0 109.944 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 133' ' ' LYS . 5.7 Cg_exo -41.0 176.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 123.855 3.036 . . . . 0.0 113.021 -178.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.43 HD12 ' O ' ' A' ' 35' ' ' CYS . 7.8 tp -130.94 123.24 28.44 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 176.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.433 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -64.94 152.99 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 10.8 t -129.54 132.86 46.95 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.107 0.479 . . . . 0.0 111.305 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.8 m -135.3 164.49 27.61 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.888 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.1 m -71.4 146.95 48.4 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.465 ' HB1' ' SG ' ' A' ' 148' ' ' CYS . . . -74.47 81.16 1.93 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.712 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 48.1 p-10 -159.43 168.06 27.19 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.303 0.573 . . . . 0.0 110.454 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.2 -162.35 1.43 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.166 -178.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 77.5 p -61.92 -39.74 93.08 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.611 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -163.61 4.85 0.07 OUTLIER Glycine 0 CA--C 1.511 -0.179 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.7 tp -81.43 127.69 72.55 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.164 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -39.24 157.94 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.7 1.6 . . . . 0.0 111.972 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.424 ' O ' ' OE1' ' A' ' 153' ' ' GLU . 76.3 Cg_endo -73.15 -163.89 0.17 Allowed 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.505 2.137 . . . . 0.0 112.242 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.465 ' SG ' ' HB1' ' A' ' 140' ' ' ALA . 11.3 m -118.52 73.71 0.93 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.524 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.511 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 37.6 ptt180 -54.14 -35.91 62.72 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.169 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.95 167.89 20.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.436 HG22 ' H ' ' A' ' 151' ' ' VAL . 0.9 OUTLIER -56.23 -18.6 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 CA-C-O 121.638 0.732 . . . . 0.0 109.128 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -64.41 -36.45 84.19 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.429 ' OE1' ' OE1' ' A' ' 157' ' ' GLN . 0.4 OUTLIER -59.26 -72.06 0.11 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.793 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.3 p -47.97 -30.17 2.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.421 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.457 ' O ' ' N ' ' A' ' 159' ' ' GLY . 4.5 tmt_? -84.01 -44.81 13.77 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 122.293 1.044 . . . . 0.0 110.187 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.41 -41.89 85.95 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.497 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.453 ' CG ' ' N ' ' A' ' 158' ' ' PHE . 8.1 pt20 -80.95 -48.52 12.18 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 113.195 -1.82 . . . . 0.0 111.978 -177.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.453 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 33.7 t80 -107.07 -35.94 6.73 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -177.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 96.86 24.64 12.79 Favored Glycine 0 N--CA 1.475 1.259 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 -178.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -43.23 -93.96 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.66 0.267 . . . . 0.0 110.655 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.47 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.66 36.11 16.73 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.518 ' H ' HG22 ' A' ' 164' ' ' VAL . 2.0 m-85 -175.18 -62.69 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.172 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -72.91 28.73 0.29 Allowed 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.364 2.043 . . . . 0.0 110.794 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.58 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.8 m -132.2 167.78 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.899 -178.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.9 t -124.0 65.5 37.56 Favored Pre-proline 0 N--CA 1.473 0.677 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.698 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.58 ' HD3' HG23 ' A' ' 164' ' ' VAL . 33.4 Cg_exo -37.51 139.99 0.25 Allowed 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 123.586 2.857 . . . . 0.0 114.967 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 160.46 174.25 30.05 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 113.987 -1.461 . . . . 0.0 110.72 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -159.51 133.77 7.63 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 10.3 t -88.3 -32.54 18.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.983 0.421 . . . . 0.0 110.148 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 150.4 -40.14 0.84 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 105.83 6.25 37.77 Favored Glycine 0 N--CA 1.466 0.639 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -83.32 139.63 32.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.464 -0.368 . . . . 0.0 110.236 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 60.3 tp -76.25 151.65 36.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.191 0.519 . . . . 0.0 110.663 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -126.39 149.41 67.37 Favored Pre-proline 0 N--CA 1.472 0.656 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.826 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -74.98 87.6 1.31 Allowed 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.046 1.831 . . . . 0.0 111.886 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 71.1 m -128.66 123.19 32.56 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.31 0.576 . . . . 0.0 110.062 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -133.85 174.3 10.61 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.81 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 178' ' ' ILE . 19.9 tt -108.47 127.91 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.212 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -127.86 164.34 22.45 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.753 0.787 . . . . 0.0 112.353 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -81.28 106.68 13.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.075 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.755 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -70.77 -12.39 61.52 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.314 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.482 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.7 mm? -64.23 -40.58 96.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.867 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.8 -41.71 6.42 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.111 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 60.29 26.95 64.66 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.4 ' HG2' ' H ' ' A' ' 185' ' ' GLU . 4.7 pt-20 -58.79 134.44 56.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.097 0.475 . . . . 0.0 110.701 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.676 ' H ' ' CD2' ' A' ' 186' ' ' LEU . 0.6 OUTLIER -108.78 -176.14 2.96 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.423 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -98.58 58.4 1.22 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.436 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.61 138.65 52.92 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.885 0.374 . . . . 0.0 110.476 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -138.01 137.06 37.49 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.285 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.833 0 CA-C-O 118.026 -1.43 . . . . 0.0 110.813 -179.935 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -95.68 6.34 49.17 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.304 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -63.37 -40.83 98.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.578 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.547 HD12 ' N ' ' A' ' 5' ' ' LEU . 9.7 mp -62.08 -42.66 99.44 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -63.95 -41.32 97.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.021 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 78.8 ttt-85 -61.96 -42.36 99.04 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.887 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -60.72 -45.2 95.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.562 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.42 -42.54 98.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.998 0.428 . . . . 0.0 110.337 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.38 -43.63 98.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.721 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.12 -47.22 78.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.493 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.06 -39.09 91.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.635 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.34 -53.08 62.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.629 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 38.2 pt -70.01 -33.43 55.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.197 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.423 ' OD1' ' OE2' ' A' ' 19' ' ' GLU . 24.6 t70 -57.74 -55.13 38.79 Favored 'General case' 0 C--O 1.217 -0.637 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.147 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 20' ' ' GLU . 97.9 t -63.6 -40.11 87.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.704 0.288 . . . . 0.0 110.675 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.681 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.3 tt -52.16 -48.91 64.69 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.303 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -80.29 -52.59 7.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.289 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.423 ' OE2' ' OD1' ' A' ' 15' ' ' ASP . 92.7 mt-10 -66.91 -34.97 78.94 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.801 -178.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.8 mt-10 60.19 87.48 0.09 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.122 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.439 ' H ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -161.08 -135.74 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.668 178.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.3 p -140.62 140.76 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -129.76 166.18 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 120.982 0.42 . . . . 0.0 111.757 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.96 129.34 39.36 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.411 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.513 ' CE2' ' O ' ' A' ' 26' ' ' PRO . 4.4 t80 -115.48 138.25 23.63 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.513 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 64.0 Cg_endo -81.41 144.08 14.16 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 121.144 1.229 . . . . 0.0 111.615 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.5 ' C ' ' H ' ' A' ' 29' ' ' ALA . 58.1 m -134.53 132.93 39.76 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.013 0.435 . . . . 0.0 111.153 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -72.84 30.3 0.06 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.71 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.5 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -158.54 -76.1 0.08 Allowed 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 120.784 0.326 . . . . 0.0 110.82 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 75.3 t -125.77 127.69 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 120.96 0.41 . . . . 0.0 110.26 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -48.88 145.76 3.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.765 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -154.83 -173.9 24.17 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.7 m -131.23 170.58 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.407 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -158.95 -176.96 31.58 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 119.765 -1.207 . . . . 0.0 112.453 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -158.16 -167.2 2.14 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.592 0.234 . . . . 0.0 110.716 -179.104 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.472 ' CG ' ' CZ ' ' A' ' 131' ' ' TYR . 18.3 t70 -95.12 109.4 44.41 Favored Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 36' ' ' ASP . 32.8 Cg_exo -37.28 172.27 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.778 2.319 . . . . 0.0 114.358 177.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 40.9 72.22 0.17 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.855 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 m -153.16 137.55 16.68 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.557 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -67.6 -33.62 75.37 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.075 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.588 HG23 ' N ' ' A' ' 42' ' ' ALA . 12.9 t -62.26 -46.11 90.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.026 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.588 ' N ' HG23 ' A' ' 41' ' ' THR . . . -58.4 -51.23 70.68 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.408 -178.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.5 p -62.59 -44.14 99.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.412 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 61.9 mtt -64.03 -39.3 93.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.15 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 51.3 ttt-85 -62.39 -34.4 76.64 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 87.9 mt -74.72 -58.78 3.07 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.3 mt -55.96 -16.3 4.63 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.36 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -68.6 -86.43 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.493 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.2 pt? -77.13 -33.66 56.75 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -76.18 -50.43 14.58 Favored 'General case' 0 C--N 1.349 0.557 0 C-N-CA 119.798 -0.761 . . . . 0.0 110.723 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 35.47 65.77 0.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.703 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 179.61 -54.28 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.83 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.235 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.09 -6.71 17.59 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.637 2.224 . . . . 0.0 112.088 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.565 HG13 ' N ' ' A' ' 55' ' ' ASP . 7.4 p -43.57 -49.29 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.73 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.565 ' N ' HG13 ' A' ' 54' ' ' VAL . 39.8 t0 -66.28 -40.94 90.43 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.687 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -60.88 -39.8 90.61 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.084 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 65.48 107.63 0.01 OUTLIER Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.564 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -52.62 -161.28 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.375 0.607 . . . . 0.0 112.278 -179.477 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 73.2 mt -106.58 142.95 18.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.166 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 16.0 mt -118.05 142.63 47.19 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.4 tp -111.82 126.91 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-O 121.408 0.623 . . . . 0.0 111.622 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.76 148.29 39.99 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.094 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.55 -27.65 9.76 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.075 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.778 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 98.6 m-20 -117.91 151.12 38.04 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.946 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -79.26 -13.51 59.63 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -52.54 -31.99 38.46 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.216 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.778 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 4.8 pm0 -93.79 -10.63 33.49 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.414 ' O ' HD13 ' A' ' 72' ' ' ILE . 4.3 mm? -90.79 -18.73 24.43 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.45 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 47.1 tttm -76.71 -39.0 2.24 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 69.7 Cg_endo -104.38 -2.38 0.23 Allowed 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 122.923 2.416 . . . . 0.0 112.582 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -94.85 -10.55 30.99 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.838 0.351 . . . . 0.0 111.06 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.633 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.1 mp -125.52 168.14 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.633 ' N ' HG22 ' A' ' 72' ' ' ILE . 93.0 m-20 -62.3 -13.03 24.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.786 0.327 . . . . 0.0 110.829 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 44.7 t0 55.54 21.74 4.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.841 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.657 HG23 ' N ' ' A' ' 76' ' ' MET . 8.4 t -89.53 -54.51 4.05 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.657 ' N ' HG23 ' A' ' 75' ' ' THR . 13.5 ptp -68.08 -37.52 81.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.225 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 tp -64.22 139.13 58.73 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.208 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.9 173.19 14.06 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.461 -176.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -60.26 -43.06 96.49 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.202 0.314 . . . . 0.0 111.23 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.9 p -60.92 -32.48 52.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.994 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -63.47 -40.89 98.32 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.094 0.473 . . . . 0.0 110.498 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.428 ' HG2' ' H ' ' A' ' 82' ' ' ARG . 7.0 mmt85 -63.34 -51.51 65.65 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 122.648 1.213 . . . . 0.0 108.782 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 87' ' ' SER . 80.7 tt0 -57.17 -50.22 73.5 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 113.667 -1.606 . . . . 0.0 110.096 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.5 m -62.04 -49.03 77.65 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.264 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 89' ' ' TRP . 13.9 tt -68.52 -26.05 32.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.585 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -86.02 -32.22 21.58 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.438 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 83' ' ' GLU . 10.7 m -88.64 -9.12 53.23 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.745 0.307 . . . . 0.0 110.784 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 89' ' ' TRP . 62.4 ttm-85 -128.47 79.53 1.91 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.514 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.448 ' O ' ' O ' ' A' ' 88' ' ' ARG . 2.7 m-90 56.43 152.54 0.07 OUTLIER Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.667 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.88 -23.15 41.53 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.879 1.719 . . . . 0.0 111.753 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 157.95 79.08 0.03 OUTLIER Glycine 0 CA--C 1.53 1.004 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.53 -35.63 86.32 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.714 2.276 . . . . 0.0 112.427 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.2 p -133.84 147.69 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.84 0.352 . . . . 0.0 110.455 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 26.4 m -84.16 141.45 31.05 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.362 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.459 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 70.8 m-85 -119.01 139.81 51.09 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.732 0.301 . . . . 0.0 110.964 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.667 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 3.3 t -96.85 103.55 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 121.424 0.63 . . . . 0.0 109.689 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -91.54 152.01 43.08 Favored Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.079 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.04 110.74 3.15 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.883 1.722 . . . . 0.0 111.341 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.7 153.23 70.33 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.852 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.66 151.95 78.58 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.155 1.904 . . . . 0.0 111.664 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -151.65 70.74 0.96 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.388 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 69.5 p -66.65 -30.92 71.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.707 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.715 ' H ' ' CD ' ' A' ' 104' ' ' PRO . 1.2 m -167.1 -38.01 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.715 ' CD ' ' H ' ' A' ' 103' ' ' THR . 15.4 Cg_exo -67.57 -163.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.448 2.099 . . . . 0.0 112.266 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.486 ' NH1' ' O ' ' A' ' 110' ' ' ARG . 5.5 tpp85 -167.77 3.35 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.935 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 63.5 p-90 -74.03 -8.6 56.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.753 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.971 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -73.56 -23.42 59.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.081 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.66 ' H ' HD22 ' A' ' 107' ' ' LEU . 88.6 m -142.71 -39.33 0.34 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.107 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 89.31 9.03 67.65 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.486 ' O ' ' NH1' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -158.24 -79.17 0.07 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 117.038 0.419 . . . . 0.0 109.911 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -93.41 -129.61 0.12 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.268 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -157.89 61.58 0.47 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.507 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.6 p -157.52 153.65 27.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.81 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.481 ' O ' HD12 ' A' ' 114' ' ' LEU . 0.3 OUTLIER -160.78 139.17 9.93 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.354 1.073 . . . . 0.0 113.461 -179.508 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.56 133.04 48.71 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 112.971 -1.922 . . . . 0.0 109.885 178.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.8 p -149.98 153.82 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.805 0.336 . . . . 0.0 110.341 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 71.7 ttp85 -147.89 158.7 44.17 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.571 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.2 t -122.18 133.55 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 116.288 -0.414 . . . . 0.0 109.928 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.7 t -132.71 130.9 40.64 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -135.85 85.22 2.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.626 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.597 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 36.2 t60 -172.83 -38.36 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.422 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.597 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 29.1 Cg_endo -92.84 -161.83 0.09 OUTLIER 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 122.026 1.818 . . . . 0.0 112.028 -178.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 123' ' ' LEU . 9.4 mp -78.35 -4.15 46.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.822 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 87.9 t -58.27 -44.96 89.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.855 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.756 HG23 ' H ' ' A' ' 126' ' ' ALA . 29.6 m -53.98 -61.94 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.844 0 C-N-CA 119.434 -0.906 . . . . 0.0 108.633 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.756 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.08 -43.34 2.19 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.91 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 45.4 tp -70.16 -47.86 59.8 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 120.589 -0.445 . . . . 0.0 111.275 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 64.2 m -70.22 -49.15 53.0 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.517 0.675 . . . . 0.0 110.791 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.465 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.0 OUTLIER -55.01 -42.02 72.02 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.455 179.354 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.07 -56.27 24.23 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.93 -177.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.472 ' CZ ' ' CG ' ' A' ' 36' ' ' ASP . 4.2 t80 -63.44 -26.33 68.68 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.263 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.92 3.26 85.69 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 134' ' ' PRO . 69.4 mttt -149.46 157.87 38.57 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-N 116.908 0.354 . . . . 0.0 110.758 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 133' ' ' LYS . 5.7 Cg_exo -42.67 178.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 123.874 3.049 . . . . 0.0 112.705 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.0 tp -134.76 122.36 22.03 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.441 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -64.23 143.1 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 C-N-CA 117.975 -1.49 . . . . 0.0 107.166 -179.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.7 t -116.76 123.88 48.26 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 123.568 0.542 . . . . 0.0 111.333 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.6 m -128.86 165.27 21.34 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.152 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.5 t -70.96 149.42 46.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.643 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.25 -38.85 91.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.178 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 55.2 p30 -55.48 152.08 9.41 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.889 0.852 . . . . 0.0 111.351 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.8 -157.0 0.72 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.575 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.5 t -60.31 -45.27 93.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.492 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -161.13 4.46 0.09 OUTLIER Glycine 0 C--N 1.329 0.17 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.2 tp -84.94 127.27 65.41 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -37.47 157.03 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.8 1.667 . . . . 0.0 112.429 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.93 -163.52 0.2 Allowed 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.38 2.053 . . . . 0.0 112.314 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 15.8 t -114.4 78.88 1.19 Allowed 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.515 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -58.67 -34.71 71.55 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.966 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -163.02 165.29 25.02 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 151' ' ' VAL . 0.7 OUTLIER -55.9 -18.84 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.59 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 156' ' ' ALA . 99.6 m-20 -65.38 -34.17 77.68 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.519 ' OE1' ' NE2' ' A' ' 157' ' ' GLN . 6.7 tm-20 -59.21 -70.56 0.15 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.507 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.4 p -50.02 -29.58 5.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.359 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -84.42 -43.76 14.35 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 122.392 1.091 . . . . 0.0 110.143 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 152' ' ' ASP . . . -58.93 -41.23 86.84 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.454 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.519 ' NE2' ' OE1' ' A' ' 153' ' ' GLU . 0.7 OUTLIER -82.46 -48.6 10.89 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 112.981 -1.918 . . . . 0.0 112.143 -177.02 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.474 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 38.3 t80 -106.97 -36.62 6.56 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -177.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 97.44 25.68 10.73 Favored Glycine 0 N--CA 1.473 1.106 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.409 ' HB1' ' HG2' ' A' ' 163' ' ' PRO . . . -43.43 -94.9 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.612 0.244 . . . . 0.0 110.734 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.424 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 63.44 36.68 11.19 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 121.292 0.568 . . . . 0.0 109.739 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.534 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.2 m-85 -177.14 -61.63 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.214 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.409 ' HG2' ' HB1' ' A' ' 160' ' ' ALA . 91.5 Cg_endo -73.85 29.24 0.32 Allowed 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.14 1.893 . . . . 0.0 110.505 178.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.581 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.9 m -132.34 167.65 25.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.558 -178.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.0 t -124.27 65.11 39.12 Favored Pre-proline 0 N--CA 1.476 0.84 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.71 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.581 ' HD3' HG23 ' A' ' 164' ' ' VAL . 31.3 Cg_exo -37.41 145.06 0.12 Allowed 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 123.815 3.01 . . . . 0.0 115.158 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 165.77 116.92 0.38 Allowed Glycine 0 CA--C 1.523 0.573 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.493 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -85.06 144.99 27.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.886 0.374 . . . . 0.0 110.068 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.8 t -147.14 151.23 36.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.205 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -61.26 -70.12 1.11 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 172' ' ' ARG . . . 167.06 -75.06 0.14 Allowed Glycine 0 CA--C 1.521 0.424 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' A' ' 171' ' ' GLY . 69.5 ttt180 58.71 136.02 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.063 0.459 . . . . 0.0 110.737 179.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.547 ' N ' HD12 ' A' ' 173' ' ' LEU . 10.2 mp -56.8 -97.84 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.777 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 41.54 63.54 6.2 Favored Pre-proline 0 N--CA 1.462 0.173 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.28 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -74.61 159.44 42.62 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.618 2.212 . . . . 0.0 111.823 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 61.3 m -94.54 115.23 27.34 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.54 0.686 . . . . 0.0 109.902 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -126.11 144.46 50.73 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.698 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.416 HD13 HG21 ' A' ' 178' ' ' ILE . 14.2 pt -106.02 134.35 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.284 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 19.3 mmm-85 -120.12 157.44 28.98 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.526 0.679 . . . . 0.0 110.189 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 184' ' ' GLY . 97.6 m-20 -72.03 104.53 3.59 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.903 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -68.49 -18.33 64.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.041 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.506 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.7 mm? -64.01 -41.38 97.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.018 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.56 HG23 ' N ' ' A' ' 184' ' ' GLY . 5.2 t -121.3 -51.46 2.09 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.695 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.56 ' N ' HG23 ' A' ' 183' ' ' THR . . . 93.54 41.96 4.34 Favored Glycine 0 N--CA 1.464 0.567 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -89.87 141.61 28.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.265 0.555 . . . . 0.0 111.334 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.498 ' H ' ' CD2' ' A' ' 186' ' ' LEU . 0.7 OUTLIER -73.63 -179.35 3.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.781 179.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -104.27 -13.67 16.08 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.608 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.94 141.34 30.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.23 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -149.86 -29.59 0.23 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.886 0.374 . . . . 0.0 110.337 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.76 0 CA-C-O 118.075 -1.403 . . . . 0.0 111.01 179.961 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.2 p30 -78.96 -6.98 57.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.455 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -62.16 -41.03 97.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.555 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.55 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.2 mp -63.15 -42.08 99.38 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.962 0.41 . . . . 0.0 110.048 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -63.32 -42.04 98.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.421 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -63.2 -39.36 94.42 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.408 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -61.52 -43.78 98.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.681 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.48 -45.23 88.24 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.808 0.337 . . . . 0.0 110.264 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.0 mm -63.69 -43.11 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.26 -47.37 78.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.045 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.01 -41.59 96.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.103 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.64 -54.62 44.34 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.9 0.381 . . . . 0.0 111.187 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 14' ' ' ILE . 19.8 pt -69.23 -37.04 75.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.149 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -56.59 -56.2 24.3 Favored 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.469 ' O ' ' N ' ' A' ' 20' ' ' GLU . 99.6 t -63.29 -39.93 87.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 121.16 -0.216 . . . . 0.0 110.59 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.671 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.4 tt -51.79 -49.9 61.79 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.701 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -80.47 -51.87 8.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.148 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -65.86 -34.98 79.4 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.506 -178.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 16' ' ' VAL . 96.2 mt-10 58.51 88.37 0.06 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.107 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.414 ' H ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -162.47 -133.99 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.8 p -141.99 140.92 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 pp -129.01 167.62 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-O 121.122 0.487 . . . . 0.0 111.875 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.77 129.6 40.35 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.735 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.539 ' CE2' ' O ' ' A' ' 26' ' ' PRO . 7.8 t80 -117.14 138.82 25.2 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.297 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.539 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 63.6 Cg_endo -79.51 144.69 18.01 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.28 1.32 . . . . 0.0 111.751 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.476 ' C ' ' H ' ' A' ' 29' ' ' ALA . 63.2 m -132.6 134.79 45.35 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.248 0.547 . . . . 0.0 111.057 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -74.69 26.27 0.09 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.77 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.476 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -160.85 -70.28 0.07 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.993 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.6 p -127.93 123.57 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 121.108 0.48 . . . . 0.0 110.097 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.524 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 94.7 m-85 -42.52 151.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.744 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -155.51 -178.68 29.98 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.2 m -130.67 169.66 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.51 -177.39 33.57 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 119.839 -1.172 . . . . 0.0 112.323 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.429 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -158.76 -171.42 3.41 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.511 ' OD1' ' CE1' ' A' ' 131' ' ' TYR . 27.8 t70 -92.66 111.82 52.77 Favored Pre-proline 0 CA--C 1.553 1.083 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 36' ' ' ASP . 12.6 Cg_exo -35.55 167.72 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.81 2.34 . . . . 0.0 114.126 177.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 40.8 78.06 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.679 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.4 m -152.89 149.81 28.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.967 0.413 . . . . 0.0 110.707 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -71.03 -33.2 70.09 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.408 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.432 ' H ' HG22 ' A' ' 41' ' ' THR . 0.0 OUTLIER -64.19 -43.19 95.84 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.808 -178.402 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.0 -50.24 74.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.227 0.536 . . . . 0.0 111.024 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.402 HG12 ' H ' ' A' ' 43' ' ' VAL . 2.9 p -64.74 -45.73 94.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.569 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 59.3 mtt -66.67 -45.04 80.18 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.3 ptt85 -64.58 -30.35 71.37 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.933 0.397 . . . . 0.0 110.102 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.1 mt -73.67 -59.75 2.57 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.273 177.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.4 mt -54.81 -20.53 8.82 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.45 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -64.16 -86.24 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.353 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.518 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.2 pt? -77.01 -34.87 57.43 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -75.3 -49.65 18.52 Favored 'General case' 0 C--N 1.352 0.682 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.193 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 36.56 65.56 0.46 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.709 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 178.55 -53.99 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.858 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.351 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -77.5 -4.74 14.95 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 C-N-CA 122.781 2.321 . . . . 0.0 112.345 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.606 HG13 ' N ' ' A' ' 55' ' ' ASP . 7.2 p -45.46 -48.66 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.56 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.606 ' N ' HG13 ' A' ' 54' ' ' VAL . 13.2 t0 -66.64 -45.41 79.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.334 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -59.69 -41.55 90.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.559 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 69.48 114.48 0.03 OUTLIER Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.567 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -51.03 -164.86 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.337 0.589 . . . . 0.0 112.304 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.4 mt -104.49 145.1 13.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 16.0 mt -117.45 144.54 44.91 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.2 tp -111.18 127.53 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-O 121.069 0.461 . . . . 0.0 110.702 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.631 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -115.11 153.35 30.9 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.57 -28.71 7.06 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.764 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.619 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 98.6 m-20 -114.39 142.1 46.78 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.973 0.416 . . . . 0.0 110.903 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -72.66 -13.65 61.41 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -50.41 -33.78 22.03 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.209 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.619 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 4.3 pm0 -94.08 -11.29 30.91 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.481 ' O ' HD13 ' A' ' 72' ' ' ILE . 4.1 mm? -90.06 -17.7 27.28 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.391 -0.818 . . . . 0.0 109.322 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.457 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 48.4 tttm -78.45 -39.17 1.62 Allowed Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.457 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 63.9 Cg_endo -104.01 -2.39 0.25 Allowed 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 122.634 2.223 . . . . 0.0 112.287 -178.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -95.45 -10.18 30.56 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.812 0.339 . . . . 0.0 110.87 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.607 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.6 mp -123.3 167.36 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.607 ' N ' HG22 ' A' ' 72' ' ' ILE . 98.6 m-20 -59.65 -14.24 12.97 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.237 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 58.8 t0 57.14 28.72 15.42 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.85 0.357 . . . . 0.0 110.467 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.524 HG23 ' N ' ' A' ' 76' ' ' MET . 9.5 t -95.86 -43.05 8.02 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.715 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.524 ' N ' HG23 ' A' ' 75' ' ' THR . 18.4 ptm -85.63 -8.13 58.42 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.144 0.497 . . . . 0.0 109.923 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.3 tp -86.51 128.26 34.95 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.611 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.36 164.42 36.35 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.08 -176.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -45.94 -46.77 16.34 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 112.088 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.6 -32.69 54.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.843 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -64.68 -39.78 94.27 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.251 0.548 . . . . 0.0 110.492 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.8 mmt85 -65.86 -52.13 52.99 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 122.33 1.062 . . . . 0.0 108.8 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -55.09 -50.89 68.04 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 113.825 -1.534 . . . . 0.0 110.03 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.3 m -61.07 -49.55 76.9 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.574 -1.194 . . . . 0.0 112.247 -177.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.424 ' O ' ' O ' ' A' ' 89' ' ' TRP . 10.0 tt -68.11 -31.11 50.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.617 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -76.75 -36.2 57.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.541 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.1 m -86.63 -44.28 11.99 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.055 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.482 ' O ' ' CD1' ' A' ' 89' ' ' TRP . 61.8 ttt85 -70.14 -77.06 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.936 0.398 . . . . 0.0 110.44 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.482 ' CD1' ' O ' ' A' ' 88' ' ' ARG . 5.8 m0 -158.4 149.37 16.29 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.449 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -66.65 -23.59 49.03 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.684 1.59 . . . . 0.0 111.946 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 152.36 83.17 0.04 OUTLIER Glycine 0 CA--C 1.533 1.189 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -76.05 -19.4 15.75 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.631 1.554 . . . . 0.0 111.472 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.405 HG13 ' CE2' ' A' ' 95' ' ' PHE . 12.4 p -136.19 148.91 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.517 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.5 m -83.18 134.21 34.99 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.813 0.34 . . . . 0.0 110.383 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.488 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 67.7 m-85 -113.93 138.93 49.66 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.843 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.667 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 5.2 t -95.87 103.04 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 121.459 0.647 . . . . 0.0 109.592 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -87.37 148.91 45.67 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.537 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.04 108.88 2.77 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.93 1.753 . . . . 0.0 111.194 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.44 155.62 92.25 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.264 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.611 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 89.2 Cg_exo -45.43 -32.33 7.76 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.661 1.574 . . . . 0.0 111.979 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.611 ' HB3' ' O ' ' A' ' 100' ' ' PRO . . . 84.64 -39.85 0.06 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.595 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 52.1 p -61.07 -31.76 71.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.353 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.446 ' CB ' ' CD ' ' A' ' 104' ' ' PRO . 0.1 OUTLIER -55.73 -178.18 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.431 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.446 ' CD ' ' CB ' ' A' ' 103' ' ' THR . 43.0 Cg_exo -57.07 -153.4 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.21 1.94 . . . . 0.0 111.998 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 109' ' ' GLY . 20.1 mmt180 -139.82 -14.7 1.06 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.869 -0.15 . . . . 0.0 111.095 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 2.7 p90 -67.9 -10.28 51.91 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.796 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 1.03 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -69.81 -39.24 76.64 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.795 ' H ' HD22 ' A' ' 107' ' ' LEU . 45.6 m -143.81 -41.4 0.28 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.858 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 56.24 -8.57 0.01 OUTLIER Glycine 0 CA--C 1.535 1.301 0 CA-C-N 115.95 -0.568 . . . . 0.0 113.077 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.548 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 0.5 OUTLIER -85.03 -52.68 5.79 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 117.898 0.849 . . . . 0.0 109.574 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.529 ' CE2' ' OD1' ' A' ' 112' ' ' ASP . 57.7 t80 -152.44 169.36 22.76 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.324 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.529 ' OD1' ' CE2' ' A' ' 111' ' ' PHE . 18.1 p30 -79.27 49.74 1.0 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.184 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.7 p -160.25 158.04 29.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.084 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.515 ' O ' HD12 ' A' ' 114' ' ' LEU . 0.3 OUTLIER -159.01 138.04 11.24 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -179.292 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.44 ' HB2' HG22 ' A' ' 96' ' ' VAL . . . -69.98 132.69 46.31 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 113.557 -1.656 . . . . 0.0 110.296 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.545 HG22 ' N ' ' A' ' 117' ' ' ARG . 4.9 p -156.61 163.79 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.545 ' N ' HG22 ' A' ' 116' ' ' VAL . 22.6 ptt180 -153.5 160.19 42.46 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.246 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.631 HG22 ' HB3' ' A' ' 62' ' ' ALA . 54.3 t -125.26 139.89 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.023 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 119' ' ' THR . 14.9 t -141.64 130.04 22.44 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.975 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -132.69 90.17 2.74 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.612 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 9.9 t-80 -173.78 -37.91 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.466 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.612 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 38.2 Cg_endo -93.82 -160.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.32 -0.922 0 C-N-CA 121.932 1.755 . . . . 0.0 112.201 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 123' ' ' LEU . 9.7 mp -78.97 -6.51 56.45 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.701 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.2 t -57.16 -45.24 84.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.989 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.738 HG23 ' H ' ' A' ' 126' ' ' ALA . 31.5 m -52.91 -62.02 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.21 -0.995 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.022 178.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.738 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.23 -45.97 3.03 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 122.369 -0.207 . . . . 0.0 110.943 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.4 tp -67.91 -48.64 65.44 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.206 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 72.1 m -69.53 -49.33 55.49 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.21 0.529 . . . . 0.0 111.197 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.485 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.2 pp0? -54.88 -42.03 71.59 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.855 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.76 -56.39 22.8 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.778 -177.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.511 ' CE1' ' OD1' ' A' ' 36' ' ' ASP . 4.8 t80 -63.0 -24.11 67.76 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.895 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.8 2.76 89.7 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 114.187 -1.37 . . . . 0.0 110.311 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.418 ' O ' ' O ' ' A' ' 134' ' ' PRO . 29.9 mttp -150.2 158.32 36.56 Favored Pre-proline 0 CA--C 1.547 0.833 0 CA-C-N 117.157 0.478 . . . . 0.0 110.342 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 133' ' ' LYS . 6.3 Cg_exo -42.36 -179.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 123.84 3.027 . . . . 0.0 113.442 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.0 tp -134.56 122.78 22.85 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 176.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.437 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.9 OUTLIER -64.07 144.87 14.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 C-N-CA 117.37 -1.732 . . . . 0.0 107.664 -179.304 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 12.6 t -116.55 126.8 53.83 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.197 0.522 . . . . 0.0 111.481 -179.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.08 162.52 31.51 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.683 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.9 t -72.12 149.14 45.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.044 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.68 78.88 7.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.577 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 56.1 p30 -157.68 165.35 35.69 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.182 0.515 . . . . 0.0 110.328 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.32 -165.82 2.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.174 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.1 p -63.47 -41.25 98.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.043 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -157.4 3.84 0.15 Allowed Glycine 0 N--CA 1.462 0.424 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.476 HD13 ' C ' ' A' ' 145' ' ' LEU . 1.3 tm? -84.0 111.35 32.35 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-O 119.078 -0.487 . . . . 0.0 109.767 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 145' ' ' LEU . 19.5 Cg_exo -34.92 156.52 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.095 1.863 . . . . 0.0 112.745 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.43 171.38 16.31 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.646 2.23 . . . . 0.0 112.229 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 34.7 t -96.09 77.46 3.11 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.664 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.524 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 36.2 ptt180 -53.58 -36.67 62.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.892 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.89 167.24 29.93 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.421 HG11 ' HA ' ' A' ' 166' ' ' PRO . 1.7 m -57.94 -18.62 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.736 0 CA-C-O 121.846 0.831 . . . . 0.0 109.081 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.62 -36.67 84.57 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.531 ' OE1' ' NE2' ' A' ' 157' ' ' GLN . 5.1 tm-20 -59.48 -73.87 0.08 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.244 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.436 HG11 HG11 ' A' ' 164' ' ' VAL . 7.1 p -45.8 -29.47 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.847 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 159' ' ' GLY . 4.8 tmt_? -83.92 -44.48 14.2 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 122.028 0.918 . . . . 0.0 110.08 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.53 -41.64 85.95 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.257 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.531 ' NE2' ' OE1' ' A' ' 153' ' ' GLU . 0.6 OUTLIER -81.63 -48.74 11.35 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 113.018 -1.901 . . . . 0.0 112.487 -177.092 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.469 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 36.0 t80 -107.04 -35.55 6.85 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -177.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 96.8 24.86 12.44 Favored Glycine 0 N--CA 1.475 1.296 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.426 ' HB1' ' HG2' ' A' ' 163' ' ' PRO . . . -44.06 -95.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.953 -0.124 . . . . 0.0 110.812 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.473 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 62.8 38.01 11.97 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.306 0.575 . . . . 0.0 109.955 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.57 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.4 m-85 -177.97 -61.14 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.377 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.426 ' HG2' ' HB1' ' A' ' 160' ' ' ALA . 93.6 Cg_endo -72.69 22.78 0.29 Allowed 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.156 1.904 . . . . 0.0 110.998 178.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.59 HG23 ' HD3' ' A' ' 166' ' ' PRO . 16.8 m -128.04 167.54 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.636 -177.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.0 t -123.84 65.69 36.48 Favored Pre-proline 0 N--CA 1.476 0.825 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.71 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.59 ' HD3' HG23 ' A' ' 164' ' ' VAL . 22.8 Cg_exo -35.81 141.83 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 123.748 2.965 . . . . 0.0 115.401 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 176.46 -176.26 47.76 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.721 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -150.91 151.49 32.25 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.2 t -122.91 137.39 54.96 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -53.21 -61.6 6.79 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.401 ' H ' ' H ' ' A' ' 172' ' ' ARG . . . 152.12 12.67 0.08 OUTLIER Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.401 ' H ' ' H ' ' A' ' 171' ' ' GLY . 96.1 mtt-85 -62.94 132.98 53.89 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 55.0 tp -62.43 -45.47 92.96 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.776 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 39.23 71.68 1.1 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.988 0.423 . . . . 0.0 111.082 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -59.81 141.78 97.41 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.428 2.085 . . . . 0.0 112.02 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 58.7 m -149.7 119.29 6.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.972 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -135.68 178.77 6.79 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.539 -178.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 8.5 pt -99.89 130.96 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.733 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -125.32 165.54 18.17 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.327 0.584 . . . . 0.0 111.552 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 184' ' ' GLY . 99.4 m-20 -76.73 105.91 8.08 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.074 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -67.99 -15.01 63.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.364 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.51 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.4 mm? -64.6 -41.1 96.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.469 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.463 HG23 ' H ' ' A' ' 185' ' ' GLU . 5.5 t -121.4 -26.97 4.9 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.956 0.407 . . . . 0.0 111.042 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 180' ' ' ASP . . . 84.39 33.24 20.41 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.463 ' H ' HG23 ' A' ' 183' ' ' THR . 7.7 pt-20 -167.19 146.92 5.32 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.66 0.267 . . . . 0.0 110.533 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.66 ' H ' HD23 ' A' ' 186' ' ' LEU . 0.8 OUTLIER -104.49 176.46 5.15 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.567 179.731 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -107.97 -13.21 15.01 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.252 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.72 144.4 30.24 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.529 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -140.76 142.65 34.73 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.389 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.803 0 CA-C-O 117.878 -1.512 . . . . 0.0 110.933 -179.478 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -63.58 -40.18 96.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.798 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -63.47 -40.36 96.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.629 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.541 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.5 mp -62.98 -42.77 99.93 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.873 0.368 . . . . 0.0 110.255 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.59 -41.6 96.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.338 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -65.69 -40.7 92.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.23 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -61.46 -47.8 84.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.698 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.79 -46.86 86.03 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.298 0.571 . . . . 0.0 110.569 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.4 -43.88 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.466 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.78 -41.64 82.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.259 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.54 -41.73 97.78 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.917 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.59 -55.24 36.99 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.319 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.4 pt -69.37 -27.49 34.66 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.148 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -60.95 -56.16 24.35 Favored 'General case' 0 C--O 1.216 -0.659 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.106 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 20' ' ' GLU . 94.0 t -64.57 -40.6 89.61 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 C-N-CA 121.264 -0.174 . . . . 0.0 111.374 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.668 HD13 ' C ' ' A' ' 17' ' ' LEU . 2.0 tm? -56.3 -48.11 77.33 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.354 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -76.51 -49.14 17.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.201 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -69.06 -34.9 75.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.557 -178.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 16' ' ' VAL . 97.2 mt-10 62.5 80.36 0.23 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.22 -139.21 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.844 0.354 . . . . 0.0 110.483 177.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 34' ' ' GLY . 8.2 p -134.58 140.61 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 pp -128.81 162.92 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-O 121.023 0.44 . . . . 0.0 111.064 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.26 129.39 41.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.71 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.514 ' CZ ' ' O ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -122.84 148.65 54.36 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -179.432 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.514 ' O ' ' CZ ' ' A' ' 25' ' ' TYR . 57.6 Cg_endo -78.91 148.66 22.31 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.993 1.795 . . . . 0.0 111.783 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.498 ' C ' ' H ' ' A' ' 29' ' ' ALA . 40.8 m -131.41 133.85 45.65 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.469 ' OE2' ' NH1' ' A' ' 117' ' ' ARG . 22.3 pt-20 -74.7 23.12 0.09 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.826 0.346 . . . . 0.0 110.425 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.498 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -155.19 -73.44 0.11 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.2 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 p -128.28 129.85 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.342 0.592 . . . . 0.0 110.751 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.507 ' CD2' ' O ' ' A' ' 148' ' ' CYS . 46.8 p90 -37.73 144.88 0.08 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.798 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -155.61 -173.41 24.24 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.5 m -132.27 168.06 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.486 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -156.96 -178.94 31.52 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.553 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.454 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.8 OUTLIER -159.24 -165.21 1.54 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.025 0.441 . . . . 0.0 111.328 -178.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.454 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 85.0 m-20 -91.61 108.02 26.34 Favored Pre-proline 0 CA--C 1.555 1.155 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -43.64 -61.18 0.6 Allowed 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.916 1.744 . . . . 0.0 112.262 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -71.94 67.01 0.6 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.058 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.1 m -155.71 133.99 11.57 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.88 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -65.73 -34.32 77.92 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.341 0.591 . . . . 0.0 110.688 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.496 HG23 ' N ' ' A' ' 42' ' ' ALA . 15.0 t -60.76 -41.19 94.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.171 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.496 ' N ' HG23 ' A' ' 41' ' ' THR . . . -56.64 -51.64 67.94 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.608 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.65 -42.14 95.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.285 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 92.2 mtp -63.77 -40.24 96.21 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.9 ttt85 -59.95 -42.54 94.28 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 121.967 0.889 . . . . 0.0 108.611 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.459 ' O ' HD23 ' A' ' 46' ' ' LEU . 1.0 OUTLIER -63.99 -53.13 54.96 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.73 -178.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.8 mt -70.77 -11.62 61.06 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.2 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -70.21 -82.6 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 121.152 0.501 . . . . 0.0 111.342 -177.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.504 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -75.97 -35.26 59.7 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -76.95 -50.28 13.57 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.966 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 35.32 65.34 0.39 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.919 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.416 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 1.6 mtt85 179.02 -53.48 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.778 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.27 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.416 ' HD2' ' H ' ' A' ' 52' ' ' ARG . 84.6 Cg_endo -79.91 -3.31 12.7 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.709 2.273 . . . . 0.0 112.388 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.54 HG13 ' N ' ' A' ' 55' ' ' ASP . 7.9 p -44.03 -43.87 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.47 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.54 ' N ' HG13 ' A' ' 54' ' ' VAL . 37.4 t0 -66.45 -41.73 88.66 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.041 0.448 . . . . 0.0 110.246 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.416 ' CD ' ' N ' ' A' ' 56' ' ' LYS . 1.1 mptm? -60.29 -39.64 87.64 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 62.29 107.71 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.561 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -53.14 -163.2 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.229 0.538 . . . . 0.0 111.591 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.533 HG23 HG21 ' A' ' 94' ' ' THR . 78.5 mt -101.01 144.32 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.538 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.4 mt -121.7 143.14 49.52 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.407 ' CD1' ' HE ' ' A' ' 117' ' ' ARG . 8.5 tp -113.86 128.67 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-O 121.244 0.545 . . . . 0.0 110.958 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.438 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -114.23 156.55 24.11 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.951 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.15 -26.37 5.94 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.422 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 98.5 m-20 -118.42 142.64 47.35 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.086 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -69.81 -12.68 61.81 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.64 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -50.75 -31.58 17.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.927 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.422 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 2.5 pm0 -95.76 -13.59 24.01 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.518 HD22 ' N ' ' A' ' 68' ' ' LEU . 4.0 mm? -92.16 -13.8 30.08 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.471 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 76.8 tttt -80.56 -38.16 1.05 Allowed Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 86.1 Cg_endo -102.38 -3.85 0.33 Allowed 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 122.696 2.264 . . . . 0.0 111.39 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.546 ' OH ' HD21 ' A' ' 114' ' ' LEU . 44.9 t80 -92.84 -14.86 27.17 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.687 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.543 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.2 mp -122.62 159.9 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.543 ' N ' HG22 ' A' ' 72' ' ' ILE . 27.7 p30 -65.86 144.37 56.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.374 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -87.19 7.2 29.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.548 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.553 HG23 ' N ' ' A' ' 76' ' ' MET . 15.0 t -78.11 -45.52 23.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.246 0.546 . . . . 0.0 110.854 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.553 ' N ' HG23 ' A' ' 75' ' ' THR . 25.0 ptm -84.92 -19.33 32.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.666 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.402 ' HG ' ' HE ' ' A' ' 82' ' ' ARG . 6.4 tp -81.78 130.07 34.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.027 -178.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.84 167.26 30.51 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.681 -177.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -48.51 -44.5 36.09 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.725 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.71 -31.76 51.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.994 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -64.52 -40.67 96.06 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.399 0.619 . . . . 0.0 110.533 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.421 ' HG2' ' H ' ' A' ' 82' ' ' ARG . 12.3 mmt85 -66.58 -51.99 50.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.477 1.132 . . . . 0.0 109.462 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 87' ' ' SER . 83.1 tt0 -55.86 -50.66 69.99 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 113.852 -1.522 . . . . 0.0 110.421 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.7 m -61.16 -49.95 75.17 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.013 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.5 tt -67.53 -29.74 46.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.853 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -79.49 -35.31 40.39 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.621 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 83' ' ' GLU . 10.9 m -89.85 -15.35 32.42 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.425 ' O ' ' O ' ' A' ' 89' ' ' TRP . 69.4 ttt180 -115.98 74.67 0.91 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.863 0.363 . . . . 0.0 110.714 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.425 ' O ' ' O ' ' A' ' 88' ' ' ARG . 1.5 m0 59.25 150.32 0.08 OUTLIER Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.668 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.57 -15.55 45.15 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.739 1.626 . . . . 0.0 110.636 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.493 ' H ' ' HD3' ' A' ' 92' ' ' PRO . . . 104.95 69.35 0.76 Allowed Glycine 0 N--CA 1.471 1.031 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.088 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.493 ' HD3' ' H ' ' A' ' 91' ' ' GLY . 48.7 Cg_exo -55.94 -38.95 93.92 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.556 2.171 . . . . 0.0 112.222 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.3 p -75.64 147.47 8.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.209 0.528 . . . . 0.0 111.104 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.533 HG21 HG23 ' A' ' 59' ' ' ILE . 19.3 m -102.45 126.25 49.42 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.981 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.573 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 43.8 m-85 -116.12 143.04 46.01 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.271 -178.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.733 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 84.2 t -84.08 98.96 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-O 121.123 0.487 . . . . 0.0 111.323 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -83.65 139.36 40.83 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.804 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.36 104.92 1.81 Allowed 'Trans proline' 0 N--CA 1.489 1.21 0 C-N-CA 121.566 1.51 . . . . 0.0 110.901 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 112' ' ' ASP . . . -61.9 149.56 85.3 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.8 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.448 ' O ' ' OG1' ' A' ' 103' ' ' THR . 93.9 Cg_endo -73.08 165.82 31.7 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.427 2.085 . . . . 0.0 112.098 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.22 -29.81 71.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.737 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 75.7 p -55.22 -44.24 75.24 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.445 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 100' ' ' PRO . 6.4 p -50.94 151.66 4.29 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.96 -103.85 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.749 1.632 . . . . 0.0 112.387 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.536 ' O ' ' N ' ' A' ' 109' ' ' GLY . 5.3 tpp85 -176.14 -5.02 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.932 0.396 . . . . 0.0 110.132 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.434 ' H ' ' H ' ' A' ' 105' ' ' ARG . 2.8 m0 -78.07 -10.86 59.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 122.05 0.929 . . . . 0.0 109.401 -179.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.672 ' H ' ' CD2' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -82.39 -16.27 49.71 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.017 -1.447 . . . . 0.0 111.064 -179.567 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.428 ' O ' ' O ' ' A' ' 54' ' ' VAL . 99.0 m -140.69 -42.06 0.4 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.942 0.401 . . . . 0.0 109.972 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 77.94 19.81 74.46 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.301 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.19 -75.78 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 117.614 0.707 . . . . 0.0 110.478 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -111.18 162.4 14.98 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.29 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' A' ' 99' ' ' ALA . 90.4 m-20 -95.2 60.39 2.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.088 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.6 p -158.13 145.04 17.8 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.546 HD21 ' OH ' ' A' ' 71' ' ' TYR . 3.7 pp -166.98 145.71 5.14 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.441 ' HB1' HG22 ' A' ' 94' ' ' THR . . . -65.55 127.38 31.64 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 113.728 -1.578 . . . . 0.0 109.398 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.464 HG22 ' N ' ' A' ' 117' ' ' ARG . 3.9 p -145.35 161.23 12.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.469 ' NH1' ' OE2' ' A' ' 28' ' ' GLU . 61.7 ttp180 -148.23 155.32 41.22 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.205 0.526 . . . . 0.0 111.811 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.438 HG22 ' HB3' ' A' ' 62' ' ' ALA . 55.7 t -119.97 135.69 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.1 t -135.51 150.31 49.73 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.925 0.393 . . . . 0.0 110.1 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 34.4 p30 -154.01 81.9 1.14 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.223 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.674 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 6.8 t60 -171.75 -35.93 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.674 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 73.3 Cg_endo -96.77 -160.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.927 0 C-N-CA 122.077 1.851 . . . . 0.0 112.114 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.4 mt -77.35 -5.14 48.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.669 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 77.8 t -58.12 -45.81 88.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.084 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.766 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.7 m -54.26 -62.73 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.21 -0.986 0 C-N-CA 119.402 -0.919 . . . . 0.0 108.696 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.766 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.35 -44.66 2.83 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.708 0.29 . . . . 0.0 111.12 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.34 -47.89 63.05 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.27 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 70.9 m -70.46 -48.99 53.23 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.204 0.526 . . . . 0.0 111.08 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.469 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -53.93 -42.78 69.19 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.437 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -59.69 -53.38 58.66 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.589 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -63.83 -24.64 67.83 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.166 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.11 1.69 90.4 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 134' ' ' PRO . 34.8 mttm -153.33 157.8 32.82 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 120.574 -0.451 . . . . 0.0 110.122 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.4 ' O ' ' O ' ' A' ' 133' ' ' LYS . 5.2 Cg_exo -41.41 175.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 123.926 3.084 . . . . 0.0 113.581 -178.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.5 tp -129.38 122.73 30.04 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 176.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.428 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -66.19 143.33 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.955 0 C-N-CA 118.108 -1.437 . . . . 0.0 107.404 -179.52 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.8 t -114.88 122.09 45.22 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 123.792 0.682 . . . . 0.0 110.597 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.9 m -130.01 162.98 27.49 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.881 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.0 m -72.25 145.45 47.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.382 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.81 81.6 1.16 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.019 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 57.7 p30 -160.47 161.42 32.87 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.616 0.722 . . . . 0.0 111.031 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.49 -167.12 1.88 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.318 -178.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.6 t -61.03 -43.24 99.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.44 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -158.32 4.71 0.13 Allowed Glycine 0 C--N 1.33 0.227 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.2 tt -83.44 127.92 66.4 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -39.74 158.21 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.549 1.499 . . . . 0.0 112.207 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -77.04 -163.22 0.2 Allowed 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.733 2.288 . . . . 0.0 111.889 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.507 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 19.5 t -126.38 78.23 1.76 Allowed 'General case' 0 C--N 1.34 0.155 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -49.8 -39.51 38.57 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.676 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.16 169.81 23.69 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.445 ' H ' HG22 ' A' ' 151' ' ' VAL . 1.5 m -58.04 -20.87 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 CA-C-O 121.786 0.803 . . . . 0.0 108.984 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -64.53 -33.34 75.67 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 155' ' ' ARG . 0.4 OUTLIER -62.26 -79.37 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.401 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.425 HG13 ' N ' ' A' ' 155' ' ' ARG . 6.8 p -34.91 -33.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.983 0.913 . . . . 0.0 111.109 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.493 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -68.61 -53.27 23.66 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.533 -179.265 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -68.76 -18.61 64.24 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 122.571 1.177 . . . . 0.0 108.068 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.61 -45.56 14.41 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 112.517 -2.128 . . . . 0.0 111.559 -178.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -130.17 -29.76 2.02 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 96.48 23.75 15.64 Favored Glycine 0 N--CA 1.469 0.894 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -178.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 159' ' ' GLY . . . -43.12 -97.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.533 -0.333 . . . . 0.0 111.17 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.518 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.95 34.81 16.56 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -178.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.524 ' C ' ' H ' ' A' ' 164' ' ' VAL . 2.2 m-85 -172.67 -62.64 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.136 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -72.99 27.07 0.29 Allowed 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.258 1.972 . . . . 0.0 110.758 177.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.557 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.4 m -129.64 167.48 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.426 -178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 16.4 t -124.37 65.86 42.3 Favored Pre-proline 0 N--CA 1.471 0.601 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.637 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.557 ' HD3' HG23 ' A' ' 164' ' ' VAL . 29.4 Cg_exo -37.15 140.04 0.21 Allowed 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 123.413 2.742 . . . . 0.0 115.189 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 162.45 170.78 27.74 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 113.929 -1.487 . . . . 0.0 110.883 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -157.99 147.19 19.55 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.665 0.269 . . . . 0.0 110.427 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.6 t -148.87 157.21 43.26 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.892 0.377 . . . . 0.0 110.529 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -64.28 -75.05 0.4 Allowed Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 89.31 32.7 10.15 Favored Glycine 0 N--CA 1.466 0.693 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -65.12 -41.6 94.73 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.206 -0.997 . . . . 0.0 111.681 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.575 ' N ' HD12 ' A' ' 173' ' ' LEU . 9.9 mp -82.48 -109.14 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.624 0.25 . . . . 0.0 110.512 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.444 ' N ' ' CD ' ' A' ' 175' ' ' PRO . 60.9 m-80 45.06 52.54 10.56 Favored Pre-proline 0 N--CA 1.466 0.326 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.141 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 174' ' ' ASN . 45.4 Cg_endo -65.08 -31.33 55.15 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.727 2.285 . . . . 0.0 112.134 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 49.8 p -162.72 128.68 3.37 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.247 0.546 . . . . 0.0 110.293 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 94' ' ' THR . 98.0 mt-10 -108.18 -50.98 2.96 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.602 -178.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.474 ' O ' HG23 ' A' ' 178' ' ' ILE . 18.4 tt -90.33 122.85 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.117 0.484 . . . . 0.0 111.834 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -134.74 170.69 15.45 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.252 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -87.01 107.2 18.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.242 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.733 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -69.21 -11.9 61.2 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.907 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.492 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.8 mm? -64.28 -42.62 96.34 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.45 -41.81 4.26 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.619 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 65.1 24.36 70.29 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -62.91 136.21 57.72 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.422 0.629 . . . . 0.0 111.269 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.574 ' H ' ' CD2' ' A' ' 186' ' ' LEU . 0.7 OUTLIER -82.0 178.68 8.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.254 179.433 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . 0.514 ' O ' ' CD2' ' A' ' 187' ' ' PHE . 88.5 t80 -96.14 67.05 2.57 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.374 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.68 140.98 51.48 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.071 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.406 ' H ' ' H ' ' A' ' 190' ' ' GLY . 57.2 tt0 -147.79 -17.12 0.36 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.224 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.406 ' H ' ' H ' ' A' ' 189' ' ' GLN . . . . . . . . 0 CA--C 1.525 0.71 0 CA-C-O 118.172 -1.349 . . . . 0.0 110.71 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -75.42 -12.54 60.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.871 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -63.78 -41.13 98.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.373 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.555 HD12 ' N ' ' A' ' 5' ' ' LEU . 9.2 mp -63.18 -42.51 99.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.155 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -64.5 -40.52 95.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.024 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.1 tpt180 -63.22 -41.65 99.14 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.35 -43.93 98.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.462 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.56 -46.49 90.01 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.993 0.425 . . . . 0.0 110.024 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.34 -43.6 98.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.636 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.07 -41.38 78.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.131 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.67 -44.07 94.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.245 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.86 -53.09 62.02 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.915 0.388 . . . . 0.0 111.561 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.8 pt -68.89 -39.36 79.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.232 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -57.92 -53.66 55.75 Favored 'General case' 0 C--O 1.215 -0.719 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.22 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.428 HG13 ' H ' ' A' ' 21' ' ' ARG . 86.5 t -61.07 -40.05 84.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.233 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.685 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.2 tt -51.89 -50.59 60.74 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.441 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -81.56 -49.26 10.76 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.253 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -66.0 -31.6 72.59 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.08 -178.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 16' ' ' VAL . 97.0 mt-10 57.14 83.91 0.1 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.075 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.428 ' H ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -164.8 -159.14 0.44 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.86 178.586 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.8 p -119.02 137.26 53.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.442 HD12 ' O ' ' A' ' 24' ' ' ALA . 2.8 pp -126.14 166.92 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 120.799 0.333 . . . . 0.0 111.327 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.442 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -63.23 137.39 58.19 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.25 0.548 . . . . 0.0 111.342 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.537 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 2.2 t80 -130.77 139.13 34.67 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.537 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 96.5 Cg_endo -76.88 144.47 24.34 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.488 1.459 . . . . 0.0 111.96 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.2 m -140.37 138.13 34.58 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.943 0.401 . . . . 0.0 110.363 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -56.73 -45.77 81.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.736 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.48 -79.28 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.806 0.336 . . . . 0.0 111.349 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 90.6 t -135.56 129.96 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -37.85 140.39 0.26 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.183 0.516 . . . . 0.0 111.546 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -137.74 -168.25 11.28 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.0 m -128.19 171.92 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -162.48 -177.53 35.59 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.221 -0.99 . . . . 0.0 111.719 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.539 ' SG ' ' HB2' ' A' ' 42' ' ' ALA . 0.8 OUTLIER -160.92 -161.42 0.83 Allowed 'General case' 0 C--N 1.342 0.259 0 C-N-CA 120.259 -0.577 . . . . 0.0 112.169 -179.227 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.504 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 69.2 m-20 -92.13 107.3 22.07 Favored Pre-proline 0 CA--C 1.557 1.241 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -45.46 -55.75 3.29 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 122.038 1.825 . . . . 0.0 111.71 177.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -50.81 -33.4 23.4 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.026 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.3 m -76.5 118.89 19.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.326 0.584 . . . . 0.0 110.659 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.535 ' O ' HG12 ' A' ' 43' ' ' VAL . 16.3 pt-20 -65.02 -32.19 73.79 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.87 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.5 t -43.48 -28.04 0.33 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.796 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.539 ' HB2' ' SG ' ' A' ' 35' ' ' CYS . . . -64.3 -51.6 62.67 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.27 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 40' ' ' GLU . 3.0 p -64.5 -39.34 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.171 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 92.6 mtp -66.11 -39.24 89.77 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.6 ttt85 -63.01 -33.27 75.07 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.86 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 87.2 mt -74.4 -59.04 2.91 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.3 mt -53.72 -19.54 4.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.334 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -66.66 -84.95 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.572 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.504 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.2 pt? -77.48 -34.75 54.2 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -74.94 -50.05 18.09 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.826 -176.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 37.25 62.01 0.88 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.665 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.9 ttm-85 -179.04 -61.91 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.895 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.215 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -63.36 -11.75 27.18 Favored 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 122.872 2.381 . . . . 0.0 112.422 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.589 HG13 ' N ' ' A' ' 55' ' ' ASP . 9.7 p -41.76 -48.61 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.831 -0.347 . . . . 0.0 111.143 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.589 ' N ' HG13 ' A' ' 54' ' ' VAL . 65.6 t0 -66.73 -39.74 88.09 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.88 0.371 . . . . 0.0 111.051 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -60.82 -39.91 90.76 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 64.73 108.3 0.01 OUTLIER Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.567 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -53.63 -159.16 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.319 0.581 . . . . 0.0 112.095 -179.603 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.446 HG23 HG21 ' A' ' 94' ' ' THR . 67.6 mt -103.94 144.07 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.896 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 20.4 mt -121.98 142.4 50.35 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.9 tp -112.45 134.59 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-O 121.368 0.604 . . . . 0.0 110.88 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.467 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -122.61 150.92 41.99 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.99 -27.27 8.49 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -116.48 151.0 36.97 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.796 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -79.68 -13.55 59.39 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -51.94 -31.44 28.81 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.482 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.13 -12.64 28.0 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.499 HD22 ' N ' ' A' ' 68' ' ' LEU . 4.1 mm? -92.63 -16.62 25.37 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 118.793 0.724 . . . . 0.0 109.276 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.474 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 44.5 tttp -77.5 -38.88 1.9 Allowed Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.774 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 67.6 Cg_endo -103.99 -2.89 0.24 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 122.91 2.407 . . . . 0.0 112.38 -178.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -95.84 -9.34 31.78 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.033 -178.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.553 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.2 mp -125.64 161.96 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.553 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -58.5 177.24 0.14 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.856 0.36 . . . . 0.0 110.232 -179.326 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -105.38 15.47 27.18 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.484 ' OG1' ' N ' ' A' ' 76' ' ' MET . 32.3 p -80.88 -64.53 1.17 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.095 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.484 ' N ' ' OG1' ' A' ' 75' ' ' THR . 26.4 ptm -70.23 -5.09 25.09 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.184 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.2 tp -83.93 100.92 11.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.32 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -155.15 160.28 40.8 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.78 -177.572 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -39.37 -48.51 1.91 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.813 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.1 p -61.86 -34.0 60.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.661 -0.415 . . . . 0.0 111.279 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 78' ' ' THR . 64.8 tp60 -65.57 -41.56 92.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.916 0.389 . . . . 0.0 110.715 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.417 ' HG2' ' H ' ' A' ' 82' ' ' ARG . 8.8 mmt85 -63.63 -51.98 62.85 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 122.589 1.185 . . . . 0.0 109.136 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -55.08 -50.3 69.5 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.776 -1.556 . . . . 0.0 110.018 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -60.52 -49.95 75.5 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.939 -178.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.0 tt -67.73 -37.19 78.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.097 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -70.37 -43.09 70.87 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.488 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.4 m -75.23 -37.73 60.93 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.195 0.521 . . . . 0.0 110.561 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -76.15 150.58 37.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -36.29 153.96 0.08 OUTLIER Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.888 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 118' ' ' VAL . 41.5 Cg_endo -64.28 -24.25 65.3 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.048 1.832 . . . . 0.0 111.439 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.492 ' O ' ' NH2' ' A' ' 117' ' ' ARG . . . 176.51 79.27 0.05 OUTLIER Glycine 0 CA--C 1.531 1.037 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.09 -44.35 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.058 1.839 . . . . 0.0 111.941 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.505 HG13 ' CE2' ' A' ' 95' ' ' PHE . 3.0 p -137.26 145.82 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.196 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.446 HG21 HG23 ' A' ' 59' ' ' ILE . 17.9 m -83.8 130.27 34.94 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.214 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.505 ' CE2' HG13 ' A' ' 93' ' ' VAL . 34.0 m-85 -117.85 140.03 50.28 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.512 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.628 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 4.4 t -90.28 101.37 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 121.477 0.656 . . . . 0.0 110.023 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -90.23 152.32 45.7 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.377 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.42 113.04 3.69 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.199 1.933 . . . . 0.0 111.189 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.14 150.95 75.22 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.26 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -72.27 156.04 55.45 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.075 1.85 . . . . 0.0 112.159 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -139.74 58.69 1.6 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.016 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 37.1 p -67.1 -35.5 79.92 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.586 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.701 ' H ' ' CD ' ' A' ' 104' ' ' PRO . 0.4 OUTLIER -165.82 -40.1 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.221 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.701 ' CD ' ' H ' ' A' ' 103' ' ' THR . 6.3 Cg_exo -71.53 -166.07 0.23 Allowed 'Trans proline' 0 C--N 1.313 -1.342 0 C-N-CA 122.379 2.052 . . . . 0.0 111.849 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 109' ' ' GLY . 7.4 tpt180 -173.93 6.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.921 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 66.8 p-90 -75.8 -7.34 54.21 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.957 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.977 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -70.91 -30.14 66.39 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.702 ' H ' HD22 ' A' ' 107' ' ' LEU . 89.9 m -140.38 -38.46 0.45 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.705 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 86.04 -11.38 62.8 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.608 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -142.13 -72.3 0.32 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.56 0.68 . . . . 0.0 110.788 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.443 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 21.4 t80 -91.32 -167.38 1.79 Allowed 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.443 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 94.9 m-20 -130.53 57.6 1.72 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.653 0.263 . . . . 0.0 110.693 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.7 p -156.51 156.92 34.53 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.187 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.446 ' O ' HD12 ' A' ' 114' ' ' LEU . 3.1 pp -168.96 138.88 2.25 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.446 ' HB2' HG22 ' A' ' 96' ' ' VAL . . . -70.32 131.56 44.33 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 113.787 -1.551 . . . . 0.0 109.932 177.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.8 p -147.06 155.35 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 120.727 0.299 . . . . 0.0 110.364 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.492 ' NH2' ' O ' ' A' ' 91' ' ' GLY . 79.3 ttt180 -146.1 153.27 40.52 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.847 -179.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.467 HG22 ' HB3' ' A' ' 62' ' ' ALA . 49.6 t -120.5 136.24 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.9 t -139.74 142.13 36.82 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.025 0.441 . . . . 0.0 110.629 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 51.0 p-10 -145.82 81.82 1.61 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.686 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.639 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 7.3 t60 -171.49 -36.29 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.639 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 43.0 Cg_endo -94.72 -161.14 0.07 OUTLIER 'Trans proline' 0 N--CA 1.483 0.907 0 C-N-CA 122.044 1.829 . . . . 0.0 111.955 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 45.3 mt -78.01 -6.17 53.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.392 0.615 . . . . 0.0 110.013 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 98.8 t -58.08 -45.29 88.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.072 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.772 HG23 ' H ' ' A' ' 126' ' ' ALA . 28.7 m -53.2 -62.15 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.906 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.019 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.772 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.68 -44.01 3.02 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 120.938 0.399 . . . . 0.0 110.723 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.3 tp -68.93 -48.26 63.68 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.235 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 60.7 m -70.28 -49.29 51.26 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.387 0.613 . . . . 0.0 110.907 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.466 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.1 pp0? -54.55 -41.95 70.36 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.341 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.64 -55.07 39.83 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.257 -178.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -62.46 -21.9 65.81 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.919 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.73 1.27 89.19 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -152.27 160.56 31.18 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 120.506 -0.477 . . . . 0.0 110.357 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -45.04 164.3 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 123.943 3.095 . . . . 0.0 112.54 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.4 tp -119.36 122.93 42.93 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.43 HG13 ' H ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -63.54 144.69 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 C-N-CA 117.913 -1.515 . . . . 0.0 106.945 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.1 t -116.82 125.1 51.06 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 123.583 0.552 . . . . 0.0 111.283 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.3 m -134.54 158.39 44.08 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.781 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 19.6 m -71.31 142.56 50.45 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.168 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.72 85.39 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.558 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -160.63 165.44 30.65 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.438 0.637 . . . . 0.0 111.079 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.93 -164.65 2.01 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.315 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 42.5 t -61.37 -43.08 99.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.022 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -157.25 3.91 0.16 Allowed Glycine 0 N--CA 1.461 0.355 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.457 HD13 ' C ' ' A' ' 145' ' ' LEU . 1.3 tm? -81.18 112.28 31.57 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 145' ' ' LEU . 20.1 Cg_exo -35.46 156.84 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.104 1.869 . . . . 0.0 112.542 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.7 -174.21 1.23 Allowed 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.4 2.067 . . . . 0.0 112.57 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 17.6 m -114.44 82.89 1.79 Allowed 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.378 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -59.07 -35.58 73.6 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.637 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.82 169.41 21.38 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.434 ' H ' HG22 ' A' ' 151' ' ' VAL . 0.9 OUTLIER -57.02 -23.19 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 CA-C-O 121.437 0.637 . . . . 0.0 109.378 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -62.71 -32.41 73.51 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 155' ' ' ARG . 6.4 tm-20 -63.09 -80.45 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.568 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.3 p -36.37 -27.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.167 0.987 . . . . 0.0 111.044 177.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.471 ' N ' ' O ' ' A' ' 153' ' ' GLU . 4.3 tmt_? -74.4 -50.73 17.34 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.855 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.7 -17.75 62.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 122.631 1.205 . . . . 0.0 107.781 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -83.32 -57.04 3.42 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 112.553 -2.112 . . . . 0.0 111.987 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -119.99 -20.6 7.42 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 160' ' ' ALA . . . 84.72 27.63 34.5 Favored Glycine 0 N--CA 1.466 0.642 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.474 ' O ' ' HB3' ' A' ' 161' ' ' ALA . . . -42.21 -98.37 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.58 -0.31 . . . . 0.0 111.36 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.516 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 67.79 34.44 4.35 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.299 0.571 . . . . 0.0 109.578 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.519 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.6 m-85 -176.36 -61.89 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.235 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -73.44 31.45 0.31 Allowed 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.044 1.829 . . . . 0.0 110.439 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.563 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.4 m -134.67 168.22 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.834 -178.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 8.3 t -125.15 64.82 46.6 Favored Pre-proline 0 N--CA 1.475 0.79 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.855 178.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.563 ' HD3' HG23 ' A' ' 164' ' ' VAL . 55.4 Cg_exo -40.13 151.0 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 123.706 2.938 . . . . 0.0 114.97 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 162.68 -174.93 39.1 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.983 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -141.68 145.12 34.53 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.1 t -148.24 161.24 41.89 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.036 0.446 . . . . 0.0 110.809 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -152.5 79.23 0.2 Allowed Glycine 0 N--CA 1.459 0.218 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -118.31 -57.8 0.28 Allowed Glycine 0 N--CA 1.468 0.772 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 41.93 37.07 0.73 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.801 0.334 . . . . 0.0 110.966 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 8.4 tp -66.29 -128.97 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.097 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -70.35 148.03 95.39 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.545 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -67.31 -21.97 46.82 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.016 1.81 . . . . 0.0 111.668 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 52.5 p -160.38 127.25 4.3 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.362 0.601 . . . . 0.0 110.683 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -105.68 49.07 0.82 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.912 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.424 ' O ' HG23 ' A' ' 178' ' ' ILE . 17.2 tt -109.68 129.87 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 120.795 0.331 . . . . 0.0 110.539 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -132.63 166.34 22.35 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.711 0.767 . . . . 0.0 112.018 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -80.36 106.87 12.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.502 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -64.47 -20.05 65.95 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.216 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.449 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.5 mm? -63.02 -42.64 99.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.933 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.85 -45.28 2.88 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.836 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 67.29 22.8 73.06 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -66.96 146.51 54.3 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.202 0.525 . . . . 0.0 111.187 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.501 HD23 ' N ' ' A' ' 186' ' ' LEU . 0.8 OUTLIER -69.14 177.7 2.61 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.725 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -125.33 85.77 2.45 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.281 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -70.54 138.89 51.36 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.313 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -174.09 -23.98 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.369 177.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.727 0 CA-C-O 118.037 -1.424 . . . . 0.0 110.939 179.894 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.8 m120 . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -63.06 -40.35 97.43 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.564 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -60.86 -40.53 93.27 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.92 0.39 . . . . 0.0 110.519 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.55 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.0 mp -61.95 -43.08 99.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.22 0.533 . . . . 0.0 109.608 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -67.96 -35.35 78.23 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.127 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -60.71 -43.61 97.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.543 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 9' ' ' ALA . 1.5 p30 -70.97 -39.22 72.67 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.166 -0.613 . . . . 0.0 110.469 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.523 ' N ' ' OD1' ' A' ' 8' ' ' ASP . . . -62.12 -48.3 80.77 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.269 0.557 . . . . 0.0 110.122 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.0 -43.59 99.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.912 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.56 -45.31 77.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.635 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.07 -46.68 88.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.924 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.94 -52.1 66.87 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 14.3 pt -69.37 -39.67 79.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.518 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -58.75 -53.47 57.99 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.123 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' A' ' 20' ' ' GLU . 89.6 t -60.76 -40.42 84.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.508 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.684 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.4 tt -51.67 -50.59 60.12 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.77 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -80.77 -50.99 9.14 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.056 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -63.7 -32.75 74.34 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.049 -178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.9 mt-10 58.49 85.35 0.09 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.385 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.57 -141.06 0.07 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.319 178.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.405 HG11 HH21 ' A' ' 45' ' ' ARG . 4.8 p -137.55 139.58 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.448 HD12 ' O ' ' A' ' 24' ' ' ALA . 2.8 pp -129.85 165.9 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-O 120.945 0.402 . . . . 0.0 111.41 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.448 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -61.63 136.97 58.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.301 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.51 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -134.54 142.23 41.92 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.51 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 62.6 Cg_endo -77.25 151.09 29.64 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.771 1.647 . . . . 0.0 111.82 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.492 ' C ' ' H ' ' A' ' 29' ' ' ALA . 45.7 m -132.13 136.49 47.16 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.844 0.354 . . . . 0.0 110.87 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -74.98 23.83 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.357 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.492 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -157.27 -73.44 0.09 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.313 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.8 p -127.52 126.95 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.316 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.511 ' CD1' ' O ' ' A' ' 148' ' ' CYS . 35.4 p90 -40.24 147.83 0.09 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.323 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -156.34 -169.45 20.46 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.3 m -133.21 170.87 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.406 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -158.58 -175.48 29.56 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 120.012 -1.089 . . . . 0.0 112.102 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.521 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -158.44 -164.13 1.41 Allowed 'General case' 0 C--O 1.227 -0.103 0 CA-C-O 120.568 0.223 . . . . 0.0 110.81 -179.312 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.521 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 90.5 m-20 -98.72 109.69 54.29 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -178.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 36' ' ' ASP . 22.4 Cg_exo -36.73 170.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.854 2.369 . . . . 0.0 114.325 177.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 41.98 71.94 0.19 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.074 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.5 m -148.81 138.86 22.23 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.373 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -69.87 -34.79 74.06 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.462 0.648 . . . . 0.0 110.54 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.449 HG22 ' H ' ' A' ' 41' ' ' THR . 0.1 OUTLIER -62.98 -43.0 99.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.667 -179.071 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.71 -51.34 70.18 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.726 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 p -63.62 -42.6 96.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 90.4 mtp -64.24 -39.71 94.52 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.451 ' O ' ' CD2' ' A' ' 49' ' ' LEU . 45.8 ttt-85 -62.15 -33.8 75.18 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.067 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 89.4 mt -75.09 -59.93 2.52 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.2 mt -54.18 -18.42 3.8 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.361 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -67.35 -85.67 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.741 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.503 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -75.72 -32.76 60.17 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.906 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -78.18 -70.44 0.49 Allowed 'General case' 0 C--N 1.349 0.571 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.489 -177.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 52.84 81.05 0.09 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.0 mtm180 161.72 -63.14 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.86 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.1 -11.68 32.79 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.819 2.346 . . . . 0.0 112.255 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.565 HG13 ' N ' ' A' ' 55' ' ' ASP . 6.9 p -41.83 -49.9 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.815 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.565 ' N ' HG13 ' A' ' 54' ' ' VAL . 65.7 t0 -66.74 -40.13 88.22 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.018 0.437 . . . . 0.0 111.146 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -61.36 -39.97 92.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.692 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 66.39 112.49 0.01 OUTLIER Glycine 0 CA--C 1.519 0.295 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.555 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -52.99 -162.37 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.325 0.583 . . . . 0.0 112.298 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 70.9 mt -105.02 145.23 13.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.825 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.6 mt -121.15 142.66 49.67 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.449 HD13 ' HE ' ' A' ' 117' ' ' ARG . 9.4 tp -110.78 127.8 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-O 121.076 0.465 . . . . 0.0 110.708 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -117.64 148.15 42.22 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -106.4 -27.68 10.81 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 116.297 -0.411 . . . . 0.0 109.915 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.674 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 12.4 m120 -115.79 150.32 37.11 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.735 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -79.98 -14.42 58.6 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -52.91 -30.82 36.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.585 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.674 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 4.4 pm0 -94.04 -12.22 29.05 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.531 HD22 ' N ' ' A' ' 68' ' ' LEU . 3.8 mm? -91.4 -20.81 21.4 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.513 -0.742 . . . . 0.0 109.591 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.462 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 49.1 tttm -76.03 -37.45 2.17 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 68.7 Cg_endo -103.39 -3.48 0.26 Allowed 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 122.548 2.166 . . . . 0.0 112.007 -178.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.446 ' OH ' ' CD1' ' A' ' 114' ' ' LEU . 53.9 t80 -98.25 -4.1 35.98 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.037 0.446 . . . . 0.0 111.07 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.618 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.6 mp -132.91 166.54 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.618 ' N ' HG22 ' A' ' 72' ' ' ILE . 98.7 m-20 -58.0 -9.66 1.47 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.475 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 58.2 t0 58.54 30.4 19.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.9 t -95.23 -36.79 11.3 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.091 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -83.07 -18.83 38.25 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.86 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 36.0 tp -86.03 125.35 33.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.148 0.499 . . . . 0.0 110.287 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -161.56 161.74 29.95 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.156 -177.075 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -39.49 -48.41 2.0 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.849 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.13 -32.96 58.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.976 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.454 ' N ' ' O ' ' A' ' 78' ' ' THR . 63.2 tp60 -65.14 -40.57 94.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.585 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.2 mmt85 -64.79 -53.05 53.07 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 122.164 0.983 . . . . 0.0 109.252 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -53.98 -51.02 65.24 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.011 -1.45 . . . . 0.0 110.39 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.5 m -61.05 -50.34 73.7 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.853 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 89' ' ' TRP . 8.6 tt -68.02 -33.75 62.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.728 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -73.82 -38.89 64.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.168 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.7 m -83.41 -34.55 25.48 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.8 0.333 . . . . 0.0 111.416 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 63.9 ttm-85 -81.14 -75.26 0.29 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.504 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.436 ' O ' ' O ' ' A' ' 85' ' ' ILE . 2.2 m0 -162.02 152.85 14.83 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -65.31 -22.51 60.21 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.296 1.997 . . . . 0.0 112.198 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 161.44 78.02 0.03 OUTLIER Glycine 0 CA--C 1.531 1.077 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.514 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.53 -23.59 11.23 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 121.946 1.764 . . . . 0.0 112.404 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.42 HG13 ' CE2' ' A' ' 95' ' ' PHE . 3.2 p -136.15 147.22 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.216 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 26.9 m -89.89 138.47 31.46 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.257 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.485 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 42.0 m-85 -124.46 139.94 53.42 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.999 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.677 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.6 t -97.76 109.72 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 CA-C-O 121.433 0.635 . . . . 0.0 111.084 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -92.08 147.64 35.16 Favored Pre-proline 0 N--CA 1.467 0.403 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.421 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.51 98.1 1.09 Allowed 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.847 1.698 . . . . 0.0 110.985 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -46.87 148.04 2.01 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -63.36 -28.71 71.82 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.261 1.974 . . . . 0.0 112.561 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 41.1 68.23 0.45 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.71 0.29 . . . . 0.0 110.617 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.421 ' O ' ' OG1' ' A' ' 103' ' ' THR . 40.4 p -64.58 -35.07 79.8 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.75 -178.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.67 ' H ' ' CD ' ' A' ' 104' ' ' PRO . 0.2 OUTLIER -169.28 -40.85 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.67 ' CD ' ' H ' ' A' ' 103' ' ' THR . 15.9 Cg_exo -67.21 -162.88 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.734 2.289 . . . . 0.0 112.12 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 109' ' ' GLY . 8.0 tpt180 -163.08 1.97 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.181 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -73.37 -6.96 49.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.669 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.968 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -77.71 -21.28 52.2 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.059 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.625 ' H ' HD22 ' A' ' 107' ' ' LEU . 93.1 m -142.79 -40.34 0.33 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.141 0.495 . . . . 0.0 109.981 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 91.44 -15.44 61.33 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.642 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.422 ' O ' ' NH2' ' A' ' 105' ' ' ARG . 17.3 tpt180 -145.23 -76.95 0.21 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 117.578 0.689 . . . . 0.0 111.488 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.449 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 22.0 t80 -87.1 -167.33 1.85 Allowed 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.449 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 52.8 p-10 -136.03 73.15 1.45 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.103 0.477 . . . . 0.0 111.302 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.7 p -159.68 129.49 5.45 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.446 ' CD1' ' OH ' ' A' ' 71' ' ' TYR . 34.4 mt -127.72 121.62 30.79 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -177.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.447 ' N ' HG13 ' A' ' 96' ' ' VAL . . . -70.84 126.56 29.93 Favored 'General case' 0 C--N 1.345 0.397 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 175.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.425 HG22 ' N ' ' A' ' 117' ' ' ARG . 14.8 p -143.88 152.84 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.198 0.523 . . . . 0.0 111.1 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.449 ' HE ' HD13 ' A' ' 61' ' ' ILE . 62.5 ttp180 -139.82 154.3 47.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.116 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.7 t -123.86 132.8 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.3 t -132.21 149.91 52.28 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.985 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 33.8 p30 -152.75 80.7 1.22 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.07 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.681 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 49.3 t-80 -171.79 -35.31 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.681 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 56.5 Cg_endo -94.99 -161.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.98 1.787 . . . . 0.0 111.834 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 11.3 mt -78.16 -4.79 49.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.978 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 82.4 t -58.24 -45.76 88.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.968 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.753 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.8 m -53.71 -62.31 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.941 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.044 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.753 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.67 -43.27 2.77 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.968 0.413 . . . . 0.0 110.842 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.7 tp -69.93 -47.66 61.53 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.414 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 62.7 m -70.48 -49.22 50.74 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.539 0.685 . . . . 0.0 110.531 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 125' ' ' VAL . 1.1 pp0? -54.41 -42.24 70.24 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.88 -54.57 45.64 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.455 -178.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -62.41 -23.25 66.74 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.001 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.51 0.58 90.06 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 134' ' ' PRO . 33.1 mttm -153.67 159.18 32.39 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 133' ' ' LYS . 6.3 Cg_exo -41.35 179.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 123.886 3.057 . . . . 0.0 113.239 -178.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 35' ' ' CYS . 8.0 tp -133.44 123.26 24.98 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 176.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.449 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -65.6 146.48 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 C-N-CA 117.64 -1.624 . . . . 0.0 107.271 -179.45 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.8 t -118.65 126.95 53.06 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 123.573 0.545 . . . . 0.0 111.214 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.7 m -132.74 163.5 28.88 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.04 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.8 m -74.2 146.94 42.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.443 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.45 83.55 1.97 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.917 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -159.12 164.71 35.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.398 0.618 . . . . 0.0 110.977 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.88 -166.18 2.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.073 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 61.1 m -60.09 -42.7 95.21 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.799 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -160.63 5.38 0.1 OUTLIER Glycine 0 C--N 1.331 0.28 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.4 tp -81.19 127.9 72.42 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 119.36 -0.352 . . . . 0.0 110.104 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -39.28 151.28 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 121.637 1.558 . . . . 0.0 111.804 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 149' ' ' ARG . 89.2 Cg_endo -75.17 148.58 34.83 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.234 1.956 . . . . 0.0 112.446 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.511 ' O ' ' CD1' ' A' ' 31' ' ' PHE . 4.2 m -62.74 71.35 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.354 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 147' ' ' PRO . 17.3 ptm180 -57.87 -32.94 68.17 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.415 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -163.11 164.22 25.44 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.441 ' H ' HG22 ' A' ' 151' ' ' VAL . 0.8 OUTLIER -56.33 -18.01 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 CA-C-O 121.721 0.772 . . . . 0.0 108.971 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -64.71 -35.53 81.35 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 177.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 150' ' ' THR . 5.6 tm-20 -58.94 -74.07 0.07 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.869 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.1 p -45.68 -30.06 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.34 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -83.98 -44.28 14.34 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 122.226 1.012 . . . . 0.0 110.285 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.36 -42.14 86.3 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.435 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.471 ' CG ' ' N ' ' A' ' 158' ' ' PHE . 8.1 pt20 -81.47 -48.93 11.22 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 112.858 -1.974 . . . . 0.0 112.134 -177.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.471 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 30.5 t80 -106.85 -36.54 6.63 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -177.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 97.68 24.45 12.09 Favored Glycine 0 N--CA 1.476 1.341 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -42.89 -94.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.564 0.221 . . . . 0.0 111.094 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.45 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.96 37.51 14.98 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.204 0.526 . . . . 0.0 109.714 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.562 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.5 m-85 -177.07 -61.83 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.764 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -73.73 28.19 0.32 Allowed 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 122.367 2.045 . . . . 0.0 110.443 178.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.586 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.9 m -131.03 167.4 26.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.85 -178.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.7 t -123.82 65.58 35.97 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.501 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.586 ' HD3' HG23 ' A' ' 164' ' ' VAL . 30.6 Cg_exo -36.68 141.22 0.15 Allowed 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 123.6 2.867 . . . . 0.0 115.15 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 154.67 145.68 4.22 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.54 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -141.99 132.25 24.92 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.303 0.573 . . . . 0.0 110.973 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.4 t -158.05 148.53 20.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.929 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -67.78 -40.76 89.7 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.545 ' C ' ' H ' ' A' ' 173' ' ' LEU . . . 138.8 -71.18 0.45 Allowed Glycine 0 N--CA 1.468 0.81 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 64.83 -30.9 0.12 Allowed 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.353 0.661 . . . . 0.0 111.788 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.545 ' H ' ' C ' ' A' ' 171' ' ' GLY . 8.4 mp -80.8 156.38 26.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.094 0.473 . . . . 0.0 110.096 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -46.61 150.26 1.26 Allowed Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.321 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.41 158.66 50.93 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 122.209 1.939 . . . . 0.0 111.578 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 8.4 t -97.33 123.25 41.08 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -126.67 158.68 35.75 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.231 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.449 ' O ' HG23 ' A' ' 178' ' ' ILE . 19.3 tt -110.93 127.82 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.112 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -129.46 166.95 18.59 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.727 0.775 . . . . 0.0 112.273 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 184' ' ' GLY . 97.7 m-20 -78.93 106.93 11.3 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.427 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -67.15 -16.93 64.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.744 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.491 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.4 mm? -63.6 -42.43 98.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.099 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.581 HG23 ' N ' ' A' ' 184' ' ' GLY . 5.0 t -120.31 -52.89 2.15 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.207 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.581 ' N ' HG23 ' A' ' 183' ' ' THR . . . 95.11 41.29 4.06 Favored Glycine 0 N--CA 1.468 0.818 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -114.49 149.38 36.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.053 -0.574 . . . . 0.0 111.398 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.515 HD23 ' N ' ' A' ' 186' ' ' LEU . 0.7 OUTLIER -65.12 -172.59 0.1 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.018 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -123.82 50.6 1.61 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.035 0.445 . . . . 0.0 110.109 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.442 ' H ' ' HG ' ' A' ' 186' ' ' LEU . 3.7 tmt_? -89.94 -64.27 1.16 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.203 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -67.45 -25.58 65.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.964 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.83 0 CA-C-O 118.192 -1.338 . . . . 0.0 110.923 179.887 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.8 m120 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 56.23 35.35 25.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.649 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -90.86 5.68 47.51 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.528 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.548 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.0 mp -62.57 -42.3 99.47 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.212 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -63.43 -39.93 95.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.163 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -63.76 -40.7 97.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.4 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 162' ' ' PHE . 65.2 t0 -61.94 -48.37 80.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.686 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.25 -45.36 93.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.487 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.96 -43.48 97.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.284 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.78 -45.02 82.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.816 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.22 -43.47 94.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.145 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.72 -52.56 64.59 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.706 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.8 pt -67.7 -39.75 82.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.163 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -57.58 -55.34 36.1 Favored 'General case' 0 C--O 1.215 -0.755 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.338 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 20' ' ' GLU . 95.4 t -60.15 -40.69 84.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.876 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.689 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.2 tt -51.61 -50.22 60.66 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.697 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -81.84 -51.51 8.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.993 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -63.63 -35.0 79.08 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.109 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 16' ' ' VAL . 97.1 mt-10 59.02 86.46 0.09 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.664 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.403 ' H ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -163.72 -134.81 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.504 HG21 ' NH2' ' A' ' 45' ' ' ARG . 6.1 p -140.22 140.36 35.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.439 HD12 ' O ' ' A' ' 24' ' ' ALA . 2.9 pp -129.87 165.82 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 120.852 0.358 . . . . 0.0 111.133 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.439 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -62.87 138.55 58.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.133 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.511 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 0.6 OUTLIER -131.19 141.59 42.43 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.363 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.511 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 91.2 Cg_endo -77.16 144.8 23.85 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 121.4 1.4 . . . . 0.0 111.892 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.471 ' C ' ' H ' ' A' ' 29' ' ' ALA . 79.4 m -135.85 135.09 39.5 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.32 0.581 . . . . 0.0 110.868 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -72.96 32.52 0.07 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.802 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.471 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -163.0 -75.73 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.833 0.349 . . . . 0.0 110.975 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.3 m -126.59 128.55 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.128 0.49 . . . . 0.0 110.229 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.519 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 80.3 m-85 -46.99 143.0 3.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.117 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -148.58 -169.15 15.12 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.8 m -133.33 169.37 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.404 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -156.98 -179.05 31.62 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.009 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.426 ' SG ' ' HB2' ' A' ' 42' ' ' ALA . 1.3 p -157.98 -165.73 1.8 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.6 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 7.0 p30 -89.65 107.68 20.29 Favored Pre-proline 0 CA--C 1.558 1.256 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -178.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -42.82 -60.78 0.66 Allowed 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.076 1.851 . . . . 0.0 112.633 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -77.63 70.65 4.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.427 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 54.9 m -156.57 144.01 19.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.619 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -71.1 -34.22 70.9 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.178 0.513 . . . . 0.0 111.158 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.443 HG22 ' H ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -60.52 -42.19 95.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.99 -178.719 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.426 ' HB2' ' SG ' ' A' ' 35' ' ' CYS . . . -57.88 -52.36 65.81 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 p -62.19 -42.6 95.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.147 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.9 mtt -64.65 -41.44 96.13 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.504 ' NH2' HG21 ' A' ' 22' ' ' VAL . 31.9 ttt-85 -60.4 -42.26 95.57 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-O 121.98 0.895 . . . . 0.0 108.916 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.457 ' O ' HD23 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -64.2 -53.47 48.74 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.664 -178.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.7 mt -71.03 -10.57 59.98 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.153 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -69.85 -82.35 0.04 OUTLIER 'General case' 0 N--CA 1.432 -1.354 0 CA-C-O 121.09 0.471 . . . . 0.0 110.924 -177.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.526 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -76.54 -35.57 58.19 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -76.51 -50.22 14.53 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.082 -177.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 35.76 65.09 0.44 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.012 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.428 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 7.1 mtm-85 178.82 -52.51 0.0 OUTLIER Pre-proline 0 CA--C 1.551 0.981 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.744 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.428 ' HD2' ' H ' ' A' ' 52' ' ' ARG . 85.6 Cg_endo -81.11 -2.81 11.92 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 123.008 2.472 . . . . 0.0 112.499 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.574 HG13 ' N ' ' A' ' 55' ' ' ASP . 8.7 p -44.61 -45.47 2.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.033 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.574 ' N ' HG13 ' A' ' 54' ' ' VAL . 41.7 t0 -64.13 -41.14 97.32 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.726 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -60.86 -35.33 76.31 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 59.19 102.26 0.01 OUTLIER Glycine 0 CA--C 1.52 0.36 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.572 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -48.73 -172.55 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.303 0.573 . . . . 0.0 112.205 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.6 mt -91.14 141.21 14.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.419 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.3 mt -118.88 145.74 45.47 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.423 ' O ' HG23 ' A' ' 61' ' ' ILE . 9.3 tp -113.38 127.68 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-O 121.203 0.525 . . . . 0.0 111.184 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.551 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -113.99 151.77 31.9 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.87 -28.16 8.17 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.686 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 99.0 m-20 -115.69 148.55 39.6 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.316 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -77.16 -13.46 59.94 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -51.87 -32.45 32.22 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.262 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.686 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 4.0 pm0 -94.28 -9.83 34.78 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.425 HD22 ' N ' ' A' ' 68' ' ' LEU . 4.3 mm? -92.18 -16.23 26.53 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.473 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 17.4 ttpp -78.07 -37.3 1.46 Allowed Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 67.5 Cg_endo -103.44 -3.23 0.27 Allowed 'Trans proline' 0 C--N 1.321 -0.921 0 C-N-CA 122.801 2.334 . . . . 0.0 111.873 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.524 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 42.0 t80 -91.73 -12.05 35.05 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.295 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.597 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.7 mp -123.2 163.43 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.597 ' N ' HG22 ' A' ' 72' ' ' ILE . 96.8 m-20 -63.43 -3.98 2.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.277 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 3.3 p30 45.01 22.85 0.07 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.883 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.555 HG23 ' N ' ' A' ' 76' ' ' MET . 8.9 t -88.72 -44.81 10.29 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.13 0.49 . . . . 0.0 109.827 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.555 ' N ' HG23 ' A' ' 75' ' ' THR . 18.2 ptp -80.63 -14.76 57.9 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.975 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 tp -79.0 134.12 36.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.701 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -158.61 161.04 37.18 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.972 -177.553 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -38.92 -48.93 1.63 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.768 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.5 p -63.26 -33.49 61.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.007 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.427 ' N ' ' O ' ' A' ' 78' ' ' THR . 62.8 tp60 -64.47 -39.47 93.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.944 0.402 . . . . 0.0 110.4 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -63.87 -53.12 55.55 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 122.517 1.151 . . . . 0.0 109.111 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.499 ' O ' ' N ' ' A' ' 87' ' ' SER . 80.8 tt0 -54.18 -50.37 67.19 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.989 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.4 m -61.48 -49.29 77.35 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.988 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 89' ' ' TRP . 8.7 tt -69.79 -31.24 47.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.574 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -80.14 -31.31 39.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.753 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 83' ' ' GLU . 53.2 m -90.1 -12.71 37.55 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.769 0.318 . . . . 0.0 111.201 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.446 ' O ' ' O ' ' A' ' 89' ' ' TRP . 62.0 ttm-85 -121.95 75.84 1.24 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.446 ' O ' ' O ' ' A' ' 88' ' ' ARG . 7.9 m-90 56.75 152.26 0.07 OUTLIER Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.377 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.24 -19.26 38.84 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.881 1.72 . . . . 0.0 111.673 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 159.56 81.05 0.04 OUTLIER Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -81.42 -9.77 12.38 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.492 2.128 . . . . 0.0 112.143 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.419 HG13 ' CE2' ' A' ' 95' ' ' PHE . 3.1 p -136.12 144.8 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.951 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.464 HG22 ' HB1' ' A' ' 115' ' ' ALA . 7.4 m -95.99 124.31 39.95 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.588 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 41.7 m-85 -113.09 143.03 45.04 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.401 -178.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.806 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 98.8 t -89.08 102.71 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 121.152 0.501 . . . . 0.0 111.393 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -90.08 146.82 35.77 Favored Pre-proline 0 N--CA 1.469 0.504 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.786 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -79.39 87.03 1.59 Allowed 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.241 1.961 . . . . 0.0 111.449 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -48.28 151.55 1.81 Allowed Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.91 144.58 88.54 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.091 1.861 . . . . 0.0 111.664 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -128.51 50.32 2.11 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.192 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.434 ' O ' ' OG1' ' A' ' 103' ' ' THR . 53.3 p -65.52 -35.49 81.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.338 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.703 ' H ' ' CD ' ' A' ' 104' ' ' PRO . 1.5 m -167.42 -37.77 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.703 ' CD ' ' H ' ' A' ' 103' ' ' THR . 24.8 Cg_exo -63.12 -168.58 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.515 2.143 . . . . 0.0 113.308 -177.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 109' ' ' GLY . 5.9 tpt180 -176.49 -7.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.489 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 66.7 p-90 -79.1 -11.59 59.99 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.665 0.745 . . . . 0.0 109.404 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.631 ' H ' ' CD2' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -76.58 -16.45 59.59 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.811 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.409 ' H ' HD23 ' A' ' 107' ' ' LEU . 94.8 m -142.93 -40.96 0.32 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.356 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 91.9 -13.4 66.96 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 119.863 -0.41 . . . . 0.0 112.896 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.451 ' O ' ' CZ ' ' A' ' 105' ' ' ARG . 13.5 tpt180 -148.01 -80.43 0.14 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.883 0.842 . . . . 0.0 111.226 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -90.95 -174.83 4.15 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -124.35 61.18 1.13 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.083 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.0 p -168.14 151.78 5.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.193 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 pp -169.34 147.58 3.71 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.464 ' HB1' HG22 ' A' ' 94' ' ' THR . . . -64.27 134.94 55.71 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 113.76 -1.564 . . . . 0.0 109.635 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.47 HG22 ' N ' ' A' ' 117' ' ' ARG . 6.6 p -147.98 160.06 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.47 ' N ' HG22 ' A' ' 116' ' ' VAL . 62.5 ttp180 -145.53 154.64 42.42 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.907 0.384 . . . . 0.0 111.425 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.551 HG22 ' HB3' ' A' ' 62' ' ' ALA . 48.3 t -123.0 136.07 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.9 t -138.38 150.25 46.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.178 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 50.7 p-10 -153.7 84.9 1.17 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.923 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.657 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 8.5 t-80 -171.52 -36.58 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.292 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.657 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 60.9 Cg_endo -95.15 -159.26 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.949 0 C-N-CA 121.879 1.719 . . . . 0.0 112.032 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.7 mt -78.79 -5.79 54.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.372 0.606 . . . . 0.0 110.459 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 87.8 t -58.1 -44.77 88.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.787 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.774 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.1 m -53.35 -62.57 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.922 0 C-N-CA 119.269 -0.972 . . . . 0.0 108.883 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.774 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.29 -43.82 2.54 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 120.831 0.348 . . . . 0.0 111.152 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.409 HD23 HD22 ' A' ' 135' ' ' LEU . 41.1 tp -69.04 -48.77 62.01 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.998 0.428 . . . . 0.0 111.224 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 75.4 m -70.26 -48.38 57.1 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.373 0.606 . . . . 0.0 110.991 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.46 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.1 pp0? -55.03 -42.26 72.38 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -57.87 -57.22 13.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.665 -178.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -62.47 -26.46 68.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.385 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.92 -2.44 88.25 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' A' ' 134' ' ' PRO . 25.0 mmtm -142.91 155.78 62.5 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 117.137 0.469 . . . . 0.0 110.043 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 133' ' ' LYS . 6.0 Cg_exo -41.34 175.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 123.604 2.869 . . . . 0.0 112.984 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.409 HD22 HD23 ' A' ' 127' ' ' LEU . 8.1 tp -128.59 122.96 32.15 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 177.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.426 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -66.11 142.67 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.9 0 C-N-CA 117.762 -1.575 . . . . 0.0 107.256 -179.712 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 t -111.69 118.91 36.93 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 123.802 0.688 . . . . 0.0 110.88 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.465 ' CB ' HH22 ' A' ' 45' ' ' ARG . 18.8 m -127.72 150.55 49.73 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.756 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 140' ' ' ALA . 24.7 m -64.59 149.21 49.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.491 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.436 ' O ' ' O ' ' A' ' 139' ' ' SER . . . -53.78 -164.09 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.997 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.431 ' O ' ' O ' ' A' ' 140' ' ' ALA . 6.7 p30 53.37 156.98 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.702 0.763 . . . . 0.0 111.687 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.07 -147.15 0.37 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.185 -178.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.4 p -63.15 -39.32 94.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.058 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.426 ' H ' ' H ' ' A' ' 145' ' ' LEU . . . -161.78 -2.4 0.05 OUTLIER Glycine 0 N--CA 1.457 0.059 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.426 ' H ' ' H ' ' A' ' 144' ' ' GLY . 11.7 tp -71.71 128.68 89.36 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 119.355 -0.355 . . . . 0.0 110.358 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 145' ' ' LEU . 26.2 Cg_exo -35.25 157.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.295 1.996 . . . . 0.0 112.451 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.98 -163.62 0.13 Allowed 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.291 1.994 . . . . 0.0 112.508 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 27.3 m -132.14 69.48 1.48 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.966 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.519 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 17.3 ptm180 -56.96 -36.47 70.34 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.581 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.85 168.79 23.98 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.418 HG11 ' HA ' ' A' ' 166' ' ' PRO . 1.7 m -59.4 -17.7 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 CA-C-O 121.612 0.72 . . . . 0.0 109.553 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -65.62 -35.19 80.07 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.432 ' OE1' ' OE1' ' A' ' 157' ' ' GLN . 5.8 tm-20 -60.11 -73.78 0.08 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.895 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.427 HG11 HG11 ' A' ' 164' ' ' VAL . 7.3 p -45.51 -30.03 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.016 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.06 -43.34 15.2 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 122.214 1.007 . . . . 0.0 110.007 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.9 -42.26 89.17 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 122.518 1.151 . . . . 0.0 109.265 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.471 ' CG ' ' N ' ' A' ' 158' ' ' PHE . 8.0 pt20 -80.74 -49.61 10.94 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 112.974 -1.921 . . . . 0.0 112.042 -177.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.471 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 39.6 t80 -106.07 -37.24 6.68 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -177.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 98.88 25.3 9.82 Favored Glycine 0 N--CA 1.473 1.11 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 161' ' ' ALA . . . -43.87 -97.27 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.561 0.219 . . . . 0.0 111.091 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.473 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 64.95 36.55 7.52 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.199 0.523 . . . . 0.0 109.899 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.547 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.5 m-85 -177.74 -61.24 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.182 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.25 29.06 0.3 Allowed 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 122.447 2.098 . . . . 0.0 110.556 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.57 HG23 ' HD3' ' A' ' 166' ' ' PRO . 16.0 m -132.65 167.37 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.215 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 9.0 t -123.49 65.13 31.34 Favored Pre-proline 0 N--CA 1.476 0.844 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.848 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.57 ' HD3' HG23 ' A' ' 164' ' ' VAL . 31.7 Cg_exo -36.54 141.39 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 123.77 2.98 . . . . 0.0 115.045 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 163.27 -161.59 34.13 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 113.761 -1.563 . . . . 0.0 110.972 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -147.49 175.39 10.87 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.982 0.42 . . . . 0.0 110.193 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.4 t -145.96 156.37 43.47 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.035 0.445 . . . . 0.0 110.509 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -52.36 -66.73 2.45 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.626 -0.989 . . . . 0.0 110.626 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 129.22 4.61 4.95 Favored Glycine 0 N--CA 1.469 0.87 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -83.95 133.64 34.69 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.89 0.376 . . . . 0.0 110.251 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.589 ' N ' HD12 ' A' ' 173' ' ' LEU . 9.2 mp -85.95 167.23 15.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.452 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.56 ' N ' ' CD ' ' A' ' 175' ' ' PRO . 3.6 m120 71.22 44.36 0.22 Allowed Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.444 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 174' ' ' ASN . 56.5 Cg_endo -66.56 -22.45 51.2 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 122.751 2.301 . . . . 0.0 111.364 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 41.2 t -166.11 129.14 2.02 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.687 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -99.11 150.37 22.09 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.277 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 13.1 tt -94.89 130.37 43.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.435 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -133.19 168.65 18.16 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.51 0.671 . . . . 0.0 111.574 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -87.25 108.05 18.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.165 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.806 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -72.93 -14.3 61.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.239 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.498 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.6 mm? -64.91 -42.02 95.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.989 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.22 -43.66 4.54 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.058 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 67.08 24.25 73.18 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -66.33 138.69 57.79 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.385 0.612 . . . . 0.0 111.034 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.5 ' H ' ' CD2' ' A' ' 186' ' ' LEU . 0.7 OUTLIER -74.18 177.28 5.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.496 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . 0.425 ' O ' ' CD2' ' A' ' 187' ' ' PHE . 88.6 t80 -103.64 73.35 1.18 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.625 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.94 143.57 50.21 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.503 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -147.92 144.65 28.21 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.09 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.73 0 CA-C-O 117.973 -1.459 . . . . 0.0 111.043 -179.98 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 61.1 t30 56.78 40.0 29.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.754 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -98.48 9.43 43.19 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.547 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.533 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.5 mp -62.46 -42.62 99.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.21 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -61.49 -40.42 94.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.934 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -64.16 -41.5 97.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.14 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -59.24 -45.78 90.23 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.198 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.42 -45.61 92.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.045 0.45 . . . . 0.0 110.424 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.5 -42.44 96.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.29 -44.69 84.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.382 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.09 -42.76 99.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.086 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.06 -52.33 65.83 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.898 0.38 . . . . 0.0 111.825 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.41 HG21 HD13 ' A' ' 14' ' ' ILE . 18.8 pt -68.58 -37.48 77.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.091 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -58.6 -51.19 70.97 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 120.281 -0.567 . . . . 0.0 110.047 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 21' ' ' ARG . 88.6 t -63.86 -38.37 82.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 119.688 -0.805 . . . . 0.0 111.007 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.68 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.3 tt -52.77 -50.58 63.25 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.439 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -79.59 -47.94 14.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.21 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -67.19 -31.97 72.73 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.831 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.46 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.7 mt-10 58.22 56.6 4.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.271 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.557 ' O ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -149.88 158.51 44.24 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.591 0.71 . . . . 0.0 110.588 178.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 34' ' ' GLY . 7.8 p -74.29 137.67 22.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.799 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.507 HG22 ' NH2' ' A' ' 21' ' ' ARG . 2.9 pp -124.58 168.25 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-O 120.587 0.232 . . . . 0.0 110.534 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.416 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -63.74 134.82 56.0 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.191 0.519 . . . . 0.0 111.023 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.532 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 0.6 OUTLIER -125.48 141.5 39.12 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.706 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.532 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 60.5 Cg_endo -80.23 151.91 20.78 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.709 1.606 . . . . 0.0 111.235 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.445 ' C ' ' H ' ' A' ' 29' ' ' ALA . 47.8 m -133.36 140.72 47.54 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.372 0.606 . . . . 0.0 111.108 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -77.51 23.06 0.23 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.132 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.445 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -160.53 -70.77 0.07 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.194 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.7 p -126.97 125.63 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-O 121.109 0.48 . . . . 0.0 110.34 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.531 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 96.7 m-85 -45.48 150.39 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.668 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -160.99 -169.07 23.74 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.2 m -130.45 170.13 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.532 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -159.25 177.77 35.66 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.686 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -155.45 -164.83 1.84 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 120.433 -0.507 . . . . 0.0 112.122 -178.52 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.467 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 23.6 m-20 -90.86 106.27 15.06 Favored Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -177.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -34.92 -62.35 0.21 Allowed 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 122.461 2.107 . . . . 0.0 112.716 178.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 56.7 p-10 -74.31 67.51 1.41 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.103 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.3 m -157.07 133.05 9.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.159 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -66.14 -20.55 66.18 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.307 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.4 t -60.08 -34.76 73.89 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.932 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.71 -52.2 66.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.874 0.368 . . . . 0.0 111.575 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 43' ' ' VAL . 2.5 p -64.61 -45.77 94.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.929 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 63.0 mtt -67.51 -46.89 71.58 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.442 ' NH2' ' OG1' ' A' ' 138' ' ' THR . 40.7 ptt85 -63.02 -30.38 71.55 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.829 0.347 . . . . 0.0 110.221 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.7 mt -73.48 -60.91 2.03 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.269 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.0 mt -54.34 -20.5 7.36 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.449 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -63.47 -86.12 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.543 -178.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.526 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.2 pt? -78.68 -34.35 46.29 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -74.92 -50.67 16.03 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.916 -176.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 37.19 64.7 0.58 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.985 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.403 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 6.3 mtt180 179.0 -54.0 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.856 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.455 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.403 ' HD2' ' H ' ' A' ' 52' ' ' ARG . 69.8 Cg_endo -75.61 -8.27 19.24 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.323 2.015 . . . . 0.0 111.493 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.575 HG13 ' N ' ' A' ' 55' ' ' ASP . 10.8 p -46.71 -43.9 6.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.254 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.575 ' N ' HG13 ' A' ' 54' ' ' VAL . 11.1 t0 -70.59 -44.58 67.04 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.198 -178.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -61.27 -38.3 86.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.6 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 74.77 101.9 0.1 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.572 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -50.92 -167.55 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.092 0.472 . . . . 0.0 112.231 -179.658 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.445 ' O ' ' OG ' ' A' ' 137' ' ' SER . 77.2 mt -100.67 135.29 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.143 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 16.0 mt -112.43 144.51 41.77 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.5 tt -114.53 129.77 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 CA-C-O 121.445 0.64 . . . . 0.0 110.88 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.552 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -116.79 155.09 29.55 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.579 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.97 -30.08 6.15 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.781 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 79.5 m-20 -112.46 150.01 31.81 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.135 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -76.77 -21.97 54.42 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.707 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -50.96 -30.31 14.59 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.875 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.781 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 5.9 pm0 -93.82 -6.13 46.58 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.823 -0.172 . . . . 0.0 111.431 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -89.79 -21.69 22.49 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.452 ' NZ ' ' CB ' ' A' ' 69' ' ' LYS . 8.0 mtpm? -73.76 -38.27 3.87 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -178.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 94.6 Cg_endo -101.75 -5.01 0.35 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.628 2.219 . . . . 0.0 111.986 -179.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -87.81 -18.96 28.18 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.772 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.623 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.1 mp -119.27 166.93 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.623 ' N ' HG22 ' A' ' 72' ' ' ILE . 97.8 m-20 -61.75 -14.39 31.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.329 . . . . 0.0 111.054 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 41.1 t0 59.54 32.67 21.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.86 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.538 HG23 ' N ' ' A' ' 76' ' ' MET . 14.1 t -105.14 -42.38 5.31 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.903 0.382 . . . . 0.0 110.476 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.538 ' N ' HG23 ' A' ' 75' ' ' THR . 21.0 ptm -88.78 -23.37 22.9 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.366 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.531 HD21 ' NH2' ' A' ' 82' ' ' ARG . 30.3 tp -67.65 133.08 48.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.124 -177.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.95 170.26 19.25 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.577 -176.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -59.94 -42.11 93.29 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 123.364 0.415 . . . . 0.0 111.389 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.1 p -60.63 -33.27 54.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.42 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -63.23 -41.17 99.06 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.113 0.482 . . . . 0.0 110.358 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.531 ' NH2' HD21 ' A' ' 77' ' ' LEU . 7.5 mmt85 -63.94 -52.11 61.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.479 1.133 . . . . 0.0 109.117 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -55.69 -50.04 71.36 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.798 -1.547 . . . . 0.0 110.028 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.2 m -61.18 -49.92 75.22 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.47 -1.241 . . . . 0.0 112.091 -178.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 85' ' ' ILE . 9.1 tt -68.25 -30.12 46.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.696 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -78.4 -37.3 44.29 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.759 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.2 m -84.72 -10.64 57.07 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.722 0.296 . . . . 0.0 111.166 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.442 ' O ' ' O ' ' A' ' 89' ' ' TRP . 62.0 ttm-85 -122.61 83.64 2.14 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.442 ' O ' ' O ' ' A' ' 88' ' ' ARG . 14.6 m95 57.68 150.33 0.07 OUTLIER Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.231 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.415 ' O ' ' O ' ' A' ' 118' ' ' VAL . 55.8 Cg_endo -68.01 -23.35 40.49 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.203 1.935 . . . . 0.0 111.973 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 159.1 80.65 0.03 OUTLIER Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.74 -24.2 7.49 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 122.163 1.909 . . . . 0.0 112.395 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.409 HG13 ' CZ ' ' A' ' 95' ' ' PHE . 3.5 p -137.04 146.56 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 120.783 0.325 . . . . 0.0 110.474 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 53.8 m -89.71 149.7 22.64 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.845 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.454 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 83.2 m-85 -128.0 144.78 51.11 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.202 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.657 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.5 t -102.05 108.67 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-O 121.34 0.59 . . . . 0.0 110.46 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -94.98 150.37 37.64 Favored Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.898 -178.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.21 89.44 0.39 Allowed 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.265 1.977 . . . . 0.0 111.47 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.93 149.71 80.19 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.138 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -72.14 157.34 54.26 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.207 1.938 . . . . 0.0 111.992 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -139.73 87.69 2.19 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.837 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.405 ' O ' ' OG1' ' A' ' 103' ' ' THR . 21.2 p -62.68 -43.53 98.57 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.099 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.682 ' H ' ' CD ' ' A' ' 104' ' ' PRO . 0.6 OUTLIER -168.43 -39.57 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.682 ' CD ' ' H ' ' A' ' 103' ' ' THR . 12.5 Cg_exo -67.8 -167.2 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.386 2.057 . . . . 0.0 112.996 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 109' ' ' GLY . 23.7 mmt180 -144.53 -11.62 0.61 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.68 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 2.0 p90 -66.73 -10.76 50.32 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.949 -0.301 . . . . 0.0 111.593 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 1.049 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -67.23 -39.8 86.25 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.798 ' H ' HD22 ' A' ' 107' ' ' LEU . 16.6 m -145.99 -39.92 0.22 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.65 177.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 58.53 -12.01 0.02 OUTLIER Glycine 0 CA--C 1.532 1.126 0 CA-C-N 115.711 -0.677 . . . . 0.0 113.29 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.557 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -86.54 -51.51 6.13 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 117.714 0.757 . . . . 0.0 109.446 -179.437 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.452 ' CD2' ' N ' ' A' ' 112' ' ' ASP . 85.4 t80 -160.18 -95.34 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.019 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.452 ' N ' ' CD2' ' A' ' 111' ' ' PHE . 35.8 t70 -171.01 67.96 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.541 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.5 p -166.77 129.36 1.81 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.742 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.647 HD21 ' OG1' ' A' ' 108' ' ' THR . 87.2 mt -126.41 128.01 46.34 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.476 ' N ' HG13 ' A' ' 96' ' ' VAL . . . -69.67 119.69 14.29 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.344 176.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.468 HG22 ' N ' ' A' ' 117' ' ' ARG . 5.4 p -145.96 158.49 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.468 ' N ' HG22 ' A' ' 116' ' ' VAL . 33.5 ptt180 -151.57 160.81 43.51 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.745 0.307 . . . . 0.0 110.983 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.552 HG22 ' HB3' ' A' ' 62' ' ' ALA . 55.9 t -123.44 137.75 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.1 t -128.65 157.44 41.3 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.304 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 5.8 p30 -158.74 77.97 0.77 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.134 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.637 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 56.9 t-80 -172.62 -35.81 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.637 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 37.3 Cg_endo -94.44 -163.33 0.09 OUTLIER 'Trans proline' 0 N--CA 1.485 0.981 0 C-N-CA 121.973 1.782 . . . . 0.0 111.991 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 36.5 mt -78.22 -4.39 47.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.511 0.672 . . . . 0.0 109.908 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 93.4 t -58.35 -44.93 89.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.061 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.77 HG23 ' H ' ' A' ' 126' ' ' ALA . 30.8 m -54.24 -62.52 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 C-N-CA 119.538 -0.865 . . . . 0.0 108.727 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.77 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.6 -43.27 2.7 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.021 0.439 . . . . 0.0 110.657 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.9 tp -69.28 -48.87 60.45 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.828 0.347 . . . . 0.0 111.455 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 80.3 m -70.46 -48.42 55.94 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.365 0.602 . . . . 0.0 110.851 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.477 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -54.72 -43.27 72.45 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.73 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -59.02 -55.21 38.08 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.235 -1.348 . . . . 0.0 109.459 -178.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -61.84 -21.84 64.98 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 114.545 -1.207 . . . . 0.0 109.151 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.54 0.69 84.83 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -151.52 158.72 34.16 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -43.8 174.16 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 123.697 2.931 . . . . 0.0 113.722 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.5 tp -128.63 123.13 32.48 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.421 HG13 ' H ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -66.12 144.34 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 C-N-CA 118.353 -1.339 . . . . 0.0 108.049 -179.674 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -110.01 120.14 41.51 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 124.305 1.003 . . . . 0.0 110.876 -179.179 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.442 ' OG1' ' NH2' ' A' ' 45' ' ' ARG . 2.4 m -134.11 160.06 38.94 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.898 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.5 m -72.11 142.44 49.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.882 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.88 -36.32 83.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.813 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' A' ' 141' ' ' ASN . 56.9 p30 -46.97 150.04 0.81 Allowed 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.959 0.885 . . . . 0.0 111.255 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.4 -161.55 0.89 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.211 -1.359 . . . . 0.0 110.569 -178.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.2 p -62.02 -39.81 93.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.297 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -164.9 9.24 0.07 OUTLIER Glycine 0 C--N 1.33 0.224 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.3 tp -91.65 127.89 48.54 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-O 119.355 -0.355 . . . . 0.0 110.186 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -38.61 156.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 121.648 1.565 . . . . 0.0 112.276 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -76.54 -167.01 0.41 Allowed 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 122.773 2.316 . . . . 0.0 112.524 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 83.3 m -111.48 74.33 0.86 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.461 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.531 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 38.0 ptt180 -51.84 -37.54 52.33 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.432 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.422 ' O ' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -159.87 168.08 26.62 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.763 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.41 HG11 ' HA ' ' A' ' 166' ' ' PRO . 1.1 m -57.88 -21.65 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.83 -30.58 71.66 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 155' ' ' ARG . 6.7 tm-20 -63.73 -79.85 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.534 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.0 p -36.45 -30.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.082 0.953 . . . . 0.0 110.971 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.466 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -70.68 -51.68 26.12 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.518 -179.351 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.09 -17.54 62.58 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 122.451 1.119 . . . . 0.0 108.024 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -83.77 -47.82 10.75 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 112.705 -2.043 . . . . 0.0 111.794 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -130.58 -19.92 2.97 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 85.82 26.15 35.84 Favored Glycine 0 N--CA 1.468 0.823 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.4 ' O ' ' O ' ' A' ' 159' ' ' GLY . . . -43.64 -95.9 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.587 0.232 . . . . 0.0 111.195 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.467 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 63.43 35.43 12.1 Favored 'General case' 0 CA--C 1.527 0.09 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.546 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.6 m-85 -175.47 -61.9 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.153 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.49 27.35 0.31 Allowed 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.298 1.999 . . . . 0.0 110.751 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.558 HG23 ' HD3' ' A' ' 166' ' ' PRO . 14.9 m -129.45 167.64 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.805 -178.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.0 t -123.16 64.53 26.31 Favored Pre-proline 0 N--CA 1.472 0.668 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.831 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.558 ' HD3' HG23 ' A' ' 164' ' ' VAL . 36.5 Cg_exo -37.65 144.27 0.15 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 123.291 2.66 . . . . 0.0 114.823 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -175.22 -158.25 18.67 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 114.101 -1.409 . . . . 0.0 111.472 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -141.92 -154.42 0.52 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.735 0.302 . . . . 0.0 110.527 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.539 ' OG1' ' N ' ' A' ' 170' ' ' GLY . 1.6 t -150.05 -122.21 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.511 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.539 ' N ' ' OG1' ' A' ' 169' ' ' THR . . . 84.44 15.81 67.88 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -149.54 51.12 0.54 Allowed Glycine 0 N--CA 1.467 0.706 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 76.8 mtm-85 -97.29 9.93 40.92 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.803 0.335 . . . . 0.0 110.336 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.552 ' N ' HD12 ' A' ' 173' ' ' LEU . 8.5 mp -61.36 -46.17 91.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.872 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.674 ' H ' HD22 ' A' ' 174' ' ' ASN . 1.2 p30 -74.41 112.51 17.53 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.008 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.99 156.47 26.67 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.796 1.664 . . . . 0.0 111.629 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 48.3 m -107.54 121.2 44.17 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.35 0.595 . . . . 0.0 110.608 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -132.71 172.94 11.9 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.726 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 39.0 pt -117.61 142.88 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.917 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -131.26 166.19 21.72 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.462 0.649 . . . . 0.0 111.654 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 184' ' ' GLY . 97.6 m-20 -78.55 106.48 10.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.679 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -65.86 -18.01 65.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.739 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.508 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.4 mm? -63.15 -41.72 99.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.221 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.43 -41.12 2.62 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.69 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 180' ' ' ASP . . . 61.55 28.92 70.49 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -80.38 158.34 26.04 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.205 0.526 . . . . 0.0 111.368 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.504 HD23 ' N ' ' A' ' 186' ' ' LEU . 0.8 OUTLIER -70.81 178.06 3.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.412 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -108.7 75.45 0.97 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.143 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 13.8 tpp85 -70.07 139.31 52.58 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 120.912 0.387 . . . . 0.0 109.997 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -174.0 -20.72 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.294 177.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.81 0 CA-C-O 118.265 -1.297 . . . . 0.0 111.114 179.818 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 57.9 p30 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -63.77 -40.68 97.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.526 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -156.51 18.91 0.34 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.78 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.525 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.7 mp -63.03 -42.75 99.86 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -64.58 -40.75 96.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.744 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 61.8 ttt85 -63.01 -41.74 99.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.166 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.7 -44.07 96.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.448 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.45 -44.52 94.27 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.166 0.508 . . . . 0.0 109.918 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.9 mt -63.52 -42.58 96.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.357 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.48 -41.09 80.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.329 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.76 -43.9 91.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.935 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.09 -53.08 62.01 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 17.6 pt -68.2 -36.94 77.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.806 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -58.06 -50.03 74.85 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.613 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.529 HG13 ' O ' ' A' ' 21' ' ' ARG . 90.8 t -64.59 -38.66 83.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.946 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.68 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.5 tt -52.7 -51.02 62.12 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.287 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -78.34 -47.97 16.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.402 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -67.83 -31.36 71.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.951 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.6 mt-10 57.54 57.64 4.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.182 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.529 ' O ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -151.15 159.17 44.61 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.582 0.706 . . . . 0.0 110.336 179.088 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 34' ' ' GLY . 8.9 p -74.08 140.17 18.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.452 -178.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.507 HG22 ' NH2' ' A' ' 21' ' ' ARG . 2.8 pp -126.69 166.43 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-O 120.879 0.371 . . . . 0.0 110.927 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.422 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -63.85 137.9 58.24 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.332 0.587 . . . . 0.0 111.008 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.53 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 0.4 OUTLIER -130.52 141.86 43.44 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.123 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.53 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 58.3 Cg_endo -79.38 146.79 19.79 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 121.451 1.434 . . . . 0.0 111.682 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.506 ' C ' ' H ' ' A' ' 29' ' ' ALA . 33.7 m -130.02 133.42 46.73 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.905 0.383 . . . . 0.0 110.931 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -74.53 25.26 0.08 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.152 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.506 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -157.3 -74.43 0.09 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.001 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.3 t -124.93 125.51 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-O 120.894 0.378 . . . . 0.0 110.313 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -44.37 139.24 2.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.934 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -149.44 -172.28 18.87 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.5 m -130.06 169.98 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.439 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -158.5 178.98 34.49 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.757 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.55 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -154.53 -162.97 1.49 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.819 0.342 . . . . 0.0 111.393 -178.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.55 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 5.7 m-20 -97.82 107.34 39.64 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -177.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 36' ' ' ASP . 38.6 Cg_exo -37.86 173.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 123.074 2.516 . . . . 0.0 114.215 177.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 66.7 t0 35.66 76.39 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.492 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.0 m -152.73 139.03 18.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.336 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -70.12 -34.3 72.92 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.244 0.545 . . . . 0.0 110.74 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 41' ' ' THR . 0.1 OUTLIER -64.32 -44.39 91.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.86 -178.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.63 -50.61 71.85 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.515 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.6 p -62.58 -44.51 99.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.177 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 90.7 mtp -64.0 -40.02 95.43 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.4 ' O ' ' CD2' ' A' ' 49' ' ' LEU . 56.0 ttt85 -61.68 -33.02 73.25 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.341 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 85.8 mt -75.04 -60.81 2.12 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.6 mt -53.56 -18.35 2.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.56 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -66.83 -86.15 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -178.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.505 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.2 pt? -76.82 -34.34 57.91 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -75.03 -49.69 18.96 Favored 'General case' 0 C--N 1.345 0.409 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.56 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 35.62 64.81 0.45 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.855 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.407 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 8.1 mtt180 179.29 -53.35 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.902 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.497 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.407 ' HD2' ' H ' ' A' ' 52' ' ' ARG . 60.1 Cg_endo -74.74 -8.79 20.7 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.399 2.066 . . . . 0.0 112.267 -179.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.546 HG13 ' N ' ' A' ' 55' ' ' ASP . 7.5 p -41.52 -48.17 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.809 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.546 ' N ' HG13 ' A' ' 54' ' ' VAL . 33.9 t0 -69.39 -38.71 78.11 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.547 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.481 ' CD ' ' N ' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -59.78 -39.26 84.31 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.767 -179.092 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 59.62 104.69 0.01 OUTLIER Glycine 0 CA--C 1.518 0.247 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.568 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -52.53 -161.3 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.615 0.721 . . . . 0.0 111.735 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.0 mt -108.41 146.77 13.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.912 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.7 mt -119.55 141.24 49.42 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.448 ' CD1' ' HE ' ' A' ' 117' ' ' ARG . 8.0 tp -108.96 131.68 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-O 121.222 0.534 . . . . 0.0 110.569 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.472 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -118.81 153.25 34.78 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.385 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.29 -26.93 7.79 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -117.46 151.17 37.64 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.823 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -78.99 -13.42 59.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.511 0.672 . . . . 0.0 109.346 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -51.14 -30.26 16.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.843 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.487 HE21 ' N ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -94.82 -13.62 25.4 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.562 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 68' ' ' LEU . 4.2 mm? -92.36 -13.67 29.83 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.479 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 79.0 tttt -80.08 -37.79 1.11 Allowed Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 68.6 Cg_endo -102.59 -3.64 0.32 Allowed 'Trans proline' 0 C--N 1.316 -1.169 0 C-N-CA 122.812 2.341 . . . . 0.0 111.564 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.508 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 42.9 t80 -93.07 -13.13 28.97 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.365 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.472 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.7 mp -125.75 155.1 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.472 ' N ' HG22 ' A' ' 72' ' ' ILE . 84.3 m-20 -64.41 153.02 39.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.063 0.459 . . . . 0.0 110.114 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 74' ' ' ASP . 66.5 t0 -96.22 46.03 1.07 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.308 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.492 HG23 ' N ' ' A' ' 76' ' ' MET . 10.9 t -115.83 -40.08 3.39 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.269 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.492 ' N ' HG23 ' A' ' 75' ' ' THR . 13.6 ptm -95.55 -24.41 16.63 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.217 0.532 . . . . 0.0 110.224 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.571 HD21 ' NH2' ' A' ' 82' ' ' ARG . 30.8 tp -80.09 134.98 36.23 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.436 -178.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.07 169.74 19.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.708 -177.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.36 -41.92 94.7 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.367 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.46 -33.39 56.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.115 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -63.24 -40.39 97.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.068 0.461 . . . . 0.0 110.569 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.571 ' NH2' HD21 ' A' ' 77' ' ' LEU . 7.5 mmt85 -64.17 -52.03 60.96 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 122.655 1.217 . . . . 0.0 109.02 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 87' ' ' SER . 82.6 tt0 -56.68 -50.42 72.18 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.618 -1.628 . . . . 0.0 110.372 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.2 m -62.41 -49.47 75.35 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.349 -1.296 . . . . 0.0 112.232 -177.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.8 tt -67.46 -25.31 33.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.325 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -86.47 -32.6 20.73 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.241 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 83' ' ' GLU . 6.7 m -88.52 -20.24 25.35 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.293 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.442 ' O ' ' O ' ' A' ' 89' ' ' TRP . 70.2 ttt180 -116.19 82.26 1.75 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.668 0.27 . . . . 0.0 110.636 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.442 ' O ' ' O ' ' A' ' 88' ' ' ARG . 3.9 m-90 56.56 151.82 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.828 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.4 -17.82 44.07 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.058 1.839 . . . . 0.0 111.449 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.459 ' H ' ' HD3' ' A' ' 92' ' ' PRO . . . 99.26 69.71 0.93 Allowed Glycine 0 N--CA 1.471 0.972 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.459 ' HD3' ' H ' ' A' ' 91' ' ' GLY . 51.9 Cg_exo -55.52 -38.55 93.95 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.893 2.396 . . . . 0.0 112.307 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.7 p -73.92 136.15 25.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.322 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 56.1 m -88.92 144.23 26.33 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.821 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.42 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 55.8 m-85 -126.94 144.55 50.97 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.227 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.623 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.5 t -99.91 103.4 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 121.296 0.569 . . . . 0.0 109.475 178.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -87.77 148.21 43.13 Favored Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.815 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.9 101.66 1.51 Allowed 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.651 1.567 . . . . 0.0 110.948 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.38 150.53 79.95 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.896 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.436 ' O ' ' OG1' ' A' ' 103' ' ' THR . 79.2 Cg_endo -71.53 152.11 59.57 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 122.222 1.948 . . . . 0.0 112.406 -179.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.61 -35.52 81.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.037 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 81.9 p -55.66 -42.52 75.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.485 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.478 ' O ' ' O ' ' A' ' 104' ' ' PRO . 4.7 p -61.94 155.69 61.55 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 103' ' ' THR . 78.1 Cg_exo -47.89 -160.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.944 0 C-N-CA 122.577 2.185 . . . . 0.0 113.707 178.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.506 HH22 ' C ' ' A' ' 111' ' ' PHE . 7.1 tpt85 -140.37 0.1 1.65 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.441 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 43.4 m95 -77.26 -2.97 37.45 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 120.839 0.352 . . . . 0.0 110.517 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.934 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -82.44 -19.6 38.64 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.537 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.64 ' H ' HD22 ' A' ' 107' ' ' LEU . 51.3 m -142.74 -41.53 0.32 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.435 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 64.81 24.06 69.62 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.453 178.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.93 -75.22 0.11 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 117.54 0.67 . . . . 0.0 110.527 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.506 ' C ' HH22 ' A' ' 105' ' ' ARG . 72.2 m-85 -113.63 159.5 19.58 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.018 0.437 . . . . 0.0 110.312 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -93.06 76.82 4.68 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.284 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.828 ' C ' HD22 ' A' ' 114' ' ' LEU . 19.5 p -163.57 128.85 3.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.967 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.828 HD22 ' C ' ' A' ' 113' ' ' SER . 3.7 mm? -134.04 128.26 33.94 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -178.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.462 ' N ' HG13 ' A' ' 96' ' ' VAL . . . -69.83 124.14 23.25 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 113.815 -1.539 . . . . 0.0 109.333 176.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.3 p -144.21 152.27 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.881 0.372 . . . . 0.0 110.783 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.448 ' HE ' ' CD1' ' A' ' 61' ' ' ILE . 62.2 ttp180 -140.58 153.81 46.25 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.682 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.472 HG22 ' HB3' ' A' ' 62' ' ' ALA . 56.0 t -121.91 134.05 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 7.9 t -134.02 153.28 51.89 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.215 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 51.2 p-10 -153.72 82.99 1.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.075 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.635 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 40.7 t60 -172.47 -37.36 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.635 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 40.7 Cg_endo -94.15 -161.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -0.977 0 C-N-CA 122.122 1.881 . . . . 0.0 112.156 -178.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 27.4 mt -79.04 -4.97 52.8 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.929 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 95.0 t -58.15 -45.03 88.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.915 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.777 HG23 ' H ' ' A' ' 126' ' ' ALA . 30.3 m -54.1 -62.54 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.847 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.777 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.41 -44.13 2.75 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 120.936 0.398 . . . . 0.0 110.819 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.5 tp -68.83 -48.32 63.8 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.469 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 61.8 m -70.66 -49.04 51.62 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.431 0.634 . . . . 0.0 110.835 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.472 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.1 pp0? -54.62 -41.93 70.57 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -59.5 -54.37 47.43 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.049 -177.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.499 ' CE1' ' OD2' ' A' ' 36' ' ' ASP . 41.4 t80 -61.78 -20.42 63.57 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.321 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.73 -1.14 84.53 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.412 ' O ' ' O ' ' A' ' 134' ' ' PRO . 33.3 mttm -151.65 159.64 32.94 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.412 ' O ' ' O ' ' A' ' 133' ' ' LYS . 4.1 Cg_exo -42.24 177.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 123.858 3.039 . . . . 0.0 112.933 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.4 tp -131.43 123.58 28.44 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.413 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -65.41 145.87 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 C-N-CA 117.927 -1.509 . . . . 0.0 107.329 -179.562 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.9 t -118.28 121.93 41.64 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 123.408 0.443 . . . . 0.0 111.191 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.2 m -129.77 162.03 29.36 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.255 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 17.7 m -72.04 145.57 48.19 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.93 81.19 1.67 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.694 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 57.6 p30 -158.7 164.71 35.66 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.335 0.588 . . . . 0.0 110.581 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.15 -163.4 1.47 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.186 -178.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 38.8 t -61.27 -44.25 97.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.676 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -159.71 4.9 0.11 Allowed Glycine 0 N--CA 1.46 0.28 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.5 tp -82.04 127.05 73.3 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -38.95 156.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.621 1.548 . . . . 0.0 112.271 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -75.71 -167.21 0.41 Allowed 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.352 2.035 . . . . 0.0 112.316 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 8.7 t -114.81 77.97 1.12 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.333 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -57.66 -34.97 69.93 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.229 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.45 168.4 20.3 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.438 HG11 ' HA ' ' A' ' 166' ' ' PRO . 1.4 m -57.66 -17.61 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.436 ' O ' ' HB2' ' A' ' 156' ' ' ALA . 66.9 t0 -65.05 -35.63 81.77 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 177.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.444 ' OE1' ' OE1' ' A' ' 157' ' ' GLN . 5.8 tm-20 -59.83 -72.5 0.1 Allowed 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.765 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.404 HG11 HG11 ' A' ' 164' ' ' VAL . 7.8 p -48.04 -30.63 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.342 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.426 ' O ' ' N ' ' A' ' 159' ' ' GLY . 3.8 tmt_? -83.84 -45.36 13.36 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 122.185 0.993 . . . . 0.0 110.285 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 152' ' ' ASP . . . -57.75 -41.03 81.07 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.416 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.466 ' CG ' ' N ' ' A' ' 158' ' ' PHE . 7.9 pt20 -82.65 -48.7 10.62 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 112.932 -1.94 . . . . 0.0 112.224 -176.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.466 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 32.0 t80 -106.85 -35.92 6.81 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 96.22 25.26 12.82 Favored Glycine 0 N--CA 1.472 1.092 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -178.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.407 ' HB1' ' HG2' ' A' ' 163' ' ' PRO . . . -43.36 -94.27 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.514 0.197 . . . . 0.0 110.901 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.474 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 62.13 36.47 15.11 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-O 121.25 0.547 . . . . 0.0 109.857 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.559 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.8 m-85 -175.77 -62.06 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.277 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.407 ' HG2' ' HB1' ' A' ' 160' ' ' ALA . 86.4 Cg_endo -73.46 28.87 0.31 Allowed 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.32 2.013 . . . . 0.0 110.367 177.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.581 HG23 ' HD3' ' A' ' 166' ' ' PRO . 16.8 m -133.27 167.01 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.053 -178.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 6.8 t -124.3 65.51 40.6 Favored Pre-proline 0 N--CA 1.473 0.696 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.694 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.581 ' HD3' HG23 ' A' ' 164' ' ' VAL . 31.0 Cg_exo -37.22 143.88 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 123.611 2.874 . . . . 0.0 115.08 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 165.94 177.65 38.25 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 113.734 -1.576 . . . . 0.0 110.598 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -151.14 151.53 32.07 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.3 t -145.75 154.13 41.72 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.991 0.424 . . . . 0.0 110.925 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -49.14 -67.56 1.68 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 129.17 36.97 0.4 Allowed Glycine 0 N--CA 1.468 0.822 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 -83.35 131.65 35.05 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.584 ' N ' HD12 ' A' ' 173' ' ' LEU . 9.0 mp -83.57 159.09 21.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.935 0.397 . . . . 0.0 110.287 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -88.8 147.67 39.68 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.921 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.22 -19.98 38.0 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.879 1.719 . . . . 0.0 111.565 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 63.1 m -157.97 123.61 4.57 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.405 0.621 . . . . 0.0 110.032 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -94.91 -91.99 0.2 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.333 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 178' ' ' ILE . 29.7 pt -90.84 132.49 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 121.13 0.49 . . . . 0.0 110.817 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 22.7 mmm-85 -129.48 158.51 39.02 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.762 0.791 . . . . 0.0 110.817 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 184' ' ' GLY . 99.8 m-20 -77.06 104.88 7.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.151 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -64.78 -22.97 67.1 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.148 -178.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.496 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.6 mm? -63.68 -41.62 98.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.611 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.1 t -121.0 -42.71 2.48 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.583 0.23 . . . . 0.0 111.099 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 180' ' ' ASP . . . 69.93 32.06 69.88 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -112.68 158.73 19.67 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.945 0.402 . . . . 0.0 111.025 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.498 HD23 ' N ' ' A' ' 186' ' ' LEU . 0.7 OUTLIER -64.95 -175.19 0.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.423 179.694 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -128.64 84.03 2.2 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.228 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -74.66 139.18 43.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.026 0.441 . . . . 0.0 110.548 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -173.62 -21.86 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.588 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.736 0 CA-C-O 118.008 -1.44 . . . . 0.0 110.928 -179.844 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 57.7 t30 . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -86.47 136.78 32.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.494 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -63.29 -40.1 96.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.764 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.559 HD12 ' N ' ' A' ' 5' ' ' LEU . 9.2 mp -62.73 -42.05 99.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.107 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -63.97 -43.29 96.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.756 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -64.07 -41.49 97.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.264 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -61.26 -44.21 97.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.109 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.75 -45.55 92.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.975 0.417 . . . . 0.0 109.959 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.6 mt -63.92 -43.15 97.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.81 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.04 -41.75 88.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.528 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.38 -47.38 79.49 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.858 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.05 -51.79 66.58 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.4 pp -67.71 -39.3 81.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.873 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -58.63 -50.04 75.29 Favored 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.306 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 21' ' ' ARG . 88.3 t -64.07 -38.66 83.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.933 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.68 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.3 tt -52.69 -51.0 62.18 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.42 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -78.91 -47.1 17.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.409 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -68.28 -31.17 70.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.136 0.494 . . . . 0.0 111.22 -178.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.4 mt-10 57.13 59.92 3.2 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.123 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.528 ' O ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -152.21 158.9 43.51 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.176 0.512 . . . . 0.0 110.13 179.039 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 34' ' ' GLY . 8.2 p -75.99 140.55 17.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.57 -178.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.421 HG22 ' NH2' ' A' ' 21' ' ' ARG . 2.8 pp -125.4 167.73 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.615 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.25 132.22 48.51 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.277 0.561 . . . . 0.0 111.718 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -115.87 133.55 22.84 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -83.76 140.68 9.32 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 CA-C-N 120.567 1.238 . . . . 0.0 111.857 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.3 m -138.45 134.63 34.28 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -56.94 -42.91 80.92 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.824 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.66 -79.6 0.07 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.8 t -132.53 129.55 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -41.08 157.05 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.796 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -159.95 -169.53 23.37 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.4 m -131.08 168.52 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.543 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -159.29 178.98 35.21 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.059 -1.067 . . . . 0.0 111.818 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.476 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.8 OUTLIER -158.22 -163.2 1.25 Allowed 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.948 -178.826 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.476 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 35.9 m-20 -91.71 105.78 14.56 Favored Pre-proline 0 CA--C 1.555 1.168 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -177.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -38.11 -62.15 0.32 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.521 2.148 . . . . 0.0 112.929 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -71.91 65.12 0.52 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.516 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 m -151.18 131.18 13.39 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.683 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -66.36 -32.75 74.34 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.214 0.531 . . . . 0.0 111.184 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.522 HG23 ' N ' ' A' ' 42' ' ' ALA . 15.1 t -60.19 -42.53 95.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.34 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.522 ' N ' HG23 ' A' ' 41' ' ' THR . . . -56.63 -50.43 72.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.968 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 p -64.44 -42.62 95.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.207 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 94.0 mtp -63.92 -39.46 94.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -60.46 -41.77 94.79 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 122.087 0.946 . . . . 0.0 108.448 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.454 ' O ' HD23 ' A' ' 46' ' ' LEU . 1.1 tt -64.15 -53.33 51.16 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.369 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.8 mt -70.0 -11.46 60.89 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.062 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -70.32 -83.02 0.03 OUTLIER 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.121 0.486 . . . . 0.0 111.193 -177.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.5 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.2 pt? -76.16 -33.92 59.37 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 -178.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -77.58 -51.93 9.87 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.435 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 36.51 66.47 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.861 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.2 mtm-85 177.8 -53.96 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.918 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.149 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -78.12 -5.96 15.45 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.604 2.202 . . . . 0.0 112.341 -178.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.537 HG13 ' N ' ' A' ' 55' ' ' ASP . 7.1 p -44.34 -44.82 2.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.888 -179.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.537 ' N ' HG13 ' A' ' 54' ' ' VAL . 48.4 t0 -64.34 -42.72 96.13 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.223 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -61.92 -36.6 81.83 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 63.15 113.73 0.01 OUTLIER Glycine 0 C--N 1.332 0.332 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.548 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -53.78 -160.67 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.008 0.433 . . . . 0.0 111.776 -179.314 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.0 mt -106.63 141.4 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.872 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.7 mt -118.89 142.62 47.58 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.8 tp -111.64 132.41 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-O 121.226 0.536 . . . . 0.0 110.853 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.481 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -119.97 153.45 35.94 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.26 -27.67 7.89 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.699 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 12.9 m120 -116.97 147.04 42.63 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.018 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -76.34 -13.5 60.14 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -50.82 -32.68 20.86 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.256 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.699 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 4.1 pm0 -93.71 -12.34 29.46 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.449 HD22 ' N ' ' A' ' 68' ' ' LEU . 4.2 mm? -91.13 -15.92 28.63 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.463 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 11.3 ttmm -79.33 -38.49 1.3 Allowed Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 84.9 Cg_endo -103.59 -3.0 0.26 Allowed 'Trans proline' 0 C--N 1.316 -1.146 0 C-N-CA 122.764 2.309 . . . . 0.0 112.116 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.456 ' OH ' ' CD2' ' A' ' 114' ' ' LEU . 64.1 t80 -96.09 -8.34 33.63 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.92 0.39 . . . . 0.0 110.549 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.591 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.3 mp -138.16 167.58 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.591 ' N ' HG22 ' A' ' 72' ' ' ILE . 98.7 m-20 -63.34 -17.42 62.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.09 0.471 . . . . 0.0 110.086 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.0 t70 54.29 5.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.954 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.487 ' H ' ' C ' ' A' ' 73' ' ' ASP . 13.4 t -69.26 -37.49 77.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.181 0.515 . . . . 0.0 109.941 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.428 ' N ' HG23 ' A' ' 75' ' ' THR . 76.1 mmm -66.47 -41.96 88.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.942 0.877 . . . . 0.0 109.018 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 77' ' ' LEU . 9.4 mp -70.79 144.64 50.78 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 113.875 -1.511 . . . . 0.0 110.845 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.49 160.89 43.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.063 -179.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -42.89 -44.92 4.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.906 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.502 HG13 ' N ' ' A' ' 81' ' ' GLN . 12.2 p -60.49 -41.06 86.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.1 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.502 ' N ' HG13 ' A' ' 80' ' ' VAL . 35.4 mt-30 -64.09 -40.16 95.62 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.608 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -65.28 -52.02 56.94 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 122.508 1.147 . . . . 0.0 108.819 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.414 ' O ' ' N ' ' A' ' 87' ' ' SER . 81.7 tt0 -54.3 -50.53 67.11 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 113.7 -1.591 . . . . 0.0 109.724 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.1 m -60.83 -50.42 73.52 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.31 -1.314 . . . . 0.0 111.666 -178.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 88' ' ' ARG . 7.6 tt -67.11 -34.09 67.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 119.371 -0.932 . . . . 0.0 109.262 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -70.16 -38.94 75.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.941 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 83' ' ' GLU . 4.5 m -87.22 -17.45 32.59 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.009 0.433 . . . . 0.0 110.869 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 85' ' ' ILE . 53.0 ttt85 -114.55 171.97 7.31 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 4.4 m0 -33.27 148.29 0.07 OUTLIER Pre-proline 0 CA--C 1.54 0.569 0 O-C-N 123.186 0.304 . . . . 0.0 111.35 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.56 -17.13 48.31 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.19 1.927 . . . . 0.0 111.506 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.465 ' H ' ' HD3' ' A' ' 92' ' ' PRO . . . 103.03 70.53 0.85 Allowed Glycine 0 N--CA 1.469 0.842 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.465 ' HD3' ' H ' ' A' ' 91' ' ' GLY . 50.8 Cg_exo -53.57 -42.23 67.45 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.495 2.13 . . . . 0.0 112.321 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.523 ' O ' ' CE1' ' A' ' 95' ' ' PHE . 11.7 p -75.37 140.03 18.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.957 0.408 . . . . 0.0 110.776 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 22.7 m -90.57 150.29 21.8 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.91 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.599 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 0.1 OUTLIER -130.49 148.44 52.3 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.087 179.69 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.715 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.9 t -102.03 112.95 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.434 ' CE1' ' HB1' ' A' ' 181' ' ' ALA . 53.1 m-85 -99.24 152.14 37.67 Favored Pre-proline 0 N--CA 1.47 0.561 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.699 -178.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.78 112.2 3.46 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.189 1.926 . . . . 0.0 111.475 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -78.71 152.82 78.05 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.82 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.36 152.37 81.72 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.028 1.819 . . . . 0.0 111.395 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.04 -28.28 19.16 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.126 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.8 m -57.96 -45.68 86.3 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.301 -178.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 104' ' ' PRO . 5.0 t -54.99 145.2 44.8 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.476 ' O ' ' O ' ' A' ' 103' ' ' THR . 0.8 OUTLIER -28.38 -109.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 123.435 2.756 . . . . 0.0 114.464 -179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.406 ' O ' ' N ' ' A' ' 109' ' ' GLY . 8.4 tpt180 -172.29 2.87 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.955 -0.466 . . . . 0.0 110.724 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 53.6 p-90 -74.47 -7.7 53.86 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.146 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.958 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -71.13 -35.58 71.77 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.605 179.551 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.702 ' H ' HD22 ' A' ' 107' ' ' LEU . 86.8 m -133.98 -39.13 0.87 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.651 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 84.57 -5.92 79.47 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.226 -0.511 . . . . 0.0 112.727 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -148.85 -72.47 0.19 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 117.723 0.762 . . . . 0.0 111.402 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.447 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 18.8 t80 -88.89 -165.5 1.35 Allowed 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.447 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 51.2 p30 -130.9 51.43 2.14 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.836 0.351 . . . . 0.0 110.897 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.2 p -152.31 153.24 33.29 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.515 ' C ' HG13 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -159.81 136.43 9.12 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -179.261 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.439 ' N ' HG13 ' A' ' 96' ' ' VAL . . . -68.39 127.32 32.54 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 113.225 -1.807 . . . . 0.0 109.967 177.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.6 p -148.01 153.61 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -146.52 155.87 42.84 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.831 0.348 . . . . 0.0 111.021 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.481 HG22 ' HB3' ' A' ' 62' ' ' ALA . 53.2 t -122.63 135.37 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.7 t -133.49 153.42 51.64 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.275 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 52.6 p-10 -154.53 81.28 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.378 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.628 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 27.0 t-80 -171.95 -37.42 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.628 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 31.2 Cg_endo -94.0 -163.08 0.1 OUTLIER 'Trans proline' 0 C--N 1.32 -0.922 0 C-N-CA 121.954 1.769 . . . . 0.0 111.959 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 16.2 mt -76.94 -4.84 45.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.939 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 91.8 t -57.86 -45.58 87.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.171 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.764 HG23 ' H ' ' A' ' 126' ' ' ALA . 28.2 m -53.17 -62.22 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 C-N-CA 119.467 -0.893 . . . . 0.0 108.67 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.764 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.79 -42.54 2.67 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.008 0.432 . . . . 0.0 110.685 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.4 tp -70.05 -48.33 58.3 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.489 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 63.9 m -70.56 -48.3 56.05 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.575 0.702 . . . . 0.0 110.781 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.465 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -55.08 -42.15 72.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.788 -1.096 . . . . 0.0 108.195 179.29 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -59.32 -55.66 31.98 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.648 -177.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -61.7 -21.94 64.91 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 114.484 -1.234 . . . . 0.0 108.656 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.6 1.48 86.68 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -151.66 160.1 32.22 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.113 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -45.41 166.17 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 123.833 3.022 . . . . 0.0 112.967 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.4 tp -121.21 122.81 40.77 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 176.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.414 ' O ' ' CA ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -63.6 146.9 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.856 0 C-N-CA 117.712 -1.595 . . . . 0.0 106.722 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.9 t -122.56 126.13 47.12 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.694 0.621 . . . . 0.0 111.572 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 3.7 m -132.37 164.55 26.23 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.53 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 30.4 t -71.07 151.19 44.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.844 0.354 . . . . 0.0 110.728 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.436 ' HB1' ' H ' ' A' ' 148' ' ' CYS . . . -60.75 -37.3 81.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.975 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 54.7 p30 -55.87 154.77 6.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.657 0.741 . . . . 0.0 111.425 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.45 -159.15 0.94 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.629 -178.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.9 p -61.36 -38.7 87.94 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.061 0.458 . . . . 0.0 110.153 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -165.8 0.78 0.05 OUTLIER Glycine 0 CA--C 1.511 -0.166 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.2 tp -81.68 124.8 79.43 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.237 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -38.73 156.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.939 1.759 . . . . 0.0 111.931 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -74.84 -162.87 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.391 2.061 . . . . 0.0 112.256 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.436 ' H ' ' HB1' ' A' ' 140' ' ' ALA . 73.0 m -119.5 76.4 1.13 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.7 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -54.16 -32.97 56.89 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.817 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.0 165.55 15.78 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.417 HG11 ' HA ' ' A' ' 166' ' ' PRO . 0.9 OUTLIER -55.75 -17.66 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.746 0 CA-C-O 121.751 0.786 . . . . 0.0 109.267 179.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -66.24 -34.58 78.33 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.33 -70.6 0.16 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.729 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.5 p -48.62 -31.11 3.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.155 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 159' ' ' GLY . 4.6 tmt_? -79.64 -51.65 8.99 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.863 0.84 . . . . 0.0 109.338 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.98 -44.22 63.95 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.886 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.504 HE21 ' C ' ' A' ' 157' ' ' GLN . 0.0 OUTLIER -84.13 -30.59 25.78 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 112.845 -1.979 . . . . 0.0 114.351 -175.279 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -126.3 -32.9 2.66 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 118.012 0.369 . . . . 0.0 111.294 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 93.75 23.41 23.41 Favored Glycine 0 N--CA 1.467 0.744 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -42.77 -95.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.493 0.187 . . . . 0.0 110.957 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.454 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.93 37.04 15.43 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.189 0.519 . . . . 0.0 109.61 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.556 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.4 m-85 -175.88 -62.1 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.907 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.28 28.05 0.3 Allowed 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.349 2.032 . . . . 0.0 110.536 178.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.573 HG23 ' HD3' ' A' ' 166' ' ' PRO . 16.0 m -131.78 167.47 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.05 -178.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.2 65.96 30.74 Favored Pre-proline 0 N--CA 1.477 0.878 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.645 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.573 ' HD3' HG23 ' A' ' 164' ' ' VAL . 33.0 Cg_exo -38.27 147.42 0.11 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 123.686 2.924 . . . . 0.0 114.962 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 174.53 -148.72 10.0 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.117 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -143.4 -164.65 1.91 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.9 t -144.41 153.25 41.74 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.354 0.597 . . . . 0.0 111.071 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -167.53 78.43 0.11 Allowed Glycine 0 N--CA 1.454 -0.148 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.25 62.41 0.02 OUTLIER Glycine 0 C--N 1.317 -0.502 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -79.52 -9.03 59.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.557 -0.322 . . . . 0.0 111.083 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.504 HD22 ' N ' ' A' ' 173' ' ' LEU . 3.6 mm? -61.36 -40.47 94.41 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.429 ' N ' ' CD ' ' A' ' 175' ' ' PRO . 0.1 OUTLIER 72.61 52.34 0.29 Allowed Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.388 179.243 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 174' ' ' ASN . 58.9 Cg_endo -69.49 -17.42 38.83 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.508 2.139 . . . . 0.0 111.014 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 6.2 p -96.93 122.91 40.43 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.715 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.442 ' H ' HG23 ' A' ' 93' ' ' VAL . 95.8 mt-10 -133.92 -163.57 1.38 Allowed 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.614 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 178' ' ' ILE . 18.8 tt -112.28 130.74 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.698 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -133.83 169.4 17.12 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.714 0.768 . . . . 0.0 112.17 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -80.63 106.99 13.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.201 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -68.47 -16.68 63.98 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.214 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.8 mm? -63.37 -41.8 98.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.047 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.09 -44.31 3.6 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.176 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 72.92 20.05 79.75 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -68.7 145.39 53.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.051 0.453 . . . . 0.0 110.886 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.515 HD23 ' N ' ' A' ' 186' ' ' LEU . 0.9 OUTLIER -69.04 174.96 4.04 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.823 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . 0.458 ' O ' ' CD2' ' A' ' 187' ' ' PHE . 65.7 t80 -122.27 12.67 10.25 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.131 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 52.3 ttt-85 -71.5 -131.43 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.352 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -67.41 -39.0 85.51 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.124 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.762 0 CA-C-O 118.111 -1.383 . . . . 0.0 111.021 -179.972 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -82.45 140.67 33.27 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -88.04 -9.33 53.72 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.642 -0.253 . . . . 0.0 110.579 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.552 HD12 ' N ' ' A' ' 5' ' ' LEU . 9.4 mp -63.27 -42.27 99.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.968 0.413 . . . . 0.0 110.252 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -64.81 -43.43 93.14 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.189 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -65.56 -38.67 90.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.277 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 162' ' ' PHE . 67.9 t0 -62.73 -45.65 91.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.613 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.14 -45.87 91.52 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.912 0.387 . . . . 0.0 110.031 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.63 -43.06 98.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.839 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.91 -42.62 85.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.541 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.13 -46.62 86.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.174 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.07 -51.4 69.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.811 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 14.7 pt -68.71 -39.84 80.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.409 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -57.15 -53.19 60.9 Favored 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 120.486 -0.485 . . . . 0.0 109.921 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 20' ' ' GLU . 89.0 t -61.61 -40.42 86.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.638 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.682 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.3 tt -52.99 -50.47 64.11 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.383 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -79.49 -51.23 9.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.753 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -64.8 -31.04 72.08 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.812 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 16' ' ' VAL . 96.7 mt-10 58.44 85.11 0.1 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.124 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.41 -142.54 0.09 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.706 0.288 . . . . 0.0 110.289 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.2 p -137.74 138.73 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 pp -128.05 163.99 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-O 121.118 0.485 . . . . 0.0 111.78 -178.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.68 128.43 36.2 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.914 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.518 ' CE2' ' O ' ' A' ' 26' ' ' PRO . 2.1 t80 -118.32 138.49 25.72 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.255 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.518 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 64.8 Cg_endo -80.93 149.51 17.83 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.191 1.26 . . . . 0.0 111.352 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.436 ' C ' ' H ' ' A' ' 29' ' ' ALA . 25.9 m -135.15 140.93 45.8 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.271 0.557 . . . . 0.0 110.808 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -77.77 20.07 0.36 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.033 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.436 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -154.97 -73.41 0.12 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.206 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 67.5 t -122.74 126.28 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 120.859 0.361 . . . . 0.0 110.737 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.521 ' CD2' ' O ' ' A' ' 149' ' ' ARG . 90.9 m-85 -53.5 144.48 17.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.195 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -154.35 -168.37 17.7 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.2 m -132.08 168.31 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.97 -176.96 27.79 Favored Glycine 0 N--CA 1.464 0.566 0 C-N-CA 120.008 -1.092 . . . . 0.0 111.925 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -153.34 -166.2 2.36 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.734 0.302 . . . . 0.0 110.359 -179.43 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.514 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 7.8 m-20 -99.43 109.79 56.17 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-O 118.729 -0.653 . . . . 0.0 112.441 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 36' ' ' ASP . 15.4 Cg_exo -35.19 168.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.68 2.254 . . . . 0.0 114.302 177.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 44.73 67.39 0.7 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.433 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.7 m -142.94 137.59 29.53 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.07 0.462 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.631 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -71.65 -34.37 69.7 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.296 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.432 ' H ' HG22 ' A' ' 41' ' ' THR . 0.1 OUTLIER -63.45 -45.28 91.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.644 -178.121 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.424 ' HB2' ' SG ' ' A' ' 35' ' ' CYS . . . -63.1 -47.68 81.81 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.598 -178.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.3 p -62.59 -44.45 99.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.249 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 62.1 mtt -64.95 -39.79 94.02 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 -61.77 -32.98 73.29 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.026 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 79.9 mt -75.95 -57.23 4.0 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.4 mt -54.46 -18.91 4.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.243 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -67.23 -84.66 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.695 -178.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.515 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -75.83 -33.26 60.05 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -77.71 -71.23 0.43 Allowed 'General case' 0 C--N 1.346 0.445 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.738 -176.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.411 ' CG ' ' O ' ' A' ' 51' ' ' GLN . 3.2 tt0 53.65 80.98 0.1 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.399 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.3 mtp85 160.69 -64.04 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.116 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -66.78 -11.25 31.26 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 122.641 2.228 . . . . 0.0 111.775 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.596 HG13 ' N ' ' A' ' 55' ' ' ASP . 13.9 p -46.05 -45.97 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.596 ' N ' HG13 ' A' ' 54' ' ' VAL . 10.3 t0 -67.58 -44.44 78.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.676 -178.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -60.35 -40.5 90.96 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.759 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 71.39 111.66 0.04 OUTLIER Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.573 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -49.54 -169.86 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.986 -0.607 . . . . 0.0 111.896 179.632 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.439 ' O ' ' OG ' ' A' ' 137' ' ' SER . 80.9 mt -100.25 139.54 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.5 mt -113.24 143.84 43.73 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -178.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.412 ' O ' HG23 ' A' ' 61' ' ' ILE . 10.0 tp -112.26 127.97 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 CA-C-O 121.122 0.487 . . . . 0.0 110.548 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.497 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -113.46 154.59 26.76 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.56 -26.29 7.11 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -118.76 145.05 45.88 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.607 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -71.62 -12.53 61.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.571 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -49.6 -33.91 16.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.565 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -95.04 -15.74 23.23 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.582 HD22 ' N ' ' A' ' 68' ' ' LEU . 3.8 mm? -92.94 -13.14 29.23 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.476 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 27.9 tptt -80.49 -39.08 1.13 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.803 -178.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 65.8 Cg_endo -103.09 -3.4 0.28 Allowed 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 122.78 2.32 . . . . 0.0 111.784 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.561 ' OH ' HD21 ' A' ' 114' ' ' LEU . 39.8 t80 -96.56 -11.01 25.98 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.161 -178.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.581 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.2 mp -131.46 159.36 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.581 ' N ' HG22 ' A' ' 72' ' ' ILE . 91.2 m-20 -71.37 160.45 32.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.06 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 39.2 p30 -95.64 7.79 45.27 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.848 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.561 HG23 ' N ' ' A' ' 76' ' ' MET . 7.1 t -67.08 -45.77 76.3 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.325 0.583 . . . . 0.0 110.547 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.561 ' N ' HG23 ' A' ' 75' ' ' THR . 23.1 ptp -84.33 -6.26 59.37 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.232 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.3 tp -94.33 116.3 28.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.619 -177.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -154.95 167.2 31.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.91 -177.817 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -42.49 -44.49 4.1 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.196 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.66 -33.03 59.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.923 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 78' ' ' THR . 1.0 OUTLIER -65.75 -43.26 89.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.203 0.525 . . . . 0.0 110.52 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.402 ' NH2' ' HZ1' ' A' ' 69' ' ' LYS . 9.5 mmt85 -59.92 -49.17 78.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 122.76 1.267 . . . . 0.0 108.657 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -57.29 -49.84 74.82 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 113.446 -1.706 . . . . 0.0 110.005 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.7 m -62.59 -49.19 76.24 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.227 -1.351 . . . . 0.0 112.444 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.8 tt -68.42 -30.75 48.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.139 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -82.37 -40.02 21.93 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.917 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.2 m -78.35 -3.31 42.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.907 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -121.92 166.95 13.64 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 15.9 m-90 -43.49 150.71 0.5 Allowed Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.12 -19.37 45.11 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.911 1.741 . . . . 0.0 111.593 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.474 ' O ' ' NH2' ' A' ' 117' ' ' ARG . . . 177.64 78.78 0.06 OUTLIER Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -79.57 -35.52 0.79 Allowed 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.042 1.828 . . . . 0.0 112.516 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.515 ' CG1' ' CZ ' ' A' ' 95' ' ' PHE . 9.7 p -137.92 149.2 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 120.801 0.334 . . . . 0.0 110.886 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 16.3 m -81.39 129.51 34.66 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.515 ' CZ ' ' CG1' ' A' ' 93' ' ' VAL . 46.2 m-85 -117.02 137.4 52.26 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.733 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.697 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 5.5 t -92.05 102.59 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 121.277 0.561 . . . . 0.0 109.759 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -81.12 143.68 53.17 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.198 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -79.64 108.16 2.24 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 122.032 1.821 . . . . 0.0 111.099 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 112' ' ' ASP . . . -64.93 156.61 79.43 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.624 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 49.0 Cg_endo -66.69 -19.23 53.81 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.231 1.954 . . . . 0.0 112.187 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 100' ' ' PRO . . . 91.63 -27.57 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.536 0.523 . . . . 0.0 110.551 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.4 m -58.19 -45.17 88.02 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.54 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.511 ' O ' ' O ' ' A' ' 104' ' ' PRO . 0.1 OUTLIER -52.32 151.66 7.02 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.217 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.511 ' O ' ' O ' ' A' ' 103' ' ' THR . 9.2 Cg_exo -31.64 -115.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.504 2.139 0 C-N-CA 124.088 3.192 . . . . 0.0 114.64 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 109' ' ' GLY . 0.6 OUTLIER -179.45 -4.25 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.957 -0.464 . . . . 0.0 110.409 -179.642 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 2.5 p90 -79.56 -9.83 59.69 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.676 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.969 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -69.28 -34.06 74.17 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.427 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.746 ' H ' HD22 ' A' ' 107' ' ' LEU . 28.5 m -141.39 -40.73 0.38 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.428 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 60.29 -13.62 0.04 OUTLIER Glycine 0 CA--C 1.536 1.398 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.657 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.558 ' H ' ' C ' ' A' ' 108' ' ' THR . 0.0 OUTLIER -85.52 -52.61 5.72 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 117.659 0.73 . . . . 0.0 109.284 179.758 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.534 ' CE2' ' OD1' ' A' ' 112' ' ' ASP . 17.6 t80 -154.37 -178.26 7.02 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.306 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.534 ' OD1' ' CE2' ' A' ' 111' ' ' PHE . 48.8 p30 -89.01 51.63 2.21 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.299 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.5 p -159.51 156.82 28.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.244 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.561 HD21 ' OH ' ' A' ' 71' ' ' TYR . 0.3 OUTLIER -163.75 141.5 7.38 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.421 ' HB2' HG22 ' A' ' 96' ' ' VAL . . . -69.7 125.23 26.09 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 113.737 -1.574 . . . . 0.0 109.617 177.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.491 HG22 ' N ' ' A' ' 117' ' ' ARG . 4.3 p -146.66 161.19 9.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.491 ' N ' HG22 ' A' ' 116' ' ' VAL . 78.7 ttt-85 -144.03 153.23 41.99 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.91 0.386 . . . . 0.0 111.389 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.497 HG22 ' HB3' ' A' ' 62' ' ' ALA . 52.2 t -122.45 136.64 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.2 t -135.24 149.04 49.77 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.249 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 35.4 p30 -151.68 78.82 1.26 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.763 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.61 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 10.3 t-80 -172.51 -36.85 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.61 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 18.9 Cg_endo -92.73 -161.66 0.09 OUTLIER 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 121.993 1.795 . . . . 0.0 111.686 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.4 mt -78.83 -4.68 50.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.016 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.4 t -58.21 -45.0 89.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.971 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.754 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.6 m -52.7 -62.2 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.935 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.754 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -40.96 -45.41 2.57 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.881 0.372 . . . . 0.0 111.027 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.435 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -66.69 -51.37 56.8 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.253 0.549 . . . . 0.0 110.778 179.535 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 71.2 m -69.5 -47.79 62.68 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.237 0.541 . . . . 0.0 111.425 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.475 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.2 pp0? -54.87 -42.2 71.75 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -60.4 -53.12 61.37 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.771 -177.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.45 ' CE1' ' OD2' ' A' ' 36' ' ' ASP . 42.0 t80 -64.48 -22.46 66.97 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.825 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.94 2.07 90.14 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 134' ' ' PRO . 34.3 mttm -152.4 159.56 32.52 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 133' ' ' LYS . 5.9 Cg_exo -41.12 -179.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 124.061 3.174 . . . . 0.0 113.941 -178.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.447 HD12 ' O ' ' A' ' 35' ' ' CYS . 8.0 tp -134.47 123.85 24.65 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 176.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.423 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.9 OUTLIER -66.14 143.73 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 C-N-CA 117.764 -1.574 . . . . 0.0 108.518 -179.153 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -108.82 121.88 46.0 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.96 0.788 . . . . 0.0 110.924 -179.346 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.9 m -132.38 157.64 44.02 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.819 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.6 m -73.0 143.2 47.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.011 0.434 . . . . 0.0 110.577 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.7 -36.76 85.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.034 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 51.8 p30 -52.37 150.38 4.82 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.774 0.797 . . . . 0.0 110.997 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.13 -158.39 0.73 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.048 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 45.2 m -59.93 -42.99 95.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.471 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -162.55 11.87 0.11 Allowed Glycine 0 N--CA 1.459 0.172 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.7 tp -93.44 127.51 46.13 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -38.76 157.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 121.758 1.638 . . . . 0.0 112.468 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -76.55 -166.94 0.41 Allowed 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 122.721 2.281 . . . . 0.0 112.487 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 70.9 m -112.03 76.93 1.0 Allowed 'General case' 0 C--O 1.231 0.103 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.521 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 17.5 ptm180 -54.06 -37.81 64.57 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.952 -178.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.42 167.64 29.13 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.441 HG22 ' H ' ' A' ' 151' ' ' VAL . 1.6 m -57.37 -20.35 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.6 0 CA-C-O 121.77 0.795 . . . . 0.0 109.248 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -64.21 -34.61 78.49 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.03 -79.49 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.872 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.439 HG13 ' N ' ' A' ' 155' ' ' ARG . 6.3 p -35.22 -34.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.687 0.795 . . . . 0.0 111.155 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.475 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -67.38 -52.79 35.66 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.347 0.594 . . . . 0.0 111.852 -178.618 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -69.35 -16.93 63.64 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 122.538 1.161 . . . . 0.0 108.035 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -84.23 -45.37 12.96 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 112.672 -2.058 . . . . 0.0 111.891 -178.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -130.34 -27.93 2.16 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.638 0.256 . . . . 0.0 111.642 -178.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 94.56 24.17 19.16 Favored Glycine 0 N--CA 1.468 0.783 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -43.68 -96.69 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.78 0.324 . . . . 0.0 111.126 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.508 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 62.3 34.8 15.61 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -178.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.544 ' H ' HG22 ' A' ' 164' ' ' VAL . 2.1 m-85 -174.04 -62.16 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.238 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.86 25.88 0.29 Allowed 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.349 2.033 . . . . 0.0 110.932 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.571 HG23 ' HD3' ' A' ' 166' ' ' PRO . 13.7 m -127.43 167.64 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.746 -178.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.1 t -122.35 64.87 21.58 Favored Pre-proline 0 N--CA 1.472 0.647 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.829 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.571 ' HD3' HG23 ' A' ' 164' ' ' VAL . 38.9 Cg_exo -37.62 144.32 0.15 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 123.652 2.901 . . . . 0.0 115.031 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 164.54 -176.78 40.36 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 113.901 -1.5 . . . . 0.0 110.878 178.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -142.09 152.8 43.63 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.4 t -144.99 155.55 43.45 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.088 0.47 . . . . 0.0 111.169 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -152.13 80.33 0.19 Allowed Glycine 0 CA--C 1.519 0.295 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -166.45 67.27 0.2 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -91.73 3.17 55.71 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.687 0.279 . . . . 0.0 111.062 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 56.9 tp -61.73 -46.8 88.07 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.786 ' H ' HD22 ' A' ' 174' ' ' ASN . 0.0 OUTLIER -117.95 89.13 33.33 Favored Pre-proline 0 N--CA 1.47 0.574 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.845 179.478 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.438 ' O ' ' CB ' ' A' ' 176' ' ' SER . 73.6 Cg_endo -76.28 -8.19 18.43 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.844 1.696 . . . . 0.0 111.985 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 175' ' ' PRO . 0.7 OUTLIER 81.34 104.0 0.06 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.514 0.674 . . . . 0.0 111.146 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.504 ' OE1' ' NH1' ' A' ' 179' ' ' ARG . 98.1 mt-10 -90.14 -178.93 5.54 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.834 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.479 ' O ' HG23 ' A' ' 178' ' ' ILE . 18.7 tt -111.25 125.13 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.653 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.504 ' NH1' ' OE1' ' A' ' 177' ' ' GLU . 7.2 mpt_? -122.5 161.43 23.62 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 122.102 0.953 . . . . 0.0 110.889 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -77.79 105.88 9.26 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.157 -1.383 . . . . 0.0 107.979 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -66.95 -13.61 61.98 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.753 -178.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.475 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.4 mm? -63.54 -42.02 98.42 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.062 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.2 -43.44 2.53 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.818 0.342 . . . . 0.0 110.623 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 63.57 24.72 68.12 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.15 156.28 36.1 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.299 0.571 . . . . 0.0 111.179 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.484 HD23 ' N ' ' A' ' 186' ' ' LEU . 0.8 OUTLIER -72.03 176.4 5.11 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.304 179.695 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -104.97 -7.81 19.01 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.915 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -74.34 135.97 42.51 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.912 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -131.87 122.68 26.09 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.011 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.892 0 CA-C-O 117.747 -1.585 . . . . 0.0 110.895 -179.923 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -80.25 147.93 31.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.176 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -63.21 -41.94 99.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.517 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.4 mp -63.11 -42.32 99.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.212 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -61.96 -49.6 75.45 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.001 0.429 . . . . 0.0 110.053 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -58.51 -41.36 85.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.947 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.74 -44.76 96.29 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.588 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.43 -45.29 93.75 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.241 0.544 . . . . 0.0 109.94 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.9 -42.94 98.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.9 -42.43 79.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.156 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.2 -47.48 85.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.149 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.02 -53.21 60.53 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.626 -0.43 . . . . 0.0 112.053 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 14.2 pt -66.75 -38.32 81.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.117 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -58.36 -50.77 72.47 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.168 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 21' ' ' ARG . 92.6 t -62.81 -39.27 84.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.75 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.671 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.3 tt -52.48 -52.2 55.57 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.209 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -76.79 -48.72 17.76 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.223 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -67.14 -29.47 69.2 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.058 0.456 . . . . 0.0 110.837 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 16' ' ' VAL . 96.7 mt-10 56.36 60.52 3.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.564 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.542 ' O ' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -153.65 159.6 42.12 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.302 0.573 . . . . 0.0 110.323 179.164 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 p -76.92 137.97 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.436 -178.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.513 HG22 ' NH2' ' A' ' 21' ' ' ARG . 2.8 pp -124.86 166.79 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-O 120.692 0.282 . . . . 0.0 110.898 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.05 133.86 53.86 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.379 0.609 . . . . 0.0 111.462 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.524 ' CE2' ' O ' ' A' ' 26' ' ' PRO . 3.5 t80 -126.66 138.68 33.0 Favored Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.524 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 64.3 Cg_endo -80.32 150.21 19.72 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 CA-C-N 120.419 1.185 . . . . 0.0 111.588 -178.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.448 ' C ' ' H ' ' A' ' 29' ' ' ALA . 30.2 m -130.14 140.09 50.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.649 0.262 . . . . 0.0 110.451 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -77.6 21.11 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.448 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -154.76 -74.59 0.11 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.124 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.4 p -123.79 127.41 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 121.24 0.543 . . . . 0.0 110.622 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 149' ' ' ARG . 97.4 m-85 -43.37 147.98 0.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.999 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -157.64 -174.72 27.71 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.4 m -131.23 169.38 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.43 178.92 33.55 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 119.946 -1.121 . . . . 0.0 112.656 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.564 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -152.97 -162.84 1.57 Allowed 'General case' 0 C--N 1.341 0.226 0 CA-C-N 115.521 -0.34 . . . . 0.0 110.309 -179.231 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.564 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 2.1 m-20 -101.52 111.12 63.39 Favored Pre-proline 0 CA--C 1.548 0.869 0 CA-C-O 118.802 -0.618 . . . . 0.0 112.622 -178.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 36' ' ' ASP . 22.8 Cg_exo -35.89 170.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.804 2.336 . . . . 0.0 114.413 177.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.8 t70 41.53 73.45 0.13 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.887 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.9 m -151.79 141.99 22.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.084 0.469 . . . . 0.0 110.308 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.644 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -70.43 -30.55 67.44 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.555 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.533 HG23 ' N ' ' A' ' 42' ' ' ALA . 12.6 t -60.09 -42.52 94.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.988 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.533 ' N ' HG23 ' A' ' 41' ' ' THR . . . -58.17 -52.53 65.15 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.345 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.07 -45.33 99.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.137 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 60.6 mtt -67.62 -45.29 75.84 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -65.8 -28.7 69.2 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.634 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 52.7 mt -74.72 -60.95 2.05 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.232 177.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.9 mt -51.63 -23.22 4.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.065 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.49 -85.73 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.723 -178.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.52 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -76.56 -33.66 58.51 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -75.5 -71.16 0.38 Allowed 'General case' 0 C--N 1.346 0.434 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.959 -176.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.406 ' O ' ' CG ' ' A' ' 51' ' ' GLN . 3.8 tt0 53.46 80.62 0.1 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.388 0.613 . . . . 0.0 109.454 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.1 mtt-85 161.07 -63.44 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.215 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.36 -10.4 28.87 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 122.737 2.291 . . . . 0.0 112.175 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.595 HG13 ' N ' ' A' ' 55' ' ' ASP . 7.3 p -44.95 -48.19 2.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.914 -178.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.595 ' N ' HG13 ' A' ' 54' ' ' VAL . 10.9 t0 -68.49 -42.29 78.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.425 -178.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -58.9 -41.96 88.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.398 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 68.97 112.86 0.02 OUTLIER Glycine 0 CA--C 1.518 0.248 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.568 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -49.64 -170.63 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.085 -0.558 . . . . 0.0 112.353 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.3 mt -97.7 148.29 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.1 mt -122.35 142.65 50.28 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 61' ' ' ILE . 8.6 tp -114.45 129.93 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-O 121.176 0.512 . . . . 0.0 110.984 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.601 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -114.11 159.9 19.52 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -124.94 -24.72 4.02 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.553 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 99.2 m-20 -116.76 125.31 51.46 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.287 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -58.46 -13.23 5.02 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -50.23 -33.58 20.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.527 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.553 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 4.3 pm0 -94.83 -11.55 28.64 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.512 HD22 ' N ' ' A' ' 68' ' ' LEU . 3.8 mm? -91.98 -14.6 29.21 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 118.864 0.757 . . . . 0.0 109.192 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.474 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 42.9 tttm -79.6 -38.56 1.26 Allowed Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.766 -178.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 73.6 Cg_endo -103.07 -3.43 0.28 Allowed 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 122.699 2.266 . . . . 0.0 111.836 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -96.53 -10.46 27.25 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.666 -178.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.602 HG22 ' N ' ' A' ' 73' ' ' ASP . 4.7 mp -137.02 164.23 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.602 ' N ' HG22 ' A' ' 72' ' ' ILE . 97.6 m-20 -66.71 160.16 26.26 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -94.85 12.01 29.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.695 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.525 HG23 ' N ' ' A' ' 76' ' ' MET . 10.7 t -72.48 -41.12 66.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.223 0.535 . . . . 0.0 110.067 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.525 ' N ' HG23 ' A' ' 75' ' ' THR . 22.1 ptp -85.15 -18.26 34.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.546 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 tp -95.25 119.36 33.63 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.904 -178.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.473 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -158.03 161.03 38.04 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.303 -177.701 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -38.92 -47.86 1.5 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.837 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.1 p -62.86 -34.13 64.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.757 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 78' ' ' THR . 67.4 tp60 -65.99 -39.54 90.4 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.808 0.337 . . . . 0.0 110.93 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.436 ' HG2' ' H ' ' A' ' 82' ' ' ARG . 6.8 mmt85 -64.4 -52.86 56.07 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 122.581 1.181 . . . . 0.0 109.14 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -55.67 -50.39 70.38 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.126 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 88' ' ' ARG . 3.1 m -60.77 -51.05 70.97 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.926 -178.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 85' ' ' ILE . 10.0 tt -65.91 -36.49 77.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.596 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -67.14 -41.03 86.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.127 178.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.9 m -84.71 -19.02 33.4 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.8 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 84' ' ' THR . 77.8 ttt-85 -103.56 151.52 22.79 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.741 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -34.38 152.62 0.05 OUTLIER Pre-proline 0 N--CA 1.469 0.484 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.188 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.12 -17.93 55.62 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.132 1.888 . . . . 0.0 110.991 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.455 ' H ' ' HD3' ' A' ' 92' ' ' PRO . . . 99.19 69.32 0.92 Allowed Glycine 0 CA--C 1.529 0.967 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.779 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.455 ' HD3' ' H ' ' A' ' 91' ' ' GLY . 52.8 Cg_exo -54.54 -39.35 88.65 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.865 2.377 . . . . 0.0 111.493 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.425 HG13 ' CE2' ' A' ' 95' ' ' PHE . 3.2 p -78.59 147.84 6.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.328 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 85.5 m -88.11 143.62 26.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.731 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.449 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 61.6 m-85 -127.01 140.35 52.37 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.661 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.649 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 3.4 t -93.86 101.77 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-O 121.474 0.654 . . . . 0.0 109.633 178.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -91.81 151.31 42.06 Favored Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.882 -177.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.82 142.19 56.69 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.764 1.643 . . . . 0.0 110.309 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -114.95 116.54 42.64 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.397 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -45.59 167.4 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 121.6 1.533 . . . . 0.0 112.623 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.49 -25.04 45.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.484 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.1 p -66.1 -33.16 75.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.473 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.495 ' O ' ' O ' ' A' ' 104' ' ' PRO . 0.9 OUTLIER -69.85 160.15 81.24 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.468 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.495 ' O ' ' O ' ' A' ' 103' ' ' THR . 84.4 Cg_exo -47.55 -158.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.251 0 C-N-CA 122.724 2.283 . . . . 0.0 113.851 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.492 ' NH1' ' OD1' ' A' ' 112' ' ' ASP . 11.4 tpp180 -168.51 -4.97 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.475 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 6.1 p90 -84.5 -9.4 58.38 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.632 ' H ' ' CD2' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -77.57 -17.65 57.67 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.678 -179.639 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.543 ' C ' ' H ' ' A' ' 110' ' ' ARG . 26.6 m -144.75 -43.85 0.24 Allowed 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.827 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 50.42 -1.87 0.01 OUTLIER Glycine 0 CA--C 1.541 1.688 0 CA-C-O 119.726 -0.485 . . . . 0.0 113.339 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.543 ' H ' ' C ' ' A' ' 108' ' ' THR . 0.5 OUTLIER -88.15 -54.87 4.0 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 117.947 0.873 . . . . 0.0 109.552 179.741 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.613 ' CG ' ' N ' ' A' ' 112' ' ' ASP . 85.4 t80 -154.51 173.72 15.9 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.417 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.613 ' N ' ' CG ' ' A' ' 111' ' ' PHE . 89.8 m-20 -79.12 50.92 1.1 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.372 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 82.1 p -158.52 160.04 36.24 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.457 ' C ' HG13 ' A' ' 96' ' ' VAL . 2.3 pp -167.13 140.02 3.51 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.87 112.21 4.17 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 113.437 -1.71 . . . . 0.0 110.75 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.499 HG22 ' N ' ' A' ' 117' ' ' ARG . 6.1 p -143.97 160.42 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.499 ' N ' HG22 ' A' ' 116' ' ' VAL . 14.8 ptt180 -155.99 162.16 40.38 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.949 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.601 HG22 ' HB3' ' A' ' 62' ' ' ALA . 54.7 t -121.24 138.82 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.543 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 7.9 t -132.62 150.43 52.16 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.957 0.408 . . . . 0.0 110.103 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.401 ' O ' ' OD1' ' A' ' 120' ' ' ASP . 30.6 p30 -150.4 81.1 1.36 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.324 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.605 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 61.7 t60 -171.81 -37.79 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.605 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 38.7 Cg_endo -95.49 -163.62 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 121.941 1.761 . . . . 0.0 112.3 -178.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.6 mt -78.54 -4.09 46.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.89 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 83.3 t -57.62 -45.96 86.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.648 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.756 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.1 m -52.96 -62.18 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.87 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.756 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.33 -43.84 2.58 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.243 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.1 tp -69.49 -48.07 61.85 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.954 0.406 . . . . 0.0 110.99 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 82.1 m -70.0 -48.96 55.98 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.408 0.623 . . . . 0.0 110.915 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.47 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.0 OUTLIER -55.24 -41.61 72.36 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.423 179.428 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.94 -54.42 47.36 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.383 -1.281 . . . . 0.0 109.605 -177.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.402 ' CE1' ' OD2' ' A' ' 36' ' ' ASP . 42.8 t80 -62.05 -21.47 64.95 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.983 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 81.43 -0.11 88.3 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 134' ' ' PRO . 24.7 mttp -152.37 159.14 33.12 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.004 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 133' ' ' LYS . 6.1 Cg_exo -41.61 179.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 123.838 3.026 . . . . 0.0 113.75 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.0 tp -134.58 123.73 24.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 113.443 -1.708 . . . . 0.0 106.578 177.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.43 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.9 OUTLIER -66.06 146.42 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 C-N-CA 117.684 -1.606 . . . . 0.0 107.327 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.0 t -118.3 129.25 55.35 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.249 0.547 . . . . 0.0 110.894 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.3 m -129.06 162.31 27.97 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.085 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 17.8 m -72.02 147.99 46.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.246 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.618 ' HB1' ' H ' ' A' ' 148' ' ' CYS . . . -63.63 -37.44 87.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.913 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.45 ' C ' HD22 ' A' ' 141' ' ' ASN . 0.1 OUTLIER -54.31 157.38 2.76 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.594 0.711 . . . . 0.0 111.256 -179.445 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.74 -158.31 0.88 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.103 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.6 t -60.33 -44.08 95.81 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.382 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -165.97 12.43 0.07 OUTLIER Glycine 0 N--CA 1.46 0.264 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.3 tp -90.24 127.64 52.47 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -39.47 153.74 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 121.702 1.602 . . . . 0.0 112.22 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.29 157.43 41.57 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.431 2.088 . . . . 0.0 112.373 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.618 ' H ' ' HB1' ' A' ' 140' ' ' ALA . 18.7 m -80.37 76.35 7.18 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.534 ' O ' ' CD1' ' A' ' 31' ' ' PHE . 32.9 ptt-85 -55.19 -35.7 65.11 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.93 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.71 169.49 24.52 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.409 ' H ' HG22 ' A' ' 151' ' ' VAL . 1.0 OUTLIER -59.62 -23.82 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.547 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.23 -23.73 67.41 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 177.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 155' ' ' ARG . 5.6 tm-20 -69.56 -78.87 0.06 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.85 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.424 ' O ' ' N ' ' A' ' 158' ' ' PHE . 3.2 p -35.08 -30.66 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.473 0.709 . . . . 0.0 110.564 177.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -72.58 -51.43 19.79 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.083 -179.32 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 153' ' ' GLU . . . -67.32 -20.12 65.56 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.666 1.222 . . . . 0.0 107.793 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -83.09 -44.62 14.94 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 112.403 -2.181 . . . . 0.0 111.808 -178.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.424 ' N ' ' O ' ' A' ' 154' ' ' VAL . 49.4 t80 -130.63 -26.62 2.22 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.816 0.341 . . . . 0.0 111.84 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 92.18 25.74 20.81 Favored Glycine 0 N--CA 1.468 0.813 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -43.67 -96.74 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.498 -0.351 . . . . 0.0 111.189 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . 63.42 33.07 14.05 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -178.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.524 ' C ' ' H ' ' A' ' 164' ' ' VAL . 0.4 OUTLIER -174.24 -61.12 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.497 -179.58 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.83 28.93 0.28 Allowed 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.003 1.802 . . . . 0.0 110.652 177.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.565 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.4 m -130.63 166.91 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.088 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.5 t -121.51 65.68 17.28 Favored Pre-proline 0 N--CA 1.476 0.836 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.869 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.565 ' HD3' HG23 ' A' ' 164' ' ' VAL . 23.1 Cg_exo -35.41 139.07 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 123.628 2.885 . . . . 0.0 115.225 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 169.28 173.7 37.13 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.905 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -158.14 144.83 17.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.957 0.408 . . . . 0.0 110.51 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.9 t -148.09 152.58 37.59 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.656 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -61.64 -74.9 0.34 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 79.99 18.82 71.43 Favored Glycine 0 CA--C 1.517 0.172 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -68.31 -38.65 81.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 113.981 -1.11 . . . . 0.0 111.346 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 44.6 tp -61.66 -46.68 88.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.461 -178.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 42.21 62.92 7.35 Favored Pre-proline 0 N--CA 1.468 0.43 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.531 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' A' ' 176' ' ' SER . 64.0 Cg_endo -71.02 -22.28 26.54 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.388 2.059 . . . . 0.0 113.496 -178.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 175' ' ' PRO . 1.6 m 162.86 147.57 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.386 0.613 . . . . 0.0 110.033 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -102.07 -71.25 0.72 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.982 -178.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 45.4 pt -122.22 143.21 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.933 0.397 . . . . 0.0 111.016 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.407 HH21 ' CB ' ' A' ' 176' ' ' SER . 89.8 mtt180 -137.8 167.52 21.57 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.778 0.799 . . . . 0.0 111.949 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -83.97 106.7 15.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.205 -1.361 . . . . 0.0 110.355 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -65.01 -13.96 59.19 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.071 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.434 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.5 mm? -62.91 -42.0 99.65 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.33 -42.69 3.65 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.265 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 72.44 19.88 79.12 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -71.02 -172.93 0.74 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.13 0.49 . . . . 0.0 110.887 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.544 ' H ' ' CD2' ' A' ' 186' ' ' LEU . 0.8 OUTLIER -80.68 175.71 10.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.722 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -122.77 82.34 1.97 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.205 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -77.94 138.14 38.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.492 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.417 ' O ' ' OE1' ' A' ' 189' ' ' GLN . 0.7 OUTLIER -173.45 -27.98 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.134 177.624 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.73 0 CA-C-O 117.932 -1.482 . . . . 0.0 110.647 179.834 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 56.6 p30 . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -62.42 -41.23 98.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.616 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -63.91 -40.39 96.37 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.289 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.547 HD12 ' N ' ' A' ' 5' ' ' LEU . 9.6 mp -61.68 -42.4 98.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.971 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -63.38 -45.57 90.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.09 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -61.62 -38.11 86.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.994 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.04 -43.6 98.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.686 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.93 -49.23 78.29 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.633 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.9 mm -63.92 -43.19 97.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.537 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.49 -46.7 83.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.705 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.0 -43.61 98.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.41 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.88 -53.24 59.75 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.62 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 12.9 pt -69.5 -38.85 77.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.482 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -58.76 -55.35 36.29 Favored 'General case' 0 C--O 1.214 -0.807 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.338 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 20' ' ' GLU . 91.1 t -61.72 -40.23 86.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.386 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.677 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.3 tt -52.56 -51.26 60.61 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.681 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -79.81 -50.48 10.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.873 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -63.67 -32.71 74.27 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.615 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 16' ' ' VAL . 96.8 mt-10 58.7 82.86 0.13 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.377 0.881 . . . . 0.0 113.377 178.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.28 -141.38 0.05 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.679 0.275 . . . . 0.0 110.488 177.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.0 p -135.13 139.16 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.475 HD12 ' O ' ' A' ' 24' ' ' ALA . 2.8 pp -129.02 164.16 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 120.924 0.392 . . . . 0.0 111.98 -178.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.475 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -64.28 141.88 58.61 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.939 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -145.55 160.81 43.53 Favored Pre-proline 0 CA--C 1.546 0.82 0 CA-C-O 119.047 -0.501 . . . . 0.0 110.522 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.52 157.17 32.46 Favored 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 121.579 1.519 . . . . 0.0 111.442 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.2 m -136.97 155.2 50.02 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.276 0.56 . . . . 0.0 110.538 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -83.78 14.54 3.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.729 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -160.43 -64.93 0.07 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.165 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.9 t -125.49 127.45 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.071 0.463 . . . . 0.0 110.685 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.561 ' CZ ' HG13 ' A' ' 151' ' ' VAL . 35.8 t80 -56.72 131.07 48.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.313 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -141.03 -153.62 6.01 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.5 m -131.57 166.68 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -156.99 -179.95 32.32 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.987 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.406 ' O ' HD12 ' A' ' 135' ' ' LEU . 0.6 OUTLIER -153.68 -179.58 7.93 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -179.667 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 37' ' ' PRO . 36.7 t70 -91.98 110.08 41.56 Favored Pre-proline 0 CA--C 1.552 1.033 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 36' ' ' ASP . 57.0 Cg_exo -36.79 173.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 123.039 2.493 . . . . 0.0 114.517 177.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 49.01 64.64 1.64 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.861 -1.518 . . . . 0.0 111.216 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 65.2 m -147.2 138.03 23.65 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.043 0.449 . . . . 0.0 110.405 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.46 -35.95 73.62 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.531 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 41' ' ' THR . 0.3 OUTLIER -64.06 -42.59 96.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.463 -179.068 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.92 75.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.643 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 p -62.4 -44.91 99.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.277 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 90.0 mtp -64.01 -40.84 97.26 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 27.8 ttt-85 -61.4 -41.52 97.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.448 ' O ' HD23 ' A' ' 46' ' ' LEU . 1.0 OUTLIER -64.41 -54.3 34.92 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.595 -178.236 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.4 mt -69.74 -12.12 61.38 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.246 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -69.03 -82.54 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.149 0.5 . . . . 0.0 111.133 -177.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -76.21 -35.1 59.22 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -178.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -76.45 -50.41 14.14 Favored 'General case' 0 C--N 1.344 0.358 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.901 -177.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 35.52 65.5 0.4 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.995 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.415 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 6.7 mtm-85 178.49 -52.85 0.0 OUTLIER Pre-proline 0 CA--C 1.551 0.986 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.644 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.415 ' HD2' ' H ' ' A' ' 52' ' ' ARG . 91.1 Cg_endo -79.25 -4.28 13.65 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.875 2.384 . . . . 0.0 112.537 -178.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.602 HG13 ' N ' ' A' ' 55' ' ' ASP . 10.9 p -47.35 -44.76 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.111 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.602 ' N ' HG13 ' A' ' 54' ' ' VAL . 41.3 t0 -66.47 -40.44 89.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.445 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -60.69 -38.04 83.66 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 64.89 107.27 0.01 OUTLIER Glycine 0 CA--C 1.518 0.264 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 179.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.567 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -52.34 -163.32 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.022 0.439 . . . . 0.0 111.673 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.449 ' O ' ' OG ' ' A' ' 137' ' ' SER . 73.6 mt -109.07 135.16 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.3 mt -109.79 142.12 41.48 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.478 ' O ' HG23 ' A' ' 61' ' ' ILE . 9.3 tp -110.21 123.93 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-O 121.033 0.444 . . . . 0.0 111.304 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.507 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -113.99 157.15 22.84 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.499 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -122.97 -24.51 4.75 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.453 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -115.88 130.66 56.92 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.73 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -63.99 -13.03 43.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.752 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -50.57 -30.36 13.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.622 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -96.06 -15.87 21.94 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.546 HD22 ' N ' ' A' ' 68' ' ' LEU . 3.9 mm? -92.11 -15.32 27.88 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.666 -0.646 . . . . 0.0 109.329 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.474 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 35.4 tttp -80.53 -38.52 1.08 Allowed Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.693 -178.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 66.0 Cg_endo -103.55 -2.77 0.27 Allowed 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 122.663 2.242 . . . . 0.0 111.896 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.471 ' OH ' HD21 ' A' ' 114' ' ' LEU . 60.7 t80 -97.89 -9.46 26.29 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.032 -178.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.543 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.3 mp -131.86 159.38 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.543 ' N ' HG22 ' A' ' 72' ' ' ILE . 95.8 m-20 -65.56 158.57 26.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.968 0.413 . . . . 0.0 110.389 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 74' ' ' ASP . 37.1 p-10 -93.72 9.35 37.37 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.882 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.469 HG23 ' N ' ' A' ' 76' ' ' MET . 13.6 t -75.85 -39.16 57.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.131 0.491 . . . . 0.0 110.538 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.469 ' N ' HG23 ' A' ' 75' ' ' THR . 20.9 ptp -96.9 -15.28 21.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.257 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.7 tp -100.21 125.68 46.4 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.436 0.636 . . . . 0.0 111.331 -177.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.476 ' OG1' ' N ' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -148.76 178.46 8.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.984 -178.143 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.476 ' N ' ' OG1' ' A' ' 78' ' ' THR . 98.2 m-20 -59.97 -42.49 94.27 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 123.233 0.333 . . . . 0.0 111.082 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.6 p -61.05 -31.23 49.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.533 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -62.74 -41.61 99.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.391 0.615 . . . . 0.0 109.939 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.407 ' HG2' ' H ' ' A' ' 82' ' ' ARG . 12.6 mmt85 -65.46 -53.77 38.0 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 122.379 1.085 . . . . 0.0 109.821 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 87' ' ' SER . 82.0 tt0 -53.74 -50.34 66.18 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.317 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.1 m -62.39 -49.8 74.08 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.576 -1.193 . . . . 0.0 112.138 -177.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 89' ' ' TRP . 8.4 tt -68.54 -26.2 32.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.484 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -87.82 -22.52 24.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.932 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 83' ' ' GLU . 68.4 m -107.17 -56.07 2.25 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.573 ' O ' ' CG ' ' A' ' 89' ' ' TRP . 78.7 ttt-85 -61.61 -45.79 92.58 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.474 -178.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.573 ' CG ' ' O ' ' A' ' 88' ' ' ARG . 1.1 m0 174.72 154.37 0.31 Allowed Pre-proline 0 N--CA 1.47 0.532 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -68.71 -16.99 42.62 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.319 2.013 . . . . 0.0 111.452 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.452 ' H ' ' HD3' ' A' ' 92' ' ' PRO . . . 97.14 69.24 0.98 Allowed Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.452 ' HD3' ' H ' ' A' ' 91' ' ' GLY . 52.1 Cg_exo -54.98 -37.25 93.71 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.478 2.119 . . . . 0.0 111.38 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.1 p -77.98 144.4 11.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.536 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 27.2 m -93.57 143.57 26.18 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.385 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.42 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 63.5 m-85 -127.39 145.09 50.93 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.436 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.608 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.9 t -96.57 103.51 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 121.545 0.688 . . . . 0.0 110.145 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -89.39 148.0 39.47 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.55 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -77.76 111.59 3.15 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.93 1.753 . . . . 0.0 111.278 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.47 148.26 90.44 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.421 ' O ' ' OG1' ' A' ' 103' ' ' THR . 38.6 Cg_endo -63.94 146.4 91.33 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.901 1.734 . . . . 0.0 112.272 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.47 -35.7 81.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.67 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 76.3 p -56.04 -41.37 74.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.52 -179.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.487 ' O ' ' O ' ' A' ' 104' ' ' PRO . 3.4 p -63.74 156.11 73.79 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 120.399 -0.521 . . . . 0.0 109.938 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' A' ' 103' ' ' THR . 73.9 Cg_exo -47.32 -156.41 0.0 OUTLIER 'Trans proline' 0 N--CA 1.505 2.161 0 C-N-CA 122.812 2.341 . . . . 0.0 114.245 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.527 ' NH2' ' O ' ' A' ' 110' ' ' ARG . 4.1 tpt180 -136.16 -1.11 2.42 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.198 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -75.0 -1.24 21.78 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.011 0.434 . . . . 0.0 110.895 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.934 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -86.56 -17.9 32.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.669 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.633 ' N ' HD22 ' A' ' 107' ' ' LEU . 95.2 m -142.01 -39.99 0.36 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.374 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 74.83 18.95 80.11 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.361 179.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.527 ' O ' ' NH2' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -158.35 -74.1 0.08 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 117.313 0.557 . . . . 0.0 110.434 179.433 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -102.78 -173.68 2.38 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.26 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 49.1 p30 -115.38 57.88 0.73 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.786 0.327 . . . . 0.0 111.051 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.0 p -159.03 159.52 34.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.32 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.769 ' O ' HD12 ' A' ' 114' ' ' LEU . 4.6 pp -166.15 142.54 5.02 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.401 ' N ' HG13 ' A' ' 96' ' ' VAL . . . -68.8 121.48 16.61 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 113.349 -1.751 . . . . 0.0 109.276 177.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.433 HG22 ' N ' ' A' ' 117' ' ' ARG . 4.9 p -142.36 157.15 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.433 ' N ' HG22 ' A' ' 116' ' ' VAL . 62.1 ttp180 -146.48 149.83 34.42 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.157 0.503 . . . . 0.0 111.46 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.507 HG22 ' HB3' ' A' ' 62' ' ' ALA . 61.5 t -115.05 134.28 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.3 t -129.87 151.09 50.82 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.025 0.441 . . . . 0.0 110.924 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 49.9 p-10 -151.87 85.57 1.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.196 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.62 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 9.2 t60 -171.67 -38.03 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.62 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 74.2 Cg_endo -97.49 -159.45 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.931 0 C-N-CA 122.45 2.1 . . . . 0.0 112.318 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 32.5 mt -79.71 -4.99 54.27 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.343 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 74.2 t -57.08 -46.13 84.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.777 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.75 HG23 ' H ' ' A' ' 126' ' ' ALA . 30.2 m -55.24 -61.49 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.302 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.024 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.75 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -40.44 -47.09 2.55 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.844 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.695 HD13 ' C ' ' A' ' 127' ' ' LEU . 2.8 tm? -69.82 -47.28 63.36 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.571 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 85.3 m -68.71 -47.3 66.71 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.103 0.477 . . . . 0.0 111.296 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.462 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.3 pp0? -55.63 -43.06 75.81 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.462 ' N ' ' HG3' ' A' ' 129' ' ' GLN . . . -59.48 -56.09 26.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.311 -177.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -63.16 -35.66 81.03 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.128 -1.397 . . . . 0.0 108.346 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 89.96 3.32 73.6 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 113.388 -1.733 . . . . 0.0 109.684 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -141.79 153.77 64.98 Favored Pre-proline 0 CA--C 1.552 1.043 0 CA-C-N 117.258 0.529 . . . . 0.0 111.21 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -48.46 -174.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 123.724 2.949 . . . . 0.0 113.969 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.406 HD12 ' O ' ' A' ' 35' ' ' CYS . 8.1 tp -140.8 125.36 17.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 113.02 -1.9 . . . . 0.0 106.31 177.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.428 HG13 ' H ' ' A' ' 136' ' ' VAL . 0.9 OUTLIER -64.67 142.93 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 C-N-CA 118.179 -1.408 . . . . 0.0 108.931 -179.494 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 59' ' ' ILE . 0.8 OUTLIER -108.96 121.1 44.42 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 123.762 0.664 . . . . 0.0 110.583 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 18.7 m -132.18 145.47 51.37 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.9 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.1 m -66.7 144.12 56.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.529 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.11 88.57 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -162.23 164.33 27.75 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.275 0.56 . . . . 0.0 110.589 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.8 -163.85 1.82 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.173 -178.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 80.2 p -63.54 -40.41 96.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.752 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -159.35 0.81 0.09 OUTLIER Glycine 0 N--CA 1.461 0.332 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.488 HD13 ' C ' ' A' ' 145' ' ' LEU . 1.2 tm? -79.24 111.83 23.49 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 145' ' ' LEU . 14.3 Cg_exo -33.59 155.23 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.213 1.942 . . . . 0.0 113.095 -179.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.51 -168.79 0.37 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.513 2.142 . . . . 0.0 112.555 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 15.3 m -129.81 82.37 2.07 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.477 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 52.2 ptt85 -52.25 -37.49 55.46 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.362 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.28 173.63 14.74 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.561 HG13 ' CZ ' ' A' ' 31' ' ' PHE . 1.2 m -58.81 -23.92 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 CA-C-O 121.567 0.699 . . . . 0.0 109.386 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -64.73 -27.27 68.79 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 155' ' ' ARG . 0.0 OUTLIER -68.99 -79.52 0.06 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.449 179.194 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.405 HG13 ' N ' ' A' ' 155' ' ' ARG . 7.7 p -34.67 -30.23 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.607 0.763 . . . . 0.0 110.418 178.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 159' ' ' GLY . 4.8 tmt_? -71.9 -52.89 15.07 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.082 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 153' ' ' GLU . . . -69.93 -18.37 63.37 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 122.493 1.14 . . . . 0.0 108.186 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -84.16 -44.69 13.73 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 112.87 -1.968 . . . . 0.0 111.578 -178.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -130.37 -24.88 2.49 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 91.03 23.95 28.54 Favored Glycine 0 N--CA 1.47 0.948 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 -178.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -43.9 -93.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.584 -0.308 . . . . 0.0 111.091 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . 60.06 31.11 20.47 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.531 ' C ' ' H ' ' A' ' 164' ' ' VAL . 0.5 OUTLIER -170.19 -61.38 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.903 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -72.85 29.5 0.29 Allowed 'Trans proline' 0 N--CA 1.502 1.99 0 C-N-CA 122.283 1.989 . . . . 0.0 110.515 177.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.577 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.7 m -132.44 167.0 27.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.64 -178.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.1 t -123.63 66.86 37.69 Favored Pre-proline 0 N--CA 1.476 0.871 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.65 178.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.577 ' HD3' HG23 ' A' ' 164' ' ' VAL . 29.8 Cg_exo -38.45 147.22 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 123.693 2.929 . . . . 0.0 115.015 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 168.49 134.28 1.7 Allowed Glycine 0 CA--C 1.528 0.849 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.2 178.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -80.92 152.12 28.23 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.5 t -145.55 148.35 33.09 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.125 0.488 . . . . 0.0 111.222 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -54.81 -66.87 2.52 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 173' ' ' LEU . . . 93.54 6.88 62.2 Favored Glycine 0 N--CA 1.466 0.661 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -76.97 26.19 0.14 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.818 -0.691 . . . . 0.0 110.903 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.583 ' N ' HD12 ' A' ' 173' ' ' LEU . 9.2 mp 53.32 -166.98 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -138.16 150.21 66.23 Favored Pre-proline 0 N--CA 1.469 0.503 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.57 -15.8 41.87 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.085 1.856 . . . . 0.0 111.82 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 27.6 p -155.04 155.94 35.02 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.087 0.47 . . . . 0.0 110.09 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.7 ' H ' ' NH1' ' A' ' 179' ' ' ARG . 96.2 mt-10 -128.72 -95.57 0.41 Allowed 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.569 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.7 pt -101.04 130.35 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 120.978 0.418 . . . . 0.0 110.337 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.7 ' NH1' ' H ' ' A' ' 177' ' ' GLU . 7.6 mpt_? -123.44 163.3 21.13 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.601 0.715 . . . . 0.0 110.26 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -77.95 104.43 8.51 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.513 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -63.95 -17.66 63.49 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.879 -178.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.467 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.4 mm? -62.5 -42.26 99.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.947 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.53 -41.54 8.12 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 60.74 25.44 63.62 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -54.3 128.64 32.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.054 0.454 . . . . 0.0 110.572 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.635 ' H ' ' CD2' ' A' ' 186' ' ' LEU . 0.7 OUTLIER -97.5 178.49 5.17 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.609 -179.792 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -87.95 -33.64 18.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.657 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -70.73 141.44 51.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.701 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -138.04 -24.5 1.0 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.825 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.739 0 CA-C-O 118.073 -1.404 . . . . 0.0 110.873 179.756 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 55.0 p30 -99.57 11.05 40.22 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.921 0.391 . . . . 0.0 110.565 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -63.9 -40.94 97.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.501 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.538 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.3 mp -62.19 -42.59 99.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.164 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -65.03 -41.49 95.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.708 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -64.51 -42.54 95.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.075 0.465 . . . . 0.0 110.758 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.432 ' OD2' ' O ' ' A' ' 164' ' ' VAL . 66.1 t0 -65.78 -45.78 81.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.332 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.54 -48.75 73.92 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.456 HG23 ' N ' ' A' ' 11' ' ' ALA . 19.3 tt -67.35 -41.75 86.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.177 0.513 . . . . 0.0 110.761 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.456 ' N ' HG23 ' A' ' 10' ' ' ILE . . . -61.53 -40.9 96.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.754 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.95 -46.41 74.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.956 0.408 . . . . 0.0 110.525 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.78 -50.57 70.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.229 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.3 pp -68.92 -38.85 79.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.346 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.35 -54.52 45.84 Favored 'General case' 0 C--O 1.216 -0.71 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.264 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.426 ' O ' ' N ' ' A' ' 20' ' ' GLU . 99.5 t -60.54 -40.1 83.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.606 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.697 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.2 tt -52.41 -49.92 63.55 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.846 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -82.17 -51.2 8.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.614 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -63.65 -33.64 76.07 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.282 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.5 mt-10 58.16 83.26 0.12 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.451 179.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.4 -145.96 0.15 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.405 178.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.2 p -133.33 140.31 47.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -128.19 165.46 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-O 120.859 0.362 . . . . 0.0 111.531 -178.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.47 127.14 30.24 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.633 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.474 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 0.6 OUTLIER -117.09 140.49 27.15 Favored Pre-proline 0 N--CA 1.473 0.721 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.741 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.474 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 93.3 Cg_endo -77.3 144.06 22.81 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.242 1.295 . . . . 0.0 111.651 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.8 m -137.66 134.43 35.43 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.433 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -53.38 -44.85 68.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.167 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.94 -81.33 0.07 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.632 0.253 . . . . 0.0 111.444 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 71.8 t -133.32 128.69 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -36.77 144.67 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.773 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -141.17 -163.93 9.74 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.9 m -130.67 168.72 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -160.18 -179.34 34.9 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 119.963 -1.113 . . . . 0.0 112.297 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -157.97 -168.2 2.44 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.975 -179.242 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 19.9 p-10 -93.24 108.7 35.07 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 36' ' ' ASP . 33.7 Cg_exo -36.86 172.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.972 2.448 . . . . 0.0 114.574 177.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 41.76 73.32 0.13 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.231 -1.349 . . . . 0.0 111.124 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.1 m -153.39 134.34 13.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.608 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -67.69 -34.16 76.34 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.811 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.574 HG23 ' N ' ' A' ' 42' ' ' ALA . 15.1 t -63.34 -46.49 86.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.996 -178.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.574 ' N ' HG23 ' A' ' 41' ' ' THR . . . -60.12 -50.43 73.74 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.538 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 p -62.04 -45.23 99.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.831 0.348 . . . . 0.0 110.279 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 61.7 mtt -64.36 -39.53 94.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.865 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 -60.91 -34.25 74.39 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 123.537 0.523 . . . . 0.0 109.831 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 82.2 mt -73.56 -60.39 2.27 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.2 mt -54.77 -18.02 4.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.678 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -67.85 -84.67 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.901 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -75.86 -33.06 59.99 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.581 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -76.1 -69.69 0.49 Allowed 'General case' 0 C--N 1.348 0.525 0 C-N-CA 119.421 -0.911 . . . . 0.0 110.382 -177.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 50.89 80.27 0.08 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.706 0.765 . . . . 0.0 109.201 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.7 mtm180 162.87 -62.71 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.271 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.14 -15.51 48.72 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.423 2.082 . . . . 0.0 112.455 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.612 HG13 ' N ' ' A' ' 55' ' ' ASP . 10.9 p -41.79 -49.31 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.72 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.612 ' N ' HG13 ' A' ' 54' ' ' VAL . 37.0 t0 -65.38 -41.87 93.28 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.029 0.443 . . . . 0.0 110.935 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -59.89 -37.06 78.29 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.392 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 63.32 107.8 0.01 OUTLIER Glycine 0 CA--C 1.519 0.284 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.566 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -52.92 -162.46 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.216 0.531 . . . . 0.0 111.661 -179.449 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.7 mt -108.17 146.95 13.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.7 mt -119.62 139.29 52.42 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.8 tp -110.28 133.08 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-O 121.133 0.492 . . . . 0.0 110.917 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.403 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -121.73 152.43 39.43 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.469 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.65 -29.6 7.95 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -111.29 149.8 30.56 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.233 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -79.26 -14.11 59.24 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -53.01 -30.83 37.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.961 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.02 -12.05 27.32 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.59 HD22 ' N ' ' A' ' 68' ' ' LEU . 3.3 mm? -92.57 -16.25 25.93 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.002 0.819 . . . . 0.0 108.97 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.467 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 50.9 tttm -77.71 -38.83 1.82 Allowed Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.671 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 67.1 Cg_endo -104.73 -2.64 0.2 Allowed 'Trans proline' 0 C--N 1.318 -1.03 0 C-N-CA 122.835 2.356 . . . . 0.0 112.648 -178.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -97.78 -8.46 28.45 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.749 0.309 . . . . 0.0 110.791 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.611 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.3 mp -135.75 162.97 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.611 ' N ' HG22 ' A' ' 72' ' ' ILE . 92.6 m-20 -64.78 156.65 29.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.628 -0.429 . . . . 0.0 109.857 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -94.29 8.48 41.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.76 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.528 HG23 ' N ' ' A' ' 76' ' ' MET . 14.9 t -73.58 -41.73 62.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.181 0.515 . . . . 0.0 110.568 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.528 ' N ' HG23 ' A' ' 75' ' ' THR . 21.7 ptp -90.12 -7.37 53.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.095 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 tp -102.0 120.41 40.37 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.097 0.475 . . . . 0.0 110.746 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -159.12 160.68 35.91 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.576 -177.828 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -39.13 -48.17 1.67 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.789 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.3 p -62.96 -33.19 59.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.852 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 78' ' ' THR . 63.6 tp60 -65.49 -39.66 92.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.974 0.416 . . . . 0.0 110.764 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.1 mmt85 -65.07 -52.14 57.4 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 122.523 1.154 . . . . 0.0 109.181 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -55.35 -50.5 69.51 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 113.702 -1.59 . . . . 0.0 110.235 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.1 m -61.19 -49.92 75.24 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.167 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 85' ' ' ILE . 9.0 tt -67.98 -34.07 64.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.202 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -75.66 -39.36 57.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.865 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.5 m -77.4 -32.46 54.82 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 120.991 0.424 . . . . 0.0 110.955 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 89' ' ' TRP . 76.1 ttt180 -97.14 75.93 2.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.389 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.435 ' O ' ' O ' ' A' ' 88' ' ' ARG . 57.7 m95 56.19 150.19 0.06 OUTLIER Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.244 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.77 -19.84 35.53 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.277 1.985 . . . . 0.0 111.738 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 163.11 82.03 0.04 OUTLIER Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -80.84 -30.91 1.58 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.352 2.035 . . . . 0.0 112.169 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.532 ' O ' ' CE1' ' A' ' 95' ' ' PHE . 9.4 p -136.76 149.14 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.738 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 91.8 m -91.59 143.16 26.86 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.627 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.543 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 0.2 OUTLIER -125.5 147.01 49.4 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.207 179.24 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.617 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 3.0 t -99.6 107.84 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 121.376 0.607 . . . . 0.0 109.394 178.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.402 ' CE1' ' HB1' ' A' ' 181' ' ' ALA . 58.8 m-85 -94.53 151.17 39.08 Favored Pre-proline 0 N--CA 1.47 0.552 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.734 -178.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.11 106.44 2.27 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 121.695 1.597 . . . . 0.0 110.403 178.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.81 150.1 83.34 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.02 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 101' ' ' ALA . 98.9 Cg_endo -73.07 157.49 50.74 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.379 2.053 . . . . 0.0 112.986 -178.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.438 ' O ' ' O ' ' A' ' 100' ' ' PRO . . . 57.27 126.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.627 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.6 p -99.46 -5.26 29.7 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.569 ' N ' ' CD ' ' A' ' 104' ' ' PRO . 0.2 OUTLIER -55.79 -42.56 96.73 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.145 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 103' ' ' THR . 37.5 Cg_endo -90.01 177.63 2.45 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.742 2.295 . . . . 0.0 111.154 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.523 ' O ' ' N ' ' A' ' 109' ' ' GLY . 11.6 tpp180 -159.92 5.03 0.08 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.679 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 61.7 p-90 -73.6 -10.75 60.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.929 0.395 . . . . 0.0 110.434 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.952 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -85.99 -16.56 37.9 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.115 -179.766 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.623 ' N ' HD22 ' A' ' 107' ' ' LEU . 98.9 m -141.9 -39.53 0.37 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.724 0.297 . . . . 0.0 110.8 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 82.31 13.86 77.84 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.66 -68.83 0.06 Allowed 'General case' 0 CA--C 1.535 0.366 0 O-C-N 122.444 -0.445 . . . . 0.0 110.166 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -103.58 -162.47 0.91 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.967 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.9 p-10 -127.64 62.29 1.39 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.026 0.441 . . . . 0.0 110.957 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.2 p -158.77 157.47 31.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.015 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.514 ' O ' HD12 ' A' ' 114' ' ' LEU . 0.3 OUTLIER -160.41 140.9 11.66 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -179.258 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.431 ' N ' HG13 ' A' ' 96' ' ' VAL . . . -70.58 126.93 31.01 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 113.094 -1.867 . . . . 0.0 109.702 177.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.4 p -146.02 152.83 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -147.81 156.94 43.25 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.783 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.403 HG22 ' HB3' ' A' ' 62' ' ' ALA . 54.7 t -119.74 132.32 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.432 ' O ' HG23 ' A' ' 119' ' ' THR . 11.3 t -133.27 128.36 35.66 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.734 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -135.82 84.1 2.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.925 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.66 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 16.6 t-80 -173.2 -35.63 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.58 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.66 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 67.7 Cg_endo -94.74 -159.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.935 0 C-N-CA 121.995 1.797 . . . . 0.0 111.907 -178.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 36.7 mt -77.69 -7.38 56.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.535 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 95.7 t -57.46 -45.27 85.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.716 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.752 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.9 m -51.63 -62.05 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.943 0 C-N-CA 119.555 -0.858 . . . . 0.0 108.797 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.752 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.34 -44.81 2.86 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.792 0.329 . . . . 0.0 110.809 178.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.441 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -66.33 -50.96 61.83 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 121.27 0.557 . . . . 0.0 110.723 179.461 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 62.3 m -69.64 -48.46 59.82 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.326 0.584 . . . . 0.0 111.558 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.457 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 0.8 OUTLIER -54.58 -42.38 70.96 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.451 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -59.28 -55.5 34.02 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.583 -177.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -62.62 -24.71 67.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.191 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.69 2.07 88.85 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 134' ' ' PRO . 59.7 mttt -153.53 159.54 32.0 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 133' ' ' LYS . 3.6 Cg_exo -42.23 177.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 123.876 3.051 . . . . 0.0 113.008 -178.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 8.3 tp -132.38 122.42 24.99 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.417 HG13 ' H ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -64.14 147.47 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 C-N-CA 117.775 -1.57 . . . . 0.0 106.83 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.9 t -122.54 127.26 49.27 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.206 0.527 . . . . 0.0 111.269 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.9 162.18 30.22 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.663 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.6 m -73.59 145.95 45.06 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.95 88.28 2.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.367 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 56.8 p30 -160.74 164.39 31.61 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.342 0.592 . . . . 0.0 110.421 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.57 -167.15 2.13 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.991 -178.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.1 p -61.77 -40.19 94.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.785 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -162.18 9.81 0.1 Allowed Glycine 0 N--CA 1.459 0.216 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.6 tp -89.99 126.88 55.83 Favored Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -37.52 157.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.942 1.761 . . . . 0.0 112.516 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.0 -166.45 0.37 Allowed 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.578 2.186 . . . . 0.0 112.668 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 7.4 t -118.14 76.7 1.09 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.359 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -56.47 -33.89 66.38 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.389 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -162.72 169.56 19.81 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.104 -0.639 . . . . 0.0 109.319 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.433 ' H ' HG22 ' A' ' 151' ' ' VAL . 0.9 OUTLIER -58.6 -20.33 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.285 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -65.21 -33.05 75.09 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 177.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.447 ' O ' ' N ' ' A' ' 155' ' ' ARG . 6.5 tm-20 -63.72 -79.78 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.804 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.431 HG11 HG11 ' A' ' 164' ' ' VAL . 7.3 p -36.11 -30.42 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.589 0.756 . . . . 0.0 110.643 178.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.447 ' N ' ' O ' ' A' ' 153' ' ' GLU . 4.1 tmt_? -71.77 -49.17 41.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.243 0.544 . . . . 0.0 111.79 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 153' ' ' GLU . . . -71.45 -18.1 62.33 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 122.628 1.204 . . . . 0.0 108.004 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.17 -55.27 4.45 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 112.349 -2.205 . . . . 0.0 112.149 -177.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -123.99 -18.05 6.07 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -177.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 85.18 25.05 41.62 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -42.3 -94.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.649 0.262 . . . . 0.0 111.437 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.405 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.95 33.83 17.14 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.365 0.602 . . . . 0.0 109.46 -178.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.519 ' C ' ' H ' ' A' ' 164' ' ' VAL . 1.8 m-85 -172.42 -62.56 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.353 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.39 28.51 0.27 Allowed 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 122.438 2.092 . . . . 0.0 110.579 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.545 HG23 ' HD3' ' A' ' 166' ' ' PRO . 15.8 m -131.52 167.93 25.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.79 -178.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.0 t -124.12 64.6 35.99 Favored Pre-proline 0 N--CA 1.473 0.724 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.055 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.545 ' HD3' HG23 ' A' ' 164' ' ' VAL . 42.6 Cg_exo -39.95 149.23 0.13 Allowed 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 123.453 2.769 . . . . 0.0 114.616 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 172.47 -141.18 6.11 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 114.33 -1.305 . . . . 0.0 111.813 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -147.79 179.88 7.39 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.752 0.311 . . . . 0.0 110.195 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.3 t -144.83 158.21 43.88 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.106 0.479 . . . . 0.0 110.631 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 167.37 62.74 0.03 OUTLIER Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -161.7 89.78 0.11 Allowed Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -136.5 88.48 2.38 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.755 0.312 . . . . 0.0 111.013 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.542 HD22 ' N ' ' A' ' 173' ' ' LEU . 2.9 mm? -82.94 -112.35 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.257 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -85.36 149.82 53.01 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.398 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.92 157.68 54.31 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.089 1.86 . . . . 0.0 112.049 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.4 m 68.69 97.31 0.06 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.643 0.735 . . . . 0.0 110.693 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -84.81 -15.52 44.55 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.482 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 31.9 pt -91.72 135.56 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.401 0.619 . . . . 0.0 111.26 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -135.28 171.74 14.0 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.254 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 184' ' ' GLY . 98.6 m-20 -78.76 104.54 9.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.227 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.617 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -65.18 -20.23 66.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.573 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.508 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.5 mm? -63.77 -42.67 97.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.486 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.18 -44.3 3.02 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.49 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 180' ' ' ASP . . . 66.28 25.14 72.34 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -69.52 -178.71 1.49 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.088 0.471 . . . . 0.0 110.763 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.468 ' H ' ' CD2' ' A' ' 186' ' ' LEU . 0.8 OUTLIER -81.33 177.23 9.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.53 -179.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -87.57 -39.29 15.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.564 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.5 138.78 51.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.716 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -149.05 -26.19 0.3 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.122 0.487 . . . . 0.0 110.359 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.71 0 CA-C-O 117.95 -1.472 . . . . 0.0 110.883 -179.652 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -63.54 -40.62 97.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.274 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 39.2 p-10 -155.1 7.66 0.27 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.576 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.529 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.1 mp -62.4 -42.17 99.22 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -63.67 -42.32 98.08 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -63.08 -41.68 99.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.771 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 162' ' ' PHE . 63.6 t0 -59.09 -46.99 86.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.498 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.34 -44.39 97.27 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.191 0.519 . . . . 0.0 110.082 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.7 mt -63.56 -42.97 97.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.469 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.73 -43.92 81.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.572 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.17 -47.11 85.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.459 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.69 -52.18 66.62 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.7 pt -68.14 -38.97 80.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.112 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -57.95 -52.92 63.5 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.215 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 20' ' ' GLU . 96.8 t -61.17 -40.55 86.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.703 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.676 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.3 tt -52.51 -51.1 61.16 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.673 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -79.88 -50.62 10.22 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.774 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -63.45 -31.64 72.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.027 0.442 . . . . 0.0 110.721 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 16' ' ' VAL . 96.5 mt-10 58.55 81.09 0.16 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 178.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.85 -146.71 0.1 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.813 0.34 . . . . 0.0 110.641 177.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.421 HG12 ' NH2' ' A' ' 45' ' ' ARG . 5.8 p -128.16 139.67 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.434 HD12 ' O ' ' A' ' 24' ' ' ALA . 2.8 pp -128.96 167.76 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 120.892 0.377 . . . . 0.0 111.564 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.434 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -63.88 135.87 56.92 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.325 0.583 . . . . 0.0 111.528 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.5 ' CE1' ' O ' ' A' ' 26' ' ' PRO . 1.6 t80 -127.96 139.19 34.67 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.5 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 68.1 Cg_endo -78.99 144.61 18.97 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 121.327 1.351 . . . . 0.0 111.572 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.503 ' C ' ' H ' ' A' ' 29' ' ' ALA . 47.6 m -134.19 132.93 40.35 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.74 0.305 . . . . 0.0 110.416 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -72.97 32.13 0.07 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.635 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.503 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -156.91 -77.75 0.09 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.723 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.1 p -128.36 130.3 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -44.01 142.6 1.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.141 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.29 -175.71 22.64 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.1 m -129.72 171.21 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.413 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -159.54 -179.38 34.31 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.111 -1.042 . . . . 0.0 111.896 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.471 ' SG ' ' N ' ' A' ' 36' ' ' ASP . 1.4 p -159.42 -161.83 0.98 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 120.209 -0.596 . . . . 0.0 112.015 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.471 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 68.0 m-20 -93.02 107.07 22.15 Favored Pre-proline 0 CA--C 1.557 1.218 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -37.88 -61.73 0.34 Allowed 'Trans proline' 0 N--CA 1.5 1.854 0 C-N-CA 122.592 2.195 . . . . 0.0 112.928 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -76.45 69.51 2.92 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.364 -178.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.1 m -153.66 130.93 11.21 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.793 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.62 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -69.58 -33.26 72.46 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.59 -179.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.504 HG23 ' N ' ' A' ' 42' ' ' ALA . 14.2 t -57.56 -41.85 81.88 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.636 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.504 ' N ' HG23 ' A' ' 41' ' ' THR . . . -60.04 -52.55 64.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.498 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.405 ' H ' HG13 ' A' ' 43' ' ' VAL . 0.8 OUTLIER -61.58 -42.97 96.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-O 120.974 0.416 . . . . 0.0 110.511 -178.719 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.418 ' O ' ' CG ' ' A' ' 48' ' ' GLU . 56.8 mtt -65.19 -52.75 52.94 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.547 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.421 ' NH2' HG12 ' A' ' 22' ' ' VAL . 7.4 ptm180 -62.75 -37.31 86.09 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.186 0.517 . . . . 0.0 111.36 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -66.57 -53.42 34.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.407 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.449 HD22 HG23 ' A' ' 54' ' ' VAL . 7.8 mt -78.49 -7.59 57.63 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.187 -178.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 44' ' ' MET . 1.3 mm-40 -68.64 -79.93 0.05 Allowed 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.312 0.577 . . . . 0.0 111.707 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.423 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -71.7 -37.56 70.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.775 -177.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -67.76 -47.93 67.83 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.787 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 30.24 66.59 0.12 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.032 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.418 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 3.5 mtt180 -178.31 -54.76 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.604 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 52' ' ' ARG . 71.4 Cg_endo -72.99 -1.43 10.48 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.965 1.777 . . . . 0.0 109.448 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.449 HG23 HD22 ' A' ' 47' ' ' LEU . 0.7 OUTLIER -45.17 -48.99 3.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.435 -179.618 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -71.59 -39.61 70.43 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.861 0.362 . . . . 0.0 110.936 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.409 ' N ' ' CD ' ' A' ' 56' ' ' LYS . 1.1 mptm? -61.2 -38.8 87.86 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.306 -179.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 62.33 107.8 0.01 OUTLIER Glycine 0 CA--C 1.521 0.437 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.553 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -54.1 -160.24 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.52 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.2 mt -110.04 148.14 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.095 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.4 mt -122.61 142.01 51.1 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.3 tp -109.44 131.02 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-O 120.878 0.37 . . . . 0.0 110.854 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.31 146.84 45.72 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.94 -29.19 10.63 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.114 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.779 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 11.8 m120 -117.95 152.27 35.8 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.146 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -79.85 -14.34 58.73 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.632 0.73 . . . . 0.0 109.438 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -51.58 -32.55 29.01 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.206 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.779 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 5.5 pm0 -93.12 -8.93 41.25 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.893 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -90.76 -18.87 24.22 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.555 ' NZ ' HH12 ' A' ' 82' ' ' ARG . 32.6 mttp -76.22 -37.92 2.21 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 63.2 Cg_endo -104.82 -2.51 0.2 Allowed 'Trans proline' 0 C--N 1.319 -1.019 0 C-N-CA 122.868 2.378 . . . . 0.0 112.755 -178.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -93.87 -10.98 32.11 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.723 0.296 . . . . 0.0 111.158 -178.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.635 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.2 mp -125.45 168.76 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.635 ' N ' HG22 ' A' ' 72' ' ' ILE . 91.5 m-20 -63.14 -17.9 62.86 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.869 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.6 t70 57.04 22.38 7.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.929 0.395 . . . . 0.0 110.8 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.526 HG23 ' N ' ' A' ' 76' ' ' MET . 13.6 t -88.76 -41.56 12.47 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.779 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.526 ' N ' HG23 ' A' ' 75' ' ' THR . 14.2 ptp -84.38 -21.89 30.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.142 179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 tp -73.18 136.25 44.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.663 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.27 165.56 35.91 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.682 -177.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -48.45 -45.61 36.7 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.211 0.32 . . . . 0.0 111.799 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.1 p -61.96 -33.27 57.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.175 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 66.7 tp60 -64.4 -40.04 95.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.922 0.391 . . . . 0.0 110.455 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.555 HH12 ' NZ ' ' A' ' 69' ' ' LYS . 5.5 mmt85 -64.2 -53.09 54.76 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 122.256 1.027 . . . . 0.0 109.169 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -54.63 -50.2 68.69 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.884 -1.507 . . . . 0.0 109.984 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 m -61.33 -50.01 74.66 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.412 -1.267 . . . . 0.0 112.003 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.8 tt -68.44 -31.16 50.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.863 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -77.53 -36.29 52.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.528 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.8 m -85.57 -18.91 31.99 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.098 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 89' ' ' TRP . 58.5 ttt85 -112.63 78.56 1.14 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.334 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.438 ' O ' ' O ' ' A' ' 88' ' ' ARG . 41.3 m95 56.94 150.26 0.06 OUTLIER Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.431 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.09 -23.31 46.26 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 122.24 1.96 . . . . 0.0 112.094 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 158.73 79.61 0.03 OUTLIER Glycine 0 CA--C 1.528 0.906 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -81.33 -15.24 10.18 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.391 2.06 . . . . 0.0 111.985 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.9 p -136.06 144.45 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.562 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.498 ' N ' ' O ' ' A' ' 177' ' ' GLU . 25.6 m -95.13 132.85 39.6 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.92 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.49 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 45.9 m-85 -118.08 140.79 49.25 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.437 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.64 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.5 t -100.12 109.79 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 121.549 0.69 . . . . 0.0 110.811 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -95.62 148.74 35.08 Favored Pre-proline 0 N--CA 1.471 0.577 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.023 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.48 87.98 0.41 Allowed 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 121.952 1.768 . . . . 0.0 110.587 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -50.59 149.94 5.36 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.894 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.445 ' O ' ' HB2' ' A' ' 101' ' ' ALA . 98.1 Cg_endo -73.99 157.36 47.07 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.116 1.877 . . . . 0.0 110.148 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.624 ' HB1' ' CG ' ' A' ' 104' ' ' PRO . . . 179.37 120.06 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.667 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.42 ' O ' HG23 ' A' ' 103' ' ' THR . 33.7 p -86.69 -57.49 2.97 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 102' ' ' THR . 35.6 p -157.38 61.79 2.42 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.223 178.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.624 ' CG ' ' HB1' ' A' ' 101' ' ' ALA . 93.4 Cg_endo -104.15 -79.55 0.0 OUTLIER 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 123.467 2.778 . . . . 0.0 112.135 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.513 ' NH2' ' O ' ' A' ' 110' ' ' ARG . 7.7 tpt180 79.9 -4.64 1.92 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.723 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 66.5 p-90 -87.3 -10.74 51.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.603 0.716 . . . . 0.0 109.927 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.679 ' H ' ' CD2' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -85.02 -18.18 35.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.618 -179.113 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.409 ' H ' HD23 ' A' ' 107' ' ' LEU . 87.2 m -144.63 -39.98 0.26 Allowed 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.573 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 84.7 -3.32 87.02 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.262 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.513 ' O ' ' NH2' ' A' ' 105' ' ' ARG . 13.6 tpt180 -154.8 -78.68 0.09 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.036 0.918 . . . . 0.0 111.311 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -95.52 -175.27 3.41 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -125.28 81.52 1.98 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.019 0.437 . . . . 0.0 110.842 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 24.9 p -166.33 128.5 1.87 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.409 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.483 ' C ' HG13 ' A' ' 96' ' ' VAL . 69.1 mt -125.27 127.33 46.54 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.524 ' HB2' HG22 ' A' ' 96' ' ' VAL . . . -75.39 130.35 38.84 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 114.274 -1.33 . . . . 0.0 108.892 176.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.416 HG22 ' N ' ' A' ' 117' ' ' ARG . 13.5 p -144.63 153.75 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 120.897 0.379 . . . . 0.0 110.563 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.416 ' N ' HG22 ' A' ' 116' ' ' VAL . 62.3 ttp180 -142.99 156.55 44.88 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.14 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.0 t -124.29 132.31 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-O 121.103 0.478 . . . . 0.0 109.795 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.443 ' O ' HG23 ' A' ' 119' ' ' THR . 14.4 t -135.32 129.01 32.82 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.656 178.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -135.47 87.08 2.29 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.859 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.653 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 34.9 t60 -172.15 -36.92 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.653 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 63.5 Cg_endo -95.24 -160.48 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.939 0 C-N-CA 122.23 1.953 . . . . 0.0 111.619 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.9 mt -77.78 -5.03 49.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.253 0.549 . . . . 0.0 110.703 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 83.2 t -58.05 -44.81 87.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.725 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.748 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.0 m -53.01 -61.73 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.82 0 C-N-CA 119.626 -0.83 . . . . 0.0 108.884 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.748 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.05 -44.17 2.36 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.886 0.374 . . . . 0.0 110.749 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.6 tp -69.41 -47.37 64.36 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.452 179.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 57.9 m -70.47 -49.93 43.4 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.574 0.702 . . . . 0.0 110.623 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.465 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.1 pp0? -54.19 -41.75 68.93 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.383 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.78 -55.22 37.88 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.221 -1.354 . . . . 0.0 109.81 -177.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.455 ' CE1' ' OD2' ' A' ' 36' ' ' ASP . 46.7 t80 -61.28 -18.96 61.05 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.565 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.61 0.44 84.29 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -154.18 159.56 31.85 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 120.614 -0.434 . . . . 0.0 109.931 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -40.99 173.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 124.043 3.162 . . . . 0.0 113.22 -178.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.405 HD12 ' O ' ' A' ' 35' ' ' CYS . 7.6 tp -127.53 123.23 35.33 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 176.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.462 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -65.56 146.83 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 C-N-CA 117.998 -1.481 . . . . 0.0 107.487 -179.492 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 t -117.44 122.64 44.33 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 123.638 0.586 . . . . 0.0 110.664 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 3.2 m -131.9 163.82 27.47 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.842 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.4 m -72.26 145.44 47.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.238 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.11 -37.81 88.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.982 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.401 ' OD1' ' O ' ' A' ' 141' ' ' ASN . 53.4 p30 -49.46 150.43 1.89 Allowed 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.674 0.749 . . . . 0.0 111.095 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.32 -158.37 0.79 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.232 -178.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.5 t -62.47 -42.51 99.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.03 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -161.75 2.62 0.07 OUTLIER Glycine 0 N--CA 1.459 0.217 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.5 tp -85.95 125.23 69.22 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-O 119.389 -0.339 . . . . 0.0 110.35 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -40.45 157.99 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.627 1.551 . . . . 0.0 111.826 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.35 -162.92 0.18 Allowed 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.519 2.146 . . . . 0.0 112.083 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 148' ' ' CYS . 29.0 p -112.29 80.01 1.29 Allowed 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -55.09 -32.75 62.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.664 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -164.77 163.86 21.26 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.342 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.427 HG11 ' HA ' ' A' ' 166' ' ' PRO . 1.3 m -56.72 -15.75 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.806 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -66.76 -34.04 76.95 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 150' ' ' THR . 5.1 tm-20 -60.48 -71.87 0.12 Allowed 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.933 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.437 HG11 HG11 ' A' ' 164' ' ' VAL . 7.3 p -48.48 -32.91 4.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.275 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 159' ' ' GLY . 4.1 tmt_? -78.96 -51.66 9.32 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.773 0.796 . . . . 0.0 109.416 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.94 -44.85 64.08 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.676 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.71 -29.33 27.63 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 112.826 -1.988 . . . . 0.0 114.28 -175.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -126.39 -33.95 2.53 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 118.341 0.519 . . . . 0.0 111.331 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 94.59 24.7 17.5 Favored Glycine 0 N--CA 1.466 0.682 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.411 ' HB1' ' HG2' ' A' ' 163' ' ' PRO . . . -43.3 -94.4 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.517 0.199 . . . . 0.0 110.685 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.435 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.55 37.18 16.53 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.546 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.5 m-85 -176.48 -62.06 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.284 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.411 ' HG2' ' HB1' ' A' ' 160' ' ' ALA . 84.3 Cg_endo -73.58 28.86 0.31 Allowed 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.544 2.163 . . . . 0.0 110.46 178.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.569 HG23 ' HD3' ' A' ' 166' ' ' PRO . 16.1 m -132.62 166.1 30.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.814 -178.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.6 t -123.06 65.41 27.87 Favored Pre-proline 0 N--CA 1.475 0.797 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.517 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.569 ' HD3' HG23 ' A' ' 164' ' ' VAL . 23.7 Cg_exo -35.41 142.78 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 123.588 2.858 . . . . 0.0 115.362 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 169.01 178.28 40.33 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 113.688 -1.596 . . . . 0.0 110.89 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -155.84 149.83 25.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.775 0.321 . . . . 0.0 110.386 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.2 t -145.82 151.74 38.4 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.457 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -55.54 -67.98 1.93 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 155.29 60.46 0.01 OUTLIER Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -79.4 106.62 11.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.781 0.324 . . . . 0.0 110.616 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.573 ' N ' HD12 ' A' ' 173' ' ' LEU . 10.2 mp -78.99 164.53 24.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.231 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -153.49 72.7 6.78 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.054 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -60.98 143.06 99.25 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.743 2.296 . . . . 0.0 112.092 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 4.3 m 59.37 72.79 0.51 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.202 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 94' ' ' THR . 1.2 pp20? -101.15 -30.75 11.39 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.052 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.501 ' O ' HG23 ' A' ' 178' ' ' ILE . 18.3 tt -96.4 121.03 46.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.307 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -129.22 165.01 22.2 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.491 0.662 . . . . 0.0 111.73 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -78.14 106.13 9.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.008 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -66.33 -18.87 65.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.664 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.472 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.5 mm? -62.61 -41.9 99.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.398 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.53 -45.07 3.03 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.716 0.293 . . . . 0.0 110.61 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 66.24 24.85 72.2 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -61.63 131.97 51.74 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.476 0.655 . . . . 0.0 110.94 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.528 ' H ' ' CD2' ' A' ' 186' ' ' LEU . 0.7 OUTLIER -76.55 -177.64 4.29 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.656 -179.874 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -104.26 68.08 0.87 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.788 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.03 144.42 51.45 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.336 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -137.41 -18.31 1.28 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.255 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.761 0 CA-C-O 118.041 -1.422 . . . . 0.0 110.794 179.825 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -91.79 5.13 51.07 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.904 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -63.23 -41.03 99.05 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.752 0.311 . . . . 0.0 110.629 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.666 HD22 ' N ' ' A' ' 5' ' ' LEU . 3.0 mm? -63.07 -41.65 99.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.878 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -61.46 -43.67 98.45 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -59.34 -41.45 89.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.459 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 162' ' ' PHE . 41.3 t0 -61.31 -40.25 93.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.264 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.6 -48.42 81.86 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.813 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.5 mm -63.51 -44.78 98.87 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.698 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.46 -46.56 76.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.053 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.48 -45.71 91.79 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.06 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.12 -51.15 70.32 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 13.3 pt -69.3 -40.09 79.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.506 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -58.47 -54.62 44.94 Favored 'General case' 0 C--O 1.218 -0.557 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.136 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.491 ' O ' ' N ' ' A' ' 20' ' ' GLU . 99.5 t -62.01 -39.81 85.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.638 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.661 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.5 tt -52.38 -50.4 62.51 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.587 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -79.95 -51.6 8.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.644 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -64.83 -34.43 78.35 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.41 -178.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' A' ' 16' ' ' VAL . 95.8 mt-10 58.5 87.41 0.07 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.311 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.47 -132.8 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 178.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.6 p -144.29 140.08 24.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.457 HD12 ' O ' ' A' ' 24' ' ' ALA . 2.8 pp -130.72 163.95 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 121.163 0.506 . . . . 0.0 111.905 -178.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.457 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -59.76 136.3 57.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.87 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.532 ' CZ ' ' O ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -132.13 145.39 57.16 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.21 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.532 ' O ' ' CZ ' ' A' ' 25' ' ' TYR . 61.9 Cg_endo -78.85 146.83 21.06 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.465 1.443 . . . . 0.0 111.383 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.489 ' C ' ' H ' ' A' ' 29' ' ' ALA . 28.7 m -130.21 135.9 48.64 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.88 0.372 . . . . 0.0 110.123 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -75.35 22.0 0.13 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.489 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -156.17 -73.63 0.1 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.327 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.4 p -122.71 126.28 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-O 121.335 0.588 . . . . 0.0 111.392 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.486 ' CD1' ' O ' ' A' ' 148' ' ' CYS . 16.7 t80 -45.34 132.36 7.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.389 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.62 -171.52 13.9 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.309 -0.717 . . . . 0.0 111.309 -179.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 m -131.12 169.51 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.408 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -157.98 -178.21 31.81 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 120.105 -1.045 . . . . 0.0 112.616 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.554 ' O ' HD12 ' A' ' 135' ' ' LEU . 0.5 OUTLIER -156.56 -163.04 1.35 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.546 0.213 . . . . 0.0 110.577 -179.757 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.516 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 44.3 m-20 -100.39 109.11 55.95 Favored Pre-proline 0 CA--C 1.554 1.123 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -178.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 36' ' ' ASP . 55.5 Cg_exo -38.36 173.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.765 2.31 . . . . 0.0 114.105 177.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 42.91 65.66 0.91 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.719 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.0 m -152.35 139.22 18.99 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.41 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -65.98 -28.43 68.88 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.104 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.524 HG23 ' N ' ' A' ' 42' ' ' ALA . 14.9 t -59.93 -42.8 94.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.666 -178.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.524 ' N ' HG23 ' A' ' 41' ' ' THR . . . -59.07 -52.02 67.53 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.38 0.61 . . . . 0.0 111.414 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.11 -45.76 95.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.895 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 91.9 mtp -66.41 -47.05 74.48 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.5 ptt85 -62.23 -30.24 70.96 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.173 -178.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 45.2 mt -73.4 -61.89 1.67 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.382 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.2 mt -54.02 -20.43 6.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.655 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -63.81 -85.61 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.666 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.497 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.2 pt? -77.5 -35.42 53.57 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -73.67 -48.18 34.22 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 119.709 -0.797 . . . . 0.0 111.049 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 35.25 65.17 0.4 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.957 -1.019 . . . . 0.0 111.78 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.407 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 8.1 mtm-85 179.84 -53.73 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.909 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.675 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.407 ' HD2' ' H ' ' A' ' 52' ' ' ARG . 72.1 Cg_endo -75.1 -7.16 18.83 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.422 2.081 . . . . 0.0 112.783 -178.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.614 HG13 ' N ' ' A' ' 55' ' ' ASP . 12.8 p -41.42 -47.03 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.119 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.614 ' N ' HG13 ' A' ' 54' ' ' VAL . 36.6 t0 -67.66 -39.5 84.55 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.076 0.465 . . . . 0.0 110.786 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.479 ' CD ' ' N ' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -61.92 -39.52 92.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.318 -179.299 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 62.9 105.6 0.01 OUTLIER Glycine 0 CA--C 1.52 0.394 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.57 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -49.76 -168.2 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.821 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.4 HG23 HG21 ' A' ' 94' ' ' THR . 75.0 mt -102.64 147.84 8.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.1 mt -120.73 141.25 50.62 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.414 HD12 ' HG3' ' A' ' 117' ' ' ARG . 8.6 tp -108.88 132.46 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-O 121.062 0.458 . . . . 0.0 109.96 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.519 ' HB3' HG22 ' A' ' 118' ' ' VAL . . . -123.35 152.99 40.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.392 0.615 . . . . 0.0 109.86 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -112.32 -30.03 7.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.181 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -114.1 151.78 32.07 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.648 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -79.05 -13.84 59.52 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.567 0.698 . . . . 0.0 109.974 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -53.8 -30.96 47.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.267 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.79 -8.81 39.52 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.53 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -89.13 -20.79 23.83 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.446 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 69.9 tttt -73.81 -39.97 4.78 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 95.2 Cg_endo -102.38 -5.36 0.29 Allowed 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 122.672 2.248 . . . . 0.0 112.478 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -88.57 -17.87 29.28 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.652 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.532 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.0 mp -122.34 157.53 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.532 ' N ' HG22 ' A' ' 72' ' ' ILE . 4.4 m-20 -64.34 146.59 54.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.846 0.355 . . . . 0.0 110.203 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -91.9 38.8 1.0 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.058 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.536 HG23 ' N ' ' A' ' 76' ' ' MET . 11.3 t -108.34 -41.76 4.78 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.995 0.426 . . . . 0.0 110.208 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.536 ' N ' HG23 ' A' ' 75' ' ' THR . 8.4 ptp -93.05 -17.5 23.78 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.239 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.51 HD21 ' NH2' ' A' ' 82' ' ' ARG . 31.7 tp -79.83 128.18 33.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.277 -177.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -153.86 163.63 39.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.726 -177.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -49.15 -45.74 44.23 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.718 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -61.09 -31.94 51.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.964 -0.295 . . . . 0.0 111.197 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 66.8 tp60 -65.56 -40.6 92.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.216 0.531 . . . . 0.0 110.427 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.51 ' NH2' HD21 ' A' ' 77' ' ' LEU . 9.7 mmt85 -64.21 -51.65 62.7 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 122.522 1.154 . . . . 0.0 109.287 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -56.44 -50.33 71.98 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 113.668 -1.605 . . . . 0.0 110.325 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -61.74 -49.7 75.37 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.826 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.1 tt -67.59 -31.53 52.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.486 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -77.32 -35.09 55.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.748 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.6 m -88.0 -18.65 28.55 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.475 0.178 . . . . 0.0 111.282 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.414 ' O ' ' O ' ' A' ' 89' ' ' TRP . 77.3 ttt-85 -110.39 77.84 1.08 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.554 ' CD1' ' N ' ' A' ' 89' ' ' TRP . 1.2 m0 59.18 148.71 0.07 OUTLIER Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.21 -31.53 35.67 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 121.741 1.627 . . . . 0.0 112.508 -178.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.445 ' H ' ' HD3' ' A' ' 92' ' ' PRO . . . 150.35 61.12 0.01 OUTLIER Glycine 0 CA--C 1.531 1.061 0 C-N-CA 121.089 -0.577 . . . . 0.0 111.97 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.445 ' HD3' ' H ' ' A' ' 91' ' ' GLY . 57.4 Cg_endo -70.22 -15.73 35.43 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.718 2.279 . . . . 0.0 111.828 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.0 p -122.6 136.47 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.137 0.494 . . . . 0.0 110.079 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 177' ' ' GLU . 27.3 m -91.37 135.26 33.95 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.936 -179.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.481 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 42.1 m-85 -120.69 139.71 52.65 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.914 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.627 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.4 t -97.17 109.02 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-O 121.347 0.594 . . . . 0.0 110.902 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -94.37 149.9 37.38 Favored Pre-proline 0 N--CA 1.469 0.506 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.965 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.403 ' O ' ' OD2' ' A' ' 73' ' ' ASP . 58.7 Cg_endo -69.41 86.93 0.52 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.991 1.794 . . . . 0.0 111.12 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.423 ' O ' ' OD1' ' A' ' 112' ' ' ASP . . . -50.95 153.51 3.0 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.452 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.44 157.47 58.97 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.193 1.929 . . . . 0.0 111.629 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -149.05 74.04 1.24 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.396 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.42 ' O ' ' OG1' ' A' ' 103' ' ' THR . 57.8 p -66.6 -33.75 76.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.915 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.698 ' H ' ' CD ' ' A' ' 104' ' ' PRO . 0.6 OUTLIER -168.18 -39.3 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -179.748 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.698 ' CD ' ' H ' ' A' ' 103' ' ' THR . 18.5 Cg_exo -66.31 -164.61 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.583 2.189 . . . . 0.0 113.129 -178.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 109' ' ' GLY . 8.2 tpt180 -172.28 0.36 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.149 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 2.4 p90 -71.67 -7.13 46.06 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.531 -179.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 1.029 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -73.08 -23.25 60.51 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.769 179.823 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.673 ' H ' HD22 ' A' ' 107' ' ' LEU . 85.1 m -143.09 -40.1 0.32 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.812 179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 80.2 -0.42 83.99 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.638 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -148.21 -80.64 0.13 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.427 0.613 . . . . 0.0 110.822 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -89.91 -173.02 3.74 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 99' ' ' ALA . 66.3 t0 -131.05 70.83 1.46 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.91 0.386 . . . . 0.0 110.832 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 80.5 p -160.6 127.83 4.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.583 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.494 ' C ' HG13 ' A' ' 96' ' ' VAL . 63.0 mt -124.03 129.04 50.25 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -178.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.528 ' HB2' HG22 ' A' ' 96' ' ' VAL . . . -77.32 122.54 25.26 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.276 176.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.447 HG22 ' N ' ' A' ' 117' ' ' ARG . 10.9 p -141.29 155.96 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.937 0.398 . . . . 0.0 110.54 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.447 ' N ' HG22 ' A' ' 116' ' ' VAL . 19.3 ptt180 -149.19 158.22 44.0 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.665 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.519 HG22 ' HB3' ' A' ' 62' ' ' ALA . 70.8 t -122.52 134.87 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.11 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 119' ' ' THR . 12.2 t -138.4 127.85 24.67 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.664 178.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -133.24 87.45 2.39 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.129 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.682 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 19.1 t60 -172.01 -35.22 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 112.486 0.551 . . . . 0.0 112.486 -179.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.682 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 73.7 Cg_endo -95.7 -158.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.482 0.795 0 C-N-CA 122.288 1.992 . . . . 0.0 111.761 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 19.4 mt -79.26 -6.18 56.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.661 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 79.9 t -57.22 -45.62 84.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.538 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.738 HG23 ' H ' ' A' ' 126' ' ' ALA . 26.9 m -51.01 -61.68 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.864 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.738 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.63 -44.52 3.12 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.984 0.421 . . . . 0.0 110.726 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.433 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -66.54 -51.54 55.43 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.08 0.467 . . . . 0.0 110.571 179.413 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 79.2 m -69.34 -48.45 61.33 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.252 0.549 . . . . 0.0 111.396 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.468 ' HG3' ' N ' ' A' ' 130' ' ' ALA . 1.1 pp0? -54.56 -42.05 70.51 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.507 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -60.11 -54.83 41.22 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.139 -1.392 . . . . 0.0 109.399 -177.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -64.13 -21.67 66.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.406 -1.27 . . . . 0.0 109.085 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.41 1.55 86.34 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 55.5 mttt -152.66 159.48 32.43 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 120.718 -0.393 . . . . 0.0 109.971 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -43.16 178.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 124.053 3.169 . . . . 0.0 113.389 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.554 HD12 ' O ' ' A' ' 35' ' ' CYS . 8.2 tp -133.35 123.29 25.14 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 177.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.43 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -64.65 146.16 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 C-N-CA 117.796 -1.562 . . . . 0.0 107.678 -179.736 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.9 t -119.37 129.53 54.87 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.283 0.563 . . . . 0.0 111.23 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.5 m -131.79 164.23 26.48 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.241 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.2 m -75.18 148.06 39.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.24 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.51 88.91 2.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.615 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 57.6 p30 -164.02 163.28 23.39 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.396 0.617 . . . . 0.0 110.814 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.85 -165.57 1.91 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.096 -178.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 38.8 t -61.95 -43.89 97.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.925 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -160.65 11.08 0.14 Allowed Glycine 0 N--CA 1.459 0.22 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 12.6 tp -88.71 127.17 57.28 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -39.13 154.12 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.682 1.588 . . . . 0.0 111.83 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.418 ' O ' ' N ' ' A' ' 149' ' ' ARG . 89.9 Cg_endo -74.38 149.99 40.71 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.227 1.951 . . . . 0.0 112.392 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.486 ' O ' ' CD1' ' A' ' 31' ' ' PHE . 72.8 m -67.92 74.22 0.19 Allowed 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 147' ' ' PRO . 32.2 ptt-85 -58.3 -34.38 70.49 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.502 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -160.33 163.75 33.04 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.472 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.412 HG11 ' HA ' ' A' ' 166' ' ' PRO . 0.9 OUTLIER -56.62 -17.45 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.821 0 CA-C-O 121.577 0.703 . . . . 0.0 109.223 -179.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -64.71 -35.67 81.79 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 177.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.437 ' OE1' ' OE1' ' A' ' 157' ' ' GLN . 5.1 tm-20 -59.49 -74.86 0.06 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.688 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.404 HG11 HG11 ' A' ' 164' ' ' VAL . 7.8 p -44.7 -29.04 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.242 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.421 ' O ' ' N ' ' A' ' 159' ' ' GLY . 0.0 OUTLIER -83.95 -45.3 13.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 122.201 1.0 . . . . 0.0 110.047 179.767 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.84 -40.69 80.7 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.769 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.437 ' OE1' ' OE1' ' A' ' 153' ' ' GLU . 8.7 pt20 -81.57 -49.02 11.04 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 113.167 -1.833 . . . . 0.0 112.566 -176.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.429 ' N ' ' CG ' ' A' ' 157' ' ' GLN . 20.8 m-85 -110.05 -33.55 6.66 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 155' ' ' ARG . . . 97.61 27.63 8.96 Favored Glycine 0 N--CA 1.475 1.285 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.606 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -44.13 -94.8 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.759 0.314 . . . . 0.0 111.07 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.507 ' O ' ' CD2' ' A' ' 162' ' ' PHE . . . 61.83 35.71 16.43 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -178.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.507 ' CD2' ' O ' ' A' ' 161' ' ' ALA . 2.1 m-85 -174.77 -62.53 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.471 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -73.03 28.85 0.29 Allowed 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.525 2.15 . . . . 0.0 110.49 178.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.567 HG23 ' HD3' ' A' ' 166' ' ' PRO . 17.1 m -131.98 167.39 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.542 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.0 t -124.24 64.82 37.87 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.549 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.567 ' HD3' HG23 ' A' ' 164' ' ' VAL . 20.4 Cg_exo -35.18 142.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 123.699 2.933 . . . . 0.0 115.056 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 167.02 -177.71 41.56 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 114.051 -1.431 . . . . 0.0 110.989 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -146.98 152.33 38.44 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.5 t -143.93 148.49 35.45 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.993 0.425 . . . . 0.0 110.944 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -107.51 58.21 0.42 Allowed Glycine 0 N--CA 1.47 0.917 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 29' ' ' ALA . . . -163.21 50.7 0.31 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 22.5 mmt85 -64.74 -43.22 94.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.749 0.309 . . . . 0.0 110.492 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 173' ' ' LEU . 9.1 mp -100.07 178.94 4.64 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.588 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 173' ' ' LEU . 9.8 t-20 82.8 55.19 0.07 OUTLIER Pre-proline 0 N--CA 1.466 0.353 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.307 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.478 ' O ' ' CB ' ' A' ' 176' ' ' SER . 72.2 Cg_endo -72.48 144.61 40.86 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.709 2.272 . . . . 0.0 111.164 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 175' ' ' PRO . 2.0 m 160.41 77.29 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 94' ' ' THR . 5.7 pt-20 -132.66 -26.57 1.79 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.134 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 178' ' ' ILE . 18.2 tt -87.08 122.63 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-O 120.922 0.391 . . . . 0.0 110.763 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -135.21 168.08 19.82 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.409 0.623 . . . . 0.0 111.648 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -78.73 106.03 10.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.562 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -65.57 -13.57 59.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.649 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.476 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 3.4 mm? -63.32 -41.08 98.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.193 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.442 HG23 ' H ' ' A' ' 185' ' ' GLU . 5.2 t -119.75 -23.49 6.48 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.955 0.407 . . . . 0.0 110.458 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 85.79 31.07 22.02 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.442 ' H ' HG23 ' A' ' 183' ' ' THR . 7.7 pt-20 -167.8 145.16 4.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.677 0.275 . . . . 0.0 110.77 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.602 ' H ' ' CD2' ' A' ' 186' ' ' LEU . 0.9 OUTLIER -88.88 175.8 7.3 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.86 0.362 . . . . 0.0 110.638 179.669 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -110.53 -12.06 14.41 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.419 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -74.19 137.6 43.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.575 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -152.94 -18.45 0.15 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.244 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.733 0 CA-C-O 117.717 -1.601 . . . . 0.0 111.183 179.771 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 53.9 p30 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -143.37 83.57 1.78 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.329 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 56.5 p30 -104.62 13.78 31.0 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.687 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 5' ' ' LEU . 10.8 mp -62.54 -42.22 99.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.039 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -63.88 -40.85 97.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.321 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -64.72 -40.87 96.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.636 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 162' ' ' PHE . 63.1 t0 -59.34 -46.38 88.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.332 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.19 -43.9 97.79 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.95 0.405 . . . . 0.0 110.17 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.1 mt -63.76 -43.19 97.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.97 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.2 -46.52 82.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.533 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.91 -45.98 92.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.423 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.25 -52.86 63.48 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 14.4 pt -68.57 -39.47 80.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.392 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -56.77 -53.72 54.51 Favored 'General case' 0 C--O 1.215 -0.738 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.197 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 20' ' ' GLU . 97.6 t -61.97 -40.62 87.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.89 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.678 ' C ' HD23 ' A' ' 17' ' ' LEU . 6.3 tt -52.48 -51.98 56.64 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.508 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -78.33 -49.92 12.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.368 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -65.47 -32.06 73.47 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.694 -178.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 16' ' ' VAL . 97.1 mt-10 59.91 80.67 0.2 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 178.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.04 -148.23 0.12 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.857 177.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.3 p -125.45 140.63 47.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.456 HD12 ' O ' ' A' ' 24' ' ' ALA . 2.9 pp -129.68 165.84 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-O 120.907 0.384 . . . . 0.0 111.62 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.456 ' O ' HD12 ' A' ' 23' ' ' ILE . . . -60.26 135.73 57.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.302 0.572 . . . . 0.0 110.793 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.53 ' CZ ' ' O ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -132.49 145.38 57.0 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.585 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.53 ' O ' ' CZ ' ' A' ' 25' ' ' TYR . 97.6 Cg_endo -75.61 145.84 29.89 Favored 'Trans proline' 0 N--CA 1.498 1.794 0 C-N-CA 121.597 1.531 . . . . 0.0 111.384 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.493 ' C ' ' H ' ' A' ' 29' ' ' ALA . 63.0 m -131.76 131.32 42.87 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.95 0.405 . . . . 0.0 110.644 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -75.01 30.94 0.09 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.411 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.493 ' H ' ' C ' ' A' ' 27' ' ' THR . . . -160.32 -73.47 0.07 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.621 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.9 p -131.77 132.22 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.045 0.45 . . . . 0.0 110.188 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.527 ' CD2' ' O ' ' A' ' 148' ' ' CYS . 36.0 p90 -39.5 144.37 0.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.45 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -156.78 -174.27 26.3 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.8 m -131.07 172.33 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.402 ' CA ' ' O ' ' A' ' 136' ' ' VAL . . . -158.42 178.51 34.63 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.095 -1.05 . . . . 0.0 111.795 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -157.25 -170.42 3.25 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.737 -178.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.467 ' CG ' ' CZ ' ' A' ' 131' ' ' TYR . 18.3 t70 -86.57 108.08 16.47 Favored Pre-proline 0 CA--C 1.555 1.168 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -177.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -36.52 -61.42 0.31 Allowed 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 122.533 2.155 . . . . 0.0 113.161 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -74.03 72.01 1.63 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.593 -178.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 m -155.73 130.52 9.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.678 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -66.33 -33.93 76.84 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.988 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.529 HG23 ' N ' ' A' ' 42' ' ' ALA . 15.1 t -62.08 -43.56 98.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.866 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.529 ' N ' HG23 ' A' ' 41' ' ' THR . . . -55.78 -52.52 63.68 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -62.19 -42.6 95.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.312 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 91.2 mtp -63.22 -40.61 97.96 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.514 HH22 ' CD1' ' A' ' 142' ' ' LEU . 7.9 ttt85 -60.52 -40.77 92.68 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-O 121.695 0.76 . . . . 0.0 108.959 178.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.44 ' O ' HD23 ' A' ' 46' ' ' LEU . 1.0 OUTLIER -65.96 -55.61 15.92 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.248 -178.8 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.6 mt -67.64 -12.1 59.7 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.981 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.71 -82.57 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.151 0 CA-C-O 120.995 0.426 . . . . 0.0 110.678 -177.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 49' ' ' LEU . 2.3 pt? -76.37 -36.28 58.24 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.2 mmmt -74.63 -51.38 14.61 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 119.552 -0.859 . . . . 0.0 111.026 -176.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 36.12 64.93 0.48 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.866 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.401 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 2.6 mtp85 178.66 -53.99 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.529 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HD2' ' H ' ' A' ' 52' ' ' ARG . 72.0 Cg_endo -77.17 -6.45 16.55 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.92 2.413 . . . . 0.0 111.93 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.561 HG13 ' N ' ' A' ' 55' ' ' ASP . 9.7 p -45.59 -43.52 3.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.404 -178.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.561 ' N ' HG13 ' A' ' 54' ' ' VAL . 50.7 t0 -65.41 -41.25 93.81 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.573 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.409 ' CD ' ' N ' ' A' ' 56' ' ' LYS . 4.1 mptp? -62.55 -37.68 87.06 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 64.4 108.71 0.01 OUTLIER Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 178.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.562 ' N ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -51.19 -166.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.057 0.456 . . . . 0.0 111.937 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.43 ' O ' ' OG ' ' A' ' 137' ' ' SER . 70.3 mt -104.55 135.35 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.044 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.6 mt -111.72 144.66 40.64 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.41 ' O ' HG23 ' A' ' 61' ' ' ILE . 8.0 tp -112.75 126.8 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-O 121.156 0.503 . . . . 0.0 111.082 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.83 147.92 39.2 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.182 178.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -106.52 -27.59 10.81 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.431 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.72 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 71.1 m-80 -121.46 151.6 40.06 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 120.789 0.328 . . . . 0.0 111.136 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -76.93 -13.29 59.99 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -50.89 -32.19 19.81 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.554 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.72 ' NE2' ' H ' ' A' ' 64' ' ' ASN . 3.0 pm0 -94.17 -13.38 26.74 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 68' ' ' LEU . 4.1 mm? -91.93 -16.19 26.96 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.658 -0.651 . . . . 0.0 109.648 179.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.467 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 77.1 tttt -78.91 -37.97 1.33 Allowed Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 69' ' ' LYS . 84.8 Cg_endo -103.47 -3.64 0.26 Allowed 'Trans proline' 0 C--N 1.319 -1.01 0 C-N-CA 122.593 2.195 . . . . 0.0 112.049 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -94.9 -10.9 29.77 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.948 0.404 . . . . 0.0 110.774 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.625 HG22 ' N ' ' A' ' 73' ' ' ASP . 5.1 mp -127.11 167.26 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.625 ' N ' HG22 ' A' ' 72' ' ' ILE . 99.9 m-20 -61.12 -12.8 13.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.007 0.432 . . . . 0.0 110.381 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 46.2 t0 56.3 22.29 6.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.709 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.458 HG23 ' N ' ' A' ' 76' ' ' MET . 9.0 t -92.6 -38.94 11.6 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.02 0.438 . . . . 0.0 110.177 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.458 ' N ' HG23 ' A' ' 75' ' ' THR . 0.0 OUTLIER -78.44 -24.4 46.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.208 0.528 . . . . 0.0 110.398 179.57 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.538 HD11 ' NE ' ' A' ' 82' ' ' ARG . 51.2 tp -77.94 134.21 37.91 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.557 0.694 . . . . 0.0 111.109 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.39 172.56 13.32 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.389 -177.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.13 -40.76 90.92 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.814 0.34 . . . . 0.0 111.105 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.5 p -61.7 -35.07 65.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.495 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.444 ' OE1' HD12 ' A' ' 77' ' ' LEU . 22.5 mt-30 -62.97 -41.34 99.51 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.868 0.366 . . . . 0.0 110.511 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.538 ' NE ' HD11 ' A' ' 77' ' ' LEU . 2.4 mmt85 -62.88 -52.81 61.64 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 122.506 1.146 . . . . 0.0 109.025 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -55.64 -50.73 69.41 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.812 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.6 m -61.44 -49.83 75.25 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.936 -177.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' A' ' 89' ' ' TRP . 9.6 tt -67.52 -32.08 55.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 119.746 -0.781 . . . . 0.0 109.595 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -75.3 -36.43 61.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.424 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.5 m -86.82 -16.44 36.17 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.741 -0.209 . . . . 0.0 111.145 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.444 ' O ' ' O ' ' A' ' 89' ' ' TRP . 77.2 ttt-85 -119.58 78.52 1.32 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.587 0.232 . . . . 0.0 110.879 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.444 ' O ' ' O ' ' A' ' 88' ' ' ARG . 27.3 m95 56.2 149.66 0.05 OUTLIER Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.029 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -67.13 -21.32 48.94 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.331 2.021 . . . . 0.0 112.045 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.529 ' O ' ' NE ' ' A' ' 117' ' ' ARG . . . 157.26 82.87 0.04 OUTLIER Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -76.44 -21.49 13.21 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.885 1.723 . . . . 0.0 112.578 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.411 HG13 ' CE2' ' A' ' 95' ' ' PHE . 3.4 p -136.39 143.62 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-O 121.088 0.471 . . . . 0.0 110.843 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 85.1 m -87.73 144.86 26.41 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.246 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.464 ' HB3' ' HB2' ' A' ' 181' ' ' ALA . 57.8 m-85 -126.85 142.32 51.58 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.754 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.635 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 3.3 t -98.2 105.59 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 121.299 0.571 . . . . 0.0 109.801 178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -90.13 150.83 44.07 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.931 -178.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.96 109.29 2.81 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 121.874 1.716 . . . . 0.0 110.525 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.401 ' O ' ' OD1' ' A' ' 112' ' ' ASP . . . -67.29 147.75 98.86 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.05 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.441 ' O ' ' OG1' ' A' ' 103' ' ' THR . 93.0 Cg_endo -73.29 155.22 51.5 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.441 2.094 . . . . 0.0 112.385 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.47 -35.94 78.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.041 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 45.7 p -56.06 -42.06 76.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.775 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.51 ' O ' ' O ' ' A' ' 104' ' ' PRO . 1.7 p -56.43 156.86 10.57 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.51 ' O ' ' O ' ' A' ' 103' ' ' THR . 78.3 Cg_exo -47.65 -139.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.507 2.305 0 C-N-CA 122.984 2.456 . . . . 0.0 114.158 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' A' ' 109' ' ' GLY . 15.0 mmt180 -142.96 -7.08 0.83 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.217 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.55 ' CD1' ' N ' ' A' ' 106' ' ' TRP . 14.2 m0 -73.04 -14.43 61.41 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.562 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.987 HD13 ' H ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -68.99 -37.63 78.84 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.736 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.748 ' H ' HD22 ' A' ' 107' ' ' LEU . 21.8 m -143.94 -39.48 0.29 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.432 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 105' ' ' ARG . . . 65.59 -13.64 0.28 Allowed Glycine 0 CA--C 1.53 0.972 0 CA-C-N 115.64 -0.709 . . . . 0.0 113.764 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 24.7 tpt85 -112.22 -83.08 0.59 Allowed 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 117.848 0.824 . . . . 0.0 111.027 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -78.88 -121.85 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.525 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 99' ' ' ALA . 44.0 t0 -171.29 51.26 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.667 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.5 p -158.7 162.75 37.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.294 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.487 ' C ' HG13 ' A' ' 96' ' ' VAL . 3.0 pp -165.79 137.59 3.93 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.421 ' N ' HG13 ' A' ' 96' ' ' VAL . . . -67.72 127.97 34.74 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 113.085 -1.87 . . . . 0.0 109.904 177.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.3 p -147.21 151.19 14.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.986 0.422 . . . . 0.0 110.063 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.529 ' NE ' ' O ' ' A' ' 91' ' ' GLY . 80.5 ttt180 -141.21 156.16 45.95 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.701 -178.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.5 t -121.41 130.87 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 119' ' ' THR . 9.9 t -134.03 127.94 33.3 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.764 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -135.43 84.3 2.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.849 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.679 ' H ' ' CD ' ' A' ' 122' ' ' PRO . 47.1 t60 -172.62 -35.56 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.308 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.679 ' CD ' ' H ' ' A' ' 121' ' ' HIS . 72.7 Cg_endo -95.07 -159.41 0.06 OUTLIER 'Trans proline' 0 C--N 1.321 -0.878 0 C-N-CA 121.889 1.726 . . . . 0.0 111.979 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 42.7 mt -78.22 -4.65 48.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.341 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 82.9 t -58.53 -45.9 90.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.964 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.772 HG23 ' H ' ' A' ' 126' ' ' ALA . 27.6 m -53.57 -61.89 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.772 ' H ' HG23 ' A' ' 125' ' ' VAL . . . -41.26 -43.95 2.53 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.717 178.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.2 tp -69.32 -48.6 61.04 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.361 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 65.1 m -70.4 -48.88 54.09 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.49 0.662 . . . . 0.0 110.913 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.472 ' N ' ' O ' ' A' ' 125' ' ' VAL . 1.1 pp0? -54.71 -42.24 71.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.572 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' A' ' 126' ' ' ALA . . . -58.78 -56.1 26.52 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.178 -1.374 . . . . 0.0 110.062 -177.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.467 ' CZ ' ' CG ' ' A' ' 36' ' ' ASP . 7.4 t80 -63.32 -29.21 70.56 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.644 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 90.26 1.0 76.05 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.407 ' O ' ' O ' ' A' ' 134' ' ' PRO . 61.2 mttt -151.0 158.64 34.68 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.999 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' A' ' 133' ' ' LYS . 5.9 Cg_exo -41.12 175.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 123.976 3.117 . . . . 0.0 113.166 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.6 tp -131.34 123.09 27.53 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 177.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.441 HG13 ' H ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -66.0 145.58 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 C-N-CA 118.477 -1.289 . . . . 0.0 108.662 -179.212 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -109.44 120.85 43.77 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.122 0.889 . . . . 0.0 110.756 -179.669 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 5.2 m -136.2 163.39 30.48 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.122 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 22.7 t -67.27 149.37 50.49 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.916 0.389 . . . . 0.0 110.976 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.54 -38.46 91.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.195 -0.457 . . . . 0.0 112.117 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 56.6 p30 -65.75 155.99 34.44 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.468 0.651 . . . . 0.0 111.599 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.514 ' CD1' HH22 ' A' ' 45' ' ' ARG . 0.8 OUTLIER -144.75 179.08 7.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.385 -178.523 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 38.8 t -61.39 -42.74 99.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.226 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -141.65 57.01 0.58 Allowed Glycine 0 N--CA 1.468 0.803 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.1 tp -157.41 108.04 1.85 Allowed Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 119.399 -0.334 . . . . 0.0 110.213 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -40.92 156.09 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.394 1.396 . . . . 0.0 111.212 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -59.97 -159.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.113 1.876 . . . . 0.0 111.855 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.527 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 79.5 m -149.12 73.32 1.2 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.027 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -54.66 -40.61 69.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.232 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.15 168.49 26.32 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.42 HG11 ' HA ' ' A' ' 166' ' ' PRO . 2.0 m -59.47 -22.76 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 CA-C-O 121.266 0.555 . . . . 0.0 109.855 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -65.12 -25.06 67.6 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 155' ' ' ARG . 6.2 tm-20 -69.08 -79.42 0.06 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.319 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.419 ' N ' ' OE1' ' A' ' 153' ' ' GLU . 5.4 p -35.83 -30.15 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.577 0.751 . . . . 0.0 110.312 177.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.482 ' N ' ' O ' ' A' ' 153' ' ' GLU . 4.1 tmt_? -71.59 -49.94 35.67 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.063 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 153' ' ' GLU . . . -72.01 -19.41 61.86 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 122.529 1.157 . . . . 0.0 108.212 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -83.04 -44.38 15.26 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 112.623 -2.081 . . . . 0.0 111.763 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -129.78 -34.26 1.75 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.775 0.322 . . . . 0.0 111.631 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 160' ' ' ALA . . . 102.12 23.91 8.82 Favored Glycine 0 N--CA 1.468 0.792 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.412 ' O ' ' O ' ' A' ' 159' ' ' GLY . . . -43.97 -97.9 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.597 0.237 . . . . 0.0 110.893 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . 64.17 33.6 11.68 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.516 ' H ' HG22 ' A' ' 164' ' ' VAL . 1.6 m-85 -173.54 -62.2 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.013 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -72.67 28.22 0.28 Allowed 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 122.296 1.997 . . . . 0.0 110.718 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.548 HG23 ' HD3' ' A' ' 166' ' ' PRO . 13.6 m -129.89 167.31 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.877 -178.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 11.7 t -121.6 65.2 17.19 Favored Pre-proline 0 N--CA 1.471 0.615 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.859 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.548 ' HD3' HG23 ' A' ' 164' ' ' VAL . 29.1 Cg_exo -36.35 139.84 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 123.612 2.875 . . . . 0.0 115.041 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 160.61 -172.81 37.05 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 114.077 -1.42 . . . . 0.0 111.112 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -159.29 170.68 21.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.935 0.397 . . . . 0.0 110.524 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.49 -40.02 0.89 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.024 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 127.69 -72.5 0.47 Allowed Glycine 0 N--CA 1.47 0.911 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 154.56 115.72 0.56 Allowed Glycine 0 CA--C 1.517 0.213 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -135.91 140.37 44.02 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.738 0.304 . . . . 0.0 110.794 -179.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 50.8 tp -62.06 -47.45 84.64 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.586 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.604 HD22 ' N ' ' A' ' 174' ' ' ASN . 0.0 OUTLIER -176.37 82.51 0.27 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.389 -179.622 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -75.04 -14.72 20.96 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.727 1.618 . . . . 0.0 111.847 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 41.3 p -149.4 127.59 12.06 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.518 0.675 . . . . 0.0 110.906 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -116.96 -175.71 2.83 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.577 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 16.3 pt -113.12 133.59 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.117 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -127.62 166.52 17.9 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.511 0.672 . . . . 0.0 111.452 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 184' ' ' GLY . 46.0 t0 -80.05 106.3 11.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.921 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 96' ' ' VAL . . . -62.61 -18.63 62.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.502 -179.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.488 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.4 mm? -63.5 -41.15 98.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.841 0.353 . . . . 0.0 110.545 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.1 -43.38 2.33 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.395 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 180' ' ' ASP . . . 74.03 19.74 79.75 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -75.04 -167.99 0.69 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.004 0.43 . . . . 0.0 111.149 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.653 ' H ' ' CD2' ' A' ' 186' ' ' LEU . 0.8 OUTLIER -98.66 -179.93 4.47 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.233 179.875 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -101.02 45.23 0.98 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.679 0.276 . . . . 0.0 110.847 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -93.81 134.71 35.88 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.469 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -142.72 -16.25 0.71 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.5 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.73 0 CA-C-O 118.056 -1.414 . . . . 0.0 111.075 -179.836 . . . . . . . . 0 0 . 1 stop_ save_